1	Induction	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	cytokine	_	NN	NN	_	4	nn	_	_
4	expression	_	NN	NN	_	2	pobj	_	_
5	in	_	IN	IN	_	1	prep	_	_
6	leukocytes	_	NNS	NNS	_	5	pobj	_	_
7	by	_	IN	IN	_	1	prep	_	_
8	binding	_	NN	NN	_	7	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	thrombin-stimulated	_	JJ	JJ	_	11	amod	_	_
11	platelets	_	NNS	NNS	_	9	pobj	_	_
12	.	_	.	.	_	1	punct	_	_

1	BACKGROUND	_	NN	NN	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	Activated	_	VBN	VBN	_	4	amod	_	_
4	platelets	_	NNS	NNS	_	5	nsubj	_	_
5	tether	_	VBP	VBP	_	1	dep	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	activate	_	VBP	VBP	_	5	conj	_	_
8	myeloid	_	JJ	JJ	_	9	amod	_	_
9	leukocytes	_	NNS	NNS	_	5	dobj	_	_
10	.	_	.	.	_	5	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	investigate	_	VB	VB	_	0	root	_	_
3	the	_	DT	DT	_	5	det	_	_
4	potential	_	JJ	JJ	_	5	amod	_	_
5	relevance	_	NN	NN	_	2	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	this	_	DT	DT	_	8	det	_	_
8	mechanism	_	NN	NN	_	6	pobj	_	_
9	in	_	IN	IN	_	5	prep	_	_
10	acute	_	JJ	JJ	_	12	amod	_	_
11	myocardial	_	JJ	JJ	_	12	amod	_	_
12	infarction	_	NN	NN	_	9	pobj	_	_
13	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
14	AMI	_	NN	NN	_	12	appos	_	_
15	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	,	_	,	,	_	2	punct	_	_
17	we	_	PRP	PRP	_	18	nsubj	_	_
18	examined	_	VBD	VBD	_	2	parataxis	_	_
19	cytokine	_	NN	NN	_	20	nn	_	_
20	induction	_	NN	NN	_	18	dobj	_	_
21	by	_	IN	IN	_	20	prep	_	_
22	leukocyte-platelet	_	JJ	JJ	_	23	amod	_	_
23	adhesion	_	NN	NN	_	21	pobj	_	_
24	and	_	CC	CC	_	20	cc	_	_
25	the	_	DT	DT	_	26	det	_	_
26	occurrence	_	NN	NN	_	20	conj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	leukocyte-platelet	_	JJ	JJ	_	29	amod	_	_
29	conjugates	_	NNS	NNS	_	27	pobj	_	_
30	in	_	IN	IN	_	18	prep	_	_
31	patients	_	NNS	NNS	_	30	pobj	_	_
32	with	_	IN	IN	_	31	prep	_	_
33	AMI	_	NN	NN	_	32	pobj	_	_
34	.	_	.	.	_	2	punct	_	_

1	METHODS	_	NNS	NNS	_	0	root	_	_
2	AND	_	CC	CC	_	1	cc	_	_
3	RESULTS	_	NNS	NNS	_	1	conj	_	_
4	:	_	:	:	_	1	punct	_	_
5	We	_	PRP	PRP	_	1	dep	_	_
6	obtained	_	VBD	VBD	_	1	vmod	_	_
7	peripheral	_	JJ	JJ	_	10	amod	_	_
8	venous	_	JJ	JJ	_	10	amod	_	_
9	blood	_	NN	NN	_	10	nn	_	_
10	samples	_	NNS	NNS	_	6	dobj	_	_
11	in	_	IN	IN	_	6	prep	_	_
12	20	_	CD	CD	_	13	num	_	_
13	patients	_	NNS	NNS	_	11	pobj	_	_
14	with	_	IN	IN	_	13	prep	_	_
15	AMI	_	NN	NN	_	14	pobj	_	_
16	before	_	IN	IN	_	13	prep	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	daily	_	RB	RB	_	19	advmod	_	_
19	for	_	IN	IN	_	16	conj	_	_
20	5	_	CD	CD	_	21	num	_	_
21	days	_	NNS	NNS	_	19	pobj	_	_
22	after	_	IN	IN	_	21	prep	_	_
23	direct	_	JJ	JJ	_	27	amod	_	_
24	percutaneous	_	JJ	JJ	_	27	amod	_	_
25	transluminal	_	JJ	JJ	_	27	amod	_	_
26	coronary	_	JJ	JJ	_	27	amod	_	_
27	angioplasty	_	NN	NN	_	22	pobj	_	_
28	-LRB-	_	-LRB-	-LRB-	_	29	punct	_	_
29	PTCA	_	NN	NN	_	27	appos	_	_
30	-RRB-	_	-RRB-	-RRB-	_	29	punct	_	_
31	and	_	CC	CC	_	11	cc	_	_
32	in	_	IN	IN	_	11	conj	_	_
33	20	_	CD	CD	_	34	num	_	_
34	patients	_	NNS	NNS	_	32	pobj	_	_
35	undergoing	_	VBG	VBG	_	34	vmod	_	_
36	elective	_	JJ	JJ	_	37	amod	_	_
37	PTCA	_	NN	NN	_	35	dobj	_	_
38	.	_	.	.	_	1	punct	_	_

1	Throughout	_	IN	IN	_	14	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	study	_	NN	NN	_	4	nn	_	_
4	period	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	14	punct	_	_
6	CD41	_	NN	NN	_	7	nn	_	_
7	immunofluorescence	_	NN	NN	_	14	nsubj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	leukocytes	_	NNS	NNS	_	8	pobj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
11	flow	_	NN	NN	_	12	nn	_	_
12	cytometry	_	NN	NN	_	7	appos	_	_
13	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
14	revealed	_	VBD	VBD	_	0	root	_	_
15	increased	_	VBN	VBN	_	17	amod	_	_
16	leukocyte-platelet	_	JJ	JJ	_	17	amod	_	_
17	adhesion	_	NN	NN	_	14	dobj	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	patients	_	NNS	NNS	_	18	pobj	_	_
20	with	_	IN	IN	_	19	prep	_	_
21	AMI	_	NN	NN	_	20	pobj	_	_
22	compared	_	VBN	VBN	_	17	prep	_	_
23	with	_	IN	IN	_	22	pcomp	_	_
24	control	_	JJ	JJ	_	25	amod	_	_
25	patients	_	NNS	NNS	_	23	pobj	_	_
26	-LRB-	_	-LRB-	-LRB-	_	27	punct	_	_
27	mean	_	NN	NN	_	25	dep	_	_
28	+/-	_	CC	CC	_	27	cc	_	_
29	SE	_	NN	NN	_	27	conj	_	_
30	of	_	IN	IN	_	27	prep	_	_
31	fluorescence	_	NN	NN	_	30	pobj	_	_
32	-LSB-	_	-LRB-	-LRB-	_	33	punct	_	_
33	channels	_	NNS	NNS	_	27	appos	_	_
34	-RSB-	_	-RRB-	-RRB-	_	33	punct	_	_
35	before	_	IN	IN	_	27	prep	_	_
36	PTCA	_	NN	NN	_	35	pobj	_	_
37	:	_	:	:	_	27	punct	_	_
38	77	_	CD	CD	_	27	dep	_	_
39	+/-	_	CC	CC	_	38	cc	_	_
40	16	_	CD	CD	_	38	conj	_	_
41	versus	_	CC	CC	_	38	cc	_	_
42	35	_	CD	CD	_	38	conj	_	_
43	+/-	_	CC	CC	_	42	cc	_	_
44	9	_	CD	CD	_	42	conj	_	_
45	;	_	:	:	_	27	punct	_	_
46	P	_	NN	NN	_	27	dep	_	_
47	=	_	JJ	JJ	_	46	amod	_	_
48	.003	_	CD	CD	_	47	dep	_	_
49	-RRB-	_	-RRB-	-RRB-	_	27	punct	_	_
50	.	_	.	.	_	14	punct	_	_

1	In	_	FW	FW	_	2	nn	_	_
2	vitro	_	FW	FW	_	7	advmod	_	_
3	,	_	,	,	_	7	punct	_	_
4	thrombin-stimulated	_	JJ	JJ	_	6	amod	_	_
5	fixed	_	JJ	JJ	_	6	amod	_	_
6	platelets	_	NNS	NNS	_	7	nsubj	_	_
7	bound	_	VBD	VBD	_	0	root	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	neutrophils	_	NNS	NNS	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	monocytes	_	NNS	NNS	_	9	conj	_	_
12	.	_	.	.	_	7	punct	_	_

1	Within	_	IN	IN	_	6	prep	_	_
2	2	_	CD	CD	_	3	num	_	_
3	hours	_	NNS	NNS	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	this	_	DT	DT	_	6	nsubj	_	_
6	resulted	_	VBD	VBD	_	0	root	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	increased	_	VBN	VBN	_	9	amod	_	_
9	mRNA	_	NN	NN	_	7	pobj	_	_
10	for	_	IN	IN	_	9	prep	_	_
11	interleukin	_	NN	NN	_	17	nn	_	_
12	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
13	IL	_	NN	NN	_	17	nn	_	_
14	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
15	,	_	,	,	_	17	punct	_	_
16	1	_	CD	CD	_	17	num	_	_
17	beta	_	NN	NN	_	10	pobj	_	_
18	,	_	,	,	_	17	punct	_	_
19	IL-8	_	NN	NN	_	17	conj	_	_
20	,	_	,	,	_	17	punct	_	_
21	and	_	CC	CC	_	17	cc	_	_
22	monocyte	_	NN	NN	_	26	nn	_	_
23	chemoattractant	_	NN	NN	_	26	nn	_	_
24	protein	_	NN	NN	_	26	nn	_	_
25	-LRB-	_	-LRB-	-LRB-	_	26	punct	_	_
26	MCP	_	NN	NN	_	17	conj	_	_
27	-RRB-	_	-RRB-	-RRB-	_	26	punct	_	_
28	-1	_	CD	CD	_	26	num	_	_
29	in	_	IN	IN	_	9	prep	_	_
30	unfractionated	_	JJ	JJ	_	31	amod	_	_
31	leukocytes	_	NNS	NNS	_	29	pobj	_	_
32	.	_	.	.	_	6	punct	_	_

1	After	_	IN	IN	_	15	prep	_	_
2	4	_	CD	CD	_	3	num	_	_
3	hours	_	NNS	NNS	_	1	pobj	_	_
4	,	_	,	,	_	15	punct	_	_
5	IL-1	_	NN	NN	_	6	nn	_	_
6	beta	_	NN	NN	_	15	nsubj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	IL-8	_	NN	NN	_	6	conj	_	_
9	concentration	_	NN	NN	_	6	dep	_	_
10	of	_	IN	IN	_	6	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	cell-free	_	JJ	JJ	_	13	amod	_	_
13	supernatant	_	NN	NN	_	10	pobj	_	_
14	had	_	VBD	VBD	_	15	aux	_	_
15	increased	_	VBN	VBN	_	0	root	_	_
16	by	_	IN	IN	_	15	prep	_	_
17	268	_	CD	CD	_	20	num	_	_
18	+/-	_	CC	CC	_	17	cc	_	_
19	36	_	CD	CD	_	17	conj	_	_
20	%	_	NN	NN	_	16	pobj	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	210	_	CD	CD	_	25	num	_	_
23	+/-	_	CC	CC	_	22	cc	_	_
24	7	_	CD	CD	_	22	conj	_	_
25	%	_	NN	NN	_	20	conj	_	_
26	,	_	,	,	_	15	punct	_	_
27	respectively	_	RB	RB	_	15	advmod	_	_
28	,	_	,	,	_	15	punct	_	_
29	and	_	CC	CC	_	15	cc	_	_
30	cellular	_	JJ	JJ	_	32	amod	_	_
31	MCP-1	_	NN	NN	_	32	nn	_	_
32	content	_	NN	NN	_	34	nsubj	_	_
33	had	_	VBD	VBD	_	34	aux	_	_
34	increased	_	VBN	VBN	_	15	conj	_	_
35	by	_	IN	IN	_	34	prep	_	_
36	170	_	CD	CD	_	39	num	_	_
37	+/-	_	CC	CC	_	36	cc	_	_
38	8	_	CD	CD	_	36	conj	_	_
39	%	_	NN	NN	_	35	pobj	_	_
40	.	_	.	.	_	15	punct	_	_

1	Addition	_	NN	NN	_	8	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	activated	_	VBN	VBN	_	4	amod	_	_
4	platelets	_	NNS	NNS	_	2	pobj	_	_
5	to	_	TO	TO	_	1	prep	_	_
6	adherent	_	JJ	JJ	_	7	amod	_	_
7	monocytes	_	NNS	NNS	_	5	pobj	_	_
8	had	_	VBD	VBD	_	0	root	_	_
9	a	_	DT	DT	_	11	det	_	_
10	similar	_	JJ	JJ	_	11	amod	_	_
11	effect	_	NN	NN	_	8	dobj	_	_
12	and	_	CC	CC	_	8	cc	_	_
13	was	_	VBD	VBD	_	14	auxpass	_	_
14	associated	_	VBN	VBN	_	8	conj	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	nuclear	_	JJ	JJ	_	18	amod	_	_
17	factor-kappa	_	NN	NN	_	18	nn	_	_
18	B	_	NN	NN	_	19	nn	_	_
19	activation	_	NN	NN	_	15	pobj	_	_
20	.	_	.	.	_	8	punct	_	_

1	Inhibition	_	NN	NN	_	8	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	binding	_	NN	NN	_	2	pobj	_	_
4	by	_	IN	IN	_	1	prep	_	_
5	anti-P	_	JJ	JJ	_	7	amod	_	_
6	selectin	_	NN	NN	_	7	nn	_	_
7	antibodies	_	NNS	NNS	_	4	pobj	_	_
8	reduced	_	VBD	VBD	_	0	root	_	_
9	the	_	DT	DT	_	10	det	_	_
10	effect	_	NN	NN	_	8	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	activated	_	VBN	VBN	_	13	amod	_	_
13	platelets	_	NNS	NNS	_	11	pobj	_	_
14	on	_	IN	IN	_	10	prep	_	_
15	cytokine	_	NN	NN	_	16	nn	_	_
16	production	_	NN	NN	_	14	pobj	_	_
17	.	_	.	.	_	8	punct	_	_

1	CONCLUSIONS	_	NNS	NNS	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	In	_	IN	IN	_	11	prep	_	_
4	patients	_	NNS	NNS	_	3	pobj	_	_
5	with	_	IN	IN	_	4	prep	_	_
6	AMI	_	NN	NN	_	5	pobj	_	_
7	,	_	,	,	_	11	punct	_	_
8	leukocyte-platelet	_	JJ	JJ	_	9	amod	_	_
9	adhesion	_	NN	NN	_	11	nsubjpass	_	_
10	is	_	VBZ	VBZ	_	11	auxpass	_	_
11	increased	_	VBN	VBN	_	1	dep	_	_
12	.	_	.	.	_	1	punct	_	_

1	Binding	_	NN	NN	_	5	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	activated	_	VBN	VBN	_	4	amod	_	_
4	platelets	_	NNS	NNS	_	2	pobj	_	_
5	induces	_	VBZ	VBZ	_	0	root	_	_
6	IL-1	_	NN	NN	_	7	nn	_	_
7	beta	_	NN	NN	_	5	dobj	_	_
8	,	_	,	,	_	7	punct	_	_
9	IL-8	_	NN	NN	_	7	conj	_	_
10	,	_	,	,	_	7	punct	_	_
11	and	_	CC	CC	_	7	cc	_	_
12	MCP-1	_	NN	NN	_	7	conj	_	_
13	in	_	IN	IN	_	5	prep	_	_
14	leukocytes	_	NNS	NNS	_	13	pobj	_	_
15	.	_	.	.	_	5	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	findings	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	7	mark	_	_
5	leukocyte-platelet	_	JJ	JJ	_	6	amod	_	_
6	adhesion	_	NN	NN	_	7	nsubj	_	_
7	contributes	_	VBZ	VBZ	_	3	ccomp	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	regulation	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	inflammatory	_	JJ	JJ	_	13	amod	_	_
13	responses	_	NNS	NNS	_	11	pobj	_	_
14	in	_	IN	IN	_	10	prep	_	_
15	AMI	_	NN	NN	_	14	pobj	_	_
16	.	_	.	.	_	3	punct	_	_

1	Defective	_	JJ	JJ	_	2	amod	_	_
2	survival	_	NN	NN	_	0	root	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	activation	_	NN	NN	_	2	conj	_	_
5	of	_	IN	IN	_	2	prep	_	_
6	thymocytes	_	NNS	NNS	_	5	pobj	_	_
7	in	_	IN	IN	_	2	prep	_	_
8	transgenic	_	JJ	JJ	_	9	amod	_	_
9	mice	_	NNS	NNS	_	7	pobj	_	_
10	expressing	_	VBG	VBG	_	9	vmod	_	_
11	a	_	DT	DT	_	14	det	_	_
12	catalytically	_	RB	RB	_	14	advmod	_	_
13	inactive	_	JJ	JJ	_	14	amod	_	_
14	form	_	NN	NN	_	10	dobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	Ca2+/calmodulin-dependent	_	JJ	JJ	_	18	amod	_	_
17	protein	_	NN	NN	_	18	nn	_	_
18	kinase	_	NN	NN	_	15	pobj	_	_
19	IV	_	CD	CD	_	18	num	_	_
20	.	_	.	.	_	2	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	generated	_	VBN	VBN	_	0	root	_	_
4	transgenic	_	JJ	JJ	_	5	amod	_	_
5	mice	_	NNS	NNS	_	3	dobj	_	_
6	that	_	WDT	WDT	_	7	nsubj	_	_
7	express	_	VBP	VBP	_	5	rcmod	_	_
8	a	_	DT	DT	_	11	det	_	_
9	catalytically	_	RB	RB	_	11	advmod	_	_
10	inactive	_	JJ	JJ	_	11	amod	_	_
11	form	_	NN	NN	_	7	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	Ca2+/calmodulin-dependent	_	JJ	JJ	_	15	amod	_	_
14	protein	_	NN	NN	_	15	nn	_	_
15	kinase	_	NN	NN	_	12	pobj	_	_
16	IV	_	CD	CD	_	15	num	_	_
17	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	CaMKIV	_	NN	NN	_	15	appos	_	_
19	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
20	specifically	_	RB	RB	_	21	advmod	_	_
21	in	_	IN	IN	_	7	prep	_	_
22	thymic	_	JJ	JJ	_	24	amod	_	_
23	T	_	NN	NN	_	24	nn	_	_
24	cells	_	NNS	NNS	_	21	pobj	_	_
25	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	presence	_	NN	NN	_	6	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	this	_	DT	DT	_	5	det	_	_
5	protein	_	NN	NN	_	3	pobj	_	_
6	results	_	VBZ	VBZ	_	0	root	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	a	_	DT	DT	_	12	det	_	_
9	markedly	_	RB	RB	_	10	advmod	_	_
10	reduced	_	VBN	VBN	_	12	amod	_	_
11	thymic	_	JJ	JJ	_	12	amod	_	_
12	cellularity	_	NN	NN	_	7	pobj	_	_
13	,	_	,	,	_	6	punct	_	_
14	although	_	IN	IN	_	22	mark	_	_
15	the	_	DT	DT	_	16	det	_	_
16	distribution	_	NN	NN	_	22	nsubj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	remaining	_	VBG	VBG	_	20	amod	_	_
20	cells	_	NNS	NNS	_	17	pobj	_	_
21	is	_	VBZ	VBZ	_	22	cop	_	_
22	normal	_	JJ	JJ	_	6	advcl	_	_
23	based	_	VBN	VBN	_	22	prep	_	_
24	on	_	IN	IN	_	23	pcomp	_	_
25	evaluation	_	NN	NN	_	24	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	28	dep	_	_
28	CD4	_	NN	NN	_	26	pobj	_	_
29	and	_	CC	CC	_	28	cc	_	_
30	CD8	_	NN	NN	_	28	conj	_	_
31	cell	_	NN	NN	_	33	nn	_	_
32	surface	_	NN	NN	_	33	nn	_	_
33	antigens	_	NNS	NNS	_	28	dep	_	_
34	that	_	WDT	WDT	_	36	nsubjpass	_	_
35	are	_	VBP	VBP	_	36	auxpass	_	_
36	used	_	VBN	VBN	_	28	rcmod	_	_
37	to	_	TO	TO	_	38	aux	_	_
38	gauge	_	VB	VB	_	36	xcomp	_	_
39	T	_	NN	NN	_	41	nn	_	_
40	cell	_	NN	NN	_	41	nn	_	_
41	development	_	NN	NN	_	38	dobj	_	_
42	.	_	.	.	_	6	punct	_	_

1	Isolated	_	VBN	VBN	_	4	amod	_	_
2	thymic	_	JJ	JJ	_	4	amod	_	_
3	T	_	NN	NN	_	4	nn	_	_
4	cells	_	NNS	NNS	_	10	nsubj	_	_
5	from	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	transgenic	_	JJ	JJ	_	8	amod	_	_
8	mice	_	NNS	NNS	_	5	pobj	_	_
9	also	_	RB	RB	_	10	advmod	_	_
10	show	_	VBP	VBP	_	0	root	_	_
11	a	_	DT	DT	_	15	det	_	_
12	dramatically	_	RB	RB	_	13	advmod	_	_
13	decreased	_	VBN	VBN	_	15	amod	_	_
14	survival	_	NN	NN	_	15	nn	_	_
15	rate	_	NN	NN	_	10	dobj	_	_
16	when	_	WRB	WRB	_	17	advmod	_	_
17	evaluated	_	VBN	VBN	_	10	advcl	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	culture	_	NN	NN	_	18	pobj	_	_
20	under	_	IN	IN	_	19	prep	_	_
21	conditions	_	NNS	NNS	_	20	pobj	_	_
22	that	_	WDT	WDT	_	25	nsubj	_	_
23	do	_	VBP	VBP	_	25	aux	_	_
24	not	_	RB	RB	_	25	neg	_	_
25	favor	_	VB	VB	_	21	rcmod	_	_
26	activation	_	NN	NN	_	25	dobj	_	_
27	.	_	.	.	_	10	punct	_	_

1	When	_	WRB	WRB	_	2	advmod	_	_
2	challenged	_	VBN	VBN	_	23	advcl	_	_
3	with	_	IN	IN	_	2	prep	_	_
4	an	_	DT	DT	_	6	det	_	_
5	activating	_	VBG	VBG	_	6	amod	_	_
6	stimulus	_	NN	NN	_	3	pobj	_	_
7	such	_	JJ	JJ	_	8	mwe	_	_
8	as	_	IN	IN	_	6	prep	_	_
9	alpha-CD3	_	NN	NN	_	8	pobj	_	_
10	or	_	CC	CC	_	9	cc	_	_
11	a	_	DT	DT	_	12	det	_	_
12	combination	_	NN	NN	_	9	conj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	phorbol	_	NN	NN	_	15	nn	_	_
15	ester	_	NN	NN	_	13	pobj	_	_
16	plus	_	CC	CC	_	15	cc	_	_
17	ionophore	_	NN	NN	_	15	conj	_	_
18	,	_	,	,	_	23	punct	_	_
19	the	_	DT	DT	_	20	det	_	_
20	cells	_	NNS	NNS	_	23	nsubjpass	_	_
21	are	_	VBP	VBP	_	23	auxpass	_	_
22	severely	_	RB	RB	_	23	advmod	_	_
23	compromised	_	VBN	VBN	_	0	root	_	_
24	in	_	IN	IN	_	23	prep	_	_
25	their	_	PRP$	PRP$	_	26	poss	_	_
26	ability	_	NN	NN	_	24	pobj	_	_
27	to	_	TO	TO	_	28	aux	_	_
28	produce	_	VB	VB	_	26	vmod	_	_
29	the	_	DT	DT	_	30	det	_	_
30	cytokine	_	NN	NN	_	28	dobj	_	_
31	interleukin-2	_	NN	NN	_	30	dep	_	_
32	-LRB-	_	-LRB-	-LRB-	_	33	punct	_	_
33	IL-2	_	NN	NN	_	31	appos	_	_
34	-RRB-	_	-RRB-	-RRB-	_	33	punct	_	_
35	.	_	.	.	_	23	punct	_	_

1	Reduction	_	NN	NN	_	6	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	IL-2	_	NN	NN	_	4	nn	_	_
4	production	_	NN	NN	_	2	pobj	_	_
5	is	_	VBZ	VBZ	_	6	cop	_	_
6	secondary	_	JJ	JJ	_	0	root	_	_
7	to	_	TO	TO	_	6	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	inability	_	NN	NN	_	7	pobj	_	_
10	to	_	TO	TO	_	11	aux	_	_
11	phosphorylate	_	VB	VB	_	9	vmod	_	_
12	the	_	DT	DT	_	17	det	_	_
13	cAMP	_	NN	NN	_	17	nn	_	_
14	response	_	NN	NN	_	17	nn	_	_
15	element	_	NN	NN	_	17	nn	_	_
16	binding	_	NN	NN	_	17	nn	_	_
17	protein	_	NN	NN	_	11	dobj	_	_
18	,	_	,	,	_	17	punct	_	_
19	CREB	_	NN	NN	_	17	appos	_	_
20	,	_	,	,	_	11	punct	_	_
21	and	_	CC	CC	_	11	cc	_	_
22	induce	_	VBP	VBP	_	11	conj	_	_
23	expression	_	NN	NN	_	22	dobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	the	_	DT	DT	_	28	det	_	_
26	immediate	_	JJ	JJ	_	28	amod	_	_
27	early	_	JJ	JJ	_	28	amod	_	_
28	genes	_	NNS	NNS	_	24	pobj	_	_
29	such	_	JJ	JJ	_	30	mwe	_	_
30	as	_	IN	IN	_	28	prep	_	_
31	Fos	_	NN	NN	_	32	nn	_	_
32	B	_	NN	NN	_	30	pobj	_	_
33	that	_	WDT	WDT	_	35	nsubjpass	_	_
34	are	_	VBP	VBP	_	35	auxpass	_	_
35	required	_	VBN	VBN	_	28	rcmod	_	_
36	to	_	TO	TO	_	37	aux	_	_
37	transactivate	_	VB	VB	_	35	xcomp	_	_
38	the	_	DT	DT	_	40	det	_	_
39	IL-2	_	NN	NN	_	40	nn	_	_
40	promoter	_	NN	NN	_	37	dobj	_	_
41	.	_	.	.	_	6	punct	_	_

1	Because	_	IN	IN	_	5	mark	_	_
2	transgene	_	NN	NN	_	3	nn	_	_
3	expression	_	NN	NN	_	5	nsubjpass	_	_
4	was	_	VBD	VBD	_	5	auxpass	_	_
5	regulated	_	VBN	VBN	_	33	advcl	_	_
6	by	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	proximal	_	JJ	JJ	_	9	amod	_	_
9	promoter	_	NN	NN	_	6	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	14	det	_	_
12	murine	_	JJ	JJ	_	14	amod	_	_
13	lck	_	NN	NN	_	14	nn	_	_
14	gene	_	NN	NN	_	10	pobj	_	_
15	and	_	CC	CC	_	5	cc	_	_
16	this	_	DT	DT	_	17	det	_	_
17	promoter	_	NN	NN	_	19	nsubjpass	_	_
18	is	_	VBZ	VBZ	_	19	auxpass	_	_
19	inactivated	_	VBN	VBN	_	5	conj	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	T	_	NN	NN	_	22	nn	_	_
22	cells	_	NNS	NNS	_	20	pobj	_	_
23	that	_	WDT	WDT	_	24	nsubj	_	_
24	exit	_	VBP	VBP	_	22	rcmod	_	_
25	the	_	DT	DT	_	26	det	_	_
26	thymus	_	NN	NN	_	24	dobj	_	_
27	,	_	,	,	_	33	punct	_	_
28	the	_	DT	DT	_	30	det	_	_
29	mutant	_	JJ	JJ	_	30	amod	_	_
30	hCaMKIV	_	NN	NN	_	33	nsubj	_	_
31	is	_	VBZ	VBZ	_	33	cop	_	_
32	not	_	RB	RB	_	33	neg	_	_
33	present	_	JJ	JJ	_	0	root	_	_
34	in	_	IN	IN	_	33	prep	_	_
35	peripheral	_	JJ	JJ	_	37	amod	_	_
36	T	_	NN	NN	_	37	nn	_	_
37	cells	_	NNS	NNS	_	34	pobj	_	_
38	.	_	.	.	_	33	punct	_	_

1	Consequently	_	RB	RB	_	11	advmod	_	_
2	,	_	,	,	_	11	punct	_	_
3	T	_	NN	NN	_	4	nn	_	_
4	lymphocytes	_	NNS	NNS	_	11	nsubjpass	_	_
5	present	_	JJ	JJ	_	4	amod	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	spleen	_	NN	NN	_	6	pobj	_	_
9	can	_	MD	MD	_	11	aux	_	_
10	be	_	VB	VB	_	11	auxpass	_	_
11	activated	_	VBN	VBN	_	0	root	_	_
12	normally	_	RB	RB	_	11	advmod	_	_
13	in	_	IN	IN	_	11	prep	_	_
14	response	_	NN	NN	_	13	pobj	_	_
15	to	_	TO	TO	_	14	prep	_	_
16	either	_	DT	DT	_	17	det	_	_
17	stimulus	_	NN	NN	_	15	pobj	_	_
18	mentioned	_	VBN	VBN	_	17	vmod	_	_
19	above	_	RB	RB	_	18	advmod	_	_
20	,	_	,	,	_	11	punct	_	_
21	demonstrating	_	VBG	VBG	_	11	vmod	_	_
22	that	_	IN	IN	_	32	mark	_	_
23	the	_	DT	DT	_	24	det	_	_
24	effects	_	NNS	NNS	_	32	nsubj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	28	det	_	_
27	inactive	_	JJ	JJ	_	28	amod	_	_
28	CaMKIV	_	NN	NN	_	25	pobj	_	_
29	on	_	IN	IN	_	24	prep	_	_
30	activation	_	NN	NN	_	29	pobj	_	_
31	are	_	VBP	VBP	_	32	cop	_	_
32	reversible	_	JJ	JJ	_	21	ccomp	_	_
33	.	_	.	.	_	11	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	7	mark	_	_
5	CaMKIV	_	NN	NN	_	7	nsubj	_	_
6	may	_	MD	MD	_	7	aux	_	_
7	represent	_	VB	VB	_	3	ccomp	_	_
8	a	_	DT	DT	_	12	det	_	_
9	physiologically	_	RB	RB	_	10	advmod	_	_
10	relevant	_	JJ	JJ	_	12	amod	_	_
11	CREB	_	NN	NN	_	12	nn	_	_
12	kinase	_	NN	NN	_	7	dobj	_	_
13	in	_	IN	IN	_	7	prep	_	_
14	T	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	13	pobj	_	_
16	and	_	CC	CC	_	7	cc	_	_
17	that	_	IN	IN	_	22	mark	_	_
18	the	_	DT	DT	_	19	det	_	_
19	enzyme	_	NN	NN	_	22	nsubjpass	_	_
20	is	_	VBZ	VBZ	_	22	auxpass	_	_
21	also	_	RB	RB	_	22	advmod	_	_
22	required	_	VBN	VBN	_	7	conj	_	_
23	to	_	TO	TO	_	24	aux	_	_
24	ensure	_	VB	VB	_	22	xcomp	_	_
25	normal	_	JJ	JJ	_	26	amod	_	_
26	expansion	_	NN	NN	_	24	dobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	T	_	NN	NN	_	29	nn	_	_
29	cells	_	NNS	NNS	_	27	pobj	_	_
30	in	_	IN	IN	_	26	prep	_	_
31	the	_	DT	DT	_	32	det	_	_
32	thymus	_	NN	NN	_	30	pobj	_	_
33	.	_	.	.	_	3	punct	_	_

1	Whereas	_	IN	IN	_	9	mark	_	_
2	the	_	DT	DT	_	3	det	_	_
3	pathway	_	NN	NN	_	9	nsubj	_	_
4	responsible	_	JJ	JJ	_	3	amod	_	_
5	for	_	IN	IN	_	4	prep	_	_
6	this	_	DT	DT	_	8	det	_	_
7	latter	_	JJ	JJ	_	8	amod	_	_
8	role	_	NN	NN	_	5	pobj	_	_
9	is	_	VBZ	VBZ	_	17	advcl	_	_
10	yet	_	RB	RB	_	9	advmod	_	_
11	to	_	TO	TO	_	13	aux	_	_
12	be	_	VB	VB	_	13	auxpass	_	_
13	elucidated	_	VBN	VBN	_	9	xcomp	_	_
14	,	_	,	,	_	17	punct	_	_
15	it	_	PRP	PRP	_	17	nsubj	_	_
16	is	_	VBZ	VBZ	_	17	cop	_	_
17	unlikely	_	JJ	JJ	_	0	root	_	_
18	to	_	TO	TO	_	19	aux	_	_
19	include	_	VB	VB	_	17	xcomp	_	_
20	CREB	_	NN	NN	_	21	nn	_	_
21	phosphorylation	_	NN	NN	_	19	dobj	_	_
22	.	_	.	.	_	17	punct	_	_

1	The	_	DT	DT	_	5	det	_	_
2	class	_	NN	NN	_	5	nn	_	_
3	II	_	CD	CD	_	5	num	_	_
4	trans-activator	_	NN	NN	_	5	nn	_	_
5	CIITA	_	NN	NN	_	6	nsubj	_	_
6	interacts	_	VBZ	VBZ	_	0	root	_	_
7	with	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	11	det	_	_
9	TBP-associated	_	JJ	JJ	_	11	amod	_	_
10	factor	_	NN	NN	_	11	nn	_	_
11	TAFII32	_	NN	NN	_	7	pobj	_	_
12	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	class	_	NN	NN	_	4	nn	_	_
3	II	_	CD	CD	_	4	num	_	_
4	trans-activator	_	NN	NN	_	12	nsubj	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	CIITA	_	NN	NN	_	4	appos	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	is	_	VBZ	VBZ	_	12	cop	_	_
9	the	_	DT	DT	_	12	det	_	_
10	main	_	JJ	JJ	_	12	amod	_	_
11	transcriptional	_	JJ	JJ	_	12	amod	_	_
12	co-activator	_	NN	NN	_	0	root	_	_
13	for	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	expression	_	NN	NN	_	13	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	MHC	_	NN	NN	_	20	nn	_	_
18	class	_	NN	NN	_	20	nn	_	_
19	II	_	CD	CD	_	20	num	_	_
20	proteins	_	NNS	NNS	_	16	pobj	_	_
21	.	_	.	.	_	12	punct	_	_

1	Its	_	PRP$	PRP$	_	5	poss	_	_
2	N-terminal	_	JJ	JJ	_	5	amod	_	_
3	125	_	CD	CD	_	5	num	_	_
4	amino	_	NN	NN	_	5	nn	_	_
5	acids	_	NNS	NNS	_	6	nsubj	_	_
6	function	_	VBP	VBP	_	0	root	_	_
7	as	_	IN	IN	_	6	prep	_	_
8	an	_	DT	DT	_	12	det	_	_
9	independent	_	JJ	JJ	_	12	amod	_	_
10	transcriptional	_	JJ	JJ	_	12	amod	_	_
11	activation	_	NN	NN	_	12	nn	_	_
12	domain	_	NN	NN	_	7	pobj	_	_
13	.	_	.	.	_	6	punct	_	_

1	Analyses	_	NNS	NNS	_	12	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	7	det	_	_
4	primary	_	JJ	JJ	_	7	amod	_	_
5	amino	_	NN	NN	_	7	nn	_	_
6	acid	_	NN	NN	_	7	nn	_	_
7	sequence	_	NN	NN	_	2	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	activation	_	NN	NN	_	11	nn	_	_
11	domain	_	NN	NN	_	8	pobj	_	_
12	predict	_	VBP	VBP	_	0	root	_	_
13	the	_	DT	DT	_	14	det	_	_
14	presence	_	NN	NN	_	12	dobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	three	_	CD	CD	_	17	num	_	_
17	alpha-helices	_	NNS	NNS	_	15	pobj	_	_
18	,	_	,	,	_	12	punct	_	_
19	each	_	DT	DT	_	12	dep	_	_
20	with	_	IN	IN	_	19	dep	_	_
21	a	_	DT	DT	_	23	det	_	_
22	high	_	JJ	JJ	_	23	amod	_	_
23	proportion	_	NN	NN	_	20	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	acidic	_	JJ	JJ	_	26	amod	_	_
26	residues	_	NNS	NNS	_	24	pobj	_	_
27	.	_	.	.	_	12	punct	_	_

1	Using	_	VBG	VBG	_	0	root	_	_
2	site-directed	_	JJ	JJ	_	3	amod	_	_
3	mutagenesis	_	NN	NN	_	1	dobj	_	_
4	,	_	,	,	_	1	punct	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	found	_	VBD	VBD	_	1	parataxis	_	_
7	that	_	IN	IN	_	14	mark	_	_
8	two	_	CD	CD	_	14	nsubjpass	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	these	_	DT	DT	_	12	det	_	_
11	predicted	_	VBN	VBN	_	12	amod	_	_
12	alpha-helices	_	NNS	NNS	_	9	pobj	_	_
13	are	_	VBP	VBP	_	14	auxpass	_	_
14	required	_	VBN	VBN	_	6	ccomp	_	_
15	for	_	IN	IN	_	14	prep	_	_
16	full	_	JJ	JJ	_	18	amod	_	_
17	transcriptional	_	JJ	JJ	_	16	dep	_	_
18	activation	_	NN	NN	_	15	pobj	_	_
19	by	_	IN	IN	_	18	prep	_	_
20	CIITA	_	NN	NN	_	19	pobj	_	_
21	.	_	.	.	_	1	punct	_	_

1	Moreover	_	RB	RB	_	14	advmod	_	_
2	,	_	,	,	_	14	punct	_	_
3	a	_	DT	DT	_	5	det	_	_
4	CIITA	_	NN	NN	_	5	nn	_	_
5	protein	_	NN	NN	_	14	nsubj	_	_
6	in	_	IN	IN	_	13	prep	_	_
7	which	_	WDT	WDT	_	6	pobj	_	_
8	both	_	DT	DT	_	10	det	_	_
9	functional	_	JJ	JJ	_	10	amod	_	_
10	alpha-helices	_	NNS	NNS	_	13	nsubjpass	_	_
11	have	_	VBP	VBP	_	13	aux	_	_
12	been	_	VBN	VBN	_	13	auxpass	_	_
13	deleted	_	VBN	VBN	_	5	rcmod	_	_
14	displays	_	VBZ	VBZ	_	0	root	_	_
15	a	_	DT	DT	_	18	det	_	_
16	dominant	_	JJ	JJ	_	18	amod	_	_
17	negative	_	JJ	JJ	_	18	amod	_	_
18	phenotype	_	NN	NN	_	14	dobj	_	_
19	.	_	.	.	_	14	punct	_	_

1	This	_	DT	DT	_	3	det	_	_
2	activation	_	NN	NN	_	3	nn	_	_
3	domain	_	NN	NN	_	6	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	CIITA	_	NN	NN	_	4	pobj	_	_
6	interacts	_	VBZ	VBZ	_	0	root	_	_
7	with	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	11	det	_	_
9	32	_	CD	CD	_	11	num	_	_
10	kDa	_	NN	NN	_	11	nn	_	_
11	subunit	_	NN	NN	_	7	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	16	det	_	_
14	general	_	JJ	JJ	_	16	amod	_	_
15	transcription	_	NN	NN	_	16	nn	_	_
16	complex	_	NN	NN	_	12	pobj	_	_
17	TFIID	_	NN	NN	_	16	dep	_	_
18	,	_	,	,	_	11	punct	_	_
19	TAFII32	_	NN	NN	_	11	appos	_	_
20	.	_	.	.	_	6	punct	_	_

1	Decreased	_	VBN	VBN	_	3	amod	_	_
2	transcriptional	_	JJ	JJ	_	3	amod	_	_
3	activation	_	NN	NN	_	10	nsubjpass	_	_
4	by	_	IN	IN	_	3	prep	_	_
5	N-terminal	_	JJ	JJ	_	6	amod	_	_
6	deletions	_	NNS	NNS	_	4	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	CIITA	_	NN	NN	_	7	pobj	_	_
9	is	_	VBZ	VBZ	_	10	auxpass	_	_
10	correlated	_	VBN	VBN	_	0	root	_	_
11	directly	_	RB	RB	_	10	advmod	_	_
12	with	_	IN	IN	_	10	prep	_	_
13	their	_	PRP$	PRP$	_	15	poss	_	_
14	reduced	_	VBN	VBN	_	15	amod	_	_
15	binding	_	NN	NN	_	12	pobj	_	_
16	to	_	TO	TO	_	15	prep	_	_
17	TAFII32	_	NN	NN	_	16	pobj	_	_
18	.	_	.	.	_	10	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	conclude	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	10	mark	_	_
4	interactions	_	NNS	NNS	_	10	nsubj	_	_
5	between	_	IN	IN	_	4	prep	_	_
6	TAFII32	_	NN	NN	_	5	pobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	CIITA	_	NN	NN	_	6	conj	_	_
9	are	_	VBP	VBP	_	10	cop	_	_
10	responsible	_	JJ	JJ	_	2	ccomp	_	_
11	for	_	IN	IN	_	10	prep	_	_
12	activation	_	NN	NN	_	11	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	class	_	NN	NN	_	16	nn	_	_
15	II	_	CD	CD	_	16	num	_	_
16	genes	_	NNS	NNS	_	13	pobj	_	_
17	.	_	.	.	_	2	punct	_	_

1	Specific	_	JJ	JJ	_	3	amod	_	_
2	complex	_	NN	NN	_	3	nn	_	_
3	formation	_	NN	NN	_	0	root	_	_
4	between	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	11	det	_	_
6	type	_	NN	NN	_	11	nn	_	_
7	II	_	CD	CD	_	11	num	_	_
8	bare	_	JJ	JJ	_	11	amod	_	_
9	lymphocyte	_	NN	NN	_	11	nn	_	_
10	syndrome-associated	_	JJ	JJ	_	11	amod	_	_
11	transactivators	_	NNS	NNS	_	4	pobj	_	_
12	CIITA	_	NN	NN	_	11	dep	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	RFX5	_	NN	NN	_	12	conj	_	_
15	.	_	.	.	_	3	punct	_	_

1	Two	_	CD	CD	_	25	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	4	det	_	_
4	genes	_	NNS	NNS	_	2	pobj	_	_
5	defective	_	JJ	JJ	_	1	amod	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	10	det	_	_
8	five	_	CD	CD	_	10	num	_	_
9	complementation	_	NN	NN	_	10	nn	_	_
10	groups	_	NNS	NNS	_	6	pobj	_	_
11	identified	_	VBN	VBN	_	1	vmod	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	18	det	_	_
14	class	_	NN	NN	_	18	nn	_	_
15	II-negative	_	JJ	JJ	_	18	amod	_	_
16	bare	_	JJ	JJ	_	18	amod	_	_
17	lymphocyte	_	NN	NN	_	18	nn	_	_
18	syndrome	_	NN	NN	_	12	pobj	_	_
19	or	_	CC	CC	_	1	cc	_	_
20	corresponding	_	JJ	JJ	_	22	amod	_	_
21	laboratory	_	JJ	JJ	_	22	amod	_	_
22	mutants	_	NNS	NNS	_	1	conj	_	_
23	have	_	VBP	VBP	_	25	aux	_	_
24	been	_	VBN	VBN	_	25	auxpass	_	_
25	cloned	_	VBN	VBN	_	0	root	_	_
26	.	_	.	.	_	25	punct	_	_

1	One	_	CD	CD	_	2	num	_	_
2	gene	_	NN	NN	_	3	nsubj	_	_
3	encodes	_	VBZ	VBZ	_	0	root	_	_
4	a	_	DT	DT	_	5	det	_	_
5	protein	_	NN	NN	_	3	dobj	_	_
6	,	_	,	,	_	5	punct	_	_
7	RFX5	_	NN	NN	_	5	appos	_	_
8	,	_	,	,	_	5	punct	_	_
9	that	_	WDT	WDT	_	12	nsubj	_	_
10	is	_	VBZ	VBZ	_	12	cop	_	_
11	a	_	DT	DT	_	12	det	_	_
12	member	_	NN	NN	_	5	rcmod	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	20	det	_	_
15	RFX	_	NN	NN	_	20	nn	_	_
16	family	_	NN	NN	_	20	nn	_	_
17	of	_	IN	IN	_	20	amod	_	_
18	DNA	_	NN	NN	_	20	nn	_	_
19	binding	_	NN	NN	_	20	nn	_	_
20	proteins	_	NNS	NNS	_	13	pobj	_	_
21	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	other	_	JJ	JJ	_	6	nsubj	_	_
3	,	_	,	,	_	2	punct	_	_
4	CIITA	_	NN	NN	_	2	appos	_	_
5	,	_	,	,	_	2	punct	_	_
6	encodes	_	VBZ	VBZ	_	0	root	_	_
7	a	_	DT	DT	_	9	det	_	_
8	large	_	JJ	JJ	_	9	amod	_	_
9	protein	_	NN	NN	_	6	dobj	_	_
10	with	_	IN	IN	_	9	prep	_	_
11	a	_	DT	DT	_	16	det	_	_
12	defined	_	VBN	VBN	_	16	amod	_	_
13	acidic	_	JJ	JJ	_	16	amod	_	_
14	transcriptional	_	JJ	JJ	_	16	amod	_	_
15	activation	_	NN	NN	_	16	nn	_	_
16	domain	_	NN	NN	_	10	pobj	_	_
17	;	_	:	:	_	6	punct	_	_
18	this	_	DT	DT	_	19	det	_	_
19	protein	_	NN	NN	_	22	nsubj	_	_
20	does	_	VBZ	VBZ	_	22	aux	_	_
21	not	_	RB	RB	_	22	neg	_	_
22	interact	_	VB	VB	_	6	parataxis	_	_
23	with	_	IN	IN	_	22	prep	_	_
24	DNA	_	NN	NN	_	23	pobj	_	_
25	.	_	.	.	_	6	punct	_	_

1	Expression	_	NN	NN	_	2	nn	_	_
2	plasmids	_	NNS	NNS	_	14	nsubj	_	_
3	encoding	_	VBG	VBG	_	2	vmod	_	_
4	regions	_	NNS	NNS	_	3	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	RFX5	_	NN	NN	_	5	pobj	_	_
7	fused	_	VBN	VBN	_	4	vmod	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	the	_	DT	DT	_	13	det	_	_
10	GAL4	_	NN	NN	_	13	nn	_	_
11	DNA	_	NN	NN	_	13	nn	_	_
12	binding	_	NN	NN	_	13	nn	_	_
13	domain	_	NN	NN	_	8	pobj	_	_
14	activated	_	VBD	VBD	_	0	root	_	_
15	transcription	_	NN	NN	_	14	dobj	_	_
16	from	_	IN	IN	_	14	prep	_	_
17	a	_	DT	DT	_	19	det	_	_
18	reporter	_	NN	NN	_	19	nn	_	_
19	construct	_	NN	NN	_	16	pobj	_	_
20	containing	_	VBG	VBG	_	19	vmod	_	_
21	GAL4	_	NN	NN	_	22	nn	_	_
22	sites	_	NNS	NNS	_	20	dobj	_	_
23	in	_	IN	IN	_	14	prep	_	_
24	a	_	DT	DT	_	26	det	_	_
25	cotransfection	_	NN	NN	_	26	nn	_	_
26	assay	_	NN	NN	_	23	pobj	_	_
27	in	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	33	det	_	_
29	Raji	_	NN	NN	_	33	nn	_	_
30	human	_	JJ	JJ	_	33	amod	_	_
31	B	_	NN	NN	_	33	nn	_	_
32	cell	_	NN	NN	_	33	nn	_	_
33	line	_	NN	NN	_	27	pobj	_	_
34	.	_	.	.	_	14	punct	_	_

1	However	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	these	_	DT	DT	_	4	det	_	_
4	plasmids	_	NNS	NNS	_	5	nsubj	_	_
5	produced	_	VBD	VBD	_	0	root	_	_
6	transcriptional	_	JJ	JJ	_	7	amod	_	_
7	activity	_	NN	NN	_	5	dobj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	HeLa	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	8	pobj	_	_
11	only	_	RB	RB	_	12	advmod	_	_
12	in	_	IN	IN	_	5	prep	_	_
13	conjunction	_	NN	NN	_	12	pobj	_	_
14	with	_	IN	IN	_	13	prep	_	_
15	interferon	_	NN	NN	_	16	nn	_	_
16	gamma	_	NN	NN	_	17	nn	_	_
17	stimulation	_	NN	NN	_	14	pobj	_	_
18	,	_	,	,	_	13	punct	_	_
19	a	_	DT	DT	_	20	det	_	_
20	condition	_	NN	NN	_	13	appos	_	_
21	in	_	IN	IN	_	36	prep	_	_
22	which	_	WDT	WDT	_	21	pobj	_	_
23	expression	_	NN	NN	_	36	nsubjpass	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	both	_	CC	CC	_	26	preconj	_	_
26	CIITA	_	NN	NN	_	24	pobj	_	_
27	and	_	CC	CC	_	26	cc	_	_
28	class	_	NN	NN	_	34	nn	_	_
29	II	_	CD	CD	_	34	num	_	_
30	major	_	JJ	JJ	_	34	amod	_	_
31	histocompatibility	_	NN	NN	_	34	nn	_	_
32	complex	_	NN	NN	_	34	nn	_	_
33	surface	_	NN	NN	_	34	nn	_	_
34	proteins	_	NNS	NNS	_	26	conj	_	_
35	are	_	VBP	VBP	_	36	auxpass	_	_
36	induced.	_	VBN	VBN	_	20	rcmod	_	_

1	Furthermore	_	RB	RB	_	7	advmod	_	_
2	,	_	,	,	_	7	punct	_	_
3	these	_	DT	DT	_	4	det	_	_
4	plasmids	_	NNS	NNS	_	7	nsubj	_	_
5	were	_	VBD	VBD	_	7	cop	_	_
6	not	_	RB	RB	_	7	neg	_	_
7	active	_	JJ	JJ	_	0	root	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	RJ2.2.5	_	NN	NN	_	8	pobj	_	_
10	,	_	,	,	_	9	punct	_	_
11	an	_	DT	DT	_	15	det	_	_
12	in	_	FW	FW	_	13	nn	_	_
13	vitro	_	FW	FW	_	14	advmod	_	_
14	mutagenized	_	VBN	VBN	_	15	amod	_	_
15	derivative	_	NN	NN	_	9	appos	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	Raji	_	NN	NN	_	16	pobj	_	_
18	in	_	IN	IN	_	25	prep	_	_
19	which	_	WDT	WDT	_	18	pobj	_	_
20	both	_	DT	DT	_	21	det	_	_
21	copies	_	NNS	NNS	_	25	nsubj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	CIITA	_	NN	NN	_	22	pobj	_	_
24	are	_	VBP	VBP	_	25	cop	_	_
25	defective	_	JJ	JJ	_	15	rcmod	_	_
26	.	_	.	.	_	7	punct	_	_

1	Transcriptional	_	JJ	JJ	_	2	amod	_	_
2	activation	_	NN	NN	_	10	nsubjpass	_	_
3	by	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	7	det	_	_
5	RFX5	_	NN	NN	_	7	nn	_	_
6	fusion	_	NN	NN	_	7	nn	_	_
7	protein	_	NN	NN	_	3	pobj	_	_
8	could	_	MD	MD	_	10	aux	_	_
9	be	_	VB	VB	_	10	auxpass	_	_
10	restored	_	VBN	VBN	_	0	root	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	RJ2.2.5	_	NN	NN	_	11	pobj	_	_
13	by	_	IN	IN	_	10	prep	_	_
14	cotransfection	_	NN	NN	_	13	pobj	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	a	_	DT	DT	_	19	det	_	_
17	CIITA	_	NN	NN	_	19	nn	_	_
18	expression	_	NN	NN	_	19	nn	_	_
19	plasmid	_	NN	NN	_	15	pobj	_	_
20	.	_	.	.	_	10	punct	_	_

1	Finally	_	RB	RB	_	11	advmod	_	_
2	,	_	,	,	_	11	punct	_	_
3	a	_	DT	DT	_	5	det	_	_
4	direct	_	JJ	JJ	_	5	amod	_	_
5	interaction	_	NN	NN	_	11	nsubjpass	_	_
6	between	_	IN	IN	_	5	prep	_	_
7	RFX5	_	NN	NN	_	6	pobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	CIITA	_	NN	NN	_	7	conj	_	_
10	was	_	VBD	VBD	_	11	auxpass	_	_
11	detected	_	VBN	VBN	_	0	root	_	_
12	with	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	14	dep	_	_
14	yeast	_	NN	NN	_	12	pobj	_	_
15	two-hybrid	_	JJ	JJ	_	14	amod	_	_
16	and	_	CC	CC	_	14	cc	_	_
17	far-Western	_	JJ	JJ	_	18	amod	_	_
18	blot	_	NN	NN	_	14	conj	_	_
19	assays	_	NNS	NNS	_	14	dep	_	_
20	.	_	.	.	_	11	punct	_	_

1	Thus	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	RFX5	_	NN	NN	_	5	nsubj	_	_
4	can	_	MD	MD	_	5	aux	_	_
5	activate	_	VB	VB	_	0	root	_	_
6	transcription	_	NN	NN	_	5	dobj	_	_
7	only	_	RB	RB	_	8	advmod	_	_
8	in	_	IN	IN	_	5	prep	_	_
9	cooperation	_	NN	NN	_	8	pobj	_	_
10	with	_	IN	IN	_	9	prep	_	_
11	CIITA	_	NN	NN	_	10	pobj	_	_
12	.	_	.	.	_	5	punct	_	_

1	RFX5	_	NN	NN	_	4	nsubj	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	CIITA	_	NN	NN	_	1	conj	_	_
4	associate	_	VBP	VBP	_	0	root	_	_
5	to	_	TO	TO	_	6	aux	_	_
6	form	_	VB	VB	_	4	xcomp	_	_
7	a	_	DT	DT	_	8	det	_	_
8	complex	_	NN	NN	_	6	dobj	_	_
9	capable	_	JJ	JJ	_	8	amod	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	activating	_	VBG	VBG	_	10	pcomp	_	_
12	transcription	_	NN	NN	_	11	dobj	_	_
13	from	_	IN	IN	_	12	prep	_	_
14	class	_	NN	NN	_	19	nn	_	_
15	II	_	CD	CD	_	19	num	_	_
16	major	_	JJ	JJ	_	19	amod	_	_
17	histocompatibility	_	NN	NN	_	19	nn	_	_
18	complex	_	NN	NN	_	19	nn	_	_
19	promoters	_	NNS	NNS	_	13	pobj	_	_
20	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	8	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	complex	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	8	punct	_	_
5	promoter	_	NN	NN	_	6	nn	_	_
6	specificity	_	NN	NN	_	8	nsubjpass	_	_
7	is	_	VBZ	VBZ	_	8	auxpass	_	_
8	determined	_	VBN	VBN	_	0	root	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	13	det	_	_
11	DNA	_	NN	NN	_	13	nn	_	_
12	binding	_	NN	NN	_	13	nn	_	_
13	domain	_	NN	NN	_	9	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	RFX5	_	NN	NN	_	14	pobj	_	_
16	and	_	CC	CC	_	8	cc	_	_
17	the	_	DT	DT	_	20	det	_	_
18	general	_	JJ	JJ	_	20	amod	_	_
19	transcription	_	NN	NN	_	20	nn	_	_
20	apparatus	_	NN	NN	_	22	nsubjpass	_	_
21	is	_	VBZ	VBZ	_	22	auxpass	_	_
22	recruited	_	VBN	VBN	_	8	conj	_	_
23	by	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	27	det	_	_
25	acidic	_	JJ	JJ	_	27	amod	_	_
26	activation	_	NN	NN	_	27	nn	_	_
27	domain	_	NN	NN	_	23	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	CIITA	_	NN	NN	_	28	pobj	_	_
30	.	_	.	.	_	8	punct	_	_

1	CCAAT/enhancer	_	NN	NN	_	4	nn	_	_
2	binding	_	NN	NN	_	4	nn	_	_
3	protein	_	NN	NN	_	4	nn	_	_
4	epsilon	_	NN	NN	_	7	nsubjpass	_	_
5	is	_	VBZ	VBZ	_	7	auxpass	_	_
6	preferentially	_	RB	RB	_	7	advmod	_	_
7	up-regulated	_	VBN	VBN	_	0	root	_	_
8	during	_	IN	IN	_	7	prep	_	_
9	granulocytic	_	JJ	JJ	_	10	amod	_	_
10	differentiation	_	NN	NN	_	8	pobj	_	_
11	and	_	CC	CC	_	7	cc	_	_
12	its	_	PRP$	PRP$	_	14	poss	_	_
13	functional	_	JJ	JJ	_	14	amod	_	_
14	versatility	_	NN	NN	_	16	nsubjpass	_	_
15	is	_	VBZ	VBZ	_	16	auxpass	_	_
16	determined	_	VBN	VBN	_	7	conj	_	_
17	by	_	IN	IN	_	16	prep	_	_
18	alternative	_	JJ	JJ	_	19	amod	_	_
19	use	_	NN	NN	_	17	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	promoters	_	NNS	NNS	_	20	pobj	_	_
22	and	_	CC	CC	_	19	cc	_	_
23	differential	_	JJ	JJ	_	24	amod	_	_
24	splicing	_	NN	NN	_	19	conj	_	_
25	.	_	.	.	_	7	punct	_	_

1	CCAAT/enhancer	_	NN	NN	_	7	nn	_	_
2	binding	_	NN	NN	_	7	nn	_	_
3	protein	_	NN	NN	_	7	nn	_	_
4	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
5	C/EBP	_	NN	NN	_	7	nn	_	_
6	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
7	epsilon	_	NN	NN	_	12	nsubj	_	_
8	is	_	VBZ	VBZ	_	12	cop	_	_
9	a	_	DT	DT	_	12	det	_	_
10	recently	_	RB	RB	_	11	advmod	_	_
11	cloned	_	VBN	VBN	_	12	amod	_	_
12	member	_	NN	NN	_	0	root	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	C/EBP	_	NN	NN	_	16	nn	_	_
16	family	_	NN	NN	_	13	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	transcription	_	NN	NN	_	19	nn	_	_
19	factors	_	NNS	NNS	_	17	pobj	_	_
20	and	_	CC	CC	_	12	cc	_	_
21	is	_	VBZ	VBZ	_	22	auxpass	_	_
22	expressed	_	VBN	VBN	_	12	conj	_	_
23	exclusively	_	RB	RB	_	24	advmod	_	_
24	in	_	IN	IN	_	22	prep	_	_
25	cells	_	NNS	NNS	_	24	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	hematopoietic	_	JJ	JJ	_	28	amod	_	_
28	origin	_	NN	NN	_	26	pobj	_	_
29	.	_	.	.	_	12	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	human	_	JJ	JJ	_	4	amod	_	_
3	C/EBPepsilon	_	NN	NN	_	4	nn	_	_
4	gene	_	NN	NN	_	6	nsubjpass	_	_
5	is	_	VBZ	VBZ	_	6	auxpass	_	_
6	transcribed	_	VBN	VBN	_	0	root	_	_
7	by	_	IN	IN	_	6	prep	_	_
8	two	_	CD	CD	_	10	num	_	_
9	alternative	_	JJ	JJ	_	10	amod	_	_
10	promoters	_	NNS	NNS	_	7	pobj	_	_
11	,	_	,	,	_	10	punct	_	_
12	Palpha	_	NN	NN	_	10	appos	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	Pbeta	_	NN	NN	_	12	conj	_	_
15	.	_	.	.	_	6	punct	_	_

1	A	_	DT	DT	_	2	det	_	_
2	combination	_	NN	NN	_	11	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	differential	_	JJ	JJ	_	5	amod	_	_
5	splicing	_	NN	NN	_	3	pobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	alternative	_	JJ	JJ	_	8	amod	_	_
8	use	_	NN	NN	_	5	conj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	promoters	_	NNS	NNS	_	9	pobj	_	_
11	generates	_	VBZ	VBZ	_	0	root	_	_
12	four	_	CD	CD	_	14	num	_	_
13	mRNA	_	NN	NN	_	14	nn	_	_
14	isoforms	_	NNS	NNS	_	11	dobj	_	_
15	,	_	,	,	_	14	punct	_	_
16	of	_	IN	IN	_	14	prep	_	_
17	2.6	_	CD	CD	_	18	num	_	_
18	kb	_	NN	NN	_	16	pobj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	1.3-1.5	_	CD	CD	_	21	num	_	_
21	kb	_	NN	NN	_	18	conj	_	_
22	in	_	IN	IN	_	18	prep	_	_
23	size	_	NN	NN	_	22	pobj	_	_
24	.	_	.	.	_	11	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	transcripts	_	NNS	NNS	_	4	nsubj	_	_
3	can	_	MD	MD	_	4	aux	_	_
4	encode	_	VB	VB	_	0	root	_	_
5	three	_	CD	CD	_	6	num	_	_
6	proteins	_	NNS	NNS	_	4	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	calculated	_	VBN	VBN	_	10	amod	_	_
9	molecular	_	JJ	JJ	_	10	amod	_	_
10	mass	_	NN	NN	_	7	pobj	_	_
11	32.2	_	CD	CD	_	12	num	_	_
12	kDa	_	NN	NN	_	10	dep	_	_
13	,	_	,	,	_	12	punct	_	_
14	27.8	_	CD	CD	_	15	num	_	_
15	kDa	_	NN	NN	_	12	conj	_	_
16	,	_	,	,	_	12	punct	_	_
17	and	_	CC	CC	_	12	cc	_	_
18	14.3	_	CD	CD	_	19	num	_	_
19	kDa	_	NN	NN	_	12	conj	_	_
20	.	_	.	.	_	4	punct	_	_

1	Accordingly	_	RB	RB	_	20	advmod	_	_
2	,	_	,	,	_	20	punct	_	_
3	Western	_	NN	NN	_	4	nn	_	_
4	blots	_	NNS	NNS	_	20	nsubj	_	_
5	with	_	IN	IN	_	4	prep	_	_
6	antibodies	_	NNS	NNS	_	5	pobj	_	_
7	specific	_	JJ	JJ	_	6	amod	_	_
8	for	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	DNA-binding	_	JJ	JJ	_	11	amod	_	_
11	domain	_	NN	NN	_	8	pobj	_	_
12	,	_	,	,	_	11	punct	_	_
13	that	_	WDT	WDT	_	15	nsubj	_	_
14	is	_	VBZ	VBZ	_	15	cop	_	_
15	common	_	JJ	JJ	_	11	rcmod	_	_
16	to	_	TO	TO	_	15	prep	_	_
17	all	_	DT	DT	_	18	det	_	_
18	forms	_	NNS	NNS	_	16	pobj	_	_
19	,	_	,	,	_	4	punct	_	_
20	identify	_	VBP	VBP	_	0	root	_	_
21	multiple	_	JJ	JJ	_	22	amod	_	_
22	proteins	_	NNS	NNS	_	20	dobj	_	_
23	.	_	.	.	_	20	punct	_	_

1	C/EBPepsilon	_	NN	NN	_	2	nn	_	_
2	mRNA	_	NN	NN	_	5	nsubjpass	_	_
3	was	_	VBD	VBD	_	5	auxpass	_	_
4	greatly	_	RB	RB	_	5	advmod	_	_
5	induced	_	VBN	VBN	_	0	root	_	_
6	during	_	IN	IN	_	5	prep	_	_
7	in	_	FW	FW	_	10	amod	_	_
8	vitro	_	FW	FW	_	7	dep	_	_
9	granulocytic	_	JJ	JJ	_	7	dep	_	_
10	differentiation	_	NN	NN	_	6	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	human	_	JJ	JJ	_	15	amod	_	_
13	primary	_	JJ	JJ	_	15	amod	_	_
14	CD34-LRB-+-RRB-	_	JJ	JJ	_	15	amod	_	_
15	cells	_	NNS	NNS	_	11	pobj	_	_
16	.	_	.	.	_	5	punct	_	_

1	Retinoic	_	JJ	JJ	_	3	amod	_	_
2	acid	_	NN	NN	_	3	nn	_	_
3	treatment	_	NN	NN	_	12	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	HL60	_	NN	NN	_	8	nn	_	_
6	promyelocytic	_	JJ	JJ	_	8	amod	_	_
7	leukemia	_	NN	NN	_	8	nn	_	_
8	cells	_	NNS	NNS	_	4	pobj	_	_
9	for	_	IN	IN	_	3	prep	_	_
10	24	_	CD	CD	_	11	num	_	_
11	hr	_	NN	NN	_	9	pobj	_	_
12	induced	_	VBD	VBD	_	0	root	_	_
13	C/EBPepsilon	_	NN	NN	_	14	nn	_	_
14	mRNA	_	NN	NN	_	15	nn	_	_
15	levels	_	NNS	NNS	_	12	dobj	_	_
16	by	_	IN	IN	_	12	prep	_	_
17	4-fold	_	RB	RB	_	16	pobj	_	_
18	,	_	,	,	_	12	punct	_	_
19	while	_	IN	IN	_	23	mark	_	_
20	prolonged	_	JJ	JJ	_	21	amod	_	_
21	treatment	_	NN	NN	_	23	nsubj	_	_
22	gradually	_	RB	RB	_	23	advmod	_	_
23	reduced	_	VBD	VBD	_	12	advcl	_	_
24	mRNA	_	NN	NN	_	25	nn	_	_
25	expression	_	NN	NN	_	23	dobj	_	_
26	to	_	TO	TO	_	23	prep	_	_
27	pretreatment	_	JJ	JJ	_	28	amod	_	_
28	levels	_	NNS	NNS	_	26	pobj	_	_
29	.	_	.	.	_	12	punct	_	_

1	Transient	_	JJ	JJ	_	3	amod	_	_
2	transfection	_	NN	NN	_	3	nn	_	_
3	experiments	_	NNS	NNS	_	12	nsubj	_	_
4	with	_	IN	IN	_	3	prep	_	_
5	expression	_	NN	NN	_	6	nn	_	_
6	vectors	_	NNS	NNS	_	4	pobj	_	_
7	for	_	IN	IN	_	6	prep	_	_
8	two	_	CD	CD	_	7	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	isoforms	_	NNS	NNS	_	9	pobj	_	_
12	demonstrated	_	VBD	VBD	_	0	root	_	_
13	that	_	IN	IN	_	19	mark	_	_
14	the	_	DT	DT	_	16	det	_	_
15	32.2-kDa	_	JJ	JJ	_	16	amod	_	_
16	protein	_	NN	NN	_	19	nsubj	_	_
17	is	_	VBZ	VBZ	_	19	cop	_	_
18	an	_	DT	DT	_	19	det	_	_
19	activator	_	NN	NN	_	12	ccomp	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	transcription	_	NN	NN	_	20	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	granulocyte	_	NN	NN	_	27	nn	_	_
24	colony-stimulating	_	JJ	JJ	_	27	amod	_	_
25	factor	_	NN	NN	_	27	nn	_	_
26	receptor	_	NN	NN	_	27	nn	_	_
27	promoter	_	NN	NN	_	22	pobj	_	_
28	,	_	,	,	_	19	punct	_	_
29	while	_	IN	IN	_	33	mark	_	_
30	the	_	DT	DT	_	32	det	_	_
31	14.3-kDa	_	JJ	JJ	_	32	amod	_	_
32	protein	_	NN	NN	_	33	nsubj	_	_
33	is	_	VBZ	VBZ	_	19	advcl	_	_
34	not	_	RB	RB	_	33	neg	_	_
35	.	_	.	.	_	12	punct	_	_

1	Thus	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	C/EBPepsilon	_	NN	NN	_	5	nsubjpass	_	_
4	is	_	VBZ	VBZ	_	5	auxpass	_	_
5	regulated	_	VBN	VBN	_	0	root	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	a	_	DT	DT	_	9	det	_	_
8	complex	_	JJ	JJ	_	9	amod	_	_
9	fashion	_	NN	NN	_	6	pobj	_	_
10	and	_	CC	CC	_	5	cc	_	_
11	may	_	MD	MD	_	12	aux	_	_
12	play	_	VB	VB	_	5	conj	_	_
13	a	_	DT	DT	_	14	det	_	_
14	role	_	NN	NN	_	12	dobj	_	_
15	in	_	IN	IN	_	12	prep	_	_
16	the	_	DT	DT	_	17	det	_	_
17	regulation	_	NN	NN	_	15	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	genes	_	NNS	NNS	_	18	pobj	_	_
20	involved	_	VBN	VBN	_	19	vmod	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	myeloid	_	JJ	JJ	_	23	amod	_	_
23	differentiation	_	NN	NN	_	21	pobj	_	_
24	.	_	.	.	_	5	punct	_	_

1	Transcriptional	_	JJ	JJ	_	2	amod	_	_
2	activity	_	NN	NN	_	0	root	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	constitutive	_	JJ	JJ	_	6	amod	_	_
5	nuclear	_	JJ	JJ	_	6	amod	_	_
6	localization	_	NN	NN	_	2	conj	_	_
7	of	_	IN	IN	_	2	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	ETS	_	NN	NN	_	10	nn	_	_
10	protein	_	NN	NN	_	7	pobj	_	_
11	Elf-1	_	NN	NN	_	10	dep	_	_
12	.	_	.	.	_	2	punct	_	_

1	Elf-1	_	NN	NN	_	6	nsubj	_	_
2	is	_	VBZ	VBZ	_	6	cop	_	_
3	a	_	DT	DT	_	6	det	_	_
4	lymphoid-specific	_	JJ	JJ	_	6	amod	_	_
5	transcription	_	NN	NN	_	6	nn	_	_
6	factor	_	NN	NN	_	0	root	_	_
7	that	_	WDT	WDT	_	8	nsubj	_	_
8	belongs	_	VBZ	VBZ	_	6	rcmod	_	_
9	to	_	TO	TO	_	8	prep	_	_
10	the	_	DT	DT	_	13	det	_	_
11	ETS	_	NN	NN	_	13	nn	_	_
12	protein	_	NN	NN	_	13	nn	_	_
13	family	_	NN	NN	_	9	pobj	_	_
14	.	_	.	.	_	6	punct	_	_

1	It	_	PRP	PRP	_	3	nsubj	_	_
2	can	_	MD	MD	_	3	aux	_	_
3	bind	_	VB	VB	_	0	root	_	_
4	to	_	TO	TO	_	3	prep	_	_
5	DNA	_	NN	NN	_	7	nn	_	_
6	target	_	NN	NN	_	7	nn	_	_
7	sequences	_	NNS	NNS	_	4	pobj	_	_
8	within	_	IN	IN	_	7	prep	_	_
9	a	_	DT	DT	_	10	det	_	_
10	variety	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	cytokine	_	NN	NN	_	13	nn	_	_
13	genes	_	NNS	NNS	_	11	pobj	_	_
14	.	_	.	.	_	3	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	demonstrate	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	7	mark	_	_
4	Elf-1	_	NN	NN	_	7	nsubj	_	_
5	is	_	VBZ	VBZ	_	7	cop	_	_
6	constitutively	_	RB	RB	_	7	advmod	_	_
7	localized	_	JJ	JJ	_	2	ccomp	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	nucleus	_	NN	NN	_	8	pobj	_	_
11	which	_	WDT	WDT	_	13	nsubj	_	_
12	is	_	VBZ	VBZ	_	13	cop	_	_
13	dependent	_	JJ	JJ	_	10	rcmod	_	_
14	on	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	presence	_	NN	NN	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	amino	_	NN	NN	_	19	nn	_	_
19	acids	_	NNS	NNS	_	17	pobj	_	_
20	86-265	_	CD	CD	_	19	num	_	_
21	.	_	.	.	_	2	punct	_	_

1	Analysis	_	NN	NN	_	6	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	Gal4-Elf-1	_	NN	NN	_	5	nn	_	_
4	fusion	_	NN	NN	_	5	nn	_	_
5	proteins	_	NNS	NNS	_	2	pobj	_	_
6	revealed	_	VBD	VBD	_	0	root	_	_
7	that	_	IN	IN	_	15	mark	_	_
8	the	_	DT	DT	_	12	det	_	_
9	N-terminal	_	JJ	JJ	_	12	amod	_	_
10	86	_	CD	CD	_	12	num	_	_
11	amino	_	NN	NN	_	12	nn	_	_
12	acids	_	NNS	NNS	_	15	nsubj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	Elf-1	_	NN	NN	_	13	pobj	_	_
15	contain	_	VBP	VBP	_	6	ccomp	_	_
16	a	_	DT	DT	_	19	det	_	_
17	transcriptional	_	JJ	JJ	_	19	amod	_	_
18	activation	_	NN	NN	_	19	nn	_	_
19	domain	_	NN	NN	_	15	dobj	_	_
20	,	_	,	,	_	19	punct	_	_
21	the	_	DT	DT	_	22	det	_	_
22	activity	_	NN	NN	_	26	nsubjpass	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	which	_	WDT	WDT	_	23	pobj	_	_
25	is	_	VBZ	VBZ	_	26	auxpass	_	_
26	attenuated	_	VBN	VBN	_	19	rcmod	_	_
27	by	_	IN	IN	_	26	prep	_	_
28	an	_	DT	DT	_	31	det	_	_
29	internal	_	JJ	JJ	_	31	amod	_	_
30	repression	_	NN	NN	_	31	nn	_	_
31	domain	_	NN	NN	_	27	pobj	_	_
32	.	_	.	.	_	6	punct	_	_

1	Furthermore	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	Elf-1	_	NN	NN	_	4	nsubj	_	_
4	interacts	_	VBZ	VBZ	_	0	root	_	_
5	specifically	_	RB	RB	_	6	advmod	_	_
6	with	_	IN	IN	_	4	prep	_	_
7	the	_	DT	DT	_	10	det	_	_
8	E74	_	NN	NN	_	10	nn	_	_
9	target	_	NN	NN	_	10	nn	_	_
10	sequence	_	NN	NN	_	6	pobj	_	_
11	and	_	CC	CC	_	4	cc	_	_
12	can	_	MD	MD	_	13	aux	_	_
13	stimulate	_	VB	VB	_	4	conj	_	_
14	transcription	_	NN	NN	_	13	dobj	_	_
15	driven	_	VBN	VBN	_	14	vmod	_	_
16	by	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	E74	_	NN	NN	_	19	nn	_	_
19	site	_	NN	NN	_	16	pobj	_	_
20	independent	_	JJ	JJ	_	19	amod	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	mitogenic	_	JJ	JJ	_	23	amod	_	_
23	signaling	_	NN	NN	_	21	pobj	_	_
24	.	_	.	.	_	4	punct	_	_

1	Thus	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	Elf-1	_	NN	NN	_	5	nsubj	_	_
4	is	_	VBZ	VBZ	_	5	cop	_	_
5	able	_	JJ	JJ	_	0	root	_	_
6	to	_	TO	TO	_	7	aux	_	_
7	stimulate	_	VB	VB	_	5	xcomp	_	_
8	gene	_	NN	NN	_	9	nn	_	_
9	transcription	_	NN	NN	_	7	dobj	_	_
10	which	_	WDT	WDT	_	13	nsubjpass	_	_
11	may	_	MD	MD	_	13	aux	_	_
12	be	_	VB	VB	_	13	auxpass	_	_
13	required	_	VBN	VBN	_	9	rcmod	_	_
14	for	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	16	dep	_	_
16	development	_	NN	NN	_	14	pobj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	activity	_	NN	NN	_	16	conj	_	_
19	of	_	IN	IN	_	16	prep	_	_
20	lymphocytes	_	NNS	NNS	_	19	pobj	_	_
21	.	_	.	.	_	5	punct	_	_

1	Histamine	_	NN	NN	_	2	nsubj	_	_
2	modulates	_	VBZ	VBZ	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	expression	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	c-fos	_	NN	NN	_	5	pobj	_	_
7	through	_	IN	IN	_	4	prep	_	_
8	cyclic	_	JJ	JJ	_	10	amod	_	_
9	AMP	_	NN	NN	_	10	nn	_	_
10	production	_	NN	NN	_	7	pobj	_	_
11	via	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	H2	_	NN	NN	_	14	nn	_	_
14	receptor	_	NN	NN	_	11	pobj	_	_
15	in	_	IN	IN	_	4	prep	_	_
16	the	_	DT	DT	_	21	det	_	_
17	human	_	JJ	JJ	_	21	amod	_	_
18	promonocytic	_	JJ	JJ	_	21	amod	_	_
19	cell	_	NN	NN	_	21	nn	_	_
20	line	_	NN	NN	_	21	nn	_	_
21	U937	_	NN	NN	_	15	pobj	_	_
22	.	_	.	.	_	2	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	examined	_	VBD	VBD	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	effects	_	NNS	NNS	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	histamine	_	NN	NN	_	5	pobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	its	_	PRP$	PRP$	_	9	poss	_	_
9	agonists	_	NNS	NNS	_	6	conj	_	_
10	on	_	IN	IN	_	4	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	expression	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	15	dep	_	_
15	c-fos	_	NN	NN	_	13	pobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	c-myc	_	NN	NN	_	15	conj	_	_
18	proto-oncogenes	_	NNS	NNS	_	15	dep	_	_
19	at	_	IN	IN	_	12	prep	_	_
20	the	_	DT	DT	_	21	dep	_	_
21	transcriptional	_	JJ	JJ	_	19	pobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	translational	_	JJ	JJ	_	21	conj	_	_
24	levels	_	NNS	NNS	_	21	dep	_	_
25	in	_	IN	IN	_	12	prep	_	_
26	the	_	DT	DT	_	31	det	_	_
27	human	_	JJ	JJ	_	31	amod	_	_
28	promonocytic	_	JJ	JJ	_	31	amod	_	_
29	U937	_	NN	NN	_	31	nn	_	_
30	cell	_	NN	NN	_	31	nn	_	_
31	line	_	NN	NN	_	25	pobj	_	_
32	.	_	.	.	_	2	punct	_	_

1	Histamine	_	NN	NN	_	3	nsubj	_	_
2	transiently	_	RB	RB	_	3	advmod	_	_
3	increased	_	VBD	VBD	_	0	root	_	_
4	cAMP	_	NN	NN	_	3	dobj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	c-fos	_	NN	NN	_	7	nn	_	_
7	expression	_	NN	NN	_	4	conj	_	_
8	through	_	IN	IN	_	3	prep	_	_
9	H2	_	NN	NN	_	10	nn	_	_
10	receptors	_	NNS	NNS	_	8	pobj	_	_
11	.	_	.	.	_	3	punct	_	_

1	Dibutyryl	_	NN	NN	_	2	nn	_	_
2	cAMP	_	NN	NN	_	4	nsubj	_	_
3	also	_	RB	RB	_	4	advmod	_	_
4	increased	_	VBD	VBD	_	0	root	_	_
5	c-fos	_	NN	NN	_	6	nn	_	_
6	mRNA	_	NN	NN	_	4	dobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	protein	_	NN	NN	_	6	conj	_	_
9	,	_	,	,	_	4	punct	_	_
10	and	_	CC	CC	_	4	cc	_	_
11	levels	_	NNS	NNS	_	12	nsubj	_	_
12	remained	_	VBD	VBD	_	4	conj	_	_
13	elevated	_	JJ	JJ	_	12	acomp	_	_
14	even	_	RB	RB	_	15	advmod	_	_
15	after	_	IN	IN	_	13	prep	_	_
16	12	_	CD	CD	_	17	num	_	_
17	hr	_	NN	NN	_	15	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	treatment	_	NN	NN	_	18	pobj	_	_
20	.	_	.	.	_	4	punct	_	_

1	Dose-dependence	_	JJ	JJ	_	2	amod	_	_
2	studies	_	NNS	NNS	_	7	nsubj	_	_
3	using	_	VBG	VBG	_	2	vmod	_	_
4	histamine	_	NN	NN	_	3	dobj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	dimaprit	_	NN	NN	_	4	conj	_	_
7	showed	_	VBD	VBD	_	0	root	_	_
8	that	_	IN	IN	_	19	mark	_	_
9	the	_	DT	DT	_	11	det	_	_
10	EC50	_	NN	NN	_	11	nn	_	_
11	values	_	NNS	NNS	_	19	nsubj	_	_
12	for	_	IN	IN	_	11	prep	_	_
13	cAMP	_	NN	NN	_	14	nn	_	_
14	production	_	NN	NN	_	12	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	c-fos	_	NN	NN	_	17	nn	_	_
17	increase	_	NN	NN	_	14	conj	_	_
18	were	_	VBD	VBD	_	19	cop	_	_
19	similar	_	JJ	JJ	_	7	ccomp	_	_
20	,	_	,	,	_	7	punct	_	_
21	suggesting	_	VBG	VBG	_	7	xcomp	_	_
22	that	_	IN	IN	_	26	mark	_	_
23	cAMP	_	NN	NN	_	26	nsubjpass	_	_
24	might	_	MD	MD	_	26	aux	_	_
25	be	_	VB	VB	_	26	auxpass	_	_
26	involved	_	VBN	VBN	_	21	ccomp	_	_
27	in	_	IN	IN	_	26	prep	_	_
28	c-fos	_	NN	NN	_	29	nn	_	_
29	induction	_	NN	NN	_	27	pobj	_	_
30	via	_	IN	IN	_	26	prep	_	_
31	H2	_	NN	NN	_	32	nn	_	_
32	receptors	_	NNS	NNS	_	30	pobj	_	_
33	.	_	.	.	_	7	punct	_	_

1	Furthermore	_	RB	RB	_	17	advmod	_	_
2	,	_	,	,	_	17	punct	_	_
3	studies	_	NNS	NNS	_	17	nsubj	_	_
4	carried	_	VBD	VBD	_	3	vmod	_	_
5	out	_	IN	IN	_	4	prt	_	_
6	using	_	VBG	VBG	_	4	xcomp	_	_
7	H7	_	NN	NN	_	6	dobj	_	_
8	,	_	,	,	_	7	punct	_	_
9	a	_	DT	DT	_	15	det	_	_
10	protein	_	NN	NN	_	15	nn	_	_
11	kinase	_	NN	NN	_	15	nn	_	_
12	A/protein	_	NN	NN	_	15	nn	_	_
13	kinase	_	NN	NN	_	15	nn	_	_
14	C	_	NN	NN	_	15	nn	_	_
15	inhibitor	_	NN	NN	_	7	appos	_	_
16	,	_	,	,	_	3	punct	_	_
17	blocked	_	VBD	VBD	_	0	root	_	_
18	c-fos	_	NN	NN	_	19	nn	_	_
19	induction	_	NN	NN	_	17	dobj	_	_
20	,	_	,	,	_	17	punct	_	_
21	whereas	_	IN	IN	_	25	mark	_	_
22	no	_	DT	DT	_	23	neg	_	_
23	effect	_	NN	NN	_	25	nsubjpass	_	_
24	was	_	VBD	VBD	_	25	auxpass	_	_
25	observed	_	VBN	VBN	_	17	advcl	_	_
26	with	_	IN	IN	_	25	prep	_	_
27	bisindolylmaleimide	_	NN	NN	_	26	pobj	_	_
28	,	_	,	,	_	27	punct	_	_
29	a	_	DT	DT	_	34	det	_	_
30	specific	_	JJ	JJ	_	34	amod	_	_
31	protein	_	NN	NN	_	33	nn	_	_
32	kinase	_	NN	NN	_	33	nn	_	_
33	C	_	NN	NN	_	34	nn	_	_
34	inhibitor	_	NN	NN	_	27	appos	_	_
35	.	_	.	.	_	17	punct	_	_

1	No	_	DT	DT	_	2	neg	_	_
2	modification	_	NN	NN	_	8	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	c-myc	_	NN	NN	_	5	nn	_	_
5	expression	_	NN	NN	_	3	pobj	_	_
6	could	_	MD	MD	_	8	aux	_	_
7	be	_	VB	VB	_	8	auxpass	_	_
8	detected	_	VBN	VBN	_	0	root	_	_
9	on	_	IN	IN	_	8	prep	_	_
10	treatment	_	NN	NN	_	9	pobj	_	_
11	with	_	IN	IN	_	10	prep	_	_
12	histamine	_	NN	NN	_	11	pobj	_	_
13	or	_	CC	CC	_	12	cc	_	_
14	its	_	PRP$	PRP$	_	15	poss	_	_
15	analogues	_	NNS	NNS	_	12	conj	_	_
16	.	_	.	.	_	8	punct	_	_

1	Nevertheless	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	dibutyryl	_	JJ	JJ	_	4	amod	_	_
4	cAMP	_	NN	NN	_	5	nsubj	_	_
5	induced	_	VBD	VBD	_	0	root	_	_
6	a	_	DT	DT	_	7	det	_	_
7	down-regulation	_	NN	NN	_	5	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	levels	_	NNS	NNS	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	this	_	DT	DT	_	13	det	_	_
13	proto-oncogene	_	NN	NN	_	11	pobj	_	_
14	.	_	.	.	_	5	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	6	punct	_	_
4	dibutyryl	_	JJ	JJ	_	5	amod	_	_
5	cAMP	_	NN	NN	_	6	nsubj	_	_
6	inhibited	_	VBD	VBD	_	0	root	_	_
7	cell	_	NN	NN	_	8	nn	_	_
8	growth	_	NN	NN	_	6	dobj	_	_
9	in	_	IN	IN	_	6	prep	_	_
10	a	_	DT	DT	_	12	det	_	_
11	dose-dependent	_	JJ	JJ	_	12	amod	_	_
12	manner	_	NN	NN	_	9	pobj	_	_
13	,	_	,	,	_	6	punct	_	_
14	whereas	_	IN	IN	_	16	mark	_	_
15	histamine	_	NN	NN	_	16	nsubj	_	_
16	failed	_	VBD	VBD	_	6	advcl	_	_
17	to	_	TO	TO	_	18	aux	_	_
18	affect	_	VB	VB	_	16	xcomp	_	_
19	proliferation	_	NN	NN	_	18	dobj	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	differentiation	_	NN	NN	_	19	conj	_	_
22	of	_	IN	IN	_	19	prep	_	_
23	U937	_	NN	NN	_	24	nn	_	_
24	cells	_	NNS	NNS	_	22	pobj	_	_
25	.	_	.	.	_	6	punct	_	_

1	Cells	_	NNS	NNS	_	5	nsubj	_	_
2	pretreated	_	JJ	JJ	_	1	amod	_	_
3	with	_	IN	IN	_	2	prep	_	_
4	dimaprit	_	NN	NN	_	3	pobj	_	_
5	showed	_	VBD	VBD	_	0	root	_	_
6	a	_	DT	DT	_	7	det	_	_
7	decrease	_	NN	NN	_	5	dobj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	cAMP	_	NN	NN	_	11	nn	_	_
11	response	_	NN	NN	_	8	pobj	_	_
12	to	_	TO	TO	_	11	prep	_	_
13	subsequent	_	JJ	JJ	_	14	amod	_	_
14	addition	_	NN	NN	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	H2	_	NN	NN	_	17	nn	_	_
17	agonists	_	NNS	NNS	_	15	pobj	_	_
18	,	_	,	,	_	5	punct	_	_
19	whereas	_	IN	IN	_	26	mark	_	_
20	the	_	DT	DT	_	22	det	_	_
21	cAMP	_	NN	NN	_	22	nn	_	_
22	response	_	NN	NN	_	26	nsubj	_	_
23	to	_	TO	TO	_	22	prep	_	_
24	prostaglandin	_	NN	NN	_	25	nn	_	_
25	E2	_	NN	NN	_	23	pobj	_	_
26	remained	_	VBD	VBD	_	5	advcl	_	_
27	unaltered	_	JJ	JJ	_	26	acomp	_	_
28	.	_	.	.	_	5	punct	_	_

1	This	_	DT	DT	_	3	det	_	_
2	homologous	_	JJ	JJ	_	3	amod	_	_
3	mechanism	_	NN	NN	_	9	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	H2	_	NN	NN	_	6	nn	_	_
6	receptor	_	NN	NN	_	7	nn	_	_
7	desensitization	_	NN	NN	_	4	pobj	_	_
8	was	_	VBD	VBD	_	9	cop	_	_
9	time	_	NN	NN	_	0	root	_	_
10	dependent	_	JJ	JJ	_	9	amod	_	_
11	.	_	.	.	_	9	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	6	mark	_	_
5	histamine	_	NN	NN	_	6	nsubj	_	_
6	activates	_	VBZ	VBZ	_	3	ccomp	_	_
7	several	_	JJ	JJ	_	8	amod	_	_
8	mechanisms	_	NNS	NNS	_	6	dobj	_	_
9	involved	_	VBN	VBN	_	8	vmod	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	induction	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	differentiation	_	NN	NN	_	13	pobj	_	_
15	,	_	,	,	_	8	punct	_	_
16	such	_	JJ	JJ	_	17	mwe	_	_
17	as	_	IN	IN	_	8	prep	_	_
18	cAMP	_	NN	NN	_	17	pobj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	c-fos	_	NN	NN	_	21	nn	_	_
21	production	_	NN	NN	_	18	conj	_	_
22	,	_	,	,	_	6	punct	_	_
23	but	_	CC	CC	_	6	cc	_	_
24	fails	_	VBZ	VBZ	_	6	conj	_	_
25	to	_	TO	TO	_	26	aux	_	_
26	promote	_	VB	VB	_	24	xcomp	_	_
27	differentiation	_	NN	NN	_	26	dobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	U937	_	NN	NN	_	30	nn	_	_
30	cells	_	NNS	NNS	_	28	pobj	_	_
31	,	_	,	,	_	24	punct	_	_
32	apparently	_	RB	RB	_	24	advmod	_	_
33	due	_	JJ	JJ	_	32	advmod	_	_
34	to	_	TO	TO	_	32	prep	_	_
35	the	_	DT	DT	_	37	det	_	_
36	rapid	_	JJ	JJ	_	37	amod	_	_
37	desensitization	_	NN	NN	_	34	pobj	_	_
38	of	_	IN	IN	_	37	prep	_	_
39	H2	_	NN	NN	_	40	nn	_	_
40	receptors	_	NNS	NNS	_	38	pobj	_	_
41	.	_	.	.	_	3	punct	_	_

1	Human	_	JJ	JJ	_	2	amod	_	_
2	cytomegalovirus	_	NN	NN	_	3	nsubj	_	_
3	induces	_	VBZ	VBZ	_	0	root	_	_
4	interleukin-8	_	NN	NN	_	5	nn	_	_
5	production	_	NN	NN	_	3	dobj	_	_
6	by	_	IN	IN	_	5	prep	_	_
7	a	_	DT	DT	_	11	det	_	_
8	human	_	JJ	JJ	_	11	amod	_	_
9	monocytic	_	JJ	JJ	_	11	amod	_	_
10	cell	_	NN	NN	_	11	nn	_	_
11	line	_	NN	NN	_	6	pobj	_	_
12	,	_	,	,	_	11	punct	_	_
13	THP-1	_	NN	NN	_	11	appos	_	_
14	,	_	,	,	_	3	punct	_	_
15	through	_	IN	IN	_	3	prep	_	_
16	acting	_	VBG	VBG	_	15	pcomp	_	_
17	concurrently	_	RB	RB	_	16	advmod	_	_
18	on	_	IN	IN	_	16	prep	_	_
19	AP-1-	_	NN	NN	_	18	pobj	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	NF-kappaB-binding	_	JJ	JJ	_	19	conj	_	_
22	sites	_	NNS	NNS	_	19	dep	_	_
23	of	_	IN	IN	_	19	prep	_	_
24	the	_	DT	DT	_	26	det	_	_
25	interleukin-8	_	NN	NN	_	26	nn	_	_
26	gene	_	NN	NN	_	23	pobj	_	_
27	.	_	.	.	_	3	punct	_	_

1	Cytomegalovirus	_	NN	NN	_	5	nn	_	_
2	-LRB-	_	-LRB-	-LRB-	_	3	punct	_	_
3	CMV	_	NN	NN	_	1	appos	_	_
4	-RRB-	_	-RRB-	-RRB-	_	3	punct	_	_
5	infection	_	NN	NN	_	6	nsubj	_	_
6	induced	_	VBD	VBD	_	0	root	_	_
7	interleukin-8	_	NN	NN	_	12	nn	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	IL-8	_	NN	NN	_	7	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	gene	_	NN	NN	_	12	nn	_	_
12	transcription	_	NN	NN	_	6	dobj	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	a	_	DT	DT	_	18	det	_	_
15	human	_	JJ	JJ	_	18	amod	_	_
16	monocytic	_	JJ	JJ	_	18	amod	_	_
17	cell	_	NN	NN	_	18	nn	_	_
18	line	_	NN	NN	_	13	pobj	_	_
19	,	_	,	,	_	18	punct	_	_
20	THP-1	_	NN	NN	_	21	nn	_	_
21	cells	_	NNS	NNS	_	18	appos	_	_
22	,	_	,	,	_	6	punct	_	_
23	leading	_	VBG	VBG	_	6	vmod	_	_
24	to	_	TO	TO	_	23	prep	_	_
25	IL-8	_	NN	NN	_	26	nn	_	_
26	secretion	_	NN	NN	_	24	pobj	_	_
27	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	functional	_	JJ	JJ	_	3	amod	_	_
3	analysis	_	NN	NN	_	8	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	7	det	_	_
6	IL-8	_	NN	NN	_	7	nn	_	_
7	gene	_	NN	NN	_	4	pobj	_	_
8	revealed	_	VBD	VBD	_	0	root	_	_
9	that	_	IN	IN	_	17	mark	_	_
10	both	_	CC	CC	_	11	preconj	_	_
11	AP-1-	_	NN	NN	_	17	nsubjpass	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	NF-kappaB	_	NN	NN	_	11	conj	_	_
14	factor-binding	_	JJ	JJ	_	13	amod	_	_
15	elements	_	NNS	NNS	_	11	dep	_	_
16	were	_	VBD	VBD	_	17	auxpass	_	_
17	involved	_	VBN	VBN	_	8	ccomp	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	conferring	_	VBG	VBG	_	18	pcomp	_	_
20	the	_	DT	DT	_	21	det	_	_
21	responsiveness	_	NN	NN	_	19	dobj	_	_
22	to	_	TO	TO	_	19	prep	_	_
23	CMV	_	NN	NN	_	22	pobj	_	_
24	.	_	.	.	_	8	punct	_	_

1	Moreover	_	RB	RB	_	7	advmod	_	_
2	,	_	,	,	_	7	punct	_	_
3	electrophoretic	_	JJ	JJ	_	6	amod	_	_
4	mobility	_	NN	NN	_	6	nn	_	_
5	shift	_	NN	NN	_	6	nn	_	_
6	assays	_	NNS	NNS	_	7	nsubj	_	_
7	demonstrated	_	VBD	VBD	_	0	root	_	_
8	that	_	IN	IN	_	10	mark	_	_
9	CMV	_	NN	NN	_	10	nsubj	_	_
10	induced	_	VBD	VBD	_	7	ccomp	_	_
11	the	_	DT	DT	_	12	det	_	_
12	formation	_	NN	NN	_	10	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	NF-kappaB	_	NN	NN	_	13	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	AP-1	_	NN	NN	_	17	nn	_	_
17	complexes	_	NNS	NNS	_	14	conj	_	_
18	.	_	.	.	_	7	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	6	mark	_	_
5	CMV	_	NN	NN	_	6	nsubj	_	_
6	activates	_	VBZ	VBZ	_	3	ccomp	_	_
7	these	_	DT	DT	_	9	det	_	_
8	transcriptional	_	JJ	JJ	_	9	amod	_	_
9	factors	_	NNS	NNS	_	6	dobj	_	_
10	,	_	,	,	_	6	punct	_	_
11	resulting	_	VBG	VBG	_	6	vmod	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	IL-8	_	NN	NN	_	15	nn	_	_
14	gene	_	NN	NN	_	15	nn	_	_
15	expression	_	NN	NN	_	12	pobj	_	_
16	.	_	.	.	_	3	punct	_	_

1	Concomitant	_	JJ	JJ	_	2	amod	_	_
2	downregulation	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	IgH	_	NN	NN	_	6	nn	_	_
5	3'	_	JJ	JJ	_	6	amod	_	_
6	enhancer	_	NN	NN	_	7	nn	_	_
7	activity	_	NN	NN	_	3	pobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	c-myc	_	NN	NN	_	10	nn	_	_
10	expression	_	NN	NN	_	7	conj	_	_
11	in	_	IN	IN	_	7	prep	_	_
12	a	_	DT	DT	_	16	det	_	_
13	plasmacytoma	_	NN	NN	_	16	nn	_	_
14	x	_	NN	NN	_	16	nn	_	_
15	fibroblast	_	NN	NN	_	16	nn	_	_
16	environment	_	NN	NN	_	11	pobj	_	_
17	:	_	:	:	_	2	punct	_	_
18	implications	_	NNS	NNS	_	2	dep	_	_
19	for	_	IN	IN	_	18	prep	_	_
20	dysregulation	_	NN	NN	_	19	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	translocated	_	VBN	VBN	_	23	amod	_	_
23	c-myc	_	NN	NN	_	21	pobj	_	_
24	.	_	.	.	_	2	punct	_	_

1	Regulation	_	NN	NN	_	12	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	immunoglobulin	_	NN	NN	_	9	nn	_	_
4	heavy	_	JJ	JJ	_	9	amod	_	_
5	chain	_	NN	NN	_	9	nn	_	_
6	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
7	IgH	_	NN	NN	_	9	nn	_	_
8	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
9	gene	_	NN	NN	_	10	nn	_	_
10	expression	_	NN	NN	_	2	pobj	_	_
11	is	_	VBZ	VBZ	_	12	auxpass	_	_
12	controlled	_	VBN	VBN	_	0	root	_	_
13	by	_	IN	IN	_	12	prep	_	_
14	a	_	DT	DT	_	17	det	_	_
15	B	_	NN	NN	_	17	nn	_	_
16	cell-specific	_	JJ	JJ	_	17	amod	_	_
17	promoter	_	NN	NN	_	13	pobj	_	_
18	,	_	,	,	_	17	punct	_	_
19	intronic	_	JJ	JJ	_	20	amod	_	_
20	enhancer	_	NN	NN	_	17	conj	_	_
21	and	_	CC	CC	_	17	cc	_	_
22	additional	_	JJ	JJ	_	26	amod	_	_
23	B	_	NN	NN	_	26	nn	_	_
24	cell-specific	_	JJ	JJ	_	26	amod	_	_
25	enhancer	_	NN	NN	_	26	nn	_	_
26	elements	_	NNS	NNS	_	17	conj	_	_
27	identified	_	VBN	VBN	_	26	vmod	_	_
28	recently	_	RB	RB	_	27	advmod	_	_
29	in	_	IN	IN	_	27	prep	_	_
30	the	_	DT	DT	_	32	det	_	_
31	3'	_	JJ	JJ	_	32	amod	_	_
32	end	_	NN	NN	_	29	pobj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	the	_	DT	DT	_	36	det	_	_
35	IgH	_	NN	NN	_	36	nn	_	_
36	locus	_	NN	NN	_	33	pobj	_	_
37	.	_	.	.	_	12	punct	_	_

1	One	_	CD	CD	_	12	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	latter	_	JJ	JJ	_	5	amod	_	_
5	elements	_	NNS	NNS	_	2	pobj	_	_
6	,	_	,	,	_	1	punct	_	_
7	the	_	DT	DT	_	10	det	_	_
8	IgH	_	NN	NN	_	10	nn	_	_
9	3'	_	JJ	JJ	_	10	amod	_	_
10	enhancer	_	NN	NN	_	1	appos	_	_
11	,	_	,	,	_	1	punct	_	_
12	is	_	VBZ	VBZ	_	0	root	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	particular	_	JJ	JJ	_	15	amod	_	_
15	interest	_	NN	NN	_	13	pobj	_	_
16	:	_	:	:	_	12	punct	_	_
17	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	1	_	LS	LS	_	23	dep	_	_
19	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
20	it	_	PRP	PRP	_	23	nsubj	_	_
21	is	_	VBZ	VBZ	_	23	cop	_	_
22	B	_	NN	NN	_	23	npadvmod	_	_
23	cell-specific	_	JJ	JJ	_	12	parataxis	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	active	_	JJ	JJ	_	23	conj	_	_
26	only	_	RB	RB	_	27	advmod	_	_
27	in	_	IN	IN	_	25	prep	_	_
28	late	_	JJ	JJ	_	31	amod	_	_
29	B	_	NN	NN	_	31	nn	_	_
30	cell	_	NN	NN	_	31	nn	_	_
31	development	_	NN	NN	_	27	pobj	_	_
32	;	_	:	:	_	23	punct	_	_
33	-LRB-	_	-LRB-	-LRB-	_	34	punct	_	_
34	2	_	LS	LS	_	48	dep	_	_
35	-RRB-	_	-RRB-	-RRB-	_	34	punct	_	_
36	in	_	IN	IN	_	48	prep	_	_
37	rodent	_	JJ	JJ	_	38	amod	_	_
38	plasmacytomas	_	NNS	NNS	_	36	pobj	_	_
39	and	_	CC	CC	_	36	cc	_	_
40	in	_	IN	IN	_	36	conj	_	_
41	some	_	DT	DT	_	45	det	_	_
42	human	_	JJ	JJ	_	45	amod	_	_
43	Burkitt	_	NN	NN	_	45	poss	_	_
44	's	_	POS	POS	_	43	possessive	_	_
45	lymphomas	_	NNS	NNS	_	40	pobj	_	_
46	it	_	PRP	PRP	_	48	nsubj	_	_
47	is	_	VBZ	VBZ	_	48	cop	_	_
48	part	_	NN	NN	_	23	conj	_	_
49	of	_	IN	IN	_	48	prep	_	_
50	a	_	DT	DT	_	53	det	_	_
51	locus	_	NN	NN	_	53	nn	_	_
52	control	_	NN	NN	_	53	nn	_	_
53	region	_	NN	NN	_	49	pobj	_	_
54	-LRB-	_	-LRB-	-LRB-	_	55	punct	_	_
55	LCR	_	NN	NN	_	53	appos	_	_
56	-RRB-	_	-RRB-	-RRB-	_	55	punct	_	_
57	that	_	WDT	WDT	_	59	nsubjpass	_	_
58	is	_	VBZ	VBZ	_	59	auxpass	_	_
59	involved	_	VBN	VBN	_	53	rcmod	_	_
60	in	_	IN	IN	_	59	prep	_	_
61	deregulation	_	NN	NN	_	60	pobj	_	_
62	of	_	IN	IN	_	61	prep	_	_
63	the	_	DT	DT	_	65	det	_	_
64	c-myc	_	NN	NN	_	65	nn	_	_
65	oncogene	_	NN	NN	_	62	pobj	_	_
66	as	_	IN	IN	_	48	prep	_	_
67	a	_	DT	DT	_	68	det	_	_
68	result	_	NN	NN	_	66	pobj	_	_
69	of	_	IN	IN	_	68	prep	_	_
70	translocation	_	NN	NN	_	69	pobj	_	_
71	into	_	IN	IN	_	70	prep	_	_
72	the	_	DT	DT	_	74	det	_	_
73	IgH	_	NN	NN	_	74	nn	_	_
74	locus	_	NN	NN	_	71	pobj	_	_
75	;	_	:	:	_	23	punct	_	_
76	and	_	CC	CC	_	23	cc	_	_
77	-LRB-	_	-LRB-	-LRB-	_	78	punct	_	_
78	3	_	LS	LS	_	83	dep	_	_
79	-RRB-	_	-RRB-	-RRB-	_	78	punct	_	_
80	it	_	PRP	PRP	_	83	nsubjpass	_	_
81	has	_	VBZ	VBZ	_	83	aux	_	_
82	been	_	VBN	VBN	_	83	auxpass	_	_
83	implicated	_	VBN	VBN	_	23	conj	_	_
84	in	_	IN	IN	_	83	prep	_	_
85	the	_	DT	DT	_	86	det	_	_
86	mechanisms	_	NNS	NNS	_	84	pobj	_	_
87	that	_	WDT	WDT	_	88	nsubj	_	_
88	control	_	VBP	VBP	_	86	rcmod	_	_
89	Ig	_	NN	NN	_	91	nn	_	_
90	gene	_	NN	NN	_	91	nn	_	_
91	class	_	NN	NN	_	93	nn	_	_
92	switch	_	NN	NN	_	93	nn	_	_
93	recombination	_	NN	NN	_	88	dobj	_	_
94	.	_	.	.	_	12	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	used	_	VBN	VBN	_	0	root	_	_
4	a	_	DT	DT	_	8	det	_	_
5	somatic	_	JJ	JJ	_	8	amod	_	_
6	cell	_	NN	NN	_	8	nn	_	_
7	hybridization	_	NN	NN	_	8	nn	_	_
8	approach	_	NN	NN	_	3	dobj	_	_
9	to	_	TO	TO	_	11	aux	_	_
10	genetically	_	RB	RB	_	11	advmod	_	_
11	analyse	_	VB	VB	_	3	xcomp	_	_
12	regulation	_	NN	NN	_	11	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	activity	_	NN	NN	_	13	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	20	det	_	_
18	IgH	_	NN	NN	_	20	nn	_	_
19	3'	_	JJ	JJ	_	20	amod	_	_
20	enhancer	_	NN	NN	_	16	pobj	_	_
21	.	_	.	.	_	3	punct	_	_

1	When	_	WRB	WRB	_	17	advmod	_	_
2	mouse	_	NN	NN	_	5	nn	_	_
3	MPC11	_	NN	NN	_	5	nn	_	_
4	plasmacytoma	_	NN	NN	_	5	nn	_	_
5	cells	_	NNS	NNS	_	17	nsubjpass	_	_
6	,	_	,	,	_	5	punct	_	_
7	in	_	IN	IN	_	14	prep	_	_
8	which	_	WDT	WDT	_	7	pobj	_	_
9	the	_	DT	DT	_	12	det	_	_
10	IgH	_	NN	NN	_	12	nn	_	_
11	3'	_	JJ	JJ	_	12	amod	_	_
12	enhancer	_	NN	NN	_	14	nsubj	_	_
13	is	_	VBZ	VBZ	_	14	cop	_	_
14	active	_	JJ	JJ	_	5	rcmod	_	_
15	,	_	,	,	_	5	punct	_	_
16	are	_	VBP	VBP	_	17	auxpass	_	_
17	fused	_	VBN	VBN	_	24	advcl	_	_
18	with	_	IN	IN	_	17	prep	_	_
19	fibroblasts	_	NNS	NNS	_	18	pobj	_	_
20	,	_	,	,	_	24	punct	_	_
21	Ig	_	NN	NN	_	22	nn	_	_
22	expression	_	NN	NN	_	24	nsubjpass	_	_
23	is	_	VBZ	VBZ	_	24	auxpass	_	_
24	extinguished	_	VBN	VBN	_	0	root	_	_
25	at	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	27	det	_	_
27	level	_	NN	NN	_	25	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	transcription	_	NN	NN	_	28	pobj	_	_
30	.	_	.	.	_	24	punct	_	_

1	Here	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	show	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	19	mark	_	_
5	in	_	IN	IN	_	19	prep	_	_
6	a	_	DT	DT	_	11	det	_	_
7	MPC11	_	NN	NN	_	11	nn	_	_
8	plasmacytoma	_	NN	NN	_	11	nn	_	_
9	x	_	NN	NN	_	11	nn	_	_
10	fibroblast	_	NN	NN	_	11	nn	_	_
11	environment	_	NN	NN	_	5	pobj	_	_
12	,	_	,	,	_	19	punct	_	_
13	the	_	DT	DT	_	16	det	_	_
14	IgH	_	NN	NN	_	16	nn	_	_
15	3'	_	JJ	JJ	_	16	amod	_	_
16	enhancer	_	NN	NN	_	19	nsubj	_	_
17	is	_	VBZ	VBZ	_	19	cop	_	_
18	transcriptionally	_	RB	RB	_	19	advmod	_	_
19	inactive	_	JJ	JJ	_	3	ccomp	_	_
20	.	_	.	.	_	3	punct	_	_

1	Furthermore	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	demonstrate	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	22	mark	_	_
6	binding	_	NN	NN	_	22	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	several	_	JJ	JJ	_	12	amod	_	_
9	B	_	NN	NN	_	12	nn	_	_
10	cell-specific	_	JJ	JJ	_	12	amod	_	_
11	transcription	_	NN	NN	_	12	nn	_	_
12	factors	_	NNS	NNS	_	7	pobj	_	_
13	,	_	,	,	_	12	punct	_	_
14	essential	_	JJ	JJ	_	12	amod	_	_
15	for	_	IN	IN	_	14	prep	_	_
16	IgH	_	NN	NN	_	18	nn	_	_
17	3'	_	JJ	JJ	_	18	amod	_	_
18	enhancer	_	NN	NN	_	19	nn	_	_
19	activity	_	NN	NN	_	15	pobj	_	_
20	,	_	,	,	_	6	punct	_	_
21	is	_	VBZ	VBZ	_	22	aux	_	_
22	lacking	_	VBG	VBG	_	4	ccomp	_	_
23	,	_	,	,	_	22	punct	_	_
24	which	_	WDT	WDT	_	26	nsubj	_	_
25	may	_	MD	MD	_	26	aux	_	_
26	explain	_	VB	VB	_	22	ccomp	_	_
27	3'	_	JJ	JJ	_	29	amod	_	_
28	enhancer	_	NN	NN	_	29	nn	_	_
29	inactivity	_	NN	NN	_	26	dobj	_	_
30	,	_	,	,	_	22	punct	_	_
31	although	_	IN	IN	_	39	mark	_	_
32	the	_	DT	DT	_	33	det	_	_
33	binding	_	NN	NN	_	39	nsubjpass	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	repressors	_	NNS	NNS	_	34	pobj	_	_
36	can	_	MD	MD	_	39	aux	_	_
37	not	_	RB	RB	_	39	neg	_	_
38	be	_	VB	VB	_	39	auxpass	_	_
39	excluded	_	VBN	VBN	_	22	advcl	_	_
40	.	_	.	.	_	4	punct	_	_

1	Moreover	_	RB	RB	_	22	advmod	_	_
2	,	_	,	,	_	22	punct	_	_
3	the	_	DT	DT	_	6	det	_	_
4	high	_	JJ	JJ	_	6	amod	_	_
5	expression	_	NN	NN	_	6	nn	_	_
6	level	_	NN	NN	_	22	nsubjpass	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	c-myc	_	NN	NN	_	7	pobj	_	_
9	,	_	,	,	_	6	punct	_	_
10	characteristic	_	JJ	JJ	_	6	advmod	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	15	det	_	_
13	parental	_	JJ	JJ	_	15	amod	_	_
14	MPC11	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	11	pobj	_	_
16	carrying	_	VBG	VBG	_	15	vmod	_	_
17	the	_	DT	DT	_	19	det	_	_
18	t-LRB-12;15-RRB-	_	NN	NN	_	19	nn	_	_
19	translocation	_	NN	NN	_	16	dobj	_	_
20	,	_	,	,	_	6	punct	_	_
21	is	_	VBZ	VBZ	_	22	auxpass	_	_
22	down-regulated	_	VBN	VBN	_	0	root	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	25	det	_	_
25	hybrids	_	NNS	NNS	_	23	pobj	_	_
26	to	_	TO	TO	_	22	prep	_	_
27	that	_	DT	DT	_	26	pobj	_	_
28	in	_	IN	IN	_	27	prep	_	_
29	unfused	_	JJ	JJ	_	30	amod	_	_
30	fibroblasts	_	NNS	NNS	_	28	pobj	_	_
31	.	_	.	.	_	22	punct	_	_

1	Therefore	_	RB	RB	_	12	advmod	_	_
2	,	_	,	,	_	12	punct	_	_
3	inactivation	_	NN	NN	_	12	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	8	det	_	_
6	IgH	_	NN	NN	_	8	nn	_	_
7	3'	_	JJ	JJ	_	8	amod	_	_
8	enhancer	_	NN	NN	_	4	pobj	_	_
9	is	_	VBZ	VBZ	_	12	cop	_	_
10	a	_	DT	DT	_	12	det	_	_
11	multifactorial	_	JJ	JJ	_	12	amod	_	_
12	process	_	NN	NN	_	0	root	_	_
13	affecting	_	VBG	VBG	_	12	vmod	_	_
14	several	_	JJ	JJ	_	16	amod	_	_
15	transcription	_	NN	NN	_	16	nn	_	_
16	factors	_	NNS	NNS	_	13	dobj	_	_
17	that	_	WDT	WDT	_	18	nsubj	_	_
18	control	_	VBP	VBP	_	16	rcmod	_	_
19	the	_	DT	DT	_	20	dep	_	_
20	cell-specific	_	JJ	JJ	_	18	dobj	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	developmental	_	JJ	JJ	_	20	conj	_	_
23	activity	_	NN	NN	_	20	dep	_	_
24	of	_	IN	IN	_	20	prep	_	_
25	the	_	DT	DT	_	26	det	_	_
26	enhancer	_	NN	NN	_	24	pobj	_	_
27	.	_	.	.	_	12	punct	_	_

1	Construction	_	NN	NN	_	0	root	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	biological	_	JJ	JJ	_	4	amod	_	_
4	characterization	_	NN	NN	_	1	conj	_	_
5	of	_	IN	IN	_	1	prep	_	_
6	an	_	DT	DT	_	9	det	_	_
7	interleukin-12	_	NN	NN	_	9	nn	_	_
8	fusion	_	NN	NN	_	9	nn	_	_
9	protein	_	NN	NN	_	5	pobj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	Flexi-12	_	NN	NN	_	9	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	:	_	:	:	_	1	punct	_	_
14	delivery	_	NN	NN	_	1	dep	_	_
15	to	_	TO	TO	_	14	prep	_	_
16	acute	_	JJ	JJ	_	19	amod	_	_
17	myeloid	_	JJ	JJ	_	19	amod	_	_
18	leukemic	_	JJ	JJ	_	19	amod	_	_
19	blasts	_	NNS	NNS	_	15	pobj	_	_
20	using	_	VBG	VBG	_	14	dep	_	_
21	adeno-associated	_	JJ	JJ	_	22	amod	_	_
22	virus	_	NN	NN	_	20	dobj	_	_
23	.	_	.	.	_	1	punct	_	_

1	Interleukin-12	_	NN	NN	_	7	nsubj	_	_
2	-LRB-	_	-LRB-	-LRB-	_	3	punct	_	_
3	IL-12	_	NN	NN	_	1	appos	_	_
4	-RRB-	_	-RRB-	-RRB-	_	3	punct	_	_
5	is	_	VBZ	VBZ	_	7	cop	_	_
6	a	_	DT	DT	_	7	det	_	_
7	cytokine	_	NN	NN	_	0	root	_	_
8	that	_	WDT	WDT	_	9	nsubj	_	_
9	exhibits	_	VBZ	VBZ	_	7	rcmod	_	_
10	pleiotropic	_	JJ	JJ	_	11	amod	_	_
11	effects	_	NNS	NNS	_	9	dobj	_	_
12	on	_	IN	IN	_	11	prep	_	_
13	lymphocytes	_	NNS	NNS	_	12	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	natural	_	JJ	JJ	_	17	amod	_	_
16	killer	_	NN	NN	_	17	nn	_	_
17	cells	_	NNS	NNS	_	13	conj	_	_
18	and	_	CC	CC	_	9	cc	_	_
19	has	_	VBZ	VBZ	_	21	aux	_	_
20	been	_	VBN	VBN	_	21	auxpass	_	_
21	shown	_	VBN	VBN	_	9	conj	_	_
22	to	_	TO	TO	_	23	aux	_	_
23	have	_	VB	VB	_	21	xcomp	_	_
24	promise	_	NN	NN	_	23	dobj	_	_
25	for	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	27	det	_	_
27	immunotherapy	_	NN	NN	_	25	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	cancer	_	NN	NN	_	28	pobj	_	_
30	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	combination	_	NN	NN	_	13	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	7	det	_	_
5	immune	_	JJ	JJ	_	7	amod	_	_
6	costimulatory	_	JJ	JJ	_	7	amod	_	_
7	molecule	_	NN	NN	_	3	pobj	_	_
8	B7.1	_	NN	NN	_	7	dep	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	IL-12	_	NN	NN	_	8	conj	_	_
11	has	_	VBZ	VBZ	_	13	aux	_	_
12	been	_	VBN	VBN	_	13	auxpass	_	_
13	shown	_	VBN	VBN	_	0	root	_	_
14	to	_	TO	TO	_	16	aux	_	_
15	be	_	VB	VB	_	16	cop	_	_
16	synergistic	_	JJ	JJ	_	13	xcomp	_	_
17	for	_	IN	IN	_	16	prep	_	_
18	T	_	NN	NN	_	20	nn	_	_
19	cell	_	NN	NN	_	20	nn	_	_
20	activation	_	NN	NN	_	17	pobj	_	_
21	.	_	.	.	_	13	punct	_	_

1	By	_	IN	IN	_	15	prep	_	_
2	transfecting	_	VBG	VBG	_	1	pcomp	_	_
3	tumor	_	NN	NN	_	4	nn	_	_
4	cells	_	NNS	NNS	_	2	dobj	_	_
5	with	_	IN	IN	_	2	prep	_	_
6	both	_	CC	CC	_	7	preconj	_	_
7	IL-12	_	NN	NN	_	5	pobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	B7.1	_	NN	NN	_	7	conj	_	_
10	cDNAs	_	NNS	NNS	_	7	dep	_	_
11	,	_	,	,	_	15	punct	_	_
12	it	_	PRP	PRP	_	15	nsubj	_	_
13	may	_	MD	MD	_	15	aux	_	_
14	be	_	VB	VB	_	15	cop	_	_
15	possible	_	JJ	JJ	_	0	root	_	_
16	to	_	TO	TO	_	17	aux	_	_
17	use	_	VB	VB	_	15	xcomp	_	_
18	these	_	DT	DT	_	20	det	_	_
19	modified	_	VBN	VBN	_	20	amod	_	_
20	targets	_	NNS	NNS	_	17	dobj	_	_
21	as	_	IN	IN	_	17	prep	_	_
22	vaccines	_	NNS	NNS	_	21	pobj	_	_
23	.	_	.	.	_	15	punct	_	_

1	A	_	DT	DT	_	3	det	_	_
2	major	_	JJ	JJ	_	3	amod	_	_
3	obstacle	_	NN	NN	_	12	nsubj	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	designing	_	VBG	VBG	_	4	pcomp	_	_
6	a	_	DT	DT	_	7	det	_	_
7	vector	_	NN	NN	_	5	dobj	_	_
8	to	_	TO	TO	_	9	aux	_	_
9	deliver	_	VB	VB	_	5	xcomp	_	_
10	these	_	DT	DT	_	11	det	_	_
11	genes	_	NNS	NNS	_	9	dobj	_	_
12	results	_	VBZ	VBZ	_	0	root	_	_
13	from	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	structure	_	NN	NN	_	13	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	IL-12	_	NN	NN	_	16	pobj	_	_
18	.	_	.	.	_	12	punct	_	_

1	Functional	_	JJ	JJ	_	2	amod	_	_
2	IL-12	_	NN	NN	_	5	nsubj	_	_
3	is	_	VBZ	VBZ	_	5	cop	_	_
4	a	_	DT	DT	_	5	det	_	_
5	heterodimer	_	NN	NN	_	0	root	_	_
6	composed	_	VBN	VBN	_	5	vmod	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	two	_	CD	CD	_	10	num	_	_
9	distinct	_	JJ	JJ	_	10	amod	_	_
10	subunits	_	NNS	NNS	_	7	pobj	_	_
11	that	_	WDT	WDT	_	13	nsubjpass	_	_
12	are	_	VBP	VBP	_	13	auxpass	_	_
13	encoded	_	VBN	VBN	_	10	rcmod	_	_
14	by	_	IN	IN	_	13	prep	_	_
15	separate	_	JJ	JJ	_	16	amod	_	_
16	genes	_	NNS	NNS	_	14	pobj	_	_
17	on	_	IN	IN	_	16	prep	_	_
18	different	_	JJ	JJ	_	19	amod	_	_
19	chromosomes	_	NNS	NNS	_	17	pobj	_	_
20	.	_	.	.	_	5	punct	_	_

1	Production	_	NN	NN	_	5	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	functional	_	JJ	JJ	_	4	amod	_	_
4	IL-12	_	NN	NN	_	2	pobj	_	_
5	requires	_	VBZ	VBZ	_	0	root	_	_
6	the	_	DT	DT	_	8	det	_	_
7	coordinated	_	VBN	VBN	_	8	amod	_	_
8	expression	_	NN	NN	_	5	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	both	_	DT	DT	_	11	det	_	_
11	genes	_	NNS	NNS	_	9	pobj	_	_
12	.	_	.	.	_	5	punct	_	_

1	This	_	DT	DT	_	2	nsubj	_	_
2	presents	_	VBZ	VBZ	_	0	root	_	_
3	several	_	JJ	JJ	_	4	amod	_	_
4	problems	_	NNS	NNS	_	2	dobj	_	_
5	in	_	IN	IN	_	2	prep	_	_
6	vectors	_	NNS	NNS	_	5	pobj	_	_
7	,	_	,	,	_	6	punct	_	_
8	particularly	_	RB	RB	_	9	advmod	_	_
9	those	_	DT	DT	_	6	appos	_	_
10	in	_	IN	IN	_	25	prep	_	_
11	which	_	WDT	WDT	_	10	pobj	_	_
12	additional	_	JJ	JJ	_	13	amod	_	_
13	genes	_	NNS	NNS	_	25	nsubjpass	_	_
14	,	_	,	,	_	13	punct	_	_
15	either	_	CC	CC	_	18	preconj	_	_
16	a	_	DT	DT	_	18	det	_	_
17	co-stimulatory	_	JJ	JJ	_	18	amod	_	_
18	gene	_	NN	NN	_	13	appos	_	_
19	or	_	CC	CC	_	18	cc	_	_
20	a	_	DT	DT	_	22	det	_	_
21	selectable	_	JJ	JJ	_	22	amod	_	_
22	marker	_	NN	NN	_	18	conj	_	_
23	,	_	,	,	_	13	punct	_	_
24	are	_	VBP	VBP	_	25	auxpass	_	_
25	inserted	_	VBN	VBN	_	9	rcmod	_	_
26	.	_	.	.	_	2	punct	_	_

1	Therefore	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	we	_	PRP	PRP	_	5	nsubj	_	_
4	have	_	VBP	VBP	_	5	aux	_	_
5	constructed	_	VBN	VBN	_	0	root	_	_
6	a	_	DT	DT	_	8	det	_	_
7	single	_	JJ	JJ	_	8	amod	_	_
8	cDNA	_	NN	NN	_	5	dobj	_	_
9	that	_	WDT	WDT	_	10	nsubj	_	_
10	encodes	_	VBZ	VBZ	_	8	rcmod	_	_
11	a	_	DT	DT	_	13	det	_	_
12	single-chain	_	JJ	JJ	_	13	amod	_	_
13	protein	_	NN	NN	_	10	dobj	_	_
14	,	_	,	,	_	8	punct	_	_
15	called	_	VBN	VBN	_	8	vmod	_	_
16	Flexi-12	_	NN	NN	_	15	dep	_	_
17	,	_	,	,	_	8	punct	_	_
18	which	_	WDT	WDT	_	19	nsubj	_	_
19	retains	_	VBZ	VBZ	_	8	rcmod	_	_
20	all	_	DT	DT	_	19	dobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	24	det	_	_
23	biological	_	JJ	JJ	_	24	amod	_	_
24	characteristics	_	NNS	NNS	_	21	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	recombinant	_	JJ	JJ	_	27	amod	_	_
27	IL-12	_	NN	NN	_	25	pobj	_	_
28	-LRB-	_	-LRB-	-LRB-	_	29	punct	_	_
29	rIL-12	_	NN	NN	_	27	appos	_	_
30	-RRB-	_	-RRB-	-RRB-	_	29	punct	_	_
31	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	monomeric	_	JJ	JJ	_	3	amod	_	_
3	polypeptide	_	NN	NN	_	6	nsubj	_	_
4	Flexi-12	_	NN	NN	_	3	dep	_	_
5	is	_	VBZ	VBZ	_	6	cop	_	_
6	able	_	JJ	JJ	_	0	root	_	_
7	to	_	TO	TO	_	8	aux	_	_
8	induce	_	VB	VB	_	6	xcomp	_	_
9	the	_	DT	DT	_	10	det	_	_
10	proliferation	_	NN	NN	_	8	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	phytohemagglutinin	_	NN	NN	_	16	nn	_	_
13	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
14	PHA	_	NN	NN	_	16	nn	_	_
15	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
16	blasts	_	NNS	NNS	_	11	pobj	_	_
17	,	_	,	,	_	8	punct	_	_
18	induce	_	VB	VB	_	8	conj	_	_
19	PHA	_	NN	NN	_	20	nn	_	_
20	blasts	_	NNS	NNS	_	18	dobj	_	_
21	to	_	TO	TO	_	22	aux	_	_
22	secrete	_	VB	VB	_	18	vmod	_	_
23	interferon-gamma	_	NN	NN	_	22	dobj	_	_
24	-LRB-	_	-LRB-	-LRB-	_	25	punct	_	_
25	IFN-gamma	_	NN	NN	_	23	appos	_	_
26	-RRB-	_	-RRB-	-RRB-	_	25	punct	_	_
27	and	_	CC	CC	_	8	cc	_	_
28	additionally	_	RB	RB	_	8	advmod	_	_
29	,	_	,	,	_	8	punct	_	_
30	by	_	IN	IN	_	8	conj	_	_
31	preincubation	_	NN	NN	_	30	pobj	_	_
32	,	_	,	,	_	8	punct	_	_
33	enhance	_	VB	VB	_	8	conj	_	_
34	the	_	DT	DT	_	35	det	_	_
35	killing	_	NN	NN	_	33	dobj	_	_
36	of	_	IN	IN	_	35	prep	_	_
37	K562	_	NN	NN	_	38	nn	_	_
38	targets	_	NNS	NNS	_	36	pobj	_	_
39	by	_	IN	IN	_	35	prep	_	_
40	PBLs	_	NNS	NNS	_	39	pobj	_	_
41	.	_	.	.	_	6	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	phenomena	_	NNS	NNS	_	8	nsubj	_	_
3	are	_	VBP	VBP	_	8	cop	_	_
4	in	_	IN	IN	_	8	prep	_	_
5	a	_	DT	DT	_	7	det	_	_
6	dose-dependent	_	JJ	JJ	_	7	amod	_	_
7	manner	_	NN	NN	_	4	pobj	_	_
8	comparable	_	JJ	JJ	_	0	root	_	_
9	to	_	TO	TO	_	8	prep	_	_
10	that	_	DT	DT	_	9	pobj	_	_
11	seen	_	VBN	VBN	_	10	vmod	_	_
12	with	_	IN	IN	_	11	prep	_	_
13	rIL-12	_	NN	NN	_	12	pobj	_	_
14	.	_	.	.	_	8	punct	_	_

1	We	_	PRP	PRP	_	4	nsubj	_	_
2	have	_	VBP	VBP	_	4	aux	_	_
3	also	_	RB	RB	_	4	advmod	_	_
4	shown	_	VBN	VBN	_	0	root	_	_
5	that	_	IN	IN	_	28	mark	_	_
6	tyrosine	_	NN	NN	_	7	nn	_	_
7	phosphorylation	_	NN	NN	_	28	nsubj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	13	det	_	_
10	STAT	_	NN	NN	_	13	nn	_	_
11	4	_	CD	CD	_	13	num	_	_
12	transcription	_	NN	NN	_	13	nn	_	_
13	factor	_	NN	NN	_	8	pobj	_	_
14	,	_	,	,	_	13	punct	_	_
15	which	_	WDT	WDT	_	18	nsubjpass	_	_
16	has	_	VBZ	VBZ	_	18	aux	_	_
17	been	_	VBN	VBN	_	18	auxpass	_	_
18	shown	_	VBN	VBN	_	13	rcmod	_	_
19	to	_	TO	TO	_	21	aux	_	_
20	be	_	VB	VB	_	21	cop	_	_
21	unique	_	JJ	JJ	_	18	xcomp	_	_
22	to	_	TO	TO	_	21	prep	_	_
23	the	_	DT	DT	_	26	det	_	_
24	IL-12	_	NN	NN	_	26	nn	_	_
25	signaling	_	NN	NN	_	26	nn	_	_
26	pathway	_	NN	NN	_	22	pobj	_	_
27	,	_	,	,	_	7	punct	_	_
28	occurs	_	VBZ	VBZ	_	4	ccomp	_	_
29	with	_	IN	IN	_	28	prep	_	_
30	Flexi-12	_	NN	NN	_	29	pobj	_	_
31	at	_	IN	IN	_	28	prep	_	_
32	levels	_	NNS	NNS	_	31	pobj	_	_
33	similar	_	JJ	JJ	_	32	amod	_	_
34	to	_	TO	TO	_	33	prep	_	_
35	those	_	DT	DT	_	34	pobj	_	_
36	seen	_	VBN	VBN	_	35	vmod	_	_
37	with	_	IN	IN	_	36	prep	_	_
38	rIL-12	_	NN	NN	_	37	pobj	_	_
39	.	_	.	.	_	4	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	packaged	_	VBN	VBN	_	0	root	_	_
4	Flexi-12	_	NN	NN	_	3	dobj	_	_
5	into	_	IN	IN	_	3	prep	_	_
6	a	_	DT	DT	_	9	det	_	_
7	recombinant	_	JJ	JJ	_	9	amod	_	_
8	adeno-associated	_	JJ	JJ	_	9	amod	_	_
9	virus	_	NN	NN	_	5	pobj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	AAV	_	NN	NN	_	9	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	and	_	CC	CC	_	3	cc	_	_
14	used	_	VBN	VBN	_	3	conj	_	_
15	this	_	DT	DT	_	16	det	_	_
16	vector	_	NN	NN	_	14	dobj	_	_
17	to	_	TO	TO	_	18	aux	_	_
18	infect	_	VB	VB	_	14	vmod	_	_
19	acute	_	JJ	JJ	_	25	amod	_	_
20	myeloid	_	JJ	JJ	_	25	amod	_	_
21	leukemic	_	JJ	JJ	_	25	amod	_	_
22	-LRB-	_	-LRB-	-LRB-	_	25	punct	_	_
23	AML	_	NN	NN	_	25	nn	_	_
24	-RRB-	_	-RRB-	-RRB-	_	25	punct	_	_
25	blasts	_	NNS	NNS	_	18	dobj	_	_
26	.	_	.	.	_	3	punct	_	_

1	Infected	_	JJ	JJ	_	3	amod	_	_
2	AML	_	NN	NN	_	3	nn	_	_
3	blasts	_	NNS	NNS	_	4	nsubj	_	_
4	produced	_	VBD	VBD	_	0	root	_	_
5	between	_	IN	IN	_	6	amod	_	_
6	2	_	CD	CD	_	9	num	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	6	_	CD	CD	_	6	conj	_	_
9	ng	_	NN	NN	_	4	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	IL-12/10	_	NN	NN	_	15	nn	_	_
12	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
13	6	_	CD	CD	_	15	num	_	_
14	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
15	cells	_	NNS	NNS	_	10	pobj	_	_
16	per	_	IN	IN	_	9	prep	_	_
17	ml	_	NN	NN	_	16	pobj	_	_
18	per	_	IN	IN	_	4	prep	_	_
19	48	_	CD	CD	_	20	num	_	_
20	hr	_	NN	NN	_	18	pobj	_	_
21	.	_	.	.	_	4	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	studies	_	NNS	NNS	_	4	nsubj	_	_
3	also	_	RB	RB	_	4	advmod	_	_
4	confirm	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	11	mark	_	_
6	AAV	_	NN	NN	_	11	nsubj	_	_
7	is	_	VBZ	VBZ	_	11	cop	_	_
8	an	_	DT	DT	_	11	det	_	_
9	efficient	_	JJ	JJ	_	11	amod	_	_
10	delivery	_	NN	NN	_	11	nn	_	_
11	vehicle	_	NN	NN	_	4	ccomp	_	_
12	for	_	IN	IN	_	11	prep	_	_
13	cytokines	_	NNS	NNS	_	12	pobj	_	_
14	to	_	TO	TO	_	11	prep	_	_
15	leukemic	_	JJ	JJ	_	16	amod	_	_
16	cells	_	NNS	NNS	_	14	pobj	_	_
17	.	_	.	.	_	4	punct	_	_

1	Direct	_	JJ	JJ	_	2	amod	_	_
2	analysis	_	NN	NN	_	12	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	these	_	DT	DT	_	6	det	_	_
5	modified	_	VBN	VBN	_	6	amod	_	_
6	cells	_	NNS	NNS	_	3	pobj	_	_
7	acting	_	VBG	VBG	_	6	vmod	_	_
8	as	_	IN	IN	_	7	prep	_	_
9	tumor	_	NN	NN	_	10	nn	_	_
10	vaccines	_	NNS	NNS	_	8	pobj	_	_
11	is	_	VBZ	VBZ	_	12	cop	_	_
12	underway	_	JJ	JJ	_	0	root	_	_
13	.	_	.	.	_	12	punct	_	_

1	ETS1	_	NN	NN	_	7	nsubj	_	_
2	,	_	,	,	_	1	punct	_	_
3	NFkappaB	_	NN	NN	_	1	conj	_	_
4	and	_	CC	CC	_	1	cc	_	_
5	AP1	_	NN	NN	_	1	conj	_	_
6	synergistically	_	RB	RB	_	7	advmod	_	_
7	transactivate	_	VBP	VBP	_	0	root	_	_
8	the	_	DT	DT	_	11	det	_	_
9	human	_	JJ	JJ	_	11	amod	_	_
10	GM-CSF	_	NN	NN	_	11	nn	_	_
11	promoter	_	NN	NN	_	7	dobj	_	_
12	.	_	.	.	_	7	punct	_	_

1	Activation	_	NN	NN	_	6	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	helper	_	NN	NN	_	5	nn	_	_
4	T	_	NN	NN	_	5	nn	_	_
5	cells	_	NNS	NNS	_	2	pobj	_	_
6	results	_	VBZ	VBZ	_	0	root	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	coordinate	_	JJ	JJ	_	9	amod	_	_
9	expression	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	a	_	DT	DT	_	12	det	_	_
12	number	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	cytokines	_	NNS	NNS	_	13	pobj	_	_
15	involved	_	VBN	VBN	_	14	vmod	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	differentiation	_	NN	NN	_	16	pobj	_	_
18	,	_	,	,	_	17	punct	_	_
19	proliferation	_	NN	NN	_	17	conj	_	_
20	and	_	CC	CC	_	17	cc	_	_
21	activation	_	NN	NN	_	17	conj	_	_
22	of	_	IN	IN	_	17	prep	_	_
23	the	_	DT	DT	_	25	det	_	_
24	haematopoietic	_	JJ	JJ	_	25	amod	_	_
25	system	_	NN	NN	_	22	pobj	_	_
26	.	_	.	.	_	6	punct	_	_

1	Granulocyte-macrophage	_	JJ	JJ	_	4	amod	_	_
2	colony	_	NN	NN	_	4	nn	_	_
3	stimulating	_	NN	NN	_	4	nn	_	_
4	factor	_	NN	NN	_	11	nsubj	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	GM-CSF	_	NN	NN	_	4	appos	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	is	_	VBZ	VBZ	_	11	cop	_	_
9	one	_	CD	CD	_	11	num	_	_
10	such	_	JJ	JJ	_	11	amod	_	_
11	cytokine	_	NN	NN	_	0	root	_	_
12	,	_	,	,	_	11	punct	_	_
13	whose	_	WP$	WP$	_	15	poss	_	_
14	increased	_	VBN	VBN	_	15	amod	_	_
15	expression	_	NN	NN	_	16	nsubj	_	_
16	results	_	VBZ	VBZ	_	11	rcmod	_	_
17	mostly	_	RB	RB	_	18	advmod	_	_
18	from	_	IN	IN	_	16	prep	_	_
19	increases	_	NNS	NNS	_	18	pobj	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	transcription	_	NN	NN	_	20	pobj	_	_
22	.	_	.	.	_	11	punct	_	_

1	Cis-acting	_	JJ	JJ	_	2	amod	_	_
2	elements	_	NNS	NNS	_	13	nsubjpass	_	_
3	with	_	IN	IN	_	2	prep	_	_
4	NFkappaB	_	NN	NN	_	3	pobj	_	_
5	,	_	,	,	_	4	punct	_	_
6	AP1	_	NN	NN	_	4	conj	_	_
7	and	_	CC	CC	_	4	cc	_	_
8	ETS-like	_	JJ	JJ	_	4	conj	_	_
9	binding	_	VBG	VBG	_	10	amod	_	_
10	motifs	_	NNS	NNS	_	4	dep	_	_
11	have	_	VBP	VBP	_	13	aux	_	_
12	been	_	VBN	VBN	_	13	auxpass	_	_
13	identified	_	VBN	VBN	_	0	root	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	17	det	_	_
16	promoter	_	NN	NN	_	17	nn	_	_
17	region	_	NN	NN	_	14	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	GM-CSF	_	NN	NN	_	21	nn	_	_
21	gene	_	NN	NN	_	18	pobj	_	_
22	,	_	,	,	_	13	punct	_	_
23	and	_	CC	CC	_	13	cc	_	_
24	are	_	VBP	VBP	_	25	cop	_	_
25	important	_	JJ	JJ	_	13	conj	_	_
26	or	_	CC	CC	_	25	cc	_	_
27	essential	_	JJ	JJ	_	25	conj	_	_
28	for	_	IN	IN	_	25	prep	_	_
29	transcriptional	_	JJ	JJ	_	30	amod	_	_
30	activity	_	NN	NN	_	28	pobj	_	_
31	following	_	VBG	VBG	_	30	prep	_	_
32	T	_	NN	NN	_	34	nn	_	_
33	cell	_	NN	NN	_	34	nn	_	_
34	activation	_	NN	NN	_	31	pobj	_	_
35	.	_	.	.	_	13	punct	_	_

1	ETS1	_	NN	NN	_	5	nsubj	_	_
2	is	_	VBZ	VBZ	_	5	cop	_	_
3	a	_	DT	DT	_	5	det	_	_
4	transcription	_	NN	NN	_	5	nn	_	_
5	factor	_	NN	NN	_	0	root	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	ETS	_	NN	NN	_	9	nn	_	_
9	family	_	NN	NN	_	6	pobj	_	_
10	that	_	WDT	WDT	_	12	nsubjpass	_	_
11	is	_	VBZ	VBZ	_	12	auxpass	_	_
12	expressed	_	VBN	VBN	_	5	rcmod	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	T	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	13	pobj	_	_
16	.	_	.	.	_	5	punct	_	_

1	We	_	PRP	PRP	_	4	nsubj	_	_
2	have	_	VBP	VBP	_	4	aux	_	_
3	previously	_	RB	RB	_	4	advmod	_	_
4	shown	_	VBN	VBN	_	0	root	_	_
5	that	_	IN	IN	_	8	mark	_	_
6	ETS1	_	NN	NN	_	8	nsubj	_	_
7	can	_	MD	MD	_	8	aux	_	_
8	transactivate	_	VB	VB	_	4	ccomp	_	_
9	GM-CSF	_	NN	NN	_	8	dobj	_	_
10	in	_	IN	IN	_	8	prep	_	_
11	Jurkat	_	NN	NN	_	13	nn	_	_
12	T	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	10	pobj	_	_
14	,	_	,	,	_	8	punct	_	_
15	but	_	CC	CC	_	8	cc	_	_
16	only	_	RB	RB	_	22	advmod	_	_
17	after	_	IN	IN	_	22	dep	_	_
18	the	_	DT	DT	_	19	det	_	_
19	cells	_	NNS	NNS	_	22	dep	_	_
20	have	_	VBP	VBP	_	22	aux	_	_
21	been	_	VBN	VBN	_	22	auxpass	_	_
22	stimulated	_	VBN	VBN	_	8	advcl	_	_
23	by	_	IN	IN	_	22	prep	_	_
24	treatment	_	NN	NN	_	23	pobj	_	_
25	with	_	IN	IN	_	24	prep	_	_
26	PMA	_	NN	NN	_	25	pobj	_	_
27	and	_	CC	CC	_	26	cc	_	_
28	ionomycin	_	NN	NN	_	26	conj	_	_
29	,	_	,	,	_	26	punct	_	_
30	agents	_	NNS	NNS	_	26	appos	_	_
31	that	_	WDT	WDT	_	32	nsubj	_	_
32	mimic	_	VBP	VBP	_	30	rcmod	_	_
33	T	_	NN	NN	_	35	nn	_	_
34	cell	_	NN	NN	_	35	nn	_	_
35	activation	_	NN	NN	_	32	dobj	_	_
36	.	_	.	.	_	4	punct	_	_

1	Thus	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	proposed	_	VBD	VBD	_	0	root	_	_
4	that	_	IN	IN	_	16	mark	_	_
5	ETS1	_	NN	NN	_	16	nsubj	_	_
6	,	_	,	,	_	5	punct	_	_
7	which	_	WDT	WDT	_	9	nsubjpass	_	_
8	is	_	VBZ	VBZ	_	9	auxpass	_	_
9	expressed	_	VBN	VBN	_	5	rcmod	_	_
10	constitutively	_	RB	RB	_	9	advmod	_	_
11	in	_	IN	IN	_	9	prep	_	_
12	Jurkat	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	11	pobj	_	_
14	,	_	,	,	_	5	punct	_	_
15	may	_	MD	MD	_	16	aux	_	_
16	act	_	VB	VB	_	3	ccomp	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	concert	_	NN	NN	_	17	pobj	_	_
19	with	_	IN	IN	_	18	prep	_	_
20	PMA/ionomycin	_	NN	NN	_	22	nn	_	_
21	inducible	_	JJ	JJ	_	22	amod	_	_
22	factors	_	NNS	NNS	_	19	pobj	_	_
23	.	_	.	.	_	3	punct	_	_

1	Here	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	show	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	7	mark	_	_
5	ETS1	_	NN	NN	_	7	nsubj	_	_
6	can	_	MD	MD	_	7	aux	_	_
7	transactivate	_	VB	VB	_	3	ccomp	_	_
8	a	_	DT	DT	_	11	det	_	_
9	GM-CSF	_	NN	NN	_	11	nn	_	_
10	reporter	_	NN	NN	_	11	nn	_	_
11	construct	_	NN	NN	_	7	dobj	_	_
12	in	_	IN	IN	_	7	prep	_	_
13	unstimulated	_	JJ	JJ	_	15	amod	_	_
14	Jurkat	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	12	pobj	_	_
16	,	_	,	,	_	7	punct	_	_
17	providing	_	VBG	VBG	_	7	prep	_	_
18	that	_	IN	IN	_	26	mark	_	_
19	either	_	CC	CC	_	20	preconj	_	_
20	NFkappaB	_	NN	NN	_	26	nsubjpass	_	_
21	or	_	CC	CC	_	20	cc	_	_
22	AP1	_	NN	NN	_	20	conj	_	_
23	transcription	_	NN	NN	_	24	nn	_	_
24	factors	_	NNS	NNS	_	20	dep	_	_
25	are	_	VBP	VBP	_	26	auxpass	_	_
26	supplied	_	VBN	VBN	_	17	pcomp	_	_
27	by	_	IN	IN	_	26	prep	_	_
28	co-transfection	_	NN	NN	_	27	pobj	_	_
29	.	_	.	.	_	3	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	confirm	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	11	mark	_	_
4	binding	_	NN	NN	_	11	nsubjpass	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	endogenous	_	JJ	JJ	_	7	amod	_	_
7	NFkappaB	_	NN	NN	_	5	pobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	AP1	_	NN	NN	_	7	conj	_	_
10	is	_	VBZ	VBZ	_	11	auxpass	_	_
11	induced	_	VBN	VBN	_	2	ccomp	_	_
12	following	_	VBG	VBG	_	11	prep	_	_
13	PMA/ionomycin	_	NN	NN	_	14	nn	_	_
14	treatment	_	NN	NN	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	T	_	NN	NN	_	17	nn	_	_
17	cells	_	NNS	NNS	_	15	pobj	_	_
18	.	_	.	.	_	2	punct	_	_

1	Transactivation	_	NN	NN	_	9	nsubj	_	_
2	by	_	IN	IN	_	1	prep	_	_
3	ETS1	_	NN	NN	_	2	pobj	_	_
4	,	_	,	,	_	3	punct	_	_
5	NFkappaB	_	NN	NN	_	3	conj	_	_
6	and	_	CC	CC	_	3	cc	_	_
7	AP1	_	NN	NN	_	3	conj	_	_
8	is	_	VBZ	VBZ	_	9	cop	_	_
9	synergistic	_	JJ	JJ	_	0	root	_	_
10	,	_	,	,	_	9	punct	_	_
11	and	_	CC	CC	_	9	cc	_	_
12	mutation	_	NN	NN	_	18	nsubj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	17	det	_	_
15	individual	_	JJ	JJ	_	17	amod	_	_
16	binding	_	VBG	VBG	_	17	amod	_	_
17	sites	_	NNS	NNS	_	13	pobj	_	_
18	reveals	_	VBZ	VBZ	_	9	conj	_	_
19	that	_	IN	IN	_	27	mark	_	_
20	the	_	DT	DT	_	22	det	_	_
21	transcriptional	_	JJ	JJ	_	22	amod	_	_
22	activities	_	NNS	NNS	_	27	nsubj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	these	_	DT	DT	_	25	det	_	_
25	factors	_	NNS	NNS	_	23	pobj	_	_
26	are	_	VBP	VBP	_	27	cop	_	_
27	interdependent	_	JJ	JJ	_	18	ccomp	_	_
28	.	_	.	.	_	9	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	14	mark	_	_
5	constitutive	_	JJ	JJ	_	6	amod	_	_
6	ETS1	_	NN	NN	_	14	nsubj	_	_
7	,	_	,	,	_	6	punct	_	_
8	and	_	CC	CC	_	6	cc	_	_
9	inducible	_	JJ	JJ	_	10	amod	_	_
10	NFkappaB	_	NN	NN	_	6	conj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	AP1	_	NN	NN	_	10	conj	_	_
13	,	_	,	,	_	6	punct	_	_
14	cooperate	_	VBP	VBP	_	3	ccomp	_	_
15	as	_	IN	IN	_	14	prep	_	_
16	part	_	NN	NN	_	15	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	a	_	DT	DT	_	20	det	_	_
19	higher	_	JJR	JJR	_	20	amod	_	_
20	order	_	NN	NN	_	17	pobj	_	_
21	transcriptional	_	JJ	JJ	_	22	amod	_	_
22	complex	_	NN	NN	_	20	dep	_	_
23	in	_	IN	IN	_	20	prep	_	_
24	activated	_	VBN	VBN	_	26	amod	_	_
25	T	_	NN	NN	_	26	nn	_	_
26	cells	_	NNS	NNS	_	23	pobj	_	_
27	.	_	.	.	_	3	punct	_	_

1	Relief	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	cyclin	_	NN	NN	_	4	nn	_	_
4	A	_	NN	NN	_	7	nn	_	_
5	gene	_	NN	NN	_	7	nn	_	_
6	transcriptional	_	JJ	JJ	_	7	amod	_	_
7	inhibition	_	NN	NN	_	2	pobj	_	_
8	during	_	IN	IN	_	1	prep	_	_
9	activation	_	NN	NN	_	8	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	human	_	JJ	JJ	_	14	amod	_	_
12	primary	_	JJ	JJ	_	14	amod	_	_
13	T	_	NN	NN	_	14	nn	_	_
14	lymphocytes	_	NNS	NNS	_	10	pobj	_	_
15	via	_	IN	IN	_	9	prep	_	_
16	CD2	_	NN	NN	_	15	pobj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	CD28	_	NN	NN	_	16	conj	_	_
19	adhesion	_	NN	NN	_	20	nn	_	_
20	molecules	_	NNS	NNS	_	16	dep	_	_
21	.	_	.	.	_	1	punct	_	_

1	Cyclin	_	NN	NN	_	2	nn	_	_
2	A	_	NN	NN	_	3	nn	_	_
3	transcription	_	NN	NN	_	7	nsubjpass	_	_
4	is	_	VBZ	VBZ	_	7	auxpass	_	_
5	cell	_	NN	NN	_	6	nn	_	_
6	cycle	_	NN	NN	_	7	npadvmod	_	_
7	regulated	_	JJ	JJ	_	0	root	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	induced	_	VBN	VBN	_	7	conj	_	_
10	by	_	IN	IN	_	9	prep	_	_
11	cell	_	NN	NN	_	13	nn	_	_
12	proliferative	_	JJ	JJ	_	13	amod	_	_
13	signals	_	NNS	NNS	_	10	pobj	_	_
14	.	_	.	.	_	7	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	understand	_	VB	VB	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	mechanisms	_	NNS	NNS	_	2	dobj	_	_
5	underlined	_	VBN	VBN	_	4	vmod	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	this	_	DT	DT	_	8	det	_	_
8	regulation	_	NN	NN	_	6	pobj	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	normal	_	JJ	JJ	_	12	amod	_	_
11	human	_	JJ	JJ	_	12	amod	_	_
12	cells	_	NNS	NNS	_	9	pobj	_	_
13	,	_	,	,	_	2	punct	_	_
14	we	_	PRP	PRP	_	16	nsubj	_	_
15	have	_	VBP	VBP	_	16	aux	_	_
16	analysed	_	VBN	VBN	_	2	parataxis	_	_
17	in	_	FW	FW	_	20	amod	_	_
18	vivo	_	FW	FW	_	17	dep	_	_
19	protein-DNA	_	JJ	JJ	_	20	amod	_	_
20	interactions	_	NNS	NNS	_	16	dobj	_	_
21	at	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	25	det	_	_
23	Cyclin	_	NN	NN	_	24	nn	_	_
24	A	_	NN	NN	_	25	nn	_	_
25	locus	_	NN	NN	_	21	pobj	_	_
26	in	_	IN	IN	_	25	prep	_	_
27	primary	_	JJ	JJ	_	29	amod	_	_
28	T	_	NN	NN	_	29	nn	_	_
29	lymphocytes	_	NNS	NNS	_	26	pobj	_	_
30	.	_	.	.	_	2	punct	_	_

1	Stimulation	_	NN	NN	_	19	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	purified	_	VBN	VBN	_	5	amod	_	_
4	T	_	NN	NN	_	5	nn	_	_
5	lymphocytes	_	NNS	NNS	_	2	pobj	_	_
6	by	_	IN	IN	_	1	prep	_	_
7	a	_	DT	DT	_	8	det	_	_
8	combination	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	monoclonal	_	JJ	JJ	_	11	amod	_	_
11	antibodies	_	NNS	NNS	_	9	pobj	_	_
12	directed	_	VBN	VBN	_	1	vmod	_	_
13	at	_	IN	IN	_	12	prep	_	_
14	CD2	_	NN	NN	_	13	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	CD28	_	NN	NN	_	14	conj	_	_
17	adhesion	_	NN	NN	_	18	nn	_	_
18	molecules	_	NNS	NNS	_	14	dep	_	_
19	gives	_	VBZ	VBZ	_	0	root	_	_
20	rise	_	NN	NN	_	19	dobj	_	_
21	to	_	TO	TO	_	19	prep	_	_
22	a	_	DT	DT	_	25	det	_	_
23	long	_	JJ	JJ	_	24	amod	_	_
24	lasting	_	JJ	JJ	_	25	amod	_	_
25	proliferation	_	NN	NN	_	21	pobj	_	_
26	in	_	IN	IN	_	19	prep	_	_
27	the	_	DT	DT	_	28	det	_	_
28	absence	_	NN	NN	_	26	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	accessory	_	NN	NN	_	31	nn	_	_
31	cells	_	NNS	NNS	_	29	pobj	_	_
32	.	_	.	.	_	19	punct	_	_

1	Cyclin	_	NN	NN	_	2	nn	_	_
2	A	_	NN	NN	_	4	nsubjpass	_	_
3	was	_	VBD	VBD	_	4	auxpass	_	_
4	observed	_	VBN	VBN	_	0	root	_	_
5	after	_	IN	IN	_	4	prep	_	_
6	4	_	CD	CD	_	7	num	_	_
7	days	_	NNS	NNS	_	5	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	costimulation	_	NN	NN	_	8	pobj	_	_
10	with	_	IN	IN	_	9	prep	_	_
11	anti	_	JJ	JJ	_	12	amod	_	_
12	CD2	_	NN	NN	_	10	pobj	_	_
13	+	_	CC	CC	_	12	cc	_	_
14	CD28	_	NN	NN	_	12	conj	_	_
15	whereas	_	IN	IN	_	26	mark	_	_
16	stimulation	_	NN	NN	_	26	nsubj	_	_
17	by	_	IN	IN	_	16	prep	_	_
18	anti	_	JJ	JJ	_	19	amod	_	_
19	CD2	_	NN	NN	_	17	pobj	_	_
20	or	_	CC	CC	_	19	cc	_	_
21	anti	_	JJ	JJ	_	22	amod	_	_
22	CD28	_	NN	NN	_	19	conj	_	_
23	alone	_	RB	RB	_	19	advmod	_	_
24	was	_	VBD	VBD	_	26	cop	_	_
25	not	_	RB	RB	_	26	neg	_	_
26	effective	_	JJ	JJ	_	4	advcl	_	_
27	.	_	.	.	_	4	punct	_	_

1	In	_	FW	FW	_	5	amod	_	_
2	vivo	_	FW	FW	_	1	dep	_	_
3	genomic	_	JJ	JJ	_	1	dep	_	_
4	DMS	_	NN	NN	_	5	nn	_	_
5	footprinting	_	NN	NN	_	6	nsubj	_	_
6	revealed	_	VBD	VBD	_	0	root	_	_
7	upstream	_	RB	RB	_	6	advmod	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	13	det	_	_
10	major	_	JJ	JJ	_	13	amod	_	_
11	transcription	_	NN	NN	_	13	nn	_	_
12	initiation	_	NN	NN	_	13	nn	_	_
13	sites	_	NNS	NNS	_	8	pobj	_	_
14	,	_	,	,	_	6	punct	_	_
15	the	_	DT	DT	_	16	det	_	_
16	presence	_	NN	NN	_	6	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	at	_	IN	IN	_	20	quantmod	_	_
19	least	_	JJS	JJS	_	18	mwe	_	_
20	three	_	CD	CD	_	23	num	_	_
21	protein	_	NN	NN	_	23	nn	_	_
22	binding	_	NN	NN	_	23	nn	_	_
23	sites	_	NNS	NNS	_	17	pobj	_	_
24	,	_	,	,	_	23	punct	_	_
25	two	_	CD	CD	_	30	nsubjpass	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	which	_	WDT	WDT	_	26	pobj	_	_
28	were	_	VBD	VBD	_	30	auxpass	_	_
29	constitutively	_	RB	RB	_	30	advmod	_	_
30	occupied	_	VBN	VBN	_	23	rcmod	_	_
31	.	_	.	.	_	6	punct	_	_

1	They	_	PRP	PRP	_	2	nsubj	_	_
2	bind	_	VBP	VBP	_	0	root	_	_
3	in	_	FW	FW	_	4	nn	_	_
4	vitro	_	FW	FW	_	2	advmod	_	_
5	respectively	_	RB	RB	_	2	advmod	_	_
6	ATF-1	_	NN	NN	_	2	dobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	NF-Y	_	NN	NN	_	9	nn	_	_
9	proteins	_	NNS	NNS	_	6	conj	_	_
10	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	third	_	JJ	JJ	_	3	amod	_	_
3	site	_	NN	NN	_	5	nsubjpass	_	_
4	was	_	VBD	VBD	_	5	auxpass	_	_
5	occupied	_	VBN	VBN	_	0	root	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	quiescent	_	JJ	JJ	_	8	amod	_	_
8	cells	_	NNS	NNS	_	6	pobj	_	_
9	or	_	CC	CC	_	6	cc	_	_
10	in	_	IN	IN	_	6	conj	_	_
11	cells	_	NNS	NNS	_	10	pobj	_	_
12	stimulated	_	VBN	VBN	_	11	vmod	_	_
13	by	_	IN	IN	_	12	prep	_	_
14	anti	_	JJ	JJ	_	15	amod	_	_
15	CD2	_	NN	NN	_	13	pobj	_	_
16	or	_	CC	CC	_	15	cc	_	_
17	anti	_	JJ	JJ	_	18	amod	_	_
18	CD28	_	NN	NN	_	15	conj	_	_
19	alone	_	RB	RB	_	15	advmod	_	_
20	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	mitogenic	_	JJ	JJ	_	3	amod	_	_
3	combination	_	NN	NN	_	10	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	anti	_	JJ	JJ	_	6	amod	_	_
6	CD2	_	NN	NN	_	4	pobj	_	_
7	+	_	CC	CC	_	6	cc	_	_
8	anti	_	JJ	JJ	_	9	amod	_	_
9	CD28	_	NN	NN	_	6	conj	_	_
10	released	_	VBD	VBD	_	0	root	_	_
11	the	_	DT	DT	_	12	det	_	_
12	footprint	_	NN	NN	_	10	dobj	_	_
13	as	_	IN	IN	_	16	mark	_	_
14	cells	_	NNS	NNS	_	16	nsubjpass	_	_
15	were	_	VBD	VBD	_	16	auxpass	_	_
16	committed	_	VBN	VBN	_	10	advcl	_	_
17	to	_	TO	TO	_	16	prep	_	_
18	proliferation	_	NN	NN	_	17	pobj	_	_
19	.	_	.	.	_	10	punct	_	_

1	Consistent	_	JJ	JJ	_	12	advmod	_	_
2	with	_	IN	IN	_	1	prep	_	_
3	theses	_	DT	DT	_	4	det	_	_
4	results	_	NNS	NNS	_	2	pobj	_	_
5	,	_	,	,	_	12	punct	_	_
6	nuclear	_	JJ	JJ	_	7	amod	_	_
7	extracts	_	NNS	NNS	_	12	nsubj	_	_
8	prepared	_	VBN	VBN	_	7	vmod	_	_
9	from	_	IN	IN	_	8	prep	_	_
10	quiescent	_	JJ	JJ	_	11	amod	_	_
11	cells	_	NNS	NNS	_	9	pobj	_	_
12	formed	_	VBD	VBD	_	0	root	_	_
13	a	_	DT	DT	_	15	det	_	_
14	specific	_	JJ	JJ	_	15	amod	_	_
15	complex	_	NN	NN	_	12	dobj	_	_
16	with	_	IN	IN	_	15	prep	_	_
17	this	_	DT	DT	_	18	det	_	_
18	element	_	NN	NN	_	16	pobj	_	_
19	,	_	,	,	_	12	punct	_	_
20	whereas	_	IN	IN	_	32	mark	_	_
21	extracts	_	NNS	NNS	_	32	nsubj	_	_
22	prepared	_	VBN	VBN	_	21	vmod	_	_
23	from	_	IN	IN	_	22	prep	_	_
24	cells	_	NNS	NNS	_	23	pobj	_	_
25	treated	_	VBN	VBN	_	24	vmod	_	_
26	with	_	IN	IN	_	25	prep	_	_
27	anti	_	JJ	JJ	_	28	amod	_	_
28	CD2	_	NN	NN	_	26	pobj	_	_
29	+	_	CC	CC	_	28	cc	_	_
30	anti	_	JJ	JJ	_	31	amod	_	_
31	CD28	_	NN	NN	_	28	conj	_	_
32	failed	_	VBD	VBD	_	12	advcl	_	_
33	to	_	TO	TO	_	34	aux	_	_
34	do	_	VB	VB	_	32	xcomp	_	_
35	so	_	RB	RB	_	34	advmod	_	_
36	after	_	IN	IN	_	38	mark	_	_
37	cells	_	NNS	NNS	_	38	nsubj	_	_
38	entered	_	VBD	VBD	_	32	advcl	_	_
39	a	_	DT	DT	_	41	det	_	_
40	proliferative	_	JJ	JJ	_	41	amod	_	_
41	state	_	NN	NN	_	38	dobj	_	_
42	.	_	.	.	_	12	punct	_	_

1	Molecular	_	JJ	JJ	_	2	amod	_	_
2	cloning	_	NN	NN	_	0	root	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	characterization	_	NN	NN	_	2	conj	_	_
5	of	_	IN	IN	_	2	prep	_	_
6	a	_	DT	DT	_	7	det	_	_
7	cDNA	_	NN	NN	_	5	pobj	_	_
8	,	_	,	,	_	7	punct	_	_
9	CHEMR1	_	NN	NN	_	7	appos	_	_
10	,	_	,	,	_	7	punct	_	_
11	encoding	_	VBG	VBG	_	7	vmod	_	_
12	a	_	DT	DT	_	14	det	_	_
13	chemokine	_	NN	NN	_	14	nn	_	_
14	receptor	_	NN	NN	_	11	dobj	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	a	_	DT	DT	_	17	det	_	_
17	homology	_	NN	NN	_	15	pobj	_	_
18	to	_	TO	TO	_	17	prep	_	_
19	the	_	DT	DT	_	23	det	_	_
20	human	_	JJ	JJ	_	23	amod	_	_
21	C-C	_	NN	NN	_	23	nn	_	_
22	chemokine	_	NN	NN	_	23	nn	_	_
23	receptor	_	NN	NN	_	18	pobj	_	_
24	,	_	,	,	_	23	punct	_	_
25	CCR-4	_	NN	NN	_	23	appos	_	_
26	.	_	.	.	_	2	punct	_	_

1	Chemokines	_	NNS	NNS	_	2	nsubj	_	_
2	refer	_	VBP	VBP	_	0	root	_	_
3	to	_	TO	TO	_	2	prep	_	_
4	a	_	DT	DT	_	7	det	_	_
5	rapidly	_	RB	RB	_	6	advmod	_	_
6	expanding	_	VBG	VBG	_	7	amod	_	_
7	family	_	NN	NN	_	3	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	small	_	JJ	JJ	_	10	amod	_	_
10	cytokines	_	NNS	NNS	_	8	pobj	_	_
11	whose	_	WP$	WP$	_	13	poss	_	_
12	primary	_	JJ	JJ	_	13	amod	_	_
13	function	_	NN	NN	_	15	nsubj	_	_
14	is	_	VBZ	VBZ	_	15	cop	_	_
15	recruitment	_	NN	NN	_	7	rcmod	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	leukocytes	_	NNS	NNS	_	16	pobj	_	_
18	to	_	TO	TO	_	15	prep	_	_
19	inflammatory	_	JJ	JJ	_	20	amod	_	_
20	sites	_	NNS	NNS	_	18	pobj	_	_
21	.	_	.	.	_	2	punct	_	_

1	These	_	DT	DT	_	3	nsubjpass	_	_
2	are	_	VBP	VBP	_	3	auxpass	_	_
3	known	_	VBN	VBN	_	0	root	_	_
4	to	_	TO	TO	_	5	aux	_	_
5	bind	_	VB	VB	_	3	xcomp	_	_
6	to	_	TO	TO	_	5	prep	_	_
7	seven-transmembrane-domain	_	NN	NN	_	9	nn	_	_
8	containing	_	VBG	VBG	_	9	amod	_	_
9	receptors	_	NNS	NNS	_	6	pobj	_	_
10	.	_	.	.	_	3	punct	_	_

1	A	_	DT	DT	_	3	det	_	_
2	cDNA	_	NN	NN	_	3	nn	_	_
3	clone	_	NN	NN	_	15	nsubjpass	_	_
4	,	_	,	,	_	3	punct	_	_
5	CHEMR1	_	NN	NN	_	3	appos	_	_
6	,	_	,	,	_	3	punct	_	_
7	resembling	_	VBG	VBG	_	3	vmod	_	_
8	the	_	DT	DT	_	12	det	_	_
9	typical	_	JJ	JJ	_	12	amod	_	_
10	G	_	NN	NN	_	12	nn	_	_
11	protein-coupled	_	JJ	JJ	_	12	amod	_	_
12	receptor	_	NN	NN	_	7	xcomp	_	_
13	,	_	,	,	_	3	punct	_	_
14	was	_	VBD	VBD	_	15	auxpass	_	_
15	isolated	_	VBN	VBN	_	0	root	_	_
16	from	_	IN	IN	_	15	prep	_	_
17	a	_	DT	DT	_	24	det	_	_
18	mouse	_	NN	NN	_	24	nn	_	_
19	cytotoxic	_	JJ	JJ	_	24	amod	_	_
20	T-lymphocyte	_	NN	NN	_	24	nn	_	_
21	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
22	CTL	_	NN	NN	_	24	nn	_	_
23	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
24	library	_	NN	NN	_	16	pobj	_	_
25	.	_	.	.	_	15	punct	_	_

1	Northern	_	NN	NN	_	3	nn	_	_
2	blot	_	NN	NN	_	3	nn	_	_
3	analysis	_	NN	NN	_	8	nsubj	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	mouse	_	NN	NN	_	7	nn	_	_
6	cell	_	NN	NN	_	7	nn	_	_
7	lines	_	NNS	NNS	_	4	pobj	_	_
8	suggests	_	VBZ	VBZ	_	0	root	_	_
9	that	_	IN	IN	_	13	mark	_	_
10	its	_	PRP$	PRP$	_	11	poss	_	_
11	expression	_	NN	NN	_	13	nsubjpass	_	_
12	is	_	VBZ	VBZ	_	13	auxpass	_	_
13	found	_	VBN	VBN	_	8	ccomp	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	a	_	DT	DT	_	16	det	_	_
16	variety	_	NN	NN	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	cells	_	NNS	NNS	_	17	pobj	_	_
19	,	_	,	,	_	16	punct	_	_
20	including	_	VBG	VBG	_	16	prep	_	_
21	T	_	NN	NN	_	22	nn	_	_
22	cells	_	NNS	NNS	_	20	pobj	_	_
23	,	_	,	,	_	22	punct	_	_
24	B	_	NN	NN	_	25	nn	_	_
25	cells	_	NNS	NNS	_	22	conj	_	_
26	,	_	,	,	_	22	punct	_	_
27	and	_	CC	CC	_	22	cc	_	_
28	macrophages	_	NNS	NNS	_	22	conj	_	_
29	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	CHEMR1	_	NN	NN	_	3	nn	_	_
3	gene	_	NN	NN	_	8	nsubj	_	_
4	Scya3r2	_	NN	NN	_	3	dep	_	_
5	is	_	VBZ	VBZ	_	8	cop	_	_
6	a	_	DT	DT	_	8	det	_	_
7	single-copy	_	JJ	JJ	_	8	amod	_	_
8	gene	_	NN	NN	_	0	root	_	_
9	whose	_	WP$	WP$	_	12	poss	_	_
10	open	_	JJ	JJ	_	12	amod	_	_
11	reading	_	NN	NN	_	12	nn	_	_
12	frame	_	NN	NN	_	14	nsubj	_	_
13	may	_	MD	MD	_	14	aux	_	_
14	be	_	VB	VB	_	8	rcmod	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	a	_	DT	DT	_	18	det	_	_
17	single	_	JJ	JJ	_	18	amod	_	_
18	exon	_	NN	NN	_	15	pobj	_	_
19	and	_	CC	CC	_	14	cc	_	_
20	maps	_	VBZ	VBZ	_	14	conj	_	_
21	to	_	TO	TO	_	20	prep	_	_
22	the	_	DT	DT	_	24	det	_	_
23	distal	_	JJ	JJ	_	24	amod	_	_
24	region	_	NN	NN	_	21	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	mouse	_	NN	NN	_	27	nn	_	_
27	Chr	_	NN	NN	_	25	pobj	_	_
28	9	_	CD	CD	_	27	num	_	_
29	where	_	WRB	WRB	_	48	advmod	_	_
30	the	_	DT	DT	_	39	det	_	_
31	mouse	_	NN	NN	_	39	nn	_	_
32	macrophage	_	NN	NN	_	39	nn	_	_
33	inflammatory	_	JJ	JJ	_	39	amod	_	_
34	protein-1alpha	_	NN	NN	_	39	nn	_	_
35	-LRB-	_	-LRB-	-LRB-	_	39	punct	_	_
36	MIP-1alpha	_	NN	NN	_	39	nn	_	_
37	-RRB-	_	-RRB-	-RRB-	_	39	punct	_	_
38	receptor	_	NN	NN	_	39	nn	_	_
39	gene	_	NN	NN	_	48	nsubj	_	_
40	Scya3r	_	NN	NN	_	39	dep	_	_
41	and	_	CC	CC	_	39	cc	_	_
42	two	_	CD	CD	_	47	num	_	_
43	related	_	JJ	JJ	_	47	amod	_	_
44	C-C	_	NN	NN	_	47	nn	_	_
45	chemokine	_	NN	NN	_	47	nn	_	_
46	receptor-like	_	JJ	JJ	_	47	amod	_	_
47	genes	_	NNS	NNS	_	39	conj	_	_
48	reside	_	VBP	VBP	_	24	rcmod	_	_
49	.	_	.	.	_	8	punct	_	_

1	Amino	_	NN	NN	_	4	nn	_	_
2	acid	_	NN	NN	_	4	nn	_	_
3	sequence	_	NN	NN	_	4	nn	_	_
4	comparison	_	NN	NN	_	5	nsubj	_	_
5	shows	_	VBZ	VBZ	_	0	root	_	_
6	that	_	IN	IN	_	11	mark	_	_
7	CHEMR1	_	NN	NN	_	11	nsubj	_	_
8	is	_	VBZ	VBZ	_	11	cop	_	_
9	84	_	CD	CD	_	10	num	_	_
10	%	_	NN	NN	_	11	npadvmod	_	_
11	identical	_	JJ	JJ	_	5	ccomp	_	_
12	to	_	TO	TO	_	11	prep	_	_
13	human	_	JJ	JJ	_	14	amod	_	_
14	CCR-4	_	NN	NN	_	12	pobj	_	_
15	,	_	,	,	_	11	punct	_	_
16	indicating	_	VBG	VBG	_	11	xcomp	_	_
17	that	_	IN	IN	_	20	mark	_	_
18	CHEMR1	_	NN	NN	_	20	nsubj	_	_
19	is	_	VBZ	VBZ	_	20	cop	_	_
20	likely	_	JJ	JJ	_	16	ccomp	_	_
21	to	_	TO	TO	_	25	aux	_	_
22	be	_	VB	VB	_	25	cop	_	_
23	a	_	DT	DT	_	25	det	_	_
24	mouse	_	NN	NN	_	25	nn	_	_
25	CCR-4	_	NN	NN	_	20	xcomp	_	_
26	.	_	.	.	_	5	punct	_	_

1	Binding	_	NN	NN	_	2	nn	_	_
2	assays	_	NNS	NNS	_	10	nsubj	_	_
3	using	_	VBG	VBG	_	2	vmod	_	_
4	125I-labeled	_	JJ	JJ	_	6	amod	_	_
5	C-C	_	NN	NN	_	6	nn	_	_
6	chemokines	_	NNS	NNS	_	3	dobj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	mammalian	_	JJ	JJ	_	9	amod	_	_
9	cells	_	NNS	NNS	_	7	pobj	_	_
10	indicated	_	VBD	VBD	_	0	root	_	_
11	that	_	IN	IN	_	15	mark	_	_
12	CHEMR1	_	NN	NN	_	15	nsubj	_	_
13	did	_	VBD	VBD	_	15	aux	_	_
14	not	_	RB	RB	_	15	neg	_	_
15	bind	_	VB	VB	_	10	ccomp	_	_
16	MIP-1alpha	_	NN	NN	_	15	dobj	_	_
17	,	_	,	,	_	16	punct	_	_
18	RANTES	_	NN	NN	_	16	conj	_	_
19	,	_	,	,	_	16	punct	_	_
20	or	_	CC	CC	_	16	cc	_	_
21	MIP-1beta	_	NN	NN	_	16	conj	_	_
22	,	_	,	,	_	15	punct	_	_
23	whereas	_	IN	IN	_	25	mark	_	_
24	CCR-1	_	NN	NN	_	25	nsubj	_	_
25	binds	_	VBZ	VBZ	_	15	advcl	_	_
26	MIP-1alpha	_	NN	NN	_	25	dobj	_	_
27	and	_	CC	CC	_	26	cc	_	_
28	RANTES	_	NN	NN	_	26	conj	_	_
29	.	_	.	.	_	10	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	result	_	NN	NN	_	4	nsubj	_	_
3	is	_	VBZ	VBZ	_	4	cop	_	_
4	different	_	JJ	JJ	_	0	root	_	_
5	from	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	reported	_	VBN	VBN	_	8	amod	_	_
8	properties	_	NNS	NNS	_	5	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	human	_	JJ	JJ	_	11	amod	_	_
11	CCR-4	_	NN	NN	_	9	pobj	_	_
12	.	_	.	.	_	4	punct	_	_

1	This	_	DT	DT	_	2	nsubj	_	_
2	suggests	_	VBZ	VBZ	_	0	root	_	_
3	that	_	IN	IN	_	8	mark	_	_
4	CHEMR1	_	NN	NN	_	8	nsubj	_	_
5	may	_	MD	MD	_	8	aux	_	_
6	be	_	VB	VB	_	8	cop	_	_
7	a	_	DT	DT	_	8	det	_	_
8	receptor	_	NN	NN	_	2	ccomp	_	_
9	for	_	IN	IN	_	8	prep	_	_
10	unidentified	_	JJ	JJ	_	12	amod	_	_
11	C-C	_	NN	NN	_	12	nn	_	_
12	chemokine	_	NN	NN	_	9	pobj	_	_
13	or	_	CC	CC	_	8	cc	_	_
14	a	_	DT	DT	_	16	det	_	_
15	low-affinity	_	JJ	JJ	_	16	amod	_	_
16	receptor	_	NN	NN	_	8	conj	_	_
17	for	_	IN	IN	_	16	prep	_	_
18	MIP-1alpha	_	NN	NN	_	17	pobj	_	_
19	.	_	.	.	_	2	punct	_	_

1	Biphasic	_	JJ	JJ	_	2	amod	_	_
2	control	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	NF-kappa	_	NN	NN	_	5	nn	_	_
5	B	_	NN	NN	_	6	nn	_	_
6	activation	_	NN	NN	_	3	pobj	_	_
7	induced	_	VBN	VBN	_	6	vmod	_	_
8	by	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	triggering	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	HLA-DR	_	NN	NN	_	13	nn	_	_
13	antigens	_	NNS	NNS	_	11	pobj	_	_
14	expressed	_	VBN	VBN	_	13	vmod	_	_
15	on	_	IN	IN	_	14	prep	_	_
16	B	_	NN	NN	_	17	nn	_	_
17	cells	_	NNS	NNS	_	15	pobj	_	_
18	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	regulation	_	NN	NN	_	18	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	NF-kappa	_	NN	NN	_	5	nn	_	_
5	B	_	NN	NN	_	6	nn	_	_
6	activation	_	NN	NN	_	3	pobj	_	_
7	following	_	VBG	VBG	_	6	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	triggering	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	HLA-DR	_	NN	NN	_	12	nn	_	_
12	antigens	_	NNS	NNS	_	10	pobj	_	_
13	by	_	IN	IN	_	9	prep	_	_
14	mAb	_	NN	NN	_	15	nn	_	_
15	L243	_	NN	NN	_	13	pobj	_	_
16	has	_	VBZ	VBZ	_	18	aux	_	_
17	been	_	VBN	VBN	_	18	auxpass	_	_
18	studied	_	VBN	VBN	_	0	root	_	_
19	at	_	IN	IN	_	18	prep	_	_
20	various	_	JJ	JJ	_	21	amod	_	_
21	times	_	NNS	NNS	_	19	pobj	_	_
22	in	_	IN	IN	_	18	prep	_	_
23	Raji	_	NN	NN	_	24	nn	_	_
24	cells	_	NNS	NNS	_	22	pobj	_	_
25	.	_	.	.	_	18	punct	_	_

1	Electrophoretic	_	JJ	JJ	_	4	amod	_	_
2	mobility	_	NN	NN	_	4	nn	_	_
3	shift	_	NN	NN	_	4	nn	_	_
4	assays	_	NNS	NNS	_	5	nsubj	_	_
5	demonstrated	_	VBD	VBD	_	0	root	_	_
6	a	_	DT	DT	_	8	det	_	_
7	strong	_	JJ	JJ	_	8	amod	_	_
8	increase	_	NN	NN	_	5	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	NF-kappa	_	NN	NN	_	11	nn	_	_
11	B	_	NN	NN	_	13	nn	_	_
12	DNA	_	NN	NN	_	13	nn	_	_
13	binding	_	NN	NN	_	9	pobj	_	_
14	after	_	IN	IN	_	13	prep	_	_
15	triggering	_	NN	NN	_	14	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	HLA-DR	_	NN	NN	_	18	nn	_	_
18	antigens	_	NNS	NNS	_	16	pobj	_	_
19	.	_	.	.	_	5	punct	_	_

1	Using	_	VBG	VBG	_	0	root	_	_
2	TNF-alpha-activity	_	NN	NN	_	4	nn	_	_
3	neutralizing	_	NN	NN	_	4	nn	_	_
4	antibodies	_	NNS	NNS	_	1	dobj	_	_
5	,	_	,	,	_	1	punct	_	_
6	the	_	DT	DT	_	7	det	_	_
7	authors	_	NNS	NNS	_	8	nsubj	_	_
8	demonstrated	_	VBD	VBD	_	1	parataxis	_	_
9	that	_	IN	IN	_	16	mark	_	_
10	the	_	DT	DT	_	11	det	_	_
11	upregulation	_	NN	NN	_	16	nsubjpass	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	NF-kappa	_	NN	NN	_	14	nn	_	_
14	B	_	NN	NN	_	12	pobj	_	_
15	was	_	VBD	VBD	_	16	auxpass	_	_
16	found	_	VBN	VBN	_	8	ccomp	_	_
17	to	_	TO	TO	_	18	aux	_	_
18	depend	_	VB	VB	_	16	xcomp	_	_
19	,	_	,	,	_	18	punct	_	_
20	at	_	IN	IN	_	18	prep	_	_
21	later	_	JJR	JJR	_	23	amod	_	_
22	time	_	NN	NN	_	23	nn	_	_
23	point	_	NN	NN	_	20	pobj	_	_
24	,	_	,	,	_	18	punct	_	_
25	on	_	IN	IN	_	18	prep	_	_
26	an	_	DT	DT	_	28	det	_	_
27	autocrine	_	JJ	JJ	_	28	amod	_	_
28	effect	_	NN	NN	_	25	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	TNF-alpha	_	NN	NN	_	29	pobj	_	_
31	secreted	_	VBN	VBN	_	30	vmod	_	_
32	following	_	VBG	VBG	_	31	prep	_	_
33	triggering	_	NN	NN	_	32	pobj	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	HLA-DR	_	NN	NN	_	36	nn	_	_
36	antigens	_	NNS	NNS	_	34	pobj	_	_
37	.	_	.	.	_	1	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	6	punct	_	_
4	it	_	PRP	PRP	_	6	nsubjpass	_	_
5	was	_	VBD	VBD	_	6	auxpass	_	_
6	found	_	VBN	VBN	_	0	root	_	_
7	to	_	TO	TO	_	10	aux	_	_
8	be	_	VB	VB	_	10	cop	_	_
9	TNF-alpha	_	NN	NN	_	10	npadvmod	_	_
10	independent	_	JJ	JJ	_	6	xcomp	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	15	det	_	_
13	early	_	JJ	JJ	_	15	amod	_	_
14	time	_	NN	NN	_	15	nn	_	_
15	point	_	NN	NN	_	11	pobj	_	_
16	.	_	.	.	_	6	punct	_	_

1	Moreover	_	RB	RB	_	11	advmod	_	_
2	,	_	,	,	_	11	punct	_	_
3	the	_	DT	DT	_	4	det	_	_
4	upregulation	_	NN	NN	_	11	nsubjpass	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	NF-kappa	_	NN	NN	_	7	nn	_	_
7	B	_	NN	NN	_	9	nn	_	_
8	binding	_	NN	NN	_	9	nn	_	_
9	activity	_	NN	NN	_	5	pobj	_	_
10	is	_	VBZ	VBZ	_	11	auxpass	_	_
11	regulated	_	VBN	VBN	_	0	root	_	_
12	by	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	14	det	_	_
14	triggering	_	NN	NN	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	selected	_	VBN	VBN	_	17	amod	_	_
17	epitopes	_	NNS	NNS	_	15	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	HLA-DR	_	NN	NN	_	20	nn	_	_
20	antigens	_	NNS	NNS	_	18	pobj	_	_
21	.	_	.	.	_	11	punct	_	_

1	In	_	IN	IN	_	23	prep	_	_
2	fact	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	23	punct	_	_
4	mAb	_	NN	NN	_	5	nn	_	_
5	L243	_	NN	NN	_	23	nsubj	_	_
6	but	_	CC	CC	_	7	cc	_	_
7	not	_	RB	RB	_	5	cc	_	_
8	the	_	DT	DT	_	10	det	_	_
9	staphylococcal	_	JJ	JJ	_	10	amod	_	_
10	superantigens	_	NNS	NNS	_	5	conj	_	_
11	,	_	,	,	_	10	punct	_	_
12	staphylococcal	_	JJ	JJ	_	17	amod	_	_
13	exotoxin	_	NN	NN	_	17	nn	_	_
14	toxic	_	JJ	JJ	_	17	amod	_	_
15	shock	_	NN	NN	_	17	nn	_	_
16	syndrome	_	NN	NN	_	17	nn	_	_
17	toxin-I	_	NN	NN	_	10	conj	_	_
18	or	_	CC	CC	_	10	cc	_	_
19	staphylococcal	_	JJ	JJ	_	21	amod	_	_
20	enterotoxin	_	NN	NN	_	21	nn	_	_
21	B	_	NN	NN	_	10	conj	_	_
22	,	_	,	,	_	5	punct	_	_
23	regulate	_	VBP	VBP	_	0	root	_	_
24	the	_	DT	DT	_	28	det	_	_
25	NF-kappa	_	NN	NN	_	26	nn	_	_
26	B	_	NN	NN	_	28	nn	_	_
27	binding	_	NN	NN	_	28	nn	_	_
28	activity	_	NN	NN	_	23	dobj	_	_
29	.	_	.	.	_	23	punct	_	_

1	Anti-Ehrlichia	_	FW	FW	_	3	nn	_	_
2	chaffeensis	_	FW	FW	_	3	nn	_	_
3	antibody	_	NN	NN	_	8	nsubj	_	_
4	complexed	_	VBN	VBN	_	3	vmod	_	_
5	with	_	IN	IN	_	4	prep	_	_
6	E.	_	FW	FW	_	7	nn	_	_
7	chaffeensis	_	FW	FW	_	5	pobj	_	_
8	induces	_	VBZ	VBZ	_	0	root	_	_
9	potent	_	JJ	JJ	_	13	amod	_	_
10	proinflammatory	_	JJ	JJ	_	12	amod	_	_
11	cytokine	_	NN	NN	_	12	nn	_	_
12	mRNA	_	NN	NN	_	13	nn	_	_
13	expression	_	NN	NN	_	8	dobj	_	_
14	in	_	IN	IN	_	8	prep	_	_
15	human	_	JJ	JJ	_	16	amod	_	_
16	monocytes	_	NNS	NNS	_	14	pobj	_	_
17	through	_	IN	IN	_	8	prep	_	_
18	sustained	_	JJ	JJ	_	19	amod	_	_
19	reduction	_	NN	NN	_	17	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	IkappaB-alpha	_	NN	NN	_	20	pobj	_	_
22	and	_	CC	CC	_	19	cc	_	_
23	activation	_	NN	NN	_	19	conj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	NF-kappaB	_	NN	NN	_	24	pobj	_	_
26	.	_	.	.	_	8	punct	_	_

1	Ehrlichia	_	FW	FW	_	2	nn	_	_
2	chaffeensis	_	FW	FW	_	7	nsubj	_	_
3	is	_	VBZ	VBZ	_	7	cop	_	_
4	an	_	DT	DT	_	7	det	_	_
5	obligatory	_	JJ	JJ	_	7	amod	_	_
6	intracellular	_	JJ	JJ	_	5	dep	_	_
7	bacterium	_	NN	NN	_	0	root	_	_
8	that	_	WDT	WDT	_	9	nsubj	_	_
9	infects	_	VBZ	VBZ	_	7	rcmod	_	_
10	monocytes	_	NNS	NNS	_	9	dobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	macrophages	_	NNS	NNS	_	10	conj	_	_
13	and	_	CC	CC	_	7	cc	_	_
14	is	_	VBZ	VBZ	_	17	cop	_	_
15	the	_	DT	DT	_	17	det	_	_
16	etiologic	_	JJ	JJ	_	17	amod	_	_
17	agent	_	NN	NN	_	7	conj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	human	_	JJ	JJ	_	20	amod	_	_
20	ehrlichiosis	_	NN	NN	_	18	pobj	_	_
21	in	_	IN	IN	_	17	prep	_	_
22	the	_	DT	DT	_	24	det	_	_
23	United	_	NNP	NNP	_	24	nn	_	_
24	States	_	NNPS	NNPS	_	21	pobj	_	_
25	.	_	.	.	_	7	punct	_	_

1	Our	_	PRP$	PRP$	_	3	poss	_	_
2	previous	_	JJ	JJ	_	3	amod	_	_
3	studies	_	NNS	NNS	_	4	nsubj	_	_
4	showed	_	VBD	VBD	_	0	root	_	_
5	that	_	IN	IN	_	14	mark	_	_
6	the	_	DT	DT	_	7	det	_	_
7	exposure	_	NN	NN	_	14	nsubj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	human	_	JJ	JJ	_	10	amod	_	_
10	monocytes	_	NNS	NNS	_	8	pobj	_	_
11	to	_	TO	TO	_	7	prep	_	_
12	E.	_	FW	FW	_	13	nn	_	_
13	chaffeensis	_	FW	FW	_	11	pobj	_	_
14	induces	_	VBZ	VBZ	_	4	ccomp	_	_
15	the	_	DT	DT	_	16	det	_	_
16	expression	_	NN	NN	_	14	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	interleukin-1beta	_	NN	NN	_	17	pobj	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	IL-1beta	_	NN	NN	_	18	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	,	_	,	,	_	18	punct	_	_
23	IL-8	_	NN	NN	_	18	conj	_	_
24	,	_	,	,	_	18	punct	_	_
25	and	_	CC	CC	_	18	cc	_	_
26	IL-10	_	NN	NN	_	27	nn	_	_
27	genes	_	NNS	NNS	_	18	conj	_	_
28	in	_	FW	FW	_	29	nn	_	_
29	vitro	_	FW	FW	_	16	advmod	_	_
30	but	_	CC	CC	_	31	cc	_	_
31	not	_	RB	RB	_	16	cc	_	_
32	the	_	DT	DT	_	33	det	_	_
33	expression	_	NN	NN	_	16	conj	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	tumor	_	NN	NN	_	38	nn	_	_
36	necrosis	_	NN	NN	_	38	nn	_	_
37	factor	_	NN	NN	_	38	nn	_	_
38	alpha	_	NN	NN	_	34	pobj	_	_
39	-LRB-	_	-LRB-	-LRB-	_	40	punct	_	_
40	TNF-alpha	_	NN	NN	_	38	appos	_	_
41	-RRB-	_	-RRB-	-RRB-	_	40	punct	_	_
42	and	_	CC	CC	_	38	cc	_	_
43	IL-6	_	NN	NN	_	38	conj	_	_
44	mRNAs	_	NNS	NNS	_	38	dep	_	_
45	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	26	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	study	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	26	punct	_	_
5	the	_	DT	DT	_	6	det	_	_
6	effect	_	NN	NN	_	26	nsubjpass	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	anti-E.	_	FW	FW	_	10	nn	_	_
9	chaffeensis	_	FW	FW	_	10	nn	_	_
10	antibody	_	NN	NN	_	7	pobj	_	_
11	complexed	_	VBN	VBN	_	10	vmod	_	_
12	with	_	IN	IN	_	11	prep	_	_
13	E.	_	FW	FW	_	14	nn	_	_
14	chaffeensis	_	FW	FW	_	12	pobj	_	_
15	on	_	IN	IN	_	6	prep	_	_
16	the	_	DT	DT	_	17	det	_	_
17	expression	_	NN	NN	_	15	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	major	_	JJ	JJ	_	21	amod	_	_
20	proinflammatory	_	JJ	JJ	_	21	amod	_	_
21	cytokines	_	NNS	NNS	_	18	pobj	_	_
22	in	_	IN	IN	_	17	prep	_	_
23	human	_	JJ	JJ	_	24	amod	_	_
24	monocytes	_	NNS	NNS	_	22	pobj	_	_
25	was	_	VBD	VBD	_	26	auxpass	_	_
26	examined	_	VBN	VBN	_	0	root	_	_
27	.	_	.	.	_	26	punct	_	_

1	Human	_	JJ	JJ	_	5	amod	_	_
2	monocytic	_	JJ	JJ	_	5	amod	_	_
3	cell	_	NN	NN	_	5	nn	_	_
4	line	_	NN	NN	_	5	nn	_	_
5	THP-1	_	NN	NN	_	7	nsubjpass	_	_
6	was	_	VBD	VBD	_	7	auxpass	_	_
7	treated	_	VBN	VBN	_	0	root	_	_
8	with	_	IN	IN	_	7	prep	_	_
9	E.	_	FW	FW	_	10	nn	_	_
10	chaffeensis	_	FW	FW	_	8	pobj	_	_
11	which	_	WDT	WDT	_	14	nsubj	_	_
12	had	_	VBD	VBD	_	14	aux	_	_
13	been	_	VBN	VBN	_	14	cop	_	_
14	preincubated	_	JJ	JJ	_	10	rcmod	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	human	_	JJ	JJ	_	19	amod	_	_
17	anti-E.	_	FW	FW	_	19	nn	_	_
18	chaffeensis	_	FW	FW	_	19	nn	_	_
19	serum	_	NN	NN	_	15	pobj	_	_
20	for	_	IN	IN	_	14	prep	_	_
21	2	_	CD	CD	_	22	num	_	_
22	h	_	NN	NN	_	20	pobj	_	_
23	,	_	,	,	_	7	punct	_	_
24	and	_	CC	CC	_	7	cc	_	_
25	the	_	DT	DT	_	26	det	_	_
26	levels	_	NNS	NNS	_	31	nsubjpass	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	cytokine	_	NN	NN	_	29	nn	_	_
29	mRNAs	_	NNS	NNS	_	27	pobj	_	_
30	were	_	VBD	VBD	_	31	auxpass	_	_
31	evaluated	_	VBN	VBN	_	7	conj	_	_
32	by	_	IN	IN	_	31	prep	_	_
33	competitive	_	JJ	JJ	_	35	amod	_	_
34	reverse	_	JJ	JJ	_	35	amod	_	_
35	transcription-PCR	_	NN	NN	_	32	pobj	_	_
36	.	_	.	.	_	7	punct	_	_

1	Anti-E.	_	FW	FW	_	3	nn	_	_
2	chaffeensis	_	FW	FW	_	3	nn	_	_
3	antibody	_	NN	NN	_	9	nsubj	_	_
4	complexed	_	VBN	VBN	_	3	vmod	_	_
5	with	_	IN	IN	_	4	prep	_	_
6	E.	_	FW	FW	_	7	nn	_	_
7	chaffeensis	_	FW	FW	_	5	pobj	_	_
8	significantly	_	RB	RB	_	9	advmod	_	_
9	enhanced	_	VBD	VBD	_	0	root	_	_
10	mRNA	_	NN	NN	_	11	nn	_	_
11	expression	_	NN	NN	_	9	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	IL-1beta	_	NN	NN	_	12	pobj	_	_
14	in	_	IN	IN	_	11	prep	_	_
15	THP-1	_	NN	NN	_	16	nn	_	_
16	cells	_	NNS	NNS	_	14	pobj	_	_
17	.	_	.	.	_	9	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	expression	_	NN	NN	_	10	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	TNF-alpha	_	NN	NN	_	3	pobj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	IL-6	_	NN	NN	_	4	conj	_	_
7	mRNAs	_	NNS	NNS	_	4	dep	_	_
8	was	_	VBD	VBD	_	10	auxpass	_	_
9	also	_	RB	RB	_	10	advmod	_	_
10	induced	_	VBN	VBN	_	0	root	_	_
11	.	_	.	.	_	10	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	levels	_	NNS	NNS	_	17	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	secreted	_	VBN	VBN	_	5	amod	_	_
5	IL-1beta	_	NN	NN	_	3	pobj	_	_
6	,	_	,	,	_	5	punct	_	_
7	TNF-alpha	_	NN	NN	_	5	conj	_	_
8	,	_	,	,	_	5	punct	_	_
9	and	_	CC	CC	_	5	cc	_	_
10	IL-6	_	NN	NN	_	5	conj	_	_
11	during	_	IN	IN	_	2	prep	_	_
12	24	_	CD	CD	_	13	num	_	_
13	h	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	stimulation	_	NN	NN	_	14	pobj	_	_
16	were	_	VBD	VBD	_	17	cop	_	_
17	comparable	_	JJ	JJ	_	0	root	_	_
18	to	_	TO	TO	_	17	prep	_	_
19	those	_	DT	DT	_	18	pobj	_	_
20	induced	_	VBN	VBN	_	19	vmod	_	_
21	by	_	IN	IN	_	20	prep	_	_
22	Escherichia	_	FW	FW	_	24	nn	_	_
23	coli	_	FW	FW	_	24	nn	_	_
24	lipopolysaccharide	_	NN	NN	_	21	pobj	_	_
25	at	_	IN	IN	_	24	prep	_	_
26	1	_	CD	CD	_	27	num	_	_
27	microg/ml	_	NN	NN	_	25	pobj	_	_
28	.	_	.	.	_	17	punct	_	_

1	Fab	_	NN	NN	_	2	nn	_	_
2	fragment	_	NN	NN	_	14	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	anti-E.	_	FW	FW	_	7	nn	_	_
5	chaffeensis	_	FW	FW	_	7	nn	_	_
6	immunoglobulin	_	NN	NN	_	7	nn	_	_
7	G	_	NN	NN	_	3	pobj	_	_
8	complexed	_	VBN	VBN	_	7	vmod	_	_
9	with	_	IN	IN	_	8	prep	_	_
10	E.	_	FW	FW	_	11	nn	_	_
11	chaffeensis	_	FW	FW	_	9	pobj	_	_
12	did	_	VBD	VBD	_	14	aux	_	_
13	not	_	RB	RB	_	14	neg	_	_
14	induce	_	VB	VB	_	0	root	_	_
15	any	_	DT	DT	_	14	dobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	these	_	DT	DT	_	19	det	_	_
18	three	_	CD	CD	_	19	num	_	_
19	cytokines	_	NNS	NNS	_	16	pobj	_	_
20	,	_	,	,	_	14	punct	_	_
21	indicating	_	VBG	VBG	_	14	vmod	_	_
22	that	_	IN	IN	_	26	mark	_	_
23	ehrlichial	_	JJ	JJ	_	24	amod	_	_
24	binding	_	NN	NN	_	26	nsubjpass	_	_
25	is	_	VBZ	VBZ	_	26	auxpass	_	_
26	required	_	VBN	VBN	_	21	ccomp	_	_
27	for	_	IN	IN	_	26	prep	_	_
28	IL-1beta	_	NN	NN	_	29	nn	_	_
29	mRNA	_	NN	NN	_	30	nn	_	_
30	expression	_	NN	NN	_	27	pobj	_	_
31	and	_	CC	CC	_	26	cc	_	_
32	that	_	IN	IN	_	44	mark	_	_
33	binding	_	NN	NN	_	44	nsubjpass	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	the	_	DT	DT	_	37	det	_	_
36	immune	_	JJ	JJ	_	37	amod	_	_
37	complex	_	NN	NN	_	34	pobj	_	_
38	to	_	TO	TO	_	33	prep	_	_
39	the	_	DT	DT	_	42	det	_	_
40	Fc	_	NN	NN	_	42	nn	_	_
41	gamma	_	NN	NN	_	42	nn	_	_
42	receptor	_	NN	NN	_	38	pobj	_	_
43	is	_	VBZ	VBZ	_	44	auxpass	_	_
44	required	_	VBN	VBN	_	26	conj	_	_
45	for	_	IN	IN	_	44	prep	_	_
46	TNF-alpha	_	NN	NN	_	45	pobj	_	_
47	and	_	CC	CC	_	46	cc	_	_
48	IL-6	_	NN	NN	_	49	nn	_	_
49	mRNA	_	NN	NN	_	46	conj	_	_
50	expression	_	NN	NN	_	46	dep	_	_
51	and	_	CC	CC	_	46	cc	_	_
52	enhanced	_	VBD	VBD	_	55	amod	_	_
53	IL-1beta	_	NN	NN	_	54	nn	_	_
54	mRNA	_	NN	NN	_	55	nn	_	_
55	expression	_	NN	NN	_	46	conj	_	_
56	.	_	.	.	_	14	punct	_	_

1	Furthermore	_	RB	RB	_	12	advmod	_	_
2	,	_	,	,	_	12	punct	_	_
3	prolonged	_	JJ	JJ	_	4	amod	_	_
4	degradation	_	NN	NN	_	12	nsubjpass	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	IkappaB-alpha	_	NN	NN	_	5	pobj	_	_
7	and	_	CC	CC	_	4	cc	_	_
8	activation	_	NN	NN	_	4	conj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	NF-kappaB	_	NN	NN	_	9	pobj	_	_
11	were	_	VBD	VBD	_	12	auxpass	_	_
12	demonstrated	_	VBN	VBN	_	0	root	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	THP-1	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	13	pobj	_	_
16	exposed	_	VBN	VBN	_	15	vmod	_	_
17	to	_	TO	TO	_	16	prep	_	_
18	anti-E.	_	FW	FW	_	20	nn	_	_
19	chaffeensis	_	FW	FW	_	20	nn	_	_
20	serum	_	NN	NN	_	17	pobj	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	E.	_	FW	FW	_	23	nn	_	_
23	chaffeensis	_	FW	FW	_	20	conj	_	_
24	.	_	.	.	_	12	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	result	_	NN	NN	_	3	nsubj	_	_
3	implies	_	VBZ	VBZ	_	0	root	_	_
4	that	_	IN	IN	_	13	mark	_	_
5	development	_	NN	NN	_	13	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	anti-E.	_	FW	FW	_	9	nn	_	_
8	chaffeensis	_	FW	FW	_	9	nn	_	_
9	antibody	_	NN	NN	_	6	pobj	_	_
10	in	_	IN	IN	_	5	prep	_	_
11	patients	_	NNS	NNS	_	10	pobj	_	_
12	can	_	MD	MD	_	13	aux	_	_
13	result	_	VB	VB	_	3	ccomp	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	production	_	NN	NN	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	major	_	JJ	JJ	_	20	amod	_	_
19	proinflammatory	_	JJ	JJ	_	20	amod	_	_
20	cytokines	_	NNS	NNS	_	17	pobj	_	_
21	,	_	,	,	_	13	punct	_	_
22	which	_	WDT	WDT	_	24	nsubj	_	_
23	may	_	MD	MD	_	24	aux	_	_
24	play	_	VB	VB	_	13	ccomp	_	_
25	an	_	DT	DT	_	27	det	_	_
26	important	_	JJ	JJ	_	27	amod	_	_
27	role	_	NN	NN	_	24	dobj	_	_
28	in	_	IN	IN	_	24	prep	_	_
29	the	_	DT	DT	_	30	det	_	_
30	pathophysiology	_	NN	NN	_	28	pobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	ehrlichiosis	_	NN	NN	_	31	pobj	_	_
33	and	_	CC	CC	_	30	cc	_	_
34	immune	_	JJ	JJ	_	35	amod	_	_
35	responses	_	NNS	NNS	_	30	conj	_	_
36	to	_	TO	TO	_	35	prep	_	_
37	it	_	PRP	PRP	_	36	pobj	_	_
38	.	_	.	.	_	3	punct	_	_

1	S-allyl	_	JJ	JJ	_	2	amod	_	_
2	cysteine	_	NN	NN	_	3	nsubj	_	_
3	inhibits	_	VBZ	VBZ	_	0	root	_	_
4	activation	_	NN	NN	_	3	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	nuclear	_	JJ	JJ	_	9	amod	_	_
7	factor	_	NN	NN	_	9	nn	_	_
8	kappa	_	NN	NN	_	9	nn	_	_
9	B	_	NN	NN	_	5	pobj	_	_
10	in	_	IN	IN	_	4	prep	_	_
11	human	_	JJ	JJ	_	13	amod	_	_
12	T	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	10	pobj	_	_
14	.	_	.	.	_	3	punct	_	_

1	Reactive	_	JJ	JJ	_	3	amod	_	_
2	oxygen	_	NN	NN	_	3	nn	_	_
3	species	_	NNS	NNS	_	5	nsubjpass	_	_
4	are	_	VBP	VBP	_	5	auxpass	_	_
5	involved	_	VBN	VBN	_	0	root	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	signal	_	NN	NN	_	9	nn	_	_
8	transduction	_	NN	NN	_	9	nn	_	_
9	pathways	_	NNS	NNS	_	6	pobj	_	_
10	leading	_	VBG	VBG	_	9	vmod	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	nuclear	_	JJ	JJ	_	15	amod	_	_
13	factor	_	NN	NN	_	15	nn	_	_
14	kappa	_	NN	NN	_	15	nn	_	_
15	B	_	NN	NN	_	20	nn	_	_
16	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
17	NF-kappa	_	NN	NN	_	18	nn	_	_
18	B	_	NN	NN	_	15	appos	_	_
19	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
20	activation	_	NN	NN	_	11	pobj	_	_
21	which	_	WDT	WDT	_	24	nsubjpass	_	_
22	has	_	VBZ	VBZ	_	24	aux	_	_
23	been	_	VBN	VBN	_	24	auxpass	_	_
24	implicated	_	VBN	VBN	_	20	rcmod	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	27	det	_	_
27	regulation	_	NN	NN	_	25	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	gene	_	NN	NN	_	30	nn	_	_
30	transcription	_	NN	NN	_	28	pobj	_	_
31	.	_	.	.	_	5	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	recently	_	RB	RB	_	3	advmod	_	_
3	reported	_	VBD	VBD	_	0	root	_	_
4	that	_	IN	IN	_	15	mark	_	_
5	a	_	DT	DT	_	7	det	_	_
6	garlic	_	JJ	JJ	_	7	amod	_	_
7	compound	_	NN	NN	_	15	nsubj	_	_
8	,	_	,	,	_	7	punct	_	_
9	S-allyl	_	JJ	JJ	_	10	amod	_	_
10	cysteine	_	NN	NN	_	7	appos	_	_
11	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
12	SAC	_	NN	NN	_	10	appos	_	_
13	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
14	,	_	,	,	_	7	punct	_	_
15	protects	_	VBZ	VBZ	_	3	ccomp	_	_
16	bovine	_	JJ	JJ	_	20	amod	_	_
17	pulmonary	_	JJ	JJ	_	20	amod	_	_
18	artery	_	NN	NN	_	20	nn	_	_
19	endothelial	_	JJ	JJ	_	20	amod	_	_
20	cells	_	NNS	NNS	_	15	dobj	_	_
21	from	_	IN	IN	_	15	prep	_	_
22	oxidant	_	JJ	JJ	_	23	amod	_	_
23	injury	_	NN	NN	_	21	pobj	_	_
24	induced	_	VBN	VBN	_	23	vmod	_	_
25	by	_	IN	IN	_	24	prep	_	_
26	hydrogen	_	NN	NN	_	27	nn	_	_
27	peroxide	_	NN	NN	_	25	pobj	_	_
28	-LRB-	_	-LRB-	-LRB-	_	29	punct	_	_
29	H2O2	_	NN	NN	_	27	appos	_	_
30	-RRB-	_	-RRB-	-RRB-	_	29	punct	_	_
31	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	5	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	study	_	NN	NN	_	1	pobj	_	_
4	we	_	PRP	PRP	_	5	nsubj	_	_
5	determined	_	VBD	VBD	_	0	root	_	_
6	the	_	DT	DT	_	7	det	_	_
7	effects	_	NNS	NNS	_	5	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	SAC	_	NN	NN	_	8	pobj	_	_
10	on	_	IN	IN	_	7	prep	_	_
11	NF-kappa	_	NN	NN	_	12	nn	_	_
12	B	_	NN	NN	_	13	nn	_	_
13	activation	_	NN	NN	_	10	pobj	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	human	_	JJ	JJ	_	17	amod	_	_
16	T	_	NN	NN	_	17	nn	_	_
17	lymphocytes	_	NNS	NNS	_	14	pobj	_	_
18	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
19	Jurkat	_	NN	NN	_	20	nn	_	_
20	cells	_	NNS	NNS	_	17	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	induced	_	VBN	VBN	_	13	vmod	_	_
23	by	_	IN	IN	_	22	prep	_	_
24	tumor	_	NN	NN	_	27	nn	_	_
25	necrosis	_	NN	NN	_	27	nn	_	_
26	factor	_	NN	NN	_	27	nn	_	_
27	alpha	_	NN	NN	_	23	pobj	_	_
28	-LRB-	_	-LRB-	-LRB-	_	29	punct	_	_
29	TNF-alpha	_	NN	NN	_	27	appos	_	_
30	-RRB-	_	-RRB-	-RRB-	_	29	punct	_	_
31	and	_	CC	CC	_	27	cc	_	_
32	H2O2	_	NN	NN	_	27	conj	_	_
33	.	_	.	.	_	5	punct	_	_

1	Activated	_	VBN	VBN	_	3	amod	_	_
2	NF-kappa	_	NN	NN	_	3	nn	_	_
3	B	_	NN	NN	_	8	nsubjpass	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	nuclear	_	JJ	JJ	_	6	amod	_	_
6	extracts	_	NNS	NNS	_	4	pobj	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	measured	_	VBN	VBN	_	0	root	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	an	_	DT	DT	_	14	det	_	_
11	electrophoretic	_	JJ	JJ	_	14	amod	_	_
12	mobility	_	NN	NN	_	14	nn	_	_
13	shift	_	NN	NN	_	14	nn	_	_
14	assay	_	NN	NN	_	9	pobj	_	_
15	using	_	VBG	VBG	_	14	vmod	_	_
16	32P-labeled	_	JJ	JJ	_	17	amod	_	_
17	probe	_	NN	NN	_	15	dobj	_	_
18	.	_	.	.	_	8	punct	_	_

1	SAC	_	NN	NN	_	3	nsubj	_	_
2	consistently	_	RB	RB	_	3	advmod	_	_
3	exhibited	_	VBD	VBD	_	0	root	_	_
4	a	_	DT	DT	_	6	det	_	_
5	dose-dependent	_	JJ	JJ	_	6	amod	_	_
6	inhibition	_	NN	NN	_	3	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	NF-kappa	_	NN	NN	_	9	nn	_	_
9	B	_	NN	NN	_	10	nn	_	_
10	activation	_	NN	NN	_	7	pobj	_	_
11	induced	_	VBN	VBN	_	10	vmod	_	_
12	by	_	IN	IN	_	11	prep	_	_
13	both	_	CC	CC	_	14	preconj	_	_
14	TNF-alpha	_	NN	NN	_	12	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	H2O2	_	NN	NN	_	14	conj	_	_
17	.	_	.	.	_	3	punct	_	_

1	Supershift	_	NN	NN	_	9	nsubj	_	_
2	with	_	IN	IN	_	1	prep	_	_
3	specific	_	JJ	JJ	_	4	amod	_	_
4	antibodies	_	NNS	NNS	_	2	pobj	_	_
5	to	_	TO	TO	_	1	prep	_	_
6	NF-kappa	_	NN	NN	_	8	nn	_	_
7	B	_	NN	NN	_	8	nn	_	_
8	subunits	_	NNS	NNS	_	5	pobj	_	_
9	confirmed	_	VBD	VBD	_	0	root	_	_
10	that	_	IN	IN	_	15	mark	_	_
11	the	_	DT	DT	_	14	det	_	_
12	inducible	_	JJ	JJ	_	14	amod	_	_
13	retarded	_	VBN	VBN	_	14	amod	_	_
14	bands	_	NNS	NNS	_	15	nsubj	_	_
15	observed	_	VBN	VBN	_	9	ccomp	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	18	det	_	_
18	EMSA	_	NN	NN	_	16	pobj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	p65-p50	_	NN	NN	_	21	nn	_	_
21	heterodimer	_	NN	NN	_	18	conj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	26	det	_	_
24	NF-kappa	_	NN	NN	_	26	nn	_	_
25	B/Rel	_	NN	NN	_	26	nn	_	_
26	protein	_	NN	NN	_	22	pobj	_	_
27	.	_	.	.	_	9	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	7	mark	_	_
5	SAC	_	NN	NN	_	7	nsubj	_	_
6	may	_	MD	MD	_	7	aux	_	_
7	act	_	VB	VB	_	3	ccomp	_	_
8	via	_	IN	IN	_	7	prep	_	_
9	antioxidant	_	JJ	JJ	_	10	amod	_	_
10	mechanisms	_	NNS	NNS	_	8	pobj	_	_
11	to	_	TO	TO	_	12	aux	_	_
12	block	_	VB	VB	_	7	xcomp	_	_
13	NF-kappa	_	NN	NN	_	14	nn	_	_
14	B	_	NN	NN	_	15	nn	_	_
15	activation	_	NN	NN	_	12	dobj	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	Jurkat	_	NN	NN	_	18	nn	_	_
18	cells	_	NNS	NNS	_	16	pobj	_	_
19	.	_	.	.	_	3	punct	_	_

1	Effect	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	adenovirus	_	NN	NN	_	2	pobj	_	_
4	2	_	CD	CD	_	3	num	_	_
5	on	_	IN	IN	_	1	prep	_	_
6	cellular	_	JJ	JJ	_	8	amod	_	_
7	gene	_	NN	NN	_	8	nn	_	_
8	activation	_	NN	NN	_	5	pobj	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	blood-derived	_	JJ	JJ	_	11	amod	_	_
11	monocytes	_	NNS	NNS	_	9	pobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	macrophages	_	NNS	NNS	_	11	conj	_	_
14	.	_	.	.	_	1	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	investigated	_	VBN	VBN	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	effect	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	adenovirus	_	NN	NN	_	12	nn	_	_
8	2	_	CD	CD	_	7	num	_	_
9	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
10	Ad2	_	NN	NN	_	7	appos	_	_
11	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
12	infection	_	NN	NN	_	6	pobj	_	_
13	on	_	IN	IN	_	5	prep	_	_
14	human	_	JJ	JJ	_	15	amod	_	_
15	monocytes	_	NNS	NNS	_	13	pobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	monocyte-derived	_	JJ	JJ	_	18	amod	_	_
18	macrophages	_	NNS	NNS	_	15	conj	_	_
19	with	_	IN	IN	_	3	prep	_	_
20	regard	_	NN	NN	_	19	pobj	_	_
21	to	_	TO	TO	_	20	prep	_	_
22	expression	_	NN	NN	_	21	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	TNF-alpha	_	NN	NN	_	23	pobj	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	IL-1	_	NN	NN	_	27	nn	_	_
27	beta	_	NN	NN	_	24	conj	_	_
28	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	monocytes	_	NNS	NNS	_	1	pobj	_	_
3	,	_	,	,	_	7	punct	_	_
4	the	_	DT	DT	_	5	det	_	_
5	virus	_	NN	NN	_	7	nsubjpass	_	_
6	was	_	VBD	VBD	_	7	auxpass	_	_
7	bound	_	VBN	VBN	_	0	root	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	surface	_	NN	NN	_	8	pobj	_	_
11	without	_	IN	IN	_	7	prep	_	_
12	being	_	VBG	VBG	_	13	auxpass	_	_
13	internalized	_	VBN	VBN	_	11	pcomp	_	_
14	.	_	.	.	_	7	punct	_	_

1	On	_	IN	IN	_	8	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	other	_	JJ	JJ	_	4	amod	_	_
4	hand	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	8	punct	_	_
6	Ad2	_	NN	NN	_	8	nsubjpass	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	internalized	_	VBN	VBN	_	0	root	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	macrophages	_	NNS	NNS	_	9	pobj	_	_
11	.	_	.	.	_	8	punct	_	_

1	No	_	DT	DT	_	3	neg	_	_
2	virus	_	NN	NN	_	3	nn	_	_
3	replication	_	NN	NN	_	13	nsubjpass	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	no	_	DT	DT	_	6	neg	_	_
6	transcription	_	NN	NN	_	3	conj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	11	det	_	_
9	Ad2	_	NN	NN	_	11	nn	_	_
10	early	_	JJ	JJ	_	11	amod	_	_
11	genes	_	NNS	NNS	_	7	pobj	_	_
12	was	_	VBD	VBD	_	13	auxpass	_	_
13	observed	_	VBN	VBN	_	0	root	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	either	_	DT	DT	_	14	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	18	det	_	_
18	cells	_	NNS	NNS	_	16	pobj	_	_
19	.	_	.	.	_	13	punct	_	_

1	Ad2	_	NN	NN	_	2	nn	_	_
2	infection	_	NN	NN	_	3	nsubj	_	_
3	induced	_	VBD	VBD	_	0	root	_	_
4	transient	_	JJ	JJ	_	5	amod	_	_
5	increase	_	NN	NN	_	3	dobj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	mRNA	_	NN	NN	_	9	nn	_	_
9	levels	_	NNS	NNS	_	6	pobj	_	_
10	for	_	IN	IN	_	9	prep	_	_
11	TNF-alpha	_	NN	NN	_	10	pobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	IL-1	_	NN	NN	_	14	nn	_	_
14	beta	_	NN	NN	_	11	conj	_	_
15	in	_	IN	IN	_	3	prep	_	_
16	both	_	CC	CC	_	17	dep	_	_
17	monocytes	_	NNS	NNS	_	15	pobj	_	_
18	and	_	CC	CC	_	15	cc	_	_
19	in	_	IN	IN	_	15	conj	_	_
20	macrophages	_	NNS	NNS	_	19	pobj	_	_
21	,	_	,	,	_	3	punct	_	_
22	although	_	IN	IN	_	30	mark	_	_
23	the	_	DT	DT	_	24	det	_	_
24	kinetics	_	NNS	NNS	_	30	nsubj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	27	det	_	_
27	transcription	_	NN	NN	_	25	pobj	_	_
28	was	_	VBD	VBD	_	30	cop	_	_
29	slightly	_	RB	RB	_	30	advmod	_	_
30	different	_	JJ	JJ	_	3	advcl	_	_
31	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	production	_	NN	NN	_	13	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	both	_	DT	DT	_	5	dep	_	_
5	cytokines	_	NNS	NNS	_	3	pobj	_	_
6	,	_	,	,	_	2	punct	_	_
7	measured	_	VBN	VBN	_	2	vmod	_	_
8	by	_	IN	IN	_	7	prep	_	_
9	ELISA	_	NN	NN	_	10	nn	_	_
10	tests	_	NNS	NNS	_	8	pobj	_	_
11	,	_	,	,	_	2	punct	_	_
12	was	_	VBD	VBD	_	13	auxpass	_	_
13	enhanced	_	VBN	VBN	_	0	root	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	monocytes	_	NNS	NNS	_	14	pobj	_	_
16	.	_	.	.	_	13	punct	_	_

1	In	_	IN	IN	_	11	prep	_	_
2	macrophages	_	NNS	NNS	_	1	pobj	_	_
3	,	_	,	,	_	11	punct	_	_
4	a	_	DT	DT	_	6	det	_	_
5	slight	_	JJ	JJ	_	6	amod	_	_
6	enhancement	_	NN	NN	_	11	nsubjpass	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	TNF-alpha	_	NN	NN	_	9	nn	_	_
9	production	_	NN	NN	_	7	pobj	_	_
10	was	_	VBD	VBD	_	11	auxpass	_	_
11	seen	_	VBN	VBN	_	0	root	_	_
12	,	_	,	,	_	11	punct	_	_
13	whereas	_	IN	IN	_	18	mark	_	_
14	IL-1	_	NN	NN	_	15	nn	_	_
15	beta	_	NN	NN	_	18	nsubjpass	_	_
16	was	_	VBD	VBD	_	18	auxpass	_	_
17	not	_	RB	RB	_	18	neg	_	_
18	detected	_	VBN	VBN	_	11	advcl	_	_
19	.	_	.	.	_	11	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	9	mark	_	_
5	cellular	_	JJ	JJ	_	6	amod	_	_
6	genes	_	NNS	NNS	_	9	nsubjpass	_	_
7	might	_	MD	MD	_	9	aux	_	_
8	be	_	VB	VB	_	9	auxpass	_	_
9	activated	_	VBN	VBN	_	3	ccomp	_	_
10	by	_	IN	IN	_	9	prep	_	_
11	Ad2	_	NN	NN	_	13	nn	_	_
12	virus	_	NN	NN	_	13	nn	_	_
13	infection	_	NN	NN	_	10	pobj	_	_
14	in	_	IN	IN	_	9	prep	_	_
15	nonpermissive	_	JJ	JJ	_	16	amod	_	_
16	cells	_	NNS	NNS	_	14	pobj	_	_
17	where	_	WRB	WRB	_	24	advmod	_	_
18	no	_	DT	DT	_	21	neg	_	_
19	viral	_	JJ	JJ	_	21	amod	_	_
20	gene	_	NN	NN	_	21	nn	_	_
21	products	_	NNS	NNS	_	24	nsubjpass	_	_
22	could	_	MD	MD	_	24	aux	_	_
23	be	_	VB	VB	_	24	auxpass	_	_
24	detected	_	VBN	VBN	_	16	rcmod	_	_
25	.	_	.	.	_	3	punct	_	_

1	AP-1	_	NN	NN	_	9	nsubj	_	_
2	derived	_	VBN	VBN	_	1	vmod	_	_
3	from	_	IN	IN	_	2	prep	_	_
4	mature	_	JJ	JJ	_	5	amod	_	_
5	monocytes	_	NNS	NNS	_	3	pobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	astrocytes	_	NNS	NNS	_	5	conj	_	_
8	preferentially	_	RB	RB	_	9	advmod	_	_
9	interacts	_	VBZ	VBZ	_	0	root	_	_
10	with	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	HTLV-I	_	NN	NN	_	13	nn	_	_
13	promoter	_	NN	NN	_	10	pobj	_	_
14	central	_	JJ	JJ	_	13	amod	_	_
15	21	_	CD	CD	_	17	num	_	_
16	bp	_	NN	NN	_	17	nn	_	_
17	repeat	_	NN	NN	_	13	dep	_	_
18	.	_	.	.	_	9	punct	_	_

1	Characterization	_	NN	NN	_	27	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	6	det	_	_
4	cellular	_	JJ	JJ	_	6	amod	_	_
5	transcription	_	NN	NN	_	6	nn	_	_
6	factors	_	NNS	NNS	_	2	pobj	_	_
7	interacting	_	VBG	VBG	_	6	vmod	_	_
8	with	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	22	det	_	_
10	human	_	JJ	JJ	_	22	amod	_	_
11	T	_	NN	NN	_	22	nn	_	_
12	cell	_	NN	NN	_	22	nn	_	_
13	lymphotropic	_	JJ	JJ	_	22	amod	_	_
14	virus	_	NN	NN	_	22	nn	_	_
15	type	_	NN	NN	_	22	nn	_	_
16	I	_	CD	CD	_	22	num	_	_
17	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
18	HTLV-I	_	NN	NN	_	22	nn	_	_
19	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
20	long	_	JJ	JJ	_	22	amod	_	_
21	terminal	_	JJ	JJ	_	22	amod	_	_
22	repeat	_	NN	NN	_	8	pobj	_	_
23	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
24	LTR	_	NN	NN	_	22	appos	_	_
25	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
26	is	_	VBZ	VBZ	_	27	cop	_	_
27	essential	_	JJ	JJ	_	0	root	_	_
28	to	_	TO	TO	_	27	prep	_	_
29	dissecting	_	VBG	VBG	_	28	pcomp	_	_
30	the	_	DT	DT	_	31	det	_	_
31	mechanisms	_	NNS	NNS	_	29	dobj	_	_
32	involved	_	VBN	VBN	_	31	vmod	_	_
33	in	_	IN	IN	_	32	prep	_	_
34	viral	_	JJ	JJ	_	35	amod	_	_
35	transcription	_	NN	NN	_	33	pobj	_	_
36	that	_	WDT	WDT	_	39	nsubj	_	_
37	may	_	MD	MD	_	39	aux	_	_
38	be	_	VB	VB	_	39	cop	_	_
39	pertinent	_	JJ	JJ	_	31	rcmod	_	_
40	to	_	TO	TO	_	39	prep	_	_
41	the	_	DT	DT	_	42	dep	_	_
42	oncogenic	_	JJ	JJ	_	40	pobj	_	_
43	and	_	CC	CC	_	42	cc	_	_
44	neuropathogenic	_	JJ	JJ	_	42	conj	_	_
45	processes	_	NNS	NNS	_	42	dep	_	_
46	associated	_	VBN	VBN	_	42	vmod	_	_
47	with	_	IN	IN	_	46	prep	_	_
48	HTLV-I	_	NN	NN	_	49	nn	_	_
49	infection	_	NN	NN	_	47	pobj	_	_
50	in	_	IN	IN	_	49	prep	_	_
51	both	_	CC	CC	_	53	preconj	_	_
52	the	_	DT	DT	_	53	dep	_	_
53	immune	_	JJ	JJ	_	50	pobj	_	_
54	and	_	CC	CC	_	53	cc	_	_
55	nervous	_	JJ	JJ	_	53	conj	_	_
56	systems	_	NNS	NNS	_	53	dep	_	_
57	.	_	.	.	_	27	punct	_	_

1	Electrophoretic	_	JJ	JJ	_	3	amod	_	_
2	mobility	_	NN	NN	_	3	nn	_	_
3	shift	_	NN	NN	_	7	nn	_	_
4	-LRB-	_	-LRB-	-LRB-	_	5	punct	_	_
5	EMS	_	NN	NN	_	3	appos	_	_
6	-RRB-	_	-RRB-	-RRB-	_	5	punct	_	_
7	analyses	_	NNS	NNS	_	39	nsubj	_	_
8	utilizing	_	VBG	VBG	_	7	vmod	_	_
9	oligonucleotides	_	NNS	NNS	_	8	dobj	_	_
10	homologous	_	JJ	JJ	_	9	amod	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	each	_	DT	DT	_	11	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	18	det	_	_
15	21	_	CD	CD	_	18	num	_	_
16	bp	_	NN	NN	_	18	nn	_	_
17	repeat	_	NN	NN	_	18	nn	_	_
18	elements	_	NNS	NNS	_	13	pobj	_	_
19	reacted	_	VBN	VBN	_	18	vmod	_	_
20	with	_	IN	IN	_	19	prep	_	_
21	nuclear	_	JJ	JJ	_	22	amod	_	_
22	extracts	_	NNS	NNS	_	20	pobj	_	_
23	derived	_	VBN	VBN	_	22	vmod	_	_
24	from	_	IN	IN	_	23	prep	_	_
25	cell	_	NN	NN	_	26	nn	_	_
26	lines	_	NNS	NNS	_	24	pobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	lymphocytic	_	JJ	JJ	_	27	pobj	_	_
29	,	_	,	,	_	28	punct	_	_
30	monocytic	_	JJ	JJ	_	28	conj	_	_
31	,	_	,	,	_	28	punct	_	_
32	neuronal	_	JJ	JJ	_	28	conj	_	_
33	,	_	,	,	_	28	punct	_	_
34	and	_	CC	CC	_	28	cc	_	_
35	glial	_	JJ	JJ	_	28	conj	_	_
36	cell	_	NN	NN	_	37	nn	_	_
37	origin	_	NN	NN	_	28	dep	_	_
38	have	_	VBP	VBP	_	39	aux	_	_
39	demonstrated	_	VBN	VBN	_	0	root	_	_
40	differential	_	JJ	JJ	_	41	amod	_	_
41	binding	_	NN	NN	_	39	dobj	_	_
42	of	_	IN	IN	_	41	prep	_	_
43	cellular	_	JJ	JJ	_	44	amod	_	_
44	factors	_	NNS	NNS	_	42	pobj	_	_
45	to	_	TO	TO	_	41	prep	_	_
46	the	_	DT	DT	_	50	det	_	_
47	three	_	CD	CD	_	50	num	_	_
48	21	_	CD	CD	_	50	num	_	_
49	bp	_	NN	NN	_	50	nn	_	_
50	repeats	_	NNS	NNS	_	45	pobj	_	_
51	-LRB-	_	-LRB-	-LRB-	_	52	punct	_	_
52	1-4	_	CD	CD	_	50	appos	_	_
53	-RRB-	_	-RRB-	-RRB-	_	52	punct	_	_
54	.	_	.	.	_	39	punct	_	_

1	ATF/CREB	_	NN	NN	_	6	nsubj	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	Sp	_	NN	NN	_	5	nn	_	_
4	family	_	NN	NN	_	5	nn	_	_
5	members	_	NNS	NNS	_	1	conj	_	_
6	interacted	_	VBD	VBD	_	0	root	_	_
7	with	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	11	det	_	_
9	21	_	CD	CD	_	11	num	_	_
10	bp	_	NN	NN	_	11	nn	_	_
11	repeats	_	NNS	NNS	_	7	pobj	_	_
12	to	_	TO	TO	_	13	aux	_	_
13	form	_	VB	VB	_	6	xcomp	_	_
14	DNA-protein	_	JJ	JJ	_	15	amod	_	_
15	complexes	_	NNS	NNS	_	13	dobj	_	_
16	common	_	JJ	JJ	_	15	amod	_	_
17	to	_	TO	TO	_	16	prep	_	_
18	all	_	DT	DT	_	20	det	_	_
19	cell	_	NN	NN	_	20	nn	_	_
20	types	_	NNS	NNS	_	17	pobj	_	_
21	examined	_	VBN	VBN	_	20	vmod	_	_
22	.	_	.	.	_	6	punct	_	_

1	However	_	RB	RB	_	8	advmod	_	_
2	,	_	,	,	_	8	punct	_	_
3	a	_	DT	DT	_	6	det	_	_
4	unique	_	JJ	JJ	_	6	amod	_	_
5	DNA-protein	_	JJ	JJ	_	6	amod	_	_
6	complex	_	NN	NN	_	8	nsubjpass	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	detected	_	VBN	VBN	_	0	root	_	_
9	when	_	WRB	WRB	_	17	advmod	_	_
10	the	_	DT	DT	_	11	det	_	_
11	promoter	_	NN	NN	_	17	nsubjpass	_	_
12	central	_	JJ	JJ	_	11	amod	_	_
13	21	_	CD	CD	_	15	num	_	_
14	bp	_	NN	NN	_	15	nn	_	_
15	repeat	_	NN	NN	_	11	dep	_	_
16	was	_	VBD	VBD	_	17	auxpass	_	_
17	reacted	_	VBN	VBN	_	8	advcl	_	_
18	with	_	IN	IN	_	17	prep	_	_
19	nuclear	_	JJ	JJ	_	20	amod	_	_
20	extracts	_	NNS	NNS	_	18	pobj	_	_
21	derived	_	VBN	VBN	_	20	vmod	_	_
22	from	_	IN	IN	_	21	prep	_	_
23	either	_	CC	CC	_	29	preconj	_	_
24	the	_	DT	DT	_	29	det	_	_
25	U-373	_	NN	NN	_	29	nn	_	_
26	MG	_	NN	NN	_	29	nn	_	_
27	glioblastoma	_	NN	NN	_	29	nn	_	_
28	cell	_	NN	NN	_	29	nn	_	_
29	line	_	NN	NN	_	22	pobj	_	_
30	or	_	CC	CC	_	29	cc	_	_
31	the	_	DT	DT	_	36	det	_	_
32	THP-1	_	NN	NN	_	36	nn	_	_
33	mature	_	JJ	JJ	_	36	amod	_	_
34	monocytic	_	JJ	JJ	_	36	amod	_	_
35	cell	_	NN	NN	_	36	nn	_	_
36	line	_	NN	NN	_	29	conj	_	_
37	.	_	.	.	_	8	punct	_	_

1	Based	_	VBN	VBN	_	10	prep	_	_
2	on	_	IN	IN	_	1	pcomp	_	_
3	nucleotide	_	NN	NN	_	2	pobj	_	_
4	sequence	_	NN	NN	_	5	nn	_	_
5	requirements	_	NNS	NNS	_	3	dep	_	_
6	and	_	CC	CC	_	3	cc	_	_
7	immunoreactivity	_	NN	NN	_	3	conj	_	_
8	,	_	,	,	_	10	punct	_	_
9	we	_	PRP	PRP	_	10	nsubj	_	_
10	demonstrate	_	VBP	VBP	_	0	root	_	_
11	that	_	IN	IN	_	16	mark	_	_
12	this	_	DT	DT	_	14	det	_	_
13	DNA-protein	_	JJ	JJ	_	14	amod	_	_
14	complex	_	NN	NN	_	16	nsubjpass	_	_
15	is	_	VBZ	VBZ	_	16	auxpass	_	_
16	comprised	_	VBN	VBN	_	10	ccomp	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	AP-1	_	NN	NN	_	20	nn	_	_
20	components	_	NNS	NNS	_	17	pobj	_	_
21	,	_	,	,	_	20	punct	_	_
22	Fos	_	NN	NN	_	20	appos	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	Jun	_	NN	NN	_	22	conj	_	_
25	.	_	.	.	_	10	punct	_	_

1	An	_	DT	DT	_	5	det	_	_
2	acute	_	JJ	JJ	_	5	amod	_	_
3	myeloid	_	JJ	JJ	_	5	amod	_	_
4	leukemia	_	NN	NN	_	5	nn	_	_
5	gene	_	NN	NN	_	9	nsubj	_	_
6	,	_	,	,	_	5	punct	_	_
7	AML1	_	NN	NN	_	5	appos	_	_
8	,	_	,	,	_	5	punct	_	_
9	regulates	_	VBZ	VBZ	_	0	root	_	_
10	transcriptional	_	JJ	JJ	_	11	amod	_	_
11	activation	_	NN	NN	_	9	dobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	hemopoietic	_	JJ	JJ	_	16	amod	_	_
14	myeloid	_	JJ	JJ	_	16	amod	_	_
15	cell	_	NN	NN	_	16	nn	_	_
16	differentiation	_	NN	NN	_	11	conj	_	_
17	antagonistically	_	RB	RB	_	9	advmod	_	_
18	by	_	IN	IN	_	9	prep	_	_
19	two	_	CD	CD	_	22	num	_	_
20	alternative	_	JJ	JJ	_	21	amod	_	_
21	spliced	_	JJ	JJ	_	22	amod	_	_
22	forms	_	NNS	NNS	_	18	pobj	_	_
23	.	_	.	.	_	9	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	AML1	_	NN	NN	_	3	nn	_	_
3	gene	_	NN	NN	_	8	nsubjpass	_	_
4	on	_	IN	IN	_	3	prep	_	_
5	chromosome	_	NN	NN	_	4	pobj	_	_
6	21	_	CD	CD	_	5	num	_	_
7	is	_	VBZ	VBZ	_	8	auxpass	_	_
8	disrupted	_	VBN	VBN	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	11	dep	_	_
11	-LRB-8;21-RRB--LRB-q22;q22-RRB-	_	NN	NN	_	9	pobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	-LRB-3;21-RRB--LRB-q26;q22-RRB-	_	NN	NN	_	11	conj	_	_
14	translocations	_	NNS	NNS	_	11	dep	_	_
15	associated	_	VBN	VBN	_	11	vmod	_	_
16	with	_	IN	IN	_	15	prep	_	_
17	myelogenous	_	JJ	JJ	_	18	amod	_	_
18	leukemias	_	NNS	NNS	_	16	pobj	_	_
19	and	_	CC	CC	_	8	cc	_	_
20	encodes	_	VBZ	VBZ	_	8	conj	_	_
21	a	_	DT	DT	_	23	det	_	_
22	DNA-binding	_	JJ	JJ	_	23	amod	_	_
23	protein	_	NN	NN	_	20	dobj	_	_
24	.	_	.	.	_	8	punct	_	_

1	From	_	IN	IN	_	16	prep	_	_
2	AML1	_	NN	NN	_	3	nn	_	_
3	gene	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	16	punct	_	_
5	two	_	CD	CD	_	7	num	_	_
6	representative	_	JJ	JJ	_	7	amod	_	_
7	forms	_	NNS	NNS	_	16	nsubjpass	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	proteins	_	NNS	NNS	_	8	pobj	_	_
10	,	_	,	,	_	7	punct	_	_
11	AML1a	_	NN	NN	_	7	appos	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	AML1b	_	NN	NN	_	11	conj	_	_
14	,	_	,	,	_	7	punct	_	_
15	are	_	VBP	VBP	_	16	auxpass	_	_
16	produced	_	VBN	VBN	_	0	root	_	_
17	by	_	IN	IN	_	16	prep	_	_
18	an	_	DT	DT	_	20	det	_	_
19	alternative	_	JJ	JJ	_	20	amod	_	_
20	splicing	_	NN	NN	_	17	pobj	_	_
21	.	_	.	.	_	16	punct	_	_

1	Both	_	DT	DT	_	2	det	_	_
2	forms	_	NNS	NNS	_	3	nsubj	_	_
3	have	_	VBP	VBP	_	0	root	_	_
4	DNA-binding	_	JJ	JJ	_	5	amod	_	_
5	domain	_	NN	NN	_	3	dobj	_	_
6	,	_	,	,	_	3	punct	_	_
7	but	_	CC	CC	_	3	cc	_	_
8	AML1a	_	NN	NN	_	9	nsubj	_	_
9	lacks	_	VBZ	VBZ	_	3	conj	_	_
10	a	_	DT	DT	_	14	det	_	_
11	putative	_	JJ	JJ	_	14	amod	_	_
12	transcriptional	_	JJ	JJ	_	14	amod	_	_
13	activation	_	NN	NN	_	14	nn	_	_
14	domain	_	NN	NN	_	9	dobj	_	_
15	which	_	WDT	WDT	_	17	dobj	_	_
16	AML1b	_	NN	NN	_	17	nsubj	_	_
17	has	_	VBZ	VBZ	_	14	rcmod	_	_
18	.	_	.	.	_	3	punct	_	_

1	Here	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	demonstrate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	18	mark	_	_
5	AML1a	_	NN	NN	_	18	nsubj	_	_
6	,	_	,	,	_	5	punct	_	_
7	which	_	WDT	WDT	_	9	nsubj	_	_
8	solely	_	RB	RB	_	9	advmod	_	_
9	has	_	VBZ	VBZ	_	5	rcmod	_	_
10	no	_	DT	DT	_	11	neg	_	_
11	effects	_	NNS	NNS	_	9	dobj	_	_
12	as	_	IN	IN	_	9	prep	_	_
13	a	_	DT	DT	_	15	det	_	_
14	transcriptional	_	JJ	JJ	_	15	amod	_	_
15	regulator	_	NN	NN	_	12	pobj	_	_
16	,	_	,	,	_	5	punct	_	_
17	dominantly	_	RB	RB	_	18	advmod	_	_
18	suppresses	_	VBZ	VBZ	_	3	ccomp	_	_
19	transcriptional	_	JJ	JJ	_	20	amod	_	_
20	activation	_	NN	NN	_	18	dobj	_	_
21	by	_	IN	IN	_	18	prep	_	_
22	AML1b	_	NN	NN	_	21	pobj	_	_
23	,	_	,	,	_	18	punct	_	_
24	and	_	CC	CC	_	18	cc	_	_
25	that	_	IN	IN	_	27	mark	_	_
26	AML1a	_	NN	NN	_	27	nsubj	_	_
27	exhibits	_	VBZ	VBZ	_	18	conj	_	_
28	the	_	DT	DT	_	30	det	_	_
29	higher	_	JJR	JJR	_	30	amod	_	_
30	affinity	_	NN	NN	_	27	dobj	_	_
31	for	_	IN	IN	_	30	prep	_	_
32	DNA-binding	_	JJ	JJ	_	31	pobj	_	_
33	than	_	IN	IN	_	34	mark	_	_
34	AML1b	_	NN	NN	_	30	dep	_	_
35	.	_	.	.	_	3	punct	_	_

1	Furthermore	_	RB	RB	_	12	advmod	_	_
2	a	_	DT	DT	_	5	det	_	_
3	dominant	_	JJ	JJ	_	5	amod	_	_
4	negative	_	JJ	JJ	_	5	amod	_	_
5	form	_	NN	NN	_	12	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	AML1	_	NN	NN	_	6	pobj	_	_
8	,	_	,	,	_	5	punct	_	_
9	AML1a	_	NN	NN	_	5	appos	_	_
10	,	_	,	,	_	5	punct	_	_
11	totally	_	RB	RB	_	12	advmod	_	_
12	suppressed	_	VBD	VBD	_	0	root	_	_
13	granulocytic	_	JJ	JJ	_	14	amod	_	_
14	differentiation	_	NN	NN	_	12	dobj	_	_
15	otherwise	_	RB	RB	_	16	advmod	_	_
16	induced	_	VBN	VBN	_	14	vmod	_	_
17	by	_	IN	IN	_	16	prep	_	_
18	granulocyte	_	NN	NN	_	20	nn	_	_
19	colony-stimulating	_	JJ	JJ	_	20	amod	_	_
20	factor	_	NN	NN	_	17	pobj	_	_
21	when	_	WRB	WRB	_	24	advmod	_	_
22	AML1a	_	NN	NN	_	24	nsubjpass	_	_
23	was	_	VBD	VBD	_	24	auxpass	_	_
24	overexpressed	_	VBN	VBN	_	12	advcl	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	32Dc13	_	NN	NN	_	29	nn	_	_
27	murine	_	JJ	JJ	_	29	amod	_	_
28	myeloid	_	JJ	JJ	_	29	amod	_	_
29	cells	_	NNS	NNS	_	25	pobj	_	_
30	.	_	.	.	_	12	punct	_	_

1	Such	_	JJ	JJ	_	3	amod	_	_
2	differentiation	_	NN	NN	_	3	nn	_	_
3	block	_	NN	NN	_	7	nsubjpass	_	_
4	by	_	IN	IN	_	3	prep	_	_
5	AML1a	_	NN	NN	_	4	pobj	_	_
6	was	_	VBD	VBD	_	7	auxpass	_	_
7	canceled	_	VBN	VBN	_	0	root	_	_
8	by	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	concomitant	_	JJ	JJ	_	11	amod	_	_
11	overexpression	_	NN	NN	_	8	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	AML1b	_	NN	NN	_	12	pobj	_	_
14	.	_	.	.	_	7	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	4	nsubj	_	_
3	strongly	_	RB	RB	_	4	advmod	_	_
4	suggest	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	13	mark	_	_
6	a	_	DT	DT	_	9	det	_	_
7	transcriptionally	_	RB	RB	_	8	advmod	_	_
8	active	_	JJ	JJ	_	9	advmod	_	_
9	form	_	NN	NN	_	13	nsubj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	AML1	_	NN	NN	_	10	pobj	_	_
12	is	_	VBZ	VBZ	_	13	cop	_	_
13	essential	_	JJ	JJ	_	4	ccomp	_	_
14	for	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	18	det	_	_
16	myeloid	_	JJ	JJ	_	18	amod	_	_
17	cell	_	NN	NN	_	18	nn	_	_
18	differentiation	_	NN	NN	_	14	pobj	_	_
19	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	5	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	5	punct	_	_
4	we	_	PRP	PRP	_	5	nsubj	_	_
5	observed	_	VBD	VBD	_	0	root	_	_
6	an	_	DT	DT	_	9	det	_	_
7	altered	_	JJ	JJ	_	9	amod	_	_
8	expression	_	NN	NN	_	9	nn	_	_
9	level	_	NN	NN	_	5	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	AML1	_	NN	NN	_	10	pobj	_	_
12	along	_	IN	IN	_	5	prep	_	_
13	with	_	IN	IN	_	12	pcomp	_	_
14	the	_	DT	DT	_	16	det	_	_
15	myeloid	_	JJ	JJ	_	16	amod	_	_
16	differentiation	_	NN	NN	_	13	pobj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	several	_	JJ	JJ	_	21	amod	_	_
19	hemopoietic	_	JJ	JJ	_	21	amod	_	_
20	cell	_	NN	NN	_	21	nn	_	_
21	lines	_	NNS	NNS	_	17	pobj	_	_
22	.	_	.	.	_	5	punct	_	_

1	In	_	IN	IN	_	15	prep	_	_
2	these	_	DT	DT	_	3	det	_	_
3	cases	_	NNS	NNS	_	1	pobj	_	_
4	,	_	,	,	_	15	punct	_	_
5	at	_	IN	IN	_	15	advmod	_	_
6	least	_	JJS	JJS	_	5	pobj	_	_
7	,	_	,	,	_	15	punct	_	_
8	the	_	DT	DT	_	11	det	_	_
9	AML1	_	NN	NN	_	11	nn	_	_
10	expression	_	NN	NN	_	11	nn	_	_
11	level	_	NN	NN	_	15	nsubj	_	_
12	is	_	VBZ	VBZ	_	15	cop	_	_
13	a	_	DT	DT	_	15	det	_	_
14	potential	_	JJ	JJ	_	15	amod	_	_
15	regulator	_	NN	NN	_	0	root	_	_
16	for	_	IN	IN	_	15	prep	_	_
17	myeloid	_	JJ	JJ	_	19	amod	_	_
18	cell	_	NN	NN	_	19	nn	_	_
19	differentiation	_	NN	NN	_	16	pobj	_	_
20	.	_	.	.	_	15	punct	_	_

1	Of	_	IN	IN	_	9	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	GATA-binding	_	JJ	JJ	_	4	amod	_	_
4	proteins	_	NNS	NNS	_	1	pobj	_	_
5	,	_	,	,	_	9	punct	_	_
6	only	_	RB	RB	_	7	advmod	_	_
7	GATA-4	_	NN	NN	_	9	nsubj	_	_
8	selectively	_	RB	RB	_	9	advmod	_	_
9	regulates	_	VBZ	VBZ	_	0	root	_	_
10	the	_	DT	DT	_	14	det	_	_
11	human	_	JJ	JJ	_	14	amod	_	_
12	IL-5	_	NN	NN	_	14	nn	_	_
13	gene	_	NN	NN	_	14	nn	_	_
14	promoter	_	NN	NN	_	9	dobj	_	_
15	in	_	IN	IN	_	9	prep	_	_
16	IL-5	_	NN	NN	_	18	nn	_	_
17	producing	_	NN	NN	_	18	nn	_	_
18	cells	_	NNS	NNS	_	15	pobj	_	_
19	which	_	WDT	WDT	_	20	nsubj	_	_
20	express	_	VBP	VBP	_	18	rcmod	_	_
21	multiple	_	JJ	JJ	_	23	amod	_	_
22	GATA-binding	_	JJ	JJ	_	23	amod	_	_
23	proteins	_	NNS	NNS	_	20	dobj	_	_
24	.	_	.	.	_	9	punct	_	_

1	Interleukin-5	_	NN	NN	_	6	nsubjpass	_	_
2	-LRB-	_	-LRB-	-LRB-	_	3	punct	_	_
3	IL-5	_	NN	NN	_	1	appos	_	_
4	-RRB-	_	-RRB-	-RRB-	_	3	punct	_	_
5	is	_	VBZ	VBZ	_	6	auxpass	_	_
6	produced	_	VBN	VBN	_	0	root	_	_
7	by	_	IN	IN	_	6	prep	_	_
8	T	_	NN	NN	_	9	nn	_	_
9	lymphocytes	_	NNS	NNS	_	7	pobj	_	_
10	and	_	CC	CC	_	6	cc	_	_
11	known	_	VBN	VBN	_	6	conj	_	_
12	to	_	TO	TO	_	13	aux	_	_
13	support	_	VB	VB	_	11	xcomp	_	_
14	B	_	NN	NN	_	16	nn	_	_
15	cell	_	NN	NN	_	16	nn	_	_
16	growth	_	NN	NN	_	13	dobj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	eosinophilic	_	JJ	JJ	_	19	amod	_	_
19	differentiation	_	NN	NN	_	16	conj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	23	det	_	_
22	progenitor	_	NN	NN	_	23	nn	_	_
23	cells	_	NNS	NNS	_	20	pobj	_	_
24	.	_	.	.	_	6	punct	_	_

1	Using	_	VBG	VBG	_	0	root	_	_
2	ATL-16T	_	NN	NN	_	3	nn	_	_
3	cells	_	NNS	NNS	_	1	dobj	_	_
4	which	_	WDT	WDT	_	5	nsubj	_	_
5	express	_	VBP	VBP	_	3	rcmod	_	_
6	IL-5	_	NN	NN	_	7	nn	_	_
7	mRNA	_	NN	NN	_	5	dobj	_	_
8	,	_	,	,	_	1	punct	_	_
9	we	_	PRP	PRP	_	11	nsubj	_	_
10	have	_	VBP	VBP	_	11	aux	_	_
11	identified	_	VBN	VBN	_	1	parataxis	_	_
12	a	_	DT	DT	_	13	det	_	_
13	region	_	NN	NN	_	11	dobj	_	_
14	,	_	,	,	_	13	punct	_	_
15	within	_	IN	IN	_	13	prep	_	_
16	the	_	DT	DT	_	20	det	_	_
17	human	_	JJ	JJ	_	20	amod	_	_
18	IL-5	_	NN	NN	_	20	nn	_	_
19	gene	_	NN	NN	_	20	nn	_	_
20	promoter	_	NN	NN	_	15	pobj	_	_
21	,	_	,	,	_	13	punct	_	_
22	that	_	WDT	WDT	_	23	nsubj	_	_
23	regulates	_	VBZ	VBZ	_	13	rcmod	_	_
24	IL-5	_	NN	NN	_	25	nn	_	_
25	gene	_	NN	NN	_	26	nn	_	_
26	transcription	_	NN	NN	_	23	dobj	_	_
27	.	_	.	.	_	1	punct	_	_

1	This	_	DT	DT	_	3	det	_	_
2	cis-acting	_	JJ	JJ	_	3	amod	_	_
3	sequence	_	NN	NN	_	4	nsubj	_	_
4	contains	_	VBZ	VBZ	_	0	root	_	_
5	the	_	DT	DT	_	8	det	_	_
6	core	_	NN	NN	_	8	nn	_	_
7	binding	_	NN	NN	_	8	nn	_	_
8	motif	_	NN	NN	_	4	dobj	_	_
9	,	_	,	,	_	8	punct	_	_
10	-LRB-A/T-RRB-GATA-LRB-A/G-RRB-	_	NN	NN	_	8	appos	_	_
11	,	_	,	,	_	8	punct	_	_
12	for	_	IN	IN	_	8	prep	_	_
13	GATA-binding	_	NN	NN	_	15	nn	_	_
14	family	_	NN	NN	_	15	nn	_	_
15	proteins	_	NNS	NNS	_	12	pobj	_	_
16	and	_	CC	CC	_	4	cc	_	_
17	thus	_	RB	RB	_	18	advmod	_	_
18	suggests	_	VBZ	VBZ	_	4	conj	_	_
19	the	_	DT	DT	_	20	det	_	_
20	involvement	_	NN	NN	_	18	dobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	these	_	DT	DT	_	24	det	_	_
23	family	_	NN	NN	_	24	nn	_	_
24	members	_	NNS	NNS	_	21	pobj	_	_
25	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	report	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	describe	_	VBP	VBP	_	0	root	_	_
7	the	_	DT	DT	_	8	det	_	_
8	cloning	_	NN	NN	_	6	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	human	_	JJ	JJ	_	11	amod	_	_
11	GATA-4	_	NN	NN	_	9	pobj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	hGATA-4	_	NN	NN	_	11	appos	_	_
14	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
15	and	_	CC	CC	_	6	cc	_	_
16	show	_	VBP	VBP	_	6	conj	_	_
17	that	_	IN	IN	_	20	mark	_	_
18	hGATA-4	_	NN	NN	_	20	nsubj	_	_
19	selectively	_	RB	RB	_	20	advmod	_	_
20	interacts	_	VBZ	VBZ	_	16	ccomp	_	_
21	with	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	25	det	_	_
23	-70	_	CD	CD	_	25	num	_	_
24	GATA	_	NN	NN	_	25	nn	_	_
25	site	_	NN	NN	_	21	pobj	_	_
26	within	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	31	det	_	_
28	IL-5	_	NN	NN	_	31	nn	_	_
29	proximal	_	JJ	JJ	_	31	amod	_	_
30	promoter	_	NN	NN	_	31	nn	_	_
31	region	_	NN	NN	_	26	pobj	_	_
32	.	_	.	.	_	6	punct	_	_

1	By	_	IN	IN	_	9	prep	_	_
2	promoter	_	NN	NN	_	1	pobj	_	_
3	deletion	_	NN	NN	_	2	dep	_	_
4	and	_	CC	CC	_	2	cc	_	_
5	mutation	_	NN	NN	_	2	conj	_	_
6	analyses	_	NNS	NNS	_	2	dep	_	_
7	,	_	,	,	_	9	punct	_	_
8	we	_	PRP	PRP	_	9	nsubj	_	_
9	established	_	VBD	VBD	_	0	root	_	_
10	this	_	DT	DT	_	11	det	_	_
11	region	_	NN	NN	_	9	dobj	_	_
12	as	_	IN	IN	_	9	prep	_	_
13	a	_	DT	DT	_	16	det	_	_
14	positive	_	JJ	JJ	_	16	amod	_	_
15	regulatory	_	JJ	JJ	_	16	amod	_	_
16	element	_	NN	NN	_	12	pobj	_	_
17	.	_	.	.	_	9	punct	_	_

1	Cotransfection	_	NN	NN	_	2	nn	_	_
2	experiments	_	NNS	NNS	_	3	nsubj	_	_
3	revealed	_	VBD	VBD	_	0	root	_	_
4	that	_	IN	IN	_	11	mark	_	_
5	both	_	CC	CC	_	6	preconj	_	_
6	hGATA-4	_	NN	NN	_	11	nsubj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	PMA/A23187	_	NN	NN	_	6	conj	_	_
9	stimulation	_	NN	NN	_	6	dep	_	_
10	are	_	VBP	VBP	_	11	cop	_	_
11	necessary	_	JJ	JJ	_	3	ccomp	_	_
12	for	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	16	det	_	_
14	IL-5	_	NN	NN	_	15	nn	_	_
15	promoter	_	NN	NN	_	16	nn	_	_
16	activation	_	NN	NN	_	12	pobj	_	_
17	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	requirement	_	NN	NN	_	21	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	another	_	DT	DT	_	6	det	_	_
5	regulatory	_	JJ	JJ	_	6	amod	_	_
6	element	_	NN	NN	_	3	pobj	_	_
7	called	_	VBN	VBN	_	6	vmod	_	_
8	CLE0	_	NN	NN	_	7	dep	_	_
9	,	_	,	,	_	6	punct	_	_
10	which	_	WDT	WDT	_	11	nsubj	_	_
11	lies	_	VBZ	VBZ	_	6	rcmod	_	_
12	downstream	_	RB	RB	_	11	advmod	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	17	det	_	_
15	-70	_	CD	CD	_	17	num	_	_
16	GATA	_	NN	NN	_	17	nn	_	_
17	site	_	NN	NN	_	13	pobj	_	_
18	,	_	,	,	_	2	punct	_	_
19	was	_	VBD	VBD	_	21	auxpass	_	_
20	also	_	RB	RB	_	21	advmod	_	_
21	demonstrated	_	VBN	VBN	_	0	root	_	_
22	.	_	.	.	_	21	punct	_	_

1	ATL-16T	_	NN	NN	_	2	nn	_	_
2	cells	_	NNS	NNS	_	3	nsubj	_	_
3	express	_	VBP	VBP	_	0	root	_	_
4	mRNA	_	NN	NN	_	3	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	three	_	CD	CD	_	8	num	_	_
7	GATA-binding	_	JJ	JJ	_	8	amod	_	_
8	proteins	_	NNS	NNS	_	5	pobj	_	_
9	,	_	,	,	_	8	punct	_	_
10	hGATA-2	_	NN	NN	_	8	appos	_	_
11	,	_	,	,	_	10	punct	_	_
12	hGATA-3	_	NN	NN	_	10	conj	_	_
13	and	_	CC	CC	_	10	cc	_	_
14	hGATA-4	_	NN	NN	_	10	conj	_	_
15	,	_	,	,	_	3	punct	_	_
16	and	_	CC	CC	_	3	cc	_	_
17	each	_	DT	DT	_	20	nsubj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	them	_	PRP	PRP	_	18	pobj	_	_
20	has	_	VBZ	VBZ	_	3	conj	_	_
21	a	_	DT	DT	_	22	det	_	_
22	potential	_	NN	NN	_	20	dobj	_	_
23	to	_	TO	TO	_	24	aux	_	_
24	bind	_	VB	VB	_	22	vmod	_	_
25	to	_	TO	TO	_	24	prep	_	_
26	the	_	DT	DT	_	29	det	_	_
27	consensus	_	NN	NN	_	29	nn	_	_
28	-LRB-A/T-RRB-GATA-LRB-G/A-RRB-	_	NN	NN	_	29	nn	_	_
29	motif	_	NN	NN	_	25	pobj	_	_
30	.	_	.	.	_	3	punct	_	_

1	However	_	RB	RB	_	3	advmod	_	_
2	,	_	,	,	_	3	punct	_	_
3	using	_	VBG	VBG	_	0	root	_	_
4	ATL-16T	_	NN	NN	_	6	nn	_	_
5	nuclear	_	JJ	JJ	_	6	amod	_	_
6	extract	_	NN	NN	_	3	dobj	_	_
7	,	_	,	,	_	3	punct	_	_
8	we	_	PRP	PRP	_	9	nsubj	_	_
9	demonstrated	_	VBD	VBD	_	3	parataxis	_	_
10	that	_	IN	IN	_	16	mark	_	_
11	GATA-4	_	NN	NN	_	16	nsubj	_	_
12	is	_	VBZ	VBZ	_	16	cop	_	_
13	the	_	DT	DT	_	16	det	_	_
14	only	_	RB	RB	_	16	advmod	_	_
15	GATA-binding	_	JJ	JJ	_	16	amod	_	_
16	protein	_	NN	NN	_	9	ccomp	_	_
17	that	_	WDT	WDT	_	18	nsubj	_	_
18	forms	_	VBZ	VBZ	_	16	rcmod	_	_
19	specific	_	JJ	JJ	_	21	amod	_	_
20	DNA-protein	_	JJ	JJ	_	21	amod	_	_
21	complex	_	NN	NN	_	18	dobj	_	_
22	with	_	IN	IN	_	18	prep	_	_
23	the	_	DT	DT	_	26	det	_	_
24	-70	_	CD	CD	_	26	num	_	_
25	GATA	_	NN	NN	_	26	nn	_	_
26	site	_	NN	NN	_	22	pobj	_	_
27	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	5	det	_	_
2	electrophoretic	_	JJ	JJ	_	5	amod	_	_
3	mobility	_	NN	NN	_	5	nn	_	_
4	shift	_	NN	NN	_	5	nn	_	_
5	assay	_	NN	NN	_	14	nsubj	_	_
6	with	_	IN	IN	_	5	prep	_	_
7	extracts	_	NNS	NNS	_	6	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	COS	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	8	pobj	_	_
11	expressing	_	VBG	VBG	_	10	vmod	_	_
12	GATA-binding	_	JJ	JJ	_	13	amod	_	_
13	proteins	_	NNS	NNS	_	11	dobj	_	_
14	showed	_	VBD	VBD	_	0	root	_	_
15	that	_	IN	IN	_	17	mark	_	_
16	GATA-4	_	NN	NN	_	17	nsubj	_	_
17	has	_	VBZ	VBZ	_	14	ccomp	_	_
18	the	_	DT	DT	_	21	det	_	_
19	highest	_	JJS	JJS	_	21	amod	_	_
20	binding	_	NN	NN	_	21	nn	_	_
21	affinity	_	NN	NN	_	17	dobj	_	_
22	to	_	TO	TO	_	21	prep	_	_
23	the	_	DT	DT	_	26	det	_	_
24	-70	_	CD	CD	_	26	num	_	_
25	GATA	_	NN	NN	_	26	nn	_	_
26	site	_	NN	NN	_	22	pobj	_	_
27	among	_	IN	IN	_	21	prep	_	_
28	the	_	DT	DT	_	31	det	_	_
29	three	_	CD	CD	_	31	num	_	_
30	GATA-binding	_	JJ	JJ	_	31	amod	_	_
31	proteins	_	NNS	NNS	_	27	pobj	_	_
32	.	_	.	.	_	14	punct	_	_

1	When	_	WRB	WRB	_	6	advmod	_	_
2	the	_	DT	DT	_	4	det	_	_
3	transactivation	_	NN	NN	_	4	nn	_	_
4	ability	_	NN	NN	_	6	nsubjpass	_	_
5	was	_	VBD	VBD	_	6	auxpass	_	_
6	compared	_	VBN	VBN	_	12	advcl	_	_
7	among	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	three	_	CD	CD	_	7	pobj	_	_
10	,	_	,	,	_	12	punct	_	_
11	GATA-4	_	NN	NN	_	12	nsubj	_	_
12	showed	_	VBD	VBD	_	0	root	_	_
13	the	_	DT	DT	_	15	det	_	_
14	highest	_	JJS	JJS	_	15	amod	_	_
15	activity	_	NN	NN	_	12	dobj	_	_
16	.	_	.	.	_	12	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	demonstrate	_	VBP	VBP	_	0	root	_	_
4	the	_	DT	DT	_	6	det	_	_
5	selective	_	JJ	JJ	_	6	amod	_	_
6	role	_	NN	NN	_	3	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	GATA-4	_	NN	NN	_	7	pobj	_	_
9	in	_	IN	IN	_	6	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	transcriptional	_	JJ	JJ	_	12	amod	_	_
12	regulation	_	NN	NN	_	9	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	IL-5	_	NN	NN	_	16	nn	_	_
16	gene	_	NN	NN	_	13	pobj	_	_
17	in	_	IN	IN	_	12	prep	_	_
18	a	_	DT	DT	_	19	det	_	_
19	circumstance	_	NN	NN	_	17	pobj	_	_
20	where	_	WRB	WRB	_	28	advmod	_	_
21	multiple	_	JJ	JJ	_	22	amod	_	_
22	members	_	NNS	NNS	_	28	nsubjpass	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	26	det	_	_
25	GATA-binding	_	JJ	JJ	_	26	amod	_	_
26	proteins	_	NNS	NNS	_	23	pobj	_	_
27	are	_	VBP	VBP	_	28	auxpass	_	_
28	expressed	_	VBN	VBN	_	19	rcmod	_	_
29	.	_	.	.	_	3	punct	_	_

1	Increased	_	VBN	VBN	_	2	amod	_	_
2	expression	_	NN	NN	_	5	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	Gs-LRB-alpha-RRB-	_	NN	NN	_	3	pobj	_	_
5	enhances	_	VBZ	VBZ	_	0	root	_	_
6	activation	_	NN	NN	_	5	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	13	det	_	_
9	adenylyl	_	NN	NN	_	10	nn	_	_
10	cyclase	_	NN	NN	_	13	nn	_	_
11	signal	_	NN	NN	_	13	nn	_	_
12	transduction	_	NN	NN	_	13	nn	_	_
13	cascade	_	NN	NN	_	7	pobj	_	_
14	.	_	.	.	_	5	punct	_	_

1	Expression	_	NN	NN	_	11	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	6	det	_	_
4	stimulatory	_	JJ	JJ	_	6	amod	_	_
5	G	_	NN	NN	_	6	nn	_	_
6	protein	_	NN	NN	_	2	pobj	_	_
7	,	_	,	,	_	6	punct	_	_
8	G-LRB-S-RRB-alpha	_	NN	NN	_	6	appos	_	_
9	,	_	,	,	_	1	punct	_	_
10	can	_	MD	MD	_	11	aux	_	_
11	vary	_	VB	VB	_	0	root	_	_
12	over	_	IN	IN	_	11	prep	_	_
13	a	_	DT	DT	_	15	det	_	_
14	3-fold	_	JJ	JJ	_	15	amod	_	_
15	range	_	NN	NN	_	12	pobj	_	_
16	in	_	IN	IN	_	11	prep	_	_
17	human	_	JJ	JJ	_	18	amod	_	_
18	tissues	_	NNS	NNS	_	16	pobj	_	_
19	and	_	CC	CC	_	16	cc	_	_
20	in	_	IN	IN	_	16	conj	_	_
21	rodent	_	JJ	JJ	_	24	amod	_	_
22	central	_	JJ	JJ	_	24	amod	_	_
23	nervous	_	JJ	JJ	_	24	amod	_	_
24	system	_	NN	NN	_	20	pobj	_	_
25	.	_	.	.	_	11	punct	_	_

1	In	_	IN	IN	_	8	prep	_	_
2	fact	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	8	punct	_	_
4	the	_	DT	DT	_	5	det	_	_
5	offspring	_	NN	NN	_	8	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	alcoholics	_	NNS	NNS	_	6	pobj	_	_
8	have	_	VBP	VBP	_	0	root	_	_
9	higher	_	JJR	JJR	_	10	amod	_	_
10	levels	_	NNS	NNS	_	8	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	G-LRB-S-RRB-alpha	_	NN	NN	_	13	nn	_	_
13	expression	_	NN	NN	_	11	pobj	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	certain	_	JJ	JJ	_	16	amod	_	_
16	tissues	_	NNS	NNS	_	14	pobj	_	_
17	compared	_	VBN	VBN	_	8	prep	_	_
18	with	_	IN	IN	_	17	pcomp	_	_
19	the	_	DT	DT	_	20	det	_	_
20	offspring	_	NN	NN	_	18	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	nonalcoholics	_	NNS	NNS	_	21	pobj	_	_
23	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	aim	_	NN	NN	_	6	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	this	_	DT	DT	_	5	det	_	_
5	research	_	NN	NN	_	3	pobj	_	_
6	was	_	VBD	VBD	_	0	root	_	_
7	to	_	TO	TO	_	8	aux	_	_
8	test	_	VB	VB	_	6	xcomp	_	_
9	the	_	DT	DT	_	10	det	_	_
10	hypothesis	_	NN	NN	_	8	dobj	_	_
11	that	_	IN	IN	_	15	mark	_	_
12	a	_	DT	DT	_	14	det	_	_
13	causal	_	JJ	JJ	_	14	amod	_	_
14	relationship	_	NN	NN	_	15	nsubj	_	_
15	exists	_	VBZ	VBZ	_	10	ccomp	_	_
16	between	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	18	det	_	_
18	level	_	NN	NN	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	expression	_	NN	NN	_	19	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	G-LRB-S-RRB-alpha	_	NN	NN	_	21	pobj	_	_
23	and	_	CC	CC	_	18	cc	_	_
24	induction	_	NN	NN	_	18	conj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	32	det	_	_
27	adenylyl	_	NN	NN	_	28	nn	_	_
28	cyclase	_	NN	NN	_	32	nn	_	_
29	-LRB-	_	-LRB-	-LRB-	_	30	punct	_	_
30	AC	_	NN	NN	_	28	appos	_	_
31	-RRB-	_	-RRB-	-RRB-	_	30	punct	_	_
32	cascade	_	NN	NN	_	25	pobj	_	_
33	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	methodology	_	NN	NN	_	3	nsubj	_	_
3	employed	_	VBD	VBD	_	0	root	_	_
4	transient	_	JJ	JJ	_	5	amod	_	_
5	transfection	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	HEK	_	NN	NN	_	9	nn	_	_
8	293	_	CD	CD	_	9	num	_	_
9	cells	_	NNS	NNS	_	6	pobj	_	_
10	with	_	IN	IN	_	5	prep	_	_
11	a	_	DT	DT	_	12	det	_	_
12	cDNA	_	NN	NN	_	10	pobj	_	_
13	for	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	52-kDa	_	JJ	JJ	_	16	amod	_	_
16	form	_	NN	NN	_	13	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	G-LRB-S-RRB-alpha	_	NN	NN	_	17	pobj	_	_
19	under	_	IN	IN	_	5	prep	_	_
20	regulation	_	NN	NN	_	19	pobj	_	_
21	by	_	IN	IN	_	20	prep	_	_
22	inducible	_	JJ	JJ	_	24	amod	_	_
23	metallothionein	_	NN	NN	_	24	nn	_	_
24	promoters	_	NNS	NNS	_	21	pobj	_	_
25	.	_	.	.	_	3	punct	_	_

1	Transfectants	_	NNS	NNS	_	3	nsubjpass	_	_
2	were	_	VBD	VBD	_	3	auxpass	_	_
3	exposed	_	VBN	VBN	_	0	root	_	_
4	to	_	TO	TO	_	3	prep	_	_
5	varying	_	VBG	VBG	_	6	amod	_	_
6	concentrations	_	NNS	NNS	_	4	pobj	_	_
7	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
8	0-125	_	CD	CD	_	9	num	_	_
9	microM	_	NN	NN	_	6	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	of	_	IN	IN	_	6	prep	_	_
12	zinc	_	NN	NN	_	13	nn	_	_
13	sulfate	_	NN	NN	_	11	pobj	_	_
14	that	_	WDT	WDT	_	15	nsubj	_	_
15	produced	_	VBD	VBD	_	6	rcmod	_	_
16	a	_	DT	DT	_	18	det	_	_
17	3-fold	_	JJ	JJ	_	18	amod	_	_
18	range	_	NN	NN	_	15	dobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	membrane	_	NN	NN	_	22	nn	_	_
21	G-LRB-S-RRB-alpha	_	NN	NN	_	22	nn	_	_
22	expression	_	NN	NN	_	19	pobj	_	_
23	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	range	_	NN	NN	_	8	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	G-LRB-S-RRB-alpha	_	NN	NN	_	5	nn	_	_
5	expression	_	NN	NN	_	3	pobj	_	_
6	produced	_	VBN	VBN	_	5	vmod	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	found	_	VBN	VBN	_	0	root	_	_
9	to	_	TO	TO	_	10	aux	_	_
10	mimic	_	VB	VB	_	8	xcomp	_	_
11	a	_	DT	DT	_	14	det	_	_
12	physiologically	_	RB	RB	_	13	advmod	_	_
13	relevant	_	JJ	JJ	_	14	amod	_	_
14	spectrum	_	NN	NN	_	10	dobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	G-LRB-S-RRB-alpha	_	NN	NN	_	17	nn	_	_
17	expression	_	NN	NN	_	15	pobj	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	membranes	_	NNS	NNS	_	18	pobj	_	_
20	derived	_	VBN	VBN	_	19	vmod	_	_
21	from	_	IN	IN	_	20	prep	_	_
22	human	_	JJ	JJ	_	23	amod	_	_
23	tissues	_	NNS	NNS	_	21	pobj	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	rat	_	NN	NN	_	26	nn	_	_
26	brain	_	NN	NN	_	23	conj	_	_
27	.	_	.	.	_	8	punct	_	_

1	It	_	PRP	PRP	_	3	nsubjpass	_	_
2	was	_	VBD	VBD	_	3	auxpass	_	_
3	observed	_	VBN	VBN	_	0	root	_	_
4	that	_	IN	IN	_	9	mark	_	_
5	induction	_	NN	NN	_	9	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	G-LRB-S-RRB-alpha	_	NN	NN	_	8	nn	_	_
8	expression	_	NN	NN	_	6	pobj	_	_
9	increased	_	VBD	VBD	_	3	ccomp	_	_
10	constitutive	_	JJ	JJ	_	9	dobj	_	_
11	as	_	RB	RB	_	12	advmod	_	_
12	well	_	RB	RB	_	10	cc	_	_
13	as	_	IN	IN	_	12	mwe	_	_
14	stimulated	_	VBN	VBN	_	10	conj	_	_
15	cAMP	_	NN	NN	_	16	nn	_	_
16	accumulation	_	NN	NN	_	10	dep	_	_
17	.	_	.	.	_	3	punct	_	_

1	Moreover	_	RB	RB	_	7	advmod	_	_
2	,	_	,	,	_	7	punct	_	_
3	induction	_	NN	NN	_	7	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	G-LRB-S-RRB-alpha	_	NN	NN	_	6	nn	_	_
6	expression	_	NN	NN	_	4	pobj	_	_
7	increased	_	VBD	VBD	_	0	root	_	_
8	events	_	NNS	NNS	_	7	dobj	_	_
9	distal	_	JJ	JJ	_	8	amod	_	_
10	to	_	TO	TO	_	9	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	accumulation	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	cAMP	_	NN	NN	_	13	pobj	_	_
15	including	_	VBG	VBG	_	8	prep	_	_
16	the	_	DT	DT	_	17	det	_	_
17	phosphorylation	_	NN	NN	_	15	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	transcription	_	NN	NN	_	21	nn	_	_
21	factor	_	NN	NN	_	18	pobj	_	_
22	,	_	,	,	_	21	punct	_	_
23	cAMP	_	NN	NN	_	27	nn	_	_
24	response	_	NN	NN	_	27	nn	_	_
25	element	_	NN	NN	_	27	nn	_	_
26	binding	_	NN	NN	_	27	nn	_	_
27	protein	_	NN	NN	_	21	appos	_	_
28	and	_	CC	CC	_	17	cc	_	_
29	transcriptional	_	JJ	JJ	_	30	amod	_	_
30	activation	_	NN	NN	_	17	conj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	cAMP-dependent	_	JJ	JJ	_	34	amod	_	_
33	reporter	_	NN	NN	_	34	nn	_	_
34	genes	_	NNS	NNS	_	31	pobj	_	_
35	.	_	.	.	_	7	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	summary	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	6	punct	_	_
4	these	_	DT	DT	_	5	det	_	_
5	studies	_	NNS	NNS	_	6	nsubj	_	_
6	show	_	VBP	VBP	_	0	root	_	_
7	that	_	IN	IN	_	13	mark	_	_
8	the	_	DT	DT	_	9	det	_	_
9	amount	_	NN	NN	_	13	nsubj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	G-LRB-S-RRB-alpha	_	NN	NN	_	12	nn	_	_
12	expression	_	NN	NN	_	10	pobj	_	_
13	has	_	VBZ	VBZ	_	6	ccomp	_	_
14	a	_	DT	DT	_	16	det	_	_
15	marked	_	JJ	JJ	_	16	amod	_	_
16	impact	_	NN	NN	_	13	dobj	_	_
17	on	_	IN	IN	_	13	prep	_	_
18	the	_	DT	DT	_	19	det	_	_
19	level	_	NN	NN	_	17	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	activity	_	NN	NN	_	20	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	25	det	_	_
24	AC	_	NN	NN	_	25	nn	_	_
25	cascade	_	NN	NN	_	22	pobj	_	_
26	from	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	28	det	_	_
28	membrane	_	NN	NN	_	26	pobj	_	_
29	through	_	IN	IN	_	25	prep	_	_
30	to	_	TO	TO	_	29	pcomp	_	_
31	the	_	DT	DT	_	32	det	_	_
32	nucleus	_	NN	NN	_	30	pobj	_	_
33	.	_	.	.	_	6	punct	_	_

1	It	_	PRP	PRP	_	3	nsubjpass	_	_
2	is	_	VBZ	VBZ	_	3	auxpass	_	_
3	hypothesized	_	VBN	VBN	_	0	root	_	_
4	that	_	IN	IN	_	13	mark	_	_
5	individuals	_	NNS	NNS	_	13	nsubj	_	_
6	who	_	WP	WP	_	7	nsubj	_	_
7	differ	_	VBP	VBP	_	5	rcmod	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	G-LRB-S-RRB-alpha	_	NN	NN	_	10	nn	_	_
10	expression	_	NN	NN	_	8	pobj	_	_
11	may	_	MD	MD	_	13	aux	_	_
12	also	_	RB	RB	_	13	advmod	_	_
13	differ	_	VB	VB	_	3	ccomp	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	expression	_	NN	NN	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	certain	_	JJ	JJ	_	20	amod	_	_
19	cAMP-dependent	_	JJ	JJ	_	20	amod	_	_
20	genes	_	NNS	NNS	_	17	pobj	_	_
21	.	_	.	.	_	3	punct	_	_

1	Expression	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	transcription	_	NN	NN	_	4	nn	_	_
4	factors	_	NNS	NNS	_	2	pobj	_	_
5	during	_	IN	IN	_	1	prep	_	_
6	sodium	_	NN	NN	_	7	dep	_	_
7	phenylacetate	_	NN	NN	_	10	amod	_	_
8	induced	_	VBD	VBD	_	7	dep	_	_
9	erythroid	_	JJ	JJ	_	10	amod	_	_
10	differentiation	_	NN	NN	_	5	pobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	K562	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	11	pobj	_	_
14	.	_	.	.	_	1	punct	_	_

1	During	_	IN	IN	_	14	prep	_	_
2	15	_	CD	CD	_	3	num	_	_
3	days	_	NNS	NNS	_	1	pobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	treatment	_	NN	NN	_	4	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	K562	_	NN	NN	_	8	nn	_	_
8	cells	_	NNS	NNS	_	6	pobj	_	_
9	with	_	IN	IN	_	5	prep	_	_
10	sodium	_	NN	NN	_	11	nn	_	_
11	phenylacetate	_	NN	NN	_	9	pobj	_	_
12	,	_	,	,	_	14	punct	_	_
13	we	_	PRP	PRP	_	14	nsubj	_	_
14	observed	_	VBD	VBD	_	0	root	_	_
15	an	_	DT	DT	_	16	det	_	_
16	increase	_	NN	NN	_	14	dobj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	21	det	_	_
19	cellular	_	JJ	JJ	_	21	amod	_	_
20	hemoglobin	_	NN	NN	_	21	nn	_	_
21	concentration	_	NN	NN	_	17	pobj	_	_
22	with	_	IN	IN	_	14	prep	_	_
23	a	_	DT	DT	_	25	det	_	_
24	similar	_	JJ	JJ	_	25	amod	_	_
25	increase	_	NN	NN	_	22	pobj	_	_
26	in	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	28	det	_	_
28	expression	_	NN	NN	_	26	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	gamma-globin	_	NN	NN	_	31	nn	_	_
31	mRNA	_	NN	NN	_	29	pobj	_	_
32	.	_	.	.	_	14	punct	_	_

1	Morphological	_	JJ	JJ	_	2	amod	_	_
2	studies	_	NNS	NNS	_	3	nsubj	_	_
3	demonstrated	_	VBD	VBD	_	0	root	_	_
4	characteristic	_	JJ	JJ	_	5	amod	_	_
5	features	_	NNS	NNS	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	erythroid	_	JJ	JJ	_	8	amod	_	_
8	differentiation	_	NN	NN	_	6	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	maturation	_	NN	NN	_	8	conj	_	_
11	.	_	.	.	_	3	punct	_	_

1	At	_	IN	IN	_	6	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	same	_	JJ	JJ	_	4	amod	_	_
4	time	_	NN	NN	_	1	pobj	_	_
5	there	_	EX	EX	_	6	expl	_	_
6	was	_	VBD	VBD	_	0	root	_	_
7	no	_	DT	DT	_	8	neg	_	_
8	change	_	NN	NN	_	6	nsubj	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	level	_	NN	NN	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	expression	_	NN	NN	_	12	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	18	det	_	_
16	cell	_	NN	NN	_	18	nn	_	_
17	surface	_	NN	NN	_	18	nn	_	_
18	antigenes	_	NNS	NNS	_	14	pobj	_	_
19	CD33	_	NN	NN	_	18	dep	_	_
20	,	_	,	,	_	19	punct	_	_
21	CD34	_	NN	NN	_	19	conj	_	_
22	,	_	,	,	_	19	punct	_	_
23	CD45	_	NN	NN	_	19	conj	_	_
24	,	_	,	,	_	19	punct	_	_
25	CD71	_	NN	NN	_	19	conj	_	_
26	and	_	CC	CC	_	19	cc	_	_
27	glycophorin	_	NN	NN	_	28	nn	_	_
28	A	_	NN	NN	_	19	conj	_	_
29	.	_	.	.	_	6	punct	_	_

1	Likewise	_	RB	RB	_	31	advmod	_	_
2	,	_	,	,	_	31	punct	_	_
3	the	_	DT	DT	_	4	det	_	_
4	level	_	NN	NN	_	31	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	expression	_	NN	NN	_	5	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	11	det	_	_
9	erythroid	_	JJ	JJ	_	11	amod	_	_
10	transcription	_	NN	NN	_	11	nn	_	_
11	factors	_	NNS	NNS	_	7	pobj	_	_
12	GATA-1	_	NN	NN	_	11	dep	_	_
13	,	_	,	,	_	12	punct	_	_
14	GATA-2	_	NN	NN	_	12	conj	_	_
15	,	_	,	,	_	12	punct	_	_
16	NF-E2	_	NN	NN	_	12	conj	_	_
17	,	_	,	,	_	12	punct	_	_
18	SCL	_	NN	NN	_	12	conj	_	_
19	and	_	CC	CC	_	12	cc	_	_
20	RBTN2	_	NN	NN	_	12	conj	_	_
21	,	_	,	,	_	6	punct	_	_
22	all	_	DT	DT	_	6	appos	_	_
23	expressed	_	VBN	VBN	_	22	vmod	_	_
24	in	_	IN	IN	_	23	prep	_	_
25	untreated	_	JJ	JJ	_	27	amod	_	_
26	K562	_	NN	NN	_	27	nn	_	_
27	cells	_	NNS	NNS	_	24	pobj	_	_
28	,	_	,	,	_	4	punct	_	_
29	did	_	VBD	VBD	_	31	aux	_	_
30	not	_	RB	RB	_	31	neg	_	_
31	increase	_	VB	VB	_	0	root	_	_
32	during	_	IN	IN	_	31	prep	_	_
33	sodium	_	NN	NN	_	35	npadvmod	_	_
34	phenylacetate	_	NN	NN	_	35	npadvmod	_	_
35	induced	_	JJ	JJ	_	37	amod	_	_
36	erythroid	_	JJ	JJ	_	37	amod	_	_
37	differentiation	_	NN	NN	_	32	pobj	_	_
38	.	_	.	.	_	31	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	expression	_	NN	NN	_	19	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	nuclear	_	JJ	JJ	_	6	amod	_	_
6	factors	_	NNS	NNS	_	3	pobj	_	_
7	Evi-1	_	NN	NN	_	6	dep	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	c-myb	_	NN	NN	_	7	conj	_	_
10	,	_	,	,	_	6	punct	_	_
11	known	_	VBN	VBN	_	6	vmod	_	_
12	to	_	TO	TO	_	13	aux	_	_
13	inhibit	_	VB	VB	_	11	xcomp	_	_
14	erythroid	_	JJ	JJ	_	15	amod	_	_
15	differentiation	_	NN	NN	_	13	dobj	_	_
16	,	_	,	,	_	2	punct	_	_
17	did	_	VBD	VBD	_	19	aux	_	_
18	not	_	RB	RB	_	19	neg	_	_
19	decrease	_	VB	VB	_	0	root	_	_
20	.	_	.	.	_	19	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	conclude	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	10	mark	_	_
4	sodium	_	NN	NN	_	6	nn	_	_
5	phenylacetate	_	NN	NN	_	6	nn	_	_
6	treatment	_	NN	NN	_	10	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	K562	_	NN	NN	_	9	nn	_	_
9	cells	_	NNS	NNS	_	7	pobj	_	_
10	increases	_	VBZ	VBZ	_	2	ccomp	_	_
11	gamma-globin	_	NN	NN	_	12	nn	_	_
12	mRNA	_	NN	NN	_	10	dobj	_	_
13	and	_	CC	CC	_	10	cc	_	_
14	induces	_	VBZ	VBZ	_	10	conj	_	_
15	cell	_	NN	NN	_	16	nn	_	_
16	maturation	_	NN	NN	_	14	dobj	_	_
17	as	_	IN	IN	_	18	mark	_	_
18	judged	_	VBN	VBN	_	10	advcl	_	_
19	by	_	IN	IN	_	18	prep	_	_
20	morphology	_	NN	NN	_	19	pobj	_	_
21	without	_	IN	IN	_	10	prep	_	_
22	affecting	_	VBG	VBG	_	21	pcomp	_	_
23	the	_	DT	DT	_	24	det	_	_
24	expression	_	NN	NN	_	22	dobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	29	det	_	_
27	erythroid	_	JJ	JJ	_	29	amod	_	_
28	transcription	_	NN	NN	_	29	nn	_	_
29	factors	_	NNS	NNS	_	25	pobj	_	_
30	,	_	,	,	_	29	punct	_	_
31	some	_	DT	DT	_	35	nsubjpass	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	which	_	WDT	WDT	_	32	pobj	_	_
34	are	_	VBP	VBP	_	35	auxpass	_	_
35	known	_	VBN	VBN	_	29	rcmod	_	_
36	to	_	TO	TO	_	38	aux	_	_
37	be	_	VB	VB	_	38	auxpass	_	_
38	involved	_	VBN	VBN	_	35	xcomp	_	_
39	in	_	IN	IN	_	38	prep	_	_
40	the	_	DT	DT	_	41	det	_	_
41	regulation	_	NN	NN	_	39	pobj	_	_
42	of	_	IN	IN	_	41	prep	_	_
43	beta-like	_	JJ	JJ	_	45	amod	_	_
44	globin	_	NN	NN	_	45	nn	_	_
45	genes	_	NNS	NNS	_	42	pobj	_	_
46	.	_	.	.	_	2	punct	_	_

1	Glucocorticoid	_	NN	NN	_	2	nn	_	_
2	receptors	_	NNS	NNS	_	0	root	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	human	_	JJ	JJ	_	8	amod	_	_
5	peripheral	_	JJ	JJ	_	8	amod	_	_
6	blood	_	NN	NN	_	8	nn	_	_
7	mononuclear	_	JJ	JJ	_	8	amod	_	_
8	cells	_	NNS	NNS	_	3	pobj	_	_
9	in	_	IN	IN	_	2	prep	_	_
10	relation	_	NN	NN	_	9	pobj	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	age	_	NN	NN	_	11	pobj	_	_
13	and	_	CC	CC	_	11	cc	_	_
14	to	_	TO	TO	_	11	conj	_	_
15	sport	_	NN	NN	_	16	nn	_	_
16	activity	_	NN	NN	_	14	pobj	_	_
17	.	_	.	.	_	2	punct	_	_

1	Glucocorticoid	_	NN	NN	_	2	nn	_	_
2	receptors	_	NNS	NNS	_	8	nsubj	_	_
3	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
4	GR	_	NNS	NNS	_	2	appos	_	_
5	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
6	are	_	VBP	VBP	_	8	cop	_	_
7	ubiquitous	_	JJ	JJ	_	8	amod	_	_
8	molecules	_	NNS	NNS	_	0	root	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	are	_	VBP	VBP	_	11	cop	_	_
11	present	_	JJ	JJ	_	8	conj	_	_
12	also	_	RB	RB	_	11	advmod	_	_
13	in	_	IN	IN	_	11	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	hippocampus	_	NN	NN	_	13	pobj	_	_
16	and	_	CC	CC	_	13	cc	_	_
17	in	_	IN	IN	_	13	conj	_	_
18	several	_	JJ	JJ	_	20	amod	_	_
19	other	_	JJ	JJ	_	20	amod	_	_
20	nervous	_	JJ	JJ	_	17	pobj	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	immune	_	JJ	JJ	_	20	conj	_	_
23	tissues	_	NNS	NNS	_	20	dep	_	_
24	.	_	.	.	_	8	punct	_	_

1	Peripheral	_	JJ	JJ	_	4	amod	_	_
2	blood	_	NN	NN	_	4	nn	_	_
3	mononuclear	_	JJ	JJ	_	4	amod	_	_
4	cells	_	NNS	NNS	_	11	nsubj	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	PBMCs	_	NNS	NNS	_	4	appos	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	are	_	VBP	VBP	_	11	cop	_	_
9	a	_	DT	DT	_	11	det	_	_
10	good	_	JJ	JJ	_	11	amod	_	_
11	model	_	NN	NN	_	0	root	_	_
12	for	_	IN	IN	_	11	prep	_	_
13	studies	_	NNS	NNS	_	12	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	GR	_	NNS	NNS	_	14	pobj	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	humans	_	NNS	NNS	_	16	pobj	_	_
18	.	_	.	.	_	11	punct	_	_

1	Glucocorticoids	_	NNS	NNS	_	3	nsubj	_	_
2	are	_	VBP	VBP	_	3	cop	_	_
3	important	_	JJ	JJ	_	0	root	_	_
4	for	_	IN	IN	_	3	prep	_	_
5	maintaining	_	VBG	VBG	_	4	pcomp	_	_
6	cellular	_	JJ	JJ	_	5	dobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	humoral	_	JJ	JJ	_	6	conj	_	_
9	homeostasis	_	NN	NN	_	6	dep	_	_
10	and	_	CC	CC	_	3	cc	_	_
11	are	_	VBP	VBP	_	13	cop	_	_
12	key	_	JJ	JJ	_	13	amod	_	_
13	mediators	_	NNS	NNS	_	3	conj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	neuroendocrine-immune	_	JJ	JJ	_	16	amod	_	_
16	regulatory	_	JJ	JJ	_	17	amod	_	_
17	interactions	_	NNS	NNS	_	14	pobj	_	_
18	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	increase	_	NN	NN	_	6	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	cortisol	_	NN	NN	_	3	pobj	_	_
5	is	_	VBZ	VBZ	_	6	cop	_	_
6	immunosuppressive	_	JJ	JJ	_	0	root	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	reduces	_	VBZ	VBZ	_	6	conj	_	_
9	GR	_	NNS	NNS	_	10	nn	_	_
10	concentration	_	NN	NN	_	8	dobj	_	_
11	both	_	CC	CC	_	12	dep	_	_
12	in	_	IN	IN	_	6	prep	_	_
13	nervous	_	JJ	JJ	_	12	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	immune	_	JJ	JJ	_	13	conj	_	_
16	systems	_	NNS	NNS	_	13	dep	_	_
17	.	_	.	.	_	6	punct	_	_

1	Variation	_	NN	NN	_	12	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	glucocorticoids	_	NNS	NNS	_	2	pobj	_	_
4	in	_	IN	IN	_	1	prep	_	_
5	healthy	_	JJ	JJ	_	7	amod	_	_
6	aged	_	JJ	JJ	_	5	dep	_	_
7	subjects	_	NNS	NNS	_	4	pobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	athletes	_	NNS	NNS	_	7	conj	_	_
10	has	_	VBZ	VBZ	_	12	aux	_	_
11	been	_	VBN	VBN	_	12	auxpass	_	_
12	shown	_	VBN	VBN	_	0	root	_	_
13	.	_	.	.	_	12	punct	_	_

1	Prompted	_	VBN	VBN	_	0	root	_	_
2	by	_	IN	IN	_	1	prep	_	_
3	these	_	DT	DT	_	4	det	_	_
4	results	_	NNS	NNS	_	2	pobj	_	_
5	,	_	,	,	_	1	punct	_	_
6	we	_	PRP	PRP	_	8	nsubj	_	_
7	have	_	VBP	VBP	_	8	aux	_	_
8	investigated	_	VBN	VBN	_	1	parataxis	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	man	_	NN	NN	_	9	pobj	_	_
11	a	_	DT	DT	_	13	det	_	_
12	possible	_	JJ	JJ	_	13	amod	_	_
13	relationship	_	NN	NN	_	8	dobj	_	_
14	between	_	IN	IN	_	13	prep	_	_
15	GR	_	NNS	NNS	_	17	nn	_	_
16	binding	_	NN	NN	_	17	nn	_	_
17	capacity	_	NN	NN	_	14	pobj	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	20	det	_	_
20	PBMCs	_	NNS	NNS	_	18	pobj	_	_
21	and	_	CC	CC	_	17	cc	_	_
22	age	_	NN	NN	_	17	conj	_	_
23	,	_	,	,	_	8	punct	_	_
24	in	_	IN	IN	_	8	prep	_	_
25	relation	_	NN	NN	_	24	pobj	_	_
26	also	_	RB	RB	_	25	advmod	_	_
27	to	_	TO	TO	_	25	prep	_	_
28	plasma	_	NN	NN	_	27	pobj	_	_
29	testosterone	_	NN	NN	_	28	dep	_	_
30	and	_	CC	CC	_	28	cc	_	_
31	cortisol	_	NN	NN	_	28	conj	_	_
32	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	same	_	JJ	JJ	_	3	amod	_	_
3	parameters	_	NNS	NNS	_	6	nsubjpass	_	_
4	have	_	VBP	VBP	_	6	aux	_	_
5	been	_	VBN	VBN	_	6	auxpass	_	_
6	examined	_	VBN	VBN	_	0	root	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	a	_	DT	DT	_	9	det	_	_
9	group	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	soccer	_	NN	NN	_	12	nn	_	_
12	players	_	NNS	NNS	_	10	pobj	_	_
13	for	_	IN	IN	_	6	prep	_	_
14	comparison	_	NN	NN	_	13	pobj	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	18	det	_	_
17	sedentary	_	JJ	JJ	_	18	amod	_	_
18	group	_	NN	NN	_	15	pobj	_	_
19	.	_	.	.	_	6	punct	_	_

1	GR	_	NNS	NNS	_	3	nn	_	_
2	binding	_	NN	NN	_	3	nn	_	_
3	capacity	_	NN	NN	_	5	nsubj	_	_
4	was	_	VBD	VBD	_	5	cop	_	_
5	higher	_	JJR	JJR	_	0	root	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	younger	_	JJR	JJR	_	8	amod	_	_
8	subjects	_	NNS	NNS	_	6	pobj	_	_
9	than	_	IN	IN	_	5	prep	_	_
10	in	_	IN	IN	_	9	pcomp	_	_
11	older	_	JJR	JJR	_	12	amod	_	_
12	ones	_	NNS	NNS	_	10	pobj	_	_
13	,	_	,	,	_	5	punct	_	_
14	and	_	CC	CC	_	5	cc	_	_
15	lower	_	JJR	JJR	_	5	conj	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	18	det	_	_
18	group	_	NN	NN	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	athletes	_	NNS	NNS	_	19	pobj	_	_
21	than	_	IN	IN	_	15	prep	_	_
22	in	_	IN	IN	_	21	pcomp	_	_
23	the	_	DT	DT	_	24	dep	_	_
24	younger	_	JJR	JJR	_	22	pobj	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	older	_	JJR	JJR	_	24	conj	_	_
27	sedentary	_	JJ	JJ	_	28	amod	_	_
28	subjects	_	NNS	NNS	_	24	dep	_	_
29	.	_	.	.	_	5	punct	_	_

1	In	_	IN	IN	_	9	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	sedentary	_	JJ	JJ	_	4	amod	_	_
4	group	_	NN	NN	_	1	pobj	_	_
5	a	_	DT	DT	_	7	det	_	_
6	negative	_	JJ	JJ	_	7	amod	_	_
7	correlation	_	NN	NN	_	9	nsubj	_	_
8	was	_	VBD	VBD	_	9	cop	_	_
9	present	_	JJ	JJ	_	0	root	_	_
10	between	_	IN	IN	_	9	prep	_	_
11	GR	_	NNS	NNS	_	13	nn	_	_
12	binding	_	NN	NN	_	13	nn	_	_
13	capacity	_	NN	NN	_	10	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	age	_	NN	NN	_	13	conj	_	_
16	.	_	.	.	_	9	punct	_	_

1	Plasma	_	NN	NN	_	2	nn	_	_
2	cortisol	_	NN	NN	_	4	nsubj	_	_
3	was	_	VBD	VBD	_	4	cop	_	_
4	higher	_	JJR	JJR	_	0	root	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	testosterone	_	NN	NN	_	7	dep	_	_
7	lower	_	JJR	JJR	_	4	conj	_	_
8	in	_	IN	IN	_	7	dep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	athletes	_	NNS	NNS	_	8	pobj	_	_
11	;	_	:	:	_	4	punct	_	_
12	they	_	PRP	PRP	_	15	nsubjpass	_	_
13	were	_	VBD	VBD	_	15	auxpass	_	_
14	negatively	_	RB	RB	_	15	advmod	_	_
15	correlated	_	VBN	VBN	_	4	parataxis	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	athletes	_	NNS	NNS	_	16	pobj	_	_
18	and	_	CC	CC	_	15	cc	_	_
19	positively	_	RB	RB	_	20	advmod	_	_
20	correlated	_	VBN	VBN	_	15	conj	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	24	det	_	_
23	sedentary	_	JJ	JJ	_	24	amod	_	_
24	subjects	_	NNS	NNS	_	21	pobj	_	_
25	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	5	nsubj	_	_
3	for	_	IN	IN	_	2	prep	_	_
4	athletes	_	NNS	NNS	_	3	pobj	_	_
5	agree	_	VBP	VBP	_	0	root	_	_
6	with	_	IN	IN	_	5	prep	_	_
7	their	_	PRP$	PRP$	_	10	poss	_	_
8	lower	_	JJR	JJR	_	9	dep	_	_
9	anabolic/catabolic	_	JJ	JJ	_	10	amod	_	_
10	balance	_	NN	NN	_	6	pobj	_	_
11	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	mechanism	_	NN	NN	_	15	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	reduced	_	VBN	VBN	_	6	amod	_	_
5	GR	_	NNS	NNS	_	6	nn	_	_
6	levels	_	NNS	NNS	_	3	pobj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	relation	_	NN	NN	_	7	pobj	_	_
9	to	_	TO	TO	_	8	prep	_	_
10	age	_	NN	NN	_	9	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	sport	_	NN	NN	_	13	nn	_	_
13	activity	_	NN	NN	_	10	conj	_	_
14	could	_	MD	MD	_	15	aux	_	_
15	involve	_	VB	VB	_	0	root	_	_
16	a	_	DT	DT	_	17	det	_	_
17	loss	_	NN	NN	_	15	dobj	_	_
18	or	_	CC	CC	_	17	cc	_	_
19	an	_	DT	DT	_	20	det	_	_
20	involution	_	NN	NN	_	17	conj	_	_
21	of	_	IN	IN	_	17	prep	_	_
22	receptor	_	NN	NN	_	23	nn	_	_
23	synthesis	_	NN	NN	_	21	pobj	_	_
24	.	_	.	.	_	15	punct	_	_

1	However	_	RB	RB	_	25	advmod	_	_
2	other	_	JJ	JJ	_	3	amod	_	_
3	possibilities	_	NNS	NNS	_	25	nsubjpass	_	_
4	,	_	,	,	_	3	punct	_	_
5	such	_	JJ	JJ	_	6	mwe	_	_
6	as	_	IN	IN	_	3	prep	_	_
7	altered	_	JJ	JJ	_	8	amod	_	_
8	distribution	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	lymphocyte	_	NN	NN	_	11	nn	_	_
11	subpopulations	_	NNS	NNS	_	9	pobj	_	_
12	with	_	IN	IN	_	8	prep	_	_
13	different	_	JJ	JJ	_	15	amod	_	_
14	receptor	_	NN	NN	_	15	nn	_	_
15	concentrations	_	NNS	NNS	_	12	pobj	_	_
16	and	_	CC	CC	_	12	cc	_	_
17	with	_	IN	IN	_	12	conj	_	_
18	different	_	JJ	JJ	_	20	amod	_	_
19	cytokine	_	NN	NN	_	20	nn	_	_
20	production	_	NN	NN	_	17	pobj	_	_
21	,	_	,	,	_	3	punct	_	_
22	can	_	MD	MD	_	25	aux	_	_
23	not	_	RB	RB	_	25	neg	_	_
24	be	_	VB	VB	_	25	auxpass	_	_
25	excluded	_	VBN	VBN	_	0	root	_	_
26	.	_	.	.	_	25	punct	_	_

1	Several	_	JJ	JJ	_	2	amod	_	_
2	neuroendocrine-immune	_	JJ	JJ	_	3	amod	_	_
3	interactions	_	NNS	NNS	_	6	nsubj	_	_
4	could	_	MD	MD	_	6	aux	_	_
5	be	_	VB	VB	_	6	cop	_	_
6	responsible	_	JJ	JJ	_	0	root	_	_
7	for	_	IN	IN	_	6	prep	_	_
8	reduced	_	VBN	VBN	_	10	amod	_	_
9	GR	_	NNS	NNS	_	10	nn	_	_
10	levels	_	NNS	NNS	_	7	pobj	_	_
11	with	_	IN	IN	_	10	prep	_	_
12	age	_	NN	NN	_	11	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	sport	_	NN	NN	_	15	nn	_	_
15	activity	_	NN	NN	_	12	conj	_	_
16	in	_	IN	IN	_	10	prep	_	_
17	man	_	NN	NN	_	16	pobj	_	_
18	.	_	.	.	_	6	punct	_	_

1	Rescue	_	NN	NN	_	0	root	_	_
2	by	_	IN	IN	_	1	prep	_	_
3	cytokines	_	NNS	NNS	_	2	pobj	_	_
4	of	_	IN	IN	_	1	prep	_	_
5	apoptotic	_	JJ	JJ	_	7	amod	_	_
6	cell	_	NN	NN	_	7	nn	_	_
7	death	_	NN	NN	_	4	pobj	_	_
8	induced	_	VBN	VBN	_	7	vmod	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	IL-2	_	NN	NN	_	11	nn	_	_
11	deprivation	_	NN	NN	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	human	_	JJ	JJ	_	17	amod	_	_
14	antigen-specific	_	JJ	JJ	_	17	amod	_	_
15	T	_	NN	NN	_	17	nn	_	_
16	cell	_	NN	NN	_	17	nn	_	_
17	clones	_	NNS	NNS	_	12	pobj	_	_
18	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	control	_	NN	NN	_	9	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	cell	_	NN	NN	_	5	nn	_	_
5	survival	_	NN	NN	_	3	pobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	cell	_	NN	NN	_	8	nn	_	_
8	death	_	NN	NN	_	5	conj	_	_
9	is	_	VBZ	VBZ	_	0	root	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	central	_	JJ	JJ	_	12	amod	_	_
12	importance	_	NN	NN	_	10	pobj	_	_
13	in	_	IN	IN	_	9	prep	_	_
14	tissues	_	NNS	NNS	_	13	pobj	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	high	_	JJ	JJ	_	18	amod	_	_
17	cell	_	NN	NN	_	18	nn	_	_
18	turnover	_	NN	NN	_	15	pobj	_	_
19	such	_	JJ	JJ	_	20	mwe	_	_
20	as	_	IN	IN	_	14	prep	_	_
21	the	_	DT	DT	_	23	det	_	_
22	lymphoid	_	JJ	JJ	_	23	amod	_	_
23	system	_	NN	NN	_	20	pobj	_	_
24	.	_	.	.	_	9	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	examined	_	VBN	VBN	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	effect	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	cytokines	_	NNS	NNS	_	6	pobj	_	_
8	on	_	IN	IN	_	5	prep	_	_
9	IL-2	_	NN	NN	_	11	nn	_	_
10	deprivation-induced	_	JJ	JJ	_	11	amod	_	_
11	apoptosis	_	NN	NN	_	8	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	human	_	JJ	JJ	_	17	amod	_	_
14	antigen-specific	_	JJ	JJ	_	17	amod	_	_
15	T	_	NN	NN	_	17	nn	_	_
16	helper	_	NN	NN	_	17	nn	_	_
17	clones	_	NNS	NNS	_	12	pobj	_	_
18	with	_	IN	IN	_	17	prep	_	_
19	different	_	JJ	JJ	_	22	amod	_	_
20	cytokine	_	NN	NN	_	22	nn	_	_
21	production	_	NN	NN	_	22	nn	_	_
22	profiles	_	NNS	NNS	_	18	pobj	_	_
23	.	_	.	.	_	3	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	found	_	VBD	VBD	_	0	root	_	_
3	that	_	IN	IN	_	13	mark	_	_
4	IL-2	_	NN	NN	_	13	nsubj	_	_
5	,	_	,	,	_	4	punct	_	_
6	interferon-alpha	_	NN	NN	_	4	conj	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	IFN-alpha	_	NN	NN	_	6	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	,	_	,	,	_	4	punct	_	_
11	and	_	CC	CC	_	4	cc	_	_
12	IFN-beta	_	NN	NN	_	4	conj	_	_
13	inhibited	_	VBD	VBD	_	2	ccomp	_	_
14	IL-2	_	NN	NN	_	16	nn	_	_
15	deprivation	_	NN	NN	_	16	nn	_	_
16	apoptosis	_	NN	NN	_	13	dobj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	Th0	_	NN	NN	_	17	pobj	_	_
19	,	_	,	,	_	18	punct	_	_
20	Th1	_	NN	NN	_	18	conj	_	_
21	,	_	,	,	_	18	punct	_	_
22	and	_	CC	CC	_	18	cc	_	_
23	Th2	_	NN	NN	_	18	conj	_	_
24	clones	_	NNS	NNS	_	18	dep	_	_
25	.	_	.	.	_	2	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	also	_	RB	RB	_	3	advmod	_	_
3	found	_	VBD	VBD	_	0	root	_	_
4	that	_	IN	IN	_	6	mark	_	_
5	IL-2	_	NN	NN	_	6	nsubj	_	_
6	protects	_	VBZ	VBZ	_	3	ccomp	_	_
7	T	_	NN	NN	_	9	nn	_	_
8	cell	_	NN	NN	_	9	nn	_	_
9	clones	_	NNS	NNS	_	6	dobj	_	_
10	from	_	IN	IN	_	6	prep	_	_
11	IL-2	_	NN	NN	_	13	nn	_	_
12	deprivation	_	NN	NN	_	13	nn	_	_
13	apoptosis	_	NN	NN	_	10	pobj	_	_
14	accompanying	_	VBG	VBG	_	6	xcomp	_	_
15	active	_	JJ	JJ	_	16	amod	_	_
16	proliferation	_	NN	NN	_	14	dobj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	enhanced	_	VBN	VBN	_	19	amod	_	_
19	expression	_	NN	NN	_	16	conj	_	_
20	of	_	IN	IN	_	16	prep	_	_
21	P53	_	NN	NN	_	20	pobj	_	_
22	,	_	,	,	_	21	punct	_	_
23	Rb	_	NN	NN	_	21	conj	_	_
24	and	_	CC	CC	_	21	cc	_	_
25	Bcl-xL	_	NN	NN	_	26	nn	_	_
26	proteins	_	NNS	NNS	_	21	conj	_	_
27	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	5	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	5	punct	_	_
4	IFN-alpha/beta	_	NN	NN	_	5	nsubj	_	_
5	rescued	_	VBD	VBD	_	0	root	_	_
6	T	_	NN	NN	_	8	nn	_	_
7	cell	_	NN	NN	_	8	nn	_	_
8	clones	_	NNS	NNS	_	5	dobj	_	_
9	from	_	IN	IN	_	5	prep	_	_
10	apoptosis	_	NN	NN	_	9	pobj	_	_
11	without	_	IN	IN	_	5	prep	_	_
12	active	_	JJ	JJ	_	13	amod	_	_
13	proliferation	_	NN	NN	_	11	pobj	_	_
14	,	_	,	,	_	5	punct	_	_
15	and	_	CC	CC	_	5	cc	_	_
16	expression	_	NN	NN	_	24	nsubj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	apoptosis-associated	_	JJ	JJ	_	19	amod	_	_
19	proteins	_	NNS	NNS	_	17	pobj	_	_
20	tested	_	VBN	VBN	_	19	vmod	_	_
21	so	_	RB	RB	_	22	advmod	_	_
22	far	_	JJ	JJ	_	20	advmod	_	_
23	was	_	VBD	VBD	_	24	cop	_	_
24	unaffected	_	JJ	JJ	_	5	conj	_	_
25	.	_	.	.	_	5	punct	_	_

1	This	_	DT	DT	_	4	nsubj	_	_
2	may	_	MD	MD	_	4	aux	_	_
3	be	_	VB	VB	_	4	cop	_	_
4	due	_	JJ	JJ	_	0	root	_	_
5	to	_	TO	TO	_	4	prep	_	_
6	the	_	DT	DT	_	7	det	_	_
7	fact	_	NN	NN	_	5	pobj	_	_
8	that	_	IN	IN	_	14	mark	_	_
9	T	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	14	nsubj	_	_
11	treated	_	VBN	VBN	_	10	vmod	_	_
12	with	_	IN	IN	_	11	prep	_	_
13	IL-2	_	NN	NN	_	12	pobj	_	_
14	contained	_	VBD	VBD	_	7	ccomp	_	_
15	those	_	DT	DT	_	14	dobj	_	_
16	located	_	JJ	JJ	_	15	amod	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	S	_	NN	NN	_	21	nn	_	_
19	+	_	CC	CC	_	18	cc	_	_
20	G2/M	_	NN	NN	_	18	conj	_	_
21	phases	_	NNS	NNS	_	17	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	25	det	_	_
24	cell	_	NN	NN	_	25	nn	_	_
25	cycle	_	NN	NN	_	22	pobj	_	_
26	,	_	,	,	_	14	punct	_	_
27	whereas	_	IN	IN	_	38	mark	_	_
28	the	_	DT	DT	_	30	det	_	_
29	vast	_	JJ	JJ	_	30	amod	_	_
30	majority	_	NN	NN	_	38	nsubj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	T	_	NN	NN	_	33	nn	_	_
33	cells	_	NNS	NNS	_	31	pobj	_	_
34	treated	_	VBN	VBN	_	33	vmod	_	_
35	with	_	IN	IN	_	34	prep	_	_
36	IFN-alpha/beta	_	NN	NN	_	35	pobj	_	_
37	were	_	VBD	VBD	_	38	cop	_	_
38	located	_	JJ	JJ	_	14	advcl	_	_
39	in	_	IN	IN	_	38	prep	_	_
40	G0/G1	_	NN	NN	_	41	nn	_	_
41	phase	_	NN	NN	_	39	pobj	_	_
42	.	_	.	.	_	4	punct	_	_

1	IFN-alpha/beta	_	NN	NN	_	3	nsubj	_	_
2	specifically	_	RB	RB	_	3	advmod	_	_
3	induced	_	VBD	VBD	_	0	root	_	_
4	tyrosine	_	NN	NN	_	5	nn	_	_
5	phosphorylation	_	NN	NN	_	3	dobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	translocation	_	NN	NN	_	5	conj	_	_
8	into	_	IN	IN	_	7	prep	_	_
9	nucleus	_	NN	NN	_	8	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	signal	_	NN	NN	_	12	nn	_	_
12	transducers	_	NNS	NNS	_	10	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	activators	_	NNS	NNS	_	21	nn	_	_
15	of	_	IN	IN	_	21	amod	_	_
16	transcription	_	NN	NN	_	21	nn	_	_
17	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
18	STAT	_	NN	NN	_	21	nn	_	_
19	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
20	2	_	CD	CD	_	21	num	_	_
21	protein	_	NN	NN	_	12	conj	_	_
22	in	_	IN	IN	_	3	prep	_	_
23	the	_	DT	DT	_	26	det	_	_
24	T	_	NN	NN	_	26	nn	_	_
25	cell	_	NN	NN	_	26	nn	_	_
26	clones	_	NNS	NNS	_	22	pobj	_	_
27	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	12	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	12	punct	_	_
4	over-expression	_	NN	NN	_	12	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	STAT2	_	NN	NN	_	5	pobj	_	_
7	by	_	IN	IN	_	4	prep	_	_
8	transfection	_	NN	NN	_	7	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	cDNA	_	NN	NN	_	9	pobj	_	_
12	prevented	_	VBD	VBD	_	0	root	_	_
13	apoptosis	_	NN	NN	_	12	dobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	18	det	_	_
16	T	_	NN	NN	_	18	nn	_	_
17	cell	_	NN	NN	_	18	nn	_	_
18	clones	_	NNS	NNS	_	14	pobj	_	_
19	.	_	.	.	_	12	punct	_	_

1	Our	_	PRP$	PRP$	_	3	poss	_	_
2	present	_	JJ	JJ	_	3	amod	_	_
3	study	_	NN	NN	_	4	nsubj	_	_
4	shows	_	VBZ	VBZ	_	0	root	_	_
5	that	_	IN	IN	_	9	mark	_	_
6	IFN-alpha	_	NN	NN	_	9	nsubj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	-beta	_	NN	NN	_	6	conj	_	_
9	mediate	_	VBP	VBP	_	4	ccomp	_	_
10	anti-apoptotic	_	JJ	JJ	_	11	amod	_	_
11	effect	_	NN	NN	_	9	dobj	_	_
12	through	_	IN	IN	_	9	prep	_	_
13	other	_	JJ	JJ	_	14	amod	_	_
14	pathways	_	NNS	NNS	_	12	pobj	_	_
15	than	_	IN	IN	_	14	prep	_	_
16	that	_	DT	DT	_	15	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	IL-2	_	NN	NN	_	17	pobj	_	_
19	in	_	IN	IN	_	9	prep	_	_
20	growth	_	NN	NN	_	23	nn	_	_
21	factor	_	NN	NN	_	23	nn	_	_
22	deprivation	_	NN	NN	_	23	nn	_	_
23	apoptosis	_	NN	NN	_	19	pobj	_	_
24	.	_	.	.	_	4	punct	_	_

1	Lipopolysaccharide	_	NN	NN	_	2	nn	_	_
2	induction	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	8	det	_	_
5	tumor	_	NN	NN	_	8	nn	_	_
6	necrosis	_	NN	NN	_	8	nn	_	_
7	factor-alpha	_	NN	NN	_	8	nn	_	_
8	promoter	_	NN	NN	_	3	pobj	_	_
9	in	_	IN	IN	_	2	prep	_	_
10	human	_	JJ	JJ	_	12	amod	_	_
11	monocytic	_	JJ	JJ	_	12	amod	_	_
12	cells	_	NNS	NNS	_	9	pobj	_	_
13	.	_	.	.	_	2	punct	_	_

1	Regulation	_	NN	NN	_	0	root	_	_
2	by	_	IN	IN	_	1	prep	_	_
3	Egr-1	_	NN	NN	_	2	pobj	_	_
4	,	_	,	,	_	3	punct	_	_
5	c-Jun	_	NN	NN	_	3	conj	_	_
6	,	_	,	,	_	3	punct	_	_
7	and	_	CC	CC	_	3	cc	_	_
8	NF-kappaB	_	NN	NN	_	3	conj	_	_
9	transcription	_	NN	NN	_	10	nn	_	_
10	factors	_	NNS	NNS	_	3	dep	_	_
11	.	_	.	.	_	1	punct	_	_

1	Biosynthesis	_	NN	NN	_	9	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	tumor	_	NN	NN	_	5	nn	_	_
4	necrosis	_	NN	NN	_	5	nn	_	_
5	factor-alpha	_	NN	NN	_	2	pobj	_	_
6	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
7	TNF-alpha	_	NN	NN	_	5	appos	_	_
8	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
9	is	_	VBZ	VBZ	_	0	root	_	_
10	predominantly	_	RB	RB	_	11	advmod	_	_
11	by	_	IN	IN	_	9	prep	_	_
12	cells	_	NNS	NNS	_	11	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	monocytic	_	JJ	JJ	_	16	amod	_	_
16	lineage	_	NN	NN	_	13	pobj	_	_
17	.	_	.	.	_	9	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	study	_	NN	NN	_	3	nsubj	_	_
3	examined	_	VBD	VBD	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	role	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	various	_	JJ	JJ	_	10	amod	_	_
8	cis-acting	_	JJ	JJ	_	10	amod	_	_
9	regulatory	_	JJ	JJ	_	10	amod	_	_
10	elements	_	NNS	NNS	_	6	pobj	_	_
11	in	_	IN	IN	_	5	prep	_	_
12	the	_	DT	DT	_	17	det	_	_
13	lipopolysaccharide	_	NN	NN	_	17	nn	_	_
14	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
15	LPS	_	NN	NN	_	13	appos	_	_
16	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
17	induction	_	NN	NN	_	11	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	22	det	_	_
20	human	_	JJ	JJ	_	22	amod	_	_
21	TNF-alpha	_	NN	NN	_	22	nn	_	_
22	promoter	_	NN	NN	_	18	pobj	_	_
23	in	_	IN	IN	_	17	prep	_	_
24	cells	_	NNS	NNS	_	23	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	monocytic	_	JJ	JJ	_	27	amod	_	_
27	lineage	_	NN	NN	_	25	pobj	_	_
28	.	_	.	.	_	3	punct	_	_

1	Functional	_	JJ	JJ	_	2	amod	_	_
2	analysis	_	NN	NN	_	16	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	monocytic	_	JJ	JJ	_	6	amod	_	_
5	THP-1	_	NN	NN	_	6	nn	_	_
6	cells	_	NNS	NNS	_	3	pobj	_	_
7	transfected	_	VBN	VBN	_	6	vmod	_	_
8	with	_	IN	IN	_	7	prep	_	_
9	plasmids	_	NNS	NNS	_	8	pobj	_	_
10	containing	_	VBG	VBG	_	9	vmod	_	_
11	various	_	JJ	JJ	_	12	amod	_	_
12	lengths	_	NNS	NNS	_	10	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	TNF-alpha	_	NN	NN	_	15	nn	_	_
15	promoter	_	NN	NN	_	13	pobj	_	_
16	localized	_	VBD	VBD	_	0	root	_	_
17	enhancer	_	NN	NN	_	18	nn	_	_
18	elements	_	NNS	NNS	_	16	dobj	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	a	_	DT	DT	_	21	det	_	_
21	region	_	NN	NN	_	19	pobj	_	_
22	-LRB-	_	-LRB-	-LRB-	_	27	punct	_	_
23	-182	_	CD	CD	_	27	num	_	_
24	to	_	TO	TO	_	27	dep	_	_
25	-37	_	CD	CD	_	27	num	_	_
26	base	_	NN	NN	_	27	nn	_	_
27	pairs	_	NNS	NNS	_	21	dep	_	_
28	-LRB-	_	-LRB-	-LRB-	_	29	punct	_	_
29	bp	_	NN	NN	_	27	appos	_	_
30	-RRB-	_	-RRB-	-RRB-	_	29	punct	_	_
31	-RRB-	_	-RRB-	-RRB-	_	27	punct	_	_
32	that	_	WDT	WDT	_	34	nsubjpass	_	_
33	were	_	VBD	VBD	_	34	auxpass	_	_
34	required	_	VBN	VBN	_	18	rcmod	_	_
35	for	_	IN	IN	_	34	prep	_	_
36	optimal	_	JJ	JJ	_	37	amod	_	_
37	transcription	_	NN	NN	_	35	pobj	_	_
38	of	_	IN	IN	_	37	prep	_	_
39	the	_	DT	DT	_	41	det	_	_
40	TNF-alpha	_	NN	NN	_	41	nn	_	_
41	gene	_	NN	NN	_	38	pobj	_	_
42	in	_	IN	IN	_	37	prep	_	_
43	response	_	NN	NN	_	42	pobj	_	_
44	to	_	TO	TO	_	43	prep	_	_
45	LPS	_	NN	NN	_	44	pobj	_	_
46	.	_	.	.	_	16	punct	_	_

1	Two	_	CD	CD	_	2	num	_	_
2	regions	_	NNS	NNS	_	4	nsubjpass	_	_
3	were	_	VBD	VBD	_	4	auxpass	_	_
4	identified	_	VBN	VBN	_	0	root	_	_
5	:	_	:	:	_	4	punct	_	_
6	region	_	NN	NN	_	14	nsubj	_	_
7	I	_	CD	CD	_	6	num	_	_
8	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
9	-182	_	CD	CD	_	12	num	_	_
10	to	_	TO	TO	_	12	dep	_	_
11	-162	_	CD	CD	_	12	num	_	_
12	bp	_	NN	NN	_	6	appos	_	_
13	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
14	contained	_	VBD	VBD	_	4	parataxis	_	_
15	an	_	DT	DT	_	18	det	_	_
16	overlapping	_	VBG	VBG	_	18	amod	_	_
17	Sp1/Egr-1	_	NN	NN	_	18	nn	_	_
18	site	_	NN	NN	_	14	dobj	_	_
19	,	_	,	,	_	14	punct	_	_
20	and	_	CC	CC	_	14	cc	_	_
21	region	_	NN	NN	_	28	nsubj	_	_
22	II	_	CD	CD	_	21	num	_	_
23	-LRB-	_	-LRB-	-LRB-	_	26	punct	_	_
24	-119	_	CD	CD	_	26	num	_	_
25	to	_	TO	TO	_	26	dep	_	_
26	-88	_	CD	CD	_	21	appos	_	_
27	-RRB-	_	-RRB-	-RRB-	_	26	punct	_	_
28	contained	_	VBD	VBD	_	14	conj	_	_
29	CRE	_	NN	NN	_	28	dobj	_	_
30	and	_	CC	CC	_	29	cc	_	_
31	NF-kappaB	_	NN	NN	_	36	nn	_	_
32	-LRB-	_	-LRB-	-LRB-	_	36	punct	_	_
33	designated	_	VBN	VBN	_	36	amod	_	_
34	kappaB3	_	NN	NN	_	36	nn	_	_
35	-RRB-	_	-RRB-	-RRB-	_	36	punct	_	_
36	sites	_	NNS	NNS	_	29	conj	_	_
37	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	17	prep	_	_
2	unstimulated	_	JJ	JJ	_	3	amod	_	_
3	THP-1	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	17	punct	_	_
5	CRE-binding	_	JJ	JJ	_	6	amod	_	_
6	protein	_	NN	NN	_	17	nsubjpass	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	,	_	,	,	_	6	punct	_	_
9	to	_	TO	TO	_	6	conj	_	_
10	a	_	DT	DT	_	12	det	_	_
11	lesser	_	JJR	JJR	_	12	amod	_	_
12	extent	_	NN	NN	_	9	pobj	_	_
13	,	_	,	,	_	6	punct	_	_
14	c-Jun	_	NN	NN	_	15	nn	_	_
15	complexes	_	NNS	NNS	_	6	conj	_	_
16	were	_	VBD	VBD	_	17	auxpass	_	_
17	found	_	VBN	VBN	_	0	root	_	_
18	to	_	TO	TO	_	19	aux	_	_
19	bind	_	VB	VB	_	17	xcomp	_	_
20	to	_	TO	TO	_	19	prep	_	_
21	the	_	DT	DT	_	23	det	_	_
22	CRE	_	NN	NN	_	23	nn	_	_
23	site	_	NN	NN	_	20	pobj	_	_
24	.	_	.	.	_	17	punct	_	_

1	LPS	_	NN	NN	_	2	nn	_	_
2	stimulation	_	NN	NN	_	3	nsubj	_	_
3	increased	_	VBD	VBD	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	binding	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	c-Jun-containing	_	JJ	JJ	_	8	amod	_	_
8	complexes	_	NNS	NNS	_	6	pobj	_	_
9	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	6	punct	_	_
4	LPS	_	NN	NN	_	5	nn	_	_
5	stimulation	_	NN	NN	_	6	nsubj	_	_
6	induced	_	VBD	VBD	_	0	root	_	_
7	the	_	DT	DT	_	8	det	_	_
8	binding	_	NN	NN	_	6	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	cognate	_	JJ	JJ	_	12	amod	_	_
11	nuclear	_	JJ	JJ	_	12	amod	_	_
12	factors	_	NNS	NNS	_	9	pobj	_	_
13	to	_	TO	TO	_	8	prep	_	_
14	the	_	DT	DT	_	15	dep	_	_
15	Egr-1	_	NN	NN	_	13	pobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	kappaB3	_	NN	NN	_	15	conj	_	_
18	sites	_	NNS	NNS	_	15	dep	_	_
19	,	_	,	,	_	15	punct	_	_
20	which	_	WDT	WDT	_	22	nsubjpass	_	_
21	were	_	VBD	VBD	_	22	auxpass	_	_
22	identified	_	VBN	VBN	_	15	rcmod	_	_
23	as	_	IN	IN	_	22	prep	_	_
24	Egr-1	_	NN	NN	_	23	pobj	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	p50/p65	_	NN	NN	_	24	conj	_	_
27	,	_	,	,	_	22	punct	_	_
28	respectively	_	RB	RB	_	22	advmod	_	_
29	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	2	dep	_	_
2	CRE	_	NN	NN	_	10	nsubj	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	kappaB3	_	NN	NN	_	2	conj	_	_
5	sites	_	NNS	NNS	_	2	dep	_	_
6	in	_	IN	IN	_	2	prep	_	_
7	region	_	NN	NN	_	6	pobj	_	_
8	II	_	CD	CD	_	7	num	_	_
9	together	_	RB	RB	_	10	advmod	_	_
10	conferred	_	VBD	VBD	_	0	root	_	_
11	strong	_	JJ	JJ	_	13	amod	_	_
12	LPS	_	NN	NN	_	13	nn	_	_
13	responsiveness	_	NN	NN	_	10	dobj	_	_
14	to	_	TO	TO	_	13	prep	_	_
15	a	_	DT	DT	_	17	det	_	_
16	heterologous	_	JJ	JJ	_	17	amod	_	_
17	promoter	_	NN	NN	_	14	pobj	_	_
18	,	_	,	,	_	10	punct	_	_
19	whereas	_	IN	IN	_	22	mark	_	_
20	individually	_	RB	RB	_	22	advmod	_	_
21	they	_	PRP	PRP	_	22	nsubj	_	_
22	failed	_	VBD	VBD	_	10	advcl	_	_
23	to	_	TO	TO	_	24	aux	_	_
24	provide	_	VB	VB	_	22	xcomp	_	_
25	transcriptional	_	JJ	JJ	_	26	amod	_	_
26	activation	_	NN	NN	_	24	dobj	_	_
27	.	_	.	.	_	10	punct	_	_

1	Furthermore	_	RB	RB	_	14	advmod	_	_
2	,	_	,	,	_	14	punct	_	_
3	increasing	_	VBG	VBG	_	14	csubj	_	_
4	the	_	DT	DT	_	5	det	_	_
5	spacing	_	NN	NN	_	3	dobj	_	_
6	between	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	CRE	_	NN	NN	_	6	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	the	_	DT	DT	_	12	det	_	_
11	kappaB3	_	NN	NN	_	12	nn	_	_
12	sites	_	NNS	NNS	_	8	conj	_	_
13	completely	_	RB	RB	_	14	advmod	_	_
14	abolished	_	VBD	VBD	_	0	root	_	_
15	LPS	_	NN	NN	_	16	nn	_	_
16	induction	_	NN	NN	_	14	dobj	_	_
17	,	_	,	,	_	14	punct	_	_
18	suggesting	_	VBG	VBG	_	14	vmod	_	_
19	a	_	DT	DT	_	21	det	_	_
20	cooperative	_	JJ	JJ	_	21	amod	_	_
21	interaction	_	NN	NN	_	18	dobj	_	_
22	between	_	IN	IN	_	21	prep	_	_
23	c-Jun	_	NN	NN	_	24	nn	_	_
24	complexes	_	NNS	NNS	_	22	pobj	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	p50/p65	_	NN	NN	_	24	conj	_	_
27	.	_	.	.	_	14	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	studies	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	13	mark	_	_
5	maximal	_	JJ	JJ	_	7	amod	_	_
6	LPS	_	NN	NN	_	7	nn	_	_
7	induction	_	NN	NN	_	13	nsubjpass	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	TNF-alpha	_	NN	NN	_	11	nn	_	_
11	promoter	_	NN	NN	_	8	pobj	_	_
12	is	_	VBZ	VBZ	_	13	auxpass	_	_
13	mediated	_	VBN	VBN	_	3	ccomp	_	_
14	by	_	IN	IN	_	13	prep	_	_
15	concerted	_	VBN	VBN	_	16	amod	_	_
16	participation	_	NN	NN	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	at	_	IN	IN	_	20	quantmod	_	_
19	least	_	JJS	JJS	_	18	mwe	_	_
20	two	_	CD	CD	_	24	num	_	_
21	separate	_	JJ	JJ	_	24	amod	_	_
22	cis-acting	_	JJ	JJ	_	24	amod	_	_
23	regulatory	_	JJ	JJ	_	24	amod	_	_
24	elements	_	NNS	NNS	_	17	pobj	_	_
25	.	_	.	.	_	3	punct	_	_

1	Inducible	_	JJ	JJ	_	2	amod	_	_
2	expression	_	NN	NN	_	0	root	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	phosphorylation	_	NN	NN	_	2	conj	_	_
5	of	_	IN	IN	_	2	prep	_	_
6	coactivator	_	NN	NN	_	7	nn	_	_
7	BOB.1/OBF.1	_	NN	NN	_	5	pobj	_	_
8	in	_	IN	IN	_	2	prep	_	_
9	T	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	8	pobj	_	_
11	-LSB-	_	-LRB-	-LRB-	_	12	punct	_	_
12	see	_	VB	VB	_	2	dep	_	_
13	comments	_	NNS	NNS	_	12	dobj	_	_
14	-RSB-	_	-RRB-	-RRB-	_	12	punct	_	_

1	BOB.1/OBF.1	_	NN	NN	_	5	nsubj	_	_
2	is	_	VBZ	VBZ	_	5	cop	_	_
3	a	_	DT	DT	_	5	det	_	_
4	transcriptional	_	JJ	JJ	_	5	amod	_	_
5	coactivator	_	NN	NN	_	0	root	_	_
6	that	_	WDT	WDT	_	9	nsubjpass	_	_
7	is	_	VBZ	VBZ	_	9	auxpass	_	_
8	constitutively	_	RB	RB	_	9	advmod	_	_
9	expressed	_	VBN	VBN	_	5	rcmod	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	B	_	NN	NN	_	12	nn	_	_
12	cells	_	NNS	NNS	_	10	pobj	_	_
13	and	_	CC	CC	_	9	cc	_	_
14	interacts	_	VBZ	VBZ	_	9	conj	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	17	dep	_	_
17	Oct1	_	NN	NN	_	15	pobj	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	Oct2	_	NN	NN	_	17	conj	_	_
20	transcription	_	NN	NN	_	21	nn	_	_
21	factors	_	NNS	NNS	_	17	dep	_	_
22	.	_	.	.	_	5	punct	_	_

1	Upon	_	IN	IN	_	23	prep	_	_
2	activation	_	NN	NN	_	1	pobj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	Jurkat	_	NN	NN	_	6	nn	_	_
5	T	_	NN	NN	_	6	nn	_	_
6	cells	_	NNS	NNS	_	3	pobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	primary	_	JJ	JJ	_	10	amod	_	_
9	murine	_	JJ	JJ	_	10	amod	_	_
10	thymocytes	_	NNS	NNS	_	6	conj	_	_
11	with	_	IN	IN	_	2	prep	_	_
12	phorbol	_	NN	NN	_	13	nn	_	_
13	esters	_	NNS	NNS	_	11	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	ionomycin	_	NN	NN	_	13	conj	_	_
16	,	_	,	,	_	23	punct	_	_
17	BOB.1/OBF.1	_	NN	NN	_	23	nsubjpass	_	_
18	expression	_	NN	NN	_	17	dep	_	_
19	and	_	CC	CC	_	17	cc	_	_
20	transactivation	_	NN	NN	_	21	nn	_	_
21	function	_	NN	NN	_	17	conj	_	_
22	were	_	VBD	VBD	_	23	auxpass	_	_
23	induced	_	VBN	VBN	_	0	root	_	_
24	.	_	.	.	_	23	punct	_	_

1	BOB.1/OBF.1	_	NN	NN	_	3	nsubjpass	_	_
2	was	_	VBD	VBD	_	3	auxpass	_	_
3	phosphorylated	_	VBN	VBN	_	0	root	_	_
4	at	_	IN	IN	_	3	prep	_	_
5	Ser184	_	NN	NN	_	4	pobj	_	_
6	both	_	CC	CC	_	8	preconj	_	_
7	in	_	FW	FW	_	8	nn	_	_
8	vivo	_	FW	FW	_	3	advmod	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	in	_	FW	FW	_	11	nn	_	_
11	vitro	_	FW	FW	_	8	conj	_	_
12	,	_	,	,	_	3	punct	_	_
13	and	_	CC	CC	_	3	cc	_	_
14	this	_	DT	DT	_	15	det	_	_
15	modification	_	NN	NN	_	17	nsubjpass	_	_
16	was	_	VBD	VBD	_	17	auxpass	_	_
17	required	_	VBN	VBN	_	3	conj	_	_
18	for	_	IN	IN	_	17	prep	_	_
19	inducible	_	JJ	JJ	_	20	amod	_	_
20	activation	_	NN	NN	_	18	pobj	_	_
21	.	_	.	.	_	3	punct	_	_

1	Mutation	_	NN	NN	_	5	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	Ser184	_	NN	NN	_	2	pobj	_	_
4	also	_	RB	RB	_	5	advmod	_	_
5	diminished	_	VBD	VBD	_	0	root	_	_
6	transactivation	_	NN	NN	_	7	nn	_	_
7	function	_	NN	NN	_	5	dobj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	B	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	8	pobj	_	_
11	,	_	,	,	_	5	punct	_	_
12	suggesting	_	VBG	VBG	_	5	vmod	_	_
13	that	_	IN	IN	_	25	mark	_	_
14	the	_	DT	DT	_	16	det	_	_
15	activating	_	VBG	VBG	_	16	amod	_	_
16	phosphorylation	_	NN	NN	_	25	nsubj	_	_
17	that	_	WDT	WDT	_	19	nsubj	_	_
18	is	_	VBZ	VBZ	_	19	cop	_	_
19	inducible	_	JJ	JJ	_	16	rcmod	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	T	_	NN	NN	_	22	nn	_	_
22	cells	_	NNS	NNS	_	20	pobj	_	_
23	is	_	VBZ	VBZ	_	25	cop	_	_
24	constitutively	_	RB	RB	_	25	advmod	_	_
25	present	_	JJ	JJ	_	12	ccomp	_	_
26	in	_	IN	IN	_	25	prep	_	_
27	B	_	NN	NN	_	28	nn	_	_
28	cells	_	NNS	NNS	_	26	pobj	_	_
29	.	_	.	.	_	5	punct	_	_

1	Thus	_	RB	RB	_	7	advmod	_	_
2	,	_	,	,	_	7	punct	_	_
3	BOB.1/OBF.1	_	NN	NN	_	7	nsubj	_	_
4	is	_	VBZ	VBZ	_	7	cop	_	_
5	a	_	DT	DT	_	7	det	_	_
6	transcriptional	_	JJ	JJ	_	7	amod	_	_
7	coactivator	_	NN	NN	_	0	root	_	_
8	that	_	WDT	WDT	_	11	nsubjpass	_	_
9	is	_	VBZ	VBZ	_	11	auxpass	_	_
10	critically	_	RB	RB	_	11	advmod	_	_
11	regulated	_	VBN	VBN	_	7	rcmod	_	_
12	by	_	IN	IN	_	11	prep	_	_
13	posttranslational	_	JJ	JJ	_	14	amod	_	_
14	modifications	_	NNS	NNS	_	12	pobj	_	_
15	to	_	TO	TO	_	16	aux	_	_
16	mediate	_	VB	VB	_	11	xcomp	_	_
17	cell	_	NN	NN	_	18	npadvmod	_	_
18	type-specific	_	JJ	JJ	_	20	amod	_	_
19	gene	_	NN	NN	_	20	nn	_	_
20	expression	_	NN	NN	_	16	dobj	_	_
21	.	_	.	.	_	7	punct	_	_

1	Cytokines	_	NNS	NNS	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	shared	_	JJ	JJ	_	4	amod	_	_
4	receptors	_	NNS	NNS	_	1	dep	_	_
5	,	_	,	,	_	4	punct	_	_
6	distinct	_	JJ	JJ	_	7	amod	_	_
7	functions	_	NNS	NNS	_	4	appos	_	_
8	.	_	.	.	_	1	punct	_	_

1	That	_	IN	IN	_	14	mark	_	_
2	the	_	DT	DT	_	5	det	_	_
3	signal	_	NN	NN	_	5	nn	_	_
4	transduction	_	NN	NN	_	5	nn	_	_
5	pathways	_	NNS	NNS	_	14	nsubj	_	_
6	used	_	VBN	VBN	_	5	vmod	_	_
7	by	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	cytokines	_	NNS	NNS	_	7	pobj	_	_
10	IL-2	_	NN	NN	_	9	dep	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	IL-15	_	NN	NN	_	10	conj	_	_
13	are	_	VBP	VBP	_	14	cop	_	_
14	identical	_	JJ	JJ	_	16	csubj	_	_
15	would	_	MD	MD	_	16	aux	_	_
16	suggest	_	VBP	VBP	_	0	root	_	_
17	that	_	IN	IN	_	20	mark	_	_
18	these	_	DT	DT	_	19	det	_	_
19	cytokines	_	NNS	NNS	_	20	nsubj	_	_
20	have	_	VBP	VBP	_	16	ccomp	_	_
21	redundant	_	JJ	JJ	_	22	amod	_	_
22	roles	_	NNS	NNS	_	20	dobj	_	_
23	in	_	IN	IN	_	20	prep	_	_
24	lymphoid	_	JJ	JJ	_	25	amod	_	_
25	development	_	NN	NN	_	23	pobj	_	_
26	;	_	:	:	_	16	punct	_	_
27	instead	_	RB	RB	_	32	advmod	_	_
28	,	_	,	,	_	32	punct	_	_
29	IL-2	_	NN	NN	_	32	nsubj	_	_
30	is	_	VBZ	VBZ	_	32	cop	_	_
31	the	_	DT	DT	_	32	det	_	_
32	guardian	_	NN	NN	_	16	parataxis	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	thymus-derived	_	JJ	JJ	_	36	amod	_	_
35	T-cell	_	NN	NN	_	36	nn	_	_
36	homeostasis	_	NN	NN	_	33	pobj	_	_
37	,	_	,	,	_	32	punct	_	_
38	while	_	IN	IN	_	40	mark	_	_
39	interleukin-15	_	NN	NN	_	40	nsubj	_	_
40	promotes	_	VBZ	VBZ	_	32	advcl	_	_
41	extrathymic	_	JJ	JJ	_	42	amod	_	_
42	development	_	NN	NN	_	40	dobj	_	_
43	of	_	IN	IN	_	42	prep	_	_
44	T	_	NN	NN	_	43	pobj	_	_
45	and	_	CC	CC	_	44	cc	_	_
46	NK	_	NN	NN	_	44	conj	_	_
47	cells	_	NNS	NNS	_	44	dep	_	_
48	.	_	.	.	_	16	punct	_	_

1	Association	_	NN	NN	_	0	root	_	_
2	between	_	IN	IN	_	1	prep	_	_
3	expression	_	NN	NN	_	2	pobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	intercellular	_	JJ	JJ	_	7	amod	_	_
6	adhesion	_	NN	NN	_	7	nn	_	_
7	molecule-1	_	NN	NN	_	4	pobj	_	_
8	and	_	CC	CC	_	3	cc	_	_
9	integration	_	NN	NN	_	3	conj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	human	_	JJ	JJ	_	14	amod	_	_
12	T-cell-leukemia	_	JJ	JJ	_	14	amod	_	_
13	virus	_	NN	NN	_	14	nn	_	_
14	type	_	NN	NN	_	10	pobj	_	_
15	1	_	CD	CD	_	14	num	_	_
16	in	_	IN	IN	_	3	prep	_	_
17	adult	_	JJ	JJ	_	20	amod	_	_
18	T-cell	_	NN	NN	_	20	nn	_	_
19	leukemia	_	NN	NN	_	20	nn	_	_
20	cells	_	NNS	NNS	_	16	pobj	_	_
21	.	_	.	.	_	1	punct	_	_

1	It	_	PRP	PRP	_	3	nsubjpass	_	_
2	is	_	VBZ	VBZ	_	3	auxpass	_	_
3	known	_	VBN	VBN	_	0	root	_	_
4	that	_	IN	IN	_	25	mark	_	_
5	the	_	DT	DT	_	7	det	_	_
6	expression	_	NN	NN	_	7	nn	_	_
7	levels	_	NNS	NNS	_	25	nsubj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	intercellular	_	JJ	JJ	_	11	amod	_	_
10	adhesion	_	NN	NN	_	11	nn	_	_
11	molecule-1	_	NN	NN	_	8	pobj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	ICAM-1	_	NN	NN	_	11	appos	_	_
14	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
15	in	_	IN	IN	_	7	prep	_	_
16	adult	_	JJ	JJ	_	23	amod	_	_
17	T	_	NN	NN	_	23	nn	_	_
18	cell	_	NN	NN	_	23	nn	_	_
19	leukemia	_	NN	NN	_	23	nn	_	_
20	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
21	ATL	_	NN	NN	_	23	nn	_	_
22	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
23	cells	_	NNS	NNS	_	15	pobj	_	_
24	are	_	VBP	VBP	_	25	cop	_	_
25	high	_	JJ	JJ	_	3	ccomp	_	_
26	,	_	,	,	_	25	punct	_	_
27	whereas	_	IN	IN	_	32	mark	_	_
28	those	_	DT	DT	_	32	nsubj	_	_
29	in	_	IN	IN	_	28	prep	_	_
30	T-lymphoid	_	NN	NN	_	31	nn	_	_
31	cells	_	NNS	NNS	_	29	pobj	_	_
32	are	_	VBP	VBP	_	25	advcl	_	_
33	not	_	RB	RB	_	32	neg	_	_
34	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	4	mark	_	_
2	order	_	NN	NN	_	4	dep	_	_
3	to	_	TO	TO	_	4	aux	_	_
4	investigate	_	VB	VB	_	45	dep	_	_
5	the	_	DT	DT	_	6	det	_	_
6	factors	_	NNS	NNS	_	4	dobj	_	_
7	that	_	WDT	WDT	_	8	nsubj	_	_
8	influence	_	VBP	VBP	_	6	rcmod	_	_
9	the	_	DT	DT	_	10	det	_	_
10	induction	_	NN	NN	_	8	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	ICAM-1	_	NN	NN	_	13	nn	_	_
13	molecules	_	NNS	NNS	_	11	pobj	_	_
14	,	_	,	,	_	45	punct	_	_
15	Northern	_	NN	NN	_	17	nn	_	_
16	blot	_	NN	NN	_	17	nn	_	_
17	analysis	_	NN	NN	_	45	nsubjpass	_	_
18	to	_	TO	TO	_	19	aux	_	_
19	measure	_	VB	VB	_	17	vmod	_	_
20	the	_	DT	DT	_	22	det	_	_
21	expression	_	NN	NN	_	22	nn	_	_
22	level	_	NN	NN	_	19	dobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	ICAM-1	_	NN	NN	_	25	nn	_	_
25	mRNAs	_	NNS	NNS	_	23	pobj	_	_
26	and	_	CC	CC	_	17	cc	_	_
27	Southern	_	NN	NN	_	29	nn	_	_
28	blot	_	NN	NN	_	29	nn	_	_
29	hybridization	_	NN	NN	_	17	conj	_	_
30	to	_	TO	TO	_	31	aux	_	_
31	analyze	_	VB	VB	_	29	vmod	_	_
32	the	_	DT	DT	_	33	det	_	_
33	integration	_	NN	NN	_	31	dobj	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	human	_	JJ	JJ	_	38	amod	_	_
36	T-cell-leukemia	_	JJ	JJ	_	38	amod	_	_
37	virus	_	NN	NN	_	38	nn	_	_
38	type	_	NN	NN	_	43	nn	_	_
39	1	_	CD	CD	_	38	num	_	_
40	-LRB-	_	-LRB-	-LRB-	_	41	punct	_	_
41	HTLV-1	_	NN	NN	_	38	appos	_	_
42	-RRB-	_	-RRB-	-RRB-	_	41	punct	_	_
43	provirus	_	NN	NN	_	34	pobj	_	_
44	were	_	VBD	VBD	_	45	auxpass	_	_
45	done	_	VBN	VBN	_	0	root	_	_
46	.	_	.	.	_	45	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	levels	_	NNS	NNS	_	12	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	ICAM-1	_	NN	NN	_	5	nn	_	_
5	mRNA	_	NN	NN	_	6	nn	_	_
6	expression	_	NN	NN	_	3	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	ATL	_	NN	NN	_	9	nn	_	_
9	cells	_	NNS	NNS	_	7	pobj	_	_
10	were	_	VBD	VBD	_	12	cop	_	_
11	generally	_	RB	RB	_	12	advmod	_	_
12	higher	_	JJR	JJR	_	0	root	_	_
13	than	_	IN	IN	_	12	prep	_	_
14	those	_	DT	DT	_	13	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	T-lymphoid	_	NN	NN	_	17	nn	_	_
17	cells	_	NNS	NNS	_	15	pobj	_	_
18	.	_	.	.	_	12	punct	_	_

1	However	_	RB	RB	_	15	advmod	_	_
2	,	_	,	,	_	15	punct	_	_
3	ILT-mat	_	NN	NN	_	4	nn	_	_
4	cells	_	NNS	NNS	_	15	nsubj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	ATL16T-LRB---RRB-	_	JJ	JJ	_	7	amod	_	_
7	cells	_	NNS	NNS	_	4	conj	_	_
8	,	_	,	,	_	4	punct	_	_
9	although	_	IN	IN	_	13	mark	_	_
10	they	_	PRP	PRP	_	13	nsubj	_	_
11	were	_	VBD	VBD	_	13	cop	_	_
12	ATL	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	15	dep	_	_
14	,	_	,	,	_	15	punct	_	_
15	showed	_	VBD	VBD	_	0	root	_	_
16	rather	_	RB	RB	_	17	advmod	_	_
17	low	_	JJ	JJ	_	20	amod	_	_
18	surface	_	NN	NN	_	20	nn	_	_
19	ICAM-1	_	NN	NN	_	20	nn	_	_
20	expression	_	NN	NN	_	15	dobj	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	ICAM-1	_	NN	NN	_	23	nn	_	_
23	mRNA	_	NN	NN	_	24	nn	_	_
24	expression	_	NN	NN	_	20	conj	_	_
25	.	_	.	.	_	15	punct	_	_

1	Southern	_	NN	NN	_	3	nn	_	_
2	blot	_	NN	NN	_	3	nn	_	_
3	hybridization	_	NN	NN	_	4	nsubj	_	_
4	showed	_	VBD	VBD	_	0	root	_	_
5	that	_	IN	IN	_	12	mark	_	_
6	only	_	RB	RB	_	7	advmod	_	_
7	two	_	CD	CD	_	12	nsubjpass	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	four	_	CD	CD	_	7	conj	_	_
10	bands	_	NNS	NNS	_	7	dep	_	_
11	were	_	VBD	VBD	_	12	auxpass	_	_
12	found	_	VBN	VBN	_	4	ccomp	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	ILT-mat	_	NN	NN	_	13	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	ATL16T-LRB---RRB-	_	JJ	JJ	_	17	amod	_	_
17	cells	_	NNS	NNS	_	14	conj	_	_
18	,	_	,	,	_	12	punct	_	_
19	respectively	_	RB	RB	_	12	advmod	_	_
20	,	_	,	,	_	12	punct	_	_
21	whereas	_	IN	IN	_	26	mark	_	_
22	&gt;	_	JJR	JJR	_	23	quantmod	_	_
23	10	_	CD	CD	_	24	num	_	_
24	bands	_	NNS	NNS	_	26	nsubjpass	_	_
25	were	_	VBD	VBD	_	26	auxpass	_	_
26	detected	_	VBN	VBN	_	12	advcl	_	_
27	in	_	IN	IN	_	26	prep	_	_
28	other	_	JJ	JJ	_	30	amod	_	_
29	ATL	_	NN	NN	_	30	nn	_	_
30	cells	_	NNS	NNS	_	27	pobj	_	_
31	.	_	.	.	_	4	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	25	mark	_	_
5	monoclonal	_	JJ	JJ	_	6	amod	_	_
6	integration	_	NN	NN	_	25	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	HTLV-1	_	NN	NN	_	9	nn	_	_
9	provirus	_	NN	NN	_	7	pobj	_	_
10	to	_	TO	TO	_	6	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	genome	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	T	_	NN	NN	_	15	nn	_	_
15	cell	_	NN	NN	_	13	pobj	_	_
16	,	_	,	,	_	6	punct	_	_
17	especially	_	RB	RB	_	19	advmod	_	_
18	the	_	DT	DT	_	19	det	_	_
19	number	_	NN	NN	_	6	appos	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	integration	_	NN	NN	_	22	nn	_	_
22	sites	_	NNS	NNS	_	20	pobj	_	_
23	,	_	,	,	_	6	punct	_	_
24	is	_	VBZ	VBZ	_	25	cop	_	_
25	one	_	CD	CD	_	3	ccomp	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	28	det	_	_
28	factors	_	NNS	NNS	_	26	pobj	_	_
29	for	_	IN	IN	_	28	prep	_	_
30	induction	_	NN	NN	_	29	pobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	ICAM-1	_	NN	NN	_	33	nn	_	_
33	molecules	_	NNS	NNS	_	31	pobj	_	_
34	.	_	.	.	_	3	punct	_	_

1	Role	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	X2	_	NN	NN	_	5	nn	_	_
5	box	_	NN	NN	_	2	pobj	_	_
6	in	_	IN	IN	_	1	prep	_	_
7	activated	_	VBN	VBN	_	8	amod	_	_
8	transcription	_	NN	NN	_	6	pobj	_	_
9	from	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	DRA	_	NN	NN	_	12	nn	_	_
12	promoter	_	NN	NN	_	9	pobj	_	_
13	in	_	IN	IN	_	8	prep	_	_
14	B	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	13	pobj	_	_
16	.	_	.	.	_	1	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	investigated	_	VBD	VBD	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	function	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	10	det	_	_
7	evolutionary	_	JJ	JJ	_	8	dep	_	_
8	conserved	_	VBN	VBN	_	10	amod	_	_
9	X2	_	NN	NN	_	10	nn	_	_
10	box	_	NN	NN	_	5	pobj	_	_
11	in	_	IN	IN	_	4	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	promoter	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	17	det	_	_
16	HLA-DRA	_	NN	NN	_	17	nn	_	_
17	gene	_	NN	NN	_	14	pobj	_	_
18	from	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	23	det	_	_
20	human	_	JJ	JJ	_	23	amod	_	_
21	major	_	JJ	JJ	_	23	amod	_	_
22	histocompatibility	_	NN	NN	_	23	nn	_	_
23	complex	_	NN	NN	_	18	pobj	_	_
24	-LRB-	_	-LRB-	-LRB-	_	25	punct	_	_
25	MHC	_	NN	NN	_	23	appos	_	_
26	-RRB-	_	-RRB-	-RRB-	_	25	punct	_	_
27	in	_	IN	IN	_	23	prep	_	_
28	resting	_	VBG	VBG	_	27	pobj	_	_
29	and	_	CC	CC	_	28	cc	_	_
30	activated	_	VBN	VBN	_	28	conj	_	_
31	B	_	NN	NN	_	32	nn	_	_
32	cells	_	NNS	NNS	_	28	dep	_	_
33	.	_	.	.	_	2	punct	_	_

1	NF-X2	_	NN	NN	_	14	nsubj	_	_
2	,	_	,	,	_	1	punct	_	_
3	which	_	WDT	WDT	_	4	nsubj	_	_
4	contains	_	VBZ	VBZ	_	1	rcmod	_	_
5	members	_	NNS	NNS	_	4	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	AP-1/ATF/CREB	_	NN	NN	_	9	nn	_	_
9	families	_	NNS	NNS	_	6	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	transcription	_	NN	NN	_	12	nn	_	_
12	factors	_	NNS	NNS	_	10	pobj	_	_
13	,	_	,	,	_	1	punct	_	_
14	interacts	_	VBZ	VBZ	_	0	root	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	18	det	_	_
17	X2	_	NN	NN	_	18	nn	_	_
18	box	_	NN	NN	_	15	pobj	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	5'-TGCGTCA-3'	_	NN	NN	_	18	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	from	_	IN	IN	_	18	prep	_	_
23	positions	_	NNS	NNS	_	22	pobj	_	_
24	-97	_	CD	CD	_	26	number	_	_
25	to	_	TO	TO	_	26	dep	_	_
26	-91	_	CD	CD	_	23	num	_	_
27	in	_	IN	IN	_	23	prep	_	_
28	the	_	DT	DT	_	30	det	_	_
29	DRA	_	NN	NN	_	30	nn	_	_
30	promoter	_	NN	NN	_	27	pobj	_	_
31	.	_	.	.	_	14	punct	_	_

1	In	_	IN	IN	_	15	prep	_	_
2	resting	_	VBG	VBG	_	4	amod	_	_
3	Raji	_	NN	NN	_	4	nn	_	_
4	cells	_	NNS	NNS	_	1	pobj	_	_
5	,	_	,	,	_	15	punct	_	_
6	little	_	JJ	JJ	_	15	nsubjpass	_	_
7	to	_	TO	TO	_	6	prep	_	_
8	no	_	DT	DT	_	7	pobj	_	_
9	binding	_	NN	NN	_	7	dep	_	_
10	to	_	TO	TO	_	6	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	X2	_	NN	NN	_	13	nn	_	_
13	box	_	NN	NN	_	10	pobj	_	_
14	was	_	VBD	VBD	_	15	auxpass	_	_
15	observed	_	VBN	VBN	_	0	root	_	_
16	.	_	.	.	_	15	punct	_	_

1	In	_	IN	IN	_	29	prep	_	_
2	sharp	_	JJ	JJ	_	3	amod	_	_
3	contrast	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	29	punct	_	_
5	in	_	IN	IN	_	29	prep	_	_
6	B	_	NN	NN	_	7	nn	_	_
7	cells	_	NNS	NNS	_	5	pobj	_	_
8	treated	_	VBN	VBN	_	7	vmod	_	_
9	with	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	phorbol	_	NN	NN	_	12	nn	_	_
12	ester	_	NN	NN	_	9	pobj	_	_
13	12-O-tetradecanoylphorbol-13-acetate	_	NN	NN	_	12	dep	_	_
14	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
15	TPA	_	NN	NN	_	13	appos	_	_
16	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
17	,	_	,	,	_	29	punct	_	_
18	strong	_	JJ	JJ	_	19	amod	_	_
19	interactions	_	NNS	NNS	_	29	nsubjpass	_	_
20	between	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	23	det	_	_
22	X2	_	NN	NN	_	23	nn	_	_
23	box	_	NN	NN	_	20	pobj	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	NF-X2	_	NN	NN	_	23	conj	_	_
26	containing	_	VBG	VBG	_	25	vmod	_	_
27	c-Fos	_	NN	NN	_	26	dobj	_	_
28	were	_	VBD	VBD	_	29	auxpass	_	_
29	observed	_	VBN	VBN	_	0	root	_	_
30	.	_	.	.	_	29	punct	_	_

1	As	_	IN	IN	_	2	mark	_	_
2	determined	_	VBN	VBN	_	20	advcl	_	_
3	by	_	IN	IN	_	2	prep	_	_
4	transient	_	JJ	JJ	_	5	amod	_	_
5	expression	_	NN	NN	_	3	pobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	RNA	_	NN	NN	_	5	conj	_	_
8	analyses	_	NNS	NNS	_	5	dep	_	_
9	,	_	,	,	_	20	punct	_	_
10	the	_	DT	DT	_	11	det	_	_
11	activation	_	NN	NN	_	20	nsubj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	protein	_	NN	NN	_	15	nn	_	_
14	kinase	_	NN	NN	_	15	nn	_	_
15	C	_	NN	NN	_	12	pobj	_	_
16	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
17	PKC	_	NN	NN	_	15	appos	_	_
18	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
19	also	_	RB	RB	_	20	advmod	_	_
20	increased	_	VBD	VBD	_	0	root	_	_
21	rates	_	NNS	NNS	_	20	dobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	transcription	_	NN	NN	_	22	pobj	_	_
24	from	_	IN	IN	_	23	prep	_	_
25	the	_	DT	DT	_	28	det	_	_
26	wild-type	_	JJ	JJ	_	28	amod	_	_
27	DRA	_	NN	NN	_	28	nn	_	_
28	promoter	_	NN	NN	_	24	pobj	_	_
29	but	_	CC	CC	_	24	cc	_	_
30	not	_	RB	RB	_	31	neg	_	_
31	from	_	IN	IN	_	24	conj	_	_
32	a	_	DT	DT	_	34	det	_	_
33	DRA	_	NN	NN	_	34	nn	_	_
34	promoter	_	NN	NN	_	31	pobj	_	_
35	bearing	_	VBG	VBG	_	34	vmod	_	_
36	clustered	_	JJ	JJ	_	38	amod	_	_
37	point	_	NN	NN	_	38	nn	_	_
38	mutations	_	NNS	NNS	_	35	dobj	_	_
39	in	_	IN	IN	_	35	prep	_	_
40	the	_	DT	DT	_	42	det	_	_
41	X2	_	NN	NN	_	42	nn	_	_
42	box	_	NN	NN	_	39	pobj	_	_
43	.	_	.	.	_	20	punct	_	_

1	Since	_	IN	IN	_	9	mark	_	_
2	the	_	DT	DT	_	3	det	_	_
3	co-expression	_	NN	NN	_	9	nsubj	_	_
4	with	_	IN	IN	_	3	prep	_	_
5	a	_	DT	DT	_	8	det	_	_
6	dominant	_	JJ	JJ	_	8	amod	_	_
7	negative	_	JJ	JJ	_	8	amod	_	_
8	c-Fos	_	NN	NN	_	4	pobj	_	_
9	abolished	_	VBD	VBD	_	16	advcl	_	_
10	the	_	DT	DT	_	11	det	_	_
11	responsiveness	_	NN	NN	_	9	dobj	_	_
12	to	_	TO	TO	_	11	prep	_	_
13	TPA	_	NN	NN	_	12	pobj	_	_
14	,	_	,	,	_	16	punct	_	_
15	we	_	PRP	PRP	_	16	nsubj	_	_
16	conclude	_	VBP	VBP	_	0	root	_	_
17	that	_	IN	IN	_	24	mark	_	_
18	activated	_	VBN	VBN	_	19	amod	_	_
19	transcription	_	NN	NN	_	24	nsubj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	23	det	_	_
22	DRA	_	NN	NN	_	23	nn	_	_
23	gene	_	NN	NN	_	20	pobj	_	_
24	depends	_	VBZ	VBZ	_	16	ccomp	_	_
25	on	_	IN	IN	_	24	prep	_	_
26	interactions	_	NNS	NNS	_	25	pobj	_	_
27	between	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	30	det	_	_
29	X2	_	NN	NN	_	30	nn	_	_
30	box	_	NN	NN	_	27	pobj	_	_
31	and	_	CC	CC	_	30	cc	_	_
32	NF-X2	_	NN	NN	_	30	conj	_	_
33	,	_	,	,	_	32	punct	_	_
34	which	_	WDT	WDT	_	35	nsubj	_	_
35	contains	_	VBZ	VBZ	_	32	rcmod	_	_
36	c-Fos	_	NN	NN	_	35	dobj	_	_
37	.	_	.	.	_	16	punct	_	_

1	Transcription	_	NN	NN	_	2	nn	_	_
2	factor	_	NN	NN	_	4	nn	_	_
3	binding	_	NN	NN	_	4	nn	_	_
4	sites	_	NNS	NNS	_	17	nsubj	_	_
5	downstream	_	JJ	JJ	_	4	advmod	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	15	det	_	_
8	human	_	JJ	JJ	_	15	amod	_	_
9	immunodeficiency	_	NN	NN	_	15	nn	_	_
10	virus	_	NN	NN	_	15	nn	_	_
11	type	_	NN	NN	_	15	nn	_	_
12	1	_	CD	CD	_	15	num	_	_
13	transcription	_	NN	NN	_	15	nn	_	_
14	start	_	NN	NN	_	15	nn	_	_
15	site	_	NN	NN	_	6	pobj	_	_
16	are	_	VBP	VBP	_	17	cop	_	_
17	important	_	JJ	JJ	_	0	root	_	_
18	for	_	IN	IN	_	17	prep	_	_
19	virus	_	NN	NN	_	20	nn	_	_
20	infectivity	_	NN	NN	_	18	pobj	_	_
21	.	_	.	.	_	17	punct	_	_

1	When	_	WRB	WRB	_	3	advmod	_	_
2	transcriptionally	_	RB	RB	_	3	advmod	_	_
3	active	_	JJ	JJ	_	13	advcl	_	_
4	,	_	,	,	_	13	punct	_	_
5	the	_	DT	DT	_	8	det	_	_
6	human	_	JJ	JJ	_	8	amod	_	_
7	immunodeficiency	_	NN	NN	_	8	nn	_	_
8	virus	_	NN	NN	_	13	nsubj	_	_
9	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
10	HIV	_	NN	NN	_	8	appos	_	_
11	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
12	promoter	_	NN	NN	_	8	dep	_	_
13	contains	_	VBZ	VBZ	_	0	root	_	_
14	a	_	DT	DT	_	16	det	_	_
15	nucleosome-free	_	JJ	JJ	_	16	amod	_	_
16	region	_	NN	NN	_	13	dobj	_	_
17	encompassing	_	VBG	VBG	_	16	vmod	_	_
18	both	_	CC	CC	_	21	preconj	_	_
19	the	_	DT	DT	_	21	det	_	_
20	promoter/enhancer	_	NN	NN	_	21	nn	_	_
21	region	_	NN	NN	_	17	dobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	a	_	DT	DT	_	25	det	_	_
24	large	_	JJ	JJ	_	25	amod	_	_
25	region	_	NN	NN	_	21	conj	_	_
26	-LRB-	_	-LRB-	-LRB-	_	28	punct	_	_
27	255	_	CD	CD	_	28	num	_	_
28	nucleotides	_	NNS	NNS	_	25	dep	_	_
29	-LSB-	_	-LRB-	-LRB-	_	30	punct	_	_
30	nt	_	NN	NN	_	28	appos	_	_
31	-RSB-	_	-RRB-	-RRB-	_	30	punct	_	_
32	-RRB-	_	-RRB-	-RRB-	_	28	punct	_	_
33	downstream	_	JJ	JJ	_	25	advmod	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	the	_	DT	DT	_	38	det	_	_
36	transcription	_	NN	NN	_	38	nn	_	_
37	start	_	NN	NN	_	38	nn	_	_
38	site	_	NN	NN	_	34	pobj	_	_
39	.	_	.	.	_	13	punct	_	_

1	We	_	PRP	PRP	_	4	nsubj	_	_
2	have	_	VBP	VBP	_	4	aux	_	_
3	previously	_	RB	RB	_	4	advmod	_	_
4	identified	_	VBN	VBN	_	0	root	_	_
5	new	_	JJ	JJ	_	7	amod	_	_
6	binding	_	VBG	VBG	_	7	amod	_	_
7	sites	_	NNS	NNS	_	4	dobj	_	_
8	for	_	IN	IN	_	7	prep	_	_
9	transcription	_	NN	NN	_	10	nn	_	_
10	factors	_	NNS	NNS	_	8	pobj	_	_
11	downstream	_	RB	RB	_	7	advmod	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	16	det	_	_
14	transcription	_	NN	NN	_	16	nn	_	_
15	start	_	NN	NN	_	16	nn	_	_
16	site	_	NN	NN	_	12	pobj	_	_
17	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	nt	_	NN	NN	_	16	appos	_	_
19	465	_	CD	CD	_	18	num	_	_
20	to	_	TO	TO	_	18	dep	_	_
21	720	_	CD	CD	_	18	num	_	_
22	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
23	:	_	:	:	_	4	punct	_	_
24	three	_	CD	CD	_	26	num	_	_
25	AP-1	_	NN	NN	_	26	nn	_	_
26	sites	_	NNS	NNS	_	4	dep	_	_
27	-LRB-	_	-LRB-	-LRB-	_	28	punct	_	_
28	I	_	CD	CD	_	26	dep	_	_
29	,	_	,	,	_	28	punct	_	_
30	II	_	CD	CD	_	28	conj	_	_
31	,	_	,	,	_	28	punct	_	_
32	and	_	CC	CC	_	28	cc	_	_
33	III	_	CD	CD	_	28	conj	_	_
34	-RRB-	_	-RRB-	-RRB-	_	28	punct	_	_
35	,	_	,	,	_	26	punct	_	_
36	an	_	DT	DT	_	38	det	_	_
37	AP3-like	_	JJ	JJ	_	38	amod	_	_
38	motif	_	NN	NN	_	26	conj	_	_
39	-LRB-	_	-LRB-	-LRB-	_	40	punct	_	_
40	AP3-L	_	NN	NN	_	38	appos	_	_
41	-RRB-	_	-RRB-	-RRB-	_	40	punct	_	_
42	,	_	,	,	_	26	punct	_	_
43	a	_	DT	DT	_	50	det	_	_
44	downstream	_	JJ	JJ	_	50	amod	_	_
45	binding	_	NN	NN	_	50	nn	_	_
46	factor	_	NN	NN	_	50	nn	_	_
47	-LRB-	_	-LRB-	-LRB-	_	50	punct	_	_
48	DBF	_	NN	NN	_	50	nn	_	_
49	-RRB-	_	-RRB-	-RRB-	_	50	punct	_	_
50	site	_	NN	NN	_	26	conj	_	_
51	,	_	,	,	_	26	punct	_	_
52	and	_	CC	CC	_	26	cc	_	_
53	juxtaposed	_	VBN	VBN	_	55	amod	_	_
54	Sp1	_	NN	NN	_	55	nn	_	_
55	sites	_	NNS	NNS	_	26	conj	_	_
56	.	_	.	.	_	4	punct	_	_

1	Here	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	show	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	17	mark	_	_
6	the	_	DT	DT	_	8	det	_	_
7	DBF	_	NN	NN	_	8	nn	_	_
8	site	_	NN	NN	_	17	nsubj	_	_
9	is	_	VBZ	VBZ	_	17	cop	_	_
10	an	_	DT	DT	_	17	det	_	_
11	interferon-responsive	_	JJ	JJ	_	17	amod	_	_
12	factor	_	NN	NN	_	17	nn	_	_
13	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
14	IRF	_	NN	NN	_	17	nn	_	_
15	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
16	binding	_	NN	NN	_	17	nn	_	_
17	site	_	NN	NN	_	4	ccomp	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	that	_	IN	IN	_	23	mark	_	_
20	the	_	DT	DT	_	22	det	_	_
21	AP3-L	_	NN	NN	_	22	nn	_	_
22	motif	_	NN	NN	_	23	nsubj	_	_
23	binds	_	VBZ	VBZ	_	17	conj	_	_
24	the	_	DT	DT	_	26	det	_	_
25	T-cell-specific	_	JJ	JJ	_	26	amod	_	_
26	factor	_	NN	NN	_	23	dobj	_	_
27	NF-AT	_	NN	NN	_	26	dep	_	_
28	.	_	.	.	_	4	punct	_	_

1	Mutations	_	NNS	NNS	_	14	nsubjpass	_	_
2	that	_	WDT	WDT	_	3	nsubj	_	_
3	abolish	_	VBP	VBP	_	1	rcmod	_	_
4	the	_	DT	DT	_	5	det	_	_
5	binding	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	each	_	DT	DT	_	8	det	_	_
8	factor	_	NN	NN	_	6	pobj	_	_
9	to	_	TO	TO	_	5	prep	_	_
10	its	_	PRP$	PRP$	_	12	poss	_	_
11	cognate	_	JJ	JJ	_	12	amod	_	_
12	site	_	NN	NN	_	9	pobj	_	_
13	are	_	VBP	VBP	_	14	auxpass	_	_
14	introduced	_	VBN	VBN	_	0	root	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	an	_	DT	DT	_	20	det	_	_
17	infectious	_	JJ	JJ	_	20	amod	_	_
18	HIV-1	_	NN	NN	_	20	nn	_	_
19	molecular	_	JJ	JJ	_	20	amod	_	_
20	clone	_	NN	NN	_	15	pobj	_	_
21	to	_	TO	TO	_	22	aux	_	_
22	study	_	VB	VB	_	14	xcomp	_	_
23	their	_	PRP$	PRP$	_	24	poss	_	_
24	effect	_	NN	NN	_	22	dobj	_	_
25	on	_	IN	IN	_	24	prep	_	_
26	HIV-1	_	NN	NN	_	25	pobj	_	_
27	transcription	_	NN	NN	_	26	dep	_	_
28	and	_	CC	CC	_	26	cc	_	_
29	replication	_	NN	NN	_	26	conj	_	_
30	.	_	.	.	_	14	punct	_	_

1	Individual	_	JJ	JJ	_	2	amod	_	_
2	mutation	_	NN	NN	_	18	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	5	dep	_	_
5	DBF	_	NN	NN	_	3	pobj	_	_
6	or	_	CC	CC	_	5	cc	_	_
7	AP3-L	_	NN	NN	_	5	conj	_	_
8	site	_	NN	NN	_	5	dep	_	_
9	as	_	RB	RB	_	10	advmod	_	_
10	well	_	RB	RB	_	2	cc	_	_
11	as	_	IN	IN	_	10	mwe	_	_
12	the	_	DT	DT	_	15	det	_	_
13	double	_	JJ	JJ	_	15	amod	_	_
14	mutation	_	NN	NN	_	15	nn	_	_
15	AP-1-LRB-III-RRB-/AP3-L	_	NN	NN	_	2	conj	_	_
16	did	_	VBD	VBD	_	18	aux	_	_
17	not	_	RB	RB	_	18	neg	_	_
18	affect	_	VB	VB	_	0	root	_	_
19	HIV-1	_	NN	NN	_	20	nn	_	_
20	replication	_	NN	NN	_	18	dobj	_	_
21	compared	_	VBN	VBN	_	18	prep	_	_
22	to	_	TO	TO	_	21	pcomp	_	_
23	that	_	DT	DT	_	22	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	the	_	DT	DT	_	27	det	_	_
26	wild-type	_	JJ	JJ	_	27	amod	_	_
27	virus	_	NN	NN	_	24	pobj	_	_
28	.	_	.	.	_	18	punct	_	_

1	In	_	IN	IN	_	13	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	13	punct	_	_
4	proviruses	_	NNS	NNS	_	13	nsubj	_	_
5	carrying	_	VBG	VBG	_	4	vmod	_	_
6	mutations	_	NNS	NNS	_	5	dobj	_	_
7	in	_	IN	IN	_	5	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	Sp1	_	NN	NN	_	10	nn	_	_
10	sites	_	NNS	NNS	_	7	pobj	_	_
11	were	_	VBD	VBD	_	13	cop	_	_
12	totally	_	RB	RB	_	13	advmod	_	_
13	defective	_	JJ	JJ	_	0	root	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	terms	_	NNS	NNS	_	14	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	replication	_	NN	NN	_	16	pobj	_	_
18	.	_	.	.	_	13	punct	_	_

1	Virus	_	NN	NN	_	2	nn	_	_
2	production	_	NN	NN	_	3	nsubj	_	_
3	occurred	_	VBD	VBD	_	0	root	_	_
4	with	_	IN	IN	_	3	prep	_	_
5	slightly	_	RB	RB	_	6	advmod	_	_
6	delayed	_	VBN	VBN	_	7	amod	_	_
7	kinetics	_	NNS	NNS	_	4	pobj	_	_
8	for	_	IN	IN	_	7	prep	_	_
9	viruses	_	NNS	NNS	_	8	pobj	_	_
10	containing	_	VBG	VBG	_	9	vmod	_	_
11	combined	_	JJ	JJ	_	12	amod	_	_
12	mutations	_	NNS	NNS	_	10	dobj	_	_
13	in	_	IN	IN	_	10	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	AP-1-LRB-III-RRB-	_	NN	NN	_	13	pobj	_	_
16	,	_	,	,	_	15	punct	_	_
17	AP3-L	_	NN	NN	_	15	conj	_	_
18	,	_	,	,	_	15	punct	_	_
19	and	_	CC	CC	_	15	cc	_	_
20	DBF	_	NN	NN	_	21	nn	_	_
21	sites	_	NNS	NNS	_	15	conj	_	_
22	and	_	CC	CC	_	13	cc	_	_
23	in	_	IN	IN	_	13	conj	_	_
24	the	_	DT	DT	_	25	dep	_	_
25	AP3-L	_	NN	NN	_	23	pobj	_	_
26	and	_	CC	CC	_	25	cc	_	_
27	DBF-sites	_	NNS	NNS	_	25	conj	_	_
28	,	_	,	,	_	3	punct	_	_
29	whereas	_	IN	IN	_	48	mark	_	_
30	viruses	_	NNS	NNS	_	48	nsubj	_	_
31	mutated	_	VBN	VBN	_	30	vmod	_	_
32	in	_	IN	IN	_	31	prep	_	_
33	the	_	DT	DT	_	34	dep	_	_
34	AP-1-LRB-I,II,III-RRB-	_	NN	NN	_	32	pobj	_	_
35	and	_	CC	CC	_	34	cc	_	_
36	AP3-L	_	NN	NN	_	37	nn	_	_
37	sites	_	NNS	NNS	_	34	conj	_	_
38	and	_	CC	CC	_	32	cc	_	_
39	in	_	IN	IN	_	32	conj	_	_
40	the	_	DT	DT	_	41	dep	_	_
41	AP-1-LRB-I,II,III-RRB-	_	NN	NN	_	39	pobj	_	_
42	,	_	,	,	_	41	punct	_	_
43	AP3-L	_	NN	NN	_	41	conj	_	_
44	,	_	,	,	_	41	punct	_	_
45	and	_	CC	CC	_	41	cc	_	_
46	DBF	_	NN	NN	_	47	nn	_	_
47	sites	_	NNS	NNS	_	41	conj	_	_
48	exhibited	_	VBD	VBD	_	3	advcl	_	_
49	a	_	DT	DT	_	53	det	_	_
50	severely	_	RB	RB	_	51	advmod	_	_
51	defective	_	JJ	JJ	_	53	amod	_	_
52	replicative	_	JJ	JJ	_	51	dep	_	_
53	phenotype	_	NN	NN	_	48	dobj	_	_
54	.	_	.	.	_	3	punct	_	_

1	No	_	DT	DT	_	3	neg	_	_
2	RNA-packaging	_	JJ	JJ	_	3	amod	_	_
3	defect	_	NN	NN	_	6	nsubjpass	_	_
4	could	_	MD	MD	_	6	aux	_	_
5	be	_	VB	VB	_	6	auxpass	_	_
6	measured	_	VBN	VBN	_	0	root	_	_
7	for	_	IN	IN	_	6	prep	_	_
8	any	_	DT	DT	_	7	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	mutant	_	JJ	JJ	_	12	amod	_	_
12	viruses	_	NNS	NNS	_	9	pobj	_	_
13	as	_	IN	IN	_	14	mark	_	_
14	determined	_	VBN	VBN	_	6	advcl	_	_
15	by	_	IN	IN	_	14	prep	_	_
16	quantification	_	NN	NN	_	15	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	their	_	PRP$	PRP$	_	21	poss	_	_
19	HIV	_	NN	NN	_	21	nn	_	_
20	genomic	_	JJ	JJ	_	21	amod	_	_
21	RNA	_	NN	NN	_	17	pobj	_	_
22	.	_	.	.	_	6	punct	_	_

1	Measurement	_	NN	NN	_	24	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	transcriptional	_	JJ	JJ	_	5	amod	_	_
5	activity	_	NN	NN	_	2	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	HIV-1	_	NN	NN	_	9	nn	_	_
9	promoter	_	NN	NN	_	6	pobj	_	_
10	after	_	IN	IN	_	5	prep	_	_
11	transient	_	JJ	JJ	_	12	amod	_	_
12	transfection	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	17	det	_	_
15	HIV-1	_	NN	NN	_	17	nn	_	_
16	provirus	_	NN	NN	_	17	nn	_	_
17	DNA	_	NN	NN	_	13	pobj	_	_
18	or	_	CC	CC	_	13	cc	_	_
19	of	_	IN	IN	_	13	conj	_	_
20	long	_	JJ	JJ	_	23	amod	_	_
21	terminal	_	JJ	JJ	_	23	amod	_	_
22	repeat-luciferase	_	JJ	JJ	_	23	amod	_	_
23	constructs	_	NNS	NNS	_	19	pobj	_	_
24	showed	_	VBD	VBD	_	0	root	_	_
25	a	_	DT	DT	_	27	det	_	_
26	positive	_	JJ	JJ	_	27	amod	_	_
27	correlation	_	NN	NN	_	24	dobj	_	_
28	between	_	IN	IN	_	27	prep	_	_
29	the	_	DT	DT	_	30	det	_	_
30	transcriptional	_	JJ	JJ	_	28	pobj	_	_
31	and	_	CC	CC	_	30	cc	_	_
32	the	_	DT	DT	_	33	det	_	_
33	replication	_	NN	NN	_	30	conj	_	_
34	defects	_	NNS	NNS	_	30	dep	_	_
35	for	_	IN	IN	_	30	prep	_	_
36	most	_	JJS	JJS	_	37	amod	_	_
37	mutants	_	NNS	NNS	_	35	pobj	_	_
38	.	_	.	.	_	24	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	role	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	nuclear	_	JJ	JJ	_	6	amod	_	_
5	factor-kappa	_	NN	NN	_	6	nn	_	_
6	B	_	NN	NN	_	3	pobj	_	_
7	in	_	IN	IN	_	2	prep	_	_
8	cytokine	_	NN	NN	_	9	nn	_	_
9	gene	_	NN	NN	_	10	nn	_	_
10	regulation	_	NN	NN	_	7	pobj	_	_
11	.	_	.	.	_	2	punct	_	_

1	Transcription	_	NN	NN	_	2	nn	_	_
2	factors	_	NNS	NNS	_	5	nsubj	_	_
3	are	_	VBP	VBP	_	5	cop	_	_
4	DNA-binding	_	JJ	JJ	_	5	amod	_	_
5	proteins	_	NNS	NNS	_	0	root	_	_
6	that	_	WDT	WDT	_	7	nsubj	_	_
7	regulate	_	VBP	VBP	_	5	rcmod	_	_
8	gene	_	NN	NN	_	9	nn	_	_
9	expression	_	NN	NN	_	7	dobj	_	_
10	.	_	.	.	_	5	punct	_	_

1	Nuclear	_	JJ	JJ	_	3	amod	_	_
2	factor-kappa	_	NN	NN	_	3	nn	_	_
3	B	_	NN	NN	_	12	nsubj	_	_
4	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
5	NF-kappa	_	NN	NN	_	6	nn	_	_
6	B	_	NN	NN	_	3	appos	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	is	_	VBZ	VBZ	_	12	cop	_	_
9	a	_	DT	DT	_	12	det	_	_
10	critical	_	JJ	JJ	_	12	amod	_	_
11	transcription	_	NN	NN	_	12	nn	_	_
12	factor	_	NN	NN	_	0	root	_	_
13	for	_	IN	IN	_	12	prep	_	_
14	maximal	_	JJ	JJ	_	15	amod	_	_
15	expression	_	NN	NN	_	13	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	many	_	JJ	JJ	_	18	amod	_	_
18	cytokines	_	NNS	NNS	_	16	pobj	_	_
19	that	_	WDT	WDT	_	21	nsubjpass	_	_
20	are	_	VBP	VBP	_	21	auxpass	_	_
21	involved	_	VBN	VBN	_	18	rcmod	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	24	det	_	_
24	pathogenesis	_	NN	NN	_	22	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	inflammatory	_	JJ	JJ	_	27	amod	_	_
27	diseases	_	NNS	NNS	_	25	pobj	_	_
28	,	_	,	,	_	27	punct	_	_
29	such	_	JJ	JJ	_	30	mwe	_	_
30	as	_	IN	IN	_	27	prep	_	_
31	adult	_	JJ	JJ	_	34	amod	_	_
32	respiratory	_	JJ	JJ	_	34	amod	_	_
33	distress	_	NN	NN	_	34	nn	_	_
34	syndrome	_	NN	NN	_	30	pobj	_	_
35	-LRB-	_	-LRB-	-LRB-	_	36	punct	_	_
36	ARDS	_	NN	NN	_	34	appos	_	_
37	-RRB-	_	-RRB-	-RRB-	_	36	punct	_	_
38	and	_	CC	CC	_	34	cc	_	_
39	sepsis	_	NN	NN	_	40	nn	_	_
40	syndrome	_	NN	NN	_	34	conj	_	_
41	.	_	.	.	_	12	punct	_	_

1	Activation	_	NN	NN	_	9	nsubjpass	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	regulation	_	NN	NN	_	1	conj	_	_
4	of	_	IN	IN	_	1	prep	_	_
5	NF-kappa	_	NN	NN	_	6	nn	_	_
6	B	_	NN	NN	_	4	pobj	_	_
7	are	_	VBP	VBP	_	9	auxpass	_	_
8	tightly	_	RB	RB	_	9	advmod	_	_
9	controlled	_	VBN	VBN	_	0	root	_	_
10	by	_	IN	IN	_	9	prep	_	_
11	a	_	DT	DT	_	12	det	_	_
12	group	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	inhibitory	_	JJ	JJ	_	15	amod	_	_
15	proteins	_	NNS	NNS	_	13	pobj	_	_
16	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
17	I	_	NN	NN	_	19	nn	_	_
18	kappa	_	NN	NN	_	19	nn	_	_
19	B	_	NN	NN	_	15	appos	_	_
20	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	that	_	WDT	WDT	_	22	nsubj	_	_
22	sequester	_	VBP	VBP	_	15	rcmod	_	_
23	NF-kappa	_	NN	NN	_	24	nn	_	_
24	B	_	NN	NN	_	22	dobj	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	27	det	_	_
27	cytoplasm	_	NN	NN	_	25	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	immune/inflammatory	_	JJ	JJ	_	31	amod	_	_
30	effector	_	NN	NN	_	31	nn	_	_
31	cells	_	NNS	NNS	_	28	pobj	_	_
32	.	_	.	.	_	9	punct	_	_

1	NF-kappa	_	NN	NN	_	2	nn	_	_
2	B	_	NN	NN	_	3	nn	_	_
3	activation	_	NN	NN	_	4	nsubj	_	_
4	involves	_	VBZ	VBZ	_	0	root	_	_
5	signaled	_	VBN	VBN	_	6	amod	_	_
6	phosphorylation	_	NN	NN	_	4	dobj	_	_
7	,	_	,	,	_	6	punct	_	_
8	ubiquitination	_	NN	NN	_	6	conj	_	_
9	,	_	,	,	_	6	punct	_	_
10	and	_	CC	CC	_	6	cc	_	_
11	proteolysis	_	NN	NN	_	6	conj	_	_
12	of	_	IN	IN	_	6	prep	_	_
13	I	_	NN	NN	_	15	nn	_	_
14	kappa	_	NN	NN	_	15	nn	_	_
15	B	_	NN	NN	_	12	pobj	_	_
16	.	_	.	.	_	4	punct	_	_

1	Liberated	_	VBN	VBN	_	3	amod	_	_
2	NF-kappa	_	NN	NN	_	3	nn	_	_
3	B	_	NN	NN	_	4	nsubj	_	_
4	migrates	_	VBZ	VBZ	_	0	root	_	_
5	to	_	TO	TO	_	4	prep	_	_
6	the	_	DT	DT	_	7	det	_	_
7	nucleus	_	NN	NN	_	5	pobj	_	_
8	,	_	,	,	_	7	punct	_	_
9	where	_	WRB	WRB	_	11	advmod	_	_
10	it	_	PRP	PRP	_	11	nsubj	_	_
11	binds	_	VBZ	VBZ	_	7	rcmod	_	_
12	to	_	TO	TO	_	11	prep	_	_
13	specific	_	JJ	JJ	_	15	amod	_	_
14	promoter	_	NN	NN	_	15	nn	_	_
15	sites	_	NNS	NNS	_	12	pobj	_	_
16	and	_	CC	CC	_	11	cc	_	_
17	activates	_	VBZ	VBZ	_	11	conj	_	_
18	gene	_	NN	NN	_	19	nn	_	_
19	transcription	_	NN	NN	_	17	dobj	_	_
20	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	activation	_	NN	NN	_	6	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	NF-kappa	_	NN	NN	_	5	nn	_	_
5	B	_	NN	NN	_	3	pobj	_	_
6	initiates	_	VBZ	VBZ	_	0	root	_	_
7	both	_	CC	CC	_	8	preconj	_	_
8	extracellular	_	JJ	JJ	_	6	dobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	intracellular	_	JJ	JJ	_	8	conj	_	_
11	regulatory	_	JJ	JJ	_	12	amod	_	_
12	events	_	NNS	NNS	_	8	dep	_	_
13	that	_	WDT	WDT	_	14	nsubj	_	_
14	result	_	VBP	VBP	_	8	rcmod	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	autoregulation	_	NN	NN	_	15	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	inflammatory	_	JJ	JJ	_	20	amod	_	_
20	cascade	_	NN	NN	_	17	pobj	_	_
21	through	_	IN	IN	_	16	prep	_	_
22	modulation	_	NN	NN	_	21	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	NF-kappa	_	NN	NN	_	25	nn	_	_
25	B	_	NN	NN	_	26	nn	_	_
26	activation	_	NN	NN	_	23	pobj	_	_
27	.	_	.	.	_	6	punct	_	_

1	Recently	_	RB	RB	_	9	advmod	_	_
2	,	_	,	,	_	9	punct	_	_
3	activation	_	NN	NN	_	9	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	NF-kappa	_	NN	NN	_	6	nn	_	_
6	B	_	NN	NN	_	4	pobj	_	_
7	has	_	VBZ	VBZ	_	9	aux	_	_
8	been	_	VBN	VBN	_	9	auxpass	_	_
9	linked	_	VBN	VBN	_	0	root	_	_
10	to	_	TO	TO	_	9	prep	_	_
11	ARDS	_	NN	NN	_	10	pobj	_	_
12	and	_	CC	CC	_	9	cc	_	_
13	has	_	VBZ	VBZ	_	15	aux	_	_
14	been	_	VBN	VBN	_	15	auxpass	_	_
15	shown	_	VBN	VBN	_	9	conj	_	_
16	to	_	TO	TO	_	21	aux	_	_
17	be	_	VB	VB	_	21	cop	_	_
18	a	_	DT	DT	_	21	det	_	_
19	critical	_	JJ	JJ	_	20	amod	_	_
20	proximal	_	JJ	JJ	_	21	amod	_	_
21	step	_	NN	NN	_	15	xcomp	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	24	det	_	_
24	initiation	_	NN	NN	_	22	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	neutrophilic	_	JJ	JJ	_	27	amod	_	_
27	inflammation	_	NN	NN	_	25	pobj	_	_
28	in	_	IN	IN	_	24	prep	_	_
29	animal	_	NN	NN	_	30	nn	_	_
30	models	_	NNS	NNS	_	28	pobj	_	_
31	.	_	.	.	_	9	punct	_	_

1	Activation	_	NN	NN	_	7	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	NF-kappa	_	NN	NN	_	4	nn	_	_
4	B	_	NN	NN	_	2	pobj	_	_
5	can	_	MD	MD	_	7	aux	_	_
6	be	_	VB	VB	_	7	auxpass	_	_
7	inhibited	_	VBN	VBN	_	0	root	_	_
8	in	_	FW	FW	_	9	nn	_	_
9	vivo	_	FW	FW	_	7	advmod	_	_
10	by	_	IN	IN	_	7	prep	_	_
11	treatment	_	NN	NN	_	10	pobj	_	_
12	with	_	IN	IN	_	11	prep	_	_
13	antioxidants	_	NNS	NNS	_	12	pobj	_	_
14	,	_	,	,	_	13	punct	_	_
15	corticosteroids	_	NNS	NNS	_	13	appos	_	_
16	,	_	,	,	_	11	punct	_	_
17	and	_	CC	CC	_	11	cc	_	_
18	the	_	DT	DT	_	19	det	_	_
19	induction	_	NN	NN	_	11	conj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	endotoxin	_	NN	NN	_	22	nn	_	_
22	tolerance	_	NN	NN	_	20	pobj	_	_
23	.	_	.	.	_	7	punct	_	_

1	Identification	_	NN	NN	_	13	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	more	_	RBR	RBR	_	4	advmod	_	_
4	specific	_	JJ	JJ	_	2	pobj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	efficacious	_	JJ	JJ	_	4	conj	_	_
7	inhibitors	_	NNS	NNS	_	4	dep	_	_
8	of	_	IN	IN	_	4	prep	_	_
9	NF-kappa	_	NN	NN	_	10	nn	_	_
10	B	_	NN	NN	_	11	nn	_	_
11	activation	_	NN	NN	_	8	pobj	_	_
12	might	_	MD	MD	_	13	aux	_	_
13	prove	_	VB	VB	_	0	root	_	_
14	beneficial	_	JJ	JJ	_	13	acomp	_	_
15	for	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	17	det	_	_
17	treatment	_	NN	NN	_	15	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	cytokine-mediated	_	JJ	JJ	_	21	amod	_	_
20	inflammatory	_	JJ	JJ	_	19	dep	_	_
21	diseases	_	NNS	NNS	_	18	pobj	_	_
22	.	_	.	.	_	13	punct	_	_

1	Pancreatic	_	JJ	JJ	_	4	amod	_	_
2	islet	_	NN	NN	_	4	nn	_	_
3	expression	_	NN	NN	_	4	nn	_	_
4	studies	_	NNS	NNS	_	0	root	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	polymorphic	_	JJ	JJ	_	8	amod	_	_
7	DNA	_	NN	NN	_	8	nn	_	_
8	markers	_	NNS	NNS	_	4	conj	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	genes	_	NNS	NNS	_	9	pobj	_	_
12	encoding	_	VBG	VBG	_	11	vmod	_	_
13	hepatocyte	_	NN	NN	_	12	dobj	_	_
14	nuclear	_	JJ	JJ	_	13	amod	_	_
15	factor-3alpha	_	NN	NN	_	13	dep	_	_
16	,	_	,	,	_	13	punct	_	_
17	-3beta	_	NN	NN	_	13	conj	_	_
18	,	_	,	,	_	13	punct	_	_
19	-3gamma	_	NN	NN	_	13	conj	_	_
20	,	_	,	,	_	13	punct	_	_
21	-4gamma	_	NN	NN	_	13	conj	_	_
22	,	_	,	,	_	13	punct	_	_
23	and	_	CC	CC	_	13	cc	_	_
24	-6	_	CD	CD	_	13	conj	_	_
25	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	genes	_	NNS	NNS	_	13	nsubj	_	_
3	encoding	_	VBG	VBG	_	2	vmod	_	_
4	the	_	DT	DT	_	9	det	_	_
5	functionally	_	RB	RB	_	6	advmod	_	_
6	related	_	JJ	JJ	_	9	amod	_	_
7	hepatocyte	_	NN	NN	_	9	nn	_	_
8	nuclear	_	JJ	JJ	_	9	amod	_	_
9	factors	_	NNS	NNS	_	3	dobj	_	_
10	HNF-1alpha	_	NN	NN	_	9	dep	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	HNF-4alpha	_	NN	NN	_	10	conj	_	_
13	play	_	VBP	VBP	_	0	root	_	_
14	a	_	DT	DT	_	16	det	_	_
15	critical	_	JJ	JJ	_	16	amod	_	_
16	role	_	NN	NN	_	13	dobj	_	_
17	in	_	IN	IN	_	13	prep	_	_
18	normal	_	JJ	JJ	_	21	amod	_	_
19	pancreatic	_	JJ	JJ	_	21	amod	_	_
20	beta-cell	_	NN	NN	_	21	nn	_	_
21	function	_	NN	NN	_	17	pobj	_	_
22	.	_	.	.	_	13	punct	_	_

1	Mutations	_	NNS	NNS	_	7	nsubj	_	_
2	in	_	IN	IN	_	1	prep	_	_
3	these	_	DT	DT	_	6	det	_	_
4	liver-enriched	_	JJ	JJ	_	6	amod	_	_
5	transcription	_	NN	NN	_	6	nn	_	_
6	factors	_	NNS	NNS	_	2	pobj	_	_
7	result	_	VBP	VBP	_	0	root	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	two	_	CD	CD	_	10	num	_	_
10	forms	_	NNS	NNS	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	early-onset	_	JJ	JJ	_	15	amod	_	_
13	type	_	NN	NN	_	15	nn	_	_
14	2	_	CD	CD	_	15	num	_	_
15	diabetes	_	NNS	NNS	_	11	pobj	_	_
16	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
17	maturity-onset	_	JJ	JJ	_	18	amod	_	_
18	diabetes	_	NNS	NNS	_	10	dep	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	21	det	_	_
21	young	_	JJ	JJ	_	19	pobj	_	_
22	-LSB-	_	-LRB-	-LRB-	_	23	punct	_	_
23	MODY	_	NN	NN	_	18	appos	_	_
24	-RSB-	_	-RRB-	-RRB-	_	23	punct	_	_
25	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
26	,	_	,	,	_	10	punct	_	_
27	MODY3	_	NN	NN	_	10	appos	_	_
28	and	_	CC	CC	_	27	cc	_	_
29	MODY1	_	NN	NN	_	27	conj	_	_
30	,	_	,	,	_	10	punct	_	_
31	which	_	WDT	WDT	_	33	nsubjpass	_	_
32	are	_	VBP	VBP	_	33	auxpass	_	_
33	characterized	_	VBN	VBN	_	10	rcmod	_	_
34	by	_	IN	IN	_	33	prep	_	_
35	impaired	_	JJ	JJ	_	36	amod	_	_
36	glucose-stimulated	_	JJ	JJ	_	38	amod	_	_
37	insulin	_	NN	NN	_	38	nn	_	_
38	secretion	_	NN	NN	_	34	pobj	_	_
39	,	_	,	,	_	38	punct	_	_
40	early	_	RB	RB	_	42	advmod	_	_
41	disease	_	NN	NN	_	42	nn	_	_
42	onset	_	NN	NN	_	38	conj	_	_
43	,	_	,	,	_	38	punct	_	_
44	and	_	CC	CC	_	38	cc	_	_
45	autosomal	_	JJ	JJ	_	47	amod	_	_
46	dominant	_	JJ	JJ	_	47	amod	_	_
47	inheritance	_	NN	NN	_	38	conj	_	_
48	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	transcriptional	_	JJ	JJ	_	3	amod	_	_
3	hierarchy	_	NN	NN	_	6	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	HNFs	_	NNS	NNS	_	4	pobj	_	_
6	suggests	_	VBZ	VBZ	_	0	root	_	_
7	that	_	IN	IN	_	16	mark	_	_
8	other	_	JJ	JJ	_	9	amod	_	_
9	proteins	_	NNS	NNS	_	16	nsubj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	regulatory	_	JJ	JJ	_	13	amod	_	_
13	cascade	_	NN	NN	_	10	pobj	_	_
14	might	_	MD	MD	_	16	aux	_	_
15	be	_	VB	VB	_	16	cop	_	_
16	responsible	_	JJ	JJ	_	6	ccomp	_	_
17	for	_	IN	IN	_	16	prep	_	_
18	other	_	JJ	JJ	_	19	amod	_	_
19	forms	_	NNS	NNS	_	17	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	MODY	_	NN	NN	_	20	pobj	_	_
22	and/or	_	CC	CC	_	19	cc	_	_
23	late-onset	_	JJ	JJ	_	26	amod	_	_
24	type	_	NN	NN	_	26	nn	_	_
25	2	_	CD	CD	_	26	num	_	_
26	diabetes	_	NNS	NNS	_	19	conj	_	_
27	.	_	.	.	_	6	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	study	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	show	_	VBP	VBP	_	0	root	_	_
7	that	_	IN	IN	_	19	mark	_	_
8	HNF-3alpha	_	NN	NN	_	19	nsubjpass	_	_
9	,	_	,	,	_	8	punct	_	_
10	-3beta	_	NN	NN	_	8	conj	_	_
11	,	_	,	,	_	8	punct	_	_
12	-3gamma	_	NN	NN	_	8	conj	_	_
13	,	_	,	,	_	8	punct	_	_
14	-4gamma	_	NN	NN	_	8	conj	_	_
15	,	_	,	,	_	8	punct	_	_
16	and	_	CC	CC	_	8	cc	_	_
17	-6	_	CD	CD	_	8	conj	_	_
18	are	_	VBP	VBP	_	19	auxpass	_	_
19	expressed	_	VBN	VBN	_	6	ccomp	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	pancreatic	_	JJ	JJ	_	22	amod	_	_
22	beta-cells	_	NNS	NNS	_	20	pobj	_	_
23	.	_	.	.	_	6	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	report	_	VBP	VBP	_	0	root	_	_
3	the	_	DT	DT	_	4	dep	_	_
4	identification	_	NN	NN	_	2	dobj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	characterization	_	NN	NN	_	4	conj	_	_
7	of	_	IN	IN	_	4	prep	_	_
8	simple	_	JJ	JJ	_	12	amod	_	_
9	tandem	_	JJ	JJ	_	12	amod	_	_
10	repeat	_	NN	NN	_	12	nn	_	_
11	DNA	_	NN	NN	_	12	nn	_	_
12	polymorphisms	_	NNS	NNS	_	7	pobj	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	genes	_	NNS	NNS	_	13	pobj	_	_
16	encoding	_	VBG	VBG	_	15	vmod	_	_
17	HNF-3alpha	_	NN	NN	_	16	dobj	_	_
18	,	_	,	,	_	17	punct	_	_
19	-3beta	_	NN	NN	_	17	conj	_	_
20	,	_	,	,	_	17	punct	_	_
21	-3gamma	_	NN	NN	_	17	conj	_	_
22	,	_	,	,	_	17	punct	_	_
23	-4gamma	_	NN	NN	_	17	conj	_	_
24	,	_	,	,	_	17	punct	_	_
25	and	_	CC	CC	_	17	cc	_	_
26	-6	_	CD	CD	_	17	conj	_	_
27	and	_	CC	CC	_	4	cc	_	_
28	the	_	DT	DT	_	29	det	_	_
29	mapping	_	NN	NN	_	4	conj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	HNF-6	_	NN	NN	_	30	pobj	_	_
32	to	_	TO	TO	_	29	prep	_	_
33	chromosome	_	NN	NN	_	34	nn	_	_
34	bands	_	NNS	NNS	_	32	pobj	_	_
35	15q21.1-21.2	_	NN	NN	_	34	dep	_	_
36	by	_	IN	IN	_	4	prep	_	_
37	fluorescence	_	NN	NN	_	40	nn	_	_
38	in	_	FW	FW	_	40	amod	_	_
39	situ	_	FW	FW	_	38	dep	_	_
40	hybridization	_	NN	NN	_	36	pobj	_	_
41	.	_	.	.	_	2	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	markers	_	NNS	NNS	_	5	nsubj	_	_
3	will	_	MD	MD	_	5	aux	_	_
4	be	_	VB	VB	_	5	cop	_	_
5	useful	_	JJ	JJ	_	0	root	_	_
6	to	_	TO	TO	_	7	aux	_	_
7	study	_	VB	VB	_	5	xcomp	_	_
8	the	_	DT	DT	_	9	det	_	_
9	role	_	NN	NN	_	7	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	genetic	_	JJ	JJ	_	12	amod	_	_
12	variation	_	NN	NN	_	10	pobj	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	these	_	DT	DT	_	15	det	_	_
15	genes	_	NNS	NNS	_	13	pobj	_	_
16	in	_	IN	IN	_	7	prep	_	_
17	the	_	DT	DT	_	18	det	_	_
18	pathogenesis	_	NN	NN	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	type	_	NN	NN	_	22	nn	_	_
21	2	_	CD	CD	_	22	num	_	_
22	diabetes	_	NNS	NNS	_	19	pobj	_	_
23	.	_	.	.	_	5	punct	_	_

1	In	_	FW	FW	_	3	amod	_	_
2	vivo	_	FW	FW	_	1	dep	_	_
3	footprinting	_	NN	NN	_	12	nsubj	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	mutational	_	JJ	JJ	_	6	amod	_	_
6	analysis	_	NN	NN	_	3	conj	_	_
7	of	_	IN	IN	_	3	prep	_	_
8	the	_	DT	DT	_	11	det	_	_
9	proximal	_	JJ	JJ	_	11	amod	_	_
10	CD19	_	NN	NN	_	11	nn	_	_
11	promoter	_	NN	NN	_	7	pobj	_	_
12	reveal	_	VBP	VBP	_	0	root	_	_
13	important	_	JJ	JJ	_	14	amod	_	_
14	roles	_	NNS	NNS	_	12	dobj	_	_
15	for	_	IN	IN	_	14	prep	_	_
16	an	_	DT	DT	_	19	det	_	_
17	SP1/Egr-1	_	NN	NN	_	19	nn	_	_
18	binding	_	NN	NN	_	19	nn	_	_
19	site	_	NN	NN	_	15	pobj	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	a	_	DT	DT	_	23	det	_	_
22	novel	_	JJ	JJ	_	23	amod	_	_
23	site	_	NN	NN	_	19	conj	_	_
24	termed	_	VBN	VBN	_	23	vmod	_	_
25	the	_	DT	DT	_	27	det	_	_
26	PyG	_	NN	NN	_	27	nn	_	_
27	box	_	NN	NN	_	24	dep	_	_
28	.	_	.	.	_	12	punct	_	_

1	CD19	_	NN	NN	_	2	nn	_	_
2	expression	_	NN	NN	_	3	nsubj	_	_
3	begins	_	VBZ	VBZ	_	0	root	_	_
4	at	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	8	det	_	_
6	pro-B	_	JJ	JJ	_	8	amod	_	_
7	cell	_	NN	NN	_	8	nn	_	_
8	stage	_	NN	NN	_	4	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	B	_	NN	NN	_	12	nn	_	_
11	cell	_	NN	NN	_	12	nn	_	_
12	development	_	NN	NN	_	9	pobj	_	_
13	.	_	.	.	_	3	punct	_	_

1	As	_	IN	IN	_	2	mark	_	_
2	such	_	JJ	JJ	_	4	advcl	_	_
3	it	_	PRP	PRP	_	4	nsubj	_	_
4	serves	_	VBZ	VBZ	_	0	root	_	_
5	as	_	IN	IN	_	4	prep	_	_
6	a	_	DT	DT	_	8	det	_	_
7	good	_	JJ	JJ	_	8	amod	_	_
8	prototype	_	NN	NN	_	5	pobj	_	_
9	for	_	IN	IN	_	8	prep	_	_
10	B	_	NN	NN	_	12	nn	_	_
11	cell-specific	_	JJ	JJ	_	12	amod	_	_
12	genes	_	NNS	NNS	_	9	pobj	_	_
13	whose	_	WP$	WP$	_	14	poss	_	_
14	expression	_	NN	NN	_	15	nsubj	_	_
15	begins	_	VBZ	VBZ	_	12	rcmod	_	_
16	shortly	_	RB	RB	_	17	advmod	_	_
17	after	_	IN	IN	_	15	prep	_	_
18	lineage	_	NN	NN	_	19	nn	_	_
19	commitment	_	NN	NN	_	17	pobj	_	_
20	.	_	.	.	_	4	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	understand	_	VB	VB	_	0	root	_	_
3	the	_	DT	DT	_	5	det	_	_
4	molecular	_	JJ	JJ	_	5	amod	_	_
5	mechanisms	_	NNS	NNS	_	2	dobj	_	_
6	controlling	_	VBG	VBG	_	5	vmod	_	_
7	CD19	_	NN	NN	_	9	nn	_	_
8	gene	_	NN	NN	_	9	nn	_	_
9	expression	_	NN	NN	_	6	dobj	_	_
10	,	_	,	,	_	2	punct	_	_
11	we	_	PRP	PRP	_	12	nsubj	_	_
12	isolated	_	VBD	VBD	_	2	parataxis	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	functionally	_	RB	RB	_	15	advmod	_	_
15	characterized	_	VBD	VBD	_	12	conj	_	_
16	the	_	DT	DT	_	18	det	_	_
17	CD19	_	NN	NN	_	18	nn	_	_
18	promoter	_	NN	NN	_	12	dobj	_	_
19	using	_	VBG	VBG	_	12	dep	_	_
20	in	_	FW	FW	_	22	amod	_	_
21	vivo	_	FW	FW	_	20	dep	_	_
22	footprinting	_	NN	NN	_	19	dobj	_	_
23	,	_	,	,	_	22	punct	_	_
24	gel	_	NN	NN	_	26	nn	_	_
25	shift	_	NN	NN	_	26	nn	_	_
26	assays	_	NNS	NNS	_	22	conj	_	_
27	,	_	,	,	_	22	punct	_	_
28	and	_	CC	CC	_	22	cc	_	_
29	transfection	_	NN	NN	_	30	nn	_	_
30	studies	_	NNS	NNS	_	22	conj	_	_
31	.	_	.	.	_	2	punct	_	_

1	Reporter	_	NN	NN	_	2	nn	_	_
2	constructs	_	NNS	NNS	_	8	nsubj	_	_
3	spanning	_	VBG	VBG	_	2	vmod	_	_
4	portions	_	NNS	NNS	_	3	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	7	det	_	_
7	promoter	_	NN	NN	_	5	pobj	_	_
8	identified	_	VBD	VBD	_	0	root	_	_
9	a	_	DT	DT	_	10	det	_	_
10	region	_	NN	NN	_	8	dobj	_	_
11	between	_	IN	IN	_	10	amod	_	_
12	-85	_	CD	CD	_	10	num	_	_
13	and	_	CC	CC	_	10	cc	_	_
14	-200	_	CD	CD	_	10	conj	_	_
15	that	_	WDT	WDT	_	16	nsubj	_	_
16	produced	_	VBD	VBD	_	10	rcmod	_	_
17	high	_	JJ	JJ	_	18	amod	_	_
18	levels	_	NNS	NNS	_	16	dobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	reporter	_	NN	NN	_	22	nn	_	_
21	gene	_	NN	NN	_	22	nn	_	_
22	activity	_	NN	NN	_	19	pobj	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	lymphoid	_	JJ	JJ	_	25	amod	_	_
25	cells	_	NNS	NNS	_	23	pobj	_	_
26	.	_	.	.	_	8	punct	_	_

1	In	_	FW	FW	_	3	amod	_	_
2	vivo	_	FW	FW	_	1	dep	_	_
3	footprinting	_	NN	NN	_	4	nsubj	_	_
4	identified	_	VBD	VBD	_	0	root	_	_
5	protected	_	JJ	JJ	_	6	amod	_	_
6	regions	_	NNS	NNS	_	4	dobj	_	_
7	over	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	11	det	_	_
9	known	_	JJ	JJ	_	11	amod	_	_
10	high	_	JJ	JJ	_	11	amod	_	_
11	affinity	_	NN	NN	_	7	pobj	_	_
12	B	_	NN	NN	_	20	nn	_	_
13	cell	_	NN	NN	_	20	nn	_	_
14	lineage-specific	_	JJ	JJ	_	20	amod	_	_
15	activator	_	NN	NN	_	20	nn	_	_
16	protein	_	NN	NN	_	20	nn	_	_
17	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
18	BSAP	_	NN	NN	_	20	nn	_	_
19	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
20	site	_	NN	NN	_	11	dep	_	_
21	,	_	,	,	_	6	punct	_	_
22	the	_	DT	DT	_	26	det	_	_
23	low	_	JJ	JJ	_	26	amod	_	_
24	affinity	_	NN	NN	_	26	nn	_	_
25	BSAP	_	NN	NN	_	26	nn	_	_
26	site	_	NN	NN	_	6	appos	_	_
27	,	_	,	,	_	26	punct	_	_
28	a	_	DT	DT	_	30	det	_	_
29	SP1/Egr-1	_	NN	NN	_	30	nn	_	_
30	site	_	NN	NN	_	26	conj	_	_
31	termed	_	VBN	VBN	_	30	vmod	_	_
32	the	_	DT	DT	_	35	det	_	_
33	CD19	_	NN	NN	_	35	nn	_	_
34	GC	_	NN	NN	_	35	nn	_	_
35	box	_	NN	NN	_	31	dep	_	_
36	,	_	,	,	_	26	punct	_	_
37	and	_	CC	CC	_	26	cc	_	_
38	two	_	CD	CD	_	40	num	_	_
39	novel	_	JJ	JJ	_	40	amod	_	_
40	sites	_	NNS	NNS	_	26	conj	_	_
41	named	_	VBN	VBN	_	40	vmod	_	_
42	the	_	DT	DT	_	44	dep	_	_
43	AT	_	NN	NN	_	44	nn	_	_
44	box	_	NN	NN	_	41	dep	_	_
45	and	_	CC	CC	_	44	cc	_	_
46	PyG	_	NN	NN	_	47	nn	_	_
47	box	_	NN	NN	_	44	conj	_	_
48	.	_	.	.	_	4	punct	_	_

1	Phorbol	_	NN	NN	_	3	nn	_	_
2	ester	_	NN	NN	_	3	nn	_	_
3	treatment	_	NN	NN	_	9	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	a	_	DT	DT	_	8	det	_	_
6	pre-B	_	JJ	JJ	_	8	amod	_	_
7	cell	_	NN	NN	_	8	nn	_	_
8	line	_	NN	NN	_	4	pobj	_	_
9	up-regulated	_	VBD	VBD	_	0	root	_	_
10	CD19	_	NN	NN	_	11	nn	_	_
11	expression	_	NN	NN	_	9	dobj	_	_
12	,	_	,	,	_	9	punct	_	_
13	induced	_	VBD	VBD	_	9	conj	_	_
14	Egr-1	_	NN	NN	_	13	dobj	_	_
15	,	_	,	,	_	9	punct	_	_
16	and	_	CC	CC	_	9	cc	_	_
17	enhanced	_	VBD	VBD	_	9	conj	_	_
18	the	_	DT	DT	_	19	det	_	_
19	footprint	_	NN	NN	_	17	dobj	_	_
20	over	_	IN	IN	_	17	prep	_	_
21	the	_	DT	DT	_	23	det	_	_
22	GC	_	NN	NN	_	23	nn	_	_
23	box	_	NN	NN	_	20	pobj	_	_
24	.	_	.	.	_	9	punct	_	_

1	Gel	_	NN	NN	_	3	nn	_	_
2	shift	_	NN	NN	_	3	nn	_	_
3	assays	_	NNS	NNS	_	4	nsubj	_	_
4	demonstrated	_	VBD	VBD	_	0	root	_	_
5	SP1	_	NN	NN	_	8	nsubj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	Egr-1	_	NN	NN	_	5	conj	_	_
8	binding	_	VBG	VBG	_	4	dep	_	_
9	to	_	TO	TO	_	8	prep	_	_
10	the	_	DT	DT	_	13	det	_	_
11	CD19	_	NN	NN	_	13	nn	_	_
12	GC	_	NN	NN	_	13	nn	_	_
13	box	_	NN	NN	_	9	pobj	_	_
14	,	_	,	,	_	4	punct	_	_
15	while	_	IN	IN	_	19	mark	_	_
16	unknown	_	JJ	JJ	_	18	amod	_	_
17	nuclear	_	JJ	JJ	_	18	amod	_	_
18	proteins	_	NNS	NNS	_	19	nsubj	_	_
19	bound	_	VBD	VBD	_	4	advcl	_	_
20	the	_	DT	DT	_	21	dep	_	_
21	PyG	_	NN	NN	_	19	dobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	AT	_	NN	NN	_	21	conj	_	_
24	boxes	_	NNS	NNS	_	21	dep	_	_
25	.	_	.	.	_	4	punct	_	_

1	Mutations	_	NNS	NNS	_	13	nsubj	_	_
2	in	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	AT	_	NN	NN	_	5	nn	_	_
5	box	_	NN	NN	_	2	pobj	_	_
6	or	_	CC	CC	_	2	cc	_	_
7	in	_	IN	IN	_	2	conj	_	_
8	the	_	DT	DT	_	10	det	_	_
9	BSAP	_	NN	NN	_	10	nn	_	_
10	sites	_	NNS	NNS	_	7	pobj	_	_
11	did	_	VBD	VBD	_	13	aux	_	_
12	not	_	RB	RB	_	13	neg	_	_
13	affect	_	VB	VB	_	0	root	_	_
14	CD19	_	NN	NN	_	17	nn	_	_
15	reporter	_	NN	NN	_	16	nn	_	_
16	construct	_	NN	NN	_	17	nn	_	_
17	activity	_	NN	NN	_	13	dobj	_	_
18	,	_	,	,	_	13	punct	_	_
19	while	_	IN	IN	_	26	mark	_	_
20	a	_	DT	DT	_	21	det	_	_
21	mutation	_	NN	NN	_	26	nsubj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	25	det	_	_
24	GC	_	NN	NN	_	25	nn	_	_
25	box	_	NN	NN	_	22	pobj	_	_
26	reduced	_	VBD	VBD	_	13	advcl	_	_
27	it	_	PRP	PRP	_	26	dobj	_	_
28	modestly	_	RB	RB	_	27	advmod	_	_
29	,	_	,	,	_	26	punct	_	_
30	and	_	CC	CC	_	26	cc	_	_
31	a	_	DT	DT	_	34	det	_	_
32	PyG	_	NN	NN	_	33	nn	_	_
33	box	_	NN	NN	_	34	nn	_	_
34	mutation	_	NN	NN	_	35	nsubj	_	_
35	reduced	_	VBD	VBD	_	26	conj	_	_
36	it	_	PRP	PRP	_	35	dobj	_	_
37	dramatically	_	RB	RB	_	36	advmod	_	_
38	.	_	.	.	_	13	punct	_	_

1	BSAP	_	NN	NN	_	2	nsubj	_	_
2	failed	_	VBD	VBD	_	0	root	_	_
3	to	_	TO	TO	_	4	aux	_	_
4	trans-activate	_	VB	VB	_	2	xcomp	_	_
5	CD19	_	NN	NN	_	7	nn	_	_
6	promoter	_	NN	NN	_	7	nn	_	_
7	constructs	_	NNS	NNS	_	4	dobj	_	_
8	in	_	IN	IN	_	4	prep	_	_
9	B	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	8	pobj	_	_
11	or	_	CC	CC	_	10	cc	_	_
12	non-B	_	JJ	JJ	_	13	amod	_	_
13	cells	_	NNS	NNS	_	10	conj	_	_
14	,	_	,	,	_	2	punct	_	_
15	suggesting	_	VBG	VBG	_	2	xcomp	_	_
16	that	_	IN	IN	_	28	mark	_	_
17	cis	_	JJ	JJ	_	18	amod	_	_
18	elements	_	NNS	NNS	_	28	nsubj	_	_
19	such	_	JJ	JJ	_	20	mwe	_	_
20	as	_	IN	IN	_	18	prep	_	_
21	the	_	DT	DT	_	22	dep	_	_
22	PyG	_	NN	NN	_	20	pobj	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	GC	_	NN	NN	_	22	conj	_	_
25	boxes	_	NNS	NNS	_	22	dep	_	_
26	are	_	VBP	VBP	_	28	cop	_	_
27	also	_	RB	RB	_	28	advmod	_	_
28	necessary	_	JJ	JJ	_	15	ccomp	_	_
29	for	_	IN	IN	_	28	prep	_	_
30	high	_	JJ	JJ	_	34	amod	_	_
31	level	_	NN	NN	_	34	nn	_	_
32	CD19	_	NN	NN	_	33	nn	_	_
33	promoter	_	NN	NN	_	34	nn	_	_
34	expression	_	NN	NN	_	29	pobj	_	_
35	.	_	.	.	_	2	punct	_	_

1	A	_	DT	DT	_	4	det	_	_
2	conserved	_	VBN	VBN	_	4	amod	_	_
3	tissue-specific	_	JJ	JJ	_	2	dep	_	_
4	structure	_	NN	NN	_	0	root	_	_
5	at	_	IN	IN	_	4	prep	_	_
6	a	_	DT	DT	_	12	det	_	_
7	human	_	JJ	JJ	_	12	amod	_	_
8	T-cell	_	NN	NN	_	12	nn	_	_
9	receptor	_	NN	NN	_	12	nn	_	_
10	beta-chain	_	NN	NN	_	12	nn	_	_
11	core	_	NN	NN	_	12	nn	_	_
12	promoter	_	NN	NN	_	5	pobj	_	_
13	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	8	det	_	_
2	T-cell	_	NN	NN	_	8	nn	_	_
3	receptor	_	NN	NN	_	8	nn	_	_
4	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
5	TCR	_	NN	NN	_	8	nn	_	_
6	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
7	beta-chain	_	NN	NN	_	8	nn	_	_
8	promoters	_	NNS	NNS	_	11	nsubjpass	_	_
9	have	_	VBP	VBP	_	11	aux	_	_
10	been	_	VBN	VBN	_	11	auxpass	_	_
11	characterized	_	VBN	VBN	_	0	root	_	_
12	as	_	IN	IN	_	11	prep	_	_
13	nonstructured	_	JJ	JJ	_	15	amod	_	_
14	basal	_	JJ	JJ	_	15	amod	_	_
15	promoters	_	NNS	NNS	_	12	pobj	_	_
16	that	_	WDT	WDT	_	17	nsubj	_	_
17	carry	_	VBP	VBP	_	15	rcmod	_	_
18	a	_	DT	DT	_	24	det	_	_
19	single	_	JJ	JJ	_	24	amod	_	_
20	conserved	_	VBN	VBN	_	19	dep	_	_
21	ubiquitous	_	JJ	JJ	_	24	amod	_	_
22	cyclic	_	JJ	JJ	_	24	amod	_	_
23	AMP-responsive	_	JJ	JJ	_	24	amod	_	_
24	element	_	NN	NN	_	17	dobj	_	_
25	.	_	.	.	_	11	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	investigation	_	NN	NN	_	9	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	8	det	_	_
5	human	_	JJ	JJ	_	8	amod	_	_
6	TCR	_	NN	NN	_	8	nn	_	_
7	beta	_	NN	NN	_	8	nn	_	_
8	gene	_	NN	NN	_	3	pobj	_	_
9	uncovers	_	VBZ	VBZ	_	0	root	_	_
10	a	_	DT	DT	_	15	det	_	_
11	surprisingly	_	RB	RB	_	12	advmod	_	_
12	complex	_	JJ	JJ	_	15	amod	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	tissue-specific	_	JJ	JJ	_	12	conj	_	_
15	structure	_	NN	NN	_	9	dobj	_	_
16	at	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	21	det	_	_
18	TCR	_	NN	NN	_	21	nn	_	_
19	Vbeta	_	NN	NN	_	21	nn	_	_
20	8.1	_	NN	NN	_	21	nn	_	_
21	promoter	_	NN	NN	_	16	pobj	_	_
22	.	_	.	.	_	9	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	core	_	NN	NN	_	13	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	5	det	_	_
5	promoter	_	NN	NN	_	3	pobj	_	_
6	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
7	positions	_	NNS	NNS	_	2	appos	_	_
8	-42	_	CD	CD	_	7	num	_	_
9	to	_	TO	TO	_	7	dep	_	_
10	+11	_	CD	CD	_	7	num	_	_
11	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
12	is	_	VBZ	VBZ	_	13	auxpass	_	_
13	recognized	_	VBN	VBN	_	0	root	_	_
14	by	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	19	det	_	_
16	lymphoid	_	JJ	JJ	_	19	amod	_	_
17	cell-specific	_	JJ	JJ	_	19	amod	_	_
18	transcription	_	NN	NN	_	19	nn	_	_
19	factors	_	NNS	NNS	_	14	pobj	_	_
20	Ets-1	_	NN	NN	_	19	dep	_	_
21	,	_	,	,	_	20	punct	_	_
22	LEF1	_	NN	NN	_	20	conj	_	_
23	,	_	,	,	_	20	punct	_	_
24	and	_	CC	CC	_	20	cc	_	_
25	AML1	_	NN	NN	_	20	conj	_	_
26	as	_	RB	RB	_	27	advmod	_	_
27	well	_	RB	RB	_	14	cc	_	_
28	as	_	IN	IN	_	27	mwe	_	_
29	by	_	IN	IN	_	14	conj	_	_
30	CREB/ATF-1	_	NN	NN	_	29	pobj	_	_
31	,	_	,	,	_	13	punct	_	_
32	as	_	IN	IN	_	34	mark	_	_
33	is	_	VBZ	VBZ	_	34	auxpass	_	_
34	demonstrated	_	VBN	VBN	_	13	advcl	_	_
35	in	_	IN	IN	_	34	prep	_	_
36	gel	_	NN	NN	_	37	nn	_	_
37	shift	_	NN	NN	_	35	pobj	_	_
38	and	_	CC	CC	_	37	cc	_	_
39	footprinting	_	NN	NN	_	37	conj	_	_
40	experiments	_	NNS	NNS	_	37	dep	_	_
41	.	_	.	.	_	13	punct	_	_

1	With	_	IN	IN	_	9	prep	_	_
2	the	_	DT	DT	_	3	det	_	_
3	exception	_	NN	NN	_	1	pobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	LEF1	_	NN	NN	_	4	pobj	_	_
6	,	_	,	,	_	9	punct	_	_
7	these	_	DT	DT	_	8	det	_	_
8	factors	_	NNS	NNS	_	9	nsubj	_	_
9	activate	_	VBP	VBP	_	0	root	_	_
10	transcription	_	NN	NN	_	9	dobj	_	_
11	in	_	IN	IN	_	9	prep	_	_
12	T	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	11	pobj	_	_
14	.	_	.	.	_	9	punct	_	_

1	Binding	_	VBG	VBG	_	2	amod	_	_
2	sites	_	NNS	NNS	_	7	nsubj	_	_
3	at	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	core	_	NN	NN	_	6	nn	_	_
6	region	_	NN	NN	_	3	pobj	_	_
7	show	_	VBP	VBP	_	0	root	_	_
8	little	_	JJ	JJ	_	9	amod	_	_
9	conservation	_	NN	NN	_	7	dobj	_	_
10	with	_	IN	IN	_	9	prep	_	_
11	consensus	_	NN	NN	_	12	nn	_	_
12	sites	_	NNS	NNS	_	10	pobj	_	_
13	.	_	.	.	_	7	punct	_	_

1	Nonetheless	_	RB	RB	_	9	advmod	_	_
2	,	_	,	,	_	9	punct	_	_
3	CREB	_	NN	NN	_	9	nsubj	_	_
4	,	_	,	,	_	3	punct	_	_
5	Ets-1	_	NN	NN	_	3	conj	_	_
6	,	_	,	,	_	3	punct	_	_
7	and	_	CC	CC	_	3	cc	_	_
8	AML1	_	NN	NN	_	3	conj	_	_
9	bind	_	VBP	VBP	_	0	root	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	activate	_	VBP	VBP	_	9	conj	_	_
12	cooperatively	_	RB	RB	_	11	advmod	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	very	_	RB	RB	_	15	advmod	_	_
15	efficiently	_	RB	RB	_	12	conj	_	_
16	through	_	IN	IN	_	9	prep	_	_
17	the	_	DT	DT	_	20	det	_	_
18	nonconsensus	_	JJ	JJ	_	20	amod	_	_
19	binding	_	VBG	VBG	_	20	amod	_	_
20	sites	_	NNS	NNS	_	16	pobj	_	_
21	at	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	25	det	_	_
23	core	_	NN	NN	_	25	nn	_	_
24	promoter	_	NN	NN	_	25	nn	_	_
25	region	_	NN	NN	_	21	pobj	_	_
26	.	_	.	.	_	9	punct	_	_

1	Moderate	_	JJ	JJ	_	3	amod	_	_
2	ubiquitous	_	JJ	JJ	_	1	dep	_	_
3	activation	_	NN	NN	_	6	nsubjpass	_	_
4	is	_	VBZ	VBZ	_	6	auxpass	_	_
5	further	_	RB	RB	_	6	advmod	_	_
6	induced	_	VBN	VBN	_	0	root	_	_
7	by	_	IN	IN	_	6	prep	_	_
8	CREB/ATF	_	NN	NN	_	7	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	Sp1	_	NN	NN	_	8	conj	_	_
11	factors	_	NNS	NNS	_	8	dep	_	_
12	through	_	IN	IN	_	6	prep	_	_
13	proximal	_	JJ	JJ	_	15	amod	_	_
14	upstream	_	JJ	JJ	_	15	amod	_	_
15	elements	_	NNS	NNS	_	12	pobj	_	_
16	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	5	det	_	_
2	tissue-specific	_	JJ	JJ	_	5	amod	_	_
3	core	_	NN	NN	_	5	nn	_	_
4	promoter	_	NN	NN	_	5	nn	_	_
5	structure	_	NN	NN	_	8	nsubjpass	_	_
6	is	_	VBZ	VBZ	_	8	auxpass	_	_
7	apparently	_	RB	RB	_	8	advmod	_	_
8	conserved	_	VBN	VBN	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	other	_	JJ	JJ	_	13	amod	_	_
11	T-cell-specifically	_	RB	RB	_	13	advmod	_	_
12	expressed	_	VBN	VBN	_	13	amod	_	_
13	genes	_	NNS	NNS	_	9	pobj	_	_
14	such	_	JJ	JJ	_	15	mwe	_	_
15	as	_	IN	IN	_	13	prep	_	_
16	the	_	DT	DT	_	18	det	_	_
17	CD4	_	NN	NN	_	18	nn	_	_
18	gene	_	NN	NN	_	15	pobj	_	_
19	.	_	.	.	_	8	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	observations	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	11	mark	_	_
5	both	_	CC	CC	_	7	preconj	_	_
6	the	_	DT	DT	_	7	det	_	_
7	enhancer	_	NN	NN	_	11	nsubj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	the	_	DT	DT	_	10	det	_	_
10	promoter	_	NN	NN	_	7	conj	_	_
11	have	_	VBP	VBP	_	3	ccomp	_	_
12	a	_	DT	DT	_	15	det	_	_
13	complex	_	JJ	JJ	_	15	amod	_	_
14	tissue-specific	_	JJ	JJ	_	13	dep	_	_
15	structure	_	NN	NN	_	11	dobj	_	_
16	whose	_	WP$	WP$	_	18	poss	_	_
17	functional	_	JJ	JJ	_	18	amod	_	_
18	interplay	_	NN	NN	_	19	nsubj	_	_
19	potentiates	_	VBZ	VBZ	_	15	rcmod	_	_
20	T-cell-specific	_	JJ	JJ	_	21	amod	_	_
21	transcription	_	NN	NN	_	19	dobj	_	_
22	.	_	.	.	_	3	punct	_	_

1	Opposite	_	JJ	JJ	_	2	amod	_	_
2	effects	_	NNS	NNS	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	11	det	_	_
5	acute	_	JJ	JJ	_	11	amod	_	_
6	promyelocytic	_	JJ	JJ	_	11	amod	_	_
7	leukemia	_	NN	NN	_	11	nn	_	_
8	PML-retinoic	_	JJ	JJ	_	11	amod	_	_
9	acid	_	NN	NN	_	11	nn	_	_
10	receptor	_	NN	NN	_	11	nn	_	_
11	alpha	_	NN	NN	_	3	pobj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
13	RAR	_	NN	NN	_	14	nn	_	_
14	alpha	_	NN	NN	_	11	appos	_	_
15	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	and	_	CC	CC	_	11	cc	_	_
17	PLZF-RAR	_	NN	NN	_	20	nn	_	_
18	alpha	_	NN	NN	_	20	nn	_	_
19	fusion	_	NN	NN	_	20	nn	_	_
20	proteins	_	NNS	NNS	_	11	conj	_	_
21	on	_	IN	IN	_	2	prep	_	_
22	retinoic	_	JJ	JJ	_	24	amod	_	_
23	acid	_	NN	NN	_	24	nn	_	_
24	signalling	_	NN	NN	_	21	pobj	_	_
25	.	_	.	.	_	2	punct	_	_

1	Fusion	_	NN	NN	_	2	nn	_	_
2	proteins	_	NNS	NNS	_	23	nsubj	_	_
3	involving	_	VBG	VBG	_	2	vmod	_	_
4	the	_	DT	DT	_	6	det	_	_
5	retinoic	_	JJ	JJ	_	6	amod	_	_
6	acid	_	NN	NN	_	3	dobj	_	_
7	receptor	_	NN	NN	_	8	nn	_	_
8	alpha	_	NN	NN	_	6	dep	_	_
9	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
10	RAR	_	NN	NN	_	11	nn	_	_
11	alpha	_	NN	NN	_	6	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	and	_	CC	CC	_	6	cc	_	_
14	the	_	DT	DT	_	15	det	_	_
15	PML	_	NN	NN	_	6	conj	_	_
16	or	_	CC	CC	_	2	cc	_	_
17	PLZF	_	NN	NN	_	19	nn	_	_
18	nuclear	_	JJ	JJ	_	19	amod	_	_
19	protein	_	NN	NN	_	2	conj	_	_
20	are	_	VBP	VBP	_	23	cop	_	_
21	the	_	DT	DT	_	23	det	_	_
22	genetic	_	JJ	JJ	_	23	amod	_	_
23	markers	_	NNS	NNS	_	0	root	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	acute	_	JJ	JJ	_	27	amod	_	_
26	promyelocytic	_	JJ	JJ	_	27	amod	_	_
27	leukemias	_	NNS	NNS	_	24	pobj	_	_
28	-LRB-	_	-LRB-	-LRB-	_	29	punct	_	_
29	APLs	_	NNS	NNS	_	27	appos	_	_
30	-RRB-	_	-RRB-	-RRB-	_	29	punct	_	_
31	.	_	.	.	_	23	punct	_	_

1	APLs	_	NNS	NNS	_	14	nsubj	_	_
2	with	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	PML-RAR	_	NN	NN	_	5	nn	_	_
5	alpha	_	NN	NN	_	2	pobj	_	_
6	or	_	CC	CC	_	5	cc	_	_
7	the	_	DT	DT	_	11	det	_	_
8	PLZF-RAR	_	NN	NN	_	11	nn	_	_
9	alpha	_	NN	NN	_	11	nn	_	_
10	fusion	_	NN	NN	_	11	nn	_	_
11	protein	_	NN	NN	_	5	conj	_	_
12	are	_	VBP	VBP	_	14	cop	_	_
13	phenotypically	_	RB	RB	_	14	advmod	_	_
14	indistinguishable	_	JJ	JJ	_	0	root	_	_
15	except	_	IN	IN	_	14	prep	_	_
16	that	_	IN	IN	_	18	mark	_	_
17	they	_	PRP	PRP	_	18	nsubj	_	_
18	differ	_	VBP	VBP	_	15	pcomp	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	their	_	PRP$	PRP$	_	21	poss	_	_
21	sensitivity	_	NN	NN	_	19	pobj	_	_
22	to	_	TO	TO	_	21	prep	_	_
23	retinoic	_	JJ	JJ	_	29	amod	_	_
24	acid	_	NN	NN	_	29	nn	_	_
25	-LRB-	_	-LRB-	-LRB-	_	29	punct	_	_
26	RA	_	NN	NN	_	29	nn	_	_
27	-RRB-	_	-RRB-	-RRB-	_	29	punct	_	_
28	-induced	_	JJ	JJ	_	29	amod	_	_
29	differentiation	_	NN	NN	_	22	pobj	_	_
30	:	_	:	:	_	14	punct	_	_
31	PML-RAR	_	NN	NN	_	32	nn	_	_
32	alpha	_	NN	NN	_	33	nn	_	_
33	blasts	_	NNS	NNS	_	35	nsubj	_	_
34	are	_	VBP	VBP	_	35	cop	_	_
35	sensitive	_	JJ	JJ	_	14	parataxis	_	_
36	to	_	TO	TO	_	35	prep	_	_
37	RA	_	NN	NN	_	36	pobj	_	_
38	and	_	CC	CC	_	35	cc	_	_
39	patients	_	NNS	NNS	_	40	nsubj	_	_
40	enter	_	VBP	VBP	_	35	conj	_	_
41	disease	_	NN	NN	_	42	nn	_	_
42	remission	_	NN	NN	_	40	dobj	_	_
43	after	_	IN	IN	_	40	prep	_	_
44	RA	_	NN	NN	_	45	nn	_	_
45	treatment	_	NN	NN	_	43	pobj	_	_
46	,	_	,	,	_	40	punct	_	_
47	while	_	IN	IN	_	52	mark	_	_
48	patients	_	NNS	NNS	_	52	nsubj	_	_
49	with	_	IN	IN	_	48	prep	_	_
50	PLZF-RAR	_	NN	NN	_	51	nn	_	_
51	alpha	_	NN	NN	_	49	pobj	_	_
52	do	_	VBP	VBP	_	40	advcl	_	_
53	not	_	RB	RB	_	52	neg	_	_
54	.	_	.	.	_	14	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	here	_	RB	RB	_	3	advmod	_	_
3	report	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	16	mark	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	i	_	LS	LS	_	16	dep	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	like	_	IN	IN	_	16	prep	_	_
9	PML-RAR	_	NN	NN	_	10	nn	_	_
10	alpha	_	NN	NN	_	11	nn	_	_
11	expression	_	NN	NN	_	8	pobj	_	_
12	,	_	,	,	_	16	punct	_	_
13	PLZF-RAR	_	NN	NN	_	14	nn	_	_
14	alpha	_	NN	NN	_	15	nn	_	_
15	expression	_	NN	NN	_	16	nsubj	_	_
16	blocks	_	VBZ	VBZ	_	3	ccomp	_	_
17	terminal	_	JJ	JJ	_	18	amod	_	_
18	differentiation	_	NN	NN	_	16	dobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	hematopoietic	_	JJ	JJ	_	23	amod	_	_
21	precursor	_	NN	NN	_	23	nn	_	_
22	cell	_	NN	NN	_	23	nn	_	_
23	lines	_	NNS	NNS	_	19	pobj	_	_
24	-LRB-	_	-LRB-	-LRB-	_	25	punct	_	_
25	U937	_	NN	NN	_	23	dep	_	_
26	and	_	CC	CC	_	25	cc	_	_
27	HL-60	_	NN	NN	_	25	conj	_	_
28	-RRB-	_	-RRB-	-RRB-	_	25	punct	_	_
29	in	_	IN	IN	_	16	prep	_	_
30	response	_	NN	NN	_	29	pobj	_	_
31	to	_	TO	TO	_	30	prep	_	_
32	different	_	JJ	JJ	_	33	amod	_	_
33	stimuli	_	NNS	NNS	_	31	pobj	_	_
34	-LRB-	_	-LRB-	-LRB-	_	36	punct	_	_
35	vitamin	_	NN	NN	_	36	nn	_	_
36	D3	_	NN	NN	_	33	dep	_	_
37	,	_	,	,	_	36	punct	_	_
38	transforming	_	VBG	VBG	_	40	amod	_	_
39	growth	_	NN	NN	_	40	nn	_	_
40	factor	_	NN	NN	_	36	conj	_	_
41	beta1	_	NN	NN	_	40	dep	_	_
42	,	_	,	,	_	36	punct	_	_
43	and	_	CC	CC	_	36	cc	_	_
44	dimethyl	_	NN	NN	_	45	nn	_	_
45	sulfoxide	_	NN	NN	_	36	conj	_	_
46	-RRB-	_	-RRB-	-RRB-	_	36	punct	_	_
47	;	_	:	:	_	16	punct	_	_
48	-LRB-	_	-LRB-	-LRB-	_	49	punct	_	_
49	ii	_	LS	LS	_	59	dep	_	_
50	-RRB-	_	-RRB-	-RRB-	_	49	punct	_	_
51	PML-RAR	_	NN	NN	_	52	nn	_	_
52	alpha	_	NN	NN	_	59	nsubj	_	_
53	,	_	,	,	_	52	punct	_	_
54	but	_	CC	CC	_	55	cc	_	_
55	not	_	RB	RB	_	52	cc	_	_
56	PLZF-RAR	_	NN	NN	_	57	nn	_	_
57	alpha	_	NN	NN	_	52	conj	_	_
58	,	_	,	,	_	52	punct	_	_
59	increases	_	VBZ	VBZ	_	16	conj	_	_
60	RA	_	NN	NN	_	61	nn	_	_
61	sensitivity	_	NN	NN	_	59	dobj	_	_
62	of	_	IN	IN	_	61	prep	_	_
63	hematopoietic	_	JJ	JJ	_	65	amod	_	_
64	precursor	_	NN	NN	_	65	nn	_	_
65	cells	_	NNS	NNS	_	62	pobj	_	_
66	and	_	CC	CC	_	59	cc	_	_
67	restores	_	VBZ	VBZ	_	59	conj	_	_
68	RA	_	NN	NN	_	69	nn	_	_
69	sensitivity	_	NN	NN	_	67	dobj	_	_
70	of	_	IN	IN	_	69	prep	_	_
71	RA-resistant	_	JJ	JJ	_	73	amod	_	_
72	hematopoietic	_	JJ	JJ	_	73	amod	_	_
73	cells	_	NNS	NNS	_	70	pobj	_	_
74	;	_	:	:	_	16	punct	_	_
75	-LRB-	_	-LRB-	-LRB-	_	76	punct	_	_
76	iii	_	LS	LS	_	83	dep	_	_
77	-RRB-	_	-RRB-	-RRB-	_	76	punct	_	_
78	PML-RAR	_	NN	NN	_	79	nn	_	_
79	alpha	_	NN	NN	_	83	nsubj	_	_
80	and	_	CC	CC	_	79	cc	_	_
81	PLZF-RAR	_	NN	NN	_	82	nn	_	_
82	alpha	_	NN	NN	_	79	conj	_	_
83	have	_	VBP	VBP	_	16	conj	_	_
84	similar	_	JJ	JJ	_	87	amod	_	_
85	RA	_	NN	NN	_	87	nn	_	_
86	binding	_	NN	NN	_	87	nn	_	_
87	affinities	_	NNS	NNS	_	83	dobj	_	_
88	;	_	:	:	_	16	punct	_	_
89	and	_	CC	CC	_	16	cc	_	_
90	-LRB-	_	-LRB-	-LRB-	_	91	punct	_	_
91	iv	_	LS	LS	_	95	dep	_	_
92	-RRB-	_	-RRB-	-RRB-	_	91	punct	_	_
93	PML-RAR	_	NN	NN	_	94	nn	_	_
94	alpha	_	NN	NN	_	95	nsubj	_	_
95	enhances	_	VBZ	VBZ	_	16	conj	_	_
96	the	_	DT	DT	_	98	det	_	_
97	RA	_	NN	NN	_	98	nn	_	_
98	response	_	NN	NN	_	95	dobj	_	_
99	of	_	IN	IN	_	98	prep	_	_
100	RA	_	NN	NN	_	102	nn	_	_
101	target	_	NN	NN	_	102	nn	_	_
102	genes	_	NNS	NNS	_	99	pobj	_	_
103	-LRB-	_	-LRB-	-LRB-	_	104	punct	_	_
104	those	_	DT	DT	_	98	dep	_	_
105	for	_	IN	IN	_	104	prep	_	_
106	RAR	_	NN	NN	_	107	nn	_	_
107	beta	_	NN	NN	_	105	pobj	_	_
108	,	_	,	,	_	107	punct	_	_
109	RAR	_	NN	NN	_	110	nn	_	_
110	gamma	_	NN	NN	_	107	conj	_	_
111	,	_	,	,	_	107	punct	_	_
112	and	_	CC	CC	_	107	cc	_	_
113	transglutaminase	_	NN	NN	_	114	nn	_	_
114	type	_	NN	NN	_	107	conj	_	_
115	II	_	CD	CD	_	114	num	_	_
116	-LSB-	_	-LRB-	-LRB-	_	117	punct	_	_
117	TGase	_	NN	NN	_	114	appos	_	_
118	-RSB-	_	-RRB-	-RRB-	_	117	punct	_	_
119	-RRB-	_	-RRB-	-RRB-	_	104	punct	_	_
120	in	_	FW	FW	_	121	nn	_	_
121	vivo	_	FW	FW	_	95	advmod	_	_
122	,	_	,	,	_	95	punct	_	_
123	while	_	IN	IN	_	127	mark	_	_
124	PLZF-RAR	_	NN	NN	_	125	nn	_	_
125	alpha	_	NN	NN	_	126	nn	_	_
126	expression	_	NN	NN	_	127	nsubj	_	_
127	has	_	VBZ	VBZ	_	95	advcl	_	_
128	either	_	CC	CC	_	130	preconj	_	_
129	no	_	DT	DT	_	130	neg	_	_
130	effect	_	NN	NN	_	127	dobj	_	_
131	-LRB-	_	-LRB-	-LRB-	_	133	punct	_	_
132	RAR	_	NN	NN	_	133	nn	_	_
133	beta	_	NN	NN	_	130	appos	_	_
134	-RRB-	_	-RRB-	-RRB-	_	133	punct	_	_
135	or	_	CC	CC	_	130	cc	_	_
136	an	_	DT	DT	_	138	det	_	_
137	inhibitory	_	JJ	JJ	_	138	amod	_	_
138	activity	_	NN	NN	_	130	conj	_	_
139	-LRB-	_	-LRB-	-LRB-	_	141	punct	_	_
140	RAR	_	NN	NN	_	141	nn	_	_
141	gamma	_	NN	NN	_	138	dep	_	_
142	and	_	CC	CC	_	141	cc	_	_
143	type	_	NN	NN	_	145	nn	_	_
144	II	_	CD	CD	_	145	num	_	_
145	TGase	_	NN	NN	_	141	conj	_	_
146	-RRB-	_	-RRB-	-RRB-	_	141	punct	_	_
147	.	_	.	.	_	3	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	demonstrate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	10	mark	_	_
5	PML-RAR	_	NN	NN	_	6	nn	_	_
6	alpha	_	NN	NN	_	10	nsubj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	PLZF-RAR	_	NN	NN	_	9	nn	_	_
9	alpha	_	NN	NN	_	6	conj	_	_
10	have	_	VBP	VBP	_	3	ccomp	_	_
11	similar	_	JJ	JJ	_	15	amod	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	inhibitory	_	JJ	JJ	_	11	dep	_	_
14	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
15	effects	_	NNS	NNS	_	10	dobj	_	_
16	on	_	IN	IN	_	15	prep	_	_
17	RA-independent	_	JJ	JJ	_	18	amod	_	_
18	differentiation	_	NN	NN	_	16	pobj	_	_
19	and	_	CC	CC	_	15	cc	_	_
20	opposite	_	JJ	JJ	_	26	amod	_	_
21	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
22	stimulatory	_	JJ	JJ	_	20	dep	_	_
23	or	_	CC	CC	_	22	cc	_	_
24	inhibitory	_	JJ	JJ	_	22	conj	_	_
25	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
26	effects	_	NNS	NNS	_	15	conj	_	_
27	on	_	IN	IN	_	26	prep	_	_
28	RA-dependent	_	JJ	JJ	_	29	amod	_	_
29	differentiation	_	NN	NN	_	27	pobj	_	_
30	and	_	CC	CC	_	10	cc	_	_
31	that	_	IN	IN	_	33	mark	_	_
32	they	_	PRP	PRP	_	33	nsubj	_	_
33	behave	_	VBP	VBP	_	10	conj	_	_
34	in	_	FW	FW	_	35	nn	_	_
35	vivo	_	FW	FW	_	33	advmod	_	_
36	as	_	IN	IN	_	33	prep	_	_
37	RA-dependent	_	JJ	JJ	_	38	amod	_	_
38	enhancers	_	NNS	NNS	_	36	pobj	_	_
39	or	_	CC	CC	_	38	cc	_	_
40	inhibitors	_	NNS	NNS	_	38	conj	_	_
41	of	_	IN	IN	_	40	prep	_	_
42	RA-responsive	_	JJ	JJ	_	43	amod	_	_
43	genes	_	NNS	NNS	_	41	pobj	_	_
44	,	_	,	,	_	33	punct	_	_
45	respectively	_	RB	RB	_	33	advmod	_	_
46	.	_	.	.	_	3	punct	_	_

1	Their	_	PRP$	PRP$	_	3	poss	_	_
2	different	_	JJ	JJ	_	3	amod	_	_
3	activities	_	NNS	NNS	_	10	nsubj	_	_
4	on	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	8	det	_	_
6	RA	_	NN	NN	_	8	nn	_	_
7	signalling	_	NN	NN	_	8	nn	_	_
8	pathway	_	NN	NN	_	4	pobj	_	_
9	might	_	MD	MD	_	10	aux	_	_
10	underlie	_	VB	VB	_	0	root	_	_
11	the	_	DT	DT	_	13	det	_	_
12	different	_	JJ	JJ	_	13	amod	_	_
13	responses	_	NNS	NNS	_	10	dobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	PML-RAR	_	NN	NN	_	16	nn	_	_
16	alpha	_	NN	NN	_	14	pobj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	PLZF-RAR	_	NN	NN	_	19	nn	_	_
19	alpha	_	NN	NN	_	16	conj	_	_
20	APLs	_	NNS	NNS	_	16	dep	_	_
21	to	_	TO	TO	_	13	prep	_	_
22	RA	_	NN	NN	_	23	nn	_	_
23	treatment	_	NN	NN	_	21	pobj	_	_
24	.	_	.	.	_	10	punct	_	_

1	The	_	DT	DT	_	5	det	_	_
2	PLZF-RAR	_	NN	NN	_	5	nn	_	_
3	alpha	_	NN	NN	_	5	nn	_	_
4	fusion	_	NN	NN	_	5	nn	_	_
5	protein	_	NN	NN	_	6	nsubj	_	_
6	contains	_	VBZ	VBZ	_	0	root	_	_
7	an	_	DT	DT	_	11	det	_	_
8	approximately	_	RB	RB	_	11	advmod	_	_
9	120-amino-acid	_	JJ	JJ	_	11	amod	_	_
10	N-terminal	_	JJ	JJ	_	11	amod	_	_
11	motif	_	NN	NN	_	6	dobj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	called	_	VBN	VBN	_	11	dep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	POZ	_	NN	NN	_	16	nn	_	_
16	domain	_	NN	NN	_	13	dep	_	_
17	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
18	,	_	,	,	_	11	punct	_	_
19	which	_	WDT	WDT	_	22	nsubjpass	_	_
20	is	_	VBZ	VBZ	_	22	auxpass	_	_
21	also	_	RB	RB	_	22	advmod	_	_
22	found	_	VBN	VBN	_	11	rcmod	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	a	_	DT	DT	_	25	det	_	_
25	variety	_	NN	NN	_	23	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	zinc	_	NN	NN	_	29	nn	_	_
28	finger	_	NN	NN	_	29	nn	_	_
29	proteins	_	NNS	NNS	_	26	pobj	_	_
30	and	_	CC	CC	_	25	cc	_	_
31	a	_	DT	DT	_	32	det	_	_
32	group	_	NN	NN	_	25	conj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	poxvirus	_	NN	NN	_	35	nn	_	_
35	proteins	_	NNS	NNS	_	33	pobj	_	_
36	and	_	CC	CC	_	22	cc	_	_
37	which	_	WDT	WDT	_	38	nsubj	_	_
38	mediates	_	VBZ	VBZ	_	22	conj	_	_
39	protein-protein	_	JJ	JJ	_	40	amod	_	_
40	interactions	_	NNS	NNS	_	38	dobj	_	_
41	.	_	.	.	_	6	punct	_	_

1	Deletion	_	NN	NN	_	8	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	6	det	_	_
4	PLZF	_	NN	NN	_	6	nn	_	_
5	POZ	_	NN	NN	_	6	nn	_	_
6	domain	_	NN	NN	_	2	pobj	_	_
7	partially	_	RB	RB	_	8	advmod	_	_
8	abrogated	_	VBD	VBD	_	0	root	_	_
9	the	_	DT	DT	_	11	det	_	_
10	inhibitory	_	JJ	JJ	_	11	amod	_	_
11	effect	_	NN	NN	_	8	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	PLZF-RAR	_	NN	NN	_	14	nn	_	_
14	alpha	_	NN	NN	_	12	pobj	_	_
15	on	_	IN	IN	_	11	prep	_	_
16	RA-induced	_	JJ	JJ	_	17	amod	_	_
17	differentiation	_	NN	NN	_	15	pobj	_	_
18	and	_	CC	CC	_	15	cc	_	_
19	on	_	IN	IN	_	15	conj	_	_
20	RA-mediated	_	JJ	JJ	_	24	amod	_	_
21	type	_	NN	NN	_	23	nn	_	_
22	II	_	CD	CD	_	23	num	_	_
23	TGase	_	NN	NN	_	24	nn	_	_
24	up-regulation	_	NN	NN	_	19	pobj	_	_
25	,	_	,	,	_	8	punct	_	_
26	suggesting	_	VBG	VBG	_	8	vmod	_	_
27	that	_	IN	IN	_	33	mark	_	_
28	POZ-mediated	_	JJ	JJ	_	30	amod	_	_
29	protein	_	NN	NN	_	30	nn	_	_
30	interactions	_	NNS	NNS	_	33	nsubj	_	_
31	might	_	MD	MD	_	33	aux	_	_
32	be	_	VB	VB	_	33	cop	_	_
33	responsible	_	JJ	JJ	_	26	ccomp	_	_
34	for	_	IN	IN	_	33	prep	_	_
35	the	_	DT	DT	_	38	det	_	_
36	inhibitory	_	JJ	JJ	_	38	amod	_	_
37	transcriptional	_	JJ	JJ	_	36	dep	_	_
38	activities	_	NNS	NNS	_	34	pobj	_	_
39	of	_	IN	IN	_	38	prep	_	_
40	PLZF-RAR	_	NN	NN	_	41	nn	_	_
41	alpha	_	NN	NN	_	39	pobj	_	_
42	.	_	.	.	_	8	punct	_	_

1	Induction	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	human	_	JJ	JJ	_	8	amod	_	_
4	immunodeficiency	_	NN	NN	_	8	nn	_	_
5	virus	_	NN	NN	_	8	nn	_	_
6	type	_	NN	NN	_	8	nn	_	_
7	1	_	CD	CD	_	8	num	_	_
8	expression	_	NN	NN	_	2	pobj	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	monocytic	_	JJ	JJ	_	11	amod	_	_
11	cells	_	NNS	NNS	_	9	pobj	_	_
12	by	_	IN	IN	_	1	prep	_	_
13	Cryptococcus	_	FW	FW	_	14	nn	_	_
14	neoformans	_	FW	FW	_	12	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	Candida	_	FW	FW	_	17	nn	_	_
17	albicans	_	FW	FW	_	14	conj	_	_
18	.	_	.	.	_	1	punct	_	_

1	Because	_	IN	IN	_	6	mark	_	_
2	candidiasis	_	NN	NN	_	6	nsubj	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	cryptococcosis	_	NN	NN	_	2	conj	_	_
5	are	_	VBP	VBP	_	6	cop	_	_
6	common	_	JJ	JJ	_	32	advcl	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	human	_	JJ	JJ	_	14	amod	_	_
9	immunodeficiency	_	NN	NN	_	14	npadvmod	_	_
10	virus	_	NN	NN	_	14	npadvmod	_	_
11	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
12	HIV	_	NN	NN	_	14	npadvmod	_	_
13	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
14	-infected	_	JJ	JJ	_	15	amod	_	_
15	persons	_	NNS	NNS	_	7	pobj	_	_
16	,	_	,	,	_	32	punct	_	_
17	the	_	DT	DT	_	18	det	_	_
18	effect	_	NN	NN	_	32	nsubjpass	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	Cryptococcus	_	FW	FW	_	21	nn	_	_
21	neoformans	_	FW	FW	_	19	pobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	Candida	_	FW	FW	_	24	nn	_	_
24	albicans	_	FW	FW	_	21	conj	_	_
25	on	_	IN	IN	_	18	prep	_	_
26	HIV	_	NN	NN	_	27	nn	_	_
27	expression	_	NN	NN	_	25	pobj	_	_
28	in	_	IN	IN	_	27	prep	_	_
29	monocytic	_	JJ	JJ	_	30	amod	_	_
30	cells	_	NNS	NNS	_	28	pobj	_	_
31	was	_	VBD	VBD	_	32	auxpass	_	_
32	examined	_	VBN	VBN	_	0	root	_	_
33	.	_	.	.	_	32	punct	_	_

1	Stimulation	_	NN	NN	_	23	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	8	det	_	_
4	latently	_	RB	RB	_	8	advmod	_	_
5	HIV-infected	_	JJ	JJ	_	8	amod	_	_
6	myelomonocytic	_	JJ	JJ	_	8	amod	_	_
7	cell	_	NN	NN	_	8	nn	_	_
8	line	_	NN	NN	_	2	pobj	_	_
9	OM-10.1	_	NN	NN	_	8	dep	_	_
10	with	_	IN	IN	_	1	prep	_	_
11	C.	_	FW	FW	_	12	nn	_	_
12	neoformans	_	FW	FW	_	10	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	C.	_	FW	FW	_	15	nn	_	_
15	albicans	_	FW	FW	_	12	conj	_	_
16	in	_	IN	IN	_	1	prep	_	_
17	the	_	DT	DT	_	18	det	_	_
18	presence	_	NN	NN	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	pooled	_	JJ	JJ	_	22	amod	_	_
21	human	_	JJ	JJ	_	20	dep	_	_
22	serum	_	NN	NN	_	19	pobj	_	_
23	caused	_	VBD	VBD	_	0	root	_	_
24	a	_	DT	DT	_	26	det	_	_
25	ratio-dependent	_	JJ	JJ	_	26	amod	_	_
26	increase	_	NN	NN	_	23	dobj	_	_
27	in	_	IN	IN	_	26	prep	_	_
28	HIV	_	NN	NN	_	29	nn	_	_
29	production	_	NN	NN	_	27	pobj	_	_
30	.	_	.	.	_	23	punct	_	_

1	Induction	_	NN	NN	_	8	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	HIV	_	NN	NN	_	2	pobj	_	_
4	by	_	IN	IN	_	1	prep	_	_
5	C.	_	FW	FW	_	6	nn	_	_
6	neoformans	_	FW	FW	_	4	pobj	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	enhanced	_	VBN	VBN	_	0	root	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	anti-capsular	_	JJ	JJ	_	11	amod	_	_
11	antibody	_	NN	NN	_	9	pobj	_	_
12	,	_	,	,	_	8	punct	_	_
13	while	_	IN	IN	_	19	mark	_	_
14	induction	_	NN	NN	_	19	nsubjpass	_	_
15	by	_	IN	IN	_	14	prep	_	_
16	both	_	DT	DT	_	17	det	_	_
17	organisms	_	NNS	NNS	_	15	pobj	_	_
18	was	_	VBD	VBD	_	19	auxpass	_	_
19	inhibited	_	VBN	VBN	_	8	advcl	_	_
20	by	_	IN	IN	_	19	prep	_	_
21	anti-TNF-alpha	_	JJ	JJ	_	22	amod	_	_
22	antibody	_	NN	NN	_	20	pobj	_	_
23	.	_	.	.	_	8	punct	_	_

1	In	_	IN	IN	_	12	prep	_	_
2	THP-1	_	NN	NN	_	3	nn	_	_
3	cells	_	NNS	NNS	_	1	pobj	_	_
4	transfected	_	VBN	VBN	_	3	vmod	_	_
5	with	_	IN	IN	_	4	prep	_	_
6	HIV	_	NN	NN	_	8	nn	_	_
7	plasmid	_	NN	NN	_	8	nn	_	_
8	constructs	_	NNS	NNS	_	5	pobj	_	_
9	,	_	,	,	_	12	punct	_	_
10	both	_	DT	DT	_	11	det	_	_
11	organisms	_	NNS	NNS	_	12	nsubj	_	_
12	induced	_	VBD	VBD	_	0	root	_	_
13	transcription	_	NN	NN	_	12	dobj	_	_
14	from	_	IN	IN	_	12	prep	_	_
15	the	_	DT	DT	_	19	det	_	_
16	HIV	_	NN	NN	_	19	nn	_	_
17	long	_	JJ	JJ	_	19	amod	_	_
18	terminal	_	JJ	JJ	_	19	amod	_	_
19	repeat	_	NN	NN	_	14	pobj	_	_
20	that	_	WDT	WDT	_	22	nsubj	_	_
21	was	_	VBD	VBD	_	22	cop	_	_
22	dependent	_	JJ	JJ	_	19	rcmod	_	_
23	on	_	IN	IN	_	22	prep	_	_
24	intact	_	JJ	JJ	_	27	amod	_	_
25	NF-kappaB	_	NN	NN	_	27	nn	_	_
26	binding	_	NN	NN	_	27	nn	_	_
27	sequences	_	NNS	NNS	_	23	pobj	_	_
28	.	_	.	.	_	12	punct	_	_

1	Thus	_	RB	RB	_	8	advmod	_	_
2	,	_	,	,	_	8	punct	_	_
3	C.	_	FW	FW	_	4	nn	_	_
4	neoformans	_	FW	FW	_	8	nsubj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	C.	_	FW	FW	_	7	nn	_	_
7	albicans	_	FW	FW	_	4	conj	_	_
8	enhance	_	VBP	VBP	_	0	root	_	_
9	HIV	_	NN	NN	_	10	nn	_	_
10	expression	_	NN	NN	_	8	dobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	monocytic	_	JJ	JJ	_	13	amod	_	_
13	cells	_	NNS	NNS	_	11	pobj	_	_
14	through	_	IN	IN	_	8	prep	_	_
15	a	_	DT	DT	_	19	det	_	_
16	TNF-alpha-	_	NN	NN	_	19	amod	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	NF-kappaB-dependent	_	JJ	JJ	_	16	conj	_	_
19	mechanism	_	NN	NN	_	14	pobj	_	_
20	.	_	.	.	_	8	punct	_	_

1	In	_	IN	IN	_	9	prep	_	_
2	HIV-infected	_	JJ	JJ	_	3	amod	_	_
3	patients	_	NNS	NNS	_	1	pobj	_	_
4	,	_	,	,	_	9	punct	_	_
5	such	_	JJ	JJ	_	6	amod	_	_
6	enhancement	_	NN	NN	_	9	nsubj	_	_
7	may	_	MD	MD	_	9	aux	_	_
8	further	_	RB	RB	_	9	advmod	_	_
9	impair	_	VB	VB	_	0	root	_	_
10	host	_	NN	NN	_	11	nn	_	_
11	immunity	_	NN	NN	_	9	dobj	_	_
12	and	_	CC	CC	_	9	cc	_	_
13	could	_	MD	MD	_	14	aux	_	_
14	accelerate	_	VB	VB	_	9	conj	_	_
15	the	_	DT	DT	_	16	det	_	_
16	course	_	NN	NN	_	14	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	HIV	_	NN	NN	_	19	nn	_	_
19	disease	_	NN	NN	_	17	pobj	_	_
20	.	_	.	.	_	9	punct	_	_

1	A	_	DT	DT	_	3	det	_	_
2	human	_	JJ	JJ	_	3	amod	_	_
3	homologue	_	NN	NN	_	9	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	8	det	_	_
6	Drosophila	_	FW	FW	_	8	nn	_	_
7	Toll	_	NN	NN	_	8	nn	_	_
8	protein	_	NN	NN	_	4	pobj	_	_
9	signals	_	VBZ	VBZ	_	0	root	_	_
10	activation	_	NN	NN	_	9	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	adaptive	_	JJ	JJ	_	13	amod	_	_
13	immunity	_	NN	NN	_	11	pobj	_	_
14	-LSB-	_	-LRB-	-LRB-	_	15	punct	_	_
15	see	_	VB	VB	_	9	parataxis	_	_
16	comments	_	NNS	NNS	_	15	dobj	_	_
17	-RSB-	_	-RRB-	-RRB-	_	15	punct	_	_

1	Induction	_	NN	NN	_	7	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	6	det	_	_
4	adaptive	_	JJ	JJ	_	6	amod	_	_
5	immune	_	JJ	JJ	_	6	amod	_	_
6	response	_	NN	NN	_	2	pobj	_	_
7	depends	_	VBZ	VBZ	_	0	root	_	_
8	on	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	expression	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	co-stimulatory	_	JJ	JJ	_	13	amod	_	_
13	molecules	_	NNS	NNS	_	11	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	cytokines	_	NNS	NNS	_	13	conj	_	_
16	by	_	IN	IN	_	10	prep	_	_
17	antigen-presenting	_	JJ	JJ	_	18	amod	_	_
18	cells	_	NNS	NNS	_	16	pobj	_	_
19	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	mechanisms	_	NNS	NNS	_	15	nsubjpass	_	_
3	that	_	WDT	WDT	_	4	nsubj	_	_
4	control	_	VBP	VBP	_	2	rcmod	_	_
5	the	_	DT	DT	_	7	det	_	_
6	initial	_	JJ	JJ	_	7	amod	_	_
7	induction	_	NN	NN	_	4	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	these	_	DT	DT	_	10	det	_	_
10	signals	_	NNS	NNS	_	8	pobj	_	_
11	upon	_	IN	IN	_	7	prep	_	_
12	infection	_	NN	NN	_	11	pobj	_	_
13	are	_	VBP	VBP	_	15	auxpass	_	_
14	poorly	_	RB	RB	_	15	advmod	_	_
15	understood	_	VBN	VBN	_	0	root	_	_
16	.	_	.	.	_	15	punct	_	_

1	It	_	PRP	PRP	_	4	nsubjpass	_	_
2	has	_	VBZ	VBZ	_	4	aux	_	_
3	been	_	VBN	VBN	_	4	auxpass	_	_
4	proposed	_	VBN	VBN	_	0	root	_	_
5	that	_	IN	IN	_	9	mark	_	_
6	their	_	PRP$	PRP$	_	7	poss	_	_
7	expression	_	NN	NN	_	9	nsubjpass	_	_
8	is	_	VBZ	VBZ	_	9	auxpass	_	_
9	controlled	_	VBN	VBN	_	4	ccomp	_	_
10	by	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	17	det	_	_
12	non-clonal	_	JJ	JJ	_	17	amod	_	_
13	,	_	,	,	_	12	punct	_	_
14	or	_	CC	CC	_	12	cc	_	_
15	innate	_	JJ	JJ	_	12	conj	_	_
16	,	_	,	,	_	17	punct	_	_
17	component	_	NN	NN	_	10	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	immunity	_	NN	NN	_	18	pobj	_	_
20	that	_	WDT	WDT	_	21	nsubj	_	_
21	preceded	_	VBD	VBD	_	17	rcmod	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	evolution	_	NN	NN	_	22	pobj	_	_
24	the	_	DT	DT	_	25	det	_	_
25	development	_	NN	NN	_	21	dobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	an	_	DT	DT	_	30	det	_	_
28	adaptive	_	JJ	JJ	_	30	amod	_	_
29	immune	_	JJ	JJ	_	30	amod	_	_
30	system	_	NN	NN	_	26	pobj	_	_
31	in	_	IN	IN	_	25	prep	_	_
32	vertebrates	_	NNS	NNS	_	31	pobj	_	_
33	.	_	.	.	_	4	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	report	_	VBP	VBP	_	0	root	_	_
3	here	_	RB	RB	_	2	advmod	_	_
4	the	_	DT	DT	_	5	dep	_	_
5	cloning	_	NN	NN	_	2	dobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	characterization	_	NN	NN	_	5	conj	_	_
8	of	_	IN	IN	_	5	prep	_	_
9	a	_	DT	DT	_	11	det	_	_
10	human	_	JJ	JJ	_	11	amod	_	_
11	homologue	_	NN	NN	_	8	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	16	det	_	_
14	Drosophila	_	FW	FW	_	16	nn	_	_
15	toll	_	NN	NN	_	16	nn	_	_
16	protein	_	NN	NN	_	12	pobj	_	_
17	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	Toll	_	NN	NN	_	16	appos	_	_
19	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
20	which	_	WDT	WDT	_	23	nsubjpass	_	_
21	has	_	VBZ	VBZ	_	23	aux	_	_
22	been	_	VBN	VBN	_	23	auxpass	_	_
23	shown	_	VBN	VBN	_	16	rcmod	_	_
24	to	_	TO	TO	_	25	aux	_	_
25	induce	_	VB	VB	_	23	xcomp	_	_
26	the	_	DT	DT	_	29	det	_	_
27	innate	_	JJ	JJ	_	29	amod	_	_
28	immune	_	JJ	JJ	_	29	amod	_	_
29	response	_	NN	NN	_	25	dobj	_	_
30	in	_	IN	IN	_	25	prep	_	_
31	adult	_	JJ	JJ	_	32	amod	_	_
32	Drosophila	_	FW	FW	_	30	pobj	_	_
33	.	_	.	.	_	2	punct	_	_

1	Like	_	IN	IN	_	12	prep	_	_
2	Drosophila	_	FW	FW	_	3	dep	_	_
3	Toll	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	12	punct	_	_
5	human	_	JJ	JJ	_	6	amod	_	_
6	Toll	_	NN	NN	_	12	nsubj	_	_
7	is	_	VBZ	VBZ	_	12	cop	_	_
8	a	_	DT	DT	_	12	det	_	_
9	type	_	NN	NN	_	12	nn	_	_
10	I	_	CD	CD	_	12	num	_	_
11	transmembrane	_	JJ	JJ	_	12	amod	_	_
12	protein	_	NN	NN	_	0	root	_	_
13	with	_	IN	IN	_	12	prep	_	_
14	an	_	DT	DT	_	16	det	_	_
15	extracellular	_	JJ	JJ	_	16	amod	_	_
16	domain	_	NN	NN	_	13	pobj	_	_
17	consisting	_	VBG	VBG	_	16	vmod	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	a	_	DT	DT	_	25	det	_	_
20	leucine-rich	_	JJ	JJ	_	25	amod	_	_
21	repeat	_	NN	NN	_	25	nn	_	_
22	-LRB-	_	-LRB-	-LRB-	_	25	punct	_	_
23	LRR	_	NN	NN	_	25	nn	_	_
24	-RRB-	_	-RRB-	-RRB-	_	25	punct	_	_
25	domain	_	NN	NN	_	18	pobj	_	_
26	,	_	,	,	_	16	punct	_	_
27	and	_	CC	CC	_	16	cc	_	_
28	a	_	DT	DT	_	30	det	_	_
29	cytoplasmic	_	JJ	JJ	_	30	amod	_	_
30	domain	_	NN	NN	_	16	conj	_	_
31	homologous	_	JJ	JJ	_	30	amod	_	_
32	to	_	TO	TO	_	31	prep	_	_
33	the	_	DT	DT	_	35	det	_	_
34	cytoplasmic	_	JJ	JJ	_	35	amod	_	_
35	domain	_	NN	NN	_	32	pobj	_	_
36	of	_	IN	IN	_	35	prep	_	_
37	the	_	DT	DT	_	44	det	_	_
38	human	_	JJ	JJ	_	44	amod	_	_
39	interleukin	_	NN	NN	_	44	nn	_	_
40	-LRB-	_	-LRB-	-LRB-	_	44	punct	_	_
41	IL	_	NN	NN	_	44	nn	_	_
42	-RRB-	_	-RRB-	-RRB-	_	44	punct	_	_
43	-1	_	CD	CD	_	44	num	_	_
44	receptor	_	NN	NN	_	36	pobj	_	_
45	.	_	.	.	_	12	punct	_	_

1	Both	_	CC	CC	_	3	preconj	_	_
2	Drosophila	_	FW	FW	_	3	dep	_	_
3	Toll	_	NN	NN	_	9	nsubjpass	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	the	_	DT	DT	_	7	det	_	_
6	IL-1	_	NN	NN	_	7	nn	_	_
7	receptor	_	NN	NN	_	3	conj	_	_
8	are	_	VBP	VBP	_	9	auxpass	_	_
9	known	_	VBN	VBN	_	0	root	_	_
10	to	_	TO	TO	_	11	aux	_	_
11	signal	_	VB	VB	_	9	xcomp	_	_
12	through	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	NF-kappaB	_	NN	NN	_	15	nn	_	_
15	pathway	_	NN	NN	_	12	pobj	_	_
16	.	_	.	.	_	9	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	show	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	17	mark	_	_
4	a	_	DT	DT	_	7	det	_	_
5	constitutively	_	RB	RB	_	6	advmod	_	_
6	active	_	JJ	JJ	_	7	amod	_	_
7	mutant	_	NN	NN	_	17	nsubj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	human	_	JJ	JJ	_	10	amod	_	_
10	Toll	_	NN	NN	_	8	pobj	_	_
11	transfected	_	VBN	VBN	_	7	vmod	_	_
12	into	_	IN	IN	_	11	prep	_	_
13	human	_	JJ	JJ	_	15	amod	_	_
14	cell	_	NN	NN	_	15	nn	_	_
15	lines	_	NNS	NNS	_	12	pobj	_	_
16	can	_	MD	MD	_	17	aux	_	_
17	induce	_	VB	VB	_	2	ccomp	_	_
18	the	_	DT	DT	_	19	det	_	_
19	activation	_	NN	NN	_	17	dobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	NF-kappaB	_	NN	NN	_	20	pobj	_	_
22	and	_	CC	CC	_	19	cc	_	_
23	the	_	DT	DT	_	24	det	_	_
24	expression	_	NN	NN	_	19	conj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	NF-kappaB-controlled	_	JJ	JJ	_	27	amod	_	_
27	genes	_	NNS	NNS	_	25	pobj	_	_
28	for	_	IN	IN	_	24	prep	_	_
29	the	_	DT	DT	_	31	det	_	_
30	inflammatory	_	JJ	JJ	_	31	amod	_	_
31	cytokines	_	NNS	NNS	_	28	pobj	_	_
32	IL-1	_	NN	NN	_	31	dep	_	_
33	,	_	,	,	_	32	punct	_	_
34	IL-6	_	NN	NN	_	32	conj	_	_
35	and	_	CC	CC	_	32	cc	_	_
36	IL-8	_	NN	NN	_	32	conj	_	_
37	,	_	,	,	_	19	punct	_	_
38	as	_	RB	RB	_	39	advmod	_	_
39	well	_	RB	RB	_	19	cc	_	_
40	as	_	IN	IN	_	39	mwe	_	_
41	the	_	DT	DT	_	42	det	_	_
42	expression	_	NN	NN	_	19	conj	_	_
43	of	_	IN	IN	_	42	prep	_	_
44	the	_	DT	DT	_	46	det	_	_
45	co-stimulatory	_	JJ	JJ	_	46	amod	_	_
46	molecule	_	NN	NN	_	43	pobj	_	_
47	B7.1	_	NN	NN	_	46	dep	_	_
48	,	_	,	,	_	46	punct	_	_
49	which	_	WDT	WDT	_	51	nsubjpass	_	_
50	is	_	VBZ	VBZ	_	51	auxpass	_	_
51	required	_	VBN	VBN	_	46	rcmod	_	_
52	for	_	IN	IN	_	51	prep	_	_
53	the	_	DT	DT	_	54	det	_	_
54	activation	_	NN	NN	_	52	pobj	_	_
55	of	_	IN	IN	_	54	prep	_	_
56	naive	_	JJ	JJ	_	58	amod	_	_
57	T	_	NN	NN	_	58	nn	_	_
58	cells	_	NNS	NNS	_	55	pobj	_	_
59	.	_	.	.	_	2	punct	_	_

1	Regulation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	B-cell	_	NN	NN	_	4	nn	_	_
4	commitment	_	NN	NN	_	2	pobj	_	_
5	to	_	TO	TO	_	4	prep	_	_
6	plasma	_	NN	NN	_	7	nn	_	_
7	cells	_	NNS	NNS	_	5	pobj	_	_
8	or	_	CC	CC	_	5	cc	_	_
9	to	_	TO	TO	_	5	conj	_	_
10	memory	_	NN	NN	_	12	nn	_	_
11	B	_	NN	NN	_	12	nn	_	_
12	cells	_	NNS	NNS	_	9	pobj	_	_
13	.	_	.	.	_	1	punct	_	_

1	During	_	IN	IN	_	9	prep	_	_
2	humoral	_	JJ	JJ	_	4	amod	_	_
3	immune	_	JJ	JJ	_	4	amod	_	_
4	responses	_	NNS	NNS	_	1	pobj	_	_
5	,	_	,	,	_	9	punct	_	_
6	B-lymphocyte	_	NN	NN	_	7	nn	_	_
7	activation	_	NN	NN	_	9	nsubjpass	_	_
8	is	_	VBZ	VBZ	_	9	auxpass	_	_
9	followed	_	VBN	VBN	_	0	root	_	_
10	by	_	IN	IN	_	9	prep	_	_
11	differentiation	_	NN	NN	_	10	pobj	_	_
12	along	_	IN	IN	_	11	prep	_	_
13	either	_	CC	CC	_	17	preconj	_	_
14	the	_	DT	DT	_	17	det	_	_
15	plasma	_	NN	NN	_	17	nn	_	_
16	cell	_	NN	NN	_	17	nn	_	_
17	pathway	_	NN	NN	_	12	pobj	_	_
18	or	_	CC	CC	_	17	cc	_	_
19	the	_	DT	DT	_	22	det	_	_
20	memory	_	NN	NN	_	22	nn	_	_
21	B-cell	_	NN	NN	_	22	nn	_	_
22	pathway	_	NN	NN	_	17	conj	_	_
23	.	_	.	.	_	9	punct	_	_

1	Recent	_	JJ	JJ	_	2	amod	_	_
2	studies	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	21	mark	_	_
5	CD40-CD40	_	JJ	JJ	_	6	amod	_	_
6	ligand	_	NN	NN	_	21	nsubj	_	_
7	,	_	,	,	_	6	punct	_	_
8	OX-OX40	_	JJ	JJ	_	9	amod	_	_
9	ligand	_	NN	NN	_	6	appos	_	_
10	,	_	,	,	_	6	punct	_	_
11	a	_	DT	DT	_	12	det	_	_
12	group	_	NN	NN	_	6	appos	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	cytokines	_	NNS	NNS	_	13	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	intracellular	_	JJ	JJ	_	18	amod	_	_
17	transcriptional	_	JJ	JJ	_	18	amod	_	_
18	factors	_	NNS	NNS	_	14	conj	_	_
19	may	_	MD	MD	_	21	aux	_	_
20	all	_	DT	DT	_	21	advmod	_	_
21	contribute	_	VB	VB	_	3	ccomp	_	_
22	to	_	TO	TO	_	21	prep	_	_
23	B-lymphocyte	_	NN	NN	_	25	nn	_	_
24	differentiation	_	NN	NN	_	25	nn	_	_
25	control	_	NN	NN	_	22	pobj	_	_
26	.	_	.	.	_	3	punct	_	_

1	A	_	DT	DT	_	4	det	_	_
2	shortened	_	VBN	VBN	_	4	amod	_	_
3	life	_	NN	NN	_	4	nn	_	_
4	span	_	NN	NN	_	19	nsubjpass	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	EKLF-/-	_	JJ	JJ	_	8	amod	_	_
7	adult	_	JJ	JJ	_	8	amod	_	_
8	erythrocytes	_	NNS	NNS	_	5	pobj	_	_
9	,	_	,	,	_	4	punct	_	_
10	due	_	JJ	JJ	_	4	amod	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	a	_	DT	DT	_	13	det	_	_
13	deficiency	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	beta-globin	_	NN	NN	_	16	nn	_	_
16	chains	_	NNS	NNS	_	14	pobj	_	_
17	,	_	,	,	_	4	punct	_	_
18	is	_	VBZ	VBZ	_	19	auxpass	_	_
19	ameliorated	_	VBN	VBN	_	0	root	_	_
20	by	_	IN	IN	_	19	prep	_	_
21	human	_	JJ	JJ	_	23	amod	_	_
22	gamma-globin	_	NN	NN	_	23	nn	_	_
23	chains	_	NNS	NNS	_	20	pobj	_	_
24	.	_	.	.	_	19	punct	_	_

1	Using	_	VBG	VBG	_	0	root	_	_
2	homologous	_	JJ	JJ	_	3	amod	_	_
3	recombination	_	NN	NN	_	1	dobj	_	_
4	,	_	,	,	_	1	punct	_	_
5	both	_	DT	DT	_	7	dep	_	_
6	EKLF	_	NN	NN	_	7	nn	_	_
7	alleles	_	NNS	NNS	_	17	nsubjpass	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	murine	_	JJ	JJ	_	15	amod	_	_
10	embryonic	_	JJ	JJ	_	15	amod	_	_
11	stem	_	NN	NN	_	15	nn	_	_
12	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
13	ES	_	NN	NN	_	15	nn	_	_
14	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
15	cells	_	NNS	NNS	_	8	pobj	_	_
16	were	_	VBD	VBD	_	17	auxpass	_	_
17	inactivated	_	VBN	VBN	_	1	parataxis	_	_
18	.	_	.	.	_	1	punct	_	_

1	These	_	DT	DT	_	4	det	_	_
2	EKLF-/-	_	JJ	JJ	_	4	amod	_	_
3	ES	_	NN	NN	_	4	nn	_	_
4	cells	_	NNS	NNS	_	6	nsubj	_	_
5	were	_	VBD	VBD	_	6	cop	_	_
6	capable	_	JJ	JJ	_	0	root	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	undergoing	_	VBG	VBG	_	7	pcomp	_	_
9	in	_	FW	FW	_	11	amod	_	_
10	vitro	_	FW	FW	_	9	dep	_	_
11	differentiation	_	NN	NN	_	8	dobj	_	_
12	to	_	TO	TO	_	13	aux	_	_
13	form	_	VB	VB	_	8	vmod	_	_
14	definitive	_	JJ	JJ	_	16	amod	_	_
15	erythroid	_	JJ	JJ	_	16	amod	_	_
16	colonies	_	NNS	NNS	_	13	dobj	_	_
17	that	_	WDT	WDT	_	19	nsubj	_	_
18	were	_	VBD	VBD	_	19	cop	_	_
19	similar	_	JJ	JJ	_	16	rcmod	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	size	_	NN	NN	_	20	pobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	number	_	NN	NN	_	21	conj	_	_
24	to	_	TO	TO	_	19	prep	_	_
25	those	_	DT	DT	_	24	pobj	_	_
26	formed	_	VBN	VBN	_	25	vmod	_	_
27	by	_	IN	IN	_	26	prep	_	_
28	wild-type	_	JJ	JJ	_	30	amod	_	_
29	ES	_	NN	NN	_	30	nn	_	_
30	cells	_	NNS	NNS	_	27	pobj	_	_
31	.	_	.	.	_	6	punct	_	_

1	However	_	RB	RB	_	8	advmod	_	_
2	,	_	,	,	_	8	punct	_	_
3	the	_	DT	DT	_	5	det	_	_
4	EKLF-/-	_	JJ	JJ	_	5	amod	_	_
5	colonies	_	NNS	NNS	_	8	nsubjpass	_	_
6	were	_	VBD	VBD	_	8	auxpass	_	_
7	poorly	_	RB	RB	_	8	advmod	_	_
8	hemoglobinized	_	VBN	VBN	_	0	root	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	enucleated	_	VBN	VBN	_	11	amod	_	_
11	erythrocytes	_	NNS	NNS	_	15	nsubj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	these	_	DT	DT	_	14	det	_	_
14	colonies	_	NNS	NNS	_	12	pobj	_	_
15	contained	_	VBD	VBD	_	8	conj	_	_
16	numerous	_	JJ	JJ	_	18	amod	_	_
17	Heinz	_	NN	NN	_	18	nn	_	_
18	bodies	_	NNS	NNS	_	15	dobj	_	_
19	.	_	.	.	_	8	punct	_	_

1	Reverse	_	JJ	JJ	_	4	amod	_	_
2	transcriptase-polymerase	_	NN	NN	_	4	nn	_	_
3	chain	_	NN	NN	_	4	nn	_	_
4	reaction	_	NN	NN	_	8	nn	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	RT-PCR	_	NN	NN	_	4	appos	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	analyses	_	NNS	NNS	_	9	nsubj	_	_
9	revealed	_	VBD	VBD	_	0	root	_	_
10	that	_	IN	IN	_	18	mark	_	_
11	adult	_	JJ	JJ	_	18	nsubjpass	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	embryonic	_	JJ	JJ	_	15	amod	_	_
14	globin	_	NN	NN	_	15	nn	_	_
15	genes	_	NNS	NNS	_	11	conj	_	_
16	were	_	VBD	VBD	_	18	auxpass	_	_
17	appropriately	_	RB	RB	_	18	advmod	_	_
18	regulated	_	VBN	VBN	_	9	ccomp	_	_
19	,	_	,	,	_	18	punct	_	_
20	with	_	IN	IN	_	18	prep	_	_
21	the	_	DT	DT	_	22	det	_	_
22	exception	_	NN	NN	_	20	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	beta	_	NN	NN	_	25	nn	_	_
25	h1-globin	_	NN	NN	_	23	pobj	_	_
26	,	_	,	,	_	25	punct	_	_
27	which	_	WDT	WDT	_	28	nsubj	_	_
28	continued	_	VBD	VBD	_	25	rcmod	_	_
29	to	_	TO	TO	_	31	aux	_	_
30	be	_	VB	VB	_	31	auxpass	_	_
31	expressed	_	VBN	VBN	_	28	xcomp	_	_
32	at	_	IN	IN	_	31	prep	_	_
33	a	_	DT	DT	_	36	det	_	_
34	very	_	RB	RB	_	35	advmod	_	_
35	low	_	JJ	JJ	_	36	amod	_	_
36	level	_	NN	NN	_	32	pobj	_	_
37	.	_	.	.	_	9	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	ratio	_	NN	NN	_	13	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	adult	_	JJ	JJ	_	6	amod	_	_
5	beta-globin/alpha-globin	_	NN	NN	_	6	nn	_	_
6	mRNA	_	NN	NN	_	3	pobj	_	_
7	in	_	IN	IN	_	2	prep	_	_
8	the	_	DT	DT	_	11	det	_	_
9	mutant	_	JJ	JJ	_	11	amod	_	_
10	ES	_	NN	NN	_	11	nn	_	_
11	cells	_	NNS	NNS	_	7	pobj	_	_
12	was	_	VBD	VBD	_	13	cop	_	_
13	1/15	_	CD	CD	_	0	root	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	that	_	DT	DT	_	14	pobj	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	wild-type	_	JJ	JJ	_	19	amod	_	_
18	ES	_	NN	NN	_	19	nn	_	_
19	cells	_	NNS	NNS	_	16	pobj	_	_
20	.	_	.	.	_	13	punct	_	_

1	When	_	WRB	WRB	_	6	advmod	_	_
2	the	_	DT	DT	_	4	det	_	_
3	EKLF-/-	_	JJ	JJ	_	4	amod	_	_
4	cells	_	NNS	NNS	_	6	nsubjpass	_	_
5	were	_	VBD	VBD	_	6	auxpass	_	_
6	injected	_	VBN	VBN	_	13	advcl	_	_
7	into	_	IN	IN	_	6	prep	_	_
8	blastocysts	_	NNS	NNS	_	7	pobj	_	_
9	,	_	,	,	_	13	punct	_	_
10	they	_	PRP	PRP	_	13	nsubj	_	_
11	did	_	VBD	VBD	_	13	aux	_	_
12	not	_	RB	RB	_	13	neg	_	_
13	contribute	_	VB	VB	_	0	root	_	_
14	at	_	IN	IN	_	13	prep	_	_
15	a	_	DT	DT	_	17	det	_	_
16	detectable	_	JJ	JJ	_	17	amod	_	_
17	level	_	NN	NN	_	14	pobj	_	_
18	to	_	TO	TO	_	13	prep	_	_
19	the	_	DT	DT	_	22	det	_	_
20	mature	_	JJ	JJ	_	22	amod	_	_
21	erythrocyte	_	NN	NN	_	22	nn	_	_
22	compartment	_	NN	NN	_	18	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	26	det	_	_
25	chimeric	_	JJ	JJ	_	26	amod	_	_
26	animals	_	NNS	NNS	_	23	pobj	_	_
27	,	_	,	,	_	13	punct	_	_
28	based	_	VBN	VBN	_	13	prep	_	_
29	on	_	IN	IN	_	28	pcomp	_	_
30	analysis	_	NN	NN	_	29	pobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	glucose	_	NN	NN	_	38	nn	_	_
33	phosphate	_	NN	NN	_	38	nn	_	_
34	isomerase-1	_	NN	NN	_	38	nn	_	_
35	-LRB-	_	-LRB-	-LRB-	_	38	punct	_	_
36	GPI-1	_	NN	NN	_	38	nn	_	_
37	-RRB-	_	-RRB-	-RRB-	_	38	punct	_	_
38	isozymes	_	NNS	NNS	_	31	pobj	_	_
39	and	_	CC	CC	_	38	cc	_	_
40	hemoglobins	_	NNS	NNS	_	38	conj	_	_
41	that	_	WDT	WDT	_	42	nsubj	_	_
42	distinguish	_	VBP	VBP	_	38	rcmod	_	_
43	ES	_	NN	NN	_	45	nn	_	_
44	cell-derived	_	JJ	JJ	_	45	amod	_	_
45	erythrocytes	_	NNS	NNS	_	42	dobj	_	_
46	from	_	IN	IN	_	42	prep	_	_
47	host	_	NN	NN	_	46	pobj	_	_
48	blastocyst-derived	_	JJ	JJ	_	49	amod	_	_
49	erythrocytes	_	NNS	NNS	_	47	dep	_	_
50	.	_	.	.	_	13	punct	_	_

1	In	_	IN	IN	_	16	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	16	punct	_	_
4	semiquantitative	_	JJ	JJ	_	6	amod	_	_
5	RT-PCR	_	NN	NN	_	6	nn	_	_
6	analysis	_	NN	NN	_	16	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	RNA	_	NN	NN	_	7	pobj	_	_
9	from	_	IN	IN	_	8	prep	_	_
10	reticulocytes	_	NNS	NNS	_	9	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	15	det	_	_
13	same	_	JJ	JJ	_	15	amod	_	_
14	chimeric	_	JJ	JJ	_	15	amod	_	_
15	animals	_	NNS	NNS	_	11	pobj	_	_
16	suggested	_	VBD	VBD	_	0	root	_	_
17	that	_	IN	IN	_	23	mark	_	_
18	the	_	DT	DT	_	21	det	_	_
19	ES	_	NN	NN	_	21	nn	_	_
20	cell-derived	_	JJ	JJ	_	21	amod	_	_
21	reticulocytes	_	NNS	NNS	_	23	nsubj	_	_
22	were	_	VBD	VBD	_	23	cop	_	_
23	present	_	JJ	JJ	_	16	ccomp	_	_
24	at	_	IN	IN	_	23	prep	_	_
25	a	_	DT	DT	_	26	det	_	_
26	level	_	NN	NN	_	24	pobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	6	_	CD	CD	_	29	num	_	_
29	%	_	NN	NN	_	27	pobj	_	_
30	to	_	TO	TO	_	29	prep	_	_
31	8	_	CD	CD	_	32	num	_	_
32	%	_	NN	NN	_	30	pobj	_	_
33	.	_	.	.	_	16	punct	_	_

1	This	_	DT	DT	_	2	nsubj	_	_
2	indicated	_	VBD	VBD	_	0	root	_	_
3	that	_	IN	IN	_	12	mark	_	_
4	the	_	DT	DT	_	6	det	_	_
5	EKLF-/-	_	JJ	JJ	_	6	amod	_	_
6	erythrocytes	_	NNS	NNS	_	12	nsubj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	adult	_	JJ	JJ	_	9	amod	_	_
9	animals	_	NNS	NNS	_	7	pobj	_	_
10	must	_	MD	MD	_	12	aux	_	_
11	be	_	VB	VB	_	12	cop	_	_
12	short-lived	_	JJ	JJ	_	2	ccomp	_	_
13	,	_	,	,	_	12	punct	_	_
14	apparently	_	RB	RB	_	12	advmod	_	_
15	due	_	JJ	JJ	_	14	advmod	_	_
16	to	_	TO	TO	_	14	prep	_	_
17	the	_	DT	DT	_	18	det	_	_
18	imbalance	_	NN	NN	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	beta-	_	NN	NN	_	19	pobj	_	_
21	versus	_	CC	CC	_	20	cc	_	_
22	alpha-globin	_	NN	NN	_	20	conj	_	_
23	chains	_	NNS	NNS	_	20	dep	_	_
24	,	_	,	,	_	18	punct	_	_
25	leading	_	VBG	VBG	_	18	dep	_	_
26	to	_	TO	TO	_	25	prep	_	_
27	the	_	DT	DT	_	28	det	_	_
28	precipitation	_	NN	NN	_	26	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	excess	_	JJ	JJ	_	32	amod	_	_
31	alpha-globin	_	NN	NN	_	32	nn	_	_
32	chains	_	NNS	NNS	_	29	pobj	_	_
33	to	_	TO	TO	_	34	aux	_	_
34	form	_	VB	VB	_	28	vmod	_	_
35	Heinz	_	NN	NN	_	36	nn	_	_
36	bodies	_	NNS	NNS	_	34	dobj	_	_
37	.	_	.	.	_	2	punct	_	_

1	Consistent	_	JJ	JJ	_	11	advmod	_	_
2	with	_	IN	IN	_	1	prep	_	_
3	this	_	DT	DT	_	4	det	_	_
4	hypothesis	_	NN	NN	_	2	pobj	_	_
5	,	_	,	,	_	11	punct	_	_
6	the	_	DT	DT	_	9	det	_	_
7	short	_	JJ	JJ	_	9	amod	_	_
8	life	_	NN	NN	_	9	nn	_	_
9	span	_	NN	NN	_	11	nsubjpass	_	_
10	was	_	VBD	VBD	_	11	auxpass	_	_
11	ameliorated	_	VBN	VBN	_	0	root	_	_
12	by	_	IN	IN	_	11	prep	_	_
13	introduction	_	NN	NN	_	12	pobj	_	_
14	into	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	18	det	_	_
16	EKLF-/-	_	JJ	JJ	_	18	amod	_	_
17	ES	_	NN	NN	_	18	nn	_	_
18	cells	_	NNS	NNS	_	14	pobj	_	_
19	of	_	IN	IN	_	13	prep	_	_
20	a	_	DT	DT	_	23	det	_	_
21	human	_	JJ	JJ	_	23	amod	_	_
22	LCR/gamma-globin	_	NN	NN	_	23	nn	_	_
23	gene	_	NN	NN	_	19	pobj	_	_
24	,	_	,	,	_	11	punct	_	_
25	as	_	IN	IN	_	26	mark	_	_
26	evidenced	_	VBN	VBN	_	11	advcl	_	_
27	by	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	29	det	_	_
29	presence	_	NN	NN	_	27	pobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	ES	_	NN	NN	_	33	nn	_	_
32	cell-derived	_	JJ	JJ	_	33	amod	_	_
33	reticulocytes	_	NNS	NNS	_	30	pobj	_	_
34	as	_	RB	RB	_	35	advmod	_	_
35	well	_	RB	RB	_	33	cc	_	_
36	as	_	IN	IN	_	35	mwe	_	_
37	mature	_	JJ	JJ	_	38	amod	_	_
38	erythrocytes	_	NNS	NNS	_	33	conj	_	_
39	in	_	IN	IN	_	29	prep	_	_
40	the	_	DT	DT	_	41	det	_	_
41	blood	_	NN	NN	_	39	pobj	_	_
42	of	_	IN	IN	_	41	prep	_	_
43	the	_	DT	DT	_	45	det	_	_
44	chimeric	_	JJ	JJ	_	45	amod	_	_
45	animals	_	NNS	NNS	_	42	pobj	_	_
46	.	_	.	.	_	11	punct	_	_

1	Induction	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	nuclear	_	JJ	JJ	_	6	amod	_	_
4	factor	_	NN	NN	_	6	nn	_	_
5	kappa	_	NN	NN	_	6	nn	_	_
6	B/Rel	_	NN	NN	_	8	nn	_	_
7	nuclear	_	JJ	JJ	_	8	amod	_	_
8	activity	_	NN	NN	_	2	pobj	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	human	_	JJ	JJ	_	14	amod	_	_
11	peripheral	_	JJ	JJ	_	14	amod	_	_
12	blood	_	NN	NN	_	14	nn	_	_
13	T	_	NN	NN	_	14	nn	_	_
14	lymphocytes	_	NNS	NNS	_	9	pobj	_	_
15	by	_	IN	IN	_	1	prep	_	_
16	anti-HLA	_	JJ	JJ	_	20	amod	_	_
17	class	_	NN	NN	_	20	nn	_	_
18	I	_	CD	CD	_	20	num	_	_
19	monoclonal	_	JJ	JJ	_	20	amod	_	_
20	antibodies	_	NNS	NNS	_	15	pobj	_	_
21	.	_	.	.	_	1	punct	_	_

1	Monoclonal	_	JJ	JJ	_	2	amod	_	_
2	antibodies	_	NNS	NNS	_	13	nsubj	_	_
3	against	_	IN	IN	_	2	prep	_	_
4	either	_	CC	CC	_	5	preconj	_	_
5	monomorphic	_	JJ	JJ	_	3	pobj	_	_
6	or	_	CC	CC	_	5	cc	_	_
7	polymorphic	_	JJ	JJ	_	5	conj	_	_
8	determinants	_	NNS	NNS	_	5	dep	_	_
9	of	_	IN	IN	_	5	prep	_	_
10	class	_	NN	NN	_	12	nn	_	_
11	I	_	CD	CD	_	12	num	_	_
12	antigen	_	NN	NN	_	9	pobj	_	_
13	induced	_	VBD	VBD	_	0	root	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	PBMC	_	NN	NN	_	14	pobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	highly	_	RB	RB	_	20	advmod	_	_
18	purified	_	VBN	VBN	_	20	amod	_	_
19	T	_	NN	NN	_	20	nn	_	_
20	lymphocytes	_	NNS	NNS	_	15	conj	_	_
21	the	_	DT	DT	_	23	det	_	_
22	nuclear	_	JJ	JJ	_	23	amod	_	_
23	activity	_	NN	NN	_	13	dobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	NF-kappa	_	NN	NN	_	27	nn	_	_
26	B/Rel	_	NN	NN	_	27	nn	_	_
27	complexes	_	NNS	NNS	_	24	pobj	_	_
28	.	_	.	.	_	13	punct	_	_

1	These	_	DT	DT	_	2	nsubj	_	_
2	included	_	VBD	VBD	_	0	root	_	_
3	both	_	CC	CC	_	4	preconj	_	_
4	p50/p50	_	NN	NN	_	2	dobj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	p50/p65	_	NN	NN	_	7	nn	_	_
7	dimers	_	NNS	NNS	_	4	conj	_	_
8	,	_	,	,	_	4	punct	_	_
9	recognized	_	VBN	VBN	_	4	vmod	_	_
10	by	_	IN	IN	_	9	prep	_	_
11	specific	_	JJ	JJ	_	12	amod	_	_
12	antibodies	_	NNS	NNS	_	10	pobj	_	_
13	in	_	IN	IN	_	9	prep	_	_
14	EMSA	_	NN	NN	_	13	pobj	_	_
15	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	induced	_	VBN	VBN	_	3	amod	_	_
3	complexes	_	NNS	NNS	_	5	nsubj	_	_
4	were	_	VBD	VBD	_	5	cop	_	_
5	detectable	_	JJ	JJ	_	0	root	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	extracts	_	NNS	NNS	_	6	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	cells	_	NNS	NNS	_	8	pobj	_	_
10	incubated	_	VBN	VBN	_	9	vmod	_	_
11	with	_	IN	IN	_	10	prep	_	_
12	anti-class	_	JJ	JJ	_	15	amod	_	_
13	I	_	CD	CD	_	15	num	_	_
14	monoclonal	_	JJ	JJ	_	15	amod	_	_
15	antibody	_	NN	NN	_	11	pobj	_	_
16	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
17	mAb	_	NN	NN	_	15	appos	_	_
18	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
19	for	_	IN	IN	_	10	prep	_	_
20	1.5	_	CD	CD	_	21	num	_	_
21	h	_	NN	NN	_	19	pobj	_	_
22	;	_	:	:	_	5	punct	_	_
23	the	_	DT	DT	_	24	det	_	_
24	induction	_	NN	NN	_	26	nsubjpass	_	_
25	was	_	VBD	VBD	_	26	auxpass	_	_
26	maximal	_	JJ	JJ	_	5	parataxis	_	_
27	at	_	IN	IN	_	26	prep	_	_
28	5	_	CD	CD	_	29	num	_	_
29	h	_	NN	NN	_	27	pobj	_	_
30	,	_	,	,	_	26	punct	_	_
31	persistent	_	JJ	JJ	_	26	conj	_	_
32	at	_	IN	IN	_	31	prep	_	_
33	16	_	CD	CD	_	34	num	_	_
34	h	_	NN	NN	_	32	pobj	_	_
35	and	_	CC	CC	_	26	cc	_	_
36	no	_	DT	DT	_	37	neg	_	_
37	longer	_	JJR	JJR	_	38	advmod	_	_
38	observed	_	VBN	VBN	_	26	conj	_	_
39	at	_	IN	IN	_	38	prep	_	_
40	40	_	CD	CD	_	41	num	_	_
41	h	_	NN	NN	_	39	pobj	_	_
42	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	mAb	_	NN	NN	_	3	nsubj	_	_
3	failed	_	VBD	VBD	_	0	root	_	_
4	to	_	TO	TO	_	5	aux	_	_
5	induce	_	VB	VB	_	3	xcomp	_	_
6	NF-kappa	_	NN	NN	_	7	nn	_	_
7	B/Rel	_	NN	NN	_	9	nn	_	_
8	nuclear	_	JJ	JJ	_	9	amod	_	_
9	activity	_	NN	NN	_	5	dobj	_	_
10	in	_	IN	IN	_	5	prep	_	_
11	cells	_	NNS	NNS	_	10	pobj	_	_
12	incubated	_	VBN	VBN	_	11	vmod	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	presence	_	NN	NN	_	13	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	3,4-dichloroisocoumarin	_	NN	NN	_	16	pobj	_	_
18	,	_	,	,	_	17	punct	_	_
19	an	_	DT	DT	_	20	det	_	_
20	inhibitor	_	NN	NN	_	17	appos	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	I	_	NN	NN	_	24	nn	_	_
23	kappa	_	NN	NN	_	24	nn	_	_
24	B-alpha	_	NN	NN	_	25	nn	_	_
25	degradation	_	NN	NN	_	21	pobj	_	_
26	.	_	.	.	_	3	punct	_	_

1	Together	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	these	_	DT	DT	_	4	det	_	_
4	results	_	NNS	NNS	_	5	nsubj	_	_
5	suggest	_	VBP	VBP	_	0	root	_	_
6	that	_	IN	IN	_	11	mark	_	_
7	class	_	NN	NN	_	9	nn	_	_
8	I	_	CD	CD	_	9	num	_	_
9	triggering	_	NN	NN	_	11	nsubj	_	_
10	can	_	MD	MD	_	11	aux	_	_
11	induce	_	VB	VB	_	5	ccomp	_	_
12	the	_	DT	DT	_	13	det	_	_
13	activity	_	NN	NN	_	11	dobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	NF-kappa	_	NN	NN	_	16	nn	_	_
16	B/Rel	_	NN	NN	_	18	nn	_	_
17	nuclear	_	JJ	JJ	_	18	amod	_	_
18	activity	_	NN	NN	_	14	pobj	_	_
19	in	_	IN	IN	_	11	prep	_	_
20	peripheral	_	JJ	JJ	_	23	amod	_	_
21	blood	_	NN	NN	_	23	nn	_	_
22	T	_	NN	NN	_	23	nn	_	_
23	lymphocytes	_	NNS	NNS	_	19	pobj	_	_
24	,	_	,	,	_	11	punct	_	_
25	thereby	_	RB	RB	_	26	advmod	_	_
26	modulating	_	VBG	VBG	_	11	vmod	_	_
27	the	_	DT	DT	_	28	det	_	_
28	expression	_	NN	NN	_	26	dobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	genes	_	NNS	NNS	_	29	pobj	_	_
31	regulated	_	VBN	VBN	_	30	vmod	_	_
32	by	_	IN	IN	_	31	prep	_	_
33	these	_	DT	DT	_	35	det	_	_
34	transcription	_	NN	NN	_	35	nn	_	_
35	factors	_	NNS	NNS	_	32	pobj	_	_
36	.	_	.	.	_	5	punct	_	_

1	EBF	_	NN	NN	_	4	nsubj	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	E47	_	NN	NN	_	1	conj	_	_
4	collaborate	_	VBP	VBP	_	0	root	_	_
5	to	_	TO	TO	_	6	aux	_	_
6	induce	_	VB	VB	_	4	xcomp	_	_
7	expression	_	NN	NN	_	6	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	15	det	_	_
10	endogenous	_	JJ	JJ	_	15	amod	_	_
11	immunoglobulin	_	NN	NN	_	15	nn	_	_
12	surrogate	_	JJ	JJ	_	15	amod	_	_
13	light	_	JJ	JJ	_	15	amod	_	_
14	chain	_	NN	NN	_	15	nn	_	_
15	genes	_	NNS	NNS	_	8	pobj	_	_
16	.	_	.	.	_	4	punct	_	_

1	Early	_	JJ	JJ	_	4	amod	_	_
2	B	_	NN	NN	_	4	nn	_	_
3	cell	_	NN	NN	_	4	nn	_	_
4	factor	_	NN	NN	_	10	nsubj	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	EBF	_	NN	NN	_	4	appos	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	and	_	CC	CC	_	4	cc	_	_
9	E47	_	NN	NN	_	4	conj	_	_
10	participate	_	VBP	VBP	_	0	root	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	transcriptional	_	JJ	JJ	_	14	amod	_	_
14	control	_	NN	NN	_	11	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	early	_	JJ	JJ	_	19	amod	_	_
17	B	_	NN	NN	_	19	nn	_	_
18	lymphocyte	_	NN	NN	_	19	nn	_	_
19	differentiation	_	NN	NN	_	15	pobj	_	_
20	.	_	.	.	_	10	punct	_	_

1	With	_	IN	IN	_	15	prep	_	_
2	the	_	DT	DT	_	3	det	_	_
3	aim	_	NN	NN	_	1	pobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	identifying	_	VBG	VBG	_	4	pcomp	_	_
6	genetic	_	JJ	JJ	_	7	amod	_	_
7	targets	_	NNS	NNS	_	5	dobj	_	_
8	for	_	IN	IN	_	7	prep	_	_
9	these	_	DT	DT	_	11	det	_	_
10	transcription	_	NN	NN	_	11	nn	_	_
11	factors	_	NNS	NNS	_	8	pobj	_	_
12	,	_	,	,	_	15	punct	_	_
13	we	_	PRP	PRP	_	15	nsubj	_	_
14	stably	_	RB	RB	_	15	advmod	_	_
15	transfected	_	VBD	VBD	_	0	root	_	_
16	cDNAs	_	NNS	NNS	_	15	dobj	_	_
17	encoding	_	VBG	VBG	_	16	vmod	_	_
18	EBF	_	NN	NN	_	17	dobj	_	_
19	or	_	CC	CC	_	18	cc	_	_
20	a	_	DT	DT	_	22	det	_	_
21	covalent	_	JJ	JJ	_	22	amod	_	_
22	homodimer	_	NN	NN	_	18	conj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	E47	_	NN	NN	_	23	pobj	_	_
25	,	_	,	,	_	15	punct	_	_
26	individually	_	RB	RB	_	15	advmod	_	_
27	or	_	CC	CC	_	26	cc	_	_
28	together	_	RB	RB	_	26	conj	_	_
29	,	_	,	,	_	15	punct	_	_
30	into	_	IN	IN	_	15	prep	_	_
31	immature	_	JJ	JJ	_	34	amod	_	_
32	hematopoietic	_	JJ	JJ	_	34	amod	_	_
33	Ba/F3	_	NN	NN	_	34	nn	_	_
34	cells	_	NNS	NNS	_	30	pobj	_	_
35	,	_	,	,	_	34	punct	_	_
36	which	_	WDT	WDT	_	37	nsubj	_	_
37	lack	_	VBP	VBP	_	34	rcmod	_	_
38	both	_	DT	DT	_	39	det	_	_
39	factors	_	NNS	NNS	_	37	dobj	_	_
40	.	_	.	.	_	15	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	combination	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	7	punct	_	_
4	EBF	_	NN	NN	_	7	nsubj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	E47	_	NN	NN	_	4	conj	_	_
7	induce	_	VBP	VBP	_	0	root	_	_
8	efficient	_	JJ	JJ	_	9	amod	_	_
9	expression	_	NN	NN	_	7	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	17	det	_	_
12	endogenous	_	JJ	JJ	_	17	amod	_	_
13	immunoglobulin	_	NN	NN	_	17	nn	_	_
14	surrogate	_	JJ	JJ	_	17	amod	_	_
15	light	_	JJ	JJ	_	17	amod	_	_
16	chain	_	NN	NN	_	17	nn	_	_
17	genes	_	NNS	NNS	_	10	pobj	_	_
18	,	_	,	,	_	17	punct	_	_
19	lambda5	_	NN	NN	_	17	appos	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	VpreB	_	NN	NN	_	19	conj	_	_
22	,	_	,	,	_	7	punct	_	_
23	whereas	_	IN	IN	_	28	mark	_	_
24	other	_	JJ	JJ	_	27	amod	_	_
25	pre-B	_	JJ	JJ	_	27	amod	_	_
26	cell-specific	_	JJ	JJ	_	27	amod	_	_
27	genes	_	NNS	NNS	_	28	nsubj	_	_
28	remain	_	VBP	VBP	_	7	advcl	_	_
29	silent	_	JJ	JJ	_	28	acomp	_	_
30	.	_	.	.	_	7	punct	_	_

1	Multiple	_	JJ	JJ	_	2	advmod	_	_
2	functionally	_	RB	RB	_	3	advmod	_	_
3	important	_	JJ	JJ	_	4	amod	_	_
4	EBF	_	NN	NN	_	10	nsubjpass	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	E47	_	NN	NN	_	4	conj	_	_
7	binding	_	NN	NN	_	8	nn	_	_
8	sites	_	NNS	NNS	_	4	dep	_	_
9	were	_	VBD	VBD	_	10	auxpass	_	_
10	identified	_	VBN	VBN	_	0	root	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	15	det	_	_
13	lambda5	_	NN	NN	_	15	nn	_	_
14	promoter/enhancer	_	NN	NN	_	15	nn	_	_
15	region	_	NN	NN	_	11	pobj	_	_
16	,	_	,	,	_	10	punct	_	_
17	indicating	_	VBG	VBG	_	10	vmod	_	_
18	that	_	IN	IN	_	24	mark	_	_
19	lambda5	_	NN	NN	_	24	nsubj	_	_
20	is	_	VBZ	VBZ	_	24	cop	_	_
21	a	_	DT	DT	_	24	det	_	_
22	direct	_	JJ	JJ	_	24	amod	_	_
23	genetic	_	JJ	JJ	_	22	dep	_	_
24	target	_	NN	NN	_	17	ccomp	_	_
25	for	_	IN	IN	_	24	prep	_	_
26	these	_	DT	DT	_	28	det	_	_
27	transcription	_	NN	NN	_	28	nn	_	_
28	factors	_	NNS	NNS	_	25	pobj	_	_
29	.	_	.	.	_	10	punct	_	_

1	Taken	_	VBN	VBN	_	0	root	_	_
2	together	_	RB	RB	_	1	advmod	_	_
3	,	_	,	,	_	1	punct	_	_
4	these	_	DT	DT	_	5	det	_	_
5	data	_	NNS	NNS	_	6	nsubj	_	_
6	suggest	_	VBP	VBP	_	1	parataxis	_	_
7	that	_	IN	IN	_	11	mark	_	_
8	EBF	_	NN	NN	_	11	nsubj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	E47	_	NN	NN	_	8	conj	_	_
11	synergize	_	VBP	VBP	_	6	ccomp	_	_
12	to	_	TO	TO	_	13	aux	_	_
13	activate	_	VB	VB	_	11	xcomp	_	_
14	expression	_	NN	NN	_	13	dobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	a	_	DT	DT	_	17	det	_	_
17	subset	_	NN	NN	_	15	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	genes	_	NNS	NNS	_	18	pobj	_	_
20	that	_	WDT	WDT	_	21	nsubj	_	_
21	define	_	VBP	VBP	_	17	rcmod	_	_
22	an	_	DT	DT	_	24	det	_	_
23	early	_	JJ	JJ	_	24	amod	_	_
24	stage	_	NN	NN	_	21	dobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	29	det	_	_
27	B	_	NN	NN	_	29	nn	_	_
28	cell	_	NN	NN	_	29	nn	_	_
29	lineage	_	NN	NN	_	25	pobj	_	_
30	.	_	.	.	_	1	punct	_	_

1	Nuclear	_	JJ	JJ	_	2	amod	_	_
2	levels	_	NNS	NNS	_	5	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	NF-kappaB	_	NN	NN	_	3	pobj	_	_
5	correlate	_	VBP	VBP	_	0	root	_	_
6	with	_	IN	IN	_	5	prep	_	_
7	syncytium-forming	_	JJ	JJ	_	8	amod	_	_
8	capacity	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	8e51	_	NN	NN	_	11	nn	_	_
11	cells	_	NNS	NNS	_	9	pobj	_	_
12	,	_	,	,	_	11	punct	_	_
13	expressing	_	VBG	VBG	_	11	vmod	_	_
14	a	_	DT	DT	_	17	det	_	_
15	defective	_	JJ	JJ	_	17	amod	_	_
16	HIV	_	NN	NN	_	17	nn	_	_
17	virus	_	NN	NN	_	13	dobj	_	_
18	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	double	_	JJ	JJ	_	4	amod	_	_
3	NF-kappaB	_	NN	NN	_	4	nn	_	_
4	site	_	NN	NN	_	19	nsubjpass	_	_
5	identified	_	VBN	VBN	_	4	vmod	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	LTR	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	13	det	_	_
11	human	_	JJ	JJ	_	13	amod	_	_
12	immunodeficiency	_	NN	NN	_	13	nn	_	_
13	virus-1	_	NN	NN	_	9	pobj	_	_
14	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
15	HIV-1	_	NN	NN	_	13	appos	_	_
16	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
17	has	_	VBZ	VBZ	_	19	aux	_	_
18	been	_	VBN	VBN	_	19	auxpass	_	_
19	demonstrated	_	VBN	VBN	_	0	root	_	_
20	to	_	TO	TO	_	22	aux	_	_
21	be	_	VB	VB	_	22	cop	_	_
22	necessary	_	JJ	JJ	_	19	xcomp	_	_
23	for	_	IN	IN	_	22	prep	_	_
24	efficient	_	JJ	JJ	_	26	amod	_	_
25	viral	_	JJ	JJ	_	26	amod	_	_
26	transcription	_	NN	NN	_	23	pobj	_	_
27	.	_	.	.	_	19	punct	_	_

1	In	_	IN	IN	_	5	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	report	_	NN	NN	_	1	pobj	_	_
4	we	_	PRP	PRP	_	5	nsubj	_	_
5	present	_	VBP	VBP	_	0	root	_	_
6	the	_	DT	DT	_	7	det	_	_
7	characterisation	_	NN	NN	_	5	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	NF-kappaB	_	NN	NN	_	10	nn	_	_
10	subunits	_	NNS	NNS	_	8	pobj	_	_
11	engaged	_	VBN	VBN	_	10	vmod	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	complexes	_	NNS	NNS	_	12	pobj	_	_
14	binding	_	VBG	VBG	_	13	vmod	_	_
15	to	_	TO	TO	_	14	prep	_	_
16	the	_	DT	DT	_	19	det	_	_
17	HIV-1	_	NN	NN	_	19	nn	_	_
18	NF-kappaB	_	NN	NN	_	19	nn	_	_
19	site	_	NN	NN	_	15	pobj	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	human	_	JJ	JJ	_	23	amod	_	_
22	8e51	_	NN	NN	_	23	nn	_	_
23	T-cells	_	NNS	NNS	_	20	pobj	_	_
24	,	_	,	,	_	23	punct	_	_
25	that	_	WDT	WDT	_	26	nsubj	_	_
26	harbour	_	VBP	VBP	_	23	rcmod	_	_
27	a	_	DT	DT	_	29	det	_	_
28	defective	_	JJ	JJ	_	29	amod	_	_
29	HIV-1	_	NN	NN	_	26	dobj	_	_
30	.	_	.	.	_	5	punct	_	_

1	At	_	IN	IN	_	3	quantmod	_	_
2	least	_	JJS	JJS	_	1	mwe	_	_
3	four	_	CD	CD	_	7	num	_	_
4	different	_	JJ	JJ	_	7	amod	_	_
5	specific	_	JJ	JJ	_	4	dep	_	_
6	NF-kappaB	_	NN	NN	_	7	nn	_	_
7	complexes	_	NNS	NNS	_	9	nsubj	_	_
8	are	_	VBP	VBP	_	9	cop	_	_
9	present	_	JJ	JJ	_	0	root	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	nucleus	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	these	_	DT	DT	_	15	det	_	_
15	cells	_	NNS	NNS	_	13	pobj	_	_
16	.	_	.	.	_	9	punct	_	_

1	With	_	IN	IN	_	9	prep	_	_
2	the	_	DT	DT	_	3	det	_	_
3	use	_	NN	NN	_	1	pobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	specific	_	JJ	JJ	_	6	amod	_	_
6	antibodies	_	NNS	NNS	_	4	pobj	_	_
7	we	_	PRP	PRP	_	9	nsubj	_	_
8	have	_	VBP	VBP	_	9	aux	_	_
9	determined	_	VBN	VBN	_	0	root	_	_
10	the	_	DT	DT	_	11	det	_	_
11	composition	_	NN	NN	_	9	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	each	_	DT	DT	_	14	det	_	_
14	complex	_	NN	NN	_	12	pobj	_	_
15	using	_	VBG	VBG	_	9	xcomp	_	_
16	electrophoretic	_	JJ	JJ	_	19	amod	_	_
17	mobility	_	NN	NN	_	19	nn	_	_
18	shift	_	NN	NN	_	19	nn	_	_
19	assays	_	NNS	NNS	_	15	dobj	_	_
20	.	_	.	.	_	9	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	show	_	VBP	VBP	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	presence	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	several	_	JJ	JJ	_	10	amod	_	_
8	NF-kappaB	_	NN	NN	_	10	nn	_	_
9	family	_	NN	NN	_	10	nn	_	_
10	members	_	NNS	NNS	_	6	pobj	_	_
11	,	_	,	,	_	10	punct	_	_
12	with	_	IN	IN	_	3	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	transactivating	_	VBG	VBG	_	15	amod	_	_
15	RelA	_	NN	NN	_	17	nsubjpass	_	_
16	being	_	VBG	VBG	_	17	auxpass	_	_
17	engaged	_	VBN	VBN	_	12	pcomp	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	multiple	_	JJ	JJ	_	20	amod	_	_
20	complexes	_	NNS	NNS	_	18	pobj	_	_
21	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	importance	_	NN	NN	_	11	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	NF-kappaB	_	NN	NN	_	5	nn	_	_
5	complexes	_	NNS	NNS	_	3	pobj	_	_
6	in	_	IN	IN	_	2	prep	_	_
7	viral	_	JJ	JJ	_	8	amod	_	_
8	functions	_	NNS	NNS	_	6	pobj	_	_
9	has	_	VBZ	VBZ	_	11	aux	_	_
10	been	_	VBN	VBN	_	11	auxpass	_	_
11	established	_	VBN	VBN	_	0	root	_	_
12	comparing	_	VBG	VBG	_	11	xcomp	_	_
13	the	_	DT	DT	_	14	det	_	_
14	level	_	NN	NN	_	12	dobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	NF-kappaB	_	NN	NN	_	18	nn	_	_
17	DNA-binding	_	JJ	JJ	_	18	amod	_	_
18	complexes	_	NNS	NNS	_	15	pobj	_	_
19	with	_	IN	IN	_	12	prep	_	_
20	syncytia-forming	_	JJ	JJ	_	21	amod	_	_
21	activity	_	NN	NN	_	19	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	8e51	_	NN	NN	_	24	nn	_	_
24	cells	_	NNS	NNS	_	22	pobj	_	_
25	.	_	.	.	_	11	punct	_	_

1	In	_	IN	IN	_	14	prep	_	_
2	fact	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	14	punct	_	_
4	8e51	_	NN	NN	_	5	nn	_	_
5	cells	_	NNS	NNS	_	14	nsubjpass	_	_
6	that	_	WDT	WDT	_	9	nsubj	_	_
7	had	_	VBD	VBD	_	9	aux	_	_
8	almost	_	RB	RB	_	9	advmod	_	_
9	lost	_	VBN	VBN	_	5	rcmod	_	_
10	their	_	PRP$	PRP$	_	12	poss	_	_
11	syncytia-forming	_	JJ	JJ	_	12	amod	_	_
12	capacity	_	NN	NN	_	9	dobj	_	_
13	were	_	VBD	VBD	_	14	auxpass	_	_
14	found	_	VBN	VBN	_	0	root	_	_
15	to	_	TO	TO	_	16	aux	_	_
16	contain	_	VB	VB	_	14	xcomp	_	_
17	at	_	IN	IN	_	20	quantmod	_	_
18	least	_	JJS	JJS	_	17	mwe	_	_
19	10	_	CD	CD	_	20	number	_	_
20	times	_	NNS	NNS	_	22	dep	_	_
21	less	_	RBR	RBR	_	20	quantmod	_	_
22	active	_	JJ	JJ	_	25	dep	_	_
23	NF-kappaB	_	NN	NN	_	25	nn	_	_
24	DNA-binding	_	JJ	JJ	_	25	amod	_	_
25	complex	_	NN	NN	_	16	dobj	_	_
26	than	_	IN	IN	_	30	mark	_	_
27	the	_	DT	DT	_	30	det	_	_
28	actively	_	RB	RB	_	30	advmod	_	_
29	fusing	_	VBG	VBG	_	30	amod	_	_
30	cells	_	NNS	NNS	_	25	dep	_	_
31	.	_	.	.	_	14	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	correlation	_	NN	NN	_	4	nsubj	_	_
3	is	_	VBZ	VBZ	_	4	cop	_	_
4	specific	_	JJ	JJ	_	0	root	_	_
5	as	_	IN	IN	_	17	mark	_	_
6	the	_	DT	DT	_	7	det	_	_
7	level	_	NN	NN	_	17	nsubj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	at	_	IN	IN	_	11	quantmod	_	_
10	least	_	JJS	JJS	_	9	mwe	_	_
11	three	_	CD	CD	_	14	num	_	_
12	other	_	JJ	JJ	_	14	amod	_	_
13	transcription	_	NN	NN	_	14	nn	_	_
14	factors	_	NNS	NNS	_	8	pobj	_	_
15	did	_	VBD	VBD	_	17	aux	_	_
16	not	_	RB	RB	_	17	neg	_	_
17	change	_	VB	VB	_	4	advcl	_	_
18	.	_	.	.	_	4	punct	_	_

1	Differential	_	JJ	JJ	_	2	amod	_	_
2	interaction	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	nuclear	_	JJ	JJ	_	5	amod	_	_
5	factors	_	NNS	NNS	_	3	pobj	_	_
6	with	_	IN	IN	_	2	prep	_	_
7	the	_	DT	DT	_	10	det	_	_
8	leukocyte-specific	_	JJ	JJ	_	10	amod	_	_
9	pp52	_	NN	NN	_	10	nn	_	_
10	promoter	_	NN	NN	_	6	pobj	_	_
11	in	_	IN	IN	_	2	prep	_	_
12	B	_	NN	NN	_	11	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	T	_	NN	NN	_	12	conj	_	_
15	cells	_	NNS	NNS	_	12	dep	_	_
16	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	11	det	_	_
2	leukocyte-specific	_	JJ	JJ	_	11	amod	_	_
3	,	_	,	,	_	2	punct	_	_
4	cytoskeleton-binding	_	JJ	JJ	_	2	dep	_	_
5	pp52	_	NN	NN	_	11	nn	_	_
6	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
7	LSP-1	_	NN	NN	_	5	dep	_	_
8	,	_	,	,	_	7	punct	_	_
9	WP-34	_	NN	NN	_	7	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
11	protein	_	NN	NN	_	14	nsubjpass	_	_
12	is	_	VBZ	VBZ	_	14	auxpass	_	_
13	widely	_	RB	RB	_	14	advmod	_	_
14	expressed	_	VBN	VBN	_	0	root	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	multiple	_	JJ	JJ	_	18	amod	_	_
17	leukocyte	_	NN	NN	_	18	nn	_	_
18	lineages	_	NNS	NNS	_	15	pobj	_	_
19	,	_	,	,	_	18	punct	_	_
20	including	_	VBG	VBG	_	18	prep	_	_
21	B	_	NN	NN	_	20	pobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	T	_	NN	NN	_	21	conj	_	_
24	lymphocytes	_	NNS	NNS	_	21	dep	_	_
25	,	_	,	,	_	21	punct	_	_
26	granulocytes	_	NNS	NNS	_	21	conj	_	_
27	,	_	,	,	_	21	punct	_	_
28	and	_	CC	CC	_	21	cc	_	_
29	macrophages	_	NNS	NNS	_	21	conj	_	_
30	.	_	.	.	_	14	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	previously	_	RB	RB	_	3	advmod	_	_
3	detected	_	VBD	VBD	_	0	root	_	_
4	a	_	DT	DT	_	6	det	_	_
5	tissue-specific	_	JJ	JJ	_	6	amod	_	_
6	promoter	_	NN	NN	_	3	dobj	_	_
7	preceding	_	VBG	VBG	_	6	vmod	_	_
8	the	_	DT	DT	_	9	det	_	_
9	exon	_	NN	NN	_	7	dobj	_	_
10	encoding	_	VBG	VBG	_	9	vmod	_	_
11	the	_	DT	DT	_	13	det	_	_
12	N	_	NN	NN	_	13	nn	_	_
13	terminus	_	NN	NN	_	10	dobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	18	det	_	_
16	pp52	_	NN	NN	_	18	nn	_	_
17	leukocyte	_	NN	NN	_	18	nn	_	_
18	protein	_	NN	NN	_	14	pobj	_	_
19	.	_	.	.	_	3	punct	_	_

1	Here	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	describe	_	VBP	VBP	_	0	root	_	_
4	the	_	DT	DT	_	6	det	_	_
5	functional	_	JJ	JJ	_	6	amod	_	_
6	characterization	_	NN	NN	_	3	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	this	_	DT	DT	_	9	det	_	_
9	promoter	_	NN	NN	_	7	pobj	_	_
10	and	_	CC	CC	_	6	cc	_	_
11	identification	_	NN	NN	_	6	conj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	14	det	_	_
14	factors	_	NNS	NNS	_	12	pobj	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	B	_	NN	NN	_	15	pobj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	T	_	NN	NN	_	16	conj	_	_
19	cells	_	NNS	NNS	_	16	dep	_	_
20	that	_	WDT	WDT	_	21	nsubj	_	_
21	regulate	_	VBP	VBP	_	16	rcmod	_	_
22	its	_	PRP$	PRP$	_	23	poss	_	_
23	activity	_	NN	NN	_	21	dobj	_	_
24	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	pp52	_	NN	NN	_	3	nn	_	_
3	promoter	_	NN	NN	_	4	nsubj	_	_
4	contains	_	VBZ	VBZ	_	0	root	_	_
5	an	_	DT	DT	_	6	det	_	_
6	initiator	_	NN	NN	_	4	dobj	_	_
7	specifying	_	VBG	VBG	_	6	vmod	_	_
8	the	_	DT	DT	_	11	det	_	_
9	unique	_	JJ	JJ	_	11	amod	_	_
10	5'	_	JJ	JJ	_	11	amod	_	_
11	terminus	_	NN	NN	_	7	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	pp52	_	NN	NN	_	14	nn	_	_
14	mRNA	_	NN	NN	_	12	pobj	_	_
15	,	_	,	,	_	6	punct	_	_
16	tandem	_	JJ	JJ	_	17	amod	_	_
17	pairs	_	NNS	NNS	_	6	conj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	Ets	_	NN	NN	_	18	pobj	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	SP1	_	NN	NN	_	19	conj	_	_
22	motifs	_	NNS	NNS	_	19	dep	_	_
23	,	_	,	,	_	6	punct	_	_
24	and	_	CC	CC	_	6	cc	_	_
25	a	_	DT	DT	_	28	det	_	_
26	lone	_	JJ	JJ	_	28	amod	_	_
27	C/EBP	_	NN	NN	_	28	nn	_	_
28	motif	_	NN	NN	_	6	conj	_	_
29	.	_	.	.	_	4	punct	_	_

1	All	_	PDT	PDT	_	3	predet	_	_
2	these	_	DT	DT	_	3	det	_	_
3	motifs	_	NNS	NNS	_	5	nsubj	_	_
4	are	_	VBP	VBP	_	5	cop	_	_
5	essential	_	JJ	JJ	_	0	root	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	collectively	_	RB	RB	_	8	advmod	_	_
8	control	_	VBP	VBP	_	5	conj	_	_
9	transcriptional	_	JJ	JJ	_	10	amod	_	_
10	activity	_	NN	NN	_	8	dobj	_	_
11	.	_	.	.	_	5	punct	_	_

1	DNA	_	NN	NN	_	3	nn	_	_
2	binding	_	NN	NN	_	3	nn	_	_
3	studies	_	NNS	NNS	_	8	nsubj	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	Ab	_	NN	NN	_	7	nn	_	_
6	supershift	_	NN	NN	_	7	nn	_	_
7	assays	_	NNS	NNS	_	3	conj	_	_
8	revealed	_	VBD	VBD	_	0	root	_	_
9	that	_	IN	IN	_	14	mark	_	_
10	different	_	JJ	JJ	_	11	amod	_	_
11	combinations	_	NNS	NNS	_	14	nsubj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	factors	_	NNS	NNS	_	12	pobj	_	_
14	interact	_	VBP	VBP	_	8	ccomp	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	these	_	DT	DT	_	17	det	_	_
17	motifs	_	NNS	NNS	_	15	pobj	_	_
18	in	_	IN	IN	_	14	prep	_	_
19	B	_	NN	NN	_	20	nn	_	_
20	cells	_	NNS	NNS	_	18	pobj	_	_
21	vs	_	CC	CC	_	20	cc	_	_
22	T	_	NN	NN	_	23	nn	_	_
23	cells	_	NNS	NNS	_	20	conj	_	_
24	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	Ets	_	NN	NN	_	3	nn	_	_
3	motifs	_	NNS	NNS	_	6	nsubjpass	_	_
4	are	_	VBP	VBP	_	6	auxpass	_	_
5	preferentially	_	RB	RB	_	6	advmod	_	_
6	bound	_	VBN	VBN	_	0	root	_	_
7	by	_	IN	IN	_	6	prep	_	_
8	PU-1	_	NN	NN	_	7	pobj	_	_
9	in	_	IN	IN	_	6	prep	_	_
10	B	_	NN	NN	_	12	nn	_	_
11	cell	_	NN	NN	_	12	nn	_	_
12	extracts	_	NNS	NNS	_	9	pobj	_	_
13	from	_	IN	IN	_	12	prep	_	_
14	all	_	DT	DT	_	15	det	_	_
15	stages	_	NNS	NNS	_	13	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	development	_	NN	NN	_	16	pobj	_	_
18	,	_	,	,	_	6	punct	_	_
19	whereas	_	IN	IN	_	25	mark	_	_
20	a	_	DT	DT	_	24	det	_	_
21	different	_	JJ	JJ	_	24	amod	_	_
22	Ets	_	NN	NN	_	24	nn	_	_
23	family	_	NN	NN	_	24	nn	_	_
24	member	_	NN	NN	_	25	nsubj	_	_
25	reacts	_	VBZ	VBZ	_	6	advcl	_	_
26	with	_	IN	IN	_	25	prep	_	_
27	these	_	DT	DT	_	28	det	_	_
28	motifs	_	NNS	NNS	_	26	pobj	_	_
29	in	_	IN	IN	_	25	prep	_	_
30	T	_	NN	NN	_	32	nn	_	_
31	cell	_	NN	NN	_	32	nn	_	_
32	extracts	_	NNS	NNS	_	29	pobj	_	_
33	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	C/EBP	_	NN	NN	_	3	nn	_	_
3	motif	_	NN	NN	_	5	nsubjpass	_	_
4	is	_	VBZ	VBZ	_	5	auxpass	_	_
5	bound	_	VBN	VBN	_	0	root	_	_
6	by	_	IN	IN	_	5	prep	_	_
7	Ig/EBP-1	_	NN	NN	_	6	pobj	_	_
8	in	_	IN	IN	_	5	prep	_	_
9	pre-B	_	JJ	JJ	_	10	amod	_	_
10	cell	_	NN	NN	_	8	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	T	_	NN	NN	_	13	nn	_	_
13	cell	_	NN	NN	_	10	conj	_	_
14	extracts	_	NNS	NNS	_	10	dep	_	_
15	,	_	,	,	_	5	punct	_	_
16	but	_	CC	CC	_	5	cc	_	_
17	is	_	VBZ	VBZ	_	18	auxpass	_	_
18	replaced	_	VBN	VBN	_	5	conj	_	_
19	by	_	IN	IN	_	18	prep	_	_
20	nuclear	_	JJ	JJ	_	21	amod	_	_
21	factor-IL-6beta	_	NN	NN	_	19	pobj	_	_
22	or	_	CC	CC	_	21	cc	_	_
23	a	_	DT	DT	_	26	det	_	_
24	nuclear	_	JJ	JJ	_	26	amod	_	_
25	factor-IL-6beta-Ig/EBP-1	_	NN	NN	_	26	nn	_	_
26	heterodimer	_	NN	NN	_	21	conj	_	_
27	in	_	IN	IN	_	18	prep	_	_
28	plasmacytoma	_	NN	NN	_	30	nn	_	_
29	cell	_	NN	NN	_	30	nn	_	_
30	extracts	_	NNS	NNS	_	27	pobj	_	_
31	.	_	.	.	_	5	punct	_	_

1	Despite	_	IN	IN	_	13	prep	_	_
2	its	_	PRP$	PRP$	_	4	poss	_	_
3	reported	_	VBN	VBN	_	4	amod	_	_
4	role	_	NN	NN	_	1	pobj	_	_
5	as	_	IN	IN	_	4	prep	_	_
6	a	_	DT	DT	_	8	det	_	_
7	negative	_	JJ	JJ	_	8	amod	_	_
8	regulator	_	NN	NN	_	5	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	transcription	_	NN	NN	_	9	pobj	_	_
11	,	_	,	,	_	13	punct	_	_
12	Ig/EBP-1	_	NN	NN	_	13	nsubj	_	_
13	appears	_	VBZ	VBZ	_	0	root	_	_
14	to	_	TO	TO	_	15	aux	_	_
15	exert	_	VB	VB	_	13	xcomp	_	_
16	a	_	DT	DT	_	18	det	_	_
17	stimulatory	_	JJ	JJ	_	18	amod	_	_
18	effect	_	NN	NN	_	15	dobj	_	_
19	on	_	IN	IN	_	15	prep	_	_
20	this	_	DT	DT	_	21	det	_	_
21	promoter	_	NN	NN	_	19	pobj	_	_
22	.	_	.	.	_	13	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	findings	_	NNS	NNS	_	3	nsubj	_	_
3	reveal	_	VBP	VBP	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	features	_	NNS	NNS	_	3	dobj	_	_
6	controlling	_	VBG	VBG	_	5	vmod	_	_
7	the	_	DT	DT	_	9	det	_	_
8	pp52	_	NN	NN	_	9	nn	_	_
9	promoter	_	NN	NN	_	6	dobj	_	_
10	in	_	IN	IN	_	6	prep	_	_
11	B	_	NN	NN	_	10	pobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	T	_	NN	NN	_	11	conj	_	_
14	cells	_	NNS	NNS	_	11	dep	_	_
15	and	_	CC	CC	_	3	cc	_	_
16	provide	_	VBP	VBP	_	3	conj	_	_
17	the	_	DT	DT	_	18	det	_	_
18	foundation	_	NN	NN	_	16	dobj	_	_
19	for	_	IN	IN	_	18	prep	_	_
20	determining	_	VBG	VBG	_	19	pcomp	_	_
21	the	_	DT	DT	_	22	det	_	_
22	regulation	_	NN	NN	_	20	dobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	this	_	DT	DT	_	25	det	_	_
25	promoter	_	NN	NN	_	23	pobj	_	_
26	in	_	IN	IN	_	22	prep	_	_
27	other	_	JJ	JJ	_	29	amod	_	_
28	leukocyte	_	NN	NN	_	29	nn	_	_
29	lineages	_	NNS	NNS	_	26	pobj	_	_
30	.	_	.	.	_	3	punct	_	_

1	Synthetic	_	JJ	JJ	_	2	amod	_	_
2	glucocorticoids	_	NNS	NNS	_	9	nsubj	_	_
3	that	_	WDT	WDT	_	4	nsubj	_	_
4	dissociate	_	VBP	VBP	_	2	rcmod	_	_
5	transactivation	_	NN	NN	_	4	dobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	AP-1	_	NN	NN	_	8	nn	_	_
8	transrepression	_	NN	NN	_	5	conj	_	_
9	exhibit	_	VBP	VBP	_	0	root	_	_
10	antiinflammatory	_	JJ	JJ	_	11	amod	_	_
11	activity	_	NN	NN	_	9	dobj	_	_
12	in	_	FW	FW	_	13	nn	_	_
13	vivo	_	FW	FW	_	9	advmod	_	_
14	.	_	.	.	_	9	punct	_	_

1	Some	_	DT	DT	_	12	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	9	det	_	_
4	most	_	RBS	RBS	_	5	advmod	_	_
5	potent	_	JJ	JJ	_	9	amod	_	_
6	antiinflammatory	_	JJ	JJ	_	5	dep	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	immunosuppressive	_	JJ	JJ	_	6	conj	_	_
9	agents	_	NNS	NNS	_	2	pobj	_	_
10	are	_	VBP	VBP	_	12	cop	_	_
11	synthetic	_	JJ	JJ	_	12	amod	_	_
12	glucocorticoids	_	NNS	NNS	_	0	root	_	_
13	.	_	.	.	_	12	punct	_	_

1	However	_	RB	RB	_	7	advmod	_	_
2	,	_	,	,	_	7	punct	_	_
3	major	_	JJ	JJ	_	5	amod	_	_
4	side	_	NN	NN	_	5	nn	_	_
5	effects	_	NNS	NNS	_	7	nsubj	_	_
6	severely	_	RB	RB	_	7	advmod	_	_
7	limit	_	VBP	VBP	_	0	root	_	_
8	their	_	PRP$	PRP$	_	10	poss	_	_
9	therapeutic	_	JJ	JJ	_	10	amod	_	_
10	use	_	NN	NN	_	7	dobj	_	_
11	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	development	_	NN	NN	_	8	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	improved	_	JJ	JJ	_	6	amod	_	_
5	glucocorticoid-based	_	JJ	JJ	_	4	dep	_	_
6	drugs	_	NNS	NNS	_	3	pobj	_	_
7	will	_	MD	MD	_	8	aux	_	_
8	require	_	VB	VB	_	0	root	_	_
9	the	_	DT	DT	_	10	det	_	_
10	separation	_	NN	NN	_	8	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	beneficial	_	JJ	JJ	_	11	pobj	_	_
13	from	_	IN	IN	_	10	prep	_	_
14	deleterious	_	JJ	JJ	_	15	amod	_	_
15	effects	_	NNS	NNS	_	13	pobj	_	_
16	.	_	.	.	_	8	punct	_	_

1	One	_	CD	CD	_	2	num	_	_
2	possibility	_	NN	NN	_	6	nsubj	_	_
3	toward	_	IN	IN	_	2	prep	_	_
4	this	_	DT	DT	_	5	det	_	_
5	goal	_	NN	NN	_	3	pobj	_	_
6	is	_	VBZ	VBZ	_	0	root	_	_
7	to	_	TO	TO	_	8	aux	_	_
8	try	_	VB	VB	_	6	xcomp	_	_
9	to	_	TO	TO	_	10	aux	_	_
10	dissociate	_	VB	VB	_	8	xcomp	_	_
11	two	_	CD	CD	_	13	num	_	_
12	main	_	JJ	JJ	_	13	amod	_	_
13	activities	_	NNS	NNS	_	10	dobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	glucocorticoids	_	NNS	NNS	_	14	pobj	_	_
16	,	_	,	,	_	13	punct	_	_
17	i.e.	_	FW	FW	_	13	prep	_	_
18	transactivation	_	NN	NN	_	13	dep	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	transrepression	_	NN	NN	_	18	conj	_	_
21	.	_	.	.	_	6	punct	_	_

1	Screening	_	NN	NN	_	17	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	a	_	DT	DT	_	4	det	_	_
4	library	_	NN	NN	_	2	pobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	compounds	_	NNS	NNS	_	5	pobj	_	_
7	using	_	VBG	VBG	_	1	dep	_	_
8	transactivation	_	NN	NN	_	7	dobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	AP-1	_	NN	NN	_	11	nn	_	_
11	transrepression	_	NN	NN	_	8	conj	_	_
12	models	_	NNS	NNS	_	8	dep	_	_
13	in	_	IN	IN	_	7	prep	_	_
14	transiently	_	RB	RB	_	15	advmod	_	_
15	transfected	_	VBN	VBN	_	16	amod	_	_
16	cells	_	NNS	NNS	_	13	pobj	_	_
17	identified	_	VBD	VBD	_	0	root	_	_
18	dissociated	_	VBN	VBN	_	19	amod	_	_
19	glucocorticoids	_	NNS	NNS	_	17	dobj	_	_
20	,	_	,	,	_	19	punct	_	_
21	which	_	WDT	WDT	_	22	nsubj	_	_
22	exert	_	VBP	VBP	_	19	rcmod	_	_
23	strong	_	JJ	JJ	_	25	amod	_	_
24	AP-1	_	NN	NN	_	25	nn	_	_
25	inhibition	_	NN	NN	_	22	dobj	_	_
26	but	_	CC	CC	_	25	cc	_	_
27	little	_	JJ	JJ	_	25	conj	_	_
28	or	_	CC	CC	_	27	cc	_	_
29	no	_	DT	DT	_	27	conj	_	_
30	transactivation	_	NN	NN	_	27	dep	_	_
31	.	_	.	.	_	17	punct	_	_

1	Importantly	_	RB	RB	_	16	advmod	_	_
2	,	_	,	,	_	16	punct	_	_
3	despite	_	IN	IN	_	16	prep	_	_
4	high	_	JJ	JJ	_	7	amod	_	_
5	ligand	_	NN	NN	_	7	nn	_	_
6	binding	_	NN	NN	_	7	nn	_	_
7	affinity	_	NN	NN	_	3	pobj	_	_
8	,	_	,	,	_	16	punct	_	_
9	the	_	DT	DT	_	12	det	_	_
10	prototypic	_	JJ	JJ	_	11	dep	_	_
11	dissociated	_	VBN	VBN	_	12	amod	_	_
12	compound	_	NN	NN	_	16	nsubj	_	_
13	,	_	,	,	_	12	punct	_	_
14	RU24858	_	NN	NN	_	12	appos	_	_
15	,	_	,	,	_	12	punct	_	_
16	acted	_	VBD	VBD	_	0	root	_	_
17	as	_	IN	IN	_	16	prep	_	_
18	a	_	DT	DT	_	20	det	_	_
19	weak	_	JJ	JJ	_	20	amod	_	_
20	agonist	_	NN	NN	_	17	pobj	_	_
21	and	_	CC	CC	_	16	cc	_	_
22	did	_	VBD	VBD	_	25	aux	_	_
23	not	_	RB	RB	_	25	neg	_	_
24	efficiently	_	RB	RB	_	25	advmod	_	_
25	antagonize	_	VB	VB	_	16	conj	_	_
26	dexamethasone-induced	_	JJ	JJ	_	27	amod	_	_
27	transcription	_	NN	NN	_	25	dobj	_	_
28	in	_	IN	IN	_	27	prep	_	_
29	transfected	_	VBN	VBN	_	30	amod	_	_
30	cells	_	NNS	NNS	_	28	pobj	_	_
31	.	_	.	.	_	16	punct	_	_

1	Similar	_	JJ	JJ	_	2	amod	_	_
2	results	_	NNS	NNS	_	4	nsubjpass	_	_
3	were	_	VBD	VBD	_	4	auxpass	_	_
4	obtained	_	VBN	VBN	_	0	root	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	hepatic	_	JJ	JJ	_	8	amod	_	_
7	HTC	_	NN	NN	_	8	nn	_	_
8	cells	_	NNS	NNS	_	5	pobj	_	_
9	for	_	IN	IN	_	4	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	transactivation	_	NN	NN	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	18	det	_	_
14	endogenous	_	JJ	JJ	_	18	amod	_	_
15	tyrosine	_	NN	NN	_	18	nn	_	_
16	amino	_	NN	NN	_	18	nn	_	_
17	transferase	_	NN	NN	_	18	nn	_	_
18	gene	_	NN	NN	_	12	pobj	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	TAT	_	NN	NN	_	18	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	,	_	,	,	_	18	punct	_	_
23	which	_	WDT	WDT	_	24	nsubj	_	_
24	encodes	_	VBZ	VBZ	_	18	rcmod	_	_
25	one	_	CD	CD	_	24	dobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	28	det	_	_
28	enzymes	_	NNS	NNS	_	26	pobj	_	_
29	involved	_	VBN	VBN	_	28	vmod	_	_
30	in	_	IN	IN	_	29	prep	_	_
31	the	_	DT	DT	_	33	det	_	_
32	glucocorticoid-dependent	_	JJ	JJ	_	33	amod	_	_
33	stimulation	_	NN	NN	_	30	pobj	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	neoglucogenesis	_	NN	NN	_	34	pobj	_	_
36	.	_	.	.	_	4	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	investigate	_	VB	VB	_	0	root	_	_
3	whether	_	IN	IN	_	6	mark	_	_
4	dissociated	_	VBN	VBN	_	5	amod	_	_
5	glucocorticoids	_	NNS	NNS	_	6	nsubj	_	_
6	retained	_	VBD	VBD	_	2	ccomp	_	_
7	the	_	DT	DT	_	11	det	_	_
8	antiinflammatory	_	JJ	JJ	_	11	amod	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	immunosuppressive	_	JJ	JJ	_	8	conj	_	_
11	potential	_	NN	NN	_	6	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	classic	_	JJ	JJ	_	14	amod	_	_
14	glucocorticoids	_	NNS	NNS	_	12	pobj	_	_
15	,	_	,	,	_	2	punct	_	_
16	several	_	JJ	JJ	_	17	amod	_	_
17	in	_	FW	FW	_	24	nsubjpass	_	_
18	vitro	_	FW	FW	_	17	dep	_	_
19	and	_	CC	CC	_	17	cc	_	_
20	in	_	FW	FW	_	17	conj	_	_
21	vivo	_	FW	FW	_	20	dep	_	_
22	models	_	NNS	NNS	_	17	dep	_	_
23	were	_	VBD	VBD	_	24	auxpass	_	_
24	used	_	VBN	VBN	_	2	parataxis	_	_
25	.	_	.	.	_	2	punct	_	_

1	Indeed	_	RB	RB	_	11	advmod	_	_
2	,	_	,	,	_	11	punct	_	_
3	secretion	_	NN	NN	_	11	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	8	det	_	_
6	proinflammatory	_	JJ	JJ	_	8	amod	_	_
7	lymphokine	_	NN	NN	_	8	nn	_	_
8	interleukin-1beta	_	NN	NN	_	4	pobj	_	_
9	was	_	VBD	VBD	_	11	auxpass	_	_
10	severely	_	RB	RB	_	11	advmod	_	_
11	inhibited	_	VBN	VBN	_	0	root	_	_
12	by	_	IN	IN	_	11	prep	_	_
13	dissociated	_	VBN	VBN	_	14	amod	_	_
14	glucocorticoids	_	NNS	NNS	_	12	pobj	_	_
15	in	_	IN	IN	_	11	prep	_	_
16	human	_	JJ	JJ	_	20	amod	_	_
17	monocytic	_	JJ	JJ	_	20	amod	_	_
18	THP	_	NN	NN	_	20	nn	_	_
19	1	_	CD	CD	_	20	num	_	_
20	cells	_	NNS	NNS	_	15	pobj	_	_
21	.	_	.	.	_	11	punct	_	_

1	Moreover	_	RB	RB	_	11	advmod	_	_
2	,	_	,	,	_	11	punct	_	_
3	in	_	IN	IN	_	11	prep	_	_
4	two	_	CD	CD	_	7	num	_	_
5	in	_	FW	FW	_	7	amod	_	_
6	vivo	_	FW	FW	_	5	dep	_	_
7	models	_	NNS	NNS	_	3	pobj	_	_
8	,	_	,	,	_	11	punct	_	_
9	these	_	DT	DT	_	10	det	_	_
10	compounds	_	NNS	NNS	_	11	nsubj	_	_
11	exerted	_	VBD	VBD	_	0	root	_	_
12	an	_	DT	DT	_	16	det	_	_
13	antiinflammatory	_	JJ	JJ	_	16	amod	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	immunosuppressive	_	JJ	JJ	_	13	conj	_	_
16	activity	_	NN	NN	_	11	dobj	_	_
17	as	_	IN	IN	_	18	dep	_	_
18	potent	_	JJ	JJ	_	16	amod	_	_
19	as	_	IN	IN	_	18	prep	_	_
20	that	_	DT	DT	_	19	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	24	det	_	_
23	classic	_	JJ	JJ	_	24	amod	_	_
24	glucocorticoid	_	NN	NN	_	21	pobj	_	_
25	prednisolone	_	NN	NN	_	24	dep	_	_
26	.	_	.	.	_	11	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	4	nsubj	_	_
3	may	_	MD	MD	_	4	aux	_	_
4	lead	_	VB	VB	_	0	root	_	_
5	to	_	TO	TO	_	4	prep	_	_
6	an	_	DT	DT	_	7	det	_	_
7	improvement	_	NN	NN	_	5	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	antiinflammatory	_	JJ	JJ	_	12	amod	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	immunosuppressive	_	JJ	JJ	_	9	conj	_	_
12	therapies	_	NNS	NNS	_	8	pobj	_	_
13	and	_	CC	CC	_	4	cc	_	_
14	provide	_	VB	VB	_	4	conj	_	_
15	a	_	DT	DT	_	17	det	_	_
16	novel	_	JJ	JJ	_	17	amod	_	_
17	concept	_	NN	NN	_	14	dobj	_	_
18	for	_	IN	IN	_	17	prep	_	_
19	drug	_	NN	NN	_	20	nn	_	_
20	discovery	_	NN	NN	_	18	pobj	_	_
21	.	_	.	.	_	4	punct	_	_

1	Activation	_	NN	NN	_	3	nn	_	_
2	domain	_	NN	NN	_	3	nn	_	_
3	requirements	_	NNS	NNS	_	0	root	_	_
4	for	_	IN	IN	_	3	prep	_	_
5	disruption	_	NN	NN	_	4	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	Epstein-Barr	_	JJ	JJ	_	9	amod	_	_
8	virus	_	NN	NN	_	9	nn	_	_
9	latency	_	NN	NN	_	6	pobj	_	_
10	by	_	IN	IN	_	5	prep	_	_
11	ZEBRA	_	NN	NN	_	10	pobj	_	_
12	.	_	.	.	_	3	punct	_	_

1	Latent	_	JJ	JJ	_	2	amod	_	_
2	infection	_	NN	NN	_	14	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	B	_	NN	NN	_	5	nn	_	_
5	lymphocytes	_	NNS	NNS	_	3	pobj	_	_
6	by	_	IN	IN	_	2	prep	_	_
7	Epstein-Barr	_	JJ	JJ	_	8	amod	_	_
8	virus	_	NN	NN	_	6	pobj	_	_
9	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
10	EBV	_	NN	NN	_	8	appos	_	_
11	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
12	can	_	MD	MD	_	14	aux	_	_
13	be	_	VB	VB	_	14	auxpass	_	_
14	disrupted	_	VBN	VBN	_	0	root	_	_
15	by	_	IN	IN	_	14	prep	_	_
16	expression	_	NN	NN	_	15	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	21	det	_	_
19	EBV	_	NN	NN	_	21	nn	_	_
20	ZEBRA	_	NN	NN	_	21	nn	_	_
21	protein	_	NN	NN	_	17	pobj	_	_
22	.	_	.	.	_	14	punct	_	_

1	ZEBRA	_	NN	NN	_	7	nsubj	_	_
2	,	_	,	,	_	1	punct	_	_
3	a	_	DT	DT	_	5	det	_	_
4	transcriptional	_	JJ	JJ	_	5	amod	_	_
5	activator	_	NN	NN	_	1	appos	_	_
6	,	_	,	,	_	1	punct	_	_
7	initiates	_	VBZ	VBZ	_	0	root	_	_
8	the	_	DT	DT	_	11	det	_	_
9	EBV	_	NN	NN	_	11	nn	_	_
10	lytic	_	JJ	JJ	_	11	amod	_	_
11	cascade	_	NN	NN	_	7	dobj	_	_
12	by	_	IN	IN	_	7	prep	_	_
13	activating	_	VBG	VBG	_	12	pcomp	_	_
14	viral	_	JJ	JJ	_	16	amod	_	_
15	gene	_	NN	NN	_	16	nn	_	_
16	expression	_	NN	NN	_	13	dobj	_	_
17	.	_	.	.	_	7	punct	_	_

1	ZEBRA	_	NN	NN	_	4	nsubj	_	_
2	is	_	VBZ	VBZ	_	4	cop	_	_
3	also	_	RB	RB	_	4	advmod	_	_
4	indispensable	_	JJ	JJ	_	0	root	_	_
5	for	_	IN	IN	_	4	prep	_	_
6	viral	_	JJ	JJ	_	7	amod	_	_
7	replication	_	NN	NN	_	5	pobj	_	_
8	and	_	CC	CC	_	4	cc	_	_
9	binds	_	VBZ	VBZ	_	4	conj	_	_
10	directly	_	RB	RB	_	9	advmod	_	_
11	to	_	TO	TO	_	9	prep	_	_
12	the	_	DT	DT	_	15	det	_	_
13	EBV	_	NN	NN	_	15	nn	_	_
14	lytic	_	JJ	JJ	_	15	amod	_	_
15	origin	_	NN	NN	_	11	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	replication	_	NN	NN	_	16	pobj	_	_
18	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	studies	_	NNS	NNS	_	5	nsubj	_	_
3	described	_	VBN	VBN	_	2	vmod	_	_
4	herein	_	RB	RB	_	3	advmod	_	_
5	demonstrate	_	VBP	VBP	_	0	root	_	_
6	that	_	IN	IN	_	7	mark	_	_
7	the	_	DT	DT	_	5	dep	_	_
8	activation	_	NN	NN	_	7	dep	_	_
9	domain	_	NN	NN	_	7	dep	_	_
10	.	_	.	.	_	5	punct	_	_

1	ZEBRA	_	NN	NN	_	2	nn	_	_
2	activation	_	NN	NN	_	5	nsubjpass	_	_
3	can	_	MD	MD	_	5	aux	_	_
4	be	_	VB	VB	_	5	auxpass	_	_
5	replaced	_	VBN	VBN	_	0	root	_	_
6	by	_	IN	IN	_	5	prep	_	_
7	a	_	DT	DT	_	9	dep	_	_
8	heterologous	_	JJ	JJ	_	9	amod	_	_
9	acidic	_	JJ	JJ	_	6	pobj	_	_
10	,	_	,	,	_	9	punct	_	_
11	proline-rich	_	JJ	JJ	_	9	conj	_	_
12	,	_	,	,	_	9	punct	_	_
13	or	_	CC	CC	_	9	cc	_	_
14	glutamine-rich	_	JJ	JJ	_	9	conj	_	_
15	activation	_	NN	NN	_	16	nn	_	_
16	domain	_	NN	NN	_	9	dep	_	_
17	.	_	.	.	_	5	punct	_	_

1	ZEBRA	_	NN	NN	_	5	nn	_	_
2	activation	_	NN	NN	_	5	nn	_	_
3	domain	_	NN	NN	_	5	nn	_	_
4	swap	_	NN	NN	_	5	nn	_	_
5	constructs	_	NNS	NNS	_	6	nsubj	_	_
6	retain	_	VBP	VBP	_	0	root	_	_
7	ZEBRA	_	NN	NN	_	10	poss	_	_
8	's	_	POS	POS	_	7	possessive	_	_
9	native	_	JJ	JJ	_	10	amod	_	_
10	abilities	_	NNS	NNS	_	6	dobj	_	_
11	to	_	TO	TO	_	12	aux	_	_
12	activate	_	VB	VB	_	10	dep	_	_
13	specific	_	JJ	JJ	_	15	amod	_	_
14	EBV	_	NN	NN	_	15	nn	_	_
15	promoters	_	NNS	NNS	_	12	dobj	_	_
16	,	_	,	,	_	12	punct	_	_
17	to	_	TO	TO	_	18	aux	_	_
18	disrupt	_	VB	VB	_	12	conj	_	_
19	EBV	_	NN	NN	_	20	nn	_	_
20	latency	_	NN	NN	_	18	dobj	_	_
21	,	_	,	,	_	12	punct	_	_
22	and	_	CC	CC	_	12	cc	_	_
23	to	_	TO	TO	_	24	aux	_	_
24	stimulate	_	VB	VB	_	12	conj	_	_
25	replication	_	NN	NN	_	24	dobj	_	_
26	at	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	30	det	_	_
28	EBV	_	NN	NN	_	30	nn	_	_
29	lytic	_	JJ	JJ	_	30	amod	_	_
30	origin	_	NN	NN	_	26	pobj	_	_
31	.	_	.	.	_	6	punct	_	_

1	Additional	_	JJ	JJ	_	2	amod	_	_
2	work	_	NN	NN	_	16	nsubj	_	_
3	,	_	,	,	_	2	punct	_	_
4	employing	_	VBG	VBG	_	2	vmod	_	_
5	sequential	_	JJ	JJ	_	4	dobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	internal	_	JJ	JJ	_	5	conj	_	_
8	deletions	_	NNS	NNS	_	5	dep	_	_
9	of	_	IN	IN	_	5	prep	_	_
10	ZEBRA	_	NN	NN	_	9	pobj	_	_
11	's	_	POS	POS	_	10	possessive	_	_
12	N-terminal	_	JJ	JJ	_	14	amod	_	_
13	activation	_	NN	NN	_	14	nn	_	_
14	domain	_	NN	NN	_	10	dep	_	_
15	,	_	,	,	_	2	punct	_	_
16	indicates	_	VBZ	VBZ	_	0	root	_	_
17	that	_	IN	IN	_	23	mark	_	_
18	its	_	PRP$	PRP$	_	20	poss	_	_
19	separate	_	JJ	JJ	_	20	amod	_	_
20	activities	_	NNS	NNS	_	23	nsubj	_	_
21	are	_	VBP	VBP	_	23	cop	_	_
22	not	_	RB	RB	_	23	neg	_	_
23	attributable	_	JJ	JJ	_	16	ccomp	_	_
24	to	_	TO	TO	_	23	prep	_	_
25	specific	_	JJ	JJ	_	26	amod	_	_
26	subdomains	_	NNS	NNS	_	24	pobj	_	_
27	but	_	CC	CC	_	23	cc	_	_
28	are	_	VBP	VBP	_	29	auxpass	_	_
29	spread	_	VBN	VBN	_	23	conj	_	_
30	throughout	_	IN	IN	_	29	prep	_	_
31	its	_	PRP$	PRP$	_	33	poss	_	_
32	N	_	NN	NN	_	33	nn	_	_
33	terminus	_	NN	NN	_	30	pobj	_	_
34	and	_	CC	CC	_	29	cc	_	_
35	therefore	_	RB	RB	_	39	advmod	_	_
36	can	_	MD	MD	_	39	aux	_	_
37	not	_	RB	RB	_	39	neg	_	_
38	be	_	VB	VB	_	39	auxpass	_	_
39	inactivated	_	VBN	VBN	_	29	conj	_	_
40	by	_	IN	IN	_	39	prep	_	_
41	deleting	_	VBG	VBG	_	40	pcomp	_	_
42	localized	_	JJ	JJ	_	43	amod	_	_
43	regions	_	NNS	NNS	_	41	dobj	_	_
44	.	_	.	.	_	16	punct	_	_

1	Transcription	_	NN	NN	_	3	nn	_	_
2	factor	_	NN	NN	_	3	nn	_	_
3	GATA-3	_	NN	NN	_	6	nsubjpass	_	_
4	is	_	VBZ	VBZ	_	6	auxpass	_	_
5	differentially	_	RB	RB	_	6	advmod	_	_
6	expressed	_	VBN	VBN	_	0	root	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	murine	_	JJ	JJ	_	9	amod	_	_
9	Th1	_	NN	NN	_	7	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	Th2	_	NN	NN	_	9	conj	_	_
12	cells	_	NNS	NNS	_	9	dep	_	_
13	and	_	CC	CC	_	6	cc	_	_
14	controls	_	VBZ	VBZ	_	6	conj	_	_
15	Th2-specific	_	JJ	JJ	_	16	amod	_	_
16	expression	_	NN	NN	_	14	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	interleukin-5	_	NN	NN	_	20	nn	_	_
20	gene	_	NN	NN	_	17	pobj	_	_
21	.	_	.	.	_	6	punct	_	_

1	Interleukin-5	_	NN	NN	_	25	nsubj	_	_
2	-LRB-	_	-LRB-	-LRB-	_	3	punct	_	_
3	IL-5	_	NN	NN	_	1	appos	_	_
4	-RRB-	_	-RRB-	-RRB-	_	3	punct	_	_
5	,	_	,	,	_	1	punct	_	_
6	which	_	WDT	WDT	_	8	nsubjpass	_	_
7	is	_	VBZ	VBZ	_	8	auxpass	_	_
8	produced	_	VBN	VBN	_	1	rcmod	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	CD4-LRB-+-RRB-	_	JJ	JJ	_	17	amod	_	_
11	T	_	NN	NN	_	17	nn	_	_
12	helper	_	NN	NN	_	17	nn	_	_
13	2	_	CD	CD	_	17	num	_	_
14	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
15	Th2	_	NN	NN	_	17	nn	_	_
16	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
17	cells	_	NNS	NNS	_	9	pobj	_	_
18	,	_	,	,	_	9	punct	_	_
19	but	_	CC	CC	_	9	cc	_	_
20	not	_	RB	RB	_	21	neg	_	_
21	by	_	IN	IN	_	9	conj	_	_
22	Th1	_	NN	NN	_	23	nn	_	_
23	cells	_	NNS	NNS	_	21	pobj	_	_
24	,	_	,	,	_	1	punct	_	_
25	plays	_	VBZ	VBZ	_	0	root	_	_
26	a	_	DT	DT	_	28	det	_	_
27	key	_	JJ	JJ	_	28	amod	_	_
28	role	_	NN	NN	_	25	dobj	_	_
29	in	_	IN	IN	_	25	prep	_	_
30	the	_	DT	DT	_	31	det	_	_
31	development	_	NN	NN	_	29	pobj	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	eosinophilia	_	NN	NN	_	32	pobj	_	_
34	in	_	IN	IN	_	31	prep	_	_
35	asthma	_	NN	NN	_	34	pobj	_	_
36	.	_	.	.	_	25	punct	_	_

1	Despite	_	IN	IN	_	38	prep	_	_
2	increasing	_	VBG	VBG	_	3	amod	_	_
3	evidence	_	NN	NN	_	1	pobj	_	_
4	that	_	IN	IN	_	11	mark	_	_
5	the	_	DT	DT	_	6	det	_	_
6	outcome	_	NN	NN	_	11	nsubjpass	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	many	_	JJ	JJ	_	9	amod	_	_
9	diseases	_	NNS	NNS	_	7	pobj	_	_
10	is	_	VBZ	VBZ	_	11	auxpass	_	_
11	determined	_	VBN	VBN	_	3	ccomp	_	_
12	by	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	14	det	_	_
14	ratio	_	NN	NN	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	18	det	_	_
17	two	_	CD	CD	_	18	num	_	_
18	subsets	_	NNS	NNS	_	15	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	CD4-LRB-+-RRB-	_	JJ	JJ	_	23	amod	_	_
21	T	_	NN	NN	_	23	nn	_	_
22	helper	_	NN	NN	_	23	nn	_	_
23	cells	_	NNS	NNS	_	19	pobj	_	_
24	,	_	,	,	_	18	punct	_	_
25	Th1	_	NN	NN	_	18	appos	_	_
26	and	_	CC	CC	_	25	cc	_	_
27	Th2	_	NN	NN	_	25	conj	_	_
28	,	_	,	,	_	38	punct	_	_
29	the	_	DT	DT	_	31	det	_	_
30	molecular	_	JJ	JJ	_	31	amod	_	_
31	basis	_	NN	NN	_	38	nsubj	_	_
32	for	_	IN	IN	_	31	prep	_	_
33	Th1-	_	NN	NN	_	32	pobj	_	_
34	and	_	CC	CC	_	33	cc	_	_
35	Th2-specific	_	JJ	JJ	_	33	conj	_	_
36	gene	_	NN	NN	_	37	nn	_	_
37	expression	_	NN	NN	_	33	dep	_	_
38	remains	_	VBZ	VBZ	_	0	root	_	_
39	to	_	TO	TO	_	41	aux	_	_
40	be	_	VB	VB	_	41	auxpass	_	_
41	elucidated	_	VBN	VBN	_	38	xcomp	_	_
42	.	_	.	.	_	38	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	previously	_	RB	RB	_	3	advmod	_	_
3	established	_	VBD	VBD	_	0	root	_	_
4	a	_	DT	DT	_	6	det	_	_
5	critical	_	JJ	JJ	_	6	amod	_	_
6	role	_	NN	NN	_	3	dobj	_	_
7	for	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	transcription	_	NN	NN	_	10	nn	_	_
10	factor	_	NN	NN	_	7	pobj	_	_
11	GATA-3	_	NN	NN	_	10	dep	_	_
12	in	_	IN	IN	_	6	prep	_	_
13	IL-5	_	NN	NN	_	14	nn	_	_
14	promoter	_	NN	NN	_	15	nn	_	_
15	activation	_	NN	NN	_	12	pobj	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	EL-4	_	NN	NN	_	18	nn	_	_
18	cells	_	NNS	NNS	_	16	pobj	_	_
19	,	_	,	,	_	15	punct	_	_
20	which	_	WDT	WDT	_	21	nsubj	_	_
21	express	_	VBP	VBP	_	15	rcmod	_	_
22	both	_	CC	CC	_	23	preconj	_	_
23	Th1-	_	NN	NN	_	21	dobj	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	Th2-type	_	JJ	JJ	_	23	conj	_	_
26	cytokines	_	NNS	NNS	_	23	dep	_	_
27	.	_	.	.	_	3	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	studies	_	NNS	NNS	_	5	nsubj	_	_
3	reported	_	VBN	VBN	_	2	vmod	_	_
4	here	_	RB	RB	_	3	advmod	_	_
5	demonstrate	_	VBP	VBP	_	0	root	_	_
6	that	_	IN	IN	_	9	mark	_	_
7	GATA-3	_	NN	NN	_	9	nsubj	_	_
8	is	_	VBZ	VBZ	_	9	cop	_	_
9	critical	_	JJ	JJ	_	5	ccomp	_	_
10	for	_	IN	IN	_	9	prep	_	_
11	expression	_	NN	NN	_	10	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	IL-5	_	NN	NN	_	15	nn	_	_
15	gene	_	NN	NN	_	12	pobj	_	_
16	in	_	IN	IN	_	11	prep	_	_
17	bona	_	FW	FW	_	20	nn	_	_
18	fide	_	FW	FW	_	20	nn	_	_
19	Th2	_	NN	NN	_	20	nn	_	_
20	cells	_	NNS	NNS	_	16	pobj	_	_
21	.	_	.	.	_	5	punct	_	_

1	Whereas	_	IN	IN	_	7	mark	_	_
2	mutations	_	NNS	NNS	_	7	nsubj	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	GATA-3	_	NN	NN	_	6	nn	_	_
6	site	_	NN	NN	_	3	pobj	_	_
7	abolished	_	VBD	VBD	_	33	advcl	_	_
8	antigen-	_	JJ	JJ	_	7	dobj	_	_
9	or	_	CC	CC	_	8	cc	_	_
10	cAMP-stimulated	_	JJ	JJ	_	8	conj	_	_
11	IL-5	_	NN	NN	_	13	nn	_	_
12	promoter	_	NN	NN	_	13	nn	_	_
13	activation	_	NN	NN	_	8	dep	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	Th2	_	NN	NN	_	16	nn	_	_
16	cells	_	NNS	NNS	_	14	pobj	_	_
17	,	_	,	,	_	33	punct	_	_
18	ectopic	_	JJ	JJ	_	19	amod	_	_
19	expression	_	NN	NN	_	33	nsubj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	GATA-3	_	NN	NN	_	20	pobj	_	_
22	in	_	IN	IN	_	19	prep	_	_
23	Th1	_	NN	NN	_	24	nn	_	_
24	cells	_	NNS	NNS	_	22	pobj	_	_
25	or	_	CC	CC	_	22	cc	_	_
26	in	_	IN	IN	_	22	conj	_	_
27	a	_	DT	DT	_	32	det	_	_
28	non-lymphoid	_	JJ	JJ	_	32	amod	_	_
29	,	_	,	,	_	32	punct	_	_
30	non-IL-5-producing	_	JJ	JJ	_	32	amod	_	_
31	cell	_	NN	NN	_	32	nn	_	_
32	line	_	NN	NN	_	26	pobj	_	_
33	activated	_	VBD	VBD	_	0	root	_	_
34	the	_	DT	DT	_	36	det	_	_
35	IL-5	_	NN	NN	_	36	nn	_	_
36	promoter	_	NN	NN	_	33	dobj	_	_
37	.	_	.	.	_	33	punct	_	_

1	During	_	IN	IN	_	21	prep	_	_
2	the	_	DT	DT	_	3	det	_	_
3	differentiation	_	NN	NN	_	1	pobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	naive	_	JJ	JJ	_	8	amod	_	_
6	CD4-LRB-+-RRB-	_	JJ	JJ	_	8	amod	_	_
7	T	_	NN	NN	_	8	nn	_	_
8	cells	_	NNS	NNS	_	4	pobj	_	_
9	isolated	_	VBN	VBN	_	8	vmod	_	_
10	from	_	IN	IN	_	9	prep	_	_
11	T	_	NN	NN	_	15	nn	_	_
12	cell	_	NN	NN	_	15	nn	_	_
13	receptor	_	NN	NN	_	15	nn	_	_
14	transgenic	_	JJ	JJ	_	15	amod	_	_
15	mice	_	NNS	NNS	_	10	pobj	_	_
16	,	_	,	,	_	21	punct	_	_
17	GATA-3	_	NN	NN	_	19	nn	_	_
18	gene	_	NN	NN	_	19	nn	_	_
19	expression	_	NN	NN	_	21	nsubjpass	_	_
20	was	_	VBD	VBD	_	21	auxpass	_	_
21	up-regulated	_	VBN	VBN	_	0	root	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	developing	_	VBG	VBG	_	25	amod	_	_
24	Th2	_	NN	NN	_	25	nn	_	_
25	cells	_	NNS	NNS	_	22	pobj	_	_
26	,	_	,	,	_	21	punct	_	_
27	but	_	CC	CC	_	21	cc	_	_
28	was	_	VBD	VBD	_	29	auxpass	_	_
29	down-regulated	_	VBN	VBN	_	21	conj	_	_
30	in	_	IN	IN	_	29	prep	_	_
31	Th1	_	NN	NN	_	32	nn	_	_
32	cells	_	NNS	NNS	_	30	pobj	_	_
33	,	_	,	,	_	21	punct	_	_
34	and	_	CC	CC	_	21	cc	_	_
35	antigen-	_	NN	NN	_	39	nn	_	_
36	or	_	CC	CC	_	35	cc	_	_
37	cAMP-activated	_	JJ	JJ	_	35	conj	_	_
38	Th2	_	NN	NN	_	39	nn	_	_
39	cells	_	NNS	NNS	_	46	nsubj	_	_
40	-LRB-	_	-LRB-	-LRB-	_	44	punct	_	_
41	but	_	CC	CC	_	42	cc	_	_
42	not	_	RB	RB	_	44	cc	_	_
43	Th1	_	NN	NN	_	44	nn	_	_
44	cells	_	NNS	NNS	_	39	appos	_	_
45	-RRB-	_	-RRB-	-RRB-	_	44	punct	_	_
46	expressed	_	VBD	VBD	_	21	conj	_	_
47	the	_	DT	DT	_	49	det	_	_
48	GATA-3	_	NN	NN	_	49	nn	_	_
49	protein	_	NN	NN	_	46	dobj	_	_
50	.	_	.	.	_	21	punct	_	_

1	Thus	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	GATA-3	_	NN	NN	_	5	nsubj	_	_
4	may	_	MD	MD	_	5	aux	_	_
5	play	_	VB	VB	_	0	root	_	_
6	an	_	DT	DT	_	8	det	_	_
7	important	_	JJ	JJ	_	8	amod	_	_
8	role	_	NN	NN	_	5	dobj	_	_
9	in	_	IN	IN	_	5	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	balance	_	NN	NN	_	9	pobj	_	_
12	between	_	IN	IN	_	11	prep	_	_
13	Th1	_	NN	NN	_	12	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	Th2	_	NN	NN	_	16	nn	_	_
16	subsets	_	NNS	NNS	_	13	conj	_	_
17	in	_	IN	IN	_	5	prep	_	_
18	immune	_	JJ	JJ	_	19	amod	_	_
19	responses	_	NNS	NNS	_	17	pobj	_	_
20	.	_	.	.	_	5	punct	_	_

1	Inhibition	_	NN	NN	_	5	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	GATA-3	_	NN	NN	_	4	nn	_	_
4	activity	_	NN	NN	_	2	pobj	_	_
5	has	_	VBZ	VBZ	_	0	root	_	_
6	therapeutic	_	JJ	JJ	_	7	amod	_	_
7	potential	_	NN	NN	_	5	dobj	_	_
8	in	_	IN	IN	_	5	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	treatment	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	asthma	_	NN	NN	_	11	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	other	_	JJ	JJ	_	16	amod	_	_
15	hypereosinophilic	_	JJ	JJ	_	16	amod	_	_
16	diseases	_	NNS	NNS	_	12	conj	_	_
17	.	_	.	.	_	5	punct	_	_

1	Transcription	_	NN	NN	_	2	nn	_	_
2	factors	_	NNS	NNS	_	0	root	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	immune-mediated	_	JJ	JJ	_	5	amod	_	_
5	disease	_	NN	NN	_	3	pobj	_	_
6	.	_	.	.	_	2	punct	_	_

1	A	_	DT	DT	_	3	det	_	_
2	large	_	JJ	JJ	_	3	amod	_	_
3	amount	_	NN	NN	_	24	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	detailed	_	JJ	JJ	_	6	amod	_	_
6	information	_	NN	NN	_	4	pobj	_	_
7	about	_	IN	IN	_	3	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	intracellular	_	JJ	JJ	_	10	amod	_	_
10	proteins	_	NNS	NNS	_	7	pobj	_	_
11	regulating	_	VBG	VBG	_	10	vmod	_	_
12	NF-kappa	_	NN	NN	_	13	nn	_	_
13	B	_	NN	NN	_	14	nn	_	_
14	activation	_	NN	NN	_	11	dobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	the	_	DT	DT	_	18	det	_	_
17	cellular	_	JJ	JJ	_	18	amod	_	_
18	response	_	NN	NN	_	14	conj	_	_
19	to	_	TO	TO	_	18	prep	_	_
20	NF-kappa	_	NN	NN	_	21	nn	_	_
21	B	_	NN	NN	_	22	nn	_	_
22	activation	_	NN	NN	_	19	pobj	_	_
23	has	_	VBZ	VBZ	_	24	aux	_	_
24	emerged	_	VBN	VBN	_	0	root	_	_
25	recently	_	RB	RB	_	24	advmod	_	_
26	.	_	.	.	_	24	punct	_	_

1	Several	_	JJ	JJ	_	2	amod	_	_
2	small	_	JJ	JJ	_	3	amod	_	_
3	molecules	_	NNS	NNS	_	20	nsubjpass	_	_
4	,	_	,	,	_	3	punct	_	_
5	an	_	DT	DT	_	7	det	_	_
6	antisense	_	JJ	JJ	_	7	amod	_	_
7	oligonucleotide	_	NN	NN	_	3	conj	_	_
8	,	_	,	,	_	3	punct	_	_
9	and	_	CC	CC	_	3	cc	_	_
10	gene	_	NN	NN	_	12	nn	_	_
11	therapeutic	_	JJ	JJ	_	12	amod	_	_
12	agents	_	NNS	NNS	_	3	conj	_	_
13	that	_	WDT	WDT	_	14	nsubj	_	_
14	inhibit	_	VBP	VBP	_	12	rcmod	_	_
15	NF-kappa	_	NN	NN	_	16	nn	_	_
16	b	_	NN	NN	_	17	nn	_	_
17	activation	_	NN	NN	_	14	dobj	_	_
18	have	_	VBP	VBP	_	20	aux	_	_
19	been	_	VBN	VBN	_	20	auxpass	_	_
20	described	_	VBN	VBN	_	0	root	_	_
21	.	_	.	.	_	20	punct	_	_

1	Despite	_	IN	IN	_	5	prep	_	_
2	this	_	DT	DT	_	1	pobj	_	_
3	,	_	,	,	_	5	punct	_	_
4	there	_	EX	EX	_	5	expl	_	_
5	are	_	VBP	VBP	_	0	root	_	_
6	still	_	RB	RB	_	5	advmod	_	_
7	significant	_	JJ	JJ	_	8	amod	_	_
8	gaps	_	NNS	NNS	_	5	nsubj	_	_
9	in	_	IN	IN	_	5	prep	_	_
10	our	_	PRP$	PRP$	_	11	poss	_	_
11	understanding	_	NN	NN	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	this	_	DT	DT	_	14	det	_	_
14	process	_	NN	NN	_	12	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	its	_	PRP$	PRP$	_	17	poss	_	_
17	consequences	_	NNS	NNS	_	14	conj	_	_
18	.	_	.	.	_	5	punct	_	_

1	In	_	IN	IN	_	18	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	18	punct	_	_
4	the	_	DT	DT	_	5	det	_	_
5	characterization	_	NN	NN	_	18	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	transcription	_	NN	NN	_	8	nn	_	_
8	factors	_	NNS	NNS	_	6	pobj	_	_
9	selectively	_	RB	RB	_	10	advmod	_	_
10	regulating	_	VBG	VBG	_	8	vmod	_	_
11	cytokine	_	NN	NN	_	12	nn	_	_
12	production	_	NN	NN	_	10	dobj	_	_
13	by	_	IN	IN	_	12	prep	_	_
14	CD4+	_	JJ	JJ	_	17	amod	_	_
15	T	_	NN	NN	_	17	nn	_	_
16	cell	_	NN	NN	_	17	nn	_	_
17	subsets	_	NNS	NNS	_	13	pobj	_	_
18	is	_	VBZ	VBZ	_	0	root	_	_
19	at	_	IN	IN	_	18	prep	_	_
20	a	_	DT	DT	_	23	det	_	_
21	very	_	RB	RB	_	22	advmod	_	_
22	early	_	JJ	JJ	_	23	amod	_	_
23	stage	_	NN	NN	_	19	pobj	_	_
24	.	_	.	.	_	18	punct	_	_

1	Three	_	CD	CD	_	3	num	_	_
2	interacting	_	VBG	VBG	_	3	amod	_	_
3	proteins	_	NNS	NNS	_	7	nsubjpass	_	_
4	have	_	VBP	VBP	_	7	aux	_	_
5	recently	_	RB	RB	_	7	advmod	_	_
6	been	_	VBN	VBN	_	7	auxpass	_	_
7	shown	_	VBN	VBN	_	0	root	_	_
8	to	_	TO	TO	_	9	aux	_	_
9	contribute	_	VB	VB	_	7	xcomp	_	_
10	to	_	TO	TO	_	9	prep	_	_
11	subset-restricted	_	JJ	JJ	_	12	amod	_	_
12	expression	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	IL-4	_	NN	NN	_	16	nn	_	_
16	gene	_	NN	NN	_	13	pobj	_	_
17	.	_	.	.	_	7	punct	_	_

1	There	_	EX	EX	_	2	expl	_	_
2	are	_	VBP	VBP	_	0	root	_	_
3	other	_	JJ	JJ	_	4	amod	_	_
4	elements	_	NNS	NNS	_	2	nsubj	_	_
5	regulating	_	VBG	VBG	_	4	vmod	_	_
6	IL-4	_	NN	NN	_	7	nn	_	_
7	gene	_	NN	NN	_	8	nn	_	_
8	expression	_	NN	NN	_	5	dobj	_	_
9	,	_	,	,	_	2	punct	_	_
10	however	_	RB	RB	_	2	advmod	_	_
11	,	_	,	,	_	2	punct	_	_
12	and	_	CC	CC	_	2	cc	_	_
13	the	_	DT	DT	_	15	det	_	_
14	relative	_	JJ	JJ	_	15	amod	_	_
15	importance	_	NN	NN	_	21	nsubj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	these	_	DT	DT	_	20	det	_	_
18	recently	_	RB	RB	_	19	advmod	_	_
19	identified	_	VBN	VBN	_	20	amod	_	_
20	proteins	_	NNS	NNS	_	16	pobj	_	_
21	has	_	VBZ	VBZ	_	2	conj	_	_
22	yet	_	RB	RB	_	25	advmod	_	_
23	to	_	TO	TO	_	25	aux	_	_
24	be	_	VB	VB	_	25	auxpass	_	_
25	determined	_	VBN	VBN	_	21	xcomp	_	_
26	.	_	.	.	_	2	punct	_	_

1	alpha-Tocopheryl	_	NN	NN	_	2	nn	_	_
2	succinate	_	NN	NN	_	3	nsubj	_	_
3	inhibits	_	VBZ	VBZ	_	0	root	_	_
4	monocytic	_	JJ	JJ	_	6	amod	_	_
5	cell	_	NN	NN	_	6	nn	_	_
6	adhesion	_	NN	NN	_	3	dobj	_	_
7	to	_	TO	TO	_	6	prep	_	_
8	endothelial	_	JJ	JJ	_	9	amod	_	_
9	cells	_	NNS	NNS	_	7	pobj	_	_
10	by	_	IN	IN	_	3	prep	_	_
11	suppressing	_	VBG	VBG	_	10	pcomp	_	_
12	NF-kappa	_	NN	NN	_	13	nn	_	_
13	B	_	NN	NN	_	14	nn	_	_
14	mobilization	_	NN	NN	_	11	dobj	_	_
15	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	adherence	_	NN	NN	_	11	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	monocytes	_	NNS	NNS	_	3	pobj	_	_
5	to	_	TO	TO	_	2	prep	_	_
6	activated	_	VBN	VBN	_	7	amod	_	_
7	endothelium	_	NN	NN	_	5	pobj	_	_
8	is	_	VBZ	VBZ	_	11	cop	_	_
9	an	_	DT	DT	_	11	det	_	_
10	early	_	JJ	JJ	_	11	amod	_	_
11	event	_	NN	NN	_	0	root	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	atherogenesis	_	NN	NN	_	12	pobj	_	_
14	.	_	.	.	_	11	punct	_	_

1	Because	_	IN	IN	_	5	mark	_	_
2	antioxidants	_	NNS	NNS	_	5	nsubjpass	_	_
3	have	_	VBP	VBP	_	5	aux	_	_
4	been	_	VBN	VBN	_	5	auxpass	_	_
5	considered	_	VBN	VBN	_	13	advcl	_	_
6	to	_	TO	TO	_	7	aux	_	_
7	be	_	VB	VB	_	5	xcomp	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	antiatherosclerotic	_	JJ	JJ	_	10	amod	_	_
10	potential	_	NN	NN	_	8	pobj	_	_
11	,	_	,	,	_	13	punct	_	_
12	we	_	PRP	PRP	_	13	nsubj	_	_
13	investigated	_	VBD	VBD	_	0	root	_	_
14	the	_	DT	DT	_	15	det	_	_
15	effects	_	NNS	NNS	_	13	dobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	alpha-tocopherol	_	NN	NN	_	16	pobj	_	_
18	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
19	TCP	_	NN	NN	_	17	appos	_	_
20	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	and	_	CC	CC	_	17	cc	_	_
22	its	_	PRP$	PRP$	_	23	poss	_	_
23	acetate	_	NN	NN	_	17	conj	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	succinate	_	NN	NN	_	23	conj	_	_
26	esters	_	NNS	NNS	_	23	dep	_	_
27	on	_	IN	IN	_	15	prep	_	_
28	monocyte	_	NN	NN	_	29	nn	_	_
29	adhesion	_	NN	NN	_	27	pobj	_	_
30	to	_	TO	TO	_	29	prep	_	_
31	cytokine-stimulated	_	JJ	JJ	_	36	amod	_	_
32	human	_	JJ	JJ	_	36	amod	_	_
33	umbilical	_	JJ	JJ	_	36	amod	_	_
34	vein	_	NN	NN	_	36	nn	_	_
35	endothelial	_	JJ	JJ	_	36	amod	_	_
36	cells	_	NNS	NNS	_	30	pobj	_	_
37	-LRB-	_	-LRB-	-LRB-	_	38	punct	_	_
38	HUVEC	_	NNS	NNS	_	36	appos	_	_
39	-RRB-	_	-RRB-	-RRB-	_	38	punct	_	_
40	.	_	.	.	_	13	punct	_	_

1	Endothelial	_	JJ	JJ	_	2	amod	_	_
2	cells	_	NNS	NNS	_	4	nsubjpass	_	_
3	were	_	VBD	VBD	_	4	auxpass	_	_
4	treated	_	VBN	VBN	_	0	root	_	_
5	with	_	IN	IN	_	4	prep	_	_
6	TCP	_	NN	NN	_	5	pobj	_	_
7	,	_	,	,	_	6	punct	_	_
8	alpha-tocopherol	_	NN	NN	_	9	nn	_	_
9	acetate	_	NN	NN	_	6	conj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
11	TCP	_	NN	NN	_	12	nn	_	_
12	acetate	_	NN	NN	_	9	appos	_	_
13	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
14	,	_	,	,	_	6	punct	_	_
15	or	_	CC	CC	_	6	cc	_	_
16	alpha-tocopheryl	_	NN	NN	_	17	nn	_	_
17	succinate	_	NN	NN	_	6	conj	_	_
18	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
19	TCP	_	NN	NN	_	20	nn	_	_
20	succinate	_	NN	NN	_	17	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	before	_	IN	IN	_	4	prep	_	_
23	stimulation	_	NN	NN	_	22	pobj	_	_
24	with	_	IN	IN	_	23	prep	_	_
25	tumor	_	NN	NN	_	27	nn	_	_
26	necrosis	_	NN	NN	_	27	nn	_	_
27	factor-alpha	_	NN	NN	_	24	pobj	_	_
28	-LRB-	_	-LRB-	-LRB-	_	29	punct	_	_
29	TNF-alpha	_	NN	NN	_	27	dep	_	_
30	;	_	:	:	_	29	punct	_	_
31	10	_	CD	CD	_	32	num	_	_
32	U/ml	_	NN	NN	_	29	dep	_	_
33	,	_	,	,	_	32	punct	_	_
34	6	_	CD	CD	_	35	num	_	_
35	h	_	NN	NN	_	32	appos	_	_
36	-RRB-	_	-RRB-	-RRB-	_	29	punct	_	_
37	or	_	CC	CC	_	27	cc	_	_
38	interleukin-1	_	NN	NN	_	39	nn	_	_
39	beta	_	NN	NN	_	27	conj	_	_
40	-LRB-	_	-LRB-	-LRB-	_	42	punct	_	_
41	IL-1	_	NN	NN	_	42	nn	_	_
42	beta	_	NN	NN	_	39	dep	_	_
43	;	_	:	:	_	42	punct	_	_
44	10	_	CD	CD	_	45	num	_	_
45	U/ml	_	NN	NN	_	42	dep	_	_
46	,	_	,	,	_	45	punct	_	_
47	6	_	CD	CD	_	48	num	_	_
48	h	_	NN	NN	_	45	appos	_	_
49	-RRB-	_	-RRB-	-RRB-	_	42	punct	_	_
50	.	_	.	.	_	4	punct	_	_

1	Cytokine-stimulated	_	JJ	JJ	_	4	amod	_	_
2	cell	_	NN	NN	_	4	nn	_	_
3	surface	_	NN	NN	_	4	nn	_	_
4	expression	_	NN	NN	_	40	nsubjpass	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	vascular	_	JJ	JJ	_	9	amod	_	_
7	cell	_	NN	NN	_	9	nn	_	_
8	adhesion	_	NN	NN	_	9	nn	_	_
9	molecule-1	_	NN	NN	_	5	pobj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	VCAM-1	_	NN	NN	_	9	dep	_	_
12	,	_	,	,	_	11	punct	_	_
13	CD106	_	NN	NN	_	11	appos	_	_
14	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
15	and	_	CC	CC	_	9	cc	_	_
16	E-selectin	_	NN	NN	_	9	conj	_	_
17	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	ELAM-1	_	NN	NN	_	16	dep	_	_
19	,	_	,	,	_	18	punct	_	_
20	CD62E	_	NN	NN	_	18	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
22	,	_	,	,	_	5	punct	_	_
23	but	_	CC	CC	_	5	cc	_	_
24	not	_	RB	RB	_	25	neg	_	_
25	of	_	IN	IN	_	5	conj	_	_
26	intercellular	_	JJ	JJ	_	28	amod	_	_
27	adhesion	_	NN	NN	_	28	nn	_	_
28	molecule-1	_	NN	NN	_	25	pobj	_	_
29	-LRB-	_	-LRB-	-LRB-	_	30	punct	_	_
30	ICAM-1	_	NN	NN	_	28	dep	_	_
31	,	_	,	,	_	30	punct	_	_
32	CD54	_	NN	NN	_	30	appos	_	_
33	-RRB-	_	-RRB-	-RRB-	_	30	punct	_	_
34	,	_	,	,	_	40	punct	_	_
35	was	_	VBD	VBD	_	40	auxpass	_	_
36	time-	_	NN	NN	_	40	advmod	_	_
37	and	_	CC	CC	_	36	cc	_	_
38	dose-	_	NN	NN	_	36	conj	_	_
39	dependently	_	RB	RB	_	36	conj	_	_
40	inhibited	_	VBN	VBN	_	0	root	_	_
41	by	_	IN	IN	_	40	prep	_	_
42	TCP	_	NN	NN	_	43	nn	_	_
43	succinate	_	NN	NN	_	41	pobj	_	_
44	but	_	CC	CC	_	41	cc	_	_
45	not	_	RB	RB	_	46	neg	_	_
46	by	_	IN	IN	_	41	conj	_	_
47	TCP	_	NN	NN	_	46	pobj	_	_
48	or	_	CC	CC	_	47	cc	_	_
49	TCP	_	NN	NN	_	50	nn	_	_
50	acetate	_	NN	NN	_	47	conj	_	_
51	.	_	.	.	_	40	punct	_	_

1	TCP	_	NN	NN	_	10	nsubj	_	_
2	succinate	_	JJ	JJ	_	1	amod	_	_
3	-LRB-	_	-LRB-	-LRB-	_	5	punct	_	_
4	200	_	CD	CD	_	5	num	_	_
5	microM	_	NN	NN	_	1	dep	_	_
6	,	_	,	,	_	5	punct	_	_
7	24	_	CD	CD	_	8	num	_	_
8	h	_	NN	NN	_	5	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	5	punct	_	_
10	reduced	_	VBD	VBD	_	0	root	_	_
11	TNF-induced	_	JJ	JJ	_	12	amod	_	_
12	VCAM-1	_	NN	NN	_	10	dobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	E-selectin	_	NN	NN	_	12	conj	_	_
15	expression	_	NN	NN	_	12	dep	_	_
16	from	_	IN	IN	_	12	prep	_	_
17	a	_	DT	DT	_	21	det	_	_
18	specific	_	JJ	JJ	_	21	amod	_	_
19	mean	_	NN	NN	_	21	nn	_	_
20	fluorescence	_	NN	NN	_	21	nn	_	_
21	intensity	_	NN	NN	_	16	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	151	_	CD	CD	_	22	pobj	_	_
24	+/-	_	CC	CC	_	23	cc	_	_
25	28	_	CD	CD	_	23	conj	_	_
26	to	_	TO	TO	_	16	prep	_	_
27	12	_	CD	CD	_	30	num	_	_
28	+/-	_	CC	CC	_	27	cc	_	_
29	4	_	CD	CD	_	27	conj	_	_
30	channels	_	NNS	NNS	_	26	pobj	_	_
31	and	_	CC	CC	_	16	cc	_	_
32	from	_	IN	IN	_	16	conj	_	_
33	225	_	CD	CD	_	32	pobj	_	_
34	+/-	_	CC	CC	_	33	cc	_	_
35	38	_	CD	CD	_	33	conj	_	_
36	to	_	TO	TO	_	32	prep	_	_
37	79	_	CD	CD	_	40	num	_	_
38	+/-	_	CC	CC	_	37	cc	_	_
39	21	_	CD	CD	_	37	conj	_	_
40	channels	_	NNS	NNS	_	36	pobj	_	_
41	,	_	,	,	_	12	punct	_	_
42	respectively	_	RB	RB	_	12	advmod	_	_
43	.	_	.	.	_	10	punct	_	_

1	Succinate	_	NN	NN	_	3	nsubj	_	_
2	alone	_	RB	RB	_	1	advmod	_	_
3	had	_	VBD	VBD	_	0	root	_	_
4	no	_	DT	DT	_	5	neg	_	_
5	effect	_	NN	NN	_	3	dobj	_	_
6	.	_	.	.	_	3	punct	_	_

1	Decreased	_	VBN	VBN	_	4	amod	_	_
2	adhesion	_	NN	NN	_	3	nn	_	_
3	molecule	_	NN	NN	_	4	nn	_	_
4	expression	_	NN	NN	_	6	nsubjpass	_	_
5	was	_	VBD	VBD	_	6	auxpass	_	_
6	associated	_	VBN	VBN	_	0	root	_	_
7	with	_	IN	IN	_	6	prep	_	_
8	a	_	DT	DT	_	9	det	_	_
9	reduction	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	monocytic	_	JJ	JJ	_	13	amod	_	_
12	cell	_	NN	NN	_	13	nn	_	_
13	adhesion	_	NN	NN	_	10	pobj	_	_
14	.	_	.	.	_	6	punct	_	_

1	TCP	_	NN	NN	_	2	nn	_	_
2	succinate	_	NN	NN	_	22	nsubj	_	_
3	-LRB-	_	-LRB-	-LRB-	_	5	punct	_	_
4	20	_	CD	CD	_	5	num	_	_
5	microM	_	NN	NN	_	2	dep	_	_
6	,	_	,	,	_	5	punct	_	_
7	72	_	CD	CD	_	8	num	_	_
8	h	_	NN	NN	_	5	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	5	punct	_	_
10	,	_	,	,	_	2	punct	_	_
11	but	_	CC	CC	_	12	cc	_	_
12	not	_	RB	RB	_	2	cc	_	_
13	TCP	_	NN	NN	_	2	conj	_	_
14	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
15	200	_	CD	CD	_	16	num	_	_
16	microM	_	NN	NN	_	13	dep	_	_
17	,	_	,	,	_	16	punct	_	_
18	72	_	CD	CD	_	19	num	_	_
19	h	_	NN	NN	_	16	appos	_	_
20	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
21	,	_	,	,	_	2	punct	_	_
22	reduced	_	VBD	VBD	_	0	root	_	_
23	U-937	_	NN	NN	_	24	nn	_	_
24	cell	_	NN	NN	_	25	nn	_	_
25	adhesion	_	NN	NN	_	22	dobj	_	_
26	to	_	TO	TO	_	25	prep	_	_
27	TNF-alpha-stimulated	_	JJ	JJ	_	35	amod	_	_
28	-LRB-	_	-LRB-	-LRB-	_	35	punct	_	_
29	10	_	CD	CD	_	35	num	_	_
30	U/ml	_	NN	NN	_	35	nn	_	_
31	,	_	,	,	_	35	punct	_	_
32	6	_	CD	CD	_	35	num	_	_
33	h	_	NN	NN	_	35	nn	_	_
34	-RRB-	_	-RRB-	-RRB-	_	35	punct	_	_
35	HUVEC	_	NNS	NNS	_	26	pobj	_	_
36	by	_	IN	IN	_	22	prep	_	_
37	30	_	CD	CD	_	38	num	_	_
38	%	_	NN	NN	_	36	pobj	_	_
39	-LRB-	_	-LRB-	-LRB-	_	40	punct	_	_
40	P	_	NN	NN	_	38	dep	_	_
41	&lt;	_	JJR	JJR	_	40	amod	_	_
42	0.025	_	CD	CD	_	41	dep	_	_
43	-RRB-	_	-RRB-	-RRB-	_	40	punct	_	_
44	and	_	CC	CC	_	22	cc	_	_
45	to	_	TO	TO	_	22	conj	_	_
46	IL-1	_	NN	NN	_	48	nn	_	_
47	beta-stimulated	_	JJ	JJ	_	48	amod	_	_
48	HUVEC	_	NNS	NNS	_	45	pobj	_	_
49	by	_	IN	IN	_	45	prep	_	_
50	56	_	CD	CD	_	51	num	_	_
51	%	_	NN	NN	_	49	pobj	_	_
52	-LRB-	_	-LRB-	-LRB-	_	53	punct	_	_
53	P	_	NN	NN	_	51	dep	_	_
54	&lt;	_	JJR	JJR	_	53	amod	_	_
55	0.010	_	CD	CD	_	54	dep	_	_
56	-RRB-	_	-RRB-	-RRB-	_	53	punct	_	_
57	.	_	.	.	_	22	punct	_	_

1	Electrophoretic	_	JJ	JJ	_	3	amod	_	_
2	mobility-shift	_	JJ	JJ	_	3	amod	_	_
3	assays	_	NNS	NNS	_	8	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	HUVEC	_	NNS	NNS	_	4	pobj	_	_
6	nuclear	_	JJ	JJ	_	7	amod	_	_
7	proteins	_	NNS	NNS	_	5	dep	_	_
8	revealed	_	VBD	VBD	_	0	root	_	_
9	a	_	DT	DT	_	10	det	_	_
10	decrease	_	NN	NN	_	8	dobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	TNF-alpha-stimulated	_	JJ	JJ	_	15	amod	_	_
13	nuclear	_	JJ	JJ	_	15	amod	_	_
14	factor-kappa	_	NN	NN	_	15	nn	_	_
15	B	_	NN	NN	_	20	nn	_	_
16	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
17	NF-kappa	_	NN	NN	_	18	nn	_	_
18	B	_	NN	NN	_	15	appos	_	_
19	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
20	activation	_	NN	NN	_	11	pobj	_	_
21	after	_	IN	IN	_	10	prep	_	_
22	pretreatment	_	NN	NN	_	21	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	HUVEC	_	NNS	NNS	_	23	pobj	_	_
25	with	_	IN	IN	_	22	prep	_	_
26	TCP	_	NN	NN	_	27	nn	_	_
27	succinate	_	NN	NN	_	25	pobj	_	_
28	but	_	CC	CC	_	25	cc	_	_
29	not	_	RB	RB	_	30	neg	_	_
30	with	_	IN	IN	_	25	conj	_	_
31	TCP	_	NN	NN	_	30	pobj	_	_
32	,	_	,	,	_	31	punct	_	_
33	TCP	_	NN	NN	_	34	nn	_	_
34	acetate	_	NN	NN	_	31	conj	_	_
35	,	_	,	,	_	31	punct	_	_
36	or	_	CC	CC	_	31	cc	_	_
37	succinate	_	NN	NN	_	31	conj	_	_
38	alone	_	RB	RB	_	31	advmod	_	_
39	.	_	.	.	_	8	punct	_	_

1	In	_	IN	IN	_	5	prep	_	_
2	conclusion	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	5	punct	_	_
4	we	_	PRP	PRP	_	5	nsubj	_	_
5	demonstrate	_	VBP	VBP	_	0	root	_	_
6	that	_	IN	IN	_	13	mark	_	_
7	the	_	DT	DT	_	12	det	_	_
8	vitamin	_	NN	NN	_	12	nn	_	_
9	E	_	NN	NN	_	12	nn	_	_
10	derivative	_	NN	NN	_	12	nn	_	_
11	TCP	_	NN	NN	_	12	nn	_	_
12	succinate	_	NN	NN	_	13	nsubj	_	_
13	prevents	_	VBZ	VBZ	_	5	ccomp	_	_
14	monocytic	_	JJ	JJ	_	16	amod	_	_
15	cell	_	NN	NN	_	16	nn	_	_
16	adhesion	_	NN	NN	_	13	dobj	_	_
17	to	_	TO	TO	_	16	prep	_	_
18	cytokine-stimulated	_	JJ	JJ	_	20	amod	_	_
19	endothelial	_	JJ	JJ	_	20	amod	_	_
20	cells	_	NNS	NNS	_	17	pobj	_	_
21	by	_	IN	IN	_	13	prep	_	_
22	inhibiting	_	VBG	VBG	_	21	pcomp	_	_
23	the	_	DT	DT	_	24	det	_	_
24	activation	_	NN	NN	_	22	dobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	NF-kappa	_	NN	NN	_	27	nn	_	_
27	B	_	NN	NN	_	25	pobj	_	_
28	,	_	,	,	_	13	punct	_	_
29	further	_	RB	RB	_	30	advmod	_	_
30	emphasizing	_	VBG	VBG	_	13	vmod	_	_
31	the	_	DT	DT	_	33	det	_	_
32	antiatherosclerotic	_	JJ	JJ	_	33	amod	_	_
33	potential	_	NN	NN	_	30	dobj	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	lipid	_	NN	NN	_	37	nn	_	_
36	soluble	_	JJ	JJ	_	37	amod	_	_
37	antioxidants	_	NNS	NNS	_	34	pobj	_	_
38	.	_	.	.	_	5	punct	_	_

1	Regulation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	inosine-5'-monophosphate	_	NN	NN	_	5	nn	_	_
4	dehydrogenase	_	NN	NN	_	5	nn	_	_
5	type	_	NN	NN	_	8	nn	_	_
6	II	_	CD	CD	_	5	num	_	_
7	gene	_	NN	NN	_	8	nn	_	_
8	expression	_	NN	NN	_	2	pobj	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	human	_	JJ	JJ	_	12	amod	_	_
11	T	_	NN	NN	_	12	nn	_	_
12	cells	_	NNS	NNS	_	9	pobj	_	_
13	.	_	.	.	_	1	punct	_	_

1	Role	_	NN	NN	_	0	root	_	_
2	for	_	IN	IN	_	1	prep	_	_
3	a	_	DT	DT	_	8	det	_	_
4	novel	_	JJ	JJ	_	8	amod	_	_
5	5'	_	JJ	JJ	_	8	amod	_	_
6	palindromic	_	JJ	JJ	_	8	amod	_	_
7	octamer	_	NN	NN	_	8	nn	_	_
8	sequence	_	NN	NN	_	2	pobj	_	_
9	.	_	.	.	_	1	punct	_	_

1	Expression	_	NN	NN	_	29	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	4	det	_	_
4	gene	_	NN	NN	_	2	pobj	_	_
5	encoding	_	VBG	VBG	_	4	vmod	_	_
6	human	_	JJ	JJ	_	12	amod	_	_
7	inosine-5'-monophosphate	_	NN	NN	_	12	nn	_	_
8	dehydrogenase	_	NN	NN	_	12	nn	_	_
9	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
10	IMPDH	_	NN	NN	_	12	nn	_	_
11	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
12	type	_	NN	NN	_	5	dobj	_	_
13	II	_	CD	CD	_	12	num	_	_
14	,	_	,	,	_	12	punct	_	_
15	an	_	DT	DT	_	16	det	_	_
16	enzyme	_	NN	NN	_	12	appos	_	_
17	catalyzing	_	VBG	VBG	_	16	vmod	_	_
18	the	_	DT	DT	_	20	det	_	_
19	rate-limiting	_	JJ	JJ	_	20	amod	_	_
20	step	_	NN	NN	_	17	dobj	_	_
21	in	_	IN	IN	_	17	prep	_	_
22	the	_	DT	DT	_	23	det	_	_
23	generation	_	NN	NN	_	21	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	guanine	_	NN	NN	_	26	nn	_	_
26	nucleotides	_	NNS	NNS	_	24	pobj	_	_
27	,	_	,	,	_	1	punct	_	_
28	is	_	VBZ	VBZ	_	29	auxpass	_	_
29	increased	_	VBN	VBN	_	0	root	_	_
30	more	_	JJR	JJR	_	29	dobj	_	_
31	than	_	IN	IN	_	30	amod	_	_
32	10-fold	_	RB	RB	_	30	advmod	_	_
33	in	_	IN	IN	_	29	prep	_	_
34	activated	_	VBN	VBN	_	38	amod	_	_
35	peripheral	_	JJ	JJ	_	38	amod	_	_
36	blood	_	NN	NN	_	38	nn	_	_
37	T	_	NN	NN	_	38	nn	_	_
38	lymphocytes	_	NNS	NNS	_	33	pobj	_	_
39	and	_	CC	CC	_	29	cc	_	_
40	is	_	VBZ	VBZ	_	41	auxpass	_	_
41	required	_	VBN	VBN	_	29	conj	_	_
42	for	_	IN	IN	_	41	prep	_	_
43	T	_	NN	NN	_	45	nn	_	_
44	cell	_	NN	NN	_	45	nn	_	_
45	activation	_	NN	NN	_	42	pobj	_	_
46	.	_	.	.	_	29	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	examined	_	VBN	VBN	_	0	root	_	_
4	the	_	DT	DT	_	6	det	_	_
5	5'-regulatory	_	JJ	JJ	_	6	amod	_	_
6	sequences	_	NNS	NNS	_	3	dobj	_	_
7	that	_	WDT	WDT	_	9	nsubj	_	_
8	are	_	VBP	VBP	_	9	cop	_	_
9	important	_	JJ	JJ	_	6	rcmod	_	_
10	for	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	transcriptional	_	JJ	JJ	_	13	amod	_	_
13	regulation	_	NN	NN	_	10	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	this	_	DT	DT	_	16	det	_	_
16	gene	_	NN	NN	_	14	pobj	_	_
17	in	_	IN	IN	_	13	prep	_	_
18	T	_	NN	NN	_	19	nn	_	_
19	cells	_	NNS	NNS	_	17	pobj	_	_
20	.	_	.	.	_	3	punct	_	_

1	DNase	_	NN	NN	_	3	nn	_	_
2	I	_	CD	CD	_	1	num	_	_
3	mapping	_	NN	NN	_	7	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	genomic	_	JJ	JJ	_	6	amod	_	_
6	DNA	_	NN	NN	_	4	pobj	_	_
7	identified	_	VBD	VBD	_	0	root	_	_
8	a	_	DT	DT	_	10	det	_	_
9	hypersensitive	_	JJ	JJ	_	10	amod	_	_
10	element	_	NN	NN	_	7	dobj	_	_
11	near	_	IN	IN	_	7	prep	_	_
12	the	_	DT	DT	_	15	det	_	_
13	transcription	_	NN	NN	_	15	nn	_	_
14	initiation	_	NN	NN	_	15	nn	_	_
15	site	_	NN	NN	_	11	pobj	_	_
16	.	_	.	.	_	7	punct	_	_

1	Fine	_	JJ	JJ	_	2	amod	_	_
2	mapping	_	NN	NN	_	7	nsubj	_	_
3	by	_	IN	IN	_	2	prep	_	_
4	in	_	FW	FW	_	6	amod	_	_
5	vivo	_	FW	FW	_	4	dep	_	_
6	footprinting	_	NN	NN	_	3	pobj	_	_
7	demonstrated	_	VBD	VBD	_	0	root	_	_
8	five	_	CD	CD	_	12	num	_	_
9	transcription	_	NN	NN	_	12	nn	_	_
10	factor	_	NN	NN	_	12	nn	_	_
11	binding	_	NN	NN	_	12	nn	_	_
12	sites	_	NNS	NNS	_	7	dobj	_	_
13	that	_	WDT	WDT	_	15	nsubjpass	_	_
14	are	_	VBP	VBP	_	15	auxpass	_	_
15	occupied	_	VBN	VBN	_	12	rcmod	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	both	_	CC	CC	_	18	preconj	_	_
18	resting	_	VBG	VBG	_	16	pobj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	activated	_	VBN	VBN	_	24	amod	_	_
21	peripheral	_	JJ	JJ	_	24	amod	_	_
22	blood	_	NN	NN	_	24	nn	_	_
23	T	_	NN	NN	_	24	nn	_	_
24	lymphocytes	_	NNS	NNS	_	18	conj	_	_
25	;	_	:	:	_	7	punct	_	_
26	these	_	DT	DT	_	30	nsubj	_	_
27	are	_	VBP	VBP	_	30	cop	_	_
28	tandem	_	JJ	JJ	_	30	amod	_	_
29	CRE	_	NN	NN	_	30	nn	_	_
30	motifs	_	NNS	NNS	_	7	parataxis	_	_
31	,	_	,	,	_	30	punct	_	_
32	a	_	DT	DT	_	34	det	_	_
33	Sp1	_	NN	NN	_	34	nn	_	_
34	site	_	NN	NN	_	30	conj	_	_
35	,	_	,	,	_	30	punct	_	_
36	an	_	DT	DT	_	39	det	_	_
37	overlapping	_	JJ	JJ	_	39	amod	_	_
38	Egr-1/Sp1	_	NN	NN	_	39	nn	_	_
39	site	_	NN	NN	_	30	conj	_	_
40	,	_	,	,	_	30	punct	_	_
41	and	_	CC	CC	_	30	cc	_	_
42	a	_	DT	DT	_	46	det	_	_
43	novel	_	JJ	JJ	_	46	amod	_	_
44	palindromic	_	JJ	JJ	_	46	amod	_	_
45	octamer	_	NN	NN	_	46	nn	_	_
46	sequence	_	NN	NN	_	30	conj	_	_
47	-LRB-	_	-LRB-	-LRB-	_	48	punct	_	_
48	POS	_	NN	NN	_	46	appos	_	_
49	-RRB-	_	-RRB-	-RRB-	_	48	punct	_	_
50	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	3	dep	_	_
2	tandem	_	JJ	JJ	_	3	amod	_	_
3	CRE	_	NN	NN	_	7	nsubj	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	POS	_	NN	NN	_	3	conj	_	_
6	sites	_	NNS	NNS	_	3	dep	_	_
7	are	_	VBP	VBP	_	0	root	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	major	_	JJ	JJ	_	11	amod	_	_
10	functional	_	JJ	JJ	_	9	dep	_	_
11	importance	_	NN	NN	_	8	pobj	_	_
12	as	_	IN	IN	_	13	mark	_	_
13	judged	_	VBN	VBN	_	7	advcl	_	_
14	by	_	IN	IN	_	13	prep	_	_
15	mutational	_	JJ	JJ	_	14	pobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	electrophoretic	_	JJ	JJ	_	15	conj	_	_
18	mobility	_	NN	NN	_	20	nn	_	_
19	shift	_	NN	NN	_	20	nn	_	_
20	analyses	_	NNS	NNS	_	15	dep	_	_
21	.	_	.	.	_	7	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	provide	_	VBP	VBP	_	0	root	_	_
4	evidence	_	NN	NN	_	3	dobj	_	_
5	that	_	IN	IN	_	16	mark	_	_
6	expression	_	NN	NN	_	16	nsubjpass	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	13	det	_	_
9	human	_	JJ	JJ	_	13	amod	_	_
10	IMPDH	_	NN	NN	_	13	nn	_	_
11	type	_	NN	NN	_	13	nn	_	_
12	II	_	CD	CD	_	13	num	_	_
13	gene	_	NN	NN	_	7	pobj	_	_
14	is	_	VBZ	VBZ	_	16	auxpass	_	_
15	predominantly	_	RB	RB	_	16	advmod	_	_
16	regulated	_	VBN	VBN	_	4	ccomp	_	_
17	by	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	nuclear	_	JJ	JJ	_	20	amod	_	_
20	factors	_	NNS	NNS	_	17	pobj	_	_
21	ATF-2	_	NN	NN	_	20	dep	_	_
22	and	_	CC	CC	_	20	cc	_	_
23	an	_	DT	DT	_	28	det	_	_
24	as	_	RB	RB	_	25	advmod	_	_
25	yet	_	RB	RB	_	26	advmod	_	_
26	unidentified	_	JJ	JJ	_	28	amod	_	_
27	POS-binding	_	JJ	JJ	_	28	amod	_	_
28	protein	_	NN	NN	_	20	conj	_	_
29	.	_	.	.	_	3	punct	_	_

1	Additional	_	JJ	JJ	_	4	amod	_	_
2	major	_	JJ	JJ	_	1	dep	_	_
3	protein-DNA	_	JJ	JJ	_	4	amod	_	_
4	interactions	_	NNS	NNS	_	7	nsubj	_	_
5	do	_	VBP	VBP	_	7	aux	_	_
6	not	_	RB	RB	_	7	neg	_	_
7	occur	_	VB	VB	_	0	root	_	_
8	within	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	promoter	_	NN	NN	_	11	nn	_	_
11	region	_	NN	NN	_	8	pobj	_	_
12	after	_	IN	IN	_	7	prep	_	_
13	T	_	NN	NN	_	15	nn	_	_
14	lymphocyte	_	NN	NN	_	15	nn	_	_
15	activation	_	NN	NN	_	12	pobj	_	_
16	,	_	,	,	_	7	punct	_	_
17	indicating	_	VBG	VBG	_	7	vmod	_	_
18	a	_	DT	DT	_	19	det	_	_
19	requirement	_	NN	NN	_	17	dobj	_	_
20	for	_	IN	IN	_	19	prep	_	_
21	additional	_	JJ	JJ	_	23	amod	_	_
22	protein-protein	_	JJ	JJ	_	23	amod	_	_
23	interactions	_	NNS	NNS	_	20	pobj	_	_
24	and/or	_	CC	CC	_	23	cc	_	_
25	post-translational	_	JJ	JJ	_	26	amod	_	_
26	modifications	_	NNS	NNS	_	23	conj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	pre-bound	_	JJ	JJ	_	30	amod	_	_
29	transcription	_	NN	NN	_	30	nn	_	_
30	factors	_	NNS	NNS	_	27	pobj	_	_
31	to	_	TO	TO	_	32	aux	_	_
32	account	_	VB	VB	_	19	vmod	_	_
33	for	_	IN	IN	_	32	prep	_	_
34	the	_	DT	DT	_	36	det	_	_
35	observed	_	VBN	VBN	_	36	amod	_	_
36	increase	_	NN	NN	_	33	pobj	_	_
37	in	_	IN	IN	_	36	prep	_	_
38	IMPDH	_	NN	NN	_	42	nn	_	_
39	type	_	NN	NN	_	42	nn	_	_
40	II	_	CD	CD	_	42	num	_	_
41	gene	_	NN	NN	_	42	nn	_	_
42	expression	_	NN	NN	_	37	pobj	_	_
43	.	_	.	.	_	7	punct	_	_

1	Transcriptional	_	JJ	JJ	_	2	amod	_	_
2	regulation	_	NN	NN	_	0	root	_	_
3	during	_	IN	IN	_	2	prep	_	_
4	myelopoiesis	_	NN	NN	_	3	pobj	_	_
5	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	coordinated	_	VBN	VBN	_	3	amod	_	_
3	production	_	NN	NN	_	17	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	all	_	DT	DT	_	7	det	_	_
6	blood	_	NN	NN	_	7	nn	_	_
7	cells	_	NNS	NNS	_	4	pobj	_	_
8	from	_	IN	IN	_	3	prep	_	_
9	a	_	DT	DT	_	12	det	_	_
10	common	_	JJ	JJ	_	12	amod	_	_
11	stem	_	NN	NN	_	12	nn	_	_
12	cell	_	NN	NN	_	8	pobj	_	_
13	is	_	VBZ	VBZ	_	17	cop	_	_
14	a	_	DT	DT	_	17	det	_	_
15	highly	_	RB	RB	_	16	advmod	_	_
16	regulated	_	VBN	VBN	_	17	amod	_	_
17	process	_	NN	NN	_	0	root	_	_
18	involving	_	VBG	VBG	_	17	vmod	_	_
19	successive	_	JJ	JJ	_	20	amod	_	_
20	stages	_	NNS	NNS	_	18	dobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	commitment	_	NN	NN	_	21	pobj	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	differentiation	_	NN	NN	_	22	conj	_	_
25	.	_	.	.	_	17	punct	_	_

1	From	_	IN	IN	_	23	prep	_	_
2	analyses	_	NNS	NNS	_	1	pobj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	mice	_	NNS	NNS	_	3	pobj	_	_
5	deficient	_	JJ	JJ	_	4	amod	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	transcription	_	NN	NN	_	9	nn	_	_
8	factor	_	NN	NN	_	9	nn	_	_
9	genes	_	NNS	NNS	_	6	pobj	_	_
10	and	_	CC	CC	_	1	cc	_	_
11	from	_	IN	IN	_	1	conj	_	_
12	the	_	DT	DT	_	13	det	_	_
13	characterizations	_	NNS	NNS	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	chromosome	_	NN	NN	_	16	nn	_	_
16	breakpoints	_	NNS	NNS	_	14	pobj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	human	_	JJ	JJ	_	19	amod	_	_
19	leukemias	_	NNS	NNS	_	17	pobj	_	_
20	,	_	,	,	_	23	punct	_	_
21	it	_	PRP	PRP	_	23	nsubj	_	_
22	has	_	VBZ	VBZ	_	23	aux	_	_
23	become	_	VBN	VBN	_	0	root	_	_
24	evident	_	JJ	JJ	_	23	acomp	_	_
25	that	_	IN	IN	_	30	mark	_	_
26	transcription	_	NN	NN	_	27	nn	_	_
27	factors	_	NNS	NNS	_	30	nsubj	_	_
28	are	_	VBP	VBP	_	30	cop	_	_
29	important	_	JJ	JJ	_	30	amod	_	_
30	regulators	_	NNS	NNS	_	23	ccomp	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	hematopoiesis	_	NN	NN	_	31	pobj	_	_
33	.	_	.	.	_	23	punct	_	_

1	During	_	IN	IN	_	20	prep	_	_
2	myelopoiesis	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	2	punct	_	_
4	which	_	WDT	WDT	_	5	nsubj	_	_
5	includes	_	VBZ	VBZ	_	2	rcmod	_	_
6	the	_	DT	DT	_	7	det	_	_
7	development	_	NN	NN	_	5	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	granulocytic	_	JJ	JJ	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	monocytic	_	JJ	JJ	_	9	conj	_	_
12	lineages	_	NNS	NNS	_	9	dep	_	_
13	,	_	,	,	_	20	punct	_	_
14	transcription	_	NN	NN	_	15	nn	_	_
15	factors	_	NNS	NNS	_	20	nsubj	_	_
16	from	_	IN	IN	_	15	prep	_	_
17	several	_	JJ	JJ	_	18	amod	_	_
18	families	_	NNS	NNS	_	16	pobj	_	_
19	are	_	VBP	VBP	_	20	cop	_	_
20	active	_	JJ	JJ	_	0	root	_	_
21	,	_	,	,	_	20	punct	_	_
22	including	_	VBG	VBG	_	20	prep	_	_
23	AML1/CBF	_	NN	NN	_	24	nn	_	_
24	beta	_	NN	NN	_	22	pobj	_	_
25	,	_	,	,	_	24	punct	_	_
26	C/EBP	_	NN	NN	_	24	conj	_	_
27	,	_	,	,	_	24	punct	_	_
28	Ets	_	NN	NN	_	24	conj	_	_
29	,	_	,	,	_	24	punct	_	_
30	c-Myb	_	NN	NN	_	24	conj	_	_
31	,	_	,	,	_	24	punct	_	_
32	HOX	_	NN	NN	_	24	conj	_	_
33	,	_	,	,	_	24	punct	_	_
34	and	_	CC	CC	_	24	cc	_	_
35	MZF-1	_	NN	NN	_	24	conj	_	_
36	.	_	.	.	_	20	punct	_	_

1	Few	_	JJ	JJ	_	6	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	these	_	DT	DT	_	4	det	_	_
4	factors	_	NNS	NNS	_	2	pobj	_	_
5	are	_	VBP	VBP	_	6	auxpass	_	_
6	expressed	_	VBN	VBN	_	0	root	_	_
7	exclusively	_	RB	RB	_	8	advmod	_	_
8	in	_	IN	IN	_	6	prep	_	_
9	myeloid	_	JJ	JJ	_	10	amod	_	_
10	cells	_	NNS	NNS	_	8	pobj	_	_
11	;	_	:	:	_	6	punct	_	_
12	instead	_	RB	RB	_	14	advmod	_	_
13	it	_	PRP	PRP	_	14	nsubj	_	_
14	appears	_	VBZ	VBZ	_	6	parataxis	_	_
15	that	_	IN	IN	_	18	mark	_	_
16	they	_	PRP	PRP	_	18	nsubj	_	_
17	cooperatively	_	RB	RB	_	18	advmod	_	_
18	regulate	_	VBP	VBP	_	14	ccomp	_	_
19	transcription	_	NN	NN	_	18	dobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	myeloid-specific	_	JJ	JJ	_	22	amod	_	_
22	genes	_	NNS	NNS	_	20	pobj	_	_
23	.	_	.	.	_	6	punct	_	_

1	Here	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	discuss	_	VBP	VBP	_	0	root	_	_
4	recent	_	JJ	JJ	_	5	amod	_	_
5	advances	_	NNS	NNS	_	3	dobj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	transcriptional	_	JJ	JJ	_	8	amod	_	_
8	regulation	_	NN	NN	_	6	pobj	_	_
9	during	_	IN	IN	_	8	prep	_	_
10	myelopoiesis	_	NN	NN	_	9	pobj	_	_
11	.	_	.	.	_	3	punct	_	_

1	Transcription	_	NN	NN	_	2	nn	_	_
2	factor	_	NN	NN	_	4	nn	_	_
3	Egr-1	_	NN	NN	_	2	dep	_	_
4	activity	_	NN	NN	_	5	nsubj	_	_
5	down-regulates	_	VBZ	VBZ	_	0	root	_	_
6	Fas	_	NN	NN	_	5	dobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	CD23	_	NN	NN	_	6	conj	_	_
9	expression	_	NN	NN	_	6	dep	_	_
10	in	_	IN	IN	_	6	prep	_	_
11	B	_	NN	NN	_	12	nn	_	_
12	cells	_	NNS	NNS	_	10	pobj	_	_
13	.	_	.	.	_	5	punct	_	_

1	Activation	_	NN	NN	_	10	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	mature	_	JJ	JJ	_	5	amod	_	_
4	B	_	NN	NN	_	5	nn	_	_
5	cells	_	NNS	NNS	_	2	pobj	_	_
6	via	_	IN	IN	_	1	prep	_	_
7	Ag	_	NN	NN	_	8	nn	_	_
8	receptor	_	NN	NN	_	9	nn	_	_
9	cross-linking	_	NN	NN	_	6	pobj	_	_
10	induces	_	VBZ	VBZ	_	0	root	_	_
11	transient	_	JJ	JJ	_	12	amod	_	_
12	expression	_	NN	NN	_	10	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	transcription	_	NN	NN	_	16	nn	_	_
16	factor	_	NN	NN	_	13	pobj	_	_
17	Egr-1	_	NN	NN	_	16	dep	_	_
18	.	_	.	.	_	10	punct	_	_

1	Although	_	IN	IN	_	11	mark	_	_
2	the	_	DT	DT	_	4	det	_	_
3	activating	_	VBG	VBG	_	4	amod	_	_
4	signals	_	NNS	NNS	_	11	nsubjpass	_	_
5	leading	_	VBG	VBG	_	4	vmod	_	_
6	to	_	TO	TO	_	5	prep	_	_
7	Egr-1	_	NN	NN	_	8	nn	_	_
8	induction	_	NN	NN	_	6	pobj	_	_
9	have	_	VBP	VBP	_	11	aux	_	_
10	been	_	VBN	VBN	_	11	auxpass	_	_
11	studied	_	VBN	VBN	_	16	advcl	_	_
12	extensively	_	RB	RB	_	11	advmod	_	_
13	,	_	,	,	_	16	punct	_	_
14	little	_	JJ	JJ	_	16	nsubjpass	_	_
15	is	_	VBZ	VBZ	_	16	auxpass	_	_
16	known	_	VBN	VBN	_	0	root	_	_
17	about	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	19	det	_	_
19	genes	_	NNS	NNS	_	17	pobj	_	_
20	that	_	WDT	WDT	_	22	nsubjpass	_	_
21	are	_	VBP	VBP	_	22	auxpass	_	_
22	placed	_	VBN	VBN	_	19	rcmod	_	_
23	further	_	RBR	RBR	_	24	advmod	_	_
24	downstream	_	RB	RB	_	22	advmod	_	_
25	within	_	IN	IN	_	24	prep	_	_
26	this	_	DT	DT	_	28	det	_	_
27	activation	_	NN	NN	_	28	nn	_	_
28	cascade	_	NN	NN	_	25	pobj	_	_
29	and	_	CC	CC	_	22	cc	_	_
30	that	_	WDT	WDT	_	33	nsubjpass	_	_
31	are	_	VBP	VBP	_	33	auxpass	_	_
32	transcriptionally	_	RB	RB	_	33	advmod	_	_
33	regulated	_	VBN	VBN	_	22	conj	_	_
34	by	_	IN	IN	_	33	prep	_	_
35	Egr-1	_	NN	NN	_	34	pobj	_	_
36	.	_	.	.	_	16	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	identify	_	VB	VB	_	0	root	_	_
3	such	_	JJ	JJ	_	5	amod	_	_
4	target	_	NN	NN	_	5	nn	_	_
5	genes	_	NNS	NNS	_	2	dobj	_	_
6	,	_	,	,	_	2	punct	_	_
7	we	_	PRP	PRP	_	8	nsubj	_	_
8	established	_	VBD	VBD	_	2	parataxis	_	_
9	Egr-1-overexpressing	_	JJ	JJ	_	10	amod	_	_
10	transfectants	_	NNS	NNS	_	8	dobj	_	_
11	from	_	IN	IN	_	8	prep	_	_
12	the	_	DT	DT	_	17	det	_	_
13	murine	_	JJ	JJ	_	17	amod	_	_
14	B	_	NN	NN	_	17	nn	_	_
15	cell	_	NN	NN	_	17	nn	_	_
16	line	_	NN	NN	_	17	nn	_	_
17	K46	_	NN	NN	_	11	pobj	_	_
18	and	_	CC	CC	_	11	cc	_	_
19	from	_	IN	IN	_	11	conj	_	_
20	human	_	JJ	JJ	_	23	amod	_	_
21	Ramos	_	NN	NN	_	23	nn	_	_
22	B	_	NN	NN	_	23	nn	_	_
23	cells	_	NNS	NNS	_	19	pobj	_	_
24	.	_	.	.	_	2	punct	_	_

1	All	_	DT	DT	_	2	det	_	_
2	clones	_	NNS	NNS	_	8	nsubj	_	_
3	derived	_	VBN	VBN	_	2	vmod	_	_
4	from	_	IN	IN	_	3	prep	_	_
5	K46	_	NN	NN	_	7	nn	_	_
6	B	_	NN	NN	_	7	nn	_	_
7	cells	_	NNS	NNS	_	4	pobj	_	_
8	showed	_	VBD	VBD	_	0	root	_	_
9	increased	_	VBN	VBN	_	10	amod	_	_
10	expression	_	NN	NN	_	8	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	CD44	_	NN	NN	_	11	pobj	_	_
13	.	_	.	.	_	8	punct	_	_

1	Most	_	RBS	RBS	_	2	advmod	_	_
2	interestingly	_	RB	RB	_	14	advmod	_	_
3	,	_	,	,	_	14	punct	_	_
4	expression	_	NN	NN	_	14	nsubjpass	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	CD95	_	NN	NN	_	5	pobj	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	Fas/Apo-1	_	NN	NN	_	6	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	and	_	CC	CC	_	5	cc	_	_
11	of	_	IN	IN	_	5	conj	_	_
12	CD23	_	NN	NN	_	11	pobj	_	_
13	was	_	VBD	VBD	_	14	auxpass	_	_
14	down-regulated	_	VBN	VBN	_	0	root	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	all	_	DT	DT	_	18	det	_	_
17	K46	_	NN	NN	_	18	nn	_	_
18	transfectants	_	NNS	NNS	_	15	pobj	_	_
19	.	_	.	.	_	14	punct	_	_

1	As	_	IN	IN	_	6	prep	_	_
2	a	_	DT	DT	_	3	det	_	_
3	consequence	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	they	_	PRP	PRP	_	6	nsubj	_	_
6	became	_	VBD	VBD	_	0	root	_	_
7	resistant	_	JJ	JJ	_	6	acomp	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	apoptosis	_	NN	NN	_	8	pobj	_	_
10	induced	_	VBN	VBN	_	9	vmod	_	_
11	by	_	IN	IN	_	10	prep	_	_
12	anti-CD95	_	JJ	JJ	_	13	amod	_	_
13	Ab	_	NN	NN	_	14	nn	_	_
14	treatment	_	NN	NN	_	11	pobj	_	_
15	.	_	.	.	_	6	punct	_	_

1	Similarly	_	RB	RB	_	7	advmod	_	_
2	,	_	,	,	_	7	punct	_	_
3	the	_	DT	DT	_	6	det	_	_
4	Egr-1-expressing	_	JJ	JJ	_	6	amod	_	_
5	Ramos	_	NN	NN	_	6	nn	_	_
6	cells	_	NNS	NNS	_	7	nsubj	_	_
7	showed	_	VBD	VBD	_	0	root	_	_
8	reduced	_	VBN	VBN	_	9	amod	_	_
9	levels	_	NNS	NNS	_	7	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	CD95	_	NN	NN	_	12	nn	_	_
12	expression	_	NN	NN	_	10	pobj	_	_
13	.	_	.	.	_	7	punct	_	_

1	Thus	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	Egr-1	_	NN	NN	_	4	nsubj	_	_
4	seems	_	VBZ	VBZ	_	0	root	_	_
5	to	_	TO	TO	_	6	aux	_	_
6	control	_	VB	VB	_	4	xcomp	_	_
7	the	_	DT	DT	_	8	det	_	_
8	expression	_	NN	NN	_	6	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	downstream	_	JJ	JJ	_	12	amod	_	_
11	target	_	NN	NN	_	12	nn	_	_
12	genes	_	NNS	NNS	_	9	pobj	_	_
13	not	_	RB	RB	_	14	neg	_	_
14	only	_	RB	RB	_	15	preconj	_	_
15	as	_	IN	IN	_	6	prep	_	_
16	a	_	DT	DT	_	18	det	_	_
17	transcriptional	_	JJ	JJ	_	18	amod	_	_
18	activator	_	NN	NN	_	15	pobj	_	_
19	,	_	,	,	_	15	punct	_	_
20	but	_	CC	CC	_	21	cc	_	_
21	also	_	RB	RB	_	15	cc	_	_
22	as	_	IN	IN	_	15	conj	_	_
23	a	_	DT	DT	_	25	det	_	_
24	repressor	_	NN	NN	_	25	nn	_	_
25	molecule	_	NN	NN	_	22	pobj	_	_
26	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	B	_	NN	NN	_	3	nn	_	_
3	cells	_	NNS	NNS	_	1	pobj	_	_
4	,	_	,	,	_	7	punct	_	_
5	Egr-1	_	NN	NN	_	7	nsubj	_	_
6	therefore	_	RB	RB	_	7	advmod	_	_
7	plays	_	VBZ	VBZ	_	0	root	_	_
8	a	_	DT	DT	_	10	det	_	_
9	critical	_	JJ	JJ	_	10	amod	_	_
10	role	_	NN	NN	_	7	dobj	_	_
11	in	_	IN	IN	_	7	prep	_	_
12	integrating	_	VBG	VBG	_	11	pcomp	_	_
13	the	_	DT	DT	_	15	det	_	_
14	short-lived	_	JJ	JJ	_	15	amod	_	_
15	signal	_	NN	NN	_	12	dobj	_	_
16	delivered	_	VBN	VBN	_	15	vmod	_	_
17	by	_	IN	IN	_	16	prep	_	_
18	triggering	_	NN	NN	_	17	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	22	det	_	_
21	Ag	_	NN	NN	_	22	nn	_	_
22	receptor	_	NN	NN	_	19	pobj	_	_
23	into	_	IN	IN	_	12	prep	_	_
24	phenotypic	_	JJ	JJ	_	25	amod	_	_
25	changes	_	NNS	NNS	_	23	pobj	_	_
26	,	_	,	,	_	25	punct	_	_
27	including	_	VBG	VBG	_	25	prep	_	_
28	repression	_	NN	NN	_	27	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	CD95	_	NN	NN	_	29	pobj	_	_
31	and	_	CC	CC	_	28	cc	_	_
32	CD23	_	NN	NN	_	33	nn	_	_
33	transcription	_	NN	NN	_	28	conj	_	_
34	.	_	.	.	_	7	punct	_	_

1	Genomic	_	JJ	JJ	_	2	amod	_	_
2	organization	_	NN	NN	_	0	root	_	_
3	,	_	,	,	_	2	punct	_	_
4	sequence	_	NN	NN	_	2	appos	_	_
5	,	_	,	,	_	2	punct	_	_
6	and	_	CC	CC	_	2	cc	_	_
7	transcriptional	_	JJ	JJ	_	8	amod	_	_
8	regulation	_	NN	NN	_	2	conj	_	_
9	of	_	IN	IN	_	2	prep	_	_
10	the	_	DT	DT	_	13	det	_	_
11	human	_	JJ	JJ	_	13	amod	_	_
12	eotaxin	_	NN	NN	_	13	nn	_	_
13	gene	_	NN	NN	_	9	pobj	_	_
14	.	_	.	.	_	2	punct	_	_

1	Eotaxin	_	NN	NN	_	6	nsubj	_	_
2	is	_	VBZ	VBZ	_	6	cop	_	_
3	an	_	DT	DT	_	6	det	_	_
4	eosinophil	_	NN	NN	_	6	nn	_	_
5	specific	_	JJ	JJ	_	6	amod	_	_
6	beta-chemokine	_	NN	NN	_	0	root	_	_
7	assumed	_	VBN	VBN	_	6	vmod	_	_
8	to	_	TO	TO	_	10	aux	_	_
9	be	_	VB	VB	_	10	auxpass	_	_
10	involved	_	VBN	VBN	_	7	xcomp	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	eosinophilic	_	JJ	JJ	_	14	amod	_	_
13	inflammatory	_	JJ	JJ	_	12	dep	_	_
14	diseases	_	NNS	NNS	_	11	pobj	_	_
15	such	_	JJ	JJ	_	16	mwe	_	_
16	as	_	IN	IN	_	14	prep	_	_
17	atopic	_	JJ	JJ	_	18	amod	_	_
18	dermatitis	_	NN	NN	_	16	pobj	_	_
19	,	_	,	,	_	18	punct	_	_
20	allergic	_	JJ	JJ	_	21	amod	_	_
21	rhinitis	_	NN	NN	_	18	conj	_	_
22	,	_	,	,	_	18	punct	_	_
23	asthma	_	NN	NN	_	18	conj	_	_
24	and	_	CC	CC	_	18	cc	_	_
25	parasitic	_	JJ	JJ	_	26	amod	_	_
26	infections	_	NNS	NNS	_	18	conj	_	_
27	.	_	.	.	_	6	punct	_	_

1	Its	_	PRP$	PRP$	_	2	poss	_	_
2	expression	_	NN	NN	_	4	nsubj	_	_
3	is	_	VBZ	VBZ	_	4	cop	_	_
4	stimulus-	_	NN	NN	_	0	root	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	cell-specific	_	JJ	JJ	_	4	conj	_	_
7	.	_	.	.	_	4	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	here	_	RB	RB	_	3	advmod	_	_
3	describe	_	VBP	VBP	_	0	root	_	_
4	the	_	DT	DT	_	6	dep	_	_
5	genomic	_	JJ	JJ	_	6	amod	_	_
6	organisation	_	NN	NN	_	3	dobj	_	_
7	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
8	3	_	CD	CD	_	9	num	_	_
9	exons	_	NNS	NNS	_	6	dep	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	132	_	CD	CD	_	10	pobj	_	_
12	,	_	,	,	_	11	punct	_	_
13	112	_	CD	CD	_	11	conj	_	_
14	and	_	CC	CC	_	11	cc	_	_
15	542	_	CD	CD	_	11	conj	_	_
16	bp	_	NN	NN	_	11	dep	_	_
17	and	_	CC	CC	_	9	cc	_	_
18	2	_	CD	CD	_	19	num	_	_
19	introns	_	NNS	NNS	_	9	conj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	1211	_	CD	CD	_	20	pobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	378	_	CD	CD	_	21	conj	_	_
24	bp	_	NN	NN	_	21	dep	_	_
25	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
26	and	_	CC	CC	_	6	cc	_	_
27	sequence	_	NN	NN	_	6	conj	_	_
28	including	_	VBG	VBG	_	27	prep	_	_
29	3	_	CD	CD	_	30	num	_	_
30	kb	_	NN	NN	_	28	pobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	DNA	_	NN	NN	_	31	pobj	_	_
33	from	_	IN	IN	_	30	prep	_	_
34	the	_	DT	DT	_	38	det	_	_
35	immediate	_	JJ	JJ	_	38	amod	_	_
36	5'	_	JJ	JJ	_	38	amod	_	_
37	upstream	_	JJ	JJ	_	38	amod	_	_
38	region	_	NN	NN	_	33	pobj	_	_
39	of	_	IN	IN	_	38	prep	_	_
40	the	_	DT	DT	_	43	det	_	_
41	human	_	JJ	JJ	_	43	amod	_	_
42	eotaxin	_	NN	NN	_	43	nn	_	_
43	gene	_	NN	NN	_	39	pobj	_	_
44	.	_	.	.	_	3	punct	_	_

1	Among	_	IN	IN	_	19	prep	_	_
2	the	_	DT	DT	_	5	det	_	_
3	regulatory	_	JJ	JJ	_	5	amod	_	_
4	promoter	_	NN	NN	_	5	nn	_	_
5	elements	_	NNS	NNS	_	1	pobj	_	_
6	potentially	_	RB	RB	_	7	advmod	_	_
7	regulating	_	VBG	VBG	_	5	dep	_	_
8	eotaxin	_	NN	NN	_	9	nn	_	_
9	gene	_	NN	NN	_	10	nn	_	_
10	expression	_	NN	NN	_	7	dobj	_	_
11	and/or	_	CC	CC	_	7	cc	_	_
12	mediating	_	VBG	VBG	_	7	conj	_	_
13	the	_	DT	DT	_	14	det	_	_
14	effects	_	NNS	NNS	_	12	dobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	anti-inflammatory	_	JJ	JJ	_	17	amod	_	_
17	drugs	_	NNS	NNS	_	15	pobj	_	_
18	we	_	PRP	PRP	_	19	nsubj	_	_
19	identified	_	VBD	VBD	_	0	root	_	_
20	consensus	_	NN	NN	_	21	nn	_	_
21	sequences	_	NNS	NNS	_	19	dobj	_	_
22	known	_	VBN	VBN	_	21	vmod	_	_
23	to	_	TO	TO	_	24	aux	_	_
24	interact	_	VB	VB	_	22	xcomp	_	_
25	with	_	IN	IN	_	24	prep	_	_
26	nuclear	_	JJ	JJ	_	27	amod	_	_
27	factors	_	NNS	NNS	_	25	pobj	_	_
28	like	_	IN	IN	_	27	prep	_	_
29	NF-IL6	_	NN	NN	_	28	pobj	_	_
30	,	_	,	,	_	29	punct	_	_
31	AP-1	_	NN	NN	_	29	conj	_	_
32	,	_	,	,	_	29	punct	_	_
33	a	_	DT	DT	_	37	det	_	_
34	NF-kappa-B	_	NN	NN	_	37	nn	_	_
35	like	_	JJ	JJ	_	37	amod	_	_
36	consensus	_	NN	NN	_	37	nn	_	_
37	sequence	_	NN	NN	_	29	conj	_	_
38	and	_	CC	CC	_	29	cc	_	_
39	gamma-interferon-	_	NN	NN	_	29	conj	_	_
40	as	_	RB	RB	_	41	advmod	_	_
41	well	_	RB	RB	_	39	cc	_	_
42	as	_	IN	IN	_	41	mwe	_	_
43	glucocorticoid	_	NN	NN	_	39	conj	_	_
44	response	_	NN	NN	_	45	nn	_	_
45	elements	_	NNS	NNS	_	39	dep	_	_
46	.	_	.	.	_	19	punct	_	_

1	Vitamin	_	NN	NN	_	3	nn	_	_
2	D	_	NN	NN	_	3	nn	_	_
3	receptor	_	NN	NN	_	0	root	_	_
4	:	_	:	:	_	3	punct	_	_
5	no	_	DT	DT	_	6	neg	_	_
6	evidence	_	NN	NN	_	3	dep	_	_
7	for	_	IN	IN	_	6	prep	_	_
8	allele-specific	_	JJ	JJ	_	10	amod	_	_
9	mRNA	_	NN	NN	_	10	nn	_	_
10	stability	_	NN	NN	_	7	pobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	cells	_	NNS	NNS	_	11	pobj	_	_
13	which	_	WDT	WDT	_	15	nsubj	_	_
14	are	_	VBP	VBP	_	15	cop	_	_
15	heterozygous	_	JJ	JJ	_	12	rcmod	_	_
16	for	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	22	det	_	_
18	Taq	_	NN	NN	_	21	nn	_	_
19	I	_	NN	NN	_	21	nn	_	_
20	restriction	_	NN	NN	_	21	nn	_	_
21	enzyme	_	NN	NN	_	22	nn	_	_
22	polymorphism	_	NN	NN	_	16	pobj	_	_
23	.	_	.	.	_	3	punct	_	_

1	Allelic	_	JJ	JJ	_	2	amod	_	_
2	variations	_	NNS	NNS	_	14	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	11	det	_	_
5	vitamin	_	NN	NN	_	11	nn	_	_
6	D	_	NN	NN	_	11	nn	_	_
7	receptor	_	NN	NN	_	11	nn	_	_
8	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
9	VDR	_	NN	NN	_	11	nn	_	_
10	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
11	gene	_	NN	NN	_	3	pobj	_	_
12	have	_	VBP	VBP	_	14	aux	_	_
13	been	_	VBN	VBN	_	14	auxpass	_	_
14	associated	_	VBN	VBN	_	0	root	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	17	det	_	_
17	risk	_	NN	NN	_	15	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	developing	_	VBG	VBG	_	18	pcomp	_	_
20	prostate	_	NN	NN	_	21	nn	_	_
21	cancer	_	NN	NN	_	19	dobj	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	men	_	NNS	NNS	_	22	pobj	_	_
24	and	_	CC	CC	_	19	cc	_	_
25	osteoporosis	_	NN	NN	_	19	conj	_	_
26	in	_	IN	IN	_	25	prep	_	_
27	postmenopausal	_	JJ	JJ	_	28	amod	_	_
28	women	_	NNS	NNS	_	26	pobj	_	_
29	.	_	.	.	_	14	punct	_	_

1	Three	_	CD	CD	_	2	num	_	_
2	RFLPs	_	NNS	NNS	_	10	nsubj	_	_
3	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
4	TaqI	_	NN	NN	_	2	dep	_	_
5	,	_	,	,	_	4	punct	_	_
6	ApaI	_	NN	NN	_	4	appos	_	_
7	,	_	,	,	_	4	punct	_	_
8	BsmI	_	NN	NN	_	4	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
10	define	_	VBP	VBP	_	0	root	_	_
11	two	_	CD	CD	_	13	num	_	_
12	common	_	JJ	JJ	_	13	amod	_	_
13	haplotypes	_	NNS	NNS	_	10	dobj	_	_
14	:	_	:	:	_	10	punct	_	_
15	BAt	_	NN	NN	_	10	dep	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	baT	_	NN	NN	_	15	conj	_	_
18	.	_	.	.	_	10	punct	_	_

1	None	_	NN	NN	_	5	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	these	_	DT	DT	_	4	det	_	_
4	polymorphisms	_	NNS	NNS	_	2	pobj	_	_
5	change	_	VBP	VBP	_	0	root	_	_
6	the	_	DT	DT	_	8	det	_	_
7	translated	_	VBN	VBN	_	8	amod	_	_
8	protein	_	NN	NN	_	5	dobj	_	_
9	.	_	.	.	_	5	punct	_	_

1	Since	_	IN	IN	_	12	mark	_	_
2	sequence	_	NN	NN	_	3	nn	_	_
3	variations	_	NNS	NNS	_	12	nsubjpass	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	7	det	_	_
6	3'	_	JJ	JJ	_	7	amod	_	_
7	UTR	_	NN	NN	_	4	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	VDR	_	NN	NN	_	8	pobj	_	_
10	have	_	VBP	VBP	_	12	aux	_	_
11	been	_	VBN	VBN	_	12	auxpass	_	_
12	linked	_	VBN	VBN	_	20	advcl	_	_
13	to	_	TO	TO	_	12	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	different	_	JJ	JJ	_	16	amod	_	_
16	haplotypes	_	NNS	NNS	_	13	pobj	_	_
17	,	_	,	,	_	20	punct	_	_
18	investigators	_	NNS	NNS	_	20	nsubj	_	_
19	have	_	VBP	VBP	_	20	aux	_	_
20	proposed	_	VBN	VBN	_	0	root	_	_
21	that	_	IN	IN	_	28	mark	_	_
22	the	_	DT	DT	_	23	det	_	_
23	stability	_	NN	NN	_	28	nsubjpass	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	VDR	_	NN	NN	_	26	nn	_	_
26	mRNA	_	NN	NN	_	24	pobj	_	_
27	is	_	VBZ	VBZ	_	28	auxpass	_	_
28	influenced	_	VBN	VBN	_	20	ccomp	_	_
29	by	_	IN	IN	_	28	prep	_	_
30	allelic	_	JJ	JJ	_	31	amod	_	_
31	variations	_	NNS	NNS	_	29	pobj	_	_
32	.	_	.	.	_	20	punct	_	_

1	Indirect	_	JJ	JJ	_	2	amod	_	_
2	evidence	_	NN	NN	_	3	nsubj	_	_
3	suggested	_	VBD	VBD	_	0	root	_	_
4	that	_	IN	IN	_	9	mark	_	_
5	allele	_	NN	NN	_	6	nn	_	_
6	T	_	NN	NN	_	9	nsubj	_	_
7	is	_	VBZ	VBZ	_	9	cop	_	_
8	less	_	RBR	RBR	_	9	advmod	_	_
9	stable	_	JJ	JJ	_	3	ccomp	_	_
10	than	_	IN	IN	_	9	prep	_	_
11	allele	_	NN	NN	_	12	nn	_	_
12	t	_	NN	NN	_	10	pobj	_	_
13	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	study	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	used	_	VBD	VBD	_	0	root	_	_
7	a	_	DT	DT	_	10	det	_	_
8	RT-PCR	_	NN	NN	_	10	nn	_	_
9	based	_	JJ	JJ	_	10	amod	_	_
10	approach	_	NN	NN	_	6	dobj	_	_
11	to	_	TO	TO	_	12	aux	_	_
12	compare	_	VB	VB	_	6	vmod	_	_
13	the	_	DT	DT	_	14	det	_	_
14	stability	_	NN	NN	_	12	dobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	18	dep	_	_
17	big	_	JJ	JJ	_	18	amod	_	_
18	T	_	NN	NN	_	15	pobj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	small	_	JJ	JJ	_	21	amod	_	_
21	t	_	NN	NN	_	18	conj	_	_
22	allele	_	NN	NN	_	18	dep	_	_
23	in	_	IN	IN	_	18	prep	_	_
24	normal	_	JJ	JJ	_	26	amod	_	_
25	heterozygous	_	JJ	JJ	_	26	amod	_	_
26	lymphocytes	_	NNS	NNS	_	23	pobj	_	_
27	and	_	CC	CC	_	26	cc	_	_
28	the	_	DT	DT	_	31	det	_	_
29	heterozygous	_	JJ	JJ	_	31	amod	_	_
30	cell	_	NN	NN	_	31	nn	_	_
31	lines	_	NNS	NNS	_	26	conj	_	_
32	NB4	_	NN	NN	_	31	dep	_	_
33	-LRB-	_	-LRB-	-LRB-	_	35	punct	_	_
34	myeloid	_	JJ	JJ	_	35	amod	_	_
35	leukemia	_	NN	NN	_	32	appos	_	_
36	-RRB-	_	-RRB-	-RRB-	_	35	punct	_	_
37	and	_	CC	CC	_	32	cc	_	_
38	PC-3	_	NN	NN	_	32	conj	_	_
39	and	_	CC	CC	_	38	cc	_	_
40	DU	_	NN	NN	_	38	conj	_	_
41	145	_	CD	CD	_	40	num	_	_
42	-LRB-	_	-LRB-	-LRB-	_	44	punct	_	_
43	prostate	_	NN	NN	_	44	nn	_	_
44	cancers	_	NNS	NNS	_	38	appos	_	_
45	-RRB-	_	-RRB-	-RRB-	_	44	punct	_	_
46	.	_	.	.	_	6	punct	_	_

1	In	_	IN	IN	_	9	prep	_	_
2	all	_	DT	DT	_	4	det	_	_
3	three	_	CD	CD	_	4	num	_	_
4	cases	_	NNS	NNS	_	1	pobj	_	_
5	,	_	,	,	_	9	punct	_	_
6	we	_	PRP	PRP	_	9	nsubj	_	_
7	did	_	VBD	VBD	_	9	aux	_	_
8	not	_	RB	RB	_	9	neg	_	_
9	find	_	VB	VB	_	0	root	_	_
10	a	_	DT	DT	_	12	det	_	_
11	significant	_	JJ	JJ	_	12	amod	_	_
12	difference	_	NN	NN	_	9	dobj	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	stability	_	NN	NN	_	13	pobj	_	_
15	.	_	.	.	_	9	punct	_	_

1	Interestingly	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	we	_	PRP	PRP	_	5	nsubj	_	_
4	consistently	_	RB	RB	_	5	advmod	_	_
5	observed	_	VBD	VBD	_	0	root	_	_
6	30	_	CD	CD	_	7	num	_	_
7	%	_	NN	NN	_	8	npadvmod	_	_
8	less	_	JJR	JJR	_	10	amod	_	_
9	RT-PCR	_	NN	NN	_	10	nn	_	_
10	product	_	NN	NN	_	5	dobj	_	_
11	derived	_	VBN	VBN	_	10	vmod	_	_
12	from	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	17	det	_	_
14	small	_	JJ	JJ	_	17	amod	_	_
15	t	_	NN	NN	_	17	nn	_	_
16	allele	_	NN	NN	_	17	nn	_	_
17	mRNA	_	NN	NN	_	12	pobj	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	steady	_	JJ	JJ	_	20	amod	_	_
20	state	_	NN	NN	_	18	pobj	_	_
21	,	_	,	,	_	5	punct	_	_
22	a	_	DT	DT	_	23	det	_	_
23	finding	_	NN	NN	_	5	dep	_	_
24	which	_	WDT	WDT	_	26	nsubj	_	_
25	also	_	RB	RB	_	26	advmod	_	_
26	speaks	_	VBZ	VBZ	_	23	rcmod	_	_
27	against	_	IN	IN	_	26	prep	_	_
28	a	_	DT	DT	_	30	det	_	_
29	higher	_	JJR	JJR	_	30	amod	_	_
30	stability	_	NN	NN	_	27	pobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	the	_	DT	DT	_	36	det	_	_
33	small	_	JJ	JJ	_	36	amod	_	_
34	t	_	NN	NN	_	36	nn	_	_
35	allele	_	NN	NN	_	36	nn	_	_
36	mRNA	_	NN	NN	_	31	pobj	_	_
37	.	_	.	.	_	5	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	a	_	DT	DT	_	5	det	_	_
5	variation	_	NN	NN	_	3	dobj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	transcriptional	_	JJ	JJ	_	8	amod	_	_
8	regulation	_	NN	NN	_	6	pobj	_	_
9	rather	_	RB	RB	_	5	cc	_	_
10	than	_	IN	IN	_	9	mwe	_	_
11	mRNA	_	NN	NN	_	12	nn	_	_
12	stability	_	NN	NN	_	5	conj	_	_
13	between	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	alleles	_	NNS	NNS	_	13	pobj	_	_
16	.	_	.	.	_	3	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	hypothesize	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	14	mark	_	_
4	an	_	DT	DT	_	6	det	_	_
5	unknown	_	JJ	JJ	_	6	amod	_	_
6	gene	_	NN	NN	_	14	nsubj	_	_
7	or	_	CC	CC	_	6	cc	_	_
8	genes	_	NNS	NNS	_	6	conj	_	_
9	in	_	IN	IN	_	6	prep	_	_
10	linkage	_	NN	NN	_	9	pobj	_	_
11	with	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	polymorphisms	_	NNS	NNS	_	11	pobj	_	_
14	is	_	VBZ	VBZ	_	2	ccomp	_	_
15	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
16	are	_	VBP	VBP	_	14	dep	_	_
17	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
18	responsible	_	JJ	JJ	_	14	acomp	_	_
19	for	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	21	det	_	_
21	relationship	_	NN	NN	_	19	pobj	_	_
22	between	_	IN	IN	_	21	prep	_	_
23	risk	_	NN	NN	_	22	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	prostate	_	NN	NN	_	26	nn	_	_
26	cancer	_	NN	NN	_	24	pobj	_	_
27	and	_	CC	CC	_	23	cc	_	_
28	VDR	_	NN	NN	_	23	conj	_	_
29	polymorphisms	_	NNS	NNS	_	28	dep	_	_
30	.	_	.	.	_	2	punct	_	_

1	Rel/NF-kappa	_	NN	NN	_	2	nn	_	_
2	B	_	NN	NN	_	0	root	_	_
3	transcription	_	NN	NN	_	4	nn	_	_
4	factors	_	NNS	NNS	_	2	dep	_	_
5	and	_	CC	CC	_	2	cc	_	_
6	the	_	DT	DT	_	7	det	_	_
7	control	_	NN	NN	_	2	conj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	apoptosis	_	NN	NN	_	8	pobj	_	_
10	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	process	_	NN	NN	_	6	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	apoptosis	_	NN	NN	_	3	pobj	_	_
5	is	_	VBZ	VBZ	_	6	auxpass	_	_
6	used	_	VBN	VBN	_	0	root	_	_
7	to	_	TO	TO	_	8	aux	_	_
8	eliminate	_	VB	VB	_	6	xcomp	_	_
9	unwanted	_	JJ	JJ	_	10	amod	_	_
10	cells	_	NNS	NNS	_	8	dobj	_	_
11	from	_	IN	IN	_	8	prep	_	_
12	a	_	DT	DT	_	14	det	_	_
13	wide	_	JJ	JJ	_	14	amod	_	_
14	variety	_	NN	NN	_	11	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	organisms	_	NNS	NNS	_	15	pobj	_	_
17	.	_	.	.	_	6	punct	_	_

1	Various	_	JJ	JJ	_	3	amod	_	_
2	extracellular	_	JJ	JJ	_	3	amod	_	_
3	signals	_	NNS	NNS	_	13	nsubj	_	_
4	,	_	,	,	_	3	punct	_	_
5	often	_	RB	RB	_	6	advmod	_	_
6	converging	_	VBG	VBG	_	3	vmod	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	common	_	JJ	JJ	_	10	amod	_	_
9	intracellular	_	JJ	JJ	_	10	amod	_	_
10	pathways	_	NNS	NNS	_	7	pobj	_	_
11	,	_	,	,	_	3	punct	_	_
12	can	_	MD	MD	_	13	aux	_	_
13	induce	_	VB	VB	_	0	root	_	_
14	apoptosis	_	NN	NN	_	13	dobj	_	_
15	in	_	IN	IN	_	13	prep	_	_
16	a	_	DT	DT	_	18	det	_	_
17	cell-type-specific	_	JJ	JJ	_	18	amod	_	_
18	fashion	_	NN	NN	_	15	pobj	_	_
19	.	_	.	.	_	13	punct	_	_

1	Recent	_	JJ	JJ	_	2	amod	_	_
2	work	_	NN	NN	_	7	nsubj	_	_
3	from	_	IN	IN	_	2	prep	_	_
4	several	_	JJ	JJ	_	5	amod	_	_
5	laboratories	_	NNS	NNS	_	3	pobj	_	_
6	has	_	VBZ	VBZ	_	7	aux	_	_
7	demonstrated	_	VBN	VBN	_	0	root	_	_
8	that	_	IN	IN	_	13	mark	_	_
9	Rel/NF-kappa	_	NN	NN	_	10	nn	_	_
10	B	_	NN	NN	_	13	nsubj	_	_
11	transcription	_	NN	NN	_	12	nn	_	_
12	factors	_	NNS	NNS	_	10	dep	_	_
13	regulate	_	VBP	VBP	_	7	ccomp	_	_
14	apoptosis	_	NN	NN	_	13	dobj	_	_
15	in	_	IN	IN	_	13	prep	_	_
16	many	_	JJ	JJ	_	18	amod	_	_
17	cell	_	NN	NN	_	18	nn	_	_
18	types	_	NNS	NNS	_	15	pobj	_	_
19	.	_	.	.	_	7	punct	_	_

1	In	_	IN	IN	_	9	prep	_	_
2	most	_	JJS	JJS	_	3	amod	_	_
3	cells	_	NNS	NNS	_	1	pobj	_	_
4	,	_	,	,	_	9	punct	_	_
5	Rel/NF-kappa	_	NN	NN	_	6	nn	_	_
6	B	_	NN	NN	_	9	nsubj	_	_
7	transcription	_	NN	NN	_	8	nn	_	_
8	factors	_	NNS	NNS	_	6	dep	_	_
9	appear	_	VBP	VBP	_	0	root	_	_
10	to	_	TO	TO	_	11	aux	_	_
11	mediate	_	VB	VB	_	9	xcomp	_	_
12	survival	_	JJ	JJ	_	13	amod	_	_
13	signals	_	NNS	NNS	_	11	dobj	_	_
14	that	_	WDT	WDT	_	15	nsubj	_	_
15	protect	_	VBP	VBP	_	13	rcmod	_	_
16	cells	_	NNS	NNS	_	15	dobj	_	_
17	from	_	IN	IN	_	15	prep	_	_
18	apoptosis	_	NN	NN	_	17	pobj	_	_
19	;	_	:	:	_	9	punct	_	_
20	however	_	RB	RB	_	32	advmod	_	_
21	,	_	,	,	_	32	punct	_	_
22	under	_	IN	IN	_	32	prep	_	_
23	some	_	DT	DT	_	24	det	_	_
24	circumstances	_	NNS	NNS	_	22	pobj	_	_
25	,	_	,	,	_	32	punct	_	_
26	activation	_	NN	NN	_	32	nsubj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	these	_	DT	DT	_	29	det	_	_
29	factors	_	NNS	NNS	_	27	pobj	_	_
30	may	_	MD	MD	_	32	aux	_	_
31	also	_	RB	RB	_	32	advmod	_	_
32	promote	_	VB	VB	_	9	parataxis	_	_
33	apoptosis	_	NN	NN	_	32	dobj	_	_
34	.	_	.	.	_	9	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	role	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	Rel/NF-kappa	_	NN	NN	_	6	nn	_	_
5	B	_	NN	NN	_	6	nn	_	_
6	proteins	_	NNS	NNS	_	3	pobj	_	_
7	in	_	IN	IN	_	2	prep	_	_
8	viral	_	JJ	JJ	_	9	amod	_	_
9	oncogenesis	_	NN	NN	_	7	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	the	_	DT	DT	_	12	det	_	_
12	regulation	_	NN	NN	_	9	conj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	viral	_	JJ	JJ	_	15	amod	_	_
15	transcription	_	NN	NN	_	13	pobj	_	_
16	.	_	.	.	_	2	punct	_	_

1	Rel/NF-kappa	_	NN	NN	_	2	nn	_	_
2	B	_	NN	NN	_	7	nsubj	_	_
3	is	_	VBZ	VBZ	_	7	cop	_	_
4	a	_	DT	DT	_	7	det	_	_
5	ubiquitous	_	JJ	JJ	_	7	amod	_	_
6	transcription	_	NN	NN	_	7	nn	_	_
7	factor	_	NN	NN	_	0	root	_	_
8	that	_	WDT	WDT	_	9	nsubj	_	_
9	consists	_	VBZ	VBZ	_	7	rcmod	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	multiple	_	JJ	JJ	_	13	amod	_	_
12	polypeptide	_	NN	NN	_	13	nn	_	_
13	subunits	_	NNS	NNS	_	10	pobj	_	_
14	,	_	,	,	_	7	punct	_	_
15	and	_	CC	CC	_	7	cc	_	_
16	is	_	VBZ	VBZ	_	17	cop	_	_
17	subject	_	JJ	JJ	_	7	conj	_	_
18	to	_	TO	TO	_	17	prep	_	_
19	complex	_	JJ	JJ	_	21	amod	_	_
20	regulatory	_	JJ	JJ	_	21	amod	_	_
21	mechanisms	_	NNS	NNS	_	18	pobj	_	_
22	that	_	WDT	WDT	_	23	nsubj	_	_
23	involve	_	VBP	VBP	_	21	rcmod	_	_
24	protein-protein	_	JJ	JJ	_	25	amod	_	_
25	interactions	_	NNS	NNS	_	23	dobj	_	_
26	,	_	,	,	_	25	punct	_	_
27	phosphorylation	_	NN	NN	_	25	conj	_	_
28	,	_	,	,	_	25	punct	_	_
29	ubiquitination	_	NN	NN	_	25	conj	_	_
30	,	_	,	,	_	25	punct	_	_
31	proteolytic	_	JJ	JJ	_	32	amod	_	_
32	degradation	_	NN	NN	_	25	conj	_	_
33	,	_	,	,	_	25	punct	_	_
34	and	_	CC	CC	_	25	cc	_	_
35	nucleocytoplasmic	_	JJ	JJ	_	36	amod	_	_
36	translocation	_	NN	NN	_	25	conj	_	_
37	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	sophisticated	_	JJ	JJ	_	3	amod	_	_
3	control	_	NN	NN	_	10	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	Rel/NF-kappa	_	NN	NN	_	6	nn	_	_
6	B	_	NN	NN	_	7	nn	_	_
7	activity	_	NN	NN	_	4	pobj	_	_
8	is	_	VBZ	VBZ	_	10	cop	_	_
9	not	_	RB	RB	_	10	neg	_	_
10	surprising	_	JJ	JJ	_	0	root	_	_
11	since	_	IN	IN	_	16	mark	_	_
12	this	_	DT	DT	_	14	det	_	_
13	transcription	_	NN	NN	_	14	nn	_	_
14	factor	_	NN	NN	_	16	nsubjpass	_	_
15	is	_	VBZ	VBZ	_	16	auxpass	_	_
16	involved	_	VBN	VBN	_	10	advcl	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	a	_	DT	DT	_	20	det	_	_
19	wide	_	JJ	JJ	_	20	amod	_	_
20	array	_	NN	NN	_	17	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	cellular	_	JJ	JJ	_	23	amod	_	_
23	responses	_	NNS	NNS	_	21	pobj	_	_
24	to	_	TO	TO	_	23	prep	_	_
25	extracellular	_	JJ	JJ	_	26	amod	_	_
26	cues	_	NNS	NNS	_	24	pobj	_	_
27	,	_	,	,	_	20	punct	_	_
28	associated	_	VBN	VBN	_	20	vmod	_	_
29	with	_	IN	IN	_	28	prep	_	_
30	growth	_	NN	NN	_	29	pobj	_	_
31	,	_	,	,	_	30	punct	_	_
32	development	_	NN	NN	_	30	conj	_	_
33	,	_	,	,	_	30	punct	_	_
34	apoptosis	_	NN	NN	_	30	conj	_	_
35	,	_	,	,	_	30	punct	_	_
36	and	_	CC	CC	_	30	cc	_	_
37	pathogen	_	NN	NN	_	38	nn	_	_
38	invasion	_	NN	NN	_	30	conj	_	_
39	.	_	.	.	_	10	punct	_	_

1	Thus	_	RB	RB	_	6	advmod	_	_
2	,	_	,	,	_	6	punct	_	_
3	it	_	PRP	PRP	_	6	nsubj	_	_
4	is	_	VBZ	VBZ	_	6	cop	_	_
5	not	_	RB	RB	_	6	neg	_	_
6	unexpected	_	JJ	JJ	_	0	root	_	_
7	that	_	IN	IN	_	15	mark	_	_
8	this	_	DT	DT	_	12	det	_	_
9	versatile	_	JJ	JJ	_	12	amod	_	_
10	cellular	_	JJ	JJ	_	11	amod	_	_
11	homeostatic	_	JJ	JJ	_	9	dep	_	_
12	switch	_	NN	NN	_	15	nsubjpass	_	_
13	would	_	MD	MD	_	15	aux	_	_
14	be	_	VB	VB	_	15	auxpass	_	_
15	affected	_	VBN	VBN	_	6	ccomp	_	_
16	by	_	IN	IN	_	15	prep	_	_
17	a	_	DT	DT	_	18	det	_	_
18	variety	_	NN	NN	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	viral	_	JJ	JJ	_	21	amod	_	_
21	pathogens	_	NNS	NNS	_	19	pobj	_	_
22	,	_	,	,	_	21	punct	_	_
23	which	_	WDT	WDT	_	25	nsubj	_	_
24	have	_	VBP	VBP	_	25	aux	_	_
25	evolved	_	VBN	VBN	_	21	rcmod	_	_
26	mechanisms	_	NNS	NNS	_	25	dobj	_	_
27	to	_	TO	TO	_	28	aux	_	_
28	utilize	_	VB	VB	_	26	vmod	_	_
29	various	_	JJ	JJ	_	30	amod	_	_
30	aspects	_	NNS	NNS	_	28	dobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	Rel/NF-kappa	_	NN	NN	_	33	nn	_	_
33	B	_	NN	NN	_	34	nn	_	_
34	activity	_	NN	NN	_	31	pobj	_	_
35	to	_	TO	TO	_	36	aux	_	_
36	facilitate	_	VB	VB	_	25	xcomp	_	_
37	their	_	PRP$	PRP$	_	38	poss	_	_
38	replication	_	NN	NN	_	36	dobj	_	_
39	,	_	,	,	_	38	punct	_	_
40	cell	_	NN	NN	_	41	nn	_	_
41	survival	_	NN	NN	_	38	conj	_	_
42	and	_	CC	CC	_	38	cc	_	_
43	possibly	_	RB	RB	_	44	advmod	_	_
44	evasion	_	NN	NN	_	38	conj	_	_
45	of	_	IN	IN	_	44	prep	_	_
46	immune	_	JJ	JJ	_	47	amod	_	_
47	responses	_	NNS	NNS	_	45	pobj	_	_
48	.	_	.	.	_	6	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	review	_	NN	NN	_	4	nsubj	_	_
3	will	_	MD	MD	_	4	aux	_	_
4	cover	_	VB	VB	_	0	root	_	_
5	the	_	DT	DT	_	7	det	_	_
6	molecular	_	JJ	JJ	_	7	amod	_	_
7	mechanisms	_	NNS	NNS	_	4	dobj	_	_
8	that	_	WDT	WDT	_	10	nsubjpass	_	_
9	are	_	VBP	VBP	_	10	auxpass	_	_
10	utilized	_	VBN	VBN	_	7	rcmod	_	_
11	by	_	IN	IN	_	10	prep	_	_
12	mammalian	_	JJ	JJ	_	14	amod	_	_
13	oncogenic	_	JJ	JJ	_	14	amod	_	_
14	viruses	_	NNS	NNS	_	11	pobj	_	_
15	to	_	TO	TO	_	16	aux	_	_
16	affect	_	VB	VB	_	10	xcomp	_	_
17	the	_	DT	DT	_	18	det	_	_
18	activity	_	NN	NN	_	16	dobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	Rel/NF-kappa	_	NN	NN	_	21	nn	_	_
21	B	_	NN	NN	_	19	pobj	_	_
22	transcription	_	NN	NN	_	23	nn	_	_
23	factors	_	NNS	NNS	_	21	dep	_	_
24	and	_	CC	CC	_	7	cc	_	_
25	the	_	DT	DT	_	26	det	_	_
26	role	_	NN	NN	_	7	conj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	Rel/NF-kappa	_	NN	NN	_	29	nn	_	_
29	B	_	NN	NN	_	27	pobj	_	_
30	in	_	IN	IN	_	26	prep	_	_
31	the	_	DT	DT	_	32	det	_	_
32	regulation	_	NN	NN	_	30	pobj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	viral	_	JJ	JJ	_	35	amod	_	_
35	gene	_	NN	NN	_	33	pobj	_	_
36	expression	_	NN	NN	_	35	dep	_	_
37	and	_	CC	CC	_	35	cc	_	_
38	replication	_	NN	NN	_	35	conj	_	_
39	.	_	.	.	_	4	punct	_	_

1	Mutations	_	NNS	NNS	_	0	root	_	_
2	in	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	TSC2	_	NN	NN	_	5	nn	_	_
5	gene	_	NN	NN	_	2	pobj	_	_
6	:	_	:	:	_	1	punct	_	_
7	analysis	_	NN	NN	_	1	dep	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	12	det	_	_
10	complete	_	JJ	JJ	_	12	amod	_	_
11	coding	_	VBG	VBG	_	12	amod	_	_
12	sequence	_	NN	NN	_	8	pobj	_	_
13	using	_	VBG	VBG	_	7	vmod	_	_
14	the	_	DT	DT	_	17	det	_	_
15	protein	_	NN	NN	_	17	nn	_	_
16	truncation	_	NN	NN	_	17	nn	_	_
17	test	_	NN	NN	_	13	dobj	_	_
18	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
19	PTT	_	NN	NN	_	17	appos	_	_
20	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	.	_	.	.	_	1	punct	_	_

1	Mutations	_	NNS	NNS	_	10	nsubj	_	_
2	in	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	TSC2	_	NN	NN	_	5	nn	_	_
5	gene	_	NN	NN	_	2	pobj	_	_
6	on	_	IN	IN	_	5	prep	_	_
7	chromosome	_	NN	NN	_	8	nn	_	_
8	16p13.3	_	NN	NN	_	6	pobj	_	_
9	are	_	VBP	VBP	_	10	cop	_	_
10	responsible	_	JJ	JJ	_	0	root	_	_
11	for	_	IN	IN	_	10	prep	_	_
12	approximately	_	RB	RB	_	13	quantmod	_	_
13	50	_	CD	CD	_	14	num	_	_
14	%	_	NN	NN	_	11	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	familial	_	JJ	JJ	_	18	amod	_	_
17	tuberous	_	JJ	JJ	_	18	amod	_	_
18	sclerosis	_	NN	NN	_	15	pobj	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	TSC	_	NN	NN	_	18	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	.	_	.	.	_	10	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	gene	_	NN	NN	_	3	nsubj	_	_
3	has	_	VBZ	VBZ	_	0	root	_	_
4	41	_	CD	CD	_	6	num	_	_
5	small	_	JJ	JJ	_	6	amod	_	_
6	exons	_	NNS	NNS	_	3	dobj	_	_
7	spanning	_	VBG	VBG	_	6	dep	_	_
8	45	_	CD	CD	_	9	num	_	_
9	kb	_	NN	NN	_	10	npadvmod	_	_
10	of	_	IN	IN	_	7	prep	_	_
11	genomic	_	JJ	JJ	_	12	amod	_	_
12	DNA	_	NN	NN	_	10	pobj	_	_
13	and	_	CC	CC	_	7	cc	_	_
14	encoding	_	VBG	VBG	_	7	conj	_	_
15	a	_	DT	DT	_	18	det	_	_
16	5.5	_	CD	CD	_	18	num	_	_
17	kb	_	NN	NN	_	18	nn	_	_
18	mRNA	_	NN	NN	_	14	dobj	_	_
19	.	_	.	.	_	3	punct	_	_

1	Large	_	JJ	JJ	_	3	amod	_	_
2	germline	_	NN	NN	_	3	nn	_	_
3	deletions	_	NNS	NNS	_	6	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	TSC2	_	NN	NN	_	4	pobj	_	_
6	occur	_	VBP	VBP	_	0	root	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	&lt;	_	JJR	JJR	_	9	quantmod	_	_
9	5	_	CD	CD	_	10	num	_	_
10	%	_	NN	NN	_	7	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	cases	_	NNS	NNS	_	11	pobj	_	_
13	,	_	,	,	_	6	punct	_	_
14	and	_	CC	CC	_	6	cc	_	_
15	a	_	DT	DT	_	16	det	_	_
16	number	_	NN	NN	_	23	nsubjpass	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	small	_	JJ	JJ	_	20	amod	_	_
19	intragenic	_	JJ	JJ	_	20	amod	_	_
20	mutations	_	NNS	NNS	_	17	pobj	_	_
21	have	_	VBP	VBP	_	23	aux	_	_
22	been	_	VBN	VBN	_	23	auxpass	_	_
23	described	_	VBN	VBN	_	6	conj	_	_
24	.	_	.	.	_	6	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	analysed	_	VBD	VBD	_	0	root	_	_
3	mRNA	_	NN	NN	_	2	dobj	_	_
4	from	_	IN	IN	_	3	prep	_	_
5	18	_	CD	CD	_	7	num	_	_
6	unrelated	_	JJ	JJ	_	7	amod	_	_
7	cases	_	NNS	NNS	_	4	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	TSC	_	NN	NN	_	8	pobj	_	_
10	for	_	IN	IN	_	2	prep	_	_
11	TSC2	_	NN	NN	_	12	nn	_	_
12	mutations	_	NNS	NNS	_	10	pobj	_	_
13	using	_	VBG	VBG	_	2	xcomp	_	_
14	the	_	DT	DT	_	17	det	_	_
15	protein	_	NN	NN	_	17	nn	_	_
16	truncation	_	NN	NN	_	17	nn	_	_
17	test	_	NN	NN	_	13	dobj	_	_
18	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
19	PTT	_	NN	NN	_	17	appos	_	_
20	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	.	_	.	.	_	2	punct	_	_

1	Three	_	CD	CD	_	2	num	_	_
2	cases	_	NNS	NNS	_	4	nsubjpass	_	_
3	were	_	VBD	VBD	_	4	auxpass	_	_
4	predicted	_	VBN	VBN	_	0	root	_	_
5	to	_	TO	TO	_	8	aux	_	_
6	be	_	VB	VB	_	8	cop	_	_
7	TSC2	_	NN	NN	_	8	nn	_	_
8	mutations	_	NNS	NNS	_	4	xcomp	_	_
9	on	_	IN	IN	_	8	dep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	basis	_	NN	NN	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	linkage	_	NN	NN	_	14	nn	_	_
14	analysis	_	NN	NN	_	12	pobj	_	_
15	or	_	CC	CC	_	9	cc	_	_
16	because	_	IN	IN	_	22	mark	_	_
17	a	_	DT	DT	_	18	det	_	_
18	hamartoma	_	NN	NN	_	22	nsubj	_	_
19	from	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	21	det	_	_
21	patient	_	NN	NN	_	19	pobj	_	_
22	showed	_	VBD	VBD	_	9	conj	_	_
23	loss	_	NN	NN	_	22	dobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	heterozygosity	_	NN	NN	_	24	pobj	_	_
26	for	_	IN	IN	_	25	prep	_	_
27	16p13.3	_	NN	NN	_	28	nn	_	_
28	markers	_	NNS	NNS	_	26	pobj	_	_
29	.	_	.	.	_	4	punct	_	_

1	Three	_	CD	CD	_	4	num	_	_
2	overlapping	_	VBG	VBG	_	4	amod	_	_
3	PCR	_	NN	NN	_	4	nn	_	_
4	products	_	NNS	NNS	_	15	nsubjpass	_	_
5	,	_	,	,	_	4	punct	_	_
6	covering	_	VBG	VBG	_	4	vmod	_	_
7	the	_	DT	DT	_	10	det	_	_
8	complete	_	JJ	JJ	_	10	amod	_	_
9	coding	_	VBG	VBG	_	10	amod	_	_
10	sequence	_	NN	NN	_	6	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	mRNA	_	NN	NN	_	11	pobj	_	_
13	,	_	,	,	_	4	punct	_	_
14	were	_	VBD	VBD	_	15	auxpass	_	_
15	generated	_	VBN	VBN	_	0	root	_	_
16	from	_	IN	IN	_	15	prep	_	_
17	lymphoblastoid	_	JJ	JJ	_	19	amod	_	_
18	cell	_	NN	NN	_	19	nn	_	_
19	lines	_	NNS	NNS	_	16	pobj	_	_
20	,	_	,	,	_	15	punct	_	_
21	translated	_	VBN	VBN	_	15	conj	_	_
22	into	_	IN	IN	_	21	prep	_	_
23	35S-methionine	_	NN	NN	_	25	nn	_	_
24	labelled	_	JJ	JJ	_	25	amod	_	_
25	protein	_	NN	NN	_	22	pobj	_	_
26	,	_	,	,	_	15	punct	_	_
27	and	_	CC	CC	_	15	cc	_	_
28	analysed	_	VBN	VBN	_	15	conj	_	_
29	by	_	IN	IN	_	28	prep	_	_
30	SDS-PAGE	_	NN	NN	_	29	pobj	_	_
31	.	_	.	.	_	15	punct	_	_

1	PCR	_	NN	NN	_	2	nn	_	_
2	products	_	NNS	NNS	_	8	nsubjpass	_	_
3	showing	_	VBG	VBG	_	2	vmod	_	_
4	PTT	_	NN	NN	_	5	nn	_	_
5	shifts	_	NNS	NNS	_	3	dobj	_	_
6	were	_	VBD	VBD	_	8	auxpass	_	_
7	directly	_	RB	RB	_	8	advmod	_	_
8	sequenced	_	VBN	VBN	_	0	root	_	_
9	,	_	,	,	_	8	punct	_	_
10	and	_	CC	CC	_	8	cc	_	_
11	mutations	_	NNS	NNS	_	12	nsubj	_	_
12	confirmed	_	VBN	VBN	_	8	conj	_	_
13	by	_	IN	IN	_	12	prep	_	_
14	restriction	_	NN	NN	_	16	nn	_	_
15	enzyme	_	NN	NN	_	16	nn	_	_
16	digestion	_	NN	NN	_	13	pobj	_	_
17	where	_	WRB	WRB	_	18	advmod	_	_
18	possible	_	JJ	JJ	_	12	advcl	_	_
19	.	_	.	.	_	8	punct	_	_

1	Six	_	CD	CD	_	3	num	_	_
2	PTT	_	NN	NN	_	3	nn	_	_
3	shifts	_	NNS	NNS	_	5	nsubjpass	_	_
4	were	_	VBD	VBD	_	5	auxpass	_	_
5	identified	_	VBN	VBN	_	0	root	_	_
6	.	_	.	.	_	5	punct	_	_

1	Five	_	CD	CD	_	5	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	these	_	DT	DT	_	2	pobj	_	_
4	were	_	VBD	VBD	_	5	auxpass	_	_
5	caused	_	VBN	VBN	_	0	root	_	_
6	by	_	IN	IN	_	5	prep	_	_
7	mutations	_	NNS	NNS	_	6	pobj	_	_
8	predicted	_	VBN	VBN	_	7	vmod	_	_
9	to	_	TO	TO	_	10	aux	_	_
10	produce	_	VB	VB	_	8	xcomp	_	_
11	a	_	DT	DT	_	13	det	_	_
12	truncated	_	VBN	VBN	_	13	amod	_	_
13	protein	_	NN	NN	_	10	dobj	_	_
14	:	_	:	:	_	5	punct	_	_
15	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
16	i	_	LS	LS	_	21	dep	_	_
17	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
18	a	_	DT	DT	_	20	det	_	_
19	sporadic	_	JJ	JJ	_	20	amod	_	_
20	case	_	NN	NN	_	21	nsubj	_	_
21	showed	_	VBD	VBD	_	5	parataxis	_	_
22	a	_	DT	DT	_	25	det	_	_
23	32	_	CD	CD	_	25	num	_	_
24	bp	_	NN	NN	_	25	nn	_	_
25	deletion	_	NN	NN	_	21	dobj	_	_
26	in	_	IN	IN	_	25	prep	_	_
27	exon	_	NN	NN	_	26	pobj	_	_
28	11	_	CD	CD	_	27	num	_	_
29	,	_	,	,	_	21	punct	_	_
30	and	_	CC	CC	_	21	cc	_	_
31	a	_	DT	DT	_	33	det	_	_
32	mutant	_	JJ	JJ	_	33	amod	_	_
33	mRNA	_	NN	NN	_	38	nsubjpass	_	_
34	without	_	IN	IN	_	33	prep	_	_
35	exon	_	NN	NN	_	34	pobj	_	_
36	11	_	CD	CD	_	35	num	_	_
37	was	_	VBD	VBD	_	38	auxpass	_	_
38	produced	_	VBN	VBN	_	21	conj	_	_
39	;	_	:	:	_	21	punct	_	_
40	the	_	DT	DT	_	42	det	_	_
41	normal	_	JJ	JJ	_	42	amod	_	_
42	exon	_	NN	NN	_	46	nsubjpass	_	_
43	10	_	CD	CD	_	42	num	_	_
44	was	_	VBD	VBD	_	46	auxpass	_	_
45	also	_	RB	RB	_	46	advmod	_	_
46	spliced	_	VBN	VBN	_	21	parataxis	_	_
47	out	_	RP	RP	_	46	prt	_	_
48	;	_	:	:	_	21	punct	_	_
49	-LRB-	_	-LRB-	-LRB-	_	50	punct	_	_
50	ii	_	LS	LS	_	55	dep	_	_
51	-RRB-	_	-RRB-	-RRB-	_	50	punct	_	_
52	a	_	DT	DT	_	54	det	_	_
53	sporadic	_	JJ	JJ	_	54	amod	_	_
54	case	_	NN	NN	_	55	nsubj	_	_
55	had	_	VBD	VBD	_	21	parataxis	_	_
56	a	_	DT	DT	_	59	det	_	_
57	1	_	CD	CD	_	59	num	_	_
58	bp	_	NN	NN	_	59	nn	_	_
59	deletion	_	NN	NN	_	55	dobj	_	_
60	in	_	IN	IN	_	59	prep	_	_
61	exon	_	NN	NN	_	60	pobj	_	_
62	12	_	CD	CD	_	61	num	_	_
63	-LRB-	_	-LRB-	-LRB-	_	64	punct	_	_
64	1634delT	_	NN	NN	_	59	appos	_	_
65	-RRB-	_	-RRB-	-RRB-	_	64	punct	_	_
66	;	_	:	:	_	21	punct	_	_
67	-LRB-	_	-LRB-	-LRB-	_	68	punct	_	_
68	iii	_	LS	LS	_	76	dep	_	_
69	-RRB-	_	-RRB-	-RRB-	_	68	punct	_	_
70	a	_	DT	DT	_	72	det	_	_
71	TSC2-linked	_	JJ	JJ	_	72	amod	_	_
72	mother	_	NN	NN	_	76	nsubj	_	_
73	and	_	CC	CC	_	72	cc	_	_
74	daughter	_	NN	NN	_	75	nn	_	_
75	pair	_	NN	NN	_	72	conj	_	_
76	had	_	VBD	VBD	_	21	parataxis	_	_
77	a	_	DT	DT	_	81	det	_	_
78	G	_	NN	NN	_	81	nn	_	_
79	--&gt;	_	TO	TO	_	81	dep	_	_
80	T	_	NN	NN	_	81	nn	_	_
81	transversion	_	NN	NN	_	76	dobj	_	_
82	in	_	IN	IN	_	81	prep	_	_
83	exon	_	NN	NN	_	82	pobj	_	_
84	23	_	CD	CD	_	83	num	_	_
85	-LRB-	_	-LRB-	-LRB-	_	86	punct	_	_
86	G2715T	_	NN	NN	_	81	appos	_	_
87	-RRB-	_	-RRB-	-RRB-	_	86	punct	_	_
88	introducing	_	VBG	VBG	_	81	vmod	_	_
89	a	_	DT	DT	_	92	det	_	_
90	cryptic	_	JJ	JJ	_	92	amod	_	_
91	splice	_	NN	NN	_	92	nn	_	_
92	site	_	NN	NN	_	88	dobj	_	_
93	causing	_	VBG	VBG	_	92	vmod	_	_
94	a	_	DT	DT	_	97	det	_	_
95	29	_	CD	CD	_	97	num	_	_
96	bp	_	NN	NN	_	97	nn	_	_
97	truncation	_	NN	NN	_	93	dobj	_	_
98	of	_	IN	IN	_	97	prep	_	_
99	mRNA	_	NN	NN	_	98	pobj	_	_
100	from	_	IN	IN	_	97	prep	_	_
101	exon	_	NN	NN	_	100	pobj	_	_
102	23	_	CD	CD	_	101	num	_	_
103	;	_	:	:	_	21	punct	_	_
104	-LRB-	_	-LRB-	-LRB-	_	105	punct	_	_
105	iv	_	LS	LS	_	110	dep	_	_
106	-RRB-	_	-RRB-	-RRB-	_	105	punct	_	_
107	a	_	DT	DT	_	109	det	_	_
108	sporadic	_	JJ	JJ	_	109	amod	_	_
109	case	_	NN	NN	_	110	nsubj	_	_
110	showed	_	VBD	VBD	_	21	parataxis	_	_
111	a	_	DT	DT	_	114	det	_	_
112	2	_	CD	CD	_	114	num	_	_
113	bp	_	NN	NN	_	114	nn	_	_
114	deletion	_	NN	NN	_	110	dobj	_	_
115	in	_	IN	IN	_	114	prep	_	_
116	exon	_	NN	NN	_	115	pobj	_	_
117	36	_	CD	CD	_	116	num	_	_
118	;	_	:	:	_	21	punct	_	_
119	-LRB-	_	-LRB-	-LRB-	_	120	punct	_	_
120	v	_	LS	LS	_	125	dep	_	_
121	-RRB-	_	-RRB-	-RRB-	_	120	punct	_	_
122	a	_	DT	DT	_	124	det	_	_
123	sporadic	_	JJ	JJ	_	124	amod	_	_
124	case	_	NN	NN	_	125	nsubj	_	_
125	showed	_	VBD	VBD	_	21	parataxis	_	_
126	a	_	DT	DT	_	129	det	_	_
127	1	_	CD	CD	_	129	num	_	_
128	bp	_	NN	NN	_	129	nn	_	_
129	insertion	_	NN	NN	_	125	dobj	_	_
130	disrupting	_	VBG	VBG	_	129	vmod	_	_
131	the	_	DT	DT	_	134	det	_	_
132	donor	_	NN	NN	_	134	nn	_	_
133	splice	_	NN	NN	_	134	nn	_	_
134	site	_	NN	NN	_	130	dobj	_	_
135	of	_	IN	IN	_	134	prep	_	_
136	exon	_	NN	NN	_	135	pobj	_	_
137	37	_	CD	CD	_	136	num	_	_
138	-LRB-	_	-LRB-	-LRB-	_	139	punct	_	_
139	5007+2insA	_	NN	NN	_	129	appos	_	_
140	-RRB-	_	-RRB-	-RRB-	_	139	punct	_	_
141	,	_	,	,	_	125	punct	_	_
142	resulting	_	VBG	VBG	_	125	vmod	_	_
143	in	_	IN	IN	_	142	prep	_	_
144	the	_	DT	DT	_	145	det	_	_
145	use	_	NN	NN	_	143	pobj	_	_
146	of	_	IN	IN	_	145	prep	_	_
147	an	_	DT	DT	_	152	det	_	_
148	upstream	_	JJ	JJ	_	152	amod	_	_
149	exonic	_	JJ	JJ	_	152	amod	_	_
150	cryptic	_	JJ	JJ	_	152	amod	_	_
151	splice	_	NN	NN	_	152	nn	_	_
152	site	_	NN	NN	_	146	pobj	_	_
153	to	_	TO	TO	_	154	aux	_	_
154	cause	_	VB	VB	_	142	xcomp	_	_
155	a	_	DT	DT	_	158	det	_	_
156	29	_	CD	CD	_	158	num	_	_
157	bp	_	NN	NN	_	158	nn	_	_
158	truncation	_	NN	NN	_	154	dobj	_	_
159	of	_	IN	IN	_	158	prep	_	_
160	mRNA	_	NN	NN	_	159	pobj	_	_
161	from	_	IN	IN	_	158	prep	_	_
162	exon	_	NN	NN	_	161	pobj	_	_
163	37	_	CD	CD	_	162	num	_	_
164	.	_	.	.	_	5	punct	_	_

1	In	_	IN	IN	_	9	prep	_	_
2	one	_	CD	CD	_	3	num	_	_
3	case	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	9	punct	_	_
5	the	_	DT	DT	_	7	det	_	_
6	PTT	_	NN	NN	_	7	nn	_	_
7	shift	_	NN	NN	_	9	nsubjpass	_	_
8	was	_	VBD	VBD	_	9	auxpass	_	_
9	explained	_	VBN	VBN	_	0	root	_	_
10	by	_	IN	IN	_	9	prep	_	_
11	in-frame	_	JJ	JJ	_	12	amod	_	_
12	splicing	_	NN	NN	_	10	pobj	_	_
13	out	_	RP	RP	_	12	prep	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	exon	_	NN	NN	_	14	pobj	_	_
16	10	_	CD	CD	_	15	num	_	_
17	,	_	,	,	_	12	punct	_	_
18	in	_	IN	IN	_	12	prep	_	_
19	the	_	DT	DT	_	20	det	_	_
20	presence	_	NN	NN	_	18	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	a	_	DT	DT	_	27	det	_	_
23	normal	_	JJ	JJ	_	27	amod	_	_
24	exon	_	NN	NN	_	27	nn	_	_
25	10	_	CD	CD	_	27	num	_	_
26	genomic	_	JJ	JJ	_	27	amod	_	_
27	sequence	_	NN	NN	_	21	pobj	_	_
28	.	_	.	.	_	9	punct	_	_

1	Alternative	_	JJ	JJ	_	2	amod	_	_
2	splicing	_	NN	NN	_	14	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	exon	_	NN	NN	_	3	pobj	_	_
5	10	_	CD	CD	_	4	num	_	_
6	of	_	IN	IN	_	2	prep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	TSC2	_	NN	NN	_	9	nn	_	_
9	gene	_	NN	NN	_	6	pobj	_	_
10	may	_	MD	MD	_	14	aux	_	_
11	be	_	VB	VB	_	14	cop	_	_
12	a	_	DT	DT	_	14	det	_	_
13	normal	_	JJ	JJ	_	14	amod	_	_
14	variant	_	NN	NN	_	0	root	_	_
15	.	_	.	.	_	14	punct	_	_

1	Three	_	CD	CD	_	5	num	_	_
2	3rd	_	JJ	JJ	_	5	amod	_	_
3	base	_	NN	NN	_	5	nn	_	_
4	substitution	_	NN	NN	_	5	nn	_	_
5	polymorphisms	_	NNS	NNS	_	8	nsubjpass	_	_
6	were	_	VBD	VBD	_	8	auxpass	_	_
7	also	_	RB	RB	_	8	advmod	_	_
8	detected	_	VBN	VBN	_	0	root	_	_
9	during	_	IN	IN	_	8	prep	_	_
10	direct	_	JJ	JJ	_	11	amod	_	_
11	sequencing	_	NN	NN	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	PCR	_	NN	NN	_	14	nn	_	_
14	products	_	NNS	NNS	_	12	pobj	_	_
15	.	_	.	.	_	8	punct	_	_

1	Confirmed	_	VBN	VBN	_	2	amod	_	_
2	mutations	_	NNS	NNS	_	4	nsubjpass	_	_
3	were	_	VBD	VBD	_	4	auxpass	_	_
4	identified	_	VBN	VBN	_	0	root	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	28	_	CD	CD	_	7	num	_	_
7	%	_	NN	NN	_	5	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	families	_	NNS	NNS	_	8	pobj	_	_
11	studied	_	VBN	VBN	_	10	vmod	_	_
12	and	_	CC	CC	_	4	cc	_	_
13	on	_	IN	IN	_	37	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	assumption	_	NN	NN	_	13	pobj	_	_
16	that	_	IN	IN	_	23	mark	_	_
17	half	_	NN	NN	_	23	nsubj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	sporadic	_	JJ	JJ	_	21	amod	_	_
21	cases	_	NNS	NNS	_	18	pobj	_	_
22	should	_	MD	MD	_	23	aux	_	_
23	have	_	VB	VB	_	15	ccomp	_	_
24	TSC2	_	NN	NN	_	25	nn	_	_
25	mutations	_	NNS	NNS	_	23	dobj	_	_
26	,	_	,	,	_	37	punct	_	_
27	a	_	DT	DT	_	29	det	_	_
28	crude	_	JJ	JJ	_	29	amod	_	_
29	estimate	_	NN	NN	_	37	nsubj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	the	_	DT	DT	_	33	det	_	_
32	detection	_	NN	NN	_	33	nn	_	_
33	rate	_	NN	NN	_	30	pobj	_	_
34	would	_	MD	MD	_	37	aux	_	_
35	be	_	VB	VB	_	37	cop	_	_
36	60	_	CD	CD	_	37	num	_	_
37	%	_	NN	NN	_	4	conj	_	_
38	.	_	.	.	_	4	punct	_	_

1	This	_	DT	DT	_	2	nsubj	_	_
2	compares	_	VBZ	VBZ	_	0	root	_	_
3	favourably	_	RB	RB	_	2	advmod	_	_
4	with	_	IN	IN	_	2	prep	_	_
5	other	_	JJ	JJ	_	7	amod	_	_
6	screening	_	NN	NN	_	7	nn	_	_
7	methods	_	NNS	NNS	_	4	pobj	_	_
8	used	_	VBN	VBN	_	7	vmod	_	_
9	for	_	IN	IN	_	8	prep	_	_
10	TSC2	_	NN	NN	_	9	pobj	_	_
11	,	_	,	,	_	10	punct	_	_
12	notably	_	RB	RB	_	13	advmod	_	_
13	SSCP	_	NN	NN	_	10	appos	_	_
14	,	_	,	,	_	2	punct	_	_
15	and	_	CC	CC	_	2	cc	_	_
16	since	_	IN	IN	_	18	mark	_	_
17	PTT	_	NN	NN	_	18	nsubj	_	_
18	involves	_	VBZ	VBZ	_	26	advcl	_	_
19	much	_	RB	RB	_	20	advmod	_	_
20	less	_	JJR	JJR	_	21	amod	_	_
21	work	_	NN	NN	_	18	dobj	_	_
22	it	_	PRP	PRP	_	26	nsubj	_	_
23	may	_	MD	MD	_	26	aux	_	_
24	be	_	VB	VB	_	26	cop	_	_
25	the	_	DT	DT	_	26	det	_	_
26	method	_	NN	NN	_	2	conj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	choice	_	NN	NN	_	27	pobj	_	_
29	.	_	.	.	_	2	punct	_	_

1	Selection	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	down-regulated	_	VBN	VBN	_	4	amod	_	_
4	sequences	_	NNS	NNS	_	2	pobj	_	_
5	along	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	monocytic	_	JJ	JJ	_	8	amod	_	_
8	differentiation	_	NN	NN	_	5	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	leukemic	_	JJ	JJ	_	12	amod	_	_
11	HL60	_	NN	NN	_	12	nn	_	_
12	cells	_	NNS	NNS	_	9	pobj	_	_
13	.	_	.	.	_	1	punct	_	_

1	In	_	IN	IN	_	4	mark	_	_
2	order	_	NN	NN	_	4	dep	_	_
3	to	_	TO	TO	_	4	aux	_	_
4	dissect	_	VB	VB	_	13	dep	_	_
5	the	_	DT	DT	_	7	det	_	_
6	molecular	_	JJ	JJ	_	7	amod	_	_
7	mechanisms	_	NNS	NNS	_	4	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	monocytic	_	JJ	JJ	_	10	amod	_	_
10	differentiation	_	NN	NN	_	8	pobj	_	_
11	we	_	PRP	PRP	_	13	nsubj	_	_
12	have	_	VBP	VBP	_	13	aux	_	_
13	developed	_	VBN	VBN	_	0	root	_	_
14	a	_	DT	DT	_	17	det	_	_
15	subtractive	_	JJ	JJ	_	17	amod	_	_
16	hybridisation	_	NN	NN	_	17	nn	_	_
17	method	_	NN	NN	_	13	dobj	_	_
18	based	_	VBN	VBN	_	13	prep	_	_
19	on	_	IN	IN	_	18	pcomp	_	_
20	a	_	DT	DT	_	25	det	_	_
21	simplified	_	JJ	JJ	_	25	amod	_	_
22	'	_	``	``	_	25	punct	_	_
23	representational	_	JJ	JJ	_	25	amod	_	_
24	difference	_	NN	NN	_	25	nn	_	_
25	analysis	_	NN	NN	_	19	pobj	_	_
26	'	_	''	''	_	25	punct	_	_
27	.	_	.	.	_	13	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	selected	_	VBN	VBN	_	0	root	_	_
4	16	_	CD	CD	_	5	num	_	_
5	sequences	_	NNS	NNS	_	3	dobj	_	_
6	and	_	CC	CC	_	3	cc	_	_
7	confirmed	_	VBN	VBN	_	3	conj	_	_
8	their	_	PRP$	PRP$	_	9	poss	_	_
9	down-regulation	_	NN	NN	_	7	dobj	_	_
10	along	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	14	det	_	_
12	TPA-induced	_	JJ	JJ	_	14	amod	_	_
13	monocytic	_	JJ	JJ	_	14	amod	_	_
14	differentiation	_	NN	NN	_	10	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	HL60	_	NN	NN	_	17	nn	_	_
17	cells	_	NNS	NNS	_	15	pobj	_	_
18	.	_	.	.	_	3	punct	_	_

1	Among	_	IN	IN	_	6	prep	_	_
2	these	_	DT	DT	_	3	det	_	_
3	sequences	_	NNS	NNS	_	1	pobj	_	_
4	we	_	PRP	PRP	_	6	nsubj	_	_
5	have	_	VBP	VBP	_	6	aux	_	_
6	identified	_	VBN	VBN	_	0	root	_	_
7	the	_	DT	DT	_	8	det	_	_
8	alpha-tubulin	_	NN	NN	_	6	dobj	_	_
9	,	_	,	,	_	8	punct	_	_
10	the	_	DT	DT	_	12	det	_	_
11	TaxREB	_	NN	NN	_	12	nn	_	_
12	protein	_	NN	NN	_	8	appos	_	_
13	and	_	CC	CC	_	8	cc	_	_
14	two	_	CD	CD	_	17	num	_	_
15	ribosomal	_	JJ	JJ	_	17	amod	_	_
16	protein	_	NN	NN	_	17	nn	_	_
17	sequences	_	NNS	NNS	_	8	conj	_	_
18	which	_	WDT	WDT	_	23	nsubjpass	_	_
19	had	_	VBD	VBD	_	23	aux	_	_
20	not	_	RB	RB	_	23	neg	_	_
21	been	_	VBN	VBN	_	23	auxpass	_	_
22	previously	_	RB	RB	_	23	advmod	_	_
23	described	_	VBN	VBN	_	17	rcmod	_	_
24	as	_	IN	IN	_	23	prep	_	_
25	differentially	_	RB	RB	_	26	advmod	_	_
26	expressed	_	VBN	VBN	_	24	pcomp	_	_
27	.	_	.	.	_	6	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	add	_	VBP	VBP	_	0	root	_	_
4	to	_	TO	TO	_	3	prep	_	_
5	our	_	PRP$	PRP$	_	6	poss	_	_
6	knowledge	_	NN	NN	_	4	pobj	_	_
7	about	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	molecules	_	NNS	NNS	_	7	pobj	_	_
10	implicated	_	VBN	VBN	_	9	vmod	_	_
11	along	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	monocytic	_	JJ	JJ	_	14	amod	_	_
14	differentiation	_	NN	NN	_	11	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	growth	_	NN	NN	_	17	nn	_	_
17	arrest	_	NN	NN	_	14	conj	_	_
18	of	_	IN	IN	_	14	prep	_	_
19	leukemic	_	JJ	JJ	_	20	amod	_	_
20	cells	_	NNS	NNS	_	18	pobj	_	_
21	and	_	CC	CC	_	3	cc	_	_
22	provide	_	VBP	VBP	_	3	conj	_	_
23	a	_	DT	DT	_	25	det	_	_
24	first	_	JJ	JJ	_	25	amod	_	_
25	step	_	NN	NN	_	22	dobj	_	_
26	in	_	IN	IN	_	22	prep	_	_
27	the	_	DT	DT	_	28	det	_	_
28	study	_	NN	NN	_	26	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	their	_	PRP$	PRP$	_	32	poss	_	_
31	respective	_	JJ	JJ	_	32	amod	_	_
32	roles	_	NNS	NNS	_	29	pobj	_	_
33	.	_	.	.	_	3	punct	_	_

1	Activation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	a	_	DT	DT	_	5	det	_	_
4	novel	_	JJ	JJ	_	5	amod	_	_
5	gene	_	NN	NN	_	2	pobj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	3q21	_	NN	NN	_	6	pobj	_	_
8	and	_	CC	CC	_	1	cc	_	_
9	identification	_	NN	NN	_	1	conj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	intergenic	_	JJ	JJ	_	13	amod	_	_
12	fusion	_	NN	NN	_	13	nn	_	_
13	transcripts	_	NNS	NNS	_	10	pobj	_	_
14	with	_	IN	IN	_	13	prep	_	_
15	ecotropic	_	JJ	JJ	_	18	amod	_	_
16	viral	_	JJ	JJ	_	18	amod	_	_
17	insertion	_	NN	NN	_	18	nn	_	_
18	site	_	NN	NN	_	14	pobj	_	_
19	I	_	CD	CD	_	18	num	_	_
20	in	_	IN	IN	_	1	prep	_	_
21	leukemia	_	NN	NN	_	20	pobj	_	_
22	.	_	.	.	_	1	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	identified	_	VBN	VBN	_	0	root	_	_
4	a	_	DT	DT	_	6	det	_	_
5	novel	_	JJ	JJ	_	6	amod	_	_
6	gene	_	NN	NN	_	3	dobj	_	_
7	,	_	,	,	_	6	punct	_	_
8	GR6	_	NN	NN	_	6	appos	_	_
9	,	_	,	,	_	6	punct	_	_
10	located	_	JJ	JJ	_	6	amod	_	_
11	within	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	15	det	_	_
13	leukemia	_	NN	NN	_	15	nn	_	_
14	breakpoint	_	NN	NN	_	15	nn	_	_
15	region	_	NN	NN	_	11	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	3q21	_	NN	NN	_	16	pobj	_	_
18	,	_	,	,	_	6	punct	_	_
19	that	_	WDT	WDT	_	22	nsubjpass	_	_
20	is	_	VBZ	VBZ	_	22	auxpass	_	_
21	normally	_	RB	RB	_	22	advmod	_	_
22	expressed	_	VBN	VBN	_	6	rcmod	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	early	_	JJ	JJ	_	26	amod	_	_
25	fetal	_	JJ	JJ	_	26	amod	_	_
26	development	_	NN	NN	_	23	pobj	_	_
27	but	_	CC	CC	_	23	cc	_	_
28	not	_	RB	RB	_	29	neg	_	_
29	in	_	IN	IN	_	23	conj	_	_
30	adult	_	JJ	JJ	_	32	amod	_	_
31	peripheral	_	JJ	JJ	_	32	amod	_	_
32	blood	_	NN	NN	_	29	pobj	_	_
33	.	_	.	.	_	3	punct	_	_

1	GR6	_	NN	NN	_	3	nsubjpass	_	_
2	is	_	VBZ	VBZ	_	3	auxpass	_	_
3	activated	_	VBN	VBN	_	0	root	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	8	det	_	_
6	UCSD-AML1	_	NN	NN	_	8	nn	_	_
7	cell	_	NN	NN	_	8	nn	_	_
8	line	_	NN	NN	_	4	pobj	_	_
9	and	_	CC	CC	_	4	cc	_	_
10	in	_	IN	IN	_	4	conj	_	_
11	a	_	DT	DT	_	13	det	_	_
12	leukemic	_	JJ	JJ	_	13	amod	_	_
13	sample	_	NN	NN	_	10	pobj	_	_
14	,	_	,	,	_	3	punct	_	_
15	both	_	DT	DT	_	18	nsubj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	which	_	WDT	WDT	_	16	pobj	_	_
18	carry	_	VBP	VBP	_	3	ccomp	_	_
19	a	_	DT	DT	_	20	det	_	_
20	t-LRB-3;3-RRB--LRB-q21;q26-RRB-	_	NN	NN	_	18	dobj	_	_
21	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	UCSD-AML1	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	7	punct	_	_
4	we	_	PRP	PRP	_	7	nsubj	_	_
5	have	_	VBP	VBP	_	7	aux	_	_
6	also	_	RB	RB	_	7	advmod	_	_
7	identified	_	VBN	VBN	_	0	root	_	_
8	fusion	_	NN	NN	_	9	nn	_	_
9	transcripts	_	NNS	NNS	_	7	dobj	_	_
10	between	_	IN	IN	_	7	prep	_	_
11	the	_	DT	DT	_	20	det	_	_
12	ecotropic	_	JJ	JJ	_	20	amod	_	_
13	viral	_	JJ	JJ	_	20	amod	_	_
14	insertion	_	NN	NN	_	20	nn	_	_
15	site	_	NN	NN	_	20	nn	_	_
16	I	_	CD	CD	_	20	num	_	_
17	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
18	EVI1	_	NN	NN	_	20	nn	_	_
19	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
20	gene	_	NN	NN	_	10	pobj	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	3q26	_	NN	NN	_	21	pobj	_	_
23	and	_	CC	CC	_	20	cc	_	_
24	GR6	_	NN	NN	_	20	conj	_	_
25	and	_	CC	CC	_	10	cc	_	_
26	between	_	IN	IN	_	10	conj	_	_
27	EVI1	_	NN	NN	_	26	pobj	_	_
28	and	_	CC	CC	_	27	cc	_	_
29	Ribophorin	_	NN	NN	_	30	nn	_	_
30	I	_	NN	NN	_	27	conj	_	_
31	that	_	WDT	WDT	_	32	nsubj	_	_
32	maps	_	VBZ	VBZ	_	30	rcmod	_	_
33	30	_	CD	CD	_	35	num	_	_
34	kb	_	NN	NN	_	35	nn	_	_
35	telomeric	_	NN	NN	_	32	dobj	_	_
36	to	_	TO	TO	_	32	prep	_	_
37	GR6	_	NN	NN	_	36	pobj	_	_
38	in	_	IN	IN	_	37	prep	_	_
39	3q21	_	NN	NN	_	38	pobj	_	_
40	.	_	.	.	_	7	punct	_	_

1	All	_	DT	DT	_	2	det	_	_
2	fusions	_	NNS	NNS	_	3	nsubj	_	_
3	splice	_	VBP	VBP	_	0	root	_	_
4	the	_	DT	DT	_	6	det	_	_
5	5'	_	JJ	JJ	_	6	amod	_	_
6	ends	_	NNS	NNS	_	3	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	3q21	_	NN	NN	_	10	nn	_	_
10	genes	_	NNS	NNS	_	7	pobj	_	_
11	into	_	IN	IN	_	3	prep	_	_
12	exon	_	NN	NN	_	11	pobj	_	_
13	2	_	CD	CD	_	12	num	_	_
14	of	_	IN	IN	_	12	prep	_	_
15	the	_	DT	DT	_	17	det	_	_
16	EVI1	_	NN	NN	_	17	nn	_	_
17	gene	_	NN	NN	_	14	pobj	_	_
18	,	_	,	,	_	3	punct	_	_
19	an	_	DT	DT	_	20	det	_	_
20	event	_	NN	NN	_	3	dep	_	_
21	that	_	WDT	WDT	_	23	nsubj	_	_
22	is	_	VBZ	VBZ	_	23	cop	_	_
23	similar	_	JJ	JJ	_	20	rcmod	_	_
24	to	_	TO	TO	_	23	prep	_	_
25	the	_	DT	DT	_	28	det	_	_
26	normal	_	JJ	JJ	_	28	amod	_	_
27	intergenic	_	JJ	JJ	_	28	amod	_	_
28	splicing	_	NN	NN	_	24	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	MDS1-EVI1	_	NN	NN	_	29	pobj	_	_
31	and	_	CC	CC	_	24	cc	_	_
32	to	_	TO	TO	_	24	conj	_	_
33	those	_	DT	DT	_	32	pobj	_	_
34	previously	_	RB	RB	_	35	advmod	_	_
35	documented	_	VBN	VBN	_	33	vmod	_	_
36	in	_	IN	IN	_	35	prep	_	_
37	leukemias	_	NNS	NNS	_	36	pobj	_	_
38	with	_	IN	IN	_	37	prep	_	_
39	t-LRB-3;21-RRB-	_	NN	NN	_	38	pobj	_	_
40	and	_	CC	CC	_	39	cc	_	_
41	t-LRB-3;12-RRB-	_	NN	NN	_	39	conj	_	_
42	,	_	,	,	_	20	punct	_	_
43	in	_	IN	IN	_	56	prep	_	_
44	which	_	WDT	WDT	_	43	pobj	_	_
45	acute	_	JJ	JJ	_	49	amod	_	_
46	myelogenous	_	JJ	JJ	_	49	amod	_	_
47	leukemia	_	NN	NN	_	49	nn	_	_
48	1-EVI1	_	NN	NN	_	49	nn	_	_
49	fusions	_	NNS	NNS	_	56	nsubj	_	_
50	and	_	CC	CC	_	49	cc	_	_
51	ETV6-EVI1	_	JJ	JJ	_	52	amod	_	_
52	fusions	_	NNS	NNS	_	49	conj	_	_
53	,	_	,	,	_	49	punct	_	_
54	respectively	_	RB	RB	_	56	advmod	_	_
55	,	_	,	,	_	56	punct	_	_
56	occur	_	VBP	VBP	_	20	rcmod	_	_
57	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	Ribophorin	_	NN	NN	_	4	nn	_	_
3	I-EVI1	_	NN	NN	_	4	nn	_	_
4	fusion	_	NN	NN	_	11	nsubj	_	_
5	in	_	IN	IN	_	11	prep	_	_
6	particular	_	JJ	JJ	_	5	pobj	_	_
7	may	_	MD	MD	_	11	aux	_	_
8	be	_	VB	VB	_	11	cop	_	_
9	a	_	DT	DT	_	11	det	_	_
10	common	_	JJ	JJ	_	11	amod	_	_
11	occurrence	_	NN	NN	_	0	root	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	t-LRB-3;3-RRB-	_	NN	NN	_	12	pobj	_	_
14	.	_	.	.	_	11	punct	_	_

1	Abnormal	_	JJ	JJ	_	2	amod	_	_
2	apoptosis	_	NN	NN	_	0	root	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	cell	_	NN	NN	_	6	nn	_	_
5	cycle	_	NN	NN	_	6	nn	_	_
6	progression	_	NN	NN	_	2	conj	_	_
7	in	_	IN	IN	_	2	prep	_	_
8	humans	_	NNS	NNS	_	7	pobj	_	_
9	exposed	_	VBN	VBN	_	8	vmod	_	_
10	to	_	TO	TO	_	9	prep	_	_
11	methyl	_	NN	NN	_	13	nn	_	_
12	tertiary-butyl	_	NN	NN	_	13	nn	_	_
13	ether	_	NN	NN	_	16	dep	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	benzene	_	NN	NN	_	13	conj	_	_
16	contaminating	_	NN	NN	_	17	amod	_	_
17	water	_	NN	NN	_	10	pobj	_	_
18	.	_	.	.	_	2	punct	_	_

1	1	_	CD	CD	_	7	dep	_	_
2	.	_	.	.	_	1	punct	_	_
3	In	_	IN	IN	_	7	prep	_	_
4	this	_	DT	DT	_	5	det	_	_
5	study	_	NN	NN	_	3	pobj	_	_
6	we	_	PRP	PRP	_	7	nsubj	_	_
7	hypothesized	_	VBD	VBD	_	0	root	_	_
8	that	_	IN	IN	_	22	mark	_	_
9	in	_	IN	IN	_	22	prep	_	_
10	individuals	_	NNS	NNS	_	9	pobj	_	_
11	with	_	IN	IN	_	10	prep	_	_
12	certain	_	JJ	JJ	_	14	amod	_	_
13	genetic	_	JJ	JJ	_	14	amod	_	_
14	makeup	_	NN	NN	_	11	pobj	_	_
15	,	_	,	,	_	22	punct	_	_
16	MTBE	_	NN	NN	_	22	nsubj	_	_
17	,	_	,	,	_	16	punct	_	_
18	benzene	_	NN	NN	_	16	conj	_	_
19	or	_	CC	CC	_	16	cc	_	_
20	their	_	PRP$	PRP$	_	21	poss	_	_
21	metabolites	_	NNS	NNS	_	16	conj	_	_
22	act	_	VBP	VBP	_	7	ccomp	_	_
23	as	_	IN	IN	_	22	prep	_	_
24	adducts	_	NNS	NNS	_	23	pobj	_	_
25	and	_	CC	CC	_	22	cc	_	_
26	may	_	MD	MD	_	27	aux	_	_
27	induce	_	VB	VB	_	22	conj	_	_
28	programmed	_	VBN	VBN	_	30	amod	_	_
29	cell	_	NN	NN	_	30	nn	_	_
30	death	_	NN	NN	_	27	dobj	_	_
31	.	_	.	.	_	7	punct	_	_

1	2	_	CD	CD	_	5	dep	_	_
2	.	_	.	.	_	1	punct	_	_
3	Our	_	PRP$	PRP$	_	4	poss	_	_
4	study	_	NN	NN	_	5	nsubj	_	_
5	involved	_	VBD	VBD	_	0	root	_	_
6	a	_	DT	DT	_	7	det	_	_
7	group	_	NN	NN	_	5	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	60	_	CD	CD	_	13	num	_	_
10	male	_	NN	NN	_	13	amod	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	female	_	JJ	JJ	_	10	conj	_	_
13	subjects	_	NNS	NNS	_	8	pobj	_	_
14	who	_	WP	WP	_	16	nsubjpass	_	_
15	were	_	VBD	VBD	_	16	auxpass	_	_
16	exposed	_	VBN	VBN	_	7	rcmod	_	_
17	to	_	TO	TO	_	16	prep	_	_
18	MTBE	_	NN	NN	_	21	amod	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	benzene-contaminated	_	JJ	JJ	_	18	conj	_	_
21	water	_	NN	NN	_	17	pobj	_	_
22	concentrations	_	NNS	NNS	_	21	dep	_	_
23	up	_	IN	IN	_	25	quantmod	_	_
24	to	_	TO	TO	_	25	dep	_	_
25	76	_	CD	CD	_	26	num	_	_
26	PPB	_	NN	NN	_	22	dep	_	_
27	for	_	IN	IN	_	26	prep	_	_
28	MTBE	_	NN	NN	_	27	pobj	_	_
29	and	_	CC	CC	_	26	cc	_	_
30	14	_	CD	CD	_	31	num	_	_
31	PPB	_	NN	NN	_	26	conj	_	_
32	for	_	IN	IN	_	31	prep	_	_
33	benzene	_	NN	NN	_	32	pobj	_	_
34	,	_	,	,	_	16	punct	_	_
35	for	_	IN	IN	_	16	prep	_	_
36	a	_	DT	DT	_	37	det	_	_
37	period	_	NN	NN	_	35	pobj	_	_
38	of	_	IN	IN	_	37	prep	_	_
39	5	_	CD	CD	_	41	number	_	_
40	to	_	TO	TO	_	41	dep	_	_
41	8	_	CD	CD	_	42	num	_	_
42	years	_	NNS	NNS	_	38	pobj	_	_
43	.	_	.	.	_	5	punct	_	_

1	For	_	IN	IN	_	5	prep	_	_
2	comparison	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	5	punct	_	_
4	we	_	PRP	PRP	_	5	nsubj	_	_
5	recruited	_	VBD	VBD	_	0	root	_	_
6	a	_	DT	DT	_	8	det	_	_
7	control	_	NN	NN	_	8	nn	_	_
8	group	_	NN	NN	_	5	dobj	_	_
9	consisting	_	VBG	VBG	_	8	vmod	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	32	_	CD	CD	_	13	num	_	_
12	healthy	_	JJ	JJ	_	13	amod	_	_
13	males	_	NNS	NNS	_	10	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	females	_	NNS	NNS	_	13	conj	_	_
16	with	_	IN	IN	_	13	prep	_	_
17	similar	_	JJ	JJ	_	19	amod	_	_
18	age	_	NN	NN	_	19	nn	_	_
19	distribution	_	NN	NN	_	16	pobj	_	_
20	and	_	CC	CC	_	16	cc	_	_
21	without	_	IN	IN	_	16	conj	_	_
22	a	_	DT	DT	_	23	det	_	_
23	history	_	NN	NN	_	21	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	exposure	_	NN	NN	_	24	pobj	_	_
26	to	_	TO	TO	_	25	prep	_	_
27	MTBE	_	NN	NN	_	26	pobj	_	_
28	or	_	CC	CC	_	27	cc	_	_
29	benzene	_	NN	NN	_	27	conj	_	_
30	.	_	.	.	_	5	punct	_	_

1	3	_	CD	CD	_	13	dep	_	_
2	.	_	.	.	_	1	punct	_	_
3	Peripheral	_	JJ	JJ	_	5	amod	_	_
4	blood	_	NN	NN	_	5	nn	_	_
5	lymphocytes	_	NNS	NNS	_	13	nsubjpass	_	_
6	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
7	PBL	_	NNS	NNS	_	5	appos	_	_
8	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
9	of	_	IN	IN	_	5	prep	_	_
10	both	_	CC	CC	_	11	dep	_	_
11	groups	_	NNS	NNS	_	9	pobj	_	_
12	were	_	VBD	VBD	_	13	auxpass	_	_
13	tested	_	VBN	VBN	_	0	root	_	_
14	for	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	percentage	_	NN	NN	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	apoptotic	_	JJ	JJ	_	19	amod	_	_
19	cells	_	NNS	NNS	_	17	pobj	_	_
20	and	_	CC	CC	_	16	cc	_	_
21	cell	_	NN	NN	_	23	nn	_	_
22	cycle	_	NN	NN	_	23	nn	_	_
23	progression	_	NN	NN	_	16	conj	_	_
24	using	_	VBG	VBG	_	13	xcomp	_	_
25	flow	_	NN	NN	_	26	nn	_	_
26	cytometry	_	NN	NN	_	24	dobj	_	_
27	.	_	.	.	_	13	punct	_	_

1	4	_	LS	LS	_	26	dep	_	_
2	.	_	.	.	_	1	punct	_	_
3	When	_	WRB	WRB	_	10	advmod	_	_
4	apoptotic	_	JJ	JJ	_	5	amod	_	_
5	lymphocytes	_	NNS	NNS	_	10	nsubjpass	_	_
6	from	_	IN	IN	_	5	prep	_	_
7	exposed	_	VBN	VBN	_	8	amod	_	_
8	individuals	_	NNS	NNS	_	6	pobj	_	_
9	were	_	VBD	VBD	_	10	auxpass	_	_
10	compared	_	VBN	VBN	_	26	advcl	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	apoptotic	_	JJ	JJ	_	13	amod	_	_
13	lymphocytes	_	NNS	NNS	_	11	pobj	_	_
14	from	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	17	det	_	_
16	control	_	JJ	JJ	_	17	amod	_	_
17	group	_	NN	NN	_	14	pobj	_	_
18	,	_	,	,	_	26	punct	_	_
19	statistically-significant	_	JJ	JJ	_	20	amod	_	_
20	differences	_	NNS	NNS	_	26	nsubjpass	_	_
21	between	_	IN	IN	_	20	prep	_	_
22	each	_	DT	DT	_	24	det	_	_
23	mean	_	NN	NN	_	24	nn	_	_
24	group	_	NN	NN	_	21	pobj	_	_
25	were	_	VBD	VBD	_	26	auxpass	_	_
26	detected	_	VBN	VBN	_	0	root	_	_
27	-LRB-	_	-LRB-	-LRB-	_	28	punct	_	_
28	26.4	_	CD	CD	_	26	dep	_	_
29	+/-	_	CC	CC	_	28	cc	_	_
30	1.8	_	CD	CD	_	28	conj	_	_
31	and	_	CC	CC	_	28	cc	_	_
32	12.1	_	CD	CD	_	28	conj	_	_
33	+/-	_	CC	CC	_	32	cc	_	_
34	1.3	_	CD	CD	_	32	conj	_	_
35	,	_	,	,	_	28	punct	_	_
36	respectively	_	RB	RB	_	28	advmod	_	_
37	-RRB-	_	-RRB-	-RRB-	_	28	punct	_	_
38	,	_	,	,	_	26	punct	_	_
39	indicating	_	VBG	VBG	_	26	dep	_	_
40	an	_	DT	DT	_	42	det	_	_
41	increased	_	VBN	VBN	_	42	amod	_	_
42	rate	_	NN	NN	_	39	dobj	_	_
43	of	_	IN	IN	_	42	prep	_	_
44	apoptosis	_	NN	NN	_	43	pobj	_	_
45	in	_	IN	IN	_	42	prep	_	_
46	80.5	_	CD	CD	_	47	num	_	_
47	%	_	NN	NN	_	45	pobj	_	_
48	of	_	IN	IN	_	47	prep	_	_
49	exposed	_	VBN	VBN	_	50	amod	_	_
50	individuals	_	NNS	NNS	_	48	pobj	_	_
51	-LRB-	_	-LRB-	-LRB-	_	52	punct	_	_
52	P	_	NN	NN	_	42	dep	_	_
53	&lt;	_	JJR	JJR	_	52	amod	_	_
54	0.0001	_	CD	CD	_	53	dep	_	_
55	,	_	,	,	_	52	punct	_	_
56	Mann-Whitney	_	JJ	JJ	_	57	amod	_	_
57	U-Test	_	NN	NN	_	52	appos	_	_
58	-RRB-	_	-RRB-	-RRB-	_	52	punct	_	_
59	.	_	.	.	_	26	punct	_	_

1	MTBE	_	NN	NN	_	4	amod	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	benzene-induced	_	JJ	JJ	_	1	conj	_	_
4	apoptosis	_	NN	NN	_	6	nsubjpass	_	_
5	is	_	VBZ	VBZ	_	6	auxpass	_	_
6	attributed	_	VBN	VBN	_	0	root	_	_
7	to	_	TO	TO	_	6	prep	_	_
8	a	_	DT	DT	_	10	det	_	_
9	discrete	_	JJ	JJ	_	10	amod	_	_
10	block	_	NN	NN	_	7	pobj	_	_
11	within	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	15	det	_	_
13	cell	_	NN	NN	_	15	nn	_	_
14	cycle	_	NN	NN	_	15	nn	_	_
15	progression	_	NN	NN	_	11	pobj	_	_
16	.	_	.	.	_	6	punct	_	_

1	Because	_	IN	IN	_	5	mark	_	_
2	cell	_	NN	NN	_	4	nn	_	_
3	cycle	_	NN	NN	_	4	nn	_	_
4	analysis	_	NN	NN	_	5	nsubj	_	_
5	showed	_	VBD	VBD	_	0	root	_	_
6	that	_	IN	IN	_	19	mark	_	_
7	in	_	IN	IN	_	19	prep	_	_
8	PBL	_	NNS	NNS	_	7	pobj	_	_
9	from	_	IN	IN	_	8	prep	_	_
10	chemically-exposed	_	JJ	JJ	_	11	amod	_	_
11	individuals	_	NNS	NNS	_	9	pobj	_	_
12	,	_	,	,	_	19	punct	_	_
13	between	_	IN	IN	_	14	quantmod	_	_
14	20-50	_	CD	CD	_	15	num	_	_
15	%	_	NN	NN	_	19	nsubjpass	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	cells	_	NNS	NNS	_	16	pobj	_	_
18	were	_	VBD	VBD	_	19	auxpass	_	_
19	accumulated	_	VBN	VBN	_	5	ccomp	_	_
20	at	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	23	det	_	_
22	S-G2/M	_	JJ	JJ	_	23	amod	_	_
23	boundaries	_	NNS	NNS	_	20	pobj	_	_
24	.	_	.	.	_	5	punct	_	_

1	5	_	CD	CD	_	16	dep	_	_
2	.	_	.	.	_	1	punct	_	_
3	One	_	CD	CD	_	16	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	7	det	_	_
6	signaling	_	VBG	VBG	_	7	amod	_	_
7	molecules	_	NNS	NNS	_	4	pobj	_	_
8	which	_	WDT	WDT	_	9	nsubj	_	_
9	mediates	_	VBZ	VBZ	_	3	rcmod	_	_
10	programmed	_	VBN	VBN	_	9	dep	_	_
11	cell	_	NN	NN	_	12	nn	_	_
12	death	_	NN	NN	_	10	dobj	_	_
13	is	_	VBZ	VBZ	_	16	cop	_	_
14	nuclear	_	JJ	JJ	_	16	amod	_	_
15	factor	_	NN	NN	_	16	nn	_	_
16	Kappa-B	_	NN	NN	_	0	root	_	_
17	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
18	NF-kappa	_	NN	NN	_	19	nn	_	_
19	B	_	NN	NN	_	16	appos	_	_
20	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	.	_	.	.	_	16	punct	_	_

1	NF-kappa	_	NN	NN	_	2	nn	_	_
2	B	_	NN	NN	_	4	nsubjpass	_	_
3	was	_	VBD	VBD	_	4	auxpass	_	_
4	examined	_	VBN	VBN	_	0	root	_	_
5	as	_	IN	IN	_	4	prep	_	_
6	one	_	CD	CD	_	5	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	11	det	_	_
9	many	_	JJ	JJ	_	11	amod	_	_
10	molecular	_	JJ	JJ	_	11	amod	_	_
11	mechanisms	_	NNS	NNS	_	7	pobj	_	_
12	for	_	IN	IN	_	11	prep	_	_
13	mediating	_	VBG	VBG	_	12	pcomp	_	_
14	cell	_	NN	NN	_	15	nn	_	_
15	death	_	NN	NN	_	13	dobj	_	_
16	by	_	IN	IN	_	15	prep	_	_
17	MTBE	_	NN	NN	_	16	pobj	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	benzene	_	NN	NN	_	17	conj	_	_
20	.	_	.	.	_	4	punct	_	_

1	Indeed	_	RB	RB	_	24	advmod	_	_
2	,	_	,	,	_	24	punct	_	_
3	addition	_	NN	NN	_	24	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	inhibitors	_	NNS	NNS	_	4	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	NF-kappa	_	NN	NN	_	8	nn	_	_
8	B	_	NN	NN	_	9	nn	_	_
9	activation	_	NN	NN	_	6	pobj	_	_
10	pyrrolidine	_	NN	NN	_	11	nn	_	_
11	dithiocarbamate	_	NN	NN	_	5	dep	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	PDTC	_	NN	NN	_	11	appos	_	_
14	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
15	,	_	,	,	_	3	punct	_	_
16	to	_	TO	TO	_	3	prep	_	_
17	the	_	DT	DT	_	18	det	_	_
18	lymphocytes	_	NNS	NNS	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	22	det	_	_
21	chemically-exposed	_	JJ	JJ	_	22	amod	_	_
22	group	_	NN	NN	_	19	pobj	_	_
23	was	_	VBD	VBD	_	24	cop	_	_
24	capable	_	JJ	JJ	_	0	root	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	inhibiting	_	VBG	VBG	_	25	pcomp	_	_
27	programmed	_	VBN	VBN	_	29	amod	_	_
28	cell	_	NN	NN	_	29	nn	_	_
29	death	_	NN	NN	_	26	dobj	_	_
30	by	_	IN	IN	_	26	prep	_	_
31	40	_	CD	CD	_	32	num	_	_
32	%	_	NN	NN	_	30	pobj	_	_
33	.	_	.	.	_	24	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	reversal	_	NN	NN	_	17	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	apoptosis	_	NN	NN	_	3	pobj	_	_
5	almost	_	RB	RB	_	6	advmod	_	_
6	to	_	TO	TO	_	2	prep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	control	_	NN	NN	_	9	nn	_	_
9	level	_	NN	NN	_	6	pobj	_	_
10	by	_	IN	IN	_	2	prep	_	_
11	inhibitor	_	NN	NN	_	10	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	NF-kappa	_	NN	NN	_	14	nn	_	_
14	B	_	NN	NN	_	15	nn	_	_
15	activation	_	NN	NN	_	12	pobj	_	_
16	may	_	MD	MD	_	17	aux	_	_
17	indicate	_	VB	VB	_	0	root	_	_
18	involvement	_	NN	NN	_	17	dobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	this	_	DT	DT	_	22	det	_	_
21	signaling	_	VBG	VBG	_	22	amod	_	_
22	molecule	_	NN	NN	_	19	pobj	_	_
23	in	_	IN	IN	_	18	prep	_	_
24	MTBE	_	NN	NN	_	23	pobj	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	benzene	_	NN	NN	_	24	conj	_	_
27	induction	_	NN	NN	_	24	dep	_	_
28	of	_	IN	IN	_	24	prep	_	_
29	programmed	_	VBN	VBN	_	31	amod	_	_
30	cell	_	NN	NN	_	31	nn	_	_
31	death	_	NN	NN	_	28	pobj	_	_
32	.	_	.	.	_	17	punct	_	_

1	Alcohol-induced	_	JJ	JJ	_	2	amod	_	_
2	regulation	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	nuclear	_	JJ	JJ	_	7	amod	_	_
5	regulatory	_	JJ	JJ	_	7	amod	_	_
6	factor-kappa	_	NN	NN	_	7	nn	_	_
7	beta	_	NN	NN	_	3	pobj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	human	_	JJ	JJ	_	10	amod	_	_
10	monocytes	_	NNS	NNS	_	8	pobj	_	_
11	.	_	.	.	_	2	punct	_	_

1	Acute	_	JJ	JJ	_	3	amod	_	_
2	ethanol	_	NN	NN	_	3	nn	_	_
3	exposure	_	NN	NN	_	4	nsubj	_	_
4	has	_	VBZ	VBZ	_	0	root	_	_
5	the	_	DT	DT	_	6	det	_	_
6	capacity	_	NN	NN	_	4	dobj	_	_
7	to	_	TO	TO	_	8	aux	_	_
8	modulate	_	VB	VB	_	6	dep	_	_
9	immune	_	JJ	JJ	_	10	amod	_	_
10	functions	_	NNS	NNS	_	8	dobj	_	_
11	,	_	,	,	_	8	punct	_	_
12	particularly	_	RB	RB	_	16	advmod	_	_
13	,	_	,	,	_	16	punct	_	_
14	to	_	TO	TO	_	16	aux	_	_
15	down	_	RP	RP	_	16	dep	_	_
16	regulate	_	VB	VB	_	8	dep	_	_
17	monocyte	_	NN	NN	_	18	nn	_	_
18	production	_	NN	NN	_	16	dobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	inflammatory	_	JJ	JJ	_	21	amod	_	_
21	cytokines	_	NNS	NNS	_	19	pobj	_	_
22	.	_	.	.	_	4	punct	_	_

1	However	_	RB	RB	_	11	advmod	_	_
2	,	_	,	,	_	11	punct	_	_
3	the	_	DT	DT	_	5	det	_	_
4	intracellular	_	JJ	JJ	_	5	amod	_	_
5	mechanisms	_	NNS	NNS	_	11	nsubj	_	_
6	for	_	IN	IN	_	5	prep	_	_
7	these	_	DT	DT	_	8	det	_	_
8	effects	_	NNS	NNS	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	ethanol	_	NN	NN	_	9	pobj	_	_
11	are	_	VBP	VBP	_	0	root	_	_
12	yet	_	RB	RB	_	11	advmod	_	_
13	to	_	TO	TO	_	15	aux	_	_
14	be	_	VB	VB	_	15	auxpass	_	_
15	understood	_	VBN	VBN	_	11	xcomp	_	_
16	.	_	.	.	_	11	punct	_	_

1	Considering	_	VBG	VBG	_	30	dep	_	_
2	that	_	IN	IN	_	16	mark	_	_
3	nuclear	_	JJ	JJ	_	6	amod	_	_
4	regulatory	_	JJ	JJ	_	6	amod	_	_
5	factor-kappa	_	NN	NN	_	6	nn	_	_
6	beta	_	NN	NN	_	16	nsubj	_	_
7	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
8	NF-kappa	_	NN	NN	_	11	nn	_	_
9	B	_	NN	NN	_	11	nn	_	_
10	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
11	/Rel	_	NN	NN	_	6	dep	_	_
12	is	_	VBZ	VBZ	_	16	cop	_	_
13	a	_	DT	DT	_	16	det	_	_
14	common	_	JJ	JJ	_	16	amod	_	_
15	regulatory	_	JJ	JJ	_	16	amod	_	_
16	element	_	NN	NN	_	1	pcomp	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	promoter	_	NN	NN	_	20	nn	_	_
20	region	_	NN	NN	_	17	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	25	det	_	_
23	inflammatory	_	JJ	JJ	_	25	amod	_	_
24	cytokine	_	NN	NN	_	25	nn	_	_
25	genes	_	NNS	NNS	_	21	pobj	_	_
26	,	_	,	,	_	30	punct	_	_
27	herein	_	RB	RB	_	30	advmod	_	_
28	,	_	,	,	_	30	punct	_	_
29	we	_	PRP	PRP	_	30	nsubj	_	_
30	tested	_	VBD	VBD	_	0	root	_	_
31	the	_	DT	DT	_	32	det	_	_
32	hypothesis	_	NN	NN	_	30	dobj	_	_
33	that	_	IN	IN	_	36	mark	_	_
34	acute	_	JJ	JJ	_	35	amod	_	_
35	ethanol	_	NN	NN	_	36	nsubj	_	_
36	affects	_	VBZ	VBZ	_	32	ccomp	_	_
37	NF-kappa	_	NN	NN	_	38	nn	_	_
38	B	_	NN	NN	_	39	nn	_	_
39	activation	_	NN	NN	_	36	dobj	_	_
40	in	_	IN	IN	_	39	prep	_	_
41	human	_	JJ	JJ	_	42	amod	_	_
42	monocytes	_	NNS	NNS	_	40	pobj	_	_
43	.	_	.	.	_	30	punct	_	_

1	Adherence-isolated	_	JJ	JJ	_	2	amod	_	_
2	monocytes	_	NNS	NNS	_	3	nsubj	_	_
3	showed	_	VBD	VBD	_	0	root	_	_
4	constitutive	_	JJ	JJ	_	7	amod	_	_
5	DNA	_	NN	NN	_	7	nn	_	_
6	binding	_	NN	NN	_	7	nn	_	_
7	activity	_	NN	NN	_	3	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	NF-kappa	_	NN	NN	_	10	nn	_	_
10	B	_	NN	NN	_	8	pobj	_	_
11	.	_	.	.	_	3	punct	_	_

1	A	_	DT	DT	_	4	det	_	_
2	clinically	_	RB	RB	_	3	advmod	_	_
3	relevant	_	JJ	JJ	_	4	amod	_	_
4	dose	_	NN	NN	_	15	nsubj	_	_
5	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
6	25	_	CD	CD	_	7	num	_	_
7	mM	_	NN	NN	_	4	appos	_	_
8	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
9	of	_	IN	IN	_	4	prep	_	_
10	acute	_	JJ	JJ	_	12	amod	_	_
11	ethanol	_	NN	NN	_	12	nn	_	_
12	treatment	_	NN	NN	_	9	pobj	_	_
13	in	_	FW	FW	_	14	nn	_	_
14	vitro	_	FW	FW	_	4	advmod	_	_
15	increased	_	VBD	VBD	_	0	root	_	_
16	NF-kappa	_	NN	NN	_	17	nn	_	_
17	B	_	NN	NN	_	19	nn	_	_
18	binding	_	NN	NN	_	19	nn	_	_
19	activity	_	NN	NN	_	15	dobj	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	monocytes	_	NNS	NNS	_	20	pobj	_	_
22	with	_	IN	IN	_	15	prep	_	_
23	a	_	DT	DT	_	25	det	_	_
24	preferential	_	JJ	JJ	_	25	amod	_	_
25	induction	_	NN	NN	_	22	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	28	det	_	_
28	inhibitory	_	JJ	JJ	_	26	pobj	_	_
29	,	_	,	,	_	28	punct	_	_
30	p50/p50	_	NN	NN	_	28	appos	_	_
31	,	_	,	,	_	28	punct	_	_
32	NF-kappa	_	NN	NN	_	34	nn	_	_
33	B/Rel	_	NN	NN	_	34	nn	_	_
34	homodimer	_	NN	NN	_	28	appos	_	_
35	,	_	,	,	_	15	punct	_	_
36	and	_	CC	CC	_	15	cc	_	_
37	resulted	_	VBD	VBD	_	15	conj	_	_
38	in	_	IN	IN	_	37	prep	_	_
39	no	_	DT	DT	_	40	neg	_	_
40	induction	_	NN	NN	_	38	pobj	_	_
41	of	_	IN	IN	_	40	prep	_	_
42	the	_	DT	DT	_	44	det	_	_
43	p65/p50	_	NN	NN	_	44	nn	_	_
44	heterodimer	_	NN	NN	_	41	pobj	_	_
45	.	_	.	.	_	15	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	7	punct	_	_
4	lipopolysaccharide	_	NN	NN	_	5	nn	_	_
5	stimulation	_	NN	NN	_	7	nsubj	_	_
6	primarily	_	RB	RB	_	7	advmod	_	_
7	induced	_	VBD	VBD	_	0	root	_	_
8	the	_	DT	DT	_	10	det	_	_
9	p65/p50	_	NN	NN	_	10	nn	_	_
10	heterodimer	_	NN	NN	_	7	dobj	_	_
11	that	_	WDT	WDT	_	14	nsubjpass	_	_
12	has	_	VBZ	VBZ	_	14	aux	_	_
13	been	_	VBN	VBN	_	14	auxpass	_	_
14	shown	_	VBN	VBN	_	10	rcmod	_	_
15	to	_	TO	TO	_	16	aux	_	_
16	result	_	VB	VB	_	14	xcomp	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	gene	_	NN	NN	_	19	nn	_	_
19	activation	_	NN	NN	_	17	pobj	_	_
20	.	_	.	.	_	7	punct	_	_

1	Thus	_	RB	RB	_	16	advmod	_	_
2	,	_	,	,	_	16	punct	_	_
3	such	_	JJ	JJ	_	4	amod	_	_
4	unique	_	JJ	JJ	_	5	amod	_	_
5	activation	_	NN	NN	_	16	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	10	det	_	_
8	inhibitory	_	JJ	JJ	_	10	amod	_	_
9	p50/p50	_	NN	NN	_	10	nn	_	_
10	homodimer	_	NN	NN	_	6	pobj	_	_
11	by	_	IN	IN	_	5	prep	_	_
12	acute	_	JJ	JJ	_	14	amod	_	_
13	ethanol	_	NN	NN	_	14	nn	_	_
14	treatment	_	NN	NN	_	11	pobj	_	_
15	may	_	MD	MD	_	16	aux	_	_
16	result	_	VB	VB	_	0	root	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	inhibition	_	NN	NN	_	17	pobj	_	_
19	rather	_	RB	RB	_	18	cc	_	_
20	than	_	IN	IN	_	19	mwe	_	_
21	activation	_	NN	NN	_	18	conj	_	_
22	of	_	IN	IN	_	18	prep	_	_
23	NF-kappa	_	NN	NN	_	27	nn	_	_
24	B-regulated	_	JJ	JJ	_	27	amod	_	_
25	inflammatory	_	JJ	JJ	_	27	amod	_	_
26	cytokine	_	NN	NN	_	27	nn	_	_
27	genes	_	NNS	NNS	_	22	pobj	_	_
28	.	_	.	.	_	16	punct	_	_

1	Consequently	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	these	_	DT	DT	_	4	det	_	_
4	results	_	NNS	NNS	_	5	nsubj	_	_
5	suggest	_	VBP	VBP	_	0	root	_	_
6	that	_	IN	IN	_	13	mark	_	_
7	physiologically	_	RB	RB	_	8	advmod	_	_
8	relevant	_	JJ	JJ	_	9	amod	_	_
9	concentrations	_	NNS	NNS	_	13	nsubj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	ethanol	_	NN	NN	_	10	pobj	_	_
12	may	_	MD	MD	_	13	aux	_	_
13	affect	_	VB	VB	_	5	ccomp	_	_
14	production	_	NN	NN	_	13	dobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	inflammatory	_	JJ	JJ	_	17	amod	_	_
17	cytokines	_	NNS	NNS	_	15	pobj	_	_
18	,	_	,	,	_	17	punct	_	_
19	such	_	JJ	JJ	_	20	mwe	_	_
20	as	_	IN	IN	_	17	prep	_	_
21	tumor	_	NN	NN	_	23	nn	_	_
22	necrosis	_	NN	NN	_	23	nn	_	_
23	factor-alpha	_	NN	NN	_	20	pobj	_	_
24	,	_	,	,	_	23	punct	_	_
25	interleukin-1	_	NN	NN	_	26	nn	_	_
26	beta	_	NN	NN	_	23	conj	_	_
27	,	_	,	,	_	23	punct	_	_
28	and	_	CC	CC	_	23	cc	_	_
29	interleukin-6	_	NN	NN	_	23	conj	_	_
30	by	_	IN	IN	_	13	prep	_	_
31	disrupting	_	VBG	VBG	_	30	pcomp	_	_
32	NF-kappa	_	NN	NN	_	33	nn	_	_
33	B	_	NN	NN	_	34	nn	_	_
34	signaling	_	NN	NN	_	31	dobj	_	_
35	in	_	IN	IN	_	34	prep	_	_
36	monocytes	_	NNS	NNS	_	35	pobj	_	_
37	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	ability	_	NN	NN	_	9	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	BHRF1	_	NN	NN	_	3	pobj	_	_
5	to	_	TO	TO	_	6	aux	_	_
6	inhibit	_	VB	VB	_	2	vmod	_	_
7	apoptosis	_	NN	NN	_	6	dobj	_	_
8	is	_	VBZ	VBZ	_	9	cop	_	_
9	dependent	_	JJ	JJ	_	0	root	_	_
10	on	_	IN	IN	_	9	prep	_	_
11	stimulus	_	NN	NN	_	10	pobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	cell	_	NN	NN	_	14	nn	_	_
14	type	_	NN	NN	_	11	conj	_	_
15	.	_	.	.	_	9	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	development	_	NN	NN	_	30	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	resistance	_	NN	NN	_	3	pobj	_	_
5	to	_	TO	TO	_	4	prep	_	_
6	host	_	NN	NN	_	8	nn	_	_
7	defense	_	NN	NN	_	8	nn	_	_
8	mechanisms	_	NNS	NNS	_	5	pobj	_	_
9	such	_	JJ	JJ	_	10	mwe	_	_
10	as	_	IN	IN	_	8	prep	_	_
11	tumor	_	NN	NN	_	13	nn	_	_
12	necrosis	_	NN	NN	_	13	nn	_	_
13	factor	_	NN	NN	_	10	pobj	_	_
14	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
15	TNF	_	NN	NN	_	13	appos	_	_
16	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
17	-	_	:	:	_	13	punct	_	_
18	and	_	CC	CC	_	13	cc	_	_
19	Fas-mediated	_	JJ	JJ	_	13	conj	_	_
20	apoptosis	_	NN	NN	_	13	dep	_	_
21	of	_	IN	IN	_	13	prep	_	_
22	transformed	_	VBN	VBN	_	21	pobj	_	_
23	or	_	CC	CC	_	22	cc	_	_
24	virus-infected	_	JJ	JJ	_	25	amod	_	_
25	cells	_	NNS	NNS	_	22	conj	_	_
26	may	_	MD	MD	_	30	aux	_	_
27	be	_	VB	VB	_	30	cop	_	_
28	a	_	DT	DT	_	30	det	_	_
29	critical	_	JJ	JJ	_	30	amod	_	_
30	component	_	NN	NN	_	0	root	_	_
31	in	_	IN	IN	_	30	prep	_	_
32	the	_	DT	DT	_	33	det	_	_
33	development	_	NN	NN	_	31	pobj	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	disease	_	NN	NN	_	34	pobj	_	_
36	.	_	.	.	_	30	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	find	_	VB	VB	_	0	root	_	_
3	genes	_	NNS	NNS	_	2	dobj	_	_
4	that	_	WDT	WDT	_	5	nsubj	_	_
5	protect	_	VBP	VBP	_	3	rcmod	_	_
6	cells	_	NNS	NNS	_	5	dobj	_	_
7	from	_	IN	IN	_	5	prep	_	_
8	apoptosis	_	NN	NN	_	7	pobj	_	_
9	,	_	,	,	_	2	punct	_	_
10	we	_	PRP	PRP	_	11	nsubj	_	_
11	used	_	VBD	VBD	_	2	parataxis	_	_
12	an	_	DT	DT	_	15	det	_	_
13	expression	_	NN	NN	_	15	nn	_	_
14	cloning	_	NN	NN	_	15	nn	_	_
15	strategy	_	NN	NN	_	11	dobj	_	_
16	and	_	CC	CC	_	11	cc	_	_
17	identified	_	VBD	VBD	_	11	conj	_	_
18	BHRF1	_	NN	NN	_	17	dobj	_	_
19	,	_	,	,	_	18	punct	_	_
20	an	_	DT	DT	_	27	det	_	_
21	Epstein-Barr	_	JJ	JJ	_	27	amod	_	_
22	virus	_	NN	NN	_	27	nn	_	_
23	-LRB-	_	-LRB-	-LRB-	_	27	punct	_	_
24	EBV	_	NN	NN	_	27	nn	_	_
25	-RRB-	_	-RRB-	-RRB-	_	27	punct	_	_
26	early-lytic-cycle	_	JJ	JJ	_	27	amod	_	_
27	protein	_	NN	NN	_	18	appos	_	_
28	with	_	IN	IN	_	27	prep	_	_
29	distant	_	JJ	JJ	_	30	amod	_	_
30	homology	_	NN	NN	_	28	pobj	_	_
31	to	_	TO	TO	_	30	prep	_	_
32	Bcl-2	_	NN	NN	_	31	pobj	_	_
33	,	_	,	,	_	17	punct	_	_
34	as	_	IN	IN	_	17	prep	_	_
35	an	_	DT	DT	_	37	det	_	_
36	anti-apoptosis	_	JJ	JJ	_	37	amod	_	_
37	protein	_	NN	NN	_	34	pobj	_	_
38	.	_	.	.	_	2	punct	_	_

1	Expression	_	NN	NN	_	7	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	BHRF1	_	NN	NN	_	2	pobj	_	_
4	in	_	IN	IN	_	1	prep	_	_
5	MCF-Fas	_	NN	NN	_	6	nn	_	_
6	cells	_	NNS	NNS	_	4	pobj	_	_
7	conferred	_	VBD	VBD	_	0	root	_	_
8	nearly	_	RB	RB	_	9	advmod	_	_
9	complete	_	JJ	JJ	_	10	amod	_	_
10	resistance	_	NN	NN	_	7	dobj	_	_
11	against	_	IN	IN	_	10	prep	_	_
12	both	_	CC	CC	_	14	preconj	_	_
13	anti-Fas	_	JJ	JJ	_	14	amod	_	_
14	antibody	_	NN	NN	_	11	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	TNF-mediated	_	JJ	JJ	_	17	amod	_	_
17	apoptosis	_	NN	NN	_	14	conj	_	_
18	.	_	.	.	_	7	punct	_	_

1	In	_	IN	IN	_	5	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	5	punct	_	_
4	BHRF1	_	NN	NN	_	5	nsubj	_	_
5	protected	_	VBD	VBD	_	0	root	_	_
6	these	_	DT	DT	_	7	det	_	_
7	cells	_	NNS	NNS	_	5	dobj	_	_
8	from	_	IN	IN	_	5	prep	_	_
9	monocyte-mediated	_	JJ	JJ	_	10	amod	_	_
10	killing	_	NN	NN	_	8	pobj	_	_
11	but	_	CC	CC	_	5	cc	_	_
12	failed	_	VBD	VBD	_	5	conj	_	_
13	to	_	TO	TO	_	14	aux	_	_
14	protect	_	VB	VB	_	12	xcomp	_	_
15	them	_	PRP	PRP	_	14	dobj	_	_
16	from	_	IN	IN	_	14	prep	_	_
17	killing	_	NN	NN	_	16	pobj	_	_
18	mediated	_	VBN	VBN	_	17	vmod	_	_
19	by	_	IN	IN	_	18	prep	_	_
20	lymphokine-activated	_	JJ	JJ	_	22	amod	_	_
21	killer	_	NN	NN	_	22	nn	_	_
22	cells	_	NNS	NNS	_	19	pobj	_	_
23	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	ability	_	NN	NN	_	16	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	BHRF1	_	NN	NN	_	3	pobj	_	_
5	to	_	TO	TO	_	6	aux	_	_
6	protect	_	VB	VB	_	2	vmod	_	_
7	MCF-Fas	_	NN	NN	_	8	nn	_	_
8	cells	_	NNS	NNS	_	6	dobj	_	_
9	from	_	IN	IN	_	6	prep	_	_
10	apoptosis	_	NN	NN	_	9	pobj	_	_
11	induced	_	VBN	VBN	_	10	vmod	_	_
12	by	_	IN	IN	_	11	prep	_	_
13	various	_	JJ	JJ	_	14	amod	_	_
14	stimuli	_	NNS	NNS	_	12	pobj	_	_
15	was	_	VBD	VBD	_	16	cop	_	_
16	identical	_	JJ	JJ	_	0	root	_	_
17	to	_	TO	TO	_	16	prep	_	_
18	that	_	DT	DT	_	17	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	Bcl-2	_	NN	NN	_	19	pobj	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	Bcl-xL	_	NN	NN	_	20	conj	_	_
23	.	_	.	.	_	16	punct	_	_

1	Moreover	_	RB	RB	_	9	advmod	_	_
2	,	_	,	,	_	9	punct	_	_
3	the	_	DT	DT	_	4	det	_	_
4	mechanism	_	NN	NN	_	9	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	action	_	NN	NN	_	5	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	BHRF1	_	NN	NN	_	7	pobj	_	_
9	resembled	_	VBD	VBD	_	0	root	_	_
10	that	_	DT	DT	_	9	xcomp	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	Bcl-2	_	NN	NN	_	11	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	Bcl-xL	_	NN	NN	_	12	conj	_	_
15	as	_	IN	IN	_	17	mark	_	_
16	it	_	PRP	PRP	_	17	nsubj	_	_
17	inhibited	_	VBD	VBD	_	9	advcl	_	_
18	TNF-	_	NN	NN	_	17	dobj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	anti-Fas-induced	_	JJ	JJ	_	18	conj	_	_
21	activation	_	NN	NN	_	18	dep	_	_
22	of	_	IN	IN	_	18	prep	_	_
23	two	_	CD	CD	_	24	num	_	_
24	enzymes	_	NNS	NNS	_	22	pobj	_	_
25	participating	_	VBG	VBG	_	24	vmod	_	_
26	in	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	29	det	_	_
28	apoptosis	_	NN	NN	_	29	nn	_	_
29	pathway	_	NN	NN	_	26	pobj	_	_
30	,	_	,	,	_	24	punct	_	_
31	cytosolic	_	JJ	JJ	_	33	amod	_	_
32	phospholipase	_	NN	NN	_	33	nn	_	_
33	A2	_	NN	NN	_	24	appos	_	_
34	and	_	CC	CC	_	33	cc	_	_
35	caspase-3/CPP32	_	NN	NN	_	33	conj	_	_
36	,	_	,	,	_	17	punct	_	_
37	but	_	CC	CC	_	17	cc	_	_
38	did	_	VBD	VBD	_	40	aux	_	_
39	not	_	RB	RB	_	40	neg	_	_
40	interfere	_	VB	VB	_	17	conj	_	_
41	with	_	IN	IN	_	40	prep	_	_
42	the	_	DT	DT	_	43	det	_	_
43	activation	_	NN	NN	_	41	pobj	_	_
44	of	_	IN	IN	_	43	prep	_	_
45	NF-kappaB-like	_	JJ	JJ	_	47	amod	_	_
46	transcription	_	NN	NN	_	47	nn	_	_
47	factors	_	NNS	NNS	_	44	pobj	_	_
48	.	_	.	.	_	9	punct	_	_

1	A	_	DT	DT	_	3	det	_	_
2	putative	_	JJ	JJ	_	3	amod	_	_
3	function	_	NN	NN	_	11	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	BHRF1	_	NN	NN	_	4	pobj	_	_
6	in	_	IN	IN	_	3	prep	_	_
7	EBV-infected	_	JJ	JJ	_	9	amod	_	_
8	epithelial	_	JJ	JJ	_	9	amod	_	_
9	cells	_	NNS	NNS	_	6	pobj	_	_
10	may	_	MD	MD	_	11	aux	_	_
11	be	_	VB	VB	_	0	root	_	_
12	to	_	TO	TO	_	13	aux	_	_
13	protect	_	VB	VB	_	11	xcomp	_	_
14	virus-infected	_	JJ	JJ	_	15	amod	_	_
15	cells	_	NNS	NNS	_	13	dobj	_	_
16	from	_	IN	IN	_	13	prep	_	_
17	TNF-	_	NN	NN	_	16	pobj	_	_
18	and/or	_	CC	CC	_	17	cc	_	_
19	anti-Fas-induced	_	JJ	JJ	_	17	conj	_	_
20	cell	_	NN	NN	_	21	nn	_	_
21	death	_	NN	NN	_	17	dep	_	_
22	in	_	IN	IN	_	25	mark	_	_
23	order	_	NN	NN	_	25	dep	_	_
24	to	_	TO	TO	_	25	aux	_	_
25	maximize	_	VB	VB	_	13	advcl	_	_
26	virus	_	NN	NN	_	27	nn	_	_
27	production	_	NN	NN	_	25	dobj	_	_
28	.	_	.	.	_	11	punct	_	_

1	Surprisingly	_	RB	RB	_	16	advmod	_	_
2	,	_	,	,	_	16	punct	_	_
3	expression	_	NN	NN	_	16	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	neither	_	CC	CC	_	6	preconj	_	_
6	BHRF1	_	NN	NN	_	4	pobj	_	_
7	nor	_	CC	CC	_	6	cc	_	_
8	Bcl-2	_	NN	NN	_	6	conj	_	_
9	in	_	IN	IN	_	3	prep	_	_
10	a	_	DT	DT	_	12	det	_	_
11	B-cell	_	NN	NN	_	12	nn	_	_
12	line	_	NN	NN	_	9	pobj	_	_
13	,	_	,	,	_	12	punct	_	_
14	BJAB	_	NN	NN	_	12	appos	_	_
15	,	_	,	,	_	3	punct	_	_
16	protected	_	VBD	VBD	_	0	root	_	_
17	the	_	DT	DT	_	18	det	_	_
18	cells	_	NNS	NNS	_	16	dobj	_	_
19	from	_	IN	IN	_	16	prep	_	_
20	anti-Fas-mediated	_	JJ	JJ	_	21	amod	_	_
21	apoptosis	_	NN	NN	_	19	pobj	_	_
22	even	_	RB	RB	_	25	advmod	_	_
23	though	_	IN	IN	_	25	mark	_	_
24	they	_	PRP	PRP	_	25	nsubj	_	_
25	increased	_	VBD	VBD	_	16	advcl	_	_
26	the	_	DT	DT	_	27	det	_	_
27	survival	_	NN	NN	_	25	dobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	serum-starved	_	JJ	JJ	_	30	amod	_	_
30	cells	_	NNS	NNS	_	28	pobj	_	_
31	.	_	.	.	_	16	punct	_	_

1	Thus	_	RB	RB	_	10	advmod	_	_
2	,	_	,	,	_	10	punct	_	_
3	the	_	DT	DT	_	5	det	_	_
4	protective	_	JJ	JJ	_	5	amod	_	_
5	role	_	NN	NN	_	10	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	BHRF1	_	NN	NN	_	6	pobj	_	_
8	against	_	IN	IN	_	5	prep	_	_
9	apoptosis	_	NN	NN	_	8	pobj	_	_
10	resembles	_	VBZ	VBZ	_	0	root	_	_
11	that	_	DT	DT	_	10	xcomp	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	Bcl-2	_	NN	NN	_	12	pobj	_	_
14	in	_	IN	IN	_	10	prep	_	_
15	being	_	VBG	VBG	_	18	cop	_	_
16	cell	_	NN	NN	_	18	npadvmod	_	_
17	type	_	NN	NN	_	18	npadvmod	_	_
18	specific	_	JJ	JJ	_	14	pcomp	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	dependent	_	JJ	JJ	_	18	conj	_	_
21	on	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	24	det	_	_
23	apoptotic	_	JJ	JJ	_	24	amod	_	_
24	stimulus	_	NN	NN	_	21	pobj	_	_
25	.	_	.	.	_	10	punct	_	_

1	Expression	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	bcl-6	_	NN	NN	_	4	nn	_	_
4	protein	_	NN	NN	_	2	pobj	_	_
5	in	_	IN	IN	_	1	prep	_	_
6	normal	_	JJ	JJ	_	7	amod	_	_
7	skin	_	NN	NN	_	5	pobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	epidermal	_	JJ	JJ	_	10	amod	_	_
10	neoplasms	_	NNS	NNS	_	7	conj	_	_
11	.	_	.	.	_	1	punct	_	_

1	Bcl-6	_	NN	NN	_	2	nn	_	_
2	protein	_	NN	NN	_	9	nsubj	_	_
3	is	_	VBZ	VBZ	_	9	cop	_	_
4	a	_	DT	DT	_	9	det	_	_
5	recently	_	RB	RB	_	6	advmod	_	_
6	identified	_	VBN	VBN	_	9	amod	_	_
7	novel	_	JJ	JJ	_	6	dep	_	_
8	transcription	_	NN	NN	_	9	nn	_	_
9	factor	_	NN	NN	_	0	root	_	_
10	whose	_	WP$	WP$	_	12	poss	_	_
11	deregulated	_	VBN	VBN	_	12	amod	_	_
12	expression	_	NN	NN	_	14	nsubjpass	_	_
13	is	_	VBZ	VBZ	_	14	auxpass	_	_
14	associated	_	VBN	VBN	_	9	rcmod	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	diffuse	_	JJ	JJ	_	17	amod	_	_
17	large	_	JJ	JJ	_	20	amod	_	_
18	B	_	NN	NN	_	20	nn	_	_
19	cell	_	NN	NN	_	20	nn	_	_
20	lymphomas	_	NNS	NNS	_	15	pobj	_	_
21	.	_	.	.	_	9	punct	_	_

1	It	_	PRP	PRP	_	4	nsubjpass	_	_
2	was	_	VBD	VBD	_	4	auxpass	_	_
3	recently	_	RB	RB	_	4	advmod	_	_
4	shown	_	VBN	VBN	_	0	root	_	_
5	by	_	IN	IN	_	4	prep	_	_
6	us	_	PRP	PRP	_	5	pobj	_	_
7	that	_	IN	IN	_	11	mark	_	_
8	the	_	DT	DT	_	9	det	_	_
9	protein	_	NN	NN	_	11	nsubj	_	_
10	is	_	VBZ	VBZ	_	11	cop	_	_
11	located	_	JJ	JJ	_	4	ccomp	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	germinal	_	JJ	JJ	_	16	amod	_	_
14	center	_	NN	NN	_	16	nn	_	_
15	B	_	NN	NN	_	16	nn	_	_
16	cells	_	NNS	NNS	_	12	pobj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	their	_	PRP$	PRP$	_	20	poss	_	_
19	neoplastic	_	JJ	JJ	_	20	amod	_	_
20	counterparts	_	NNS	NNS	_	16	conj	_	_
21	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	35	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	present	_	JJ	JJ	_	4	amod	_	_
4	study	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	35	punct	_	_
6	the	_	DT	DT	_	7	det	_	_
7	expression	_	NN	NN	_	35	nsubjpass	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	bcl-6	_	NN	NN	_	10	nn	_	_
10	protein	_	NN	NN	_	8	pobj	_	_
11	on	_	IN	IN	_	7	prep	_	_
12	normal	_	JJ	JJ	_	13	amod	_	_
13	epidermis	_	NN	NN	_	11	pobj	_	_
14	,	_	,	,	_	13	punct	_	_
15	benign	_	JJ	JJ	_	13	conj	_	_
16	,	_	,	,	_	15	punct	_	_
17	and	_	CC	CC	_	15	cc	_	_
18	malignant	_	JJ	JJ	_	15	conj	_	_
19	tumors	_	NNS	NNS	_	15	dep	_	_
20	originating	_	VBG	VBG	_	15	vmod	_	_
21	from	_	IN	IN	_	20	prep	_	_
22	epidermal	_	JJ	JJ	_	23	amod	_	_
23	cells	_	NNS	NNS	_	21	pobj	_	_
24	,	_	,	,	_	13	punct	_	_
25	and	_	CC	CC	_	13	cc	_	_
26	squamous	_	JJ	JJ	_	33	amod	_	_
27	cell	_	NN	NN	_	33	nn	_	_
28	carcinoma	_	NN	NN	_	33	nn	_	_
29	-LRB-	_	-LRB-	-LRB-	_	33	punct	_	_
30	SCC	_	NN	NN	_	33	nn	_	_
31	-RRB-	_	-RRB-	-RRB-	_	33	punct	_	_
32	cell	_	NN	NN	_	33	nn	_	_
33	lines	_	NNS	NNS	_	13	conj	_	_
34	are	_	VBP	VBP	_	35	auxpass	_	_
35	investigated	_	VBN	VBN	_	0	root	_	_
36	.	_	.	.	_	35	punct	_	_

1	With	_	IN	IN	_	10	prep	_	_
2	the	_	DT	DT	_	3	det	_	_
3	use	_	NN	NN	_	1	pobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	immunohistochemistry	_	NN	NN	_	4	pobj	_	_
6	,	_	,	,	_	10	punct	_	_
7	bcl-6	_	NN	NN	_	8	nn	_	_
8	protein	_	NN	NN	_	10	nsubjpass	_	_
9	was	_	VBD	VBD	_	10	auxpass	_	_
10	shown	_	VBN	VBN	_	0	root	_	_
11	to	_	TO	TO	_	12	aux	_	_
12	stain	_	VB	VB	_	10	xcomp	_	_
13	intensely	_	RB	RB	_	12	advmod	_	_
14	on	_	IN	IN	_	13	prep	_	_
15	normal	_	JJ	JJ	_	17	amod	_	_
16	prickle	_	NN	NN	_	17	nn	_	_
17	cells	_	NNS	NNS	_	14	pobj	_	_
18	,	_	,	,	_	13	punct	_	_
19	but	_	CC	CC	_	13	cc	_	_
20	none	_	NN	NN	_	13	conj	_	_
21	to	_	TO	TO	_	20	prep	_	_
22	only	_	RB	RB	_	23	advmod	_	_
23	slightly	_	RB	RB	_	21	pcomp	_	_
24	on	_	IN	IN	_	13	conj	_	_
25	epidermal	_	JJ	JJ	_	27	amod	_	_
26	basal	_	JJ	JJ	_	27	amod	_	_
27	cells	_	NNS	NNS	_	24	pobj	_	_
28	.	_	.	.	_	10	punct	_	_

1	Papillomas	_	NNS	NNS	_	4	nsubj	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	keratoacanthomas	_	NNS	NNS	_	1	conj	_	_
4	copied	_	VBD	VBD	_	0	root	_	_
5	their	_	PRP$	PRP$	_	7	poss	_	_
6	normal	_	JJ	JJ	_	7	amod	_	_
7	counterparts	_	NNS	NNS	_	4	dobj	_	_
8	in	_	IN	IN	_	4	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	mode	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	expression	_	NN	NN	_	11	pobj	_	_
13	.	_	.	.	_	4	punct	_	_

1	Various	_	JJ	JJ	_	2	amod	_	_
2	levels	_	NNS	NNS	_	6	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	expression	_	NN	NN	_	3	pobj	_	_
5	were	_	VBD	VBD	_	6	auxpass	_	_
6	found	_	VBN	VBN	_	0	root	_	_
7	on	_	IN	IN	_	6	prep	_	_
8	seborrheic	_	JJ	JJ	_	9	amod	_	_
9	keratoses	_	NNS	NNS	_	7	pobj	_	_
10	,	_	,	,	_	6	punct	_	_
11	while	_	IN	IN	_	20	mark	_	_
12	the	_	DT	DT	_	14	det	_	_
13	expression	_	NN	NN	_	14	nn	_	_
14	level	_	NN	NN	_	20	nsubj	_	_
15	on	_	IN	IN	_	14	prep	_	_
16	basal	_	JJ	JJ	_	18	amod	_	_
17	cell	_	NN	NN	_	18	nn	_	_
18	epitheliomas	_	NNS	NNS	_	15	pobj	_	_
19	was	_	VBD	VBD	_	20	cop	_	_
20	low	_	JJ	JJ	_	6	advcl	_	_
21	.	_	.	.	_	6	punct	_	_

1	Peculiarly	_	RB	RB	_	13	advmod	_	_
2	,	_	,	,	_	13	punct	_	_
3	eccrine	_	JJ	JJ	_	4	amod	_	_
4	poromas	_	NNS	NNS	_	13	nsubj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	undifferentiated	_	JJ	JJ	_	10	amod	_	_
7	spindle-shaped	_	JJ	JJ	_	6	dep	_	_
8	basal	_	JJ	JJ	_	10	amod	_	_
9	cell	_	NN	NN	_	10	nn	_	_
10	epitheliomas	_	NNS	NNS	_	4	conj	_	_
11	were	_	VBD	VBD	_	13	cop	_	_
12	totally	_	RB	RB	_	13	advmod	_	_
13	unstained	_	JJ	JJ	_	0	root	_	_
14	.	_	.	.	_	13	punct	_	_

1	Squamous	_	JJ	JJ	_	3	amod	_	_
2	cell	_	NN	NN	_	3	nn	_	_
3	carcinomas	_	NNS	NNS	_	4	nsubj	_	_
4	showed	_	VBD	VBD	_	0	root	_	_
5	a	_	DT	DT	_	6	det	_	_
6	variety	_	NN	NN	_	4	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	expression	_	NN	NN	_	9	nn	_	_
9	levels	_	NNS	NNS	_	7	pobj	_	_
10	,	_	,	,	_	4	punct	_	_
11	while	_	IN	IN	_	22	mark	_	_
12	two	_	CD	CD	_	15	num	_	_
13	undifferentiated	_	JJ	JJ	_	15	amod	_	_
14	spindle-shaped	_	JJ	JJ	_	13	dep	_	_
15	carcinomas	_	NNS	NNS	_	22	nsubj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	one	_	CD	CD	_	21	num	_	_
18	undifferentiated	_	JJ	JJ	_	21	amod	_	_
19	SCC	_	NN	NN	_	21	nn	_	_
20	cell	_	NN	NN	_	21	nn	_	_
21	line	_	NN	NN	_	15	conj	_	_
22	remained	_	VBD	VBD	_	4	advcl	_	_
23	unstained	_	JJ	JJ	_	22	acomp	_	_
24	.	_	.	.	_	4	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	12	mark	_	_
5	the	_	DT	DT	_	6	det	_	_
6	expression	_	NN	NN	_	12	nsubjpass	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	bcl-6	_	NN	NN	_	9	nn	_	_
9	protein	_	NN	NN	_	7	pobj	_	_
10	may	_	MD	MD	_	12	aux	_	_
11	be	_	VB	VB	_	12	auxpass	_	_
12	associated	_	VBN	VBN	_	3	ccomp	_	_
13	with	_	IN	IN	_	12	prep	_	_
14	morphological	_	JJ	JJ	_	15	amod	_	_
15	differentiation	_	NN	NN	_	13	pobj	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	normal	_	JJ	JJ	_	16	pobj	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	neoplastic	_	JJ	JJ	_	21	amod	_	_
20	epidermal	_	JJ	JJ	_	21	amod	_	_
21	cells	_	NNS	NNS	_	17	conj	_	_
22	.	_	.	.	_	3	punct	_	_

1	Tissue	_	NN	NN	_	2	npadvmod	_	_
2	transglutaminase-dependent	_	JJ	JJ	_	4	amod	_	_
3	posttranslational	_	JJ	JJ	_	2	dep	_	_
4	modification	_	NN	NN	_	0	root	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	9	det	_	_
7	retinoblastoma	_	NN	NN	_	9	nn	_	_
8	gene	_	NN	NN	_	9	nn	_	_
9	product	_	NN	NN	_	5	pobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	promonocytic	_	JJ	JJ	_	12	amod	_	_
12	cells	_	NNS	NNS	_	10	pobj	_	_
13	undergoing	_	VBG	VBG	_	12	vmod	_	_
14	apoptosis	_	NN	NN	_	13	dobj	_	_
15	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	retinoblastoma	_	NN	NN	_	4	nn	_	_
3	gene	_	NN	NN	_	4	nn	_	_
4	product	_	NN	NN	_	8	nsubj	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	pRB	_	NN	NN	_	4	appos	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	plays	_	VBZ	VBZ	_	0	root	_	_
9	an	_	DT	DT	_	11	det	_	_
10	important	_	JJ	JJ	_	11	amod	_	_
11	role	_	NN	NN	_	8	dobj	_	_
12	in	_	IN	IN	_	8	prep	_	_
13	controlling	_	VBG	VBG	_	12	pcomp	_	_
14	both	_	CC	CC	_	16	preconj	_	_
15	cell	_	NN	NN	_	16	nn	_	_
16	release	_	NN	NN	_	13	dobj	_	_
17	from	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	G1	_	NN	NN	_	20	nn	_	_
20	phase	_	NN	NN	_	17	pobj	_	_
21	and	_	CC	CC	_	16	cc	_	_
22	apoptosis	_	NN	NN	_	16	conj	_	_
23	.	_	.	.	_	8	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	show	_	VBP	VBP	_	0	root	_	_
3	here	_	RB	RB	_	2	advmod	_	_
4	that	_	IN	IN	_	15	mark	_	_
5	in	_	IN	IN	_	15	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	early	_	JJ	JJ	_	8	amod	_	_
8	phases	_	NNS	NNS	_	5	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	apoptosis	_	NN	NN	_	9	pobj	_	_
11	,	_	,	,	_	15	punct	_	_
12	pRB	_	NN	NN	_	15	nsubjpass	_	_
13	is	_	VBZ	VBZ	_	15	auxpass	_	_
14	posttranslationally	_	RB	RB	_	15	advmod	_	_
15	modified	_	VBN	VBN	_	2	ccomp	_	_
16	by	_	IN	IN	_	15	prep	_	_
17	a	_	DT	DT	_	24	det	_	_
18	tissue	_	NN	NN	_	24	nn	_	_
19	transglutaminase	_	NN	NN	_	24	nn	_	_
20	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
21	tTG	_	NN	NN	_	24	nn	_	_
22	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
23	-catalyzed	_	JJ	JJ	_	24	amod	_	_
24	reaction	_	NN	NN	_	16	pobj	_	_
25	.	_	.	.	_	2	punct	_	_

1	In	_	IN	IN	_	23	prep	_	_
2	fact	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	23	punct	_	_
4	by	_	IN	IN	_	23	prep	_	_
5	employing	_	VBG	VBG	_	4	pcomp	_	_
6	a	_	DT	DT	_	11	det	_	_
7	novel	_	JJ	JJ	_	11	amod	_	_
8	haptenized	_	VBN	VBN	_	11	amod	_	_
9	lysis	_	NN	NN	_	11	nn	_	_
10	synthetic	_	JJ	JJ	_	11	amod	_	_
11	substrate	_	NN	NN	_	5	dobj	_	_
12	which	_	WDT	WDT	_	13	nsubj	_	_
13	allows	_	VBZ	VBZ	_	11	rcmod	_	_
14	the	_	DT	DT	_	15	det	_	_
15	isolation	_	NN	NN	_	13	dobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	glutaminyl-tTG	_	JJ	JJ	_	18	amod	_	_
18	substrates	_	NNS	NNS	_	16	pobj	_	_
19	in	_	FW	FW	_	20	nn	_	_
20	vivo	_	FW	FW	_	15	advmod	_	_
21	,	_	,	,	_	23	punct	_	_
22	we	_	PRP	PRP	_	23	nsubj	_	_
23	identified	_	VBD	VBD	_	0	root	_	_
24	pRB	_	NN	NN	_	23	dobj	_	_
25	as	_	IN	IN	_	23	prep	_	_
26	a	_	DT	DT	_	29	det	_	_
27	potential	_	JJ	JJ	_	29	amod	_	_
28	tTG	_	NN	NN	_	29	nn	_	_
29	substrate	_	NN	NN	_	25	pobj	_	_
30	in	_	IN	IN	_	29	prep	_	_
31	U937	_	NN	NN	_	32	nn	_	_
32	cells	_	NNS	NNS	_	30	pobj	_	_
33	undergoing	_	VBG	VBG	_	32	vmod	_	_
34	apoptosis	_	NN	NN	_	33	dobj	_	_
35	.	_	.	.	_	23	punct	_	_

1	In	_	IN	IN	_	8	prep	_	_
2	keeping	_	VBG	VBG	_	1	pcomp	_	_
3	with	_	IN	IN	_	2	prep	_	_
4	this	_	DT	DT	_	5	det	_	_
5	finding	_	NN	NN	_	3	pobj	_	_
6	,	_	,	,	_	8	punct	_	_
7	we	_	PRP	PRP	_	8	nsubj	_	_
8	showed	_	VBD	VBD	_	0	root	_	_
9	that	_	IN	IN	_	15	mark	_	_
10	apoptosis	_	NN	NN	_	15	nsubjpass	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	U937	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	11	pobj	_	_
14	is	_	VBZ	VBZ	_	15	auxpass	_	_
15	characterized	_	VBN	VBN	_	8	ccomp	_	_
16	by	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	rapid	_	JJ	JJ	_	19	amod	_	_
19	disappearance	_	NN	NN	_	16	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	26	det	_	_
22	105,000-	_	CD	CD	_	24	number	_	_
23	to	_	TO	TO	_	24	dep	_	_
24	110,000-molecular-weight	_	JJ	JJ	_	26	amod	_	_
25	pRB	_	NN	NN	_	26	nn	_	_
26	forms	_	NNS	NNS	_	20	pobj	_	_
27	concomitantly	_	RB	RB	_	19	advmod	_	_
28	with	_	IN	IN	_	27	prep	_	_
29	the	_	DT	DT	_	30	det	_	_
30	appearance	_	NN	NN	_	28	pobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	a	_	DT	DT	_	33	det	_	_
33	smear	_	NN	NN	_	31	pobj	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	immunoreactive	_	JJ	JJ	_	36	amod	_	_
36	products	_	NNS	NNS	_	34	pobj	_	_
37	with	_	IN	IN	_	36	prep	_	_
38	a	_	DT	DT	_	40	det	_	_
39	molecular	_	JJ	JJ	_	40	amod	_	_
40	weight	_	NN	NN	_	37	pobj	_	_
41	of	_	IN	IN	_	40	prep	_	_
42	greater	_	JJR	JJR	_	43	mwe	_	_
43	than	_	IN	IN	_	44	quantmod	_	_
44	250,000	_	CD	CD	_	41	pobj	_	_
45	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	shift	_	NN	NN	_	8	nsubjpass	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	pRB	_	NN	NN	_	6	nn	_	_
5	molecular	_	JJ	JJ	_	6	amod	_	_
6	weight	_	NN	NN	_	3	pobj	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	reproduced	_	VBN	VBN	_	0	root	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	adding	_	VBG	VBG	_	9	pcomp	_	_
11	exogenous	_	JJ	JJ	_	13	amod	_	_
12	purified	_	VBN	VBN	_	13	amod	_	_
13	tTG	_	NN	NN	_	10	dobj	_	_
14	to	_	TO	TO	_	10	prep	_	_
15	extracts	_	NNS	NNS	_	14	pobj	_	_
16	obtained	_	VBN	VBN	_	15	vmod	_	_
17	from	_	IN	IN	_	16	prep	_	_
18	viable	_	JJ	JJ	_	20	amod	_	_
19	U937	_	NN	NN	_	20	nn	_	_
20	cells	_	NNS	NNS	_	17	pobj	_	_
21	and	_	CC	CC	_	8	cc	_	_
22	was	_	VBD	VBD	_	23	auxpass	_	_
23	prevented	_	VBN	VBN	_	8	conj	_	_
24	by	_	IN	IN	_	23	prep	_	_
25	dansylcadaverine	_	NN	NN	_	24	pobj	_	_
26	,	_	,	,	_	25	punct	_	_
27	a	_	DT	DT	_	30	det	_	_
28	potent	_	JJ	JJ	_	30	amod	_	_
29	enzyme	_	NN	NN	_	30	nn	_	_
30	inhibitor	_	NN	NN	_	25	appos	_	_
31	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	effect	_	NN	NN	_	11	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	7	det	_	_
5	pRB	_	NN	NN	_	7	nn	_	_
6	posttranslational	_	JJ	JJ	_	7	amod	_	_
7	modification	_	NN	NN	_	3	pobj	_	_
8	during	_	IN	IN	_	2	prep	_	_
9	apoptosis	_	NN	NN	_	8	pobj	_	_
10	was	_	VBD	VBD	_	11	auxpass	_	_
11	investigated	_	VBN	VBN	_	0	root	_	_
12	by	_	IN	IN	_	11	prep	_	_
13	determining	_	VBG	VBG	_	12	pcomp	_	_
14	the	_	DT	DT	_	16	det	_	_
15	E2F-1	_	NN	NN	_	16	nn	_	_
16	levels	_	NNS	NNS	_	13	dobj	_	_
17	and	_	CC	CC	_	12	cc	_	_
18	by	_	IN	IN	_	12	conj	_	_
19	isolating	_	VBG	VBG	_	18	pcomp	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	characterizing	_	VBG	VBG	_	19	conj	_	_
22	pRB-null	_	JJ	JJ	_	23	amod	_	_
23	clones	_	NNS	NNS	_	19	dobj	_	_
24	from	_	IN	IN	_	23	prep	_	_
25	U937	_	NN	NN	_	26	nn	_	_
26	cells	_	NNS	NNS	_	24	pobj	_	_
27	.	_	.	.	_	11	punct	_	_

1	Notably	_	RB	RB	_	11	advmod	_	_
2	,	_	,	,	_	11	punct	_	_
3	the	_	DT	DT	_	4	det	_	_
4	lack	_	NN	NN	_	11	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	pRB	_	NN	NN	_	5	pobj	_	_
7	in	_	IN	IN	_	4	prep	_	_
8	these	_	DT	DT	_	10	det	_	_
9	U937-derived	_	JJ	JJ	_	10	amod	_	_
10	clones	_	NNS	NNS	_	7	pobj	_	_
11	renders	_	VBZ	VBZ	_	0	root	_	_
12	these	_	DT	DT	_	14	det	_	_
13	p53-null	_	JJ	JJ	_	14	amod	_	_
14	cells	_	NNS	NNS	_	16	nsubj	_	_
15	highly	_	RB	RB	_	16	advmod	_	_
16	resistant	_	JJ	JJ	_	11	xcomp	_	_
17	to	_	TO	TO	_	16	prep	_	_
18	apoptosis	_	NN	NN	_	17	pobj	_	_
19	induced	_	VBN	VBN	_	18	vmod	_	_
20	by	_	IN	IN	_	19	prep	_	_
21	serum	_	NN	NN	_	22	nn	_	_
22	withdrawal	_	NN	NN	_	20	pobj	_	_
23	,	_	,	,	_	22	punct	_	_
24	calphostin	_	NN	NN	_	25	nn	_	_
25	C	_	NN	NN	_	22	conj	_	_
26	,	_	,	,	_	22	punct	_	_
27	and	_	CC	CC	_	22	cc	_	_
28	ceramide	_	NN	NN	_	22	conj	_	_
29	.	_	.	.	_	11	punct	_	_

1	Taken	_	VBN	VBN	_	0	root	_	_
2	together	_	RB	RB	_	1	advmod	_	_
3	,	_	,	,	_	1	punct	_	_
4	these	_	DT	DT	_	5	det	_	_
5	data	_	NNS	NNS	_	6	nsubj	_	_
6	suggest	_	VBP	VBP	_	1	parataxis	_	_
7	that	_	IN	IN	_	17	mark	_	_
8	tTG	_	NN	NN	_	17	nsubj	_	_
9	,	_	,	,	_	8	punct	_	_
10	acting	_	VBG	VBG	_	8	vmod	_	_
11	on	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	pRB	_	NN	NN	_	14	nn	_	_
14	protein	_	NN	NN	_	11	pobj	_	_
15	,	_	,	,	_	8	punct	_	_
16	might	_	MD	MD	_	17	aux	_	_
17	play	_	VB	VB	_	6	ccomp	_	_
18	an	_	DT	DT	_	20	det	_	_
19	important	_	JJ	JJ	_	20	amod	_	_
20	role	_	NN	NN	_	17	dobj	_	_
21	in	_	IN	IN	_	17	prep	_	_
22	the	_	DT	DT	_	24	det	_	_
23	cell	_	NN	NN	_	24	nn	_	_
24	progression	_	NN	NN	_	21	pobj	_	_
25	through	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	28	det	_	_
27	death	_	NN	NN	_	28	nn	_	_
28	program	_	NN	NN	_	25	pobj	_	_
29	.	_	.	.	_	1	punct	_	_

1	Evidence	_	NN	NN	_	0	root	_	_
2	that	_	IN	IN	_	5	mark	_	_
3	calcineurin	_	NN	NN	_	5	nsubj	_	_
4	is	_	VBZ	VBZ	_	5	cop	_	_
5	rate-limiting	_	JJ	JJ	_	1	ccomp	_	_
6	for	_	IN	IN	_	5	prep	_	_
7	primary	_	JJ	JJ	_	10	amod	_	_
8	human	_	JJ	JJ	_	10	amod	_	_
9	lymphocyte	_	NN	NN	_	10	nn	_	_
10	activation	_	NN	NN	_	6	pobj	_	_
11	.	_	.	.	_	1	punct	_	_

1	Cyclosporine	_	NN	NN	_	10	nsubj	_	_
2	-LRB-	_	-LRB-	-LRB-	_	3	punct	_	_
3	CsA	_	NN	NN	_	1	appos	_	_
4	-RRB-	_	-RRB-	-RRB-	_	3	punct	_	_
5	is	_	VBZ	VBZ	_	10	cop	_	_
6	both	_	CC	CC	_	10	preconj	_	_
7	a	_	DT	DT	_	10	det	_	_
8	clinical	_	JJ	JJ	_	10	amod	_	_
9	immunosuppressive	_	JJ	JJ	_	8	dep	_	_
10	drug	_	NN	NN	_	0	root	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	a	_	DT	DT	_	13	det	_	_
13	probe	_	NN	NN	_	10	conj	_	_
14	to	_	TO	TO	_	15	aux	_	_
15	dissect	_	VB	VB	_	13	vmod	_	_
16	intracellular	_	JJ	JJ	_	18	amod	_	_
17	signaling	_	NN	NN	_	18	nn	_	_
18	pathways	_	NNS	NNS	_	15	dobj	_	_
19	.	_	.	.	_	10	punct	_	_

1	In	_	FW	FW	_	2	nn	_	_
2	vitro	_	FW	FW	_	5	advmod	_	_
3	,	_	,	,	_	5	punct	_	_
4	CsA	_	NN	NN	_	5	nsubj	_	_
5	inhibits	_	VBZ	VBZ	_	0	root	_	_
6	lymphocyte	_	NN	NN	_	7	nn	_	_
7	gene	_	NN	NN	_	8	nn	_	_
8	activation	_	NN	NN	_	5	dobj	_	_
9	by	_	IN	IN	_	5	prep	_	_
10	inhibiting	_	VBG	VBG	_	9	pcomp	_	_
11	the	_	DT	DT	_	13	det	_	_
12	phosphatase	_	NN	NN	_	13	nn	_	_
13	activity	_	NN	NN	_	10	dobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	calcineurin	_	NN	NN	_	14	pobj	_	_
16	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
17	CN	_	NN	NN	_	15	appos	_	_
18	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
19	.	_	.	.	_	5	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	clinical	_	JJ	JJ	_	3	amod	_	_
3	use	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	7	punct	_	_
5	CsA	_	NN	NN	_	6	nn	_	_
6	treatment	_	NN	NN	_	7	nsubj	_	_
7	inhibits	_	VBZ	VBZ	_	0	root	_	_
8	50-75	_	CD	CD	_	9	num	_	_
9	%	_	NN	NN	_	7	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	CN	_	NN	NN	_	12	nn	_	_
12	activity	_	NN	NN	_	10	pobj	_	_
13	in	_	IN	IN	_	9	prep	_	_
14	circulating	_	VBG	VBG	_	15	amod	_	_
15	leukocytes	_	NNS	NNS	_	13	pobj	_	_
16	.	_	.	.	_	7	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	modeled	_	VBD	VBD	_	0	root	_	_
3	this	_	DT	DT	_	4	det	_	_
4	degree	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	CN	_	NN	NN	_	7	nn	_	_
7	inhibition	_	NN	NN	_	5	pobj	_	_
8	in	_	IN	IN	_	5	prep	_	_
9	primary	_	JJ	JJ	_	11	amod	_	_
10	human	_	JJ	JJ	_	11	amod	_	_
11	leukocytes	_	NNS	NNS	_	8	pobj	_	_
12	in	_	FW	FW	_	13	nn	_	_
13	vitro	_	FW	FW	_	2	advmod	_	_
14	in	_	IN	IN	_	17	mark	_	_
15	order	_	NN	NN	_	17	dep	_	_
16	to	_	TO	TO	_	17	aux	_	_
17	study	_	VB	VB	_	2	advcl	_	_
18	the	_	DT	DT	_	19	det	_	_
19	effect	_	NN	NN	_	17	dobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	partial	_	JJ	JJ	_	23	amod	_	_
22	CN	_	NN	NN	_	23	nn	_	_
23	inhibition	_	NN	NN	_	20	pobj	_	_
24	on	_	IN	IN	_	19	prep	_	_
25	the	_	DT	DT	_	28	det	_	_
26	downstream	_	JJ	JJ	_	28	amod	_	_
27	signaling	_	NN	NN	_	28	nn	_	_
28	events	_	NNS	NNS	_	24	pobj	_	_
29	that	_	WDT	WDT	_	30	nsubj	_	_
30	lead	_	VBP	VBP	_	28	rcmod	_	_
31	to	_	TO	TO	_	30	prep	_	_
32	gene	_	NN	NN	_	33	nn	_	_
33	activation	_	NN	NN	_	31	pobj	_	_
34	.	_	.	.	_	2	punct	_	_

1	In	_	IN	IN	_	17	prep	_	_
2	CsA-treated	_	JJ	JJ	_	3	amod	_	_
3	leukocytes	_	NNS	NNS	_	1	pobj	_	_
4	stimulated	_	VBN	VBN	_	3	vmod	_	_
5	by	_	IN	IN	_	4	prep	_	_
6	calcium	_	NN	NN	_	7	nn	_	_
7	ionophore	_	NN	NN	_	5	pobj	_	_
8	,	_	,	,	_	17	punct	_	_
9	the	_	DT	DT	_	10	det	_	_
10	degree	_	NN	NN	_	17	nsubjpass	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	reduction	_	NN	NN	_	11	pobj	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	CN	_	NN	NN	_	15	nn	_	_
15	activity	_	NN	NN	_	13	pobj	_	_
16	was	_	VBD	VBD	_	17	auxpass	_	_
17	accompanied	_	VBN	VBN	_	0	root	_	_
18	by	_	IN	IN	_	17	prep	_	_
19	a	_	DT	DT	_	21	det	_	_
20	similar	_	JJ	JJ	_	21	amod	_	_
21	degree	_	NN	NN	_	18	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	inhibition	_	NN	NN	_	22	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	each	_	DT	DT	_	26	det	_	_
26	event	_	NN	NN	_	24	pobj	_	_
27	tested	_	VBN	VBN	_	26	vmod	_	_
28	:	_	:	:	_	17	punct	_	_
29	dephosphorylation	_	NN	NN	_	17	dep	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	nuclear	_	JJ	JJ	_	37	amod	_	_
32	factor	_	NN	NN	_	37	nn	_	_
33	of	_	IN	IN	_	37	amod	_	_
34	activated	_	VBN	VBN	_	37	amod	_	_
35	T	_	NN	NN	_	37	nn	_	_
36	cell	_	NN	NN	_	37	nn	_	_
37	proteins	_	NNS	NNS	_	30	pobj	_	_
38	,	_	,	,	_	29	punct	_	_
39	nuclear	_	JJ	JJ	_	41	amod	_	_
40	DNA	_	NN	NN	_	41	nn	_	_
41	binding	_	NN	NN	_	29	conj	_	_
42	,	_	,	,	_	29	punct	_	_
43	activation	_	NN	NN	_	29	conj	_	_
44	of	_	IN	IN	_	43	prep	_	_
45	a	_	DT	DT	_	49	det	_	_
46	transfected	_	VBN	VBN	_	49	amod	_	_
47	reporter	_	NN	NN	_	49	nn	_	_
48	gene	_	NN	NN	_	49	nn	_	_
49	construct	_	NN	NN	_	44	pobj	_	_
50	,	_	,	,	_	29	punct	_	_
51	IFN-gamma	_	NN	NN	_	29	conj	_	_
52	and	_	CC	CC	_	51	cc	_	_
53	IL-2	_	NN	NN	_	54	nn	_	_
54	mRNA	_	NN	NN	_	51	conj	_	_
55	accumulation	_	NN	NN	_	51	dep	_	_
56	,	_	,	,	_	29	punct	_	_
57	and	_	CC	CC	_	29	cc	_	_
58	IFN-gamma	_	NN	NN	_	59	nn	_	_
59	production	_	NN	NN	_	29	conj	_	_
60	.	_	.	.	_	17	punct	_	_

1	Furthermore	_	RB	RB	_	9	advmod	_	_
2	,	_	,	,	_	9	punct	_	_
3	the	_	DT	DT	_	4	det	_	_
4	degree	_	NN	NN	_	9	nsubjpass	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	CN	_	NN	NN	_	7	nn	_	_
7	inhibition	_	NN	NN	_	5	pobj	_	_
8	was	_	VBD	VBD	_	9	auxpass	_	_
9	reflected	_	VBN	VBN	_	0	root	_	_
10	by	_	IN	IN	_	9	prep	_	_
11	a	_	DT	DT	_	13	det	_	_
12	similar	_	JJ	JJ	_	13	amod	_	_
13	degree	_	NN	NN	_	10	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	reduction	_	NN	NN	_	14	pobj	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	lymphocyte	_	NN	NN	_	18	nn	_	_
18	proliferation	_	NN	NN	_	16	pobj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	IFN-gamma	_	NN	NN	_	21	nn	_	_
21	production	_	NN	NN	_	18	conj	_	_
22	in	_	IN	IN	_	18	prep	_	_
23	the	_	DT	DT	_	27	det	_	_
24	allogeneic	_	JJ	JJ	_	27	amod	_	_
25	mixed	_	JJ	JJ	_	27	amod	_	_
26	lymphocyte	_	NN	NN	_	27	nn	_	_
27	cultures	_	NNS	NNS	_	22	pobj	_	_
28	.	_	.	.	_	9	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	support	_	VBP	VBP	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	conclusion	_	NN	NN	_	3	dobj	_	_
6	that	_	IN	IN	_	10	mark	_	_
7	CN	_	NN	NN	_	8	nn	_	_
8	activity	_	NN	NN	_	10	nsubj	_	_
9	is	_	VBZ	VBZ	_	10	cop	_	_
10	rate-limiting	_	JJ	JJ	_	5	ccomp	_	_
11	for	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	activation	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	primary	_	JJ	JJ	_	18	amod	_	_
16	human	_	JJ	JJ	_	18	amod	_	_
17	T	_	NN	NN	_	18	nn	_	_
18	lymphocytes	_	NNS	NNS	_	14	pobj	_	_
19	.	_	.	.	_	3	punct	_	_

1	Thus	_	RB	RB	_	13	advmod	_	_
2	,	_	,	,	_	13	punct	_	_
3	the	_	DT	DT	_	4	det	_	_
4	reduction	_	NN	NN	_	13	nsubjpass	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	CN	_	NN	NN	_	7	nn	_	_
7	activity	_	NN	NN	_	5	pobj	_	_
8	observed	_	VBN	VBN	_	4	vmod	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	CsA-treated	_	JJ	JJ	_	11	amod	_	_
11	patients	_	NNS	NNS	_	9	pobj	_	_
12	is	_	VBZ	VBZ	_	13	auxpass	_	_
13	accompanied	_	VBN	VBN	_	0	root	_	_
14	by	_	IN	IN	_	13	prep	_	_
15	a	_	DT	DT	_	17	det	_	_
16	similar	_	JJ	JJ	_	17	amod	_	_
17	degree	_	NN	NN	_	14	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	reduction	_	NN	NN	_	18	pobj	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	lymphocyte	_	NN	NN	_	22	nn	_	_
22	gene	_	NN	NN	_	23	nn	_	_
23	activation	_	NN	NN	_	20	pobj	_	_
24	,	_	,	,	_	13	punct	_	_
25	and	_	CC	CC	_	13	cc	_	_
26	accounts	_	VBZ	VBZ	_	13	conj	_	_
27	for	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	29	det	_	_
29	immunosuppression	_	NN	NN	_	27	pobj	_	_
30	observed	_	VBN	VBN	_	29	vmod	_	_
31	.	_	.	.	_	13	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	DNA	_	NN	NN	_	4	nn	_	_
3	binding	_	NN	NN	_	4	nn	_	_
4	domain	_	NN	NN	_	11	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	7	det	_	_
7	A-MYB	_	NN	NN	_	5	pobj	_	_
8	transcription	_	NN	NN	_	9	nn	_	_
9	factor	_	NN	NN	_	7	dep	_	_
10	is	_	VBZ	VBZ	_	11	cop	_	_
11	responsible	_	JJ	JJ	_	0	root	_	_
12	for	_	IN	IN	_	11	prep	_	_
13	its	_	PRP$	PRP$	_	16	poss	_	_
14	B	_	NN	NN	_	16	nn	_	_
15	cell-specific	_	JJ	JJ	_	16	amod	_	_
16	activity	_	NN	NN	_	12	pobj	_	_
17	and	_	CC	CC	_	11	cc	_	_
18	binds	_	VBZ	VBZ	_	11	conj	_	_
19	to	_	TO	TO	_	18	prep	_	_
20	a	_	DT	DT	_	25	det	_	_
21	B	_	NN	NN	_	25	nn	_	_
22	cell	_	NN	NN	_	25	nn	_	_
23	110-kDa	_	JJ	JJ	_	25	amod	_	_
24	nuclear	_	JJ	JJ	_	25	amod	_	_
25	protein	_	NN	NN	_	19	pobj	_	_
26	.	_	.	.	_	11	punct	_	_

1	Expression	_	NN	NN	_	2	nn	_	_
2	studies	_	NNS	NNS	_	12	nsubj	_	_
3	as	_	RB	RB	_	4	advmod	_	_
4	well	_	RB	RB	_	2	cc	_	_
5	as	_	IN	IN	_	4	mwe	_	_
6	the	_	DT	DT	_	7	det	_	_
7	use	_	NN	NN	_	2	conj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	transgenic	_	JJ	JJ	_	10	amod	_	_
10	animals	_	NNS	NNS	_	8	pobj	_	_
11	have	_	VBP	VBP	_	12	aux	_	_
12	demonstrated	_	VBN	VBN	_	0	root	_	_
13	that	_	IN	IN	_	18	mark	_	_
14	the	_	DT	DT	_	15	det	_	_
15	A-MYB	_	NN	NN	_	18	nsubj	_	_
16	transcription	_	NN	NN	_	17	nn	_	_
17	factor	_	NN	NN	_	15	dep	_	_
18	plays	_	VBZ	VBZ	_	12	ccomp	_	_
19	central	_	JJ	JJ	_	22	amod	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	specific	_	JJ	JJ	_	19	conj	_	_
22	role	_	NN	NN	_	18	dobj	_	_
23	in	_	IN	IN	_	18	prep	_	_
24	the	_	DT	DT	_	25	det	_	_
25	regulation	_	NN	NN	_	23	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	mature	_	JJ	JJ	_	29	amod	_	_
28	B	_	NN	NN	_	29	nn	_	_
29	cell	_	NN	NN	_	26	pobj	_	_
30	proliferation	_	NN	NN	_	29	dep	_	_
31	and/or	_	CC	CC	_	29	cc	_	_
32	differentiation	_	NN	NN	_	29	conj	_	_
33	.	_	.	.	_	12	punct	_	_

1	Furthermore	_	RB	RB	_	6	advmod	_	_
2	,	_	,	,	_	6	punct	_	_
3	it	_	PRP	PRP	_	6	nsubjpass	_	_
4	is	_	VBZ	VBZ	_	6	auxpass	_	_
5	highly	_	RB	RB	_	6	advmod	_	_
6	expressed	_	VBN	VBN	_	0	root	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	Burkitt	_	NN	NN	_	11	poss	_	_
9	's	_	POS	POS	_	11	possessive	_	_
10	lymphoma	_	NN	NN	_	11	nn	_	_
11	cells	_	NNS	NNS	_	7	pobj	_	_
12	and	_	CC	CC	_	6	cc	_	_
13	may	_	MD	MD	_	14	aux	_	_
14	participate	_	VB	VB	_	6	conj	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	17	det	_	_
17	pathogenesis	_	NN	NN	_	15	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	this	_	DT	DT	_	20	det	_	_
20	disease	_	NN	NN	_	18	pobj	_	_
21	.	_	.	.	_	6	punct	_	_

1	We	_	PRP	PRP	_	4	nsubj	_	_
2	have	_	VBP	VBP	_	4	aux	_	_
3	therefore	_	RB	RB	_	4	advmod	_	_
4	investigated	_	VBN	VBN	_	0	root	_	_
5	the	_	DT	DT	_	7	det	_	_
6	transcriptional	_	JJ	JJ	_	7	amod	_	_
7	activity	_	NN	NN	_	4	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	A-MYB	_	NN	NN	_	8	pobj	_	_
10	and	_	CC	CC	_	7	cc	_	_
11	its	_	PRP$	PRP$	_	12	poss	_	_
12	regulation	_	NN	NN	_	7	conj	_	_
13	in	_	IN	IN	_	7	prep	_	_
14	several	_	JJ	JJ	_	18	amod	_	_
15	human	_	JJ	JJ	_	18	amod	_	_
16	lymphoid	_	JJ	JJ	_	18	amod	_	_
17	cell	_	NN	NN	_	18	nn	_	_
18	lines	_	NNS	NNS	_	13	pobj	_	_
19	using	_	VBG	VBG	_	4	xcomp	_	_
20	co-transfection	_	NN	NN	_	21	nn	_	_
21	assays	_	NNS	NNS	_	19	dobj	_	_
22	and	_	CC	CC	_	4	cc	_	_
23	show	_	VBP	VBP	_	4	conj	_	_
24	that	_	IN	IN	_	28	mark	_	_
25	A-MYB	_	NN	NN	_	28	nsubj	_	_
26	is	_	VBZ	VBZ	_	28	cop	_	_
27	transcriptionally	_	RB	RB	_	28	advmod	_	_
28	active	_	JJ	JJ	_	23	ccomp	_	_
29	in	_	IN	IN	_	28	prep	_	_
30	all	_	PDT	PDT	_	34	dep	_	_
31	the	_	DT	DT	_	34	det	_	_
32	B	_	NN	NN	_	34	nn	_	_
33	cell	_	NN	NN	_	34	nn	_	_
34	lines	_	NNS	NNS	_	29	pobj	_	_
35	studied	_	VBN	VBN	_	34	vmod	_	_
36	,	_	,	,	_	29	punct	_	_
37	but	_	CC	CC	_	29	cc	_	_
38	not	_	RB	RB	_	39	neg	_	_
39	in	_	IN	IN	_	29	conj	_	_
40	T	_	NN	NN	_	41	nn	_	_
41	cells	_	NNS	NNS	_	39	pobj	_	_
42	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	14	prep	_	_
2	particular	_	JJ	JJ	_	1	pobj	_	_
3	the	_	DT	DT	_	7	det	_	_
4	best	_	JJS	JJS	_	7	amod	_	_
5	responder	_	NN	NN	_	7	nn	_	_
6	cell	_	NN	NN	_	7	nn	_	_
7	line	_	NN	NN	_	14	nsubj	_	_
8	was	_	VBD	VBD	_	14	cop	_	_
9	the	_	DT	DT	_	14	det	_	_
10	Burkitt	_	NN	NN	_	14	poss	_	_
11	's	_	POS	POS	_	14	possessive	_	_
12	cell	_	NN	NN	_	14	nn	_	_
13	line	_	NN	NN	_	14	nn	_	_
14	Namalwa	_	NN	NN	_	0	root	_	_
15	.	_	.	.	_	14	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	activity	_	NN	NN	_	12	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	A-MYB	_	NN	NN	_	3	pobj	_	_
5	in	_	IN	IN	_	2	prep	_	_
6	B	_	NN	NN	_	5	pobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	not	_	RB	RB	_	9	neg	_	_
9	T	_	NN	NN	_	6	conj	_	_
10	cells	_	NNS	NNS	_	6	dep	_	_
11	was	_	VBD	VBD	_	12	auxpass	_	_
12	observed	_	VBN	VBN	_	0	root	_	_
13	when	_	WRB	WRB	_	23	advmod	_	_
14	either	_	CC	CC	_	17	preconj	_	_
15	an	_	DT	DT	_	17	det	_	_
16	artificial	_	JJ	JJ	_	17	amod	_	_
17	construct	_	NN	NN	_	23	nsubjpass	_	_
18	or	_	CC	CC	_	17	cc	_	_
19	the	_	DT	DT	_	21	det	_	_
20	c-MYC	_	NN	NN	_	21	nn	_	_
21	promoter	_	NN	NN	_	17	conj	_	_
22	was	_	VBD	VBD	_	23	auxpass	_	_
23	used	_	VBN	VBN	_	12	advcl	_	_
24	as	_	IN	IN	_	23	prep	_	_
25	a	_	DT	DT	_	26	det	_	_
26	reporter	_	NN	NN	_	24	pobj	_	_
27	.	_	.	.	_	12	punct	_	_

1	Furthermore	_	RB	RB	_	25	advmod	_	_
2	,	_	,	,	_	25	punct	_	_
3	the	_	DT	DT	_	5	det	_	_
4	functional	_	JJ	JJ	_	5	amod	_	_
5	domains	_	NNS	NNS	_	25	nsubjpass	_	_
6	responsible	_	JJ	JJ	_	5	amod	_	_
7	for	_	IN	IN	_	6	prep	_	_
8	DNA	_	NN	NN	_	9	nn	_	_
9	binding	_	NN	NN	_	7	pobj	_	_
10	,	_	,	,	_	9	punct	_	_
11	transactivation	_	NN	NN	_	9	conj	_	_
12	,	_	,	,	_	9	punct	_	_
13	and	_	CC	CC	_	9	cc	_	_
14	negative	_	JJ	JJ	_	15	amod	_	_
15	regulation	_	NN	NN	_	9	conj	_	_
16	,	_	,	,	_	5	punct	_	_
17	previously	_	RB	RB	_	18	advmod	_	_
18	characterized	_	VBN	VBN	_	5	vmod	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	a	_	DT	DT	_	22	det	_	_
21	fibroblast	_	NN	NN	_	22	nn	_	_
22	context	_	NN	NN	_	19	pobj	_	_
23	,	_	,	,	_	5	punct	_	_
24	were	_	VBD	VBD	_	25	auxpass	_	_
25	found	_	VBN	VBN	_	0	root	_	_
26	to	_	TO	TO	_	27	aux	_	_
27	have	_	VB	VB	_	25	xcomp	_	_
28	similar	_	JJ	JJ	_	29	amod	_	_
29	activity	_	NN	NN	_	27	dobj	_	_
30	in	_	IN	IN	_	27	prep	_	_
31	B	_	NN	NN	_	32	nn	_	_
32	cells	_	NNS	NNS	_	30	pobj	_	_
33	.	_	.	.	_	25	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	region	_	NN	NN	_	13	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	A-MYB	_	NN	NN	_	3	pobj	_	_
5	responsible	_	JJ	JJ	_	2	amod	_	_
6	for	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	11	det	_	_
8	B	_	NN	NN	_	11	nn	_	_
9	cell	_	NN	NN	_	11	nn	_	_
10	specific	_	JJ	JJ	_	11	amod	_	_
11	activity	_	NN	NN	_	6	pobj	_	_
12	was	_	VBD	VBD	_	13	auxpass	_	_
13	defined	_	VBN	VBN	_	0	root	_	_
14	to	_	TO	TO	_	20	aux	_	_
15	be	_	VB	VB	_	20	cop	_	_
16	the	_	DT	DT	_	20	det	_	_
17	N-terminal	_	JJ	JJ	_	20	amod	_	_
18	218	_	CD	CD	_	20	num	_	_
19	amino	_	NN	NN	_	20	nn	_	_
20	acids	_	NNS	NNS	_	13	xcomp	_	_
21	containing	_	VBG	VBG	_	20	vmod	_	_
22	the	_	DT	DT	_	25	det	_	_
23	DNA	_	NN	NN	_	25	nn	_	_
24	binding	_	NN	NN	_	25	nn	_	_
25	domain	_	NN	NN	_	21	dobj	_	_
26	.	_	.	.	_	13	punct	_	_

1	Finally	_	RB	RB	_	8	advmod	_	_
2	,	_	,	,	_	8	punct	_	_
3	a	_	DT	DT	_	5	det	_	_
4	110-kDa	_	JJ	JJ	_	5	amod	_	_
5	protein	_	NN	NN	_	8	nsubjpass	_	_
6	has	_	VBZ	VBZ	_	8	aux	_	_
7	been	_	VBN	VBN	_	8	auxpass	_	_
8	identified	_	VBN	VBN	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	nuclei	_	NNS	NNS	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	all	_	PDT	PDT	_	15	dep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	B	_	NN	NN	_	12	pobj	_	_
16	,	_	,	,	_	15	punct	_	_
17	but	_	CC	CC	_	18	cc	_	_
18	not	_	RB	RB	_	15	cc	_	_
19	T	_	NN	NN	_	15	conj	_	_
20	,	_	,	,	_	15	punct	_	_
21	cell	_	NN	NN	_	22	nn	_	_
22	lines	_	NNS	NNS	_	15	conj	_	_
23	that	_	WDT	WDT	_	25	nsubj	_	_
24	specifically	_	RB	RB	_	25	advmod	_	_
25	binds	_	VBZ	VBZ	_	8	dep	_	_
26	to	_	TO	TO	_	25	prep	_	_
27	this	_	DT	DT	_	30	det	_	_
28	A-MYB	_	NN	NN	_	30	nn	_	_
29	N-terminal	_	JJ	JJ	_	30	amod	_	_
30	domain	_	NN	NN	_	26	pobj	_	_
31	.	_	.	.	_	8	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	hypothesize	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	14	mark	_	_
4	this	_	DT	DT	_	6	det	_	_
5	110-kDa	_	JJ	JJ	_	6	amod	_	_
6	protein	_	NN	NN	_	14	nsubj	_	_
7	may	_	MD	MD	_	14	aux	_	_
8	be	_	VB	VB	_	14	cop	_	_
9	a	_	DT	DT	_	14	det	_	_
10	functionally	_	RB	RB	_	11	advmod	_	_
11	important	_	JJ	JJ	_	14	amod	_	_
12	B	_	NN	NN	_	14	nn	_	_
13	cell-specific	_	JJ	JJ	_	14	amod	_	_
14	co-activator	_	NN	NN	_	2	ccomp	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	A-MYB	_	NN	NN	_	15	pobj	_	_
17	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	A-myb	_	NN	NN	_	4	nn	_	_
3	transcription	_	NN	NN	_	4	nn	_	_
4	factor	_	NN	NN	_	0	root	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	neoplastic	_	JJ	JJ	_	5	pobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	normal	_	JJ	JJ	_	6	conj	_	_
9	B	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	6	dep	_	_
11	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	myb	_	NN	NN	_	3	nn	_	_
3	family	_	NN	NN	_	10	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	transcription	_	NN	NN	_	6	nn	_	_
6	factors	_	NNS	NNS	_	4	pobj	_	_
7	has	_	VBZ	VBZ	_	10	aux	_	_
8	been	_	VBN	VBN	_	10	auxpass	_	_
9	strongly	_	RB	RB	_	10	advmod	_	_
10	implicated	_	VBN	VBN	_	0	root	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	regulation	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	cell	_	NN	NN	_	14	pobj	_	_
16	growth	_	NN	NN	_	15	dep	_	_
17	and	_	CC	CC	_	15	cc	_	_
18	differentiation	_	NN	NN	_	15	conj	_	_
19	in	_	IN	IN	_	13	prep	_	_
20	the	_	DT	DT	_	22	det	_	_
21	haematopoietic	_	JJ	JJ	_	22	amod	_	_
22	system	_	NN	NN	_	19	pobj	_	_
23	.	_	.	.	_	10	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	v-myb	_	NN	NN	_	3	nn	_	_
3	oncogene	_	NN	NN	_	11	nsubj	_	_
4	,	_	,	,	_	3	punct	_	_
5	carried	_	VBN	VBN	_	3	vmod	_	_
6	by	_	IN	IN	_	5	prep	_	_
7	avian	_	JJ	JJ	_	9	amod	_	_
8	defective	_	JJ	JJ	_	9	amod	_	_
9	retroviruses	_	NNS	NNS	_	6	pobj	_	_
10	,	_	,	,	_	3	punct	_	_
11	causes	_	VBZ	VBZ	_	0	root	_	_
12	leukaemias	_	NNS	NNS	_	11	dobj	_	_
13	in	_	IN	IN	_	11	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	chicken	_	NN	NN	_	13	pobj	_	_
16	and	_	CC	CC	_	11	cc	_	_
17	transforms	_	VBZ	VBZ	_	11	conj	_	_
18	haematopoietic	_	JJ	JJ	_	19	amod	_	_
19	cells	_	NNS	NNS	_	17	dobj	_	_
20	in	_	FW	FW	_	21	nn	_	_
21	vitro	_	FW	FW	_	17	advmod	_	_
22	.	_	.	.	_	11	punct	_	_

1	Its	_	PRP$	PRP$	_	4	poss	_	_
2	normal	_	JJ	JJ	_	4	amod	_	_
3	cellular	_	JJ	JJ	_	4	amod	_	_
4	equivalent	_	JJ	JJ	_	9	nsubjpass	_	_
5	c-myb	_	NN	NN	_	4	dep	_	_
6	,	_	,	,	_	4	punct	_	_
7	has	_	VBZ	VBZ	_	9	aux	_	_
8	been	_	VBN	VBN	_	9	auxpass	_	_
9	shown	_	VBN	VBN	_	0	root	_	_
10	to	_	TO	TO	_	11	aux	_	_
11	promote	_	VB	VB	_	9	xcomp	_	_
12	the	_	DT	DT	_	13	det	_	_
13	proliferation	_	NN	NN	_	11	dobj	_	_
14	and	_	CC	CC	_	11	cc	_	_
15	block	_	VB	VB	_	11	conj	_	_
16	the	_	DT	DT	_	17	det	_	_
17	differentiation	_	NN	NN	_	15	dobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	haematopoietic	_	JJ	JJ	_	20	amod	_	_
20	cells	_	NNS	NNS	_	18	pobj	_	_
21	in	_	IN	IN	_	11	prep	_	_
22	several	_	JJ	JJ	_	24	amod	_	_
23	experimental	_	JJ	JJ	_	24	amod	_	_
24	models	_	NNS	NNS	_	21	pobj	_	_
25	and	_	CC	CC	_	9	cc	_	_
26	is	_	VBZ	VBZ	_	27	auxpass	_	_
27	required	_	VBN	VBN	_	9	conj	_	_
28	for	_	IN	IN	_	27	prep	_	_
29	fetal	_	JJ	JJ	_	30	amod	_	_
30	haematopoiesis	_	NN	NN	_	28	pobj	_	_
31	.	_	.	.	_	9	punct	_	_

1	Two	_	CD	CD	_	3	num	_	_
2	other	_	JJ	JJ	_	3	amod	_	_
3	members	_	NNS	NNS	_	9	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	6	det	_	_
6	family	_	NN	NN	_	4	pobj	_	_
7	have	_	VBP	VBP	_	9	aux	_	_
8	been	_	VBN	VBN	_	9	auxpass	_	_
9	cloned	_	VBN	VBN	_	0	root	_	_
10	more	_	RBR	RBR	_	11	advmod	_	_
11	recently	_	RB	RB	_	9	advmod	_	_
12	,	_	,	,	_	9	punct	_	_
13	A-myb	_	NN	NN	_	9	dep	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	B-myb	_	NN	NN	_	13	conj	_	_
16	,	_	,	,	_	13	punct	_	_
17	which	_	WDT	WDT	_	18	nsubj	_	_
18	show	_	VBP	VBP	_	13	rcmod	_	_
19	sequence	_	NN	NN	_	20	nn	_	_
20	homology	_	NN	NN	_	18	dobj	_	_
21	with	_	IN	IN	_	20	prep	_	_
22	c-myb	_	NN	NN	_	21	pobj	_	_
23	in	_	IN	IN	_	18	prep	_	_
24	several	_	JJ	JJ	_	25	amod	_	_
25	domains	_	NNS	NNS	_	23	pobj	_	_
26	,	_	,	,	_	25	punct	_	_
27	of	_	IN	IN	_	32	prep	_	_
28	which	_	WDT	WDT	_	27	pobj	_	_
29	the	_	DT	DT	_	32	det	_	_
30	DNA	_	NN	NN	_	32	nn	_	_
31	binding	_	NN	NN	_	32	nn	_	_
32	domain	_	NN	NN	_	25	rcmod	_	_
33	as	_	RB	RB	_	34	advmod	_	_
34	well	_	RB	RB	_	32	cc	_	_
35	as	_	IN	IN	_	34	mwe	_	_
36	other	_	JJ	JJ	_	38	amod	_	_
37	regulatory	_	JJ	JJ	_	38	amod	_	_
38	domains	_	NNS	NNS	_	32	conj	_	_
39	.	_	.	.	_	9	punct	_	_

1	Both	_	DT	DT	_	4	nsubjpass	_	_
2	have	_	VBP	VBP	_	4	aux	_	_
3	been	_	VBN	VBN	_	4	auxpass	_	_
4	shown	_	VBN	VBN	_	0	root	_	_
5	to	_	TO	TO	_	8	aux	_	_
6	be	_	VB	VB	_	8	cop	_	_
7	transcription	_	NN	NN	_	8	nn	_	_
8	factors	_	NNS	NNS	_	4	xcomp	_	_
9	.	_	.	.	_	4	punct	_	_

1	B-myb	_	NN	NN	_	4	nsubjpass	_	_
2	is	_	VBZ	VBZ	_	4	auxpass	_	_
3	also	_	RB	RB	_	4	advmod	_	_
4	involved	_	VBN	VBN	_	0	root	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	7	det	_	_
7	control	_	NN	NN	_	5	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	proliferation	_	NN	NN	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	differentiation	_	NN	NN	_	9	conj	_	_
12	,	_	,	,	_	4	punct	_	_
13	but	_	CC	CC	_	4	cc	_	_
14	,	_	,	,	_	4	punct	_	_
15	unlike	_	IN	IN	_	20	prep	_	_
16	c-myb	_	NN	NN	_	15	pobj	_	_
17	,	_	,	,	_	20	punct	_	_
18	it	_	PRP	PRP	_	20	nsubjpass	_	_
19	is	_	VBZ	VBZ	_	20	auxpass	_	_
20	expressed	_	VBN	VBN	_	4	conj	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	many	_	JJ	JJ	_	24	amod	_	_
23	cell	_	NN	NN	_	24	nn	_	_
24	types	_	NNS	NNS	_	21	pobj	_	_
25	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	third	_	JJ	JJ	_	3	amod	_	_
3	member	_	NN	NN	_	10	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	6	det	_	_
6	family	_	NN	NN	_	4	pobj	_	_
7	,	_	,	,	_	3	punct	_	_
8	A-myb	_	NN	NN	_	3	appos	_	_
9	,	_	,	,	_	3	punct	_	_
10	shows	_	VBZ	VBZ	_	0	root	_	_
11	the	_	DT	DT	_	14	det	_	_
12	most	_	RBS	RBS	_	13	advmod	_	_
13	restricted	_	JJ	JJ	_	14	amod	_	_
14	pattern	_	NN	NN	_	10	dobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	expression	_	NN	NN	_	15	pobj	_	_
17	,	_	,	,	_	10	punct	_	_
18	suggesting	_	VBG	VBG	_	10	vmod	_	_
19	a	_	DT	DT	_	22	det	_	_
20	very	_	RB	RB	_	21	advmod	_	_
21	specific	_	JJ	JJ	_	22	amod	_	_
22	role	_	NN	NN	_	18	dobj	_	_
23	for	_	IN	IN	_	22	prep	_	_
24	this	_	DT	DT	_	26	det	_	_
25	transcription	_	NN	NN	_	26	nn	_	_
26	factor	_	NN	NN	_	23	pobj	_	_
27	.	_	.	.	_	10	punct	_	_

1	A-myb	_	NN	NN	_	3	nsubjpass	_	_
2	is	_	VBZ	VBZ	_	3	auxpass	_	_
3	expressed	_	VBN	VBN	_	0	root	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	a	_	DT	DT	_	6	det	_	_
6	subpopulation	_	NN	NN	_	4	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	normal	_	JJ	JJ	_	10	amod	_	_
9	B	_	NN	NN	_	10	nn	_	_
10	lymphocytes	_	NNS	NNS	_	7	pobj	_	_
11	activated	_	VBN	VBN	_	6	dep	_	_
12	in	_	FW	FW	_	13	nn	_	_
13	vivo	_	FW	FW	_	11	advmod	_	_
14	and	_	CC	CC	_	11	cc	_	_
15	localised	_	JJ	JJ	_	11	conj	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	germinal	_	JJ	JJ	_	19	amod	_	_
19	center	_	NN	NN	_	16	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	peripheral	_	JJ	JJ	_	23	amod	_	_
22	lymphoid	_	JJ	JJ	_	23	amod	_	_
23	organs	_	NNS	NNS	_	20	pobj	_	_
24	and	_	CC	CC	_	3	cc	_	_
25	is	_	VBZ	VBZ	_	27	auxpass	_	_
26	not	_	RB	RB	_	27	neg	_	_
27	detected	_	VBN	VBN	_	3	conj	_	_
28	at	_	IN	IN	_	27	prep	_	_
29	significant	_	JJ	JJ	_	30	amod	_	_
30	levels	_	NNS	NNS	_	28	pobj	_	_
31	in	_	IN	IN	_	27	prep	_	_
32	all	_	DT	DT	_	34	dep	_	_
33	other	_	JJ	JJ	_	34	amod	_	_
34	mature	_	JJ	JJ	_	31	pobj	_	_
35	or	_	CC	CC	_	34	cc	_	_
36	immature	_	JJ	JJ	_	38	amod	_	_
37	haematopoietic	_	JJ	JJ	_	38	amod	_	_
38	populations	_	NNS	NNS	_	34	conj	_	_
39	studied	_	VBN	VBN	_	34	vmod	_	_
40	,	_	,	,	_	34	punct	_	_
41	including	_	VBG	VBG	_	34	prep	_	_
42	bone	_	NN	NN	_	44	nn	_	_
43	marrow	_	JJ	JJ	_	44	amod	_	_
44	cells	_	NNS	NNS	_	41	pobj	_	_
45	,	_	,	,	_	44	punct	_	_
46	T	_	NN	NN	_	47	nn	_	_
47	lymphocytes	_	NNS	NNS	_	44	appos	_	_
48	,	_	,	,	_	44	punct	_	_
49	granulocytes	_	NNS	NNS	_	44	appos	_	_
50	,	_	,	,	_	44	punct	_	_
51	monocytes	_	NNS	NNS	_	44	appos	_	_
52	,	_	,	,	_	34	punct	_	_
53	either	_	CC	CC	_	54	preconj	_	_
54	at	_	IN	IN	_	34	prep	_	_
55	rest	_	NN	NN	_	54	pobj	_	_
56	or	_	CC	CC	_	54	cc	_	_
57	after	_	RB	RB	_	54	conj	_	_
58	in	_	FW	FW	_	60	amod	_	_
59	vitro	_	FW	FW	_	58	dep	_	_
60	activation	_	NN	NN	_	57	pobj	_	_
61	.	_	.	.	_	3	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	studies	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	6	mark	_	_
5	A-myb	_	NN	NN	_	6	nsubj	_	_
6	plays	_	VBZ	VBZ	_	3	ccomp	_	_
7	a	_	DT	DT	_	8	det	_	_
8	role	_	NN	NN	_	6	dobj	_	_
9	during	_	IN	IN	_	6	prep	_	_
10	a	_	DT	DT	_	12	det	_	_
11	narrow	_	JJ	JJ	_	12	amod	_	_
12	window	_	NN	NN	_	9	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	normal	_	JJ	JJ	_	16	amod	_	_
15	B	_	NN	NN	_	16	nn	_	_
16	cell	_	NN	NN	_	17	nn	_	_
17	differentiation	_	NN	NN	_	13	pobj	_	_
18	.	_	.	.	_	3	punct	_	_

1	A-myb	_	NN	NN	_	2	nn	_	_
2	expression	_	NN	NN	_	6	nsubjpass	_	_
3	has	_	VBZ	VBZ	_	6	aux	_	_
4	also	_	RB	RB	_	6	advmod	_	_
5	been	_	VBN	VBN	_	6	auxpass	_	_
6	studied	_	VBN	VBN	_	0	root	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	a	_	DT	DT	_	10	det	_	_
9	wide	_	JJ	JJ	_	10	amod	_	_
10	range	_	NN	NN	_	7	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	neoplastic	_	JJ	JJ	_	14	amod	_	_
13	B	_	NN	NN	_	14	nn	_	_
14	cells	_	NNS	NNS	_	11	pobj	_	_
15	,	_	,	,	_	10	punct	_	_
16	representing	_	VBG	VBG	_	10	vmod	_	_
17	the	_	DT	DT	_	19	det	_	_
18	whole	_	JJ	JJ	_	19	amod	_	_
19	spectrum	_	NN	NN	_	16	dobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	B	_	NN	NN	_	23	nn	_	_
22	cell	_	NN	NN	_	23	nn	_	_
23	differentiation	_	NN	NN	_	20	pobj	_	_
24	.	_	.	.	_	6	punct	_	_

1	A-myb	_	NN	NN	_	4	nsubjpass	_	_
2	is	_	VBZ	VBZ	_	4	auxpass	_	_
3	strongly	_	RB	RB	_	4	advmod	_	_
4	expressed	_	VBN	VBN	_	0	root	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	Burkitt	_	NN	NN	_	8	poss	_	_
7	's	_	POS	POS	_	8	possessive	_	_
8	lymphomas	_	NNS	NNS	_	5	pobj	_	_
9	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
10	BL	_	NNS	NNS	_	8	appos	_	_
11	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
12	and	_	CC	CC	_	8	cc	_	_
13	slg+	_	JJ	JJ	_	16	amod	_	_
14	B-acute	_	JJ	JJ	_	16	amod	_	_
15	lymphoblastic	_	JJ	JJ	_	16	amod	_	_
16	leukaemias	_	NNS	NNS	_	8	conj	_	_
17	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	B-ALL	_	NNS	NNS	_	16	appos	_	_
19	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
20	and	_	CC	CC	_	5	cc	_	_
21	not	_	RB	RB	_	22	neg	_	_
22	in	_	IN	IN	_	5	conj	_	_
23	all	_	DT	DT	_	25	det	_	_
24	other	_	JJ	JJ	_	25	amod	_	_
25	leukaemias/lymphomas	_	NNS	NNS	_	22	pobj	_	_
26	tested	_	VBN	VBN	_	25	vmod	_	_
27	,	_	,	,	_	4	punct	_	_
28	with	_	IN	IN	_	4	prep	_	_
29	the	_	DT	DT	_	30	det	_	_
30	exception	_	NN	NN	_	28	pobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	a	_	DT	DT	_	33	det	_	_
33	subset	_	NN	NN	_	31	pobj	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	CLL	_	NN	NN	_	34	pobj	_	_
36	-LRB-	_	-LRB-	-LRB-	_	39	punct	_	_
37	about	_	RB	RB	_	38	quantmod	_	_
38	25	_	CD	CD	_	39	num	_	_
39	%	_	NN	NN	_	30	dep	_	_
40	of	_	IN	IN	_	39	prep	_	_
41	cases	_	NNS	NNS	_	40	pobj	_	_
42	-RRB-	_	-RRB-	-RRB-	_	39	punct	_	_
43	.	_	.	.	_	4	punct	_	_

1	It	_	PRP	PRP	_	3	nsubj	_	_
2	is	_	VBZ	VBZ	_	3	cop	_	_
3	intriguing	_	JJ	JJ	_	0	root	_	_
4	that	_	IN	IN	_	10	mark	_	_
5	the	_	DT	DT	_	7	det	_	_
6	A-myb	_	NN	NN	_	7	nn	_	_
7	genome	_	NN	NN	_	10	nsubj	_	_
8	has	_	VBZ	VBZ	_	10	aux	_	_
9	been	_	VBN	VBN	_	10	cop	_	_
10	localised	_	JJ	JJ	_	3	ccomp	_	_
11	relatively	_	RB	RB	_	12	advmod	_	_
12	close	_	RB	RB	_	13	dep	_	_
13	to	_	TO	TO	_	10	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	c-myc	_	NN	NN	_	16	nn	_	_
16	gene	_	NN	NN	_	13	pobj	_	_
17	on	_	IN	IN	_	16	prep	_	_
18	chromosome	_	NN	NN	_	17	pobj	_	_
19	8	_	CD	CD	_	18	num	_	_
20	,	_	,	,	_	3	punct	_	_
21	suggesting	_	VBG	VBG	_	3	xcomp	_	_
22	that	_	IN	IN	_	31	mark	_	_
23	the	_	DT	DT	_	25	det	_	_
24	c-myc	_	NN	NN	_	25	nn	_	_
25	translocation	_	NN	NN	_	31	nsubj	_	_
26	in	_	IN	IN	_	25	prep	_	_
27	BL	_	NNS	NNS	_	26	pobj	_	_
28	and	_	CC	CC	_	27	cc	_	_
29	B-ALL	_	NNS	NNS	_	27	conj	_	_
30	may	_	MD	MD	_	31	aux	_	_
31	affect	_	VB	VB	_	21	ccomp	_	_
32	A-myb	_	NN	NN	_	33	nn	_	_
33	transcription	_	NN	NN	_	31	dobj	_	_
34	.	_	.	.	_	3	punct	_	_

1	Studies	_	NNS	NNS	_	2	nsubj	_	_
2	are	_	VBP	VBP	_	0	root	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	progress	_	NN	NN	_	3	pobj	_	_
5	to	_	TO	TO	_	6	aux	_	_
6	investigate	_	VB	VB	_	2	dep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	functional	_	JJ	JJ	_	9	amod	_	_
9	relationship	_	NN	NN	_	6	dobj	_	_
10	between	_	IN	IN	_	9	prep	_	_
11	A-myb	_	NN	NN	_	10	pobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	c-myc	_	NN	NN	_	11	conj	_	_
14	,	_	,	,	_	9	punct	_	_
15	particularly	_	RB	RB	_	16	advmod	_	_
16	in	_	IN	IN	_	9	prep	_	_
17	the	_	DT	DT	_	18	det	_	_
18	context	_	NN	NN	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	BL	_	NNS	NNS	_	21	nn	_	_
21	cells	_	NNS	NNS	_	19	pobj	_	_
22	and	_	CC	CC	_	6	cc	_	_
23	to	_	TO	TO	_	24	aux	_	_
24	determine	_	VB	VB	_	6	conj	_	_
25	whether	_	IN	IN	_	28	mark	_	_
26	A-myb	_	NN	NN	_	28	nsubjpass	_	_
27	is	_	VBZ	VBZ	_	28	auxpass	_	_
28	deregulated	_	VBN	VBN	_	24	ccomp	_	_
29	in	_	IN	IN	_	28	prep	_	_
30	these	_	DT	DT	_	31	det	_	_
31	cells	_	NNS	NNS	_	29	pobj	_	_
32	.	_	.	.	_	2	punct	_	_

1	Human	_	JJ	JJ	_	2	amod	_	_
2	neutrophils	_	NNS	NNS	_	3	nsubj	_	_
3	express	_	VBP	VBP	_	0	root	_	_
4	GH-N	_	NN	NN	_	6	nn	_	_
5	gene	_	NN	NN	_	6	nn	_	_
6	transcripts	_	NNS	NNS	_	3	dobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	the	_	DT	DT	_	11	det	_	_
9	pituitary	_	JJ	JJ	_	11	amod	_	_
10	transcription	_	NN	NN	_	11	nn	_	_
11	factor	_	NN	NN	_	6	conj	_	_
12	Pit-1b	_	NN	NN	_	11	dep	_	_
13	.	_	.	.	_	3	punct	_	_

1	Since	_	IN	IN	_	3	mark	_	_
2	GH	_	NN	NN	_	3	nsubj	_	_
3	stimulates	_	VBZ	VBZ	_	12	advcl	_	_
4	the	_	DT	DT	_	5	dep	_	_
5	development	_	NN	NN	_	3	dobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	function	_	NN	NN	_	5	conj	_	_
8	of	_	IN	IN	_	5	prep	_	_
9	granulocytes	_	NNS	NNS	_	8	pobj	_	_
10	,	_	,	,	_	12	punct	_	_
11	we	_	PRP	PRP	_	12	nsubj	_	_
12	investigated	_	VBD	VBD	_	0	root	_	_
13	the	_	DT	DT	_	14	det	_	_
14	expression	_	NN	NN	_	12	dobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	GH	_	NN	NN	_	15	pobj	_	_
17	in	_	IN	IN	_	14	prep	_	_
18	granulocyte	_	JJ	JJ	_	19	amod	_	_
19	subsets	_	NNS	NNS	_	17	pobj	_	_
20	.	_	.	.	_	12	punct	_	_

1	By	_	IN	IN	_	13	prep	_	_
2	immunocytochemistry	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	13	punct	_	_
4	25	_	CD	CD	_	7	num	_	_
5	+/-	_	CC	CC	_	4	cc	_	_
6	7	_	CD	CD	_	4	conj	_	_
7	%	_	NN	NN	_	13	nsubjpass	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	human	_	JJ	JJ	_	11	amod	_	_
11	neutrophils	_	NNS	NNS	_	8	pobj	_	_
12	were	_	VBD	VBD	_	13	auxpass	_	_
13	shown	_	VBN	VBN	_	0	root	_	_
14	to	_	TO	TO	_	15	aux	_	_
15	express	_	VB	VB	_	13	xcomp	_	_
16	immunoreactive	_	JJ	JJ	_	17	amod	_	_
17	GH	_	NN	NN	_	15	dobj	_	_
18	,	_	,	,	_	13	punct	_	_
19	whereas	_	IN	IN	_	22	mark	_	_
20	eosinophils	_	NNS	NNS	_	22	nsubj	_	_
21	were	_	VBD	VBD	_	22	cop	_	_
22	negative	_	JJ	JJ	_	13	advcl	_	_
23	.	_	.	.	_	13	punct	_	_

1	Reversed	_	VBN	VBN	_	7	amod	_	_
2	transcription	_	NN	NN	_	7	nn	_	_
3	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
4	RT	_	NN	NN	_	7	nn	_	_
5	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
6	-PCR	_	JJ	JJ	_	7	amod	_	_
7	analysis	_	NN	NN	_	8	nsubj	_	_
8	demonstrated	_	VBD	VBD	_	0	root	_	_
9	GH	_	NN	NN	_	10	nn	_	_
10	mRNA	_	NN	NN	_	8	dobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	neutrophils	_	NNS	NNS	_	11	pobj	_	_
13	.	_	.	.	_	8	punct	_	_

1	Restriction	_	NN	NN	_	2	nn	_	_
2	analysis	_	NN	NN	_	3	nsubj	_	_
3	revealed	_	VBD	VBD	_	0	root	_	_
4	that	_	IN	IN	_	6	mark	_	_
5	neutrophils	_	NNS	NNS	_	6	nsubj	_	_
6	express	_	VBP	VBP	_	3	ccomp	_	_
7	the	_	DT	DT	_	9	det	_	_
8	GH-N	_	NN	NN	_	9	nn	_	_
9	gene	_	NN	NN	_	6	dobj	_	_
10	but	_	CC	CC	_	11	cc	_	_
11	not	_	RB	RB	_	9	cc	_	_
12	the	_	DT	DT	_	14	det	_	_
13	GH-V	_	NN	NN	_	14	nn	_	_
14	gene	_	NN	NN	_	9	conj	_	_
15	.	_	.	.	_	3	punct	_	_

1	Furthermore	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	demonstrated	_	VBD	VBD	_	0	root	_	_
5	by	_	IN	IN	_	4	prep	_	_
6	western	_	NN	NN	_	8	nn	_	_
7	blot	_	NN	NN	_	8	nn	_	_
8	analysis	_	NN	NN	_	5	pobj	_	_
9	that	_	IN	IN	_	11	mark	_	_
10	neutrophils	_	NNS	NNS	_	11	nsubj	_	_
11	express	_	VBP	VBP	_	4	ccomp	_	_
12	an	_	DT	DT	_	15	det	_	_
13	alternatively	_	RB	RB	_	14	advmod	_	_
14	spliced	_	VBN	VBN	_	15	amod	_	_
15	variant	_	NN	NN	_	11	dobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	20	det	_	_
18	pituitary	_	JJ	JJ	_	20	amod	_	_
19	transcription	_	NN	NN	_	20	nn	_	_
20	factor	_	NN	NN	_	16	pobj	_	_
21	Pit-1	_	NN	NN	_	20	dep	_	_
22	,	_	,	,	_	15	punct	_	_
23	designated	_	VBN	VBN	_	15	vmod	_	_
24	Pit-1b	_	NN	NN	_	23	dep	_	_
25	.	_	.	.	_	4	punct	_	_

1	Analysis	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	myeloid-associated	_	JJ	JJ	_	4	amod	_	_
4	genes	_	NNS	NNS	_	2	pobj	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	human	_	JJ	JJ	_	9	amod	_	_
7	hematopoietic	_	JJ	JJ	_	9	amod	_	_
8	progenitor	_	NN	NN	_	9	nn	_	_
9	cells	_	NNS	NNS	_	5	pobj	_	_
10	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	distribution	_	NN	NN	_	12	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	myeloid	_	JJ	JJ	_	7	amod	_	_
5	lineage-associated	_	JJ	JJ	_	7	amod	_	_
6	cytokine	_	NN	NN	_	7	nn	_	_
7	receptors	_	NNS	NNS	_	3	pobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	lysosomal	_	JJ	JJ	_	10	amod	_	_
10	proteins	_	NNS	NNS	_	7	conj	_	_
11	was	_	VBD	VBD	_	12	auxpass	_	_
12	analyzed	_	VBN	VBN	_	0	root	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	human	_	JJ	JJ	_	22	amod	_	_
15	CD34+	_	JJ	JJ	_	22	amod	_	_
16	cord	_	NN	NN	_	22	nn	_	_
17	blood	_	NN	NN	_	22	nn	_	_
18	cell	_	NN	NN	_	22	nn	_	_
19	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
20	CB	_	NN	NN	_	22	nn	_	_
21	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
22	subsets	_	NNS	NNS	_	13	pobj	_	_
23	at	_	IN	IN	_	12	prep	_	_
24	different	_	JJ	JJ	_	25	amod	_	_
25	stages	_	NNS	NNS	_	23	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	myeloid	_	JJ	JJ	_	28	amod	_	_
28	commitment	_	NN	NN	_	26	pobj	_	_
29	by	_	IN	IN	_	12	prep	_	_
30	reverse-transcriptase	_	NN	NN	_	33	nn	_	_
31	polymerase	_	NN	NN	_	33	nn	_	_
32	chain	_	NN	NN	_	33	nn	_	_
33	reaction	_	NN	NN	_	29	pobj	_	_
34	-LRB-	_	-LRB-	-LRB-	_	35	punct	_	_
35	RT-PCR	_	NN	NN	_	33	appos	_	_
36	-RRB-	_	-RRB-	-RRB-	_	35	punct	_	_
37	.	_	.	.	_	12	punct	_	_

1	The	_	DT	DT	_	6	det	_	_
2	highly	_	RB	RB	_	3	advmod	_	_
3	specific	_	JJ	JJ	_	6	amod	_	_
4	granulomonocyte-associated	_	JJ	JJ	_	6	amod	_	_
5	lysosomal	_	JJ	JJ	_	6	amod	_	_
6	proteins	_	NNS	NNS	_	27	nsubj	_	_
7	myeloperoxidase	_	NN	NN	_	6	dep	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	MPO	_	NN	NN	_	7	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	and	_	CC	CC	_	7	cc	_	_
12	lysozyme	_	NN	NN	_	7	conj	_	_
13	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
14	LZ	_	NN	NN	_	12	appos	_	_
15	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	,	_	,	,	_	6	punct	_	_
17	as	_	RB	RB	_	18	advmod	_	_
18	well	_	RB	RB	_	6	cc	_	_
19	as	_	IN	IN	_	18	mwe	_	_
20	the	_	DT	DT	_	22	det	_	_
21	transcription	_	NN	NN	_	22	nn	_	_
22	factor	_	NN	NN	_	6	conj	_	_
23	PU.1	_	NN	NN	_	22	dep	_	_
24	,	_	,	,	_	6	punct	_	_
25	were	_	VBD	VBD	_	27	cop	_	_
26	already	_	RB	RB	_	27	advmod	_	_
27	detectable	_	JJ	JJ	_	0	root	_	_
28	in	_	IN	IN	_	27	prep	_	_
29	the	_	DT	DT	_	33	det	_	_
30	most	_	RBS	RBS	_	31	advmod	_	_
31	immature	_	JJ	JJ	_	33	amod	_	_
32	CD34+Thy-1+	_	JJ	JJ	_	33	amod	_	_
33	subset	_	NN	NN	_	28	pobj	_	_
34	.	_	.	.	_	27	punct	_	_

1	Messenger	_	NN	NN	_	2	nn	_	_
2	RNA	_	NN	NN	_	6	nn	_	_
3	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
4	mRNA	_	NN	NN	_	2	appos	_	_
5	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
6	levels	_	NNS	NNS	_	44	nsubjpass	_	_
7	for	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	15	det	_	_
9	granulocyte-colony	_	NN	NN	_	15	nn	_	_
10	stimulating	_	NN	NN	_	15	nn	_	_
11	factor	_	NN	NN	_	15	nn	_	_
12	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
13	G-CSF	_	NN	NN	_	15	nn	_	_
14	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
15	receptor	_	NN	NN	_	7	pobj	_	_
16	,	_	,	,	_	15	punct	_	_
17	granulocyte-macrophage	_	JJ	JJ	_	24	amod	_	_
18	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
19	GM	_	NN	NN	_	24	nn	_	_
20	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
21	-CSF	_	NN	NN	_	24	nn	_	_
22	receptor	_	NN	NN	_	24	nn	_	_
23	alpha	_	NN	NN	_	24	nn	_	_
24	subunit	_	NN	NN	_	15	conj	_	_
25	and	_	CC	CC	_	15	cc	_	_
26	tumor	_	NN	NN	_	28	nn	_	_
27	necrosis	_	NN	NN	_	28	nn	_	_
28	factor	_	NN	NN	_	32	nn	_	_
29	-LRB-	_	-LRB-	-LRB-	_	30	punct	_	_
30	TNF	_	NN	NN	_	28	appos	_	_
31	-RRB-	_	-RRB-	-RRB-	_	30	punct	_	_
32	receptors	_	NNS	NNS	_	15	conj	_	_
33	I	_	CD	CD	_	32	dep	_	_
34	-LRB-	_	-LRB-	-LRB-	_	35	punct	_	_
35	p55	_	NN	NN	_	33	appos	_	_
36	-RRB-	_	-RRB-	-RRB-	_	35	punct	_	_
37	and	_	CC	CC	_	32	cc	_	_
38	II	_	CD	CD	_	32	conj	_	_
39	-LRB-	_	-LRB-	-LRB-	_	40	punct	_	_
40	p75	_	NN	NN	_	38	appos	_	_
41	-RRB-	_	-RRB-	-RRB-	_	40	punct	_	_
42	were	_	VBD	VBD	_	44	auxpass	_	_
43	also	_	RB	RB	_	44	advmod	_	_
44	detected	_	VBN	VBN	_	0	root	_	_
45	in	_	IN	IN	_	44	prep	_	_
46	this	_	DT	DT	_	47	det	_	_
47	subset	_	NN	NN	_	45	pobj	_	_
48	in	_	IN	IN	_	44	prep	_	_
49	addition	_	NN	NN	_	48	pobj	_	_
50	to	_	TO	TO	_	49	prep	_	_
51	c-kit	_	NN	NN	_	50	pobj	_	_
52	and	_	CC	CC	_	51	cc	_	_
53	flt-3	_	NN	NN	_	51	conj	_	_
54	,	_	,	,	_	51	punct	_	_
55	receptors	_	NNS	NNS	_	51	appos	_	_
56	known	_	VBN	VBN	_	55	vmod	_	_
57	to	_	TO	TO	_	59	aux	_	_
58	be	_	VB	VB	_	59	auxpass	_	_
59	expressed	_	VBN	VBN	_	56	xcomp	_	_
60	on	_	IN	IN	_	59	prep	_	_
61	progenitor	_	NN	NN	_	62	nn	_	_
62	cells	_	NNS	NNS	_	60	pobj	_	_
63	.	_	.	.	_	44	punct	_	_

1	By	_	IN	IN	_	15	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	15	punct	_	_
4	the	_	DT	DT	_	12	det	_	_
5	monocyte-macrophage	_	JJ	JJ	_	12	amod	_	_
6	colony	_	NN	NN	_	12	nn	_	_
7	stimulating	_	NN	NN	_	12	nn	_	_
8	factor	_	NN	NN	_	12	nn	_	_
9	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
10	M-CSF	_	NN	NN	_	12	nn	_	_
11	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
12	receptor	_	NN	NN	_	15	nsubj	_	_
13	was	_	VBD	VBD	_	15	cop	_	_
14	largely	_	RB	RB	_	15	advmod	_	_
15	absent	_	JJ	JJ	_	0	root	_	_
16	at	_	IN	IN	_	15	prep	_	_
17	this	_	DT	DT	_	18	det	_	_
18	stage	_	NN	NN	_	16	pobj	_	_
19	and	_	CC	CC	_	16	cc	_	_
20	in	_	IN	IN	_	16	conj	_	_
21	the	_	DT	DT	_	23	det	_	_
22	CD34+Thy-1-CD45RA-	_	JJ	JJ	_	23	amod	_	_
23	subsets	_	NNS	NNS	_	20	pobj	_	_
24	.	_	.	.	_	15	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	M-CSF	_	NN	NN	_	3	nn	_	_
3	receptor	_	NN	NN	_	6	nsubj	_	_
4	was	_	VBD	VBD	_	6	cop	_	_
5	first	_	RB	RB	_	6	advmod	_	_
6	detectable	_	JJ	JJ	_	0	root	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	11	det	_	_
9	myeloid-committed	_	JJ	JJ	_	11	amod	_	_
10	CD34+Thy-l-CD45RA+	_	JJ	JJ	_	11	amod	_	_
11	subset	_	NN	NN	_	7	pobj	_	_
12	.	_	.	.	_	6	punct	_	_

1	All	_	DT	DT	_	3	det	_	_
2	other	_	JJ	JJ	_	3	amod	_	_
3	molecules	_	NNS	NNS	_	6	nsubjpass	_	_
4	studied	_	VBN	VBN	_	3	vmod	_	_
5	were	_	VBD	VBD	_	6	auxpass	_	_
6	found	_	VBN	VBN	_	0	root	_	_
7	to	_	TO	TO	_	9	aux	_	_
8	be	_	VB	VB	_	9	auxpass	_	_
9	expressed	_	VBN	VBN	_	6	xcomp	_	_
10	at	_	IN	IN	_	9	prep	_	_
11	this	_	DT	DT	_	12	det	_	_
12	stage	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	differentiation	_	NN	NN	_	13	pobj	_	_
15	.	_	.	.	_	6	punct	_	_

1	Different	_	JJ	JJ	_	2	amod	_	_
2	cocktails	_	NNS	NNS	_	8	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	identified	_	VBN	VBN	_	6	amod	_	_
6	ligands	_	NNS	NNS	_	3	pobj	_	_
7	were	_	VBD	VBD	_	8	auxpass	_	_
8	added	_	VBN	VBN	_	0	root	_	_
9	to	_	TO	TO	_	8	prep	_	_
10	sorted	_	VBN	VBN	_	13	amod	_	_
11	CD34+Thy-1+	_	JJ	JJ	_	13	amod	_	_
12	single	_	JJ	JJ	_	13	amod	_	_
13	cells	_	NNS	NNS	_	9	pobj	_	_
14	.	_	.	.	_	8	punct	_	_

1	Low	_	JJ	JJ	_	3	amod	_	_
2	proliferative	_	JJ	JJ	_	1	dep	_	_
3	capacity	_	NN	NN	_	5	nsubjpass	_	_
4	was	_	VBD	VBD	_	5	auxpass	_	_
5	observed	_	VBN	VBN	_	0	root	_	_
6	after	_	IN	IN	_	5	prep	_	_
7	1	_	CD	CD	_	8	num	_	_
8	week	_	NN	NN	_	6	pobj	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	culture	_	NN	NN	_	9	pobj	_	_
11	in	_	IN	IN	_	5	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	presence	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	stem	_	NN	NN	_	17	nn	_	_
16	cell	_	NN	NN	_	17	nn	_	_
17	factor	_	NN	NN	_	14	pobj	_	_
18	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
19	SCF	_	NN	NN	_	17	appos	_	_
20	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	+	_	JJ	JJ	_	17	amod	_	_
22	Flt-3	_	NN	NN	_	23	nn	_	_
23	ligand	_	NN	NN	_	17	dep	_	_
24	-LRB-	_	-LRB-	-LRB-	_	25	punct	_	_
25	FL	_	NN	NN	_	23	appos	_	_
26	-RRB-	_	-RRB-	-RRB-	_	25	punct	_	_
27	+	_	JJ	JJ	_	17	amod	_	_
28	G-CSF	_	NN	NN	_	17	dep	_	_
29	.	_	.	.	_	5	punct	_	_

1	Addition	_	NN	NN	_	9	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	GM-CSF	_	NN	NN	_	2	pobj	_	_
4	to	_	TO	TO	_	1	prep	_	_
5	this	_	DT	DT	_	7	det	_	_
6	basic	_	JJ	JJ	_	7	amod	_	_
7	cocktail	_	NN	NN	_	4	pobj	_	_
8	consistently	_	RB	RB	_	9	advmod	_	_
9	increased	_	VBD	VBD	_	0	root	_	_
10	the	_	DT	DT	_	12	det	_	_
11	clonogenic	_	JJ	JJ	_	12	amod	_	_
12	capacity	_	NN	NN	_	9	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	single	_	JJ	JJ	_	16	amod	_	_
15	CD34+Thy-1+	_	JJ	JJ	_	16	amod	_	_
16	cells	_	NNS	NNS	_	13	pobj	_	_
17	,	_	,	,	_	9	punct	_	_
18	and	_	CC	CC	_	9	cc	_	_
19	this	_	DT	DT	_	20	det	_	_
20	effect	_	NN	NN	_	23	nsubjpass	_	_
21	was	_	VBD	VBD	_	23	auxpass	_	_
22	further	_	RB	RB	_	23	advmod	_	_
23	enhanced	_	VBN	VBN	_	9	conj	_	_
24	-LRB-	_	-LRB-	-LRB-	_	31	punct	_	_
25	up	_	RB	RB	_	27	advmod	_	_
26	to	_	TO	TO	_	27	dep	_	_
27	72.3	_	CD	CD	_	30	num	_	_
28	+/-	_	CC	CC	_	27	cc	_	_
29	4.3	_	CD	CD	_	27	conj	_	_
30	%	_	NN	NN	_	31	npadvmod	_	_
31	on	_	IN	IN	_	23	dep	_	_
32	day	_	NN	NN	_	31	pobj	_	_
33	7	_	CD	CD	_	32	num	_	_
34	-RRB-	_	-RRB-	-RRB-	_	31	punct	_	_
35	by	_	IN	IN	_	23	prep	_	_
36	the	_	DT	DT	_	37	det	_	_
37	inclusion	_	NN	NN	_	35	pobj	_	_
38	of	_	IN	IN	_	37	prep	_	_
39	TNF-alpha	_	NN	NN	_	38	pobj	_	_
40	.	_	.	.	_	9	punct	_	_

1	In	_	IN	IN	_	18	prep	_	_
2	conclusion	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	18	punct	_	_
4	the	_	DT	DT	_	5	det	_	_
5	presence	_	NN	NN	_	18	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	myeloid-associated	_	JJ	JJ	_	11	amod	_	_
8	growth	_	NN	NN	_	11	nn	_	_
9	factor	_	NN	NN	_	11	nn	_	_
10	receptor	_	NN	NN	_	11	nn	_	_
11	transcripts	_	NNS	NNS	_	6	pobj	_	_
12	in	_	IN	IN	_	5	prep	_	_
13	CD34+	_	JJ	JJ	_	15	amod	_	_
14	CB	_	NN	NN	_	15	nn	_	_
15	subsets	_	NNS	NNS	_	12	pobj	_	_
16	does	_	VBZ	VBZ	_	18	aux	_	_
17	not	_	RB	RB	_	18	neg	_	_
18	discriminate	_	VB	VB	_	0	root	_	_
19	the	_	DT	DT	_	21	det	_	_
20	various	_	JJ	JJ	_	21	amod	_	_
21	stages	_	NNS	NNS	_	18	dobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	differentiation	_	NN	NN	_	22	pobj	_	_
24	,	_	,	,	_	18	punct	_	_
25	with	_	IN	IN	_	18	prep	_	_
26	the	_	DT	DT	_	27	det	_	_
27	exception	_	NN	NN	_	25	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	the	_	DT	DT	_	31	det	_	_
30	M-CSF	_	NN	NN	_	31	nn	_	_
31	receptor	_	NN	NN	_	28	pobj	_	_
32	.	_	.	.	_	18	punct	_	_

1	In	_	IN	IN	_	5	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	5	punct	_	_
4	we	_	PRP	PRP	_	5	nsubj	_	_
5	show	_	VBP	VBP	_	0	root	_	_
6	that	_	IN	IN	_	12	mark	_	_
7	TNF-alpha	_	NN	NN	_	12	nsubj	_	_
8	is	_	VBZ	VBZ	_	12	cop	_	_
9	a	_	DT	DT	_	12	det	_	_
10	potent	_	JJ	JJ	_	12	amod	_	_
11	costimulatory	_	JJ	JJ	_	12	amod	_	_
12	factor	_	NN	NN	_	5	ccomp	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	19	det	_	_
15	very	_	RB	RB	_	19	advmod	_	_
16	immature	_	JJ	JJ	_	19	amod	_	_
17	CD34+Thy-1+	_	JJ	JJ	_	19	amod	_	_
18	CB	_	NN	NN	_	19	nn	_	_
19	subset	_	NN	NN	_	13	pobj	_	_
20	.	_	.	.	_	5	punct	_	_

1	Glucocorticoids	_	NNS	NNS	_	0	root	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	the	_	DT	DT	_	5	det	_	_
4	immune	_	JJ	JJ	_	5	amod	_	_
5	function	_	NN	NN	_	1	conj	_	_
6	in	_	IN	IN	_	1	prep	_	_
7	the	_	DT	DT	_	11	det	_	_
8	human	_	JJ	JJ	_	11	amod	_	_
9	immunodeficiency	_	NN	NN	_	11	nn	_	_
10	virus	_	NN	NN	_	11	nn	_	_
11	infection	_	NN	NN	_	6	pobj	_	_
12	:	_	:	:	_	1	punct	_	_
13	a	_	DT	DT	_	14	det	_	_
14	study	_	NN	NN	_	1	dep	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	hypercortisolemic	_	JJ	JJ	_	15	pobj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	cortisol-resistant	_	JJ	JJ	_	16	conj	_	_
19	patients	_	NNS	NNS	_	16	dep	_	_
20	.	_	.	.	_	1	punct	_	_

1	Immunological	_	JJ	JJ	_	2	amod	_	_
2	studies	_	NNS	NNS	_	12	nsubj	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	human	_	JJ	JJ	_	11	amod	_	_
5	immunodeficiency	_	NN	NN	_	11	nn	_	_
6	virus	_	NN	NN	_	11	nn	_	_
7	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
8	HIV	_	NN	NN	_	11	nn	_	_
9	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
10	-positive	_	JJ	JJ	_	11	amod	_	_
11	patients	_	NNS	NNS	_	3	pobj	_	_
12	suggest	_	VBP	VBP	_	0	root	_	_
13	that	_	IN	IN	_	18	mark	_	_
14	the	_	DT	DT	_	16	det	_	_
15	disease	_	NN	NN	_	16	nn	_	_
16	progression	_	NN	NN	_	18	nsubjpass	_	_
17	is	_	VBZ	VBZ	_	18	auxpass	_	_
18	accompanied	_	VBN	VBN	_	12	ccomp	_	_
19	by	_	IN	IN	_	18	prep	_	_
20	a	_	DT	DT	_	22	det	_	_
21	defective	_	JJ	JJ	_	22	amod	_	_
22	production	_	NN	NN	_	19	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	type	_	NN	NN	_	23	pobj	_	_
25	1	_	CD	CD	_	26	num	_	_
26	cytokines	_	NNS	NNS	_	24	dep	_	_
27	-LRB-	_	-LRB-	-LRB-	_	28	punct	_	_
28	interleukin-2	_	NN	NN	_	24	dep	_	_
29	-LRB-	_	-LRB-	-LRB-	_	30	punct	_	_
30	IL-2	_	NN	NN	_	28	appos	_	_
31	-RRB-	_	-RRB-	-RRB-	_	30	punct	_	_
32	and	_	CC	CC	_	28	cc	_	_
33	IL-12	_	NN	NN	_	28	conj	_	_
34	-RSB-	_	-RRB-	-RRB-	_	28	punct	_	_
35	,	_	,	,	_	22	punct	_	_
36	an	_	DT	DT	_	38	det	_	_
37	increased	_	VBN	VBN	_	38	amod	_	_
38	production	_	NN	NN	_	22	conj	_	_
39	of	_	IN	IN	_	38	prep	_	_
40	type	_	NN	NN	_	42	nn	_	_
41	2	_	CD	CD	_	42	num	_	_
42	cytokines	_	NNS	NNS	_	39	pobj	_	_
43	-LRB-	_	-LRB-	-LRB-	_	44	punct	_	_
44	IL-4	_	NN	NN	_	42	dep	_	_
45	,	_	,	,	_	44	punct	_	_
46	IL-6	_	NN	NN	_	44	conj	_	_
47	,	_	,	,	_	44	punct	_	_
48	and	_	CC	CC	_	44	cc	_	_
49	IL-10	_	NN	NN	_	44	conj	_	_
50	-RRB-	_	-RRB-	-RRB-	_	44	punct	_	_
51	,	_	,	,	_	22	punct	_	_
52	and	_	CC	CC	_	22	cc	_	_
53	an	_	DT	DT	_	55	det	_	_
54	increased	_	VBN	VBN	_	55	amod	_	_
55	production	_	NN	NN	_	22	conj	_	_
56	of	_	IN	IN	_	55	prep	_	_
57	IgE	_	NN	NN	_	56	pobj	_	_
58	.	_	.	.	_	12	punct	_	_

1	HIV	_	NN	NN	_	2	nn	_	_
2	infection	_	NN	NN	_	5	nsubjpass	_	_
3	is	_	VBZ	VBZ	_	5	auxpass	_	_
4	also	_	RB	RB	_	5	advmod	_	_
5	associated	_	VBN	VBN	_	0	root	_	_
6	with	_	IN	IN	_	5	prep	_	_
7	activation	_	NN	NN	_	6	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	12	det	_	_
10	hypothalamo-pituitary-adrenal	_	JJ	JJ	_	12	amod	_	_
11	axis	_	NN	NN	_	12	nn	_	_
12	function	_	NN	NN	_	8	pobj	_	_
13	and	_	CC	CC	_	7	cc	_	_
14	increased	_	VBD	VBD	_	15	amod	_	_
15	plasma	_	NN	NN	_	7	conj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	urinary	_	JJ	JJ	_	15	conj	_	_
18	cortisol	_	NN	NN	_	19	nn	_	_
19	concentrations	_	NNS	NNS	_	15	dep	_	_
20	.	_	.	.	_	5	punct	_	_

1	As	_	IN	IN	_	4	mark	_	_
2	cortisol	_	NN	NN	_	4	nsubjpass	_	_
3	is	_	VBZ	VBZ	_	4	auxpass	_	_
4	involved	_	VBN	VBN	_	15	advcl	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	physiological	_	JJ	JJ	_	8	amod	_	_
8	regulation	_	NN	NN	_	5	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	cytokines	_	NNS	NNS	_	9	pobj	_	_
11	,	_	,	,	_	15	punct	_	_
12	a	_	DT	DT	_	13	det	_	_
13	study	_	NN	NN	_	15	nsubjpass	_	_
14	was	_	VBD	VBD	_	15	auxpass	_	_
15	conducted	_	VBN	VBN	_	0	root	_	_
16	to	_	TO	TO	_	17	aux	_	_
17	examine	_	VB	VB	_	15	dep	_	_
18	cytokine	_	NN	NN	_	19	nn	_	_
19	patterns	_	NNS	NNS	_	17	dobj	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	two	_	CD	CD	_	22	num	_	_
22	groups	_	NNS	NNS	_	20	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	hypercortisolemic	_	JJ	JJ	_	25	amod	_	_
25	patients	_	NNS	NNS	_	23	pobj	_	_
26	,	_	,	,	_	22	punct	_	_
27	one	_	CD	CD	_	22	appos	_	_
28	with	_	IN	IN	_	27	prep	_	_
29	normal	_	JJ	JJ	_	30	amod	_	_
30	sensitivity	_	NN	NN	_	28	pobj	_	_
31	to	_	TO	TO	_	30	prep	_	_
32	glucocorticoids	_	NNS	NNS	_	31	pobj	_	_
33	and	_	CC	CC	_	27	cc	_	_
34	the	_	DT	DT	_	35	det	_	_
35	other	_	JJ	JJ	_	27	conj	_	_
36	with	_	IN	IN	_	35	prep	_	_
37	glucocorticoid	_	NN	NN	_	38	nn	_	_
38	resistance	_	NN	NN	_	36	pobj	_	_
39	.	_	.	.	_	15	punct	_	_

1	Ten	_	CD	CD	_	3	num	_	_
2	HIV-infected	_	JJ	JJ	_	3	amod	_	_
3	patients	_	NNS	NNS	_	32	nsubjpass	_	_
4	with	_	IN	IN	_	3	prep	_	_
5	normal	_	JJ	JJ	_	7	amod	_	_
6	receptor	_	NN	NN	_	7	nn	_	_
7	affinity	_	NN	NN	_	4	pobj	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	glucocorticoids	_	NNS	NNS	_	8	pobj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	AIDS-C	_	NN	NN	_	3	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	,	_	,	,	_	3	punct	_	_
14	10	_	CD	CD	_	16	num	_	_
15	HIV-infected	_	JJ	JJ	_	16	amod	_	_
16	patients	_	NNS	NNS	_	3	conj	_	_
17	with	_	IN	IN	_	16	prep	_	_
18	low	_	JJ	JJ	_	20	amod	_	_
19	receptor	_	NN	NN	_	20	nn	_	_
20	affinity	_	NN	NN	_	17	pobj	_	_
21	to	_	TO	TO	_	20	prep	_	_
22	glucocorticoids	_	NNS	NNS	_	21	pobj	_	_
23	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
24	AIDS-GR	_	NN	NN	_	16	appos	_	_
25	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
26	,	_	,	,	_	3	punct	_	_
27	and	_	CC	CC	_	3	cc	_	_
28	20	_	CD	CD	_	30	num	_	_
29	healthy	_	JJ	JJ	_	30	amod	_	_
30	subjects	_	NNS	NNS	_	3	conj	_	_
31	were	_	VBD	VBD	_	32	auxpass	_	_
32	studied	_	VBN	VBN	_	0	root	_	_
33	.	_	.	.	_	32	punct	_	_

1	Receptor	_	NN	NN	_	2	nn	_	_
2	characteristics	_	NNS	NNS	_	9	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	peripheral	_	JJ	JJ	_	7	amod	_	_
5	blood	_	NN	NN	_	7	nn	_	_
6	mononuclear	_	JJ	JJ	_	7	amod	_	_
7	cells	_	NNS	NNS	_	3	pobj	_	_
8	were	_	VBD	VBD	_	9	auxpass	_	_
9	evaluated	_	VBN	VBN	_	0	root	_	_
10	by	_	IN	IN	_	9	prep	_	_
11	-LSB-3H-RSB-dexamethasone	_	NN	NN	_	12	nn	_	_
12	binding	_	NN	NN	_	10	pobj	_	_
13	.	_	.	.	_	9	punct	_	_

1	Serum	_	NN	NN	_	2	nn	_	_
2	cortisol	_	NN	NN	_	8	nsubjpass	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	urinary	_	JJ	JJ	_	6	amod	_	_
5	free	_	JJ	JJ	_	6	amod	_	_
6	cortisol	_	NN	NN	_	2	conj	_	_
7	were	_	VBD	VBD	_	8	auxpass	_	_
8	measured	_	VBN	VBN	_	0	root	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	RIA	_	NN	NN	_	9	pobj	_	_
11	.	_	.	.	_	8	punct	_	_

1	Serum	_	NN	NN	_	6	nsubjpass	_	_
2	ACTH	_	NN	NN	_	1	dep	_	_
3	and	_	CC	CC	_	1	cc	_	_
4	IgE	_	NN	NN	_	1	conj	_	_
5	were	_	VBD	VBD	_	6	auxpass	_	_
6	measured	_	VBN	VBN	_	0	root	_	_
7	by	_	IN	IN	_	6	prep	_	_
8	immunoradiometric	_	JJ	JJ	_	9	amod	_	_
9	assay	_	NN	NN	_	7	pobj	_	_
10	,	_	,	,	_	6	punct	_	_
11	and	_	CC	CC	_	6	cc	_	_
12	IL-2	_	NN	NN	_	22	nsubjpass	_	_
13	,	_	,	,	_	12	punct	_	_
14	IL-4	_	NN	NN	_	12	conj	_	_
15	,	_	,	,	_	12	punct	_	_
16	and	_	CC	CC	_	12	cc	_	_
17	IL-10	_	NN	NN	_	12	conj	_	_
18	cytokines	_	NNS	NNS	_	12	dep	_	_
19	and	_	CC	CC	_	12	cc	_	_
20	interferon-gamma	_	NN	NN	_	12	conj	_	_
21	were	_	VBD	VBD	_	22	auxpass	_	_
22	measured	_	VBN	VBN	_	6	conj	_	_
23	by	_	IN	IN	_	22	prep	_	_
24	enzyme-linked	_	JJ	JJ	_	26	amod	_	_
25	immunosorbent	_	JJ	JJ	_	24	dep	_	_
26	assay	_	NN	NN	_	23	pobj	_	_
27	.	_	.	.	_	6	punct	_	_

1	AIDS-C	_	NN	NN	_	2	nn	_	_
2	patients	_	NNS	NNS	_	3	nsubj	_	_
3	showed	_	VBD	VBD	_	0	root	_	_
4	low	_	JJ	JJ	_	5	amod	_	_
5	IL-2	_	NN	NN	_	3	dobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	high	_	JJ	JJ	_	8	amod	_	_
8	IL-4	_	NN	NN	_	5	conj	_	_
9	,	_	,	,	_	8	punct	_	_
10	IL-10	_	NN	NN	_	8	conj	_	_
11	,	_	,	,	_	8	punct	_	_
12	and	_	CC	CC	_	8	cc	_	_
13	IgE	_	NN	NN	_	8	conj	_	_
14	concentratios	_	NNS	NNS	_	5	dep	_	_
15	;	_	:	:	_	3	punct	_	_
16	conversely	_	RB	RB	_	20	advmod	_	_
17	,	_	,	,	_	20	punct	_	_
18	AIDS-GR	_	NN	NN	_	19	nn	_	_
19	patients	_	NNS	NNS	_	20	nsubj	_	_
20	showed	_	VBD	VBD	_	3	parataxis	_	_
21	high	_	JJ	JJ	_	22	amod	_	_
22	IL-2	_	NN	NN	_	20	dobj	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	low	_	JJ	JJ	_	25	amod	_	_
25	IL-4	_	NN	NN	_	22	conj	_	_
26	and	_	CC	CC	_	25	cc	_	_
27	IgE	_	NN	NN	_	25	conj	_	_
28	concentrations	_	NNS	NNS	_	25	dep	_	_
29	.	_	.	.	_	3	punct	_	_

1	Thus	_	RB	RB	_	10	advmod	_	_
2	,	_	,	,	_	10	punct	_	_
3	in	_	IN	IN	_	10	prep	_	_
4	HIV	_	NN	NN	_	5	nn	_	_
5	infection	_	NN	NN	_	3	pobj	_	_
6	,	_	,	,	_	10	punct	_	_
7	elevated	_	JJ	JJ	_	9	amod	_	_
8	cortisol	_	NN	NN	_	9	nn	_	_
9	levels	_	NNS	NNS	_	10	nsubj	_	_
10	suppress	_	VBP	VBP	_	0	root	_	_
11	cell-mediated	_	JJ	JJ	_	12	amod	_	_
12	immunity	_	NN	NN	_	10	dobj	_	_
13	and	_	CC	CC	_	10	cc	_	_
14	stimulate	_	VBP	VBP	_	10	conj	_	_
15	humoral	_	JJ	JJ	_	16	amod	_	_
16	immunity	_	NN	NN	_	14	dobj	_	_
17	,	_	,	,	_	10	punct	_	_
18	whereas	_	IN	IN	_	23	mark	_	_
19	this	_	DT	DT	_	20	det	_	_
20	response	_	NN	NN	_	23	nsubjpass	_	_
21	is	_	VBZ	VBZ	_	23	auxpass	_	_
22	not	_	RB	RB	_	23	neg	_	_
23	detected	_	VBN	VBN	_	10	advcl	_	_
24	in	_	IN	IN	_	23	prep	_	_
25	cortisol-resistant	_	JJ	JJ	_	26	amod	_	_
26	patients	_	NNS	NNS	_	24	pobj	_	_
27	.	_	.	.	_	10	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	findings	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	11	mark	_	_
5	cortisol	_	NN	NN	_	11	nsubjpass	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	its	_	PRP$	PRP$	_	8	poss	_	_
8	receptors	_	NNS	NNS	_	5	conj	_	_
9	are	_	VBP	VBP	_	11	auxpass	_	_
10	critically	_	RB	RB	_	11	advmod	_	_
11	involved	_	VBN	VBN	_	3	ccomp	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	14	det	_	_
14	regulation	_	NN	NN	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	immune	_	JJ	JJ	_	17	amod	_	_
17	function	_	NN	NN	_	15	pobj	_	_
18	in	_	IN	IN	_	14	prep	_	_
19	HIV	_	NN	NN	_	20	nn	_	_
20	infection	_	NN	NN	_	18	pobj	_	_
21	.	_	.	.	_	3	punct	_	_

1	Dominant	_	JJ	JJ	_	5	amod	_	_
2	cytotoxic	_	JJ	JJ	_	4	amod	_	_
3	T	_	NN	NN	_	4	nn	_	_
4	lymphocyte	_	NN	NN	_	5	nn	_	_
5	response	_	NN	NN	_	0	root	_	_
6	to	_	TO	TO	_	5	prep	_	_
7	the	_	DT	DT	_	10	det	_	_
8	immediate-early	_	JJ	JJ	_	10	amod	_	_
9	trans-activator	_	JJ	JJ	_	10	amod	_	_
10	protein	_	NN	NN	_	6	pobj	_	_
11	,	_	,	,	_	10	punct	_	_
12	BZLF1	_	NN	NN	_	10	appos	_	_
13	,	_	,	,	_	5	punct	_	_
14	in	_	IN	IN	_	5	prep	_	_
15	persistent	_	JJ	JJ	_	16	amod	_	_
16	type	_	NN	NN	_	14	pobj	_	_
17	A	_	NN	NN	_	16	dep	_	_
18	or	_	CC	CC	_	16	cc	_	_
19	B	_	NN	NN	_	16	conj	_	_
20	Epstein-Barr	_	JJ	JJ	_	22	amod	_	_
21	virus	_	NN	NN	_	22	nn	_	_
22	infection	_	NN	NN	_	16	dep	_	_
23	.	_	.	.	_	5	punct	_	_

1	Five	_	CD	CD	_	11	num	_	_
2	healthy	_	JJ	JJ	_	11	amod	_	_
3	human	_	JJ	JJ	_	11	amod	_	_
4	leukocyte	_	NN	NN	_	11	nn	_	_
5	antigen-B8	_	NN	NN	_	11	nn	_	_
6	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
7	HLA-B8	_	NN	NN	_	11	nn	_	_
8	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
9	-positive	_	JJ	JJ	_	11	amod	_	_
10	virus	_	NN	NN	_	11	nn	_	_
11	carriers	_	NNS	NNS	_	13	nsubjpass	_	_
12	were	_	VBD	VBD	_	13	auxpass	_	_
13	studied	_	VBN	VBN	_	0	root	_	_
14	to	_	TO	TO	_	15	aux	_	_
15	investigate	_	VB	VB	_	13	xcomp	_	_
16	the	_	DT	DT	_	20	det	_	_
17	CD8+	_	JJ	JJ	_	20	amod	_	_
18	cytotoxic	_	JJ	JJ	_	20	amod	_	_
19	T	_	NN	NN	_	20	nn	_	_
20	lymphocyte	_	NN	NN	_	24	nn	_	_
21	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
22	CTL	_	NN	NN	_	20	appos	_	_
23	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
24	response	_	NN	NN	_	15	dobj	_	_
25	to	_	TO	TO	_	24	prep	_	_
26	an	_	DT	DT	_	28	det	_	_
27	HLA-B8-restricted	_	JJ	JJ	_	28	amod	_	_
28	peptide	_	NN	NN	_	25	pobj	_	_
29	,	_	,	,	_	28	punct	_	_
30	RAKFKQLLQ	_	NN	NN	_	28	appos	_	_
31	,	_	,	,	_	28	punct	_	_
32	located	_	JJ	JJ	_	28	amod	_	_
33	in	_	IN	IN	_	32	prep	_	_
34	the	_	DT	DT	_	42	det	_	_
35	Epstein-Barr	_	JJ	JJ	_	42	amod	_	_
36	virus	_	NN	NN	_	42	nn	_	_
37	-LRB-	_	-LRB-	-LRB-	_	42	punct	_	_
38	EBV	_	NN	NN	_	42	nn	_	_
39	-RRB-	_	-RRB-	-RRB-	_	42	punct	_	_
40	immediate-early	_	JJ	JJ	_	42	amod	_	_
41	trans-activator	_	NN	NN	_	42	nn	_	_
42	protein	_	NN	NN	_	33	pobj	_	_
43	,	_	,	,	_	42	punct	_	_
44	BZLF1	_	NN	NN	_	42	appos	_	_
45	.	_	.	.	_	13	punct	_	_

1	Of	_	IN	IN	_	9	prep	_	_
2	the	_	DT	DT	_	5	det	_	_
3	5	_	CD	CD	_	5	num	_	_
4	virus	_	NN	NN	_	5	nn	_	_
5	carriers	_	NNS	NNS	_	1	pobj	_	_
6	,	_	,	,	_	9	punct	_	_
7	4	_	CD	CD	_	9	nsubjpass	_	_
8	were	_	VBD	VBD	_	9	auxpass	_	_
9	infected	_	VBN	VBN	_	0	root	_	_
10	with	_	IN	IN	_	9	prep	_	_
11	type	_	NN	NN	_	12	nn	_	_
12	A	_	NN	NN	_	10	pobj	_	_
13	and	_	CC	CC	_	9	cc	_	_
14	1	_	CD	CD	_	9	conj	_	_
15	with	_	IN	IN	_	14	dep	_	_
16	type	_	NN	NN	_	18	nn	_	_
17	B	_	NN	NN	_	18	nn	_	_
18	EBV	_	NN	NN	_	15	pobj	_	_
19	.	_	.	.	_	9	punct	_	_

1	Using	_	VBG	VBG	_	0	root	_	_
2	limiting-dilution	_	JJ	JJ	_	3	amod	_	_
3	analysis	_	NN	NN	_	1	dobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	peripheral	_	JJ	JJ	_	8	amod	_	_
6	blood	_	NN	NN	_	8	nn	_	_
7	mononuclear	_	JJ	JJ	_	8	amod	_	_
8	cells	_	NNS	NNS	_	4	pobj	_	_
9	,	_	,	,	_	1	punct	_	_
10	a	_	DT	DT	_	15	det	_	_
11	high	_	JJ	JJ	_	15	amod	_	_
12	RAKFKQLLQ-specific	_	JJ	JJ	_	11	dep	_	_
13	CTL	_	NN	NN	_	15	nn	_	_
14	precursor	_	NN	NN	_	15	nn	_	_
15	frequency	_	NN	NN	_	17	nsubjpass	_	_
16	was	_	VBD	VBD	_	17	auxpass	_	_
17	demonstrated	_	VBN	VBN	_	1	parataxis	_	_
18	after	_	IN	IN	_	17	prep	_	_
19	specific	_	JJ	JJ	_	20	amod	_	_
20	peptide	_	NN	NN	_	18	pobj	_	_
21	or	_	CC	CC	_	20	cc	_	_
22	autologous	_	JJ	JJ	_	25	amod	_	_
23	lymphoblastoid	_	JJ	JJ	_	25	amod	_	_
24	cell	_	NN	NN	_	25	nn	_	_
25	line	_	NN	NN	_	20	conj	_	_
26	stimulation	_	NN	NN	_	20	dep	_	_
27	in	_	IN	IN	_	20	prep	_	_
28	both	_	CC	CC	_	30	preconj	_	_
29	type	_	NN	NN	_	30	nn	_	_
30	A	_	NN	NN	_	27	pobj	_	_
31	and	_	CC	CC	_	30	cc	_	_
32	type	_	NN	NN	_	33	nn	_	_
33	B	_	NN	NN	_	30	conj	_	_
34	EBV	_	NN	NN	_	35	nn	_	_
35	carriers	_	NNS	NNS	_	30	dep	_	_
36	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	5	det	_	_
2	RAKFKQLLQ-specific	_	JJ	JJ	_	5	amod	_	_
3	CTL	_	NN	NN	_	5	nn	_	_
4	precursor	_	NN	NN	_	5	nn	_	_
5	frequencies	_	NNS	NNS	_	14	nsubj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	all	_	DT	DT	_	9	det	_	_
8	5	_	CD	CD	_	9	num	_	_
9	persons	_	NNS	NNS	_	6	pobj	_	_
10	were	_	VBD	VBD	_	14	cop	_	_
11	at	_	IN	IN	_	14	advmod	_	_
12	least	_	JJS	JJS	_	11	pobj	_	_
13	as	_	RB	RB	_	14	advmod	_	_
14	dominant	_	JJ	JJ	_	0	root	_	_
15	as	_	IN	IN	_	14	prep	_	_
16	those	_	DT	DT	_	15	pobj	_	_
17	observed	_	VBN	VBN	_	16	vmod	_	_
18	with	_	IN	IN	_	17	prep	_	_
19	two	_	CD	CD	_	25	num	_	_
20	other	_	JJ	JJ	_	25	amod	_	_
21	EBV-associated	_	JJ	JJ	_	25	amod	_	_
22	,	_	,	,	_	25	punct	_	_
23	HLA-B8-restricted	_	JJ	JJ	_	25	amod	_	_
24	latent	_	JJ	JJ	_	25	amod	_	_
25	epitopes	_	NNS	NNS	_	18	pobj	_	_
26	,	_	,	,	_	25	punct	_	_
27	FLRGRAYGL	_	NN	NN	_	25	appos	_	_
28	and	_	CC	CC	_	27	cc	_	_
29	QAKWRLQTL	_	NN	NN	_	27	conj	_	_
30	.	_	.	.	_	14	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	findings	_	NNS	NNS	_	3	nsubj	_	_
3	show	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	8	mark	_	_
5	healthy	_	JJ	JJ	_	7	amod	_	_
6	virus	_	NN	NN	_	7	nn	_	_
7	carriers	_	NNS	NNS	_	8	nsubj	_	_
8	maintain	_	VBP	VBP	_	3	ccomp	_	_
9	a	_	DT	DT	_	11	det	_	_
10	high	_	JJ	JJ	_	11	amod	_	_
11	frequency	_	NN	NN	_	8	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	BZLF1-specific	_	JJ	JJ	_	16	amod	_	_
14	memory	_	NN	NN	_	16	nn	_	_
15	T	_	NN	NN	_	16	nn	_	_
16	cells	_	NNS	NNS	_	12	pobj	_	_
17	,	_	,	,	_	8	punct	_	_
18	potentially	_	RB	RB	_	20	advmod	_	_
19	to	_	TO	TO	_	20	aux	_	_
20	control	_	VB	VB	_	8	vmod	_	_
21	virus	_	NN	NN	_	20	dobj	_	_
22	spread	_	VBN	VBN	_	21	amod	_	_
23	from	_	IN	IN	_	21	prep	_	_
24	lytically	_	RB	RB	_	26	advmod	_	_
25	infected	_	JJ	JJ	_	26	amod	_	_
26	cells	_	NNS	NNS	_	23	pobj	_	_
27	.	_	.	.	_	3	punct	_	_

1	Molecular	_	JJ	JJ	_	2	amod	_	_
2	characterization	_	NN	NN	_	0	root	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	pattern	_	NN	NN	_	2	conj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	tissue	_	NN	NN	_	7	nn	_	_
7	expression	_	NN	NN	_	5	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	gene	_	NN	NN	_	8	pobj	_	_
11	for	_	IN	IN	_	2	prep	_	_
12	neutrophil	_	NN	NN	_	14	nn	_	_
13	gelatinase-associated	_	JJ	JJ	_	14	amod	_	_
14	lipocalin	_	NN	NN	_	11	pobj	_	_
15	from	_	IN	IN	_	14	prep	_	_
16	humans	_	NNS	NNS	_	15	pobj	_	_
17	.	_	.	.	_	2	punct	_	_

1	Neutrophil	_	NN	NN	_	3	nn	_	_
2	gelatinase-associated	_	JJ	JJ	_	3	amod	_	_
3	lipocalin	_	NN	NN	_	10	nsubj	_	_
4	-LRB-	_	-LRB-	-LRB-	_	5	punct	_	_
5	NGAL	_	NN	NN	_	3	appos	_	_
6	-RRB-	_	-RRB-	-RRB-	_	5	punct	_	_
7	is	_	VBZ	VBZ	_	10	cop	_	_
8	a	_	DT	DT	_	10	det	_	_
9	25-kDa	_	JJ	JJ	_	10	amod	_	_
10	lipocalin	_	NN	NN	_	0	root	_	_
11	first	_	RB	RB	_	12	advmod	_	_
12	identified	_	VBN	VBN	_	10	vmod	_	_
13	as	_	IN	IN	_	12	prep	_	_
14	a	_	DT	DT	_	15	det	_	_
15	protein	_	NN	NN	_	13	pobj	_	_
16	stored	_	VBN	VBN	_	15	vmod	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	specific	_	JJ	JJ	_	19	amod	_	_
19	granules	_	NNS	NNS	_	17	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	23	det	_	_
22	human	_	JJ	JJ	_	23	amod	_	_
23	neutrophil	_	NN	NN	_	20	pobj	_	_
24	.	_	.	.	_	10	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	protein	_	NN	NN	_	4	nsubjpass	_	_
3	is	_	VBZ	VBZ	_	4	auxpass	_	_
4	believed	_	VBN	VBN	_	0	root	_	_
5	to	_	TO	TO	_	6	aux	_	_
6	bind	_	VB	VB	_	4	xcomp	_	_
7	small	_	JJ	JJ	_	9	amod	_	_
8	lipophilic	_	JJ	JJ	_	9	amod	_	_
9	substances	_	NNS	NNS	_	6	dobj	_	_
10	such	_	JJ	JJ	_	11	mwe	_	_
11	as	_	IN	IN	_	9	prep	_	_
12	bacterial	_	JJ	JJ	_	13	dep	_	_
13	derived	_	VBN	VBN	_	14	amod	_	_
14	formylpeptides	_	NNS	NNS	_	11	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	lipopolysaccharides	_	NNS	NNS	_	14	conj	_	_
17	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	LPS	_	NNS	NNS	_	16	appos	_	_
19	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
20	and	_	CC	CC	_	4	cc	_	_
21	might	_	MD	MD	_	4	conj	_	_
22	function	_	NN	NN	_	21	dobj	_	_
23	as	_	IN	IN	_	22	prep	_	_
24	a	_	DT	DT	_	25	det	_	_
25	modulator	_	NN	NN	_	23	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	inflammation	_	NN	NN	_	26	pobj	_	_
28	.	_	.	.	_	4	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	characterize	_	VB	VB	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	regulation	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	NGAL	_	NN	NN	_	5	pobj	_	_
7	further	_	RB	RB	_	2	advmod	_	_
8	,	_	,	,	_	2	punct	_	_
9	we	_	PRP	PRP	_	11	nsubj	_	_
10	have	_	VBP	VBP	_	11	aux	_	_
11	cloned	_	VBN	VBN	_	2	parataxis	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	sequenced	_	VBN	VBN	_	11	conj	_	_
14	a	_	DT	DT	_	16	det	_	_
15	5869-bp	_	JJ	JJ	_	16	amod	_	_
16	region	_	NN	NN	_	11	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	NGAL	_	NN	NN	_	20	nn	_	_
20	gene	_	NN	NN	_	17	pobj	_	_
21	including	_	VBG	VBG	_	16	prep	_	_
22	1695	_	CD	CD	_	23	num	_	_
23	bp	_	NN	NN	_	21	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	the	_	DT	DT	_	28	det	_	_
26	5'	_	JJ	JJ	_	28	amod	_	_
27	nontranscribed	_	JJ	JJ	_	28	amod	_	_
28	region	_	NN	NN	_	24	pobj	_	_
29	and	_	CC	CC	_	23	cc	_	_
30	a	_	DT	DT	_	33	det	_	_
31	3696-bp	_	JJ	JJ	_	33	amod	_	_
32	coding	_	VBG	VBG	_	33	amod	_	_
33	region	_	NN	NN	_	23	conj	_	_
34	encompassing	_	VBG	VBG	_	33	vmod	_	_
35	seven	_	CD	CD	_	36	num	_	_
36	exons	_	NNS	NNS	_	34	dobj	_	_
37	and	_	CC	CC	_	36	cc	_	_
38	six	_	CD	CD	_	39	num	_	_
39	introns	_	NNS	NNS	_	36	conj	_	_
40	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	transcriptional	_	JJ	JJ	_	4	amod	_	_
3	start	_	NN	NN	_	4	nn	_	_
4	sites	_	NNS	NNS	_	6	nsubjpass	_	_
5	were	_	VBD	VBD	_	6	auxpass	_	_
6	identified	_	VBN	VBN	_	0	root	_	_
7	by	_	IN	IN	_	6	prep	_	_
8	an	_	DT	DT	_	11	det	_	_
9	RNase	_	NN	NN	_	11	nn	_	_
10	protection	_	NN	NN	_	11	nn	_	_
11	assay	_	NN	NN	_	7	pobj	_	_
12	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	NGAL	_	NN	NN	_	3	nn	_	_
3	gene	_	NN	NN	_	6	nsubj	_	_
4	is	_	VBZ	VBZ	_	6	cop	_	_
5	highly	_	RB	RB	_	6	advmod	_	_
6	homologous	_	JJ	JJ	_	0	root	_	_
7	to	_	TO	TO	_	6	prep	_	_
8	the	_	DT	DT	_	11	det	_	_
9	mouse	_	NN	NN	_	11	nn	_	_
10	gene	_	NN	NN	_	11	nn	_	_
11	24p3	_	NN	NN	_	7	pobj	_	_
12	.	_	.	.	_	6	punct	_	_

1	NGAL	_	NN	NN	_	3	nsubjpass	_	_
2	was	_	VBD	VBD	_	3	auxpass	_	_
3	expressed	_	VBN	VBN	_	0	root	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	bone	_	NN	NN	_	6	nn	_	_
6	marrow	_	NN	NN	_	4	pobj	_	_
7	and	_	CC	CC	_	4	cc	_	_
8	in	_	IN	IN	_	4	conj	_	_
9	tissues	_	NNS	NNS	_	8	pobj	_	_
10	that	_	WDT	WDT	_	12	nsubj	_	_
11	are	_	VBP	VBP	_	12	cop	_	_
12	prone	_	JJ	JJ	_	9	rcmod	_	_
13	to	_	TO	TO	_	12	prep	_	_
14	exposure	_	NN	NN	_	13	pobj	_	_
15	to	_	TO	TO	_	14	prep	_	_
16	microorganisms	_	NNS	NNS	_	15	pobj	_	_
17	.	_	.	.	_	3	punct	_	_

1	Potential	_	JJ	JJ	_	3	amod	_	_
2	cis-acting	_	JJ	JJ	_	3	amod	_	_
3	elements	_	NNS	NNS	_	5	nsubjpass	_	_
4	were	_	VBD	VBD	_	5	auxpass	_	_
5	identified	_	VBN	VBN	_	0	root	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	promoter	_	NN	NN	_	9	nn	_	_
9	region	_	NN	NN	_	6	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	NGAL	_	NN	NN	_	13	nn	_	_
13	gene	_	NN	NN	_	10	pobj	_	_
14	by	_	IN	IN	_	5	prep	_	_
15	computer	_	NN	NN	_	16	nn	_	_
16	analysis	_	NN	NN	_	14	pobj	_	_
17	and	_	CC	CC	_	5	cc	_	_
18	include	_	VBP	VBP	_	5	conj	_	_
19	binding	_	VBG	VBG	_	20	amod	_	_
20	sites	_	NNS	NNS	_	18	dobj	_	_
21	for	_	IN	IN	_	20	prep	_	_
22	CTF/CBP	_	NN	NN	_	21	pobj	_	_
23	,	_	,	,	_	22	punct	_	_
24	the	_	DT	DT	_	27	det	_	_
25	hematopoietic	_	JJ	JJ	_	27	amod	_	_
26	transcription	_	NN	NN	_	27	nn	_	_
27	factors	_	NNS	NNS	_	22	conj	_	_
28	GATA-1	_	NN	NN	_	27	dep	_	_
29	and	_	CC	CC	_	28	cc	_	_
30	PU.1	_	NN	NN	_	28	conj	_	_
31	,	_	,	,	_	22	punct	_	_
32	and	_	CC	CC	_	22	cc	_	_
33	the	_	DT	DT	_	37	det	_	_
34	LPS-inducible	_	JJ	JJ	_	37	amod	_	_
35	factor	_	NN	NN	_	37	nn	_	_
36	NF-kappa	_	NN	NN	_	37	nn	_	_
37	B	_	NN	NN	_	22	conj	_	_
38	.	_	.	.	_	5	punct	_	_

1	Monocytic	_	JJ	JJ	_	2	amod	_	_
2	differentiation	_	NN	NN	_	8	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	HL-60	_	NN	NN	_	7	nn	_	_
5	promyelocytic	_	JJ	JJ	_	7	amod	_	_
6	leukemia	_	NN	NN	_	7	nn	_	_
7	cells	_	NNS	NNS	_	3	pobj	_	_
8	correlates	_	VBZ	VBZ	_	0	root	_	_
9	with	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	induction	_	NN	NN	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	Bcl-xL	_	NN	NN	_	12	pobj	_	_
14	.	_	.	.	_	8	punct	_	_

1	Treatment	_	NN	NN	_	12	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	human	_	JJ	JJ	_	7	amod	_	_
4	promyelocytic	_	JJ	JJ	_	7	amod	_	_
5	leukemia	_	NN	NN	_	7	nn	_	_
6	HL-60	_	NN	NN	_	7	nn	_	_
7	cells	_	NNS	NNS	_	2	pobj	_	_
8	with	_	IN	IN	_	1	prep	_	_
9	phorbol	_	NN	NN	_	10	nn	_	_
10	esters	_	NNS	NNS	_	8	pobj	_	_
11	ultimately	_	RB	RB	_	12	advmod	_	_
12	induces	_	VBZ	VBZ	_	0	root	_	_
13	the	_	DT	DT	_	14	det	_	_
14	differentiation	_	NN	NN	_	12	dobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	these	_	DT	DT	_	17	det	_	_
17	cells	_	NNS	NNS	_	15	pobj	_	_
18	along	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	monocyte/macrophage	_	NN	NN	_	21	nn	_	_
21	lineage	_	NN	NN	_	18	pobj	_	_
22	,	_	,	,	_	12	punct	_	_
23	whereas	_	IN	IN	_	30	mark	_	_
24	treatment	_	NN	NN	_	30	nsubj	_	_
25	with	_	IN	IN	_	24	prep	_	_
26	retinoic	_	JJ	JJ	_	27	amod	_	_
27	acid	_	NN	NN	_	25	pobj	_	_
28	or	_	CC	CC	_	27	cc	_	_
29	DMSO	_	NN	NN	_	27	conj	_	_
30	induces	_	VBZ	VBZ	_	12	advcl	_	_
31	granulocytic/neutrophillic	_	JJ	JJ	_	32	amod	_	_
32	differentiation	_	NN	NN	_	30	dobj	_	_
33	.	_	.	.	_	12	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	study	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	demonstrate	_	VBP	VBP	_	0	root	_	_
7	the	_	DT	DT	_	9	det	_	_
8	disparate	_	JJ	JJ	_	9	amod	_	_
9	fates	_	NNS	NNS	_	6	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	HL-60	_	NN	NN	_	12	nn	_	_
12	cells	_	NNS	NNS	_	10	pobj	_	_
13	treated	_	VBN	VBN	_	12	vmod	_	_
14	with	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	20	det	_	_
16	phorbol	_	NN	NN	_	20	nn	_	_
17	ester	_	NN	NN	_	20	nn	_	_
18	12,13-phorbol	_	NN	NN	_	20	nn	_	_
19	dibutyric	_	JJ	JJ	_	20	amod	_	_
20	acid	_	NN	NN	_	14	pobj	_	_
21	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
22	PDBu	_	NN	NN	_	20	appos	_	_
23	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
24	or	_	CC	CC	_	20	cc	_	_
25	DMSO	_	NN	NN	_	20	conj	_	_
26	.	_	.	.	_	6	punct	_	_

1	After	_	IN	IN	_	8	prep	_	_
2	DMSO	_	NN	NN	_	3	nn	_	_
3	treatment	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	8	punct	_	_
5	HL-60	_	NN	NN	_	6	nn	_	_
6	cells	_	NNS	NNS	_	8	nsubj	_	_
7	eventually	_	RB	RB	_	8	advmod	_	_
8	died	_	VBD	VBD	_	0	root	_	_
9	via	_	IN	IN	_	8	prep	_	_
10	apoptosis	_	NN	NN	_	9	pobj	_	_
11	,	_	,	,	_	8	punct	_	_
12	whereas	_	IN	IN	_	20	mark	_	_
13	the	_	DT	DT	_	14	det	_	_
14	viability	_	NN	NN	_	20	nsubjpass	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	PDBu-treated	_	JJ	JJ	_	17	amod	_	_
17	cells	_	NNS	NNS	_	15	pobj	_	_
18	was	_	VBD	VBD	_	20	auxpass	_	_
19	not	_	RB	RB	_	20	neg	_	_
20	affected	_	VBN	VBN	_	8	advcl	_	_
21	during	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	24	det	_	_
23	same	_	JJ	JJ	_	24	amod	_	_
24	interval	_	NN	NN	_	21	pobj	_	_
25	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	levels	_	NNS	NNS	_	12	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	7	det	_	_
5	apoptosis	_	NN	NN	_	7	nn	_	_
6	effector	_	NN	NN	_	7	nn	_	_
7	proteins	_	NNS	NNS	_	3	pobj	_	_
8	Bak	_	NN	NN	_	7	dep	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	Bad	_	NN	NN	_	8	conj	_	_
11	were	_	VBD	VBD	_	12	auxpass	_	_
12	enhanced	_	VBN	VBN	_	0	root	_	_
13	,	_	,	,	_	12	punct	_	_
14	whereas	_	IN	IN	_	16	mark	_	_
15	there	_	EX	EX	_	16	expl	_	_
16	was	_	VBD	VBD	_	12	advcl	_	_
17	a	_	DT	DT	_	19	det	_	_
18	slight	_	JJ	JJ	_	19	amod	_	_
19	down-regulation	_	NN	NN	_	16	nsubj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	24	det	_	_
22	apoptosis	_	NN	NN	_	24	nn	_	_
23	suppressor	_	NN	NN	_	24	nn	_	_
24	protein	_	NN	NN	_	20	pobj	_	_
25	Bcl-2	_	NN	NN	_	24	dep	_	_
26	after	_	IN	IN	_	16	prep	_	_
27	treatment	_	NN	NN	_	26	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	the	_	DT	DT	_	30	det	_	_
30	cells	_	NNS	NNS	_	28	pobj	_	_
31	with	_	IN	IN	_	27	prep	_	_
32	PDBu	_	NN	NN	_	31	pobj	_	_
33	and	_	CC	CC	_	32	cc	_	_
34	DMSO	_	NN	NN	_	32	conj	_	_
35	.	_	.	.	_	12	punct	_	_

1	Treatment	_	NN	NN	_	4	nsubj	_	_
2	with	_	IN	IN	_	1	prep	_	_
3	DMSO	_	NN	NN	_	2	pobj	_	_
4	resulted	_	VBD	VBD	_	0	root	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	7	det	_	_
7	elevation	_	NN	NN	_	5	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	apoptosis	_	NN	NN	_	11	nn	_	_
11	effector	_	NN	NN	_	8	pobj	_	_
12	Bax	_	NN	NN	_	11	dep	_	_
13	,	_	,	,	_	4	punct	_	_
14	whereas	_	IN	IN	_	21	mark	_	_
15	treatment	_	NN	NN	_	21	nsubj	_	_
16	with	_	IN	IN	_	15	prep	_	_
17	PDBu	_	NN	NN	_	16	pobj	_	_
18	did	_	VBD	VBD	_	21	aux	_	_
19	not	_	RB	RB	_	21	neg	_	_
20	significantly	_	RB	RB	_	21	advmod	_	_
21	alter	_	VB	VB	_	4	advcl	_	_
22	the	_	DT	DT	_	23	det	_	_
23	levels	_	NNS	NNS	_	21	dobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	this	_	DT	DT	_	26	det	_	_
26	protein	_	NN	NN	_	24	pobj	_	_
27	.	_	.	.	_	4	punct	_	_

1	However	_	RB	RB	_	9	advmod	_	_
2	,	_	,	,	_	9	punct	_	_
3	treatment	_	NN	NN	_	9	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	HL-60	_	NN	NN	_	6	nn	_	_
6	cells	_	NNS	NNS	_	4	pobj	_	_
7	with	_	IN	IN	_	3	prep	_	_
8	PDBu	_	NN	NN	_	7	pobj	_	_
9	induced	_	VBD	VBD	_	0	root	_	_
10	the	_	DT	DT	_	12	det	_	_
11	rapid	_	JJ	JJ	_	12	amod	_	_
12	expression	_	NN	NN	_	9	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	17	det	_	_
15	apoptosis	_	NN	NN	_	17	nn	_	_
16	suppressor	_	NN	NN	_	17	nn	_	_
17	protein	_	NN	NN	_	13	pobj	_	_
18	Bcl-xL	_	NN	NN	_	17	dep	_	_
19	,	_	,	,	_	9	punct	_	_
20	whereas	_	IN	IN	_	26	mark	_	_
21	the	_	DT	DT	_	22	det	_	_
22	expression	_	NN	NN	_	26	nsubj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	this	_	DT	DT	_	25	det	_	_
25	protein	_	NN	NN	_	23	pobj	_	_
26	remained	_	VBD	VBD	_	9	advcl	_	_
27	unaltered	_	JJ	JJ	_	26	acomp	_	_
28	in	_	IN	IN	_	27	prep	_	_
29	DMSO-treated	_	JJ	JJ	_	30	amod	_	_
30	cells	_	NNS	NNS	_	28	pobj	_	_
31	.	_	.	.	_	9	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	generality	_	NN	NN	_	7	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	this	_	DT	DT	_	5	det	_	_
5	finding	_	NN	NN	_	3	pobj	_	_
6	was	_	VBD	VBD	_	7	auxpass	_	_
7	confirmed	_	VBN	VBN	_	0	root	_	_
8	by	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	induction	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	Bcl-xL	_	NN	NN	_	11	pobj	_	_
13	in	_	IN	IN	_	10	prep	_	_
14	human	_	JJ	JJ	_	17	amod	_	_
15	myeloid	_	JJ	JJ	_	17	amod	_	_
16	U-937	_	NN	NN	_	17	nn	_	_
17	cells	_	NNS	NNS	_	13	pobj	_	_
18	,	_	,	,	_	17	punct	_	_
19	human	_	JJ	JJ	_	22	amod	_	_
20	peripheral	_	JJ	JJ	_	22	amod	_	_
21	blood	_	NN	NN	_	22	nn	_	_
22	monocytes	_	NNS	NNS	_	17	conj	_	_
23	exposed	_	VBN	VBN	_	22	vmod	_	_
24	to	_	TO	TO	_	23	prep	_	_
25	phorbol	_	NN	NN	_	26	nn	_	_
26	ester	_	NN	NN	_	24	pobj	_	_
27	,	_	,	,	_	17	punct	_	_
28	and	_	CC	CC	_	17	cc	_	_
29	mouse	_	NN	NN	_	30	npadvmod	_	_
30	thioglycollate-activated	_	JJ	JJ	_	17	conj	_	_
31	and	_	CC	CC	_	30	cc	_	_
32	resident	_	JJ	JJ	_	34	amod	_	_
33	peritoneal	_	JJ	JJ	_	34	amod	_	_
34	macrophages	_	NNS	NNS	_	30	conj	_	_
35	.	_	.	.	_	7	punct	_	_

1	PDBu-treated	_	JJ	JJ	_	3	amod	_	_
2	HL-60	_	NN	NN	_	3	nn	_	_
3	cells	_	NNS	NNS	_	4	nsubj	_	_
4	remained	_	VBD	VBD	_	0	root	_	_
5	viable	_	JJ	JJ	_	4	acomp	_	_
6	for	_	IN	IN	_	5	prep	_	_
7	7	_	CD	CD	_	8	num	_	_
8	days	_	NNS	NNS	_	6	pobj	_	_
9	and	_	CC	CC	_	4	cc	_	_
10	thereafter	_	RB	RB	_	11	advmod	_	_
11	began	_	VBD	VBD	_	4	conj	_	_
12	to	_	TO	TO	_	13	aux	_	_
13	die	_	VB	VB	_	11	xcomp	_	_
14	via	_	IN	IN	_	13	prep	_	_
15	apoptosis	_	NN	NN	_	14	pobj	_	_
16	,	_	,	,	_	13	punct	_	_
17	with	_	IN	IN	_	13	prep	_	_
18	a	_	DT	DT	_	20	det	_	_
19	concomitant	_	JJ	JJ	_	20	amod	_	_
20	down-regulation	_	NN	NN	_	17	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	Bcl-xL	_	NN	NN	_	21	pobj	_	_
23	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	5	prep	_	_
2	conclusion	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	5	punct	_	_
4	we	_	PRP	PRP	_	5	nsubj	_	_
5	propose	_	VBP	VBP	_	0	root	_	_
6	that	_	IN	IN	_	10	mark	_	_
7	Bcl-xL	_	NN	NN	_	8	nn	_	_
8	expression	_	NN	NN	_	10	nsubjpass	_	_
9	is	_	VBZ	VBZ	_	10	auxpass	_	_
10	associated	_	VBN	VBN	_	5	ccomp	_	_
11	with	_	IN	IN	_	10	prep	_	_
12	differentiation	_	NN	NN	_	11	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	survival	_	NN	NN	_	12	conj	_	_
15	of	_	IN	IN	_	12	prep	_	_
16	hematopoietic	_	JJ	JJ	_	17	amod	_	_
17	cells	_	NNS	NNS	_	15	pobj	_	_
18	along	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	monocyte/macrophage	_	NN	NN	_	21	nn	_	_
21	lineage	_	NN	NN	_	18	pobj	_	_
22	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	spatial	_	JJ	JJ	_	3	amod	_	_
3	distribution	_	NN	NN	_	0	root	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	human	_	JJ	JJ	_	7	amod	_	_
6	immunoglobulin	_	NN	NN	_	7	nn	_	_
7	genes	_	NNS	NNS	_	4	pobj	_	_
8	within	_	IN	IN	_	3	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	nucleus	_	NN	NN	_	8	pobj	_	_
11	:	_	:	:	_	3	punct	_	_
12	evidence	_	NN	NN	_	3	dep	_	_
13	for	_	IN	IN	_	12	prep	_	_
14	gene	_	NN	NN	_	15	nn	_	_
15	topography	_	NN	NN	_	13	pobj	_	_
16	independent	_	JJ	JJ	_	15	amod	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	cell	_	NN	NN	_	19	nn	_	_
19	type	_	NN	NN	_	17	pobj	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	transcriptional	_	JJ	JJ	_	22	amod	_	_
22	activity	_	NN	NN	_	19	conj	_	_
23	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	three-dimensional	_	JJ	JJ	_	3	amod	_	_
3	positioning	_	NN	NN	_	17	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	immunoglobulin	_	NN	NN	_	9	nn	_	_
6	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
7	Ig	_	NN	NN	_	9	nn	_	_
8	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
9	genes	_	NNS	NNS	_	4	pobj	_	_
10	within	_	IN	IN	_	3	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	nucleus	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	human	_	JJ	JJ	_	15	amod	_	_
15	cells	_	NNS	NNS	_	13	pobj	_	_
16	was	_	VBD	VBD	_	17	auxpass	_	_
17	investigated	_	VBN	VBN	_	0	root	_	_
18	using	_	VBG	VBG	_	17	xcomp	_	_
19	in	_	FW	FW	_	21	amod	_	_
20	situ	_	FW	FW	_	19	dep	_	_
21	hybridization	_	NN	NN	_	18	dobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	confocal	_	JJ	JJ	_	24	amod	_	_
24	microscopy	_	NN	NN	_	21	conj	_	_
25	.	_	.	.	_	17	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	visualization	_	NN	NN	_	12	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	heavy	_	JJ	JJ	_	3	pobj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	light	_	JJ	JJ	_	4	conj	_	_
7	chain	_	NN	NN	_	8	nn	_	_
8	genes	_	NNS	NNS	_	4	dep	_	_
9	in	_	IN	IN	_	4	prep	_	_
10	B-lymphoid	_	JJ	JJ	_	11	amod	_	_
11	cells	_	NNS	NNS	_	9	pobj	_	_
12	showed	_	VBD	VBD	_	0	root	_	_
13	that	_	IN	IN	_	22	mark	_	_
14	the	_	DT	DT	_	17	det	_	_
15	three	_	CD	CD	_	17	num	_	_
16	Ig	_	NN	NN	_	17	nn	_	_
17	genes	_	NNS	NNS	_	22	nsubjpass	_	_
18	are	_	VBP	VBP	_	22	auxpass	_	_
19	differentially	_	RB	RB	_	22	advmod	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	nonrandomly	_	RB	RB	_	19	conj	_	_
22	distributed	_	VBN	VBN	_	12	ccomp	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	different	_	JJ	JJ	_	26	amod	_	_
25	nuclear	_	JJ	JJ	_	26	amod	_	_
26	subvolumes	_	NNS	NNS	_	23	pobj	_	_
27	:	_	:	:	_	12	punct	_	_
28	the	_	DT	DT	_	30	det	_	_
29	kappa	_	NN	NN	_	30	nn	_	_
30	genes	_	NNS	NNS	_	32	nsubjpass	_	_
31	were	_	VBD	VBD	_	32	auxpass	_	_
32	found	_	VBN	VBN	_	12	parataxis	_	_
33	to	_	TO	TO	_	36	aux	_	_
34	be	_	VB	VB	_	36	auxpass	_	_
35	preferentially	_	RB	RB	_	36	advmod	_	_
36	confined	_	VBN	VBN	_	32	xcomp	_	_
37	to	_	TO	TO	_	36	prep	_	_
38	an	_	DT	DT	_	41	det	_	_
39	outer	_	JJ	JJ	_	41	amod	_	_
40	nuclear	_	JJ	JJ	_	41	amod	_	_
41	volume	_	NN	NN	_	37	pobj	_	_
42	,	_	,	,	_	32	punct	_	_
43	whereas	_	IN	IN	_	50	mark	_	_
44	the	_	DT	DT	_	45	dep	_	_
45	gamma	_	NN	NN	_	50	nsubj	_	_
46	and	_	CC	CC	_	45	cc	_	_
47	lambda	_	NN	NN	_	45	conj	_	_
48	genes	_	NNS	NNS	_	45	dep	_	_
49	consistently	_	RB	RB	_	50	advmod	_	_
50	occupied	_	VBD	VBD	_	32	advcl	_	_
51	more	_	RBR	RBR	_	52	advmod	_	_
52	central	_	JJ	JJ	_	53	amod	_	_
53	positions	_	NNS	NNS	_	50	dobj	_	_
54	within	_	IN	IN	_	53	prep	_	_
55	the	_	DT	DT	_	56	det	_	_
56	nucleus	_	NN	NN	_	54	pobj	_	_
57	,	_	,	,	_	50	punct	_	_
58	the	_	DT	DT	_	60	det	_	_
59	lambda	_	NN	NN	_	60	nn	_	_
60	genes	_	NNS	NNS	_	63	nsubj	_	_
61	being	_	VBG	VBG	_	63	cop	_	_
62	more	_	RBR	RBR	_	63	advmod	_	_
63	interior	_	JJ	JJ	_	50	vmod	_	_
64	when	_	WRB	WRB	_	65	advmod	_	_
65	compared	_	VBN	VBN	_	63	advcl	_	_
66	with	_	IN	IN	_	65	prep	_	_
67	the	_	DT	DT	_	69	det	_	_
68	gamma	_	NN	NN	_	69	nn	_	_
69	genes	_	NNS	NNS	_	66	pobj	_	_
70	.	_	.	.	_	12	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	4	nsubj	_	_
3	further	_	RB	RB	_	4	advmod	_	_
4	show	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	11	mark	_	_
6	these	_	DT	DT	_	9	det	_	_
7	overall	_	JJ	JJ	_	9	amod	_	_
8	topographical	_	JJ	JJ	_	7	dep	_	_
9	distributions	_	NNS	NNS	_	11	nsubj	_	_
10	are	_	VBP	VBP	_	11	cop	_	_
11	independent	_	JJ	JJ	_	4	ccomp	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	gene	_	NN	NN	_	15	nn	_	_
14	transcriptional	_	JJ	JJ	_	15	amod	_	_
15	activity	_	NN	NN	_	12	pobj	_	_
16	and	_	CC	CC	_	11	cc	_	_
17	are	_	VBP	VBP	_	18	auxpass	_	_
18	conserved	_	VBN	VBN	_	11	conj	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	different	_	JJ	JJ	_	22	amod	_	_
21	cell	_	NN	NN	_	22	nn	_	_
22	types	_	NNS	NNS	_	19	pobj	_	_
23	.	_	.	.	_	4	punct	_	_

1	Although	_	IN	IN	_	13	mark	_	_
2	subtle	_	JJ	JJ	_	4	amod	_	_
3	gene	_	NN	NN	_	4	nn	_	_
4	movements	_	NNS	NNS	_	13	nsubjpass	_	_
5	within	_	IN	IN	_	4	prep	_	_
6	those	_	DT	DT	_	9	det	_	_
7	defined	_	VBN	VBN	_	9	amod	_	_
8	topographical	_	JJ	JJ	_	7	dep	_	_
9	regions	_	NNS	NNS	_	5	pobj	_	_
10	can	_	MD	MD	_	13	aux	_	_
11	not	_	RB	RB	_	13	neg	_	_
12	be	_	VB	VB	_	13	auxpass	_	_
13	excluded	_	VBN	VBN	_	20	advcl	_	_
14	by	_	IN	IN	_	13	prep	_	_
15	this	_	DT	DT	_	16	det	_	_
16	study	_	NN	NN	_	14	pobj	_	_
17	,	_	,	,	_	20	punct	_	_
18	the	_	DT	DT	_	19	det	_	_
19	results	_	NNS	NNS	_	20	nsubj	_	_
20	indicate	_	VBP	VBP	_	0	root	_	_
21	that	_	IN	IN	_	29	mark	_	_
22	tissue	_	NN	NN	_	23	nn	_	_
23	specificity	_	NN	NN	_	29	nsubjpass	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	gene	_	NN	NN	_	26	nn	_	_
26	expression	_	NN	NN	_	24	pobj	_	_
27	is	_	VBZ	VBZ	_	29	auxpass	_	_
28	not	_	RB	RB	_	29	neg	_	_
29	accompanied	_	VBN	VBN	_	20	ccomp	_	_
30	by	_	IN	IN	_	29	prep	_	_
31	drastic	_	JJ	JJ	_	32	amod	_	_
32	changes	_	NNS	NNS	_	30	pobj	_	_
33	in	_	IN	IN	_	32	prep	_	_
34	gene	_	NN	NN	_	36	nn	_	_
35	nuclear	_	JJ	JJ	_	36	amod	_	_
36	topography	_	NN	NN	_	33	pobj	_	_
37	,	_	,	,	_	20	punct	_	_
38	rather	_	RB	RB	_	39	advmod	_	_
39	suggesting	_	VBG	VBG	_	20	xcomp	_	_
40	that	_	IN	IN	_	49	mark	_	_
41	gene	_	NN	NN	_	42	nn	_	_
42	organization	_	NN	NN	_	49	nsubj	_	_
43	within	_	IN	IN	_	42	prep	_	_
44	the	_	DT	DT	_	45	det	_	_
45	nucleus	_	NN	NN	_	43	pobj	_	_
46	may	_	MD	MD	_	49	aux	_	_
47	be	_	VB	VB	_	49	cop	_	_
48	primarily	_	RB	RB	_	49	advmod	_	_
49	dependent	_	JJ	JJ	_	39	ccomp	_	_
50	on	_	IN	IN	_	49	prep	_	_
51	structural	_	JJ	JJ	_	52	amod	_	_
52	constraints	_	NNS	NNS	_	50	pobj	_	_
53	imposed	_	VBN	VBN	_	52	vmod	_	_
54	on	_	IN	IN	_	53	prep	_	_
55	the	_	DT	DT	_	57	det	_	_
56	respective	_	JJ	JJ	_	57	amod	_	_
57	chromosomes	_	NNS	NNS	_	54	pobj	_	_
58	.	_	.	.	_	20	punct	_	_

1	Epstein-Barr	_	JJ	JJ	_	2	amod	_	_
2	virus	_	NN	NN	_	4	nsubj	_	_
3	EBNA3C	_	NN	NN	_	2	dep	_	_
4	represses	_	VBZ	VBZ	_	0	root	_	_
5	Cp	_	NN	NN	_	4	dobj	_	_
6	,	_	,	,	_	5	punct	_	_
7	the	_	DT	DT	_	9	det	_	_
8	major	_	JJ	JJ	_	9	amod	_	_
9	promoter	_	NN	NN	_	5	appos	_	_
10	for	_	IN	IN	_	9	prep	_	_
11	EBNA	_	NN	NN	_	12	nn	_	_
12	expression	_	NN	NN	_	10	pobj	_	_
13	,	_	,	,	_	4	punct	_	_
14	but	_	CC	CC	_	4	cc	_	_
15	has	_	VBZ	VBZ	_	4	conj	_	_
16	no	_	DT	DT	_	17	neg	_	_
17	effect	_	NN	NN	_	15	dobj	_	_
18	on	_	IN	IN	_	15	prep	_	_
19	the	_	DT	DT	_	20	det	_	_
20	promoter	_	NN	NN	_	18	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	25	det	_	_
23	cell	_	NN	NN	_	25	nn	_	_
24	gene	_	NN	NN	_	25	nn	_	_
25	CD21	_	NN	NN	_	21	pobj	_	_
26	.	_	.	.	_	4	punct	_	_

1	EBNA3C	_	NN	NN	_	5	nsubj	_	_
2	is	_	VBZ	VBZ	_	5	cop	_	_
3	a	_	DT	DT	_	5	det	_	_
4	potent	_	JJ	JJ	_	5	amod	_	_
5	repressor	_	NN	NN	_	0	root	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	transcription	_	NN	NN	_	6	pobj	_	_
8	when	_	WRB	WRB	_	9	advmod	_	_
9	bound	_	VBN	VBN	_	5	advcl	_	_
10	to	_	TO	TO	_	9	prep	_	_
11	DNA	_	NN	NN	_	10	pobj	_	_
12	as	_	IN	IN	_	9	prep	_	_
13	a	_	DT	DT	_	14	det	_	_
14	fusion	_	NN	NN	_	12	pobj	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	19	det	_	_
17	DNA	_	NN	NN	_	19	nn	_	_
18	binding	_	NN	NN	_	19	nn	_	_
19	domain	_	NN	NN	_	15	pobj	_	_
20	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
21	DBD	_	NN	NN	_	19	appos	_	_
22	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
23	of	_	IN	IN	_	19	prep	_	_
24	GALA	_	NN	NN	_	23	pobj	_	_
25	.	_	.	.	_	5	punct	_	_

1	A	_	DT	DT	_	2	det	_	_
2	survey	_	NN	NN	_	6	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	promoters	_	NNS	NNS	_	3	pobj	_	_
5	has	_	VBZ	VBZ	_	6	aux	_	_
6	revealed	_	VBN	VBN	_	0	root	_	_
7	that	_	IN	IN	_	15	mark	_	_
8	the	_	DT	DT	_	12	det	_	_
9	wild-type	_	JJ	JJ	_	12	amod	_	_
10	,	_	,	,	_	12	punct	_	_
11	unfused	_	JJ	JJ	_	12	amod	_	_
12	EBNA3C	_	NN	NN	_	15	nsubj	_	_
13	can	_	MD	MD	_	15	aux	_	_
14	specifically	_	RB	RB	_	15	advmod	_	_
15	repress	_	VB	VB	_	6	ccomp	_	_
16	expression	_	NN	NN	_	15	dobj	_	_
17	from	_	IN	IN	_	16	prep	_	_
18	reporter	_	NN	NN	_	19	nn	_	_
19	plasmids	_	NNS	NNS	_	17	pobj	_	_
20	containing	_	VBG	VBG	_	19	vmod	_	_
21	the	_	DT	DT	_	23	det	_	_
22	Epstein-Barr	_	JJ	JJ	_	23	amod	_	_
23	virus	_	NN	NN	_	20	dobj	_	_
24	Cp	_	NN	NN	_	26	nn	_	_
25	latency-associated	_	JJ	JJ	_	26	amod	_	_
26	promoter	_	NN	NN	_	23	dep	_	_
27	.	_	.	.	_	6	punct	_	_

1	Repression	_	NN	NN	_	5	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	Cp	_	NN	NN	_	4	nn	_	_
4	activity	_	NN	NN	_	2	pobj	_	_
5	required	_	VBD	VBD	_	0	root	_	_
6	amino	_	NN	NN	_	7	nn	_	_
7	acids	_	NNS	NNS	_	5	dobj	_	_
8	207	_	CD	CD	_	7	num	_	_
9	to	_	TO	TO	_	7	dep	_	_
10	368	_	CD	CD	_	7	num	_	_
11	,	_	,	,	_	7	punct	_	_
12	which	_	WDT	WDT	_	13	nsubj	_	_
13	encompasses	_	VBZ	VBZ	_	7	rcmod	_	_
14	a	_	DT	DT	_	15	det	_	_
15	region	_	NN	NN	_	13	dobj	_	_
16	resembling	_	VBG	VBG	_	15	vmod	_	_
17	a	_	DT	DT	_	19	det	_	_
18	basic	_	JJ	JJ	_	19	amod	_	_
19	DBD	_	NN	NN	_	16	xcomp	_	_
20	adjacent	_	JJ	JJ	_	19	amod	_	_
21	to	_	TO	TO	_	20	prep	_	_
22	a	_	DT	DT	_	27	det	_	_
23	leucine	_	NN	NN	_	27	nn	_	_
24	zipper	_	NN	NN	_	27	nn	_	_
25	DNA	_	NN	NN	_	27	nn	_	_
26	binding	_	NN	NN	_	27	nn	_	_
27	motif	_	NN	NN	_	21	pobj	_	_
28	and	_	CC	CC	_	15	cc	_	_
29	a	_	DT	DT	_	30	det	_	_
30	site	_	NN	NN	_	15	conj	_	_
31	which	_	WDT	WDT	_	32	nsubj	_	_
32	binds	_	VBZ	VBZ	_	30	rcmod	_	_
33	to	_	TO	TO	_	32	prep	_	_
34	the	_	DT	DT	_	37	det	_	_
35	cellular	_	JJ	JJ	_	37	amod	_	_
36	factor	_	NN	NN	_	37	nn	_	_
37	CBF1/RBP-Jkappa	_	NN	NN	_	33	pobj	_	_
38	.	_	.	.	_	5	punct	_	_

1	However	_	RB	RB	_	9	advmod	_	_
2	,	_	,	,	_	9	punct	_	_
3	amino	_	NN	NN	_	4	nn	_	_
4	acids	_	NNS	NNS	_	9	nsubj	_	_
5	207	_	CD	CD	_	4	num	_	_
6	to	_	TO	TO	_	4	dep	_	_
7	368	_	CD	CD	_	4	num	_	_
8	are	_	VBP	VBP	_	9	cop	_	_
9	dispensable	_	JJ	JJ	_	0	root	_	_
10	when	_	WRB	WRB	_	14	advmod	_	_
11	the	_	DT	DT	_	12	det	_	_
12	protein	_	NN	NN	_	14	nsubjpass	_	_
13	is	_	VBZ	VBZ	_	14	auxpass	_	_
14	bound	_	VBN	VBN	_	9	advcl	_	_
15	to	_	TO	TO	_	14	prep	_	_
16	DNA	_	NN	NN	_	15	pobj	_	_
17	as	_	IN	IN	_	14	prep	_	_
18	a	_	DT	DT	_	19	det	_	_
19	fusion	_	NN	NN	_	17	pobj	_	_
20	with	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	22	det	_	_
22	GAL4	_	NN	NN	_	20	pobj	_	_
23	DBD	_	NN	NN	_	22	dep	_	_
24	,	_	,	,	_	9	punct	_	_
25	thus	_	RB	RB	_	26	advmod	_	_
26	implicating	_	VBG	VBG	_	9	xcomp	_	_
27	this	_	DT	DT	_	28	det	_	_
28	region	_	NN	NN	_	26	dobj	_	_
29	in	_	IN	IN	_	26	prep	_	_
30	DNA	_	NN	NN	_	31	nn	_	_
31	binding	_	NN	NN	_	29	pobj	_	_
32	.	_	.	.	_	9	punct	_	_

1	Mutation	_	NN	NN	_	9	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	6	det	_	_
4	CBF1/RBP-Jkappa	_	NN	NN	_	6	nn	_	_
5	binding	_	NN	NN	_	6	nn	_	_
6	site	_	NN	NN	_	2	pobj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	EBNA3C	_	NN	NN	_	7	pobj	_	_
9	abrogated	_	VBD	VBD	_	0	root	_	_
10	repression	_	NN	NN	_	9	dobj	_	_
11	,	_	,	,	_	9	punct	_	_
12	strongly	_	RB	RB	_	13	advmod	_	_
13	suggesting	_	VBG	VBG	_	9	vmod	_	_
14	that	_	IN	IN	_	17	mark	_	_
15	CBF1/RBP-Jkappa	_	NN	NN	_	17	nsubj	_	_
16	is	_	VBZ	VBZ	_	17	cop	_	_
17	necessary	_	JJ	JJ	_	13	ccomp	_	_
18	for	_	IN	IN	_	17	prep	_	_
19	targeting	_	VBG	VBG	_	18	pcomp	_	_
20	the	_	DT	DT	_	22	det	_	_
21	viral	_	JJ	JJ	_	22	amod	_	_
22	protein	_	NN	NN	_	19	dobj	_	_
23	to	_	TO	TO	_	19	prep	_	_
24	Cp	_	NN	NN	_	23	pobj	_	_
25	.	_	.	.	_	9	punct	_	_

1	Consistent	_	JJ	JJ	_	21	advmod	_	_
2	with	_	IN	IN	_	1	prep	_	_
3	this	_	DT	DT	_	4	det	_	_
4	result	_	NN	NN	_	2	pobj	_	_
5	,	_	,	,	_	21	punct	_	_
6	mutation	_	NN	NN	_	21	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	11	det	_	_
9	EBNA2	_	NN	NN	_	11	nn	_	_
10	response	_	NN	NN	_	11	nn	_	_
11	element	_	NN	NN	_	7	pobj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
13	a	_	DT	DT	_	16	det	_	_
14	CBF1/RBP-Jkappa	_	NN	NN	_	16	nn	_	_
15	binding	_	NN	NN	_	16	nn	_	_
16	site	_	NN	NN	_	11	appos	_	_
17	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
18	in	_	IN	IN	_	11	prep	_	_
19	Cp	_	NN	NN	_	18	pobj	_	_
20	also	_	RB	RB	_	21	advmod	_	_
21	prevented	_	VBD	VBD	_	0	root	_	_
22	significant	_	JJ	JJ	_	23	amod	_	_
23	repression	_	NN	NN	_	21	dobj	_	_
24	.	_	.	.	_	21	punct	_	_

1	In	_	IN	IN	_	27	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	27	punct	_	_
4	amino	_	NN	NN	_	5	nn	_	_
5	acids	_	NNS	NNS	_	27	nsubj	_	_
6	346	_	CD	CD	_	5	num	_	_
7	to	_	TO	TO	_	5	dep	_	_
8	543	_	CD	CD	_	5	num	_	_
9	,	_	,	,	_	5	punct	_	_
10	which	_	WDT	WDT	_	13	nsubjpass	_	_
11	were	_	VBD	VBD	_	13	auxpass	_	_
12	previously	_	RB	RB	_	13	advmod	_	_
13	defined	_	VBN	VBN	_	5	rcmod	_	_
14	as	_	IN	IN	_	13	prep	_	_
15	important	_	JJ	JJ	_	14	pcomp	_	_
16	for	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	repressor	_	NN	NN	_	19	nn	_	_
19	activity	_	NN	NN	_	16	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	24	det	_	_
22	GAL4-EBNA3C	_	NN	NN	_	24	nn	_	_
23	fusion	_	NN	NN	_	24	nn	_	_
24	proteins	_	NNS	NNS	_	20	pobj	_	_
25	,	_	,	,	_	5	punct	_	_
26	also	_	RB	RB	_	27	advmod	_	_
27	appear	_	VBP	VBP	_	0	root	_	_
28	to	_	TO	TO	_	30	aux	_	_
29	be	_	VB	VB	_	30	cop	_	_
30	necessary	_	JJ	JJ	_	27	xcomp	_	_
31	for	_	IN	IN	_	30	prep	_	_
32	the	_	DT	DT	_	33	det	_	_
33	repression	_	NN	NN	_	31	pobj	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	Cp	_	NN	NN	_	34	pobj	_	_
36	.	_	.	.	_	27	punct	_	_

1	Since	_	IN	IN	_	8	mark	_	_
2	repression	_	NN	NN	_	8	nsubjpass	_	_
3	by	_	IN	IN	_	2	prep	_	_
4	these	_	DT	DT	_	5	det	_	_
5	fusions	_	NNS	NNS	_	3	pobj	_	_
6	was	_	VBD	VBD	_	8	auxpass	_	_
7	not	_	RB	RB	_	8	neg	_	_
8	observed	_	VBN	VBN	_	15	advcl	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	all	_	DT	DT	_	12	det	_	_
11	cell	_	NN	NN	_	12	nn	_	_
12	types	_	NNS	NNS	_	9	pobj	_	_
13	,	_	,	,	_	15	punct	_	_
14	it	_	PRP	PRP	_	15	nsubj	_	_
15	seems	_	VBZ	VBZ	_	0	root	_	_
16	likely	_	RB	RB	_	15	acomp	_	_
17	that	_	IN	IN	_	20	mark	_	_
18	EBNA3C	_	NN	NN	_	20	nsubj	_	_
19	either	_	CC	CC	_	20	preconj	_	_
20	depends	_	VBZ	VBZ	_	15	ccomp	_	_
21	on	_	IN	IN	_	20	prep	_	_
22	a	_	DT	DT	_	23	det	_	_
23	corepressor	_	NN	NN	_	21	pobj	_	_
24	which	_	WDT	WDT	_	26	nsubj	_	_
25	may	_	MD	MD	_	26	aux	_	_
26	interact	_	VB	VB	_	23	rcmod	_	_
27	with	_	IN	IN	_	26	prep	_	_
28	amino	_	NN	NN	_	29	nn	_	_
29	acids	_	NNS	NNS	_	27	pobj	_	_
30	346	_	CD	CD	_	29	num	_	_
31	to	_	TO	TO	_	29	dep	_	_
32	543	_	CD	CD	_	29	num	_	_
33	or	_	CC	CC	_	20	cc	_	_
34	is	_	VBZ	VBZ	_	35	auxpass	_	_
35	modified	_	VBN	VBN	_	20	conj	_	_
36	in	_	IN	IN	_	35	prep	_	_
37	a	_	DT	DT	_	39	det	_	_
38	cell-specific	_	JJ	JJ	_	39	amod	_	_
39	manner	_	NN	NN	_	36	pobj	_	_
40	in	_	IN	IN	_	43	mark	_	_
41	order	_	NN	NN	_	43	dep	_	_
42	to	_	TO	TO	_	43	aux	_	_
43	repress	_	VB	VB	_	35	advcl	_	_
44	.	_	.	.	_	15	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	4	nsubj	_	_
3	are	_	VBP	VBP	_	4	cop	_	_
4	consistent	_	JJ	JJ	_	0	root	_	_
5	with	_	IN	IN	_	4	prep	_	_
6	EBNA3C	_	NN	NN	_	5	pobj	_	_
7	contributing	_	VBG	VBG	_	6	vmod	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	regulation	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	EBNA	_	NN	NN	_	13	nn	_	_
13	expression	_	NN	NN	_	11	pobj	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	latently	_	RB	RB	_	18	advmod	_	_
16	infected	_	JJ	JJ	_	18	amod	_	_
17	B	_	NN	NN	_	18	nn	_	_
18	cells	_	NNS	NNS	_	14	pobj	_	_
19	through	_	IN	IN	_	10	prep	_	_
20	CBF1/RBP-Jkappa	_	NN	NN	_	19	pobj	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	another	_	DT	DT	_	23	det	_	_
23	factor	_	NN	NN	_	20	conj	_	_
24	,	_	,	,	_	4	punct	_	_
25	but	_	CC	CC	_	4	cc	_	_
26	this	_	DT	DT	_	27	nsubj	_	_
27	need	_	VBP	VBP	_	4	conj	_	_
28	not	_	RB	RB	_	30	neg	_	_
29	directly	_	RB	RB	_	30	advmod	_	_
30	involve	_	VB	VB	_	27	ccomp	_	_
31	EBNA2	_	NN	NN	_	30	dobj	_	_
32	.	_	.	.	_	4	punct	_	_

1	Finally	_	RB	RB	_	20	advmod	_	_
2	,	_	,	,	_	20	punct	_	_
3	although	_	IN	IN	_	7	mark	_	_
4	it	_	PRP	PRP	_	7	nsubjpass	_	_
5	has	_	VBZ	VBZ	_	7	aux	_	_
6	been	_	VBN	VBN	_	7	auxpass	_	_
7	reported	_	VBN	VBN	_	20	dep	_	_
8	that	_	IN	IN	_	11	mark	_	_
9	EBNA3C	_	NN	NN	_	11	nsubj	_	_
10	can	_	MD	MD	_	11	aux	_	_
11	upregulate	_	VB	VB	_	7	ccomp	_	_
12	CD21	_	NN	NN	_	11	dobj	_	_
13	in	_	IN	IN	_	11	prep	_	_
14	some	_	DT	DT	_	16	det	_	_
15	B	_	NN	NN	_	16	nn	_	_
16	cells	_	NNS	NNS	_	13	pobj	_	_
17	,	_	,	,	_	20	punct	_	_
18	we	_	PRP	PRP	_	20	nsubj	_	_
19	were	_	VBD	VBD	_	20	cop	_	_
20	unable	_	JJ	JJ	_	0	root	_	_
21	to	_	TO	TO	_	22	aux	_	_
22	demonstrate	_	VB	VB	_	20	xcomp	_	_
23	any	_	DT	DT	_	24	det	_	_
24	effect	_	NN	NN	_	22	dobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	EBNA3C	_	NN	NN	_	25	pobj	_	_
27	on	_	IN	IN	_	24	prep	_	_
28	reporter	_	NN	NN	_	29	nn	_	_
29	plasmids	_	NNS	NNS	_	27	pobj	_	_
30	which	_	WDT	WDT	_	31	nsubj	_	_
31	contain	_	VBP	VBP	_	29	rcmod	_	_
32	the	_	DT	DT	_	34	det	_	_
33	CD21	_	NN	NN	_	34	nn	_	_
34	promoter	_	NN	NN	_	31	dobj	_	_
35	.	_	.	.	_	20	punct	_	_

1	Late	_	JJ	JJ	_	3	amod	_	_
2	gene	_	NN	NN	_	3	nn	_	_
3	expression	_	NN	NN	_	14	nsubj	_	_
4	from	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	7	det	_	_
6	Epstein-Barr	_	JJ	JJ	_	7	amod	_	_
7	virus	_	NN	NN	_	4	pobj	_	_
8	BcLF1	_	NN	NN	_	7	dep	_	_
9	and	_	CC	CC	_	7	cc	_	_
10	BFRF3	_	NN	NN	_	7	conj	_	_
11	promoters	_	NNS	NNS	_	7	dep	_	_
12	does	_	VBZ	VBZ	_	14	aux	_	_
13	not	_	RB	RB	_	14	neg	_	_
14	require	_	VB	VB	_	0	root	_	_
15	DNA	_	NN	NN	_	16	nn	_	_
16	replication	_	NN	NN	_	14	dobj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	cis	_	NN	NN	_	17	pobj	_	_
19	.	_	.	.	_	14	punct	_	_

1	Late	_	JJ	JJ	_	3	amod	_	_
2	gene	_	NN	NN	_	3	nn	_	_
3	expression	_	NN	NN	_	4	nsubj	_	_
4	follows	_	VBZ	VBZ	_	0	root	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	is	_	VBZ	VBZ	_	7	cop	_	_
7	dependent	_	JJ	JJ	_	4	conj	_	_
8	upon	_	IN	IN	_	7	prep	_	_
9	lytic	_	JJ	JJ	_	10	amod	_	_
10	replication	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	viral	_	JJ	JJ	_	14	amod	_	_
14	genome	_	NN	NN	_	11	pobj	_	_
15	.	_	.	.	_	4	punct	_	_

1	Although	_	IN	IN	_	5	mark	_	_
2	experimental	_	JJ	JJ	_	3	amod	_	_
3	evidence	_	NN	NN	_	5	nsubj	_	_
4	is	_	VBZ	VBZ	_	5	cop	_	_
5	lacking	_	JJ	JJ	_	12	advcl	_	_
6	,	_	,	,	_	12	punct	_	_
7	lytic	_	JJ	JJ	_	10	amod	_	_
8	viral	_	JJ	JJ	_	10	amod	_	_
9	DNA	_	NN	NN	_	10	nn	_	_
10	replication	_	NN	NN	_	12	nsubjpass	_	_
11	is	_	VBZ	VBZ	_	12	auxpass	_	_
12	believed	_	VBN	VBN	_	0	root	_	_
13	to	_	TO	TO	_	14	aux	_	_
14	remove	_	VB	VB	_	12	xcomp	_	_
15	modifications	_	NNS	NNS	_	14	dobj	_	_
16	or	_	CC	CC	_	15	cc	_	_
17	binding	_	VBG	VBG	_	18	amod	_	_
18	factors	_	NNS	NNS	_	15	conj	_	_
19	from	_	IN	IN	_	15	prep	_	_
20	the	_	DT	DT	_	21	det	_	_
21	genome	_	NN	NN	_	19	pobj	_	_
22	which	_	WDT	WDT	_	23	nsubj	_	_
23	serve	_	VBP	VBP	_	12	dep	_	_
24	to	_	TO	TO	_	25	aux	_	_
25	repress	_	VB	VB	_	23	xcomp	_	_
26	late	_	JJ	JJ	_	28	amod	_	_
27	gene	_	NN	NN	_	28	nn	_	_
28	expression	_	NN	NN	_	25	dobj	_	_
29	during	_	IN	IN	_	25	prep	_	_
30	latency	_	NN	NN	_	29	pobj	_	_
31	or	_	CC	CC	_	30	cc	_	_
32	the	_	DT	DT	_	35	det	_	_
33	early	_	JJ	JJ	_	35	amod	_	_
34	lytic	_	JJ	JJ	_	35	amod	_	_
35	cycle	_	NN	NN	_	30	conj	_	_
36	.	_	.	.	_	12	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	developed	_	VBN	VBN	_	0	root	_	_
4	a	_	DT	DT	_	6	det	_	_
5	reporter	_	NN	NN	_	6	nn	_	_
6	assay	_	NN	NN	_	3	dobj	_	_
7	to	_	TO	TO	_	8	aux	_	_
8	begin	_	VB	VB	_	3	xcomp	_	_
9	characterizing	_	VBG	VBG	_	8	xcomp	_	_
10	the	_	DT	DT	_	11	det	_	_
11	mechanisms	_	NNS	NNS	_	9	dobj	_	_
12	that	_	WDT	WDT	_	13	nsubj	_	_
13	regulate	_	VBP	VBP	_	11	rcmod	_	_
14	late	_	JJ	JJ	_	16	amod	_	_
15	gene	_	NN	NN	_	16	nn	_	_
16	expression	_	NN	NN	_	13	dobj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	Epstein-Barr	_	JJ	JJ	_	19	amod	_	_
19	virus	_	NN	NN	_	17	pobj	_	_
20	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
21	EBV	_	NN	NN	_	19	appos	_	_
22	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
23	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	13	prep	_	_
2	this	_	DT	DT	_	4	det	_	_
3	model	_	NN	NN	_	4	nn	_	_
4	system	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	13	punct	_	_
6	the	_	DT	DT	_	7	det	_	_
7	activities	_	NNS	NNS	_	13	nsubjpass	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	late	_	JJ	JJ	_	11	amod	_	_
10	promoter-reporter	_	JJ	JJ	_	11	amod	_	_
11	fusions	_	NNS	NNS	_	8	pobj	_	_
12	are	_	VBP	VBP	_	13	auxpass	_	_
13	measured	_	VBN	VBN	_	0	root	_	_
14	following	_	VBG	VBG	_	13	prep	_	_
15	transient	_	JJ	JJ	_	16	amod	_	_
16	transfection	_	NN	NN	_	14	pobj	_	_
17	into	_	IN	IN	_	16	prep	_	_
18	tissue	_	NN	NN	_	20	nn	_	_
19	culture	_	NN	NN	_	20	nn	_	_
20	cells	_	NNS	NNS	_	17	pobj	_	_
21	expressing	_	VBG	VBG	_	20	vmod	_	_
22	EBV	_	NN	NN	_	21	dobj	_	_
23	during	_	IN	IN	_	21	prep	_	_
24	different	_	JJ	JJ	_	25	amod	_	_
25	stages	_	NNS	NNS	_	23	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	29	det	_	_
28	lytic	_	JJ	JJ	_	29	amod	_	_
29	cycle	_	NN	NN	_	26	pobj	_	_
30	.	_	.	.	_	13	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	system	_	NN	NN	_	4	nsubj	_	_
3	faithfully	_	RB	RB	_	4	advmod	_	_
4	recapitulates	_	VBZ	VBZ	_	0	root	_	_
5	late	_	JJ	JJ	_	7	amod	_	_
6	expression	_	NN	NN	_	7	nn	_	_
7	patterns	_	NNS	NNS	_	4	dobj	_	_
8	from	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	endogenous	_	JJ	JJ	_	11	amod	_	_
11	virus	_	NN	NN	_	8	pobj	_	_
12	,	_	,	,	_	4	punct	_	_
13	implicating	_	VBG	VBG	_	4	vmod	_	_
14	specific	_	JJ	JJ	_	16	amod	_	_
15	cis-active	_	JJ	JJ	_	16	amod	_	_
16	sequences	_	NNS	NNS	_	13	dobj	_	_
17	in	_	IN	IN	_	13	prep	_	_
18	the	_	DT	DT	_	19	det	_	_
19	control	_	NN	NN	_	17	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	late	_	JJ	JJ	_	23	amod	_	_
22	gene	_	NN	NN	_	23	nn	_	_
23	expression	_	NN	NN	_	20	pobj	_	_
24	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	6	punct	_	_
4	these	_	DT	DT	_	5	det	_	_
5	promoters	_	NNS	NNS	_	6	nsubj	_	_
6	respond	_	VBP	VBP	_	0	root	_	_
7	only	_	RB	RB	_	8	advmod	_	_
8	indirectly	_	RB	RB	_	6	advmod	_	_
9	to	_	TO	TO	_	6	prep	_	_
10	the	_	DT	DT	_	13	det	_	_
11	viral	_	JJ	JJ	_	13	amod	_	_
12	immediate-early	_	JJ	JJ	_	13	amod	_	_
13	transactivator	_	NN	NN	_	9	pobj	_	_
14	,	_	,	,	_	13	punct	_	_
15	ZEBRA	_	NN	NN	_	13	appos	_	_
16	.	_	.	.	_	6	punct	_	_

1	This	_	DT	DT	_	3	det	_	_
2	indirect	_	JJ	JJ	_	3	amod	_	_
3	response	_	NN	NN	_	5	nsubjpass	_	_
4	is	_	VBZ	VBZ	_	5	auxpass	_	_
5	mediated	_	VBN	VBN	_	0	root	_	_
6	by	_	IN	IN	_	5	prep	_	_
7	other	_	JJ	JJ	_	8	amod	_	_
8	viral	_	JJ	JJ	_	6	pobj	_	_
9	or	_	CC	CC	_	8	cc	_	_
10	virally	_	RB	RB	_	11	advmod	_	_
11	induced	_	VBN	VBN	_	8	conj	_	_
12	activities	_	NNS	NNS	_	8	dep	_	_
13	downstream	_	JJ	JJ	_	12	advmod	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	ZEBRA	_	NN	NN	_	14	pobj	_	_
16	in	_	IN	IN	_	8	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	lytic	_	JJ	JJ	_	19	amod	_	_
19	cascade	_	NN	NN	_	16	pobj	_	_
20	.	_	.	.	_	5	punct	_	_

1	In	_	IN	IN	_	9	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	system	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	9	punct	_	_
5	late	_	JJ	JJ	_	7	amod	_	_
6	gene	_	NN	NN	_	7	nn	_	_
7	expression	_	NN	NN	_	9	nsubj	_	_
8	is	_	VBZ	VBZ	_	9	cop	_	_
9	sensitive	_	JJ	JJ	_	0	root	_	_
10	to	_	TO	TO	_	9	prep	_	_
11	inhibitors	_	NNS	NNS	_	10	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	16	det	_	_
14	viral	_	JJ	JJ	_	16	amod	_	_
15	DNA	_	NN	NN	_	16	nn	_	_
16	polymerase	_	NN	NN	_	12	pobj	_	_
17	such	_	JJ	JJ	_	18	mwe	_	_
18	as	_	IN	IN	_	11	prep	_	_
19	phosphonoacetic	_	JJ	JJ	_	20	amod	_	_
20	acid	_	NN	NN	_	18	pobj	_	_
21	,	_	,	,	_	9	punct	_	_
22	although	_	IN	IN	_	25	mark	_	_
23	the	_	DT	DT	_	24	det	_	_
24	reporters	_	NNS	NNS	_	25	nsubj	_	_
25	lack	_	VBP	VBP	_	9	advcl	_	_
26	a	_	DT	DT	_	28	det	_	_
27	eukaryotic	_	JJ	JJ	_	28	amod	_	_
28	origin	_	NN	NN	_	25	dobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	replication	_	NN	NN	_	29	pobj	_	_
31	and	_	CC	CC	_	25	cc	_	_
32	are	_	VBP	VBP	_	34	auxpass	_	_
33	not	_	RB	RB	_	34	neg	_	_
34	replicated	_	VBN	VBN	_	25	conj	_	_
35	under	_	IN	IN	_	34	prep	_	_
36	the	_	DT	DT	_	38	det	_	_
37	assay	_	NN	NN	_	38	nn	_	_
38	conditions	_	NNS	NNS	_	35	pobj	_	_
39	.	_	.	.	_	9	punct	_	_

1	Thus	_	RB	RB	_	11	advmod	_	_
2	,	_	,	,	_	11	punct	_	_
3	replication	_	NN	NN	_	11	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	7	det	_	_
6	transcriptional	_	JJ	JJ	_	7	amod	_	_
7	template	_	NN	NN	_	4	pobj	_	_
8	is	_	VBZ	VBZ	_	11	cop	_	_
9	not	_	RB	RB	_	11	neg	_	_
10	a	_	DT	DT	_	11	det	_	_
11	prerequisite	_	NN	NN	_	0	root	_	_
12	for	_	IN	IN	_	11	prep	_	_
13	expression	_	NN	NN	_	12	pobj	_	_
14	with	_	IN	IN	_	13	prep	_	_
15	late	_	JJ	JJ	_	16	amod	_	_
16	kinetics	_	NNS	NNS	_	14	pobj	_	_
17	,	_	,	,	_	11	punct	_	_
18	a	_	DT	DT	_	19	det	_	_
19	finding	_	NN	NN	_	11	dep	_	_
20	inconsistent	_	JJ	JJ	_	19	amod	_	_
21	with	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	24	det	_	_
23	current	_	JJ	JJ	_	24	amod	_	_
24	models	_	NNS	NNS	_	21	pobj	_	_
25	which	_	WDT	WDT	_	26	nsubj	_	_
26	posit	_	VBP	VBP	_	24	rcmod	_	_
27	a	_	DT	DT	_	29	det	_	_
28	cis-active	_	JJ	JJ	_	29	amod	_	_
29	relationship	_	NN	NN	_	26	dobj	_	_
30	between	_	IN	IN	_	29	prep	_	_
31	lytic	_	JJ	JJ	_	34	amod	_	_
32	EBV	_	NN	NN	_	34	nn	_	_
33	DNA	_	NN	NN	_	34	nn	_	_
34	replication	_	NN	NN	_	30	pobj	_	_
35	and	_	CC	CC	_	34	cc	_	_
36	late	_	JJ	JJ	_	38	amod	_	_
37	gene	_	NN	NN	_	38	nn	_	_
38	expression	_	NN	NN	_	34	conj	_	_
39	.	_	.	.	_	11	punct	_	_

1	Rather	_	RB	RB	_	8	advmod	_	_
2	,	_	,	,	_	8	punct	_	_
3	analysis	_	NN	NN	_	8	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	this	_	DT	DT	_	6	det	_	_
6	system	_	NN	NN	_	4	pobj	_	_
7	has	_	VBZ	VBZ	_	8	aux	_	_
8	revealed	_	VBN	VBN	_	0	root	_	_
9	a	_	DT	DT	_	11	det	_	_
10	trans	_	JJ	JJ	_	11	amod	_	_
11	relationship	_	NN	NN	_	8	dobj	_	_
12	between	_	IN	IN	_	11	prep	_	_
13	late	_	JJ	JJ	_	15	amod	_	_
14	gene	_	NN	NN	_	15	nn	_	_
15	expression	_	NN	NN	_	12	pobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	viral	_	JJ	JJ	_	19	amod	_	_
18	DNA	_	NN	NN	_	19	nn	_	_
19	replication	_	NN	NN	_	15	conj	_	_
20	and	_	CC	CC	_	8	cc	_	_
21	highlights	_	VBZ	VBZ	_	8	conj	_	_
22	the	_	DT	DT	_	26	det	_	_
23	indirect	_	JJ	JJ	_	26	amod	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	complex	_	JJ	JJ	_	23	conj	_	_
26	link	_	NN	NN	_	21	dobj	_	_
27	between	_	IN	IN	_	26	prep	_	_
28	these	_	DT	DT	_	30	det	_	_
29	two	_	CD	CD	_	30	num	_	_
30	events	_	NNS	NNS	_	27	pobj	_	_
31	.	_	.	.	_	8	punct	_	_

1	Purification	_	NN	NN	_	0	root	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	characterization	_	NN	NN	_	1	conj	_	_
4	of	_	IN	IN	_	1	prep	_	_
5	the	_	DT	DT	_	9	det	_	_
6	human	_	JJ	JJ	_	9	amod	_	_
7	SR	_	NN	NN	_	9	nn	_	_
8	31747A-binding	_	JJ	JJ	_	9	amod	_	_
9	protein	_	NN	NN	_	4	pobj	_	_
10	.	_	.	.	_	1	punct	_	_

1	A	_	DT	DT	_	4	det	_	_
2	nuclear	_	JJ	JJ	_	4	amod	_	_
3	membrane	_	NN	NN	_	4	nn	_	_
4	protein	_	NN	NN	_	0	root	_	_
5	related	_	JJ	JJ	_	4	amod	_	_
6	to	_	TO	TO	_	5	prep	_	_
7	yeast	_	NN	NN	_	9	nn	_	_
8	sterol	_	NN	NN	_	9	nn	_	_
9	isomerase	_	NN	NN	_	6	pobj	_	_
10	.	_	.	.	_	4	punct	_	_

1	SR	_	NN	NN	_	2	nn	_	_
2	31747A	_	NN	NN	_	14	nsubj	_	_
3	,	_	,	,	_	2	punct	_	_
4	defined	_	VBN	VBN	_	2	vmod	_	_
5	as	_	IN	IN	_	4	prep	_	_
6	a	_	DT	DT	_	8	det	_	_
7	sigma	_	NN	NN	_	8	nn	_	_
8	ligand	_	NN	NN	_	5	pobj	_	_
9	,	_	,	,	_	2	punct	_	_
10	is	_	VBZ	VBZ	_	14	cop	_	_
11	a	_	DT	DT	_	14	det	_	_
12	novel	_	JJ	JJ	_	14	amod	_	_
13	immunosuppressive	_	JJ	JJ	_	12	dep	_	_
14	agent	_	NN	NN	_	0	root	_	_
15	that	_	WDT	WDT	_	16	nsubj	_	_
16	blocks	_	VBZ	VBZ	_	14	rcmod	_	_
17	proliferation	_	NN	NN	_	16	dobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	human	_	JJ	JJ	_	18	pobj	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	mouse	_	NN	NN	_	19	conj	_	_
22	lymphocytes	_	NNS	NNS	_	19	dep	_	_
23	.	_	.	.	_	14	punct	_	_

1	Using	_	VBG	VBG	_	0	root	_	_
2	a	_	DT	DT	_	5	det	_	_
3	radiolabeled	_	JJ	JJ	_	5	amod	_	_
4	chemical	_	JJ	JJ	_	3	dep	_	_
5	probe	_	NN	NN	_	1	dobj	_	_
6	,	_	,	,	_	1	punct	_	_
7	we	_	PRP	PRP	_	9	nsubj	_	_
8	here	_	RB	RB	_	9	advmod	_	_
9	purified	_	VBD	VBD	_	1	parataxis	_	_
10	a	_	DT	DT	_	11	det	_	_
11	target	_	NN	NN	_	9	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	SR	_	NN	NN	_	14	nn	_	_
14	31747A	_	NN	NN	_	12	pobj	_	_
15	and	_	CC	CC	_	9	cc	_	_
16	called	_	VBD	VBD	_	9	conj	_	_
17	it	_	PRP	PRP	_	20	nsubj	_	_
18	SR	_	NN	NN	_	20	nn	_	_
19	31747A-binding	_	JJ	JJ	_	20	amod	_	_
20	protein	_	NN	NN	_	16	xcomp	_	_
21	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
22	SR-BP	_	NN	NN	_	20	appos	_	_
23	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
24	.	_	.	.	_	1	punct	_	_

1	Purified	_	VBN	VBN	_	2	amod	_	_
2	SR-BP	_	NN	NN	_	3	nsubj	_	_
3	retained	_	VBD	VBD	_	0	root	_	_
4	its	_	PRP$	PRP$	_	6	poss	_	_
5	binding	_	NN	NN	_	6	nn	_	_
6	properties	_	NNS	NNS	_	3	dobj	_	_
7	and	_	CC	CC	_	3	cc	_	_
8	migrated	_	VBD	VBD	_	3	conj	_	_
9	on	_	IN	IN	_	8	prep	_	_
10	SDS-polyacrylamide	_	JJ	JJ	_	11	amod	_	_
11	gel	_	NN	NN	_	9	pobj	_	_
12	as	_	IN	IN	_	8	prep	_	_
13	a	_	DT	DT	_	16	det	_	_
14	Mr	_	NN	NN	_	16	nn	_	_
15	28,000	_	CD	CD	_	16	num	_	_
16	protein	_	NN	NN	_	12	pobj	_	_
17	.	_	.	.	_	3	punct	_	_

1	Cloning	_	NN	NN	_	8	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	4	det	_	_
4	cDNA	_	NN	NN	_	2	pobj	_	_
5	encoding	_	VBG	VBG	_	4	vmod	_	_
6	human	_	JJ	JJ	_	7	amod	_	_
7	SR-BP	_	NN	NN	_	5	dobj	_	_
8	shows	_	VBZ	VBZ	_	0	root	_	_
9	an	_	DT	DT	_	12	det	_	_
10	open	_	JJ	JJ	_	12	amod	_	_
11	reading	_	NN	NN	_	12	nn	_	_
12	frame	_	NN	NN	_	8	dobj	_	_
13	for	_	IN	IN	_	8	prep	_	_
14	a	_	DT	DT	_	17	det	_	_
15	223-amino	_	NN	NN	_	17	nn	_	_
16	acid	_	NN	NN	_	17	nn	_	_
17	protein	_	NN	NN	_	13	pobj	_	_
18	,	_	,	,	_	17	punct	_	_
19	which	_	WDT	WDT	_	21	nsubj	_	_
20	is	_	VBZ	VBZ	_	21	cop	_	_
21	homologous	_	JJ	JJ	_	17	rcmod	_	_
22	to	_	TO	TO	_	21	prep	_	_
23	the	_	DT	DT	_	28	det	_	_
24	recently	_	RB	RB	_	25	advmod	_	_
25	cloned	_	VBN	VBN	_	28	amod	_	_
26	sigma	_	NN	NN	_	28	nn	_	_
27	1	_	CD	CD	_	28	num	_	_
28	receptor	_	NN	NN	_	22	pobj	_	_
29	.	_	.	.	_	8	punct	_	_

1	Interestingly	_	RB	RB	_	9	advmod	_	_
2	,	_	,	,	_	9	punct	_	_
3	the	_	DT	DT	_	7	det	_	_
4	deduced	_	VBN	VBN	_	7	amod	_	_
5	amino	_	NN	NN	_	7	nn	_	_
6	acid	_	NN	NN	_	7	nn	_	_
7	sequence	_	NN	NN	_	9	nsubjpass	_	_
8	was	_	VBD	VBD	_	9	auxpass	_	_
9	found	_	VBN	VBN	_	0	root	_	_
10	to	_	TO	TO	_	12	aux	_	_
11	be	_	VB	VB	_	12	cop	_	_
12	related	_	JJ	JJ	_	9	xcomp	_	_
13	to	_	TO	TO	_	12	prep	_	_
14	fungal	_	JJ	JJ	_	17	amod	_	_
15	C8-C7	_	NN	NN	_	17	nn	_	_
16	sterol	_	NN	NN	_	17	nn	_	_
17	isomerase	_	NN	NN	_	13	pobj	_	_
18	,	_	,	,	_	17	punct	_	_
19	encoded	_	VBN	VBN	_	17	vmod	_	_
20	by	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	23	det	_	_
22	ERG2	_	NN	NN	_	23	nn	_	_
23	gene	_	NN	NN	_	20	pobj	_	_
24	.	_	.	.	_	9	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	ERG2	_	NN	NN	_	4	nn	_	_
3	gene	_	NN	NN	_	4	nn	_	_
4	product	_	NN	NN	_	7	nsubjpass	_	_
5	has	_	VBZ	VBZ	_	7	aux	_	_
6	been	_	VBN	VBN	_	7	auxpass	_	_
7	identified	_	VBN	VBN	_	0	root	_	_
8	recently	_	RB	RB	_	7	advmod	_	_
9	as	_	IN	IN	_	7	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	molecular	_	JJ	JJ	_	12	amod	_	_
12	target	_	NN	NN	_	9	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	SR	_	NN	NN	_	15	nn	_	_
15	31747A	_	NN	NN	_	13	pobj	_	_
16	that	_	WDT	WDT	_	17	nsubj	_	_
17	mediates	_	VBZ	VBZ	_	15	rcmod	_	_
18	antiproliferative	_	JJ	JJ	_	19	amod	_	_
19	effects	_	NNS	NNS	_	17	dobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	22	det	_	_
22	drug	_	NN	NN	_	20	pobj	_	_
23	in	_	IN	IN	_	17	prep	_	_
24	yeast	_	NN	NN	_	23	pobj	_	_
25	.	_	.	.	_	7	punct	_	_

1	Northern	_	NN	NN	_	3	nn	_	_
2	blot	_	NN	NN	_	3	nn	_	_
3	analysis	_	NN	NN	_	8	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	SR-BP	_	NN	NN	_	7	nn	_	_
6	gene	_	NN	NN	_	7	nn	_	_
7	expression	_	NN	NN	_	4	pobj	_	_
8	revealed	_	VBD	VBD	_	0	root	_	_
9	a	_	DT	DT	_	11	det	_	_
10	single	_	JJ	JJ	_	11	amod	_	_
11	transcript	_	NN	NN	_	8	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	2	_	CD	CD	_	14	num	_	_
14	kilobases	_	NNS	NNS	_	12	pobj	_	_
15	which	_	WDT	WDT	_	18	nsubjpass	_	_
16	was	_	VBD	VBD	_	18	auxpass	_	_
17	widely	_	RB	RB	_	18	advmod	_	_
18	expressed	_	VBN	VBN	_	11	rcmod	_	_
19	among	_	IN	IN	_	18	prep	_	_
20	organs	_	NNS	NNS	_	19	pobj	_	_
21	,	_	,	,	_	18	punct	_	_
22	with	_	IN	IN	_	18	prep	_	_
23	the	_	DT	DT	_	25	det	_	_
24	highest	_	JJS	JJS	_	25	amod	_	_
25	abundance	_	NN	NN	_	22	pobj	_	_
26	in	_	IN	IN	_	25	prep	_	_
27	liver	_	NN	NN	_	26	pobj	_	_
28	and	_	CC	CC	_	25	cc	_	_
29	the	_	DT	DT	_	31	det	_	_
30	lowest	_	JJS	JJS	_	31	amod	_	_
31	abundance	_	NN	NN	_	25	conj	_	_
32	in	_	IN	IN	_	31	prep	_	_
33	brain	_	NN	NN	_	32	pobj	_	_
34	.	_	.	.	_	8	punct	_	_

1	Subcellular	_	JJ	JJ	_	3	amod	_	_
2	localization	_	NN	NN	_	3	nn	_	_
3	analysis	_	NN	NN	_	17	nsubj	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	various	_	JJ	JJ	_	6	amod	_	_
6	cells	_	NNS	NNS	_	4	pobj	_	_
7	,	_	,	,	_	3	punct	_	_
8	using	_	VBG	VBG	_	3	vmod	_	_
9	a	_	DT	DT	_	12	det	_	_
10	specific	_	JJ	JJ	_	12	amod	_	_
11	monoclonal	_	JJ	JJ	_	12	amod	_	_
12	antibody	_	NN	NN	_	8	dobj	_	_
13	raised	_	VBN	VBN	_	12	vmod	_	_
14	against	_	IN	IN	_	13	prep	_	_
15	SR-BP	_	NN	NN	_	14	pobj	_	_
16	,	_	,	,	_	3	punct	_	_
17	demonstrated	_	VBD	VBD	_	0	root	_	_
18	that	_	IN	IN	_	22	mark	_	_
19	this	_	DT	DT	_	20	det	_	_
20	protein	_	NN	NN	_	22	nsubjpass	_	_
21	was	_	VBD	VBD	_	22	auxpass	_	_
22	associated	_	VBN	VBN	_	17	ccomp	_	_
23	with	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	26	det	_	_
25	nuclear	_	JJ	JJ	_	26	amod	_	_
26	envelope	_	NN	NN	_	23	pobj	_	_
27	.	_	.	.	_	17	punct	_	_

1	When	_	WRB	WRB	_	2	advmod	_	_
2	studying	_	VBG	VBG	_	16	advcl	_	_
3	the	_	DT	DT	_	4	det	_	_
4	binding	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	SR	_	NN	NN	_	7	nn	_	_
7	31747A	_	NN	NN	_	5	pobj	_	_
8	on	_	IN	IN	_	7	prep	_	_
9	membranes	_	NNS	NNS	_	8	pobj	_	_
10	from	_	IN	IN	_	9	prep	_	_
11	yeast	_	NN	NN	_	10	pobj	_	_
12	expressing	_	VBG	VBG	_	11	vmod	_	_
13	SR-BP	_	NN	NN	_	12	dobj	_	_
14	,	_	,	,	_	16	punct	_	_
15	we	_	PRP	PRP	_	16	nsubj	_	_
16	found	_	VBD	VBD	_	0	root	_	_
17	a	_	DT	DT	_	19	det	_	_
18	pharmacological	_	JJ	JJ	_	19	amod	_	_
19	profile	_	NN	NN	_	16	dobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	sigma	_	NN	NN	_	23	nn	_	_
22	1	_	CD	CD	_	23	num	_	_
23	receptors	_	NNS	NNS	_	20	pobj	_	_
24	;	_	:	:	_	16	punct	_	_
25	binding	_	NN	NN	_	27	nsubjpass	_	_
26	was	_	VBD	VBD	_	27	auxpass	_	_
27	displaced	_	VBN	VBN	_	16	parataxis	_	_
28	by	_	IN	IN	_	27	prep	_	_
29	-LRB-+-RRB--pentazocine	_	NN	NN	_	28	pobj	_	_
30	,	_	,	,	_	29	punct	_	_
31	haloperidol	_	NN	NN	_	29	conj	_	_
32	,	_	,	,	_	29	punct	_	_
33	and	_	CC	CC	_	29	cc	_	_
34	-LRB-+-RRB--SKF	_	NN	NN	_	29	conj	_	_
35	10,047	_	CD	CD	_	34	num	_	_
36	,	_	,	,	_	27	punct	_	_
37	with	_	IN	IN	_	27	prep	_	_
38	-LRB-+-RRB--SKF	_	NN	NN	_	44	nsubj	_	_
39	10,047	_	CD	CD	_	38	num	_	_
40	being	_	VBG	VBG	_	44	cop	_	_
41	a	_	DT	DT	_	44	det	_	_
42	more	_	RBR	RBR	_	43	advmod	_	_
43	potent	_	JJ	JJ	_	44	amod	_	_
44	competitor	_	NN	NN	_	37	pcomp	_	_
45	than	_	IN	IN	_	44	prep	_	_
46	-LRB---RRB--SKF	_	NN	NN	_	45	pobj	_	_
47	10,047	_	CD	CD	_	46	num	_	_
48	.	_	.	.	_	16	punct	_	_

1	Scatchard	_	NN	NN	_	3	nn	_	_
2	plot	_	NN	NN	_	3	nn	_	_
3	analysis	_	NN	NN	_	4	nsubj	_	_
4	revealed	_	VBD	VBD	_	0	root	_	_
5	Kd	_	NN	NN	_	6	nn	_	_
6	values	_	NNS	NNS	_	4	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	7.1	_	CD	CD	_	9	num	_	_
9	nM	_	NN	NN	_	7	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	0.15	_	CD	CD	_	12	num	_	_
12	nM	_	NN	NN	_	9	conj	_	_
13	for	_	IN	IN	_	6	prep	_	_
14	-LRB-+-RRB--pentazocine	_	NN	NN	_	13	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	SR	_	NN	NN	_	17	nn	_	_
17	31747A	_	NN	NN	_	14	conj	_	_
18	,	_	,	,	_	4	punct	_	_
19	respectively	_	RB	RB	_	4	advmod	_	_
20	,	_	,	,	_	4	punct	_	_
21	indicating	_	VBG	VBG	_	4	vmod	_	_
22	an	_	DT	DT	_	23	det	_	_
23	affinity	_	NN	NN	_	21	dobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	SR-BP	_	NN	NN	_	24	pobj	_	_
26	50-fold	_	RB	RB	_	27	npadvmod	_	_
27	higher	_	JJR	JJR	_	23	amod	_	_
28	for	_	IN	IN	_	27	prep	_	_
29	SR	_	NN	NN	_	30	nn	_	_
30	31747A	_	NN	NN	_	28	pobj	_	_
31	than	_	IN	IN	_	27	prep	_	_
32	for	_	IN	IN	_	31	pcomp	_	_
33	pentazocine	_	NN	NN	_	32	pobj	_	_
34	.	_	.	.	_	4	punct	_	_

1	Additionally	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	showed	_	VBD	VBD	_	0	root	_	_
5	that	_	IN	IN	_	17	mark	_	_
6	pentazocine	_	NN	NN	_	17	nsubj	_	_
7	,	_	,	,	_	6	punct	_	_
8	a	_	DT	DT	_	10	det	_	_
9	competitive	_	JJ	JJ	_	10	amod	_	_
10	inhibitor	_	NN	NN	_	6	appos	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	SR	_	NN	NN	_	14	nn	_	_
13	31747A	_	NN	NN	_	14	nn	_	_
14	binding	_	NN	NN	_	11	pobj	_	_
15	,	_	,	,	_	6	punct	_	_
16	also	_	RB	RB	_	17	advmod	_	_
17	prevents	_	VBZ	VBZ	_	4	ccomp	_	_
18	the	_	DT	DT	_	20	det	_	_
19	immunosuppressive	_	JJ	JJ	_	20	amod	_	_
20	effect	_	NN	NN	_	17	dobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	SR	_	NN	NN	_	23	nn	_	_
23	31747A	_	NN	NN	_	21	pobj	_	_
24	.	_	.	.	_	4	punct	_	_

1	Taken	_	VBN	VBN	_	0	root	_	_
2	together	_	RB	RB	_	1	advmod	_	_
3	,	_	,	,	_	1	punct	_	_
4	these	_	DT	DT	_	5	det	_	_
5	findings	_	NNS	NNS	_	7	nsubj	_	_
6	strongly	_	RB	RB	_	7	advmod	_	_
7	suggest	_	VBP	VBP	_	1	parataxis	_	_
8	that	_	IN	IN	_	10	mark	_	_
9	SR-BP	_	NN	NN	_	10	nsubj	_	_
10	represents	_	VBZ	VBZ	_	7	ccomp	_	_
11	the	_	DT	DT	_	13	det	_	_
12	molecular	_	JJ	JJ	_	13	amod	_	_
13	target	_	NN	NN	_	10	dobj	_	_
14	for	_	IN	IN	_	13	prep	_	_
15	SR	_	NN	NN	_	16	nn	_	_
16	31747A	_	NN	NN	_	14	pobj	_	_
17	in	_	IN	IN	_	10	prep	_	_
18	mammalian	_	JJ	JJ	_	19	amod	_	_
19	tissues	_	NNS	NNS	_	17	pobj	_	_
20	,	_	,	,	_	7	punct	_	_
21	which	_	WDT	WDT	_	24	nsubj	_	_
22	could	_	MD	MD	_	24	aux	_	_
23	be	_	VB	VB	_	24	cop	_	_
24	critical	_	JJ	JJ	_	7	dep	_	_
25	for	_	IN	IN	_	24	prep	_	_
26	T	_	NN	NN	_	28	nn	_	_
27	cell	_	NN	NN	_	28	nn	_	_
28	proliferation	_	NN	NN	_	25	pobj	_	_
29	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	tax	_	NN	NN	_	3	nn	_	_
3	protein	_	NN	NN	_	11	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	human	_	JJ	JJ	_	9	amod	_	_
6	T-cell	_	NN	NN	_	9	nn	_	_
7	leukemia	_	NN	NN	_	9	nn	_	_
8	virus	_	NN	NN	_	9	nn	_	_
9	type	_	NN	NN	_	4	pobj	_	_
10	1	_	CD	CD	_	9	num	_	_
11	mediates	_	VBZ	VBZ	_	0	root	_	_
12	the	_	DT	DT	_	13	det	_	_
13	transactivation	_	NN	NN	_	11	dobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	19	det	_	_
16	c-sis/platelet-derived	_	JJ	JJ	_	19	amod	_	_
17	growth	_	NN	NN	_	19	nn	_	_
18	factor-B	_	NN	NN	_	19	nn	_	_
19	promoter	_	NN	NN	_	14	pobj	_	_
20	through	_	IN	IN	_	11	prep	_	_
21	interactions	_	NNS	NNS	_	20	pobj	_	_
22	with	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	27	det	_	_
24	zinc	_	NN	NN	_	27	nn	_	_
25	finger	_	NN	NN	_	27	nn	_	_
26	transcription	_	NN	NN	_	27	nn	_	_
27	factors	_	NNS	NNS	_	22	pobj	_	_
28	Sp1	_	NN	NN	_	27	dep	_	_
29	and	_	CC	CC	_	28	cc	_	_
30	NGFI-A/Egr-1	_	NN	NN	_	28	conj	_	_
31	.	_	.	.	_	11	punct	_	_

1	Transcriptional	_	JJ	JJ	_	2	amod	_	_
2	up-regulation	_	NN	NN	_	25	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	11	det	_	_
5	c-sis/platelet-derived	_	JJ	JJ	_	11	amod	_	_
6	growth	_	NN	NN	_	11	nn	_	_
7	factor-B	_	NN	NN	_	11	nn	_	_
8	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
9	PDGF-B	_	NN	NN	_	11	nn	_	_
10	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
11	proto-oncogene	_	NN	NN	_	3	pobj	_	_
12	by	_	IN	IN	_	2	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	Tax	_	NN	NN	_	15	nn	_	_
15	protein	_	NN	NN	_	12	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	human	_	JJ	JJ	_	21	amod	_	_
18	T-cell	_	NN	NN	_	21	nn	_	_
19	leukemia	_	NN	NN	_	21	nn	_	_
20	virus	_	NN	NN	_	21	nn	_	_
21	type	_	NN	NN	_	16	pobj	_	_
22	1	_	CD	CD	_	21	num	_	_
23	has	_	VBZ	VBZ	_	25	aux	_	_
24	been	_	VBN	VBN	_	25	auxpass	_	_
25	implicated	_	VBN	VBN	_	0	root	_	_
26	as	_	IN	IN	_	25	prep	_	_
27	one	_	CD	CD	_	29	num	_	_
28	possible	_	JJ	JJ	_	29	amod	_	_
29	mechanism	_	NN	NN	_	26	pobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	cellular	_	JJ	JJ	_	32	amod	_	_
32	transformation	_	NN	NN	_	30	pobj	_	_
33	by	_	IN	IN	_	32	prep	_	_
34	human	_	JJ	JJ	_	38	amod	_	_
35	T-cell	_	NN	NN	_	38	nn	_	_
36	leukemia	_	NN	NN	_	38	nn	_	_
37	virus	_	NN	NN	_	38	nn	_	_
38	type	_	NN	NN	_	33	pobj	_	_
39	1	_	CD	CD	_	38	num	_	_
40	.	_	.	.	_	25	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	previous	_	JJ	JJ	_	3	amod	_	_
3	work	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	identified	_	VBD	VBD	_	0	root	_	_
7	an	_	DT	DT	_	9	det	_	_
8	essential	_	JJ	JJ	_	9	amod	_	_
9	site	_	NN	NN	_	6	dobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	c-sis/PDGF-B	_	NN	NN	_	13	nn	_	_
13	promoter	_	NN	NN	_	10	pobj	_	_
14	,	_	,	,	_	9	punct	_	_
15	Tax-responsive	_	JJ	JJ	_	16	amod	_	_
16	element	_	NN	NN	_	9	appos	_	_
17	1	_	CD	CD	_	16	num	_	_
18	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
19	TRE1	_	NN	NN	_	16	appos	_	_
20	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	,	_	,	,	_	9	punct	_	_
22	necessary	_	JJ	JJ	_	9	amod	_	_
23	for	_	IN	IN	_	22	prep	_	_
24	transactivation	_	NN	NN	_	23	pobj	_	_
25	by	_	IN	IN	_	24	prep	_	_
26	Tax	_	NN	NN	_	25	pobj	_	_
27	.	_	.	.	_	6	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	also	_	RB	RB	_	3	advmod	_	_
3	identified	_	VBD	VBD	_	0	root	_	_
4	Sp1	_	NN	NN	_	3	dobj	_	_
5	,	_	,	,	_	4	punct	_	_
6	Sp3	_	NN	NN	_	4	conj	_	_
7	,	_	,	,	_	4	punct	_	_
8	and	_	CC	CC	_	4	cc	_	_
9	NGFI-A/Egr-1	_	NN	NN	_	4	conj	_	_
10	as	_	IN	IN	_	3	prep	_	_
11	the	_	DT	DT	_	15	det	_	_
12	primary	_	JJ	JJ	_	15	amod	_	_
13	nuclear	_	JJ	JJ	_	15	amod	_	_
14	transcription	_	NN	NN	_	15	nn	_	_
15	factors	_	NNS	NNS	_	10	pobj	_	_
16	binding	_	VBG	VBG	_	15	vmod	_	_
17	to	_	TO	TO	_	16	prep	_	_
18	TRE1	_	NN	NN	_	17	pobj	_	_
19	which	_	WDT	WDT	_	20	nsubj	_	_
20	mediate	_	VBP	VBP	_	15	rcmod	_	_
21	Tax	_	NN	NN	_	22	nn	_	_
22	responsiveness	_	NN	NN	_	20	dobj	_	_
23	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	8	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	present	_	JJ	JJ	_	4	amod	_	_
4	work	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	8	punct	_	_
6	we	_	PRP	PRP	_	8	nsubj	_	_
7	have	_	VBP	VBP	_	8	aux	_	_
8	investigated	_	VBN	VBN	_	0	root	_	_
9	the	_	DT	DT	_	12	det	_	_
10	mechanism	_	NN	NN	_	12	nn	_	_
11	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
12	s	_	NNS	NNS	_	8	dobj	_	_
13	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
14	whereby	_	WRB	WRB	_	16	advmod	_	_
15	Tax	_	NN	NN	_	16	nsubj	_	_
16	transactivates	_	VBZ	VBZ	_	12	rcmod	_	_
17	the	_	DT	DT	_	19	det	_	_
18	c-sis/PDGF-B	_	NN	NN	_	19	nn	_	_
19	proto-oncogene	_	NN	NN	_	16	dobj	_	_
20	.	_	.	.	_	8	punct	_	_

1	In	_	FW	FW	_	4	amod	_	_
2	vitro	_	FW	FW	_	1	dep	_	_
3	transcription	_	NN	NN	_	4	nn	_	_
4	assays	_	NNS	NNS	_	5	nsubj	_	_
5	showed	_	VBD	VBD	_	0	root	_	_
6	that	_	IN	IN	_	9	mark	_	_
7	Tax	_	NN	NN	_	9	nsubj	_	_
8	was	_	VBD	VBD	_	9	cop	_	_
9	able	_	JJ	JJ	_	5	ccomp	_	_
10	to	_	TO	TO	_	12	aux	_	_
11	significantly	_	RB	RB	_	12	advmod	_	_
12	increase	_	VB	VB	_	9	xcomp	_	_
13	the	_	DT	DT	_	15	det	_	_
14	transcriptional	_	JJ	JJ	_	15	amod	_	_
15	activity	_	NN	NN	_	12	dobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	a	_	DT	DT	_	18	det	_	_
18	template	_	NN	NN	_	16	pobj	_	_
19	containing	_	VBG	VBG	_	18	vmod	_	_
20	the	_	DT	DT	_	24	det	_	_
21	-257	_	CD	CD	_	24	num	_	_
22	to	_	TO	TO	_	24	dep	_	_
23	+74	_	CD	CD	_	24	num	_	_
24	region	_	NN	NN	_	19	dobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	28	det	_	_
27	c-sis/PDGF-B	_	NN	NN	_	28	nn	_	_
28	promoter	_	NN	NN	_	25	pobj	_	_
29	.	_	.	.	_	5	punct	_	_

1	Electrophoretic	_	JJ	JJ	_	5	amod	_	_
2	mobility	_	NN	NN	_	5	nn	_	_
3	shift	_	NN	NN	_	5	nn	_	_
4	assay	_	NN	NN	_	5	nn	_	_
5	analysis	_	NN	NN	_	6	nsubj	_	_
6	showed	_	VBD	VBD	_	0	root	_	_
7	that	_	DT	DT	_	9	mark	_	_
8	Tax	_	NN	NN	_	9	nsubj	_	_
9	increased	_	VBD	VBD	_	6	ccomp	_	_
10	the	_	DT	DT	_	13	det	_	_
11	DNA	_	NN	NN	_	13	nn	_	_
12	binding	_	NN	NN	_	13	nn	_	_
13	activity	_	NN	NN	_	9	dobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	both	_	CC	CC	_	16	preconj	_	_
16	Sp1	_	NN	NN	_	14	pobj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	NGFI-A/Egr-1	_	NN	NN	_	16	conj	_	_
19	using	_	VBG	VBG	_	9	xcomp	_	_
20	a	_	DT	DT	_	22	det	_	_
21	TRE1	_	NN	NN	_	22	nn	_	_
22	probe	_	NN	NN	_	19	dobj	_	_
23	.	_	.	.	_	6	punct	_	_

1	Analysis	_	NN	NN	_	5	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	Tax	_	NN	NN	_	4	nn	_	_
4	mutants	_	NNS	NNS	_	2	pobj	_	_
5	showed	_	VBD	VBD	_	0	root	_	_
6	that	_	IN	IN	_	15	mark	_	_
7	two	_	CD	CD	_	8	num	_	_
8	mutants	_	NNS	NNS	_	15	nsubj	_	_
9	,	_	,	,	_	8	punct	_	_
10	IEXC29S	_	NN	NN	_	8	appos	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	IEXL320G	_	NN	NN	_	10	conj	_	_
13	,	_	,	,	_	8	punct	_	_
14	were	_	VBD	VBD	_	15	cop	_	_
15	unable	_	JJ	JJ	_	5	ccomp	_	_
16	to	_	TO	TO	_	18	aux	_	_
17	significantly	_	RB	RB	_	18	advmod	_	_
18	transactivate	_	VB	VB	_	15	xcomp	_	_
19	the	_	DT	DT	_	21	det	_	_
20	c-sis/PDGF-B	_	NN	NN	_	21	nn	_	_
21	promoter	_	NN	NN	_	18	dobj	_	_
22	.	_	.	.	_	5	punct	_	_

1	Finally	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	co-immunoprecipitation	_	NN	NN	_	4	nn	_	_
4	analysis	_	NN	NN	_	5	nsubj	_	_
5	revealed	_	VBD	VBD	_	0	root	_	_
6	that	_	IN	IN	_	9	mark	_	_
7	Tax	_	NN	NN	_	9	nsubj	_	_
8	is	_	VBZ	VBZ	_	9	cop	_	_
9	able	_	JJ	JJ	_	5	ccomp	_	_
10	to	_	TO	TO	_	12	aux	_	_
11	stably	_	RB	RB	_	12	advmod	_	_
12	bind	_	VB	VB	_	9	xcomp	_	_
13	to	_	TO	TO	_	12	prep	_	_
14	both	_	CC	CC	_	15	preconj	_	_
15	Sp1	_	NN	NN	_	13	pobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	NGFI-A/Egr-1	_	NN	NN	_	15	conj	_	_
18	.	_	.	.	_	5	punct	_	_

1	Interestingly	_	RB	RB	_	6	advmod	_	_
2	,	_	,	,	_	6	punct	_	_
3	co-immunoprecipitation	_	NN	NN	_	4	nn	_	_
4	analysis	_	NN	NN	_	6	nsubj	_	_
5	also	_	RB	RB	_	6	advmod	_	_
6	revealed	_	VBD	VBD	_	0	root	_	_
7	that	_	IN	IN	_	12	mark	_	_
8	Tax	_	NN	NN	_	9	nn	_	_
9	mutant	_	NN	NN	_	12	nsubj	_	_
10	IEXC29S	_	NN	NN	_	9	dep	_	_
11	is	_	VBZ	VBZ	_	12	cop	_	_
12	unable	_	JJ	JJ	_	6	ccomp	_	_
13	to	_	TO	TO	_	14	aux	_	_
14	interact	_	VB	VB	_	12	xcomp	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	NGFI-A/Egr-1	_	NN	NN	_	15	pobj	_	_
17	,	_	,	,	_	12	punct	_	_
18	whereas	_	IN	IN	_	23	mark	_	_
19	Tax	_	NN	NN	_	20	nn	_	_
20	mutant	_	NN	NN	_	23	nsubj	_	_
21	IEXL320G	_	NN	NN	_	20	dep	_	_
22	is	_	VBZ	VBZ	_	23	cop	_	_
23	able	_	JJ	JJ	_	12	advcl	_	_
24	to	_	TO	TO	_	25	aux	_	_
25	interact	_	VB	VB	_	23	xcomp	_	_
26	with	_	IN	IN	_	25	prep	_	_
27	NGFI-A/Egr-1	_	NN	NN	_	26	pobj	_	_
28	.	_	.	.	_	6	punct	_	_

1	Stable	_	JJ	JJ	_	2	amod	_	_
2	transfection	_	NN	NN	_	12	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	U937	_	NN	NN	_	5	nn	_	_
5	cells	_	NNS	NNS	_	3	pobj	_	_
6	with	_	IN	IN	_	2	prep	_	_
7	sense	_	NN	NN	_	6	pobj	_	_
8	or	_	CC	CC	_	7	cc	_	_
9	antisense	_	JJ	JJ	_	11	amod	_	_
10	RXR-alpha	_	NN	NN	_	11	nn	_	_
11	cDNA	_	NN	NN	_	7	conj	_	_
12	suggests	_	VBZ	VBZ	_	0	root	_	_
13	a	_	DT	DT	_	14	det	_	_
14	role	_	NN	NN	_	12	dobj	_	_
15	for	_	IN	IN	_	14	prep	_	_
16	RXR-alpha	_	NN	NN	_	15	pobj	_	_
17	in	_	IN	IN	_	14	prep	_	_
18	the	_	DT	DT	_	19	det	_	_
19	control	_	NN	NN	_	17	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	monoblastic	_	JJ	JJ	_	22	amod	_	_
22	differentiation	_	NN	NN	_	20	pobj	_	_
23	induced	_	VBN	VBN	_	22	vmod	_	_
24	by	_	IN	IN	_	23	prep	_	_
25	retinoic	_	JJ	JJ	_	26	amod	_	_
26	acid	_	NN	NN	_	24	pobj	_	_
27	and	_	CC	CC	_	26	cc	_	_
28	vitamin	_	NN	NN	_	29	nn	_	_
29	D	_	NN	NN	_	26	conj	_	_
30	.	_	.	.	_	12	punct	_	_

1	Although	_	IN	IN	_	9	mark	_	_
2	retinoic	_	JJ	JJ	_	3	amod	_	_
3	acid	_	NN	NN	_	9	nsubjpass	_	_
4	-LRB-	_	-LRB-	-LRB-	_	5	punct	_	_
5	RA	_	NN	NN	_	3	appos	_	_
6	-RRB-	_	-RRB-	-RRB-	_	5	punct	_	_
7	has	_	VBZ	VBZ	_	9	aux	_	_
8	been	_	VBN	VBN	_	9	auxpass	_	_
9	known	_	VBN	VBN	_	38	advcl	_	_
10	for	_	IN	IN	_	17	prep	_	_
11	many	_	JJ	JJ	_	12	amod	_	_
12	years	_	NNS	NNS	_	10	pobj	_	_
13	to	_	TO	TO	_	17	aux	_	_
14	be	_	VB	VB	_	17	cop	_	_
15	a	_	DT	DT	_	17	det	_	_
16	modulating	_	VBG	VBG	_	17	amod	_	_
17	agent	_	NN	NN	_	9	xcomp	_	_
18	that	_	WDT	WDT	_	19	nsubj	_	_
19	plays	_	VBZ	VBZ	_	17	rcmod	_	_
20	a	_	DT	DT	_	21	det	_	_
21	role	_	NN	NN	_	19	dobj	_	_
22	in	_	IN	IN	_	19	prep	_	_
23	generating	_	VBG	VBG	_	22	pcomp	_	_
24	both	_	CC	CC	_	25	preconj	_	_
25	granulocytes	_	NNS	NNS	_	23	dobj	_	_
26	and	_	CC	CC	_	25	cc	_	_
27	monocytes	_	NNS	NNS	_	25	conj	_	_
28	,	_	,	,	_	38	punct	_	_
29	the	_	DT	DT	_	31	det	_	_
30	molecular	_	JJ	JJ	_	31	amod	_	_
31	mechanism	_	NN	NN	_	38	nsubjpass	_	_
32	underlying	_	VBG	VBG	_	31	vmod	_	_
33	this	_	DT	DT	_	34	det	_	_
34	role	_	NN	NN	_	32	dobj	_	_
35	has	_	VBZ	VBZ	_	38	aux	_	_
36	not	_	RB	RB	_	38	neg	_	_
37	been	_	VBN	VBN	_	38	auxpass	_	_
38	defined	_	VBN	VBN	_	0	root	_	_
39	in	_	IN	IN	_	38	prep	_	_
40	the	_	DT	DT	_	42	det	_	_
41	monoblast	_	NN	NN	_	42	nn	_	_
42	lineage	_	NN	NN	_	39	pobj	_	_
43	.	_	.	.	_	38	punct	_	_

1	In	_	IN	IN	_	30	prep	_	_
2	particular	_	JJ	JJ	_	1	pobj	_	_
3	,	_	,	,	_	30	punct	_	_
4	the	_	DT	DT	_	5	det	_	_
5	part	_	NN	NN	_	30	nsubjpass	_	_
6	played	_	VBN	VBN	_	5	vmod	_	_
7	by	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	11	det	_	_
9	retinoid	_	JJ	JJ	_	11	amod	_	_
10	X	_	NN	NN	_	11	nn	_	_
11	receptors	_	NNS	NNS	_	7	pobj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	RXRs	_	NNS	NNS	_	11	appos	_	_
14	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
15	,	_	,	,	_	11	punct	_	_
16	which	_	WDT	WDT	_	18	nsubj	_	_
17	are	_	VBP	VBP	_	18	cop	_	_
18	members	_	NNS	NNS	_	11	rcmod	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	25	det	_	_
21	steroid/thyroid	_	NN	NN	_	25	nn	_	_
22	hormone	_	NN	NN	_	25	nn	_	_
23	nuclear	_	JJ	JJ	_	25	amod	_	_
24	receptor	_	NN	NN	_	25	nn	_	_
25	family	_	NN	NN	_	19	pobj	_	_
26	,	_	,	,	_	5	punct	_	_
27	has	_	VBZ	VBZ	_	30	aux	_	_
28	not	_	RB	RB	_	30	neg	_	_
29	been	_	VBN	VBN	_	30	auxpass	_	_
30	explored	_	VBN	VBN	_	0	root	_	_
31	.	_	.	.	_	30	punct	_	_

1	In	_	IN	IN	_	16	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	study	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	16	punct	_	_
5	therefore	_	RB	RB	_	16	advmod	_	_
6	,	_	,	,	_	16	punct	_	_
7	the	_	DT	DT	_	13	det	_	_
8	human	_	JJ	JJ	_	13	amod	_	_
9	monoblastic	_	JJ	JJ	_	13	amod	_	_
10	leukemia	_	NN	NN	_	13	nn	_	_
11	cell	_	NN	NN	_	13	nn	_	_
12	line	_	NN	NN	_	13	nn	_	_
13	U937	_	NN	NN	_	16	nsubjpass	_	_
14	has	_	VBZ	VBZ	_	16	aux	_	_
15	been	_	VBN	VBN	_	16	auxpass	_	_
16	used	_	VBN	VBN	_	0	root	_	_
17	as	_	IN	IN	_	16	prep	_	_
18	a	_	DT	DT	_	20	det	_	_
19	model	_	NN	NN	_	20	nn	_	_
20	system	_	NN	NN	_	17	pobj	_	_
21	to	_	TO	TO	_	22	aux	_	_
22	investigate	_	VB	VB	_	20	vmod	_	_
23	the	_	DT	DT	_	24	det	_	_
24	role	_	NN	NN	_	22	dobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	one	_	CD	CD	_	25	pobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	29	det	_	_
29	RXRs	_	NNS	NNS	_	27	pobj	_	_
30	,	_	,	,	_	26	punct	_	_
31	RXR-alpha	_	NN	NN	_	26	appos	_	_
32	,	_	,	,	_	24	punct	_	_
33	in	_	IN	IN	_	24	prep	_	_
34	monoblast	_	NN	NN	_	35	nn	_	_
35	differentiation	_	NN	NN	_	33	pobj	_	_
36	.	_	.	.	_	16	punct	_	_

1	RXR-alpha	_	NN	NN	_	2	nn	_	_
2	mRNA	_	NN	NN	_	4	nsubj	_	_
3	was	_	VBD	VBD	_	4	cop	_	_
4	present	_	JJ	JJ	_	0	root	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	untreated	_	JJ	JJ	_	8	amod	_	_
7	U937	_	NN	NN	_	8	nn	_	_
8	cells	_	NNS	NNS	_	5	pobj	_	_
9	,	_	,	,	_	4	punct	_	_
10	and	_	CC	CC	_	4	cc	_	_
11	levels	_	NNS	NNS	_	12	nsubj	_	_
12	increased	_	VBD	VBD	_	4	conj	_	_
13	after	_	IN	IN	_	12	prep	_	_
14	induction	_	NN	NN	_	13	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	differentiation	_	NN	NN	_	15	pobj	_	_
17	with	_	IN	IN	_	14	prep	_	_
18	phorbol	_	NN	NN	_	19	nn	_	_
19	ester	_	NN	NN	_	17	pobj	_	_
20	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	same	_	JJ	JJ	_	4	nsubjpass	_	_
3	was	_	VBD	VBD	_	4	auxpass	_	_
4	found	_	VBN	VBN	_	0	root	_	_
5	for	_	IN	IN	_	4	prep	_	_
6	RXR-beta	_	NN	NN	_	7	nn	_	_
7	mRNA	_	NN	NN	_	5	pobj	_	_
8	.	_	.	.	_	4	punct	_	_

1	Using	_	VBG	VBG	_	0	root	_	_
2	plasmids	_	NNS	NNS	_	1	dobj	_	_
3	containing	_	VBG	VBG	_	2	vmod	_	_
4	sense	_	NN	NN	_	3	dobj	_	_
5	or	_	CC	CC	_	4	cc	_	_
6	antisense	_	JJ	JJ	_	8	amod	_	_
7	RXR-alpha	_	NN	NN	_	8	nn	_	_
8	sequences	_	NNS	NNS	_	4	conj	_	_
9	under	_	IN	IN	_	4	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	control	_	NN	NN	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	an	_	DT	DT	_	15	det	_	_
14	inducible	_	JJ	JJ	_	15	amod	_	_
15	promoter	_	NN	NN	_	12	pobj	_	_
16	,	_	,	,	_	1	punct	_	_
17	we	_	PRP	PRP	_	18	nsubj	_	_
18	generated	_	VBD	VBD	_	1	parataxis	_	_
19	stably	_	RB	RB	_	20	advmod	_	_
20	transfected	_	VBN	VBN	_	22	amod	_	_
21	cell	_	NN	NN	_	22	nn	_	_
22	lines	_	NNS	NNS	_	18	dobj	_	_
23	which	_	WDT	WDT	_	24	nsubj	_	_
24	expressed	_	VBD	VBD	_	22	rcmod	_	_
25	either	_	CC	CC	_	26	preconj	_	_
26	increased	_	VBN	VBN	_	24	dobj	_	_
27	or	_	CC	CC	_	26	cc	_	_
28	decreased	_	VBN	VBN	_	26	conj	_	_
29	levels	_	NNS	NNS	_	26	dep	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	RXR-alpha	_	NN	NN	_	30	pobj	_	_
32	,	_	,	,	_	24	punct	_	_
33	respectively	_	RB	RB	_	24	advmod	_	_
34	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	sense	_	NN	NN	_	4	nn	_	_
3	cell	_	NN	NN	_	4	nn	_	_
4	lines	_	NNS	NNS	_	16	nsubj	_	_
5	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
6	U	_	NN	NN	_	8	nn	_	_
7	alpha	_	NN	NN	_	8	nn	_	_
8	S	_	NN	NN	_	4	dep	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	its	_	PRP$	PRP$	_	12	poss	_	_
11	clonal	_	JJ	JJ	_	12	amod	_	_
12	derivative	_	JJ	JJ	_	8	conj	_	_
13	alpha	_	NN	NN	_	12	dep	_	_
14	G2S	_	NN	NN	_	13	dep	_	_
15	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
16	showed	_	VBD	VBD	_	0	root	_	_
17	increased	_	VBN	VBN	_	18	amod	_	_
18	sensitivity	_	NN	NN	_	16	dobj	_	_
19	to	_	TO	TO	_	18	prep	_	_
20	RA	_	NN	NN	_	19	pobj	_	_
21	,	_	,	,	_	16	punct	_	_
22	while	_	IN	IN	_	38	mark	_	_
23	the	_	DT	DT	_	26	det	_	_
24	antisense	_	JJ	JJ	_	26	amod	_	_
25	cell	_	NN	NN	_	26	nn	_	_
26	lines	_	NNS	NNS	_	38	nsubj	_	_
27	-LRB-	_	-LRB-	-LRB-	_	30	punct	_	_
28	U	_	NN	NN	_	30	nn	_	_
29	alpha	_	NN	NN	_	30	nn	_	_
30	A	_	NN	NN	_	26	dep	_	_
31	and	_	CC	CC	_	30	cc	_	_
32	its	_	PRP$	PRP$	_	34	poss	_	_
33	clonal	_	JJ	JJ	_	34	amod	_	_
34	derivative	_	JJ	JJ	_	30	conj	_	_
35	alpha	_	NN	NN	_	34	dep	_	_
36	B5A	_	NN	NN	_	35	dep	_	_
37	-RRB-	_	-RRB-	-RRB-	_	30	punct	_	_
38	showed	_	VBD	VBD	_	16	advcl	_	_
39	decreased	_	VBN	VBN	_	40	amod	_	_
40	sensitivity	_	NN	NN	_	38	dobj	_	_
41	to	_	TO	TO	_	40	prep	_	_
42	RA	_	NN	NN	_	41	pobj	_	_
43	,	_	,	,	_	16	punct	_	_
44	as	_	IN	IN	_	45	dep	_	_
45	demonstrated	_	VBN	VBN	_	16	advcl	_	_
46	by	_	IN	IN	_	45	prep	_	_
47	growth	_	NN	NN	_	48	nn	_	_
48	inhibition	_	NN	NN	_	46	pobj	_	_
49	and	_	CC	CC	_	46	cc	_	_
50	by	_	IN	IN	_	46	conj	_	_
51	regulation	_	NN	NN	_	50	pobj	_	_
52	of	_	IN	IN	_	51	prep	_	_
53	an	_	DT	DT	_	56	det	_	_
54	RA-responsive	_	JJ	JJ	_	56	amod	_	_
55	reporter	_	NN	NN	_	56	nn	_	_
56	gene	_	NN	NN	_	52	pobj	_	_
57	.	_	.	.	_	16	punct	_	_

1	Both	_	CC	CC	_	4	preconj	_	_
2	U	_	NN	NN	_	4	nn	_	_
3	alpha	_	NN	NN	_	4	nn	_	_
4	A	_	NN	NN	_	9	nsubj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	alpha	_	NN	NN	_	4	conj	_	_
7	B5A	_	NN	NN	_	6	dep	_	_
8	also	_	RB	RB	_	9	advmod	_	_
9	failed	_	VBD	VBD	_	0	root	_	_
10	to	_	TO	TO	_	11	aux	_	_
11	respond	_	VB	VB	_	9	xcomp	_	_
12	to	_	TO	TO	_	11	prep	_	_
13	another	_	DT	DT	_	15	det	_	_
14	modulating	_	VBG	VBG	_	15	amod	_	_
15	agent	_	NN	NN	_	12	pobj	_	_
16	,	_	,	,	_	15	punct	_	_
17	1	_	CD	CD	_	18	num	_	_
18	alpha,25-dihydroxycholecalciferol	_	NN	NN	_	15	appos	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	DHCC	_	NN	NN	_	18	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	,	_	,	,	_	9	punct	_	_
23	but	_	CC	CC	_	9	cc	_	_
24	only	_	RB	RB	_	27	advmod	_	_
25	U	_	NN	NN	_	27	nn	_	_
26	alpha	_	NN	NN	_	27	nn	_	_
27	S	_	NN	NN	_	32	nsubj	_	_
28	and	_	CC	CC	_	27	cc	_	_
29	not	_	RB	RB	_	31	neg	_	_
30	alpha	_	NN	NN	_	31	nn	_	_
31	G2S	_	NN	NN	_	27	conj	_	_
32	showed	_	VBD	VBD	_	9	conj	_	_
33	an	_	DT	DT	_	35	det	_	_
34	enhanced	_	VBN	VBN	_	35	amod	_	_
35	response	_	NN	NN	_	32	dobj	_	_
36	to	_	TO	TO	_	35	prep	_	_
37	DHCC	_	NN	NN	_	36	pobj	_	_
38	.	_	.	.	_	9	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	combination	_	NN	NN	_	8	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	RA	_	NN	NN	_	3	pobj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	DHCC	_	NN	NN	_	4	conj	_	_
7	together	_	RB	RB	_	8	advmod	_	_
8	inhibited	_	VBD	VBD	_	0	root	_	_
9	growth	_	NN	NN	_	8	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	both	_	CC	CC	_	12	preconj	_	_
12	sense	_	NN	NN	_	10	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	antisense	_	JJ	JJ	_	16	amod	_	_
15	cell	_	NN	NN	_	16	nn	_	_
16	lines	_	NNS	NNS	_	12	conj	_	_
17	.	_	.	.	_	8	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	6	punct	_	_
4	alpha	_	NN	NN	_	5	nn	_	_
5	G2S	_	NN	NN	_	6	nsubj	_	_
6	exhibited	_	VBD	VBD	_	0	root	_	_
7	increased	_	VBN	VBN	_	8	amod	_	_
8	expression	_	NN	NN	_	6	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	CD11b	_	NN	NN	_	9	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	CD54	_	NN	NN	_	10	conj	_	_
13	,	_	,	,	_	6	punct	_	_
14	while	_	IN	IN	_	18	mark	_	_
15	alpha	_	NN	NN	_	17	nn	_	_
16	B5A	_	NN	NN	_	17	nn	_	_
17	cells	_	NNS	NNS	_	18	nsubj	_	_
18	showed	_	VBD	VBD	_	6	advcl	_	_
19	increased	_	VBN	VBN	_	20	amod	_	_
20	expression	_	NN	NN	_	18	dobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	CD102	_	NN	NN	_	21	pobj	_	_
23	,	_	,	,	_	6	punct	_	_
24	suggesting	_	VBG	VBG	_	6	xcomp	_	_
25	that	_	IN	IN	_	27	mark	_	_
26	RXR-alpha	_	NN	NN	_	27	nsubj	_	_
27	has	_	VBZ	VBZ	_	24	ccomp	_	_
28	a	_	DT	DT	_	29	det	_	_
29	role	_	NN	NN	_	27	dobj	_	_
30	in	_	IN	IN	_	27	prep	_	_
31	regulating	_	VBG	VBG	_	30	pcomp	_	_
32	expression	_	NN	NN	_	31	dobj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	cell	_	NN	NN	_	36	nn	_	_
35	adhesion	_	NN	NN	_	36	nn	_	_
36	molecules	_	NNS	NNS	_	33	pobj	_	_
37	in	_	IN	IN	_	31	prep	_	_
38	U937	_	NN	NN	_	39	nn	_	_
39	cells	_	NNS	NNS	_	37	pobj	_	_
40	.	_	.	.	_	6	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	demonstrate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	6	mark	_	_
5	RXR-alpha	_	NN	NN	_	6	nsubj	_	_
6	has	_	VBZ	VBZ	_	3	ccomp	_	_
7	a	_	DT	DT	_	8	det	_	_
8	role	_	NN	NN	_	6	dobj	_	_
9	in	_	IN	IN	_	6	prep	_	_
10	mediating	_	VBG	VBG	_	9	pcomp	_	_
11	growth	_	NN	NN	_	12	nn	_	_
12	inhibition	_	NN	NN	_	10	dobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	cell	_	NN	NN	_	15	nn	_	_
15	adhesion	_	NN	NN	_	12	conj	_	_
16	during	_	IN	IN	_	10	prep	_	_
17	myelomonocytic	_	JJ	JJ	_	18	amod	_	_
18	differentiation	_	NN	NN	_	16	pobj	_	_
19	,	_	,	,	_	3	punct	_	_
20	and	_	CC	CC	_	3	cc	_	_
21	suggest	_	VBP	VBP	_	3	conj	_	_
22	that	_	IN	IN	_	30	mark	_	_
23	different	_	JJ	JJ	_	24	amod	_	_
24	species	_	NNS	NNS	_	30	nsubj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	heterodimers	_	NNS	NNS	_	25	pobj	_	_
27	involving	_	VBG	VBG	_	24	vmod	_	_
28	RXR-alpha	_	NN	NN	_	27	dobj	_	_
29	may	_	MD	MD	_	30	aux	_	_
30	control	_	VB	VB	_	21	ccomp	_	_
31	the	_	DT	DT	_	32	det	_	_
32	acquisition	_	NN	NN	_	30	dobj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	different	_	JJ	JJ	_	35	amod	_	_
35	features	_	NNS	NNS	_	33	pobj	_	_
36	of	_	IN	IN	_	35	prep	_	_
37	mature	_	JJ	JJ	_	39	amod	_	_
38	monocyte/macrophage	_	NN	NN	_	39	nn	_	_
39	function	_	NN	NN	_	36	pobj	_	_
40	.	_	.	.	_	3	punct	_	_

1	B-lymphoblastoid	_	JJ	JJ	_	3	amod	_	_
2	cell	_	NN	NN	_	3	nn	_	_
3	lines	_	NNS	NNS	_	0	root	_	_
4	from	_	IN	IN	_	3	prep	_	_
5	multiple	_	JJ	JJ	_	7	amod	_	_
6	sclerosis	_	NN	NN	_	7	nn	_	_
7	patients	_	NNS	NNS	_	4	pobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	a	_	DT	DT	_	11	det	_	_
10	healthy	_	JJ	JJ	_	11	amod	_	_
11	control	_	NN	NN	_	7	conj	_	_
12	producing	_	VBG	VBG	_	3	vmod	_	_
13	a	_	DT	DT	_	17	det	_	_
14	putative	_	JJ	JJ	_	15	amod	_	_
15	new	_	JJ	JJ	_	17	amod	_	_
16	human	_	JJ	JJ	_	17	amod	_	_
17	retrovirus	_	NN	NN	_	12	dobj	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	Epstein-Barr	_	JJ	JJ	_	20	amod	_	_
20	virus	_	NN	NN	_	17	conj	_	_
21	.	_	.	.	_	3	punct	_	_

1	On	_	IN	IN	_	6	prep	_	_
2	several	_	JJ	JJ	_	3	amod	_	_
3	occasions	_	NNS	NNS	_	1	pobj	_	_
4	we	_	PRP	PRP	_	6	nsubj	_	_
5	have	_	VBP	VBP	_	6	aux	_	_
6	observed	_	VBN	VBN	_	0	root	_	_
7	retrovirus-like	_	JJ	JJ	_	8	amod	_	_
8	particles	_	NNS	NNS	_	6	dobj	_	_
9	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
10	RVLPs	_	NNS	NNS	_	8	appos	_	_
11	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
12	by	_	IN	IN	_	6	prep	_	_
13	transmission	_	NN	NN	_	15	nn	_	_
14	electron	_	NN	NN	_	15	nn	_	_
15	microscopy	_	NN	NN	_	12	pobj	_	_
16	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
17	EM	_	NN	NN	_	15	appos	_	_
18	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
19	of	_	IN	IN	_	15	prep	_	_
20	cultured	_	VBN	VBN	_	22	amod	_	_
21	T	_	NN	NN	_	22	nn	_	_
22	cells	_	NNS	NNS	_	19	pobj	_	_
23	from	_	IN	IN	_	22	prep	_	_
24	a	_	DT	DT	_	25	det	_	_
25	patient	_	NN	NN	_	23	pobj	_	_
26	with	_	IN	IN	_	25	prep	_	_
27	MS	_	NN	NN	_	26	pobj	_	_
28	.	_	.	.	_	6	punct	_	_

1	Later	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	established	_	VBD	VBD	_	0	root	_	_
4	spontaneously	_	RB	RB	_	5	advmod	_	_
5	formed	_	VBN	VBN	_	8	amod	_	_
6	B-lymphoblastoid	_	JJ	JJ	_	8	amod	_	_
7	cell	_	NN	NN	_	8	nn	_	_
8	lines	_	NNS	NNS	_	3	dobj	_	_
9	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
10	LCLs	_	NNS	NNS	_	8	appos	_	_
11	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
12	from	_	IN	IN	_	3	prep	_	_
13	a	_	DT	DT	_	14	det	_	_
14	patient	_	NN	NN	_	12	pobj	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	an	_	DT	DT	_	18	det	_	_
17	MS-like	_	JJ	JJ	_	18	amod	_	_
18	disease	_	NN	NN	_	15	pobj	_	_
19	and	_	CC	CC	_	12	cc	_	_
20	from	_	IN	IN	_	12	conj	_	_
21	another	_	DT	DT	_	22	det	_	_
22	patient	_	NN	NN	_	20	pobj	_	_
23	with	_	IN	IN	_	22	prep	_	_
24	MS	_	NN	NN	_	23	pobj	_	_
25	who	_	WP	WP	_	26	nsubj	_	_
26	had	_	VBD	VBD	_	22	rcmod	_	_
27	a	_	DT	DT	_	34	det	_	_
28	reactivated	_	VBN	VBN	_	34	amod	_	_
29	Epstein-Barr	_	JJ	JJ	_	30	amod	_	_
30	virus	_	NN	NN	_	34	nn	_	_
31	-LRB-	_	-LRB-	-LRB-	_	32	punct	_	_
32	EBV	_	NN	NN	_	30	appos	_	_
33	-RRB-	_	-RRB-	-RRB-	_	32	punct	_	_
34	infection	_	NN	NN	_	26	dobj	_	_
35	.	_	.	.	_	3	punct	_	_

1	Both	_	DT	DT	_	2	dep	_	_
2	LCLs	_	NNS	NNS	_	4	nsubjpass	_	_
3	were	_	VBD	VBD	_	4	auxpass	_	_
4	found	_	VBN	VBN	_	0	root	_	_
5	by	_	IN	IN	_	8	prep	_	_
6	EM	_	NN	NN	_	5	pobj	_	_
7	to	_	TO	TO	_	8	aux	_	_
8	produce	_	VB	VB	_	4	xcomp	_	_
9	RVLP	_	NN	NN	_	8	dobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	EBV	_	NN	NN	_	12	nn	_	_
12	particles	_	NNS	NNS	_	9	conj	_	_
13	.	_	.	.	_	4	punct	_	_

1	Reverse	_	JJ	JJ	_	2	amod	_	_
2	transcriptase	_	NN	NN	_	6	nn	_	_
3	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
4	RT	_	NN	NN	_	2	appos	_	_
5	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
6	assays	_	NNS	NNS	_	8	nsubj	_	_
7	were	_	VBD	VBD	_	8	cop	_	_
8	positive	_	JJ	JJ	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	purified	_	VBN	VBN	_	12	amod	_	_
11	viral	_	JJ	JJ	_	12	amod	_	_
12	material	_	NN	NN	_	9	pobj	_	_
13	from	_	IN	IN	_	12	prep	_	_
14	both	_	DT	DT	_	15	dep	_	_
15	LCLs	_	NNS	NNS	_	13	pobj	_	_
16	.	_	.	.	_	8	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	substantiate	_	VB	VB	_	0	root	_	_
3	these	_	DT	DT	_	4	det	_	_
4	findings	_	NNS	NNS	_	2	dobj	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	initiated	_	VBD	VBD	_	2	parataxis	_	_
7	an	_	DT	DT	_	10	det	_	_
8	intensified	_	VBN	VBN	_	10	amod	_	_
9	culturing	_	NN	NN	_	10	nn	_	_
10	procedure	_	NN	NN	_	6	dobj	_	_
11	and	_	CC	CC	_	6	cc	_	_
12	were	_	VBD	VBD	_	13	cop	_	_
13	able	_	JJ	JJ	_	6	conj	_	_
14	to	_	TO	TO	_	15	aux	_	_
15	establish	_	VB	VB	_	13	xcomp	_	_
16	LCLs	_	NNS	NNS	_	15	dobj	_	_
17	from	_	IN	IN	_	15	prep	_	_
18	5	_	CD	CD	_	21	number	_	_
19	out	_	RB	RB	_	21	quantmod	_	_
20	of	_	IN	IN	_	21	quantmod	_	_
21	21	_	CD	CD	_	24	num	_	_
22	consecutive	_	JJ	JJ	_	24	amod	_	_
23	MS	_	NN	NN	_	24	nn	_	_
24	patients	_	NNS	NNS	_	17	pobj	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	1	_	CD	CD	_	29	number	_	_
27	out	_	RB	RB	_	29	quantmod	_	_
28	of	_	IN	IN	_	29	quantmod	_	_
29	13	_	CD	CD	_	32	num	_	_
30	consecutive	_	JJ	JJ	_	31	amod	_	_
31	healthy	_	JJ	JJ	_	32	amod	_	_
32	controls	_	NNS	NNS	_	24	conj	_	_
33	.	_	.	.	_	2	punct	_	_

1	All	_	DT	DT	_	2	det	_	_
2	LCLs	_	NNS	NNS	_	4	nsubjpass	_	_
3	were	_	VBD	VBD	_	4	auxpass	_	_
4	found	_	VBN	VBN	_	0	root	_	_
5	to	_	TO	TO	_	6	aux	_	_
6	produce	_	VB	VB	_	4	xcomp	_	_
7	both	_	CC	CC	_	8	preconj	_	_
8	RVLP	_	NN	NN	_	6	dobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	EBV	_	NN	NN	_	11	nn	_	_
11	particles	_	NNS	NNS	_	8	conj	_	_
12	by	_	IN	IN	_	4	prep	_	_
13	EM	_	NN	NN	_	12	pobj	_	_
14	.	_	.	.	_	4	punct	_	_

1	Whether	_	IN	IN	_	11	mark	_	_
2	the	_	DT	DT	_	5	det	_	_
3	putative	_	JJ	JJ	_	4	amod	_	_
4	new	_	JJ	JJ	_	5	amod	_	_
5	retrovirus	_	NN	NN	_	11	nsubj	_	_
6	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
7	es	_	NNS	NNS	_	5	appos	_	_
8	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
9	and	_	CC	CC	_	5	cc	_	_
10	EBV	_	NN	NN	_	5	conj	_	_
11	have	_	VBP	VBP	_	20	csubjpass	_	_
12	any	_	DT	DT	_	14	det	_	_
13	causal	_	JJ	JJ	_	14	amod	_	_
14	relationship	_	NN	NN	_	11	dobj	_	_
15	to	_	TO	TO	_	14	prep	_	_
16	MS	_	NN	NN	_	15	pobj	_	_
17	is	_	VBZ	VBZ	_	20	auxpass	_	_
18	still	_	RB	RB	_	20	advmod	_	_
19	not	_	RB	RB	_	20	neg	_	_
20	known	_	VBN	VBN	_	0	root	_	_
21	,	_	,	,	_	20	punct	_	_
22	but	_	CC	CC	_	20	cc	_	_
23	the	_	DT	DT	_	24	det	_	_
24	findings	_	NNS	NNS	_	25	nsubj	_	_
25	support	_	VBP	VBP	_	20	conj	_	_
26	this	_	DT	DT	_	27	det	_	_
27	possibility	_	NN	NN	_	25	dobj	_	_
28	.	_	.	.	_	20	punct	_	_

1	Involvement	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	different	_	JJ	JJ	_	5	amod	_	_
4	transduction	_	NN	NN	_	5	nn	_	_
5	pathways	_	NNS	NNS	_	2	pobj	_	_
6	in	_	IN	IN	_	1	prep	_	_
7	NF-kappa	_	NN	NN	_	8	nn	_	_
8	B	_	NN	NN	_	9	nn	_	_
9	activation	_	NN	NN	_	6	pobj	_	_
10	by	_	IN	IN	_	9	prep	_	_
11	several	_	JJ	JJ	_	12	amod	_	_
12	inducers	_	NNS	NNS	_	10	pobj	_	_
13	.	_	.	.	_	1	punct	_	_

1	Double-stimulation	_	NN	NN	_	3	nsubjpass	_	_
2	was	_	VBD	VBD	_	3	auxpass	_	_
3	used	_	VBN	VBN	_	0	root	_	_
4	to	_	TO	TO	_	5	aux	_	_
5	demonstrate	_	VB	VB	_	3	xcomp	_	_
6	that	_	IN	IN	_	25	mark	_	_
7	,	_	,	,	_	25	punct	_	_
8	in	_	IN	IN	_	25	prep	_	_
9	a	_	DT	DT	_	13	det	_	_
10	T	_	NN	NN	_	13	nn	_	_
11	lymphocytic	_	JJ	JJ	_	13	amod	_	_
12	cell	_	NN	NN	_	13	nn	_	_
13	line	_	NN	NN	_	8	pobj	_	_
14	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
15	CEM	_	NN	NN	_	13	appos	_	_
16	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
17	,	_	,	,	_	25	punct	_	_
18	phorbol	_	NN	NN	_	20	nn	_	_
19	myristate	_	NN	NN	_	20	nn	_	_
20	acetate	_	NN	NN	_	25	nsubj	_	_
21	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
22	PMA	_	NN	NN	_	20	appos	_	_
23	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
24	rapidly	_	RB	RB	_	25	advmod	_	_
25	induced	_	VBD	VBD	_	5	ccomp	_	_
26	NF-kappa	_	NN	NN	_	27	nn	_	_
27	B	_	NN	NN	_	25	dobj	_	_
28	through	_	IN	IN	_	25	prep	_	_
29	a	_	DT	DT	_	31	det	_	_
30	signaling	_	NN	NN	_	31	nn	_	_
31	pathway	_	NN	NN	_	28	pobj	_	_
32	which	_	WDT	WDT	_	35	nsubj	_	_
33	did	_	VBD	VBD	_	35	aux	_	_
34	not	_	RB	RB	_	35	neg	_	_
35	involve	_	VB	VB	_	25	dep	_	_
36	reactive	_	JJ	JJ	_	38	amod	_	_
37	oxygen	_	NN	NN	_	38	nn	_	_
38	species	_	NNS	NNS	_	35	dobj	_	_
39	-LRB-	_	-LRB-	-LRB-	_	40	punct	_	_
40	ROS	_	NNS	NNS	_	38	appos	_	_
41	-RRB-	_	-RRB-	-RRB-	_	40	punct	_	_
42	and	_	CC	CC	_	35	cc	_	_
43	was	_	VBD	VBD	_	44	cop	_	_
44	different	_	JJ	JJ	_	35	conj	_	_
45	from	_	IN	IN	_	44	prep	_	_
46	the	_	DT	DT	_	47	det	_	_
47	activation	_	NN	NN	_	45	pobj	_	_
48	triggered	_	VBN	VBN	_	47	vmod	_	_
49	by	_	IN	IN	_	48	prep	_	_
50	either	_	CC	CC	_	51	preconj	_	_
51	H2O2	_	NN	NN	_	49	pobj	_	_
52	or	_	CC	CC	_	51	cc	_	_
53	tumor	_	NN	NN	_	55	nn	_	_
54	necrosis	_	NN	NN	_	55	nn	_	_
55	factor-alpha	_	NN	NN	_	51	conj	_	_
56	-LRB-	_	-LRB-	-LRB-	_	57	punct	_	_
57	TNF-alpha	_	NN	NN	_	55	appos	_	_
58	-RRB-	_	-RRB-	-RRB-	_	57	punct	_	_
59	.	_	.	.	_	3	punct	_	_

1	Since	_	IN	IN	_	6	mark	_	_
2	these	_	DT	DT	_	4	det	_	_
3	latter	_	JJ	JJ	_	4	amod	_	_
4	compounds	_	NNS	NNS	_	6	nsubjpass	_	_
5	were	_	VBD	VBD	_	6	auxpass	_	_
6	known	_	VBN	VBN	_	19	advcl	_	_
7	to	_	TO	TO	_	8	aux	_	_
8	activate	_	VB	VB	_	6	xcomp	_	_
9	NF-kappa	_	NN	NN	_	10	nn	_	_
10	B	_	NN	NN	_	11	nn	_	_
11	translocation	_	NN	NN	_	8	dobj	_	_
12	in	_	IN	IN	_	8	prep	_	_
13	a	_	DT	DT	_	15	det	_	_
14	redox-sensitive	_	JJ	JJ	_	15	amod	_	_
15	way	_	NN	NN	_	12	pobj	_	_
16	,	_	,	,	_	19	punct	_	_
17	we	_	PRP	PRP	_	19	nsubj	_	_
18	have	_	VBP	VBP	_	19	aux	_	_
19	demonstrated	_	VBN	VBN	_	0	root	_	_
20	that	_	IN	IN	_	27	mark	_	_
21	NF-kappa	_	NN	NN	_	22	nn	_	_
22	B	_	NN	NN	_	23	nn	_	_
23	activation	_	NN	NN	_	27	nsubj	_	_
24	by	_	IN	IN	_	23	prep	_	_
25	PMA	_	NN	NN	_	24	pobj	_	_
26	was	_	VBD	VBD	_	27	cop	_	_
27	resistant	_	JJ	JJ	_	19	ccomp	_	_
28	to	_	TO	TO	_	27	prep	_	_
29	antioxidant	_	JJ	JJ	_	28	pobj	_	_
30	N-acetyl-L-cysteine	_	NN	NN	_	29	dep	_	_
31	-LRB-	_	-LRB-	-LRB-	_	32	punct	_	_
32	NAC	_	NN	NN	_	30	appos	_	_
33	-RRB-	_	-RRB-	-RRB-	_	32	punct	_	_
34	and	_	CC	CC	_	27	cc	_	_
35	sensitive	_	JJ	JJ	_	27	conj	_	_
36	to	_	TO	TO	_	35	prep	_	_
37	kinase	_	NN	NN	_	38	nn	_	_
38	inhibitors	_	NNS	NNS	_	36	pobj	_	_
39	staurosporine	_	NN	NN	_	38	dep	_	_
40	and	_	CC	CC	_	39	cc	_	_
41	H7	_	NN	NN	_	39	conj	_	_
42	while	_	IN	IN	_	48	mark	_	_
43	activation	_	NN	NN	_	48	nsubj	_	_
44	by	_	IN	IN	_	43	prep	_	_
45	H2O2	_	NN	NN	_	44	pobj	_	_
46	or	_	CC	CC	_	45	cc	_	_
47	TNF-alpha	_	NN	NN	_	45	conj	_	_
48	were	_	VBD	VBD	_	27	advcl	_	_
49	not	_	RB	RB	_	48	neg	_	_
50	.	_	.	.	_	19	punct	_	_

1	Association	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	glucocorticoid	_	NN	NN	_	4	nn	_	_
4	insensitivity	_	NN	NN	_	2	pobj	_	_
5	with	_	IN	IN	_	1	prep	_	_
6	increased	_	VBN	VBN	_	7	amod	_	_
7	expression	_	NN	NN	_	5	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	glucocorticoid	_	NN	NN	_	11	nn	_	_
10	receptor	_	NN	NN	_	11	nn	_	_
11	beta	_	NN	NN	_	8	pobj	_	_
12	.	_	.	.	_	1	punct	_	_

1	In	_	IN	IN	_	16	prep	_	_
2	many	_	JJ	JJ	_	5	amod	_	_
3	chronic	_	JJ	JJ	_	5	amod	_	_
4	inflammatory	_	JJ	JJ	_	5	amod	_	_
5	disorders	_	NNS	NNS	_	1	pobj	_	_
6	,	_	,	,	_	16	punct	_	_
7	glucocorticoid	_	NN	NN	_	11	nn	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	GC	_	NN	NN	_	7	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	insensitivity	_	NN	NN	_	16	nsubj	_	_
12	is	_	VBZ	VBZ	_	16	cop	_	_
13	a	_	DT	DT	_	16	det	_	_
14	challenging	_	JJ	JJ	_	16	amod	_	_
15	clinical	_	JJ	JJ	_	14	dep	_	_
16	problem	_	NN	NN	_	0	root	_	_
17	associated	_	VBN	VBN	_	16	vmod	_	_
18	with	_	IN	IN	_	17	prep	_	_
19	life-threatening	_	JJ	JJ	_	21	amod	_	_
20	disease	_	NN	NN	_	21	nn	_	_
21	progression	_	NN	NN	_	18	pobj	_	_
22	.	_	.	.	_	16	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	molecular	_	JJ	JJ	_	3	amod	_	_
3	basis	_	NN	NN	_	11	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	GC	_	NN	NN	_	6	nn	_	_
6	insensitivity	_	NN	NN	_	4	pobj	_	_
7	,	_	,	,	_	3	punct	_	_
8	however	_	RB	RB	_	11	advmod	_	_
9	,	_	,	,	_	11	punct	_	_
10	is	_	VBZ	VBZ	_	11	cop	_	_
11	unknown	_	JJ	JJ	_	0	root	_	_
12	.	_	.	.	_	11	punct	_	_

1	Alternative	_	JJ	JJ	_	2	amod	_	_
2	splicing	_	NN	NN	_	12	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	11	det	_	_
5	GC	_	NN	NN	_	11	nn	_	_
6	receptor	_	NN	NN	_	11	nn	_	_
7	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
8	R	_	NN	NN	_	11	nn	_	_
9	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
10	pre-messenger	_	NN	NN	_	11	nn	_	_
11	RNA	_	NN	NN	_	3	pobj	_	_
12	generates	_	VBZ	VBZ	_	0	root	_	_
13	a	_	DT	DT	_	15	det	_	_
14	second	_	JJ	JJ	_	15	amod	_	_
15	GCR	_	NN	NN	_	12	dobj	_	_
16	,	_	,	,	_	15	punct	_	_
17	termed	_	VBN	VBN	_	15	vmod	_	_
18	GCR-beta	_	NN	NN	_	17	dep	_	_
19	,	_	,	,	_	15	punct	_	_
20	which	_	WDT	WDT	_	23	nsubj	_	_
21	does	_	VBZ	VBZ	_	23	aux	_	_
22	not	_	RB	RB	_	23	neg	_	_
23	bind	_	VB	VB	_	15	rcmod	_	_
24	GCs	_	NNS	NNS	_	23	dobj	_	_
25	but	_	CC	CC	_	23	cc	_	_
26	antagonizes	_	VBZ	VBZ	_	23	conj	_	_
27	the	_	DT	DT	_	29	det	_	_
28	transactivating	_	NN	NN	_	29	nn	_	_
29	activity	_	NN	NN	_	26	dobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	the	_	DT	DT	_	33	det	_	_
32	classic	_	JJ	JJ	_	33	amod	_	_
33	GCR	_	NN	NN	_	30	pobj	_	_
34	,	_	,	,	_	33	punct	_	_
35	termed	_	VBN	VBN	_	33	vmod	_	_
36	GCR-alpha	_	NN	NN	_	35	dep	_	_
37	.	_	.	.	_	12	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	current	_	JJ	JJ	_	4	amod	_	_
4	study	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	7	punct	_	_
6	we	_	PRP	PRP	_	7	nsubj	_	_
7	demonstrate	_	VBP	VBP	_	0	root	_	_
8	that	_	IN	IN	_	12	mark	_	_
9	GC-insensitive	_	JJ	JJ	_	10	amod	_	_
10	asthma	_	NN	NN	_	12	nsubjpass	_	_
11	is	_	VBZ	VBZ	_	12	auxpass	_	_
12	associated	_	VBN	VBN	_	7	ccomp	_	_
13	with	_	IN	IN	_	12	prep	_	_
14	a	_	DT	DT	_	17	det	_	_
15	significantly	_	RB	RB	_	16	advmod	_	_
16	higher	_	JJR	JJR	_	17	amod	_	_
17	number	_	NN	NN	_	13	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	GCR-beta-immunoreactive	_	JJ	JJ	_	20	amod	_	_
20	cells	_	NNS	NNS	_	18	pobj	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	peripheral	_	JJ	JJ	_	23	amod	_	_
23	blood	_	NN	NN	_	21	pobj	_	_
24	than	_	IN	IN	_	26	mark	_	_
25	GC-sensitive	_	JJ	JJ	_	26	amod	_	_
26	asthmatics	_	NNS	NNS	_	17	dep	_	_
27	or	_	CC	CC	_	26	cc	_	_
28	normal	_	JJ	JJ	_	29	amod	_	_
29	controls	_	NNS	NNS	_	26	conj	_	_
30	.	_	.	.	_	7	punct	_	_

1	Furthermore	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	show	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	10	mark	_	_
6	patients	_	NNS	NNS	_	10	nsubj	_	_
7	with	_	IN	IN	_	6	prep	_	_
8	GC-insensitive	_	JJ	JJ	_	9	amod	_	_
9	asthma	_	NN	NN	_	7	pobj	_	_
10	have	_	VBP	VBP	_	4	ccomp	_	_
11	cytokine-induced	_	JJ	JJ	_	12	amod	_	_
12	abnormalities	_	NNS	NNS	_	10	dobj	_	_
13	in	_	IN	IN	_	10	prep	_	_
14	the	_	DT	DT	_	17	det	_	_
15	DNA	_	NN	NN	_	17	nn	_	_
16	binding	_	NN	NN	_	17	nn	_	_
17	capability	_	NN	NN	_	13	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	20	det	_	_
20	GCR	_	NN	NN	_	18	pobj	_	_
21	.	_	.	.	_	4	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	abnormalities	_	NNS	NNS	_	5	nsubjpass	_	_
3	can	_	MD	MD	_	5	aux	_	_
4	be	_	VB	VB	_	5	auxpass	_	_
5	reproduced	_	VBN	VBN	_	0	root	_	_
6	by	_	IN	IN	_	5	prep	_	_
7	transfection	_	NN	NN	_	6	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	cell	_	NN	NN	_	10	nn	_	_
10	lines	_	NNS	NNS	_	8	pobj	_	_
11	with	_	IN	IN	_	7	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	GCR-beta	_	NN	NN	_	14	nn	_	_
14	gene	_	NN	NN	_	11	pobj	_	_
15	resulting	_	VBG	VBG	_	5	xcomp	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	significant	_	JJ	JJ	_	18	amod	_	_
18	reduction	_	NN	NN	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	their	_	PRP$	PRP$	_	24	poss	_	_
21	GCR-alpha	_	NN	NN	_	24	nn	_	_
22	DNA	_	NN	NN	_	24	nn	_	_
23	binding	_	NN	NN	_	24	nn	_	_
24	capacity	_	NN	NN	_	19	pobj	_	_
25	.	_	.	.	_	5	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	conclude	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	10	mark	_	_
4	increased	_	VBN	VBN	_	5	amod	_	_
5	expression	_	NN	NN	_	10	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	GCR-beta	_	NN	NN	_	6	pobj	_	_
8	is	_	VBZ	VBZ	_	10	cop	_	_
9	cytokine	_	NN	NN	_	10	npadvmod	_	_
10	inducible	_	JJ	JJ	_	2	ccomp	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	may	_	MD	MD	_	13	aux	_	_
13	account	_	VB	VB	_	10	conj	_	_
14	for	_	IN	IN	_	13	prep	_	_
15	GC	_	NN	NN	_	16	nn	_	_
16	insensitivity	_	NN	NN	_	14	pobj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	this	_	DT	DT	_	21	det	_	_
19	common	_	JJ	JJ	_	21	amod	_	_
20	inflammatory	_	JJ	JJ	_	19	dep	_	_
21	condition	_	NN	NN	_	17	pobj	_	_
22	.	_	.	.	_	2	punct	_	_

1	Inhibition	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	T	_	NN	NN	_	4	nn	_	_
4	cell	_	NN	NN	_	2	pobj	_	_
5	and	_	CC	CC	_	1	cc	_	_
6	promotion	_	NN	NN	_	1	conj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	natural	_	JJ	JJ	_	11	amod	_	_
9	killer	_	NN	NN	_	11	nn	_	_
10	cell	_	NN	NN	_	11	nn	_	_
11	development	_	NN	NN	_	7	pobj	_	_
12	by	_	IN	IN	_	1	prep	_	_
13	the	_	DT	DT	_	19	det	_	_
14	dominant	_	JJ	JJ	_	19	amod	_	_
15	negative	_	JJ	JJ	_	19	amod	_	_
16	helix	_	NN	NN	_	19	nn	_	_
17	loop	_	NN	NN	_	19	nn	_	_
18	helix	_	NN	NN	_	19	nn	_	_
19	factor	_	NN	NN	_	12	pobj	_	_
20	Id3	_	NN	NN	_	19	dep	_	_
21	.	_	.	.	_	1	punct	_	_

1	Bipotential	_	JJ	JJ	_	8	amod	_	_
2	T/natural	_	JJ	JJ	_	8	amod	_	_
3	killer	_	NN	NN	_	8	nn	_	_
4	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
5	NK	_	NN	NN	_	8	nn	_	_
6	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
7	progenitor	_	NN	NN	_	8	nn	_	_
8	cells	_	NNS	NNS	_	10	nsubj	_	_
9	are	_	VBP	VBP	_	10	cop	_	_
10	present	_	JJ	JJ	_	0	root	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	human	_	JJ	JJ	_	14	amod	_	_
14	thymus	_	NN	NN	_	11	pobj	_	_
15	.	_	.	.	_	10	punct	_	_

1	Despite	_	IN	IN	_	8	prep	_	_
2	their	_	PRP$	PRP$	_	4	poss	_	_
3	bipotential	_	JJ	JJ	_	4	amod	_	_
4	capacity	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	8	punct	_	_
6	these	_	DT	DT	_	7	det	_	_
7	progenitors	_	NNS	NNS	_	8	nsubj	_	_
8	develop	_	VBP	VBP	_	0	root	_	_
9	predominantly	_	RB	RB	_	10	advmod	_	_
10	to	_	TO	TO	_	8	prep	_	_
11	T	_	NN	NN	_	12	nn	_	_
12	cells	_	NNS	NNS	_	10	pobj	_	_
13	in	_	IN	IN	_	8	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	thymus	_	NN	NN	_	13	pobj	_	_
16	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	mechanisms	_	NNS	NNS	_	8	nsubj	_	_
3	controlling	_	VBG	VBG	_	2	vmod	_	_
4	this	_	DT	DT	_	6	det	_	_
5	developmental	_	JJ	JJ	_	6	amod	_	_
6	choice	_	NN	NN	_	3	dobj	_	_
7	are	_	VBP	VBP	_	8	cop	_	_
8	unknown	_	JJ	JJ	_	0	root	_	_
9	.	_	.	.	_	8	punct	_	_

1	Here	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	present	_	VBP	VBP	_	0	root	_	_
4	evidence	_	NN	NN	_	3	dobj	_	_
5	that	_	IN	IN	_	24	mark	_	_
6	a	_	DT	DT	_	9	det	_	_
7	member	_	NN	NN	_	9	nn	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	s	_	NNS	NNS	_	24	nsubj	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	of	_	IN	IN	_	9	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	family	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	basic	_	JJ	JJ	_	23	amod	_	_
16	helix	_	NN	NN	_	23	nn	_	_
17	loop	_	NN	NN	_	23	nn	_	_
18	helix	_	NN	NN	_	23	nn	_	_
19	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
20	bHLH	_	JJ	JJ	_	23	amod	_	_
21	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
22	transcription	_	NN	NN	_	23	nn	_	_
23	factors	_	NNS	NNS	_	14	pobj	_	_
24	determines	_	VBZ	VBZ	_	4	ccomp	_	_
25	lineage	_	NN	NN	_	26	nn	_	_
26	specification	_	NN	NN	_	24	dobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	NK/T	_	NN	NN	_	30	nn	_	_
29	cell	_	NN	NN	_	30	nn	_	_
30	progenitors	_	NNS	NNS	_	27	pobj	_	_
31	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	6	det	_	_
2	natural	_	JJ	JJ	_	6	amod	_	_
3	dominant	_	JJ	JJ	_	6	amod	_	_
4	negative	_	JJ	JJ	_	6	amod	_	_
5	HLH	_	JJ	JJ	_	6	amod	_	_
6	factor	_	NN	NN	_	22	nsubjpass	_	_
7	Id3	_	NN	NN	_	6	dep	_	_
8	,	_	,	,	_	6	punct	_	_
9	which	_	WDT	WDT	_	10	nsubj	_	_
10	blocks	_	VBZ	VBZ	_	6	rcmod	_	_
11	transcriptional	_	JJ	JJ	_	12	amod	_	_
12	activity	_	NN	NN	_	10	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	a	_	DT	DT	_	15	det	_	_
15	number	_	NN	NN	_	13	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	known	_	JJ	JJ	_	19	amod	_	_
18	bHLH	_	JJ	JJ	_	19	amod	_	_
19	factors	_	NNS	NNS	_	16	pobj	_	_
20	,	_	,	,	_	6	punct	_	_
21	was	_	VBD	VBD	_	22	auxpass	_	_
22	expressed	_	VBN	VBN	_	0	root	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	CD34+	_	JJ	JJ	_	26	amod	_	_
25	progenitor	_	NN	NN	_	26	nn	_	_
26	cells	_	NNS	NNS	_	23	pobj	_	_
27	by	_	IN	IN	_	22	prep	_	_
28	retrovirus-mediated	_	JJ	JJ	_	30	amod	_	_
29	gene	_	NN	NN	_	30	nn	_	_
30	transfer	_	NN	NN	_	27	pobj	_	_
31	.	_	.	.	_	22	punct	_	_

1	Constitutive	_	JJ	JJ	_	2	amod	_	_
2	expression	_	NN	NN	_	6	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	Id3	_	NN	NN	_	3	pobj	_	_
5	completely	_	RB	RB	_	6	advmod	_	_
6	blocks	_	VBZ	VBZ	_	0	root	_	_
7	development	_	NN	NN	_	6	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	CD34+	_	JJ	JJ	_	10	amod	_	_
10	cells	_	NNS	NNS	_	8	pobj	_	_
11	into	_	IN	IN	_	7	prep	_	_
12	T	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	11	pobj	_	_
14	in	_	IN	IN	_	7	prep	_	_
15	a	_	DT	DT	_	19	det	_	_
16	fetal	_	JJ	JJ	_	19	amod	_	_
17	thymic	_	JJ	JJ	_	19	amod	_	_
18	organ	_	NN	NN	_	19	nn	_	_
19	culture	_	NN	NN	_	14	pobj	_	_
20	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
21	FTOC	_	NN	NN	_	19	appos	_	_
22	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
23	.	_	.	.	_	6	punct	_	_

1	In	_	IN	IN	_	12	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	12	punct	_	_
4	development	_	NN	NN	_	12	nsubjpass	_	_
5	into	_	IN	IN	_	4	prep	_	_
6	NK	_	NN	NN	_	7	nn	_	_
7	cells	_	NNS	NNS	_	5	pobj	_	_
8	in	_	IN	IN	_	4	prep	_	_
9	an	_	DT	DT	_	10	det	_	_
10	FTOC	_	NN	NN	_	8	pobj	_	_
11	is	_	VBZ	VBZ	_	12	auxpass	_	_
12	enhanced	_	VBN	VBN	_	0	root	_	_
13	.	_	.	.	_	12	punct	_	_

1	Thus	_	RB	RB	_	11	advmod	_	_
2	,	_	,	,	_	11	punct	_	_
3	the	_	DT	DT	_	4	det	_	_
4	activity	_	NN	NN	_	11	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	a	_	DT	DT	_	9	det	_	_
7	bHLH	_	JJ	JJ	_	9	amod	_	_
8	transcription	_	NN	NN	_	9	nn	_	_
9	factor	_	NN	NN	_	5	pobj	_	_
10	is	_	VBZ	VBZ	_	11	cop	_	_
11	necessary	_	JJ	JJ	_	0	root	_	_
12	for	_	IN	IN	_	11	prep	_	_
13	T	_	NN	NN	_	15	nn	_	_
14	lineage	_	NN	NN	_	15	nn	_	_
15	differentiation	_	NN	NN	_	12	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	bipotential	_	JJ	JJ	_	18	amod	_	_
18	precursors	_	NNS	NNS	_	16	pobj	_	_
19	,	_	,	,	_	18	punct	_	_
20	in	_	IN	IN	_	34	prep	_	_
21	the	_	DT	DT	_	22	det	_	_
22	absence	_	NN	NN	_	20	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	which	_	WDT	WDT	_	23	pobj	_	_
25	a	_	DT	DT	_	27	det	_	_
26	default	_	NN	NN	_	27	nn	_	_
27	pathway	_	NN	NN	_	34	nsubjpass	_	_
28	leading	_	VBG	VBG	_	27	vmod	_	_
29	to	_	TO	TO	_	28	prep	_	_
30	NK	_	NN	NN	_	32	nn	_	_
31	cell	_	NN	NN	_	32	nn	_	_
32	development	_	NN	NN	_	29	pobj	_	_
33	is	_	VBZ	VBZ	_	34	auxpass	_	_
34	chosen	_	VBN	VBN	_	18	rcmod	_	_
35	.	_	.	.	_	11	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	identify	_	VBP	VBP	_	0	root	_	_
4	a	_	DT	DT	_	6	det	_	_
5	molecular	_	JJ	JJ	_	6	amod	_	_
6	switch	_	NN	NN	_	3	dobj	_	_
7	for	_	IN	IN	_	6	prep	_	_
8	lineage	_	NN	NN	_	9	nn	_	_
9	specification	_	NN	NN	_	7	pobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	early	_	JJ	JJ	_	13	amod	_	_
12	lymphoid	_	JJ	JJ	_	13	amod	_	_
13	precursors	_	NNS	NNS	_	10	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	humans	_	NNS	NNS	_	14	pobj	_	_
16	.	_	.	.	_	3	punct	_	_

1	Suppression	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	MHC	_	NN	NN	_	4	nn	_	_
4	class	_	NN	NN	_	6	nn	_	_
5	II	_	CD	CD	_	4	num	_	_
6	expression	_	NN	NN	_	2	pobj	_	_
7	by	_	IN	IN	_	1	prep	_	_
8	human	_	JJ	JJ	_	12	amod	_	_
9	class	_	NN	NN	_	12	nn	_	_
10	II	_	CD	CD	_	12	num	_	_
11	trans-activator	_	NN	NN	_	12	nn	_	_
12	constructs	_	NNS	NNS	_	7	pobj	_	_
13	lacking	_	VBG	VBG	_	12	vmod	_	_
14	the	_	DT	DT	_	16	det	_	_
15	N-terminal	_	JJ	JJ	_	16	amod	_	_
16	domain	_	NN	NN	_	13	dobj	_	_
17	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	class	_	NN	NN	_	4	nn	_	_
3	II	_	CD	CD	_	4	num	_	_
4	trans-activator	_	NN	NN	_	14	nsubj	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	CIITA	_	NN	NN	_	4	appos	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	is	_	VBZ	VBZ	_	14	cop	_	_
9	a	_	DT	DT	_	14	det	_	_
10	bi-	_	RB	RB	_	14	nn	_	_
11	or	_	CC	CC	_	10	cc	_	_
12	multi-functional	_	JJ	JJ	_	10	conj	_	_
13	domain	_	NN	NN	_	14	nn	_	_
14	protein	_	NN	NN	_	0	root	_	_
15	which	_	WDT	WDT	_	16	nsubj	_	_
16	plays	_	VBZ	VBZ	_	14	rcmod	_	_
17	a	_	DT	DT	_	19	det	_	_
18	critical	_	JJ	JJ	_	19	amod	_	_
19	role	_	NN	NN	_	16	dobj	_	_
20	in	_	IN	IN	_	16	prep	_	_
21	the	_	DT	DT	_	22	det	_	_
22	expression	_	NN	NN	_	20	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	MHC	_	NN	NN	_	27	nn	_	_
25	class	_	NN	NN	_	27	nn	_	_
26	II	_	CD	CD	_	27	num	_	_
27	genes	_	NNS	NNS	_	23	pobj	_	_
28	.	_	.	.	_	14	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	report	_	VBP	VBP	_	0	root	_	_
3	that	_	DT	DT	_	25	mark	_	_
4	removal	_	NN	NN	_	25	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	10	det	_	_
7	N-terminal	_	JJ	JJ	_	10	amod	_	_
8	151	_	CD	CD	_	10	num	_	_
9	amino	_	NN	NN	_	10	nn	_	_
10	acids	_	NNS	NNS	_	5	pobj	_	_
11	,	_	,	,	_	4	punct	_	_
12	encompassing	_	VBG	VBG	_	4	dep	_	_
13	all	_	DT	DT	_	12	dobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	17	det	_	_
16	acidic	_	JJ	JJ	_	17	amod	_	_
17	domain	_	NN	NN	_	14	pobj	_	_
18	but	_	CC	CC	_	12	cc	_	_
19	leaving	_	VBG	VBG	_	12	conj	_	_
20	intact	_	JJ	JJ	_	19	dep	_	_
21	the	_	DT	DT	_	23	det	_	_
22	proline/serine/threonine-rich	_	JJ	JJ	_	23	amod	_	_
23	domain	_	NN	NN	_	20	dep	_	_
24	,	_	,	,	_	4	punct	_	_
25	results	_	VBZ	VBZ	_	2	ccomp	_	_
26	in	_	IN	IN	_	25	prep	_	_
27	a	_	DT	DT	_	29	det	_	_
28	mutant	_	JJ	JJ	_	29	amod	_	_
29	protein	_	NN	NN	_	26	pobj	_	_
30	with	_	IN	IN	_	29	prep	_	_
31	potent	_	JJ	JJ	_	33	amod	_	_
32	suppressive	_	JJ	JJ	_	31	dep	_	_
33	properties	_	NNS	NNS	_	30	pobj	_	_
34	for	_	IN	IN	_	33	prep	_	_
35	MHC	_	NN	NN	_	36	nn	_	_
36	class	_	NN	NN	_	38	nn	_	_
37	II	_	CD	CD	_	36	num	_	_
38	expression	_	NN	NN	_	34	pobj	_	_
39	.	_	.	.	_	2	punct	_	_

1	HeLa	_	NN	NN	_	2	nn	_	_
2	cells	_	NNS	NNS	_	11	nsubj	_	_
3	stably	_	RB	RB	_	6	advmod	_	_
4	or	_	CC	CC	_	3	cc	_	_
5	transiently	_	RB	RB	_	3	conj	_	_
6	transfected	_	VBN	VBN	_	2	vmod	_	_
7	with	_	IN	IN	_	6	prep	_	_
8	mutant	_	JJ	JJ	_	10	amod	_	_
9	CIITA	_	NN	NN	_	10	nn	_	_
10	constructs	_	NNS	NNS	_	7	pobj	_	_
11	showed	_	VBD	VBD	_	0	root	_	_
12	up	_	RB	RB	_	14	quantmod	_	_
13	to	_	TO	TO	_	14	dep	_	_
14	99	_	CD	CD	_	15	dep	_	_
15	%	_	NN	NN	_	16	dep	_	_
16	suppression	_	NN	NN	_	11	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	MHC	_	NN	NN	_	19	nn	_	_
19	class	_	NN	NN	_	22	nn	_	_
20	II	_	CD	CD	_	19	num	_	_
21	antigen	_	NN	NN	_	22	nn	_	_
22	induction	_	NN	NN	_	17	pobj	_	_
23	by	_	IN	IN	_	22	prep	_	_
24	IFN-gamma	_	NN	NN	_	23	pobj	_	_
25	and	_	CC	CC	_	16	cc	_	_
26	marked	_	JJ	JJ	_	27	amod	_	_
27	suppression	_	NN	NN	_	16	conj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	HLA-DRA	_	NN	NN	_	30	nn	_	_
30	mRNA	_	NN	NN	_	31	nn	_	_
31	expression	_	NN	NN	_	28	pobj	_	_
32	.	_	.	.	_	11	punct	_	_

1	Transient	_	JJ	JJ	_	2	amod	_	_
2	transfection	_	NN	NN	_	8	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	a	_	DT	DT	_	7	det	_	_
5	B	_	NN	NN	_	7	nn	_	_
6	lymphoma	_	NN	NN	_	7	nn	_	_
7	line	_	NN	NN	_	3	pobj	_	_
8	resulted	_	VBD	VBD	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	up	_	RB	RB	_	12	quantmod	_	_
11	to	_	TO	TO	_	12	dep	_	_
12	89	_	CD	CD	_	13	dep	_	_
13	%	_	NN	NN	_	14	dep	_	_
14	reduction	_	NN	NN	_	9	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	constitutive	_	JJ	JJ	_	20	amod	_	_
17	MHC	_	NN	NN	_	18	nn	_	_
18	class	_	NN	NN	_	20	nn	_	_
19	II	_	CD	CD	_	18	num	_	_
20	expression	_	NN	NN	_	15	pobj	_	_
21	within	_	IN	IN	_	14	prep	_	_
22	5	_	CD	CD	_	23	num	_	_
23	days	_	NNS	NNS	_	21	pobj	_	_
24	and	_	CC	CC	_	14	cc	_	_
25	suppression	_	NN	NN	_	14	conj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	HLA-DRA	_	NN	NN	_	28	nn	_	_
28	mRNA	_	NN	NN	_	29	nn	_	_
29	synthesis	_	NN	NN	_	26	pobj	_	_
30	.	_	.	.	_	8	punct	_	_

1	Inhibition	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	proliferation	_	NN	NN	_	2	pobj	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	apoptosis	_	NN	NN	_	3	conj	_	_
6	of	_	IN	IN	_	3	prep	_	_
7	human	_	JJ	JJ	_	6	pobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	rat	_	NN	NN	_	7	conj	_	_
10	T	_	NN	NN	_	11	nn	_	_
11	lymphocytes	_	NNS	NNS	_	7	dep	_	_
12	by	_	IN	IN	_	1	prep	_	_
13	curcumin	_	NN	NN	_	12	pobj	_	_
14	,	_	,	,	_	13	punct	_	_
15	a	_	DT	DT	_	17	det	_	_
16	curry	_	NN	NN	_	17	nn	_	_
17	pigment	_	NN	NN	_	13	appos	_	_
18	.	_	.	.	_	1	punct	_	_

1	Curcumin	_	NN	NN	_	26	nsubjpass	_	_
2	-LRB-	_	-LRB-	-LRB-	_	3	punct	_	_
3	diferuoylmethane	_	NN	NN	_	1	appos	_	_
4	-RRB-	_	-RRB-	-RRB-	_	3	punct	_	_
5	,	_	,	,	_	1	punct	_	_
6	the	_	DT	DT	_	8	det	_	_
7	yellow	_	JJ	JJ	_	8	amod	_	_
8	pigment	_	NN	NN	_	1	appos	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	rhizome	_	NN	NN	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	tumeric	_	JJ	JJ	_	12	pobj	_	_
14	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
15	Curcuma	_	FW	FW	_	16	nn	_	_
16	longa	_	FW	FW	_	13	dep	_	_
17	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
18	,	_	,	,	_	1	punct	_	_
19	an	_	DT	DT	_	20	det	_	_
20	ingredient	_	NN	NN	_	1	appos	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	curry	_	NN	NN	_	23	nn	_	_
23	spice	_	NN	NN	_	21	pobj	_	_
24	,	_	,	,	_	1	punct	_	_
25	is	_	VBZ	VBZ	_	26	auxpass	_	_
26	known	_	VBN	VBN	_	0	root	_	_
27	to	_	TO	TO	_	28	aux	_	_
28	exhibit	_	VB	VB	_	26	xcomp	_	_
29	a	_	DT	DT	_	30	det	_	_
30	variety	_	NN	NN	_	28	dobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	pharmacological	_	JJ	JJ	_	33	amod	_	_
33	effects	_	NNS	NNS	_	31	pobj	_	_
34	including	_	VBG	VBG	_	30	prep	_	_
35	antitumor	_	JJ	JJ	_	34	pobj	_	_
36	,	_	,	,	_	35	punct	_	_
37	antiinflammatory	_	JJ	JJ	_	35	conj	_	_
38	,	_	,	,	_	35	punct	_	_
39	and	_	CC	CC	_	35	cc	_	_
40	antiinfectious	_	JJ	JJ	_	35	conj	_	_
41	activities	_	NNS	NNS	_	35	dep	_	_
42	.	_	.	.	_	26	punct	_	_

1	Although	_	IN	IN	_	7	mark	_	_
2	its	_	PRP$	PRP$	_	4	poss	_	_
3	precise	_	JJ	JJ	_	4	amod	_	_
4	mode	_	NN	NN	_	7	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	action	_	NN	NN	_	5	pobj	_	_
7	remains	_	VBZ	VBZ	_	13	advcl	_	_
8	elusive	_	JJ	JJ	_	7	acomp	_	_
9	,	_	,	,	_	13	punct	_	_
10	curcumin	_	NN	NN	_	13	nsubjpass	_	_
11	has	_	VBZ	VBZ	_	13	aux	_	_
12	been	_	VBN	VBN	_	13	auxpass	_	_
13	shown	_	VBN	VBN	_	0	root	_	_
14	to	_	TO	TO	_	15	aux	_	_
15	suppress	_	VB	VB	_	13	xcomp	_	_
16	the	_	DT	DT	_	17	det	_	_
17	activity	_	NN	NN	_	15	dobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	20	det	_	_
20	AP-1	_	NN	NN	_	18	pobj	_	_
21	transcription	_	NN	NN	_	22	nn	_	_
22	factor	_	NN	NN	_	20	dep	_	_
23	in	_	IN	IN	_	17	prep	_	_
24	cells	_	NNS	NNS	_	23	pobj	_	_
25	stimulated	_	VBN	VBN	_	24	vmod	_	_
26	to	_	TO	TO	_	27	aux	_	_
27	proliferate	_	VB	VB	_	25	xcomp	_	_
28	.	_	.	.	_	13	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	study	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	observed	_	VBD	VBD	_	0	root	_	_
7	that	_	IN	IN	_	13	mark	_	_
8	curcumin	_	NN	NN	_	13	nsubj	_	_
9	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
10	50	_	CD	CD	_	11	num	_	_
11	microM	_	NN	NN	_	8	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	inhibited	_	VBD	VBD	_	6	ccomp	_	_
14	proliferation	_	NN	NN	_	13	dobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	rat	_	NN	NN	_	17	nn	_	_
17	thymocytes	_	NNS	NNS	_	15	pobj	_	_
18	stimulated	_	VBN	VBN	_	17	vmod	_	_
19	with	_	IN	IN	_	18	prep	_	_
20	concanavalin	_	NN	NN	_	21	nn	_	_
21	A	_	NN	NN	_	19	pobj	_	_
22	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
23	Con	_	NN	NN	_	24	nn	_	_
24	A	_	NN	NN	_	21	appos	_	_
25	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
26	as	_	RB	RB	_	27	advmod	_	_
27	well	_	RB	RB	_	14	cc	_	_
28	as	_	IN	IN	_	27	mwe	_	_
29	that	_	DT	DT	_	14	conj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	human	_	JJ	JJ	_	34	amod	_	_
32	Jurkat	_	NN	NN	_	34	nn	_	_
33	lymphoblastoid	_	JJ	JJ	_	34	amod	_	_
34	cells	_	NNS	NNS	_	30	pobj	_	_
35	in	_	IN	IN	_	34	prep	_	_
36	the	_	DT	DT	_	39	det	_	_
37	logarithmic	_	JJ	JJ	_	39	amod	_	_
38	growth	_	NN	NN	_	39	nn	_	_
39	phase	_	NN	NN	_	35	pobj	_	_
40	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	pigment	_	NN	NN	_	4	nsubj	_	_
3	also	_	RB	RB	_	4	advmod	_	_
4	inhibited	_	VBD	VBD	_	0	root	_	_
5	apoptosis	_	NN	NN	_	4	dobj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	dexamethasone-treated	_	JJ	JJ	_	9	amod	_	_
8	rat	_	NN	NN	_	9	nn	_	_
9	thymocytes	_	NNS	NNS	_	6	pobj	_	_
10	and	_	CC	CC	_	6	cc	_	_
11	in	_	IN	IN	_	6	conj	_	_
12	UV-irradiated	_	JJ	JJ	_	14	amod	_	_
13	Jurkat	_	NN	NN	_	14	nn	_	_
14	cells	_	NNS	NNS	_	11	pobj	_	_
15	as	_	IN	IN	_	16	mark	_	_
16	judged	_	VBN	VBN	_	4	advcl	_	_
17	by	_	IN	IN	_	16	prep	_	_
18	DNA	_	NN	NN	_	20	nn	_	_
19	ladder	_	NN	NN	_	20	nn	_	_
20	formation	_	NN	NN	_	17	pobj	_	_
21	,	_	,	,	_	20	punct	_	_
22	cellular	_	JJ	JJ	_	24	amod	_	_
23	morphological	_	JJ	JJ	_	24	amod	_	_
24	changes	_	NNS	NNS	_	20	conj	_	_
25	,	_	,	,	_	20	punct	_	_
26	and	_	CC	CC	_	20	cc	_	_
27	flow	_	NN	NN	_	28	nn	_	_
28	cytometry	_	NN	NN	_	20	conj	_	_
29	analysis	_	NN	NN	_	20	dep	_	_
30	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	inhibition	_	NN	NN	_	11	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	apoptosis	_	NN	NN	_	3	pobj	_	_
5	by	_	IN	IN	_	2	prep	_	_
6	curcumin	_	NN	NN	_	5	pobj	_	_
7	in	_	IN	IN	_	2	prep	_	_
8	rat	_	NN	NN	_	9	nn	_	_
9	thymocytes	_	NNS	NNS	_	7	pobj	_	_
10	was	_	VBD	VBD	_	11	auxpass	_	_
11	accompanied	_	VBN	VBN	_	0	root	_	_
12	by	_	IN	IN	_	11	prep	_	_
13	partial	_	JJ	JJ	_	14	amod	_	_
14	suppression	_	NN	NN	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	AP-1	_	NN	NN	_	17	nn	_	_
17	activity	_	NN	NN	_	15	pobj	_	_
18	.	_	.	.	_	11	punct	_	_

1	Complete	_	JJ	JJ	_	2	amod	_	_
2	suppression	_	NN	NN	_	7	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	AP-1	_	NN	NN	_	5	nn	_	_
5	activity	_	NN	NN	_	3	pobj	_	_
6	was	_	VBD	VBD	_	7	auxpass	_	_
7	observed	_	VBN	VBN	_	0	root	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	Con	_	NN	NN	_	13	nn	_	_
10	A-treated	_	NN	NN	_	13	nn	_	_
11	,	_	,	,	_	13	punct	_	_
12	proliferating	_	VBG	VBG	_	13	amod	_	_
13	thymocytes	_	NNS	NNS	_	8	pobj	_	_
14	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	capacity	_	NN	NN	_	13	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	curcumin	_	NN	NN	_	3	pobj	_	_
5	to	_	TO	TO	_	6	aux	_	_
6	inhibit	_	VB	VB	_	2	vmod	_	_
7	both	_	CC	CC	_	8	preconj	_	_
8	cell	_	NN	NN	_	6	dobj	_	_
9	growth	_	NN	NN	_	8	dep	_	_
10	and	_	CC	CC	_	8	cc	_	_
11	death	_	NN	NN	_	8	conj	_	_
12	strongly	_	RB	RB	_	13	advmod	_	_
13	implies	_	VBZ	VBZ	_	0	root	_	_
14	that	_	IN	IN	_	19	mark	_	_
15	these	_	DT	DT	_	18	det	_	_
16	two	_	CD	CD	_	18	num	_	_
17	biological	_	JJ	JJ	_	18	amod	_	_
18	processes	_	NNS	NNS	_	19	nsubj	_	_
19	share	_	VBP	VBP	_	13	ccomp	_	_
20	a	_	DT	DT	_	22	det	_	_
21	common	_	JJ	JJ	_	22	amod	_	_
22	pathway	_	NN	NN	_	19	dobj	_	_
23	at	_	IN	IN	_	19	prep	_	_
24	some	_	DT	DT	_	25	det	_	_
25	point	_	NN	NN	_	23	pobj	_	_
26	and	_	CC	CC	_	19	cc	_	_
27	that	_	IN	IN	_	29	mark	_	_
28	curcumin	_	NN	NN	_	29	nsubj	_	_
29	affects	_	VBZ	VBZ	_	19	conj	_	_
30	a	_	DT	DT	_	32	det	_	_
31	common	_	JJ	JJ	_	32	amod	_	_
32	step	_	NN	NN	_	29	dobj	_	_
33	,	_	,	,	_	32	punct	_	_
34	presumably	_	RB	RB	_	35	advmod	_	_
35	involving	_	VBG	VBG	_	32	vmod	_	_
36	a	_	DT	DT	_	37	det	_	_
37	modulation	_	NN	NN	_	35	dobj	_	_
38	of	_	IN	IN	_	37	prep	_	_
39	the	_	DT	DT	_	40	det	_	_
40	AP-1	_	NN	NN	_	38	pobj	_	_
41	transcription	_	NN	NN	_	42	nn	_	_
42	factor	_	NN	NN	_	40	dep	_	_
43	.	_	.	.	_	13	punct	_	_

1	Nuclear	_	JJ	JJ	_	2	amod	_	_
2	localization	_	NN	NN	_	6	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	RelB	_	NN	NN	_	3	pobj	_	_
5	is	_	VBZ	VBZ	_	6	auxpass	_	_
6	associated	_	VBN	VBN	_	0	root	_	_
7	with	_	IN	IN	_	6	prep	_	_
8	effective	_	JJ	JJ	_	11	amod	_	_
9	antigen-presenting	_	JJ	JJ	_	8	dep	_	_
10	cell	_	NN	NN	_	11	nn	_	_
11	function	_	NN	NN	_	7	pobj	_	_
12	.	_	.	.	_	6	punct	_	_

1	Dendritic	_	JJ	JJ	_	2	amod	_	_
2	cells	_	NNS	NNS	_	8	nsubj	_	_
3	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
4	DC	_	NNS	NNS	_	2	appos	_	_
5	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
6	are	_	VBP	VBP	_	8	cop	_	_
7	potent	_	JJ	JJ	_	8	amod	_	_
8	APCs	_	NNS	NNS	_	0	root	_	_
9	that	_	WDT	WDT	_	10	nsubj	_	_
10	enter	_	VBP	VBP	_	8	rcmod	_	_
11	resting	_	VBG	VBG	_	12	amod	_	_
12	tissues	_	NNS	NNS	_	10	dobj	_	_
13	as	_	IN	IN	_	10	prep	_	_
14	precursors	_	NNS	NNS	_	13	pobj	_	_
15	and	_	CC	CC	_	10	cc	_	_
16	,	_	,	,	_	10	punct	_	_
17	after	_	IN	IN	_	21	prep	_	_
18	Ag	_	NN	NN	_	19	nn	_	_
19	exposure	_	NN	NN	_	17	pobj	_	_
20	,	_	,	,	_	21	punct	_	_
21	differentiate	_	VBP	VBP	_	10	conj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	migrate	_	VBP	VBP	_	21	conj	_	_
24	to	_	TO	TO	_	23	prep	_	_
25	draining	_	VBG	VBG	_	27	amod	_	_
26	lymph	_	NN	NN	_	27	nn	_	_
27	nodes	_	NNS	NNS	_	24	pobj	_	_
28	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	phenotype	_	NN	NN	_	7	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	RelB	_	NN	NN	_	6	nn	_	_
5	knockout	_	NN	NN	_	6	nn	_	_
6	mice	_	NNS	NNS	_	3	pobj	_	_
7	implicates	_	VBZ	VBZ	_	0	root	_	_
8	this	_	DT	DT	_	9	det	_	_
9	member	_	NN	NN	_	7	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	15	det	_	_
12	NF	_	NN	NN	_	15	nn	_	_
13	kappa	_	NN	NN	_	15	nn	_	_
14	B/Rel	_	NN	NN	_	15	nn	_	_
15	family	_	NN	NN	_	10	pobj	_	_
16	in	_	IN	IN	_	7	prep	_	_
17	DC	_	NNS	NNS	_	18	nn	_	_
18	differentiation	_	NN	NN	_	16	pobj	_	_
19	.	_	.	.	_	7	punct	_	_

1	To	_	TO	TO	_	3	aux	_	_
2	further	_	RB	RB	_	3	advmod	_	_
3	elucidate	_	VB	VB	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	role	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	RelB	_	NN	NN	_	6	pobj	_	_
8	in	_	IN	IN	_	5	prep	_	_
9	DC	_	NNS	NNS	_	10	nn	_	_
10	differentiation	_	NN	NN	_	8	pobj	_	_
11	,	_	,	,	_	3	punct	_	_
12	mRNA	_	NN	NN	_	25	nsubjpass	_	_
13	,	_	,	,	_	12	punct	_	_
14	intracellular	_	JJ	JJ	_	16	amod	_	_
15	protein	_	NN	NN	_	16	nn	_	_
16	expression	_	NN	NN	_	12	conj	_	_
17	,	_	,	,	_	12	punct	_	_
18	and	_	CC	CC	_	12	cc	_	_
19	DNA	_	NN	NN	_	21	nn	_	_
20	binding	_	NN	NN	_	21	nn	_	_
21	activity	_	NN	NN	_	12	conj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	RelB	_	NN	NN	_	22	pobj	_	_
24	were	_	VBD	VBD	_	25	auxpass	_	_
25	examined	_	VBN	VBN	_	3	parataxis	_	_
26	in	_	IN	IN	_	25	prep	_	_
27	immature	_	JJ	JJ	_	26	pobj	_	_
28	and	_	CC	CC	_	27	cc	_	_
29	differentiated	_	VBN	VBN	_	27	conj	_	_
30	human	_	JJ	JJ	_	31	amod	_	_
31	DC	_	NNS	NNS	_	27	dep	_	_
32	,	_	,	,	_	27	punct	_	_
33	as	_	RB	RB	_	34	advmod	_	_
34	well	_	RB	RB	_	27	cc	_	_
35	as	_	IN	IN	_	34	mwe	_	_
36	other	_	JJ	JJ	_	40	amod	_	_
37	PB	_	NN	NN	_	40	nn	_	_
38	mononuclear	_	JJ	JJ	_	40	amod	_	_
39	cell	_	NN	NN	_	40	nn	_	_
40	populations	_	NNS	NNS	_	27	conj	_	_
41	.	_	.	.	_	3	punct	_	_

1	RelB	_	NN	NN	_	2	nn	_	_
2	protein	_	NN	NN	_	6	nsubjpass	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	mRNA	_	NN	NN	_	2	conj	_	_
5	were	_	VBD	VBD	_	6	auxpass	_	_
6	detected	_	VBN	VBN	_	0	root	_	_
7	constitutively	_	RB	RB	_	6	advmod	_	_
8	in	_	IN	IN	_	6	prep	_	_
9	lymphocytes	_	NNS	NNS	_	8	pobj	_	_
10	and	_	CC	CC	_	8	cc	_	_
11	in	_	IN	IN	_	8	conj	_	_
12	activated	_	VBN	VBN	_	13	amod	_	_
13	monocytes	_	NNS	NNS	_	11	pobj	_	_
14	,	_	,	,	_	13	punct	_	_
15	differentiated	_	VBN	VBN	_	16	amod	_	_
16	DC	_	NNS	NNS	_	13	conj	_	_
17	,	_	,	,	_	13	punct	_	_
18	and	_	CC	CC	_	13	cc	_	_
19	monocyte-derived	_	JJ	JJ	_	20	amod	_	_
20	DC	_	NNS	NNS	_	13	conj	_	_
21	.	_	.	.	_	6	punct	_	_

1	Immunohistochemical	_	JJ	JJ	_	2	amod	_	_
2	staining	_	NN	NN	_	3	nsubj	_	_
3	demonstrated	_	VBD	VBD	_	0	root	_	_
4	RelB	_	NN	NN	_	3	dobj	_	_
5	within	_	IN	IN	_	3	prep	_	_
6	the	_	DT	DT	_	11	det	_	_
7	differentiated	_	VBN	VBN	_	11	amod	_	_
8	lymph	_	NN	NN	_	11	nn	_	_
9	node	_	NN	NN	_	11	nn	_	_
10	interdigitating	_	NN	NN	_	11	nn	_	_
11	DC	_	NNS	NNS	_	5	pobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	follicular	_	JJ	JJ	_	14	amod	_	_
14	DC	_	NNS	NNS	_	11	conj	_	_
15	,	_	,	,	_	11	punct	_	_
16	but	_	CC	CC	_	17	cc	_	_
17	not	_	RB	RB	_	11	cc	_	_
18	undifferentiated	_	JJ	JJ	_	19	amod	_	_
19	DC	_	NNS	NNS	_	11	conj	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	normal	_	JJ	JJ	_	22	amod	_	_
22	skin	_	NN	NN	_	20	pobj	_	_
23	.	_	.	.	_	3	punct	_	_

1	Active	_	JJ	JJ	_	2	amod	_	_
2	nuclear	_	JJ	JJ	_	3	amod	_	_
3	RelB	_	NN	NN	_	5	nsubjpass	_	_
4	was	_	VBD	VBD	_	5	auxpass	_	_
5	detected	_	VBN	VBN	_	0	root	_	_
6	by	_	IN	IN	_	5	prep	_	_
7	supershift	_	NN	NN	_	8	nn	_	_
8	assay	_	NN	NN	_	6	pobj	_	_
9	only	_	RB	RB	_	10	advmod	_	_
10	in	_	IN	IN	_	5	prep	_	_
11	differentiated	_	JJ	JJ	_	12	amod	_	_
12	DC	_	NNS	NNS	_	10	pobj	_	_
13	derived	_	VBN	VBN	_	12	vmod	_	_
14	from	_	IN	IN	_	13	prep	_	_
15	either	_	CC	CC	_	17	preconj	_	_
16	PB	_	NN	NN	_	17	nn	_	_
17	precursors	_	NNS	NNS	_	14	pobj	_	_
18	or	_	CC	CC	_	17	cc	_	_
19	monocytes	_	NNS	NNS	_	17	conj	_	_
20	and	_	CC	CC	_	10	cc	_	_
21	in	_	IN	IN	_	10	conj	_	_
22	activated	_	VBN	VBN	_	24	amod	_	_
23	B	_	NN	NN	_	24	nn	_	_
24	cells	_	NNS	NNS	_	21	pobj	_	_
25	.	_	.	.	_	5	punct	_	_

1	These	_	DT	DT	_	3	det	_	_
2	RelB+	_	JJ	JJ	_	3	amod	_	_
3	APC	_	NN	NN	_	6	nsubj	_	_
4	were	_	VBD	VBD	_	6	cop	_	_
5	potent	_	JJ	JJ	_	6	amod	_	_
6	stimulators	_	NNS	NNS	_	0	root	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	MLR	_	NN	NN	_	7	pobj	_	_
10	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	8	mark	_	_
5	RelB	_	NN	NN	_	6	nn	_	_
6	expression	_	NN	NN	_	8	nsubjpass	_	_
7	is	_	VBZ	VBZ	_	8	auxpass	_	_
8	regulated	_	VBN	VBN	_	3	ccomp	_	_
9	both	_	CC	CC	_	10	preconj	_	_
10	transcriptionally	_	RB	RB	_	8	advmod	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	post-translationally	_	RB	RB	_	10	conj	_	_
13	in	_	IN	IN	_	8	prep	_	_
14	myeloid	_	JJ	JJ	_	15	amod	_	_
15	cells	_	NNS	NNS	_	13	pobj	_	_
16	.	_	.	.	_	3	punct	_	_

1	Within	_	IN	IN	_	8	prep	_	_
2	the	_	DT	DT	_	3	det	_	_
3	nucleus	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	8	punct	_	_
5	RelB	_	NN	NN	_	6	nn	_	_
6	may	_	NN	NN	_	8	nsubj	_	_
7	specifically	_	RB	RB	_	8	advmod	_	_
8	transactivate	_	VB	VB	_	0	root	_	_
9	genes	_	NNS	NNS	_	8	dobj	_	_
10	that	_	WDT	WDT	_	12	nsubj	_	_
11	are	_	VBP	VBP	_	12	cop	_	_
12	critical	_	JJ	JJ	_	9	rcmod	_	_
13	for	_	IN	IN	_	12	prep	_	_
14	APC	_	NN	NN	_	15	nn	_	_
15	function	_	NN	NN	_	13	pobj	_	_
16	.	_	.	.	_	8	punct	_	_

1	Regulation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	nuclear	_	JJ	JJ	_	5	amod	_	_
4	factor-kappa	_	NN	NN	_	5	nn	_	_
5	B	_	NN	NN	_	2	pobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	its	_	PRP$	PRP$	_	8	poss	_	_
8	inhibitor	_	NN	NN	_	5	conj	_	_
9	I	_	NN	NN	_	11	nn	_	_
10	kappa	_	NN	NN	_	11	nn	_	_
11	B-alpha/MAD-3	_	NN	NN	_	8	dep	_	_
12	in	_	IN	IN	_	1	prep	_	_
13	monocytes	_	NNS	NNS	_	12	pobj	_	_
14	by	_	IN	IN	_	1	prep	_	_
15	Mycobacterium	_	NN	NN	_	16	nn	_	_
16	tuberculosis	_	NN	NN	_	14	pobj	_	_
17	and	_	CC	CC	_	14	cc	_	_
18	during	_	IN	IN	_	14	conj	_	_
19	human	_	JJ	JJ	_	20	amod	_	_
20	tuberculosis	_	NN	NN	_	18	pobj	_	_
21	.	_	.	.	_	1	punct	_	_

1	Blood	_	NN	NN	_	2	nn	_	_
2	monocytes	_	NNS	NNS	_	9	nsubjpass	_	_
3	from	_	IN	IN	_	2	prep	_	_
4	patients	_	NNS	NNS	_	3	pobj	_	_
5	with	_	IN	IN	_	4	prep	_	_
6	active	_	JJ	JJ	_	7	amod	_	_
7	tuberculosis	_	NN	NN	_	5	pobj	_	_
8	are	_	VBP	VBP	_	9	auxpass	_	_
9	activated	_	VBN	VBN	_	0	root	_	_
10	in	_	FW	FW	_	11	nn	_	_
11	vivo	_	FW	FW	_	9	advmod	_	_
12	,	_	,	,	_	9	punct	_	_
13	as	_	IN	IN	_	14	mark	_	_
14	evidenced	_	VBN	VBN	_	9	advcl	_	_
15	by	_	IN	IN	_	14	prep	_	_
16	an	_	DT	DT	_	17	det	_	_
17	increase	_	NN	NN	_	15	pobj	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	stimulated	_	VBN	VBN	_	21	amod	_	_
21	release	_	NN	NN	_	18	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	proinflammatory	_	JJ	JJ	_	24	amod	_	_
24	cytokines	_	NNS	NNS	_	22	pobj	_	_
25	,	_	,	,	_	24	punct	_	_
26	such	_	JJ	JJ	_	27	mwe	_	_
27	as	_	IN	IN	_	24	prep	_	_
28	TNF-alpha	_	NN	NN	_	27	pobj	_	_
29	,	_	,	,	_	17	punct	_	_
30	and	_	CC	CC	_	17	cc	_	_
31	the	_	DT	DT	_	33	det	_	_
32	spontaneous	_	JJ	JJ	_	33	amod	_	_
33	expression	_	NN	NN	_	17	conj	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	IL-2R	_	NN	NN	_	34	pobj	_	_
36	.	_	.	.	_	9	punct	_	_

1	Further	_	RB	RB	_	6	advmod	_	_
2	,	_	,	,	_	6	punct	_	_
3	monocytes	_	NNS	NNS	_	6	nsubj	_	_
4	from	_	IN	IN	_	3	prep	_	_
5	patients	_	NNS	NNS	_	4	pobj	_	_
6	demonstrate	_	VBP	VBP	_	0	root	_	_
7	an	_	DT	DT	_	9	det	_	_
8	augmented	_	JJ	JJ	_	9	amod	_	_
9	susceptibility	_	NN	NN	_	6	dobj	_	_
10	to	_	TO	TO	_	9	prep	_	_
11	a	_	DT	DT	_	13	det	_	_
12	productive	_	JJ	JJ	_	13	amod	_	_
13	infection	_	NN	NN	_	10	pobj	_	_
14	with	_	IN	IN	_	13	prep	_	_
15	HIV-1	_	NN	NN	_	14	pobj	_	_
16	in	_	FW	FW	_	17	nn	_	_
17	vitro	_	FW	FW	_	6	advmod	_	_
18	.	_	.	.	_	6	punct	_	_

1	Mycobacterium	_	NN	NN	_	2	nn	_	_
2	tuberculosis	_	NN	NN	_	8	nsubj	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	its	_	PRP$	PRP$	_	5	poss	_	_
5	components	_	NNS	NNS	_	2	conj	_	_
6	are	_	VBP	VBP	_	8	cop	_	_
7	strong	_	JJ	JJ	_	8	amod	_	_
8	signals	_	NNS	NNS	_	0	root	_	_
9	to	_	TO	TO	_	10	aux	_	_
10	activate	_	VB	VB	_	8	vmod	_	_
11	monocytes	_	NNS	NNS	_	10	dobj	_	_
12	to	_	TO	TO	_	10	prep	_	_
13	production	_	NN	NN	_	12	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	cytokines	_	NNS	NNS	_	14	pobj	_	_
16	.	_	.	.	_	8	punct	_	_

1	In	_	IN	IN	_	5	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	study	_	NN	NN	_	1	pobj	_	_
4	we	_	PRP	PRP	_	5	nsubj	_	_
5	examined	_	VBD	VBD	_	0	root	_	_
6	the	_	DT	DT	_	7	det	_	_
7	basis	_	NN	NN	_	5	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	activation	_	NN	NN	_	8	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	monocytes	_	NNS	NNS	_	10	pobj	_	_
12	during	_	IN	IN	_	9	prep	_	_
13	active	_	JJ	JJ	_	14	amod	_	_
14	tuberculosis	_	NN	NN	_	12	pobj	_	_
15	and	_	CC	CC	_	12	cc	_	_
16	by	_	IN	IN	_	12	conj	_	_
17	M.	_	NN	NN	_	18	nn	_	_
18	tuberculosis	_	NN	NN	_	16	pobj	_	_
19	.	_	.	.	_	5	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	found	_	VBD	VBD	_	0	root	_	_
3	a	_	DT	DT	_	5	det	_	_
4	constitutive	_	JJ	JJ	_	5	amod	_	_
5	degradation	_	NN	NN	_	2	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	I	_	NN	NN	_	9	nn	_	_
8	kappa	_	NN	NN	_	9	nn	_	_
9	B-alpha	_	NN	NN	_	6	pobj	_	_
10	,	_	,	,	_	9	punct	_	_
11	the	_	DT	DT	_	14	det	_	_
12	major	_	JJ	JJ	_	14	amod	_	_
13	cytoplasmic	_	JJ	JJ	_	14	amod	_	_
14	inhibitor	_	NN	NN	_	9	appos	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	nuclear	_	JJ	JJ	_	19	amod	_	_
17	factor	_	NN	NN	_	19	nn	_	_
18	kappa	_	NN	NN	_	19	nn	_	_
19	B	_	NN	NN	_	15	pobj	_	_
20	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
21	NF-kappa	_	NN	NN	_	22	nn	_	_
22	B	_	NN	NN	_	19	appos	_	_
23	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
24	,	_	,	,	_	5	punct	_	_
25	in	_	IN	IN	_	5	prep	_	_
26	freshly	_	RB	RB	_	27	advmod	_	_
27	isolated	_	VBN	VBN	_	28	amod	_	_
28	PBMC	_	NN	NN	_	25	pobj	_	_
29	and	_	CC	CC	_	28	cc	_	_
30	monocytes	_	NNS	NNS	_	28	conj	_	_
31	from	_	IN	IN	_	28	prep	_	_
32	patients	_	NNS	NNS	_	31	pobj	_	_
33	with	_	IN	IN	_	32	prep	_	_
34	tuberculosis	_	NN	NN	_	33	pobj	_	_
35	.	_	.	.	_	2	punct	_	_

1	In	_	IN	IN	_	23	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	23	punct	_	_
4	I	_	NN	NN	_	6	nn	_	_
5	kappa	_	NN	NN	_	6	nn	_	_
6	B-alpha	_	NN	NN	_	7	nn	_	_
7	levels	_	NNS	NNS	_	23	nsubj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	PBMC	_	NN	NN	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	monocytes	_	NNS	NNS	_	9	conj	_	_
12	from	_	IN	IN	_	9	prep	_	_
13	healthy	_	JJ	JJ	_	14	amod	_	_
14	subjects	_	NNS	NNS	_	12	pobj	_	_
15	or	_	CC	CC	_	12	cc	_	_
16	from	_	IN	IN	_	12	conj	_	_
17	patients	_	NNS	NNS	_	16	pobj	_	_
18	with	_	IN	IN	_	17	prep	_	_
19	nontuberculous	_	JJ	JJ	_	20	amod	_	_
20	pulmonary	_	JJ	JJ	_	21	amod	_	_
21	conditions	_	NNS	NNS	_	18	pobj	_	_
22	were	_	VBD	VBD	_	23	cop	_	_
23	intact	_	JJ	JJ	_	0	root	_	_
24	.	_	.	.	_	23	punct	_	_

1	Further	_	RB	RB	_	12	advmod	_	_
2	,	_	,	,	_	12	punct	_	_
3	by	_	IN	IN	_	12	prep	_	_
4	electrophoretic	_	JJ	JJ	_	7	amod	_	_
5	mobility	_	NN	NN	_	7	nn	_	_
6	shift	_	NN	NN	_	7	nn	_	_
7	assay	_	NN	NN	_	3	pobj	_	_
8	,	_	,	,	_	12	punct	_	_
9	NF-kappa	_	NN	NN	_	10	nn	_	_
10	B	_	NN	NN	_	12	nsubjpass	_	_
11	was	_	VBD	VBD	_	12	auxpass	_	_
12	activated	_	VBN	VBN	_	0	root	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	monocytes	_	NNS	NNS	_	13	pobj	_	_
15	from	_	IN	IN	_	14	prep	_	_
16	tuberculous	_	JJ	JJ	_	17	amod	_	_
17	patients	_	NNS	NNS	_	15	pobj	_	_
18	.	_	.	.	_	12	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	expression	_	NN	NN	_	19	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	I	_	NN	NN	_	6	nn	_	_
5	kappa	_	NN	NN	_	6	nn	_	_
6	B-alpha	_	NN	NN	_	7	nn	_	_
7	gene	_	NN	NN	_	3	pobj	_	_
8	,	_	,	,	_	7	punct	_	_
9	which	_	WDT	WDT	_	11	nsubj	_	_
10	is	_	VBZ	VBZ	_	11	cop	_	_
11	responsive	_	JJ	JJ	_	7	rcmod	_	_
12	to	_	TO	TO	_	11	prep	_	_
13	activation	_	NN	NN	_	12	pobj	_	_
14	by	_	IN	IN	_	13	prep	_	_
15	NF-kappa	_	NN	NN	_	16	nn	_	_
16	B	_	NN	NN	_	14	pobj	_	_
17	,	_	,	,	_	2	punct	_	_
18	was	_	VBD	VBD	_	19	auxpass	_	_
19	up-regulated	_	VBN	VBN	_	0	root	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	PBMC	_	NN	NN	_	20	pobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	monocytes	_	NNS	NNS	_	21	conj	_	_
24	from	_	IN	IN	_	21	prep	_	_
25	patients	_	NNS	NNS	_	24	pobj	_	_
26	,	_	,	,	_	20	punct	_	_
27	but	_	CC	CC	_	20	cc	_	_
28	not	_	RB	RB	_	29	neg	_	_
29	in	_	IN	IN	_	20	conj	_	_
30	mononuclear	_	JJ	JJ	_	31	amod	_	_
31	cells	_	NNS	NNS	_	29	pobj	_	_
32	from	_	IN	IN	_	31	prep	_	_
33	healthy	_	JJ	JJ	_	34	amod	_	_
34	subjects	_	NNS	NNS	_	32	pobj	_	_
35	or	_	CC	CC	_	34	cc	_	_
36	those	_	DT	DT	_	34	conj	_	_
37	with	_	IN	IN	_	36	prep	_	_
38	nontuberculous	_	JJ	JJ	_	40	amod	_	_
39	lung	_	NN	NN	_	40	nn	_	_
40	diseases	_	NNS	NNS	_	37	pobj	_	_
41	.	_	.	.	_	19	punct	_	_

1	By	_	IN	IN	_	21	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	21	punct	_	_
4	the	_	DT	DT	_	5	det	_	_
5	expression	_	NN	NN	_	21	nsubjpass	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	other	_	JJ	JJ	_	10	amod	_	_
8	adherence-associated	_	JJ	JJ	_	10	amod	_	_
9	early	_	JJ	JJ	_	10	amod	_	_
10	genes	_	NNS	NNS	_	6	pobj	_	_
11	,	_	,	,	_	10	punct	_	_
12	such	_	JJ	JJ	_	13	mwe	_	_
13	as	_	IN	IN	_	10	prep	_	_
14	IL-8	_	NN	NN	_	13	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	IL-1	_	NN	NN	_	17	nn	_	_
17	beta	_	NN	NN	_	14	conj	_	_
18	,	_	,	,	_	5	punct	_	_
19	was	_	VBD	VBD	_	21	auxpass	_	_
20	not	_	RB	RB	_	21	neg	_	_
21	up-regulated	_	VBN	VBN	_	0	root	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	PBMC	_	NN	NN	_	22	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	tuberculous	_	JJ	JJ	_	26	amod	_	_
26	patients	_	NNS	NNS	_	24	pobj	_	_
27	.	_	.	.	_	21	punct	_	_

1	Further	_	RB	RB	_	13	advmod	_	_
2	,	_	,	,	_	13	punct	_	_
3	M.	_	NN	NN	_	4	nn	_	_
4	tuberculosis	_	NN	NN	_	13	nsubj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	its	_	PRP$	PRP$	_	7	poss	_	_
7	tuberculin	_	NN	NN	_	4	conj	_	_
8	,	_	,	,	_	7	punct	_	_
9	purified	_	VBN	VBN	_	11	amod	_	_
10	protein	_	NN	NN	_	11	nn	_	_
11	derivative	_	NN	NN	_	7	appos	_	_
12	,	_	,	,	_	4	punct	_	_
13	induced	_	VBD	VBD	_	0	root	_	_
14	the	_	DT	DT	_	15	det	_	_
15	degradation	_	NN	NN	_	13	dobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	I	_	NN	NN	_	19	nn	_	_
18	kappa	_	NN	NN	_	19	nn	_	_
19	B-alpha	_	NN	NN	_	16	pobj	_	_
20	and	_	CC	CC	_	15	cc	_	_
21	the	_	DT	DT	_	22	det	_	_
22	expression	_	NN	NN	_	15	conj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	I	_	NN	NN	_	27	nn	_	_
25	kappa	_	NN	NN	_	27	nn	_	_
26	B-alpha	_	NN	NN	_	27	nn	_	_
27	mRNA	_	NN	NN	_	23	pobj	_	_
28	,	_	,	,	_	13	punct	_	_
29	and	_	CC	CC	_	13	cc	_	_
30	purified	_	VBN	VBN	_	32	amod	_	_
31	protein	_	NN	NN	_	32	nn	_	_
32	derivative	_	NN	NN	_	33	nsubj	_	_
33	induced	_	VBD	VBD	_	13	conj	_	_
34	the	_	DT	DT	_	35	det	_	_
35	activation	_	NN	NN	_	33	dobj	_	_
36	of	_	IN	IN	_	35	prep	_	_
37	NF-kappa	_	NN	NN	_	38	nn	_	_
38	B	_	NN	NN	_	36	pobj	_	_
39	in	_	IN	IN	_	33	prep	_	_
40	monocytes	_	NNS	NNS	_	39	pobj	_	_
41	.	_	.	.	_	13	punct	_	_

1	Relationship	_	NN	NN	_	0	root	_	_
2	between	_	IN	IN	_	1	prep	_	_
3	glucocorticoid	_	NN	NN	_	4	nn	_	_
4	receptor	_	NN	NN	_	2	pobj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	response	_	NN	NN	_	4	conj	_	_
7	to	_	TO	TO	_	6	prep	_	_
8	glucocorticoid	_	NN	NN	_	9	nn	_	_
9	therapy	_	NN	NN	_	7	pobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	ulcerative	_	JJ	JJ	_	12	amod	_	_
12	colitis	_	NN	NN	_	10	pobj	_	_
13	.	_	.	.	_	1	punct	_	_

1	PURPOSE	_	NN	NN	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	To	_	TO	TO	_	4	aux	_	_
4	clarify	_	VB	VB	_	1	dep	_	_
5	the	_	DT	DT	_	6	det	_	_
6	relationship	_	NN	NN	_	4	dobj	_	_
7	between	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	glucocorticoid	_	NN	NN	_	10	nn	_	_
10	receptor	_	NN	NN	_	7	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	the	_	DT	DT	_	13	det	_	_
13	effectiveness	_	NN	NN	_	10	conj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	glucocorticoid	_	NN	NN	_	16	nn	_	_
16	therapy	_	NN	NN	_	14	pobj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	patients	_	NNS	NNS	_	17	pobj	_	_
19	with	_	IN	IN	_	18	prep	_	_
20	ulcerative	_	JJ	JJ	_	21	amod	_	_
21	colitis	_	NN	NN	_	19	pobj	_	_
22	,	_	,	,	_	4	punct	_	_
23	we	_	PRP	PRP	_	24	nsubj	_	_
24	investigated	_	VBD	VBD	_	4	parataxis	_	_
25	the	_	DT	DT	_	26	dep	_	_
26	number	_	NN	NN	_	24	dobj	_	_
27	and	_	CC	CC	_	26	cc	_	_
28	apparent	_	JJ	JJ	_	30	amod	_	_
29	dissociation	_	NN	NN	_	30	nn	_	_
30	constant	_	NN	NN	_	26	conj	_	_
31	of	_	IN	IN	_	26	prep	_	_
32	glucocorticoid	_	NN	NN	_	33	nn	_	_
33	receptor	_	NN	NN	_	31	pobj	_	_
34	in	_	IN	IN	_	33	prep	_	_
35	peripheral	_	JJ	JJ	_	38	amod	_	_
36	blood	_	NN	NN	_	38	nn	_	_
37	mononuclear	_	JJ	JJ	_	38	amod	_	_
38	leukocytes	_	NNS	NNS	_	34	pobj	_	_
39	of	_	IN	IN	_	38	prep	_	_
40	patients	_	NNS	NNS	_	39	pobj	_	_
41	with	_	IN	IN	_	40	prep	_	_
42	ulcerative	_	JJ	JJ	_	43	amod	_	_
43	colitis	_	NN	NN	_	41	pobj	_	_
44	.	_	.	.	_	4	punct	_	_

1	MATERIALS	_	NNS	NNS	_	0	root	_	_
2	AND	_	CC	CC	_	1	cc	_	_
3	METHODS	_	NNS	NNS	_	1	conj	_	_
4	:	_	:	:	_	1	punct	_	_
5	Eleven	_	CD	CD	_	6	num	_	_
6	patients	_	NNS	NNS	_	28	nsubjpass	_	_
7	with	_	IN	IN	_	6	prep	_	_
8	ulcerative	_	JJ	JJ	_	9	amod	_	_
9	colitis	_	NN	NN	_	7	pobj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	5	_	CD	CD	_	6	dep	_	_
12	who	_	WP	WP	_	13	nsubj	_	_
13	responded	_	VBD	VBD	_	11	rcmod	_	_
14	to	_	TO	TO	_	13	prep	_	_
15	intravenous	_	JJ	JJ	_	16	amod	_	_
16	glucocorticoids	_	NNS	NNS	_	14	pobj	_	_
17	and	_	CC	CC	_	11	cc	_	_
18	6	_	CD	CD	_	11	conj	_	_
19	who	_	WP	WP	_	20	nsubj	_	_
20	did	_	VBD	VBD	_	18	rcmod	_	_
21	not	_	RB	RB	_	20	neg	_	_
22	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
23	and	_	CC	CC	_	6	cc	_	_
24	ten	_	CD	CD	_	26	num	_	_
25	control	_	JJ	JJ	_	26	amod	_	_
26	subjects	_	NNS	NNS	_	6	conj	_	_
27	were	_	VBD	VBD	_	28	auxpass	_	_
28	studied	_	VBN	VBN	_	1	dep	_	_
29	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	2	dep	_	_
2	number	_	NN	NN	_	11	nsubjpass	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	apparent	_	JJ	JJ	_	6	amod	_	_
5	dissociation	_	NN	NN	_	6	nn	_	_
6	constant	_	NN	NN	_	2	conj	_	_
7	of	_	IN	IN	_	2	prep	_	_
8	glucocorticoid	_	NN	NN	_	9	nn	_	_
9	receptor	_	NN	NN	_	7	pobj	_	_
10	were	_	VBD	VBD	_	11	auxpass	_	_
11	measured	_	VBN	VBN	_	0	root	_	_
12	using	_	VBG	VBG	_	11	xcomp	_	_
13	a	_	DT	DT	_	16	det	_	_
14	whole-cell	_	JJ	JJ	_	16	amod	_	_
15	binding	_	NN	NN	_	16	nn	_	_
16	assay	_	NN	NN	_	12	dobj	_	_
17	.	_	.	.	_	11	punct	_	_

1	Results	_	NNS	NNS	_	3	nsubjpass	_	_
2	were	_	VBD	VBD	_	3	auxpass	_	_
3	expressed	_	VBN	VBN	_	0	root	_	_
4	as	_	IN	IN	_	3	prep	_	_
5	a	_	DT	DT	_	6	det	_	_
6	median	_	NN	NN	_	4	pobj	_	_
7	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
8	interquartile	_	JJ	JJ	_	9	amod	_	_
9	range	_	NN	NN	_	6	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	.	_	.	.	_	3	punct	_	_

1	RESULTS	_	NNS	NNS	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	The	_	DT	DT	_	4	det	_	_
4	number	_	NN	NN	_	21	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	glucocorticoid	_	NN	NN	_	7	nn	_	_
7	receptors	_	NNS	NNS	_	5	pobj	_	_
8	from	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	dep	_	_
10	six	_	CD	CD	_	11	num	_	_
11	nonresponders	_	NNS	NNS	_	8	pobj	_	_
12	,	_	,	,	_	11	punct	_	_
13	five	_	CD	CD	_	14	num	_	_
14	responders	_	NNS	NNS	_	11	conj	_	_
15	,	_	,	,	_	11	punct	_	_
16	and	_	CC	CC	_	11	cc	_	_
17	ten	_	CD	CD	_	19	num	_	_
18	healthy	_	JJ	JJ	_	19	amod	_	_
19	controls	_	NNS	NNS	_	11	conj	_	_
20	were	_	VBD	VBD	_	21	cop	_	_
21	4922	_	CD	CD	_	1	dep	_	_
22	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
23	range	_	NN	NN	_	21	dep	_	_
24	,	_	,	,	_	23	punct	_	_
25	4484-5643	_	CD	CD	_	23	amod	_	_
26	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
27	,	_	,	,	_	21	punct	_	_
28	3413	_	CD	CD	_	21	conj	_	_
29	-LRB-	_	-LRB-	-LRB-	_	30	punct	_	_
30	range	_	NN	NN	_	28	dep	_	_
31	,	_	,	,	_	30	punct	_	_
32	3183-4450	_	CD	CD	_	30	amod	_	_
33	-RRB-	_	-RRB-	-RRB-	_	30	punct	_	_
34	,	_	,	,	_	21	punct	_	_
35	and	_	CC	CC	_	21	cc	_	_
36	3610	_	CD	CD	_	21	conj	_	_
37	-LRB-	_	-LRB-	-LRB-	_	38	punct	_	_
38	range	_	NN	NN	_	36	dep	_	_
39	,	_	,	,	_	38	punct	_	_
40	2594-3979	_	CD	CD	_	38	amod	_	_
41	-RRB-	_	-RRB-	-RRB-	_	38	punct	_	_
42	binding	_	VBG	VBG	_	43	amod	_	_
43	sites/cell	_	NNS	NNS	_	21	dep	_	_
44	,	_	,	,	_	21	punct	_	_
45	respectively	_	RB	RB	_	21	advmod	_	_
46	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	apparent	_	JJ	JJ	_	4	amod	_	_
3	dissociation	_	NN	NN	_	4	nn	_	_
4	constant	_	NN	NN	_	19	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	glucocorticoid	_	NN	NN	_	8	nn	_	_
8	receptors	_	NNS	NNS	_	5	pobj	_	_
9	from	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	11	dep	_	_
11	nonresponders	_	NNS	NNS	_	9	pobj	_	_
12	,	_	,	,	_	11	punct	_	_
13	responders	_	NNS	NNS	_	11	conj	_	_
14	,	_	,	,	_	11	punct	_	_
15	and	_	CC	CC	_	11	cc	_	_
16	healthy	_	JJ	JJ	_	17	amod	_	_
17	controls	_	NNS	NNS	_	11	conj	_	_
18	were	_	VBD	VBD	_	19	cop	_	_
19	7.03	_	CD	CD	_	0	root	_	_
20	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
21	range	_	NN	NN	_	19	dep	_	_
22	,	_	,	,	_	21	punct	_	_
23	5.66-10	_	CD	CD	_	21	amod	_	_
24	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
25	,	_	,	,	_	19	punct	_	_
26	4.27	_	CD	CD	_	19	conj	_	_
27	-LRB-	_	-LRB-	-LRB-	_	28	punct	_	_
28	range	_	NN	NN	_	26	dep	_	_
29	,	_	,	,	_	28	punct	_	_
30	4-5.13	_	CD	CD	_	28	amod	_	_
31	-RRB-	_	-RRB-	-RRB-	_	28	punct	_	_
32	,	_	,	,	_	19	punct	_	_
33	and	_	CC	CC	_	19	cc	_	_
34	6.18	_	CD	CD	_	19	conj	_	_
35	-LRB-	_	-LRB-	-LRB-	_	36	punct	_	_
36	range	_	NN	NN	_	34	dep	_	_
37	,	_	,	,	_	36	punct	_	_
38	5.86-6.74	_	CD	CD	_	36	amod	_	_
39	-RRB-	_	-RRB-	-RRB-	_	36	punct	_	_
40	nM	_	NN	NN	_	19	dep	_	_
41	,	_	,	,	_	19	punct	_	_
42	respectively	_	RB	RB	_	19	advmod	_	_
43	.	_	.	.	_	19	punct	_	_

1	Nonresponders	_	NNS	NNS	_	2	nsubj	_	_
2	had	_	VBD	VBD	_	0	root	_	_
3	a	_	DT	DT	_	5	det	_	_
4	significant	_	JJ	JJ	_	5	amod	_	_
5	increase	_	NN	NN	_	2	dobj	_	_
6	both	_	CC	CC	_	7	preconj	_	_
7	in	_	IN	IN	_	2	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	number	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	binding	_	VBG	VBG	_	12	amod	_	_
12	sites	_	NNS	NNS	_	10	pobj	_	_
13	and	_	CC	CC	_	7	cc	_	_
14	in	_	IN	IN	_	7	conj	_	_
15	the	_	DT	DT	_	18	det	_	_
16	apparent	_	JJ	JJ	_	18	amod	_	_
17	dissociation	_	NN	NN	_	18	nn	_	_
18	constant	_	NN	NN	_	14	pobj	_	_
19	compared	_	VBN	VBN	_	2	prep	_	_
20	with	_	IN	IN	_	19	pcomp	_	_
21	responders	_	NNS	NNS	_	20	pobj	_	_
22	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
23	P	_	NN	NN	_	2	dep	_	_
24	=	_	JJ	JJ	_	23	amod	_	_
25	0.045	_	CD	CD	_	24	dep	_	_
26	;	_	:	:	_	23	punct	_	_
27	P	_	NN	NN	_	23	dep	_	_
28	=	_	JJ	JJ	_	27	amod	_	_
29	0.029	_	CD	CD	_	28	dep	_	_
30	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
31	.	_	.	.	_	2	punct	_	_

1	CONCLUSIONS	_	NNS	NNS	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	The	_	DT	DT	_	5	dep	_	_
4	increased	_	VBN	VBN	_	5	amod	_	_
5	number	_	NN	NN	_	15	nsubjpass	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	apparent	_	JJ	JJ	_	9	amod	_	_
8	dissociation	_	NN	NN	_	9	nn	_	_
9	constant	_	NN	NN	_	5	conj	_	_
10	of	_	IN	IN	_	5	prep	_	_
11	glucocorticoid	_	NN	NN	_	12	nn	_	_
12	receptor	_	NN	NN	_	10	pobj	_	_
13	are	_	VBP	VBP	_	15	auxpass	_	_
14	closely	_	RB	RB	_	15	advmod	_	_
15	associated	_	VBN	VBN	_	1	dep	_	_
16	with	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	18	det	_	_
18	effectiveness	_	NN	NN	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	glucocorticoid	_	NN	NN	_	21	nn	_	_
21	therapy	_	NN	NN	_	19	pobj	_	_
22	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	measurement	_	NN	NN	_	15	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	5	dep	_	_
5	number	_	NN	NN	_	3	pobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	apparent	_	JJ	JJ	_	9	amod	_	_
8	dissociation	_	NN	NN	_	9	nn	_	_
9	constant	_	NN	NN	_	5	conj	_	_
10	of	_	IN	IN	_	5	prep	_	_
11	glucocorticoid	_	NN	NN	_	12	nn	_	_
12	receptor	_	NN	NN	_	10	pobj	_	_
13	may	_	MD	MD	_	15	aux	_	_
14	be	_	VB	VB	_	15	cop	_	_
15	useful	_	JJ	JJ	_	0	root	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	predicting	_	VBG	VBG	_	16	pcomp	_	_
18	response	_	NN	NN	_	17	dobj	_	_
19	to	_	TO	TO	_	18	prep	_	_
20	glucocorticoids	_	NNS	NNS	_	19	pobj	_	_
21	.	_	.	.	_	15	punct	_	_

1	Switching	_	VBG	VBG	_	0	root	_	_
2	gears	_	NNS	NNS	_	1	dobj	_	_
3	during	_	IN	IN	_	1	prep	_	_
4	T-cell	_	NN	NN	_	5	nn	_	_
5	maturation	_	NN	NN	_	3	pobj	_	_
6	:	_	:	:	_	1	punct	_	_
7	RANTES	_	NN	NN	_	1	dep	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	late	_	JJ	JJ	_	10	amod	_	_
10	transcription	_	NN	NN	_	7	conj	_	_
11	.	_	.	.	_	1	punct	_	_

1	Although	_	IN	IN	_	4	mark	_	_
2	much	_	JJ	JJ	_	4	nsubjpass	_	_
3	is	_	VBZ	VBZ	_	4	auxpass	_	_
4	understood	_	VBN	VBN	_	23	advcl	_	_
5	about	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	7	det	_	_
7	induction	_	NN	NN	_	5	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	genes	_	NNS	NNS	_	8	pobj	_	_
10	expressed	_	VBN	VBN	_	9	vmod	_	_
11	early	_	RB	RB	_	17	advmod	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	within	_	IN	IN	_	11	dep	_	_
14	24	_	CD	CD	_	15	num	_	_
15	h	_	NN	NN	_	13	pobj	_	_
16	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
17	after	_	IN	IN	_	10	prep	_	_
18	T-cell	_	NN	NN	_	19	nn	_	_
19	activation	_	NN	NN	_	17	pobj	_	_
20	,	_	,	,	_	23	punct	_	_
21	little	_	JJ	JJ	_	23	nsubjpass	_	_
22	is	_	VBZ	VBZ	_	23	auxpass	_	_
23	known	_	VBN	VBN	_	0	root	_	_
24	about	_	IN	IN	_	23	prep	_	_
25	the	_	DT	DT	_	26	det	_	_
26	regulation	_	NN	NN	_	24	pobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	expression	_	NN	NN	_	27	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	genes	_	NNS	NNS	_	29	pobj	_	_
31	expressed	_	VBN	VBN	_	30	vmod	_	_
32	'	_	``	``	_	33	punct	_	_
33	late	_	JJ	JJ	_	41	advmod	_	_
34	'	_	''	''	_	33	punct	_	_
35	-LRB-	_	-LRB-	-LRB-	_	36	punct	_	_
36	three	_	CD	CD	_	41	dep	_	_
37	or	_	CC	CC	_	36	cc	_	_
38	more	_	JJR	JJR	_	36	conj	_	_
39	days	_	NNS	NNS	_	36	dep	_	_
40	-RRB-	_	-RRB-	-RRB-	_	36	punct	_	_
41	post-stimulation	_	NN	NN	_	31	dobj	_	_
42	.	_	.	.	_	23	punct	_	_

1	A	_	DT	DT	_	3	det	_	_
2	better	_	JJR	JJR	_	3	amod	_	_
3	understanding	_	NN	NN	_	15	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	transcriptional	_	JJ	JJ	_	6	amod	_	_
6	regulation	_	NN	NN	_	4	pobj	_	_
7	at	_	IN	IN	_	6	prep	_	_
8	this	_	DT	DT	_	10	det	_	_
9	important	_	JJ	JJ	_	10	amod	_	_
10	stage	_	NN	NN	_	7	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	T-cell	_	NN	NN	_	13	nn	_	_
13	maturation	_	NN	NN	_	11	pobj	_	_
14	may	_	MD	MD	_	15	aux	_	_
15	yield	_	VB	VB	_	0	root	_	_
16	new	_	JJ	JJ	_	17	amod	_	_
17	insights	_	NNS	NNS	_	15	dobj	_	_
18	into	_	IN	IN	_	17	prep	_	_
19	T-cell	_	NN	NN	_	20	nn	_	_
20	development	_	NN	NN	_	18	pobj	_	_
21	and	_	CC	CC	_	17	cc	_	_
22	new	_	JJ	JJ	_	24	amod	_	_
23	immunotherapeutic	_	JJ	JJ	_	22	dep	_	_
24	targets	_	NNS	NNS	_	17	conj	_	_
25	.	_	.	.	_	15	punct	_	_

1	Analysis	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	interactions	_	NNS	NNS	_	2	pobj	_	_
4	between	_	IN	IN	_	3	prep	_	_
5	huGATA-3	_	NN	NN	_	7	nn	_	_
6	transcription	_	NN	NN	_	7	nn	_	_
7	factor	_	NN	NN	_	4	pobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	three	_	CD	CD	_	12	num	_	_
10	GATA	_	NN	NN	_	12	nn	_	_
11	regulatory	_	JJ	JJ	_	12	amod	_	_
12	elements	_	NNS	NNS	_	7	conj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	HIV-1	_	NN	NN	_	17	nn	_	_
15	long	_	JJ	JJ	_	17	amod	_	_
16	terminal	_	JJ	JJ	_	17	amod	_	_
17	repeat	_	NN	NN	_	13	pobj	_	_
18	,	_	,	,	_	1	punct	_	_
19	by	_	IN	IN	_	1	prep	_	_
20	surface	_	NN	NN	_	22	nn	_	_
21	plasmon	_	NN	NN	_	22	nn	_	_
22	resonance	_	NN	NN	_	19	pobj	_	_
23	.	_	.	.	_	1	punct	_	_

1	Relative	_	JJ	JJ	_	2	amod	_	_
2	affinities	_	NNS	NNS	_	14	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	transcriptional	_	JJ	JJ	_	6	amod	_	_
5	regulatory	_	JJ	JJ	_	6	amod	_	_
6	elements	_	NNS	NNS	_	3	pobj	_	_
7	for	_	IN	IN	_	2	prep	_	_
8	their	_	PRP$	PRP$	_	10	poss	_	_
9	respective	_	JJ	JJ	_	10	amod	_	_
10	factor	_	NN	NN	_	7	pobj	_	_
11	have	_	VBP	VBP	_	14	aux	_	_
12	been	_	VBN	VBN	_	14	auxpass	_	_
13	essentially	_	RB	RB	_	14	advmod	_	_
14	studied	_	VBN	VBN	_	0	root	_	_
15	by	_	IN	IN	_	14	prep	_	_
16	bandshift	_	NN	NN	_	17	nn	_	_
17	analysis	_	NN	NN	_	15	pobj	_	_
18	.	_	.	.	_	14	punct	_	_

1	Here	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	report	_	VBP	VBP	_	0	root	_	_
4	a	_	DT	DT	_	6	det	_	_
5	real-time	_	JJ	JJ	_	6	amod	_	_
6	study	_	NN	NN	_	3	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	factor/DNA	_	NN	NN	_	9	nn	_	_
9	interactions	_	NNS	NNS	_	7	pobj	_	_
10	using	_	VBG	VBG	_	6	vmod	_	_
11	a	_	DT	DT	_	15	det	_	_
12	surface	_	NN	NN	_	15	nn	_	_
13	plasmon	_	NN	NN	_	15	nn	_	_
14	resonance	_	NN	NN	_	15	nn	_	_
15	approach	_	NN	NN	_	10	dobj	_	_
16	and	_	CC	CC	_	6	cc	_	_
17	further	_	JJ	JJ	_	18	amod	_	_
18	characterization	_	NN	NN	_	6	conj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	recovered	_	VBN	VBN	_	21	amod	_	_
21	proteins	_	NNS	NNS	_	19	pobj	_	_
22	involved	_	VBN	VBN	_	21	vmod	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	this	_	DT	DT	_	25	det	_	_
25	interaction	_	NN	NN	_	23	pobj	_	_
26	.	_	.	.	_	3	punct	_	_

1	For	_	IN	IN	_	36	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	purpose	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	36	punct	_	_
5	human	_	JJ	JJ	_	6	amod	_	_
6	GATA-3	_	NN	NN	_	36	nsubjpass	_	_
7	,	_	,	,	_	6	punct	_	_
8	either	_	CC	CC	_	6	dep	_	_
9	recombinant	_	JJ	JJ	_	8	dep	_	_
10	or	_	CC	CC	_	8	cc	_	_
11	in	_	IN	IN	_	8	conj	_	_
12	nuclear	_	JJ	JJ	_	13	amod	_	_
13	extracts	_	NNS	NNS	_	11	pobj	_	_
14	,	_	,	,	_	6	punct	_	_
15	and	_	CC	CC	_	6	cc	_	_
16	three	_	CD	CD	_	19	num	_	_
17	natural	_	JJ	JJ	_	19	amod	_	_
18	GATA	_	NN	NN	_	19	nn	_	_
19	elements	_	NNS	NNS	_	6	conj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	25	det	_	_
22	HIV-1	_	NN	NN	_	25	nn	_	_
23	long	_	JJ	JJ	_	25	amod	_	_
24	terminal	_	JJ	JJ	_	25	amod	_	_
25	repeat	_	NN	NN	_	20	pobj	_	_
26	-LRB-	_	-LRB-	-LRB-	_	27	punct	_	_
27	sites	_	NNS	NNS	_	19	appos	_	_
28	1	_	CD	CD	_	27	dep	_	_
29	,	_	,	,	_	27	punct	_	_
30	2	_	CD	CD	_	27	conj	_	_
31	,	_	,	,	_	27	punct	_	_
32	and	_	CC	CC	_	27	cc	_	_
33	3	_	CD	CD	_	27	conj	_	_
34	-RRB-	_	-RRB-	-RRB-	_	27	punct	_	_
35	were	_	VBD	VBD	_	36	auxpass	_	_
36	chosen	_	VBN	VBN	_	0	root	_	_
37	,	_	,	,	_	36	punct	_	_
38	in	_	IN	IN	_	47	prep	_	_
39	which	_	WDT	WDT	_	38	pobj	_	_
40	only	_	JJ	JJ	_	41	amod	_	_
41	site	_	NN	NN	_	47	nsubj	_	_
42	2	_	CD	CD	_	41	num	_	_
43	is	_	VBZ	VBZ	_	47	cop	_	_
44	a	_	DT	DT	_	47	det	_	_
45	noncanonical	_	JJ	JJ	_	47	amod	_	_
46	GATA	_	NN	NN	_	47	nn	_	_
47	site	_	NN	NN	_	36	dep	_	_
48	.	_	.	.	_	36	punct	_	_

1	Direct	_	JJ	JJ	_	2	amod	_	_
2	analysis	_	NN	NN	_	10	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	sensorgrams	_	NNS	NNS	_	3	pobj	_	_
5	,	_	,	,	_	2	punct	_	_
6	with	_	IN	IN	_	2	prep	_	_
7	recombinant	_	JJ	JJ	_	8	amod	_	_
8	huGATA-3	_	NN	NN	_	6	pobj	_	_
9	,	_	,	,	_	2	punct	_	_
10	allowed	_	VBD	VBD	_	0	root	_	_
11	the	_	DT	DT	_	12	det	_	_
12	comparison	_	NN	NN	_	10	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	association	_	NN	NN	_	13	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	dissociation	_	NN	NN	_	14	conj	_	_
17	profiles	_	NNS	NNS	_	14	dep	_	_
18	of	_	IN	IN	_	14	prep	_	_
19	the	_	DT	DT	_	22	det	_	_
20	three	_	CD	CD	_	22	num	_	_
21	DNA	_	NN	NN	_	22	nn	_	_
22	regions	_	NNS	NNS	_	18	pobj	_	_
23	and	_	CC	CC	_	12	cc	_	_
24	their	_	PRP$	PRP$	_	25	poss	_	_
25	ranking	_	NN	NN	_	12	conj	_	_
26	according	_	VBG	VBG	_	25	prep	_	_
27	to	_	TO	TO	_	26	pcomp	_	_
28	their	_	PRP$	PRP$	_	30	poss	_	_
29	relative	_	JJ	JJ	_	30	amod	_	_
30	affinities	_	NNS	NNS	_	27	pobj	_	_
31	.	_	.	.	_	10	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	result	_	NN	NN	_	12	nsubj	_	_
3	,	_	,	,	_	2	punct	_	_
4	confirmed	_	VBN	VBN	_	2	vmod	_	_
5	by	_	IN	IN	_	4	prep	_	_
6	competitions	_	NNS	NNS	_	5	pobj	_	_
7	with	_	IN	IN	_	6	prep	_	_
8	each	_	DT	DT	_	10	det	_	_
9	GATA	_	NN	NN	_	10	nn	_	_
10	site	_	NN	NN	_	7	pobj	_	_
11	,	_	,	,	_	2	punct	_	_
12	demonstrated	_	VBD	VBD	_	0	root	_	_
13	the	_	DT	DT	_	16	det	_	_
14	higher	_	JJR	JJR	_	16	amod	_	_
15	relative	_	JJ	JJ	_	14	dep	_	_
16	affinity	_	NN	NN	_	12	dobj	_	_
17	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
18	at	_	IN	IN	_	20	advmod	_	_
19	least	_	JJS	JJS	_	18	pobj	_	_
20	sevenfold	_	JJ	JJ	_	16	dep	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	of	_	IN	IN	_	16	prep	_	_
23	site	_	NN	NN	_	22	pobj	_	_
24	3	_	CD	CD	_	23	num	_	_
25	.	_	.	.	_	12	punct	_	_

1	Interactions	_	NNS	NNS	_	15	nsubjpass	_	_
2	between	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	8	det	_	_
4	canonical	_	JJ	JJ	_	8	amod	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	unique	_	JJ	JJ	_	4	conj	_	_
7	GATA	_	NN	NN	_	8	nn	_	_
8	site	_	NN	NN	_	2	pobj	_	_
9	3	_	CD	CD	_	8	num	_	_
10	and	_	CC	CC	_	8	cc	_	_
11	nuclear	_	JJ	JJ	_	12	amod	_	_
12	extracts	_	NNS	NNS	_	8	conj	_	_
13	were	_	VBD	VBD	_	15	auxpass	_	_
14	also	_	RB	RB	_	15	advmod	_	_
15	studied	_	VBN	VBN	_	0	root	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	real	_	JJ	JJ	_	18	amod	_	_
18	time	_	NN	NN	_	16	pobj	_	_
19	and	_	CC	CC	_	15	cc	_	_
20	provided	_	VBD	VBD	_	15	conj	_	_
21	information	_	NN	NN	_	20	dobj	_	_
22	on	_	IN	IN	_	21	prep	_	_
23	its	_	PRP$	PRP$	_	24	poss	_	_
24	association	_	NN	NN	_	22	pobj	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	dissociation	_	NN	NN	_	24	conj	_	_
27	rates	_	NNS	NNS	_	24	dep	_	_
28	for	_	IN	IN	_	24	prep	_	_
29	native	_	JJ	JJ	_	30	amod	_	_
30	huGATA-3	_	NN	NN	_	28	pobj	_	_
31	.	_	.	.	_	15	punct	_	_

1	Finally	_	RB	RB	_	6	advmod	_	_
2	,	_	,	,	_	6	punct	_	_
3	recovered	_	VBN	VBN	_	4	amod	_	_
4	protein	_	NN	NN	_	6	nsubjpass	_	_
5	was	_	VBD	VBD	_	6	auxpass	_	_
6	identified	_	VBN	VBN	_	0	root	_	_
7	as	_	IN	IN	_	6	prep	_	_
8	genuine	_	JJ	JJ	_	9	amod	_	_
9	huGATA-3	_	NN	NN	_	7	pobj	_	_
10	by	_	IN	IN	_	6	prep	_	_
11	SDS-PAGE	_	NN	NN	_	10	pobj	_	_
12	,	_	,	,	_	11	punct	_	_
13	Western	_	NN	NN	_	14	nn	_	_
14	blotting	_	NN	NN	_	11	conj	_	_
15	,	_	,	,	_	11	punct	_	_
16	and	_	CC	CC	_	11	cc	_	_
17	bandshift	_	NN	NN	_	11	conj	_	_
18	assays	_	NNS	NNS	_	11	dep	_	_
19	.	_	.	.	_	6	punct	_	_

1	Copyright	_	NN	NN	_	4	nn	_	_
2	1997	_	CD	CD	_	4	num	_	_
3	Academic	_	NNP	NNP	_	4	nn	_	_
4	Press	_	NNP	NNP	_	0	root	_	_
5	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	5	det	_	_
2	Epstein-Barr	_	JJ	JJ	_	5	amod	_	_
3	virus	_	NN	NN	_	5	nn	_	_
4	oncogene	_	NN	NN	_	5	nn	_	_
5	product	_	NN	NN	_	10	nsubj	_	_
6	latent	_	JJ	JJ	_	8	amod	_	_
7	membrane	_	NN	NN	_	8	nn	_	_
8	protein	_	NN	NN	_	5	dep	_	_
9	1	_	CD	CD	_	8	num	_	_
10	engages	_	VBZ	VBZ	_	0	root	_	_
11	the	_	DT	DT	_	18	det	_	_
12	tumor	_	NN	NN	_	18	nn	_	_
13	necrosis	_	NN	NN	_	18	nn	_	_
14	factor	_	NN	NN	_	18	nn	_	_
15	receptor-associated	_	JJ	JJ	_	18	amod	_	_
16	death	_	NN	NN	_	18	nn	_	_
17	domain	_	NN	NN	_	18	nn	_	_
18	protein	_	NN	NN	_	10	dobj	_	_
19	to	_	TO	TO	_	20	aux	_	_
20	mediate	_	VB	VB	_	10	vmod	_	_
21	B	_	NN	NN	_	24	nn	_	_
22	lymphocyte	_	NN	NN	_	24	nn	_	_
23	growth	_	NN	NN	_	24	nn	_	_
24	transformation	_	NN	NN	_	20	dobj	_	_
25	and	_	CC	CC	_	20	cc	_	_
26	activate	_	VB	VB	_	20	conj	_	_
27	NF-kappaB	_	NN	NN	_	26	dobj	_	_
28	.	_	.	.	_	10	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	Epstein-Barr	_	JJ	JJ	_	3	amod	_	_
3	virus	_	NN	NN	_	12	nsubj	_	_
4	latent	_	JJ	JJ	_	6	amod	_	_
5	membrane	_	NN	NN	_	6	nn	_	_
6	protein	_	NN	NN	_	3	dep	_	_
7	1	_	CD	CD	_	6	num	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	LMP1	_	NN	NN	_	6	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	is	_	VBZ	VBZ	_	12	cop	_	_
12	essential	_	JJ	JJ	_	0	root	_	_
13	for	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	transformation	_	NN	NN	_	13	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	B	_	NN	NN	_	18	nn	_	_
18	lymphocytes	_	NNS	NNS	_	16	pobj	_	_
19	into	_	IN	IN	_	15	prep	_	_
20	lymphoblastoid	_	JJ	JJ	_	22	amod	_	_
21	cell	_	NN	NN	_	22	nn	_	_
22	lines	_	NNS	NNS	_	19	pobj	_	_
23	.	_	.	.	_	12	punct	_	_

1	Previous	_	JJ	JJ	_	2	amod	_	_
2	data	_	NNS	NNS	_	4	nsubj	_	_
3	are	_	VBP	VBP	_	4	cop	_	_
4	consistent	_	JJ	JJ	_	0	root	_	_
5	with	_	IN	IN	_	4	prep	_	_
6	a	_	DT	DT	_	7	det	_	_
7	model	_	NN	NN	_	5	pobj	_	_
8	that	_	IN	IN	_	14	mark	_	_
9	LMP1	_	NN	NN	_	14	nsubj	_	_
10	is	_	VBZ	VBZ	_	14	cop	_	_
11	a	_	DT	DT	_	14	det	_	_
12	constitutively	_	RB	RB	_	14	advmod	_	_
13	activated	_	VBN	VBN	_	14	amod	_	_
14	receptor	_	NN	NN	_	7	ccomp	_	_
15	that	_	WDT	WDT	_	16	nsubj	_	_
16	transduces	_	VBZ	VBZ	_	14	rcmod	_	_
17	signals	_	NNS	NNS	_	16	dobj	_	_
18	for	_	IN	IN	_	16	prep	_	_
19	transformation	_	NN	NN	_	18	pobj	_	_
20	through	_	IN	IN	_	16	prep	_	_
21	its	_	PRP$	PRP$	_	24	poss	_	_
22	carboxyl-terminal	_	JJ	JJ	_	24	amod	_	_
23	cytoplasmic	_	JJ	JJ	_	24	amod	_	_
24	tail	_	NN	NN	_	20	pobj	_	_
25	.	_	.	.	_	4	punct	_	_

1	One	_	CD	CD	_	4	num	_	_
2	transformation	_	NN	NN	_	4	nn	_	_
3	effector	_	NN	NN	_	4	nn	_	_
4	site	_	NN	NN	_	22	nsubj	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	TES1	_	NN	NN	_	4	appos	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	,	_	,	,	_	4	punct	_	_
9	located	_	JJ	JJ	_	4	amod	_	_
10	within	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	15	det	_	_
12	membrane	_	NN	NN	_	15	nn	_	_
13	proximal	_	JJ	JJ	_	15	amod	_	_
14	45	_	CD	CD	_	15	num	_	_
15	residues	_	NNS	NNS	_	10	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	cytoplasmic	_	JJ	JJ	_	19	amod	_	_
19	tail	_	NN	NN	_	16	pobj	_	_
20	,	_	,	,	_	4	punct	_	_
21	constitutively	_	RB	RB	_	22	advmod	_	_
22	engages	_	VBZ	VBZ	_	0	root	_	_
23	tumor	_	NN	NN	_	27	nn	_	_
24	necrosis	_	NN	NN	_	27	nn	_	_
25	factor	_	NN	NN	_	27	nn	_	_
26	receptor-associated	_	JJ	JJ	_	27	amod	_	_
27	factors	_	NNS	NNS	_	22	dobj	_	_
28	.	_	.	.	_	22	punct	_	_

1	Signals	_	NNS	NNS	_	5	nsubj	_	_
2	from	_	IN	IN	_	1	prep	_	_
3	TES1	_	NN	NN	_	2	pobj	_	_
4	are	_	VBP	VBP	_	5	cop	_	_
5	sufficient	_	JJ	JJ	_	0	root	_	_
6	to	_	TO	TO	_	7	aux	_	_
7	drive	_	VB	VB	_	5	xcomp	_	_
8	initial	_	JJ	JJ	_	9	amod	_	_
9	proliferation	_	NN	NN	_	7	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	infected	_	JJ	JJ	_	13	amod	_	_
12	resting	_	VBG	VBG	_	11	dep	_	_
13	B	_	NN	NN	_	10	pobj	_	_
14	lymphocytes	_	NNS	NNS	_	13	dep	_	_
15	,	_	,	,	_	5	punct	_	_
16	but	_	CC	CC	_	5	cc	_	_
17	most	_	JJS	JJS	_	19	amod	_	_
18	lymphoblastoid	_	JJ	JJ	_	19	amod	_	_
19	cells	_	NNS	NNS	_	33	nsubj	_	_
20	infected	_	VBN	VBN	_	19	vmod	_	_
21	with	_	IN	IN	_	20	prep	_	_
22	a	_	DT	DT	_	23	det	_	_
23	virus	_	NN	NN	_	21	pobj	_	_
24	that	_	WDT	WDT	_	27	nsubj	_	_
25	does	_	VBZ	VBZ	_	27	aux	_	_
26	not	_	RB	RB	_	27	neg	_	_
27	express	_	VB	VB	_	23	rcmod	_	_
28	the	_	DT	DT	_	30	det	_	_
29	155	_	CD	CD	_	30	num	_	_
30	residues	_	NNS	NNS	_	27	dobj	_	_
31	beyond	_	IN	IN	_	27	prep	_	_
32	TES1	_	NN	NN	_	31	pobj	_	_
33	fail	_	VBP	VBP	_	5	conj	_	_
34	to	_	TO	TO	_	35	aux	_	_
35	grow	_	VB	VB	_	33	xcomp	_	_
36	as	_	IN	IN	_	35	prep	_	_
37	long-term	_	JJ	JJ	_	39	amod	_	_
38	cell	_	NN	NN	_	39	nn	_	_
39	lines	_	NNS	NNS	_	36	pobj	_	_
40	.	_	.	.	_	5	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	now	_	RB	RB	_	3	advmod	_	_
3	find	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	19	mark	_	_
5	mutating	_	VBG	VBG	_	19	csubj	_	_
6	two	_	CD	CD	_	7	num	_	_
7	tyrosines	_	NNS	NNS	_	5	dobj	_	_
8	to	_	TO	TO	_	5	prep	_	_
9	an	_	DT	DT	_	10	det	_	_
10	isoleucine	_	NN	NN	_	8	pobj	_	_
11	at	_	IN	IN	_	5	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	carboxyl	_	NN	NN	_	14	nn	_	_
14	end	_	NN	NN	_	11	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	18	det	_	_
17	cytoplasmic	_	JJ	JJ	_	18	amod	_	_
18	tail	_	NN	NN	_	15	pobj	_	_
19	cripples	_	VBZ	VBZ	_	3	ccomp	_	_
20	the	_	DT	DT	_	21	det	_	_
21	ability	_	NN	NN	_	19	dobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	EBV	_	NN	NN	_	22	pobj	_	_
24	to	_	TO	TO	_	25	aux	_	_
25	cause	_	VB	VB	_	21	vmod	_	_
26	lymphoblastoid	_	JJ	JJ	_	28	amod	_	_
27	cell	_	NN	NN	_	28	nn	_	_
28	outgrowth	_	NN	NN	_	25	dobj	_	_
29	,	_	,	,	_	19	punct	_	_
30	thereby	_	RB	RB	_	31	advmod	_	_
31	marking	_	VBG	VBG	_	19	vmod	_	_
32	a	_	DT	DT	_	36	det	_	_
33	second	_	JJ	JJ	_	36	amod	_	_
34	transformation	_	NN	NN	_	36	nn	_	_
35	effector	_	NN	NN	_	36	nn	_	_
36	site	_	NN	NN	_	31	dobj	_	_
37	,	_	,	,	_	36	punct	_	_
38	TES2	_	NN	NN	_	36	appos	_	_
39	.	_	.	.	_	3	punct	_	_

1	A	_	DT	DT	_	4	det	_	_
2	yeast	_	NN	NN	_	4	nn	_	_
3	two-hybrid	_	JJ	JJ	_	4	amod	_	_
4	screen	_	NN	NN	_	5	nsubj	_	_
5	identified	_	VBD	VBD	_	0	root	_	_
6	TES2	_	NN	NN	_	8	nn	_	_
7	interacting	_	NN	NN	_	8	nn	_	_
8	proteins	_	NNS	NNS	_	5	dobj	_	_
9	,	_	,	,	_	8	punct	_	_
10	including	_	VBG	VBG	_	8	prep	_	_
11	the	_	DT	DT	_	18	det	_	_
12	tumor	_	NN	NN	_	18	nn	_	_
13	necrosis	_	NN	NN	_	18	nn	_	_
14	factor	_	NN	NN	_	18	nn	_	_
15	receptor-associated	_	JJ	JJ	_	18	amod	_	_
16	death	_	NN	NN	_	18	nn	_	_
17	domain	_	NN	NN	_	18	nn	_	_
18	protein	_	NN	NN	_	10	pobj	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	TRADD	_	NN	NN	_	18	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	.	_	.	.	_	5	punct	_	_

1	TRADD	_	NN	NN	_	5	nsubj	_	_
2	was	_	VBD	VBD	_	5	cop	_	_
3	the	_	DT	DT	_	5	det	_	_
4	only	_	JJ	JJ	_	5	amod	_	_
5	protein	_	NN	NN	_	0	root	_	_
6	that	_	WDT	WDT	_	7	nsubj	_	_
7	interacted	_	VBD	VBD	_	5	rcmod	_	_
8	with	_	IN	IN	_	7	prep	_	_
9	wild-type	_	JJ	JJ	_	10	amod	_	_
10	TES2	_	NN	NN	_	8	pobj	_	_
11	and	_	CC	CC	_	8	cc	_	_
12	not	_	RB	RB	_	13	neg	_	_
13	with	_	IN	IN	_	8	conj	_	_
14	isoleucine-mutated	_	JJ	JJ	_	15	amod	_	_
15	TES2	_	NN	NN	_	13	pobj	_	_
16	.	_	.	.	_	5	punct	_	_

1	TRADD	_	NN	NN	_	2	nsubj	_	_
2	associated	_	VBD	VBD	_	0	root	_	_
3	with	_	IN	IN	_	2	prep	_	_
4	wild-type	_	JJ	JJ	_	5	amod	_	_
5	LMP1	_	NN	NN	_	3	pobj	_	_
6	but	_	CC	CC	_	3	cc	_	_
7	not	_	RB	RB	_	8	neg	_	_
8	with	_	IN	IN	_	3	conj	_	_
9	isoleucine-mutated	_	JJ	JJ	_	10	amod	_	_
10	LMP1	_	NN	NN	_	8	pobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	mammalian	_	JJ	JJ	_	13	amod	_	_
13	cells	_	NNS	NNS	_	11	pobj	_	_
14	,	_	,	,	_	2	punct	_	_
15	and	_	CC	CC	_	2	cc	_	_
16	TRADD	_	NN	NN	_	18	nsubj	_	_
17	constitutively	_	RB	RB	_	18	advmod	_	_
18	associated	_	VBD	VBD	_	2	conj	_	_
19	with	_	IN	IN	_	18	prep	_	_
20	LMP1	_	NN	NN	_	19	pobj	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	EBV-transformed	_	JJ	JJ	_	23	amod	_	_
23	cells	_	NNS	NNS	_	21	pobj	_	_
24	.	_	.	.	_	2	punct	_	_

1	In	_	IN	IN	_	9	prep	_	_
2	transfection	_	NN	NN	_	3	nn	_	_
3	assays	_	NNS	NNS	_	1	pobj	_	_
4	,	_	,	,	_	9	punct	_	_
5	TRADD	_	NN	NN	_	9	nsubj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	TES2	_	NN	NN	_	5	conj	_	_
8	synergistically	_	RB	RB	_	9	advmod	_	_
9	mediated	_	VBD	VBD	_	0	root	_	_
10	high-level	_	JJ	JJ	_	12	amod	_	_
11	NF-kappaB	_	NN	NN	_	12	nn	_	_
12	activation	_	NN	NN	_	9	dobj	_	_
13	.	_	.	.	_	9	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	6	mark	_	_
5	LMP1	_	NN	NN	_	6	nsubj	_	_
6	appropriates	_	VBZ	VBZ	_	3	ccomp	_	_
7	TRADD	_	NN	NN	_	6	dobj	_	_
8	to	_	TO	TO	_	9	aux	_	_
9	enable	_	VB	VB	_	6	vmod	_	_
10	efficient	_	JJ	JJ	_	14	amod	_	_
11	long-term	_	JJ	JJ	_	10	dep	_	_
12	lymphoblastoid	_	JJ	JJ	_	14	amod	_	_
13	cell	_	NN	NN	_	14	nn	_	_
14	outgrowth	_	NN	NN	_	9	dobj	_	_
15	.	_	.	.	_	3	punct	_	_

1	High-level	_	JJ	JJ	_	3	amod	_	_
2	NF-kappaB	_	NN	NN	_	3	nn	_	_
3	activation	_	NN	NN	_	5	nsubj	_	_
4	also	_	RB	RB	_	5	advmod	_	_
5	appears	_	VBZ	VBZ	_	0	root	_	_
6	to	_	TO	TO	_	10	aux	_	_
7	be	_	VB	VB	_	10	cop	_	_
8	a	_	DT	DT	_	10	det	_	_
9	critical	_	JJ	JJ	_	10	amod	_	_
10	component	_	NN	NN	_	5	xcomp	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	long-term	_	JJ	JJ	_	13	amod	_	_
13	outgrowth	_	NN	NN	_	11	pobj	_	_
14	.	_	.	.	_	5	punct	_	_

1	Modulation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	mRNA	_	NN	NN	_	4	nn	_	_
4	expression	_	NN	NN	_	2	pobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	a	_	DT	DT	_	13	det	_	_
7	novel	_	JJ	JJ	_	13	amod	_	_
8	human	_	JJ	JJ	_	13	amod	_	_
9	myeloid-selective	_	JJ	JJ	_	13	amod	_	_
10	CCAAT/enhancer	_	NN	NN	_	13	nn	_	_
11	binding	_	NN	NN	_	13	nn	_	_
12	protein	_	NN	NN	_	13	nn	_	_
13	gene	_	NN	NN	_	5	pobj	_	_
14	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
15	C/EBP	_	NN	NN	_	16	nn	_	_
16	epsilon	_	NN	NN	_	13	appos	_	_
17	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
18	.	_	.	.	_	1	punct	_	_

1	Human	_	JJ	JJ	_	3	amod	_	_
2	C/EBP	_	NN	NN	_	3	nn	_	_
3	epsilon	_	NN	NN	_	8	nsubj	_	_
4	is	_	VBZ	VBZ	_	8	cop	_	_
5	a	_	DT	DT	_	8	det	_	_
6	newly	_	RB	RB	_	7	advmod	_	_
7	cloned	_	VBN	VBN	_	8	amod	_	_
8	gene	_	NN	NN	_	0	root	_	_
9	coding	_	VBG	VBG	_	8	vmod	_	_
10	for	_	IN	IN	_	9	prep	_	_
11	a	_	DT	DT	_	14	det	_	_
12	CCAAT/enhancer	_	NN	NN	_	14	nn	_	_
13	binding	_	NN	NN	_	14	nn	_	_
14	protein	_	NN	NN	_	10	pobj	_	_
15	that	_	WDT	WDT	_	18	nsubjpass	_	_
16	may	_	MD	MD	_	18	aux	_	_
17	be	_	VB	VB	_	18	auxpass	_	_
18	involved	_	VBN	VBN	_	8	rcmod	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	21	det	_	_
21	regulation	_	NN	NN	_	19	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	myeloid	_	JJ	JJ	_	24	amod	_	_
24	differentiation	_	NN	NN	_	22	pobj	_	_
25	.	_	.	.	_	8	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	studies	_	NNS	NNS	_	3	nsubj	_	_
3	showed	_	VBD	VBD	_	0	root	_	_
4	that	_	IN	IN	_	12	mark	_	_
5	levels	_	NNS	NNS	_	12	nsubjpass	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	C/EBP	_	NN	NN	_	9	nn	_	_
8	epsilon	_	NN	NN	_	9	nn	_	_
9	mRNA	_	NN	NN	_	6	pobj	_	_
10	were	_	VBD	VBD	_	12	auxpass	_	_
11	markedly	_	RB	RB	_	12	advmod	_	_
12	increased	_	VBN	VBN	_	3	ccomp	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	NB4	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	13	pobj	_	_
16	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
17	promyelocytic	_	JJ	JJ	_	19	amod	_	_
18	leukemia	_	NN	NN	_	19	nn	_	_
19	line	_	NN	NN	_	15	appos	_	_
20	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	,	_	,	,	_	12	punct	_	_
22	because	_	IN	IN	_	25	mark	_	_
23	they	_	PRP	PRP	_	25	nsubjpass	_	_
24	were	_	VBD	VBD	_	25	auxpass	_	_
25	induced	_	VBN	VBN	_	12	advcl	_	_
26	by	_	IN	IN	_	35	prep	_	_
27	9-cis	_	JJ	JJ	_	29	amod	_	_
28	retinoic	_	JJ	JJ	_	29	amod	_	_
29	acid	_	NN	NN	_	26	pobj	_	_
30	-LRB-	_	-LRB-	-LRB-	_	32	punct	_	_
31	9-cis	_	JJ	JJ	_	32	amod	_	_
32	RA	_	NN	NN	_	29	appos	_	_
33	-RRB-	_	-RRB-	-RRB-	_	32	punct	_	_
34	to	_	TO	TO	_	35	aux	_	_
35	differentiate	_	VB	VB	_	25	xcomp	_	_
36	towards	_	IN	IN	_	35	prep	_	_
37	granulocytes	_	NNS	NNS	_	36	pobj	_	_
38	.	_	.	.	_	3	punct	_	_

1	Accumulation	_	NN	NN	_	6	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	C/EBP	_	NN	NN	_	5	nn	_	_
4	epsilon	_	NN	NN	_	5	nn	_	_
5	mRNA	_	NN	NN	_	2	pobj	_	_
6	occurred	_	VBD	VBD	_	0	root	_	_
7	as	_	RB	RB	_	8	advmod	_	_
8	early	_	RB	RB	_	6	advmod	_	_
9	as	_	IN	IN	_	8	prep	_	_
10	1	_	CD	CD	_	11	num	_	_
11	hour	_	NN	NN	_	12	npadvmod	_	_
12	after	_	IN	IN	_	9	pcomp	_	_
13	exposure	_	NN	NN	_	12	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	NB4	_	NN	NN	_	16	nn	_	_
16	cells	_	NNS	NNS	_	14	pobj	_	_
17	to	_	TO	TO	_	13	prep	_	_
18	9-cis	_	JJ	JJ	_	19	amod	_	_
19	RA	_	NN	NN	_	17	pobj	_	_
20	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
21	5	_	CD	CD	_	24	num	_	_
22	x	_	CC	CC	_	21	cc	_	_
23	10-LRB--7-RRB-	_	CD	CD	_	21	conj	_	_
24	mol/L	_	NN	NN	_	19	appos	_	_
25	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
26	;	_	:	:	_	6	punct	_	_
27	and	_	CC	CC	_	6	cc	_	_
28	at	_	IN	IN	_	34	prep	_	_
29	48	_	CD	CD	_	30	num	_	_
30	hours	_	NNS	NNS	_	28	pobj	_	_
31	,	_	,	,	_	34	punct	_	_
32	levels	_	NNS	NNS	_	34	nsubjpass	_	_
33	were	_	VBD	VBD	_	34	auxpass	_	_
34	increased	_	VBN	VBN	_	6	conj	_	_
35	by	_	IN	IN	_	34	prep	_	_
36	5.1-fold	_	RB	RB	_	35	pobj	_	_
37	.	_	.	.	_	6	punct	_	_

1	Dose-response	_	JJ	JJ	_	2	amod	_	_
2	studies	_	NNS	NNS	_	3	nsubj	_	_
3	showed	_	VBD	VBD	_	0	root	_	_
4	that	_	IN	IN	_	15	mark	_	_
5	10-LRB--7-RRB-	_	CD	CD	_	7	number	_	_
6	to	_	TO	TO	_	7	dep	_	_
7	10-LRB--6-RRB-	_	CD	CD	_	8	dep	_	_
8	mol/L	_	NN	NN	_	10	dep	_	_
9	9-cis	_	JJ	JJ	_	10	amod	_	_
10	RA	_	NN	NN	_	15	nsubj	_	_
11	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
12	12	_	CD	CD	_	13	num	_	_
13	hours	_	NNS	NNS	_	10	appos	_	_
14	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
15	resulted	_	VBD	VBD	_	3	ccomp	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	peak	_	NN	NN	_	18	nn	_	_
18	levels	_	NNS	NNS	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	C/EBP	_	NN	NN	_	22	nn	_	_
21	epsilon	_	NN	NN	_	22	nn	_	_
22	mRNA	_	NN	NN	_	19	pobj	_	_
23	;	_	:	:	_	3	punct	_	_
24	but	_	CC	CC	_	3	cc	_	_
25	even	_	RB	RB	_	29	advmod	_	_
26	10-LRB--10-RRB-	_	CD	CD	_	27	number	_	_
27	mol/L	_	NN	NN	_	29	amod	_	_
28	9-cis	_	JJ	JJ	_	29	amod	_	_
29	RA	_	NN	NN	_	30	nsubj	_	_
30	increased	_	VBD	VBD	_	3	conj	_	_
31	levels	_	NNS	NNS	_	30	dobj	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	these	_	DT	DT	_	34	det	_	_
34	transcripts	_	NNS	NNS	_	32	pobj	_	_
35	.	_	.	.	_	3	punct	_	_

1	NB4	_	NN	NN	_	2	nn	_	_
2	cells	_	NNS	NNS	_	36	nsubj	_	_
3	pulse-exposed	_	JJ	JJ	_	2	amod	_	_
4	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
5	30	_	CD	CD	_	6	num	_	_
6	minutes	_	NNS	NNS	_	3	dep	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	to	_	TO	TO	_	3	prep	_	_
9	all-trans	_	JJ	JJ	_	11	amod	_	_
10	retinoic	_	JJ	JJ	_	11	amod	_	_
11	acid	_	NN	NN	_	8	pobj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	ATRA	_	NN	NN	_	11	appos	_	_
14	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
15	,	_	,	,	_	3	punct	_	_
16	washed	_	VBN	VBN	_	3	conj	_	_
17	,	_	,	,	_	3	punct	_	_
18	and	_	CC	CC	_	3	cc	_	_
19	cultured	_	VBN	VBN	_	3	conj	_	_
20	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
21	3	_	CD	CD	_	22	num	_	_
22	days	_	NNS	NNS	_	19	dep	_	_
23	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
24	with	_	IN	IN	_	19	prep	_	_
25	either	_	CC	CC	_	26	preconj	_	_
26	dimethylsulfoxide	_	NN	NN	_	24	pobj	_	_
27	-LRB-	_	-LRB-	-LRB-	_	28	punct	_	_
28	DMSO	_	NN	NN	_	26	appos	_	_
29	-RRB-	_	-RRB-	-RRB-	_	28	punct	_	_
30	or	_	CC	CC	_	26	cc	_	_
31	hexamethylene	_	NN	NN	_	32	nn	_	_
32	bisacetamide	_	NN	NN	_	26	conj	_	_
33	-LRB-	_	-LRB-	-LRB-	_	34	punct	_	_
34	HMBA	_	NN	NN	_	32	appos	_	_
35	-RRB-	_	-RRB-	-RRB-	_	34	punct	_	_
36	had	_	VBD	VBD	_	0	root	_	_
37	a	_	DT	DT	_	39	det	_	_
38	prominent	_	JJ	JJ	_	39	amod	_	_
39	increase	_	NN	NN	_	36	dobj	_	_
40	in	_	IN	IN	_	39	prep	_	_
41	levels	_	NNS	NNS	_	40	pobj	_	_
42	of	_	IN	IN	_	41	prep	_	_
43	C/EBP	_	NN	NN	_	45	nn	_	_
44	epsilon	_	NN	NN	_	45	nn	_	_
45	mRNA	_	NN	NN	_	42	pobj	_	_
46	and	_	CC	CC	_	39	cc	_	_
47	an	_	DT	DT	_	48	det	_	_
48	increase	_	NN	NN	_	39	conj	_	_
49	in	_	IN	IN	_	48	prep	_	_
50	granulocytic	_	JJ	JJ	_	51	amod	_	_
51	differentiation	_	NN	NN	_	49	pobj	_	_
52	,	_	,	,	_	36	punct	_	_
53	but	_	CC	CC	_	36	cc	_	_
54	exposure	_	NN	NN	_	61	nsubj	_	_
55	to	_	TO	TO	_	54	prep	_	_
56	either	_	CC	CC	_	57	preconj	_	_
57	DMSO	_	NN	NN	_	55	pobj	_	_
58	or	_	CC	CC	_	57	cc	_	_
59	HMBA	_	NN	NN	_	57	conj	_	_
60	alone	_	RB	RB	_	57	advmod	_	_
61	had	_	VBD	VBD	_	36	conj	_	_
62	no	_	DT	DT	_	63	neg	_	_
63	effect	_	NN	NN	_	61	dobj	_	_
64	on	_	IN	IN	_	61	prep	_	_
65	base	_	NN	NN	_	66	nn	_	_
66	levels	_	NNS	NNS	_	64	pobj	_	_
67	of	_	IN	IN	_	66	prep	_	_
68	C/EBP	_	NN	NN	_	69	nn	_	_
69	epsilon	_	NN	NN	_	67	pobj	_	_
70	and	_	CC	CC	_	61	cc	_	_
71	did	_	VBD	VBD	_	73	aux	_	_
72	not	_	RB	RB	_	73	neg	_	_
73	induce	_	VB	VB	_	61	conj	_	_
74	differentiation	_	NN	NN	_	73	dobj	_	_
75	.	_	.	.	_	36	punct	_	_

1	Macrophage-differentiation	_	NN	NN	_	4	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	NB4	_	NN	NN	_	2	pobj	_	_
4	reduced	_	VBD	VBD	_	0	root	_	_
5	levels	_	NNS	NNS	_	4	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	C/EBP	_	NN	NN	_	9	nn	_	_
8	epsilon	_	NN	NN	_	9	nn	_	_
9	mRNA	_	NN	NN	_	6	pobj	_	_
10	.	_	.	.	_	4	punct	_	_

1	Nuclear	_	JJ	JJ	_	3	amod	_	_
2	run-off	_	JJ	JJ	_	3	amod	_	_
3	assays	_	NNS	NNS	_	7	nsubj	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	half-life	_	JJ	JJ	_	6	amod	_	_
6	studies	_	NNS	NNS	_	3	conj	_	_
7	showed	_	VBD	VBD	_	0	root	_	_
8	that	_	IN	IN	_	18	mark	_	_
9	accumulation	_	NN	NN	_	18	nsubj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	C/EBP	_	NN	NN	_	13	nn	_	_
12	epsilon	_	NN	NN	_	13	nn	_	_
13	mRNA	_	NN	NN	_	10	pobj	_	_
14	by	_	IN	IN	_	9	prep	_	_
15	9-cis	_	JJ	JJ	_	16	amod	_	_
16	RA	_	NN	NN	_	14	pobj	_	_
17	was	_	VBD	VBD	_	18	cop	_	_
18	due	_	JJ	JJ	_	7	ccomp	_	_
19	to	_	TO	TO	_	18	prep	_	_
20	enhanced	_	VBN	VBN	_	21	amod	_	_
21	transcription	_	NN	NN	_	19	pobj	_	_
22	.	_	.	.	_	7	punct	_	_

1	Furthermore	_	RB	RB	_	10	advmod	_	_
2	,	_	,	,	_	10	punct	_	_
3	this	_	DT	DT	_	7	det	_	_
4	C/EBP	_	NN	NN	_	6	nn	_	_
5	epsilon	_	NN	NN	_	6	nn	_	_
6	mRNA	_	NN	NN	_	7	nn	_	_
7	accumulation	_	NN	NN	_	10	nsubj	_	_
8	did	_	VBD	VBD	_	10	aux	_	_
9	not	_	RB	RB	_	10	neg	_	_
10	require	_	VB	VB	_	0	root	_	_
11	synthesis	_	NN	NN	_	10	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	new	_	JJ	JJ	_	15	amod	_	_
14	protein	_	NN	NN	_	15	nn	_	_
15	factors	_	NNS	NNS	_	12	pobj	_	_
16	because	_	IN	IN	_	19	mark	_	_
17	9-cis	_	JJ	JJ	_	18	amod	_	_
18	RA	_	NN	NN	_	19	nsubj	_	_
19	induced	_	VBD	VBD	_	10	advcl	_	_
20	C/EBP	_	NN	NN	_	22	nn	_	_
21	epsilon	_	NN	NN	_	22	nn	_	_
22	mRNA	_	NN	NN	_	23	nn	_	_
23	accumulation	_	NN	NN	_	19	dobj	_	_
24	in	_	IN	IN	_	19	prep	_	_
25	the	_	DT	DT	_	26	det	_	_
26	absence	_	NN	NN	_	24	pobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	new	_	JJ	JJ	_	30	amod	_	_
29	protein	_	NN	NN	_	30	nn	_	_
30	synthesis	_	NN	NN	_	27	pobj	_	_
31	.	_	.	.	_	10	punct	_	_

1	ATRA	_	NN	NN	_	3	nsubj	_	_
2	also	_	RB	RB	_	3	advmod	_	_
3	induced	_	VBD	VBD	_	0	root	_	_
4	expression	_	NN	NN	_	3	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	C/EBP	_	NN	NN	_	8	nn	_	_
7	epsilon	_	NN	NN	_	8	nn	_	_
8	protein	_	NN	NN	_	5	pobj	_	_
9	in	_	IN	IN	_	3	prep	_	_
10	NB4	_	NN	NN	_	11	nn	_	_
11	cells	_	NNS	NNS	_	9	pobj	_	_
12	,	_	,	,	_	3	punct	_	_
13	as	_	IN	IN	_	14	mark	_	_
14	shown	_	VBN	VBN	_	3	advcl	_	_
15	by	_	IN	IN	_	14	prep	_	_
16	Western	_	NN	NN	_	17	nn	_	_
17	blotting	_	NN	NN	_	15	pobj	_	_
18	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	26	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	to	_	TO	TO	_	2	prep	_	_
4	the	_	DT	DT	_	5	det	_	_
5	increase	_	NN	NN	_	3	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	C/EBP	_	NN	NN	_	8	nn	_	_
8	epsilon	_	NN	NN	_	6	pobj	_	_
9	in	_	IN	IN	_	5	prep	_	_
10	9-cis	_	JJ	JJ	_	11	amod	_	_
11	RA-mediated	_	JJ	JJ	_	13	amod	_	_
12	granulocytic	_	JJ	JJ	_	13	amod	_	_
13	differentiation	_	NN	NN	_	9	pobj	_	_
14	,	_	,	,	_	26	punct	_	_
15	the	_	DT	DT	_	17	det	_	_
16	DMSO-induced	_	JJ	JJ	_	17	amod	_	_
17	differentiation	_	NN	NN	_	26	nsubjpass	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	HL-60	_	NN	NN	_	20	nn	_	_
20	cells	_	NNS	NNS	_	18	pobj	_	_
21	down	_	IN	IN	_	17	advmod	_	_
22	the	_	DT	DT	_	24	det	_	_
23	granulocytic	_	JJ	JJ	_	24	amod	_	_
24	pathway	_	NN	NN	_	21	pobj	_	_
25	was	_	VBD	VBD	_	26	auxpass	_	_
26	associated	_	VBN	VBN	_	0	root	_	_
27	with	_	IN	IN	_	26	prep	_	_
28	an	_	DT	DT	_	30	det	_	_
29	initial	_	JJ	JJ	_	30	amod	_	_
30	reduction	_	NN	NN	_	27	pobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	C/EBP	_	NN	NN	_	34	nn	_	_
33	epsilon	_	NN	NN	_	34	nn	_	_
34	mRNA	_	NN	NN	_	35	nn	_	_
35	levels	_	NNS	NNS	_	31	pobj	_	_
36	.	_	.	.	_	26	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	summary	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	6	punct	_	_
4	we	_	PRP	PRP	_	6	nsubj	_	_
5	have	_	VBP	VBP	_	6	aux	_	_
6	discovered	_	VBN	VBN	_	0	root	_	_
7	that	_	IN	IN	_	15	mark	_	_
8	expression	_	NN	NN	_	15	nsubjpass	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	C/EBP	_	NN	NN	_	12	nn	_	_
11	epsilon	_	NN	NN	_	12	nn	_	_
12	mRNA	_	NN	NN	_	9	pobj	_	_
13	is	_	VBZ	VBZ	_	15	auxpass	_	_
14	markedly	_	RB	RB	_	15	advmod	_	_
15	enhanced	_	VBN	VBN	_	6	ccomp	_	_
16	as	_	IN	IN	_	21	mark	_	_
17	the	_	DT	DT	_	19	det	_	_
18	NB4	_	NN	NN	_	19	nn	_	_
19	promyelocytes	_	NNS	NNS	_	21	nsubjpass	_	_
20	are	_	VBP	VBP	_	21	auxpass	_	_
21	induced	_	VBN	VBN	_	15	advcl	_	_
22	by	_	IN	IN	_	25	prep	_	_
23	retinoids	_	NNS	NNS	_	22	pobj	_	_
24	to	_	TO	TO	_	25	aux	_	_
25	differentiate	_	VB	VB	_	21	xcomp	_	_
26	towards	_	IN	IN	_	25	prep	_	_
27	granulocytes	_	NNS	NNS	_	26	pobj	_	_
28	.	_	.	.	_	6	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	induction	_	NN	NN	_	10	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	C/EBP	_	NN	NN	_	6	nn	_	_
5	epsilon	_	NN	NN	_	6	nn	_	_
6	mRNA	_	NN	NN	_	7	nn	_	_
7	expression	_	NN	NN	_	3	pobj	_	_
8	is	_	VBZ	VBZ	_	10	auxpass	_	_
9	transcriptionally	_	RB	RB	_	10	advmod	_	_
10	mediated	_	VBN	VBN	_	0	root	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	occurs	_	VBZ	VBZ	_	10	conj	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	absence	_	NN	NN	_	13	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	synthesis	_	NN	NN	_	16	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	additional	_	JJ	JJ	_	21	amod	_	_
20	protein	_	NN	NN	_	21	nn	_	_
21	factors	_	NNS	NNS	_	18	pobj	_	_
22	.	_	.	.	_	10	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	suspect	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	8	mark	_	_
4	the	_	DT	DT	_	7	det	_	_
5	C/EBP	_	NN	NN	_	7	nn	_	_
6	epsilon	_	NN	NN	_	7	nn	_	_
7	promoter/enhancer	_	NN	NN	_	8	nsubj	_	_
8	contains	_	VBZ	VBZ	_	2	ccomp	_	_
9	a	_	DT	DT	_	12	det	_	_
10	retinoic	_	JJ	JJ	_	12	amod	_	_
11	acid-response	_	JJ	JJ	_	12	amod	_	_
12	element	_	NN	NN	_	8	dobj	_	_
13	that	_	WDT	WDT	_	16	nsubjpass	_	_
14	is	_	VBZ	VBZ	_	16	auxpass	_	_
15	directly	_	RB	RB	_	16	advmod	_	_
16	stimulated	_	VBN	VBN	_	12	rcmod	_	_
17	by	_	IN	IN	_	16	prep	_	_
18	retinoids	_	NNS	NNS	_	17	pobj	_	_
19	.	_	.	.	_	2	punct	_	_

1	Expression	_	NN	NN	_	4	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	c-fos	_	NN	NN	_	2	pobj	_	_
4	correlates	_	VBZ	VBZ	_	0	root	_	_
5	with	_	IN	IN	_	4	prep	_	_
6	IFN-alpha	_	NN	NN	_	7	nn	_	_
7	responsiveness	_	NN	NN	_	5	pobj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	Philadelphia	_	NN	NN	_	14	nn	_	_
10	chromosome	_	NN	NN	_	14	nn	_	_
11	positive	_	JJ	JJ	_	14	amod	_	_
12	chronic	_	JJ	JJ	_	14	amod	_	_
13	myelogenous	_	JJ	JJ	_	14	amod	_	_
14	leukemia	_	NN	NN	_	8	pobj	_	_
15	.	_	.	.	_	4	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	study	_	NN	NN	_	3	nsubj	_	_
3	evaluates	_	VBZ	VBZ	_	0	root	_	_
4	-LRB-	_	-LRB-	-LRB-	_	5	punct	_	_
5	i	_	LS	LS	_	8	dep	_	_
6	-RRB-	_	-RRB-	-RRB-	_	5	punct	_	_
7	constitutive	_	JJ	JJ	_	8	amod	_	_
8	levels	_	NNS	NNS	_	3	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	oncogene	_	NN	NN	_	9	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	p53	_	NN	NN	_	13	nn	_	_
13	transcripts	_	NNS	NNS	_	10	conj	_	_
14	in	_	IN	IN	_	8	prep	_	_
15	chronic	_	JJ	JJ	_	18	amod	_	_
16	phase	_	NN	NN	_	18	nn	_	_
17	CML	_	NN	NN	_	18	nn	_	_
18	patients	_	NNS	NNS	_	14	pobj	_	_
19	and	_	CC	CC	_	8	cc	_	_
20	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
21	ii	_	LS	LS	_	24	dep	_	_
22	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
23	their	_	PRP$	PRP$	_	24	poss	_	_
24	modulations	_	NNS	NNS	_	8	conj	_	_
25	subsequent	_	JJ	JJ	_	24	amod	_	_
26	to	_	TO	TO	_	25	prep	_	_
27	in	_	FW	FW	_	29	amod	_	_
28	vivo	_	FW	FW	_	27	dep	_	_
29	therapy	_	NN	NN	_	26	pobj	_	_
30	with	_	IN	IN	_	29	prep	_	_
31	rIFN-alpha	_	NN	NN	_	32	nn	_	_
32	2c	_	NN	NN	_	30	pobj	_	_
33	.	_	.	.	_	3	punct	_	_

1	Peripheral	_	JJ	JJ	_	4	amod	_	_
2	blood	_	NN	NN	_	4	nn	_	_
3	mononuclear	_	JJ	JJ	_	4	amod	_	_
4	cells	_	NNS	NNS	_	16	nsubjpass	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	pbmc	_	NN	NN	_	4	appos	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	and	_	CC	CC	_	4	cc	_	_
9	bone	_	NN	NN	_	11	nn	_	_
10	marrow	_	NN	NN	_	11	nn	_	_
11	cells	_	NNS	NNS	_	4	conj	_	_
12	of	_	IN	IN	_	4	prep	_	_
13	26	_	CD	CD	_	14	num	_	_
14	patients	_	NNS	NNS	_	12	pobj	_	_
15	were	_	VBD	VBD	_	16	auxpass	_	_
16	examined	_	VBN	VBN	_	0	root	_	_
17	for	_	IN	IN	_	16	prep	_	_
18	c-fos	_	NN	NN	_	17	pobj	_	_
19	,	_	,	,	_	18	punct	_	_
20	c-myc	_	NN	NN	_	18	conj	_	_
21	,	_	,	,	_	18	punct	_	_
22	p53	_	NN	NN	_	18	conj	_	_
23	and	_	CC	CC	_	18	cc	_	_
24	the	_	DT	DT	_	26	det	_	_
25	hybrid	_	NN	NN	_	26	nn	_	_
26	bcr/abl	_	NN	NN	_	18	conj	_	_
27	mRNA	_	NN	NN	_	28	nn	_	_
28	levels	_	NNS	NNS	_	18	dep	_	_
29	.	_	.	.	_	16	punct	_	_

1	Results	_	NNS	NNS	_	2	nsubj	_	_
2	indicated	_	VBD	VBD	_	0	root	_	_
3	that	_	IN	IN	_	13	mark	_	_
4	-LRB-	_	-LRB-	-LRB-	_	5	punct	_	_
5	i	_	LS	LS	_	13	dep	_	_
6	-RRB-	_	-RRB-	-RRB-	_	5	punct	_	_
7	constitutive	_	JJ	JJ	_	10	amod	_	_
8	c-fos	_	NN	NN	_	9	nn	_	_
9	transcript	_	NN	NN	_	10	nn	_	_
10	levels	_	NNS	NNS	_	13	nsubj	_	_
11	are	_	VBP	VBP	_	13	cop	_	_
12	significantly	_	RB	RB	_	13	advmod	_	_
13	higher	_	JJR	JJR	_	2	ccomp	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	patients	_	NNS	NNS	_	14	pobj	_	_
16	subsequently	_	RB	RB	_	17	advmod	_	_
17	responding	_	VBG	VBG	_	15	vmod	_	_
18	to	_	TO	TO	_	17	prep	_	_
19	IFN-alpha	_	NN	NN	_	20	nn	_	_
20	therapy	_	NN	NN	_	18	pobj	_	_
21	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
22	p	_	NN	NN	_	13	dep	_	_
23	&lt;	_	JJR	JJR	_	22	amod	_	_
24	0.01	_	CD	CD	_	23	dep	_	_
25	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
26	and	_	CC	CC	_	13	cc	_	_
27	positively	_	RB	RB	_	28	advmod	_	_
28	correlated	_	VBN	VBN	_	13	conj	_	_
29	with	_	IN	IN	_	28	prep	_	_
30	the	_	DT	DT	_	31	det	_	_
31	proportion	_	NN	NN	_	29	pobj	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	lymphocytes	_	NNS	NNS	_	32	pobj	_	_
34	-LRB-	_	-LRB-	-LRB-	_	35	punct	_	_
35	r	_	NN	NN	_	28	dep	_	_
36	=	_	JJ	JJ	_	35	amod	_	_
37	0.6895	_	CD	CD	_	36	dep	_	_
38	,	_	,	,	_	35	punct	_	_
39	p	_	NN	NN	_	35	appos	_	_
40	&lt;	_	JJR	JJR	_	39	amod	_	_
41	0.01	_	CD	CD	_	40	dep	_	_
42	-RRB-	_	-RRB-	-RRB-	_	35	punct	_	_
43	and	_	CC	CC	_	28	cc	_	_
44	negatively	_	RB	RB	_	60	advmod	_	_
45	with	_	IN	IN	_	60	prep	_	_
46	the	_	DT	DT	_	47	det	_	_
47	proportion	_	NN	NN	_	45	pobj	_	_
48	of	_	IN	IN	_	47	prep	_	_
49	immature	_	JJ	JJ	_	50	amod	_	_
50	cells	_	NNS	NNS	_	48	pobj	_	_
51	-LRB-	_	-LRB-	-LRB-	_	52	punct	_	_
52	r	_	NN	NN	_	60	dep	_	_
53	=	_	JJ	JJ	_	52	amod	_	_
54	-0.568	_	CD	CD	_	53	dep	_	_
55	,	_	,	,	_	52	punct	_	_
56	p	_	NN	NN	_	52	appos	_	_
57	&lt;	_	JJR	JJR	_	56	amod	_	_
58	0.01	_	CD	CD	_	57	dep	_	_
59	-RRB-	_	-RRB-	-RRB-	_	52	punct	_	_
60	contained	_	VBN	VBN	_	28	conj	_	_
61	in	_	IN	IN	_	60	prep	_	_
62	the	_	DT	DT	_	64	det	_	_
63	pbmc	_	NN	NN	_	64	nn	_	_
64	preparations	_	NNS	NNS	_	61	pobj	_	_
65	tested	_	VBN	VBN	_	64	vmod	_	_
66	,	_	,	,	_	13	punct	_	_
67	-LRB-	_	-LRB-	-LRB-	_	68	punct	_	_
68	ii	_	LS	LS	_	83	dep	_	_
69	-RRB-	_	-RRB-	-RRB-	_	68	punct	_	_
70	constitutive	_	JJ	JJ	_	71	amod	_	_
71	mRNA	_	NN	NN	_	72	nn	_	_
72	levels	_	NNS	NNS	_	83	nsubjpass	_	_
73	of	_	IN	IN	_	72	prep	_	_
74	the	_	DT	DT	_	76	det	_	_
75	hybrid	_	NN	NN	_	76	nn	_	_
76	bcr/abl	_	NN	NN	_	73	pobj	_	_
77	,	_	,	,	_	76	punct	_	_
78	c-myc	_	NN	NN	_	76	conj	_	_
79	and	_	CC	CC	_	76	cc	_	_
80	p53	_	NN	NN	_	76	conj	_	_
81	are	_	VBP	VBP	_	83	auxpass	_	_
82	positively	_	RB	RB	_	83	advmod	_	_
83	correlated	_	VBN	VBN	_	13	ccomp	_	_
84	with	_	IN	IN	_	83	prep	_	_
85	each	_	DT	DT	_	86	det	_	_
86	other	_	JJ	JJ	_	84	pobj	_	_
87	,	_	,	,	_	83	punct	_	_
88	but	_	CC	CC	_	83	cc	_	_
89	failed	_	VBD	VBD	_	83	conj	_	_
90	to	_	TO	TO	_	91	aux	_	_
91	relate	_	VB	VB	_	89	xcomp	_	_
92	to	_	TO	TO	_	91	prep	_	_
93	disease	_	NN	NN	_	94	nn	_	_
94	parameters	_	NNS	NNS	_	92	pobj	_	_
95	,	_	,	,	_	13	punct	_	_
96	and	_	CC	CC	_	13	cc	_	_
97	-LRB-	_	-LRB-	-LRB-	_	98	punct	_	_
98	iii	_	LS	LS	_	109	dep	_	_
99	-RRB-	_	-RRB-	-RRB-	_	98	punct	_	_
100	acute	_	JJ	JJ	_	109	nsubjpass	_	_
101	and	_	CC	CC	_	100	cc	_	_
102	chronic	_	JJ	JJ	_	100	conj	_	_
103	in	_	FW	FW	_	105	amod	_	_
104	vivo	_	FW	FW	_	103	dep	_	_
105	exposure	_	NN	NN	_	100	dep	_	_
106	to	_	TO	TO	_	100	prep	_	_
107	IFN-alpha	_	NN	NN	_	106	pobj	_	_
108	is	_	VBZ	VBZ	_	109	auxpass	_	_
109	accompanied	_	VBN	VBN	_	13	conj	_	_
110	by	_	IN	IN	_	109	prep	_	_
111	upregulation	_	NN	NN	_	110	pobj	_	_
112	of	_	IN	IN	_	111	prep	_	_
113	c-fos	_	NN	NN	_	112	pobj	_	_
114	and	_	CC	CC	_	111	cc	_	_
115	downregulation	_	NN	NN	_	111	conj	_	_
116	of	_	IN	IN	_	115	prep	_	_
117	c-myc	_	NN	NN	_	118	nn	_	_
118	mRNA	_	NN	NN	_	119	nn	_	_
119	levels	_	NNS	NNS	_	116	pobj	_	_
120	in	_	IN	IN	_	111	prep	_	_
121	responder	_	NN	NN	_	122	nn	_	_
122	patients	_	NNS	NNS	_	120	pobj	_	_
123	.	_	.	.	_	2	punct	_	_

1	Paternal	_	JJ	JJ	_	2	amod	_	_
2	expression	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	WT1	_	NN	NN	_	3	pobj	_	_
5	in	_	IN	IN	_	2	prep	_	_
6	human	_	JJ	JJ	_	7	amod	_	_
7	fibroblasts	_	NNS	NNS	_	5	pobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	lymphocytes	_	NNS	NNS	_	7	conj	_	_
10	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	6	det	_	_
2	Wilms	_	NN	NN	_	6	poss	_	_
3	'	_	POS	POS	_	6	possessive	_	_
4	tumor	_	NN	NN	_	6	nn	_	_
5	suppressor	_	NN	NN	_	6	nn	_	_
6	gene	_	NN	NN	_	12	nsubjpass	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	WT1	_	NN	NN	_	6	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	was	_	VBD	VBD	_	12	auxpass	_	_
11	previously	_	RB	RB	_	12	advmod	_	_
12	identified	_	VBN	VBN	_	0	root	_	_
13	as	_	IN	IN	_	12	prep	_	_
14	being	_	VBG	VBG	_	15	auxpass	_	_
15	imprinted	_	VBN	VBN	_	13	pcomp	_	_
16	,	_	,	,	_	15	punct	_	_
17	with	_	IN	IN	_	15	prep	_	_
18	frequent	_	JJ	JJ	_	20	amod	_	_
19	maternal	_	JJ	JJ	_	20	amod	_	_
20	expression	_	NN	NN	_	17	pobj	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	human	_	JJ	JJ	_	23	amod	_	_
23	placentae	_	NN	NN	_	21	pobj	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	fetal	_	JJ	JJ	_	26	amod	_	_
26	brains	_	NNS	NNS	_	23	conj	_	_
27	.	_	.	.	_	12	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	examined	_	VBD	VBD	_	0	root	_	_
3	the	_	DT	DT	_	5	det	_	_
4	allele-specific	_	JJ	JJ	_	5	amod	_	_
5	expression	_	NN	NN	_	2	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	WT1	_	NN	NN	_	6	pobj	_	_
8	in	_	IN	IN	_	5	prep	_	_
9	cultured	_	VBN	VBN	_	11	amod	_	_
10	human	_	JJ	JJ	_	11	amod	_	_
11	fibroblasts	_	NNS	NNS	_	8	pobj	_	_
12	from	_	IN	IN	_	11	prep	_	_
13	15	_	CD	CD	_	14	num	_	_
14	individuals	_	NNS	NNS	_	12	pobj	_	_
15	.	_	.	.	_	2	punct	_	_

1	Seven	_	CD	CD	_	3	number	_	_
2	of	_	IN	IN	_	3	quantmod	_	_
3	15	_	CD	CD	_	5	num	_	_
4	fibroblast	_	NN	NN	_	5	nn	_	_
5	lines	_	NNS	NNS	_	7	nsubj	_	_
6	were	_	VBD	VBD	_	7	cop	_	_
7	heterozygous	_	JJ	JJ	_	0	root	_	_
8	for	_	IN	IN	_	7	prep	_	_
9	polymorphic	_	JJ	JJ	_	10	amod	_	_
10	alleles	_	NNS	NNS	_	8	pobj	_	_
11	,	_	,	,	_	7	punct	_	_
12	and	_	CC	CC	_	7	cc	_	_
13	the	_	DT	DT	_	15	det	_	_
14	expression	_	NN	NN	_	15	nn	_	_
15	patterns	_	NNS	NNS	_	17	nsubj	_	_
16	were	_	VBD	VBD	_	17	cop	_	_
17	variable	_	JJ	JJ	_	7	conj	_	_
18	,	_	,	,	_	17	punct	_	_
19	i.e.	_	FW	FW	_	17	prep	_	_
20	,	_	,	,	_	17	punct	_	_
21	equal	_	JJ	JJ	_	17	dep	_	_
22	,	_	,	,	_	21	punct	_	_
23	unequal	_	JJ	JJ	_	21	conj	_	_
24	or	_	CC	CC	_	21	cc	_	_
25	monoallelic	_	JJ	JJ	_	26	amod	_	_
26	paternal	_	JJ	JJ	_	21	conj	_	_
27	expression	_	NN	NN	_	21	dep	_	_
28	in	_	IN	IN	_	17	prep	_	_
29	three	_	CD	CD	_	28	pobj	_	_
30	,	_	,	,	_	29	punct	_	_
31	two	_	CD	CD	_	29	conj	_	_
32	and	_	CC	CC	_	29	cc	_	_
33	two	_	CD	CD	_	29	conj	_	_
34	cases	_	NNS	NNS	_	29	dep	_	_
35	,	_	,	,	_	17	punct	_	_
36	respectively	_	RB	RB	_	17	advmod	_	_
37	.	_	.	.	_	7	punct	_	_

1	Exclusive	_	JJ	JJ	_	3	amod	_	_
2	paternal	_	JJ	JJ	_	3	amod	_	_
3	expression	_	NN	NN	_	8	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	WT1	_	NN	NN	_	4	pobj	_	_
6	was	_	VBD	VBD	_	8	auxpass	_	_
7	also	_	RB	RB	_	8	advmod	_	_
8	shown	_	VBN	VBN	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	non-cultured	_	JJ	JJ	_	12	amod	_	_
11	peripheral	_	JJ	JJ	_	12	amod	_	_
12	lymphocytes	_	NNS	NNS	_	9	pobj	_	_
13	from	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	17	det	_	_
15	latter	_	JJ	JJ	_	17	amod	_	_
16	two	_	CD	CD	_	17	num	_	_
17	individuals	_	NNS	NNS	_	13	pobj	_	_
18	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	allele-specific	_	JJ	JJ	_	4	amod	_	_
3	expression	_	NN	NN	_	4	nn	_	_
4	profiles	_	NNS	NNS	_	19	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	other	_	JJ	JJ	_	8	amod	_	_
7	imprinted	_	JJ	JJ	_	8	amod	_	_
8	genes	_	NNS	NNS	_	5	pobj	_	_
9	,	_	,	,	_	8	punct	_	_
10	IGF2	_	NN	NN	_	8	appos	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	H19	_	NN	NN	_	10	conj	_	_
13	,	_	,	,	_	8	punct	_	_
14	on	_	IN	IN	_	8	prep	_	_
15	human	_	JJ	JJ	_	16	amod	_	_
16	chromosome	_	NN	NN	_	14	pobj	_	_
17	11	_	CD	CD	_	16	num	_	_
18	were	_	VBD	VBD	_	19	cop	_	_
19	constant	_	JJ	JJ	_	0	root	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	consistent	_	JJ	JJ	_	19	conj	_	_
22	with	_	IN	IN	_	21	prep	_	_
23	those	_	DT	DT	_	22	pobj	_	_
24	in	_	IN	IN	_	23	prep	_	_
25	other	_	JJ	JJ	_	26	amod	_	_
26	tissues	_	NNS	NNS	_	24	pobj	_	_
27	.	_	.	.	_	19	punct	_	_

1	Our	_	PRP$	PRP$	_	3	poss	_	_
2	unexpected	_	JJ	JJ	_	3	amod	_	_
3	observations	_	NNS	NNS	_	31	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	paternal	_	JJ	JJ	_	4	pobj	_	_
6	or	_	CC	CC	_	5	cc	_	_
7	biallelic	_	JJ	JJ	_	5	conj	_	_
8	expression	_	NN	NN	_	5	dep	_	_
9	of	_	IN	IN	_	5	prep	_	_
10	WT1	_	NN	NN	_	9	pobj	_	_
11	in	_	IN	IN	_	5	prep	_	_
12	fibroblasts	_	NNS	NNS	_	11	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	lymphocytes	_	NNS	NNS	_	12	conj	_	_
15	,	_	,	,	_	3	punct	_	_
16	together	_	RB	RB	_	17	advmod	_	_
17	with	_	IN	IN	_	31	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	previous	_	JJ	JJ	_	20	amod	_	_
20	findings	_	NNS	NNS	_	17	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	maternal	_	JJ	JJ	_	21	pobj	_	_
23	or	_	CC	CC	_	22	cc	_	_
24	biallelic	_	JJ	JJ	_	22	conj	_	_
25	expression	_	NN	NN	_	22	dep	_	_
26	in	_	IN	IN	_	22	prep	_	_
27	placentae	_	NN	NN	_	26	pobj	_	_
28	and	_	CC	CC	_	27	cc	_	_
29	brains	_	NNS	NNS	_	27	conj	_	_
30	,	_	,	,	_	31	punct	_	_
31	suggest	_	VBP	VBP	_	0	root	_	_
32	that	_	IN	IN	_	40	mark	_	_
33	the	_	DT	DT	_	36	det	_	_
34	allele-specific	_	JJ	JJ	_	36	amod	_	_
35	regulatory	_	JJ	JJ	_	36	amod	_	_
36	system	_	NN	NN	_	40	nsubj	_	_
37	of	_	IN	IN	_	36	prep	_	_
38	WT1	_	NN	NN	_	37	pobj	_	_
39	is	_	VBZ	VBZ	_	40	cop	_	_
40	unique	_	JJ	JJ	_	31	ccomp	_	_
41	and	_	CC	CC	_	40	cc	_	_
42	may	_	MD	MD	_	44	aux	_	_
43	be	_	VB	VB	_	44	auxpass	_	_
44	controlled	_	VBN	VBN	_	40	conj	_	_
45	by	_	IN	IN	_	44	prep	_	_
46	a	_	DT	DT	_	51	det	_	_
47	putative	_	JJ	JJ	_	51	amod	_	_
48	tissue-	_	NN	NN	_	47	dep	_	_
49	and	_	CC	CC	_	48	cc	_	_
50	individual-specific	_	JJ	JJ	_	48	conj	_	_
51	modifier	_	NN	NN	_	45	pobj	_	_
52	.	_	.	.	_	31	punct	_	_

1	Aberrant	_	JJ	JJ	_	2	amod	_	_
2	splicing	_	NN	NN	_	9	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	5	dep	_	_
5	TSG101	_	NN	NN	_	3	pobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	FHIT	_	NN	NN	_	5	conj	_	_
8	genes	_	NNS	NNS	_	5	dep	_	_
9	occurs	_	VBZ	VBZ	_	0	root	_	_
10	frequently	_	RB	RB	_	9	advmod	_	_
11	in	_	IN	IN	_	9	prep	_	_
12	multiple	_	JJ	JJ	_	13	amod	_	_
13	malignancies	_	NNS	NNS	_	11	pobj	_	_
14	and	_	CC	CC	_	11	cc	_	_
15	in	_	IN	IN	_	11	conj	_	_
16	normal	_	JJ	JJ	_	17	amod	_	_
17	tissues	_	NNS	NNS	_	15	pobj	_	_
18	and	_	CC	CC	_	9	cc	_	_
19	mimics	_	VBZ	VBZ	_	9	conj	_	_
20	alterations	_	NNS	NNS	_	19	dobj	_	_
21	previously	_	RB	RB	_	22	advmod	_	_
22	described	_	VBN	VBN	_	20	vmod	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	tumours	_	NNS	NNS	_	23	pobj	_	_
25	.	_	.	.	_	9	punct	_	_

1	Intragenic	_	JJ	JJ	_	2	amod	_	_
2	deletions	_	NNS	NNS	_	25	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	TSG101	_	NN	NN	_	3	pobj	_	_
5	,	_	,	,	_	4	punct	_	_
6	the	_	DT	DT	_	8	det	_	_
7	human	_	JJ	JJ	_	8	amod	_	_
8	homolog	_	NN	NN	_	4	appos	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	a	_	DT	DT	_	12	det	_	_
11	mouse	_	NN	NN	_	12	nn	_	_
12	gene	_	NN	NN	_	9	pobj	_	_
13	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
14	tsg101	_	NN	NN	_	12	appos	_	_
15	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	that	_	WDT	WDT	_	17	nsubj	_	_
17	acts	_	VBZ	VBZ	_	8	rcmod	_	_
18	to	_	TO	TO	_	19	aux	_	_
19	suppress	_	VB	VB	_	17	xcomp	_	_
20	malignant	_	JJ	JJ	_	22	amod	_	_
21	cell	_	NN	NN	_	22	nn	_	_
22	growth	_	NN	NN	_	19	dobj	_	_
23	,	_	,	,	_	2	punct	_	_
24	were	_	VBD	VBD	_	25	auxpass	_	_
25	reported	_	VBN	VBN	_	0	root	_	_
26	in	_	IN	IN	_	25	prep	_	_
27	human	_	JJ	JJ	_	29	amod	_	_
28	breast	_	NN	NN	_	29	nn	_	_
29	tumours	_	NNS	NNS	_	26	pobj	_	_
30	.	_	.	.	_	25	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	screened	_	VBD	VBD	_	0	root	_	_
3	TSG101	_	NN	NN	_	2	dobj	_	_
4	for	_	IN	IN	_	2	prep	_	_
5	somatic	_	JJ	JJ	_	6	amod	_	_
6	mutations	_	NNS	NNS	_	4	pobj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	DNA	_	NN	NN	_	7	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	RNA	_	NN	NN	_	8	conj	_	_
11	samples	_	NNS	NNS	_	8	dep	_	_
12	isolated	_	VBN	VBN	_	8	vmod	_	_
13	from	_	IN	IN	_	12	prep	_	_
14	a	_	DT	DT	_	15	det	_	_
15	variety	_	NN	NN	_	13	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	common	_	JJ	JJ	_	19	amod	_	_
18	human	_	JJ	JJ	_	19	amod	_	_
19	malignancies	_	NNS	NNS	_	16	pobj	_	_
20	,	_	,	,	_	15	punct	_	_
21	EBV-immortalised	_	JJ	JJ	_	22	amod	_	_
22	B-cells	_	NNS	NNS	_	15	conj	_	_
23	,	_	,	,	_	15	punct	_	_
24	and	_	CC	CC	_	15	cc	_	_
25	normal	_	JJ	JJ	_	27	amod	_	_
26	lung	_	NN	NN	_	27	nn	_	_
27	parenchyma	_	NN	NN	_	15	conj	_	_
28	.	_	.	.	_	2	punct	_	_

1	Intragenic	_	JJ	JJ	_	3	amod	_	_
2	TSG101	_	NN	NN	_	3	nn	_	_
3	deletions	_	NNS	NNS	_	9	nsubjpass	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	RNA	_	NN	NN	_	6	nn	_	_
6	transcripts	_	NNS	NNS	_	4	pobj	_	_
7	were	_	VBD	VBD	_	9	auxpass	_	_
8	frequently	_	RB	RB	_	9	advmod	_	_
9	found	_	VBN	VBN	_	0	root	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	all	_	DT	DT	_	12	det	_	_
12	types	_	NNS	NNS	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	samples	_	NNS	NNS	_	13	pobj	_	_
15	.	_	.	.	_	9	punct	_	_

1	Analysis	_	NN	NN	_	4	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	DNA	_	NN	NN	_	2	pobj	_	_
4	failed	_	VBD	VBD	_	0	root	_	_
5	to	_	TO	TO	_	6	aux	_	_
6	show	_	VB	VB	_	4	xcomp	_	_
7	genomic	_	JJ	JJ	_	8	amod	_	_
8	rearrangements	_	NNS	NNS	_	6	dobj	_	_
9	corresponding	_	VBG	VBG	_	8	vmod	_	_
10	to	_	TO	TO	_	9	prep	_	_
11	transcripts	_	NNS	NNS	_	10	pobj	_	_
12	containing	_	VBG	VBG	_	11	vmod	_	_
13	deletions	_	NNS	NNS	_	12	dobj	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	17	det	_	_
16	same	_	JJ	JJ	_	17	amod	_	_
17	samples	_	NNS	NNS	_	14	pobj	_	_
18	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	breakpoints	_	NNS	NNS	_	7	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	most	_	JJS	JJS	_	6	amod	_	_
5	transcript	_	NN	NN	_	6	nn	_	_
6	deletions	_	NNS	NNS	_	3	pobj	_	_
7	coincide	_	VBP	VBP	_	0	root	_	_
8	with	_	IN	IN	_	7	prep	_	_
9	genuine	_	JJ	JJ	_	8	pobj	_	_
10	or	_	CC	CC	_	9	cc	_	_
11	cryptic	_	JJ	JJ	_	9	conj	_	_
12	splice	_	NN	NN	_	14	nn	_	_
13	site	_	NN	NN	_	14	nn	_	_
14	sequences	_	NNS	NNS	_	9	dep	_	_
15	,	_	,	,	_	7	punct	_	_
16	suggesting	_	VBG	VBG	_	7	xcomp	_	_
17	that	_	IN	IN	_	19	mark	_	_
18	they	_	PRP	PRP	_	19	nsubj	_	_
19	result	_	VBP	VBP	_	16	ccomp	_	_
20	from	_	IN	IN	_	19	prep	_	_
21	alternative	_	JJ	JJ	_	20	pobj	_	_
22	or	_	CC	CC	_	21	cc	_	_
23	aberrant	_	JJ	JJ	_	21	conj	_	_
24	splicing	_	NN	NN	_	21	dep	_	_
25	.	_	.	.	_	7	punct	_	_

1	A	_	DT	DT	_	3	det	_	_
2	similar	_	JJ	JJ	_	3	amod	_	_
3	spectrum	_	NN	NN	_	10	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	transcript	_	NN	NN	_	6	nn	_	_
6	deletions	_	NNS	NNS	_	4	pobj	_	_
7	has	_	VBZ	VBZ	_	10	aux	_	_
8	previously	_	RB	RB	_	10	advmod	_	_
9	been	_	VBN	VBN	_	10	auxpass	_	_
10	described	_	VBN	VBN	_	0	root	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	16	det	_	_
13	putative	_	JJ	JJ	_	16	amod	_	_
14	tumour	_	NN	NN	_	16	nn	_	_
15	suppressor	_	NN	NN	_	16	nn	_	_
16	gene	_	NN	NN	_	11	pobj	_	_
17	FHIT	_	NN	NN	_	16	dep	_	_
18	.	_	.	.	_	10	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	analysed	_	VBD	VBD	_	0	root	_	_
3	FHIT	_	NN	NN	_	2	dobj	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	7	det	_	_
6	same	_	JJ	JJ	_	7	amod	_	_
7	series	_	NN	NN	_	4	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	RNA	_	NN	NN	_	10	nn	_	_
10	samples	_	NNS	NNS	_	8	pobj	_	_
11	and	_	CC	CC	_	2	cc	_	_
12	detected	_	VBD	VBD	_	2	conj	_	_
13	truncated	_	VBN	VBN	_	15	amod	_	_
14	FHIT	_	NN	NN	_	15	nn	_	_
15	transcripts	_	NNS	NNS	_	12	dobj	_	_
16	frequently	_	RB	RB	_	12	advmod	_	_
17	in	_	IN	IN	_	12	prep	_	_
18	both	_	CC	CC	_	19	preconj	_	_
19	tumour	_	NN	NN	_	17	pobj	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	normal	_	JJ	JJ	_	19	conj	_	_
22	tissues	_	NNS	NNS	_	19	dep	_	_
23	.	_	.	.	_	2	punct	_	_

1	In	_	IN	IN	_	14	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	14	punct	_	_
4	transcripts	_	NNS	NNS	_	14	nsubjpass	_	_
5	from	_	IN	IN	_	4	prep	_	_
6	TSG101	_	NN	NN	_	5	pobj	_	_
7	,	_	,	,	_	6	punct	_	_
8	FHIT	_	NN	NN	_	6	conj	_	_
9	and	_	CC	CC	_	6	cc	_	_
10	seven	_	CD	CD	_	12	num	_	_
11	other	_	JJ	JJ	_	12	amod	_	_
12	genes	_	NNS	NNS	_	6	conj	_	_
13	were	_	VBD	VBD	_	14	auxpass	_	_
14	analysed	_	VBN	VBN	_	0	root	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	RNA	_	NN	NN	_	15	pobj	_	_
17	isolated	_	VBN	VBN	_	16	vmod	_	_
18	from	_	IN	IN	_	17	prep	_	_
19	normal	_	JJ	JJ	_	22	amod	_	_
20	peripheral	_	JJ	JJ	_	22	amod	_	_
21	blood	_	NN	NN	_	22	nn	_	_
22	lymphocytes	_	NNS	NNS	_	18	pobj	_	_
23	.	_	.	.	_	14	punct	_	_

1	Large	_	JJ	JJ	_	2	amod	_	_
2	TSG101	_	NN	NN	_	9	nsubjpass	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	FHIT	_	NN	NN	_	2	conj	_	_
5	intragenic	_	JJ	JJ	_	7	amod	_	_
6	transcript	_	NN	NN	_	7	nn	_	_
7	deletions	_	NNS	NNS	_	2	dep	_	_
8	were	_	VBD	VBD	_	9	auxpass	_	_
9	detected	_	VBN	VBN	_	0	root	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	these	_	DT	DT	_	12	nsubj	_	_
12	appeared	_	VBD	VBD	_	9	conj	_	_
13	to	_	TO	TO	_	17	aux	_	_
14	be	_	VB	VB	_	17	cop	_	_
15	the	_	DT	DT	_	17	det	_	_
16	predominant	_	JJ	JJ	_	17	amod	_	_
17	transcript	_	NN	NN	_	12	xcomp	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	'	_	``	``	_	22	punct	_	_
20	aged	_	JJ	JJ	_	22	amod	_	_
21	'	_	''	''	_	22	punct	_	_
22	lymphocytes	_	NNS	NNS	_	18	pobj	_	_
23	.	_	.	.	_	9	punct	_	_

1	Similar	_	JJ	JJ	_	2	amod	_	_
2	alterations	_	NNS	NNS	_	5	nsubjpass	_	_
3	were	_	VBD	VBD	_	5	auxpass	_	_
4	not	_	RB	RB	_	5	neg	_	_
5	detected	_	VBN	VBN	_	0	root	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	transcripts	_	NNS	NNS	_	6	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	other	_	JJ	JJ	_	11	amod	_	_
11	genes	_	NNS	NNS	_	8	pobj	_	_
12	which	_	WDT	WDT	_	14	nsubjpass	_	_
13	were	_	VBD	VBD	_	14	auxpass	_	_
14	analysed	_	VBN	VBN	_	7	rcmod	_	_
15	.	_	.	.	_	5	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	findings	_	NNS	NNS	_	3	nsubj	_	_
3	demonstrate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	12	mark	_	_
5	truncated	_	VBN	VBN	_	6	amod	_	_
6	TSG101	_	NN	NN	_	12	nsubjpass	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	FHIT	_	NN	NN	_	6	conj	_	_
9	transcripts	_	NNS	NNS	_	6	dep	_	_
10	are	_	VBP	VBP	_	12	auxpass	_	_
11	commonly	_	RB	RB	_	12	advmod	_	_
12	detected	_	VBN	VBN	_	3	ccomp	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	both	_	CC	CC	_	15	preconj	_	_
15	normal	_	JJ	JJ	_	13	pobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	malignant	_	JJ	JJ	_	15	conj	_	_
18	tissues	_	NNS	NNS	_	15	dep	_	_
19	and	_	CC	CC	_	12	cc	_	_
20	that	_	IN	IN	_	27	mark	_	_
21	a	_	DT	DT	_	23	det	_	_
22	significant	_	JJ	JJ	_	23	amod	_	_
23	fraction	_	NN	NN	_	27	nsubj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	these	_	DT	DT	_	24	pobj	_	_
26	are	_	VBP	VBP	_	27	cop	_	_
27	likely	_	JJ	JJ	_	12	conj	_	_
28	to	_	TO	TO	_	31	aux	_	_
29	be	_	VB	VB	_	31	cop	_	_
30	the	_	DT	DT	_	31	det	_	_
31	result	_	NN	NN	_	27	xcomp	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	aberrant	_	JJ	JJ	_	34	amod	_	_
34	splicing	_	NN	NN	_	32	pobj	_	_
35	.	_	.	.	_	3	punct	_	_

1	While	_	IN	IN	_	5	mark	_	_
2	we	_	PRP	PRP	_	5	nsubj	_	_
3	can	_	MD	MD	_	5	aux	_	_
4	not	_	RB	RB	_	5	neg	_	_
5	exclude	_	VB	VB	_	19	advcl	_	_
6	that	_	IN	IN	_	12	mark	_	_
7	alterations	_	NNS	NNS	_	12	nsubj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	TSG101	_	NN	NN	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	FHIT	_	NN	NN	_	9	conj	_	_
12	occur	_	VBP	VBP	_	5	ccomp	_	_
13	during	_	IN	IN	_	12	prep	_	_
14	cancer	_	NN	NN	_	15	nn	_	_
15	development	_	NN	NN	_	13	pobj	_	_
16	,	_	,	,	_	19	punct	_	_
17	our	_	PRP$	PRP$	_	18	poss	_	_
18	data	_	NNS	NNS	_	19	nsubj	_	_
19	indicate	_	VBP	VBP	_	0	root	_	_
20	that	_	IN	IN	_	30	mark	_	_
21	in	_	IN	IN	_	30	prep	_	_
22	this	_	DT	DT	_	23	det	_	_
23	context	_	NN	NN	_	21	pobj	_	_
24	the	_	DT	DT	_	28	det	_	_
25	commonly	_	RB	RB	_	26	advmod	_	_
26	observed	_	VBN	VBN	_	28	amod	_	_
27	transcript	_	NN	NN	_	28	nn	_	_
28	abnormalities	_	NNS	NNS	_	30	nsubj	_	_
29	are	_	VBP	VBP	_	30	cop	_	_
30	misleading	_	JJ	JJ	_	19	ccomp	_	_
31	.	_	.	.	_	19	punct	_	_

1	Impaired	_	JJ	JJ	_	3	amod	_	_
2	cortisol	_	NN	NN	_	3	nn	_	_
3	binding	_	NN	NN	_	0	root	_	_
4	to	_	TO	TO	_	3	prep	_	_
5	glucocorticoid	_	NN	NN	_	6	nn	_	_
6	receptors	_	NNS	NNS	_	4	pobj	_	_
7	in	_	IN	IN	_	3	prep	_	_
8	hypertensive	_	JJ	JJ	_	9	amod	_	_
9	patients	_	NNS	NNS	_	7	pobj	_	_
10	.	_	.	.	_	3	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	compared	_	VBD	VBD	_	0	root	_	_
3	glucocorticoid	_	NN	NN	_	6	nn	_	_
4	receptor	_	NN	NN	_	6	nn	_	_
5	binding	_	NN	NN	_	6	nn	_	_
6	characteristics	_	NNS	NNS	_	2	dobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	glucocorticoid	_	NN	NN	_	9	nn	_	_
9	responsiveness	_	NN	NN	_	6	conj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	human	_	JJ	JJ	_	13	amod	_	_
12	mononuclear	_	JJ	JJ	_	13	amod	_	_
13	leukocytes	_	NNS	NNS	_	10	pobj	_	_
14	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
15	HML	_	NN	NN	_	13	appos	_	_
16	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
17	from	_	IN	IN	_	13	prep	_	_
18	hypertensive	_	JJ	JJ	_	19	amod	_	_
19	patients	_	NNS	NNS	_	17	pobj	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	matched	_	VBD	VBD	_	23	amod	_	_
22	normotensive	_	JJ	JJ	_	23	amod	_	_
23	volunteers	_	NNS	NNS	_	19	conj	_	_
24	.	_	.	.	_	2	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	also	_	RB	RB	_	3	advmod	_	_
3	considered	_	VBD	VBD	_	0	root	_	_
4	associations	_	NNS	NNS	_	3	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	these	_	DT	DT	_	7	det	_	_
7	variables	_	NNS	NNS	_	5	pobj	_	_
8	with	_	IN	IN	_	4	prep	_	_
9	plasma	_	NN	NN	_	11	nn	_	_
10	renin	_	NN	NN	_	11	nn	_	_
11	activity	_	NN	NN	_	8	pobj	_	_
12	,	_	,	,	_	11	punct	_	_
13	aldosterone	_	NN	NN	_	11	appos	_	_
14	,	_	,	,	_	13	punct	_	_
15	cortisol	_	NN	NN	_	13	conj	_	_
16	,	_	,	,	_	13	punct	_	_
17	corticotropin	_	NN	NN	_	13	conj	_	_
18	,	_	,	,	_	13	punct	_	_
19	and	_	CC	CC	_	13	cc	_	_
20	electrolyte	_	NN	NN	_	13	conj	_	_
21	concentrations	_	NNS	NNS	_	13	dep	_	_
22	.	_	.	.	_	3	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	calculated	_	VBD	VBD	_	0	root	_	_
3	binding	_	NN	NN	_	2	dobj	_	_
4	affinity	_	NN	NN	_	3	dep	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	Kd	_	NN	NN	_	4	dep	_	_
7	;	_	:	:	_	6	punct	_	_
8	nmol/L	_	NN	NN	_	6	dep	_	_
9	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
10	and	_	CC	CC	_	3	cc	_	_
11	capacity	_	NN	NN	_	3	conj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	Bmax	_	NN	NN	_	11	dep	_	_
14	;	_	:	:	_	13	punct	_	_
15	sites/cell	_	NNS	NNS	_	13	dep	_	_
16	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
17	for	_	IN	IN	_	3	prep	_	_
18	dexamethasone	_	NN	NN	_	17	pobj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	cortisol	_	NN	NN	_	18	conj	_	_
21	from	_	IN	IN	_	2	prep	_	_
22	homologous	_	JJ	JJ	_	21	pobj	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	heterologous	_	JJ	JJ	_	22	conj	_	_
25	competition	_	NN	NN	_	26	nn	_	_
26	curves	_	NNS	NNS	_	22	dep	_	_
27	for	_	IN	IN	_	22	prep	_	_
28	specific	_	JJ	JJ	_	31	amod	_	_
29	-LSB-3H-RSB-dexamethasone	_	NN	NN	_	31	nn	_	_
30	binding	_	NN	NN	_	31	nn	_	_
31	sites	_	NNS	NNS	_	27	pobj	_	_
32	on	_	IN	IN	_	31	prep	_	_
33	HML	_	NN	NN	_	32	pobj	_	_
34	isolated	_	VBN	VBN	_	33	vmod	_	_
35	from	_	IN	IN	_	34	prep	_	_
36	the	_	DT	DT	_	37	det	_	_
37	blood	_	NN	NN	_	35	pobj	_	_
38	of	_	IN	IN	_	37	prep	_	_
39	normotensive	_	JJ	JJ	_	40	amod	_	_
40	volunteers	_	NNS	NNS	_	38	pobj	_	_
41	and	_	CC	CC	_	40	cc	_	_
42	subjects	_	NNS	NNS	_	40	conj	_	_
43	with	_	IN	IN	_	42	prep	_	_
44	essential	_	JJ	JJ	_	45	amod	_	_
45	hypertension	_	NN	NN	_	43	pobj	_	_
46	.	_	.	.	_	2	punct	_	_

1	Glucocorticoid	_	NN	NN	_	2	nn	_	_
2	responsiveness	_	NN	NN	_	6	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	HML	_	NN	NN	_	3	pobj	_	_
5	was	_	VBD	VBD	_	6	auxpass	_	_
6	evaluated	_	VBN	VBN	_	0	root	_	_
7	as	_	IN	IN	_	6	prep	_	_
8	IC50	_	NN	NN	_	9	nn	_	_
9	values	_	NNS	NNS	_	7	pobj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	nmol/L	_	NN	NN	_	9	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	for	_	IN	IN	_	9	prep	_	_
14	dexamethasone	_	NN	NN	_	13	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	cortisol	_	NN	NN	_	14	conj	_	_
17	for	_	IN	IN	_	14	prep	_	_
18	the	_	DT	DT	_	19	det	_	_
19	inhibition	_	NN	NN	_	17	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	lysozyme	_	NN	NN	_	22	nn	_	_
22	release	_	NN	NN	_	20	pobj	_	_
23	.	_	.	.	_	6	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	measured	_	VBD	VBD	_	0	root	_	_
3	plasma	_	NN	NN	_	4	nn	_	_
4	hormones	_	NNS	NNS	_	2	dobj	_	_
5	by	_	IN	IN	_	2	prep	_	_
6	radioimmunoassay	_	NN	NN	_	5	pobj	_	_
7	.	_	.	.	_	2	punct	_	_

1	Kd	_	NN	NN	_	2	nn	_	_
2	values	_	NNS	NNS	_	14	nsubj	_	_
3	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
4	mean+/-SE	_	NN	NN	_	2	appos	_	_
5	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
6	for	_	IN	IN	_	2	prep	_	_
7	cortisol	_	NN	NN	_	6	pobj	_	_
8	in	_	IN	IN	_	2	prep	_	_
9	HML	_	NN	NN	_	8	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	hypertensive	_	JJ	JJ	_	12	amod	_	_
12	patients	_	NNS	NNS	_	10	pobj	_	_
13	were	_	VBD	VBD	_	14	cop	_	_
14	higher	_	JJR	JJR	_	0	root	_	_
15	than	_	IN	IN	_	14	prep	_	_
16	in	_	IN	IN	_	15	pcomp	_	_
17	control	_	NN	NN	_	18	nn	_	_
18	subjects	_	NNS	NNS	_	16	pobj	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	24.6+/-2.4	_	CD	CD	_	14	dep	_	_
21	versus	_	CC	CC	_	20	cc	_	_
22	17.5+/-1.7	_	CD	CD	_	20	conj	_	_
23	nmol/L	_	NN	NN	_	20	dep	_	_
24	,	_	,	,	_	20	punct	_	_
25	P	_	NN	NN	_	20	appos	_	_
26	&lt;	_	JJR	JJR	_	25	amod	_	_
27	.04	_	CD	CD	_	26	dep	_	_
28	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
29	.	_	.	.	_	14	punct	_	_

1	Binding	_	NN	NN	_	2	nn	_	_
2	capacity	_	NN	NN	_	43	nsubj	_	_
3	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
4	4978+/-391	_	CD	CD	_	2	dep	_	_
5	versus	_	CC	CC	_	4	cc	_	_
6	4131+/-321	_	CD	CD	_	4	conj	_	_
7	sites/cell	_	NNS	NNS	_	4	dep	_	_
8	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
9	,	_	,	,	_	2	punct	_	_
10	Kd	_	NN	NN	_	11	nn	_	_
11	values	_	NNS	NNS	_	2	conj	_	_
12	for	_	IN	IN	_	11	prep	_	_
13	dexamethasone	_	NN	NN	_	12	pobj	_	_
14	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
15	6.7+/-0.5	_	CD	CD	_	11	dep	_	_
16	versus	_	CC	CC	_	15	cc	_	_
17	5.7+/-0.3	_	CD	CD	_	15	conj	_	_
18	nmol/L	_	NN	NN	_	15	dep	_	_
19	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
20	,	_	,	,	_	2	punct	_	_
21	and	_	CC	CC	_	2	cc	_	_
22	IC50	_	NN	NN	_	23	nn	_	_
23	values	_	NNS	NNS	_	2	conj	_	_
24	for	_	IN	IN	_	23	prep	_	_
25	dexamethasone	_	NN	NN	_	24	pobj	_	_
26	-LRB-	_	-LRB-	-LRB-	_	27	punct	_	_
27	3.4+/-0.3	_	CD	CD	_	25	dep	_	_
28	versus	_	CC	CC	_	27	cc	_	_
29	3.1+/-0.2	_	CD	CD	_	27	conj	_	_
30	nmol/L	_	NN	NN	_	27	dep	_	_
31	-RRB-	_	-RRB-	-RRB-	_	27	punct	_	_
32	and	_	CC	CC	_	25	cc	_	_
33	cortisol	_	NN	NN	_	25	conj	_	_
34	-LRB-	_	-LRB-	-LRB-	_	35	punct	_	_
35	12.2+/-1.6	_	CD	CD	_	33	dep	_	_
36	versus	_	CC	CC	_	35	cc	_	_
37	9.5+/-0.3	_	CD	CD	_	35	conj	_	_
38	nmol/L	_	NN	NN	_	35	dep	_	_
39	-RRB-	_	-RRB-	-RRB-	_	35	punct	_	_
40	were	_	VBD	VBD	_	43	cop	_	_
41	not	_	RB	RB	_	43	neg	_	_
42	significantly	_	RB	RB	_	43	advmod	_	_
43	different	_	JJ	JJ	_	0	root	_	_
44	.	_	.	.	_	43	punct	_	_

1	Patients	_	NNS	NNS	_	16	nsubj	_	_
2	with	_	IN	IN	_	1	prep	_	_
3	renin	_	NN	NN	_	4	nn	_	_
4	values	_	NNS	NNS	_	2	pobj	_	_
5	less	_	JJR	JJR	_	4	amod	_	_
6	than	_	IN	IN	_	5	prep	_	_
7	0.13	_	CD	CD	_	8	number	_	_
8	ng	_	NN	NN	_	10	amod	_	_
9	angiotensin	_	NN	NN	_	10	nn	_	_
10	I/L	_	NN	NN	_	6	pobj	_	_
11	per	_	IN	IN	_	10	prep	_	_
12	second	_	NN	NN	_	11	pobj	_	_
13	were	_	VBD	VBD	_	16	cop	_	_
14	markedly	_	RB	RB	_	15	advmod	_	_
15	less	_	RBR	RBR	_	16	advmod	_	_
16	sensitive	_	JJ	JJ	_	0	root	_	_
17	to	_	TO	TO	_	16	prep	_	_
18	cortisol	_	NN	NN	_	17	pobj	_	_
19	than	_	IN	IN	_	16	prep	_	_
20	those	_	DT	DT	_	19	pobj	_	_
21	with	_	IN	IN	_	20	prep	_	_
22	higher	_	JJR	JJR	_	23	amod	_	_
23	values	_	NNS	NNS	_	21	pobj	_	_
24	.	_	.	.	_	16	punct	_	_

1	Both	_	CC	CC	_	2	preconj	_	_
2	Kd	_	NN	NN	_	22	nsubj	_	_
3	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
4	30.3+/-2.5	_	CD	CD	_	2	dep	_	_
5	versus	_	CC	CC	_	4	cc	_	_
6	19.2+/-2.4	_	CD	CD	_	4	conj	_	_
7	nmol/L	_	NN	NN	_	4	dep	_	_
8	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
9	and	_	CC	CC	_	2	cc	_	_
10	IC50	_	NN	NN	_	11	nn	_	_
11	values	_	NNS	NNS	_	2	conj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	15.5+/-1.8	_	CD	CD	_	11	dep	_	_
14	versus	_	CC	CC	_	13	cc	_	_
15	8.9+/-1.2	_	CD	CD	_	13	conj	_	_
16	nmol/L	_	NN	NN	_	13	dep	_	_
17	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
18	for	_	IN	IN	_	2	prep	_	_
19	cortisol	_	NN	NN	_	18	pobj	_	_
20	were	_	VBD	VBD	_	22	cop	_	_
21	significantly	_	RB	RB	_	22	advmod	_	_
22	higher	_	JJR	JJR	_	0	root	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	patients	_	NNS	NNS	_	23	pobj	_	_
25	with	_	IN	IN	_	24	prep	_	_
26	lower	_	JJR	JJR	_	28	amod	_	_
27	renin	_	NN	NN	_	28	nn	_	_
28	values	_	NNS	NNS	_	25	pobj	_	_
29	-LRB-	_	-LRB-	-LRB-	_	30	punct	_	_
30	P	_	NN	NN	_	28	dep	_	_
31	&lt;	_	JJR	JJR	_	30	amod	_	_
32	.03	_	CD	CD	_	31	dep	_	_
33	-RRB-	_	-RRB-	-RRB-	_	30	punct	_	_
34	.	_	.	.	_	22	punct	_	_

1	Other	_	JJ	JJ	_	2	amod	_	_
2	variables	_	NNS	NNS	_	18	nsubj	_	_
3	,	_	,	,	_	2	punct	_	_
4	including	_	VBG	VBG	_	2	prep	_	_
5	plasma	_	NN	NN	_	6	nn	_	_
6	hormone	_	NN	NN	_	4	pobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	electrolyte	_	NN	NN	_	6	conj	_	_
9	values	_	NNS	NNS	_	6	dep	_	_
10	and	_	CC	CC	_	6	cc	_	_
11	binding	_	NN	NN	_	12	nn	_	_
12	characteristics	_	NNS	NNS	_	6	conj	_	_
13	for	_	IN	IN	_	12	prep	_	_
14	dexamethasone	_	NN	NN	_	13	pobj	_	_
15	,	_	,	,	_	2	punct	_	_
16	were	_	VBD	VBD	_	18	cop	_	_
17	not	_	RB	RB	_	18	neg	_	_
18	different	_	JJ	JJ	_	0	root	_	_
19	.	_	.	.	_	18	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	12	mark	_	_
5	cortisol	_	NN	NN	_	6	nn	_	_
6	binding	_	NN	NN	_	12	nsubj	_	_
7	to	_	TO	TO	_	6	prep	_	_
8	glucocorticoid	_	NN	NN	_	9	nn	_	_
9	receptor	_	NN	NN	_	7	pobj	_	_
10	is	_	VBZ	VBZ	_	12	cop	_	_
11	slightly	_	RB	RB	_	12	advmod	_	_
12	impaired	_	JJ	JJ	_	3	ccomp	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	patients	_	NNS	NNS	_	13	pobj	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	essential	_	JJ	JJ	_	17	amod	_	_
17	hypertension	_	NN	NN	_	15	pobj	_	_
18	.	_	.	.	_	3	punct	_	_

1	In	_	FW	FW	_	2	nn	_	_
2	vivo	_	FW	FW	_	6	advmod	_	_
3	,	_	,	,	_	6	punct	_	_
4	this	_	DT	DT	_	6	nsubj	_	_
5	could	_	MD	MD	_	6	aux	_	_
6	lead	_	VB	VB	_	0	root	_	_
7	to	_	TO	TO	_	6	prep	_	_
8	inappropriate	_	JJ	JJ	_	9	amod	_	_
9	binding	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	cortisol	_	NN	NN	_	10	pobj	_	_
12	to	_	TO	TO	_	9	prep	_	_
13	mineralocorticoid	_	NN	NN	_	14	nn	_	_
14	receptors	_	NNS	NNS	_	12	pobj	_	_
15	.	_	.	.	_	6	punct	_	_

1	Hence	_	RB	RB	_	8	advmod	_	_
2	,	_	,	,	_	8	punct	_	_
3	decreased	_	VBN	VBN	_	4	amod	_	_
4	sensitivity	_	NN	NN	_	8	nsubjpass	_	_
5	to	_	TO	TO	_	4	prep	_	_
6	cortisol	_	NN	NN	_	5	pobj	_	_
7	is	_	VBZ	VBZ	_	8	auxpass	_	_
8	associated	_	VBN	VBN	_	0	root	_	_
9	with	_	IN	IN	_	8	prep	_	_
10	renin	_	NN	NN	_	11	nn	_	_
11	suppression	_	NN	NN	_	9	pobj	_	_
12	.	_	.	.	_	8	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	hypothesis	_	NN	NN	_	4	nsubjpass	_	_
3	is	_	VBZ	VBZ	_	4	auxpass	_	_
4	supported	_	VBN	VBN	_	0	root	_	_
5	by	_	IN	IN	_	4	prep	_	_
6	evidence	_	NN	NN	_	5	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	hypertension	_	NN	NN	_	7	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	low	_	JJ	JJ	_	12	amod	_	_
11	renin	_	NN	NN	_	12	nn	_	_
12	activity	_	NN	NN	_	8	conj	_	_
13	,	_	,	,	_	8	punct	_	_
14	which	_	WDT	WDT	_	17	dobj	_	_
15	others	_	NNS	NNS	_	17	nsubj	_	_
16	have	_	VBP	VBP	_	17	aux	_	_
17	described	_	VBN	VBN	_	8	rcmod	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	patients	_	NNS	NNS	_	18	pobj	_	_
20	with	_	IN	IN	_	19	prep	_	_
21	primary	_	JJ	JJ	_	23	amod	_	_
22	glucocorticoid	_	NN	NN	_	23	nn	_	_
23	resistance	_	NN	NN	_	20	pobj	_	_
24	due	_	JJ	JJ	_	23	amod	_	_
25	to	_	TO	TO	_	24	prep	_	_
26	mutations	_	NNS	NNS	_	25	pobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	30	det	_	_
29	glucocorticoid	_	NN	NN	_	30	nn	_	_
30	receptor	_	NN	NN	_	27	pobj	_	_
31	.	_	.	.	_	4	punct	_	_

1	Repression	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	human	_	JJ	JJ	_	6	amod	_	_
4	immunodeficiency	_	NN	NN	_	6	nn	_	_
5	virus	_	NN	NN	_	6	nn	_	_
6	type	_	NN	NN	_	2	pobj	_	_
7	1	_	CD	CD	_	6	num	_	_
8	through	_	IN	IN	_	1	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	novel	_	JJ	JJ	_	11	amod	_	_
11	cooperation	_	NN	NN	_	8	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	human	_	JJ	JJ	_	14	amod	_	_
14	factors	_	NNS	NNS	_	12	pobj	_	_
15	YY1	_	NN	NN	_	14	dep	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	LSF	_	NN	NN	_	15	conj	_	_
18	-LSB-	_	-LRB-	-LRB-	_	21	punct	_	_
19	published	_	VBN	VBN	_	20	amod	_	_
20	erratum	_	NN	NN	_	21	nsubj	_	_
21	appears	_	VBZ	VBZ	_	1	dep	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	J	_	NNP	NNP	_	24	nn	_	_
24	Virol	_	NNP	NNP	_	22	pobj	_	_
25	1998	_	CD	CD	_	26	num	_	_
26	Feb	_	NNP	NNP	_	24	dep	_	_
27	;	_	:	:	_	24	punct	_	_
28	72	_	CD	CD	_	30	num	_	_
29	-LRB-	_	-LRB-	-LRB-	_	30	punct	_	_
30	2	_	CD	CD	_	24	dep	_	_
31	-RRB-	_	-RRB-	-RRB-	_	30	punct	_	_
32	:	_	:	:	_	24	punct	_	_
33	1709	_	CD	CD	_	24	dep	_	_
34	-RSB-	_	-RRB-	-RRB-	_	21	punct	_	_

1	A	_	DT	DT	_	2	det	_	_
2	subpopulation	_	NN	NN	_	16	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	stably	_	RB	RB	_	7	advmod	_	_
5	infected	_	JJ	JJ	_	7	amod	_	_
6	CD4+	_	JJ	JJ	_	7	amod	_	_
7	cells	_	NNS	NNS	_	3	pobj	_	_
8	capable	_	JJ	JJ	_	2	amod	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	producing	_	VBG	VBG	_	9	pcomp	_	_
11	virus	_	NN	NN	_	10	dobj	_	_
12	upon	_	IN	IN	_	10	prep	_	_
13	stimulation	_	NN	NN	_	12	pobj	_	_
14	has	_	VBZ	VBZ	_	16	aux	_	_
15	been	_	VBN	VBN	_	16	auxpass	_	_
16	identified	_	VBN	VBN	_	0	root	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	human	_	JJ	JJ	_	25	amod	_	_
19	immunodeficiency	_	NN	NN	_	25	nn	_	_
20	virus	_	NN	NN	_	25	nn	_	_
21	-LRB-	_	-LRB-	-LRB-	_	25	punct	_	_
22	HIV	_	NN	NN	_	25	nn	_	_
23	-RRB-	_	-RRB-	-RRB-	_	25	punct	_	_
24	-positive	_	JJ	JJ	_	25	amod	_	_
25	individuals	_	NNS	NNS	_	17	pobj	_	_
26	-LRB-	_	-LRB-	-LRB-	_	27	punct	_	_
27	T.-W.Chun	_	NNP	NNP	_	16	dep	_	_
28	,	_	,	,	_	27	punct	_	_
29	D.Finzi	_	NNP	NNP	_	27	conj	_	_
30	,	_	,	,	_	27	punct	_	_
31	J.Margolick	_	NNP	NNP	_	27	conj	_	_
32	,	_	,	,	_	27	punct	_	_
33	K.Chadwick	_	NNP	NNP	_	27	conj	_	_
34	,	_	,	,	_	27	punct	_	_
35	D.Schwartz	_	NNP	NNP	_	27	conj	_	_
36	,	_	,	,	_	27	punct	_	_
37	and	_	CC	CC	_	27	cc	_	_
38	R.F.Siliciano	_	NNP	NNP	_	27	conj	_	_
39	,	_	,	,	_	27	punct	_	_
40	Nat.Med.1	_	NNP	NNP	_	27	appos	_	_
41	:	_	:	:	_	27	punct	_	_
42	1284-1290	_	CD	CD	_	27	dep	_	_
43	,	_	,	,	_	27	punct	_	_
44	1995	_	CD	CD	_	27	amod	_	_
45	-RRB-	_	-RRB-	-RRB-	_	27	punct	_	_
46	.	_	.	.	_	16	punct	_	_

1	Few	_	JJ	JJ	_	3	amod	_	_
2	host	_	NN	NN	_	3	nn	_	_
3	factors	_	NNS	NNS	_	20	nsubjpass	_	_
4	that	_	WDT	WDT	_	6	nsubj	_	_
5	directly	_	RB	RB	_	6	advmod	_	_
6	limit	_	VBP	VBP	_	3	rcmod	_	_
7	HIV-1	_	NN	NN	_	8	nn	_	_
8	transcription	_	NN	NN	_	6	dobj	_	_
9	and	_	CC	CC	_	6	cc	_	_
10	could	_	MD	MD	_	11	aux	_	_
11	support	_	VB	VB	_	6	conj	_	_
12	this	_	DT	DT	_	13	det	_	_
13	state	_	NN	NN	_	11	dobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	nonproductive	_	JJ	JJ	_	17	amod	_	_
16	HIV-1	_	NN	NN	_	17	nn	_	_
17	infection	_	NN	NN	_	14	pobj	_	_
18	have	_	VBP	VBP	_	20	aux	_	_
19	been	_	VBN	VBN	_	20	auxpass	_	_
20	described	_	VBN	VBN	_	0	root	_	_
21	.	_	.	.	_	20	punct	_	_

1	YY1	_	NN	NN	_	11	nsubjpass	_	_
2	,	_	,	,	_	1	punct	_	_
3	a	_	DT	DT	_	8	det	_	_
4	widely	_	RB	RB	_	5	advmod	_	_
5	distributed	_	VBN	VBN	_	8	amod	_	_
6	human	_	JJ	JJ	_	8	amod	_	_
7	transcription	_	NN	NN	_	8	nn	_	_
8	factor	_	NN	NN	_	1	appos	_	_
9	,	_	,	,	_	1	punct	_	_
10	is	_	VBZ	VBZ	_	11	auxpass	_	_
11	known	_	VBN	VBN	_	0	root	_	_
12	to	_	TO	TO	_	13	aux	_	_
13	inhibit	_	VB	VB	_	11	xcomp	_	_
14	HIV-1	_	NN	NN	_	17	nn	_	_
15	long	_	JJ	JJ	_	17	amod	_	_
16	terminal	_	JJ	JJ	_	17	amod	_	_
17	repeat	_	NN	NN	_	21	nn	_	_
18	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
19	LTR	_	NN	NN	_	17	appos	_	_
20	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	transcription	_	NN	NN	_	13	dobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	virus	_	NN	NN	_	24	nn	_	_
24	production	_	NN	NN	_	21	conj	_	_
25	.	_	.	.	_	11	punct	_	_

1	LSF	_	NN	NN	_	15	nsubjpass	_	_
2	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
3	also	_	RB	RB	_	4	advmod	_	_
4	known	_	VBN	VBN	_	1	dep	_	_
5	as	_	IN	IN	_	4	prep	_	_
6	LBP-1	_	NN	NN	_	5	pobj	_	_
7	,	_	,	,	_	6	punct	_	_
8	UBP	_	NN	NN	_	6	conj	_	_
9	,	_	,	,	_	6	punct	_	_
10	and	_	CC	CC	_	6	cc	_	_
11	CP-2	_	NN	NN	_	6	conj	_	_
12	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
13	has	_	VBZ	VBZ	_	15	aux	_	_
14	been	_	VBN	VBN	_	15	auxpass	_	_
15	shown	_	VBN	VBN	_	0	root	_	_
16	to	_	TO	TO	_	17	aux	_	_
17	repress	_	VB	VB	_	15	xcomp	_	_
18	LTR	_	NN	NN	_	19	nn	_	_
19	transcription	_	NN	NN	_	17	dobj	_	_
20	in	_	FW	FW	_	21	nn	_	_
21	vitro	_	FW	FW	_	17	advmod	_	_
22	,	_	,	,	_	15	punct	_	_
23	but	_	CC	CC	_	15	cc	_	_
24	transient	_	JJ	JJ	_	25	amod	_	_
25	expression	_	NN	NN	_	28	nsubj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	LSF	_	NN	NN	_	26	pobj	_	_
28	has	_	VBZ	VBZ	_	15	conj	_	_
29	no	_	DT	DT	_	30	neg	_	_
30	effect	_	NN	NN	_	28	dobj	_	_
31	on	_	IN	IN	_	28	prep	_	_
32	LTR	_	NN	NN	_	33	nn	_	_
33	activity	_	NN	NN	_	31	pobj	_	_
34	in	_	FW	FW	_	35	nn	_	_
35	vivo	_	FW	FW	_	28	advmod	_	_
36	.	_	.	.	_	15	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	report	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	8	mark	_	_
4	both	_	CC	CC	_	5	preconj	_	_
5	YY1	_	NN	NN	_	8	nsubj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	LSF	_	NN	NN	_	5	conj	_	_
8	participate	_	VBP	VBP	_	2	ccomp	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	formation	_	NN	NN	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	a	_	DT	DT	_	14	det	_	_
14	complex	_	NN	NN	_	12	pobj	_	_
15	that	_	WDT	WDT	_	16	nsubj	_	_
16	recognizes	_	VBZ	VBZ	_	14	rcmod	_	_
17	the	_	DT	DT	_	19	det	_	_
18	initiation	_	NN	NN	_	19	nn	_	_
19	region	_	NN	NN	_	16	dobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	23	det	_	_
22	HIV-1	_	NN	NN	_	23	nn	_	_
23	LTR	_	NN	NN	_	20	pobj	_	_
24	.	_	.	.	_	2	punct	_	_

1	Further	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	we	_	PRP	PRP	_	5	nsubj	_	_
4	have	_	VBP	VBP	_	5	aux	_	_
5	found	_	VBN	VBN	_	0	root	_	_
6	that	_	IN	IN	_	9	mark	_	_
7	these	_	DT	DT	_	8	det	_	_
8	factors	_	NNS	NNS	_	9	nsubj	_	_
9	cooperate	_	VBP	VBP	_	5	ccomp	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	repression	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	LTR	_	NN	NN	_	15	nn	_	_
15	expression	_	NN	NN	_	13	pobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	viral	_	JJ	JJ	_	18	amod	_	_
18	replication	_	NN	NN	_	15	conj	_	_
19	.	_	.	.	_	5	punct	_	_

1	This	_	DT	DT	_	3	det	_	_
2	cooperative	_	JJ	JJ	_	3	amod	_	_
3	function	_	NN	NN	_	5	nsubj	_	_
4	may	_	MD	MD	_	5	aux	_	_
5	account	_	VB	VB	_	0	root	_	_
6	for	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	divergent	_	JJ	JJ	_	9	amod	_	_
9	effects	_	NNS	NNS	_	6	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	LSF	_	NN	NN	_	10	pobj	_	_
12	previously	_	RB	RB	_	13	advmod	_	_
13	observed	_	VBN	VBN	_	9	vmod	_	_
14	in	_	FW	FW	_	15	nn	_	_
15	vitro	_	FW	FW	_	13	advmod	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	in	_	FW	FW	_	15	conj	_	_
18	vivo	_	FW	FW	_	17	dep	_	_
19	.	_	.	.	_	5	punct	_	_

1	Thus	_	RB	RB	_	12	advmod	_	_
2	,	_	,	,	_	12	punct	_	_
3	the	_	DT	DT	_	4	det	_	_
4	cooperation	_	NN	NN	_	12	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	two	_	CD	CD	_	10	num	_	_
7	general	_	JJ	JJ	_	10	amod	_	_
8	cellular	_	JJ	JJ	_	10	amod	_	_
9	transcription	_	NN	NN	_	10	nn	_	_
10	factors	_	NNS	NNS	_	5	pobj	_	_
11	may	_	MD	MD	_	12	aux	_	_
12	allow	_	VB	VB	_	0	root	_	_
13	for	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	selective	_	JJ	JJ	_	16	amod	_	_
16	downregulation	_	NN	NN	_	13	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	HIV	_	NN	NN	_	19	nn	_	_
19	transcription	_	NN	NN	_	17	pobj	_	_
20	.	_	.	.	_	12	punct	_	_

1	Through	_	IN	IN	_	12	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	mechanism	_	NN	NN	_	1	pobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	gene	_	NN	NN	_	6	nn	_	_
6	regulation	_	NN	NN	_	4	pobj	_	_
7	,	_	,	,	_	12	punct	_	_
8	YY1	_	NN	NN	_	12	nsubj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	LSF	_	NN	NN	_	8	conj	_	_
11	could	_	MD	MD	_	12	aux	_	_
12	contribute	_	VB	VB	_	0	root	_	_
13	to	_	TO	TO	_	12	prep	_	_
14	the	_	DT	DT	_	15	dep	_	_
15	establishment	_	NN	NN	_	13	pobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	maintenance	_	NN	NN	_	15	conj	_	_
18	of	_	IN	IN	_	15	prep	_	_
19	a	_	DT	DT	_	20	det	_	_
20	population	_	NN	NN	_	18	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	cells	_	NNS	NNS	_	21	pobj	_	_
23	stably	_	RB	RB	_	26	advmod	_	_
24	but	_	CC	CC	_	23	cc	_	_
25	nonproductively	_	RB	RB	_	23	conj	_	_
26	infected	_	VBN	VBN	_	20	vmod	_	_
27	with	_	IN	IN	_	26	prep	_	_
28	HIV-1	_	NN	NN	_	27	pobj	_	_
29	.	_	.	.	_	12	punct	_	_

1	Ras-related	_	JJ	JJ	_	3	amod	_	_
2	GTP-binding	_	JJ	JJ	_	3	amod	_	_
3	proteins	_	NNS	NNS	_	0	root	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	leukocyte	_	NN	NN	_	7	nn	_	_
6	signal	_	NN	NN	_	7	nn	_	_
7	transduction	_	NN	NN	_	3	conj	_	_
8	.	_	.	.	_	3	punct	_	_

1	Many	_	JJ	JJ	_	2	amod	_	_
2	aspects	_	NNS	NNS	_	7	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	leukocyte	_	NN	NN	_	5	nn	_	_
5	function	_	NN	NN	_	3	pobj	_	_
6	are	_	VBP	VBP	_	7	auxpass	_	_
7	regulated	_	VBN	VBN	_	0	root	_	_
8	by	_	IN	IN	_	7	prep	_	_
9	both	_	CC	CC	_	10	preconj	_	_
10	heterotrimeric	_	JJ	JJ	_	8	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	Ras-related	_	JJ	JJ	_	14	amod	_	_
13	GTP-binding	_	JJ	JJ	_	14	amod	_	_
14	proteins	_	NNS	NNS	_	10	conj	_	_
15	,	_	,	,	_	7	punct	_	_
16	but	_	CC	CC	_	7	cc	_	_
17	there	_	EX	EX	_	18	expl	_	_
18	is	_	VBZ	VBZ	_	7	conj	_	_
19	little	_	JJ	JJ	_	21	amod	_	_
20	definite	_	JJ	JJ	_	19	dep	_	_
21	information	_	NN	NN	_	18	nsubj	_	_
22	about	_	IN	IN	_	21	prep	_	_
23	their	_	PRP$	PRP$	_	24	poss	_	_
24	roles	_	NNS	NNS	_	22	pobj	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	28	det	_	_
27	specialized	_	JJ	JJ	_	28	amod	_	_
28	processes	_	NNS	NNS	_	25	pobj	_	_
29	utilized	_	VBN	VBN	_	24	vmod	_	_
30	by	_	IN	IN	_	29	prep	_	_
31	leukocytes	_	NNS	NNS	_	30	pobj	_	_
32	for	_	IN	IN	_	29	prep	_	_
33	cell	_	NN	NN	_	34	nn	_	_
34	killing	_	NN	NN	_	32	pobj	_	_
35	.	_	.	.	_	7	punct	_	_

1	Recent	_	JJ	JJ	_	2	amod	_	_
2	progress	_	NN	NN	_	17	nsubj	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	understanding	_	VBG	VBG	_	3	pcomp	_	_
5	the	_	DT	DT	_	6	det	_	_
6	regulation	_	NN	NN	_	4	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	11	det	_	_
9	phagocyte	_	NN	NN	_	11	nn	_	_
10	NADPH	_	NN	NN	_	11	nn	_	_
11	oxidase	_	NN	NN	_	7	pobj	_	_
12	by	_	IN	IN	_	6	prep	_	_
13	the	_	DT	DT	_	16	det	_	_
14	Rac	_	NN	NN	_	16	nn	_	_
15	GTP-binding	_	JJ	JJ	_	16	amod	_	_
16	proteins	_	NNS	NNS	_	12	pobj	_	_
17	provides	_	VBZ	VBZ	_	0	root	_	_
18	a	_	DT	DT	_	19	det	_	_
19	basis	_	NN	NN	_	17	dobj	_	_
20	for	_	IN	IN	_	19	prep	_	_
21	defining	_	VBG	VBG	_	20	pcomp	_	_
22	the	_	DT	DT	_	24	det	_	_
23	operational	_	JJ	JJ	_	24	amod	_	_
24	characteristics	_	NNS	NNS	_	21	dobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	one	_	CD	CD	_	29	num	_	_
27	such	_	JJ	JJ	_	29	amod	_	_
28	phagocyte	_	NN	NN	_	29	nn	_	_
29	system	_	NN	NN	_	25	pobj	_	_
30	.	_	.	.	_	17	punct	_	_

1	It	_	PRP	PRP	_	3	nsubj	_	_
2	is	_	VBZ	VBZ	_	3	cop	_	_
3	clear	_	JJ	JJ	_	0	root	_	_
4	from	_	IN	IN	_	3	prep	_	_
5	various	_	JJ	JJ	_	6	amod	_	_
6	studies	_	NNS	NNS	_	4	pobj	_	_
7	that	_	IN	IN	_	16	mark	_	_
8	the	_	DT	DT	_	9	det	_	_
9	activity	_	NN	NN	_	16	nsubjpass	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	NADPH	_	NN	NN	_	13	nn	_	_
13	oxidase	_	NN	NN	_	10	pobj	_	_
14	can	_	MD	MD	_	16	aux	_	_
15	be	_	VB	VB	_	16	auxpass	_	_
16	modulated	_	VBN	VBN	_	3	ccomp	_	_
17	through	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	19	det	_	_
19	regulation	_	NN	NN	_	17	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	23	det	_	_
22	GTP-GDP	_	JJ	JJ	_	23	amod	_	_
23	state	_	NN	NN	_	20	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	Rac	_	NN	NN	_	24	pobj	_	_
26	.	_	.	.	_	3	punct	_	_

1	Proteins	_	NNS	NNS	_	2	nsubj	_	_
2	exist	_	VBP	VBP	_	0	root	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	leukocytes	_	NNS	NNS	_	3	pobj	_	_
5	able	_	JJ	JJ	_	2	dep	_	_
6	to	_	TO	TO	_	5	dep	_	_
7	modify	_	VB	VB	_	6	ccomp	_	_
8	GTP-binding	_	JJ	JJ	_	9	amod	_	_
9	protein	_	NN	NN	_	10	nn	_	_
10	function	_	NN	NN	_	7	dobj	_	_
11	in	_	IN	IN	_	7	prep	_	_
12	this	_	DT	DT	_	13	det	_	_
13	manner	_	NN	NN	_	11	pobj	_	_
14	,	_	,	,	_	2	punct	_	_
15	and	_	CC	CC	_	2	cc	_	_
16	their	_	PRP$	PRP$	_	17	poss	_	_
17	activity	_	NN	NN	_	20	nsubjpass	_	_
18	may	_	MD	MD	_	20	aux	_	_
19	be	_	VB	VB	_	20	auxpass	_	_
20	regulated	_	VBN	VBN	_	2	conj	_	_
21	by	_	IN	IN	_	20	prep	_	_
22	signals	_	NNS	NNS	_	21	pobj	_	_
23	generated	_	VBN	VBN	_	22	vmod	_	_
24	on	_	IN	IN	_	23	prep	_	_
25	phagocyte	_	NN	NN	_	26	nn	_	_
26	stimulation	_	NN	NN	_	24	pobj	_	_
27	.	_	.	.	_	2	punct	_	_

1	Proteins	_	NNS	NNS	_	7	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	Ras	_	NN	NN	_	5	nn	_	_
5	superfamily	_	NN	NN	_	2	pobj	_	_
6	are	_	VBP	VBP	_	7	cop	_	_
7	likely	_	JJ	JJ	_	0	root	_	_
8	to	_	TO	TO	_	10	aux	_	_
9	be	_	VB	VB	_	10	auxpass	_	_
10	involved	_	VBN	VBN	_	7	xcomp	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	a	_	DT	DT	_	13	det	_	_
13	variety	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	normal	_	JJ	JJ	_	17	amod	_	_
16	phagocyte	_	NN	NN	_	17	nn	_	_
17	functions	_	NNS	NNS	_	14	pobj	_	_
18	through	_	IN	IN	_	10	prep	_	_
19	their	_	PRP$	PRP$	_	20	poss	_	_
20	ability	_	NN	NN	_	18	pobj	_	_
21	to	_	TO	TO	_	22	aux	_	_
22	modulate	_	VB	VB	_	20	vmod	_	_
23	the	_	DT	DT	_	24	det	_	_
24	assembly	_	NN	NN	_	22	dobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	actin	_	NN	NN	_	27	nn	_	_
27	filaments	_	NNS	NNS	_	25	pobj	_	_
28	,	_	,	,	_	24	punct	_	_
29	direct	_	JJ	JJ	_	30	amod	_	_
30	vesicle	_	NN	NN	_	24	conj	_	_
31	trafficking	_	NN	NN	_	30	dep	_	_
32	and	_	CC	CC	_	30	cc	_	_
33	fusion	_	NN	NN	_	30	conj	_	_
34	,	_	,	,	_	24	punct	_	_
35	and	_	CC	CC	_	24	cc	_	_
36	so	_	RB	RB	_	37	advmod	_	_
37	forth	_	RB	RB	_	24	advmod	_	_
38	.	_	.	.	_	7	punct	_	_

1	OCA-B	_	NN	NN	_	5	nsubj	_	_
2	is	_	VBZ	VBZ	_	5	cop	_	_
3	a	_	DT	DT	_	5	det	_	_
4	functional	_	JJ	JJ	_	5	amod	_	_
5	analog	_	NN	NN	_	0	root	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	VP16	_	NN	NN	_	6	pobj	_	_
8	but	_	CC	CC	_	5	cc	_	_
9	targets	_	VBZ	VBZ	_	5	conj	_	_
10	a	_	DT	DT	_	12	det	_	_
11	separate	_	JJ	JJ	_	12	amod	_	_
12	surface	_	NN	NN	_	9	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	17	det	_	_
15	Oct-1	_	NN	NN	_	17	nn	_	_
16	POU	_	NN	NN	_	17	nn	_	_
17	domain	_	NN	NN	_	13	pobj	_	_
18	-LSB-	_	-LRB-	-LRB-	_	21	punct	_	_
19	published	_	VBN	VBN	_	20	amod	_	_
20	erratum	_	NN	NN	_	21	nsubj	_	_
21	appears	_	VBZ	VBZ	_	5	parataxis	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	Mol	_	NNP	NNP	_	25	nn	_	_
24	Cell	_	NNP	NNP	_	25	nn	_	_
25	Biol	_	NNP	NNP	_	22	pobj	_	_
26	1998	_	CD	CD	_	27	num	_	_
27	Apr	_	NNP	NNP	_	25	dep	_	_
28	;	_	:	:	_	25	punct	_	_
29	18	_	CD	CD	_	31	num	_	_
30	-LRB-	_	-LRB-	-LRB-	_	31	punct	_	_
31	4	_	CD	CD	_	25	dep	_	_
32	-RRB-	_	-RRB-	-RRB-	_	31	punct	_	_
33	:	_	:	:	_	25	punct	_	_
34	2430	_	CD	CD	_	25	dep	_	_
35	-RSB-	_	-RRB-	-RRB-	_	21	punct	_	_

1	OCA-B	_	NN	NN	_	5	nsubj	_	_
2	is	_	VBZ	VBZ	_	5	cop	_	_
3	a	_	DT	DT	_	5	det	_	_
4	B-cell-specific	_	JJ	JJ	_	5	amod	_	_
5	coregulator	_	NN	NN	_	0	root	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	13	det	_	_
8	broadly	_	RB	RB	_	9	advmod	_	_
9	expressed	_	VBN	VBN	_	13	amod	_	_
10	POU	_	NN	NN	_	13	nn	_	_
11	domain	_	NN	NN	_	13	nn	_	_
12	transcription	_	NN	NN	_	13	nn	_	_
13	factor	_	NN	NN	_	6	pobj	_	_
14	Oct-1	_	NN	NN	_	13	dep	_	_
15	.	_	.	.	_	5	punct	_	_

1	OCA-B	_	NN	NN	_	2	nsubj	_	_
2	associates	_	VBZ	VBZ	_	0	root	_	_
3	with	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	7	det	_	_
5	Oct-1	_	NN	NN	_	7	nn	_	_
6	POU	_	NN	NN	_	7	nn	_	_
7	domain	_	NN	NN	_	3	pobj	_	_
8	,	_	,	,	_	7	punct	_	_
9	a	_	DT	DT	_	12	det	_	_
10	bipartite	_	JJ	JJ	_	12	amod	_	_
11	DNA-binding	_	JJ	JJ	_	10	dep	_	_
12	structure	_	NN	NN	_	7	appos	_	_
13	containing	_	VBG	VBG	_	12	vmod	_	_
14	a	_	DT	DT	_	19	det	_	_
15	POU-specific	_	JJ	JJ	_	19	amod	_	_
16	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
17	POU-LSB-S-RSB-	_	JJ	JJ	_	19	amod	_	_
18	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
19	domain	_	NN	NN	_	13	dobj	_	_
20	joined	_	VBN	VBN	_	19	vmod	_	_
21	by	_	IN	IN	_	20	prep	_	_
22	a	_	DT	DT	_	24	det	_	_
23	flexible	_	JJ	JJ	_	24	amod	_	_
24	linker	_	NN	NN	_	21	pobj	_	_
25	to	_	TO	TO	_	24	prep	_	_
26	a	_	DT	DT	_	28	det	_	_
27	POU	_	NN	NN	_	28	nn	_	_
28	homeodomain	_	NN	NN	_	25	pobj	_	_
29	-LRB-	_	-LRB-	-LRB-	_	30	punct	_	_
30	POU-LSB-H-RSB-	_	NN	NN	_	28	appos	_	_
31	-RRB-	_	-RRB-	-RRB-	_	30	punct	_	_
32	.	_	.	.	_	2	punct	_	_

1	Here	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	show	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	7	mark	_	_
6	OCA-B	_	NN	NN	_	7	nsubj	_	_
7	alters	_	VBZ	VBZ	_	4	ccomp	_	_
8	the	_	DT	DT	_	9	det	_	_
9	activity	_	NN	NN	_	7	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	Oct-1	_	NN	NN	_	10	pobj	_	_
12	in	_	IN	IN	_	7	prep	_	_
13	two	_	CD	CD	_	14	num	_	_
14	ways	_	NNS	NNS	_	12	pobj	_	_
15	.	_	.	.	_	4	punct	_	_

1	It	_	PRP	PRP	_	2	nsubj	_	_
2	provides	_	VBZ	VBZ	_	0	root	_	_
3	a	_	DT	DT	_	6	det	_	_
4	transcriptional	_	JJ	JJ	_	6	amod	_	_
5	activation	_	NN	NN	_	6	nn	_	_
6	domain	_	NN	NN	_	2	dobj	_	_
7	which	_	WDT	WDT	_	12	nsubj	_	_
8	,	_	,	,	_	12	punct	_	_
9	unlike	_	IN	IN	_	12	prep	_	_
10	Oct-1	_	NN	NN	_	9	pobj	_	_
11	,	_	,	,	_	12	punct	_	_
12	activates	_	VBZ	VBZ	_	6	rcmod	_	_
13	an	_	DT	DT	_	15	det	_	_
14	mRNA-type	_	JJ	JJ	_	15	amod	_	_
15	promoter	_	NN	NN	_	12	dobj	_	_
16	effectively	_	RB	RB	_	12	advmod	_	_
17	,	_	,	,	_	2	punct	_	_
18	and	_	CC	CC	_	2	cc	_	_
19	it	_	PRP	PRP	_	20	nsubj	_	_
20	stabilizes	_	VBZ	VBZ	_	2	conj	_	_
21	Oct-1	_	NN	NN	_	20	dobj	_	_
22	on	_	IN	IN	_	20	prep	_	_
23	the	_	DT	DT	_	26	det	_	_
24	Oct-1-responsive	_	JJ	JJ	_	26	amod	_	_
25	octamer	_	NN	NN	_	26	nn	_	_
26	sequence	_	NN	NN	_	22	pobj	_	_
27	ATGCAAAT	_	NN	NN	_	26	dep	_	_
28	.	_	.	.	_	2	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	properties	_	NNS	NNS	_	5	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	OCA-B	_	NN	NN	_	3	pobj	_	_
5	parallel	_	VBP	VBP	_	0	root	_	_
6	those	_	DT	DT	_	5	dobj	_	_
7	displayed	_	VBN	VBN	_	6	vmod	_	_
8	by	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	14	det	_	_
10	herpes	_	NN	NN	_	14	nn	_	_
11	simplex	_	JJ	JJ	_	14	amod	_	_
12	virus	_	NN	NN	_	14	nn	_	_
13	Oct-1	_	NN	NN	_	14	nn	_	_
14	coregulator	_	NN	NN	_	8	pobj	_	_
15	VP16	_	NN	NN	_	14	dep	_	_
16	.	_	.	.	_	5	punct	_	_

1	OCA-B	_	NN	NN	_	5	nsubj	_	_
2	,	_	,	,	_	1	punct	_	_
3	however	_	RB	RB	_	5	advmod	_	_
4	,	_	,	,	_	5	punct	_	_
5	interacts	_	VBZ	VBZ	_	0	root	_	_
6	with	_	IN	IN	_	5	prep	_	_
7	a	_	DT	DT	_	9	det	_	_
8	different	_	JJ	JJ	_	9	amod	_	_
9	surface	_	NN	NN	_	6	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	15	det	_	_
12	DNA-bound	_	JJ	JJ	_	15	amod	_	_
13	Oct-1	_	NN	NN	_	15	nn	_	_
14	POU	_	NN	NN	_	15	nn	_	_
15	domain	_	NN	NN	_	10	pobj	_	_
16	,	_	,	,	_	5	punct	_	_
17	interacting	_	VBG	VBG	_	5	xcomp	_	_
18	with	_	IN	IN	_	17	prep	_	_
19	both	_	CC	CC	_	24	preconj	_	_
20	the	_	DT	DT	_	24	det	_	_
21	POU-LRB-S-RRB-	_	JJ	JJ	_	24	amod	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	POU-LRB-H-RRB-	_	NN	NN	_	21	conj	_	_
24	domains	_	NNS	NNS	_	18	pobj	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	the	_	DT	DT	_	27	det	_	_
27	center	_	NN	NN	_	24	conj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	the	_	DT	DT	_	32	det	_	_
30	ATGCAAAT	_	NN	NN	_	32	nn	_	_
31	octamer	_	NN	NN	_	32	nn	_	_
32	sequence	_	NN	NN	_	28	pobj	_	_
33	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	2	dep	_	_
2	OCA-B	_	NN	NN	_	13	nsubj	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	VP16	_	NN	NN	_	2	conj	_	_
5	interactions	_	NNS	NNS	_	2	dep	_	_
6	with	_	IN	IN	_	2	prep	_	_
7	the	_	DT	DT	_	10	det	_	_
8	Oct-1	_	NN	NN	_	10	nn	_	_
9	POU	_	NN	NN	_	10	nn	_	_
10	domain	_	NN	NN	_	6	pobj	_	_
11	are	_	VBP	VBP	_	13	cop	_	_
12	sufficiently	_	RB	RB	_	13	advmod	_	_
13	different	_	JJ	JJ	_	0	root	_	_
14	to	_	TO	TO	_	15	aux	_	_
15	permit	_	VB	VB	_	13	xcomp	_	_
16	OCA-B	_	NN	NN	_	15	dobj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	VP16	_	NN	NN	_	16	conj	_	_
19	to	_	TO	TO	_	20	aux	_	_
20	bind	_	VB	VB	_	15	xcomp	_	_
21	the	_	DT	DT	_	24	det	_	_
22	Oct-1	_	NN	NN	_	24	nn	_	_
23	POU	_	NN	NN	_	24	nn	_	_
24	domain	_	NN	NN	_	20	dobj	_	_
25	simultaneously	_	RB	RB	_	20	advmod	_	_
26	.	_	.	.	_	13	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	emphasize	_	VBP	VBP	_	0	root	_	_
4	the	_	DT	DT	_	6	det	_	_
5	structural	_	JJ	JJ	_	6	amod	_	_
6	versatility	_	NN	NN	_	3	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	11	det	_	_
9	Oct-1	_	NN	NN	_	11	nn	_	_
10	POU	_	NN	NN	_	11	nn	_	_
11	domain	_	NN	NN	_	7	pobj	_	_
12	in	_	IN	IN	_	6	prep	_	_
13	its	_	PRP$	PRP$	_	14	poss	_	_
14	interaction	_	NN	NN	_	12	pobj	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	coregulators	_	NNS	NNS	_	15	pobj	_	_
17	.	_	.	.	_	3	punct	_	_

1	Extinction	_	NN	NN	_	15	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	immunoglobulin	_	NN	NN	_	4	nn	_	_
4	gene	_	NN	NN	_	5	nn	_	_
5	expression	_	NN	NN	_	2	pobj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	B	_	NN	NN	_	8	nn	_	_
8	cells	_	NNS	NNS	_	6	pobj	_	_
9	upon	_	IN	IN	_	1	prep	_	_
10	fusion	_	NN	NN	_	9	pobj	_	_
11	with	_	IN	IN	_	10	prep	_	_
12	HeLa	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	11	pobj	_	_
14	is	_	VBZ	VBZ	_	15	auxpass	_	_
15	preceded	_	VBN	VBN	_	0	root	_	_
16	by	_	IN	IN	_	15	prep	_	_
17	rapid	_	JJ	JJ	_	19	amod	_	_
18	nuclear	_	JJ	JJ	_	19	amod	_	_
19	depletion	_	NN	NN	_	16	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	essential	_	JJ	JJ	_	23	amod	_	_
22	transcription	_	NN	NN	_	23	nn	_	_
23	factors	_	NNS	NNS	_	20	pobj	_	_
24	and	_	CC	CC	_	15	cc	_	_
25	is	_	VBZ	VBZ	_	26	auxpass	_	_
26	accompanied	_	VBN	VBN	_	15	conj	_	_
27	by	_	IN	IN	_	26	prep	_	_
28	widespread	_	JJ	JJ	_	29	amod	_	_
29	inactivation	_	NN	NN	_	27	pobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	genes	_	NNS	NNS	_	30	pobj	_	_
32	expressed	_	VBN	VBN	_	31	vmod	_	_
33	in	_	IN	IN	_	32	prep	_	_
34	a	_	DT	DT	_	37	det	_	_
35	B	_	NN	NN	_	37	nn	_	_
36	cell-specific	_	JJ	JJ	_	37	amod	_	_
37	manner	_	NN	NN	_	33	pobj	_	_
38	.	_	.	.	_	15	punct	_	_

1	When	_	WRB	WRB	_	10	advmod	_	_
2	immunoglobulin	_	NN	NN	_	8	nn	_	_
3	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
4	Ig	_	NN	NN	_	8	nn	_	_
5	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
6	expressing	_	NN	NN	_	8	nn	_	_
7	B	_	NN	NN	_	8	nn	_	_
8	cells	_	NNS	NNS	_	10	nsubjpass	_	_
9	are	_	VBP	VBP	_	10	auxpass	_	_
10	fused	_	VBN	VBN	_	19	advcl	_	_
11	with	_	IN	IN	_	10	prep	_	_
12	non-B	_	JJ	JJ	_	13	amod	_	_
13	cells	_	NNS	NNS	_	11	pobj	_	_
14	,	_	,	,	_	19	punct	_	_
15	Ig	_	NN	NN	_	16	nn	_	_
16	expression	_	NN	NN	_	19	nsubjpass	_	_
17	is	_	VBZ	VBZ	_	19	auxpass	_	_
18	rapidly	_	RB	RB	_	19	advmod	_	_
19	suppressed	_	VBN	VBN	_	0	root	_	_
20	at	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	22	det	_	_
22	level	_	NN	NN	_	20	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	transcription	_	NN	NN	_	23	pobj	_	_
25	,	_	,	,	_	19	punct	_	_
26	a	_	DT	DT	_	27	det	_	_
27	phenomenon	_	NN	NN	_	19	dep	_	_
28	termed	_	VBN	VBN	_	27	vmod	_	_
29	extinction	_	NN	NN	_	28	dep	_	_
30	.	_	.	.	_	19	punct	_	_

1	Here	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	demonstrate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	19	mark	_	_
5	fusion	_	NN	NN	_	19	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	HeLa	_	NN	NN	_	8	nn	_	_
8	cells	_	NNS	NNS	_	6	pobj	_	_
9	with	_	IN	IN	_	5	prep	_	_
10	either	_	CC	CC	_	11	preconj	_	_
11	diploid	_	JJ	JJ	_	9	pobj	_	_
12	or	_	CC	CC	_	11	cc	_	_
13	tetraploid	_	JJ	JJ	_	11	conj	_	_
14	B	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	11	dep	_	_
16	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
17	Daudi	_	NN	NN	_	9	dep	_	_
18	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
19	results	_	VBZ	VBZ	_	3	ccomp	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	widespread	_	JJ	JJ	_	22	amod	_	_
22	extinction	_	NN	NN	_	20	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	several	_	JJ	JJ	_	25	amod	_	_
25	other	_	JJ	JJ	_	28	amod	_	_
26	B	_	NN	NN	_	28	nn	_	_
27	cell-encoded	_	JJ	JJ	_	28	amod	_	_
28	genes	_	NNS	NNS	_	23	pobj	_	_
29	that	_	WDT	WDT	_	31	nsubjpass	_	_
30	are	_	VBP	VBP	_	31	auxpass	_	_
31	expressed	_	VBN	VBN	_	28	rcmod	_	_
32	in	_	IN	IN	_	31	prep	_	_
33	a	_	DT	DT	_	36	det	_	_
34	B	_	NN	NN	_	36	nn	_	_
35	cell-specific	_	JJ	JJ	_	36	amod	_	_
36	manner	_	NN	NN	_	32	pobj	_	_
37	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	17	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	17	punct	_	_
4	expression	_	NN	NN	_	17	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	B	_	NN	NN	_	8	nn	_	_
7	cell-expressed	_	JJ	JJ	_	8	amod	_	_
8	genes	_	NNS	NNS	_	5	pobj	_	_
9	that	_	WDT	WDT	_	12	nsubj	_	_
10	are	_	VBP	VBP	_	12	cop	_	_
11	not	_	RB	RB	_	12	neg	_	_
12	dependent	_	JJ	JJ	_	8	rcmod	_	_
13	on	_	IN	IN	_	12	prep	_	_
14	cell-specific	_	JJ	JJ	_	15	amod	_	_
15	controls	_	NNS	NNS	_	13	pobj	_	_
16	is	_	VBZ	VBZ	_	17	cop	_	_
17	unaffected	_	JJ	JJ	_	0	root	_	_
18	.	_	.	.	_	17	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	show	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	16	mark	_	_
4	the	_	DT	DT	_	8	det	_	_
5	molecular	_	JJ	JJ	_	8	amod	_	_
6	mechanism	_	NN	NN	_	8	nn	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	s	_	NNS	NNS	_	16	nsubjpass	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	underlying	_	VBG	VBG	_	8	vmod	_	_
11	Ig	_	NN	NN	_	12	nn	_	_
12	gene	_	NN	NN	_	13	nn	_	_
13	extinction	_	NN	NN	_	10	dobj	_	_
14	can	_	MD	MD	_	16	aux	_	_
15	be	_	VB	VB	_	16	auxpass	_	_
16	explained	_	VBN	VBN	_	2	ccomp	_	_
17	,	_	,	,	_	16	punct	_	_
18	at	_	IN	IN	_	20	advmod	_	_
19	least	_	JJS	JJS	_	18	pobj	_	_
20	in	_	IN	IN	_	16	prep	_	_
21	part	_	NN	NN	_	20	pobj	_	_
22	,	_	,	,	_	16	punct	_	_
23	by	_	IN	IN	_	16	prep	_	_
24	a	_	DT	DT	_	25	det	_	_
25	lack	_	NN	NN	_	23	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	transcription	_	NN	NN	_	28	nn	_	_
28	factors	_	NNS	NNS	_	26	pobj	_	_
29	that	_	WDT	WDT	_	31	nsubj	_	_
30	are	_	VBP	VBP	_	31	cop	_	_
31	essential	_	JJ	JJ	_	28	rcmod	_	_
32	for	_	IN	IN	_	31	prep	_	_
33	Ig	_	NN	NN	_	34	nn	_	_
34	gene	_	NN	NN	_	35	nn	_	_
35	transcription	_	NN	NN	_	32	pobj	_	_
36	.	_	.	.	_	2	punct	_	_

1	These	_	DT	DT	_	3	det	_	_
2	transcription	_	NN	NN	_	3	nn	_	_
3	factors	_	NNS	NNS	_	4	nsubj	_	_
4	are	_	VBP	VBP	_	0	root	_	_
5	either	_	CC	CC	_	4	dep	_	_
6	not	_	RB	RB	_	7	neg	_	_
7	produced	_	VBN	VBN	_	4	conj	_	_
8	due	_	JJ	JJ	_	7	acomp	_	_
9	to	_	TO	TO	_	8	prep	_	_
10	block	_	NN	NN	_	9	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	transcription	_	NN	NN	_	11	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	their	_	PRP$	PRP$	_	16	poss	_	_
15	respective	_	JJ	JJ	_	16	amod	_	_
16	genes	_	NNS	NNS	_	13	pobj	_	_
17	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	Oct-2	_	NN	NN	_	16	dep	_	_
19	,	_	,	,	_	18	punct	_	_
20	OBF-1	_	NN	NN	_	18	appos	_	_
21	,	_	,	,	_	18	punct	_	_
22	PU.1	_	NN	NN	_	18	appos	_	_
23	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
24	,	_	,	,	_	4	punct	_	_
25	or	_	CC	CC	_	4	cc	_	_
26	are	_	VBP	VBP	_	27	auxpass	_	_
27	rendered	_	VBN	VBN	_	4	conj	_	_
28	inactive	_	JJ	JJ	_	27	xcomp	_	_
29	posttranslationally	_	RB	RB	_	28	advmod	_	_
30	-LRB-	_	-LRB-	-LRB-	_	32	punct	_	_
31	NF-kappa	_	NN	NN	_	32	nn	_	_
32	B	_	NN	NN	_	29	dep	_	_
33	,	_	,	,	_	32	punct	_	_
34	E47	_	NN	NN	_	32	appos	_	_
35	-RRB-	_	-RRB-	-RRB-	_	32	punct	_	_
36	.	_	.	.	_	4	punct	_	_

1	By	_	IN	IN	_	15	prep	_	_
2	isolating	_	VBG	VBG	_	1	pcomp	_	_
3	Daudi	_	JJ	JJ	_	6	amod	_	_
4	x	_	NN	NN	_	6	nn	_	_
5	HeLa	_	NN	NN	_	6	nn	_	_
6	heterokaryons	_	NNS	NNS	_	2	dobj	_	_
7	a	_	DT	DT	_	9	det	_	_
8	few	_	JJ	JJ	_	9	amod	_	_
9	hours	_	NNS	NNS	_	10	npadvmod	_	_
10	after	_	IN	IN	_	2	prep	_	_
11	fusion	_	NN	NN	_	10	pobj	_	_
12	,	_	,	,	_	15	punct	_	_
13	we	_	PRP	PRP	_	15	nsubj	_	_
14	have	_	VBP	VBP	_	15	aux	_	_
15	studied	_	VBN	VBN	_	0	root	_	_
16	the	_	DT	DT	_	18	det	_	_
17	initial	_	JJ	JJ	_	18	amod	_	_
18	fate	_	NN	NN	_	15	dobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	two	_	CD	CD	_	24	num	_	_
21	B	_	NN	NN	_	24	nn	_	_
22	cell-specific	_	JJ	JJ	_	24	amod	_	_
23	transcription	_	NN	NN	_	24	nn	_	_
24	factors	_	NNS	NNS	_	19	pobj	_	_
25	involved	_	VBN	VBN	_	24	vmod	_	_
26	in	_	IN	IN	_	25	prep	_	_
27	Ig	_	NN	NN	_	28	nn	_	_
28	gene	_	NN	NN	_	29	nn	_	_
29	transcription	_	NN	NN	_	26	pobj	_	_
30	,	_	,	,	_	24	punct	_	_
31	Oct-2	_	NN	NN	_	24	appos	_	_
32	and	_	CC	CC	_	31	cc	_	_
33	NF-kappa	_	NN	NN	_	34	nn	_	_
34	B	_	NN	NN	_	31	conj	_	_
35	.	_	.	.	_	15	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	report	_	NN	NN	_	3	nsubj	_	_
3	provides	_	VBZ	VBZ	_	0	root	_	_
4	the	_	DT	DT	_	6	det	_	_
5	first	_	JJ	JJ	_	6	amod	_	_
6	demonstration	_	NN	NN	_	3	dobj	_	_
7	that	_	IN	IN	_	23	mark	_	_
8	upon	_	IN	IN	_	23	prep	_	_
9	fusion	_	NN	NN	_	8	pobj	_	_
10	with	_	IN	IN	_	9	prep	_	_
11	HeLa	_	NN	NN	_	12	nn	_	_
12	cells	_	NNS	NNS	_	10	pobj	_	_
13	,	_	,	,	_	23	punct	_	_
14	the	_	DT	DT	_	16	det	_	_
15	nuclear	_	JJ	JJ	_	16	amod	_	_
16	contents	_	NNS	NNS	_	23	nsubjpass	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	B	_	NN	NN	_	21	nn	_	_
19	cell-expressed	_	JJ	JJ	_	21	amod	_	_
20	transcription	_	NN	NN	_	21	nn	_	_
21	factors	_	NNS	NNS	_	17	pobj	_	_
22	are	_	VBP	VBP	_	23	auxpass	_	_
23	depleted	_	VBN	VBN	_	6	ccomp	_	_
24	within	_	IN	IN	_	23	prep	_	_
25	a	_	DT	DT	_	27	det	_	_
26	few	_	JJ	JJ	_	27	amod	_	_
27	hours	_	NNS	NNS	_	24	pobj	_	_
28	with	_	IN	IN	_	23	prep	_	_
29	kinetics	_	NNS	NNS	_	28	pobj	_	_
30	that	_	WDT	WDT	_	33	nsubj	_	_
31	are	_	VBP	VBP	_	33	cop	_	_
32	as	_	IN	IN	_	33	dep	_	_
33	fast	_	JJ	JJ	_	29	rcmod	_	_
34	or	_	CC	CC	_	33	cc	_	_
35	faster	_	JJR	JJR	_	33	conj	_	_
36	than	_	IN	IN	_	33	prep	_	_
37	that	_	DT	DT	_	36	pobj	_	_
38	of	_	IN	IN	_	37	prep	_	_
39	Ig	_	NN	NN	_	40	nn	_	_
40	gene	_	NN	NN	_	41	nn	_	_
41	extinction	_	NN	NN	_	38	pobj	_	_
42	.	_	.	.	_	3	punct	_	_

1	Thus	_	RB	RB	_	7	advmod	_	_
2	,	_	,	,	_	7	punct	_	_
3	the	_	DT	DT	_	5	det	_	_
4	extinguishing	_	NN	NN	_	5	nn	_	_
5	mechanism	_	NN	NN	_	7	nsubj	_	_
6	is	_	VBZ	VBZ	_	7	cop	_	_
7	effective	_	JJ	JJ	_	0	root	_	_
8	very	_	RB	RB	_	9	advmod	_	_
9	early	_	RB	RB	_	10	advmod	_	_
10	after	_	IN	IN	_	7	prep	_	_
11	fusion	_	NN	NN	_	10	pobj	_	_
12	.	_	.	.	_	7	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	suggest	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	9	mark	_	_
4	extinction	_	NN	NN	_	9	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	Ig	_	NN	NN	_	7	nn	_	_
7	genes	_	NNS	NNS	_	5	pobj	_	_
8	is	_	VBZ	VBZ	_	9	cop	_	_
9	part	_	NN	NN	_	2	ccomp	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	a	_	DT	DT	_	13	det	_	_
12	global	_	JJ	JJ	_	13	amod	_	_
13	mechanism	_	NN	NN	_	10	pobj	_	_
14	that	_	WDT	WDT	_	15	nsubj	_	_
15	suppresses	_	VBZ	VBZ	_	13	rcmod	_	_
16	the	_	DT	DT	_	18	det	_	_
17	differentiation	_	NN	NN	_	18	nn	_	_
18	program	_	NN	NN	_	15	dobj	_	_
19	foreign	_	JJ	JJ	_	18	amod	_	_
20	to	_	TO	TO	_	19	prep	_	_
21	the	_	DT	DT	_	23	det	_	_
22	HeLa	_	NN	NN	_	23	nn	_	_
23	phenotype	_	NN	NN	_	20	pobj	_	_
24	.	_	.	.	_	2	punct	_	_

1	Nuclear	_	JJ	JJ	_	2	amod	_	_
2	accumulation	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	NFAT4	_	NN	NN	_	3	pobj	_	_
5	opposed	_	VBN	VBN	_	2	vmod	_	_
6	by	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	11	det	_	_
8	JNK	_	NN	NN	_	11	nn	_	_
9	signal	_	NN	NN	_	11	nn	_	_
10	transduction	_	NN	NN	_	11	nn	_	_
11	pathway	_	NN	NN	_	6	pobj	_	_
12	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	11	det	_	_
2	nuclear	_	JJ	JJ	_	11	amod	_	_
3	factor	_	NN	NN	_	11	nn	_	_
4	of	_	IN	IN	_	11	amod	_	_
5	activated	_	VBN	VBN	_	11	amod	_	_
6	T	_	NN	NN	_	11	nn	_	_
7	cells	_	NNS	NNS	_	11	nn	_	_
8	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
9	NFAT	_	NN	NN	_	11	nn	_	_
10	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
11	group	_	NN	NN	_	16	nsubjpass	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	transcription	_	NN	NN	_	14	nn	_	_
14	factors	_	NNS	NNS	_	12	pobj	_	_
15	is	_	VBZ	VBZ	_	16	auxpass	_	_
16	retained	_	VBN	VBN	_	0	root	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	19	det	_	_
19	cytoplasm	_	NN	NN	_	17	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	quiescent	_	JJ	JJ	_	22	amod	_	_
22	cells	_	NNS	NNS	_	20	pobj	_	_
23	.	_	.	.	_	16	punct	_	_

1	NFAT	_	NN	NN	_	2	nn	_	_
2	activation	_	NN	NN	_	4	nsubjpass	_	_
3	is	_	VBZ	VBZ	_	4	auxpass	_	_
4	mediated	_	VBN	VBN	_	0	root	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	part	_	NN	NN	_	5	pobj	_	_
7	by	_	IN	IN	_	4	prep	_	_
8	induced	_	VBN	VBN	_	10	amod	_	_
9	nuclear	_	JJ	JJ	_	10	amod	_	_
10	import	_	NN	NN	_	7	pobj	_	_
11	.	_	.	.	_	4	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	process	_	NN	NN	_	3	nsubj	_	_
3	requires	_	VBZ	VBZ	_	0	root	_	_
4	calcium-dependent	_	JJ	JJ	_	5	amod	_	_
5	dephosphorylation	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	NFAT	_	NN	NN	_	6	pobj	_	_
8	caused	_	VBN	VBN	_	5	vmod	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	phosphatase	_	NN	NN	_	9	pobj	_	_
12	calcineurin	_	NN	NN	_	11	dep	_	_
13	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	c-Jun	_	NN	NN	_	4	nn	_	_
3	amino-terminal	_	JJ	JJ	_	4	amod	_	_
4	kinase	_	NN	NN	_	8	nsubj	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	JNK	_	NN	NN	_	4	appos	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	phosphorylates	_	VBZ	VBZ	_	0	root	_	_
9	NFAT4	_	NN	NN	_	8	dobj	_	_
10	on	_	IN	IN	_	8	prep	_	_
11	two	_	CD	CD	_	12	num	_	_
12	sites	_	NNS	NNS	_	10	pobj	_	_
13	.	_	.	.	_	8	punct	_	_

1	Mutational	_	JJ	JJ	_	2	amod	_	_
2	removal	_	NN	NN	_	8	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	7	det	_	_
5	JNK	_	NN	NN	_	7	nn	_	_
6	phosphorylation	_	NN	NN	_	7	nn	_	_
7	sites	_	NNS	NNS	_	3	pobj	_	_
8	caused	_	VBD	VBD	_	0	root	_	_
9	constitutive	_	JJ	JJ	_	11	amod	_	_
10	nuclear	_	JJ	JJ	_	11	amod	_	_
11	localization	_	NN	NN	_	8	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	NFAT4	_	NN	NN	_	12	pobj	_	_
14	.	_	.	.	_	8	punct	_	_

1	In	_	IN	IN	_	9	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	9	punct	_	_
4	JNK	_	NN	NN	_	5	nn	_	_
5	activation	_	NN	NN	_	9	nsubj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	calcineurin-stimulated	_	JJ	JJ	_	8	amod	_	_
8	cells	_	NNS	NNS	_	6	pobj	_	_
9	caused	_	VBD	VBD	_	0	root	_	_
10	nuclear	_	JJ	JJ	_	11	amod	_	_
11	exclusion	_	NN	NN	_	9	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	NFAT4	_	NN	NN	_	12	pobj	_	_
14	.	_	.	.	_	9	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	findings	_	NNS	NNS	_	3	nsubj	_	_
3	show	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	14	mark	_	_
5	the	_	DT	DT	_	7	det	_	_
6	nuclear	_	JJ	JJ	_	7	amod	_	_
7	accumulation	_	NN	NN	_	14	nsubjpass	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	NFAT4	_	NN	NN	_	8	pobj	_	_
10	promoted	_	VBN	VBN	_	7	vmod	_	_
11	by	_	IN	IN	_	10	prep	_	_
12	calcineurin	_	NN	NN	_	11	pobj	_	_
13	is	_	VBZ	VBZ	_	14	auxpass	_	_
14	opposed	_	VBN	VBN	_	3	ccomp	_	_
15	by	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	20	det	_	_
17	JNK	_	NN	NN	_	20	nn	_	_
18	signal	_	NN	NN	_	20	nn	_	_
19	transduction	_	NN	NN	_	20	nn	_	_
20	pathway	_	NN	NN	_	15	pobj	_	_
21	.	_	.	.	_	3	punct	_	_

1	Pathogenesis	_	NN	NN	_	0	root	_	_
2	.	_	.	.	_	1	punct	_	_

1	There	_	EX	EX	_	2	expl	_	_
2	are	_	VBP	VBP	_	0	root	_	_
3	many	_	JJ	JJ	_	4	amod	_	_
4	hypotheses	_	NNS	NNS	_	2	nsubj	_	_
5	concerning	_	VBG	VBG	_	4	vmod	_	_
6	the	_	DT	DT	_	7	det	_	_
7	pathogenesis	_	NN	NN	_	5	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	endometriosis	_	NN	NN	_	8	pobj	_	_
10	,	_	,	,	_	2	punct	_	_
11	though	_	IN	IN	_	16	mark	_	_
12	no	_	DT	DT	_	14	neg	_	_
13	single	_	JJ	JJ	_	14	amod	_	_
14	theory	_	NN	NN	_	16	nsubj	_	_
15	can	_	MD	MD	_	16	aux	_	_
16	explain	_	VB	VB	_	2	advcl	_	_
17	all	_	DT	DT	_	18	det	_	_
18	cases	_	NNS	NNS	_	16	dobj	_	_
19	.	_	.	.	_	2	punct	_	_

1	It	_	PRP	PRP	_	3	nsubj	_	_
2	is	_	VBZ	VBZ	_	3	cop	_	_
3	likely	_	JJ	JJ	_	0	root	_	_
4	that	_	IN	IN	_	8	mark	_	_
5	several	_	JJ	JJ	_	6	amod	_	_
6	mechanisms	_	NNS	NNS	_	8	nsubjpass	_	_
7	are	_	VBP	VBP	_	8	auxpass	_	_
8	involved	_	VBN	VBN	_	3	ccomp	_	_
9	.	_	.	.	_	3	punct	_	_

1	Early	_	JJ	JJ	_	2	amod	_	_
2	studies	_	NNS	NNS	_	3	nsubj	_	_
3	concentrated	_	VBD	VBD	_	0	root	_	_
4	on	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	6	det	_	_
6	histogenesis	_	NN	NN	_	4	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	endometriotic	_	JJ	JJ	_	10	amod	_	_
10	lesion	_	NN	NN	_	7	pobj	_	_
11	.	_	.	.	_	3	punct	_	_

1	Recent	_	JJ	JJ	_	2	amod	_	_
2	evidence	_	NN	NN	_	4	nsubj	_	_
3	has	_	VBZ	VBZ	_	4	aux	_	_
4	implicated	_	VBN	VBN	_	0	root	_	_
5	components	_	NNS	NNS	_	4	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	immune	_	JJ	JJ	_	9	amod	_	_
9	system	_	NN	NN	_	6	pobj	_	_
10	in	_	IN	IN	_	4	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	pathogenesis	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	endometriosis	_	NN	NN	_	13	pobj	_	_
15	.	_	.	.	_	4	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	review	_	NN	NN	_	3	nsubj	_	_
3	considers	_	VBZ	VBZ	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	evidence	_	NN	NN	_	3	dobj	_	_
6	for	_	IN	IN	_	5	prep	_	_
7	different	_	JJ	JJ	_	8	amod	_	_
8	theories	_	NNS	NNS	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	histogenesis	_	NN	NN	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	endometriosis	_	NN	NN	_	12	pobj	_	_
14	and	_	CC	CC	_	3	cc	_	_
15	discusses	_	VBZ	VBZ	_	3	conj	_	_
16	possible	_	JJ	JJ	_	18	amod	_	_
17	immune	_	JJ	JJ	_	18	amod	_	_
18	factors	_	NNS	NNS	_	15	dobj	_	_
19	that	_	WDT	WDT	_	22	nsubjpass	_	_
20	may	_	MD	MD	_	22	aux	_	_
21	be	_	VB	VB	_	22	auxpass	_	_
22	involved	_	VBN	VBN	_	18	rcmod	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	25	det	_	_
25	pathophysiology	_	NN	NN	_	23	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	28	det	_	_
28	disease	_	NN	NN	_	26	pobj	_	_
29	.	_	.	.	_	3	punct	_	_

1	-LSB-	_	-LRB-	-LRB-	_	3	punct	_	_
2	The	_	DT	DT	_	3	det	_	_
3	value	_	NN	NN	_	0	root	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	7	det	_	_
6	clinical	_	JJ	JJ	_	7	amod	_	_
7	test	_	NN	NN	_	4	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	glucocorticoid	_	NN	NN	_	10	nn	_	_
10	receptors	_	NNS	NNS	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	peripheral	_	JJ	JJ	_	14	amod	_	_
13	blood	_	NN	NN	_	14	nn	_	_
14	leukocytes	_	NNS	NNS	_	11	pobj	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	patients	_	NNS	NNS	_	15	pobj	_	_
17	with	_	IN	IN	_	16	prep	_	_
18	chronic	_	JJ	JJ	_	21	amod	_	_
19	pulmonary	_	JJ	JJ	_	21	amod	_	_
20	heart	_	NN	NN	_	21	nn	_	_
21	disease	_	NN	NN	_	17	pobj	_	_
22	-RSB-	_	-RRB-	-RRB-	_	3	punct	_	_

1	In	_	IN	IN	_	4	mark	_	_
2	order	_	NN	NN	_	4	dep	_	_
3	to	_	TO	TO	_	4	dep	_	_
4	inquire	_	VB	VB	_	39	dep	_	_
5	into	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	functional	_	JJ	JJ	_	8	amod	_	_
8	state	_	NN	NN	_	5	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	adrenal	_	JJ	JJ	_	11	amod	_	_
11	cortex	_	NN	NN	_	9	pobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	patients	_	NNS	NNS	_	12	pobj	_	_
14	with	_	IN	IN	_	13	prep	_	_
15	pulmonary	_	JJ	JJ	_	17	amod	_	_
16	heart	_	NN	NN	_	17	nn	_	_
17	disease	_	NN	NN	_	14	pobj	_	_
18	,	_	,	,	_	39	punct	_	_
19	the	_	DT	DT	_	20	det	_	_
20	number	_	NN	NN	_	39	nsubjpass	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	glucocorticoid	_	NN	NN	_	23	nn	_	_
23	receptors	_	NNS	NNS	_	21	pobj	_	_
24	-LRB-	_	-LRB-	-LRB-	_	25	punct	_	_
25	GCR	_	NN	NN	_	23	appos	_	_
26	-RRB-	_	-RRB-	-RRB-	_	25	punct	_	_
27	of	_	IN	IN	_	23	prep	_	_
28	peripheral	_	JJ	JJ	_	30	amod	_	_
29	blood	_	NN	NN	_	30	nn	_	_
30	leukocytes	_	NNS	NNS	_	27	pobj	_	_
31	in	_	IN	IN	_	30	prep	_	_
32	patients	_	NNS	NNS	_	31	pobj	_	_
33	with	_	IN	IN	_	32	prep	_	_
34	chronic	_	JJ	JJ	_	37	amod	_	_
35	pulmonary	_	JJ	JJ	_	37	amod	_	_
36	heart	_	NN	NN	_	37	nn	_	_
37	disease	_	NN	NN	_	33	pobj	_	_
38	was	_	VBD	VBD	_	39	auxpass	_	_
39	determined	_	VBN	VBN	_	0	root	_	_
40	with	_	IN	IN	_	39	prep	_	_
41	radioligand-binding	_	JJ	JJ	_	42	amod	_	_
42	assay	_	NN	NN	_	40	pobj	_	_
43	and	_	CC	CC	_	39	cc	_	_
44	the	_	DT	DT	_	48	det	_	_
45	corresponding	_	JJ	JJ	_	48	amod	_	_
46	plasma	_	NN	NN	_	48	nn	_	_
47	cortisol	_	NN	NN	_	48	nn	_	_
48	levels	_	NNS	NNS	_	50	nsubjpass	_	_
49	were	_	VBD	VBD	_	50	auxpass	_	_
50	assessed	_	VBN	VBN	_	39	conj	_	_
51	with	_	IN	IN	_	50	prep	_	_
52	radioimmune	_	JJ	JJ	_	53	amod	_	_
53	assays	_	NNS	NNS	_	51	pobj	_	_
54	.	_	.	.	_	39	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	showed	_	VBD	VBD	_	0	root	_	_
4	that	_	IN	IN	_	14	mark	_	_
5	the	_	DT	DT	_	6	det	_	_
6	number	_	NN	NN	_	14	nsubjpass	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	GCR	_	NN	NN	_	7	pobj	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	patients	_	NNS	NNS	_	9	pobj	_	_
12	was	_	VBD	VBD	_	14	auxpass	_	_
13	significantly	_	RB	RB	_	14	advmod	_	_
14	reduced	_	VBN	VBN	_	3	ccomp	_	_
15	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
16	P	_	NN	NN	_	18	dep	_	_
17	&lt;	_	JJR	JJR	_	18	quantmod	_	_
18	0.01	_	CD	CD	_	14	parataxis	_	_
19	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
20	and	_	CC	CC	_	14	cc	_	_
21	it	_	PRP	PRP	_	23	nsubjpass	_	_
22	was	_	VBD	VBD	_	23	auxpass	_	_
23	increased	_	VBN	VBN	_	14	conj	_	_
24	when	_	WRB	WRB	_	29	advmod	_	_
25	their	_	PRP$	PRP$	_	27	poss	_	_
26	health	_	NN	NN	_	27	nn	_	_
27	state	_	NN	NN	_	29	nsubjpass	_	_
28	was	_	VBD	VBD	_	29	auxpass	_	_
29	improved	_	VBN	VBN	_	23	advcl	_	_
30	.	_	.	.	_	3	punct	_	_

1	However	_	RB	RB	_	6	advmod	_	_
2	,	_	,	,	_	6	punct	_	_
3	it	_	PRP	PRP	_	6	nsubj	_	_
4	was	_	VBD	VBD	_	6	cop	_	_
5	still	_	RB	RB	_	6	advmod	_	_
6	lower	_	JJR	JJR	_	0	root	_	_
7	than	_	IN	IN	_	6	prep	_	_
8	that	_	DT	DT	_	7	pobj	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	healthy	_	JJ	JJ	_	11	amod	_	_
11	subjects	_	NNS	NNS	_	9	pobj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
13	P	_	NN	NN	_	15	dep	_	_
14	&lt;	_	JJR	JJR	_	15	quantmod	_	_
15	0.01	_	CD	CD	_	6	parataxis	_	_
16	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
17	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	number	_	NN	NN	_	10	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	GCR	_	NN	NN	_	3	pobj	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	7	det	_	_
7	patients	_	NNS	NNS	_	5	pobj	_	_
8	was	_	VBD	VBD	_	10	auxpass	_	_
9	greatly	_	RB	RB	_	10	advmod	_	_
10	increased	_	VBN	VBN	_	0	root	_	_
11	when	_	WRB	WRB	_	15	advmod	_	_
12	these	_	DT	DT	_	13	det	_	_
13	patients	_	NNS	NNS	_	15	nsubjpass	_	_
14	were	_	VBD	VBD	_	15	auxpass	_	_
15	treated	_	VBN	VBN	_	10	advcl	_	_
16	with	_	IN	IN	_	15	prep	_	_
17	oxygen	_	NN	NN	_	16	pobj	_	_
18	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
19	P	_	NN	NN	_	21	dep	_	_
20	&lt;	_	JJR	JJR	_	21	quantmod	_	_
21	0.01	_	CD	CD	_	10	parataxis	_	_
22	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
23	.	_	.	.	_	10	punct	_	_

1	No	_	DT	DT	_	2	neg	_	_
2	difference	_	NN	NN	_	7	nsubjpass	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	plasma	_	NN	NN	_	5	nn	_	_
5	cortisol	_	NN	NN	_	3	pobj	_	_
6	was	_	VBD	VBD	_	7	auxpass	_	_
7	found	_	VBN	VBN	_	0	root	_	_
8	between	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	patients	_	NNS	NNS	_	8	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	the	_	DT	DT	_	14	det	_	_
13	healthy	_	JJ	JJ	_	14	amod	_	_
14	subjects	_	NNS	NNS	_	10	conj	_	_
15	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
16	P	_	NN	NN	_	18	dep	_	_
17	&gt;	_	JJR	JJR	_	18	quantmod	_	_
18	0.05	_	CD	CD	_	7	parataxis	_	_
19	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
20	.	_	.	.	_	7	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	12	mark	_	_
5	the	_	DT	DT	_	6	det	_	_
6	function	_	NN	NN	_	12	nsubjpass	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	adrenal	_	JJ	JJ	_	9	amod	_	_
9	cortex	_	NN	NN	_	7	pobj	_	_
10	may	_	MD	MD	_	12	aux	_	_
11	be	_	VB	VB	_	12	auxpass	_	_
12	improved	_	VBN	VBN	_	3	ccomp	_	_
13	by	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	compensation	_	NN	NN	_	16	nn	_	_
16	mechanism	_	NN	NN	_	13	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	19	det	_	_
19	patients	_	NNS	NNS	_	17	pobj	_	_
20	,	_	,	,	_	12	punct	_	_
21	but	_	CC	CC	_	12	cc	_	_
22	the	_	DT	DT	_	25	det	_	_
23	lower	_	JJR	JJR	_	25	amod	_	_
24	GCR	_	NN	NN	_	25	nn	_	_
25	number	_	NN	NN	_	28	nsubj	_	_
26	was	_	VBD	VBD	_	28	cop	_	_
27	the	_	DT	DT	_	28	det	_	_
28	result	_	NN	NN	_	12	conj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	lacking	_	NN	NN	_	29	pobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	oxygen	_	NN	NN	_	31	pobj	_	_
33	in	_	IN	IN	_	30	prep	_	_
34	the	_	DT	DT	_	35	det	_	_
35	patients	_	NNS	NNS	_	33	pobj	_	_
36	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	number	_	NN	NN	_	7	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	GCR	_	NN	NN	_	3	pobj	_	_
5	may	_	MD	MD	_	7	aux	_	_
6	be	_	VB	VB	_	7	auxpass	_	_
7	improved	_	VBN	VBN	_	0	root	_	_
8	by	_	IN	IN	_	7	prep	_	_
9	inhalation	_	NN	NN	_	8	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	oxygen	_	NN	NN	_	10	pobj	_	_
12	.	_	.	.	_	7	punct	_	_

1	Therefore	_	RB	RB	_	5	advmod	_	_
2	oxygen	_	NN	NN	_	3	nn	_	_
3	therapy	_	NN	NN	_	5	nsubj	_	_
4	is	_	VBZ	VBZ	_	5	cop	_	_
5	helpful	_	JJ	JJ	_	0	root	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	raising	_	VBG	VBG	_	6	pcomp	_	_
8	the	_	DT	DT	_	9	det	_	_
9	activity	_	NN	NN	_	7	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	glucocorticoid	_	NN	NN	_	12	nn	_	_
12	receptors	_	NNS	NNS	_	10	pobj	_	_
13	and	_	CC	CC	_	7	cc	_	_
14	controlling	_	VBG	VBG	_	7	conj	_	_
15	the	_	DT	DT	_	16	det	_	_
16	development	_	NN	NN	_	14	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	19	det	_	_
19	disease	_	NN	NN	_	17	pobj	_	_
20	.	_	.	.	_	5	punct	_	_

1	Molecular	_	JJ	JJ	_	2	amod	_	_
2	cloning	_	NN	NN	_	0	root	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	functional	_	JJ	JJ	_	5	amod	_	_
5	characterization	_	NN	NN	_	2	conj	_	_
6	of	_	IN	IN	_	2	prep	_	_
7	murine	_	JJ	JJ	_	11	amod	_	_
8	cDNA	_	NN	NN	_	11	nn	_	_
9	encoding	_	NN	NN	_	11	nn	_	_
10	transcription	_	NN	NN	_	11	nn	_	_
11	factor	_	NN	NN	_	6	pobj	_	_
12	NFATc	_	NN	NN	_	11	dep	_	_
13	.	_	.	.	_	2	punct	_	_

1	Transcription	_	NN	NN	_	2	nn	_	_
2	factors	_	NNS	NNS	_	15	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	14	det	_	_
5	NFAT	_	NN	NN	_	14	nn	_	_
6	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
7	nuclear	_	JJ	JJ	_	14	amod	_	_
8	factor	_	NN	NN	_	14	nn	_	_
9	of	_	IN	IN	_	14	amod	_	_
10	activated	_	VBN	VBN	_	14	amod	_	_
11	T	_	NN	NN	_	14	nn	_	_
12	cells	_	NNS	NNS	_	14	nn	_	_
13	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
14	family	_	NN	NN	_	3	pobj	_	_
15	play	_	VBP	VBP	_	0	root	_	_
16	important	_	JJ	JJ	_	17	amod	_	_
17	roles	_	NNS	NNS	_	15	dobj	_	_
18	in	_	IN	IN	_	15	prep	_	_
19	immune	_	JJ	JJ	_	18	pobj	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	inflammatory	_	JJ	JJ	_	19	conj	_	_
22	responses	_	NNS	NNS	_	19	dep	_	_
23	by	_	IN	IN	_	15	prep	_	_
24	regulating	_	VBG	VBG	_	23	pcomp	_	_
25	the	_	DT	DT	_	26	det	_	_
26	expression	_	NN	NN	_	24	dobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	genes	_	NNS	NNS	_	27	pobj	_	_
29	encoding	_	VBG	VBG	_	28	vmod	_	_
30	cytokines	_	NNS	NNS	_	29	dobj	_	_
31	and	_	CC	CC	_	30	cc	_	_
32	immunoregulatory	_	JJ	JJ	_	33	amod	_	_
33	proteins	_	NNS	NNS	_	30	conj	_	_
34	.	_	.	.	_	15	punct	_	_

1	Here	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	describe	_	VBP	VBP	_	0	root	_	_
4	cloning	_	NN	NN	_	3	dobj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	characterization	_	NN	NN	_	4	conj	_	_
7	of	_	IN	IN	_	4	prep	_	_
8	full-length	_	JJ	JJ	_	15	amod	_	_
9	cDNA	_	NN	NN	_	15	nn	_	_
10	encoding	_	NN	NN	_	15	nn	_	_
11	murine	_	JJ	JJ	_	15	amod	_	_
12	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
13	m	_	JJ	JJ	_	15	amod	_	_
14	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
15	NFATc	_	NN	NN	_	7	pobj	_	_
16	which	_	WDT	WDT	_	17	nsubj	_	_
17	predicts	_	VBZ	VBZ	_	4	rcmod	_	_
18	that	_	IN	IN	_	21	mark	_	_
19	the	_	DT	DT	_	20	det	_	_
20	protein	_	NN	NN	_	21	nsubj	_	_
21	has	_	VBZ	VBZ	_	17	ccomp	_	_
22	all	_	PDT	PDT	_	26	dep	_	_
23	the	_	DT	DT	_	26	det	_	_
24	conserved	_	VBN	VBN	_	26	amod	_	_
25	structural	_	JJ	JJ	_	26	amod	_	_
26	motifs	_	NNS	NNS	_	21	dobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	NFAT	_	NN	NN	_	30	nn	_	_
29	family	_	NN	NN	_	30	nn	_	_
30	members	_	NNS	NNS	_	27	pobj	_	_
31	,	_	,	,	_	26	punct	_	_
32	including	_	VBG	VBG	_	26	prep	_	_
33	the	_	DT	DT	_	36	det	_	_
34	rel	_	NN	NN	_	36	nn	_	_
35	homology	_	NN	NN	_	36	nn	_	_
36	domain	_	NN	NN	_	32	pobj	_	_
37	,	_	,	,	_	36	punct	_	_
38	the	_	DT	DT	_	41	det	_	_
39	NFAT	_	NN	NN	_	41	nn	_	_
40	homology	_	NN	NN	_	41	nn	_	_
41	domain	_	NN	NN	_	36	conj	_	_
42	and	_	CC	CC	_	36	cc	_	_
43	the	_	DT	DT	_	46	det	_	_
44	nuclear	_	JJ	JJ	_	46	amod	_	_
45	translocation	_	NN	NN	_	46	nn	_	_
46	signals	_	NNS	NNS	_	36	conj	_	_
47	.	_	.	.	_	3	punct	_	_

1	mNFATc	_	NN	NN	_	5	nsubj	_	_
2	complexed	_	VBN	VBN	_	1	vmod	_	_
3	with	_	IN	IN	_	2	prep	_	_
4	AP-1	_	NN	NN	_	3	pobj	_	_
5	bound	_	VBD	VBD	_	0	root	_	_
6	specifically	_	RB	RB	_	5	advmod	_	_
7	to	_	TO	TO	_	5	prep	_	_
8	the	_	DT	DT	_	13	det	_	_
9	murine	_	JJ	JJ	_	13	amod	_	_
10	IL-2	_	NN	NN	_	13	nn	_	_
11	NFAT	_	NN	NN	_	13	nn	_	_
12	recognition	_	NN	NN	_	13	nn	_	_
13	sequence	_	NN	NN	_	7	pobj	_	_
14	and	_	CC	CC	_	5	cc	_	_
15	activated	_	VBD	VBD	_	5	conj	_	_
16	transcription	_	NN	NN	_	15	dobj	_	_
17	from	_	IN	IN	_	15	prep	_	_
18	the	_	DT	DT	_	21	det	_	_
19	co-transfected	_	JJ	JJ	_	21	amod	_	_
20	IL-2	_	NN	NN	_	21	nn	_	_
21	promoter	_	NN	NN	_	17	pobj	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	COS-7	_	NN	NN	_	24	nn	_	_
24	cells	_	NNS	NNS	_	22	pobj	_	_
25	.	_	.	.	_	5	punct	_	_

1	Northern	_	NN	NN	_	3	nn	_	_
2	blot	_	NN	NN	_	3	nn	_	_
3	analysis	_	NN	NN	_	4	nsubj	_	_
4	showed	_	VBD	VBD	_	0	root	_	_
5	that	_	IN	IN	_	9	mark	_	_
6	the	_	DT	DT	_	8	det	_	_
7	cDNA	_	NN	NN	_	8	nn	_	_
8	probe	_	NN	NN	_	9	nsubj	_	_
9	hybridized	_	VBD	VBD	_	4	ccomp	_	_
10	with	_	IN	IN	_	9	prep	_	_
11	a	_	DT	DT	_	14	det	_	_
12	4.5	_	CD	CD	_	13	number	_	_
13	kb	_	NN	NN	_	14	amod	_	_
14	transcript	_	NN	NN	_	10	pobj	_	_
15	which	_	WDT	WDT	_	18	nsubj	_	_
16	is	_	VBZ	VBZ	_	18	cop	_	_
17	highly	_	RB	RB	_	18	advmod	_	_
18	inducible	_	JJ	JJ	_	14	rcmod	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	murine	_	JJ	JJ	_	22	amod	_	_
21	T	_	NN	NN	_	22	nn	_	_
22	cells	_	NNS	NNS	_	19	pobj	_	_
23	.	_	.	.	_	4	punct	_	_

1	By	_	IN	IN	_	11	prep	_	_
2	Northern	_	NN	NN	_	1	pobj	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	in	_	FW	FW	_	2	conj	_	_
5	situ	_	FW	FW	_	4	dep	_	_
6	hybridization	_	NN	NN	_	2	dep	_	_
7	,	_	,	,	_	11	punct	_	_
8	mNFATc	_	NN	NN	_	9	nn	_	_
9	transcript	_	NN	NN	_	11	nsubjpass	_	_
10	was	_	VBD	VBD	_	11	auxpass	_	_
11	detected	_	VBN	VBN	_	0	root	_	_
12	from	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	early	_	JJ	JJ	_	15	amod	_	_
15	stage	_	NN	NN	_	12	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	development	_	NN	NN	_	16	pobj	_	_
18	.	_	.	.	_	11	punct	_	_

1	In	_	IN	IN	_	10	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	mouse	_	NN	NN	_	4	nn	_	_
4	embryo	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	10	punct	_	_
6	mNFATc	_	NN	NN	_	7	nn	_	_
7	transcript	_	NN	NN	_	10	nsubjpass	_	_
8	was	_	VBD	VBD	_	10	auxpass	_	_
9	strongly	_	RB	RB	_	10	advmod	_	_
10	expressed	_	VBN	VBN	_	0	root	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	thymus	_	NN	NN	_	11	pobj	_	_
13	,	_	,	,	_	12	punct	_	_
14	lung	_	NN	NN	_	12	conj	_	_
15	and	_	CC	CC	_	12	cc	_	_
16	submandibular	_	JJ	JJ	_	17	amod	_	_
17	gland	_	NN	NN	_	12	conj	_	_
18	and	_	CC	CC	_	10	cc	_	_
19	weakly	_	RB	RB	_	10	conj	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	skeletal	_	JJ	JJ	_	22	amod	_	_
22	muscle	_	NN	NN	_	20	pobj	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	heart	_	NN	NN	_	22	conj	_	_
25	suggesting	_	VBG	VBG	_	10	xcomp	_	_
26	that	_	IN	IN	_	29	mark	_	_
27	mNFATc	_	NN	NN	_	29	nsubj	_	_
28	may	_	MD	MD	_	29	aux	_	_
29	have	_	VB	VB	_	25	ccomp	_	_
30	a	_	DT	DT	_	31	det	_	_
31	role	_	NN	NN	_	29	dobj	_	_
32	both	_	CC	CC	_	33	preconj	_	_
33	in	_	IN	IN	_	29	prep	_	_
34	embryogenesis	_	NN	NN	_	33	pobj	_	_
35	and	_	CC	CC	_	33	cc	_	_
36	in	_	IN	IN	_	33	conj	_	_
37	mature	_	JJ	JJ	_	39	amod	_	_
38	T	_	NN	NN	_	39	nn	_	_
39	cells	_	NNS	NNS	_	36	pobj	_	_
40	.	_	.	.	_	10	punct	_	_

1	Differanisole	_	NN	NN	_	2	nn	_	_
2	A	_	NN	NN	_	9	nsubj	_	_
3	,	_	,	,	_	2	punct	_	_
4	a	_	DT	DT	_	7	det	_	_
5	novel	_	JJ	JJ	_	7	amod	_	_
6	antitumor	_	JJ	JJ	_	5	dep	_	_
7	antibiotic	_	NN	NN	_	2	appos	_	_
8	,	_	,	,	_	2	punct	_	_
9	enhances	_	VBZ	VBZ	_	0	root	_	_
10	growth	_	NN	NN	_	11	nn	_	_
11	inhibition	_	NN	NN	_	9	dobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	differentiation	_	NN	NN	_	11	conj	_	_
14	of	_	IN	IN	_	11	prep	_	_
15	human	_	JJ	JJ	_	18	amod	_	_
16	myeloid	_	JJ	JJ	_	18	amod	_	_
17	leukemia	_	NN	NN	_	18	nn	_	_
18	cells	_	NNS	NNS	_	14	pobj	_	_
19	induced	_	VBN	VBN	_	11	vmod	_	_
20	by	_	IN	IN	_	19	prep	_	_
21	9-cis	_	JJ	JJ	_	23	amod	_	_
22	retinoic	_	JJ	JJ	_	23	amod	_	_
23	acid	_	NN	NN	_	20	pobj	_	_
24	.	_	.	.	_	9	punct	_	_

1	Differanisole	_	NN	NN	_	2	nn	_	_
2	A	_	NN	NN	_	7	nsubj	_	_
3	,	_	,	,	_	2	punct	_	_
4	3,5-dichloro-2-hydroxy-4-methoxy-6-n-propylbenzoic	_	JJ	JJ	_	5	amod	_	_
5	acid	_	NN	NN	_	2	appos	_	_
6	,	_	,	,	_	2	punct	_	_
7	inhibited	_	VBD	VBD	_	0	root	_	_
8	growth	_	NN	NN	_	7	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	human	_	JJ	JJ	_	13	amod	_	_
11	myeloid	_	JJ	JJ	_	13	amod	_	_
12	leukemia	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	9	pobj	_	_
14	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	compound	_	NN	NN	_	3	nsubj	_	_
3	induced	_	VBD	VBD	_	0	root	_	_
4	G1	_	NN	NN	_	5	nn	_	_
5	arrest	_	NN	NN	_	3	dobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	granulocytic	_	JJ	JJ	_	8	amod	_	_
8	differentiation	_	NN	NN	_	5	conj	_	_
9	of	_	IN	IN	_	5	prep	_	_
10	HL-60	_	NN	NN	_	11	nn	_	_
11	cells	_	NNS	NNS	_	9	pobj	_	_
12	,	_	,	,	_	3	punct	_	_
13	although	_	IN	IN	_	18	mark	_	_
14	the	_	DT	DT	_	16	det	_	_
15	differentiation-inducing	_	JJ	JJ	_	16	amod	_	_
16	effect	_	NN	NN	_	18	nsubj	_	_
17	was	_	VBD	VBD	_	18	cop	_	_
18	modest	_	JJ	JJ	_	3	advcl	_	_
19	.	_	.	.	_	3	punct	_	_

1	Differanisole	_	NN	NN	_	11	nsubj	_	_
2	A	_	DT	DT	_	1	dep	_	_
3	and	_	CC	CC	_	1	cc	_	_
4	9-cis	_	JJ	JJ	_	6	amod	_	_
5	retinoic	_	JJ	JJ	_	6	amod	_	_
6	acid	_	NN	NN	_	1	conj	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	9cisRA	_	NN	NN	_	6	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	synergistically	_	RB	RB	_	11	advmod	_	_
11	inhibited	_	VBD	VBD	_	0	root	_	_
12	the	_	DT	DT	_	13	det	_	_
13	growth	_	NN	NN	_	11	dobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	induced	_	VBD	VBD	_	16	amod	_	_
16	functional	_	JJ	JJ	_	13	conj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	morphologic	_	JJ	JJ	_	16	conj	_	_
19	differentiation	_	NN	NN	_	16	dep	_	_
20	of	_	IN	IN	_	13	prep	_	_
21	HL-60	_	NN	NN	_	20	pobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	NB4	_	NN	NN	_	21	conj	_	_
24	cells	_	NNS	NNS	_	21	dep	_	_
25	,	_	,	,	_	11	punct	_	_
26	whereas	_	IN	IN	_	42	mark	_	_
27	the	_	DT	DT	_	29	det	_	_
28	combined	_	JJ	JJ	_	29	amod	_	_
29	treatment	_	NN	NN	_	42	nsubj	_	_
30	with	_	IN	IN	_	29	prep	_	_
31	differanisole	_	NN	NN	_	32	nn	_	_
32	A	_	NN	NN	_	30	pobj	_	_
33	and	_	CC	CC	_	32	cc	_	_
34	all-trans	_	JJ	JJ	_	36	amod	_	_
35	retinoic	_	JJ	JJ	_	36	amod	_	_
36	acid	_	NN	NN	_	32	conj	_	_
37	or	_	CC	CC	_	36	cc	_	_
38	1alpha,25-dihydroxyvitamin	_	NN	NN	_	39	nn	_	_
39	D3	_	NN	NN	_	36	conj	_	_
40	was	_	VBD	VBD	_	42	cop	_	_
41	less	_	RBR	RBR	_	42	advmod	_	_
42	effective	_	JJ	JJ	_	11	advcl	_	_
43	.	_	.	.	_	11	punct	_	_

1	Similar	_	JJ	JJ	_	2	amod	_	_
2	results	_	NNS	NNS	_	4	nsubjpass	_	_
3	were	_	VBD	VBD	_	4	auxpass	_	_
4	obtained	_	VBN	VBN	_	0	root	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	primary	_	JJ	JJ	_	7	amod	_	_
7	culture	_	NN	NN	_	5	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	leukemia	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	8	pobj	_	_
11	from	_	IN	IN	_	10	prep	_	_
12	a	_	DT	DT	_	13	det	_	_
13	patient	_	NN	NN	_	11	pobj	_	_
14	with	_	IN	IN	_	13	prep	_	_
15	acute	_	JJ	JJ	_	17	amod	_	_
16	promyelocytic	_	JJ	JJ	_	17	amod	_	_
17	leukemia	_	NN	NN	_	14	pobj	_	_
18	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	synergistic	_	JJ	JJ	_	3	amod	_	_
3	effect	_	NN	NN	_	11	nsubj	_	_
4	on	_	IN	IN	_	3	prep	_	_
5	growth	_	NN	NN	_	6	nn	_	_
6	inhibition	_	NN	NN	_	4	pobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	induction	_	NN	NN	_	6	conj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	differentiation	_	NN	NN	_	9	pobj	_	_
11	required	_	VBD	VBD	_	0	root	_	_
12	simultaneous	_	JJ	JJ	_	13	amod	_	_
13	treatment	_	NN	NN	_	11	dobj	_	_
14	with	_	IN	IN	_	13	prep	_	_
15	differanisole	_	NN	NN	_	16	nn	_	_
16	A	_	NN	NN	_	14	pobj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	9cisRA	_	NN	NN	_	16	conj	_	_
19	.	_	.	.	_	11	punct	_	_

1	Differanisole	_	NN	NN	_	2	nn	_	_
2	A	_	NN	NN	_	11	nsubj	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	an	_	DT	DT	_	6	det	_	_
5	RXR-specific	_	JJ	JJ	_	6	amod	_	_
6	ligand	_	NN	NN	_	2	conj	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	Ro47-5944	_	NN	NN	_	6	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	cooperatively	_	RB	RB	_	11	advmod	_	_
11	inhibited	_	VBD	VBD	_	0	root	_	_
12	the	_	DT	DT	_	14	det	_	_
13	cell	_	NN	NN	_	14	nn	_	_
14	growth	_	NN	NN	_	11	dobj	_	_
15	,	_	,	,	_	11	punct	_	_
16	while	_	IN	IN	_	30	mark	_	_
17	the	_	DT	DT	_	19	det	_	_
18	combined	_	JJ	JJ	_	19	amod	_	_
19	effect	_	NN	NN	_	30	nsubj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	differanisole	_	NN	NN	_	22	nn	_	_
22	A	_	NN	NN	_	20	pobj	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	an	_	DT	DT	_	26	det	_	_
25	RAR-specific	_	JJ	JJ	_	26	amod	_	_
26	ligand	_	NN	NN	_	22	conj	_	_
27	Am80	_	NN	NN	_	26	dep	_	_
28	was	_	VBD	VBD	_	30	cop	_	_
29	just	_	RB	RB	_	30	advmod	_	_
30	additive	_	JJ	JJ	_	11	advcl	_	_
31	.	_	.	.	_	11	punct	_	_

1	Differanisole	_	NN	NN	_	2	nn	_	_
2	A	_	NN	NN	_	8	nsubj	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	combination	_	NN	NN	_	3	pobj	_	_
5	with	_	IN	IN	_	4	prep	_	_
6	9cisRA	_	NN	NN	_	5	pobj	_	_
7	may	_	MD	MD	_	8	aux	_	_
8	have	_	VB	VB	_	0	root	_	_
9	implications	_	NNS	NNS	_	8	dobj	_	_
10	for	_	IN	IN	_	8	prep	_	_
11	therapy	_	NN	NN	_	10	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	acute	_	JJ	JJ	_	16	amod	_	_
14	promyelocytic	_	JJ	JJ	_	16	amod	_	_
15	leukemia	_	NN	NN	_	16	nn	_	_
16	patients	_	NNS	NNS	_	12	pobj	_	_
17	.	_	.	.	_	8	punct	_	_

1	Molecular	_	JJ	JJ	_	2	amod	_	_
2	mechanisms	_	NNS	NNS	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	anoxia/reoxygenation-induced	_	JJ	JJ	_	6	amod	_	_
5	neutrophil	_	NN	NN	_	6	nn	_	_
6	adherence	_	NN	NN	_	3	pobj	_	_
7	to	_	TO	TO	_	6	prep	_	_
8	cultured	_	VBN	VBN	_	10	amod	_	_
9	endothelial	_	JJ	JJ	_	10	amod	_	_
10	cells	_	NNS	NNS	_	7	pobj	_	_
11	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	objectives	_	NNS	NNS	_	6	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	this	_	DT	DT	_	5	det	_	_
5	study	_	NN	NN	_	3	pobj	_	_
6	were	_	VBD	VBD	_	0	root	_	_
7	to	_	TO	TO	_	11	aux	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	1	_	LS	LS	_	11	dep	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	determine	_	VB	VB	_	6	xcomp	_	_
12	the	_	DT	DT	_	14	det	_	_
13	time	_	NN	NN	_	14	nn	_	_
14	course	_	NN	NN	_	11	dobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	neutrophil	_	NN	NN	_	17	nn	_	_
17	adhesion	_	NN	NN	_	15	pobj	_	_
18	to	_	TO	TO	_	17	prep	_	_
19	monolayers	_	NNS	NNS	_	18	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	human	_	JJ	JJ	_	25	amod	_	_
22	umbilical	_	JJ	JJ	_	25	amod	_	_
23	vein	_	NN	NN	_	25	nn	_	_
24	endothelial	_	JJ	JJ	_	25	amod	_	_
25	cells	_	NNS	NNS	_	20	pobj	_	_
26	-LRB-	_	-LRB-	-LRB-	_	27	punct	_	_
27	HUVECs	_	NNS	NNS	_	25	appos	_	_
28	-RRB-	_	-RRB-	-RRB-	_	27	punct	_	_
29	that	_	WDT	WDT	_	31	nsubjpass	_	_
30	were	_	VBD	VBD	_	31	auxpass	_	_
31	exposed	_	VBN	VBN	_	19	rcmod	_	_
32	to	_	TO	TO	_	31	prep	_	_
33	60	_	CD	CD	_	34	num	_	_
34	minutes	_	NNS	NNS	_	32	pobj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	anoxia	_	NN	NN	_	35	pobj	_	_
37	followed	_	VBN	VBN	_	34	vmod	_	_
38	by	_	IN	IN	_	37	prep	_	_
39	30	_	CD	CD	_	41	number	_	_
40	to	_	TO	TO	_	41	dep	_	_
41	600	_	CD	CD	_	42	num	_	_
42	minutes	_	NNS	NNS	_	38	pobj	_	_
43	of	_	IN	IN	_	42	prep	_	_
44	reoxygenation	_	NN	NN	_	43	pobj	_	_
45	and	_	CC	CC	_	11	cc	_	_
46	-LRB-	_	-LRB-	-LRB-	_	47	punct	_	_
47	2	_	LS	LS	_	49	dep	_	_
48	-RRB-	_	-RRB-	-RRB-	_	47	punct	_	_
49	define	_	VB	VB	_	11	conj	_	_
50	the	_	DT	DT	_	51	det	_	_
51	mechanisms	_	NNS	NNS	_	49	dobj	_	_
52	responsible	_	JJ	JJ	_	51	amod	_	_
53	for	_	IN	IN	_	52	prep	_	_
54	both	_	CC	CC	_	56	preconj	_	_
55	the	_	DT	DT	_	56	dep	_	_
56	early	_	JJ	JJ	_	53	pobj	_	_
57	-LRB-	_	-LRB-	-LRB-	_	58	punct	_	_
58	minutes	_	NNS	NNS	_	56	dep	_	_
59	-RRB-	_	-RRB-	-RRB-	_	58	punct	_	_
60	and	_	CC	CC	_	56	cc	_	_
61	late	_	JJ	JJ	_	56	conj	_	_
62	-LRB-	_	-LRB-	-LRB-	_	63	punct	_	_
63	hours	_	NNS	NNS	_	61	dep	_	_
64	-RRB-	_	-RRB-	-RRB-	_	63	punct	_	_
65	hyperadhesivity	_	NN	NN	_	56	dep	_	_
66	of	_	IN	IN	_	65	prep	_	_
67	postanoxic	_	JJ	JJ	_	68	amod	_	_
68	HUVECs	_	NNS	NNS	_	66	pobj	_	_
69	to	_	TO	TO	_	65	prep	_	_
70	human	_	JJ	JJ	_	71	amod	_	_
71	neutrophils	_	NNS	NNS	_	69	pobj	_	_
72	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	4	nsubj	_	_
3	clearly	_	RB	RB	_	4	advmod	_	_
4	demonstrate	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	10	mark	_	_
6	anoxia/reoxygenation	_	NN	NN	_	10	nsubj	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	A/R	_	NN	NN	_	6	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	leads	_	VBZ	VBZ	_	4	ccomp	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	a	_	DT	DT	_	14	det	_	_
13	biphasic	_	JJ	JJ	_	14	amod	_	_
14	increase	_	NN	NN	_	11	pobj	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	neutrophil	_	NN	NN	_	17	nn	_	_
17	adhesion	_	NN	NN	_	15	pobj	_	_
18	to	_	TO	TO	_	17	prep	_	_
19	HUVECs	_	NNS	NNS	_	18	pobj	_	_
20	,	_	,	,	_	10	punct	_	_
21	with	_	IN	IN	_	10	prep	_	_
22	peak	_	NN	NN	_	23	nn	_	_
23	responses	_	NNS	NNS	_	24	nsubj	_	_
24	occurring	_	VBG	VBG	_	21	pcomp	_	_
25	at	_	IN	IN	_	24	prep	_	_
26	30	_	CD	CD	_	27	num	_	_
27	minutes	_	NNS	NNS	_	25	pobj	_	_
28	-LRB-	_	-LRB-	-LRB-	_	29	punct	_	_
29	phase	_	NN	NN	_	27	appos	_	_
30	1	_	CD	CD	_	29	num	_	_
31	-RRB-	_	-RRB-	-RRB-	_	29	punct	_	_
32	and	_	CC	CC	_	27	cc	_	_
33	240	_	CD	CD	_	34	num	_	_
34	minutes	_	NNS	NNS	_	27	conj	_	_
35	-LRB-	_	-LRB-	-LRB-	_	36	punct	_	_
36	phase	_	NN	NN	_	34	appos	_	_
37	2	_	CD	CD	_	36	num	_	_
38	-RRB-	_	-RRB-	-RRB-	_	36	punct	_	_
39	after	_	IN	IN	_	27	prep	_	_
40	reoxygenation	_	NN	NN	_	39	pobj	_	_
41	.	_	.	.	_	4	punct	_	_

1	Oxypurinol	_	NN	NN	_	4	nsubj	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	catalase	_	NN	NN	_	1	conj	_	_
4	inhibited	_	VBD	VBD	_	0	root	_	_
5	phase-1	_	JJ	JJ	_	6	amod	_	_
6	adhesion	_	NN	NN	_	4	dobj	_	_
7	,	_	,	,	_	4	punct	_	_
8	suggesting	_	VBG	VBG	_	4	vmod	_	_
9	a	_	DT	DT	_	10	det	_	_
10	role	_	NN	NN	_	8	dobj	_	_
11	for	_	IN	IN	_	8	prep	_	_
12	xanthine	_	NN	NN	_	13	nn	_	_
13	oxidase	_	NN	NN	_	11	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	H2O2	_	NN	NN	_	13	conj	_	_
16	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	10	prep	_	_
2	comparison	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	10	punct	_	_
4	platelet	_	NN	NN	_	6	nn	_	_
5	activating	_	NN	NN	_	6	nn	_	_
6	factor	_	NN	NN	_	10	nsubj	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	PAF	_	NN	NN	_	6	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	contributed	_	VBD	VBD	_	0	root	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	both	_	CC	CC	_	13	dep	_	_
13	phases	_	NNS	NNS	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	neutrophil	_	NN	NN	_	16	nn	_	_
16	adhesion	_	NN	NN	_	14	pobj	_	_
17	.	_	.	.	_	10	punct	_	_

1	Anti-intercellular	_	JJ	JJ	_	3	amod	_	_
2	adhesion	_	NN	NN	_	3	nn	_	_
3	molecule-1	_	NN	NN	_	17	nsubj	_	_
4	-LRB-	_	-LRB-	-LRB-	_	5	punct	_	_
5	ICAM-1	_	NN	NN	_	3	appos	_	_
6	-RRB-	_	-RRB-	-RRB-	_	5	punct	_	_
7	and	_	CC	CC	_	3	cc	_	_
8	anti-P-selectin	_	JJ	JJ	_	9	amod	_	_
9	antibodies	_	NNS	NNS	_	3	conj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
11	monoclonal	_	JJ	JJ	_	12	amod	_	_
12	antibodies	_	NNS	NNS	_	9	dep	_	_
13	-LSB-	_	-LRB-	-LRB-	_	14	punct	_	_
14	mAbs	_	NNS	NNS	_	12	appos	_	_
15	-RSB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
17	attenuated	_	VBD	VBD	_	0	root	_	_
18	phase-1	_	JJ	JJ	_	20	amod	_	_
19	neutrophil	_	NN	NN	_	20	nn	_	_
20	adhesion	_	NN	NN	_	17	dobj	_	_
21	,	_	,	,	_	17	punct	_	_
22	consistent	_	JJ	JJ	_	17	advmod	_	_
23	with	_	IN	IN	_	22	prep	_	_
24	roles	_	NNS	NNS	_	23	pobj	_	_
25	for	_	IN	IN	_	24	prep	_	_
26	constitutively	_	RB	RB	_	27	advmod	_	_
27	expressed	_	VBN	VBN	_	28	amod	_	_
28	ICAM-1	_	NN	NN	_	25	pobj	_	_
29	and	_	CC	CC	_	28	cc	_	_
30	enhanced	_	VBN	VBN	_	32	amod	_	_
31	surface	_	NN	NN	_	32	nn	_	_
32	expression	_	NN	NN	_	28	conj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	preformed	_	JJ	JJ	_	35	amod	_	_
35	P-selectin	_	NN	NN	_	33	pobj	_	_
36	.	_	.	.	_	17	punct	_	_

1	Phase-2	_	NN	NN	_	3	nn	_	_
2	neutrophil	_	NN	NN	_	3	nn	_	_
3	adhesion	_	NN	NN	_	5	nsubjpass	_	_
4	was	_	VBD	VBD	_	5	auxpass	_	_
5	attenuated	_	VBN	VBN	_	0	root	_	_
6	by	_	IN	IN	_	5	prep	_	_
7	an	_	DT	DT	_	9	det	_	_
8	anti-E-selectin	_	JJ	JJ	_	9	amod	_	_
9	mAb	_	NN	NN	_	6	pobj	_	_
10	,	_	,	,	_	5	punct	_	_
11	indicating	_	VBG	VBG	_	5	vmod	_	_
12	a	_	DT	DT	_	14	det	_	_
13	dominant	_	JJ	JJ	_	14	amod	_	_
14	role	_	NN	NN	_	11	dobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	this	_	DT	DT	_	18	det	_	_
17	adhesion	_	NN	NN	_	18	nn	_	_
18	molecule	_	NN	NN	_	15	pobj	_	_
19	in	_	IN	IN	_	14	prep	_	_
20	the	_	DT	DT	_	23	det	_	_
21	late	_	JJ	JJ	_	23	amod	_	_
22	phase	_	NN	NN	_	23	nn	_	_
23	response	_	NN	NN	_	19	pobj	_	_
24	.	_	.	.	_	5	punct	_	_

1	Pretreatment	_	NN	NN	_	23	nsubj	_	_
2	with	_	IN	IN	_	1	prep	_	_
3	actinomycin	_	NN	NN	_	4	nn	_	_
4	D	_	NN	NN	_	2	pobj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	cycloheximide	_	NN	NN	_	4	conj	_	_
7	or	_	CC	CC	_	2	cc	_	_
8	with	_	IN	IN	_	2	conj	_	_
9	competing	_	VBG	VBG	_	10	amod	_	_
10	ds-oligonucleotides	_	NNS	NNS	_	8	pobj	_	_
11	containing	_	VBG	VBG	_	10	vmod	_	_
12	the	_	DT	DT	_	15	det	_	_
13	nuclear	_	JJ	JJ	_	15	amod	_	_
14	factor-kappa	_	NN	NN	_	15	nn	_	_
15	B	_	NN	NN	_	11	dobj	_	_
16	or	_	CC	CC	_	15	cc	_	_
17	activator	_	NN	NN	_	18	nn	_	_
18	protein-1	_	NN	NN	_	15	conj	_	_
19	cognate	_	NN	NN	_	21	nn	_	_
20	DNA	_	NN	NN	_	21	nn	_	_
21	sequences	_	NNS	NNS	_	18	dep	_	_
22	significantly	_	RB	RB	_	23	advmod	_	_
23	attenuated	_	VBD	VBD	_	0	root	_	_
24	phase-2	_	NN	NN	_	25	nn	_	_
25	response	_	NN	NN	_	23	dobj	_	_
26	,	_	,	,	_	23	punct	_	_
27	suggesting	_	VBG	VBG	_	23	vmod	_	_
28	a	_	DT	DT	_	29	det	_	_
29	role	_	NN	NN	_	27	dobj	_	_
30	for	_	IN	IN	_	29	prep	_	_
31	de	_	FW	FW	_	34	amod	_	_
32	novo	_	FW	FW	_	31	dep	_	_
33	macromolecule	_	NN	NN	_	34	nn	_	_
34	synthesis	_	NN	NN	_	30	pobj	_	_
35	.	_	.	.	_	23	punct	_	_

1	Surface	_	NN	NN	_	2	nn	_	_
2	expression	_	NN	NN	_	12	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	ICAM-1	_	NN	NN	_	3	pobj	_	_
5	,	_	,	,	_	4	punct	_	_
6	P-selectin	_	NN	NN	_	4	conj	_	_
7	,	_	,	,	_	4	punct	_	_
8	and	_	CC	CC	_	4	cc	_	_
9	E-selectin	_	NN	NN	_	4	conj	_	_
10	on	_	IN	IN	_	2	prep	_	_
11	HUVECs	_	NNS	NNS	_	10	pobj	_	_
12	correlated	_	VBD	VBD	_	0	root	_	_
13	with	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	15	dep	_	_
15	phase-1	_	JJ	JJ	_	13	pobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	-2	_	CD	CD	_	15	conj	_	_
18	neutrophil	_	NN	NN	_	20	nn	_	_
19	adhesion	_	NN	NN	_	20	nn	_	_
20	responses	_	NNS	NNS	_	15	dep	_	_
21	.	_	.	.	_	12	punct	_	_

1	Collectively	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	these	_	DT	DT	_	4	det	_	_
4	findings	_	NNS	NNS	_	5	nsubj	_	_
5	indicate	_	VBP	VBP	_	0	root	_	_
6	that	_	IN	IN	_	8	mark	_	_
7	A/R	_	NN	NN	_	8	nsubj	_	_
8	elicits	_	VBZ	VBZ	_	5	ccomp	_	_
9	a	_	DT	DT	_	14	det	_	_
10	two-phase	_	JJ	JJ	_	14	amod	_	_
11	neutrophil-endothelial	_	JJ	JJ	_	14	amod	_	_
12	cell	_	NN	NN	_	14	nn	_	_
13	adhesion	_	NN	NN	_	14	nn	_	_
14	response	_	NN	NN	_	8	dobj	_	_
15	that	_	WDT	WDT	_	16	nsubj	_	_
16	involves	_	VBZ	VBZ	_	14	rcmod	_	_
17	transcription-independent	_	JJ	JJ	_	16	dobj	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	transcription-dependent	_	JJ	JJ	_	17	conj	_	_
20	surface	_	NN	NN	_	21	nn	_	_
21	expression	_	NN	NN	_	17	dep	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	different	_	JJ	JJ	_	27	amod	_	_
24	endothelial	_	JJ	JJ	_	27	amod	_	_
25	cell	_	NN	NN	_	27	nn	_	_
26	adhesion	_	NN	NN	_	27	nn	_	_
27	molecules	_	NNS	NNS	_	22	pobj	_	_
28	.	_	.	.	_	5	punct	_	_

1	B	_	NN	NN	_	2	nn	_	_
2	lymphocytes	_	NNS	NNS	_	9	nsubj	_	_
3	from	_	IN	IN	_	2	prep	_	_
4	patients	_	NNS	NNS	_	3	pobj	_	_
5	with	_	IN	IN	_	4	prep	_	_
6	chronic	_	JJ	JJ	_	8	amod	_	_
7	lymphocytic	_	JJ	JJ	_	8	amod	_	_
8	leukemia	_	NN	NN	_	5	pobj	_	_
9	contain	_	VBP	VBP	_	0	root	_	_
10	signal	_	NN	NN	_	11	nn	_	_
11	transducer	_	NN	NN	_	9	dobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	activator	_	NN	NN	_	17	nn	_	_
14	of	_	IN	IN	_	17	amod	_	_
15	transcription	_	NN	NN	_	17	nn	_	_
16	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
17	STAT	_	NN	NN	_	11	conj	_	_
18	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
19	1	_	CD	CD	_	17	num	_	_
20	and	_	CC	CC	_	11	cc	_	_
21	STAT3	_	NN	NN	_	11	conj	_	_
22	constitutively	_	RB	RB	_	23	advmod	_	_
23	phosphorylated	_	VBN	VBN	_	11	vmod	_	_
24	on	_	IN	IN	_	23	prep	_	_
25	serine	_	NN	NN	_	26	nn	_	_
26	residues	_	NNS	NNS	_	24	pobj	_	_
27	.	_	.	.	_	9	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	explore	_	VB	VB	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	pathogenesis	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	chronic	_	JJ	JJ	_	8	amod	_	_
7	lymphocytic	_	JJ	JJ	_	8	amod	_	_
8	leukemia	_	NN	NN	_	5	pobj	_	_
9	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
10	CLL	_	NN	NN	_	8	appos	_	_
11	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
12	,	_	,	,	_	2	punct	_	_
13	we	_	PRP	PRP	_	14	nsubj	_	_
14	examined	_	VBD	VBD	_	2	parataxis	_	_
15	whether	_	IN	IN	_	32	mark	_	_
16	phosphorylation	_	NN	NN	_	32	nsubj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	one	_	CD	CD	_	17	pobj	_	_
19	or	_	CC	CC	_	18	cc	_	_
20	more	_	JJR	JJR	_	18	conj	_	_
21	signal	_	NN	NN	_	22	nn	_	_
22	transducer	_	NN	NN	_	18	dep	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	activator	_	NN	NN	_	30	nn	_	_
25	of	_	IN	IN	_	30	amod	_	_
26	transcription	_	NN	NN	_	30	nn	_	_
27	-LRB-	_	-LRB-	-LRB-	_	30	punct	_	_
28	STAT	_	NN	NN	_	30	nn	_	_
29	-RRB-	_	-RRB-	-RRB-	_	30	punct	_	_
30	factors	_	NNS	NNS	_	22	conj	_	_
31	was	_	VBD	VBD	_	32	cop	_	_
32	abnormal	_	JJ	JJ	_	14	ccomp	_	_
33	in	_	IN	IN	_	32	prep	_	_
34	cells	_	NNS	NNS	_	33	pobj	_	_
35	from	_	IN	IN	_	34	prep	_	_
36	CLL	_	NN	NN	_	37	nn	_	_
37	patients	_	NNS	NNS	_	35	pobj	_	_
38	.	_	.	.	_	2	punct	_	_

1	No	_	DT	DT	_	4	neg	_	_
2	constitutive	_	JJ	JJ	_	4	amod	_	_
3	tyrosine	_	NN	NN	_	4	nn	_	_
4	phosphorylation	_	NN	NN	_	6	nsubjpass	_	_
5	was	_	VBD	VBD	_	6	auxpass	_	_
6	detected	_	VBN	VBN	_	0	root	_	_
7	on	_	IN	IN	_	6	prep	_	_
8	any	_	DT	DT	_	9	det	_	_
9	STAT	_	NN	NN	_	7	pobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	CLL	_	NN	NN	_	12	nn	_	_
12	cells	_	NNS	NNS	_	10	pobj	_	_
13	.	_	.	.	_	6	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	assess	_	VB	VB	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	phosphorylation	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	serine	_	NN	NN	_	7	nn	_	_
7	residues	_	NNS	NNS	_	5	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	STAT1	_	NN	NN	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	STAT3	_	NN	NN	_	9	conj	_	_
12	in	_	IN	IN	_	9	prep	_	_
13	CLL	_	NN	NN	_	14	nn	_	_
14	cells	_	NNS	NNS	_	12	pobj	_	_
15	,	_	,	,	_	2	punct	_	_
16	we	_	PRP	PRP	_	17	nsubj	_	_
17	raised	_	VBD	VBD	_	2	parataxis	_	_
18	antibodies	_	NNS	NNS	_	17	dobj	_	_
19	that	_	WDT	WDT	_	21	nsubj	_	_
20	specifically	_	RB	RB	_	21	advmod	_	_
21	recognize	_	VBP	VBP	_	18	rcmod	_	_
22	the	_	DT	DT	_	23	det	_	_
23	form	_	NN	NN	_	21	dobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	STAT1	_	NN	NN	_	24	pobj	_	_
26	phosphorylated	_	VBN	VBN	_	25	vmod	_	_
27	on	_	IN	IN	_	26	prep	_	_
28	ser-727	_	NN	NN	_	27	pobj	_	_
29	and	_	CC	CC	_	23	cc	_	_
30	the	_	DT	DT	_	31	det	_	_
31	form	_	NN	NN	_	23	conj	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	STAT3	_	NN	NN	_	32	pobj	_	_
34	phosphorylated	_	VBN	VBN	_	33	vmod	_	_
35	on	_	IN	IN	_	34	prep	_	_
36	ser-727	_	NN	NN	_	35	pobj	_	_
37	.	_	.	.	_	2	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	found	_	VBD	VBD	_	0	root	_	_
3	that	_	IN	IN	_	22	mark	_	_
4	in	_	IN	IN	_	22	prep	_	_
5	100	_	CD	CD	_	6	num	_	_
6	%	_	NN	NN	_	4	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	patients	_	NNS	NNS	_	7	pobj	_	_
9	with	_	IN	IN	_	8	prep	_	_
10	CLL	_	NN	NN	_	9	pobj	_	_
11	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
12	n	_	NN	NN	_	8	dep	_	_
13	=	_	JJ	JJ	_	12	amod	_	_
14	32	_	CD	CD	_	13	dep	_	_
15	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
16	,	_	,	,	_	22	punct	_	_
17	STAT1	_	NN	NN	_	22	nsubjpass	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	STAT3	_	NN	NN	_	17	conj	_	_
20	were	_	VBD	VBD	_	22	auxpass	_	_
21	constitutively	_	RB	RB	_	22	advmod	_	_
22	phosphorylated	_	VBN	VBN	_	2	ccomp	_	_
23	on	_	IN	IN	_	22	prep	_	_
24	serine	_	NN	NN	_	23	pobj	_	_
25	.	_	.	.	_	2	punct	_	_

1	This	_	DT	DT	_	2	nsubj	_	_
2	was	_	VBD	VBD	_	0	root	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	contrast	_	NN	NN	_	3	pobj	_	_
5	to	_	TO	TO	_	4	prep	_	_
6	normal	_	JJ	JJ	_	8	amod	_	_
7	peripheral	_	JJ	JJ	_	8	amod	_	_
8	blood	_	NN	NN	_	5	pobj	_	_
9	B	_	NN	NN	_	10	nn	_	_
10	lymphocytes	_	NNS	NNS	_	8	dep	_	_
11	or	_	CC	CC	_	8	cc	_	_
12	CD5+-RRB-	_	JJ	JJ	_	14	amod	_	_
13	B	_	NN	NN	_	14	nn	_	_
14	cells	_	NNS	NNS	_	8	conj	_	_
15	isolated	_	VBN	VBN	_	8	vmod	_	_
16	from	_	IN	IN	_	15	prep	_	_
17	tonsils	_	NNS	NNS	_	16	pobj	_	_
18	,	_	,	,	_	8	punct	_	_
19	in	_	IN	IN	_	24	prep	_	_
20	which	_	WDT	WDT	_	19	pobj	_	_
21	this	_	DT	DT	_	22	det	_	_
22	phosphorylation	_	NN	NN	_	24	nsubj	_	_
23	was	_	VBD	VBD	_	24	cop	_	_
24	absent	_	JJ	JJ	_	8	rcmod	_	_
25	.	_	.	.	_	2	punct	_	_

1	Serine	_	NN	NN	_	2	nn	_	_
2	phosphorylation	_	NN	NN	_	8	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	STAT1	_	NN	NN	_	3	pobj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	STAT3	_	NN	NN	_	4	conj	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	seen	_	VBN	VBN	_	0	root	_	_
9	occasionally	_	RB	RB	_	8	advmod	_	_
10	in	_	IN	IN	_	8	prep	_	_
11	other	_	JJ	JJ	_	12	amod	_	_
12	leukemias	_	NNS	NNS	_	10	pobj	_	_
13	,	_	,	,	_	8	punct	_	_
14	but	_	CC	CC	_	8	cc	_	_
15	it	_	PRP	PRP	_	19	nsubj	_	_
16	was	_	VBD	VBD	_	19	cop	_	_
17	a	_	DT	DT	_	19	det	_	_
18	universal	_	JJ	JJ	_	19	amod	_	_
19	finding	_	NN	NN	_	8	conj	_	_
20	only	_	RB	RB	_	21	advmod	_	_
21	in	_	IN	IN	_	19	prep	_	_
22	CLL	_	NN	NN	_	21	pobj	_	_
23	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	serine	_	NN	NN	_	3	nn	_	_
3	phosphorylation	_	NN	NN	_	10	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	these	_	DT	DT	_	6	det	_	_
6	STATs	_	NNS	NNS	_	4	pobj	_	_
7	was	_	VBD	VBD	_	10	cop	_	_
8	a	_	DT	DT	_	10	det	_	_
9	continuous	_	JJ	JJ	_	10	amod	_	_
10	process	_	NN	NN	_	0	root	_	_
11	,	_	,	,	_	10	punct	_	_
12	as	_	IN	IN	_	22	mark	_	_
13	incubation	_	NN	NN	_	22	nsubj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	CLL	_	NN	NN	_	16	nn	_	_
16	cells	_	NNS	NNS	_	14	pobj	_	_
17	with	_	IN	IN	_	13	prep	_	_
18	the	_	DT	DT	_	21	det	_	_
19	kinase	_	NN	NN	_	21	nn	_	_
20	inhibitor	_	NN	NN	_	21	nn	_	_
21	H7	_	NN	NN	_	17	pobj	_	_
22	led	_	VBD	VBD	_	10	advcl	_	_
23	to	_	TO	TO	_	22	prep	_	_
24	the	_	DT	DT	_	25	det	_	_
25	dephosphorylation	_	NN	NN	_	23	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	these	_	DT	DT	_	29	det	_	_
28	serine	_	NN	NN	_	29	nn	_	_
29	residues	_	NNS	NNS	_	26	pobj	_	_
30	.	_	.	.	_	10	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	STAT	_	NN	NN	_	4	nn	_	_
3	serine	_	NN	NN	_	4	nn	_	_
4	kinase	_	NN	NN	_	11	nsubjpass	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	CLL	_	NN	NN	_	7	nn	_	_
7	cells	_	NNS	NNS	_	5	pobj	_	_
8	has	_	VBZ	VBZ	_	11	aux	_	_
9	not	_	RB	RB	_	11	neg	_	_
10	been	_	VBN	VBN	_	11	auxpass	_	_
11	identified	_	VBN	VBN	_	0	root	_	_
12	,	_	,	,	_	11	punct	_	_
13	and	_	CC	CC	_	11	cc	_	_
14	appears	_	VBZ	VBZ	_	11	conj	_	_
15	to	_	TO	TO	_	20	aux	_	_
16	be	_	VB	VB	_	20	cop	_	_
17	neither	_	DT	DT	_	20	preconj	_	_
18	mitogen-activated	_	JJ	JJ	_	20	amod	_	_
19	protein	_	NN	NN	_	20	nn	_	_
20	kinase	_	NN	NN	_	14	xcomp	_	_
21	nor	_	CC	CC	_	20	cc	_	_
22	pp70-LRB-s6k-RRB-	_	NN	NN	_	20	conj	_	_
23	.	_	.	.	_	11	punct	_	_

1	In	_	IN	IN	_	13	prep	_	_
2	summary	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	13	punct	_	_
4	the	_	DT	DT	_	7	det	_	_
5	constitutive	_	JJ	JJ	_	7	amod	_	_
6	serine	_	NN	NN	_	7	nn	_	_
7	phosphorylation	_	NN	NN	_	13	nsubj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	STAT1	_	NN	NN	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	STAT3	_	NN	NN	_	9	conj	_	_
12	is	_	VBZ	VBZ	_	13	cop	_	_
13	present	_	JJ	JJ	_	0	root	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	all	_	DT	DT	_	17	det	_	_
16	CLL	_	NN	NN	_	17	nn	_	_
17	samples	_	NNS	NNS	_	14	pobj	_	_
18	tested	_	VBN	VBN	_	17	vmod	_	_
19	to	_	TO	TO	_	18	prep	_	_
20	date	_	NN	NN	_	19	pobj	_	_
21	,	_	,	,	_	13	punct	_	_
22	although	_	IN	IN	_	29	mark	_	_
23	the	_	DT	DT	_	25	det	_	_
24	physiologic	_	JJ	JJ	_	25	amod	_	_
25	significance	_	NN	NN	_	29	nsubj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	this	_	DT	DT	_	28	det	_	_
28	modification	_	NN	NN	_	26	pobj	_	_
29	remains	_	VBZ	VBZ	_	13	advcl	_	_
30	to	_	TO	TO	_	32	aux	_	_
31	be	_	VB	VB	_	32	auxpass	_	_
32	determined	_	VBN	VBN	_	29	xcomp	_	_
33	.	_	.	.	_	13	punct	_	_

1	C/EBP	_	NN	NN	_	2	nsubj	_	_
2	activates	_	VBZ	VBZ	_	0	root	_	_
3	the	_	DT	DT	_	8	det	_	_
4	human	_	JJ	JJ	_	8	amod	_	_
5	corticotropin-releasing	_	JJ	JJ	_	8	amod	_	_
6	hormone	_	NN	NN	_	8	nn	_	_
7	gene	_	NN	NN	_	8	nn	_	_
8	promoter	_	NN	NN	_	2	dobj	_	_
9	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	purpose	_	NN	NN	_	6	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	these	_	DT	DT	_	5	det	_	_
5	studies	_	NNS	NNS	_	3	pobj	_	_
6	was	_	VBD	VBD	_	0	root	_	_
7	to	_	TO	TO	_	8	aux	_	_
8	identify	_	VB	VB	_	6	xcomp	_	_
9	whether	_	IN	IN	_	18	mark	_	_
10	transcription	_	NN	NN	_	11	nn	_	_
11	factors	_	NNS	NNS	_	18	nsubj	_	_
12	,	_	,	,	_	11	punct	_	_
13	associated	_	VBN	VBN	_	11	vmod	_	_
14	with	_	IN	IN	_	13	prep	_	_
15	cytokine	_	NN	NN	_	16	nn	_	_
16	signalling	_	NN	NN	_	14	pobj	_	_
17	,	_	,	,	_	11	punct	_	_
18	affected	_	VBD	VBD	_	8	ccomp	_	_
19	promoter	_	NN	NN	_	20	nn	_	_
20	activity	_	NN	NN	_	18	dobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	29	det	_	_
23	corticotropin	_	NN	NN	_	29	nn	_	_
24	releasing	_	NN	NN	_	29	nn	_	_
25	hormone	_	NN	NN	_	29	nn	_	_
26	-LRB-	_	-LRB-	-LRB-	_	29	punct	_	_
27	CRH	_	NN	NN	_	29	nn	_	_
28	-RRB-	_	-RRB-	-RRB-	_	29	punct	_	_
29	gene	_	NN	NN	_	21	pobj	_	_
30	.	_	.	.	_	6	punct	_	_

1	Fragments	_	NNS	NNS	_	14	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	a	_	DT	DT	_	6	det	_	_
4	3.6	_	CD	CD	_	5	number	_	_
5	kb	_	NN	NN	_	6	amod	_	_
6	sequence	_	NN	NN	_	2	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	12	det	_	_
9	human	_	JJ	JJ	_	12	amod	_	_
10	CRH	_	NN	NN	_	12	nn	_	_
11	gene	_	NN	NN	_	12	nn	_	_
12	promoter	_	NN	NN	_	7	pobj	_	_
13	were	_	VBD	VBD	_	14	auxpass	_	_
14	amplified	_	VBN	VBN	_	0	root	_	_
15	by	_	IN	IN	_	14	prep	_	_
16	PCR	_	NN	NN	_	15	pobj	_	_
17	and	_	CC	CC	_	14	cc	_	_
18	ligated	_	VBN	VBN	_	14	conj	_	_
19	upstream	_	RB	RB	_	18	advmod	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	a	_	DT	DT	_	23	det	_	_
22	CAT	_	NN	NN	_	23	nn	_	_
23	reporter	_	NN	NN	_	20	pobj	_	_
24	.	_	.	.	_	14	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	constructs	_	NNS	NNS	_	4	nsubjpass	_	_
3	were	_	VBD	VBD	_	4	auxpass	_	_
4	transfected	_	VBN	VBN	_	0	root	_	_
5	into	_	IN	IN	_	4	prep	_	_
6	a	_	DT	DT	_	7	det	_	_
7	variety	_	NN	NN	_	5	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	cell	_	NN	NN	_	10	nn	_	_
10	lines	_	NNS	NNS	_	8	pobj	_	_
11	,	_	,	,	_	4	punct	_	_
12	either	_	CC	CC	_	13	preconj	_	_
13	alone	_	RB	RB	_	4	advmod	_	_
14	or	_	CC	CC	_	13	cc	_	_
15	together	_	RB	RB	_	13	conj	_	_
16	,	_	,	,	_	4	punct	_	_
17	with	_	IN	IN	_	4	prep	_	_
18	transcription	_	NN	NN	_	19	nn	_	_
19	factor	_	NN	NN	_	21	nn	_	_
20	expression	_	NN	NN	_	21	nn	_	_
21	vectors	_	NNS	NNS	_	17	pobj	_	_
22	.	_	.	.	_	4	punct	_	_

1	Basal	_	JJ	JJ	_	2	amod	_	_
2	activity	_	NN	NN	_	12	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	a	_	DT	DT	_	9	det	_	_
5	3070	_	CD	CD	_	9	num	_	_
6	bp	_	NN	NN	_	9	nn	_	_
7	CRH	_	NN	NN	_	9	nn	_	_
8	promoter	_	NN	NN	_	9	nn	_	_
9	fragment	_	NN	NN	_	3	pobj	_	_
10	was	_	VBD	VBD	_	12	auxpass	_	_
11	only	_	RB	RB	_	12	advmod	_	_
12	seen	_	VBN	VBN	_	0	root	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	neuronal	_	JJ	JJ	_	13	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	lymphoblastoid	_	JJ	JJ	_	18	amod	_	_
17	cell	_	NN	NN	_	18	nn	_	_
18	lines	_	NNS	NNS	_	14	conj	_	_
19	.	_	.	.	_	12	punct	_	_

1	Promoter	_	NN	NN	_	2	nn	_	_
2	activity	_	NN	NN	_	4	nsubjpass	_	_
3	was	_	VBD	VBD	_	4	auxpass	_	_
4	increased	_	VBN	VBN	_	0	root	_	_
5	by	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	transcription	_	NN	NN	_	8	nn	_	_
8	factors	_	NNS	NNS	_	5	pobj	_	_
9	C/EBPbeta	_	NN	NN	_	8	dep	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	NF-IL6	_	NN	NN	_	8	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	and	_	CC	CC	_	5	cc	_	_
14	more	_	RBR	RBR	_	15	advmod	_	_
15	strongly	_	RB	RB	_	5	conj	_	_
16	,	_	,	,	_	5	punct	_	_
17	by	_	IN	IN	_	5	conj	_	_
18	C/EBPdelta	_	NN	NN	_	17	pobj	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	NF-IL6beta	_	NN	NN	_	18	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	.	_	.	.	_	4	punct	_	_

1	Increased	_	VBN	VBN	_	4	amod	_	_
2	CRH	_	NN	NN	_	4	nn	_	_
3	promoter	_	NN	NN	_	4	nn	_	_
4	activity	_	NN	NN	_	10	nsubjpass	_	_
5	following	_	VBG	VBG	_	4	prep	_	_
6	phorbol	_	NN	NN	_	8	nn	_	_
7	ester	_	NN	NN	_	8	nn	_	_
8	treatment	_	NN	NN	_	5	pobj	_	_
9	was	_	VBD	VBD	_	10	auxpass	_	_
10	inhibited	_	VBN	VBN	_	0	root	_	_
11	by	_	IN	IN	_	10	prep	_	_
12	a	_	DT	DT	_	16	det	_	_
13	dominant	_	JJ	JJ	_	16	amod	_	_
14	negative	_	JJ	JJ	_	16	amod	_	_
15	NF-IL6	_	NN	NN	_	16	nn	_	_
16	mutant	_	NN	NN	_	11	pobj	_	_
17	,	_	,	,	_	10	punct	_	_
18	showing	_	VBG	VBG	_	10	vmod	_	_
19	that	_	IN	IN	_	27	mark	_	_
20	the	_	DT	DT	_	21	det	_	_
21	effects	_	NNS	NNS	_	27	nsubjpass	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	phorbol	_	NN	NN	_	24	nn	_	_
24	ester	_	NN	NN	_	22	pobj	_	_
25	were	_	VBD	VBD	_	27	auxpass	_	_
26	principally	_	RB	RB	_	27	advmod	_	_
27	mediated	_	VBN	VBN	_	18	ccomp	_	_
28	by	_	IN	IN	_	27	prep	_	_
29	C/EBP	_	NN	NN	_	28	pobj	_	_
30	.	_	.	.	_	10	punct	_	_

1	Moreover	_	RB	RB	_	20	advmod	_	_
2	,	_	,	,	_	20	punct	_	_
3	the	_	DT	DT	_	5	det	_	_
4	inverse	_	JJ	JJ	_	5	amod	_	_
5	changes	_	NNS	NNS	_	20	nsubjpass	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	expression	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	CRH	_	NN	NN	_	9	pobj	_	_
11	in	_	IN	IN	_	8	prep	_	_
12	the	_	DT	DT	_	13	dep	_	_
13	hypothalamus	_	NN	NN	_	11	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	spleens	_	NNS	NNS	_	13	conj	_	_
16	of	_	IN	IN	_	13	prep	_	_
17	arthritic	_	JJ	JJ	_	18	amod	_	_
18	rats	_	NNS	NNS	_	16	pobj	_	_
19	were	_	VBD	VBD	_	20	auxpass	_	_
20	paralleled	_	VBN	VBN	_	0	root	_	_
21	by	_	IN	IN	_	20	prep	_	_
22	similar	_	JJ	JJ	_	24	amod	_	_
23	inverse	_	NN	NN	_	24	nn	_	_
24	changes	_	NNS	NNS	_	21	pobj	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	NF-IL6beta	_	NN	NN	_	27	nn	_	_
27	expression	_	NN	NN	_	25	pobj	_	_
28	in	_	IN	IN	_	27	prep	_	_
29	these	_	DT	DT	_	30	det	_	_
30	organs	_	NNS	NNS	_	28	pobj	_	_
31	.	_	.	.	_	20	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	show	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	14	mark	_	_
5	some	_	DT	DT	_	7	det	_	_
6	transcription	_	NN	NN	_	7	nn	_	_
7	factors	_	NNS	NNS	_	14	nsubj	_	_
8	associated	_	VBN	VBN	_	7	vmod	_	_
9	with	_	IN	IN	_	8	prep	_	_
10	cytokine	_	NN	NN	_	11	nn	_	_
11	signalling	_	NN	NN	_	9	pobj	_	_
12	can	_	MD	MD	_	14	aux	_	_
13	also	_	RB	RB	_	14	advmod	_	_
14	activate	_	VB	VB	_	3	ccomp	_	_
15	the	_	DT	DT	_	17	det	_	_
16	CRH	_	NN	NN	_	17	nn	_	_
17	promoter	_	NN	NN	_	14	dobj	_	_
18	.	_	.	.	_	3	punct	_	_

1	A	_	DT	DT	_	3	det	_	_
2	novel	_	JJ	JJ	_	3	amod	_	_
3	form	_	NN	NN	_	0	root	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	9	det	_	_
6	myeloid-specific	_	JJ	JJ	_	9	amod	_	_
7	zinc	_	NN	NN	_	9	nn	_	_
8	finger	_	NN	NN	_	9	nn	_	_
9	protein	_	NN	NN	_	4	pobj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	MZF-2	_	NN	NN	_	3	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	.	_	.	.	_	3	punct	_	_

1	BACKGROUND	_	NN	NN	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	Myeloid	_	JJ	JJ	_	5	amod	_	_
4	cell	_	NN	NN	_	5	nn	_	_
5	development	_	NN	NN	_	7	nsubjpass	_	_
6	is	_	VBZ	VBZ	_	7	auxpass	_	_
7	controlled	_	VBN	VBN	_	1	dep	_	_
8	by	_	IN	IN	_	7	prep	_	_
9	tissue-specific	_	JJ	JJ	_	11	amod	_	_
10	transcription	_	NN	NN	_	11	nn	_	_
11	factors	_	NNS	NNS	_	8	pobj	_	_
12	.	_	.	.	_	7	punct	_	_

1	Human	_	JJ	JJ	_	5	amod	_	_
2	myeloid	_	JJ	JJ	_	5	amod	_	_
3	zinc	_	NN	NN	_	5	nn	_	_
4	finger	_	NN	NN	_	5	nn	_	_
5	protein	_	NN	NN	_	13	nsubj	_	_
6	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
7	MZF-1	_	NN	NN	_	5	appos	_	_
8	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
9	is	_	VBZ	VBZ	_	13	cop	_	_
10	a	_	DT	DT	_	13	det	_	_
11	putative	_	JJ	JJ	_	13	amod	_	_
12	transcription	_	NN	NN	_	13	nn	_	_
13	factor	_	NN	NN	_	0	root	_	_
14	containing	_	VBG	VBG	_	13	vmod	_	_
15	13	_	CD	CD	_	17	num	_	_
16	zinc	_	NN	NN	_	17	nn	_	_
17	fingers	_	NNS	NNS	_	14	dobj	_	_
18	,	_	,	,	_	13	punct	_	_
19	and	_	CC	CC	_	13	cc	_	_
20	has	_	VBZ	VBZ	_	22	aux	_	_
21	been	_	VBN	VBN	_	22	auxpass	_	_
22	suggested	_	VBN	VBN	_	13	conj	_	_
23	that	_	IN	IN	_	25	mark	_	_
24	it	_	PRP	PRP	_	25	nsubj	_	_
25	regulates	_	VBZ	VBZ	_	22	ccomp	_	_
26	the	_	DT	DT	_	27	det	_	_
27	development	_	NN	NN	_	25	dobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	neutrophilic	_	JJ	JJ	_	30	amod	_	_
30	granulocytes	_	NNS	NNS	_	28	pobj	_	_
31	.	_	.	.	_	13	punct	_	_

1	RESULTS	_	NNS	NNS	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	Here	_	RB	RB	_	7	advmod	_	_
4	,	_	,	,	_	7	punct	_	_
5	we	_	PRP	PRP	_	7	nsubj	_	_
6	have	_	VBP	VBP	_	7	aux	_	_
7	isolated	_	VBN	VBN	_	1	dep	_	_
8	the	_	DT	DT	_	9	dep	_	_
9	murine	_	JJ	JJ	_	7	dobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	human	_	JJ	JJ	_	9	conj	_	_
12	cDNAs	_	NNS	NNS	_	9	dep	_	_
13	which	_	WDT	WDT	_	14	nsubj	_	_
14	encode	_	VBP	VBP	_	9	rcmod	_	_
15	a	_	DT	DT	_	17	det	_	_
16	novel	_	JJ	JJ	_	17	amod	_	_
17	form	_	NN	NN	_	14	dobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	MZF	_	NN	NN	_	20	nn	_	_
20	protein	_	NN	NN	_	18	pobj	_	_
21	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
22	MZF-2	_	NN	NN	_	17	appos	_	_
23	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
24	.	_	.	.	_	1	punct	_	_

1	Murine	_	JJ	JJ	_	6	nsubj	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	human	_	JJ	JJ	_	1	conj	_	_
4	MZF-2	_	NN	NN	_	5	nn	_	_
5	proteins	_	NNS	NNS	_	1	dep	_	_
6	consisted	_	VBD	VBD	_	0	root	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	814	_	CD	CD	_	7	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	775	_	CD	CD	_	8	conj	_	_
11	amino	_	NN	NN	_	12	nn	_	_
12	acids	_	NNS	NNS	_	8	dep	_	_
13	,	_	,	,	_	6	punct	_	_
14	respectively	_	RB	RB	_	6	advmod	_	_
15	,	_	,	,	_	6	punct	_	_
16	and	_	CC	CC	_	6	cc	_	_
17	have	_	VBP	VBP	_	6	conj	_	_
18	identity	_	NN	NN	_	17	dobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	75.3	_	CD	CD	_	21	num	_	_
21	%	_	NN	NN	_	19	pobj	_	_
22	between	_	IN	IN	_	17	prep	_	_
23	them	_	PRP	PRP	_	22	pobj	_	_
24	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	C-terminal	_	JJ	JJ	_	3	amod	_	_
3	half	_	NN	NN	_	16	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	human	_	JJ	JJ	_	6	amod	_	_
6	MZF-2	_	NN	NN	_	4	pobj	_	_
7	,	_	,	,	_	3	punct	_	_
8	carrying	_	VBG	VBG	_	3	vmod	_	_
9	the	_	DT	DT	_	12	det	_	_
10	zinc	_	NN	NN	_	12	nn	_	_
11	finger	_	NN	NN	_	12	nn	_	_
12	domains	_	NNS	NNS	_	8	dobj	_	_
13	,	_	,	,	_	3	punct	_	_
14	was	_	VBD	VBD	_	16	cop	_	_
15	completely	_	RB	RB	_	16	advmod	_	_
16	identical	_	JJ	JJ	_	0	root	_	_
17	with	_	IN	IN	_	16	prep	_	_
18	that	_	DT	DT	_	17	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	human	_	JJ	JJ	_	21	amod	_	_
21	MZF-1	_	NN	NN	_	19	pobj	_	_
22	,	_	,	,	_	16	punct	_	_
23	whereas	_	IN	IN	_	30	mark	_	_
24	the	_	DT	DT	_	26	det	_	_
25	N-terminal	_	JJ	JJ	_	26	amod	_	_
26	half	_	NN	NN	_	30	nsubj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	MZF-2	_	NN	NN	_	27	pobj	_	_
29	was	_	VBD	VBD	_	30	cop	_	_
30	different	_	JJ	JJ	_	16	advcl	_	_
31	from	_	IN	IN	_	30	prep	_	_
32	the	_	DT	DT	_	34	det	_	_
33	corresponding	_	JJ	JJ	_	34	amod	_	_
34	region	_	NN	NN	_	31	pobj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	human	_	JJ	JJ	_	37	amod	_	_
37	MZF-1	_	NN	NN	_	35	pobj	_	_
38	,	_	,	,	_	30	punct	_	_
39	and	_	CC	CC	_	30	cc	_	_
40	was	_	VBD	VBD	_	41	auxpass	_	_
41	coded	_	VBN	VBN	_	30	conj	_	_
42	by	_	IN	IN	_	41	prep	_	_
43	distinct	_	JJ	JJ	_	44	amod	_	_
44	exons	_	NNS	NNS	_	42	pobj	_	_
45	.	_	.	.	_	16	punct	_	_

1	MZF-2	_	NN	NN	_	2	nn	_	_
2	mRNA	_	NN	NN	_	4	nsubjpass	_	_
3	was	_	VBD	VBD	_	4	auxpass	_	_
4	expressed	_	VBN	VBN	_	0	root	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	myeloid	_	JJ	JJ	_	7	amod	_	_
7	cells	_	NNS	NNS	_	5	pobj	_	_
8	,	_	,	,	_	5	punct	_	_
9	particularly	_	RB	RB	_	10	advmod	_	_
10	in	_	IN	IN	_	5	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	cells	_	NNS	NNS	_	10	pobj	_	_
13	committed	_	VBN	VBN	_	12	vmod	_	_
14	to	_	TO	TO	_	13	prep	_	_
15	the	_	DT	DT	_	17	det	_	_
16	neutrophilic	_	JJ	JJ	_	17	amod	_	_
17	lineage	_	NN	NN	_	14	pobj	_	_
18	,	_	,	,	_	4	punct	_	_
19	and	_	CC	CC	_	4	cc	_	_
20	down-regulated	_	VBN	VBN	_	4	conj	_	_
21	by	_	IN	IN	_	20	prep	_	_
22	G-CSF	_	NN	NN	_	21	pobj	_	_
23	.	_	.	.	_	4	punct	_	_

1	CONCLUSIONS	_	NNS	NNS	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	MZF-1	_	NN	NN	_	7	nsubj	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	MZF-2	_	NN	NN	_	3	conj	_	_
6	mRNAs	_	NNS	NNS	_	3	dep	_	_
7	seem	_	VBP	VBP	_	1	dep	_	_
8	to	_	TO	TO	_	10	aux	_	_
9	be	_	VB	VB	_	10	auxpass	_	_
10	produced	_	VBN	VBN	_	7	xcomp	_	_
11	by	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	alternative	_	JJ	JJ	_	14	amod	_	_
14	use	_	NN	NN	_	11	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	two	_	CD	CD	_	20	num	_	_
17	different	_	JJ	JJ	_	20	amod	_	_
18	transcription	_	NN	NN	_	20	nn	_	_
19	initiation	_	NN	NN	_	20	nn	_	_
20	sites	_	NNS	NNS	_	15	pobj	_	_
21	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	distinct	_	JJ	JJ	_	4	amod	_	_
3	N-terminal	_	JJ	JJ	_	4	amod	_	_
4	half	_	NN	NN	_	7	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	MZF-2	_	NN	NN	_	5	pobj	_	_
7	carries	_	VBZ	VBZ	_	0	root	_	_
8	two	_	CD	CD	_	10	num	_	_
9	characteristic	_	JJ	JJ	_	10	amod	_	_
10	domains	_	NNS	NNS	_	7	dobj	_	_
11	,	_	,	,	_	10	punct	_	_
12	a	_	DT	DT	_	14	det	_	_
13	leucine-rich	_	JJ	JJ	_	14	amod	_	_
14	domain	_	NN	NN	_	10	appos	_	_
15	called	_	VBN	VBN	_	14	vmod	_	_
16	LeR	_	NN	NN	_	15	dep	_	_
17	and	_	CC	CC	_	14	cc	_	_
18	an	_	DT	DT	_	20	det	_	_
19	acidic	_	JJ	JJ	_	20	amod	_	_
20	domain	_	NN	NN	_	14	conj	_	_
21	,	_	,	,	_	7	punct	_	_
22	which	_	WDT	WDT	_	23	nsubj	_	_
23	suggests	_	VBZ	VBZ	_	7	dep	_	_
24	a	_	DT	DT	_	26	det	_	_
25	unique	_	JJ	JJ	_	26	amod	_	_
26	function	_	NN	NN	_	23	dobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	MZF-2	_	NN	NN	_	27	pobj	_	_
29	in	_	IN	IN	_	26	prep	_	_
30	neutrophil	_	NN	NN	_	31	nn	_	_
31	development	_	NN	NN	_	29	pobj	_	_
32	.	_	.	.	_	7	punct	_	_

1	c-Rel	_	NN	NN	_	5	nsubj	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	p65	_	NN	NN	_	1	conj	_	_
4	subunits	_	NNS	NNS	_	1	dep	_	_
5	bind	_	VBP	VBP	_	0	root	_	_
6	to	_	TO	TO	_	5	prep	_	_
7	an	_	DT	DT	_	10	det	_	_
8	upstream	_	JJ	JJ	_	10	amod	_	_
9	NF-kappaB	_	NN	NN	_	10	nn	_	_
10	site	_	NN	NN	_	6	pobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	human	_	JJ	JJ	_	17	amod	_	_
13	granulocyte	_	NN	NN	_	17	nn	_	_
14	macrophage-colony	_	NN	NN	_	17	nn	_	_
15	stimulating	_	NN	NN	_	17	nn	_	_
16	factor	_	NN	NN	_	17	nn	_	_
17	promoter	_	NN	NN	_	11	pobj	_	_
18	involved	_	VBN	VBN	_	17	vmod	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	phorbol	_	NN	NN	_	22	nn	_	_
21	ester	_	NN	NN	_	22	nn	_	_
22	response	_	NN	NN	_	19	pobj	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	5637	_	CD	CD	_	25	num	_	_
25	cells	_	NNS	NNS	_	23	pobj	_	_
26	.	_	.	.	_	5	punct	_	_

1	To	_	TO	TO	_	3	aux	_	_
2	further	_	RB	RB	_	3	advmod	_	_
3	clarify	_	VB	VB	_	0	root	_	_
4	the	_	DT	DT	_	7	det	_	_
5	complex	_	JJ	JJ	_	7	amod	_	_
6	transcriptional	_	JJ	JJ	_	7	amod	_	_
7	regulation	_	NN	NN	_	3	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	12	det	_	_
10	human	_	JJ	JJ	_	12	amod	_	_
11	GM-CSF	_	NN	NN	_	12	nn	_	_
12	gene	_	NN	NN	_	8	pobj	_	_
13	,	_	,	,	_	7	punct	_	_
14	which	_	WDT	WDT	_	17	nsubjpass	_	_
15	was	_	VBD	VBD	_	17	auxpass	_	_
16	extensively	_	RB	RB	_	17	advmod	_	_
17	investigated	_	VBN	VBN	_	7	rcmod	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	activated	_	VBN	VBN	_	21	amod	_	_
20	T	_	NN	NN	_	21	nn	_	_
21	cells	_	NNS	NNS	_	18	pobj	_	_
22	,	_	,	,	_	3	punct	_	_
23	we	_	PRP	PRP	_	25	nsubj	_	_
24	have	_	VBP	VBP	_	25	aux	_	_
25	studied	_	VBN	VBN	_	3	parataxis	_	_
26	the	_	DT	DT	_	27	det	_	_
27	role	_	NN	NN	_	25	dobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	an	_	DT	DT	_	33	det	_	_
30	upstream	_	JJ	JJ	_	33	amod	_	_
31	NF-kappaB	_	NN	NN	_	33	nn	_	_
32	like	_	JJ	JJ	_	33	amod	_	_
33	site	_	NN	NN	_	28	pobj	_	_
34	in	_	IN	IN	_	33	prep	_	_
35	the	_	DT	DT	_	39	det	_	_
36	5637	_	CD	CD	_	39	num	_	_
37	non-lymphoid	_	JJ	JJ	_	39	amod	_	_
38	cell	_	NN	NN	_	39	nn	_	_
39	line	_	NN	NN	_	34	pobj	_	_
40	,	_	,	,	_	39	punct	_	_
41	which	_	WDT	WDT	_	42	nsubj	_	_
42	derives	_	VBZ	VBZ	_	39	rcmod	_	_
43	from	_	IN	IN	_	42	prep	_	_
44	a	_	DT	DT	_	46	det	_	_
45	bladder	_	NN	NN	_	46	nn	_	_
46	carcinoma	_	NN	NN	_	43	pobj	_	_
47	and	_	CC	CC	_	42	cc	_	_
48	constitutively	_	RB	RB	_	49	advmod	_	_
49	produces	_	VBZ	VBZ	_	42	conj	_	_
50	GM-CSF	_	NN	NN	_	49	dobj	_	_
51	.	_	.	.	_	3	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	sequence	_	NN	NN	_	9	nsubj	_	_
3	,	_	,	,	_	2	punct	_	_
4	named	_	VBN	VBN	_	2	vmod	_	_
5	the	_	DT	DT	_	7	det	_	_
6	A	_	NN	NN	_	7	nn	_	_
7	element	_	NN	NN	_	4	dep	_	_
8	,	_	,	,	_	2	punct	_	_
9	has	_	VBZ	VBZ	_	0	root	_	_
10	an	_	DT	DT	_	12	det	_	_
11	active	_	JJ	JJ	_	12	amod	_	_
12	role	_	NN	NN	_	9	dobj	_	_
13	on	_	IN	IN	_	9	prep	_	_
14	GM-CSF	_	NN	NN	_	15	nn	_	_
15	transcription	_	NN	NN	_	13	pobj	_	_
16	and	_	CC	CC	_	9	cc	_	_
17	is	_	VBZ	VBZ	_	18	cop	_	_
18	responsive	_	JJ	JJ	_	9	conj	_	_
19	to	_	TO	TO	_	18	prep	_	_
20	the	_	DT	DT	_	23	det	_	_
21	tumor	_	NN	NN	_	23	nn	_	_
22	promoter	_	NN	NN	_	23	nn	_	_
23	PMA	_	NN	NN	_	19	pobj	_	_
24	in	_	IN	IN	_	18	prep	_	_
25	transient	_	JJ	JJ	_	27	amod	_	_
26	transfection	_	NN	NN	_	27	nn	_	_
27	experiments	_	NNS	NNS	_	24	pobj	_	_
28	.	_	.	.	_	9	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	describe	_	VBP	VBP	_	0	root	_	_
3	here	_	RB	RB	_	2	advmod	_	_
4	a	_	DT	DT	_	7	det	_	_
5	heterodimeric	_	JJ	JJ	_	7	amod	_	_
6	binding	_	NN	NN	_	7	nn	_	_
7	complex	_	NN	NN	_	2	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	NF-kappaB	_	NN	NN	_	10	nn	_	_
10	subunits	_	NNS	NNS	_	8	pobj	_	_
11	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
12	c-Rel	_	NN	NN	_	10	dep	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	p65	_	NN	NN	_	12	conj	_	_
15	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
16	which	_	WDT	WDT	_	18	nsubj	_	_
17	is	_	VBZ	VBZ	_	18	cop	_	_
18	identical	_	JJ	JJ	_	2	dep	_	_
19	to	_	TO	TO	_	18	prep	_	_
20	the	_	DT	DT	_	21	det	_	_
21	one	_	CD	CD	_	19	pobj	_	_
22	obtained	_	VBN	VBN	_	21	vmod	_	_
23	using	_	VBG	VBG	_	22	xcomp	_	_
24	the	_	DT	DT	_	26	det	_	_
25	HIV-LTR-kappaB	_	NN	NN	_	26	nn	_	_
26	site	_	NN	NN	_	23	dobj	_	_
27	as	_	IN	IN	_	23	prep	_	_
28	recognition	_	NN	NN	_	29	nn	_	_
29	sequence	_	NN	NN	_	27	pobj	_	_
30	and	_	CC	CC	_	18	cc	_	_
31	different	_	JJ	JJ	_	18	conj	_	_
32	from	_	IN	IN	_	31	prep	_	_
33	the	_	DT	DT	_	34	det	_	_
34	one	_	CD	CD	_	32	pobj	_	_
35	-LRB-	_	-LRB-	-LRB-	_	36	punct	_	_
36	c-Rel	_	NN	NN	_	34	dep	_	_
37	and	_	CC	CC	_	36	cc	_	_
38	p50	_	NN	NN	_	36	conj	_	_
39	-RRB-	_	-RRB-	-RRB-	_	36	punct	_	_
40	observed	_	VBN	VBN	_	34	vmod	_	_
41	with	_	IN	IN	_	40	prep	_	_
42	nuclear	_	JJ	JJ	_	43	amod	_	_
43	extracts	_	NNS	NNS	_	41	pobj	_	_
44	from	_	IN	IN	_	43	prep	_	_
45	Mo	_	NN	NN	_	49	nn	_	_
46	T-lymphoid	_	NN	NN	_	49	nn	_	_
47	HTLV-II	_	NN	NN	_	49	nn	_	_
48	infected	_	JJ	JJ	_	49	amod	_	_
49	cells	_	NNS	NNS	_	44	pobj	_	_
50	.	_	.	.	_	2	punct	_	_

1	Cyclosporin	_	NN	NN	_	2	nn	_	_
2	A	_	NN	NN	_	3	nsubj	_	_
3	inhibits	_	VBZ	VBZ	_	0	root	_	_
4	monocyte	_	NN	NN	_	7	nn	_	_
5	tissue	_	NN	NN	_	6	nn	_	_
6	factor	_	NN	NN	_	7	nn	_	_
7	activation	_	NN	NN	_	3	dobj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	cardiac	_	JJ	JJ	_	11	amod	_	_
10	transplant	_	NN	NN	_	11	nn	_	_
11	recipients	_	NNS	NNS	_	8	pobj	_	_
12	.	_	.	.	_	3	punct	_	_

1	BACKGROUND	_	NN	NN	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	Fibrin	_	NN	NN	_	4	nn	_	_
4	deposition	_	NN	NN	_	9	nsubjpass	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	thrombosis	_	NN	NN	_	4	conj	_	_
7	have	_	VBP	VBP	_	9	aux	_	_
8	been	_	VBN	VBN	_	9	auxpass	_	_
9	implicated	_	VBN	VBN	_	1	dep	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	both	_	CC	CC	_	13	preconj	_	_
12	allograft	_	NN	NN	_	13	nn	_	_
13	rejection	_	NN	NN	_	10	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	vasculopathy	_	NN	NN	_	13	conj	_	_
16	after	_	IN	IN	_	9	prep	_	_
17	cardiac	_	JJ	JJ	_	18	amod	_	_
18	transplantation	_	NN	NN	_	16	pobj	_	_
19	.	_	.	.	_	9	punct	_	_

1	Because	_	IN	IN	_	3	mark	_	_
2	monocytes	_	NNS	NNS	_	3	nsubj	_	_
3	play	_	VBP	VBP	_	26	advcl	_	_
4	a	_	DT	DT	_	6	det	_	_
5	pivotal	_	JJ	JJ	_	6	amod	_	_
6	role	_	NN	NN	_	3	dobj	_	_
7	in	_	IN	IN	_	3	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	pathophysiology	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	intravascular	_	JJ	JJ	_	13	amod	_	_
12	coagulation	_	NN	NN	_	13	nn	_	_
13	activation	_	NN	NN	_	10	pobj	_	_
14	through	_	IN	IN	_	3	prep	_	_
15	their	_	PRP$	PRP$	_	16	poss	_	_
16	ability	_	NN	NN	_	14	pobj	_	_
17	to	_	TO	TO	_	18	aux	_	_
18	synthesize	_	VB	VB	_	16	vmod	_	_
19	tissue	_	NN	NN	_	20	nn	_	_
20	factor	_	NN	NN	_	18	dobj	_	_
21	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
22	TF	_	NN	NN	_	20	appos	_	_
23	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
24	,	_	,	,	_	26	punct	_	_
25	we	_	PRP	PRP	_	26	nsubj	_	_
26	asked	_	VBD	VBD	_	0	root	_	_
27	-LRB-	_	-LRB-	-LRB-	_	28	punct	_	_
28	1	_	LS	LS	_	34	dep	_	_
29	-RRB-	_	-RRB-	-RRB-	_	28	punct	_	_
30	whether	_	IN	IN	_	34	mark	_	_
31	monocyte	_	NN	NN	_	33	nn	_	_
32	TF	_	NN	NN	_	33	nn	_	_
33	activation	_	NN	NN	_	34	nsubj	_	_
34	occurs	_	VBZ	VBZ	_	26	dep	_	_
35	in	_	IN	IN	_	34	prep	_	_
36	cardiac	_	JJ	JJ	_	38	amod	_	_
37	transplant	_	NN	NN	_	38	nn	_	_
38	recipients	_	NNS	NNS	_	35	pobj	_	_
39	and	_	CC	CC	_	34	cc	_	_
40	-LRB-	_	-LRB-	-LRB-	_	41	punct	_	_
41	2	_	LS	LS	_	48	dep	_	_
42	-RRB-	_	-RRB-	-RRB-	_	41	punct	_	_
43	whether	_	IN	IN	_	48	mark	_	_
44	monocyte	_	NN	NN	_	46	nn	_	_
45	TF	_	NN	NN	_	46	nn	_	_
46	expression	_	NN	NN	_	48	nsubjpass	_	_
47	is	_	VBZ	VBZ	_	48	auxpass	_	_
48	affected	_	VBN	VBN	_	34	conj	_	_
49	by	_	IN	IN	_	48	prep	_	_
50	treatment	_	NN	NN	_	49	pobj	_	_
51	with	_	IN	IN	_	50	prep	_	_
52	cyclosporin	_	NN	NN	_	53	nn	_	_
53	A	_	NN	NN	_	51	pobj	_	_
54	-LRB-	_	-LRB-	-LRB-	_	55	punct	_	_
55	CsA	_	NN	NN	_	53	appos	_	_
56	-RRB-	_	-RRB-	-RRB-	_	55	punct	_	_
57	.	_	.	.	_	26	punct	_	_

1	METHODS	_	NNS	NNS	_	0	root	_	_
2	AND	_	CC	CC	_	1	cc	_	_
3	RESULTS	_	NNS	NNS	_	1	conj	_	_
4	:	_	:	:	_	1	punct	_	_
5	We	_	PRP	PRP	_	6	nsubj	_	_
6	measured	_	VBD	VBD	_	1	dep	_	_
7	levels	_	NNS	NNS	_	6	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	TF	_	NN	NN	_	10	nn	_	_
10	activity	_	NN	NN	_	8	pobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	peripheral	_	JJ	JJ	_	15	amod	_	_
13	blood	_	NN	NN	_	15	nn	_	_
14	mononuclear	_	JJ	JJ	_	15	amod	_	_
15	cells	_	NNS	NNS	_	11	pobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	highly	_	RB	RB	_	19	advmod	_	_
18	purified	_	VBN	VBN	_	19	amod	_	_
19	monocytes/macrophages	_	NNS	NNS	_	15	conj	_	_
20	from	_	IN	IN	_	15	prep	_	_
21	10	_	CD	CD	_	25	num	_	_
22	consecutive	_	JJ	JJ	_	25	amod	_	_
23	cardiac	_	JJ	JJ	_	25	amod	_	_
24	transplant	_	NN	NN	_	25	nn	_	_
25	recipients	_	NNS	NNS	_	20	pobj	_	_
26	and	_	CC	CC	_	25	cc	_	_
27	10	_	CD	CD	_	30	num	_	_
28	healthy	_	JJ	JJ	_	30	amod	_	_
29	control	_	JJ	JJ	_	30	amod	_	_
30	subjects	_	NNS	NNS	_	25	conj	_	_
31	.	_	.	.	_	1	punct	_	_

1	TF	_	NN	NN	_	2	nn	_	_
2	activity	_	NN	NN	_	12	nsubj	_	_
3	generated	_	VBN	VBN	_	2	vmod	_	_
4	by	_	IN	IN	_	3	prep	_	_
5	both	_	CC	CC	_	6	preconj	_	_
6	unstimulated	_	JJ	JJ	_	4	pobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	endotoxin-stimulated	_	JJ	JJ	_	9	amod	_	_
9	cells	_	NNS	NNS	_	6	conj	_	_
10	was	_	VBD	VBD	_	12	cop	_	_
11	significantly	_	RB	RB	_	12	advmod	_	_
12	higher	_	JJR	JJR	_	0	root	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	transplant	_	NN	NN	_	15	nn	_	_
15	recipients	_	NNS	NNS	_	13	pobj	_	_
16	than	_	IN	IN	_	12	prep	_	_
17	in	_	IN	IN	_	16	pcomp	_	_
18	control	_	JJ	JJ	_	19	amod	_	_
19	subjects	_	NNS	NNS	_	17	pobj	_	_
20	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
21	P	_	NN	NN	_	19	dep	_	_
22	&lt;	_	JJR	JJR	_	21	amod	_	_
23	.05	_	CD	CD	_	22	dep	_	_
24	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
25	.	_	.	.	_	12	punct	_	_

1	Increased	_	VBN	VBN	_	4	amod	_	_
2	monocyte	_	NN	NN	_	4	nn	_	_
3	TF	_	NN	NN	_	4	nn	_	_
4	expression	_	NN	NN	_	9	nsubjpass	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	transplant	_	NN	NN	_	7	nn	_	_
7	recipients	_	NNS	NNS	_	5	pobj	_	_
8	was	_	VBD	VBD	_	9	auxpass	_	_
9	shown	_	VBN	VBN	_	0	root	_	_
10	to	_	TO	TO	_	13	aux	_	_
11	be	_	VB	VB	_	13	auxpass	_	_
12	adversely	_	RB	RB	_	13	advmod	_	_
13	affected	_	VBN	VBN	_	9	xcomp	_	_
14	by	_	IN	IN	_	13	prep	_	_
15	treatment	_	NN	NN	_	14	pobj	_	_
16	with	_	IN	IN	_	15	prep	_	_
17	CsA	_	NN	NN	_	16	pobj	_	_
18	:	_	:	:	_	9	punct	_	_
19	TF	_	NN	NN	_	20	nn	_	_
20	induction	_	NN	NN	_	23	nsubjpass	_	_
21	was	_	VBD	VBD	_	23	auxpass	_	_
22	markedly	_	RB	RB	_	23	advmod	_	_
23	reduced	_	VBN	VBN	_	9	parataxis	_	_
24	by	_	IN	IN	_	23	prep	_	_
25	CsA	_	NN	NN	_	27	nn	_	_
26	serum	_	NN	NN	_	27	nn	_	_
27	concentrations	_	NNS	NNS	_	24	pobj	_	_
28	reaching	_	VBG	VBG	_	27	vmod	_	_
29	peak	_	JJ	JJ	_	32	amod	_	_
30	CsA	_	NN	NN	_	32	nn	_	_
31	drug	_	NN	NN	_	32	nn	_	_
32	levels	_	NNS	NNS	_	28	dobj	_	_
33	.	_	.	.	_	9	punct	_	_

1	Inhibition	_	NN	NN	_	15	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	TF	_	NN	NN	_	4	nn	_	_
4	induction	_	NN	NN	_	2	pobj	_	_
5	in	_	IN	IN	_	1	prep	_	_
6	the	_	DT	DT	_	7	det	_	_
7	presence	_	NN	NN	_	5	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	high	_	JJ	JJ	_	12	amod	_	_
10	CsA	_	NN	NN	_	12	nn	_	_
11	blood	_	NN	NN	_	12	nn	_	_
12	concentrations	_	NNS	NNS	_	8	pobj	_	_
13	was	_	VBD	VBD	_	15	auxpass	_	_
14	also	_	RB	RB	_	15	advmod	_	_
15	observed	_	VBN	VBN	_	0	root	_	_
16	when	_	WRB	WRB	_	21	advmod	_	_
17	stimulation	_	NN	NN	_	21	nsubjpass	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	cells	_	NNS	NNS	_	18	pobj	_	_
20	was	_	VBD	VBD	_	21	auxpass	_	_
21	performed	_	VBN	VBN	_	15	advcl	_	_
22	with	_	IN	IN	_	21	prep	_	_
23	interferon-gamma	_	NN	NN	_	22	pobj	_	_
24	or	_	CC	CC	_	23	cc	_	_
25	interleukin-1beta	_	NN	NN	_	23	conj	_	_
26	.	_	.	.	_	15	punct	_	_

1	As	_	IN	IN	_	2	mark	_	_
2	shown	_	VBN	VBN	_	19	advcl	_	_
3	by	_	IN	IN	_	2	prep	_	_
4	reverse	_	JJ	JJ	_	7	amod	_	_
5	transcription-polymerase	_	NN	NN	_	7	nn	_	_
6	chain	_	NN	NN	_	7	nn	_	_
7	reaction	_	NN	NN	_	3	pobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	electrophoretic	_	JJ	JJ	_	12	amod	_	_
10	mobility	_	NN	NN	_	12	nn	_	_
11	shift	_	NN	NN	_	12	nn	_	_
12	assay	_	NN	NN	_	7	conj	_	_
13	,	_	,	,	_	2	punct	_	_
14	respectively	_	RB	RB	_	2	advmod	_	_
15	,	_	,	,	_	19	punct	_	_
16	treatment	_	NN	NN	_	19	nsubj	_	_
17	with	_	IN	IN	_	16	prep	_	_
18	CsA	_	NN	NN	_	17	pobj	_	_
19	leads	_	VBZ	VBZ	_	0	root	_	_
20	to	_	TO	TO	_	19	prep	_	_
21	decreased	_	VBN	VBN	_	24	amod	_	_
22	TF	_	NN	NN	_	23	nn	_	_
23	mRNA	_	NN	NN	_	24	nn	_	_
24	expression	_	NN	NN	_	20	pobj	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	reduced	_	VBN	VBN	_	27	amod	_	_
27	activation	_	NN	NN	_	24	conj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	the	_	DT	DT	_	32	det	_	_
30	NF-kappaB	_	NN	NN	_	32	nn	_	_
31	transcription	_	NN	NN	_	32	nn	_	_
32	factor	_	NN	NN	_	28	pobj	_	_
33	,	_	,	,	_	32	punct	_	_
34	which	_	WDT	WDT	_	36	nsubjpass	_	_
35	is	_	VBZ	VBZ	_	36	auxpass	_	_
36	known	_	VBN	VBN	_	32	rcmod	_	_
37	to	_	TO	TO	_	38	aux	_	_
38	contribute	_	VB	VB	_	36	xcomp	_	_
39	to	_	TO	TO	_	38	prep	_	_
40	the	_	DT	DT	_	41	det	_	_
41	induction	_	NN	NN	_	39	pobj	_	_
42	of	_	IN	IN	_	41	prep	_	_
43	the	_	DT	DT	_	45	det	_	_
44	TF	_	NN	NN	_	45	nn	_	_
45	promotor	_	NN	NN	_	42	pobj	_	_
46	in	_	IN	IN	_	41	prep	_	_
47	human	_	JJ	JJ	_	48	amod	_	_
48	monocytes	_	NNS	NNS	_	46	pobj	_	_
49	.	_	.	.	_	19	punct	_	_

1	CONCLUSIONS	_	NNS	NNS	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	This	_	DT	DT	_	4	det	_	_
4	study	_	NN	NN	_	5	nsubj	_	_
5	demonstrates	_	VBZ	VBZ	_	1	dep	_	_
6	that	_	IN	IN	_	20	mark	_	_
7	TF	_	NN	NN	_	8	nn	_	_
8	activation	_	NN	NN	_	20	nsubjpass	_	_
9	,	_	,	,	_	8	punct	_	_
10	occurring	_	VBG	VBG	_	8	vmod	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	mononuclear	_	JJ	JJ	_	13	amod	_	_
13	cells	_	NNS	NNS	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	cardiac	_	JJ	JJ	_	17	amod	_	_
16	transplant	_	NN	NN	_	17	nn	_	_
17	recipients	_	NNS	NNS	_	14	pobj	_	_
18	,	_	,	,	_	8	punct	_	_
19	is	_	VBZ	VBZ	_	20	auxpass	_	_
20	inhibited	_	VBN	VBN	_	5	ccomp	_	_
21	by	_	IN	IN	_	20	prep	_	_
22	treatment	_	NN	NN	_	21	pobj	_	_
23	with	_	IN	IN	_	22	prep	_	_
24	CsA	_	NN	NN	_	23	pobj	_	_
25	.	_	.	.	_	1	punct	_	_

1	Inhibition	_	NN	NN	_	9	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	monocyte	_	NN	NN	_	5	nn	_	_
4	TF	_	NN	NN	_	5	nn	_	_
5	induction	_	NN	NN	_	2	pobj	_	_
6	by	_	IN	IN	_	1	prep	_	_
7	CsA	_	NN	NN	_	6	pobj	_	_
8	may	_	MD	MD	_	9	aux	_	_
9	contribute	_	VB	VB	_	0	root	_	_
10	to	_	TO	TO	_	9	prep	_	_
11	its	_	PRP$	PRP$	_	13	poss	_	_
12	successful	_	JJ	JJ	_	13	amod	_	_
13	use	_	NN	NN	_	10	pobj	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	cardiac	_	JJ	JJ	_	17	amod	_	_
16	transplant	_	NN	NN	_	17	nn	_	_
17	medicine	_	NN	NN	_	14	pobj	_	_
18	and	_	CC	CC	_	9	cc	_	_
19	might	_	MD	MD	_	21	aux	_	_
20	be	_	VB	VB	_	21	cop	_	_
21	useful	_	JJ	JJ	_	9	conj	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	managing	_	VBG	VBG	_	22	pcomp	_	_
24	further	_	JJ	JJ	_	25	amod	_	_
25	settings	_	NNS	NNS	_	23	dobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	vascular	_	JJ	JJ	_	28	amod	_	_
28	pathology	_	NN	NN	_	26	pobj	_	_
29	also	_	RB	RB	_	28	advmod	_	_
30	known	_	VBN	VBN	_	28	vmod	_	_
31	to	_	TO	TO	_	32	aux	_	_
32	involve	_	VB	VB	_	30	xcomp	_	_
33	TF	_	NN	NN	_	34	nn	_	_
34	expression	_	NN	NN	_	32	dobj	_	_
35	and	_	CC	CC	_	34	cc	_	_
36	NF-kappaB	_	NN	NN	_	37	nn	_	_
37	activation	_	NN	NN	_	34	conj	_	_
38	.	_	.	.	_	9	punct	_	_

1	Agonistic	_	JJ	JJ	_	2	amod	_	_
2	activity	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	a	_	DT	DT	_	7	det	_	_
5	CD40-specific	_	JJ	JJ	_	7	amod	_	_
6	single-chain	_	JJ	JJ	_	7	amod	_	_
7	Fv	_	NN	NN	_	3	pobj	_	_
8	constructed	_	VBN	VBN	_	7	vmod	_	_
9	from	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	variable	_	JJ	JJ	_	12	amod	_	_
12	regions	_	NNS	NNS	_	9	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	mAb	_	NN	NN	_	15	nn	_	_
15	G28-5	_	NN	NN	_	13	pobj	_	_
16	.	_	.	.	_	2	punct	_	_

1	A	_	DT	DT	_	3	det	_	_
2	single-chain	_	JJ	JJ	_	3	amod	_	_
3	Fv	_	NN	NN	_	8	nsubjpass	_	_
4	-LRB-	_	-LRB-	-LRB-	_	5	punct	_	_
5	sFv	_	NN	NN	_	3	appos	_	_
6	-RRB-	_	-RRB-	-RRB-	_	5	punct	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	expressed	_	VBN	VBN	_	0	root	_	_
9	from	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	variable	_	JJ	JJ	_	12	amod	_	_
12	regions	_	NNS	NNS	_	9	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	17	det	_	_
15	CD40-specific	_	JJ	JJ	_	17	amod	_	_
16	mAb	_	NN	NN	_	17	nn	_	_
17	G28-5	_	NN	NN	_	13	pobj	_	_
18	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	molecule	_	NN	NN	_	3	nsubj	_	_
3	bound	_	VBD	VBD	_	0	root	_	_
4	CD40	_	NN	NN	_	3	dobj	_	_
5	with	_	IN	IN	_	3	prep	_	_
6	a	_	DT	DT	_	8	det	_	_
7	high	_	JJ	JJ	_	8	amod	_	_
8	affinity	_	NN	NN	_	5	pobj	_	_
9	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
10	2.2	_	CD	CD	_	11	num	_	_
11	nM	_	NN	NN	_	8	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	and	_	CC	CC	_	3	cc	_	_
14	was	_	VBD	VBD	_	16	cop	_	_
15	a	_	DT	DT	_	16	det	_	_
16	monomer	_	NN	NN	_	3	conj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	solution	_	NN	NN	_	17	pobj	_	_
19	.	_	.	.	_	3	punct	_	_

1	Surprisingly	_	RB	RB	_	9	advmod	_	_
2	,	_	,	,	_	9	punct	_	_
3	G28-5	_	NN	NN	_	4	nn	_	_
4	sFv	_	NN	NN	_	9	nsubj	_	_
5	was	_	VBD	VBD	_	9	cop	_	_
6	a	_	DT	DT	_	9	det	_	_
7	potent	_	JJ	JJ	_	9	amod	_	_
8	CD40	_	NN	NN	_	9	nn	_	_
9	agonist	_	NN	NN	_	0	root	_	_
10	that	_	WDT	WDT	_	12	nsubj	_	_
11	rapidly	_	RB	RB	_	12	advmod	_	_
12	crosslinked	_	VBD	VBD	_	9	rcmod	_	_
13	CD40	_	NN	NN	_	12	dobj	_	_
14	on	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	17	det	_	_
16	cell	_	NN	NN	_	17	nn	_	_
17	surface	_	NN	NN	_	14	pobj	_	_
18	but	_	CC	CC	_	12	cc	_	_
19	did	_	VBD	VBD	_	21	aux	_	_
20	not	_	RB	RB	_	21	neg	_	_
21	crosslink	_	VB	VB	_	12	conj	_	_
22	CD40-Ig	_	NN	NN	_	21	dobj	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	solution	_	NN	NN	_	23	pobj	_	_
25	.	_	.	.	_	9	punct	_	_

1	G28-5	_	NN	NN	_	2	nn	_	_
2	sFv	_	NN	NN	_	7	nsubj	_	_
3	was	_	VBD	VBD	_	7	cop	_	_
4	a	_	DT	DT	_	7	det	_	_
5	more	_	RBR	RBR	_	6	advmod	_	_
6	potent	_	JJ	JJ	_	7	amod	_	_
7	agonist	_	NN	NN	_	0	root	_	_
8	than	_	IN	IN	_	7	prep	_	_
9	G28-5	_	NN	NN	_	10	nn	_	_
10	IgG	_	NN	NN	_	8	pobj	_	_
11	and	_	CC	CC	_	7	cc	_	_
12	was	_	VBD	VBD	_	13	cop	_	_
13	able	_	JJ	JJ	_	7	conj	_	_
14	to	_	TO	TO	_	15	aux	_	_
15	stimulate	_	VB	VB	_	13	xcomp	_	_
16	CD40	_	NN	NN	_	17	nn	_	_
17	responses	_	NNS	NNS	_	15	dobj	_	_
18	by	_	IN	IN	_	17	prep	_	_
19	B	_	NN	NN	_	20	nn	_	_
20	cells	_	NNS	NNS	_	18	pobj	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	monocytes	_	NNS	NNS	_	20	conj	_	_
23	.	_	.	.	_	7	punct	_	_

1	G28-5	_	NN	NN	_	2	nn	_	_
2	IgG	_	NN	NN	_	4	nsubj	_	_
3	partially	_	RB	RB	_	4	advmod	_	_
4	blocked	_	VBD	VBD	_	0	root	_	_
5	,	_	,	,	_	4	punct	_	_
6	whereas	_	IN	IN	_	9	mark	_	_
7	G28-5	_	NN	NN	_	8	nn	_	_
8	sFv	_	NN	NN	_	9	nsubj	_	_
9	augmented	_	VBD	VBD	_	4	advcl	_	_
10	CD40	_	NN	NN	_	11	nn	_	_
11	responses	_	NNS	NNS	_	9	dobj	_	_
12	during	_	IN	IN	_	9	prep	_	_
13	stimulation	_	NN	NN	_	12	pobj	_	_
14	with	_	IN	IN	_	13	prep	_	_
15	natural	_	JJ	JJ	_	16	amod	_	_
16	ligand	_	NN	NN	_	14	pobj	_	_
17	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
18	gp39-CD8	_	JJ	JJ	_	20	amod	_	_
19	fusion	_	NN	NN	_	20	nn	_	_
20	protein	_	NN	NN	_	16	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	.	_	.	.	_	4	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	19	mark	_	_
5	the	_	DT	DT	_	7	det	_	_
6	functional	_	JJ	JJ	_	7	amod	_	_
7	activity	_	NN	NN	_	19	nsubj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	ligands	_	NNS	NNS	_	8	pobj	_	_
10	built	_	VBN	VBN	_	9	vmod	_	_
11	from	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	binding	_	VBG	VBG	_	14	amod	_	_
14	site	_	NN	NN	_	11	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	G28-5	_	NN	NN	_	15	pobj	_	_
17	is	_	VBZ	VBZ	_	19	cop	_	_
18	highly	_	RB	RB	_	19	advmod	_	_
19	dependent	_	JJ	JJ	_	3	ccomp	_	_
20	upon	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	22	dep	_	_
22	size	_	NN	NN	_	20	pobj	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	physical	_	JJ	JJ	_	25	amod	_	_
25	properties	_	NNS	NNS	_	22	conj	_	_
26	of	_	IN	IN	_	22	prep	_	_
27	the	_	DT	DT	_	28	det	_	_
28	molecule	_	NN	NN	_	26	pobj	_	_
29	both	_	CC	CC	_	30	preconj	_	_
30	in	_	IN	IN	_	19	prep	_	_
31	solution	_	NN	NN	_	30	pobj	_	_
32	and	_	CC	CC	_	30	cc	_	_
33	on	_	IN	IN	_	30	conj	_	_
34	the	_	DT	DT	_	36	det	_	_
35	cell	_	NN	NN	_	36	nn	_	_
36	surfaces	_	NNS	NNS	_	33	pobj	_	_
37	.	_	.	.	_	3	punct	_	_

1	Competent	_	JJ	JJ	_	3	amod	_	_
2	transcription	_	NN	NN	_	3	nn	_	_
3	initiation	_	NN	NN	_	0	root	_	_
4	by	_	IN	IN	_	3	prep	_	_
5	RNA	_	NN	NN	_	6	nn	_	_
6	polymerase	_	NN	NN	_	4	pobj	_	_
7	II	_	CD	CD	_	6	num	_	_
8	in	_	IN	IN	_	3	prep	_	_
9	cell-free	_	JJ	JJ	_	10	amod	_	_
10	extracts	_	NNS	NNS	_	8	pobj	_	_
11	from	_	IN	IN	_	10	prep	_	_
12	xeroderma	_	NN	NN	_	14	nn	_	_
13	pigmentosum	_	NN	NN	_	14	nn	_	_
14	groups	_	NNS	NNS	_	11	pobj	_	_
15	B	_	NN	NN	_	14	dep	_	_
16	and	_	CC	CC	_	14	cc	_	_
17	D	_	NN	NN	_	14	conj	_	_
18	in	_	IN	IN	_	3	prep	_	_
19	an	_	DT	DT	_	23	det	_	_
20	optimized	_	VBN	VBN	_	23	amod	_	_
21	RNA	_	NN	NN	_	23	nn	_	_
22	transcription	_	NN	NN	_	23	nn	_	_
23	assay	_	NN	NN	_	18	pobj	_	_
24	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	5	det	_	_
2	human	_	JJ	JJ	_	5	amod	_	_
3	autosomal	_	JJ	JJ	_	5	amod	_	_
4	recessive	_	JJ	JJ	_	5	amod	_	_
5	disease	_	NN	NN	_	14	nsubj	_	_
6	,	_	,	,	_	5	punct	_	_
7	xeroderma	_	NN	NN	_	8	nn	_	_
8	pigmentosum	_	NN	NN	_	5	appos	_	_
9	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
10	XP	_	NN	NN	_	8	appos	_	_
11	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
12	,	_	,	,	_	5	punct	_	_
13	can	_	MD	MD	_	14	aux	_	_
14	result	_	VB	VB	_	0	root	_	_
15	from	_	IN	IN	_	14	prep	_	_
16	mutations	_	NNS	NNS	_	15	pobj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	any	_	DT	DT	_	19	det	_	_
19	one	_	CD	CD	_	17	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	seven	_	CD	CD	_	22	num	_	_
22	genes	_	NNS	NNS	_	20	pobj	_	_
23	,	_	,	,	_	22	punct	_	_
24	designated	_	VBN	VBN	_	22	vmod	_	_
25	XPA	_	NN	NN	_	24	dep	_	_
26	through	_	IN	IN	_	25	prep	_	_
27	XPG	_	NN	NN	_	26	pobj	_	_
28	.	_	.	.	_	14	punct	_	_

1	Of	_	IN	IN	_	9	prep	_	_
2	these	_	DT	DT	_	1	pobj	_	_
3	,	_	,	,	_	9	punct	_	_
4	the	_	DT	DT	_	5	dep	_	_
5	XPB	_	NN	NN	_	9	nsubj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	XPD	_	NN	NN	_	5	conj	_	_
8	genes	_	NNS	NNS	_	5	dep	_	_
9	encode	_	VBP	VBP	_	0	root	_	_
10	proteins	_	NNS	NNS	_	9	dobj	_	_
11	that	_	WDT	WDT	_	13	nsubj	_	_
12	are	_	VBP	VBP	_	13	cop	_	_
13	subunits	_	NNS	NNS	_	10	rcmod	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	a	_	DT	DT	_	18	det	_	_
16	general	_	JJ	JJ	_	18	amod	_	_
17	transcription	_	NN	NN	_	18	nn	_	_
18	factor	_	NN	NN	_	14	pobj	_	_
19	,	_	,	,	_	18	punct	_	_
20	TFIIH	_	NN	NN	_	18	appos	_	_
21	,	_	,	,	_	13	punct	_	_
22	involved	_	VBN	VBN	_	13	vmod	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	both	_	CC	CC	_	27	preconj	_	_
25	nucleotide	_	NN	NN	_	27	nn	_	_
26	excision	_	NN	NN	_	27	nn	_	_
27	repair	_	NN	NN	_	23	pobj	_	_
28	-LRB-	_	-LRB-	-LRB-	_	29	punct	_	_
29	NER	_	NN	NN	_	27	appos	_	_
30	-RRB-	_	-RRB-	-RRB-	_	29	punct	_	_
31	and	_	CC	CC	_	27	cc	_	_
32	initiation	_	NN	NN	_	27	conj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	mRNA	_	NN	NN	_	35	nn	_	_
35	transcription	_	NN	NN	_	33	pobj	_	_
36	by	_	IN	IN	_	27	prep	_	_
37	RNA	_	NN	NN	_	38	nn	_	_
38	polymerase	_	NN	NN	_	36	pobj	_	_
39	II	_	CD	CD	_	38	num	_	_
40	.	_	.	.	_	9	punct	_	_

1	In	_	IN	IN	_	11	prep	_	_
2	humans	_	NNS	NNS	_	1	pobj	_	_
3	,	_	,	,	_	11	punct	_	_
4	mutation	_	NN	NN	_	11	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	7	dep	_	_
7	XPB	_	NN	NN	_	5	pobj	_	_
8	or	_	CC	CC	_	7	cc	_	_
9	XPD	_	NN	NN	_	7	conj	_	_
10	gene	_	NN	NN	_	7	dep	_	_
11	impairs	_	VBZ	VBZ	_	0	root	_	_
12	NER	_	NN	NN	_	11	dobj	_	_
13	,	_	,	,	_	11	punct	_	_
14	resulting	_	VBG	VBG	_	11	vmod	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	hyper-sensitivity	_	NN	NN	_	15	pobj	_	_
17	to	_	TO	TO	_	16	prep	_	_
18	sunlight	_	NN	NN	_	17	pobj	_	_
19	and	_	CC	CC	_	16	cc	_	_
20	greatly	_	RB	RB	_	21	advmod	_	_
21	increased	_	VBN	VBN	_	24	amod	_	_
22	skin	_	NN	NN	_	24	nn	_	_
23	tumor	_	NN	NN	_	24	nn	_	_
24	formation	_	NN	NN	_	16	conj	_	_
25	.	_	.	.	_	11	punct	_	_

1	However	_	RB	RB	_	8	advmod	_	_
2	,	_	,	,	_	8	punct	_	_
3	no	_	DT	DT	_	5	neg	_	_
4	transcription	_	NN	NN	_	5	nn	_	_
5	deficiency	_	NN	NN	_	8	nsubjpass	_	_
6	has	_	VBZ	VBZ	_	8	aux	_	_
7	been	_	VBN	VBN	_	8	auxpass	_	_
8	demonstrated	_	VBN	VBN	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	either	_	CC	CC	_	11	preconj	_	_
11	XP-B	_	NN	NN	_	9	pobj	_	_
12	or	_	CC	CC	_	11	cc	_	_
13	XP-D	_	NN	NN	_	11	conj	_	_
14	.	_	.	.	_	8	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	employed	_	VBN	VBN	_	0	root	_	_
4	an	_	DT	DT	_	9	det	_	_
5	optimized	_	VBN	VBN	_	9	amod	_	_
6	cell-free	_	JJ	JJ	_	9	amod	_	_
7	RNA	_	NN	NN	_	9	nn	_	_
8	transcription	_	NN	NN	_	9	nn	_	_
9	assay	_	NN	NN	_	3	dobj	_	_
10	to	_	TO	TO	_	11	aux	_	_
11	analyze	_	VB	VB	_	3	xcomp	_	_
12	transcription	_	NN	NN	_	13	nn	_	_
13	activity	_	NN	NN	_	11	dobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	XP-B	_	NN	NN	_	14	pobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	XP-D	_	NN	NN	_	15	conj	_	_
18	.	_	.	.	_	3	punct	_	_

1	Although	_	IN	IN	_	6	mark	_	_
2	the	_	DT	DT	_	4	det	_	_
3	growth	_	NN	NN	_	4	nn	_	_
4	rate	_	NN	NN	_	6	nsubj	_	_
5	was	_	VBD	VBD	_	6	cop	_	_
6	normal	_	JJ	JJ	_	13	advcl	_	_
7	,	_	,	,	_	13	punct	_	_
8	the	_	DT	DT	_	9	dep	_	_
9	XP-B	_	NN	NN	_	13	nsubj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	XP-D	_	NN	NN	_	9	conj	_	_
12	cells	_	NNS	NNS	_	9	dep	_	_
13	contained	_	VBD	VBD	_	0	root	_	_
14	reduced	_	VBN	VBN	_	15	amod	_	_
15	amounts	_	NNS	NNS	_	13	dobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	TFIIH	_	NN	NN	_	16	pobj	_	_
18	.	_	.	.	_	13	punct	_	_

1	Extracts	_	NNS	NNS	_	9	nsubj	_	_
2	prepared	_	VBN	VBN	_	1	vmod	_	_
3	from	_	IN	IN	_	2	prep	_	_
4	XP-B	_	NN	NN	_	3	pobj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	XP-D	_	NN	NN	_	4	conj	_	_
7	lymphoblastoid	_	JJ	JJ	_	8	amod	_	_
8	cells	_	NNS	NNS	_	4	dep	_	_
9	exhibited	_	VBD	VBD	_	0	root	_	_
10	similar	_	JJ	JJ	_	12	amod	_	_
11	transcription	_	NN	NN	_	12	nn	_	_
12	activity	_	NN	NN	_	9	dobj	_	_
13	from	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	18	det	_	_
15	adenovirus	_	NN	NN	_	18	nn	_	_
16	major	_	JJ	JJ	_	18	amod	_	_
17	late	_	JJ	JJ	_	18	amod	_	_
18	promoter	_	NN	NN	_	13	pobj	_	_
19	when	_	WRB	WRB	_	20	advmod	_	_
20	compared	_	VBN	VBN	_	9	advcl	_	_
21	to	_	TO	TO	_	20	prep	_	_
22	that	_	DT	DT	_	21	pobj	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	extracts	_	NNS	NNS	_	23	pobj	_	_
25	from	_	IN	IN	_	24	prep	_	_
26	normal	_	JJ	JJ	_	27	amod	_	_
27	cells	_	NNS	NNS	_	25	pobj	_	_
28	.	_	.	.	_	9	punct	_	_

1	Thus	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	conclude	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	14	mark	_	_
6	the	_	DT	DT	_	7	dep	_	_
7	XP-B	_	NN	NN	_	14	nsubj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	XP-D	_	NN	NN	_	7	conj	_	_
10	lymphoblastoid	_	JJ	JJ	_	11	amod	_	_
11	cells	_	NNS	NNS	_	7	dep	_	_
12	do	_	VBP	VBP	_	14	aux	_	_
13	not	_	RB	RB	_	14	neg	_	_
14	have	_	VB	VB	_	4	ccomp	_	_
15	impaired	_	JJ	JJ	_	18	amod	_	_
16	RNA	_	NN	NN	_	18	nn	_	_
17	transcription	_	NN	NN	_	18	nn	_	_
18	activity	_	NN	NN	_	14	dobj	_	_
19	.	_	.	.	_	4	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	consider	_	VBP	VBP	_	0	root	_	_
3	the	_	DT	DT	_	5	det	_	_
4	possible	_	JJ	JJ	_	5	amod	_	_
5	consequences	_	NNS	NNS	_	2	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	10	det	_	_
8	reduced	_	VBN	VBN	_	10	amod	_	_
9	cellular	_	JJ	JJ	_	10	amod	_	_
10	content	_	NN	NN	_	6	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	TFIIH	_	NN	NN	_	11	pobj	_	_
13	for	_	IN	IN	_	2	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	clinical	_	JJ	JJ	_	16	amod	_	_
16	symptoms	_	NNS	NNS	_	13	pobj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	XP-B	_	NN	NN	_	17	pobj	_	_
19	or	_	CC	CC	_	18	cc	_	_
20	XP-D	_	NN	NN	_	18	conj	_	_
21	patients	_	NNS	NNS	_	18	dep	_	_
22	,	_	,	,	_	2	punct	_	_
23	and	_	CC	CC	_	2	cc	_	_
24	discuss	_	VBP	VBP	_	2	conj	_	_
25	a	_	DT	DT	_	28	det	_	_
26	'	_	``	``	_	28	punct	_	_
27	conditional	_	JJ	JJ	_	28	amod	_	_
28	phenotype	_	NN	NN	_	24	dobj	_	_
29	'	_	''	''	_	28	punct	_	_
30	that	_	WDT	WDT	_	32	nsubj	_	_
31	may	_	MD	MD	_	32	aux	_	_
32	involve	_	VB	VB	_	28	rcmod	_	_
33	an	_	DT	DT	_	34	det	_	_
34	impairment	_	NN	NN	_	32	dobj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	cellular	_	JJ	JJ	_	37	amod	_	_
37	function	_	NN	NN	_	35	pobj	_	_
38	only	_	RB	RB	_	39	advmod	_	_
39	under	_	IN	IN	_	32	prep	_	_
40	certain	_	JJ	JJ	_	42	amod	_	_
41	growth	_	NN	NN	_	42	nn	_	_
42	conditions	_	NNS	NNS	_	39	pobj	_	_
43	.	_	.	.	_	2	punct	_	_

1	Cyclosporin	_	NN	NN	_	2	nn	_	_
2	A	_	NN	NN	_	3	nsubj	_	_
3	inhibits	_	VBZ	VBZ	_	0	root	_	_
4	early	_	JJ	JJ	_	6	amod	_	_
5	mRNA	_	NN	NN	_	6	nn	_	_
6	expression	_	NN	NN	_	3	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	G0/G1	_	NN	NN	_	10	nn	_	_
9	switch	_	NN	NN	_	10	nn	_	_
10	gene	_	NN	NN	_	7	pobj	_	_
11	2	_	CD	CD	_	10	num	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	G0S2	_	NN	NN	_	10	appos	_	_
14	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
15	in	_	IN	IN	_	6	prep	_	_
16	cultured	_	VBN	VBN	_	20	amod	_	_
17	human	_	JJ	JJ	_	20	amod	_	_
18	blood	_	NN	NN	_	20	nn	_	_
19	mononuclear	_	JJ	JJ	_	20	amod	_	_
20	cells	_	NNS	NNS	_	15	pobj	_	_
21	.	_	.	.	_	3	punct	_	_

1	Cyclosporin	_	NN	NN	_	2	nn	_	_
2	A	_	NN	NN	_	7	nsubj	_	_
3	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
4	CsA	_	NN	NN	_	2	appos	_	_
5	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
6	may	_	MD	MD	_	7	aux	_	_
7	achieve	_	VB	VB	_	0	root	_	_
8	its	_	PRP$	PRP$	_	10	poss	_	_
9	immunosuppressive	_	JJ	JJ	_	10	amod	_	_
10	effects	_	NNS	NNS	_	7	dobj	_	_
11	by	_	IN	IN	_	7	prep	_	_
12	inhibiting	_	VBG	VBG	_	11	pcomp	_	_
13	the	_	DT	DT	_	17	det	_	_
14	calcium-	_	NN	NN	_	17	nn	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	calmodulin-dependent	_	JJ	JJ	_	14	conj	_	_
17	phosphatase	_	NN	NN	_	12	dobj	_	_
18	calcineurin	_	NN	NN	_	17	dep	_	_
19	which	_	WDT	WDT	_	21	nsubjpass	_	_
20	is	_	VBZ	VBZ	_	21	auxpass	_	_
21	required	_	VBN	VBN	_	17	rcmod	_	_
22	for	_	IN	IN	_	21	prep	_	_
23	activation	_	NN	NN	_	22	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	target	_	NN	NN	_	26	nn	_	_
26	genes	_	NNS	NNS	_	24	pobj	_	_
27	by	_	IN	IN	_	23	prep	_	_
28	members	_	NNS	NNS	_	27	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	the	_	DT	DT	_	42	det	_	_
31	NFAT	_	NN	NN	_	42	nn	_	_
32	-LRB-	_	-LRB-	-LRB-	_	42	punct	_	_
33	nuclear	_	JJ	JJ	_	42	amod	_	_
34	factor	_	NN	NN	_	42	nn	_	_
35	of	_	IN	IN	_	42	amod	_	_
36	activated	_	VBN	VBN	_	42	amod	_	_
37	T	_	NN	NN	_	42	nn	_	_
38	cells	_	NNS	NNS	_	42	nn	_	_
39	-RRB-	_	-RRB-	-RRB-	_	42	punct	_	_
40	transcription	_	NN	NN	_	42	nn	_	_
41	factor	_	NN	NN	_	42	nn	_	_
42	family	_	NN	NN	_	29	pobj	_	_
43	.	_	.	.	_	7	punct	_	_

1	Among	_	IN	IN	_	5	prep	_	_
2	these	_	DT	DT	_	4	det	_	_
3	target	_	NN	NN	_	4	nn	_	_
4	genes	_	NNS	NNS	_	1	pobj	_	_
5	is	_	VBZ	VBZ	_	0	root	_	_
6	the	_	DT	DT	_	7	det	_	_
7	gene	_	NN	NN	_	5	dep	_	_
8	encoding	_	VBG	VBG	_	7	vmod	_	_
9	interleukin-2	_	NN	NN	_	8	dobj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	IL2	_	NN	NN	_	9	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	,	_	,	,	_	9	punct	_	_
14	a	_	DT	DT	_	15	det	_	_
15	cytokine	_	NN	NN	_	9	appos	_	_
16	facilitating	_	VBG	VBG	_	15	vmod	_	_
17	progression	_	NN	NN	_	16	dobj	_	_
18	through	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	G1	_	NN	NN	_	21	nn	_	_
21	phase	_	NN	NN	_	18	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	25	det	_	_
24	cell	_	NN	NN	_	25	nn	_	_
25	cycle	_	NN	NN	_	22	pobj	_	_
26	.	_	.	.	_	5	punct	_	_

1	However	_	RB	RB	_	6	advmod	_	_
2	,	_	,	,	_	6	punct	_	_
3	IL2	_	NN	NN	_	6	nsubj	_	_
4	does	_	VBZ	VBZ	_	6	aux	_	_
5	not	_	RB	RB	_	6	neg	_	_
6	reverse	_	VB	VB	_	0	root	_	_
7	CsA	_	NN	NN	_	8	nn	_	_
8	inhibition	_	NN	NN	_	6	dobj	_	_
9	,	_	,	,	_	6	punct	_	_
10	suggesting	_	VBG	VBG	_	6	vmod	_	_
11	that	_	IN	IN	_	20	mark	_	_
12	at	_	IN	IN	_	14	quantmod	_	_
13	least	_	JJS	JJS	_	12	mwe	_	_
14	one	_	CD	CD	_	17	num	_	_
15	other	_	JJ	JJ	_	17	amod	_	_
16	NFAT-sensitive	_	JJ	JJ	_	17	amod	_	_
17	gene	_	NN	NN	_	20	nsubjpass	_	_
18	may	_	MD	MD	_	20	aux	_	_
19	be	_	VB	VB	_	20	auxpass	_	_
20	involved	_	VBN	VBN	_	10	ccomp	_	_
21	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	5	det	_	_
2	human	_	JJ	JJ	_	5	amod	_	_
3	G0/G1	_	NN	NN	_	5	nn	_	_
4	switch	_	NN	NN	_	5	nn	_	_
5	gene	_	NN	NN	_	9	nsubj	_	_
6	,	_	,	,	_	5	punct	_	_
7	G0S2	_	NN	NN	_	5	appos	_	_
8	,	_	,	,	_	5	punct	_	_
9	has	_	VBZ	VBZ	_	0	root	_	_
10	potential	_	JJ	JJ	_	12	amod	_	_
11	NFAT-binding	_	JJ	JJ	_	12	amod	_	_
12	sites	_	NNS	NNS	_	9	dobj	_	_
13	in	_	IN	IN	_	9	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	5'	_	JJ	JJ	_	16	amod	_	_
16	flank	_	NN	NN	_	13	pobj	_	_
17	and	_	CC	CC	_	9	cc	_	_
18	encodes	_	VBZ	VBZ	_	9	conj	_	_
19	a	_	DT	DT	_	23	det	_	_
20	small	_	JJ	JJ	_	23	amod	_	_
21	basic	_	JJ	JJ	_	23	amod	_	_
22	potential	_	JJ	JJ	_	23	amod	_	_
23	phosphoprotein	_	NN	NN	_	18	dobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	unknown	_	JJ	JJ	_	26	amod	_	_
26	function	_	NN	NN	_	24	pobj	_	_
27	.	_	.	.	_	9	punct	_	_

1	Using	_	VBG	VBG	_	0	root	_	_
2	a	_	DT	DT	_	12	det	_	_
3	sensitive	_	JJ	JJ	_	12	amod	_	_
4	,	_	,	,	_	12	punct	_	_
5	reverse	_	JJ	JJ	_	8	amod	_	_
6	transcription-polymerase	_	NN	NN	_	8	nn	_	_
7	chain	_	NN	NN	_	8	nn	_	_
8	reaction	_	NN	NN	_	12	dep	_	_
9	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
10	RT-PCR	_	NN	NN	_	8	appos	_	_
11	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
12	assay	_	NN	NN	_	1	dobj	_	_
13	,	_	,	,	_	1	punct	_	_
14	G0S2	_	NN	NN	_	16	nn	_	_
15	mRNA	_	NN	NN	_	16	nn	_	_
16	levels	_	NNS	NNS	_	18	nsubjpass	_	_
17	were	_	VBD	VBD	_	18	auxpass	_	_
18	assayed	_	VBN	VBN	_	1	parataxis	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	cultured	_	VBN	VBN	_	23	amod	_	_
21	blood	_	NN	NN	_	23	nn	_	_
22	mononuclear	_	JJ	JJ	_	23	amod	_	_
23	cells	_	NNS	NNS	_	19	pobj	_	_
24	.	_	.	.	_	1	punct	_	_

1	Freshly	_	RB	RB	_	2	advmod	_	_
2	isolated	_	VBN	VBN	_	3	amod	_	_
3	cells	_	NNS	NNS	_	4	nsubj	_	_
4	contain	_	VBP	VBP	_	0	root	_	_
5	high	_	JJ	JJ	_	6	amod	_	_
6	levels	_	NNS	NNS	_	4	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	G0S2	_	NN	NN	_	9	nn	_	_
9	mRNA	_	NN	NN	_	7	pobj	_	_
10	which	_	WDT	WDT	_	12	nsubj	_	_
11	rapidly	_	RB	RB	_	12	advmod	_	_
12	decline	_	VBP	VBP	_	6	rcmod	_	_
13	.	_	.	.	_	4	punct	_	_

1	This	_	DT	DT	_	4	det	_	_
2	``	_	``	``	_	4	punct	_	_
3	spontaneous	_	JJ	JJ	_	4	amod	_	_
4	stimulation	_	NN	NN	_	7	nsubjpass	_	_
5	is	_	VBZ	VBZ	_	7	auxpass	_	_
6	also	_	RB	RB	_	7	advmod	_	_
7	noted	_	VBN	VBN	_	0	root	_	_
8	with	_	IN	IN	_	7	prep	_	_
9	some	_	DT	DT	_	12	det	_	_
10	other	_	JJ	JJ	_	12	amod	_	_
11	G0S	_	NN	NN	_	12	nn	_	_
12	genes	_	NNS	NNS	_	8	pobj	_	_
13	and	_	CC	CC	_	7	cc	_	_
14	has	_	VBZ	VBZ	_	16	aux	_	_
15	been	_	VBN	VBN	_	16	auxpass	_	_
16	attributed	_	VBN	VBN	_	7	conj	_	_
17	to	_	TO	TO	_	16	prep	_	_
18	some	_	DT	DT	_	19	det	_	_
19	aspect	_	NN	NN	_	17	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	23	det	_	_
22	isolation	_	NN	NN	_	23	nn	_	_
23	procedure	_	NN	NN	_	20	pobj	_	_
24	.	_	.	.	_	7	punct	_	_

1	In	_	IN	IN	_	13	prep	_	_
2	cells	_	NNS	NNS	_	1	pobj	_	_
3	that	_	WDT	WDT	_	6	nsubjpass	_	_
4	have	_	VBP	VBP	_	6	aux	_	_
5	been	_	VBN	VBN	_	6	auxpass	_	_
6	preincubated	_	VBN	VBN	_	2	rcmod	_	_
7	to	_	TO	TO	_	8	aux	_	_
8	lower	_	VB	VB	_	6	dep	_	_
9	mRNA	_	NN	NN	_	10	nn	_	_
10	levels	_	NNS	NNS	_	8	dobj	_	_
11	,	_	,	,	_	13	punct	_	_
12	there	_	EX	EX	_	13	expl	_	_
13	is	_	VBZ	VBZ	_	0	root	_	_
14	a	_	DT	DT	_	16	det	_	_
15	transient	_	JJ	JJ	_	16	amod	_	_
16	increase	_	NN	NN	_	13	nsubj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	G0S2	_	NN	NN	_	19	nn	_	_
19	mRNA	_	NN	NN	_	17	pobj	_	_
20	,	_	,	,	_	16	punct	_	_
21	peaking	_	VBG	VBG	_	16	vmod	_	_
22	between	_	IN	IN	_	21	prep	_	_
23	1-2	_	CD	CD	_	24	num	_	_
24	h	_	NN	NN	_	22	pobj	_	_
25	,	_	,	,	_	16	punct	_	_
26	in	_	IN	IN	_	16	prep	_	_
27	response	_	NN	NN	_	26	pobj	_	_
28	to	_	TO	TO	_	27	prep	_	_
29	Concanavalin-A	_	NN	NN	_	28	pobj	_	_
30	-LRB-	_	-LRB-	-LRB-	_	31	punct	_	_
31	ConA	_	NN	NN	_	29	appos	_	_
32	-RRB-	_	-RRB-	-RRB-	_	31	punct	_	_
33	,	_	,	,	_	28	punct	_	_
34	or	_	CC	CC	_	28	cc	_	_
35	to	_	TO	TO	_	28	conj	_	_
36	the	_	DT	DT	_	37	det	_	_
37	combination	_	NN	NN	_	35	pobj	_	_
38	of	_	IN	IN	_	37	prep	_	_
39	phorbol	_	NN	NN	_	40	nn	_	_
40	ester	_	NN	NN	_	38	pobj	_	_
41	-LRB-	_	-LRB-	-LRB-	_	42	punct	_	_
42	TPA	_	NN	NN	_	40	appos	_	_
43	-RRB-	_	-RRB-	-RRB-	_	42	punct	_	_
44	,	_	,	,	_	40	punct	_	_
45	and	_	CC	CC	_	40	cc	_	_
46	the	_	DT	DT	_	48	det	_	_
47	calcium	_	NN	NN	_	48	nn	_	_
48	ionophore	_	NN	NN	_	40	conj	_	_
49	,	_	,	,	_	48	punct	_	_
50	ionomycin	_	NN	NN	_	48	appos	_	_
51	.	_	.	.	_	13	punct	_	_

1	Both	_	PDT	PDT	_	3	predet	_	_
2	these	_	DT	DT	_	3	det	_	_
3	responses	_	NNS	NNS	_	5	nsubjpass	_	_
4	are	_	VBP	VBP	_	5	auxpass	_	_
5	inhibited	_	VBN	VBN	_	0	root	_	_
6	by	_	IN	IN	_	5	prep	_	_
7	CsA	_	NN	NN	_	6	pobj	_	_
8	.	_	.	.	_	5	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	8	mark	_	_
5	G0S2	_	NN	NN	_	6	nn	_	_
6	expression	_	NN	NN	_	8	nsubjpass	_	_
7	is	_	VBZ	VBZ	_	8	auxpass	_	_
8	required	_	VBN	VBN	_	3	ccomp	_	_
9	to	_	TO	TO	_	10	aux	_	_
10	commit	_	VB	VB	_	8	xcomp	_	_
11	cells	_	NNS	NNS	_	10	dobj	_	_
12	to	_	TO	TO	_	13	aux	_	_
13	enter	_	VB	VB	_	10	xcomp	_	_
14	the	_	DT	DT	_	16	det	_	_
15	G1	_	NN	NN	_	16	nn	_	_
16	phase	_	NN	NN	_	13	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	cell	_	NN	NN	_	20	nn	_	_
20	cycle	_	NN	NN	_	17	pobj	_	_
21	,	_	,	,	_	8	punct	_	_
22	and	_	CC	CC	_	8	cc	_	_
23	that	_	IN	IN	_	41	mark	_	_
24	,	_	,	,	_	41	punct	_	_
25	while	_	IN	IN	_	27	mark	_	_
26	not	_	RB	RB	_	27	neg	_	_
27	excluding	_	VBG	VBG	_	41	advcl	_	_
28	other	_	DT	DT	_	30	det	_	_
29	possible	_	JJ	JJ	_	30	amod	_	_
30	targets	_	NNS	NNS	_	27	dobj	_	_
31	,	_	,	,	_	41	punct	_	_
32	early	_	JJ	JJ	_	33	amod	_	_
33	inhibition	_	NN	NN	_	41	nsubj	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	G0S2	_	NN	NN	_	36	nn	_	_
36	expression	_	NN	NN	_	34	pobj	_	_
37	by	_	IN	IN	_	33	prep	_	_
38	CsA	_	NN	NN	_	37	pobj	_	_
39	may	_	MD	MD	_	41	aux	_	_
40	be	_	VB	VB	_	41	cop	_	_
41	important	_	JJ	JJ	_	8	conj	_	_
42	in	_	IN	IN	_	41	prep	_	_
43	achieving	_	VBG	VBG	_	42	pcomp	_	_
44	immunosuppression	_	NN	NN	_	43	dobj	_	_
45	.	_	.	.	_	3	punct	_	_

1	G0S2	_	NN	NN	_	3	nsubj	_	_
2	may	_	MD	MD	_	3	aux	_	_
3	be	_	VB	VB	_	0	root	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	value	_	NN	NN	_	4	pobj	_	_
6	as	_	IN	IN	_	3	prep	_	_
7	a	_	DT	DT	_	9	det	_	_
8	reporter	_	NN	NN	_	9	nn	_	_
9	gene	_	NN	NN	_	6	pobj	_	_
10	for	_	IN	IN	_	9	prep	_	_
11	analyzing	_	VBG	VBG	_	10	pcomp	_	_
12	the	_	DT	DT	_	13	det	_	_
13	mechanism	_	NN	NN	_	11	dobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	action	_	NN	NN	_	14	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	CsA	_	NN	NN	_	16	pobj	_	_
18	and	_	CC	CC	_	13	cc	_	_
19	its	_	PRP$	PRP$	_	20	poss	_	_
20	influence	_	NN	NN	_	13	conj	_	_
21	on	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	23	dep	_	_
23	positive	_	JJ	JJ	_	21	pobj	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	negative	_	JJ	JJ	_	23	conj	_	_
26	selection	_	NN	NN	_	23	dep	_	_
27	of	_	IN	IN	_	23	prep	_	_
28	lymphocytes	_	NNS	NNS	_	27	pobj	_	_
29	in	_	IN	IN	_	23	prep	_	_
30	response	_	NN	NN	_	29	pobj	_	_
31	to	_	TO	TO	_	30	prep	_	_
32	self	_	NN	NN	_	31	pobj	_	_
33	and	_	CC	CC	_	32	cc	_	_
34	not-self	_	JJ	JJ	_	32	conj	_	_
35	antigens	_	NNS	NNS	_	32	dep	_	_
36	.	_	.	.	_	3	punct	_	_

1	Estrogen	_	NN	NN	_	2	nn	_	_
2	receptor	_	NN	NN	_	3	nsubj	_	_
3	diminishes	_	VBZ	VBZ	_	0	root	_	_
4	DNA-binding	_	JJ	JJ	_	5	amod	_	_
5	activities	_	NNS	NNS	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	chicken	_	NN	NN	_	8	nn	_	_
8	GATA-1	_	NN	NN	_	6	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	CACCC-binding	_	JJ	JJ	_	11	amod	_	_
11	proteins	_	NNS	NNS	_	8	conj	_	_
12	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	estrogen	_	NN	NN	_	3	nn	_	_
3	receptor	_	NN	NN	_	7	nsubj	_	_
4	-LRB-	_	-LRB-	-LRB-	_	5	punct	_	_
5	ER	_	NN	NN	_	3	appos	_	_
6	-RRB-	_	-RRB-	-RRB-	_	5	punct	_	_
7	repressed	_	VBD	VBD	_	0	root	_	_
8	erythroid	_	JJ	JJ	_	9	amod	_	_
9	differentiation	_	NN	NN	_	7	dobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	erythroid-specific	_	JJ	JJ	_	12	amod	_	_
12	gene	_	NN	NN	_	13	nn	_	_
13	expression	_	NN	NN	_	9	conj	_	_
14	.	_	.	.	_	7	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	study	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	investigated	_	VBD	VBD	_	0	root	_	_
7	the	_	DT	DT	_	8	det	_	_
8	effect	_	NN	NN	_	6	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	ER	_	NN	NN	_	11	nn	_	_
11	alpha	_	NN	NN	_	9	pobj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	referred	_	VBN	VBN	_	11	dep	_	_
14	to	_	TO	TO	_	13	prep	_	_
15	throughout	_	RB	RB	_	13	advmod	_	_
16	as	_	IN	IN	_	13	prep	_	_
17	ER	_	NN	NN	_	16	pobj	_	_
18	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
19	on	_	IN	IN	_	8	prep	_	_
20	DNA-binding	_	JJ	JJ	_	21	amod	_	_
21	activities	_	NNS	NNS	_	19	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	transcription	_	NN	NN	_	24	nn	_	_
24	factors	_	NNS	NNS	_	22	pobj	_	_
25	involved	_	VBN	VBN	_	24	vmod	_	_
26	in	_	IN	IN	_	25	prep	_	_
27	regulating	_	VBG	VBG	_	26	pcomp	_	_
28	the	_	DT	DT	_	29	det	_	_
29	expression	_	NN	NN	_	27	dobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	erythroid-specific	_	JJ	JJ	_	32	amod	_	_
32	genes	_	NNS	NNS	_	30	pobj	_	_
33	,	_	,	,	_	32	punct	_	_
34	and	_	CC	CC	_	32	cc	_	_
35	,	_	,	,	_	32	punct	_	_
36	in	_	IN	IN	_	32	conj	_	_
37	particular	_	JJ	JJ	_	36	pobj	_	_
38	,	_	,	,	_	32	punct	_	_
39	the	_	DT	DT	_	42	det	_	_
40	histone	_	NN	NN	_	42	nn	_	_
41	H5	_	NN	NN	_	42	nn	_	_
42	gene	_	NN	NN	_	32	conj	_	_
43	.	_	.	.	_	6	punct	_	_

1	Using	_	VBG	VBG	_	0	root	_	_
2	electrophoretic	_	JJ	JJ	_	5	amod	_	_
3	mobility	_	NN	NN	_	5	nn	_	_
4	shift	_	NN	NN	_	5	nn	_	_
5	assays	_	NNS	NNS	_	1	dobj	_	_
6	,	_	,	,	_	1	punct	_	_
7	we	_	PRP	PRP	_	8	nsubj	_	_
8	found	_	VBD	VBD	_	1	parataxis	_	_
9	that	_	IN	IN	_	20	mark	_	_
10	in	_	IN	IN	_	20	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	presence	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	rabbit	_	NN	NN	_	16	nn	_	_
15	reticulocyte	_	NN	NN	_	16	nn	_	_
16	lysate	_	NN	NN	_	13	pobj	_	_
17	,	_	,	,	_	20	punct	_	_
18	human	_	JJ	JJ	_	19	amod	_	_
19	ER	_	NN	NN	_	20	nsubj	_	_
20	reduced	_	VBD	VBD	_	8	ccomp	_	_
21	the	_	DT	DT	_	23	det	_	_
22	binding	_	NN	NN	_	23	nn	_	_
23	activities	_	NNS	NNS	_	20	dobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	chicken	_	NN	NN	_	30	nn	_	_
26	immature	_	JJ	JJ	_	30	amod	_	_
27	erythrocyte	_	NN	NN	_	30	nn	_	_
28	nuclear	_	JJ	JJ	_	30	amod	_	_
29	extracted	_	JJ	JJ	_	30	amod	_	_
30	proteins	_	NNS	NNS	_	24	pobj	_	_
31	to	_	TO	TO	_	23	prep	_	_
32	GATA	_	NN	NN	_	31	pobj	_	_
33	and	_	CC	CC	_	32	cc	_	_
34	CACCC	_	NN	NN	_	32	conj	_	_
35	sites	_	NNS	NNS	_	32	dep	_	_
36	in	_	IN	IN	_	32	prep	_	_
37	the	_	DT	DT	_	38	det	_	_
38	H5	_	NN	NN	_	36	pobj	_	_
39	promoter	_	NN	NN	_	38	dep	_	_
40	and	_	CC	CC	_	38	cc	_	_
41	enhancer	_	NN	NN	_	38	conj	_	_
42	.	_	.	.	_	1	punct	_	_

1	In	_	IN	IN	_	13	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	13	punct	_	_
4	the	_	DT	DT	_	6	det	_	_
5	binding	_	NN	NN	_	6	nn	_	_
6	activities	_	NNS	NNS	_	13	nsubjpass	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	NF1	_	NN	NN	_	7	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	Sp1	_	NN	NN	_	8	conj	_	_
11	were	_	VBD	VBD	_	13	auxpass	_	_
12	not	_	RB	RB	_	13	neg	_	_
13	affected	_	VBN	VBN	_	0	root	_	_
14	by	_	IN	IN	_	13	prep	_	_
15	ER	_	NN	NN	_	14	pobj	_	_
16	.	_	.	.	_	13	punct	_	_

1	Binding	_	NN	NN	_	10	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	ER	_	NN	NN	_	2	pobj	_	_
4	to	_	TO	TO	_	1	prep	_	_
5	an	_	DT	DT	_	8	det	_	_
6	estrogen	_	NN	NN	_	8	nn	_	_
7	response	_	NN	NN	_	8	nn	_	_
8	element	_	NN	NN	_	4	pobj	_	_
9	was	_	VBD	VBD	_	10	auxpass	_	_
10	enhanced	_	VBN	VBN	_	0	root	_	_
11	by	_	IN	IN	_	10	prep	_	_
12	addition	_	NN	NN	_	11	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	rabbit	_	NN	NN	_	16	nn	_	_
15	reticulocyte	_	NN	NN	_	16	nn	_	_
16	lysate	_	NN	NN	_	13	pobj	_	_
17	.	_	.	.	_	10	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	lysate	_	NN	NN	_	5	nsubj	_	_
3	was	_	VBD	VBD	_	5	cop	_	_
4	also	_	RB	RB	_	5	advmod	_	_
5	necessary	_	JJ	JJ	_	0	root	_	_
6	for	_	IN	IN	_	9	mark	_	_
7	ER	_	NN	NN	_	9	nsubj	_	_
8	to	_	TO	TO	_	9	aux	_	_
9	diminish	_	VB	VB	_	5	ccomp	_	_
10	the	_	DT	DT	_	12	det	_	_
11	DNA-binding	_	JJ	JJ	_	12	amod	_	_
12	activity	_	NN	NN	_	9	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	GATA-1	_	NN	NN	_	13	pobj	_	_
15	.	_	.	.	_	5	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	11	mark	_	_
5	additional	_	JJ	JJ	_	8	amod	_	_
6	factor	_	NN	NN	_	8	nn	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	s	_	NNS	NNS	_	11	nsubj	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	are	_	VBP	VBP	_	11	cop	_	_
11	necessary	_	JJ	JJ	_	3	ccomp	_	_
12	for	_	IN	IN	_	11	prep	_	_
13	full	_	JJ	JJ	_	15	amod	_	_
14	ER	_	NN	NN	_	15	nn	_	_
15	function	_	NN	NN	_	12	pobj	_	_
16	.	_	.	.	_	3	punct	_	_

1	Both	_	CC	CC	_	2	preconj	_	_
2	GATA-1	_	NN	NN	_	7	nsubj	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	CACCC-binding	_	JJ	JJ	_	5	amod	_	_
5	proteins	_	NNS	NNS	_	2	conj	_	_
6	are	_	VBP	VBP	_	7	cop	_	_
7	critical	_	JJ	JJ	_	0	root	_	_
8	for	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	12	det	_	_
10	developmentally	_	RB	RB	_	11	advmod	_	_
11	regulated	_	VBN	VBN	_	12	amod	_	_
12	expression	_	NN	NN	_	8	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	erythroid-specific	_	JJ	JJ	_	15	amod	_	_
15	genes	_	NNS	NNS	_	13	pobj	_	_
16	.	_	.	.	_	7	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	hypothesize	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	15	mark	_	_
4	interference	_	NN	NN	_	15	nsubj	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	DNA-binding	_	JJ	JJ	_	7	amod	_	_
7	activities	_	NNS	NNS	_	5	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	GATA-1	_	NN	NN	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	CACCC-binding	_	JJ	JJ	_	12	amod	_	_
12	proteins	_	NNS	NNS	_	9	conj	_	_
13	is	_	VBZ	VBZ	_	15	cop	_	_
14	the	_	DT	DT	_	15	det	_	_
15	mechanism	_	NN	NN	_	2	ccomp	_	_
16	by	_	IN	IN	_	20	prep	_	_
17	which	_	WDT	WDT	_	16	pobj	_	_
18	the	_	DT	DT	_	19	det	_	_
19	ER	_	NN	NN	_	20	nsubj	_	_
20	inhibits	_	VBZ	VBZ	_	15	rcmod	_	_
21	regulation	_	NN	NN	_	20	dobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	these	_	DT	DT	_	24	det	_	_
24	genes	_	NNS	NNS	_	22	pobj	_	_
25	.	_	.	.	_	2	punct	_	_

1	HLA	_	NN	NN	_	3	nn	_	_
2	binding	_	NN	NN	_	3	nn	_	_
3	characteristics	_	NNS	NNS	_	0	root	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	generation	_	NN	NN	_	3	conj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	cytotoxic	_	JJ	JJ	_	8	amod	_	_
8	lymphocytes	_	NNS	NNS	_	6	pobj	_	_
9	against	_	IN	IN	_	8	prep	_	_
10	peptides	_	NNS	NNS	_	9	pobj	_	_
11	derived	_	VBN	VBN	_	10	vmod	_	_
12	from	_	IN	IN	_	11	prep	_	_
13	oncogenic	_	JJ	JJ	_	14	amod	_	_
14	proteins	_	NNS	NNS	_	12	pobj	_	_
15	.	_	.	.	_	3	punct	_	_

1	AIMS	_	NNS	NNS	_	19	nsubjpass	_	_
2	AND	_	CC	CC	_	1	cc	_	_
3	BACKGROUND	_	NN	NN	_	1	conj	_	_
4	:	_	:	:	_	1	punct	_	_
5	Structurally	_	RB	RB	_	6	advmod	_	_
6	altered	_	VBN	VBN	_	7	amod	_	_
7	proteins	_	NNS	NNS	_	19	nsubjpass	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	derived	_	VBN	VBN	_	7	dep	_	_
10	from	_	IN	IN	_	9	prep	_	_
11	chromosomal	_	JJ	JJ	_	12	amod	_	_
12	translocations	_	NNS	NNS	_	10	pobj	_	_
13	or	_	CC	CC	_	12	cc	_	_
14	gene	_	NN	NN	_	15	nn	_	_
15	mutations	_	NNS	NNS	_	12	conj	_	_
16	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
17	can	_	MD	MD	_	19	aux	_	_
18	be	_	VB	VB	_	19	auxpass	_	_
19	considered	_	VBN	VBN	_	0	root	_	_
20	tumor	_	NN	NN	_	22	nn	_	_
21	specific	_	JJ	JJ	_	22	amod	_	_
22	antigens	_	NNS	NNS	_	19	xcomp	_	_
23	and	_	CC	CC	_	19	cc	_	_
24	represent	_	VB	VB	_	19	conj	_	_
25	an	_	DT	DT	_	27	det	_	_
26	attractive	_	JJ	JJ	_	27	amod	_	_
27	target	_	NN	NN	_	24	dobj	_	_
28	for	_	IN	IN	_	27	prep	_	_
29	a	_	DT	DT	_	32	det	_	_
30	T-cell	_	NN	NN	_	32	nn	_	_
31	mediated	_	JJ	JJ	_	32	amod	_	_
32	response	_	NN	NN	_	28	pobj	_	_
33	.	_	.	.	_	19	punct	_	_

1	T	_	NN	NN	_	2	nn	_	_
2	lymphocytes	_	NNS	NNS	_	3	nsubj	_	_
3	recognize	_	VBP	VBP	_	0	root	_	_
4	antigens	_	NNS	NNS	_	3	dobj	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	7	det	_	_
7	form	_	NN	NN	_	5	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	peptides	_	NNS	NNS	_	8	pobj	_	_
10	bound	_	VBN	VBN	_	9	vmod	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	HLA-molecules	_	NNS	NNS	_	11	pobj	_	_
13	.	_	.	.	_	3	punct	_	_

1	MATERIALS	_	NNS	NNS	_	0	root	_	_
2	AND	_	CC	CC	_	1	cc	_	_
3	METHODS	_	NNS	NNS	_	1	conj	_	_
4	:	_	:	:	_	1	punct	_	_
5	Peptides	_	NNS	NNS	_	11	nsubjpass	_	_
6	derived	_	VBN	VBN	_	5	vmod	_	_
7	from	_	IN	IN	_	6	prep	_	_
8	oncogenic	_	JJ	JJ	_	9	amod	_	_
9	proteins	_	NNS	NNS	_	7	pobj	_	_
10	were	_	VBD	VBD	_	11	auxpass	_	_
11	screened	_	VBN	VBN	_	1	dep	_	_
12	for	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	14	det	_	_
14	presence	_	NN	NN	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	HLA	_	NN	NN	_	18	nn	_	_
17	binding	_	NN	NN	_	18	nn	_	_
18	motifs	_	NNS	NNS	_	15	pobj	_	_
19	;	_	:	:	_	11	punct	_	_
20	actual	_	JJ	JJ	_	21	amod	_	_
21	binding	_	NN	NN	_	23	nsubjpass	_	_
22	were	_	VBD	VBD	_	23	auxpass	_	_
23	evaluated	_	VBN	VBN	_	11	parataxis	_	_
24	by	_	IN	IN	_	23	prep	_	_
25	HLA	_	NN	NN	_	27	nn	_	_
26	stabilization	_	NN	NN	_	27	nn	_	_
27	experiments	_	NNS	NNS	_	24	pobj	_	_
28	using	_	VBG	VBG	_	23	xcomp	_	_
29	transfectants	_	NNS	NNS	_	28	dobj	_	_
30	and	_	CC	CC	_	29	cc	_	_
31	specific	_	JJ	JJ	_	33	amod	_	_
32	anti-HLA	_	JJ	JJ	_	33	amod	_	_
33	antibodies	_	NNS	NNS	_	29	conj	_	_
34	.	_	.	.	_	1	punct	_	_

1	Specific	_	JJ	JJ	_	2	amod	_	_
2	lymphocytes	_	NNS	NNS	_	4	nsubjpass	_	_
3	were	_	VBD	VBD	_	4	auxpass	_	_
4	induced	_	VBN	VBN	_	0	root	_	_
5	by	_	IN	IN	_	4	prep	_	_
6	in	_	FW	FW	_	9	amod	_	_
7	vitro	_	FW	FW	_	6	dep	_	_
8	peptide	_	NN	NN	_	9	nn	_	_
9	sensitization	_	NN	NN	_	5	pobj	_	_
10	and	_	CC	CC	_	4	cc	_	_
11	screened	_	VBN	VBN	_	4	conj	_	_
12	by	_	IN	IN	_	11	prep	_	_
13	thymidine	_	NN	NN	_	14	nn	_	_
14	uptake	_	NN	NN	_	12	pobj	_	_
15	or	_	CC	CC	_	14	cc	_	_
16	cellular	_	JJ	JJ	_	18	amod	_	_
17	cytotoxic	_	JJ	JJ	_	18	amod	_	_
18	assays	_	NNS	NNS	_	14	conj	_	_
19	.	_	.	.	_	4	punct	_	_

1	RESULTS	_	NNS	NNS	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	We	_	PRP	PRP	_	4	nsubj	_	_
4	identified	_	VBD	VBD	_	1	dep	_	_
5	peptides	_	NNS	NNS	_	4	dobj	_	_
6	derived	_	VBN	VBN	_	5	vmod	_	_
7	from	_	IN	IN	_	6	prep	_	_
8	EWS/FLI-1	_	NN	NN	_	10	nn	_	_
9	fusion	_	NN	NN	_	10	nn	_	_
10	protein	_	NN	NN	_	7	pobj	_	_
11	and	_	CC	CC	_	7	cc	_	_
12	from	_	IN	IN	_	7	conj	_	_
13	mutated	_	VBN	VBN	_	15	amod	_	_
14	K-RAS	_	NN	NN	_	15	nn	_	_
15	protein	_	NN	NN	_	12	pobj	_	_
16	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
17	encompassing	_	VBG	VBG	_	7	dep	_	_
18	respectively	_	RB	RB	_	17	advmod	_	_
19	the	_	DT	DT	_	21	det	_	_
20	fusion	_	NN	NN	_	21	nn	_	_
21	point	_	NN	NN	_	17	dobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	the	_	DT	DT	_	24	det	_	_
24	mutation	_	NN	NN	_	21	conj	_	_
25	at	_	IN	IN	_	24	prep	_	_
26	position	_	NN	NN	_	25	pobj	_	_
27	12	_	CD	CD	_	26	num	_	_
28	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
29	that	_	WDT	WDT	_	30	nsubj	_	_
30	showed	_	VBD	VBD	_	5	rcmod	_	_
31	binding	_	VBG	VBG	_	32	amod	_	_
32	motif	_	NN	NN	_	30	dobj	_	_
33	for	_	IN	IN	_	32	prep	_	_
34	HLA-Cw*0702	_	NN	NN	_	33	pobj	_	_
35	and	_	CC	CC	_	34	cc	_	_
36	HLA-A3	_	NN	NN	_	34	conj	_	_
37	respectively	_	RB	RB	_	30	advmod	_	_
38	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	actual	_	JJ	JJ	_	3	amod	_	_
3	binding	_	NN	NN	_	8	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	these	_	DT	DT	_	6	det	_	_
6	peptides	_	NNS	NNS	_	4	pobj	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	analysed	_	VBN	VBN	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	a	_	DT	DT	_	12	det	_	_
11	stabilization	_	NN	NN	_	12	nn	_	_
12	assay	_	NN	NN	_	9	pobj	_	_
13	.	_	.	.	_	8	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	detected	_	VBD	VBD	_	0	root	_	_
3	binding	_	NN	NN	_	2	dobj	_	_
4	for	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	7	det	_	_
6	EWS/FLI-1	_	NN	NN	_	7	nn	_	_
7	peptide	_	NN	NN	_	4	pobj	_	_
8	and	_	CC	CC	_	4	cc	_	_
9	for	_	IN	IN	_	4	conj	_	_
10	5	_	CD	CD	_	12	num	_	_
11	RAS	_	NN	NN	_	12	nn	_	_
12	peptides	_	NNS	NNS	_	9	pobj	_	_
13	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
14	1	_	CD	CD	_	16	num	_	_
15	wild	_	JJ	JJ	_	16	amod	_	_
16	type	_	NN	NN	_	12	dep	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	4	_	CD	CD	_	16	conj	_	_
19	mutated	_	VBN	VBN	_	18	amod	_	_
20	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
21	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	effect	_	NN	NN	_	30	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	temperature	_	NN	NN	_	3	pobj	_	_
5	,	_	,	,	_	4	punct	_	_
6	beta	_	NN	NN	_	7	nn	_	_
7	2-microglobulin	_	NN	NN	_	4	conj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
9	beta	_	NN	NN	_	10	nn	_	_
10	2-m	_	NN	NN	_	7	appos	_	_
11	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
12	and	_	CC	CC	_	4	cc	_	_
13	fetal	_	JJ	JJ	_	15	amod	_	_
14	calf	_	NN	NN	_	15	nn	_	_
15	serum	_	NN	NN	_	4	conj	_	_
16	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
17	FCS	_	NN	NN	_	15	appos	_	_
18	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
19	on	_	IN	IN	_	2	prep	_	_
20	the	_	DT	DT	_	21	det	_	_
21	binding	_	NN	NN	_	19	pobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	the	_	DT	DT	_	24	det	_	_
24	stability	_	NN	NN	_	21	conj	_	_
25	of	_	IN	IN	_	21	prep	_	_
26	the	_	DT	DT	_	28	det	_	_
27	HLA/peptide	_	NN	NN	_	28	nn	_	_
28	complex	_	NN	NN	_	25	pobj	_	_
29	was	_	VBD	VBD	_	30	auxpass	_	_
30	studied	_	VBN	VBN	_	0	root	_	_
31	.	_	.	.	_	30	punct	_	_

1	A	_	DT	DT	_	3	det	_	_
2	low	_	JJ	JJ	_	3	amod	_	_
3	temperature	_	NN	NN	_	9	nsubj	_	_
4	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
5	26	_	CD	CD	_	7	num	_	_
6	degrees	_	NNS	NNS	_	7	nn	_	_
7	C	_	NN	NN	_	3	appos	_	_
8	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
9	increased	_	VBD	VBD	_	0	root	_	_
10	the	_	DT	DT	_	11	det	_	_
11	binding	_	NN	NN	_	9	dobj	_	_
12	both	_	CC	CC	_	13	dep	_	_
13	in	_	IN	IN	_	11	prep	_	_
14	HLA-A3	_	NN	NN	_	13	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	HLA-Cw*0702	_	NN	NN	_	14	conj	_	_
17	,	_	,	,	_	9	punct	_	_
18	while	_	IN	IN	_	20	mark	_	_
19	FCS	_	NN	NN	_	20	nsubj	_	_
20	reduced	_	VBD	VBD	_	9	advcl	_	_
21	it	_	PRP	PRP	_	20	dobj	_	_
22	.	_	.	.	_	9	punct	_	_

1	beta	_	NN	NN	_	2	nn	_	_
2	2-m	_	NN	NN	_	3	nsubj	_	_
3	increased	_	VBD	VBD	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	binding	_	NN	NN	_	3	dobj	_	_
6	to	_	TO	TO	_	5	prep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	HLA-A3	_	NN	NN	_	9	nn	_	_
9	molecule	_	NN	NN	_	6	pobj	_	_
10	but	_	CC	CC	_	3	cc	_	_
11	did	_	VBD	VBD	_	13	aux	_	_
12	not	_	RB	RB	_	13	neg	_	_
13	influence	_	VB	VB	_	3	conj	_	_
14	the	_	DT	DT	_	15	det	_	_
15	binding	_	NN	NN	_	13	dobj	_	_
16	to	_	TO	TO	_	15	prep	_	_
17	the	_	DT	DT	_	18	det	_	_
18	HLA-Cw*0702	_	NN	NN	_	16	pobj	_	_
19	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	stability	_	NN	NN	_	9	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	already	_	RB	RB	_	3	pobj	_	_
5	formed	_	VBN	VBN	_	4	amod	_	_
6	complexed	_	VBN	VBN	_	4	amod	_	_
7	was	_	VBD	VBD	_	9	cop	_	_
8	somewhat	_	RB	RB	_	9	advmod	_	_
9	different	_	JJ	JJ	_	0	root	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	12	dep	_	_
12	HLA-A3	_	NN	NN	_	10	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	HLA-Cw*0702	_	NN	NN	_	12	conj	_	_
15	system	_	NN	NN	_	12	dep	_	_
16	:	_	:	:	_	9	punct	_	_
17	both	_	DT	DT	_	20	nsubj	_	_
18	were	_	VBD	VBD	_	20	cop	_	_
19	more	_	RBR	RBR	_	20	advmod	_	_
20	stable	_	JJ	JJ	_	9	parataxis	_	_
21	at	_	IN	IN	_	20	prep	_	_
22	26	_	CD	CD	_	24	num	_	_
23	degrees	_	NNS	NNS	_	24	nn	_	_
24	C	_	NN	NN	_	21	pobj	_	_
25	than	_	IN	IN	_	20	prep	_	_
26	at	_	IN	IN	_	25	pcomp	_	_
27	37	_	CD	CD	_	29	num	_	_
28	degrees	_	NNS	NNS	_	29	nn	_	_
29	C	_	NN	NN	_	26	pobj	_	_
30	but	_	CC	CC	_	20	cc	_	_
31	while	_	IN	IN	_	39	mark	_	_
32	the	_	DT	DT	_	34	dep	_	_
33	beta	_	NN	NN	_	34	nn	_	_
34	2-m	_	NN	NN	_	39	nsubj	_	_
35	and	_	CC	CC	_	34	cc	_	_
36	FCS	_	NN	NN	_	34	conj	_	_
37	did	_	VBD	VBD	_	39	aux	_	_
38	not	_	RB	RB	_	39	neg	_	_
39	influence	_	VB	VB	_	48	advcl	_	_
40	the	_	DT	DT	_	41	det	_	_
41	stability	_	NN	NN	_	39	dobj	_	_
42	of	_	IN	IN	_	41	prep	_	_
43	the	_	DT	DT	_	45	det	_	_
44	HLA-A3/peptide	_	NN	NN	_	45	nn	_	_
45	complex	_	NN	NN	_	42	pobj	_	_
46	,	_	,	,	_	48	punct	_	_
47	they	_	PRP	PRP	_	48	nsubj	_	_
48	seemed	_	VBD	VBD	_	20	conj	_	_
49	to	_	TO	TO	_	50	aux	_	_
50	cause	_	VB	VB	_	48	xcomp	_	_
51	opposite	_	JJ	JJ	_	52	amod	_	_
52	effects	_	NNS	NNS	_	50	dobj	_	_
53	in	_	IN	IN	_	50	prep	_	_
54	the	_	DT	DT	_	56	det	_	_
55	HLA-Cw*0702	_	NN	NN	_	56	nn	_	_
56	system	_	NN	NN	_	53	pobj	_	_
57	-LRB-	_	-LRB-	-LRB-	_	60	punct	_	_
58	beta	_	NN	NN	_	59	nn	_	_
59	2-m	_	NN	NN	_	60	nsubj	_	_
60	stabilized	_	VBD	VBD	_	48	dep	_	_
61	and	_	CC	CC	_	60	cc	_	_
62	FCS	_	NN	NN	_	63	nsubj	_	_
63	destabilized	_	VBD	VBD	_	60	conj	_	_
64	the	_	DT	DT	_	65	det	_	_
65	complex	_	NN	NN	_	63	dobj	_	_
66	-RRB-	_	-RRB-	-RRB-	_	60	punct	_	_
67	.	_	.	.	_	9	punct	_	_

1	Finally	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	we	_	PRP	PRP	_	5	nsubj	_	_
4	were	_	VBD	VBD	_	5	cop	_	_
5	able	_	JJ	JJ	_	0	root	_	_
6	to	_	TO	TO	_	7	aux	_	_
7	generate	_	VB	VB	_	5	xcomp	_	_
8	a	_	DT	DT	_	12	det	_	_
9	specific	_	JJ	JJ	_	12	amod	_	_
10	CD8+	_	JJ	JJ	_	12	amod	_	_
11	CTL	_	NN	NN	_	12	nn	_	_
12	line	_	NN	NN	_	7	dobj	_	_
13	against	_	IN	IN	_	7	prep	_	_
14	a	_	DT	DT	_	17	det	_	_
15	K-RAS	_	NN	NN	_	17	nn	_	_
16	mutated	_	JJ	JJ	_	17	amod	_	_
17	peptide	_	NN	NN	_	13	pobj	_	_
18	.	_	.	.	_	5	punct	_	_

1	CONCLUSIONS	_	NNS	NNS	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	Although	_	IN	IN	_	12	mark	_	_
4	binding	_	VBG	VBG	_	5	amod	_	_
5	motifs	_	NNS	NNS	_	12	nsubjpass	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	actual	_	JJ	JJ	_	9	amod	_	_
8	HLA	_	NN	NN	_	9	nn	_	_
9	binding	_	NN	NN	_	5	conj	_	_
10	can	_	MD	MD	_	12	aux	_	_
11	be	_	VB	VB	_	12	auxpass	_	_
12	detected	_	VBN	VBN	_	24	advcl	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	several	_	JJ	JJ	_	15	amod	_	_
15	cases	_	NNS	NNS	_	13	pobj	_	_
16	,	_	,	,	_	24	punct	_	_
17	the	_	DT	DT	_	18	det	_	_
18	generation	_	NN	NN	_	24	nsubj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	a	_	DT	DT	_	22	det	_	_
21	cellular	_	JJ	JJ	_	22	amod	_	_
22	response	_	NN	NN	_	19	pobj	_	_
23	is	_	VBZ	VBZ	_	24	cop	_	_
24	infrequent	_	JJ	JJ	_	1	dep	_	_
25	,	_	,	,	_	24	punct	_	_
26	confirming	_	VBG	VBG	_	24	xcomp	_	_
27	that	_	IN	IN	_	31	mark	_	_
28	HLA	_	NN	NN	_	29	nn	_	_
29	binding	_	NN	NN	_	31	nsubj	_	_
30	is	_	VBZ	VBZ	_	31	cop	_	_
31	necessary	_	JJ	JJ	_	26	ccomp	_	_
32	but	_	CC	CC	_	31	cc	_	_
33	not	_	RB	RB	_	34	neg	_	_
34	sufficient	_	JJ	JJ	_	31	conj	_	_
35	to	_	TO	TO	_	36	aux	_	_
36	obtain	_	VB	VB	_	31	xcomp	_	_
37	an	_	DT	DT	_	40	det	_	_
38	in	_	FW	FW	_	40	amod	_	_
39	vitro	_	FW	FW	_	38	dep	_	_
40	response	_	NN	NN	_	36	dobj	_	_
41	.	_	.	.	_	1	punct	_	_

1	Further	_	RB	RB	_	2	advmod	_	_
2	optimization	_	NN	NN	_	26	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	culture	_	NN	NN	_	5	nn	_	_
5	conditions	_	NNS	NNS	_	3	pobj	_	_
6	,	_	,	,	_	5	punct	_	_
7	type	_	NN	NN	_	5	appos	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	Antigen	_	NN	NN	_	11	nn	_	_
10	Presenting	_	NN	NN	_	11	nn	_	_
11	Cells	_	NNS	NNS	_	8	pobj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	APC	_	NNS	NNS	_	11	appos	_	_
14	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
15	,	_	,	,	_	11	punct	_	_
16	peptides	_	NNS	NNS	_	11	appos	_	_
17	,	_	,	,	_	5	punct	_	_
18	use	_	NN	NN	_	5	appos	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	stabilizers	_	NNS	NNS	_	19	pobj	_	_
21	like	_	IN	IN	_	20	prep	_	_
22	beta	_	NN	NN	_	23	nn	_	_
23	2-m	_	NN	NN	_	21	pobj	_	_
24	are	_	VBP	VBP	_	26	auxpass	_	_
25	still	_	RB	RB	_	26	advmod	_	_
26	needed	_	VBN	VBN	_	0	root	_	_
27	.	_	.	.	_	26	punct	_	_

1	Control	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	NF-kappa	_	NN	NN	_	4	nn	_	_
4	B	_	NN	NN	_	5	nn	_	_
5	activity	_	NN	NN	_	2	pobj	_	_
6	by	_	IN	IN	_	1	prep	_	_
7	the	_	DT	DT	_	12	det	_	_
8	I	_	NN	NN	_	12	nn	_	_
9	kappa	_	NN	NN	_	12	nn	_	_
10	B	_	NN	NN	_	12	nn	_	_
11	beta	_	NN	NN	_	12	nn	_	_
12	inhibitor	_	NN	NN	_	6	pobj	_	_
13	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	transcription	_	NN	NN	_	3	nn	_	_
3	factor	_	NN	NN	_	7	nsubj	_	_
4	NF-kappa	_	NN	NN	_	5	nn	_	_
5	B	_	NN	NN	_	3	dep	_	_
6	is	_	VBZ	VBZ	_	7	aux	_	_
7	maintained	_	JJ	JJ	_	0	root	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	an	_	DT	DT	_	12	det	_	_
10	inactive	_	JJ	JJ	_	12	amod	_	_
11	cytoplasmic	_	JJ	JJ	_	10	dep	_	_
12	state	_	NN	NN	_	8	pobj	_	_
13	by	_	IN	IN	_	7	prep	_	_
14	I	_	NN	NN	_	17	nn	_	_
15	kappa	_	NN	NN	_	17	nn	_	_
16	B	_	NN	NN	_	17	nn	_	_
17	inhibitors	_	NNS	NNS	_	13	pobj	_	_
18	.	_	.	.	_	7	punct	_	_

1	In	_	IN	IN	_	17	prep	_	_
2	mammalian	_	JJ	JJ	_	3	amod	_	_
3	cells	_	NNS	NNS	_	1	pobj	_	_
4	,	_	,	,	_	17	punct	_	_
5	I	_	NN	NN	_	8	nn	_	_
6	kappa	_	NN	NN	_	8	nn	_	_
7	B	_	NN	NN	_	8	nn	_	_
8	alpha	_	NN	NN	_	17	nsubjpass	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	I	_	NN	NN	_	14	nn	_	_
11	kappa	_	NN	NN	_	14	nn	_	_
12	B	_	NN	NN	_	14	nn	_	_
13	beta	_	NN	NN	_	14	nn	_	_
14	proteins	_	NNS	NNS	_	8	conj	_	_
15	have	_	VBP	VBP	_	17	aux	_	_
16	been	_	VBN	VBN	_	17	auxpass	_	_
17	purified	_	VBN	VBN	_	0	root	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	shown	_	VBN	VBN	_	17	conj	_	_
20	to	_	TO	TO	_	23	aux	_	_
21	be	_	VB	VB	_	23	cop	_	_
22	the	_	DT	DT	_	23	det	_	_
23	inhibitors	_	NNS	NNS	_	19	xcomp	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	NF-kappa	_	NN	NN	_	26	nn	_	_
26	B	_	NN	NN	_	24	pobj	_	_
27	through	_	IN	IN	_	23	prep	_	_
28	their	_	PRP$	PRP$	_	29	poss	_	_
29	association	_	NN	NN	_	27	pobj	_	_
30	with	_	IN	IN	_	29	prep	_	_
31	the	_	DT	DT	_	32	dep	_	_
32	p65	_	NN	NN	_	30	pobj	_	_
33	or	_	CC	CC	_	32	cc	_	_
34	c-Rel	_	NN	NN	_	32	conj	_	_
35	subunits	_	NNS	NNS	_	32	dep	_	_
36	.	_	.	.	_	17	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	6	punct	_	_
4	we	_	PRP	PRP	_	6	nsubj	_	_
5	have	_	VBP	VBP	_	6	aux	_	_
6	isolated	_	VBN	VBN	_	0	root	_	_
7	a	_	DT	DT	_	11	det	_	_
8	third	_	JJ	JJ	_	11	amod	_	_
9	NF-kappa	_	NN	NN	_	11	nn	_	_
10	B	_	NN	NN	_	11	nn	_	_
11	inhibitor	_	NN	NN	_	6	dobj	_	_
12	,	_	,	,	_	11	punct	_	_
13	I	_	NN	NN	_	16	nn	_	_
14	kappa	_	NN	NN	_	16	nn	_	_
15	B	_	NN	NN	_	16	nn	_	_
16	epsilon	_	NN	NN	_	11	appos	_	_
17	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
18	1	_	CD	CD	_	16	num	_	_
19	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
20	.	_	.	.	_	6	punct	_	_

1	Upon	_	IN	IN	_	21	prep	_	_
2	treatment	_	NN	NN	_	1	pobj	_	_
3	with	_	IN	IN	_	2	prep	_	_
4	a	_	DT	DT	_	6	det	_	_
5	large	_	JJ	JJ	_	6	amod	_	_
6	variety	_	NN	NN	_	3	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	inducers	_	NNS	NNS	_	7	pobj	_	_
9	,	_	,	,	_	21	punct	_	_
10	I	_	NN	NN	_	13	nn	_	_
11	kappa	_	NN	NN	_	13	nn	_	_
12	B	_	NN	NN	_	13	nn	_	_
13	alpha	_	NN	NN	_	21	nsubjpass	_	_
14	,	_	,	,	_	13	punct	_	_
15	I	_	NN	NN	_	18	nn	_	_
16	kappa	_	NN	NN	_	18	nn	_	_
17	B	_	NN	NN	_	18	nn	_	_
18	beta	_	NN	NN	_	13	appos	_	_
19	are	_	VBP	VBP	_	21	auxpass	_	_
20	proteolytically	_	RB	RB	_	21	advmod	_	_
21	degraded	_	VBN	VBN	_	0	root	_	_
22	,	_	,	,	_	21	punct	_	_
23	resulting	_	VBG	VBG	_	21	vmod	_	_
24	in	_	IN	IN	_	23	prep	_	_
25	NF-kappa	_	NN	NN	_	26	nn	_	_
26	B	_	NN	NN	_	27	nn	_	_
27	translocation	_	NN	NN	_	24	pobj	_	_
28	into	_	IN	IN	_	27	prep	_	_
29	the	_	DT	DT	_	30	det	_	_
30	nucleus	_	NN	NN	_	28	pobj	_	_
31	.	_	.	.	_	21	punct	_	_

1	Here	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	show	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	21	mark	_	_
5	in	_	IN	IN	_	21	prep	_	_
6	E29.1	_	NN	NN	_	9	nn	_	_
7	T	_	NN	NN	_	9	nn	_	_
8	cell	_	NN	NN	_	9	nn	_	_
9	hybridoma	_	NN	NN	_	5	pobj	_	_
10	I	_	NN	NN	_	13	nn	_	_
11	kappa	_	NN	NN	_	13	nn	_	_
12	B	_	NN	NN	_	13	nn	_	_
13	alpha	_	NN	NN	_	21	nsubjpass	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	I	_	NN	NN	_	18	nn	_	_
16	kappa	_	NN	NN	_	18	nn	_	_
17	B	_	NN	NN	_	18	nn	_	_
18	beta	_	NN	NN	_	13	conj	_	_
19	are	_	VBP	VBP	_	21	auxpass	_	_
20	equally	_	RB	RB	_	21	advmod	_	_
21	associated	_	VBN	VBN	_	3	ccomp	_	_
22	with	_	IN	IN	_	21	prep	_	_
23	p65	_	NN	NN	_	22	pobj	_	_
24	and	_	CC	CC	_	21	cc	_	_
25	that	_	IN	IN	_	31	mark	_	_
26	I	_	NN	NN	_	29	nn	_	_
27	kappa	_	NN	NN	_	29	nn	_	_
28	B	_	NN	NN	_	29	nn	_	_
29	beta	_	NN	NN	_	31	nsubjpass	_	_
30	is	_	VBZ	VBZ	_	31	auxpass	_	_
31	degraded	_	VBN	VBN	_	21	conj	_	_
32	in	_	IN	IN	_	31	prep	_	_
33	response	_	NN	NN	_	32	pobj	_	_
34	to	_	TO	TO	_	33	prep	_	_
35	TNF	_	NN	NN	_	36	nn	_	_
36	alpha	_	NN	NN	_	34	pobj	_	_
37	in	_	IN	IN	_	31	prep	_	_
38	contrast	_	NN	NN	_	37	pobj	_	_
39	to	_	TO	TO	_	38	prep	_	_
40	what	_	WP	WP	_	44	nsubjpass	_	_
41	has	_	VBZ	VBZ	_	44	aux	_	_
42	been	_	VBN	VBN	_	44	auxpass	_	_
43	originally	_	RB	RB	_	44	advmod	_	_
44	published	_	VBN	VBN	_	39	pcomp	_	_
45	.	_	.	.	_	3	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	data	_	NNS	NNS	_	4	nsubj	_	_
3	also	_	RB	RB	_	4	advmod	_	_
4	suggest	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	19	mark	_	_
6	,	_	,	,	_	19	punct	_	_
7	unlike	_	IN	IN	_	19	prep	_	_
8	I	_	NN	NN	_	11	nn	_	_
9	kappa	_	NN	NN	_	11	nn	_	_
10	B	_	NN	NN	_	11	nn	_	_
11	alpha	_	NN	NN	_	7	pobj	_	_
12	,	_	,	,	_	19	punct	_	_
13	I	_	NN	NN	_	16	nn	_	_
14	kappa	_	NN	NN	_	16	nn	_	_
15	B	_	NN	NN	_	16	nn	_	_
16	beta	_	NN	NN	_	19	nsubjpass	_	_
17	is	_	VBZ	VBZ	_	19	auxpass	_	_
18	constitutively	_	RB	RB	_	19	advmod	_	_
19	phosphorylated	_	VBN	VBN	_	4	ccomp	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	resynthesized	_	VBN	VBN	_	19	conj	_	_
22	as	_	IN	IN	_	21	prep	_	_
23	a	_	DT	DT	_	25	det	_	_
24	hypophosphorylated	_	VBN	VBN	_	25	amod	_	_
25	form	_	NN	NN	_	22	pobj	_	_
26	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	absence	_	NN	NN	_	14	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	slow	_	JJ	JJ	_	5	amod	_	_
5	migrating	_	JJ	JJ	_	6	amod	_	_
6	forms	_	NNS	NNS	_	3	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	I	_	NN	NN	_	11	nn	_	_
9	kappa	_	NN	NN	_	11	nn	_	_
10	B	_	NN	NN	_	11	nn	_	_
11	beta	_	NN	NN	_	7	pobj	_	_
12	following	_	VBG	VBG	_	2	vmod	_	_
13	stimulation	_	NN	NN	_	12	dobj	_	_
14	suggests	_	VBZ	VBZ	_	0	root	_	_
15	that	_	IN	IN	_	21	mark	_	_
16	the	_	DT	DT	_	17	det	_	_
17	phosphorylation	_	NN	NN	_	21	nsubj	_	_
18	does	_	VBZ	VBZ	_	21	aux	_	_
19	not	_	RB	RB	_	21	neg	_	_
20	necessarily	_	RB	RB	_	21	advmod	_	_
21	constitute	_	VB	VB	_	14	ccomp	_	_
22	the	_	DT	DT	_	24	det	_	_
23	signal-induced	_	JJ	JJ	_	24	amod	_	_
24	event	_	NN	NN	_	21	dobj	_	_
25	which	_	WDT	WDT	_	26	nsubj	_	_
26	targets	_	VBZ	VBZ	_	24	rcmod	_	_
27	the	_	DT	DT	_	28	det	_	_
28	molecule	_	NN	NN	_	26	dobj	_	_
29	for	_	IN	IN	_	28	prep	_	_
30	proteolysis	_	NN	NN	_	29	pobj	_	_
31	.	_	.	.	_	14	punct	_	_

1	LPS	_	NN	NN	_	2	nn	_	_
2	tolerance	_	NN	NN	_	0	root	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	monocytes/macrophages	_	NNS	NNS	_	3	pobj	_	_
5	:	_	:	:	_	2	punct	_	_
6	three	_	CD	CD	_	8	num	_	_
7	3'	_	JJ	JJ	_	8	amod	_	_
8	cytosins	_	NNS	NNS	_	10	nsubjpass	_	_
9	are	_	VBP	VBP	_	10	auxpass	_	_
10	required	_	VBN	VBN	_	2	dep	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	15	det	_	_
13	DNA	_	NN	NN	_	15	nn	_	_
14	binding	_	NN	NN	_	15	nn	_	_
15	motif	_	NN	NN	_	11	pobj	_	_
16	for	_	IN	IN	_	10	prep	_	_
17	detection	_	NN	NN	_	16	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	upregulated	_	VBN	VBN	_	23	amod	_	_
20	NF-kappa	_	NN	NN	_	23	nn	_	_
21	B	_	NN	NN	_	23	nn	_	_
22	p50	_	NN	NN	_	23	nn	_	_
23	homodimers	_	NNS	NNS	_	18	pobj	_	_
24	.	_	.	.	_	2	punct	_	_

1	When	_	WRB	WRB	_	4	advmod	_	_
2	monocytes	_	NNS	NNS	_	4	nsubjpass	_	_
3	are	_	VBP	VBP	_	4	auxpass	_	_
4	stimulated	_	VBN	VBN	_	28	advcl	_	_
5	with	_	IN	IN	_	4	prep	_	_
6	LPS	_	NN	NN	_	5	pobj	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	lipopolysaccharide	_	NN	NN	_	6	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	repeatedly	_	RB	RB	_	4	advmod	_	_
11	then	_	RB	RB	_	28	advmod	_	_
12	the	_	DT	DT	_	15	det	_	_
13	initially	_	RB	RB	_	14	advmod	_	_
14	high	_	JJ	JJ	_	15	amod	_	_
15	expression	_	NN	NN	_	28	nsubj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	24	det	_	_
18	TNF	_	NN	NN	_	24	nn	_	_
19	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
20	tumor	_	NN	NN	_	24	nn	_	_
21	necrosis	_	NN	NN	_	24	nn	_	_
22	factor	_	NN	NN	_	24	nn	_	_
23	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
24	gene	_	NN	NN	_	16	pobj	_	_
25	is	_	VBZ	VBZ	_	28	cop	_	_
26	only	_	RB	RB	_	28	advmod	_	_
27	very	_	RB	RB	_	28	advmod	_	_
28	low	_	JJ	JJ	_	0	root	_	_
29	,	_	,	,	_	28	punct	_	_
30	i.e.	_	FW	FW	_	28	prep	_	_
31	the	_	DT	DT	_	32	det	_	_
32	cells	_	NNS	NNS	_	34	nsubj	_	_
33	are	_	VBP	VBP	_	34	cop	_	_
34	tolerant	_	JJ	JJ	_	28	parataxis	_	_
35	to	_	TO	TO	_	34	prep	_	_
36	LPS	_	NN	NN	_	35	pobj	_	_
37	.	_	.	.	_	28	punct	_	_

1	Tolerant	_	JJ	JJ	_	2	amod	_	_
2	cells	_	NNS	NNS	_	4	nsubj	_	_
3	still	_	RB	RB	_	4	advmod	_	_
4	express	_	VBP	VBP	_	0	root	_	_
5	the	_	DT	DT	_	7	det	_	_
6	CD14	_	NN	NN	_	7	nn	_	_
7	receptor	_	NN	NN	_	4	dobj	_	_
8	and	_	CC	CC	_	4	cc	_	_
9	they	_	PRP	PRP	_	13	nsubjpass	_	_
10	can	_	MD	MD	_	13	aux	_	_
11	still	_	RB	RB	_	13	advmod	_	_
12	be	_	VB	VB	_	13	auxpass	_	_
13	activated	_	VBN	VBN	_	4	conj	_	_
14	to	_	TO	TO	_	15	aux	_	_
15	mobilize	_	VB	VB	_	13	xcomp	_	_
16	NF-kappa	_	NN	NN	_	17	nn	_	_
17	B	_	NN	NN	_	15	dobj	_	_
18	into	_	IN	IN	_	15	prep	_	_
19	nucleus	_	NN	NN	_	18	pobj	_	_
20	.	_	.	.	_	4	punct	_	_

1	Analysis	_	NN	NN	_	18	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	binding	_	VBG	VBG	_	5	amod	_	_
5	proteins	_	NNS	NNS	_	2	pobj	_	_
6	employing	_	VBG	VBG	_	5	vmod	_	_
7	the	_	DT	DT	_	9	det	_	_
8	-605	_	CD	CD	_	9	num	_	_
9	motif	_	NN	NN	_	6	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	14	det	_	_
12	human	_	JJ	JJ	_	14	amod	_	_
13	TNF	_	NN	NN	_	14	nn	_	_
14	promoter	_	NN	NN	_	10	pobj	_	_
15	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
16	GGGGCTGTCCC	_	NN	NN	_	9	appos	_	_
17	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
18	revealed	_	VBD	VBD	_	0	root	_	_
19	that	_	IN	IN	_	33	mark	_	_
20	in	_	IN	IN	_	33	prep	_	_
21	tolerant	_	JJ	JJ	_	22	amod	_	_
22	cells	_	NNS	NNS	_	20	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	28	det	_	_
25	human	_	JJ	JJ	_	28	amod	_	_
26	monocytic	_	JJ	JJ	_	28	amod	_	_
27	cell	_	NN	NN	_	28	nn	_	_
28	line	_	NN	NN	_	23	pobj	_	_
29	Mono	_	NN	NN	_	30	nn	_	_
30	Mac	_	NN	NN	_	28	dep	_	_
31	6	_	CD	CD	_	30	num	_	_
32	there	_	EX	EX	_	33	expl	_	_
33	is	_	VBZ	VBZ	_	18	ccomp	_	_
34	a	_	DT	DT	_	35	det	_	_
35	predominance	_	NN	NN	_	33	nsubj	_	_
36	of	_	IN	IN	_	35	prep	_	_
37	p50p50	_	NN	NN	_	36	pobj	_	_
38	of	_	IN	IN	_	37	prep	_	_
39	NF-kappa	_	NN	NN	_	40	nn	_	_
40	B	_	NN	NN	_	38	pobj	_	_
41	.	_	.	.	_	18	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	now	_	RB	RB	_	3	advmod	_	_
3	show	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	17	mark	_	_
5	a	_	DT	DT	_	7	det	_	_
6	mutant	_	JJ	JJ	_	7	amod	_	_
7	motif	_	NN	NN	_	17	nsubj	_	_
8	that	_	WDT	WDT	_	9	nsubj	_	_
9	exchanges	_	VBZ	VBZ	_	7	rcmod	_	_
10	the	_	DT	DT	_	13	det	_	_
11	terminal	_	JJ	JJ	_	13	amod	_	_
12	3'	_	JJ	JJ	_	13	amod	_	_
13	C	_	NN	NN	_	9	dobj	_	_
14	for	_	IN	IN	_	9	prep	_	_
15	a	_	DT	DT	_	16	det	_	_
16	G	_	NN	NN	_	14	pobj	_	_
17	fails	_	VBZ	VBZ	_	3	ccomp	_	_
18	to	_	TO	TO	_	19	aux	_	_
19	bind	_	VB	VB	_	17	xcomp	_	_
20	the	_	DT	DT	_	22	det	_	_
21	p50	_	NN	NN	_	22	nn	_	_
22	homodimer	_	NN	NN	_	19	dobj	_	_
23	that	_	WDT	WDT	_	25	nsubjpass	_	_
24	is	_	VBZ	VBZ	_	25	auxpass	_	_
25	upregulated	_	VBN	VBN	_	22	rcmod	_	_
26	in	_	IN	IN	_	25	prep	_	_
27	LPS	_	NN	NN	_	29	npadvmod	_	_
28	toler	_	NN	NN	_	29	npadvmod	_	_
29	ant	_	JJ	JJ	_	34	amod	_	_
30	human	_	JJ	JJ	_	34	amod	_	_
31	Mono	_	NN	NN	_	34	nn	_	_
32	Mac	_	NN	NN	_	34	nn	_	_
33	6	_	CD	CD	_	34	num	_	_
34	cells	_	NNS	NNS	_	26	pobj	_	_
35	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	same	_	JJ	JJ	_	4	nsubj	_	_
3	is	_	VBZ	VBZ	_	4	cop	_	_
4	true	_	JJ	JJ	_	0	root	_	_
5	for	_	IN	IN	_	4	prep	_	_
6	nuclear	_	JJ	JJ	_	7	amod	_	_
7	extracts	_	NNS	NNS	_	5	pobj	_	_
8	taken	_	VBN	VBN	_	7	vmod	_	_
9	from	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	15	det	_	_
11	murine	_	JJ	JJ	_	15	amod	_	_
12	P388D1	_	NN	NN	_	15	nn	_	_
13	macrophage	_	NN	NN	_	15	nn	_	_
14	cell	_	NN	NN	_	15	nn	_	_
15	line	_	NN	NN	_	9	pobj	_	_
16	when	_	WRB	WRB	_	17	advmod	_	_
17	tested	_	VBN	VBN	_	4	advcl	_	_
18	with	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	-516	_	CD	CD	_	21	num	_	_
21	motif	_	NN	NN	_	18	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	26	det	_	_
24	murine	_	JJ	JJ	_	26	amod	_	_
25	TNF	_	NN	NN	_	26	nn	_	_
26	promoter	_	NN	NN	_	22	pobj	_	_
27	-LRB-	_	-LRB-	-LRB-	_	28	punct	_	_
28	GGGGGCTTTCCC	_	NN	NN	_	21	appos	_	_
29	-RRB-	_	-RRB-	-RRB-	_	28	punct	_	_
30	.	_	.	.	_	4	punct	_	_

1	Here	_	RB	RB	_	6	advmod	_	_
2	the	_	DT	DT	_	5	det	_	_
3	wild	_	JJ	JJ	_	5	amod	_	_
4	type	_	NN	NN	_	5	nn	_	_
5	motif	_	NN	NN	_	6	nsubj	_	_
6	gives	_	VBZ	VBZ	_	0	root	_	_
7	efficient	_	JJ	JJ	_	8	amod	_	_
8	binding	_	NN	NN	_	6	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	p50p50	_	NN	NN	_	9	pobj	_	_
11	that	_	WDT	WDT	_	14	nsubjpass	_	_
12	again	_	RB	RB	_	14	advmod	_	_
13	is	_	VBZ	VBZ	_	14	auxpass	_	_
14	upregulated	_	VBN	VBN	_	10	rcmod	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	tolerant	_	JJ	JJ	_	17	amod	_	_
17	cells	_	NNS	NNS	_	15	pobj	_	_
18	whereas	_	IN	IN	_	25	mark	_	_
19	a	_	DT	DT	_	20	det	_	_
20	mutant	_	NN	NN	_	25	nsubj	_	_
21	with	_	IN	IN	_	20	prep	_	_
22	a	_	DT	DT	_	24	det	_	_
23	3'	_	JJ	JJ	_	24	amod	_	_
24	G	_	NN	NN	_	21	pobj	_	_
25	shows	_	VBZ	VBZ	_	6	advcl	_	_
26	hardly	_	RB	RB	_	27	advmod	_	_
27	any	_	DT	DT	_	28	amod	_	_
28	binding	_	NN	NN	_	25	dobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	p50p50	_	NN	NN	_	29	pobj	_	_
31	.	_	.	.	_	6	punct	_	_

1	Conversely	_	RB	RB	_	16	advmod	_	_
2	,	_	,	,	_	16	punct	_	_
3	the	_	DT	DT	_	9	det	_	_
4	murine	_	JJ	JJ	_	9	amod	_	_
5	kappa	_	NN	NN	_	9	nn	_	_
6	light	_	JJ	JJ	_	9	amod	_	_
7	chain	_	NN	NN	_	9	nn	_	_
8	enhancer	_	NN	NN	_	9	nn	_	_
9	motif	_	NN	NN	_	16	nsubj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	GGGGACTTTCCG	_	NN	NN	_	9	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	does	_	VBZ	VBZ	_	16	aux	_	_
14	not	_	RB	RB	_	16	neg	_	_
15	efficiently	_	RB	RB	_	16	advmod	_	_
16	bind	_	VB	VB	_	0	root	_	_
17	the	_	DT	DT	_	19	det	_	_
18	nuclear	_	JJ	JJ	_	19	amod	_	_
19	p50p50	_	NN	NN	_	16	dobj	_	_
20	from	_	IN	IN	_	19	prep	_	_
21	tolerant	_	JJ	JJ	_	24	amod	_	_
22	murine	_	JJ	JJ	_	24	amod	_	_
23	P388	_	NN	NN	_	24	nn	_	_
24	macrophages	_	NNS	NNS	_	20	pobj	_	_
25	.	_	.	.	_	16	punct	_	_

1	Binding	_	NN	NN	_	7	nsubjpass	_	_
2	is	_	VBZ	VBZ	_	7	auxpass	_	_
3	,	_	,	,	_	7	punct	_	_
4	however	_	RB	RB	_	7	advmod	_	_
5	,	_	,	,	_	7	punct	_	_
6	readily	_	RB	RB	_	7	advmod	_	_
7	detected	_	VBN	VBN	_	0	root	_	_
8	when	_	WRB	WRB	_	13	advmod	_	_
9	the	_	DT	DT	_	11	det	_	_
10	3'	_	JJ	JJ	_	11	amod	_	_
11	G	_	NN	NN	_	13	nsubjpass	_	_
12	is	_	VBZ	VBZ	_	13	auxpass	_	_
13	replaced	_	VBN	VBN	_	7	advcl	_	_
14	by	_	IN	IN	_	13	prep	_	_
15	a	_	DT	DT	_	16	det	_	_
16	C	_	NN	NN	_	14	pobj	_	_
17	.	_	.	.	_	7	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	show	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	16	mark	_	_
5	the	_	DT	DT	_	6	det	_	_
6	detection	_	NN	NN	_	16	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	upregulated	_	VBN	VBN	_	10	amod	_	_
9	p50	_	NN	NN	_	10	nn	_	_
10	homodimers	_	NNS	NNS	_	7	pobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	LPS	_	NN	NN	_	11	pobj	_	_
13	tolerant	_	JJ	JJ	_	14	amod	_	_
14	cells	_	NNS	NNS	_	12	dep	_	_
15	is	_	VBZ	VBZ	_	16	cop	_	_
16	dependent	_	JJ	JJ	_	3	ccomp	_	_
17	on	_	IN	IN	_	16	prep	_	_
18	subtle	_	JJ	JJ	_	19	amod	_	_
19	differences	_	NNS	NNS	_	17	pobj	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	22	det	_	_
22	sequence	_	NN	NN	_	20	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	27	det	_	_
25	DNA	_	NN	NN	_	27	nn	_	_
26	binding	_	NN	NN	_	27	nn	_	_
27	motif	_	NN	NN	_	23	pobj	_	_
28	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	winged-helix	_	JJ	JJ	_	4	amod	_	_
3	transcription	_	NN	NN	_	4	nn	_	_
4	factor	_	NN	NN	_	7	nsubjpass	_	_
5	Trident	_	NN	NN	_	4	dep	_	_
6	is	_	VBZ	VBZ	_	7	auxpass	_	_
7	expressed	_	VBN	VBN	_	0	root	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	actively	_	RB	RB	_	11	advmod	_	_
10	dividing	_	VBG	VBG	_	11	amod	_	_
11	lymphocytes	_	NNS	NNS	_	8	pobj	_	_
12	.	_	.	.	_	7	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	recently	_	RB	RB	_	3	advmod	_	_
3	identified	_	VBD	VBD	_	0	root	_	_
4	the	_	DT	DT	_	7	det	_	_
5	winged-helix	_	JJ	JJ	_	7	amod	_	_
6	transcription	_	NN	NN	_	7	nn	_	_
7	factor	_	NN	NN	_	3	dobj	_	_
8	Trident	_	NN	NN	_	7	dep	_	_
9	and	_	CC	CC	_	3	cc	_	_
10	described	_	VBD	VBD	_	3	conj	_	_
11	its	_	PRP$	PRP$	_	13	poss	_	_
12	expression	_	NN	NN	_	13	nn	_	_
13	pattern	_	NN	NN	_	10	dobj	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	synchronized	_	VBN	VBN	_	16	amod	_	_
16	fibroblasts	_	NNS	NNS	_	14	pobj	_	_
17	.	_	.	.	_	3	punct	_	_

1	We	_	PRP	PRP	_	4	nsubj	_	_
2	have	_	VBP	VBP	_	4	aux	_	_
3	now	_	RB	RB	_	4	advmod	_	_
4	studied	_	VBN	VBN	_	0	root	_	_
5	Trident	_	NN	NN	_	6	nn	_	_
6	expression	_	NN	NN	_	4	dobj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	cell	_	NN	NN	_	9	nn	_	_
9	lines	_	NNS	NNS	_	7	pobj	_	_
10	,	_	,	,	_	9	punct	_	_
11	differentiating	_	VBG	VBG	_	12	amod	_	_
12	thymocytes	_	NNS	NNS	_	9	appos	_	_
13	and	_	CC	CC	_	7	cc	_	_
14	in	_	IN	IN	_	7	conj	_	_
15	lymphocytes	_	NNS	NNS	_	14	pobj	_	_
16	derived	_	VBN	VBN	_	15	vmod	_	_
17	from	_	IN	IN	_	16	prep	_	_
18	peripheral	_	JJ	JJ	_	19	amod	_	_
19	blood	_	NN	NN	_	17	pobj	_	_
20	.	_	.	.	_	4	punct	_	_

1	During	_	IN	IN	_	7	prep	_	_
2	T	_	NN	NN	_	4	nn	_	_
3	cell	_	NN	NN	_	4	nn	_	_
4	differentiation	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	7	punct	_	_
6	expression	_	NN	NN	_	7	nsubj	_	_
7	peaked	_	VBD	VBD	_	0	root	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	15	det	_	_
10	actively	_	RB	RB	_	15	advmod	_	_
11	dividing	_	VBG	VBG	_	15	amod	_	_
12	immature	_	JJ	JJ	_	15	amod	_	_
13	single	_	JJ	JJ	_	15	amod	_	_
14	positive	_	JJ	JJ	_	15	amod	_	_
15	cells	_	NNS	NNS	_	8	pobj	_	_
16	.	_	.	.	_	7	punct	_	_

1	In	_	IN	IN	_	11	prep	_	_
2	peripheral	_	JJ	JJ	_	4	amod	_	_
3	blood	_	NN	NN	_	4	nn	_	_
4	lymphocytes	_	NNS	NNS	_	1	pobj	_	_
5	,	_	,	,	_	11	punct	_	_
6	expression	_	NN	NN	_	11	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	Trident	_	NN	NN	_	9	nn	_	_
9	mRNA	_	NN	NN	_	7	pobj	_	_
10	was	_	VBD	VBD	_	11	cop	_	_
11	absent	_	JJ	JJ	_	0	root	_	_
12	,	_	,	,	_	11	punct	_	_
13	but	_	CC	CC	_	11	cc	_	_
14	could	_	MD	MD	_	16	aux	_	_
15	be	_	VB	VB	_	16	auxpass	_	_
16	induced	_	VBN	VBN	_	11	conj	_	_
17	upon	_	IN	IN	_	16	prep	_	_
18	stimulation	_	NN	NN	_	17	pobj	_	_
19	with	_	IN	IN	_	18	prep	_	_
20	mitogens	_	NNS	NNS	_	19	pobj	_	_
21	in	_	FW	FW	_	22	nn	_	_
22	vitro	_	FW	FW	_	18	advmod	_	_
23	.	_	.	.	_	11	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	observations	_	NNS	NNS	_	3	nsubj	_	_
3	imply	_	VBP	VBP	_	0	root	_	_
4	a	_	DT	DT	_	5	det	_	_
5	function	_	NN	NN	_	3	dobj	_	_
6	for	_	IN	IN	_	5	prep	_	_
7	Trident	_	NN	NN	_	6	pobj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	dividing	_	VBG	VBG	_	10	amod	_	_
10	lymphocytes	_	NNS	NNS	_	8	pobj	_	_
11	.	_	.	.	_	3	punct	_	_

1	Temporal	_	JJ	JJ	_	2	amod	_	_
2	control	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	IgH	_	JJ	JJ	_	5	amod	_	_
5	gene	_	NN	NN	_	6	nn	_	_
6	expression	_	NN	NN	_	3	pobj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	developing	_	VBG	VBG	_	10	amod	_	_
9	B	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	7	pobj	_	_
11	by	_	IN	IN	_	2	prep	_	_
12	the	_	DT	DT	_	16	det	_	_
13	3'	_	JJ	JJ	_	16	amod	_	_
14	locus	_	NN	NN	_	16	nn	_	_
15	control	_	NN	NN	_	16	nn	_	_
16	region	_	NN	NN	_	11	pobj	_	_
17	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	suggested	_	VBN	VBN	_	3	amod	_	_
3	roles	_	NNS	NNS	_	20	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	8	det	_	_
6	downstream	_	JJ	JJ	_	8	amod	_	_
7	3'	_	JJ	JJ	_	8	amod	_	_
8	regions	_	NNS	NNS	_	4	pobj	_	_
9	acting	_	VBG	VBG	_	8	vmod	_	_
10	as	_	IN	IN	_	9	prep	_	_
11	a	_	DT	DT	_	14	det	_	_
12	Locus	_	NN	NN	_	14	nn	_	_
13	Control	_	NN	NN	_	14	nn	_	_
14	Region	_	NN	NN	_	10	pobj	_	_
15	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
16	LCR	_	NN	NN	_	14	appos	_	_
17	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
18	,	_	,	,	_	3	punct	_	_
19	have	_	VBP	VBP	_	20	aux	_	_
20	allowed	_	VBN	VBN	_	0	root	_	_
21	comparisons	_	NNS	NNS	_	20	dobj	_	_
22	to	_	TO	TO	_	24	aux	_	_
23	be	_	VB	VB	_	24	auxpass	_	_
24	made	_	VBN	VBN	_	20	xcomp	_	_
25	between	_	IN	IN	_	20	prep	_	_
26	the	_	DT	DT	_	27	det	_	_
27	regulation	_	NN	NN	_	25	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	the	_	DT	DT	_	31	det	_	_
30	IgH	_	JJ	JJ	_	31	amod	_	_
31	locus	_	NN	NN	_	28	pobj	_	_
32	with	_	IN	IN	_	20	prep	_	_
33	other	_	JJ	JJ	_	35	amod	_	_
34	model	_	NN	NN	_	35	nn	_	_
35	systems	_	NNS	NNS	_	32	pobj	_	_
36	whose	_	WP$	WP$	_	38	poss	_	_
37	gene	_	NN	NN	_	38	nn	_	_
38	expression	_	NN	NN	_	40	nsubjpass	_	_
39	is	_	VBZ	VBZ	_	40	auxpass	_	_
40	governed	_	VBN	VBN	_	35	rcmod	_	_
41	by	_	IN	IN	_	40	prep	_	_
42	LCR	_	NN	NN	_	43	nn	_	_
43	activity	_	NN	NN	_	41	pobj	_	_
44	.	_	.	.	_	20	punct	_	_

1	Here	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	summarize	_	VBP	VBP	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	importance	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	IgH	_	JJ	JJ	_	9	amod	_	_
9	3'LCR	_	NN	NN	_	6	pobj	_	_
10	and	_	CC	CC	_	5	cc	_	_
11	its	_	PRP$	PRP$	_	14	poss	_	_
12	putative	_	JJ	JJ	_	14	amod	_	_
13	functional	_	JJ	JJ	_	14	amod	_	_
14	role	_	NN	NN	_	5	conj	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	IgH	_	JJ	JJ	_	17	amod	_	_
17	gene	_	NN	NN	_	18	nn	_	_
18	expression	_	NN	NN	_	15	pobj	_	_
19	and	_	CC	CC	_	3	cc	_	_
20	compare	_	VBP	VBP	_	3	conj	_	_
21	it	_	PRP	PRP	_	20	dobj	_	_
22	with	_	IN	IN	_	20	prep	_	_
23	the	_	DT	DT	_	26	det	_	_
24	5'LCR	_	NN	NN	_	26	nn	_	_
25	regulatory	_	JJ	JJ	_	26	amod	_	_
26	region	_	NN	NN	_	22	pobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	31	det	_	_
29	human	_	JJ	JJ	_	31	amod	_	_
30	beta-globin	_	NN	NN	_	31	nn	_	_
31	locus	_	NN	NN	_	27	pobj	_	_
32	.	_	.	.	_	3	punct	_	_

1	Expression	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	transcription	_	NN	NN	_	5	nn	_	_
4	factor	_	NN	NN	_	5	nn	_	_
5	genes	_	NNS	NNS	_	2	pobj	_	_
6	after	_	IN	IN	_	1	prep	_	_
7	influenza	_	NN	NN	_	10	nn	_	_
8	A	_	NN	NN	_	10	nn	_	_
9	virus	_	NN	NN	_	10	nn	_	_
10	infection	_	NN	NN	_	6	pobj	_	_
11	.	_	.	.	_	1	punct	_	_

1	Infection	_	NN	NN	_	9	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	human	_	JJ	JJ	_	4	amod	_	_
4	monocytes	_	NNS	NNS	_	2	pobj	_	_
5	with	_	IN	IN	_	1	prep	_	_
6	influenza	_	NN	NN	_	8	nn	_	_
7	A	_	NN	NN	_	8	nn	_	_
8	virus	_	NN	NN	_	5	pobj	_	_
9	induces	_	VBZ	VBZ	_	0	root	_	_
10	a	_	DT	DT	_	12	det	_	_
11	broad	_	JJ	JJ	_	12	amod	_	_
12	range	_	NN	NN	_	9	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	proinflammatory	_	JJ	JJ	_	15	amod	_	_
15	cytokines	_	NNS	NNS	_	13	pobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	mononuclear	_	JJ	JJ	_	18	amod	_	_
18	cell	_	NN	NN	_	15	conj	_	_
19	attracting	_	NN	NN	_	18	dep	_	_
20	chemokines	_	NNS	NNS	_	19	dobj	_	_
21	before	_	IN	IN	_	25	mark	_	_
22	the	_	DT	DT	_	24	det	_	_
23	infected	_	JJ	JJ	_	24	amod	_	_
24	cells	_	NNS	NNS	_	25	nsubj	_	_
25	undergo	_	VBP	VBP	_	9	advcl	_	_
26	apoptosis	_	NN	NN	_	25	dobj	_	_
27	.	_	.	.	_	9	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	underlying	_	VBG	VBG	_	3	amod	_	_
3	mechanisms	_	NNS	NNS	_	18	nsubjpass	_	_
4	by	_	IN	IN	_	11	prep	_	_
5	which	_	WDT	WDT	_	4	pobj	_	_
6	the	_	DT	DT	_	8	det	_	_
7	corresponding	_	JJ	JJ	_	8	amod	_	_
8	genes	_	NNS	NNS	_	11	nsubjpass	_	_
9	are	_	VBP	VBP	_	11	auxpass	_	_
10	transcriptionally	_	RB	RB	_	11	advmod	_	_
11	initiated	_	VBN	VBN	_	3	rcmod	_	_
12	after	_	IN	IN	_	11	prep	_	_
13	virus	_	NN	NN	_	14	nn	_	_
14	infection	_	NN	NN	_	12	pobj	_	_
15	are	_	VBP	VBP	_	18	auxpass	_	_
16	still	_	RB	RB	_	18	advmod	_	_
17	poorly	_	RB	RB	_	18	advmod	_	_
18	understood	_	VBN	VBN	_	0	root	_	_
19	.	_	.	.	_	18	punct	_	_

1	Activation	_	NN	NN	_	5	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	NF-kappa	_	NN	NN	_	4	nn	_	_
4	B	_	NN	NN	_	2	pobj	_	_
5	seems	_	VBZ	VBZ	_	0	root	_	_
6	to	_	TO	TO	_	7	aux	_	_
7	play	_	VB	VB	_	5	xcomp	_	_
8	an	_	DT	DT	_	10	det	_	_
9	important	_	JJ	JJ	_	10	amod	_	_
10	role	_	NN	NN	_	7	dobj	_	_
11	in	_	IN	IN	_	7	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	regulation	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	many	_	JJ	JJ	_	18	amod	_	_
16	proinflammatory	_	JJ	JJ	_	18	amod	_	_
17	cytokine	_	NN	NN	_	18	nn	_	_
18	genes	_	NNS	NNS	_	14	pobj	_	_
19	,	_	,	,	_	5	punct	_	_
20	but	_	CC	CC	_	5	cc	_	_
21	can	_	MD	MD	_	26	aux	_	_
22	not	_	RB	RB	_	26	neg	_	_
23	be	_	VB	VB	_	26	cop	_	_
24	the	_	DT	DT	_	26	det	_	_
25	only	_	JJ	JJ	_	26	amod	_	_
26	mechanism	_	NN	NN	_	5	conj	_	_
27	,	_	,	,	_	26	punct	_	_
28	since	_	IN	IN	_	32	mark	_	_
29	several	_	JJ	JJ	_	31	amod	_	_
30	cytokine	_	NN	NN	_	31	nn	_	_
31	genes	_	NNS	NNS	_	32	nsubj	_	_
32	lack	_	VBP	VBP	_	26	advcl	_	_
33	respective	_	JJ	JJ	_	35	amod	_	_
34	binding	_	VBG	VBG	_	35	amod	_	_
35	sites	_	NNS	NNS	_	32	dobj	_	_
36	in	_	IN	IN	_	32	prep	_	_
37	their	_	PRP$	PRP$	_	39	poss	_	_
38	promoter	_	NN	NN	_	39	nn	_	_
39	regions	_	NNS	NNS	_	36	pobj	_	_
40	.	_	.	.	_	5	punct	_	_

1	Therefore	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	we	_	PRP	PRP	_	5	nsubj	_	_
4	additionally	_	RB	RB	_	5	advmod	_	_
5	investigated	_	VBD	VBD	_	0	root	_	_
6	other	_	JJ	JJ	_	8	amod	_	_
7	transcription	_	NN	NN	_	8	nn	_	_
8	factors	_	NNS	NNS	_	5	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	possible	_	JJ	JJ	_	11	amod	_	_
11	importance	_	NN	NN	_	9	pobj	_	_
12	such	_	JJ	JJ	_	13	mwe	_	_
13	as	_	IN	IN	_	8	prep	_	_
14	CREB	_	NN	NN	_	13	pobj	_	_
15	,	_	,	,	_	14	punct	_	_
16	CTF	_	NN	NN	_	14	conj	_	_
17	,	_	,	,	_	14	punct	_	_
18	OTF-1	_	NN	NN	_	14	conj	_	_
19	,	_	,	,	_	14	punct	_	_
20	and	_	CC	CC	_	14	cc	_	_
21	OTF-2	_	NN	NN	_	14	conj	_	_
22	.	_	.	.	_	5	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	explore	_	VB	VB	_	0	root	_	_
3	long-term	_	JJ	JJ	_	5	amod	_	_
4	regulatory	_	JJ	JJ	_	5	amod	_	_
5	mechanisms	_	NNS	NNS	_	2	dobj	_	_
6	,	_	,	,	_	2	punct	_	_
7	we	_	PRP	PRP	_	8	nsubj	_	_
8	investigated	_	VBD	VBD	_	2	parataxis	_	_
9	the	_	DT	DT	_	10	det	_	_
10	induction	_	NN	NN	_	8	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	transcription	_	NN	NN	_	13	nn	_	_
13	factors	_	NNS	NNS	_	11	pobj	_	_
14	on	_	IN	IN	_	10	prep	_	_
15	the	_	DT	DT	_	18	det	_	_
16	gene	_	NN	NN	_	18	nn	_	_
17	expression	_	NN	NN	_	18	nn	_	_
18	level	_	NN	NN	_	14	pobj	_	_
19	which	_	WDT	WDT	_	22	nsubj	_	_
20	may	_	MD	MD	_	22	aux	_	_
21	be	_	VB	VB	_	22	cop	_	_
22	important	_	JJ	JJ	_	10	rcmod	_	_
23	to	_	TO	TO	_	24	aux	_	_
24	substitute	_	VB	VB	_	22	xcomp	_	_
25	for	_	IN	IN	_	24	prep	_	_
26	metabolized	_	VBN	VBN	_	29	amod	_	_
27	transcription	_	NN	NN	_	29	nn	_	_
28	factor	_	NN	NN	_	29	nn	_	_
29	proteins	_	NNS	NNS	_	25	pobj	_	_
30	after	_	IN	IN	_	24	prep	_	_
31	their	_	PRP$	PRP$	_	32	poss	_	_
32	activation	_	NN	NN	_	30	pobj	_	_
33	.	_	.	.	_	2	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	identified	_	VBD	VBD	_	0	root	_	_
3	a	_	DT	DT	_	6	det	_	_
4	cell-type-specific	_	JJ	JJ	_	6	amod	_	_
5	differential	_	JJ	JJ	_	4	dep	_	_
6	response	_	NN	NN	_	2	dobj	_	_
7	:	_	:	:	_	2	punct	_	_
8	CREB	_	NN	NN	_	22	nsubjpass	_	_
9	,	_	,	,	_	8	punct	_	_
10	CTF	_	NN	NN	_	8	conj	_	_
11	,	_	,	,	_	8	punct	_	_
12	OTF-1	_	NN	NN	_	8	conj	_	_
13	,	_	,	,	_	8	punct	_	_
14	OFT-2	_	NN	NN	_	8	conj	_	_
15	,	_	,	,	_	8	punct	_	_
16	and	_	CC	CC	_	8	cc	_	_
17	NF-kappa	_	NN	NN	_	18	nn	_	_
18	B	_	NN	NN	_	8	conj	_	_
19	genes	_	NNS	NNS	_	8	dep	_	_
20	were	_	VBD	VBD	_	22	auxpass	_	_
21	strongly	_	RB	RB	_	22	advmod	_	_
22	induced	_	VBN	VBN	_	2	parataxis	_	_
23	1	_	CD	CD	_	25	number	_	_
24	to	_	TO	TO	_	25	dep	_	_
25	4	_	CD	CD	_	26	num	_	_
26	hours	_	NNS	NNS	_	27	npadvmod	_	_
27	after	_	IN	IN	_	22	prep	_	_
28	influenza	_	NN	NN	_	31	nn	_	_
29	A	_	NN	NN	_	31	nn	_	_
30	virus	_	NN	NN	_	31	nn	_	_
31	infection	_	NN	NN	_	27	pobj	_	_
32	in	_	IN	IN	_	22	prep	_	_
33	the	_	DT	DT	_	36	det	_	_
34	monocytic	_	JJ	JJ	_	36	amod	_	_
35	cell	_	NN	NN	_	36	nn	_	_
36	line	_	NN	NN	_	32	pobj	_	_
37	Mono	_	NN	NN	_	38	nn	_	_
38	Mac	_	NN	NN	_	36	dep	_	_
39	6	_	CD	CD	_	38	num	_	_
40	,	_	,	,	_	22	punct	_	_
41	while	_	IN	IN	_	51	mark	_	_
42	in	_	IN	IN	_	51	prep	_	_
43	freshly	_	RB	RB	_	44	advmod	_	_
44	prepared	_	VBN	VBN	_	46	amod	_	_
45	human	_	JJ	JJ	_	46	amod	_	_
46	monocytes	_	NNS	NNS	_	42	pobj	_	_
47	no	_	DT	DT	_	49	neg	_	_
48	significant	_	JJ	JJ	_	49	amod	_	_
49	changes	_	NNS	NNS	_	51	nsubjpass	_	_
50	were	_	VBD	VBD	_	51	auxpass	_	_
51	detected	_	VBN	VBN	_	22	advcl	_	_
52	.	_	.	.	_	2	punct	_	_

1	In	_	IN	IN	_	21	prep	_	_
2	infected	_	JJ	JJ	_	3	amod	_	_
3	monocytes	_	NNS	NNS	_	1	pobj	_	_
4	,	_	,	,	_	3	punct	_	_
5	which	_	WDT	WDT	_	6	nsubj	_	_
6	die	_	VBP	VBP	_	3	rcmod	_	_
7	by	_	IN	IN	_	6	prep	_	_
8	apoptosis	_	NN	NN	_	7	pobj	_	_
9	,	_	,	,	_	21	punct	_	_
10	the	_	DT	DT	_	11	det	_	_
11	expression	_	NN	NN	_	21	nsubjpass	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	CREB	_	NN	NN	_	12	pobj	_	_
14	,	_	,	,	_	13	punct	_	_
15	CTF	_	NN	NN	_	13	conj	_	_
16	,	_	,	,	_	13	punct	_	_
17	and	_	CC	CC	_	13	cc	_	_
18	OTF-2	_	NN	NN	_	13	conj	_	_
19	was	_	VBD	VBD	_	21	auxpass	_	_
20	rather	_	RB	RB	_	21	advmod	_	_
21	suppressed	_	VBN	VBN	_	0	root	_	_
22	8	_	CD	CD	_	23	num	_	_
23	hours	_	NNS	NNS	_	24	npadvmod	_	_
24	after	_	IN	IN	_	21	prep	_	_
25	infection	_	NN	NN	_	24	pobj	_	_
26	.	_	.	.	_	21	punct	_	_

1	In	_	IN	IN	_	15	prep	_	_
2	conclusion	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	15	punct	_	_
4	the	_	DT	DT	_	6	det	_	_
5	long-term	_	JJ	JJ	_	6	amod	_	_
6	regulation	_	NN	NN	_	15	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	transcription	_	NN	NN	_	9	nn	_	_
9	factor	_	NN	NN	_	11	nn	_	_
10	gene	_	NN	NN	_	11	nn	_	_
11	expression	_	NN	NN	_	7	pobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	non-proliferating	_	JJ	JJ	_	14	amod	_	_
14	cells	_	NNS	NNS	_	12	pobj	_	_
15	seems	_	VBZ	VBZ	_	0	root	_	_
16	to	_	TO	TO	_	17	aux	_	_
17	be	_	VB	VB	_	15	xcomp	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	minor	_	JJ	JJ	_	20	amod	_	_
20	importance	_	NN	NN	_	18	pobj	_	_
21	after	_	IN	IN	_	17	prep	_	_
22	influenza	_	NN	NN	_	23	nn	_	_
23	infection	_	NN	NN	_	21	pobj	_	_
24	since	_	IN	IN	_	36	mark	_	_
25	in	_	IN	IN	_	36	prep	_	_
26	apoptosisprone	_	JJ	JJ	_	27	amod	_	_
27	cells	_	NNS	NNS	_	25	pobj	_	_
28	an	_	DT	DT	_	30	det	_	_
29	immediate	_	JJ	JJ	_	30	amod	_	_
30	availability	_	NN	NN	_	36	nsubjpass	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	transcription	_	NN	NN	_	34	nn	_	_
33	factor	_	NN	NN	_	34	nn	_	_
34	proteins	_	NNS	NNS	_	31	pobj	_	_
35	is	_	VBZ	VBZ	_	36	auxpass	_	_
36	required	_	VBN	VBN	_	15	advcl	_	_
37	.	_	.	.	_	15	punct	_	_

1	Induction	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	interleukin-12	_	NN	NN	_	2	pobj	_	_
4	p40	_	NN	NN	_	5	nn	_	_
5	transcript	_	NN	NN	_	3	dep	_	_
6	by	_	IN	IN	_	1	prep	_	_
7	CD40	_	NN	NN	_	8	nn	_	_
8	ligation	_	NN	NN	_	6	pobj	_	_
9	via	_	IN	IN	_	8	prep	_	_
10	activation	_	NN	NN	_	9	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	nuclear	_	JJ	JJ	_	13	amod	_	_
13	factor-kappaB	_	NN	NN	_	11	pobj	_	_
14	.	_	.	.	_	1	punct	_	_

1	Interleukin-12	_	NN	NN	_	3	nsubjpass	_	_
2	is	_	VBZ	VBZ	_	3	auxpass	_	_
3	produced	_	VBN	VBN	_	0	root	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	response	_	NN	NN	_	4	pobj	_	_
6	to	_	TO	TO	_	5	prep	_	_
7	infection	_	NN	NN	_	6	pobj	_	_
8	with	_	IN	IN	_	7	prep	_	_
9	bacteria	_	NNS	NNS	_	8	pobj	_	_
10	or	_	CC	CC	_	9	cc	_	_
11	parasites	_	NNS	NNS	_	9	conj	_	_
12	or	_	CC	CC	_	6	cc	_	_
13	to	_	TO	TO	_	6	conj	_	_
14	bacterial	_	JJ	JJ	_	15	amod	_	_
15	constituents	_	NNS	NNS	_	13	pobj	_	_
16	such	_	JJ	JJ	_	17	mwe	_	_
17	as	_	IN	IN	_	15	prep	_	_
18	LPS	_	NN	NN	_	17	pobj	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	monocytes/macrophages	_	NNS	NNS	_	19	pobj	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	dendritic	_	JJ	JJ	_	23	amod	_	_
23	cells	_	NNS	NNS	_	20	conj	_	_
24	,	_	,	,	_	3	punct	_	_
25	and	_	CC	CC	_	3	cc	_	_
26	also	_	RB	RB	_	27	advmod	_	_
27	generated	_	VBN	VBN	_	3	conj	_	_
28	by	_	IN	IN	_	27	prep	_	_
29	the	_	DT	DT	_	30	det	_	_
30	interaction	_	NN	NN	_	28	pobj	_	_
31	between	_	IN	IN	_	30	prep	_	_
32	activated	_	VBN	VBN	_	34	amod	_	_
33	T	_	NN	NN	_	34	nn	_	_
34	cells	_	NNS	NNS	_	31	pobj	_	_
35	and	_	CC	CC	_	34	cc	_	_
36	antigen-presenting	_	JJ	JJ	_	37	amod	_	_
37	cells	_	NNS	NNS	_	34	conj	_	_
38	via	_	IN	IN	_	34	prep	_	_
39	CD40-CD40	_	NN	NN	_	40	nn	_	_
40	ligand	_	NN	NN	_	38	pobj	_	_
41	-LRB-	_	-LRB-	-LRB-	_	42	punct	_	_
42	CD40L	_	NN	NN	_	40	appos	_	_
43	-RRB-	_	-RRB-	-RRB-	_	42	punct	_	_
44	.	_	.	.	_	3	punct	_	_

1	So	_	RB	RB	_	2	advmod	_	_
2	far	_	RB	RB	_	10	advmod	_	_
3	,	_	,	,	_	10	punct	_	_
4	transcriptional	_	JJ	JJ	_	5	amod	_	_
5	analyses	_	NNS	NNS	_	10	nsubjpass	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	p40	_	NN	NN	_	6	pobj	_	_
8	have	_	VBP	VBP	_	10	aux	_	_
9	been	_	VBN	VBN	_	10	auxpass	_	_
10	carried	_	VBN	VBN	_	0	root	_	_
11	out	_	RP	RP	_	10	prt	_	_
12	only	_	RB	RB	_	13	advmod	_	_
13	using	_	VBG	VBG	_	10	xcomp	_	_
14	bacterial	_	JJ	JJ	_	15	amod	_	_
15	constituents	_	NNS	NNS	_	13	dobj	_	_
16	such	_	JJ	JJ	_	17	mwe	_	_
17	as	_	IN	IN	_	15	prep	_	_
18	LPS	_	NN	NN	_	17	pobj	_	_
19	as	_	IN	IN	_	13	prep	_	_
20	stimuli	_	NNS	NNS	_	19	pobj	_	_
21	.	_	.	.	_	10	punct	_	_

1	In	_	IN	IN	_	8	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	present	_	JJ	JJ	_	4	amod	_	_
4	study	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	8	punct	_	_
6	we	_	PRP	PRP	_	8	nsubj	_	_
7	have	_	VBP	VBP	_	8	aux	_	_
8	characterized	_	VBN	VBN	_	0	root	_	_
9	the	_	DT	DT	_	11	det	_	_
10	transcriptional	_	JJ	JJ	_	11	amod	_	_
11	induction	_	NN	NN	_	8	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	p40	_	NN	NN	_	12	pobj	_	_
14	by	_	IN	IN	_	11	prep	_	_
15	CD40	_	NN	NN	_	16	nn	_	_
16	ligation	_	NN	NN	_	14	pobj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	a	_	DT	DT	_	23	det	_	_
19	human	_	JJ	JJ	_	23	amod	_	_
20	B	_	NN	NN	_	23	nn	_	_
21	lymphoblastoid	_	JJ	JJ	_	23	amod	_	_
22	cell	_	NN	NN	_	23	nn	_	_
23	line	_	NN	NN	_	17	pobj	_	_
24	,	_	,	,	_	23	punct	_	_
25	Daudi	_	NN	NN	_	23	appos	_	_
26	,	_	,	,	_	23	punct	_	_
27	and	_	CC	CC	_	23	cc	_	_
28	a	_	DT	DT	_	34	det	_	_
29	human	_	JJ	JJ	_	34	amod	_	_
30	acute	_	JJ	JJ	_	34	amod	_	_
31	monocytic	_	JJ	JJ	_	34	amod	_	_
32	leukemia	_	NN	NN	_	34	nn	_	_
33	cell	_	NN	NN	_	34	nn	_	_
34	line	_	NN	NN	_	23	conj	_	_
35	,	_	,	,	_	34	punct	_	_
36	THP-1	_	NN	NN	_	34	appos	_	_
37	.	_	.	.	_	8	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	cells	_	NNS	NNS	_	21	nsubj	_	_
3	,	_	,	,	_	2	punct	_	_
4	stimulated	_	VBN	VBN	_	2	vmod	_	_
5	by	_	IN	IN	_	4	prep	_	_
6	an	_	DT	DT	_	9	det	_	_
7	agonistic	_	JJ	JJ	_	9	amod	_	_
8	monoclonal	_	JJ	JJ	_	9	amod	_	_
9	antibody	_	NN	NN	_	5	pobj	_	_
10	against	_	IN	IN	_	9	prep	_	_
11	CD40	_	NN	NN	_	10	pobj	_	_
12	or	_	CC	CC	_	5	cc	_	_
13	by	_	IN	IN	_	5	conj	_	_
14	transfection	_	NN	NN	_	13	pobj	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	a	_	DT	DT	_	19	det	_	_
17	CD40L	_	NN	NN	_	19	nn	_	_
18	expression	_	NN	NN	_	19	nn	_	_
19	vector	_	NN	NN	_	15	pobj	_	_
20	,	_	,	,	_	2	punct	_	_
21	secreted	_	VBD	VBD	_	0	root	_	_
22	p40	_	NN	NN	_	21	dobj	_	_
23	and	_	CC	CC	_	21	cc	_	_
24	showed	_	VBD	VBD	_	21	conj	_	_
25	enhanced	_	VBN	VBN	_	28	amod	_	_
26	p40	_	NN	NN	_	27	nn	_	_
27	mRNA	_	NN	NN	_	28	nn	_	_
28	expression	_	NN	NN	_	24	dobj	_	_
29	.	_	.	.	_	21	punct	_	_

1	Sequence	_	NN	NN	_	2	nn	_	_
2	analysis	_	NN	NN	_	8	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	7	det	_	_
5	p40	_	NN	NN	_	7	nn	_	_
6	promoter	_	NN	NN	_	7	nn	_	_
7	region	_	NN	NN	_	3	pobj	_	_
8	identified	_	VBD	VBD	_	0	root	_	_
9	two	_	CD	CD	_	18	num	_	_
10	potential	_	JJ	JJ	_	18	amod	_	_
11	nuclear	_	JJ	JJ	_	18	amod	_	_
12	factor	_	NN	NN	_	18	nn	_	_
13	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
14	NF	_	NN	NN	_	18	nn	_	_
15	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
16	-kappaB	_	NN	NN	_	18	nn	_	_
17	binding	_	NN	NN	_	18	nn	_	_
18	sites	_	NNS	NNS	_	8	dobj	_	_
19	conserved	_	VBN	VBN	_	18	vmod	_	_
20	between	_	IN	IN	_	19	prep	_	_
21	mouse	_	NN	NN	_	20	pobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	human	_	NN	NN	_	21	conj	_	_
24	.	_	.	.	_	8	punct	_	_

1	Electrophoretic	_	JJ	JJ	_	4	amod	_	_
2	mobility	_	NN	NN	_	4	nn	_	_
3	shift	_	NN	NN	_	4	nn	_	_
4	assay	_	NN	NN	_	5	nsubj	_	_
5	revealed	_	VBD	VBD	_	0	root	_	_
6	that	_	IN	IN	_	30	mark	_	_
7	the	_	DT	DT	_	11	det	_	_
8	potential	_	JJ	JJ	_	11	amod	_	_
9	NF-kappaB	_	NN	NN	_	11	nn	_	_
10	binding	_	NN	NN	_	11	nn	_	_
11	sequence	_	NN	NN	_	30	nsubj	_	_
12	which	_	WDT	WDT	_	14	nsubj	_	_
13	is	_	VBZ	VBZ	_	14	cop	_	_
14	located	_	JJ	JJ	_	11	rcmod	_	_
15	around	_	IN	IN	_	14	prep	_	_
16	120	_	CD	CD	_	17	num	_	_
17	bp	_	NN	NN	_	15	pobj	_	_
18	upstream	_	RB	RB	_	17	advmod	_	_
19	of	_	IN	IN	_	17	prep	_	_
20	the	_	DT	DT	_	23	det	_	_
21	transcription	_	NN	NN	_	23	nn	_	_
22	initiation	_	NN	NN	_	23	nn	_	_
23	site	_	NN	NN	_	19	pobj	_	_
24	in	_	IN	IN	_	23	prep	_	_
25	murine	_	JJ	JJ	_	24	pobj	_	_
26	and	_	CC	CC	_	25	cc	_	_
27	human	_	JJ	JJ	_	25	conj	_	_
28	p40	_	NN	NN	_	29	nn	_	_
29	genes	_	NNS	NNS	_	25	dep	_	_
30	formed	_	VBD	VBD	_	5	ccomp	_	_
31	an	_	DT	DT	_	33	det	_	_
32	NF-kappaB	_	NN	NN	_	33	nn	_	_
33	complex	_	NN	NN	_	30	dobj	_	_
34	with	_	IN	IN	_	33	prep	_	_
35	nuclear	_	JJ	JJ	_	36	amod	_	_
36	extract	_	NN	NN	_	34	pobj	_	_
37	from	_	IN	IN	_	36	prep	_	_
38	Daudi	_	NN	NN	_	39	nn	_	_
39	cells	_	NNS	NNS	_	37	pobj	_	_
40	stimulated	_	VBN	VBN	_	39	vmod	_	_
41	by	_	IN	IN	_	40	prep	_	_
42	CD40	_	NN	NN	_	43	nn	_	_
43	ligation	_	NN	NN	_	41	pobj	_	_
44	.	_	.	.	_	5	punct	_	_

1	Moreover	_	RB	RB	_	25	advmod	_	_
2	,	_	,	,	_	25	punct	_	_
3	transfection	_	NN	NN	_	25	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	Daudi	_	NN	NN	_	6	nn	_	_
6	cells	_	NNS	NNS	_	4	pobj	_	_
7	with	_	IN	IN	_	3	prep	_	_
8	the	_	DT	DT	_	12	det	_	_
9	polymerized	_	JJ	JJ	_	12	amod	_	_
10	NF-kappaB	_	NN	NN	_	12	nn	_	_
11	binding	_	NN	NN	_	12	nn	_	_
12	sequence	_	NN	NN	_	7	pobj	_	_
13	ligated	_	VBN	VBN	_	12	vmod	_	_
14	to	_	TO	TO	_	13	prep	_	_
15	a	_	DT	DT	_	23	det	_	_
16	thymidine	_	NN	NN	_	23	nn	_	_
17	kinase/chloramphenicol	_	NN	NN	_	23	nn	_	_
18	acetyltransferase	_	NN	NN	_	23	nn	_	_
19	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
20	CAT	_	NN	NN	_	23	nn	_	_
21	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
22	reporter	_	NN	NN	_	23	nn	_	_
23	plasmid	_	NN	NN	_	14	pobj	_	_
24	greatly	_	RB	RB	_	25	advmod	_	_
25	induced	_	VBD	VBD	_	0	root	_	_
26	CAT	_	NN	NN	_	27	nn	_	_
27	activity	_	NN	NN	_	25	dobj	_	_
28	,	_	,	,	_	25	punct	_	_
29	but	_	CC	CC	_	25	cc	_	_
30	transfection	_	NN	NN	_	38	nsubj	_	_
31	with	_	IN	IN	_	30	prep	_	_
32	the	_	DT	DT	_	37	det	_	_
33	polymerized	_	JJ	JJ	_	37	amod	_	_
34	mutated	_	VBN	VBN	_	37	amod	_	_
35	NF-kappaB	_	NN	NN	_	37	nn	_	_
36	binding	_	NN	NN	_	37	nn	_	_
37	sequence	_	NN	NN	_	31	pobj	_	_
38	did	_	VBD	VBD	_	25	conj	_	_
39	not	_	RB	RB	_	38	neg	_	_
40	.	_	.	.	_	25	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	28	mark	_	_
5	the	_	DT	DT	_	8	det	_	_
6	NF-kappaB	_	NN	NN	_	8	nn	_	_
7	binding	_	NN	NN	_	8	nn	_	_
8	site	_	NN	NN	_	28	nsubj	_	_
9	located	_	JJ	JJ	_	8	amod	_	_
10	around	_	IN	IN	_	9	prep	_	_
11	120	_	CD	CD	_	12	num	_	_
12	bp	_	NN	NN	_	10	pobj	_	_
13	upstream	_	RB	RB	_	12	advmod	_	_
14	of	_	IN	IN	_	12	prep	_	_
15	the	_	DT	DT	_	18	det	_	_
16	transcription	_	NN	NN	_	18	nn	_	_
17	initiation	_	NN	NN	_	18	nn	_	_
18	site	_	NN	NN	_	14	pobj	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	murine	_	JJ	JJ	_	19	pobj	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	human	_	JJ	JJ	_	20	conj	_	_
23	p40	_	NN	NN	_	25	nn	_	_
24	promoter	_	NN	NN	_	25	nn	_	_
25	regions	_	NNS	NNS	_	20	dep	_	_
26	could	_	MD	MD	_	28	aux	_	_
27	be	_	VB	VB	_	28	cop	_	_
28	important	_	JJ	JJ	_	3	ccomp	_	_
29	for	_	IN	IN	_	28	prep	_	_
30	the	_	DT	DT	_	32	det	_	_
31	p40	_	NN	NN	_	32	nn	_	_
32	induction	_	NN	NN	_	29	pobj	_	_
33	by	_	IN	IN	_	32	prep	_	_
34	CD40	_	NN	NN	_	35	nn	_	_
35	ligation	_	NN	NN	_	33	pobj	_	_
36	via	_	IN	IN	_	35	prep	_	_
37	activation	_	NN	NN	_	36	pobj	_	_
38	of	_	IN	IN	_	37	prep	_	_
39	NF-kappaB	_	NN	NN	_	38	pobj	_	_
40	.	_	.	.	_	3	punct	_	_

1	Inhibition	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	nuclear	_	JJ	JJ	_	10	amod	_	_
4	factor	_	NN	NN	_	10	nn	_	_
5	kappa	_	NN	NN	_	10	nn	_	_
6	B	_	NN	NN	_	10	nn	_	_
7	subunit	_	NN	NN	_	10	nn	_	_
8	p65	_	NN	NN	_	10	nn	_	_
9	mRNA	_	NN	NN	_	10	nn	_	_
10	accumulation	_	NN	NN	_	2	pobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	lipopolysaccharide-stimulated	_	JJ	JJ	_	15	amod	_	_
13	human	_	JJ	JJ	_	15	amod	_	_
14	monocytic	_	JJ	JJ	_	15	amod	_	_
15	cells	_	NNS	NNS	_	11	pobj	_	_
16	treated	_	VBN	VBN	_	15	vmod	_	_
17	with	_	IN	IN	_	16	prep	_	_
18	sodium	_	NN	NN	_	19	nn	_	_
19	salicylate	_	NN	NN	_	17	pobj	_	_
20	.	_	.	.	_	1	punct	_	_

1	Lipopolysaccharide	_	NN	NN	_	14	nsubj	_	_
2	is	_	VBZ	VBZ	_	14	cop	_	_
3	one	_	CD	CD	_	14	dep	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	9	det	_	_
6	most	_	RBS	RBS	_	7	advmod	_	_
7	potent	_	JJ	JJ	_	9	amod	_	_
8	trigger	_	NN	NN	_	9	nn	_	_
9	substances	_	NNS	NNS	_	4	pobj	_	_
10	for	_	IN	IN	_	14	prep	_	_
11	monocytes	_	NNS	NNS	_	10	pobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	macrophages	_	NNS	NNS	_	11	conj	_	_
14	causing	_	VBG	VBG	_	0	root	_	_
15	secretion	_	NN	NN	_	14	dobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	inflammatory	_	JJ	JJ	_	18	amod	_	_
18	mediators	_	NNS	NNS	_	16	pobj	_	_
19	such	_	JJ	JJ	_	20	mwe	_	_
20	as	_	IN	IN	_	18	prep	_	_
21	tumor	_	NN	NN	_	23	nn	_	_
22	necrosis	_	NN	NN	_	23	nn	_	_
23	factor	_	NN	NN	_	20	pobj	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	interleukin-1	_	NN	NN	_	23	conj	_	_
26	.	_	.	.	_	14	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	nature	_	NN	NN	_	16	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	nuclear	_	JJ	JJ	_	6	amod	_	_
6	factors	_	NNS	NNS	_	3	pobj	_	_
7	involved	_	VBN	VBN	_	6	vmod	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	regulation	_	NN	NN	_	8	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	these	_	DT	DT	_	13	det	_	_
12	cytokine	_	NN	NN	_	13	nn	_	_
13	genes	_	NNS	NNS	_	10	pobj	_	_
14	is	_	VBZ	VBZ	_	16	cop	_	_
15	still	_	RB	RB	_	16	advmod	_	_
16	unknown	_	JJ	JJ	_	0	root	_	_
17	.	_	.	.	_	16	punct	_	_

1	Nuclear	_	JJ	JJ	_	15	amod	_	_
2	factor	_	NN	NN	_	15	nn	_	_
3	kappa	_	NN	NN	_	15	nn	_	_
4	B	_	NN	NN	_	15	nn	_	_
5	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
6	NF-kappa	_	NN	NN	_	7	nn	_	_
7	B	_	NN	NN	_	15	dep	_	_
8	;	_	:	:	_	7	punct	_	_
9	heterodimer	_	NN	NN	_	7	dep	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	p50	_	NN	NN	_	10	pobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	p65	_	NN	NN	_	11	conj	_	_
14	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
15	proteins	_	NNS	NNS	_	18	nsubjpass	_	_
16	have	_	VBP	VBP	_	18	aux	_	_
17	been	_	VBN	VBN	_	18	auxpass	_	_
18	suggested	_	VBN	VBN	_	0	root	_	_
19	to	_	TO	TO	_	20	aux	_	_
20	play	_	VB	VB	_	18	xcomp	_	_
21	an	_	DT	DT	_	23	det	_	_
22	important	_	JJ	JJ	_	23	amod	_	_
23	role	_	NN	NN	_	20	dobj	_	_
24	in	_	IN	IN	_	20	prep	_	_
25	gene	_	NN	NN	_	26	nn	_	_
26	transcription	_	NN	NN	_	24	pobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	inflammatory	_	JJ	JJ	_	29	amod	_	_
29	mediators	_	NNS	NNS	_	27	pobj	_	_
30	when	_	WRB	WRB	_	33	advmod	_	_
31	monocytes	_	NNS	NNS	_	33	nsubjpass	_	_
32	are	_	VBP	VBP	_	33	auxpass	_	_
33	stimulated	_	VBN	VBN	_	20	dep	_	_
34	with	_	IN	IN	_	33	prep	_	_
35	lipopolysaccharide	_	NN	NN	_	34	pobj	_	_
36	.	_	.	.	_	18	punct	_	_

1	Nonsteroidal	_	JJ	JJ	_	3	amod	_	_
2	anti-inflammatory	_	JJ	JJ	_	3	amod	_	_
3	drugs	_	NNS	NNS	_	9	nsubjpass	_	_
4	such	_	JJ	JJ	_	5	mwe	_	_
5	as	_	IN	IN	_	3	prep	_	_
6	salicylates	_	NNS	NNS	_	5	pobj	_	_
7	have	_	VBP	VBP	_	9	aux	_	_
8	been	_	VBN	VBN	_	9	auxpass	_	_
9	used	_	VBN	VBN	_	0	root	_	_
10	to	_	TO	TO	_	11	aux	_	_
11	treat	_	VB	VB	_	9	xcomp	_	_
12	symptoms	_	NNS	NNS	_	11	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	inflammation	_	NN	NN	_	13	pobj	_	_
15	,	_	,	,	_	9	punct	_	_
16	and	_	CC	CC	_	9	cc	_	_
17	a	_	DT	DT	_	19	det	_	_
18	new	_	JJ	JJ	_	19	amod	_	_
19	mechanism	_	NN	NN	_	24	nsubjpass	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	drug	_	NN	NN	_	22	nn	_	_
22	action	_	NN	NN	_	20	pobj	_	_
23	was	_	VBD	VBD	_	24	auxpass	_	_
24	suggested	_	VBN	VBN	_	9	conj	_	_
25	recently	_	RB	RB	_	24	advmod	_	_
26	.	_	.	.	_	9	punct	_	_

1	Salicylates	_	NNS	NNS	_	4	nsubjpass	_	_
2	have	_	VBP	VBP	_	4	aux	_	_
3	been	_	VBN	VBN	_	4	auxpass	_	_
4	shown	_	VBN	VBN	_	0	root	_	_
5	to	_	TO	TO	_	6	aux	_	_
6	inhibit	_	VB	VB	_	4	xcomp	_	_
7	lipopolysaccharide-induced	_	JJ	JJ	_	9	amod	_	_
8	gene	_	NN	NN	_	9	nn	_	_
9	transcription	_	NN	NN	_	6	dobj	_	_
10	via	_	IN	IN	_	6	prep	_	_
11	inhibition	_	NN	NN	_	10	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	NF-kappa	_	NN	NN	_	15	nn	_	_
14	B	_	NN	NN	_	15	nn	_	_
15	activation	_	NN	NN	_	12	pobj	_	_
16	by	_	IN	IN	_	11	prep	_	_
17	preventing	_	VBG	VBG	_	16	pcomp	_	_
18	the	_	DT	DT	_	19	det	_	_
19	degradation	_	NN	NN	_	17	dobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	NF-kappa	_	NN	NN	_	23	nn	_	_
22	B	_	NN	NN	_	23	nn	_	_
23	inhibitor	_	NN	NN	_	20	pobj	_	_
24	``	_	``	``	_	27	punct	_	_
25	I	_	NN	NN	_	27	nn	_	_
26	kappa	_	NN	NN	_	27	nn	_	_
27	B	_	NN	NN	_	23	dep	_	_
28	,	_	,	,	_	17	punct	_	_
29	blocking	_	VBG	VBG	_	17	dep	_	_
30	the	_	DT	DT	_	31	det	_	_
31	translocation	_	NN	NN	_	29	dobj	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	NF-kappa	_	NN	NN	_	34	nn	_	_
34	B	_	NN	NN	_	32	pobj	_	_
35	into	_	IN	IN	_	31	prep	_	_
36	the	_	DT	DT	_	38	det	_	_
37	nuclear	_	JJ	JJ	_	38	amod	_	_
38	compartment	_	NN	NN	_	35	pobj	_	_
39	.	_	.	.	_	4	punct	_	_

1	However	_	RB	RB	_	15	advmod	_	_
2	,	_	,	,	_	15	punct	_	_
3	the	_	DT	DT	_	4	det	_	_
4	nature	_	NN	NN	_	15	nsubjpass	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	7	det	_	_
7	subunit	_	NN	NN	_	5	pobj	_	_
8	involved	_	VBN	VBN	_	7	vmod	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	this	_	DT	DT	_	11	det	_	_
11	mechanism	_	NN	NN	_	9	pobj	_	_
12	has	_	VBZ	VBZ	_	15	aux	_	_
13	not	_	RB	RB	_	15	neg	_	_
14	been	_	VBN	VBN	_	15	auxpass	_	_
15	defined	_	VBN	VBN	_	0	root	_	_
16	.	_	.	.	_	15	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	examine	_	VB	VB	_	34	advcl	_	_
3	the	_	DT	DT	_	4	det	_	_
4	mechanisms	_	NNS	NNS	_	2	dobj	_	_
5	by	_	IN	IN	_	8	prep	_	_
6	which	_	WDT	WDT	_	5	pobj	_	_
7	salicylates	_	NNS	NNS	_	8	nsubj	_	_
8	affect	_	VBP	VBP	_	4	rcmod	_	_
9	cytokine	_	NN	NN	_	11	nn	_	_
10	gene	_	NN	NN	_	11	nn	_	_
11	transcription	_	NN	NN	_	8	dobj	_	_
12	,	_	,	,	_	34	punct	_	_
13	the	_	DT	DT	_	14	det	_	_
14	amount	_	NN	NN	_	34	nsubjpass	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	active	_	JJ	JJ	_	20	amod	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	inactive	_	JJ	JJ	_	16	conj	_	_
19	NF-kappa	_	NN	NN	_	20	nn	_	_
20	B	_	NN	NN	_	15	pobj	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	NF-kappa	_	NN	NN	_	24	nn	_	_
23	B	_	NN	NN	_	24	nn	_	_
24	mRNA	_	NN	NN	_	20	conj	_	_
25	,	_	,	,	_	14	punct	_	_
26	in	_	IN	IN	_	14	prep	_	_
27	Porphyromonas	_	NN	NN	_	32	nn	_	_
28	gingivalis	_	NN	NN	_	32	nn	_	_
29	lipopolysaccharide-stimulated	_	JJ	JJ	_	32	amod	_	_
30	human	_	JJ	JJ	_	32	amod	_	_
31	monocytic	_	JJ	JJ	_	32	amod	_	_
32	cells	_	NNS	NNS	_	26	pobj	_	_
33	was	_	VBD	VBD	_	34	auxpass	_	_
34	assessed	_	VBN	VBN	_	0	root	_	_
35	.	_	.	.	_	34	punct	_	_

1	High	_	JJ	JJ	_	2	amod	_	_
2	doses	_	NNS	NNS	_	6	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	sodium	_	NN	NN	_	5	nn	_	_
5	salicylate	_	NN	NN	_	3	pobj	_	_
6	suppressed	_	VBD	VBD	_	0	root	_	_
7	NF-kappa	_	NN	NN	_	11	nn	_	_
8	B	_	NN	NN	_	11	nn	_	_
9	p65	_	NN	NN	_	11	nn	_	_
10	mRNA	_	NN	NN	_	11	nn	_	_
11	accumulation	_	NN	NN	_	6	dobj	_	_
12	,	_	,	,	_	6	punct	_	_
13	resulting	_	VBG	VBG	_	6	vmod	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	suppression	_	NN	NN	_	14	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	total	_	JJ	JJ	_	19	amod	_	_
18	NF-kappa	_	NN	NN	_	19	nn	_	_
19	B	_	NN	NN	_	16	pobj	_	_
20	,	_	,	,	_	6	punct	_	_
21	p50	_	NN	NN	_	25	nsubj	_	_
22	on	_	IN	IN	_	21	prep	_	_
23	tissue	_	NN	NN	_	24	nn	_	_
24	oligonucleotide	_	NN	NN	_	22	pobj	_	_
25	had	_	VBD	VBD	_	6	parataxis	_	_
26	no	_	DT	DT	_	27	neg	_	_
27	effects	_	NNS	NNS	_	25	dobj	_	_
28	on	_	IN	IN	_	25	prep	_	_
29	lipopolysaccharide-induced	_	JJ	JJ	_	32	amod	_	_
30	NF-kappa	_	NN	NN	_	32	nn	_	_
31	B	_	NN	NN	_	32	nn	_	_
32	activation	_	NN	NN	_	28	pobj	_	_
33	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	demonstrate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	12	mark	_	_
5	the	_	DT	DT	_	7	det	_	_
6	p65	_	NN	NN	_	7	nn	_	_
7	subunit	_	NN	NN	_	12	nsubjpass	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	NF-kappa	_	NN	NN	_	10	nn	_	_
10	B	_	NN	NN	_	8	pobj	_	_
11	is	_	VBZ	VBZ	_	12	auxpass	_	_
12	inhibited	_	VBN	VBN	_	3	ccomp	_	_
13	by	_	IN	IN	_	12	prep	_	_
14	salicylate	_	NN	NN	_	15	nn	_	_
15	treatment	_	NN	NN	_	13	pobj	_	_
16	and	_	CC	CC	_	12	cc	_	_
17	highlight	_	VBP	VBP	_	12	conj	_	_
18	the	_	DT	DT	_	19	det	_	_
19	role	_	NN	NN	_	17	dobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	salicylate	_	NN	NN	_	20	pobj	_	_
22	in	_	IN	IN	_	17	prep	_	_
23	the	_	DT	DT	_	24	det	_	_
24	control	_	NN	NN	_	22	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	gene	_	NN	NN	_	27	nn	_	_
27	expression	_	NN	NN	_	25	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	inflammatory	_	JJ	JJ	_	30	amod	_	_
30	mediators	_	NNS	NNS	_	28	pobj	_	_
31	.	_	.	.	_	3	punct	_	_

1	Glucocorticoid	_	NN	NN	_	2	nn	_	_
2	receptors	_	NNS	NNS	_	0	root	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	cord	_	NN	NN	_	6	nn	_	_
5	blood	_	NN	NN	_	6	nn	_	_
6	lymphocytes	_	NNS	NNS	_	3	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	healthy	_	JJ	JJ	_	9	amod	_	_
9	neonates	_	NNS	NNS	_	7	pobj	_	_
10	and	_	CC	CC	_	7	cc	_	_
11	of	_	IN	IN	_	7	conj	_	_
12	preterms	_	NNS	NNS	_	11	pobj	_	_
13	suffering	_	VBG	VBG	_	12	vmod	_	_
14	from	_	IN	IN	_	13	prep	_	_
15	respiratory	_	JJ	JJ	_	17	amod	_	_
16	distress	_	NN	NN	_	17	nn	_	_
17	syndrome	_	NN	NN	_	14	pobj	_	_
18	.	_	.	.	_	2	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	measured	_	VBD	VBD	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	number	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	glucocorticoid	_	NN	NN	_	7	nn	_	_
7	receptors	_	NNS	NNS	_	5	pobj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	GR	_	NN	NN	_	7	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	in	_	IN	IN	_	7	prep	_	_
12	cord	_	NN	NN	_	14	nn	_	_
13	blood	_	NN	NN	_	14	nn	_	_
14	lymphocytes	_	NNS	NNS	_	11	pobj	_	_
15	and	_	CC	CC	_	4	cc	_	_
16	the	_	DT	DT	_	18	det	_	_
17	binding	_	NN	NN	_	18	nn	_	_
18	affinity	_	NN	NN	_	4	conj	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	Kd	_	NN	NN	_	18	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	in	_	IN	IN	_	4	prep	_	_
23	15	_	CD	CD	_	24	num	_	_
24	term	_	NN	NN	_	22	pobj	_	_
25	and	_	CC	CC	_	22	cc	_	_
26	in	_	IN	IN	_	22	conj	_	_
27	20	_	CD	CD	_	29	num	_	_
28	preterm	_	JJ	JJ	_	29	amod	_	_
29	babies	_	NNS	NNS	_	26	pobj	_	_
30	.	_	.	.	_	2	punct	_	_

1	Thirteen	_	CD	CD	_	2	num	_	_
2	preterms	_	NNS	NNS	_	7	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	latter	_	JJ	JJ	_	6	amod	_	_
6	group	_	NN	NN	_	3	pobj	_	_
7	received	_	VBD	VBD	_	0	root	_	_
8	prenatal	_	JJ	JJ	_	10	amod	_	_
9	steroid	_	NN	NN	_	10	nn	_	_
10	treatment	_	NN	NN	_	7	dobj	_	_
11	.	_	.	.	_	7	punct	_	_

1	Seven	_	CD	CD	_	2	num	_	_
2	preterms	_	NNS	NNS	_	3	nsubj	_	_
3	developed	_	VBD	VBD	_	0	root	_	_
4	neonatal	_	JJ	JJ	_	7	amod	_	_
5	respiratory	_	JJ	JJ	_	7	amod	_	_
6	distress	_	NN	NN	_	7	nn	_	_
7	syndrome	_	NN	NN	_	3	dobj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	NRDS	_	NN	NN	_	7	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	number	_	NN	NN	_	9	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	GR	_	NN	NN	_	3	pobj	_	_
5	and	_	CC	CC	_	2	cc	_	_
6	the	_	DT	DT	_	7	det	_	_
7	Kd	_	NN	NN	_	2	conj	_	_
8	were	_	VBD	VBD	_	9	cop	_	_
9	similar	_	JJ	JJ	_	0	root	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	12	dep	_	_
12	term	_	NN	NN	_	10	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	preterm	_	JJ	JJ	_	12	conj	_	_
15	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
16	with	_	IN	IN	_	14	prep	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	without	_	IN	IN	_	16	conj	_	_
19	NRDS	_	NN	NN	_	16	pobj	_	_
20	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
21	babies	_	NNS	NNS	_	12	dep	_	_
22	.	_	.	.	_	9	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	maximum	_	NN	NN	_	4	nn	_	_
3	-LRB-3H-RRB--thymidine	_	NN	NN	_	4	nn	_	_
4	incorporation	_	NN	NN	_	20	nsubjpass	_	_
5	into	_	IN	IN	_	4	prep	_	_
6	DNA	_	NN	NN	_	5	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	cord	_	NN	NN	_	10	nn	_	_
9	blood	_	NN	NN	_	10	nn	_	_
10	lymphocytes	_	NNS	NNS	_	7	pobj	_	_
11	from	_	IN	IN	_	10	prep	_	_
12	all	_	DT	DT	_	13	det	_	_
13	preterms	_	NNS	NNS	_	11	pobj	_	_
14	,	_	,	,	_	13	punct	_	_
15	with	_	IN	IN	_	13	prep	_	_
16	or	_	CC	CC	_	15	cc	_	_
17	without	_	IN	IN	_	15	conj	_	_
18	NRDS	_	NN	NN	_	15	pobj	_	_
19	was	_	VBD	VBD	_	20	auxpass	_	_
20	suppressed	_	VBN	VBN	_	0	root	_	_
21	when	_	WRB	WRB	_	22	advmod	_	_
22	compared	_	VBN	VBN	_	20	advcl	_	_
23	to	_	TO	TO	_	22	prep	_	_
24	that	_	DT	DT	_	23	pobj	_	_
25	from	_	IN	IN	_	24	prep	_	_
26	term	_	NN	NN	_	27	nn	_	_
27	babies	_	NNS	NNS	_	25	pobj	_	_
28	or	_	CC	CC	_	27	cc	_	_
29	adults	_	NNS	NNS	_	27	conj	_	_
30	.	_	.	.	_	20	punct	_	_

1	This	_	DT	DT	_	5	nsubjpass	_	_
2	could	_	MD	MD	_	5	aux	_	_
3	partly	_	RB	RB	_	5	advmod	_	_
4	be	_	VB	VB	_	5	auxpass	_	_
5	explained	_	VBN	VBN	_	0	root	_	_
6	by	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	10	det	_	_
8	antenatal	_	JJ	JJ	_	10	amod	_	_
9	steroid	_	NN	NN	_	10	nn	_	_
10	treatment	_	NN	NN	_	6	pobj	_	_
11	.	_	.	.	_	5	punct	_	_

1	Sensitivity	_	NN	NN	_	16	nsubj	_	_
2	-LRB-	_	-LRB-	-LRB-	_	3	punct	_	_
3	ID50	_	NN	NN	_	1	appos	_	_
4	-RRB-	_	-RRB-	-RRB-	_	3	punct	_	_
5	of	_	IN	IN	_	1	prep	_	_
6	the	_	DT	DT	_	7	det	_	_
7	lymphocytes	_	NNS	NNS	_	5	pobj	_	_
8	for	_	IN	IN	_	1	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	inhibitory	_	JJ	JJ	_	11	amod	_	_
11	effect	_	NN	NN	_	8	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	dexamethasone	_	NN	NN	_	12	pobj	_	_
14	was	_	VBD	VBD	_	16	cop	_	_
15	the	_	DT	DT	_	16	det	_	_
16	same	_	JJ	JJ	_	0	root	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	all	_	DT	DT	_	19	det	_	_
19	groups	_	NNS	NNS	_	17	pobj	_	_
20	.	_	.	.	_	16	punct	_	_

1	In	_	IN	IN	_	16	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	study	_	NN	NN	_	1	pobj	_	_
4	on	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	6	dep	_	_
6	number	_	NN	NN	_	4	pobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	function	_	NN	NN	_	6	conj	_	_
9	of	_	IN	IN	_	6	prep	_	_
10	GR	_	NN	NN	_	9	pobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	lymphocytes	_	NNS	NNS	_	11	pobj	_	_
13	,	_	,	,	_	16	punct	_	_
14	we	_	PRP	PRP	_	16	nsubj	_	_
15	were	_	VBD	VBD	_	16	cop	_	_
16	unable	_	JJ	JJ	_	0	root	_	_
17	to	_	TO	TO	_	18	aux	_	_
18	find	_	VB	VB	_	16	xcomp	_	_
19	a	_	DT	DT	_	20	det	_	_
20	relation	_	NN	NN	_	18	dobj	_	_
21	between	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	23	det	_	_
23	functionality	_	NN	NN	_	21	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	the	_	DT	DT	_	26	det	_	_
26	GR	_	NN	NN	_	24	pobj	_	_
27	and	_	CC	CC	_	23	cc	_	_
28	the	_	DT	DT	_	29	det	_	_
29	development	_	NN	NN	_	23	conj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	NRDS	_	NN	NN	_	30	pobj	_	_
32	.	_	.	.	_	16	punct	_	_

1	Oxidants	_	NNS	NNS	_	0	root	_	_
2	,	_	,	,	_	1	punct	_	_
3	transcription	_	NN	NN	_	4	nn	_	_
4	factors	_	NNS	NNS	_	1	conj	_	_
5	,	_	,	,	_	1	punct	_	_
6	and	_	CC	CC	_	1	cc	_	_
7	intestinal	_	JJ	JJ	_	8	amod	_	_
8	inflammation	_	NN	NN	_	1	conj	_	_
9	.	_	.	.	_	1	punct	_	_

1	It	_	PRP	PRP	_	5	nsubjpass	_	_
2	is	_	VBZ	VBZ	_	5	auxpass	_	_
3	now	_	RB	RB	_	5	advmod	_	_
4	well	_	RB	RB	_	5	advmod	_	_
5	appreciated	_	VBN	VBN	_	0	root	_	_
6	that	_	IN	IN	_	11	mark	_	_
7	chronic	_	JJ	JJ	_	9	amod	_	_
8	gut	_	NN	NN	_	9	nn	_	_
9	inflammation	_	NN	NN	_	11	nsubjpass	_	_
10	is	_	VBZ	VBZ	_	11	auxpass	_	_
11	characterized	_	VBN	VBN	_	5	ccomp	_	_
12	by	_	IN	IN	_	11	prep	_	_
13	enhanced	_	VBN	VBN	_	14	amod	_	_
14	production	_	NN	NN	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	reactive	_	JJ	JJ	_	17	amod	_	_
17	metabolites	_	NNS	NNS	_	15	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	oxygen	_	NN	NN	_	18	pobj	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	nitrogen	_	NN	NN	_	19	conj	_	_
22	.	_	.	.	_	5	punct	_	_

1	Some	_	DT	DT	_	6	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	these	_	DT	DT	_	4	det	_	_
4	oxidants	_	NNS	NNS	_	2	pobj	_	_
5	are	_	VBP	VBP	_	6	auxpass	_	_
6	known	_	VBN	VBN	_	0	root	_	_
7	to	_	TO	TO	_	8	aux	_	_
8	modulate	_	VB	VB	_	6	xcomp	_	_
9	the	_	DT	DT	_	10	det	_	_
10	expression	_	NN	NN	_	8	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	a	_	DT	DT	_	13	det	_	_
13	variety	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	genes	_	NNS	NNS	_	14	pobj	_	_
16	that	_	WDT	WDT	_	18	nsubjpass	_	_
17	are	_	VBP	VBP	_	18	auxpass	_	_
18	involved	_	VBN	VBN	_	13	rcmod	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	21	dep	_	_
21	immune	_	JJ	JJ	_	19	pobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	inflammatory	_	JJ	JJ	_	21	conj	_	_
24	responses	_	NNS	NNS	_	21	dep	_	_
25	.	_	.	.	_	6	punct	_	_

1	For	_	IN	IN	_	7	prep	_	_
2	example	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	7	punct	_	_
4	certain	_	JJ	JJ	_	5	amod	_	_
5	oxidants	_	NNS	NNS	_	7	nsubjpass	_	_
6	are	_	VBP	VBP	_	7	auxpass	_	_
7	known	_	VBN	VBN	_	0	root	_	_
8	to	_	TO	TO	_	9	aux	_	_
9	activate	_	VB	VB	_	7	xcomp	_	_
10	the	_	DT	DT	_	15	det	_	_
11	nuclear	_	JJ	JJ	_	15	amod	_	_
12	transcription	_	NN	NN	_	15	nn	_	_
13	factor	_	NN	NN	_	15	nn	_	_
14	kappa	_	NN	NN	_	15	nn	_	_
15	B	_	NN	NN	_	9	dobj	_	_
16	,	_	,	,	_	15	punct	_	_
17	which	_	WDT	WDT	_	18	nsubj	_	_
18	regulates	_	VBZ	VBZ	_	15	rcmod	_	_
19	the	_	DT	DT	_	20	det	_	_
20	expression	_	NN	NN	_	18	dobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	a	_	DT	DT	_	23	det	_	_
23	variety	_	NN	NN	_	21	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	different	_	JJ	JJ	_	27	amod	_	_
26	adhesion	_	NN	NN	_	27	nn	_	_
27	molecules	_	NNS	NNS	_	24	pobj	_	_
28	,	_	,	,	_	27	punct	_	_
29	cytokines	_	NNS	NNS	_	27	conj	_	_
30	,	_	,	,	_	27	punct	_	_
31	and	_	CC	CC	_	27	cc	_	_
32	enzymes	_	NNS	NNS	_	27	conj	_	_
33	.	_	.	.	_	7	punct	_	_

1	Oxidants	_	NNS	NNS	_	4	nsubjpass	_	_
2	are	_	VBP	VBP	_	4	auxpass	_	_
3	also	_	RB	RB	_	4	advmod	_	_
4	known	_	VBN	VBN	_	0	root	_	_
5	to	_	TO	TO	_	6	aux	_	_
6	activate	_	VB	VB	_	4	xcomp	_	_
7	another	_	DT	DT	_	9	det	_	_
8	transcription	_	NN	NN	_	9	nn	_	_
9	factor	_	NN	NN	_	6	dobj	_	_
10	,	_	,	,	_	9	punct	_	_
11	activator	_	NN	NN	_	12	nn	_	_
12	protein-1	_	NN	NN	_	9	appos	_	_
13	.	_	.	.	_	4	punct	_	_

1	This	_	DT	DT	_	3	det	_	_
2	transcription	_	NN	NN	_	3	nn	_	_
3	factor	_	NN	NN	_	5	nsubjpass	_	_
4	is	_	VBZ	VBZ	_	5	auxpass	_	_
5	composed	_	VBN	VBN	_	0	root	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	products	_	NNS	NNS	_	6	pobj	_	_
8	from	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	14	det	_	_
10	fos	_	NN	NN	_	14	nn	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	jun	_	NN	NN	_	10	conj	_	_
13	proto-oncogene	_	NN	NN	_	14	nn	_	_
14	family	_	NN	NN	_	8	pobj	_	_
15	and	_	CC	CC	_	5	cc	_	_
16	is	_	VBZ	VBZ	_	17	auxpass	_	_
17	believed	_	VBN	VBN	_	5	conj	_	_
18	to	_	TO	TO	_	20	aux	_	_
19	be	_	VB	VB	_	20	cop	_	_
20	important	_	JJ	JJ	_	17	xcomp	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	regulating	_	VBG	VBG	_	21	pcomp	_	_
23	cell	_	NN	NN	_	22	dobj	_	_
24	growth	_	NN	NN	_	23	dep	_	_
25	and	_	CC	CC	_	23	cc	_	_
26	proliferation	_	NN	NN	_	23	conj	_	_
27	.	_	.	.	_	5	punct	_	_

1	Finally	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	oxidants	_	NNS	NNS	_	5	nsubjpass	_	_
4	are	_	VBP	VBP	_	5	auxpass	_	_
5	believed	_	VBN	VBN	_	0	root	_	_
6	to	_	TO	TO	_	7	aux	_	_
7	promote	_	VB	VB	_	5	xcomp	_	_
8	intestinal	_	JJ	JJ	_	10	amod	_	_
9	epithelial	_	JJ	JJ	_	10	amod	_	_
10	cell	_	NN	NN	_	11	nn	_	_
11	apoptosis	_	NN	NN	_	7	dobj	_	_
12	,	_	,	,	_	5	punct	_	_
13	and	_	CC	CC	_	5	cc	_	_
14	the	_	DT	DT	_	18	det	_	_
15	B-cell	_	NN	NN	_	18	nn	_	_
16	lymphoma/leukemia-2	_	NN	NN	_	18	nn	_	_
17	gene	_	NN	NN	_	18	nn	_	_
18	product	_	NN	NN	_	20	nsubjpass	_	_
19	is	_	VBZ	VBZ	_	20	auxpass	_	_
20	believed	_	VBN	VBN	_	5	conj	_	_
21	to	_	TO	TO	_	22	aux	_	_
22	inhibit	_	VB	VB	_	20	xcomp	_	_
23	this	_	DT	DT	_	24	det	_	_
24	phenomenon	_	NN	NN	_	22	dobj	_	_
25	in	_	IN	IN	_	22	prep	_	_
26	an	_	DT	DT	_	28	det	_	_
27	antioxidant-dependent	_	JJ	JJ	_	28	amod	_	_
28	manner	_	NN	NN	_	25	pobj	_	_
29	.	_	.	.	_	5	punct	_	_

1	Taken	_	VBN	VBN	_	0	root	_	_
2	together	_	RB	RB	_	1	advmod	_	_
3	,	_	,	,	_	1	punct	_	_
4	these	_	DT	DT	_	5	det	_	_
5	observations	_	NNS	NNS	_	6	nsubj	_	_
6	suggest	_	VBP	VBP	_	1	parataxis	_	_
7	that	_	IN	IN	_	17	mark	_	_
8	nontoxic	_	JJ	JJ	_	9	amod	_	_
9	concentrations	_	NNS	NNS	_	17	nsubj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	reactive	_	JJ	JJ	_	12	amod	_	_
12	metabolites	_	NNS	NNS	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	oxygen	_	NN	NN	_	13	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	nitrogen	_	NN	NN	_	14	conj	_	_
17	play	_	VBP	VBP	_	6	ccomp	_	_
18	an	_	DT	DT	_	20	det	_	_
19	important	_	JJ	JJ	_	20	amod	_	_
20	role	_	NN	NN	_	17	dobj	_	_
21	in	_	IN	IN	_	17	prep	_	_
22	regulating	_	VBG	VBG	_	21	pcomp	_	_
23	the	_	DT	DT	_	24	det	_	_
24	expression	_	NN	NN	_	22	dobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	genes	_	NNS	NNS	_	25	pobj	_	_
27	involved	_	VBN	VBN	_	26	vmod	_	_
28	in	_	IN	IN	_	27	prep	_	_
29	the	_	DT	DT	_	31	det	_	_
30	inflammatory	_	JJ	JJ	_	31	amod	_	_
31	response	_	NN	NN	_	28	pobj	_	_
32	and	_	CC	CC	_	21	cc	_	_
33	in	_	IN	IN	_	21	conj	_	_
34	modulating	_	VBG	VBG	_	33	pcomp	_	_
35	apoptosis	_	NN	NN	_	34	dobj	_	_
36	.	_	.	.	_	1	punct	_	_

1	Glucocorticoid	_	NN	NN	_	2	nn	_	_
2	receptors	_	NNS	NNS	_	0	root	_	_
3	,	_	,	,	_	2	punct	_	_
4	fibromyalgia	_	NN	NN	_	2	appos	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	low	_	JJ	JJ	_	8	amod	_	_
7	back	_	JJ	JJ	_	8	amod	_	_
8	pain	_	NN	NN	_	4	conj	_	_
9	.	_	.	.	_	2	punct	_	_

1	Recently	_	RB	RB	_	8	advmod	_	_
2	,	_	,	,	_	8	punct	_	_
3	fibromyalgia	_	NN	NN	_	8	nsubjpass	_	_
4	-LRB-	_	-LRB-	-LRB-	_	5	punct	_	_
5	FMS	_	NN	NN	_	3	appos	_	_
6	-RRB-	_	-RRB-	-RRB-	_	5	punct	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	shown	_	VBN	VBN	_	0	root	_	_
9	to	_	TO	TO	_	12	aux	_	_
10	be	_	VB	VB	_	12	cop	_	_
11	a	_	DT	DT	_	12	det	_	_
12	disorder	_	NN	NN	_	8	xcomp	_	_
13	associated	_	VBN	VBN	_	12	vmod	_	_
14	with	_	IN	IN	_	13	prep	_	_
15	an	_	DT	DT	_	17	det	_	_
16	altered	_	JJ	JJ	_	17	amod	_	_
17	functioning	_	NN	NN	_	14	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	22	det	_	_
20	stress	_	NN	NN	_	22	nn	_	_
21	response	_	NN	NN	_	22	nn	_	_
22	system	_	NN	NN	_	18	pobj	_	_
23	.	_	.	.	_	8	punct	_	_

1	FMS	_	NN	NN	_	2	nn	_	_
2	patients	_	NNS	NNS	_	3	nsubj	_	_
3	display	_	VBP	VBP	_	0	root	_	_
4	a	_	DT	DT	_	12	det	_	_
5	hyperreactive	_	JJ	JJ	_	12	amod	_	_
6	pituitary	_	JJ	JJ	_	5	dep	_	_
7	adrenocorticotropic	_	JJ	JJ	_	8	amod	_	_
8	hormone	_	NN	NN	_	12	nn	_	_
9	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
10	ACTH	_	NN	NN	_	8	appos	_	_
11	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
12	release	_	NN	NN	_	3	dobj	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	response	_	NN	NN	_	13	pobj	_	_
15	to	_	TO	TO	_	14	prep	_	_
16	corticotropin-releasing	_	JJ	JJ	_	17	amod	_	_
17	hormone	_	NN	NN	_	15	pobj	_	_
18	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
19	CRH	_	NN	NN	_	17	appos	_	_
20	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	and	_	CC	CC	_	15	cc	_	_
22	to	_	TO	TO	_	15	conj	_	_
23	insulin-induced	_	JJ	JJ	_	24	amod	_	_
24	hypoglycemia	_	NN	NN	_	22	pobj	_	_
25	.	_	.	.	_	3	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	suggested	_	VBD	VBD	_	0	root	_	_
3	that	_	IN	IN	_	10	mark	_	_
4	negative	_	JJ	JJ	_	5	amod	_	_
5	feedback	_	NN	NN	_	10	nsubjpass	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	cortisol	_	NN	NN	_	6	pobj	_	_
8	could	_	MD	MD	_	10	aux	_	_
9	be	_	VB	VB	_	10	auxpass	_	_
10	deranged	_	VBN	VBN	_	2	ccomp	_	_
11	.	_	.	.	_	2	punct	_	_

1	Therefore	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	investigated	_	VBD	VBD	_	0	root	_	_
4	the	_	DT	DT	_	5	dep	_	_
5	properties	_	NNS	NNS	_	3	dobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	function	_	NN	NN	_	5	conj	_	_
8	of	_	IN	IN	_	5	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	glucocorticoid	_	NN	NN	_	11	nn	_	_
11	receptors	_	NNS	NNS	_	8	pobj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	GR	_	NN	NN	_	11	appos	_	_
14	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
15	in	_	IN	IN	_	11	prep	_	_
16	FMS	_	NN	NN	_	17	nn	_	_
17	patients	_	NNS	NNS	_	15	pobj	_	_
18	and	_	CC	CC	_	3	cc	_	_
19	compared	_	VBD	VBD	_	3	conj	_	_
20	the	_	DT	DT	_	21	det	_	_
21	results	_	NNS	NNS	_	19	dobj	_	_
22	with	_	IN	IN	_	19	prep	_	_
23	those	_	DT	DT	_	22	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	healthy	_	JJ	JJ	_	26	amod	_	_
26	persons	_	NNS	NNS	_	24	pobj	_	_
27	and	_	CC	CC	_	26	cc	_	_
28	patients	_	NNS	NNS	_	26	conj	_	_
29	with	_	IN	IN	_	28	prep	_	_
30	chronic	_	JJ	JJ	_	33	amod	_	_
31	low	_	JJ	JJ	_	33	amod	_	_
32	back	_	JJ	JJ	_	33	amod	_	_
33	pain	_	NN	NN	_	29	pobj	_	_
34	-LRB-	_	-LRB-	-LRB-	_	35	punct	_	_
35	LBP	_	NN	NN	_	33	appos	_	_
36	a	_	DT	DT	_	39	det	_	_
37	localized	_	JJ	JJ	_	39	amod	_	_
38	pain	_	NN	NN	_	39	nn	_	_
39	condition	_	NN	NN	_	35	dep	_	_
40	-RRB-	_	-RRB-	-RRB-	_	35	punct	_	_
41	.	_	.	.	_	3	punct	_	_

1	Forty	_	CD	CD	_	4	num	_	_
2	primary	_	JJ	JJ	_	4	amod	_	_
3	FMS	_	NN	NN	_	4	nn	_	_
4	patients	_	NNS	NNS	_	36	nsubjpass	_	_
5	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
6	F	_	NN	NN	_	8	nn	_	_
7	:	_	:	:	_	8	punct	_	_
8	M	_	NN	NN	_	4	dep	_	_
9	=	_	JJ	JJ	_	8	amod	_	_
10	36	_	CD	CD	_	12	num	_	_
11	:	_	:	:	_	12	punct	_	_
12	4	_	CD	CD	_	9	dep	_	_
13	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
14	,	_	,	,	_	4	punct	_	_
15	28	_	CD	CD	_	17	num	_	_
16	LBP	_	NN	NN	_	17	nn	_	_
17	patients	_	NNS	NNS	_	4	conj	_	_
18	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
19	25	_	CD	CD	_	21	num	_	_
20	:	_	:	:	_	21	punct	_	_
21	3	_	CD	CD	_	17	appos	_	_
22	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
23	and	_	CC	CC	_	4	cc	_	_
24	14	_	CD	CD	_	34	num	_	_
25	-LRB-	_	-LRB-	-LRB-	_	28	punct	_	_
26	12	_	CD	CD	_	28	num	_	_
27	:	_	:	:	_	28	punct	_	_
28	2	_	CD	CD	_	24	dep	_	_
29	-RRB-	_	-RRB-	-RRB-	_	28	punct	_	_
30	healthy	_	JJ	JJ	_	34	amod	_	_
31	,	_	,	,	_	30	punct	_	_
32	sedentary	_	JJ	JJ	_	30	dep	_	_
33	control	_	JJ	JJ	_	34	amod	_	_
34	persons	_	NNS	NNS	_	4	conj	_	_
35	were	_	VBD	VBD	_	36	auxpass	_	_
36	recruited	_	VBN	VBN	_	0	root	_	_
37	for	_	IN	IN	_	36	prep	_	_
38	the	_	DT	DT	_	39	det	_	_
39	study	_	NN	NN	_	37	pobj	_	_
40	.	_	.	.	_	36	punct	_	_

1	Urinary	_	JJ	JJ	_	4	amod	_	_
2	free	_	JJ	JJ	_	4	amod	_	_
3	cortisol	_	NN	NN	_	4	nn	_	_
4	excretion	_	NN	NN	_	11	nsubj	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	FMS	_	NN	NN	_	5	pobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	LBP	_	NN	NN	_	6	conj	_	_
9	patients	_	NNS	NNS	_	6	dep	_	_
10	was	_	VBD	VBD	_	11	cop	_	_
11	lower	_	JJR	JJR	_	0	root	_	_
12	compared	_	VBN	VBN	_	11	prep	_	_
13	to	_	TO	TO	_	12	pcomp	_	_
14	controls	_	NNS	NNS	_	13	pobj	_	_
15	.	_	.	.	_	11	punct	_	_

1	Only	_	RB	RB	_	3	advmod	_	_
2	FMS	_	NN	NN	_	3	nn	_	_
3	patients	_	NNS	NNS	_	4	nsubj	_	_
4	displayed	_	VBD	VBD	_	0	root	_	_
5	lower	_	JJR	JJR	_	6	amod	_	_
6	CBG	_	NN	NN	_	4	dobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	basal	_	JJ	JJ	_	11	amod	_	_
9	serum	_	NN	NN	_	11	nn	_	_
10	cortisol	_	NN	NN	_	11	nn	_	_
11	concentrations	_	NNS	NNS	_	6	conj	_	_
12	when	_	WRB	WRB	_	13	advmod	_	_
13	compared	_	VBN	VBN	_	4	advcl	_	_
14	to	_	TO	TO	_	13	prep	_	_
15	controls	_	NNS	NNS	_	14	pobj	_	_
16	.	_	.	.	_	4	punct	_	_

1	However	_	RB	RB	_	8	advmod	_	_
2	,	_	,	,	_	8	punct	_	_
3	plasma	_	NN	NN	_	6	nn	_	_
4	free	_	JJ	JJ	_	6	amod	_	_
5	cortisol	_	NN	NN	_	6	nn	_	_
6	concentrations	_	NNS	NNS	_	8	nsubj	_	_
7	were	_	VBD	VBD	_	8	cop	_	_
8	similar	_	JJ	JJ	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	three	_	CD	CD	_	12	num	_	_
12	groups	_	NNS	NNS	_	9	pobj	_	_
13	.	_	.	.	_	8	punct	_	_

1	There	_	EX	EX	_	2	expl	_	_
2	was	_	VBD	VBD	_	0	root	_	_
3	no	_	DT	DT	_	4	neg	_	_
4	difference	_	NN	NN	_	2	nsubj	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	7	det	_	_
7	number	_	NN	NN	_	5	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	GR	_	NN	NN	_	8	pobj	_	_
10	per	_	IN	IN	_	7	prep	_	_
11	cell	_	NN	NN	_	10	pobj	_	_
12	among	_	IN	IN	_	4	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	three	_	CD	CD	_	15	num	_	_
15	groups	_	NNS	NNS	_	12	pobj	_	_
16	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
17	FMS	_	NN	NN	_	4	dep	_	_
18	:	_	:	:	_	17	punct	_	_
19	6498	_	CD	CD	_	17	dep	_	_
20	+/-	_	CC	CC	_	19	cc	_	_
21	252	_	CD	CD	_	19	conj	_	_
22	,	_	,	,	_	17	punct	_	_
23	LBP	_	NN	NN	_	17	appos	_	_
24	:	_	:	:	_	23	punct	_	_
25	6625	_	CD	CD	_	23	dep	_	_
26	+/-	_	CC	CC	_	25	cc	_	_
27	284	_	CD	CD	_	25	conj	_	_
28	,	_	,	,	_	17	punct	_	_
29	controls	_	NNS	NNS	_	17	appos	_	_
30	:	_	:	:	_	29	punct	_	_
31	6576	_	CD	CD	_	29	dep	_	_
32	+/-	_	CC	CC	_	31	cc	_	_
33	304	_	CD	CD	_	31	conj	_	_
34	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
35	,	_	,	,	_	2	punct	_	_
36	but	_	CC	CC	_	2	cc	_	_
37	the	_	DT	DT	_	39	det	_	_
38	dissociation	_	NN	NN	_	39	nn	_	_
39	constant	_	NN	NN	_	63	nsubj	_	_
40	-LRB-	_	-LRB-	-LRB-	_	41	punct	_	_
41	Kd	_	NN	NN	_	39	appos	_	_
42	-RRB-	_	-RRB-	-RRB-	_	41	punct	_	_
43	of	_	IN	IN	_	39	prep	_	_
44	the	_	DT	DT	_	45	dep	_	_
45	FMS	_	NN	NN	_	43	pobj	_	_
46	-LRB-	_	-LRB-	-LRB-	_	50	punct	_	_
47	14.5	_	CD	CD	_	50	num	_	_
48	+/-	_	CC	CC	_	47	cc	_	_
49	0.9	_	CD	CD	_	47	conj	_	_
50	nmol/l	_	NN	NN	_	45	appos	_	_
51	-RRB-	_	-RRB-	-RRB-	_	50	punct	_	_
52	and	_	CC	CC	_	45	cc	_	_
53	LBP	_	NN	NN	_	45	conj	_	_
54	-LRB-	_	-LRB-	-LRB-	_	58	punct	_	_
55	14.7	_	CD	CD	_	58	num	_	_
56	+/-	_	CC	CC	_	55	cc	_	_
57	1.3	_	CD	CD	_	55	conj	_	_
58	nmol/l	_	NN	NN	_	53	appos	_	_
59	-RRB-	_	-RRB-	-RRB-	_	58	punct	_	_
60	subjects	_	NNS	NNS	_	45	dep	_	_
61	was	_	VBD	VBD	_	63	cop	_	_
62	significantly	_	RB	RB	_	63	advmod	_	_
63	higher	_	JJR	JJR	_	2	conj	_	_
64	than	_	IN	IN	_	63	prep	_	_
65	that	_	DT	DT	_	64	pobj	_	_
66	of	_	IN	IN	_	65	prep	_	_
67	the	_	DT	DT	_	68	det	_	_
68	controls	_	NNS	NNS	_	66	pobj	_	_
69	-LRB-	_	-LRB-	-LRB-	_	73	punct	_	_
70	10.9	_	CD	CD	_	73	num	_	_
71	+/-	_	CC	CC	_	70	cc	_	_
72	0.8	_	CD	CD	_	70	conj	_	_
73	nmol/l	_	NN	NN	_	65	appos	_	_
74	-RRB-	_	-RRB-	-RRB-	_	73	punct	_	_
75	-LRB-	_	-LRB-	-LRB-	_	76	punct	_	_
76	p	_	NN	NN	_	63	dep	_	_
77	&lt;	_	JJR	JJR	_	76	amod	_	_
78	.05	_	CD	CD	_	77	dep	_	_
79	-RRB-	_	-RRB-	-RRB-	_	76	punct	_	_
80	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	maximal	_	JJ	JJ	_	3	amod	_	_
3	stimulation	_	NN	NN	_	29	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	6	det	_	_
6	lymphocytes	_	NNS	NNS	_	4	pobj	_	_
7	,	_	,	,	_	3	punct	_	_
8	as	_	IN	IN	_	9	mark	_	_
9	measured	_	VBN	VBN	_	29	dep	_	_
10	by	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	14	det	_	_
12	maximal	_	JJ	JJ	_	14	amod	_	_
13	thymidine	_	NN	NN	_	14	nn	_	_
14	incorporation	_	NN	NN	_	10	pobj	_	_
15	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
16	in	_	IN	IN	_	14	prep	_	_
17	the	_	DT	DT	_	18	det	_	_
18	absence	_	NN	NN	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	cortisol	_	NN	NN	_	19	pobj	_	_
21	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
22	in	_	IN	IN	_	9	prep	_	_
23	the	_	DT	DT	_	25	det	_	_
24	FMS	_	NN	NN	_	25	nn	_	_
25	group	_	NN	NN	_	22	pobj	_	_
26	was	_	VBD	VBD	_	29	cop	_	_
27	approximately	_	RB	RB	_	29	quantmod	_	_
28	1.5	_	CD	CD	_	29	number	_	_
29	times	_	NNS	NNS	_	0	root	_	_
30	higher	_	JJR	JJR	_	29	dep	_	_
31	-LRB-	_	-LRB-	-LRB-	_	32	punct	_	_
32	p	_	NN	NN	_	29	dep	_	_
33	&lt;	_	JJR	JJR	_	32	amod	_	_
34	.05	_	CD	CD	_	33	dep	_	_
35	-RRB-	_	-RRB-	-RRB-	_	32	punct	_	_
36	than	_	IN	IN	_	29	prep	_	_
37	in	_	IN	IN	_	36	pcomp	_	_
38	the	_	DT	DT	_	39	dep	_	_
39	control	_	JJ	JJ	_	37	pobj	_	_
40	or	_	CC	CC	_	39	cc	_	_
41	LBP	_	NN	NN	_	42	nn	_	_
42	group	_	NN	NN	_	39	conj	_	_
43	.	_	.	.	_	29	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	ED50	_	NN	NN	_	20	nsubj	_	_
3	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
4	the	_	DT	DT	_	6	det	_	_
5	cortisol	_	NN	NN	_	6	nn	_	_
6	concentration	_	NN	NN	_	2	dep	_	_
7	giving	_	VBG	VBG	_	6	vmod	_	_
8	50	_	CD	CD	_	9	number	_	_
9	%	_	NN	NN	_	10	amod	_	_
10	inhibition	_	NN	NN	_	7	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	thymidine	_	JJ	JJ	_	14	amod	_	_
14	incorporation	_	NN	NN	_	11	pobj	_	_
15	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
16	,	_	,	,	_	2	punct	_	_
17	however	_	RB	RB	_	20	advmod	_	_
18	,	_	,	,	_	20	punct	_	_
19	was	_	VBD	VBD	_	20	cop	_	_
20	identical	_	JJ	JJ	_	0	root	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	all	_	DT	DT	_	24	det	_	_
23	three	_	CD	CD	_	24	num	_	_
24	groups	_	NNS	NNS	_	21	pobj	_	_
25	.	_	.	.	_	20	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	conclude	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	6	mark	_	_
4	FMS	_	NN	NN	_	5	nn	_	_
5	patients	_	NNS	NNS	_	6	nsubj	_	_
6	have	_	VBP	VBP	_	2	ccomp	_	_
7	a	_	DT	DT	_	9	det	_	_
8	mild	_	JJ	JJ	_	9	amod	_	_
9	hypocortisolemia	_	NN	NN	_	6	dobj	_	_
10	,	_	,	,	_	9	punct	_	_
11	increased	_	VBN	VBN	_	14	amod	_	_
12	cortisol	_	NN	NN	_	14	nn	_	_
13	feedback	_	NN	NN	_	14	nn	_	_
14	resistance	_	NN	NN	_	9	appos	_	_
15	in	_	IN	IN	_	9	prep	_	_
16	combination	_	NN	NN	_	15	pobj	_	_
17	probably	_	RB	RB	_	18	advmod	_	_
18	with	_	IN	IN	_	16	prep	_	_
19	a	_	DT	DT	_	21	det	_	_
20	reduced	_	VBN	VBN	_	21	amod	_	_
21	CRH	_	NN	NN	_	18	pobj	_	_
22	synthesis	_	NN	NN	_	21	dep	_	_
23	or	_	CC	CC	_	21	cc	_	_
24	release	_	NN	NN	_	21	conj	_	_
25	in	_	IN	IN	_	21	prep	_	_
26	the	_	DT	DT	_	27	det	_	_
27	hypothalamus	_	NN	NN	_	25	pobj	_	_
28	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	role	_	NN	NN	_	20	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	5	dep	_	_
5	GR	_	NN	NN	_	3	pobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	mineralocorticoid	_	NN	NN	_	8	nn	_	_
8	receptor	_	NN	NN	_	5	conj	_	_
9	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
10	MR	_	NN	NN	_	8	appos	_	_
11	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
12	in	_	IN	IN	_	2	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	CRH	_	NN	NN	_	15	nn	_	_
15	regulation	_	NN	NN	_	12	pobj	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	FMS	_	NN	NN	_	19	nn	_	_
19	patients	_	NNS	NNS	_	16	pobj	_	_
20	remains	_	VBZ	VBZ	_	0	root	_	_
21	to	_	TO	TO	_	23	aux	_	_
22	be	_	VB	VB	_	23	auxpass	_	_
23	solved	_	VBN	VBN	_	20	xcomp	_	_
24	.	_	.	.	_	20	punct	_	_

1	Transcription	_	NN	NN	_	2	nn	_	_
2	factors	_	NNS	NNS	_	0	root	_	_
3	required	_	VBN	VBN	_	2	vmod	_	_
4	for	_	IN	IN	_	3	prep	_	_
5	lymphoid	_	JJ	JJ	_	7	amod	_	_
6	lineage	_	NN	NN	_	7	nn	_	_
7	commitment	_	NN	NN	_	4	pobj	_	_
8	.	_	.	.	_	2	punct	_	_

1	Intimate	_	JJ	JJ	_	2	amod	_	_
2	interactions	_	NNS	NNS	_	11	nsubj	_	_
3	between	_	IN	IN	_	2	prep	_	_
4	multipotential	_	JJ	JJ	_	7	amod	_	_
5	hemopoietic	_	JJ	JJ	_	7	amod	_	_
6	stem	_	NN	NN	_	7	nn	_	_
7	cells	_	NNS	NNS	_	3	pobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	their	_	PRP$	PRP$	_	10	poss	_	_
10	microenvironment	_	NN	NN	_	7	conj	_	_
11	work	_	VBP	VBP	_	0	root	_	_
12	towards	_	IN	IN	_	11	prep	_	_
13	redefining	_	VBG	VBG	_	12	pcomp	_	_
14	the	_	DT	DT	_	15	det	_	_
15	identity	_	NN	NN	_	13	dobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	the	_	DT	DT	_	19	det	_	_
18	differentiative	_	JJ	JJ	_	19	amod	_	_
19	fate	_	NN	NN	_	15	conj	_	_
20	of	_	IN	IN	_	15	prep	_	_
21	these	_	DT	DT	_	23	det	_	_
22	primitive	_	JJ	JJ	_	23	amod	_	_
23	cells	_	NNS	NNS	_	20	pobj	_	_
24	.	_	.	.	_	11	punct	_	_

1	Molecular	_	JJ	JJ	_	2	amod	_	_
2	cues	_	NNS	NNS	_	8	nsubj	_	_
3	delivered	_	VBN	VBN	_	2	vmod	_	_
4	by	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	6	det	_	_
6	microenvironment	_	NN	NN	_	4	pobj	_	_
7	frequently	_	RB	RB	_	8	advmod	_	_
8	act	_	VBP	VBP	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	an	_	DT	DT	_	12	det	_	_
11	instructive	_	JJ	JJ	_	12	amod	_	_
12	fashion	_	NN	NN	_	9	pobj	_	_
13	by	_	IN	IN	_	8	prep	_	_
14	initiating	_	VBG	VBG	_	13	pcomp	_	_
15	intracellular	_	JJ	JJ	_	17	amod	_	_
16	signaling	_	NN	NN	_	17	nn	_	_
17	pathways	_	NNS	NNS	_	14	dobj	_	_
18	that	_	WDT	WDT	_	20	nsubj	_	_
19	ultimately	_	RB	RB	_	20	advmod	_	_
20	target	_	VBP	VBP	_	17	rcmod	_	_
21	a	_	DT	DT	_	23	det	_	_
22	select	_	JJ	JJ	_	23	amod	_	_
23	group	_	NN	NN	_	20	dobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	transcription	_	NN	NN	_	26	nn	_	_
26	factors	_	NNS	NNS	_	24	pobj	_	_
27	.	_	.	.	_	8	punct	_	_

1	These	_	DT	DT	_	3	det	_	_
2	transcriptional	_	JJ	JJ	_	3	amod	_	_
3	regulators	_	NNS	NNS	_	6	nsubj	_	_
4	in	_	IN	IN	_	6	prep	_	_
5	turn	_	NN	NN	_	4	pobj	_	_
6	trigger	_	VBP	VBP	_	0	root	_	_
7	a	_	DT	DT	_	8	det	_	_
8	cascade	_	NN	NN	_	6	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	genetic	_	JJ	JJ	_	11	amod	_	_
11	changes	_	NNS	NNS	_	9	pobj	_	_
12	that	_	WDT	WDT	_	14	nsubj	_	_
13	ultimately	_	RB	RB	_	14	advmod	_	_
14	determine	_	VBP	VBP	_	11	rcmod	_	_
15	the	_	DT	DT	_	16	det	_	_
16	course	_	NN	NN	_	14	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	19	det	_	_
19	cells	_	NNS	NNS	_	17	pobj	_	_
20	during	_	IN	IN	_	14	prep	_	_
21	differentiation	_	NN	NN	_	20	pobj	_	_
22	.	_	.	.	_	6	punct	_	_

1	Gene	_	NN	NN	_	3	nn	_	_
2	inactivation	_	NN	NN	_	3	nn	_	_
3	studies	_	NNS	NNS	_	13	nsubj	_	_
4	on	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	6	dep	_	_
6	PU.1	_	NN	NN	_	4	pobj	_	_
7	,	_	,	,	_	6	punct	_	_
8	Ikaros	_	NN	NN	_	6	conj	_	_
9	and	_	CC	CC	_	6	cc	_	_
10	GATA-3	_	NN	NN	_	6	conj	_	_
11	genes	_	NNS	NNS	_	6	dep	_	_
12	have	_	VBP	VBP	_	13	aux	_	_
13	revealed	_	VBN	VBN	_	0	root	_	_
14	that	_	IN	IN	_	19	mark	_	_
15	their	_	PRP$	PRP$	_	17	poss	_	_
16	encoded	_	VBN	VBN	_	17	amod	_	_
17	factors	_	NNS	NNS	_	19	nsubj	_	_
18	are	_	VBP	VBP	_	19	cop	_	_
19	essential	_	JJ	JJ	_	13	ccomp	_	_
20	for	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	24	det	_	_
22	earliest	_	JJS	JJS	_	24	amod	_	_
23	commitment	_	NN	NN	_	24	nn	_	_
24	step	_	NN	NN	_	20	pobj	_	_
25	into	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	27	dep	_	_
27	B	_	NN	NN	_	25	pobj	_	_
28	and	_	CC	CC	_	27	cc	_	_
29	T	_	NN	NN	_	27	conj	_	_
30	lymphoid	_	JJ	JJ	_	31	amod	_	_
31	lineages	_	NNS	NNS	_	27	dep	_	_
32	.	_	.	.	_	13	punct	_	_

1	Cytokine	_	NN	NN	_	2	nn	_	_
2	rescue	_	NN	NN	_	11	nsubjpass	_	_
3	from	_	IN	IN	_	2	prep	_	_
4	glucocorticoid	_	NN	NN	_	5	npadvmod	_	_
5	induced	_	JJ	JJ	_	6	amod	_	_
6	apoptosis	_	NN	NN	_	3	pobj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	T	_	NN	NN	_	9	nn	_	_
9	cells	_	NNS	NNS	_	7	pobj	_	_
10	is	_	VBZ	VBZ	_	11	auxpass	_	_
11	mediated	_	VBN	VBN	_	0	root	_	_
12	through	_	IN	IN	_	11	prep	_	_
13	inhibition	_	NN	NN	_	12	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	IkappaBalpha	_	NN	NN	_	14	pobj	_	_
16	.	_	.	.	_	11	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	previously	_	RB	RB	_	3	advmod	_	_
3	reported	_	VBD	VBD	_	0	root	_	_
4	that	_	IN	IN	_	14	mark	_	_
5	dexamethasone	_	NN	NN	_	14	nsubj	_	_
6	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
7	DEX	_	NN	NN	_	5	appos	_	_
8	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
9	,	_	,	,	_	5	punct	_	_
10	a	_	DT	DT	_	12	det	_	_
11	synthetic	_	JJ	JJ	_	12	amod	_	_
12	glucocorticoid	_	NN	NN	_	5	appos	_	_
13	,	_	,	,	_	5	punct	_	_
14	causes	_	VBZ	VBZ	_	3	ccomp	_	_
15	apoptosis	_	NN	NN	_	14	dobj	_	_
16	in	_	IN	IN	_	14	prep	_	_
17	mature	_	JJ	JJ	_	20	amod	_	_
18	Th	_	NN	NN	_	20	nn	_	_
19	cell	_	NN	NN	_	20	nn	_	_
20	lines	_	NNS	NNS	_	16	pobj	_	_
21	,	_	,	,	_	14	punct	_	_
22	and	_	CC	CC	_	14	cc	_	_
23	that	_	IN	IN	_	30	mark	_	_
24	this	_	DT	DT	_	25	det	_	_
25	induction	_	NN	NN	_	30	nsubjpass	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	cell	_	NN	NN	_	28	nn	_	_
28	death	_	NN	NN	_	26	pobj	_	_
29	is	_	VBZ	VBZ	_	30	auxpass	_	_
30	prevented	_	VBN	VBN	_	14	conj	_	_
31	by	_	IN	IN	_	30	prep	_	_
32	specific	_	JJ	JJ	_	33	amod	_	_
33	cytokines	_	NNS	NNS	_	31	pobj	_	_
34	,	_	,	,	_	31	punct	_	_
35	namely	_	RB	RB	_	31	dep	_	_
36	,	_	,	,	_	31	punct	_	_
37	by	_	IN	IN	_	31	prep	_	_
38	IL-2	_	NN	NN	_	37	pobj	_	_
39	in	_	IN	IN	_	38	prep	_	_
40	Th1	_	NN	NN	_	41	nn	_	_
41	cells	_	NNS	NNS	_	39	pobj	_	_
42	and	_	CC	CC	_	37	cc	_	_
43	by	_	IN	IN	_	37	conj	_	_
44	IL-4	_	NN	NN	_	43	pobj	_	_
45	in	_	IN	IN	_	44	prep	_	_
46	Th2	_	NN	NN	_	47	nn	_	_
47	cells	_	NNS	NNS	_	45	pobj	_	_
48	.	_	.	.	_	3	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	now	_	RB	RB	_	3	advmod	_	_
3	show	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	14	mark	_	_
5	this	_	DT	DT	_	7	det	_	_
6	differential	_	JJ	JJ	_	7	amod	_	_
7	rescue	_	NN	NN	_	14	nsubj	_	_
8	by	_	IN	IN	_	7	prep	_	_
9	specific	_	JJ	JJ	_	10	amod	_	_
10	cytokines	_	NNS	NNS	_	8	pobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	Th	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	11	pobj	_	_
14	correlates	_	VBZ	VBZ	_	3	ccomp	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	17	det	_	_
17	level	_	NN	NN	_	15	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	IkappaBalpha	_	NN	NN	_	18	pobj	_	_
20	that	_	WDT	WDT	_	22	nsubjpass	_	_
21	is	_	VBZ	VBZ	_	22	auxpass	_	_
22	regulated	_	VBN	VBN	_	19	rcmod	_	_
23	by	_	IN	IN	_	22	prep	_	_
24	DEX	_	NN	NN	_	23	pobj	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	cytokines	_	NNS	NNS	_	24	conj	_	_
27	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	14	prep	_	_
2	both	_	DT	DT	_	4	det	_	_
3	cell	_	NN	NN	_	4	nn	_	_
4	types	_	NNS	NNS	_	1	pobj	_	_
5	the	_	DT	DT	_	7	det	_	_
6	cellular	_	JJ	JJ	_	7	amod	_	_
7	levels	_	NNS	NNS	_	14	nsubjpass	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	IkappaBalpha	_	NN	NN	_	10	nn	_	_
10	mRNA	_	NN	NN	_	8	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	protein	_	NN	NN	_	10	conj	_	_
13	were	_	VBD	VBD	_	14	auxpass	_	_
14	evaluated	_	VBN	VBN	_	0	root	_	_
15	by	_	IN	IN	_	14	prep	_	_
16	DEX	_	NN	NN	_	17	nn	_	_
17	treatment	_	NN	NN	_	15	pobj	_	_
18	.	_	.	.	_	14	punct	_	_

1	Interestingly	_	RB	RB	_	9	advmod	_	_
2	,	_	,	,	_	9	punct	_	_
3	the	_	DT	DT	_	6	det	_	_
4	DEX-mediated	_	JJ	JJ	_	6	amod	_	_
5	IkappaBalpha	_	NN	NN	_	6	nn	_	_
6	induction	_	NN	NN	_	9	nsubjpass	_	_
7	was	_	VBD	VBD	_	9	auxpass	_	_
8	completely	_	RB	RB	_	9	advmod	_	_
9	inhibited	_	VBN	VBN	_	0	root	_	_
10	by	_	IN	IN	_	9	prep	_	_
11	IL-2	_	NN	NN	_	10	pobj	_	_
12	,	_	,	,	_	11	punct	_	_
13	but	_	CC	CC	_	14	cc	_	_
14	not	_	RB	RB	_	11	cc	_	_
15	IL-4	_	NN	NN	_	11	conj	_	_
16	,	_	,	,	_	11	punct	_	_
17	in	_	IN	IN	_	11	prep	_	_
18	Th1	_	NN	NN	_	19	nn	_	_
19	cells	_	NNS	NNS	_	17	pobj	_	_
20	,	_	,	,	_	9	punct	_	_
21	while	_	IN	IN	_	26	mark	_	_
22	the	_	DT	DT	_	24	det	_	_
23	reverse	_	NN	NN	_	24	nn	_	_
24	profile	_	NN	NN	_	26	nsubjpass	_	_
25	was	_	VBD	VBD	_	26	auxpass	_	_
26	seen	_	VBN	VBN	_	9	advcl	_	_
27	in	_	IN	IN	_	26	prep	_	_
28	Th2	_	NN	NN	_	29	nn	_	_
29	cells	_	NNS	NNS	_	27	pobj	_	_
30	.	_	.	.	_	9	punct	_	_

1	In	_	IN	IN	_	18	prep	_	_
2	both	_	DT	DT	_	4	det	_	_
3	cell	_	NN	NN	_	4	nn	_	_
4	types	_	NNS	NNS	_	1	pobj	_	_
5	,	_	,	,	_	18	punct	_	_
6	the	_	DT	DT	_	7	det	_	_
7	cytokine	_	NN	NN	_	18	nsubj	_	_
8	that	_	WDT	WDT	_	9	nsubj	_	_
9	inhibits	_	VBZ	VBZ	_	7	rcmod	_	_
10	the	_	DT	DT	_	11	det	_	_
11	induction	_	NN	NN	_	9	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	IkappaBalpha	_	NN	NN	_	12	pobj	_	_
14	by	_	IN	IN	_	11	prep	_	_
15	DEX	_	NN	NN	_	14	pobj	_	_
16	,	_	,	,	_	7	punct	_	_
17	also	_	RB	RB	_	18	advmod	_	_
18	rescues	_	VBZ	VBZ	_	0	root	_	_
19	these	_	DT	DT	_	20	det	_	_
20	cells	_	NNS	NNS	_	18	dobj	_	_
21	from	_	IN	IN	_	18	prep	_	_
22	DEX-induced	_	JJ	JJ	_	23	amod	_	_
23	apoptosis	_	NN	NN	_	21	pobj	_	_
24	,	_	,	,	_	18	punct	_	_
25	although	_	IN	IN	_	30	mark	_	_
26	the	_	DT	DT	_	28	det	_	_
27	rescue	_	NN	NN	_	28	nn	_	_
28	cytokine	_	NN	NN	_	30	nsubj	_	_
29	is	_	VBZ	VBZ	_	30	cop	_	_
30	different	_	JJ	JJ	_	18	advcl	_	_
31	in	_	IN	IN	_	30	prep	_	_
32	Th1	_	NN	NN	_	31	pobj	_	_
33	and	_	CC	CC	_	32	cc	_	_
34	Th2	_	NN	NN	_	32	conj	_	_
35	cells	_	NNS	NNS	_	32	dep	_	_
36	.	_	.	.	_	18	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	imply	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	7	mark	_	_
5	T	_	NN	NN	_	6	nn	_	_
6	cells	_	NNS	NNS	_	7	nsubj	_	_
7	need	_	VBP	VBP	_	3	ccomp	_	_
8	to	_	TO	TO	_	9	aux	_	_
9	maintain	_	VB	VB	_	7	xcomp	_	_
10	a	_	DT	DT	_	12	det	_	_
11	certain	_	JJ	JJ	_	12	amod	_	_
12	level	_	NN	NN	_	9	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	NF-kappaB	_	NN	NN	_	16	nn	_	_
15	transcriptional	_	JJ	JJ	_	16	amod	_	_
16	activity	_	NN	NN	_	13	pobj	_	_
17	in	_	IN	IN	_	20	mark	_	_
18	order	_	NN	NN	_	20	dep	_	_
19	to	_	TO	TO	_	20	aux	_	_
20	survive	_	VB	VB	_	7	advcl	_	_
21	;	_	:	:	_	3	punct	_	_
22	up-	_	JJ	JJ	_	39	nsubj	_	_
23	or	_	CC	CC	_	22	cc	_	_
24	down-regulation	_	NN	NN	_	22	conj	_	_
25	of	_	IN	IN	_	22	prep	_	_
26	nuclear	_	JJ	JJ	_	28	amod	_	_
27	NF	_	NN	NN	_	28	nn	_	_
28	kappaB	_	NN	NN	_	25	pobj	_	_
29	through	_	IN	IN	_	22	prep	_	_
30	modulation	_	NN	NN	_	29	pobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	IkappaBalpha	_	NN	NN	_	33	nn	_	_
33	expression	_	NN	NN	_	31	pobj	_	_
34	by	_	IN	IN	_	33	prep	_	_
35	cytokines	_	NNS	NNS	_	34	pobj	_	_
36	or	_	CC	CC	_	35	cc	_	_
37	DEX	_	NN	NN	_	35	conj	_	_
38	may	_	MD	MD	_	39	aux	_	_
39	lead	_	VB	VB	_	3	parataxis	_	_
40	to	_	TO	TO	_	39	prep	_	_
41	cell	_	NN	NN	_	42	nn	_	_
42	survival	_	NN	NN	_	40	pobj	_	_
43	or	_	CC	CC	_	42	cc	_	_
44	cell	_	NN	NN	_	45	nn	_	_
45	death	_	NN	NN	_	42	conj	_	_
46	,	_	,	,	_	39	punct	_	_
47	respectively	_	RB	RB	_	39	advmod	_	_
48	.	_	.	.	_	3	punct	_	_

1	Genes	_	NNS	NNS	_	0	root	_	_
2	that	_	WDT	WDT	_	3	nsubj	_	_
3	regulate	_	VBP	VBP	_	1	rcmod	_	_
4	interleukin-4	_	NN	NN	_	5	nn	_	_
5	expression	_	NN	NN	_	3	dobj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	T	_	NN	NN	_	8	nn	_	_
8	cells	_	NNS	NNS	_	6	pobj	_	_
9	.	_	.	.	_	1	punct	_	_

1	Interleukin-4	_	NN	NN	_	5	nsubj	_	_
2	is	_	VBZ	VBZ	_	5	cop	_	_
3	an	_	DT	DT	_	5	det	_	_
4	immunomodulatory	_	JJ	JJ	_	5	amod	_	_
5	cytokine	_	NN	NN	_	0	root	_	_
6	which	_	WDT	WDT	_	7	nsubj	_	_
7	plays	_	VBZ	VBZ	_	5	rcmod	_	_
8	a	_	DT	DT	_	10	det	_	_
9	central	_	JJ	JJ	_	10	amod	_	_
10	role	_	NN	NN	_	7	dobj	_	_
11	in	_	IN	IN	_	7	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	regulation	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	allergic	_	JJ	JJ	_	14	pobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	atopic	_	JJ	JJ	_	15	conj	_	_
18	immune	_	JJ	JJ	_	19	amod	_	_
19	responses	_	NNS	NNS	_	15	dep	_	_
20	.	_	.	.	_	5	punct	_	_

1	Significant	_	JJ	JJ	_	2	amod	_	_
2	progress	_	NN	NN	_	5	nsubjpass	_	_
3	has	_	VBZ	VBZ	_	5	aux	_	_
4	been	_	VBN	VBN	_	5	auxpass	_	_
5	made	_	VBN	VBN	_	0	root	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	gaining	_	VBG	VBG	_	6	pcomp	_	_
8	a	_	DT	DT	_	10	det	_	_
9	detailed	_	JJ	JJ	_	10	amod	_	_
10	understanding	_	NN	NN	_	7	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	transcriptional	_	JJ	JJ	_	14	amod	_	_
14	regulation	_	NN	NN	_	11	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	18	det	_	_
17	interleukin-4	_	NN	NN	_	18	nn	_	_
18	gene	_	NN	NN	_	15	pobj	_	_
19	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	3	dep	_	_
2	recent	_	JJ	JJ	_	3	amod	_	_
3	identification	_	NN	NN	_	12	nsubj	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	characterization	_	NN	NN	_	3	conj	_	_
6	of	_	IN	IN	_	3	prep	_	_
7	several	_	JJ	JJ	_	10	amod	_	_
8	key	_	JJ	JJ	_	10	amod	_	_
9	transcription	_	NN	NN	_	10	nn	_	_
10	factors	_	NNS	NNS	_	6	pobj	_	_
11	has	_	VBZ	VBZ	_	12	aux	_	_
12	helped	_	VBN	VBN	_	0	root	_	_
13	to	_	TO	TO	_	14	aux	_	_
14	elucidate	_	VB	VB	_	12	xcomp	_	_
15	the	_	DT	DT	_	17	det	_	_
16	molecular	_	JJ	JJ	_	17	amod	_	_
17	mechanisms	_	NNS	NNS	_	14	dobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	T	_	NN	NN	_	23	nn	_	_
20	helper	_	NN	NN	_	23	nn	_	_
21	cell	_	NN	NN	_	23	nn	_	_
22	cytokine	_	NN	NN	_	23	nn	_	_
23	gene	_	NN	NN	_	24	nn	_	_
24	expression	_	NN	NN	_	18	pobj	_	_
25	.	_	.	.	_	12	punct	_	_

1	Xenogeneic	_	JJ	JJ	_	3	amod	_	_
2	human	_	JJ	JJ	_	3	amod	_	_
3	serum	_	NN	NN	_	4	nsubj	_	_
4	promotes	_	VBZ	VBZ	_	0	root	_	_
5	leukocyte	_	NN	NN	_	6	nn	_	_
6	adhesion	_	NN	NN	_	4	dobj	_	_
7	to	_	TO	TO	_	6	prep	_	_
8	porcine	_	NN	NN	_	9	nn	_	_
9	endothelium	_	NN	NN	_	7	pobj	_	_
10	under	_	IN	IN	_	4	prep	_	_
11	flow	_	NN	NN	_	12	nn	_	_
12	conditions	_	NNS	NNS	_	10	pobj	_	_
13	,	_	,	,	_	4	punct	_	_
14	possibly	_	RB	RB	_	15	advmod	_	_
15	through	_	IN	IN	_	4	prep	_	_
16	the	_	DT	DT	_	17	det	_	_
17	activation	_	NN	NN	_	15	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	23	det	_	_
20	transcription	_	NN	NN	_	23	nn	_	_
21	factor	_	NN	NN	_	23	nn	_	_
22	NF-kappa	_	NN	NN	_	23	nn	_	_
23	B	_	NN	NN	_	18	pobj	_	_
24	.	_	.	.	_	4	punct	_	_

1	Endothelial	_	JJ	JJ	_	3	amod	_	_
2	cell	_	NN	NN	_	3	nn	_	_
3	activation	_	NN	NN	_	10	nsubj	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	leukocyte	_	NN	NN	_	6	nn	_	_
6	infiltration	_	NN	NN	_	3	conj	_	_
7	are	_	VBP	VBP	_	10	cop	_	_
8	a	_	DT	DT	_	10	det	_	_
9	consistent	_	JJ	JJ	_	10	amod	_	_
10	feature	_	NN	NN	_	0	root	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	discordant	_	JJ	JJ	_	14	amod	_	_
13	xenograft	_	NN	NN	_	14	nn	_	_
14	rejection	_	NN	NN	_	11	pobj	_	_
15	.	_	.	.	_	10	punct	_	_

1	Here	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	evaluated	_	VBD	VBD	_	0	root	_	_
4	whether	_	IN	IN	_	18	mark	_	_
5	xenogeneic	_	JJ	JJ	_	6	amod	_	_
6	serum	_	NN	NN	_	18	nsubj	_	_
7	,	_	,	,	_	6	punct	_	_
8	as	_	IN	IN	_	18	prep	_	_
9	a	_	DT	DT	_	10	det	_	_
10	source	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	xenoreactive	_	JJ	JJ	_	14	amod	_	_
13	natural	_	JJ	JJ	_	14	amod	_	_
14	antibodies	_	NNS	NNS	_	11	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	complement	_	NN	NN	_	14	conj	_	_
17	,	_	,	,	_	18	punct	_	_
18	induced	_	VBD	VBD	_	3	ccomp	_	_
19	endothelial	_	JJ	JJ	_	21	amod	_	_
20	cell	_	NN	NN	_	21	nn	_	_
21	activation	_	NN	NN	_	18	dobj	_	_
22	with	_	IN	IN	_	18	prep	_	_
23	consequent	_	JJ	JJ	_	25	amod	_	_
24	leukocyte	_	NN	NN	_	25	nn	_	_
25	adhesion	_	NN	NN	_	22	pobj	_	_
26	under	_	IN	IN	_	18	prep	_	_
27	flow	_	NN	NN	_	28	nn	_	_
28	conditions	_	NNS	NNS	_	26	pobj	_	_
29	.	_	.	.	_	3	punct	_	_

1	Porcine	_	JJ	JJ	_	4	amod	_	_
2	aortic	_	JJ	JJ	_	4	amod	_	_
3	endothelial	_	JJ	JJ	_	4	amod	_	_
4	cells	_	NNS	NNS	_	9	nsubjpass	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	PAEC	_	NNS	NNS	_	4	appos	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	were	_	VBD	VBD	_	9	auxpass	_	_
9	incubated	_	VBN	VBN	_	0	root	_	_
10	for	_	IN	IN	_	9	prep	_	_
11	1	_	CD	CD	_	14	num	_	_
12	hr	_	NN	NN	_	14	nn	_	_
13	30	_	CD	CD	_	14	num	_	_
14	min	_	NN	NN	_	10	pobj	_	_
15	or	_	CC	CC	_	14	cc	_	_
16	5	_	CD	CD	_	17	num	_	_
17	hr	_	NN	NN	_	14	conj	_	_
18	with	_	IN	IN	_	9	prep	_	_
19	10	_	CD	CD	_	20	number	_	_
20	%	_	NN	NN	_	23	amod	_	_
21	homologous	_	JJ	JJ	_	23	amod	_	_
22	porcine	_	JJ	JJ	_	23	amod	_	_
23	serum	_	NN	NN	_	18	pobj	_	_
24	-LRB-	_	-LRB-	-LRB-	_	25	punct	_	_
25	control	_	NN	NN	_	23	appos	_	_
26	-RRB-	_	-RRB-	-RRB-	_	25	punct	_	_
27	or	_	CC	CC	_	23	cc	_	_
28	10	_	CD	CD	_	29	number	_	_
29	%	_	NN	NN	_	32	amod	_	_
30	xenogeneic	_	JJ	JJ	_	32	amod	_	_
31	human	_	JJ	JJ	_	32	amod	_	_
32	serum	_	NN	NN	_	23	conj	_	_
33	and	_	CC	CC	_	9	cc	_	_
34	then	_	RB	RB	_	35	advmod	_	_
35	perfused	_	VBN	VBN	_	9	conj	_	_
36	with	_	IN	IN	_	35	prep	_	_
37	total	_	JJ	JJ	_	39	amod	_	_
38	human	_	JJ	JJ	_	39	amod	_	_
39	leukocytes	_	NNS	NNS	_	36	pobj	_	_
40	in	_	IN	IN	_	35	prep	_	_
41	a	_	DT	DT	_	45	det	_	_
42	parallel	_	NN	NN	_	45	nn	_	_
43	plate	_	NN	NN	_	45	nn	_	_
44	flow	_	NN	NN	_	45	nn	_	_
45	chamber	_	NN	NN	_	40	pobj	_	_
46	under	_	IN	IN	_	35	prep	_	_
47	laminar	_	JJ	JJ	_	48	amod	_	_
48	flow	_	NN	NN	_	46	pobj	_	_
49	-LRB-	_	-LRB-	-LRB-	_	51	punct	_	_
50	1.5	_	CD	CD	_	51	num	_	_
51	dynes/cm2	_	NNS	NNS	_	48	appos	_	_
52	-RRB-	_	-RRB-	-RRB-	_	51	punct	_	_
53	.	_	.	.	_	9	punct	_	_

1	Adherent	_	JJ	JJ	_	2	amod	_	_
2	cells	_	NNS	NNS	_	4	nsubjpass	_	_
3	were	_	VBD	VBD	_	4	auxpass	_	_
4	counted	_	VBN	VBN	_	0	root	_	_
5	by	_	IN	IN	_	4	prep	_	_
6	digital	_	JJ	JJ	_	8	amod	_	_
7	image	_	NN	NN	_	8	nn	_	_
8	analysis	_	NN	NN	_	5	pobj	_	_
9	.	_	.	.	_	4	punct	_	_

1	Xenogeneic	_	JJ	JJ	_	3	amod	_	_
2	human	_	JJ	JJ	_	3	amod	_	_
3	serum	_	NN	NN	_	10	nsubj	_	_
4	significantly	_	RB	RB	_	10	advmod	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	P	_	NN	NN	_	4	dep	_	_
7	&lt;	_	JJR	JJR	_	6	amod	_	_
8	0.01	_	CD	CD	_	7	dep	_	_
9	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
10	increased	_	VBD	VBD	_	0	root	_	_
11	the	_	DT	DT	_	12	det	_	_
12	number	_	NN	NN	_	10	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	adherent	_	JJ	JJ	_	15	amod	_	_
15	leukocytes	_	NNS	NNS	_	13	pobj	_	_
16	as	_	IN	IN	_	17	mark	_	_
17	compared	_	VBN	VBN	_	10	advcl	_	_
18	with	_	IN	IN	_	17	prep	_	_
19	porcine	_	JJ	JJ	_	20	amod	_	_
20	serum	_	NN	NN	_	18	pobj	_	_
21	.	_	.	.	_	10	punct	_	_

1	A	_	DT	DT	_	4	det	_	_
2	similar	_	JJ	JJ	_	4	amod	_	_
3	adhesive	_	JJ	JJ	_	2	dep	_	_
4	response	_	NN	NN	_	6	nsubjpass	_	_
5	was	_	VBD	VBD	_	6	auxpass	_	_
6	elicited	_	VBN	VBN	_	0	root	_	_
7	by	_	IN	IN	_	6	prep	_	_
8	TNF	_	NN	NN	_	9	nn	_	_
9	alpha	_	NN	NN	_	7	pobj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
11	100	_	CD	CD	_	12	num	_	_
12	U/ml	_	NN	NN	_	9	appos	_	_
13	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
14	,	_	,	,	_	9	punct	_	_
15	one	_	CD	CD	_	9	appos	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	20	det	_	_
18	most	_	RBS	RBS	_	19	advmod	_	_
19	potent	_	JJ	JJ	_	20	amod	_	_
20	inducers	_	NNS	NNS	_	16	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	endothelial	_	JJ	JJ	_	23	amod	_	_
23	cell	_	NN	NN	_	25	nn	_	_
24	adhesive	_	JJ	JJ	_	25	amod	_	_
25	properties	_	NNS	NNS	_	21	pobj	_	_
26	,	_	,	,	_	15	punct	_	_
27	here	_	RB	RB	_	28	advmod	_	_
28	used	_	VBN	VBN	_	15	vmod	_	_
29	as	_	IN	IN	_	28	prep	_	_
30	positive	_	JJ	JJ	_	31	amod	_	_
31	control	_	NN	NN	_	29	pobj	_	_
32	.	_	.	.	_	6	punct	_	_

1	In	_	IN	IN	_	4	mark	_	_
2	order	_	NN	NN	_	4	dep	_	_
3	to	_	TO	TO	_	4	aux	_	_
4	elucidate	_	VB	VB	_	16	dep	_	_
5	possible	_	JJ	JJ	_	6	amod	_	_
6	mechanisms	_	NNS	NNS	_	4	dobj	_	_
7	underlying	_	VBG	VBG	_	6	vmod	_	_
8	endothelial	_	JJ	JJ	_	9	amod	_	_
9	cell	_	NN	NN	_	10	nn	_	_
10	activation	_	NN	NN	_	7	dobj	_	_
11	by	_	IN	IN	_	10	prep	_	_
12	xenogeneic	_	JJ	JJ	_	13	amod	_	_
13	serum	_	NN	NN	_	11	pobj	_	_
14	,	_	,	,	_	16	punct	_	_
15	we	_	PRP	PRP	_	16	nsubj	_	_
16	focussed	_	VBD	VBD	_	0	root	_	_
17	on	_	IN	IN	_	16	prep	_	_
18	transcription	_	NN	NN	_	21	nn	_	_
19	factor	_	NN	NN	_	21	nn	_	_
20	NF-kappa	_	NN	NN	_	21	nn	_	_
21	B	_	NN	NN	_	17	pobj	_	_
22	,	_	,	,	_	21	punct	_	_
23	a	_	DT	DT	_	25	det	_	_
24	central	_	JJ	JJ	_	25	amod	_	_
25	regulator	_	NN	NN	_	21	appos	_	_
26	for	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	28	det	_	_
28	induction	_	NN	NN	_	26	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	different	_	JJ	JJ	_	31	amod	_	_
31	genes	_	NNS	NNS	_	29	pobj	_	_
32	,	_	,	,	_	31	punct	_	_
33	including	_	VBG	VBG	_	31	prep	_	_
34	adhesive	_	JJ	JJ	_	35	amod	_	_
35	molecules	_	NNS	NNS	_	33	pobj	_	_
36	and	_	CC	CC	_	35	cc	_	_
37	chemoattractants	_	NNS	NNS	_	35	conj	_	_
38	.	_	.	.	_	16	punct	_	_

1	By	_	IN	IN	_	7	prep	_	_
2	confocal	_	JJ	JJ	_	4	amod	_	_
3	fluorescence	_	NN	NN	_	4	nn	_	_
4	microscopy	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	7	punct	_	_
6	we	_	PRP	PRP	_	7	nsubj	_	_
7	observed	_	VBD	VBD	_	0	root	_	_
8	a	_	DT	DT	_	10	det	_	_
9	positive	_	JJ	JJ	_	10	amod	_	_
10	staining	_	NN	NN	_	7	dobj	_	_
11	for	_	IN	IN	_	10	prep	_	_
12	NF-kappa	_	NN	NN	_	13	nn	_	_
13	B	_	NN	NN	_	11	pobj	_	_
14	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
15	p65	_	NN	NN	_	16	nn	_	_
16	subunit	_	NN	NN	_	13	appos	_	_
17	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
18	in	_	IN	IN	_	7	prep	_	_
19	the	_	DT	DT	_	20	det	_	_
20	nuclei	_	NNS	NNS	_	18	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	PAEC	_	NNS	NNS	_	21	pobj	_	_
23	exposed	_	VBN	VBN	_	22	vmod	_	_
24	for	_	IN	IN	_	23	prep	_	_
25	1	_	CD	CD	_	28	num	_	_
26	hr	_	NN	NN	_	28	nn	_	_
27	30	_	CD	CD	_	28	num	_	_
28	min	_	NN	NN	_	24	pobj	_	_
29	to	_	TO	TO	_	23	prep	_	_
30	human	_	JJ	JJ	_	31	amod	_	_
31	serum	_	NN	NN	_	29	pobj	_	_
32	,	_	,	,	_	7	punct	_	_
33	which	_	WDT	WDT	_	34	nsubj	_	_
34	indicated	_	VBD	VBD	_	7	dep	_	_
35	NF-kappa	_	NN	NN	_	36	nn	_	_
36	B	_	NN	NN	_	37	nn	_	_
37	activation	_	NN	NN	_	34	dobj	_	_
38	in	_	IN	IN	_	34	prep	_	_
39	this	_	DT	DT	_	40	det	_	_
40	setting	_	NN	NN	_	38	pobj	_	_
41	.	_	.	.	_	7	punct	_	_

1	At	_	IN	IN	_	16	prep	_	_
2	variance	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	16	punct	_	_
4	in	_	IN	IN	_	16	prep	_	_
5	PAEC	_	NNS	NNS	_	4	pobj	_	_
6	incubated	_	VBN	VBN	_	5	vmod	_	_
7	with	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	homologous	_	JJ	JJ	_	10	amod	_	_
10	serum	_	NN	NN	_	7	pobj	_	_
11	,	_	,	,	_	16	punct	_	_
12	NF-kappa	_	NN	NN	_	13	nn	_	_
13	B	_	NN	NN	_	16	nsubj	_	_
14	was	_	VBD	VBD	_	16	cop	_	_
15	strictly	_	RB	RB	_	16	advmod	_	_
16	localized	_	JJ	JJ	_	0	root	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	cell	_	NN	NN	_	20	nn	_	_
20	cytoplasm	_	NN	NN	_	17	pobj	_	_
21	.	_	.	.	_	16	punct	_	_

1	Treatment	_	NN	NN	_	34	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	PAEC	_	NNS	NNS	_	2	pobj	_	_
4	exposed	_	VBN	VBN	_	3	vmod	_	_
5	to	_	TO	TO	_	4	prep	_	_
6	xenogeneic	_	JJ	JJ	_	7	amod	_	_
7	serum	_	NN	NN	_	5	pobj	_	_
8	with	_	IN	IN	_	1	prep	_	_
9	the	_	DT	DT	_	12	det	_	_
10	NF-kappa	_	NN	NN	_	11	nn	_	_
11	B	_	NN	NN	_	12	nn	_	_
12	inhibitors	_	NNS	NNS	_	8	pobj	_	_
13	pyrrolidinedithiocarbamate	_	NN	NN	_	12	dep	_	_
14	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
15	PDTC	_	NN	NN	_	13	dep	_	_
16	,	_	,	,	_	15	punct	_	_
17	25	_	CD	CD	_	18	num	_	_
18	microM	_	NN	NN	_	15	appos	_	_
19	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
20	and	_	CC	CC	_	13	cc	_	_
21	tosyl-phechloromethylketone	_	NN	NN	_	13	conj	_	_
22	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
23	TPCK	_	NN	NN	_	21	dep	_	_
24	,	_	,	,	_	23	punct	_	_
25	25	_	CD	CD	_	26	num	_	_
26	microM	_	NN	NN	_	23	appos	_	_
27	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
28	significantly	_	RB	RB	_	34	advmod	_	_
29	-LRB-	_	-LRB-	-LRB-	_	30	punct	_	_
30	P	_	NN	NN	_	28	dep	_	_
31	&lt;	_	JJR	JJR	_	30	amod	_	_
32	0.01	_	CD	CD	_	31	dep	_	_
33	-RRB-	_	-RRB-	-RRB-	_	30	punct	_	_
34	reduced	_	VBD	VBD	_	0	root	_	_
35	leukocyte	_	NN	NN	_	36	nn	_	_
36	adhesion	_	NN	NN	_	34	dobj	_	_
37	in	_	IN	IN	_	34	prep	_	_
38	respect	_	NN	NN	_	37	pobj	_	_
39	to	_	TO	TO	_	38	prep	_	_
40	PAEC	_	NNS	NNS	_	39	pobj	_	_
41	treated	_	VBN	VBN	_	40	vmod	_	_
42	with	_	IN	IN	_	41	prep	_	_
43	human	_	JJ	JJ	_	44	amod	_	_
44	serum	_	NN	NN	_	42	pobj	_	_
45	alone	_	RB	RB	_	44	advmod	_	_
46	.	_	.	.	_	34	punct	_	_

1	Findings	_	NNS	NNS	_	15	nsubj	_	_
2	that	_	IN	IN	_	5	mark	_	_
3	xenogeneic	_	JJ	JJ	_	4	amod	_	_
4	serum	_	NN	NN	_	5	nsubj	_	_
5	promotes	_	VBZ	VBZ	_	1	ccomp	_	_
6	leukocyte-endothelium	_	JJ	JJ	_	7	amod	_	_
7	interaction	_	NN	NN	_	5	dobj	_	_
8	possibly	_	RB	RB	_	9	advmod	_	_
9	through	_	IN	IN	_	5	prep	_	_
10	NF-kappa	_	NN	NN	_	11	nn	_	_
11	B	_	NN	NN	_	12	nn	_	_
12	activation	_	NN	NN	_	9	pobj	_	_
13	might	_	MD	MD	_	15	aux	_	_
14	be	_	VB	VB	_	15	cop	_	_
15	relevant	_	JJ	JJ	_	0	root	_	_
16	for	_	IN	IN	_	15	prep	_	_
17	designing	_	VBG	VBG	_	16	pcomp	_	_
18	future	_	JJ	JJ	_	20	amod	_	_
19	therapeutic	_	JJ	JJ	_	18	dep	_	_
20	strategies	_	NNS	NNS	_	17	dobj	_	_
21	aimed	_	VBN	VBN	_	20	vmod	_	_
22	at	_	IN	IN	_	21	prep	_	_
23	prolonging	_	VBG	VBG	_	22	pcomp	_	_
24	xenograft	_	NN	NN	_	25	nn	_	_
25	survival	_	NN	NN	_	23	dobj	_	_
26	.	_	.	.	_	15	punct	_	_

1	Delta-opioid	_	JJ	JJ	_	2	amod	_	_
2	receptors	_	NNS	NNS	_	8	nsubj	_	_
3	expressed	_	VBN	VBN	_	2	vmod	_	_
4	by	_	IN	IN	_	3	prep	_	_
5	Jurkat	_	NN	NN	_	7	nn	_	_
6	T	_	NN	NN	_	7	nn	_	_
7	cells	_	NNS	NNS	_	4	pobj	_	_
8	enhance	_	VBP	VBP	_	0	root	_	_
9	IL-2	_	NN	NN	_	10	nn	_	_
10	secretion	_	NN	NN	_	8	dobj	_	_
11	by	_	IN	IN	_	10	prep	_	_
12	increasing	_	VBG	VBG	_	11	pcomp	_	_
13	AP-1	_	NN	NN	_	14	nn	_	_
14	complexes	_	NNS	NNS	_	12	dobj	_	_
15	and	_	CC	CC	_	10	cc	_	_
16	activity	_	NN	NN	_	10	conj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	21	det	_	_
19	NF-AT/AP-1-binding	_	JJ	JJ	_	21	amod	_	_
20	promoter	_	NN	NN	_	21	nn	_	_
21	element	_	NN	NN	_	17	pobj	_	_
22	.	_	.	.	_	8	punct	_	_

1	Recent	_	JJ	JJ	_	3	amod	_	_
2	molecular	_	JJ	JJ	_	1	dep	_	_
3	evidence	_	NN	NN	_	4	nsubj	_	_
4	points	_	VBZ	VBZ	_	0	root	_	_
5	to	_	TO	TO	_	4	prep	_	_
6	transient	_	JJ	JJ	_	5	pobj	_	_
7	and/or	_	CC	CC	_	6	cc	_	_
8	stage-specific	_	JJ	JJ	_	6	conj	_	_
9	expression	_	NN	NN	_	6	dep	_	_
10	of	_	IN	IN	_	6	prep	_	_
11	delta-	_	NN	NN	_	10	pobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	kappa-opioid	_	JJ	JJ	_	11	conj	_	_
14	receptors	_	NNS	NNS	_	11	dep	_	_
15	by	_	IN	IN	_	6	prep	_	_
16	thymic	_	JJ	JJ	_	15	pobj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	peripheral	_	JJ	JJ	_	19	amod	_	_
19	T	_	NN	NN	_	16	conj	_	_
20	lymphocytes	_	NNS	NNS	_	16	dep	_	_
21	.	_	.	.	_	4	punct	_	_

1	Since	_	IN	IN	_	7	mark	_	_
2	medical	_	JJ	JJ	_	3	amod	_	_
3	treatments	_	NNS	NNS	_	7	nsubj	_	_
4	or	_	CC	CC	_	3	cc	_	_
5	stress	_	NN	NN	_	3	conj	_	_
6	commonly	_	RB	RB	_	7	advmod	_	_
7	increase	_	VBP	VBP	_	13	advcl	_	_
8	opioid	_	JJ	JJ	_	9	amod	_	_
9	levels	_	NNS	NNS	_	7	dobj	_	_
10	,	_	,	,	_	13	punct	_	_
11	it	_	PRP	PRP	_	13	nsubj	_	_
12	is	_	VBZ	VBZ	_	13	cop	_	_
13	important	_	JJ	JJ	_	0	root	_	_
14	to	_	TO	TO	_	15	aux	_	_
15	understand	_	VB	VB	_	13	xcomp	_	_
16	the	_	DT	DT	_	17	det	_	_
17	mechanisms	_	NNS	NNS	_	15	dobj	_	_
18	by	_	IN	IN	_	21	prep	_	_
19	which	_	WDT	WDT	_	18	pobj	_	_
20	opioids	_	NNS	NNS	_	21	nsubj	_	_
21	affect	_	VBP	VBP	_	17	rcmod	_	_
22	T	_	NN	NN	_	24	nn	_	_
23	lymphocyte	_	NN	NN	_	24	nn	_	_
24	functions	_	NNS	NNS	_	21	dobj	_	_
25	.	_	.	.	_	13	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	therefore	_	RB	RB	_	3	advmod	_	_
3	created	_	VBD	VBD	_	0	root	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	studied	_	VBD	VBD	_	3	conj	_	_
6	a	_	DT	DT	_	9	det	_	_
7	T	_	NN	NN	_	9	nn	_	_
8	cell	_	NN	NN	_	9	nn	_	_
9	line	_	NN	NN	_	3	dobj	_	_
10	expressing	_	VBG	VBG	_	9	vmod	_	_
11	the	_	DT	DT	_	14	det	_	_
12	cloned	_	VBN	VBN	_	14	amod	_	_
13	delta-opioid	_	JJ	JJ	_	14	amod	_	_
14	receptor	_	NN	NN	_	10	dobj	_	_
15	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
16	DOR1	_	NN	NN	_	14	appos	_	_
17	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
18	.	_	.	.	_	3	punct	_	_

1	DOR1	_	NN	NN	_	2	nn	_	_
2	ligation	_	NN	NN	_	11	nsubj	_	_
3	by	_	IN	IN	_	2	prep	_	_
4	a	_	DT	DT	_	7	det	_	_
5	specific	_	JJ	JJ	_	7	amod	_	_
6	DOR1	_	NN	NN	_	7	nn	_	_
7	agonist	_	NN	NN	_	3	pobj	_	_
8	,	_	,	,	_	7	punct	_	_
9	deltorphin	_	NN	NN	_	7	appos	_	_
10	,	_	,	,	_	2	punct	_	_
11	augmented	_	VBD	VBD	_	0	root	_	_
12	IL-2	_	NN	NN	_	13	nn	_	_
13	secretion	_	NN	NN	_	11	dobj	_	_
14	by	_	IN	IN	_	11	prep	_	_
15	synergizing	_	VBG	VBG	_	14	pcomp	_	_
16	with	_	IN	IN	_	15	prep	_	_
17	signals	_	NNS	NNS	_	16	pobj	_	_
18	from	_	IN	IN	_	17	prep	_	_
19	TCR-CD3	_	NN	NN	_	18	pobj	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	CD28	_	NN	NN	_	19	conj	_	_
22	.	_	.	.	_	11	punct	_	_

1	Reporter	_	NN	NN	_	3	nn	_	_
2	gene	_	NN	NN	_	3	nn	_	_
3	constructs	_	NNS	NNS	_	5	nsubjpass	_	_
4	were	_	VBD	VBD	_	5	auxpass	_	_
5	used	_	VBN	VBN	_	0	root	_	_
6	to	_	TO	TO	_	7	aux	_	_
7	map	_	VB	VB	_	5	xcomp	_	_
8	this	_	DT	DT	_	9	det	_	_
9	effect	_	NN	NN	_	7	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	deltorphin	_	NN	NN	_	10	pobj	_	_
12	to	_	TO	TO	_	7	prep	_	_
13	the	_	DT	DT	_	14	dep	_	_
14	AP-1-	_	NN	NN	_	12	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	NF-AT/AP-1-binding	_	JJ	JJ	_	14	conj	_	_
17	sites	_	NNS	NNS	_	14	dep	_	_
18	of	_	IN	IN	_	14	prep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	IL-2	_	NN	NN	_	21	nn	_	_
21	promoter	_	NN	NN	_	18	pobj	_	_
22	.	_	.	.	_	5	punct	_	_

1	Although	_	IN	IN	_	4	mark	_	_
2	DOR1	_	NN	NN	_	3	nn	_	_
3	signaling	_	NN	NN	_	4	nsubj	_	_
4	increased	_	VBD	VBD	_	8	advcl	_	_
5	-LSB-Ca2+-RSB-i	_	NN	NN	_	4	dobj	_	_
6	,	_	,	,	_	8	punct	_	_
7	deltorphin	_	NN	NN	_	8	nsubj	_	_
8	enhanced	_	VBD	VBD	_	0	root	_	_
9	transcriptional	_	JJ	JJ	_	10	amod	_	_
10	activity	_	NN	NN	_	8	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	NF-AT/AP-1-binding	_	JJ	JJ	_	14	amod	_	_
14	site	_	NN	NN	_	11	pobj	_	_
15	via	_	IN	IN	_	8	prep	_	_
16	a	_	DT	DT	_	17	det	_	_
17	mechanism	_	NN	NN	_	15	pobj	_	_
18	independent	_	JJ	JJ	_	17	amod	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	calcineurin	_	NN	NN	_	19	pobj	_	_
21	and	_	CC	CC	_	18	cc	_	_
22	distinct	_	JJ	JJ	_	18	conj	_	_
23	from	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	25	det	_	_
25	effects	_	NNS	NNS	_	23	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	elevated	_	JJ	JJ	_	28	amod	_	_
28	-LSB-Ca2+-RSB-i	_	NN	NN	_	26	pobj	_	_
29	.	_	.	.	_	8	punct	_	_

1	Deltorphin	_	NN	NN	_	3	nsubj	_	_
2	also	_	RB	RB	_	3	advmod	_	_
3	increased	_	VBD	VBD	_	0	root	_	_
4	accumulation	_	NN	NN	_	3	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	AP-1	_	NN	NN	_	9	nn	_	_
7	transcription	_	NN	NN	_	9	nn	_	_
8	factor	_	NN	NN	_	9	nn	_	_
9	complexes	_	NNS	NNS	_	5	pobj	_	_
10	,	_	,	,	_	3	punct	_	_
11	suggesting	_	VBG	VBG	_	3	vmod	_	_
12	that	_	IN	IN	_	14	mark	_	_
13	DOR1	_	NN	NN	_	14	nsubj	_	_
14	augments	_	VBZ	VBZ	_	11	ccomp	_	_
15	IL-2	_	NN	NN	_	16	nn	_	_
16	secretion	_	NN	NN	_	14	dobj	_	_
17	by	_	IN	IN	_	14	prep	_	_
18	increasing	_	VBG	VBG	_	17	pcomp	_	_
19	the	_	DT	DT	_	21	det	_	_
20	AP-1	_	NN	NN	_	21	nn	_	_
21	component	_	NN	NN	_	18	dobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	26	det	_	_
24	NF-AT/AP-1	_	NN	NN	_	26	nn	_	_
25	transcription	_	NN	NN	_	26	nn	_	_
26	factor	_	NN	NN	_	22	pobj	_	_
27	.	_	.	.	_	3	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	advance	_	VBP	VBP	_	0	root	_	_
4	the	_	DT	DT	_	6	det	_	_
5	molecular	_	JJ	JJ	_	6	amod	_	_
6	understanding	_	NN	NN	_	3	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	opioid	_	JJ	JJ	_	9	amod	_	_
9	effects	_	NNS	NNS	_	7	pobj	_	_
10	on	_	IN	IN	_	9	prep	_	_
11	lymphocytes	_	NNS	NNS	_	10	pobj	_	_
12	,	_	,	,	_	3	punct	_	_
13	and	_	CC	CC	_	3	cc	_	_
14	in	_	IN	IN	_	3	conj	_	_
15	addition	_	NN	NN	_	14	pobj	_	_
16	,	_	,	,	_	3	punct	_	_
17	demonstrate	_	VBP	VBP	_	3	conj	_	_
18	regulation	_	NN	NN	_	17	dobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	IL-2	_	NN	NN	_	19	pobj	_	_
21	synthesis	_	NN	NN	_	20	dep	_	_
22	and	_	CC	CC	_	20	cc	_	_
23	secretion	_	NN	NN	_	20	conj	_	_
24	by	_	IN	IN	_	18	prep	_	_
25	the	_	DT	DT	_	27	det	_	_
26	novel	_	JJ	JJ	_	27	amod	_	_
27	mechanism	_	NN	NN	_	24	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	receptor-mediated	_	JJ	JJ	_	31	amod	_	_
30	AP-1	_	NN	NN	_	31	nn	_	_
31	induction	_	NN	NN	_	28	pobj	_	_
32	.	_	.	.	_	3	punct	_	_

1	Pharmacological	_	JJ	JJ	_	2	amod	_	_
2	control	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	antigen	_	NN	NN	_	5	nn	_	_
5	responsiveness	_	NN	NN	_	3	pobj	_	_
6	in	_	IN	IN	_	2	prep	_	_
7	genetically	_	RB	RB	_	10	advmod	_	_
8	modified	_	VBN	VBN	_	10	amod	_	_
9	T	_	NN	NN	_	10	nn	_	_
10	lymphocytes	_	NNS	NNS	_	6	pobj	_	_
11	.	_	.	.	_	2	punct	_	_

1	A	_	DT	DT	_	4	det	_	_
2	chimeric	_	JJ	JJ	_	4	amod	_	_
3	TCR	_	NN	NN	_	4	nn	_	_
4	gene	_	NN	NN	_	27	nsubjpass	_	_
5	,	_	,	,	_	4	punct	_	_
6	comprising	_	VBG	VBG	_	4	vmod	_	_
7	an	_	DT	DT	_	12	det	_	_
8	anti-hapten	_	JJ	JJ	_	12	amod	_	_
9	single-chain	_	JJ	JJ	_	12	amod	_	_
10	Ab	_	NN	NN	_	12	nn	_	_
11	variable	_	JJ	JJ	_	12	amod	_	_
12	fragment	_	NN	NN	_	6	dobj	_	_
13	fused	_	VBN	VBN	_	12	vmod	_	_
14	to	_	TO	TO	_	13	prep	_	_
15	the	_	DT	DT	_	19	det	_	_
16	transmembrane	_	JJ	JJ	_	19	amod	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	cytoplasmic	_	JJ	JJ	_	16	conj	_	_
19	regions	_	NNS	NNS	_	14	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	24	det	_	_
22	human	_	JJ	JJ	_	24	amod	_	_
23	TCR	_	NN	NN	_	24	nn	_	_
24	zeta-chain	_	NN	NN	_	20	pobj	_	_
25	,	_	,	,	_	4	punct	_	_
26	was	_	VBD	VBD	_	27	auxpass	_	_
27	used	_	VBN	VBN	_	0	root	_	_
28	to	_	TO	TO	_	29	aux	_	_
29	determine	_	VB	VB	_	27	xcomp	_	_
30	whether	_	IN	IN	_	36	mark	_	_
31	the	_	DT	DT	_	33	det	_	_
32	tetracycline-regulatable	_	JJ	JJ	_	33	amod	_	_
33	system	_	NN	NN	_	36	nsubjpass	_	_
34	could	_	MD	MD	_	36	aux	_	_
35	be	_	VB	VB	_	36	auxpass	_	_
36	used	_	VBN	VBN	_	29	ccomp	_	_
37	to	_	TO	TO	_	38	aux	_	_
38	regulate	_	VB	VB	_	36	xcomp	_	_
39	gene	_	NN	NN	_	40	nn	_	_
40	expression	_	NN	NN	_	38	dobj	_	_
41	in	_	IN	IN	_	40	prep	_	_
42	T	_	NN	NN	_	43	nn	_	_
43	cells	_	NNS	NNS	_	41	pobj	_	_
44	.	_	.	.	_	27	punct	_	_

1	Jurkat	_	NN	NN	_	3	nn	_	_
2	T	_	NN	NN	_	3	nn	_	_
3	cells	_	NNS	NNS	_	6	nsubjpass	_	_
4	were	_	VBD	VBD	_	6	auxpass	_	_
5	stably	_	RB	RB	_	6	advmod	_	_
6	transfected	_	VBN	VBN	_	0	root	_	_
7	with	_	IN	IN	_	6	prep	_	_
8	a	_	DT	DT	_	10	det	_	_
9	single	_	JJ	JJ	_	10	amod	_	_
10	vector	_	NN	NN	_	7	pobj	_	_
11	encoding	_	VBG	VBG	_	10	vmod	_	_
12	the	_	DT	DT	_	15	det	_	_
13	tetracycline	_	NN	NN	_	15	nn	_	_
14	trans-activator	_	JJ	JJ	_	15	amod	_	_
15	protein	_	NN	NN	_	11	dobj	_	_
16	,	_	,	,	_	15	punct	_	_
17	controlled	_	VBN	VBN	_	15	vmod	_	_
18	by	_	IN	IN	_	17	prep	_	_
19	a	_	DT	DT	_	21	det	_	_
20	constitutive	_	JJ	JJ	_	21	amod	_	_
21	promoter	_	NN	NN	_	18	pobj	_	_
22	,	_	,	,	_	10	punct	_	_
23	and	_	CC	CC	_	10	cc	_	_
24	the	_	DT	DT	_	26	det	_	_
25	chimeric	_	JJ	JJ	_	26	amod	_	_
26	TCR	_	NN	NN	_	10	conj	_	_
27	,	_	,	,	_	6	punct	_	_
28	under	_	IN	IN	_	6	prep	_	_
29	the	_	DT	DT	_	30	det	_	_
30	control	_	NN	NN	_	28	pobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	a	_	DT	DT	_	35	det	_	_
33	trans-activator	_	JJ	JJ	_	35	amod	_	_
34	protein-responsive	_	JJ	JJ	_	35	amod	_	_
35	promoter	_	NN	NN	_	31	pobj	_	_
36	.	_	.	.	_	6	punct	_	_

1	In	_	IN	IN	_	12	prep	_	_
2	the	_	DT	DT	_	3	det	_	_
3	absence	_	NN	NN	_	1	pobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	tetracyclines	_	NNS	NNS	_	4	pobj	_	_
6	,	_	,	,	_	12	punct	_	_
7	the	_	DT	DT	_	10	det	_	_
8	transfected	_	VBN	VBN	_	10	amod	_	_
9	T	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	12	nsubjpass	_	_
11	were	_	VBD	VBD	_	12	auxpass	_	_
12	shown	_	VBN	VBN	_	0	root	_	_
13	to	_	TO	TO	_	14	aux	_	_
14	express	_	VB	VB	_	12	xcomp	_	_
15	the	_	DT	DT	_	17	det	_	_
16	chimeric	_	JJ	JJ	_	17	amod	_	_
17	receptor	_	NN	NN	_	14	dobj	_	_
18	on	_	IN	IN	_	14	prep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	cell	_	NN	NN	_	21	nn	_	_
21	surface	_	NN	NN	_	18	pobj	_	_
22	and	_	CC	CC	_	12	cc	_	_
23	could	_	MD	MD	_	25	aux	_	_
24	be	_	VB	VB	_	25	auxpass	_	_
25	activated	_	VBN	VBN	_	12	conj	_	_
26	by	_	IN	IN	_	25	prep	_	_
27	its	_	PRP$	PRP$	_	29	poss	_	_
28	cognate	_	JJ	JJ	_	29	amod	_	_
29	Ag	_	NN	NN	_	26	pobj	_	_
30	,	_	,	,	_	12	punct	_	_
31	leading	_	VBG	VBG	_	12	vmod	_	_
32	to	_	TO	TO	_	31	prep	_	_
33	the	_	DT	DT	_	34	det	_	_
34	secretion	_	NN	NN	_	32	pobj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	IL-2	_	NN	NN	_	35	pobj	_	_
37	.	_	.	.	_	12	punct	_	_

1	When	_	WRB	WRB	_	5	advmod	_	_
2	the	_	DT	DT	_	3	det	_	_
3	cells	_	NNS	NNS	_	5	nsubjpass	_	_
4	were	_	VBD	VBD	_	5	auxpass	_	_
5	exposed	_	VBN	VBN	_	19	advcl	_	_
6	to	_	TO	TO	_	5	prep	_	_
7	increasing	_	VBG	VBG	_	8	amod	_	_
8	concentrations	_	NNS	NNS	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	tetracyclines	_	NNS	NNS	_	9	pobj	_	_
11	,	_	,	,	_	19	punct	_	_
12	surface	_	NN	NN	_	13	nn	_	_
13	expression	_	NN	NN	_	19	nsubjpass	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	17	det	_	_
16	chimeric	_	JJ	JJ	_	17	amod	_	_
17	receptor	_	NN	NN	_	14	pobj	_	_
18	was	_	VBD	VBD	_	19	auxpass	_	_
19	suppressed	_	VBN	VBN	_	0	root	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	a	_	DT	DT	_	23	det	_	_
22	dose-dependent	_	JJ	JJ	_	23	amod	_	_
23	manner	_	NN	NN	_	20	pobj	_	_
24	,	_	,	,	_	19	punct	_	_
25	and	_	CC	CC	_	19	cc	_	_
26	this	_	DT	DT	_	27	det	_	_
27	suppression	_	NN	NN	_	29	nsubj	_	_
28	was	_	VBD	VBD	_	29	cop	_	_
29	sufficient	_	JJ	JJ	_	19	conj	_	_
30	to	_	TO	TO	_	31	aux	_	_
31	result	_	VB	VB	_	29	xcomp	_	_
32	in	_	IN	IN	_	31	prep	_	_
33	complete	_	JJ	JJ	_	34	amod	_	_
34	loss	_	NN	NN	_	32	pobj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	responsiveness	_	NN	NN	_	35	pobj	_	_
37	to	_	TO	TO	_	36	prep	_	_
38	the	_	DT	DT	_	40	det	_	_
39	targeted	_	VBN	VBN	_	40	amod	_	_
40	Ag	_	NN	NN	_	37	pobj	_	_
41	.	_	.	.	_	19	punct	_	_

1	Prolonged	_	JJ	JJ	_	2	amod	_	_
2	suppression	_	NN	NN	_	12	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	trans-gene	_	JJ	JJ	_	5	amod	_	_
5	expression	_	NN	NN	_	3	pobj	_	_
6	for	_	IN	IN	_	2	prep	_	_
7	up	_	RB	RB	_	9	quantmod	_	_
8	to	_	TO	TO	_	9	dep	_	_
9	7	_	CD	CD	_	10	num	_	_
10	days	_	NNS	NNS	_	6	pobj	_	_
11	was	_	VBD	VBD	_	12	auxpass	_	_
12	observed	_	VBN	VBN	_	0	root	_	_
13	after	_	IN	IN	_	16	mark	_	_
14	doxycycline	_	NN	NN	_	16	nsubjpass	_	_
15	was	_	VBD	VBD	_	16	auxpass	_	_
16	removed	_	VBN	VBN	_	12	advcl	_	_
17	from	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	19	det	_	_
19	cultures	_	NNS	NNS	_	17	pobj	_	_
20	,	_	,	,	_	12	punct	_	_
21	but	_	CC	CC	_	12	cc	_	_
22	eventual	_	JJ	JJ	_	23	amod	_	_
23	recovery	_	NN	NN	_	28	nsubj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	surface	_	NN	NN	_	26	nn	_	_
26	expression	_	NN	NN	_	24	pobj	_	_
27	was	_	VBD	VBD	_	28	cop	_	_
28	complete	_	JJ	JJ	_	12	conj	_	_
29	,	_	,	,	_	28	punct	_	_
30	and	_	CC	CC	_	28	cc	_	_
31	the	_	DT	DT	_	33	det	_	_
32	absolute	_	JJ	JJ	_	33	amod	_	_
33	time	_	NN	NN	_	38	nsubj	_	_
34	to	_	TO	TO	_	33	prep	_	_
35	recovery	_	NN	NN	_	34	pobj	_	_
36	was	_	VBD	VBD	_	38	cop	_	_
37	directly	_	RB	RB	_	38	advmod	_	_
38	proportional	_	JJ	JJ	_	28	conj	_	_
39	to	_	TO	TO	_	38	prep	_	_
40	the	_	DT	DT	_	42	det	_	_
41	initial	_	JJ	JJ	_	42	amod	_	_
42	concentration	_	NN	NN	_	39	pobj	_	_
43	of	_	IN	IN	_	42	prep	_	_
44	the	_	DT	DT	_	45	det	_	_
45	drug	_	NN	NN	_	43	pobj	_	_
46	.	_	.	.	_	12	punct	_	_

1	Pharmacologic	_	JJ	JJ	_	2	amod	_	_
2	control	_	NN	NN	_	10	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	trans-gene	_	JJ	JJ	_	5	amod	_	_
5	expression	_	NN	NN	_	3	pobj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	gene-modified	_	JJ	JJ	_	9	amod	_	_
8	T	_	NN	NN	_	9	nn	_	_
9	cells	_	NNS	NNS	_	6	pobj	_	_
10	will	_	MD	MD	_	0	root	_	_
11	not	_	RB	RB	_	12	neg	_	_
12	only	_	RB	RB	_	10	dep	_	_
13	facilitate	_	VB	VB	_	10	conj	_	_
14	new	_	JJ	JJ	_	15	amod	_	_
15	approaches	_	NNS	NNS	_	13	dobj	_	_
16	to	_	TO	TO	_	15	prep	_	_
17	the	_	DT	DT	_	18	det	_	_
18	study	_	NN	NN	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	different	_	JJ	JJ	_	21	amod	_	_
21	aspects	_	NNS	NNS	_	19	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	T	_	NN	NN	_	25	nn	_	_
24	cell	_	NN	NN	_	25	nn	_	_
25	biology	_	NN	NN	_	22	pobj	_	_
26	,	_	,	,	_	10	punct	_	_
27	but	_	CC	CC	_	10	cc	_	_
28	will	_	MD	MD	_	30	aux	_	_
29	also	_	RB	RB	_	30	advmod	_	_
30	provide	_	VB	VB	_	10	conj	_	_
31	the	_	DT	DT	_	32	det	_	_
32	basis	_	NN	NN	_	30	dobj	_	_
33	for	_	IN	IN	_	32	prep	_	_
34	new	_	JJ	JJ	_	37	amod	_	_
35	gene	_	NN	NN	_	37	nn	_	_
36	therapy	_	NN	NN	_	37	nn	_	_
37	strategies	_	NNS	NNS	_	33	pobj	_	_
38	.	_	.	.	_	10	punct	_	_

1	Human	_	JJ	JJ	_	9	amod	_	_
2	immunodeficiency	_	NN	NN	_	9	nn	_	_
3	virus	_	NN	NN	_	9	nn	_	_
4	type	_	NN	NN	_	9	nn	_	_
5	1	_	CD	CD	_	9	num	_	_
6	long	_	JJ	JJ	_	9	amod	_	_
7	terminal	_	JJ	JJ	_	9	amod	_	_
8	repeat	_	NN	NN	_	9	nn	_	_
9	quasispecies	_	NNS	NNS	_	10	nsubj	_	_
10	differ	_	VBP	VBP	_	0	root	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	basal	_	JJ	JJ	_	13	amod	_	_
13	transcription	_	NN	NN	_	11	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	nuclear	_	JJ	JJ	_	16	amod	_	_
16	factor	_	NN	NN	_	17	nn	_	_
17	recruitment	_	NN	NN	_	13	conj	_	_
18	in	_	IN	IN	_	13	prep	_	_
19	human	_	JJ	JJ	_	21	amod	_	_
20	glial	_	JJ	JJ	_	21	amod	_	_
21	cells	_	NNS	NNS	_	18	pobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	lymphocytes	_	NNS	NNS	_	21	conj	_	_
24	.	_	.	.	_	10	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	generation	_	NN	NN	_	11	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	genomic	_	JJ	JJ	_	5	amod	_	_
5	diversity	_	NN	NN	_	3	pobj	_	_
6	during	_	IN	IN	_	2	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	course	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	infection	_	NN	NN	_	9	pobj	_	_
11	has	_	VBZ	VBZ	_	0	root	_	_
12	the	_	DT	DT	_	13	det	_	_
13	potential	_	NN	NN	_	11	dobj	_	_
14	to	_	TO	TO	_	15	aux	_	_
15	affect	_	VB	VB	_	13	vmod	_	_
16	all	_	DT	DT	_	17	det	_	_
17	aspects	_	NNS	NNS	_	15	dobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	HIV-1	_	NN	NN	_	20	nn	_	_
20	replication	_	NN	NN	_	18	pobj	_	_
21	,	_	,	,	_	17	punct	_	_
22	including	_	VBG	VBG	_	17	prep	_	_
23	expression	_	NN	NN	_	22	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	the	_	DT	DT	_	27	det	_	_
26	proviral	_	JJ	JJ	_	27	amod	_	_
27	genome	_	NN	NN	_	24	pobj	_	_
28	.	_	.	.	_	11	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	gain	_	VB	VB	_	0	root	_	_
3	a	_	DT	DT	_	5	det	_	_
4	better	_	JJR	JJR	_	5	amod	_	_
5	understanding	_	NN	NN	_	2	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	impact	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	long	_	JJ	JJ	_	12	amod	_	_
11	terminal	_	JJ	JJ	_	12	amod	_	_
12	repeat	_	NN	NN	_	17	nn	_	_
13	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
14	LTR	_	NN	NN	_	12	appos	_	_
15	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	sequence	_	NN	NN	_	17	nn	_	_
17	diversity	_	NN	NN	_	9	pobj	_	_
18	on	_	IN	IN	_	8	prep	_	_
19	LTR-directed	_	JJ	JJ	_	20	amod	_	_
20	gene	_	NN	NN	_	21	nn	_	_
21	expression	_	NN	NN	_	18	pobj	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	cells	_	NNS	NNS	_	22	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	the	_	DT	DT	_	28	dep	_	_
26	central	_	JJ	JJ	_	28	amod	_	_
27	nervous	_	JJ	JJ	_	28	amod	_	_
28	system	_	NN	NN	_	24	pobj	_	_
29	-LRB-	_	-LRB-	-LRB-	_	30	punct	_	_
30	CNS	_	NN	NN	_	28	appos	_	_
31	-RRB-	_	-RRB-	-RRB-	_	30	punct	_	_
32	and	_	CC	CC	_	28	cc	_	_
33	immune	_	JJ	JJ	_	34	amod	_	_
34	system	_	NN	NN	_	28	conj	_	_
35	,	_	,	,	_	2	punct	_	_
36	we	_	PRP	PRP	_	37	nsubj	_	_
37	amplified	_	VBD	VBD	_	2	parataxis	_	_
38	and	_	CC	CC	_	37	cc	_	_
39	cloned	_	VBN	VBN	_	37	conj	_	_
40	LTRs	_	NNS	NNS	_	37	dobj	_	_
41	from	_	IN	IN	_	40	prep	_	_
42	proviral	_	JJ	JJ	_	43	amod	_	_
43	DNA	_	NN	NN	_	41	pobj	_	_
44	in	_	IN	IN	_	43	prep	_	_
45	HIV-1-infected	_	JJ	JJ	_	47	amod	_	_
46	peripheral	_	JJ	JJ	_	47	amod	_	_
47	blood	_	NN	NN	_	44	pobj	_	_
48	.	_	.	.	_	2	punct	_	_

1	Sequence	_	NN	NN	_	2	nn	_	_
2	analysis	_	NN	NN	_	14	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	nineteen	_	CD	CD	_	5	num	_	_
5	LTRs	_	NNS	NNS	_	3	pobj	_	_
6	cloned	_	VBN	VBN	_	5	vmod	_	_
7	from	_	IN	IN	_	6	prep	_	_
8	2	_	CD	CD	_	7	pobj	_	_
9	adult	_	JJ	JJ	_	8	amod	_	_
10	and	_	CC	CC	_	8	cc	_	_
11	3	_	CD	CD	_	8	conj	_	_
12	pediatric	_	JJ	JJ	_	11	amod	_	_
13	patients	_	NNS	NNS	_	8	dep	_	_
14	revealed	_	VBD	VBD	_	0	root	_	_
15	an	_	DT	DT	_	16	det	_	_
16	average	_	NN	NN	_	14	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	33	_	CD	CD	_	20	num	_	_
19	nucleotide	_	NN	NN	_	20	nn	_	_
20	changes	_	NNS	NNS	_	17	pobj	_	_
21	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
22	with	_	IN	IN	_	16	prep	_	_
23	respect	_	NN	NN	_	22	pobj	_	_
24	to	_	TO	TO	_	23	prep	_	_
25	the	_	DT	DT	_	26	det	_	_
26	sequence	_	NN	NN	_	24	pobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	30	det	_	_
29	LAI	_	NN	NN	_	30	nn	_	_
30	LTR	_	NN	NN	_	27	pobj	_	_
31	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
32	within	_	IN	IN	_	16	prep	_	_
33	the	_	DT	DT	_	36	det	_	_
34	455-bp	_	JJ	JJ	_	36	amod	_	_
35	U3	_	NN	NN	_	36	nn	_	_
36	region	_	NN	NN	_	32	pobj	_	_
37	.	_	.	.	_	14	punct	_	_

1	Transient	_	JJ	JJ	_	3	amod	_	_
2	expression	_	NN	NN	_	3	nn	_	_
3	analyses	_	NNS	NNS	_	11	nsubj	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	cells	_	NNS	NNS	_	4	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	neuroglial	_	JJ	JJ	_	6	pobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	lymphocytic	_	JJ	JJ	_	7	conj	_	_
10	origin	_	NN	NN	_	7	dep	_	_
11	demonstrated	_	VBD	VBD	_	0	root	_	_
12	that	_	IN	IN	_	17	mark	_	_
13	some	_	DT	DT	_	17	nsubj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	these	_	DT	DT	_	16	det	_	_
16	LTRs	_	NNS	NNS	_	14	pobj	_	_
17	had	_	VBD	VBD	_	11	ccomp	_	_
18	activities	_	NNS	NNS	_	17	dobj	_	_
19	which	_	WDT	WDT	_	20	nsubj	_	_
20	varied	_	VBD	VBD	_	18	rcmod	_	_
21	significantly	_	RB	RB	_	20	advmod	_	_
22	from	_	IN	IN	_	20	prep	_	_
23	the	_	DT	DT	_	25	det	_	_
24	LAI	_	NN	NN	_	25	nn	_	_
25	LTR	_	NN	NN	_	22	pobj	_	_
26	in	_	IN	IN	_	25	prep	_	_
27	U-373	_	NN	NN	_	29	nn	_	_
28	MG	_	NN	NN	_	29	nn	_	_
29	cells	_	NNS	NNS	_	26	pobj	_	_
30	-LRB-	_	-LRB-	-LRB-	_	34	punct	_	_
31	an	_	DT	DT	_	34	det	_	_
32	astrocytoma	_	NN	NN	_	34	nn	_	_
33	cell	_	NN	NN	_	34	nn	_	_
34	line	_	NN	NN	_	29	dep	_	_
35	-RRB-	_	-RRB-	-RRB-	_	34	punct	_	_
36	as	_	RB	RB	_	37	advmod	_	_
37	well	_	RB	RB	_	26	cc	_	_
38	as	_	IN	IN	_	37	mwe	_	_
39	in	_	IN	IN	_	26	conj	_	_
40	Jurkat	_	NN	NN	_	41	nn	_	_
41	cells	_	NNS	NNS	_	39	pobj	_	_
42	-LRB-	_	-LRB-	-LRB-	_	48	punct	_	_
43	a	_	DT	DT	_	48	det	_	_
44	CD4-	_	JJ	JJ	_	48	amod	_	_
45	positive	_	JJ	JJ	_	48	amod	_	_
46	lymphocyte	_	NN	NN	_	48	nn	_	_
47	cell	_	NN	NN	_	48	nn	_	_
48	line	_	NN	NN	_	41	dep	_	_
49	-RRB-	_	-RRB-	-RRB-	_	48	punct	_	_
50	.	_	.	.	_	11	punct	_	_

1	While	_	IN	IN	_	13	mark	_	_
2	LTRs	_	NNS	NNS	_	13	nsubj	_	_
3	which	_	WDT	WDT	_	4	nsubj	_	_
4	demonstrated	_	VBD	VBD	_	2	rcmod	_	_
5	the	_	DT	DT	_	7	det	_	_
6	highest	_	JJS	JJS	_	7	amod	_	_
7	activities	_	NNS	NNS	_	4	dobj	_	_
8	in	_	IN	IN	_	4	prep	_	_
9	U-373	_	NN	NN	_	11	nn	_	_
10	MG	_	NN	NN	_	11	nn	_	_
11	cells	_	NNS	NNS	_	8	pobj	_	_
12	also	_	RB	RB	_	13	advmod	_	_
13	yielded	_	VBD	VBD	_	25	advcl	_	_
14	high	_	JJ	JJ	_	15	amod	_	_
15	activities	_	NNS	NNS	_	13	dobj	_	_
16	in	_	IN	IN	_	13	prep	_	_
17	Jurkat	_	NN	NN	_	18	nn	_	_
18	cells	_	NNS	NNS	_	16	pobj	_	_
19	,	_	,	,	_	25	punct	_	_
20	the	_	DT	DT	_	21	det	_	_
21	LTRs	_	NNS	NNS	_	25	nsubj	_	_
22	were	_	VBD	VBD	_	25	cop	_	_
23	generally	_	RB	RB	_	25	advmod	_	_
24	more	_	RBR	RBR	_	25	advmod	_	_
25	active	_	JJ	JJ	_	0	root	_	_
26	in	_	IN	IN	_	25	prep	_	_
27	Jurkat	_	NN	NN	_	28	nn	_	_
28	cells	_	NNS	NNS	_	26	pobj	_	_
29	when	_	WRB	WRB	_	30	advmod	_	_
30	compared	_	VBN	VBN	_	25	advcl	_	_
31	to	_	TO	TO	_	30	prep	_	_
32	the	_	DT	DT	_	34	det	_	_
33	LAI	_	NN	NN	_	34	nn	_	_
34	LTR	_	NN	NN	_	31	pobj	_	_
35	.	_	.	.	_	25	punct	_	_

1	Differences	_	NNS	NNS	_	6	nsubj	_	_
2	in	_	IN	IN	_	1	prep	_	_
3	LTR	_	NN	NN	_	4	nn	_	_
4	sequence	_	NN	NN	_	2	pobj	_	_
5	also	_	RB	RB	_	6	advmod	_	_
6	resulted	_	VBD	VBD	_	0	root	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	differences	_	NNS	NNS	_	7	pobj	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	transcription	_	NN	NN	_	12	nn	_	_
11	factor	_	NN	NN	_	12	nn	_	_
12	recruitment	_	NN	NN	_	9	pobj	_	_
13	to	_	TO	TO	_	12	prep	_	_
14	cis-acting	_	JJ	JJ	_	15	amod	_	_
15	sites	_	NNS	NNS	_	13	pobj	_	_
16	within	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	U3	_	NN	NN	_	19	nn	_	_
19	region	_	NN	NN	_	16	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	22	det	_	_
22	LTR	_	NN	NN	_	20	pobj	_	_
23	,	_	,	,	_	6	punct	_	_
24	as	_	IN	IN	_	25	mark	_	_
25	demonstrated	_	VBN	VBN	_	6	advcl	_	_
26	by	_	IN	IN	_	25	prep	_	_
27	electrophoretic	_	JJ	JJ	_	30	amod	_	_
28	mobility	_	NN	NN	_	30	nn	_	_
29	shift	_	NN	NN	_	30	nn	_	_
30	assays	_	NNS	NNS	_	26	pobj	_	_
31	.	_	.	.	_	6	punct	_	_

1	In	_	IN	IN	_	8	prep	_	_
2	particular	_	JJ	JJ	_	1	pobj	_	_
3	,	_	,	,	_	8	punct	_	_
4	naturally	_	RB	RB	_	5	advmod	_	_
5	occurring	_	VBG	VBG	_	7	amod	_	_
6	sequence	_	NN	NN	_	7	nn	_	_
7	variation	_	NN	NN	_	8	nsubj	_	_
8	impacted	_	JJ	JJ	_	0	root	_	_
9	transcription	_	NN	NN	_	10	nn	_	_
10	factor	_	NN	NN	_	8	dobj	_	_
11	binding	_	VBG	VBG	_	10	vmod	_	_
12	to	_	TO	TO	_	11	prep	_	_
13	an	_	DT	DT	_	24	det	_	_
14	activating	_	VBG	VBG	_	24	amod	_	_
15	transcription	_	NN	NN	_	24	nn	_	_
16	factor/cAMP	_	NN	NN	_	24	nn	_	_
17	response	_	NN	NN	_	24	nn	_	_
18	element	_	NN	NN	_	24	nn	_	_
19	binding	_	NN	NN	_	24	nn	_	_
20	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
21	ATF/CREB	_	NN	NN	_	24	nn	_	_
22	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
23	binding	_	NN	NN	_	24	nn	_	_
24	site	_	NN	NN	_	12	pobj	_	_
25	-LRB-	_	-LRB-	-LRB-	_	26	punct	_	_
26	located	_	JJ	JJ	_	24	dep	_	_
27	between	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	29	dep	_	_
29	LEF-1	_	NN	NN	_	27	pobj	_	_
30	and	_	CC	CC	_	29	cc	_	_
31	distal	_	JJ	JJ	_	34	amod	_	_
32	NF-kappaB	_	NN	NN	_	34	nn	_	_
33	transcription	_	NN	NN	_	34	nn	_	_
34	factor	_	NN	NN	_	29	conj	_	_
35	binding	_	NN	NN	_	36	nn	_	_
36	sites	_	NNS	NNS	_	29	dep	_	_
37	-RRB-	_	-RRB-	-RRB-	_	26	punct	_	_
38	that	_	WDT	WDT	_	40	dobj	_	_
39	we	_	PRP	PRP	_	40	nsubj	_	_
40	identified	_	VBN	VBN	_	24	rcmod	_	_
41	in	_	IN	IN	_	40	prep	_	_
42	previous	_	JJ	JJ	_	43	amod	_	_
43	studies	_	NNS	NNS	_	41	pobj	_	_
44	of	_	IN	IN	_	43	prep	_	_
45	the	_	DT	DT	_	47	det	_	_
46	HIV-1	_	NN	NN	_	47	nn	_	_
47	LTR	_	NN	NN	_	44	pobj	_	_
48	.	_	.	.	_	8	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	findings	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	10	mark	_	_
5	LTR	_	NN	NN	_	6	nn	_	_
6	sequence	_	NN	NN	_	7	nn	_	_
7	changes	_	NNS	NNS	_	10	nsubj	_	_
8	can	_	MD	MD	_	10	aux	_	_
9	significantly	_	RB	RB	_	10	advmod	_	_
10	affect	_	VB	VB	_	3	ccomp	_	_
11	basal	_	JJ	JJ	_	13	amod	_	_
12	LTR	_	NN	NN	_	13	nn	_	_
13	function	_	NN	NN	_	10	dobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	transcription	_	NN	NN	_	16	nn	_	_
16	factor	_	NN	NN	_	17	nn	_	_
17	recruitment	_	NN	NN	_	13	conj	_	_
18	,	_	,	,	_	10	punct	_	_
19	which	_	WDT	WDT	_	25	nsubj	_	_
20	may	_	MD	MD	_	25	aux	_	_
21	,	_	,	,	_	25	punct	_	_
22	in	_	IN	IN	_	25	prep	_	_
23	turn	_	NN	NN	_	22	pobj	_	_
24	,	_	,	,	_	25	punct	_	_
25	alter	_	VB	VB	_	10	ccomp	_	_
26	the	_	DT	DT	_	27	det	_	_
27	course	_	NN	NN	_	25	dobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	viral	_	JJ	JJ	_	30	amod	_	_
30	replication	_	NN	NN	_	28	pobj	_	_
31	in	_	IN	IN	_	30	prep	_	_
32	cells	_	NNS	NNS	_	31	pobj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	CNS	_	NN	NN	_	33	pobj	_	_
35	and	_	CC	CC	_	34	cc	_	_
36	immune	_	JJ	JJ	_	38	amod	_	_
37	system	_	NN	NN	_	38	nn	_	_
38	origin	_	NN	NN	_	34	conj	_	_
39	.	_	.	.	_	3	punct	_	_

1	Inhibition	_	NN	NN	_	7	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	nuclear	_	JJ	JJ	_	5	amod	_	_
4	factor	_	NN	NN	_	5	nn	_	_
5	kappaB	_	NN	NN	_	6	nn	_	_
6	activation	_	NN	NN	_	2	pobj	_	_
7	attenuates	_	VBZ	VBZ	_	0	root	_	_
8	apoptosis	_	NN	NN	_	9	nn	_	_
9	resistance	_	NN	NN	_	7	dobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	lymphoid	_	JJ	JJ	_	12	amod	_	_
12	cells	_	NNS	NNS	_	10	pobj	_	_
13	.	_	.	.	_	7	punct	_	_

1	Death-inducing	_	NN	NN	_	2	nn	_	_
2	ligands	_	NNS	NNS	_	22	nsubjpass	_	_
3	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
4	DILs	_	NNS	NNS	_	2	appos	_	_
5	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
6	such	_	JJ	JJ	_	7	mwe	_	_
7	as	_	IN	IN	_	2	prep	_	_
8	tumor	_	NN	NN	_	11	nn	_	_
9	necrosis	_	NN	NN	_	11	nn	_	_
10	factor	_	NN	NN	_	11	nn	_	_
11	alpha	_	NN	NN	_	7	pobj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	TNFalpha	_	NN	NN	_	11	appos	_	_
14	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
15	or	_	CC	CC	_	11	cc	_	_
16	the	_	DT	DT	_	18	det	_	_
17	cytotoxic	_	JJ	JJ	_	18	amod	_	_
18	drug	_	NN	NN	_	11	conj	_	_
19	doxorubicin	_	NN	NN	_	18	dep	_	_
20	have	_	VBP	VBP	_	22	aux	_	_
21	been	_	VBN	VBN	_	22	auxpass	_	_
22	shown	_	VBN	VBN	_	0	root	_	_
23	to	_	TO	TO	_	24	aux	_	_
24	activate	_	VB	VB	_	22	xcomp	_	_
25	a	_	DT	DT	_	33	det	_	_
26	nuclear	_	JJ	JJ	_	28	amod	_	_
27	factor	_	NN	NN	_	28	nn	_	_
28	kappaB	_	NN	NN	_	33	nn	_	_
29	-LRB-	_	-LRB-	-LRB-	_	33	punct	_	_
30	NFkappaB	_	NN	NN	_	33	nn	_	_
31	-RRB-	_	-RRB-	-RRB-	_	33	punct	_	_
32	-dependent	_	JJ	JJ	_	33	amod	_	_
33	program	_	NN	NN	_	24	dobj	_	_
34	that	_	WDT	WDT	_	36	nsubj	_	_
35	may	_	MD	MD	_	36	aux	_	_
36	rescue	_	VB	VB	_	33	rcmod	_	_
37	cells	_	NNS	NNS	_	36	dobj	_	_
38	from	_	IN	IN	_	36	prep	_	_
39	apoptosis	_	NN	NN	_	40	nn	_	_
40	induction	_	NN	NN	_	38	pobj	_	_
41	.	_	.	.	_	22	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	demonstrate	_	VBP	VBP	_	0	root	_	_
3	here	_	RB	RB	_	2	advmod	_	_
4	that	_	IN	IN	_	18	mark	_	_
5	TRAIL	_	NN	NN	_	18	nsubj	_	_
6	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
7	TNF-related	_	JJ	JJ	_	9	amod	_	_
8	apoptosis-inducing	_	NN	NN	_	9	nn	_	_
9	ligand	_	NN	NN	_	5	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	,	_	,	,	_	5	punct	_	_
12	a	_	DT	DT	_	15	det	_	_
13	recently	_	RB	RB	_	14	advmod	_	_
14	identified	_	VBN	VBN	_	15	amod	_	_
15	DIL	_	NN	NN	_	5	appos	_	_
16	,	_	,	,	_	5	punct	_	_
17	also	_	RB	RB	_	18	advmod	_	_
18	activates	_	VBZ	VBZ	_	2	ccomp	_	_
19	NFkappaB	_	NN	NN	_	18	dobj	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	lymphoid	_	JJ	JJ	_	23	amod	_	_
22	cell	_	NN	NN	_	23	nn	_	_
23	lines	_	NNS	NNS	_	20	pobj	_	_
24	in	_	IN	IN	_	18	prep	_	_
25	a	_	DT	DT	_	26	det	_	_
26	kinetic	_	JJ	JJ	_	24	pobj	_	_
27	similar	_	JJ	JJ	_	26	amod	_	_
28	to	_	TO	TO	_	27	prep	_	_
29	TNFalpha	_	NN	NN	_	28	pobj	_	_
30	.	_	.	.	_	2	punct	_	_

1	NFkappaB	_	NN	NN	_	2	nn	_	_
2	activity	_	NN	NN	_	4	nsubj	_	_
3	is	_	VBZ	VBZ	_	4	cop	_	_
4	independent	_	JJ	JJ	_	0	root	_	_
5	from	_	IN	IN	_	4	prep	_	_
6	FADD	_	NN	NN	_	5	pobj	_	_
7	,	_	,	,	_	6	punct	_	_
8	caspases	_	NNS	NNS	_	6	conj	_	_
9	,	_	,	,	_	6	punct	_	_
10	and	_	CC	CC	_	6	cc	_	_
11	apoptosis	_	NN	NN	_	12	nn	_	_
12	induction	_	NN	NN	_	6	conj	_	_
13	.	_	.	.	_	4	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	study	_	VB	VB	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	influence	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	NFkappaB	_	NN	NN	_	7	nn	_	_
7	activity	_	NN	NN	_	5	pobj	_	_
8	on	_	IN	IN	_	4	prep	_	_
9	apoptosis	_	NN	NN	_	8	pobj	_	_
10	mediated	_	VBN	VBN	_	9	vmod	_	_
11	by	_	IN	IN	_	10	prep	_	_
12	TRAIL	_	NN	NN	_	11	pobj	_	_
13	,	_	,	,	_	12	punct	_	_
14	CD95	_	NN	NN	_	12	conj	_	_
15	,	_	,	,	_	12	punct	_	_
16	TNFalpha	_	NN	NN	_	12	conj	_	_
17	,	_	,	,	_	12	punct	_	_
18	or	_	CC	CC	_	12	cc	_	_
19	doxorubicin	_	NN	NN	_	12	conj	_	_
20	,	_	,	,	_	2	punct	_	_
21	NFkappaB	_	NN	NN	_	22	nn	_	_
22	activation	_	NN	NN	_	24	nsubjpass	_	_
23	was	_	VBD	VBD	_	24	auxpass	_	_
24	inhibited	_	VBN	VBN	_	2	parataxis	_	_
25	using	_	VBG	VBG	_	24	xcomp	_	_
26	the	_	DT	DT	_	28	det	_	_
27	proteasome	_	NN	NN	_	28	nn	_	_
28	inhibitor	_	NN	NN	_	25	dobj	_	_
29	N-acetyl-L-leucinyl-L-leucinyl-L-norleucinal	_	NN	NN	_	28	dep	_	_
30	or	_	CC	CC	_	28	cc	_	_
31	transient	_	JJ	JJ	_	32	amod	_	_
32	overexpression	_	NN	NN	_	28	conj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	mutant	_	JJ	JJ	_	35	amod	_	_
35	IkappaBalpha	_	NN	NN	_	33	pobj	_	_
36	.	_	.	.	_	2	punct	_	_

1	Sensitivity	_	NN	NN	_	8	nsubjpass	_	_
2	for	_	IN	IN	_	1	prep	_	_
3	induction	_	NN	NN	_	2	pobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	apoptosis	_	NN	NN	_	4	pobj	_	_
6	was	_	VBD	VBD	_	8	auxpass	_	_
7	markedly	_	RB	RB	_	8	advmod	_	_
8	increased	_	VBN	VBN	_	0	root	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	these	_	DT	DT	_	11	det	_	_
11	treatments	_	NNS	NNS	_	9	pobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	apoptosis	_	NN	NN	_	14	npadvmod	_	_
14	sensitive	_	JJ	JJ	_	16	amod	_	_
15	cell	_	NN	NN	_	16	nn	_	_
16	lines	_	NNS	NNS	_	12	pobj	_	_
17	.	_	.	.	_	8	punct	_	_

1	Moreover	_	RB	RB	_	29	advmod	_	_
2	,	_	,	,	_	29	punct	_	_
3	both	_	CC	CC	_	4	preconj	_	_
4	in	_	IN	IN	_	29	dep	_	_
5	cell	_	NN	NN	_	6	nn	_	_
6	lines	_	NNS	NNS	_	4	pobj	_	_
7	and	_	CC	CC	_	4	cc	_	_
8	in	_	IN	IN	_	4	conj	_	_
9	primary	_	JJ	JJ	_	11	amod	_	_
10	leukemia	_	NN	NN	_	11	nn	_	_
11	cells	_	NNS	NNS	_	8	pobj	_	_
12	that	_	WDT	WDT	_	14	nsubj	_	_
13	are	_	VBP	VBP	_	14	cop	_	_
14	resistant	_	JJ	JJ	_	4	dep	_	_
15	towards	_	IN	IN	_	14	prep	_	_
16	induction	_	NN	NN	_	15	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	apoptosis	_	NN	NN	_	17	pobj	_	_
19	by	_	IN	IN	_	18	prep	_	_
20	DILs	_	NN	NN	_	19	pobj	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	doxorubicin	_	NN	NN	_	20	conj	_	_
23	,	_	,	,	_	29	punct	_	_
24	antagonization	_	NN	NN	_	29	nsubj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	NFkappaB	_	NN	NN	_	27	nn	_	_
27	activity	_	NN	NN	_	25	pobj	_	_
28	partially	_	RB	RB	_	29	advmod	_	_
29	restored	_	VBD	VBD	_	0	root	_	_
30	apoptosis	_	NN	NN	_	31	nn	_	_
31	sensitivity	_	NN	NN	_	29	dobj	_	_
32	.	_	.	.	_	29	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	10	mark	_	_
5	inhibition	_	NN	NN	_	10	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	NFkappaB	_	NN	NN	_	8	nn	_	_
8	activation	_	NN	NN	_	6	pobj	_	_
9	may	_	MD	MD	_	10	aux	_	_
10	provide	_	VB	VB	_	3	ccomp	_	_
11	a	_	DT	DT	_	13	det	_	_
12	molecular	_	JJ	JJ	_	13	amod	_	_
13	approach	_	NN	NN	_	10	dobj	_	_
14	to	_	TO	TO	_	15	aux	_	_
15	increase	_	VB	VB	_	13	vmod	_	_
16	apoptosis	_	NN	NN	_	17	nn	_	_
17	sensitivity	_	NN	NN	_	15	dobj	_	_
18	in	_	IN	IN	_	15	prep	_	_
19	anticancer	_	JJ	JJ	_	20	amod	_	_
20	treatment	_	NN	NN	_	18	pobj	_	_
21	.	_	.	.	_	3	punct	_	_

1	HMG	_	NN	NN	_	2	nn	_	_
2	box	_	NN	NN	_	0	root	_	_
3	containing	_	VBG	VBG	_	2	vmod	_	_
4	transcription	_	NN	NN	_	5	nn	_	_
5	factors	_	NNS	NNS	_	3	dobj	_	_
6	in	_	IN	IN	_	2	prep	_	_
7	lymphocyte	_	NN	NN	_	8	nn	_	_
8	differentiation	_	NN	NN	_	6	pobj	_	_
9	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	identification	_	NN	NN	_	10	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	8	det	_	_
5	mammalian	_	JJ	JJ	_	8	amod	_	_
6	sex-determining	_	JJ	JJ	_	8	amod	_	_
7	gene	_	NN	NN	_	8	nn	_	_
8	Sry	_	NN	NN	_	3	pobj	_	_
9	has	_	VBZ	VBZ	_	10	aux	_	_
10	led	_	VBN	VBN	_	0	root	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	discovery	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	a	_	DT	DT	_	17	det	_	_
16	large	_	JJ	JJ	_	17	amod	_	_
17	family	_	NN	NN	_	14	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	related	_	JJ	JJ	_	27	amod	_	_
20	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
21	'	_	``	``	_	23	punct	_	_
22	HMG	_	NN	NN	_	23	nn	_	_
23	box	_	NN	NN	_	19	dep	_	_
24	'	_	''	''	_	23	punct	_	_
25	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
26	transcription	_	NN	NN	_	27	nn	_	_
27	factors	_	NNS	NNS	_	18	pobj	_	_
28	that	_	WDT	WDT	_	29	nsubj	_	_
29	control	_	VBP	VBP	_	17	rcmod	_	_
30	developmental	_	JJ	JJ	_	31	amod	_	_
31	events	_	NNS	NNS	_	29	dobj	_	_
32	in	_	IN	IN	_	29	prep	_	_
33	yeast	_	NN	NN	_	32	pobj	_	_
34	,	_	,	,	_	33	punct	_	_
35	C.	_	FW	FW	_	36	nn	_	_
36	elegans	_	FW	FW	_	33	conj	_	_
37	,	_	,	,	_	33	punct	_	_
38	Drosophila	_	FW	FW	_	33	conj	_	_
39	and	_	CC	CC	_	33	cc	_	_
40	vertebrates	_	NNS	NNS	_	33	conj	_	_
41	.	_	.	.	_	10	punct	_	_

1	In	_	IN	IN	_	9	prep	_	_
2	lymphocyte	_	NN	NN	_	3	nn	_	_
3	differentiation	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	9	punct	_	_
5	several	_	JJ	JJ	_	8	amod	_	_
6	HMG	_	NN	NN	_	8	nn	_	_
7	box	_	NN	NN	_	8	nn	_	_
8	proteins	_	NNS	NNS	_	9	nsubj	_	_
9	play	_	VBP	VBP	_	0	root	_	_
10	a	_	DT	DT	_	12	det	_	_
11	decisive	_	JJ	JJ	_	12	amod	_	_
12	role	_	NN	NN	_	9	dobj	_	_
13	.	_	.	.	_	9	punct	_	_

1	Sox-4	_	NN	NN	_	3	nsubj	_	_
2	is	_	VBZ	VBZ	_	3	cop	_	_
3	important	_	JJ	JJ	_	0	root	_	_
4	for	_	IN	IN	_	3	prep	_	_
5	very	_	RB	RB	_	6	advmod	_	_
6	early	_	JJ	JJ	_	8	amod	_	_
7	B-cell	_	NN	NN	_	8	nn	_	_
8	differentiation	_	NN	NN	_	4	pobj	_	_
9	,	_	,	,	_	3	punct	_	_
10	while	_	IN	IN	_	12	mark	_	_
11	TCF-1/LEF-1	_	NN	NN	_	12	nsubj	_	_
12	play	_	VBP	VBP	_	3	advcl	_	_
13	a	_	DT	DT	_	15	det	_	_
14	crucial	_	JJ	JJ	_	15	amod	_	_
15	role	_	NN	NN	_	12	dobj	_	_
16	in	_	IN	IN	_	12	prep	_	_
17	early	_	JJ	JJ	_	19	amod	_	_
18	thymocyte	_	NN	NN	_	19	nn	_	_
19	development	_	NN	NN	_	16	pobj	_	_
20	.	_	.	.	_	3	punct	_	_

1	TCF/LEF	_	NN	NN	_	2	nn	_	_
2	proteins	_	NNS	NNS	_	6	nsubjpass	_	_
3	have	_	VBP	VBP	_	6	aux	_	_
4	recently	_	RB	RB	_	6	advmod	_	_
5	been	_	VBN	VBN	_	6	auxpass	_	_
6	found	_	VBN	VBN	_	0	root	_	_
7	to	_	TO	TO	_	8	aux	_	_
8	constitute	_	VB	VB	_	6	xcomp	_	_
9	a	_	DT	DT	_	11	det	_	_
10	downstream	_	JJ	JJ	_	11	amod	_	_
11	component	_	NN	NN	_	8	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	17	det	_	_
14	Wingless/Wnt	_	NN	NN	_	17	nn	_	_
15	signal	_	NN	NN	_	17	nn	_	_
16	transduction	_	NN	NN	_	17	nn	_	_
17	pathway	_	NN	NN	_	12	pobj	_	_
18	.	_	.	.	_	6	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	flies	_	NNS	NNS	_	1	pobj	_	_
3	,	_	,	,	_	6	punct	_	_
4	this	_	DT	DT	_	5	det	_	_
5	pathway	_	NN	NN	_	6	nsubj	_	_
6	controls	_	VBZ	VBZ	_	0	root	_	_
7	segment	_	NN	NN	_	8	nn	_	_
8	polarity	_	NN	NN	_	6	dobj	_	_
9	;	_	:	:	_	6	punct	_	_
10	in	_	IN	IN	_	13	prep	_	_
11	Xenopus	_	FW	FW	_	10	pobj	_	_
12	it	_	PRP	PRP	_	13	nsubj	_	_
13	controls	_	VBZ	VBZ	_	6	parataxis	_	_
14	the	_	DT	DT	_	15	det	_	_
15	definition	_	NN	NN	_	13	dobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	body	_	NN	NN	_	19	nn	_	_
19	axis	_	NN	NN	_	16	pobj	_	_
20	.	_	.	.	_	6	punct	_	_

1	Deregulation	_	NN	NN	_	5	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	4	det	_	_
4	pathway	_	NN	NN	_	2	pobj	_	_
5	occurs	_	VBZ	VBZ	_	0	root	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	several	_	JJ	JJ	_	9	amod	_	_
8	human	_	JJ	JJ	_	9	amod	_	_
9	tumors	_	NNS	NNS	_	6	pobj	_	_
10	.	_	.	.	_	5	punct	_	_

1	These	_	DT	DT	_	18	nsubj	_	_
2	insights	_	VBZ	VBZ	_	1	dep	_	_
3	in	_	IN	IN	_	1	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	molecular	_	JJ	JJ	_	6	amod	_	_
6	events	_	NNS	NNS	_	3	pobj	_	_
7	that	_	WDT	WDT	_	9	nsubjpass	_	_
8	are	_	VBP	VBP	_	9	auxpass	_	_
9	involved	_	VBN	VBN	_	6	rcmod	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	TCF/LEF	_	NN	NN	_	12	nn	_	_
12	function	_	NN	NN	_	10	pobj	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	these	_	DT	DT	_	15	det	_	_
15	organisms	_	NNS	NNS	_	13	pobj	_	_
16	may	_	MD	MD	_	18	aux	_	_
17	eventually	_	RB	RB	_	18	advmod	_	_
18	lead	_	VB	VB	_	0	root	_	_
19	to	_	TO	TO	_	18	prep	_	_
20	the	_	DT	DT	_	21	det	_	_
21	understanding	_	NN	NN	_	19	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	24	det	_	_
24	function	_	NN	NN	_	22	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	these	_	DT	DT	_	29	det	_	_
27	HMG	_	NN	NN	_	29	nn	_	_
28	box	_	NN	NN	_	29	nn	_	_
29	proteins	_	NNS	NNS	_	25	pobj	_	_
30	in	_	IN	IN	_	24	prep	_	_
31	lymphoid	_	JJ	JJ	_	32	amod	_	_
32	development	_	NN	NN	_	30	pobj	_	_
33	.	_	.	.	_	18	punct	_	_

1	Loss-	_	NN	NN	_	5	nsubj	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	gain-of-function	_	NN	NN	_	1	conj	_	_
4	mutations	_	NNS	NNS	_	1	dep	_	_
5	reveal	_	VBP	VBP	_	0	root	_	_
6	an	_	DT	DT	_	8	det	_	_
7	important	_	JJ	JJ	_	8	amod	_	_
8	role	_	NN	NN	_	5	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	BSAP	_	NN	NN	_	9	pobj	_	_
11	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
12	Pax-5	_	NN	NN	_	10	appos	_	_
13	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
14	at	_	IN	IN	_	8	prep	_	_
15	the	_	DT	DT	_	16	dep	_	_
16	start	_	NN	NN	_	14	pobj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	end	_	NN	NN	_	16	conj	_	_
19	of	_	IN	IN	_	16	prep	_	_
20	B	_	NN	NN	_	22	nn	_	_
21	cell	_	NN	NN	_	22	nn	_	_
22	differentiation	_	NN	NN	_	19	pobj	_	_
23	.	_	.	.	_	5	punct	_	_

1	Pax-5	_	NN	NN	_	2	nsubj	_	_
2	codes	_	VBZ	VBZ	_	0	root	_	_
3	for	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	transcription	_	NN	NN	_	6	nn	_	_
6	factor	_	NN	NN	_	3	pobj	_	_
7	BSAP	_	NN	NN	_	6	dep	_	_
8	which	_	WDT	WDT	_	10	nsubjpass	_	_
9	is	_	VBZ	VBZ	_	10	auxpass	_	_
10	expressed	_	VBN	VBN	_	6	rcmod	_	_
11	throughout	_	IN	IN	_	10	prep	_	_
12	B	_	NN	NN	_	14	nn	_	_
13	cell	_	NN	NN	_	14	nn	_	_
14	development	_	NN	NN	_	11	pobj	_	_
15	except	_	NN	NN	_	16	dep	_	_
16	in	_	IN	IN	_	10	prep	_	_
17	terminally	_	RB	RB	_	20	advmod	_	_
18	differentiated	_	VBN	VBN	_	20	amod	_	_
19	plasma	_	NN	NN	_	20	nn	_	_
20	cells	_	NNS	NNS	_	16	pobj	_	_
21	.	_	.	.	_	2	punct	_	_

1	Gene	_	NN	NN	_	3	nn	_	_
2	targeting	_	NN	NN	_	3	nn	_	_
3	experiments	_	NNS	NNS	_	7	nsubj	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	6	det	_	_
6	mouse	_	NN	NN	_	4	pobj	_	_
7	revealed	_	VBD	VBD	_	0	root	_	_
8	a	_	DT	DT	_	10	det	_	_
9	differential	_	JJ	JJ	_	10	amod	_	_
10	dependency	_	NN	NN	_	7	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	fetal	_	JJ	JJ	_	11	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	adult	_	JJ	JJ	_	12	conj	_	_
15	B-lymphopoiesis	_	NN	NN	_	12	dep	_	_
16	on	_	IN	IN	_	10	prep	_	_
17	this	_	DT	DT	_	19	det	_	_
18	transcription	_	NN	NN	_	19	nn	_	_
19	factor	_	NN	NN	_	16	pobj	_	_
20	.	_	.	.	_	7	punct	_	_

1	BSAP	_	NN	NN	_	3	nsubjpass	_	_
2	is	_	VBZ	VBZ	_	3	auxpass	_	_
3	required	_	VBN	VBN	_	0	root	_	_
4	for	_	IN	IN	_	3	prep	_	_
5	B-lineage	_	NN	NN	_	6	nn	_	_
6	commitment	_	NN	NN	_	4	pobj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	fetal	_	JJ	JJ	_	10	amod	_	_
10	liver	_	NN	NN	_	7	pobj	_	_
11	and	_	CC	CC	_	4	cc	_	_
12	for	_	IN	IN	_	4	conj	_	_
13	progression	_	NN	NN	_	12	pobj	_	_
14	beyond	_	IN	IN	_	13	prep	_	_
15	an	_	DT	DT	_	19	det	_	_
16	early	_	JJ	JJ	_	19	amod	_	_
17	pro-B	_	NN	NN	_	19	nn	_	_
18	cell	_	NN	NN	_	19	nn	_	_
19	stage	_	NN	NN	_	14	pobj	_	_
20	in	_	IN	IN	_	13	prep	_	_
21	adult	_	JJ	JJ	_	23	amod	_	_
22	bone	_	NN	NN	_	23	nn	_	_
23	marrow	_	NN	NN	_	20	pobj	_	_
24	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	characterization	_	NN	NN	_	7	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	Pax-5-deficient	_	JJ	JJ	_	6	amod	_	_
5	pro-B	_	NN	NN	_	6	nn	_	_
6	cells	_	NNS	NNS	_	3	pobj	_	_
7	demonstrated	_	VBD	VBD	_	0	root	_	_
8	an	_	DT	DT	_	10	det	_	_
9	important	_	JJ	JJ	_	10	amod	_	_
10	role	_	NN	NN	_	7	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	BSAP	_	NN	NN	_	11	pobj	_	_
13	in	_	IN	IN	_	10	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	regulation	_	NN	NN	_	13	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	18	dep	_	_
18	CD19	_	NN	NN	_	16	pobj	_	_
19	,	_	,	,	_	18	punct	_	_
20	mb-1	_	NN	NN	_	18	conj	_	_
21	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
22	Ig	_	NN	NN	_	23	nn	_	_
23	alpha	_	NN	NN	_	20	appos	_	_
24	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
25	and	_	CC	CC	_	18	cc	_	_
26	N-myc	_	NN	NN	_	27	nn	_	_
27	genes	_	NNS	NNS	_	18	conj	_	_
28	as	_	RB	RB	_	29	advmod	_	_
29	well	_	RB	RB	_	13	cc	_	_
30	as	_	IN	IN	_	29	mwe	_	_
31	in	_	IN	IN	_	13	conj	_	_
32	the	_	DT	DT	_	34	det	_	_
33	developmental	_	JJ	JJ	_	34	amod	_	_
34	pathway	_	NN	NN	_	31	pobj	_	_
35	controlling	_	VBG	VBG	_	34	vmod	_	_
36	VH-to-DHJH	_	JJ	JJ	_	37	amod	_	_
37	recombination	_	NN	NN	_	35	dobj	_	_
38	at	_	IN	IN	_	37	prep	_	_
39	the	_	DT	DT	_	45	det	_	_
40	immunoglobulin	_	NN	NN	_	45	nn	_	_
41	heavy-chain	_	JJ	JJ	_	45	amod	_	_
42	-LRB-	_	-LRB-	-LRB-	_	45	punct	_	_
43	IgH	_	NN	NN	_	45	nn	_	_
44	-RRB-	_	-RRB-	-RRB-	_	45	punct	_	_
45	locus	_	NN	NN	_	38	pobj	_	_
46	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	human	_	JJ	JJ	_	4	amod	_	_
3	PAX-5	_	NN	NN	_	4	nn	_	_
4	gene	_	NN	NN	_	7	nsubjpass	_	_
5	was	_	VBD	VBD	_	7	auxpass	_	_
6	recently	_	RB	RB	_	7	advmod	_	_
7	shown	_	VBN	VBN	_	0	root	_	_
8	to	_	TO	TO	_	9	aux	_	_
9	participate	_	VB	VB	_	7	xcomp	_	_
10	together	_	RB	RB	_	11	advmod	_	_
11	with	_	IN	IN	_	9	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	IgH	_	NN	NN	_	14	nn	_	_
14	locus	_	NN	NN	_	11	pobj	_	_
15	in	_	IN	IN	_	9	prep	_	_
16	the	_	DT	DT	_	18	det	_	_
17	chromosomal	_	JJ	JJ	_	18	amod	_	_
18	translocation	_	NN	NN	_	15	pobj	_	_
19	t-LRB-9;14-RRB--LRB-p13;q32-RRB-	_	NN	NN	_	18	dep	_	_
20	.	_	.	.	_	7	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	translocation	_	NN	NN	_	4	nsubj	_	_
3	is	_	VBZ	VBZ	_	4	cop	_	_
4	characteristic	_	JJ	JJ	_	0	root	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	a	_	DT	DT	_	8	det	_	_
7	small	_	JJ	JJ	_	8	amod	_	_
8	subset	_	NN	NN	_	5	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	non-Hodgkin	_	JJ	JJ	_	11	amod	_	_
11	lymphomas	_	NNS	NNS	_	9	pobj	_	_
12	exhibiting	_	VBG	VBG	_	8	vmod	_	_
13	plasmacytoid	_	JJ	JJ	_	14	amod	_	_
14	differentiation	_	NN	NN	_	12	dobj	_	_
15	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	translocated	_	JJ	JJ	_	4	amod	_	_
3	PAX-5	_	NN	NN	_	4	nn	_	_
4	gene	_	NN	NN	_	6	nsubjpass	_	_
5	is	_	VBZ	VBZ	_	6	auxpass	_	_
6	deregulated	_	VBN	VBN	_	0	root	_	_
7	by	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	insertion	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	IgH	_	NN	NN	_	13	nn	_	_
12	regulatory	_	JJ	JJ	_	13	amod	_	_
13	elements	_	NNS	NNS	_	10	pobj	_	_
14	into	_	IN	IN	_	9	prep	_	_
15	its	_	PRP$	PRP$	_	17	poss	_	_
16	5'	_	JJ	JJ	_	17	amod	_	_
17	region	_	NN	NN	_	14	pobj	_	_
18	,	_	,	,	_	6	punct	_	_
19	which	_	WDT	WDT	_	21	nsubj	_	_
20	may	_	MD	MD	_	21	aux	_	_
21	contribute	_	VB	VB	_	6	ccomp	_	_
22	to	_	TO	TO	_	21	prep	_	_
23	tumorigenesis	_	NN	NN	_	22	pobj	_	_
24	by	_	IN	IN	_	21	prep	_	_
25	interfering	_	VBG	VBG	_	24	pcomp	_	_
26	with	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	28	det	_	_
28	shut-down	_	NN	NN	_	26	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	PAX-5	_	NN	NN	_	31	nn	_	_
31	transcription	_	NN	NN	_	29	pobj	_	_
32	and	_	CC	CC	_	26	cc	_	_
33	thus	_	RB	RB	_	34	advmod	_	_
34	with	_	IN	IN	_	26	conj	_	_
35	the	_	DT	DT	_	36	det	_	_
36	completion	_	NN	NN	_	34	pobj	_	_
37	of	_	IN	IN	_	36	prep	_	_
38	plasma	_	NN	NN	_	39	nn	_	_
39	cell	_	NN	NN	_	40	nn	_	_
40	differentiation	_	NN	NN	_	37	pobj	_	_
41	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	role	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	E-proteins	_	NNS	NNS	_	3	pobj	_	_
5	in	_	IN	IN	_	2	prep	_	_
6	B-	_	NN	NN	_	5	pobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	T-lymphocyte	_	NN	NN	_	6	conj	_	_
9	development	_	NN	NN	_	6	dep	_	_
10	.	_	.	.	_	2	punct	_	_

1	Department	_	NN	NN	_	9	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	lymphocytes	_	NNS	NNS	_	2	pobj	_	_
4	from	_	IN	IN	_	3	prep	_	_
5	hematopoietic	_	JJ	JJ	_	7	amod	_	_
6	stem	_	NN	NN	_	7	nn	_	_
7	cells	_	NNS	NNS	_	4	pobj	_	_
8	is	_	VBZ	VBZ	_	9	auxpass	_	_
9	controlled	_	VBN	VBN	_	0	root	_	_
10	,	_	,	,	_	9	punct	_	_
11	in	_	IN	IN	_	9	prep	_	_
12	part	_	NN	NN	_	11	pobj	_	_
13	,	_	,	,	_	9	punct	_	_
14	by	_	IN	IN	_	9	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	activity	_	NN	NN	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	transcriptional	_	JJ	JJ	_	20	amod	_	_
19	regulatory	_	JJ	JJ	_	20	amod	_	_
20	proteins	_	NNS	NNS	_	17	pobj	_	_
21	.	_	.	.	_	9	punct	_	_

1	In	_	IN	IN	_	15	prep	_	_
2	particular	_	JJ	JJ	_	1	pobj	_	_
3	,	_	,	,	_	15	punct	_	_
4	one	_	CD	CD	_	5	num	_	_
5	class	_	NN	NN	_	15	nsubjpass	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	helix-loop-helix	_	JJ	JJ	_	8	amod	_	_
8	proteins	_	NNS	NNS	_	6	pobj	_	_
9	,	_	,	,	_	5	punct	_	_
10	termed	_	VBN	VBN	_	5	vmod	_	_
11	E-proteins	_	NNS	NNS	_	10	dep	_	_
12	,	_	,	,	_	5	punct	_	_
13	have	_	VBP	VBP	_	15	aux	_	_
14	been	_	VBN	VBN	_	15	auxpass	_	_
15	implicated	_	VBN	VBN	_	0	root	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	18	det	_	_
18	regulation	_	NN	NN	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	gene	_	NN	NN	_	21	nn	_	_
21	expression	_	NN	NN	_	19	pobj	_	_
22	during	_	IN	IN	_	15	prep	_	_
23	B-cell	_	NN	NN	_	24	nn	_	_
24	development	_	NN	NN	_	22	pobj	_	_
25	.	_	.	.	_	15	punct	_	_

1	Recent	_	JJ	JJ	_	2	amod	_	_
2	analysis	_	NN	NN	_	7	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	gene-targeted	_	JJ	JJ	_	5	amod	_	_
5	mice	_	NNS	NNS	_	3	pobj	_	_
6	has	_	VBZ	VBZ	_	7	aux	_	_
7	allowed	_	VBN	VBN	_	0	root	_	_
8	a	_	DT	DT	_	10	det	_	_
9	direct	_	JJ	JJ	_	10	amod	_	_
10	assessment	_	NN	NN	_	7	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	functional	_	JJ	JJ	_	14	amod	_	_
14	roles	_	NNS	NNS	_	11	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	several	_	JJ	JJ	_	19	amod	_	_
17	E-protein	_	NN	NN	_	19	nn	_	_
18	family	_	NN	NN	_	19	nn	_	_
19	members	_	NNS	NNS	_	15	pobj	_	_
20	in	_	IN	IN	_	14	prep	_	_
21	hematopoiesis	_	NN	NN	_	20	pobj	_	_
22	.	_	.	.	_	7	punct	_	_

1	In	_	IN	IN	_	5	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	review	_	NN	NN	_	1	pobj	_	_
4	we	_	PRP	PRP	_	5	nsubj	_	_
5	describe	_	VBP	VBP	_	0	root	_	_
6	the	_	DT	DT	_	7	det	_	_
7	defects	_	NNS	NNS	_	5	dobj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	B-	_	NN	NN	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	T-lymphocyte	_	NN	NN	_	9	conj	_	_
12	development	_	NN	NN	_	9	dep	_	_
13	in	_	IN	IN	_	5	prep	_	_
14	mice	_	NNS	NNS	_	13	pobj	_	_
15	carrying	_	VBG	VBG	_	14	vmod	_	_
16	targeted	_	VBN	VBN	_	17	amod	_	_
17	mutations	_	NNS	NNS	_	15	dobj	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	E-protein	_	NN	NN	_	21	nn	_	_
21	genes	_	NNS	NNS	_	18	pobj	_	_
22	and	_	CC	CC	_	5	cc	_	_
23	discuss	_	VBP	VBP	_	5	conj	_	_
24	our	_	PRP$	PRP$	_	26	poss	_	_
25	current	_	JJ	JJ	_	26	amod	_	_
26	understanding	_	NN	NN	_	23	dobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	29	det	_	_
29	role	_	NN	NN	_	27	pobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	these	_	DT	DT	_	32	det	_	_
32	proteins	_	NNS	NNS	_	30	pobj	_	_
33	in	_	IN	IN	_	29	prep	_	_
34	lymphoid	_	JJ	JJ	_	35	amod	_	_
35	development	_	NN	NN	_	33	pobj	_	_
36	.	_	.	.	_	5	punct	_	_

1	Oxidative	_	JJ	JJ	_	2	amod	_	_
2	stress	_	NN	NN	_	3	nsubj	_	_
3	suppresses	_	VBZ	VBZ	_	0	root	_	_
4	transcription	_	NN	NN	_	5	nn	_	_
5	factor	_	NN	NN	_	6	nn	_	_
6	activities	_	NNS	NNS	_	3	dobj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	stimulated	_	VBN	VBN	_	9	amod	_	_
9	lymphocytes	_	NNS	NNS	_	7	pobj	_	_
10	.	_	.	.	_	3	punct	_	_

1	Effects	_	NNS	NNS	_	16	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	oxidative	_	JJ	JJ	_	4	amod	_	_
4	stress	_	NN	NN	_	2	pobj	_	_
5	on	_	IN	IN	_	1	prep	_	_
6	stimulation-dependent	_	JJ	JJ	_	8	amod	_	_
7	signal	_	NN	NN	_	8	nn	_	_
8	transduction	_	NN	NN	_	5	pobj	_	_
9	,	_	,	,	_	8	punct	_	_
10	leading	_	VBG	VBG	_	8	vmod	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	IL-2	_	NN	NN	_	13	nn	_	_
13	expression	_	NN	NN	_	11	pobj	_	_
14	,	_	,	,	_	1	punct	_	_
15	were	_	VBD	VBD	_	16	auxpass	_	_
16	studied	_	VBN	VBN	_	0	root	_	_
17	.	_	.	.	_	16	punct	_	_

1	Purified	_	VBN	VBN	_	6	amod	_	_
2	quiescent	_	JJ	JJ	_	6	amod	_	_
3	human	_	JJ	JJ	_	6	amod	_	_
4	blood	_	NN	NN	_	6	nn	_	_
5	T	_	NN	NN	_	6	nn	_	_
6	lymphocytes	_	NNS	NNS	_	8	nsubjpass	_	_
7	were	_	VBD	VBD	_	8	auxpass	_	_
8	subjected	_	VBN	VBN	_	0	root	_	_
9	to	_	TO	TO	_	8	prep	_	_
10	:	_	:	:	_	8	punct	_	_
11	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
12	i	_	LS	LS	_	15	dep	_	_
13	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
14	acute	_	JJ	JJ	_	15	amod	_	_
15	exposure	_	NN	NN	_	8	dep	_	_
16	to	_	TO	TO	_	15	prep	_	_
17	hydrogen	_	NN	NN	_	18	nn	_	_
18	peroxide	_	NN	NN	_	16	pobj	_	_
19	;	_	:	:	_	15	punct	_	_
20	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
21	ii	_	LS	LS	_	24	dep	_	_
22	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
23	chronic	_	JJ	JJ	_	24	amod	_	_
24	exposure	_	NN	NN	_	15	conj	_	_
25	to	_	TO	TO	_	24	prep	_	_
26	hydrogen	_	NN	NN	_	27	nn	_	_
27	peroxide	_	NN	NN	_	25	pobj	_	_
28	;	_	:	:	_	15	punct	_	_
29	and	_	CC	CC	_	15	cc	_	_
30	-LRB-	_	-LRB-	-LRB-	_	31	punct	_	_
31	iii	_	LS	LS	_	34	dep	_	_
32	-RRB-	_	-RRB-	-RRB-	_	31	punct	_	_
33	acute	_	JJ	JJ	_	34	amod	_	_
34	exposure	_	NN	NN	_	15	conj	_	_
35	to	_	TO	TO	_	34	prep	_	_
36	ionizing	_	VBG	VBG	_	37	amod	_	_
37	radiation	_	NN	NN	_	35	pobj	_	_
38	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	cells	_	NNS	NNS	_	5	nsubjpass	_	_
3	were	_	VBD	VBD	_	5	auxpass	_	_
4	then	_	RB	RB	_	5	advmod	_	_
5	stimulated	_	VBN	VBN	_	0	root	_	_
6	for	_	IN	IN	_	5	prep	_	_
7	6	_	CD	CD	_	8	num	_	_
8	h	_	NN	NN	_	6	pobj	_	_
9	.	_	.	.	_	5	punct	_	_

1	DNA-binding	_	JJ	JJ	_	2	amod	_	_
2	activities	_	NNS	NNS	_	24	nsubjpass	_	_
3	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
4	determined	_	VBN	VBN	_	2	dep	_	_
5	by	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	10	det	_	_
7	electrophoretic	_	JJ	JJ	_	10	amod	_	_
8	mobility	_	NN	NN	_	10	nn	_	_
9	shift	_	NN	NN	_	10	nn	_	_
10	assay	_	NN	NN	_	5	pobj	_	_
11	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
12	of	_	IN	IN	_	2	prep	_	_
13	three	_	CD	CD	_	15	num	_	_
14	transcription	_	NN	NN	_	15	nn	_	_
15	factors	_	NNS	NNS	_	12	pobj	_	_
16	:	_	:	:	_	15	punct	_	_
17	NFkappaB	_	NN	NN	_	15	dep	_	_
18	,	_	,	,	_	17	punct	_	_
19	AP-1	_	NN	NN	_	17	conj	_	_
20	and	_	CC	CC	_	17	cc	_	_
21	NFAT	_	NN	NN	_	17	conj	_	_
22	,	_	,	,	_	2	punct	_	_
23	were	_	VBD	VBD	_	24	auxpass	_	_
24	abolished	_	VBN	VBN	_	0	root	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	27	det	_	_
27	lymphocytes	_	NNS	NNS	_	25	pobj	_	_
28	by	_	IN	IN	_	24	prep	_	_
29	all	_	DT	DT	_	31	det	_	_
30	three	_	CD	CD	_	31	num	_	_
31	modes	_	NNS	NNS	_	28	pobj	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	oxidative	_	JJ	JJ	_	34	amod	_	_
34	stress	_	NN	NN	_	32	pobj	_	_
35	.	_	.	.	_	24	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	lymphocytes	_	NNS	NNS	_	3	nsubj	_	_
3	exhibited	_	VBD	VBD	_	0	root	_	_
4	lipid	_	NN	NN	_	5	nn	_	_
5	peroxidation	_	NN	NN	_	3	dobj	_	_
6	only	_	RB	RB	_	7	advmod	_	_
7	upon	_	IN	IN	_	3	prep	_	_
8	exposure	_	NN	NN	_	7	pobj	_	_
9	to	_	TO	TO	_	8	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	lowest	_	JJS	JJS	_	12	amod	_	_
12	level	_	NN	NN	_	9	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	hydrogen	_	NN	NN	_	15	nn	_	_
15	peroxide	_	NN	NN	_	13	pobj	_	_
16	used	_	VBN	VBN	_	15	vmod	_	_
17	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
18	20	_	CD	CD	_	19	num	_	_
19	microM	_	NN	NN	_	12	appos	_	_
20	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	.	_	.	.	_	3	punct	_	_

1	All	_	DT	DT	_	3	det	_	_
2	three	_	CD	CD	_	3	num	_	_
3	modes	_	NNS	NNS	_	7	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	oxidative	_	JJ	JJ	_	6	amod	_	_
6	stress	_	NN	NN	_	4	pobj	_	_
7	induced	_	VBD	VBD	_	0	root	_	_
8	catalase	_	NN	NN	_	9	nn	_	_
9	activity	_	NN	NN	_	7	dobj	_	_
10	in	_	IN	IN	_	7	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	lymphocytes	_	NNS	NNS	_	10	pobj	_	_
13	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	only	_	RB	RB	_	3	advmod	_	_
3	exception	_	NN	NN	_	6	nsubj	_	_
4	was	_	VBD	VBD	_	6	cop	_	_
5	hydrogen	_	NN	NN	_	6	nn	_	_
6	peroxide	_	NN	NN	_	0	root	_	_
7	at	_	IN	IN	_	6	prep	_	_
8	20	_	CD	CD	_	9	num	_	_
9	microM	_	NN	NN	_	7	pobj	_	_
10	,	_	,	,	_	6	punct	_	_
11	which	_	WDT	WDT	_	14	nsubj	_	_
12	did	_	VBD	VBD	_	14	aux	_	_
13	not	_	RB	RB	_	14	neg	_	_
14	induce	_	VB	VB	_	6	rcmod	_	_
15	catalase	_	NN	NN	_	16	nn	_	_
16	activity	_	NN	NN	_	14	dobj	_	_
17	.	_	.	.	_	6	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	conclude	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	16	mark	_	_
4	:	_	:	:	_	16	punct	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	i	_	LS	LS	_	16	dep	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	suppression	_	NN	NN	_	16	nsubj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	specific	_	JJ	JJ	_	13	amod	_	_
11	transcription	_	NN	NN	_	12	nn	_	_
12	factor	_	NN	NN	_	13	nn	_	_
13	functions	_	NNS	NNS	_	9	pobj	_	_
14	can	_	MD	MD	_	16	aux	_	_
15	potentially	_	RB	RB	_	16	advmod	_	_
16	serve	_	VB	VB	_	2	ccomp	_	_
17	as	_	IN	IN	_	16	prep	_	_
18	a	_	DT	DT	_	19	det	_	_
19	marker	_	NN	NN	_	17	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	exposure	_	NN	NN	_	20	pobj	_	_
22	to	_	TO	TO	_	21	prep	_	_
23	oxidative	_	JJ	JJ	_	24	amod	_	_
24	stress	_	NN	NN	_	22	pobj	_	_
25	and	_	CC	CC	_	21	cc	_	_
26	its	_	PRP$	PRP$	_	27	poss	_	_
27	effects	_	NNS	NNS	_	21	conj	_	_
28	on	_	IN	IN	_	27	prep	_	_
29	human	_	JJ	JJ	_	30	amod	_	_
30	lymphocytes	_	NNS	NNS	_	28	pobj	_	_
31	;	_	:	:	_	16	punct	_	_
32	-LRB-	_	-LRB-	-LRB-	_	33	punct	_	_
33	ii	_	LS	LS	_	39	dep	_	_
34	-RRB-	_	-RRB-	-RRB-	_	33	punct	_	_
35	lipid	_	NN	NN	_	36	nn	_	_
36	peroxidation	_	NN	NN	_	39	nsubj	_	_
37	is	_	VBZ	VBZ	_	39	cop	_	_
38	only	_	RB	RB	_	39	advmod	_	_
39	detectable	_	JJ	JJ	_	16	parataxis	_	_
40	in	_	IN	IN	_	39	prep	_	_
41	human	_	JJ	JJ	_	42	amod	_	_
42	lymphocytes	_	NNS	NNS	_	40	pobj	_	_
43	upon	_	IN	IN	_	39	prep	_	_
44	exposure	_	NN	NN	_	43	pobj	_	_
45	to	_	TO	TO	_	44	prep	_	_
46	weak	_	JJ	JJ	_	47	amod	_	_
47	oxidative	_	JJ	JJ	_	48	amod	_	_
48	stress	_	NN	NN	_	45	pobj	_	_
49	which	_	WDT	WDT	_	52	nsubj	_	_
50	does	_	VBZ	VBZ	_	52	aux	_	_
51	not	_	RB	RB	_	52	neg	_	_
52	induce	_	VB	VB	_	44	rcmod	_	_
53	catalase	_	NN	NN	_	54	nn	_	_
54	activity	_	NN	NN	_	52	dobj	_	_
55	;	_	:	:	_	16	punct	_	_
56	-LRB-	_	-LRB-	-LRB-	_	57	punct	_	_
57	iii	_	LS	LS	_	67	dep	_	_
58	-RRB-	_	-RRB-	-RRB-	_	57	punct	_	_
59	therefore	_	RB	RB	_	67	advmod	_	_
60	,	_	,	,	_	67	punct	_	_
61	transcription	_	NN	NN	_	62	nn	_	_
62	factor	_	NN	NN	_	64	nn	_	_
63	DNA-binding	_	JJ	JJ	_	64	amod	_	_
64	activities	_	NNS	NNS	_	67	nsubj	_	_
65	are	_	VBP	VBP	_	67	cop	_	_
66	more	_	RBR	RBR	_	67	advmod	_	_
67	sensitive	_	JJ	JJ	_	16	parataxis	_	_
68	to	_	TO	TO	_	67	prep	_	_
69	oxidative	_	JJ	JJ	_	70	amod	_	_
70	stress	_	NN	NN	_	68	pobj	_	_
71	than	_	IN	IN	_	73	mark	_	_
72	lipid	_	NN	NN	_	73	nn	_	_
73	peroxidation	_	NN	NN	_	67	ccomp	_	_
74	.	_	.	.	_	2	punct	_	_

1	Ro	_	NN	NN	_	3	nsubj	_	_
2	09-2210	_	CD	CD	_	1	num	_	_
3	exhibits	_	VBZ	VBZ	_	0	root	_	_
4	potent	_	JJ	JJ	_	6	amod	_	_
5	anti-proliferative	_	JJ	JJ	_	4	dep	_	_
6	effects	_	NNS	NNS	_	3	dobj	_	_
7	on	_	IN	IN	_	6	prep	_	_
8	activated	_	VBN	VBN	_	10	amod	_	_
9	T	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	7	pobj	_	_
11	by	_	IN	IN	_	3	prep	_	_
12	selectively	_	RB	RB	_	13	advmod	_	_
13	blocking	_	VBG	VBG	_	11	pcomp	_	_
14	MKK	_	NN	NN	_	15	nn	_	_
15	activity	_	NN	NN	_	13	dobj	_	_
16	.	_	.	.	_	3	punct	_	_

1	By	_	IN	IN	_	12	prep	_	_
2	using	_	VBG	VBG	_	1	pcomp	_	_
3	high	_	JJ	JJ	_	5	amod	_	_
4	throughput	_	NN	NN	_	5	nn	_	_
5	screening	_	NN	NN	_	2	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	microbial	_	JJ	JJ	_	8	amod	_	_
8	broths	_	NNS	NNS	_	6	pobj	_	_
9	,	_	,	,	_	12	punct	_	_
10	we	_	PRP	PRP	_	12	nsubj	_	_
11	have	_	VBP	VBP	_	12	aux	_	_
12	identified	_	VBN	VBN	_	0	root	_	_
13	a	_	DT	DT	_	14	det	_	_
14	compound	_	NN	NN	_	12	dobj	_	_
15	,	_	,	,	_	14	punct	_	_
16	designated	_	VBN	VBN	_	14	vmod	_	_
17	Ro	_	NN	NN	_	16	dep	_	_
18	09-2210	_	CD	CD	_	17	num	_	_
19	,	_	,	,	_	14	punct	_	_
20	which	_	WDT	WDT	_	22	nsubj	_	_
21	is	_	VBZ	VBZ	_	22	cop	_	_
22	able	_	JJ	JJ	_	14	rcmod	_	_
23	to	_	TO	TO	_	24	aux	_	_
24	block	_	VB	VB	_	22	xcomp	_	_
25	anti-CD3	_	JJ	JJ	_	26	npadvmod	_	_
26	induced	_	JJ	JJ	_	31	amod	_	_
27	peripheral	_	JJ	JJ	_	31	amod	_	_
28	blood	_	NN	NN	_	31	nn	_	_
29	T	_	NN	NN	_	31	nn	_	_
30	cell	_	NN	NN	_	31	nn	_	_
31	activation	_	NN	NN	_	24	dobj	_	_
32	with	_	IN	IN	_	24	prep	_	_
33	an	_	DT	DT	_	34	det	_	_
34	IC50	_	NN	NN	_	32	pobj	_	_
35	=	_	JJ	JJ	_	34	amod	_	_
36	40	_	CD	CD	_	37	num	_	_
37	nM	_	NN	NN	_	35	dep	_	_
38	.	_	.	.	_	12	punct	_	_

1	Ro	_	NN	NN	_	5	nsubj	_	_
2	09-2210	_	CD	CD	_	1	num	_	_
3	was	_	VBD	VBD	_	5	cop	_	_
4	also	_	RB	RB	_	5	advmod	_	_
5	able	_	JJ	JJ	_	0	root	_	_
6	to	_	TO	TO	_	7	aux	_	_
7	block	_	VB	VB	_	5	xcomp	_	_
8	antigen-induced	_	JJ	JJ	_	10	amod	_	_
9	IL-2	_	NN	NN	_	10	nn	_	_
10	secretion	_	NN	NN	_	7	dobj	_	_
11	with	_	IN	IN	_	7	prep	_	_
12	an	_	DT	DT	_	13	det	_	_
13	IC50	_	NN	NN	_	11	pobj	_	_
14	=	_	JJ	JJ	_	13	amod	_	_
15	30	_	CD	CD	_	16	num	_	_
16	nM	_	NN	NN	_	14	dep	_	_
17	,	_	,	,	_	5	punct	_	_
18	but	_	CC	CC	_	5	cc	_	_
19	was	_	VBD	VBD	_	22	cop	_	_
20	considerably	_	RB	RB	_	21	advmod	_	_
21	less	_	RBR	RBR	_	22	advmod	_	_
22	potent	_	JJ	JJ	_	5	conj	_	_
23	at	_	IN	IN	_	22	prep	_	_
24	blocking	_	VBG	VBG	_	23	pcomp	_	_
25	Ca2+	_	NN	NN	_	26	nn	_	_
26	flux	_	NN	NN	_	24	dobj	_	_
27	stimulated	_	VBN	VBN	_	26	vmod	_	_
28	by	_	IN	IN	_	27	prep	_	_
29	anti-CD3	_	JJ	JJ	_	30	nn	_	_
30	treatment	_	NN	NN	_	28	pobj	_	_
31	.	_	.	.	_	5	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	determine	_	VB	VB	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	mechanism	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	action	_	NN	NN	_	5	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	Ro	_	NN	NN	_	7	pobj	_	_
9	09-2210	_	CD	CD	_	8	num	_	_
10	,	_	,	,	_	2	punct	_	_
11	we	_	PRP	PRP	_	12	nsubj	_	_
12	set	_	VBD	VBD	_	2	parataxis	_	_
13	up	_	IN	IN	_	12	prt	_	_
14	a	_	DT	DT	_	17	det	_	_
15	transient	_	JJ	JJ	_	17	amod	_	_
16	expression	_	NN	NN	_	17	nn	_	_
17	system	_	NN	NN	_	12	dobj	_	_
18	in	_	IN	IN	_	12	prep	_	_
19	Jurkat	_	NN	NN	_	21	nn	_	_
20	T	_	NN	NN	_	21	nn	_	_
21	cells	_	NNS	NNS	_	18	pobj	_	_
22	using	_	VBG	VBG	_	12	xcomp	_	_
23	a	_	DT	DT	_	24	det	_	_
24	variety	_	NN	NN	_	22	dobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	reporter	_	NN	NN	_	28	nn	_	_
27	gene	_	NN	NN	_	28	nn	_	_
28	constructs	_	NNS	NNS	_	25	pobj	_	_
29	and	_	CC	CC	_	12	cc	_	_
30	showed	_	VBD	VBD	_	12	conj	_	_
31	effective	_	JJ	JJ	_	32	amod	_	_
32	inhibition	_	NN	NN	_	30	dobj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	phorbol	_	NN	NN	_	35	npadvmod	_	_
35	ester/ionomycin-induced	_	JJ	JJ	_	37	amod	_	_
36	NF-AT	_	NN	NN	_	37	nn	_	_
37	activation	_	NN	NN	_	33	pobj	_	_
38	and	_	CC	CC	_	37	cc	_	_
39	anti-CD3	_	NN	NN	_	41	amod	_	_
40	induced	_	VBD	VBD	_	39	dep	_	_
41	NF-AT	_	NN	NN	_	37	conj	_	_
42	with	_	IN	IN	_	32	prep	_	_
43	IC50	_	NN	NN	_	42	pobj	_	_
44	=	_	JJ	JJ	_	43	amod	_	_
45	7.7	_	CD	CD	_	44	dep	_	_
46	and	_	CC	CC	_	45	cc	_	_
47	10	_	CD	CD	_	45	conj	_	_
48	nM	_	NN	NN	_	45	dep	_	_
49	,	_	,	,	_	32	punct	_	_
50	respectively	_	RB	RB	_	32	advmod	_	_
51	.	_	.	.	_	2	punct	_	_

1	Ro	_	NN	NN	_	5	nsubj	_	_
2	09-2210	_	CD	CD	_	1	num	_	_
3	was	_	VBD	VBD	_	5	cop	_	_
4	also	_	RB	RB	_	5	advmod	_	_
5	able	_	JJ	JJ	_	0	root	_	_
6	to	_	TO	TO	_	7	aux	_	_
7	inhibit	_	VB	VB	_	5	xcomp	_	_
8	phorbol	_	NN	NN	_	9	npadvmod	_	_
9	ester/ionomycin-induced	_	JJ	JJ	_	10	amod	_	_
10	activation	_	NN	NN	_	7	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	AP1	_	NN	NN	_	11	pobj	_	_
13	with	_	IN	IN	_	7	prep	_	_
14	IC50	_	NN	NN	_	13	pobj	_	_
15	=	_	JJ	JJ	_	14	amod	_	_
16	&lt;	_	JJR	JJR	_	15	dep	_	_
17	10	_	CD	CD	_	18	num	_	_
18	nM	_	NN	NN	_	15	dep	_	_
19	.	_	.	.	_	5	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	further	_	RB	RB	_	3	advmod	_	_
3	showed	_	VBD	VBD	_	0	root	_	_
4	that	_	IN	IN	_	8	mark	_	_
5	Ro	_	NN	NN	_	8	nsubj	_	_
6	09-2210	_	CD	CD	_	5	num	_	_
7	was	_	VBD	VBD	_	8	cop	_	_
8	unable	_	JJ	JJ	_	3	ccomp	_	_
9	to	_	TO	TO	_	10	aux	_	_
10	inhibit	_	VB	VB	_	8	xcomp	_	_
11	c-jun	_	NN	NN	_	12	npadvmod	_	_
12	induced	_	JJ	JJ	_	13	amod	_	_
13	expression	_	NN	NN	_	10	dobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	AP1-dependent	_	JJ	JJ	_	17	amod	_	_
16	reporter	_	NN	NN	_	17	nn	_	_
17	constructs	_	NNS	NNS	_	14	pobj	_	_
18	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
19	IC50	_	NN	NN	_	10	dep	_	_
20	&gt;	_	JJR	JJR	_	19	amod	_	_
21	500	_	CD	CD	_	22	num	_	_
22	nM	_	NN	NN	_	20	dep	_	_
23	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
24	,	_	,	,	_	8	punct	_	_
25	but	_	CC	CC	_	8	cc	_	_
26	was	_	VBD	VBD	_	27	cop	_	_
27	able	_	JJ	JJ	_	8	conj	_	_
28	to	_	TO	TO	_	30	aux	_	_
29	potently	_	RB	RB	_	30	advmod	_	_
30	inhibit	_	VB	VB	_	27	xcomp	_	_
31	ras-induced	_	JJ	JJ	_	33	amod	_	_
32	AP1	_	NN	NN	_	33	nn	_	_
33	activation	_	NN	NN	_	30	dobj	_	_
34	-LRB-	_	-LRB-	-LRB-	_	35	punct	_	_
35	IC50	_	NN	NN	_	30	dep	_	_
36	=	_	JJ	JJ	_	35	amod	_	_
37	20	_	CD	CD	_	38	num	_	_
38	nM	_	NN	NN	_	36	dep	_	_
39	-RRB-	_	-RRB-	-RRB-	_	35	punct	_	_
40	.	_	.	.	_	3	punct	_	_

1	This	_	DT	DT	_	2	nsubj	_	_
2	suggested	_	VBD	VBD	_	0	root	_	_
3	that	_	IN	IN	_	7	mark	_	_
4	Ro	_	NN	NN	_	7	nsubj	_	_
5	09-2210	_	CD	CD	_	4	num	_	_
6	was	_	VBD	VBD	_	7	aux	_	_
7	inhibiting	_	VBG	VBG	_	2	ccomp	_	_
8	an	_	DT	DT	_	9	det	_	_
9	activator	_	NN	NN	_	7	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	AP-1	_	NN	NN	_	10	pobj	_	_
12	which	_	WDT	WDT	_	13	nsubj	_	_
13	was	_	VBD	VBD	_	11	rcmod	_	_
14	upstream	_	JJ	JJ	_	13	advmod	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	c-jun	_	NN	NN	_	15	pobj	_	_
17	and	_	CC	CC	_	14	cc	_	_
18	downstream	_	RB	RB	_	14	conj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	ras	_	NN	NN	_	21	nn	_	_
21	signaling	_	NN	NN	_	19	pobj	_	_
22	.	_	.	.	_	2	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	investigate	_	VB	VB	_	0	root	_	_
3	further	_	RB	RB	_	2	advmod	_	_
4	,	_	,	,	_	2	punct	_	_
5	we	_	PRP	PRP	_	7	nsubj	_	_
6	then	_	RB	RB	_	7	advmod	_	_
7	purified	_	VBN	VBN	_	2	parataxis	_	_
8	a	_	DT	DT	_	9	det	_	_
9	number	_	NN	NN	_	7	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	different	_	JJ	JJ	_	12	amod	_	_
12	kinases	_	NNS	NNS	_	10	pobj	_	_
13	,	_	,	,	_	9	punct	_	_
14	including	_	VBG	VBG	_	9	prep	_	_
15	PKC	_	NN	NN	_	14	pobj	_	_
16	,	_	,	,	_	15	punct	_	_
17	PhK	_	NN	NN	_	15	conj	_	_
18	,	_	,	,	_	15	punct	_	_
19	ZAP-70	_	NN	NN	_	15	conj	_	_
20	,	_	,	,	_	15	punct	_	_
21	ERK	_	NN	NN	_	15	conj	_	_
22	,	_	,	,	_	15	punct	_	_
23	and	_	CC	CC	_	15	cc	_	_
24	MEK	_	NN	NN	_	15	conj	_	_
25	1	_	CD	CD	_	24	num	_	_
26	-LRB-	_	-LRB-	-LRB-	_	27	punct	_	_
27	a	_	NN	NN	_	24	appos	_	_
28	MKK	_	NN	NN	_	27	dep	_	_
29	-RRB-	_	-RRB-	-RRB-	_	27	punct	_	_
30	,	_	,	,	_	7	punct	_	_
31	and	_	CC	CC	_	7	cc	_	_
32	showed	_	VBD	VBD	_	7	conj	_	_
33	that	_	IN	IN	_	39	mark	_	_
34	Ro	_	NN	NN	_	39	nsubj	_	_
35	09-2210	_	CD	CD	_	34	num	_	_
36	was	_	VBD	VBD	_	39	cop	_	_
37	a	_	DT	DT	_	39	det	_	_
38	selective	_	JJ	JJ	_	39	amod	_	_
39	inhibitor	_	NN	NN	_	32	ccomp	_	_
40	of	_	IN	IN	_	39	prep	_	_
41	MEK1	_	NN	NN	_	40	pobj	_	_
42	in	_	FW	FW	_	43	nn	_	_
43	vitro	_	FW	FW	_	39	advmod	_	_
44	-LRB-	_	-LRB-	-LRB-	_	45	punct	_	_
45	IC50	_	NN	NN	_	39	dep	_	_
46	=	_	JJ	JJ	_	45	amod	_	_
47	59	_	CD	CD	_	48	num	_	_
48	nM	_	NN	NN	_	46	dep	_	_
49	-RRB-	_	-RRB-	-RRB-	_	45	punct	_	_
50	.	_	.	.	_	2	punct	_	_

1	Role	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	GATA-1	_	NN	NN	_	2	pobj	_	_
4	in	_	IN	IN	_	1	prep	_	_
5	proliferation	_	NN	NN	_	4	pobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	differentiation	_	NN	NN	_	5	conj	_	_
8	of	_	IN	IN	_	5	prep	_	_
9	definitive	_	JJ	JJ	_	10	amod	_	_
10	erythroid	_	JJ	JJ	_	8	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	megakaryocytic	_	JJ	JJ	_	10	conj	_	_
13	cells	_	NNS	NNS	_	10	dep	_	_
14	in	_	FW	FW	_	15	nn	_	_
15	vivo	_	FW	FW	_	5	advmod	_	_
16	.	_	.	.	_	1	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	elucidate	_	VB	VB	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	contributions	_	NNS	NNS	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	GATA-1	_	NN	NN	_	5	pobj	_	_
7	to	_	TO	TO	_	4	prep	_	_
8	definitive	_	JJ	JJ	_	9	amod	_	_
9	hematopoiesis	_	NN	NN	_	7	pobj	_	_
10	in	_	FW	FW	_	11	nn	_	_
11	vivo	_	FW	FW	_	9	advmod	_	_
12	,	_	,	,	_	2	punct	_	_
13	we	_	PRP	PRP	_	15	nsubj	_	_
14	have	_	VBP	VBP	_	15	aux	_	_
15	examined	_	VBN	VBN	_	2	parataxis	_	_
16	adult	_	JJ	JJ	_	17	amod	_	_
17	mice	_	NNS	NNS	_	15	dobj	_	_
18	that	_	WDT	WDT	_	20	nsubjpass	_	_
19	were	_	VBD	VBD	_	20	auxpass	_	_
20	rendered	_	VBN	VBN	_	17	rcmod	_	_
21	genetically	_	RB	RB	_	22	advmod	_	_
22	defective	_	JJ	JJ	_	20	xcomp	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	GATA-1	_	NN	NN	_	25	nn	_	_
25	synthesis	_	NN	NN	_	23	pobj	_	_
26	-LRB-	_	-LRB-	-LRB-	_	27	punct	_	_
27	Takahashi	_	NNP	NNP	_	2	dep	_	_
28	et	_	FW	FW	_	27	nn	_	_
29	al	_	FW	FW	_	27	dep	_	_
30	,	_	,	,	_	27	punct	_	_
31	J	_	NNP	NNP	_	33	nn	_	_
32	Biol	_	NNP	NNP	_	33	nn	_	_
33	Chem	_	NNP	NNP	_	27	appos	_	_
34	272	_	CD	CD	_	33	num	_	_
35	:	_	:	:	_	27	punct	_	_
36	12611	_	CD	CD	_	27	dep	_	_
37	,	_	,	,	_	27	punct	_	_
38	1997	_	CD	CD	_	27	amod	_	_
39	-RRB-	_	-RRB-	-RRB-	_	27	punct	_	_
40	.	_	.	.	_	2	punct	_	_

1	Because	_	IN	IN	_	6	mark	_	_
2	the	_	DT	DT	_	4	det	_	_
3	GATA-1	_	NN	NN	_	4	nn	_	_
4	gene	_	NN	NN	_	6	nsubj	_	_
5	is	_	VBZ	VBZ	_	6	cop	_	_
6	located	_	JJ	JJ	_	23	advcl	_	_
7	on	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	X	_	NN	NN	_	10	nn	_	_
10	chromosome	_	NN	NN	_	7	pobj	_	_
11	,	_	,	,	_	10	punct	_	_
12	which	_	WDT	WDT	_	15	nsubjpass	_	_
13	is	_	VBZ	VBZ	_	15	auxpass	_	_
14	randomly	_	RB	RB	_	15	advmod	_	_
15	inactivated	_	VBN	VBN	_	10	rcmod	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	every	_	JJ	JJ	_	18	amod	_	_
18	cell	_	NN	NN	_	16	pobj	_	_
19	,	_	,	,	_	23	punct	_	_
20	heterozygous	_	JJ	JJ	_	21	amod	_	_
21	females	_	NNS	NNS	_	23	nsubj	_	_
22	can	_	MD	MD	_	23	aux	_	_
23	bear	_	VB	VB	_	0	root	_	_
24	either	_	CC	CC	_	27	preconj	_	_
25	an	_	DT	DT	_	27	dep	_	_
26	active	_	JJ	JJ	_	27	amod	_	_
27	wild-type	_	JJ	JJ	_	23	dobj	_	_
28	or	_	CC	CC	_	27	cc	_	_
29	mutant	_	JJ	JJ	_	27	conj	_	_
30	-LRB-	_	-LRB-	-LRB-	_	31	punct	_	_
31	referred	_	VBN	VBN	_	29	dep	_	_
32	to	_	TO	TO	_	31	prep	_	_
33	as	_	IN	IN	_	31	prep	_	_
34	GATA-1.05	_	NN	NN	_	33	pobj	_	_
35	-RRB-	_	-RRB-	-RRB-	_	31	punct	_	_
36	GATA-1	_	NN	NN	_	37	nn	_	_
37	allele	_	NN	NN	_	27	dep	_	_
38	,	_	,	,	_	23	punct	_	_
39	consequently	_	RB	RB	_	40	advmod	_	_
40	leading	_	VBG	VBG	_	23	vmod	_	_
41	to	_	TO	TO	_	40	prep	_	_
42	variable	_	JJ	JJ	_	44	amod	_	_
43	anemic	_	JJ	JJ	_	42	dep	_	_
44	severity	_	NN	NN	_	41	pobj	_	_
45	.	_	.	.	_	23	punct	_	_

1	These	_	DT	DT	_	4	det	_	_
2	heterozygous	_	JJ	JJ	_	4	amod	_	_
3	mutant	_	JJ	JJ	_	4	amod	_	_
4	mice	_	NNS	NNS	_	6	nsubj	_	_
5	usually	_	RB	RB	_	6	advmod	_	_
6	developed	_	VBN	VBN	_	0	root	_	_
7	normally	_	RB	RB	_	6	advmod	_	_
8	,	_	,	,	_	6	punct	_	_
9	but	_	CC	CC	_	6	cc	_	_
10	they	_	PRP	PRP	_	11	nsubj	_	_
11	began	_	VBD	VBD	_	6	conj	_	_
12	to	_	TO	TO	_	13	aux	_	_
13	die	_	VB	VB	_	11	xcomp	_	_
14	after	_	IN	IN	_	13	prep	_	_
15	5	_	CD	CD	_	16	num	_	_
16	months	_	NNS	NNS	_	14	pobj	_	_
17	.	_	.	.	_	6	punct	_	_

1	These	_	DT	DT	_	3	det	_	_
2	affected	_	VBN	VBN	_	3	amod	_	_
3	animals	_	NNS	NNS	_	4	nsubj	_	_
4	displayed	_	VBD	VBD	_	0	root	_	_
5	marked	_	JJ	JJ	_	6	amod	_	_
6	splenomegaly	_	NN	NN	_	4	dobj	_	_
7	,	_	,	,	_	6	punct	_	_
8	anemia	_	NN	NN	_	6	conj	_	_
9	,	_	,	,	_	6	punct	_	_
10	and	_	CC	CC	_	6	cc	_	_
11	thrombocytopenia	_	NN	NN	_	6	conj	_	_
12	.	_	.	.	_	4	punct	_	_

1	Proerythroblasts	_	NNS	NNS	_	5	nsubj	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	megakaryocytes	_	NNS	NNS	_	1	conj	_	_
4	massively	_	RB	RB	_	5	advmod	_	_
5	accumulated	_	VBN	VBN	_	0	root	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	spleens	_	NNS	NNS	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	heterozygotes	_	NNS	NNS	_	9	pobj	_	_
12	,	_	,	,	_	5	punct	_	_
13	and	_	CC	CC	_	5	cc	_	_
14	we	_	PRP	PRP	_	15	nsubj	_	_
15	showed	_	VBD	VBD	_	5	conj	_	_
16	that	_	IN	IN	_	33	mark	_	_
17	the	_	DT	DT	_	20	det	_	_
18	neomycin	_	NN	NN	_	20	nn	_	_
19	resistance	_	NN	NN	_	20	nn	_	_
20	gene	_	NN	NN	_	33	nsubjpass	_	_
21	-LRB-	_	-LRB-	-LRB-	_	27	punct	_	_
22	which	_	WDT	WDT	_	27	nsubj	_	_
23	is	_	VBZ	VBZ	_	27	cop	_	_
24	the	_	DT	DT	_	27	det	_	_
25	positive	_	JJ	JJ	_	27	amod	_	_
26	selection	_	NN	NN	_	27	nn	_	_
27	marker	_	NN	NN	_	20	dep	_	_
28	in	_	IN	IN	_	27	prep	_	_
29	ES	_	NN	NN	_	30	nn	_	_
30	cells	_	NNS	NNS	_	28	pobj	_	_
31	-RRB-	_	-RRB-	-RRB-	_	27	punct	_	_
32	was	_	VBD	VBD	_	33	auxpass	_	_
33	expressed	_	VBN	VBN	_	15	ccomp	_	_
34	profusely	_	RB	RB	_	33	advmod	_	_
35	in	_	IN	IN	_	33	prep	_	_
36	the	_	DT	DT	_	39	det	_	_
37	abnormally	_	RB	RB	_	38	advmod	_	_
38	abundant	_	JJ	JJ	_	39	amod	_	_
39	cells	_	NNS	NNS	_	35	pobj	_	_
40	generated	_	VBN	VBN	_	39	vmod	_	_
41	in	_	IN	IN	_	40	prep	_	_
42	the	_	DT	DT	_	45	det	_	_
43	GATA-1.05	_	NN	NN	_	45	nn	_	_
44	mutant	_	JJ	JJ	_	45	amod	_	_
45	females	_	NNS	NNS	_	41	pobj	_	_
46	.	_	.	.	_	5	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	also	_	RB	RB	_	3	advmod	_	_
3	observed	_	VBD	VBD	_	0	root	_	_
4	hematopoiesis	_	NN	NN	_	3	dobj	_	_
5	outside	_	NN	NN	_	6	dep	_	_
6	of	_	IN	IN	_	4	prep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	bone	_	NN	NN	_	9	nn	_	_
9	marrow	_	NN	NN	_	6	pobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	14	det	_	_
12	affected	_	VBN	VBN	_	14	amod	_	_
13	mutant	_	JJ	JJ	_	14	amod	_	_
14	mice	_	NNS	NNS	_	10	pobj	_	_
15	.	_	.	.	_	3	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	14	mark	_	_
5	a	_	DT	DT	_	7	det	_	_
6	small	_	JJ	JJ	_	7	amod	_	_
7	number	_	NN	NN	_	14	nsubj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	GATA-1.05	_	NN	NN	_	13	nn	_	_
10	mutant	_	JJ	JJ	_	13	amod	_	_
11	hematopoietic	_	JJ	JJ	_	13	amod	_	_
12	progenitor	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	8	pobj	_	_
14	begin	_	VBP	VBP	_	3	ccomp	_	_
15	to	_	TO	TO	_	16	aux	_	_
16	proliferate	_	VB	VB	_	14	xcomp	_	_
17	vigorously	_	RB	RB	_	16	advmod	_	_
18	during	_	IN	IN	_	16	prep	_	_
19	early	_	JJ	JJ	_	20	amod	_	_
20	adulthood	_	NN	NN	_	18	pobj	_	_
21	,	_	,	,	_	14	punct	_	_
22	but	_	CC	CC	_	14	cc	_	_
23	because	_	IN	IN	_	27	mark	_	_
24	the	_	DT	DT	_	25	det	_	_
25	cells	_	NNS	NNS	_	27	nsubj	_	_
26	are	_	VBP	VBP	_	27	cop	_	_
27	unable	_	JJ	JJ	_	33	advcl	_	_
28	to	_	TO	TO	_	30	aux	_	_
29	terminally	_	RB	RB	_	30	advmod	_	_
30	differentiate	_	VB	VB	_	27	xcomp	_	_
31	,	_	,	,	_	33	punct	_	_
32	this	_	DT	DT	_	33	nsubj	_	_
33	leads	_	VBZ	VBZ	_	14	conj	_	_
34	to	_	TO	TO	_	33	prep	_	_
35	progenitor	_	NN	NN	_	36	nn	_	_
36	proliferation	_	NN	NN	_	34	pobj	_	_
37	in	_	IN	IN	_	36	prep	_	_
38	the	_	DT	DT	_	39	det	_	_
39	spleen	_	NN	NN	_	37	pobj	_	_
40	and	_	CC	CC	_	36	cc	_	_
41	consequently	_	RB	RB	_	42	advmod	_	_
42	death	_	NN	NN	_	36	conj	_	_
43	.	_	.	.	_	3	punct	_	_

1	Thus	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	GATA-1	_	NN	NN	_	4	nsubj	_	_
4	plays	_	VBZ	VBZ	_	0	root	_	_
5	important	_	JJ	JJ	_	8	amod	_	_
6	in	_	FW	FW	_	5	dep	_	_
7	vivo	_	FW	FW	_	6	dep	_	_
8	roles	_	NNS	NNS	_	4	dobj	_	_
9	for	_	IN	IN	_	4	prep	_	_
10	directing	_	VBG	VBG	_	9	pcomp	_	_
11	definitive	_	JJ	JJ	_	13	amod	_	_
12	hematopoietic	_	JJ	JJ	_	13	amod	_	_
13	progenitors	_	NNS	NNS	_	10	dobj	_	_
14	to	_	TO	TO	_	15	aux	_	_
15	differentiate	_	VB	VB	_	10	xcomp	_	_
16	along	_	IN	IN	_	15	prep	_	_
17	both	_	CC	CC	_	19	preconj	_	_
18	the	_	DT	DT	_	19	dep	_	_
19	erythroid	_	JJ	JJ	_	16	pobj	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	megakaryocytic	_	JJ	JJ	_	19	conj	_	_
22	pathways	_	NNS	NNS	_	19	dep	_	_
23	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	5	det	_	_
2	GATA-1	_	NN	NN	_	5	nn	_	_
3	heterozygous	_	JJ	JJ	_	5	amod	_	_
4	mutant	_	JJ	JJ	_	5	amod	_	_
5	mouse	_	NN	NN	_	6	nsubj	_	_
6	shows	_	VBZ	VBZ	_	0	root	_	_
7	a	_	DT	DT	_	8	det	_	_
8	phenotype	_	NN	NN	_	6	dobj	_	_
9	that	_	WDT	WDT	_	11	nsubj	_	_
10	is	_	VBZ	VBZ	_	11	cop	_	_
11	analogous	_	JJ	JJ	_	8	rcmod	_	_
12	to	_	TO	TO	_	11	prep	_	_
13	human	_	JJ	JJ	_	15	amod	_	_
14	myelodysplastic	_	JJ	JJ	_	15	amod	_	_
15	syndrome	_	NN	NN	_	12	pobj	_	_
16	and	_	CC	CC	_	6	cc	_	_
17	thus	_	RB	RB	_	19	advmod	_	_
18	may	_	MD	MD	_	19	aux	_	_
19	serve	_	VB	VB	_	6	conj	_	_
20	as	_	IN	IN	_	19	prep	_	_
21	a	_	DT	DT	_	23	det	_	_
22	useful	_	JJ	JJ	_	23	amod	_	_
23	model	_	NN	NN	_	20	pobj	_	_
24	for	_	IN	IN	_	23	prep	_	_
25	this	_	DT	DT	_	26	det	_	_
26	disorder	_	NN	NN	_	24	pobj	_	_
27	.	_	.	.	_	6	punct	_	_

1	Erythropoietin	_	NN	NN	_	2	nsubj	_	_
2	induces	_	VBZ	VBZ	_	0	root	_	_
3	tyrosine	_	NN	NN	_	4	nn	_	_
4	phosphorylation	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	Jak2	_	NN	NN	_	5	pobj	_	_
7	,	_	,	,	_	6	punct	_	_
8	STAT5A	_	NN	NN	_	6	conj	_	_
9	,	_	,	,	_	6	punct	_	_
10	and	_	CC	CC	_	6	cc	_	_
11	STAT5B	_	NN	NN	_	6	conj	_	_
12	in	_	IN	IN	_	2	prep	_	_
13	primary	_	JJ	JJ	_	17	amod	_	_
14	cultured	_	VBN	VBN	_	17	amod	_	_
15	human	_	JJ	JJ	_	17	amod	_	_
16	erythroid	_	JJ	JJ	_	17	amod	_	_
17	precursors	_	NNS	NNS	_	12	pobj	_	_
18	.	_	.	.	_	2	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	examined	_	VBD	VBD	_	0	root	_	_
3	signaling	_	NN	NN	_	2	dobj	_	_
4	by	_	IN	IN	_	3	prep	_	_
5	erythropoietin	_	NN	NN	_	4	pobj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	highly	_	RB	RB	_	13	advmod	_	_
8	purified	_	VBN	VBN	_	13	amod	_	_
9	human	_	JJ	JJ	_	13	amod	_	_
10	colony	_	NN	NN	_	13	nn	_	_
11	forming	_	NN	NN	_	13	nn	_	_
12	unit-erythroid	_	JJ	JJ	_	13	amod	_	_
13	cells	_	NNS	NNS	_	6	pobj	_	_
14	,	_	,	,	_	13	punct	_	_
15	generated	_	VBN	VBN	_	13	vmod	_	_
16	in	_	FW	FW	_	17	nn	_	_
17	vitro	_	FW	FW	_	15	advmod	_	_
18	from	_	IN	IN	_	15	prep	_	_
19	CD34-LRB-+-RRB-	_	JJ	JJ	_	20	amod	_	_
20	cells	_	NNS	NNS	_	18	pobj	_	_
21	.	_	.	.	_	2	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	found	_	VBD	VBD	_	0	root	_	_
3	that	_	IN	IN	_	5	mark	_	_
4	erythropoietin	_	NN	NN	_	5	nsubj	_	_
5	induces	_	VBZ	VBZ	_	2	ccomp	_	_
6	tyrosine	_	NN	NN	_	7	nn	_	_
7	phosphorylation	_	NN	NN	_	5	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	Jak2	_	NN	NN	_	8	pobj	_	_
10	,	_	,	,	_	9	punct	_	_
11	STAT5A	_	NN	NN	_	9	conj	_	_
12	,	_	,	,	_	9	punct	_	_
13	and	_	CC	CC	_	9	cc	_	_
14	STAT5B	_	NN	NN	_	9	conj	_	_
15	.	_	.	.	_	2	punct	_	_

1	Tyrosine	_	NN	NN	_	2	nn	_	_
2	phosphorylation	_	NN	NN	_	5	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	Jak2	_	NN	NN	_	3	pobj	_	_
5	reaches	_	VBZ	VBZ	_	0	root	_	_
6	a	_	DT	DT	_	7	det	_	_
7	peak	_	NN	NN	_	5	dobj	_	_
8	around	_	IN	IN	_	5	prep	_	_
9	10	_	CD	CD	_	10	num	_	_
10	minutes	_	NNS	NNS	_	8	pobj	_	_
11	after	_	IN	IN	_	10	prep	_	_
12	stimulation	_	NN	NN	_	11	pobj	_	_
13	and	_	CC	CC	_	5	cc	_	_
14	is	_	VBZ	VBZ	_	15	cop	_	_
15	maximum	_	JJ	JJ	_	5	conj	_	_
16	at	_	IN	IN	_	15	prep	_	_
17	5	_	CD	CD	_	18	num	_	_
18	U/mL	_	NN	NN	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	erythropoietin	_	NN	NN	_	19	pobj	_	_
21	.	_	.	.	_	5	punct	_	_

1	Tyrosine	_	NN	NN	_	2	nn	_	_
2	phosphorylation	_	NN	NN	_	6	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	STAT5	_	NN	NN	_	3	pobj	_	_
5	is	_	VBZ	VBZ	_	6	auxpass	_	_
6	accompanied	_	VBN	VBN	_	0	root	_	_
7	by	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	translocation	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	activated	_	VBN	VBN	_	12	amod	_	_
12	STAT5	_	NN	NN	_	10	pobj	_	_
13	to	_	TO	TO	_	9	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	nucleus	_	NN	NN	_	13	pobj	_	_
16	as	_	IN	IN	_	17	mark	_	_
17	shown	_	VBN	VBN	_	6	advcl	_	_
18	by	_	IN	IN	_	17	prep	_	_
19	electrophoretic	_	JJ	JJ	_	22	amod	_	_
20	mobility	_	NN	NN	_	22	nn	_	_
21	shift	_	NN	NN	_	22	nn	_	_
22	assay	_	NN	NN	_	18	pobj	_	_
23	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
24	EMSA	_	NN	NN	_	22	appos	_	_
25	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
26	using	_	VBG	VBG	_	22	vmod	_	_
27	32Pi-labeled	_	JJ	JJ	_	30	amod	_	_
28	STAT5	_	NN	NN	_	30	nn	_	_
29	binding	_	NN	NN	_	30	nn	_	_
30	site	_	NN	NN	_	26	dobj	_	_
31	in	_	IN	IN	_	30	prep	_	_
32	the	_	DT	DT	_	34	det	_	_
33	beta-casein	_	NN	NN	_	34	nn	_	_
34	promoter	_	NN	NN	_	31	pobj	_	_
35	.	_	.	.	_	6	punct	_	_

1	Tyrosine	_	NN	NN	_	2	nn	_	_
2	phosphorylation	_	NN	NN	_	8	nsubjpass	_	_
3	STAT1	_	NN	NN	_	2	dep	_	_
4	or	_	CC	CC	_	3	cc	_	_
5	STAT3	_	NN	NN	_	3	conj	_	_
6	was	_	VBD	VBD	_	8	auxpass	_	_
7	not	_	RB	RB	_	8	neg	_	_
8	detected	_	VBN	VBN	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	human	_	JJ	JJ	_	12	amod	_	_
11	erythroid	_	JJ	JJ	_	12	amod	_	_
12	precursors	_	NNS	NNS	_	9	pobj	_	_
13	after	_	IN	IN	_	8	prep	_	_
14	stimulation	_	NN	NN	_	13	pobj	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	erythropoietin	_	NN	NN	_	15	pobj	_	_
17	.	_	.	.	_	8	punct	_	_

1	Crkl	_	NN	NN	_	8	nsubj	_	_
2	,	_	,	,	_	1	punct	_	_
3	an	_	DT	DT	_	6	det	_	_
4	SH2/SH3	_	NN	NN	_	6	nn	_	_
5	adapter	_	NN	NN	_	6	nn	_	_
6	protein	_	NN	NN	_	1	appos	_	_
7	,	_	,	,	_	1	punct	_	_
8	becomes	_	VBZ	VBZ	_	0	root	_	_
9	coimmunoprecipitated	_	VBN	VBN	_	8	acomp	_	_
10	specifically	_	RB	RB	_	11	advmod	_	_
11	with	_	IN	IN	_	9	prep	_	_
12	STAT5	_	NN	NN	_	11	pobj	_	_
13	from	_	IN	IN	_	12	prep	_	_
14	erythropoietin-stimulated	_	JJ	JJ	_	16	amod	_	_
15	erythroid	_	JJ	JJ	_	16	amod	_	_
16	cells	_	NNS	NNS	_	13	pobj	_	_
17	;	_	:	:	_	8	punct	_	_
18	although	_	IN	IN	_	21	mark	_	_
19	it	_	PRP	PRP	_	21	nsubjpass	_	_
20	was	_	VBD	VBD	_	21	auxpass	_	_
21	shown	_	VBN	VBN	_	8	parataxis	_	_
22	to	_	TO	TO	_	23	aux	_	_
23	become	_	VB	VB	_	21	xcomp	_	_
24	associated	_	VBN	VBN	_	23	acomp	_	_
25	with	_	IN	IN	_	24	prep	_	_
26	c-Cbl	_	NN	NN	_	25	pobj	_	_
27	in	_	IN	IN	_	21	prep	_	_
28	the	_	DT	DT	_	29	det	_	_
29	studies	_	NNS	NNS	_	27	pobj	_	_
30	using	_	VBG	VBG	_	29	vmod	_	_
31	cell	_	NN	NN	_	32	nn	_	_
32	lines	_	NNS	NNS	_	30	dobj	_	_
33	.	_	.	.	_	8	punct	_	_

1	Thus	_	RB	RB	_	8	advmod	_	_
2	,	_	,	,	_	8	punct	_	_
3	human	_	JJ	JJ	_	5	amod	_	_
4	erythroid	_	JJ	JJ	_	5	amod	_	_
5	precursors	_	NNS	NNS	_	8	nsubjpass	_	_
6	can	_	MD	MD	_	8	aux	_	_
7	be	_	VB	VB	_	8	auxpass	_	_
8	expanded	_	VBN	VBN	_	0	root	_	_
9	in	_	FW	FW	_	10	nn	_	_
10	vitro	_	FW	FW	_	8	advmod	_	_
11	in	_	IN	IN	_	8	prep	_	_
12	sufficient	_	JJ	JJ	_	13	amod	_	_
13	numbers	_	NNS	NNS	_	11	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	purity	_	NN	NN	_	13	conj	_	_
16	to	_	TO	TO	_	17	aux	_	_
17	allow	_	VB	VB	_	8	xcomp	_	_
18	its	_	PRP$	PRP$	_	19	poss	_	_
19	usage	_	NN	NN	_	17	dobj	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	signal	_	NN	NN	_	23	nn	_	_
22	transduction	_	NN	NN	_	23	nn	_	_
23	studies	_	NNS	NNS	_	20	pobj	_	_
24	.	_	.	.	_	8	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	report	_	NN	NN	_	3	nsubj	_	_
3	sets	_	VBZ	VBZ	_	0	root	_	_
4	a	_	DT	DT	_	5	det	_	_
5	basis	_	NN	NN	_	3	dobj	_	_
6	for	_	IN	IN	_	5	prep	_	_
7	further	_	JJ	JJ	_	8	amod	_	_
8	studies	_	NNS	NNS	_	6	pobj	_	_
9	on	_	IN	IN	_	8	prep	_	_
10	signaling	_	NN	NN	_	9	pobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	primary	_	JJ	JJ	_	16	amod	_	_
13	cultured	_	VBN	VBN	_	16	amod	_	_
14	human	_	JJ	JJ	_	16	amod	_	_
15	erythroid	_	JJ	JJ	_	16	amod	_	_
16	precursors	_	NNS	NNS	_	11	pobj	_	_
17	,	_	,	,	_	3	punct	_	_
18	which	_	WDT	WDT	_	21	nsubj	_	_
19	in	_	IN	IN	_	21	prep	_	_
20	turn	_	NN	NN	_	19	pobj	_	_
21	contribute	_	VBP	VBP	_	3	dep	_	_
22	to	_	TO	TO	_	21	prep	_	_
23	our	_	PRP$	PRP$	_	25	poss	_	_
24	better	_	JJR	JJR	_	25	amod	_	_
25	understanding	_	NN	NN	_	22	pobj	_	_
26	in	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	29	det	_	_
28	differentiation	_	NN	NN	_	29	nn	_	_
29	processes	_	NNS	NNS	_	26	pobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	erythrocytes	_	NNS	NNS	_	30	pobj	_	_
32	and	_	CC	CC	_	31	cc	_	_
33	their	_	PRP$	PRP$	_	34	poss	_	_
34	precursors	_	NNS	NNS	_	31	conj	_	_
35	.	_	.	.	_	3	punct	_	_

1	A	_	DT	DT	_	5	det	_	_
2	small	_	JJ	JJ	_	5	amod	_	_
3	,	_	,	,	_	2	punct	_	_
4	nonpeptidyl	_	JJ	JJ	_	2	dep	_	_
5	mimic	_	NN	NN	_	0	root	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	granulocyte-colony-stimulating	_	JJ	JJ	_	8	amod	_	_
8	factor	_	NN	NN	_	6	pobj	_	_
9	-LSB-	_	-LRB-	-LRB-	_	10	punct	_	_
10	see	_	VB	VB	_	5	dep	_	_
11	commetns	_	NNS	NNS	_	10	dobj	_	_
12	-RSB-	_	-RRB-	-RRB-	_	10	punct	_	_

1	A	_	DT	DT	_	4	det	_	_
2	nonpeptidyl	_	JJ	JJ	_	4	amod	_	_
3	small	_	JJ	JJ	_	2	dep	_	_
4	molecule	_	NN	NN	_	21	nsubjpass	_	_
5	SB	_	NN	NN	_	4	dep	_	_
6	247464	_	CD	CD	_	5	num	_	_
7	,	_	,	,	_	4	punct	_	_
8	capable	_	JJ	JJ	_	4	amod	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	activating	_	VBG	VBG	_	9	pcomp	_	_
11	granulocyte-colony-stimulating	_	JJ	JJ	_	12	amod	_	_
12	factor	_	NN	NN	_	18	nn	_	_
13	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
14	G-CSF	_	NN	NN	_	12	appos	_	_
15	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	signal	_	NN	NN	_	18	nn	_	_
17	transduction	_	NN	NN	_	18	nn	_	_
18	pathways	_	NNS	NNS	_	10	dobj	_	_
19	,	_	,	,	_	4	punct	_	_
20	was	_	VBD	VBD	_	21	auxpass	_	_
21	identified	_	VBN	VBN	_	0	root	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	a	_	DT	DT	_	25	det	_	_
24	high-throughput	_	JJ	JJ	_	25	amod	_	_
25	assay	_	NN	NN	_	22	pobj	_	_
26	in	_	IN	IN	_	21	prep	_	_
27	cultured	_	VBN	VBN	_	28	amod	_	_
28	cells	_	NNS	NNS	_	26	pobj	_	_
29	.	_	.	.	_	21	punct	_	_

1	Like	_	IN	IN	_	6	prep	_	_
2	G-CSF	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	6	punct	_	_
4	SB	_	NN	NN	_	6	nsubj	_	_
5	247464	_	CD	CD	_	4	num	_	_
6	induced	_	VBD	VBD	_	0	root	_	_
7	tyrosine	_	NN	NN	_	8	nn	_	_
8	phosphorylation	_	NN	NN	_	6	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	multiple	_	JJ	JJ	_	12	amod	_	_
11	signaling	_	NN	NN	_	12	nn	_	_
12	proteins	_	NNS	NNS	_	9	pobj	_	_
13	and	_	CC	CC	_	6	cc	_	_
14	stimulated	_	VBN	VBN	_	6	conj	_	_
15	primary	_	JJ	JJ	_	19	amod	_	_
16	murine	_	JJ	JJ	_	19	amod	_	_
17	bone	_	NN	NN	_	19	nn	_	_
18	marrow	_	NN	NN	_	19	nn	_	_
19	cells	_	NNS	NNS	_	14	dobj	_	_
20	to	_	TO	TO	_	21	aux	_	_
21	form	_	VB	VB	_	14	vmod	_	_
22	granulocytic	_	JJ	JJ	_	23	amod	_	_
23	colonies	_	NNS	NNS	_	21	dobj	_	_
24	in	_	FW	FW	_	25	nn	_	_
25	vitro	_	FW	FW	_	21	advmod	_	_
26	.	_	.	.	_	6	punct	_	_

1	It	_	PRP	PRP	_	3	nsubj	_	_
2	also	_	RB	RB	_	3	advmod	_	_
3	elevated	_	JJ	JJ	_	0	root	_	_
4	peripheral	_	JJ	JJ	_	6	amod	_	_
5	blood	_	NN	NN	_	6	nn	_	_
6	neutrophil	_	NN	NN	_	7	nn	_	_
7	counts	_	NNS	NNS	_	3	dobj	_	_
8	in	_	IN	IN	_	3	prep	_	_
9	mice	_	NNS	NNS	_	8	pobj	_	_
10	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	extracellular	_	JJ	JJ	_	3	amod	_	_
3	domain	_	NN	NN	_	10	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	8	det	_	_
6	murine	_	JJ	JJ	_	8	amod	_	_
7	G-CSF	_	NN	NN	_	8	nn	_	_
8	receptor	_	NN	NN	_	4	pobj	_	_
9	was	_	VBD	VBD	_	10	auxpass	_	_
10	required	_	VBN	VBN	_	0	root	_	_
11	for	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	activity	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	SB	_	NN	NN	_	14	pobj	_	_
16	247464	_	CD	CD	_	15	num	_	_
17	,	_	,	,	_	10	punct	_	_
18	suggesting	_	VBG	VBG	_	10	vmod	_	_
19	that	_	IN	IN	_	22	mark	_	_
20	the	_	DT	DT	_	21	det	_	_
21	compound	_	NN	NN	_	22	nsubj	_	_
22	acts	_	VBZ	VBZ	_	18	ccomp	_	_
23	by	_	IN	IN	_	22	prep	_	_
24	oligomerizing	_	VBG	VBG	_	23	pcomp	_	_
25	receptor	_	NN	NN	_	26	nn	_	_
26	chains	_	NNS	NNS	_	24	dobj	_	_
27	.	_	.	.	_	10	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	9	mark	_	_
5	a	_	DT	DT	_	7	det	_	_
6	small	_	JJ	JJ	_	7	amod	_	_
7	molecule	_	NN	NN	_	9	nsubj	_	_
8	can	_	MD	MD	_	9	aux	_	_
9	activate	_	VB	VB	_	3	ccomp	_	_
10	a	_	DT	DT	_	11	det	_	_
11	receptor	_	NN	NN	_	9	dobj	_	_
12	that	_	WDT	WDT	_	14	nsubj	_	_
13	normally	_	RB	RB	_	14	advmod	_	_
14	binds	_	VBZ	VBZ	_	11	rcmod	_	_
15	a	_	DT	DT	_	19	det	_	_
16	relatively	_	RB	RB	_	17	advmod	_	_
17	large	_	JJ	JJ	_	19	amod	_	_
18	protein	_	NN	NN	_	19	nn	_	_
19	ligand	_	NN	NN	_	14	dobj	_	_
20	.	_	.	.	_	3	punct	_	_

1	Thrombopoietin	_	NN	NN	_	2	nsubj	_	_
2	supports	_	VBZ	VBZ	_	0	root	_	_
3	in	_	FW	FW	_	6	amod	_	_
4	vitro	_	FW	FW	_	3	dep	_	_
5	erythroid	_	JJ	JJ	_	6	amod	_	_
6	differentiation	_	NN	NN	_	2	dobj	_	_
7	via	_	IN	IN	_	2	prep	_	_
8	its	_	PRP$	PRP$	_	11	poss	_	_
9	specific	_	JJ	JJ	_	11	amod	_	_
10	receptor	_	NN	NN	_	11	nn	_	_
11	c-Mpl	_	NN	NN	_	7	pobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	a	_	DT	DT	_	17	det	_	_
14	human	_	JJ	JJ	_	17	amod	_	_
15	leukemia	_	NN	NN	_	17	nn	_	_
16	cell	_	NN	NN	_	17	nn	_	_
17	line	_	NN	NN	_	12	pobj	_	_
18	.	_	.	.	_	2	punct	_	_

1	Thrombopoietin	_	NN	NN	_	5	nsubj	_	_
2	-LRB-	_	-LRB-	-LRB-	_	3	punct	_	_
3	TPO	_	NN	NN	_	1	appos	_	_
4	-RRB-	_	-RRB-	-RRB-	_	3	punct	_	_
5	acts	_	VBZ	VBZ	_	0	root	_	_
6	on	_	IN	IN	_	5	prep	_	_
7	megakaryopoiesis	_	NN	NN	_	6	pobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	erythropoiesis	_	NN	NN	_	7	conj	_	_
10	in	_	FW	FW	_	11	nn	_	_
11	vitro	_	FW	FW	_	5	advmod	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	in	_	FW	FW	_	14	nn	_	_
14	vivo	_	FW	FW	_	11	conj	_	_
15	.	_	.	.	_	5	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	isolated	_	VBD	VBD	_	0	root	_	_
3	a	_	DT	DT	_	5	det	_	_
4	novel	_	JJ	JJ	_	5	amod	_	_
5	subline	_	NN	NN	_	2	dobj	_	_
6	,	_	,	,	_	5	punct	_	_
7	UT-7/GMT	_	NN	NN	_	5	appos	_	_
8	,	_	,	,	_	5	punct	_	_
9	from	_	IN	IN	_	2	prep	_	_
10	the	_	DT	DT	_	15	det	_	_
11	human	_	JJ	JJ	_	15	amod	_	_
12	leukemia	_	NN	NN	_	15	nn	_	_
13	cell	_	NN	NN	_	15	nn	_	_
14	line	_	NN	NN	_	15	nn	_	_
15	UT-7/GM	_	NN	NN	_	9	pobj	_	_
16	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
17	N.	_	NN	NN	_	18	nn	_	_
18	Komatsu	_	NN	NN	_	2	dep	_	_
19	,	_	,	,	_	18	punct	_	_
20	et	_	FW	FW	_	18	dep	_	_
21	al.	_	FW	FW	_	18	dep	_	_
22	,	_	,	,	_	18	punct	_	_
23	Blood	_	NN	NN	_	18	dep	_	_
24	,	_	,	,	_	18	punct	_	_
25	89	_	CD	CD	_	27	num	_	_
26	:	_	:	:	_	27	punct	_	_
27	4021-4033	_	CD	CD	_	18	dep	_	_
28	,	_	,	,	_	18	punct	_	_
29	1997	_	CD	CD	_	18	dep	_	_
30	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
31	.	_	.	.	_	2	punct	_	_

1	A	_	DT	DT	_	3	det	_	_
2	small	_	JJ	JJ	_	3	amod	_	_
3	population	_	NN	NN	_	8	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	UT-7/GM	_	NN	NN	_	6	nn	_	_
6	cells	_	NNS	NNS	_	4	pobj	_	_
7	positively	_	RB	RB	_	8	advmod	_	_
8	stained	_	VBN	VBN	_	0	root	_	_
9	for	_	IN	IN	_	8	prep	_	_
10	hemoglobin	_	NN	NN	_	9	pobj	_	_
11	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
12	Hb	_	NN	NN	_	10	appos	_	_
13	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
14	after	_	IN	IN	_	8	prep	_	_
15	a	_	DT	DT	_	17	det	_	_
16	7-day	_	JJ	JJ	_	17	amod	_	_
17	exposure	_	NN	NN	_	14	pobj	_	_
18	to	_	TO	TO	_	17	prep	_	_
19	TPO	_	NN	NN	_	18	pobj	_	_
20	.	_	.	.	_	8	punct	_	_

1	More	_	JJR	JJR	_	2	mwe	_	_
2	than	_	IN	IN	_	3	quantmod	_	_
3	50	_	CD	CD	_	4	num	_	_
4	%	_	NN	NN	_	10	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	TPO-treated	_	JJ	JJ	_	8	amod	_	_
7	UT-7/GMT	_	NN	NN	_	8	nn	_	_
8	cells	_	NNS	NNS	_	5	pobj	_	_
9	positively	_	RB	RB	_	10	advmod	_	_
10	stained	_	VBN	VBN	_	0	root	_	_
11	for	_	IN	IN	_	10	prep	_	_
12	Hb	_	NN	NN	_	11	pobj	_	_
13	.	_	.	.	_	10	punct	_	_

1	Using	_	VBG	VBG	_	6	vmod	_	_
2	UT-7/GMT	_	NN	NN	_	3	nn	_	_
3	cells	_	NNS	NNS	_	1	dobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	examined	_	VBD	VBD	_	0	root	_	_
7	how	_	WRB	WRB	_	9	advmod	_	_
8	TPO	_	NN	NN	_	9	nsubj	_	_
9	promotes	_	VBZ	VBZ	_	6	ccomp	_	_
10	hemoglobinization	_	NN	NN	_	9	dobj	_	_
11	.	_	.	.	_	6	punct	_	_

1	TPO	_	NN	NN	_	2	nsubj	_	_
2	induced	_	VBD	VBD	_	0	root	_	_
3	tyrosine	_	NN	NN	_	4	nn	_	_
4	phosphorylation	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	TPO	_	NN	NN	_	8	nn	_	_
8	receptor	_	NN	NN	_	5	pobj	_	_
9	but	_	CC	CC	_	10	cc	_	_
10	not	_	RB	RB	_	8	cc	_	_
11	the	_	DT	DT	_	16	det	_	_
12	erythropoietin	_	NN	NN	_	16	nn	_	_
13	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
14	EPO	_	NN	NN	_	16	nn	_	_
15	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
16	receptor	_	NN	NN	_	8	conj	_	_
17	.	_	.	.	_	2	punct	_	_

1	There	_	EX	EX	_	2	expl	_	_
2	was	_	VBD	VBD	_	0	root	_	_
3	no	_	DT	DT	_	4	neg	_	_
4	competition	_	NN	NN	_	2	nsubj	_	_
5	between	_	IN	IN	_	4	prep	_	_
6	TPO	_	NN	NN	_	5	pobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	EPO	_	NN	NN	_	6	conj	_	_
9	for	_	IN	IN	_	4	prep	_	_
10	binding	_	NN	NN	_	9	pobj	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	EPO	_	NN	NN	_	13	nn	_	_
13	receptor	_	NN	NN	_	11	pobj	_	_
14	.	_	.	.	_	2	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	findings	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	6	mark	_	_
5	TPO	_	NN	NN	_	6	nsubj	_	_
6	has	_	VBZ	VBZ	_	3	ccomp	_	_
7	a	_	DT	DT	_	9	det	_	_
8	direct	_	JJ	JJ	_	9	amod	_	_
9	effect	_	NN	NN	_	6	dobj	_	_
10	on	_	IN	IN	_	6	prep	_	_
11	hemoglobinization	_	NN	NN	_	10	pobj	_	_
12	via	_	IN	IN	_	6	prep	_	_
13	a	_	DT	DT	_	15	det	_	_
14	specific	_	JJ	JJ	_	15	amod	_	_
15	receptor	_	NN	NN	_	12	pobj	_	_
16	on	_	IN	IN	_	15	prep	_	_
17	UT-7/GMT	_	NN	NN	_	18	nn	_	_
18	cells	_	NNS	NNS	_	16	pobj	_	_
19	.	_	.	.	_	3	punct	_	_

1	Isoelectric	_	JJ	JJ	_	2	amod	_	_
2	focusing	_	NN	NN	_	3	nsubj	_	_
3	demonstrated	_	VBD	VBD	_	0	root	_	_
4	that	_	IN	IN	_	6	mark	_	_
5	TPO	_	NN	NN	_	6	nsubj	_	_
6	induced	_	VBD	VBD	_	3	ccomp	_	_
7	fetal	_	JJ	JJ	_	11	amod	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	adult	_	JJ	JJ	_	7	conj	_	_
10	Hb	_	NN	NN	_	11	nn	_	_
11	synthesis	_	NN	NN	_	6	dobj	_	_
12	,	_	,	,	_	6	punct	_	_
13	whereas	_	IN	IN	_	6	dep	_	_
14	EPO	_	NN	NN	_	15	nsubj	_	_
15	induced	_	VBD	VBD	_	6	parataxis	_	_
16	embryonic	_	JJ	JJ	_	23	amod	_	_
17	,	_	,	,	_	16	punct	_	_
18	fetal	_	JJ	JJ	_	16	conj	_	_
19	,	_	,	,	_	16	punct	_	_
20	and	_	CC	CC	_	16	cc	_	_
21	adult	_	JJ	JJ	_	16	conj	_	_
22	Hb	_	NN	NN	_	23	nn	_	_
23	synthesis	_	NN	NN	_	15	dobj	_	_
24	.	_	.	.	_	3	punct	_	_

1	Thus	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	our	_	PRP$	PRP$	_	4	poss	_	_
4	data	_	NNS	NNS	_	5	nsubj	_	_
5	suggest	_	VBP	VBP	_	0	root	_	_
6	that	_	IN	IN	_	8	mark	_	_
7	TPO	_	NN	NN	_	8	nsubj	_	_
8	has	_	VBZ	VBZ	_	5	ccomp	_	_
9	a	_	DT	DT	_	11	det	_	_
10	distinct	_	JJ	JJ	_	11	amod	_	_
11	action	_	NN	NN	_	8	dobj	_	_
12	on	_	IN	IN	_	8	prep	_	_
13	erythropoiesis	_	NN	NN	_	12	pobj	_	_
14	.	_	.	.	_	5	punct	_	_

1	Macrophages	_	NNS	NNS	_	5	nsubj	_	_
2	in	_	IN	IN	_	1	prep	_	_
3	human	_	JJ	JJ	_	4	amod	_	_
4	atheroma	_	NN	NN	_	2	pobj	_	_
5	contain	_	VBP	VBP	_	0	root	_	_
6	PPARgamma	_	NN	NN	_	5	dobj	_	_
7	:	_	:	:	_	5	punct	_	_
8	differentiation-dependent	_	JJ	JJ	_	12	amod	_	_
9	peroxisomal	_	JJ	JJ	_	12	amod	_	_
10	proliferator-activated	_	JJ	JJ	_	12	amod	_	_
11	receptor	_	NN	NN	_	12	nn	_	_
12	gamma	_	NN	NN	_	5	dep	_	_
13	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
14	PPARgamma	_	NN	NN	_	12	appos	_	_
15	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	expression	_	NN	NN	_	12	dep	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	reduction	_	NN	NN	_	16	conj	_	_
19	of	_	IN	IN	_	12	prep	_	_
20	MMP-9	_	NN	NN	_	21	nn	_	_
21	activity	_	NN	NN	_	19	pobj	_	_
22	through	_	IN	IN	_	21	prep	_	_
23	PPARgamma	_	NN	NN	_	24	nn	_	_
24	activation	_	NN	NN	_	22	pobj	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	mononuclear	_	JJ	JJ	_	27	amod	_	_
27	phagocytes	_	NNS	NNS	_	25	pobj	_	_
28	in	_	FW	FW	_	29	nn	_	_
29	vitro	_	FW	FW	_	24	advmod	_	_
30	.	_	.	.	_	5	punct	_	_

1	Mononuclear	_	JJ	JJ	_	2	amod	_	_
2	phagocytes	_	NNS	NNS	_	3	nsubj	_	_
3	play	_	VBP	VBP	_	0	root	_	_
4	an	_	DT	DT	_	6	det	_	_
5	important	_	JJ	JJ	_	6	amod	_	_
6	role	_	NN	NN	_	3	dobj	_	_
7	in	_	IN	IN	_	3	prep	_	_
8	atherosclerosis	_	NN	NN	_	7	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	its	_	PRP$	PRP$	_	13	poss	_	_
11	sequela	_	NN	NN	_	13	nn	_	_
12	plaque	_	NN	NN	_	13	nn	_	_
13	rupture	_	NN	NN	_	8	conj	_	_
14	in	_	IN	IN	_	3	prep	_	_
15	part	_	NN	NN	_	14	pobj	_	_
16	by	_	IN	IN	_	3	prep	_	_
17	their	_	PRP$	PRP$	_	18	poss	_	_
18	secretion	_	NN	NN	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	matrix	_	NN	NN	_	21	nn	_	_
21	metalloproteinases	_	NNS	NNS	_	19	pobj	_	_
22	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
23	MMPs	_	NNS	NNS	_	21	appos	_	_
24	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
25	,	_	,	,	_	21	punct	_	_
26	including	_	VBG	VBG	_	21	prep	_	_
27	MMP-9	_	NN	NN	_	26	pobj	_	_
28	.	_	.	.	_	3	punct	_	_

1	Peroxisomal	_	JJ	JJ	_	4	amod	_	_
2	proliferator-activated	_	JJ	JJ	_	4	amod	_	_
3	receptor	_	NN	NN	_	4	nn	_	_
4	gamma	_	NN	NN	_	18	nsubj	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	PPARgamma	_	NN	NN	_	4	appos	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	,	_	,	,	_	4	punct	_	_
9	a	_	DT	DT	_	11	det	_	_
10	transcription	_	NN	NN	_	11	nn	_	_
11	factor	_	NN	NN	_	4	appos	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	16	det	_	_
14	nuclear	_	JJ	JJ	_	16	amod	_	_
15	receptor	_	NN	NN	_	16	nn	_	_
16	superfamily	_	NN	NN	_	12	pobj	_	_
17	,	_	,	,	_	4	punct	_	_
18	regulates	_	VBZ	VBZ	_	0	root	_	_
19	gene	_	NN	NN	_	20	nn	_	_
20	expression	_	NN	NN	_	18	dobj	_	_
21	in	_	IN	IN	_	18	prep	_	_
22	response	_	NN	NN	_	21	dep	_	_
23	to	_	TO	TO	_	21	dep	_	_
24	various	_	JJ	JJ	_	25	amod	_	_
25	activators	_	NNS	NNS	_	21	pobj	_	_
26	,	_	,	,	_	25	punct	_	_
27	including	_	VBG	VBG	_	25	prep	_	_
28	15-deoxy-delta12,14-prostaglandin	_	NN	NN	_	29	nn	_	_
29	J2	_	NN	NN	_	27	pobj	_	_
30	and	_	CC	CC	_	29	cc	_	_
31	the	_	DT	DT	_	34	det	_	_
32	antidiabetic	_	JJ	JJ	_	34	amod	_	_
33	agent	_	NN	NN	_	34	nn	_	_
34	troglitazone	_	NN	NN	_	29	conj	_	_
35	.	_	.	.	_	18	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	role	_	NN	NN	_	9	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	PPARgamma	_	NN	NN	_	3	pobj	_	_
5	in	_	IN	IN	_	2	prep	_	_
6	human	_	JJ	JJ	_	7	amod	_	_
7	atherosclerosis	_	NN	NN	_	5	pobj	_	_
8	is	_	VBZ	VBZ	_	9	cop	_	_
9	unexplored	_	JJ	JJ	_	0	root	_	_
10	.	_	.	.	_	9	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	report	_	VBP	VBP	_	0	root	_	_
3	here	_	RB	RB	_	2	advmod	_	_
4	that	_	IN	IN	_	15	mark	_	_
5	monocytes/macrophages	_	NNS	NNS	_	15	nsubj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	human	_	JJ	JJ	_	9	amod	_	_
8	atherosclerotic	_	JJ	JJ	_	9	amod	_	_
9	lesions	_	NNS	NNS	_	6	pobj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
11	n	_	NN	NN	_	12	nsubj	_	_
12	=	_	JJ	JJ	_	9	dep	_	_
13	12	_	CD	CD	_	12	dobj	_	_
14	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
15	express	_	VBP	VBP	_	2	ccomp	_	_
16	immunostainable	_	JJ	JJ	_	17	amod	_	_
17	PPARgamma	_	NN	NN	_	15	dobj	_	_
18	.	_	.	.	_	2	punct	_	_

1	Normal	_	JJ	JJ	_	3	amod	_	_
2	artery	_	NN	NN	_	3	nn	_	_
3	specimens	_	NNS	NNS	_	9	nsubj	_	_
4	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
5	n	_	NN	NN	_	6	nsubj	_	_
6	=	_	JJ	JJ	_	3	dep	_	_
7	6	_	CD	CD	_	6	dobj	_	_
8	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
9	reveal	_	VBP	VBP	_	0	root	_	_
10	minimal	_	JJ	JJ	_	12	amod	_	_
11	immunoreactive	_	JJ	JJ	_	12	amod	_	_
12	PPARgamma	_	NN	NN	_	9	dobj	_	_
13	.	_	.	.	_	9	punct	_	_

1	Human	_	JJ	JJ	_	2	amod	_	_
2	monocytes	_	NNS	NNS	_	15	nsubj	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	monocyte-derived	_	JJ	JJ	_	5	amod	_	_
5	macrophages	_	NNS	NNS	_	2	conj	_	_
6	cultured	_	VBN	VBN	_	2	vmod	_	_
7	for	_	IN	IN	_	6	prep	_	_
8	6	_	CD	CD	_	9	num	_	_
9	days	_	NNS	NNS	_	7	pobj	_	_
10	in	_	IN	IN	_	6	prep	_	_
11	5	_	CD	CD	_	12	num	_	_
12	%	_	NN	NN	_	10	pobj	_	_
13	human	_	JJ	JJ	_	14	amod	_	_
14	serum	_	NN	NN	_	12	dep	_	_
15	expressed	_	VBD	VBD	_	0	root	_	_
16	PPARgamma	_	NN	NN	_	17	nn	_	_
17	mRNA	_	NN	NN	_	15	dobj	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	protein	_	NN	NN	_	17	conj	_	_
20	by	_	IN	IN	_	15	prep	_	_
21	reverse	_	JJ	JJ	_	24	amod	_	_
22	transcription-polymerase	_	NN	NN	_	24	nn	_	_
23	chain	_	NN	NN	_	24	nn	_	_
24	reaction	_	NN	NN	_	20	pobj	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	Western	_	NN	NN	_	27	nn	_	_
27	blotting	_	NN	NN	_	24	conj	_	_
28	,	_	,	,	_	15	punct	_	_
29	respectively	_	RB	RB	_	15	advmod	_	_
30	.	_	.	.	_	15	punct	_	_

1	In	_	IN	IN	_	10	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	10	punct	_	_
4	PPARgamma	_	NN	NN	_	6	nn	_	_
5	mRNA	_	NN	NN	_	6	nn	_	_
6	expression	_	NN	NN	_	10	nsubj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	U937	_	NN	NN	_	9	nn	_	_
9	cells	_	NNS	NNS	_	7	pobj	_	_
10	increased	_	VBN	VBN	_	0	root	_	_
11	during	_	IN	IN	_	10	prep	_	_
12	phorbol	_	NN	NN	_	15	npadvmod	_	_
13	12-myristate	_	NN	NN	_	15	npadvmod	_	_
14	13	_	CD	CD	_	15	number	_	_
15	acetate-induced	_	JJ	JJ	_	16	amod	_	_
16	differentiation	_	NN	NN	_	11	pobj	_	_
17	.	_	.	.	_	10	punct	_	_

1	Stimulation	_	NN	NN	_	13	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	PPARgamma	_	NN	NN	_	2	pobj	_	_
4	with	_	IN	IN	_	1	prep	_	_
5	troglitazone	_	NN	NN	_	4	pobj	_	_
6	or	_	CC	CC	_	5	cc	_	_
7	15-deoxy-delta12,14-prostaglandin	_	NN	NN	_	8	nn	_	_
8	J2	_	NN	NN	_	5	conj	_	_
9	in	_	IN	IN	_	5	prep	_	_
10	human	_	JJ	JJ	_	11	amod	_	_
11	monocyte-derived	_	JJ	JJ	_	12	amod	_	_
12	macrophages	_	NNS	NNS	_	9	pobj	_	_
13	inhibited	_	VBD	VBD	_	0	root	_	_
14	MMP-9	_	NN	NN	_	16	nn	_	_
15	gelatinolytic	_	JJ	JJ	_	16	amod	_	_
16	activity	_	NN	NN	_	13	dobj	_	_
17	in	_	IN	IN	_	13	prep	_	_
18	a	_	DT	DT	_	20	det	_	_
19	concentration-dependent	_	JJ	JJ	_	20	amod	_	_
20	fashion	_	NN	NN	_	17	pobj	_	_
21	as	_	IN	IN	_	22	mark	_	_
22	revealed	_	VBN	VBN	_	13	advcl	_	_
23	by	_	IN	IN	_	22	prep	_	_
24	zymography	_	NN	NN	_	23	pobj	_	_
25	.	_	.	.	_	13	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	inhibition	_	NN	NN	_	3	nsubj	_	_
3	correlates	_	VBZ	VBZ	_	0	root	_	_
4	with	_	IN	IN	_	3	prep	_	_
5	decreased	_	VBN	VBN	_	7	amod	_	_
6	MMP-9	_	NN	NN	_	7	nn	_	_
7	secretion	_	NN	NN	_	4	pobj	_	_
8	as	_	IN	IN	_	9	mark	_	_
9	determined	_	VBN	VBN	_	3	advcl	_	_
10	by	_	IN	IN	_	9	prep	_	_
11	Western	_	NN	NN	_	12	nn	_	_
12	blotting	_	NN	NN	_	10	pobj	_	_
13	.	_	.	.	_	3	punct	_	_

1	Thus	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	PPARgamma	_	NN	NN	_	5	nsubj	_	_
4	is	_	VBZ	VBZ	_	5	cop	_	_
5	present	_	JJ	JJ	_	0	root	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	macrophages	_	NNS	NNS	_	6	pobj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	human	_	JJ	JJ	_	11	amod	_	_
10	atherosclerotic	_	JJ	JJ	_	11	amod	_	_
11	lesions	_	NNS	NNS	_	8	pobj	_	_
12	and	_	CC	CC	_	5	cc	_	_
13	may	_	MD	MD	_	14	aux	_	_
14	regulate	_	VB	VB	_	5	conj	_	_
15	expression	_	NN	NN	_	14	dobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	activity	_	NN	NN	_	15	conj	_	_
18	of	_	IN	IN	_	15	prep	_	_
19	MMP-9	_	NN	NN	_	18	pobj	_	_
20	,	_	,	,	_	19	punct	_	_
21	an	_	DT	DT	_	22	det	_	_
22	enzyme	_	NN	NN	_	19	appos	_	_
23	implicated	_	VBN	VBN	_	22	vmod	_	_
24	in	_	IN	IN	_	23	prep	_	_
25	plaque	_	NN	NN	_	26	nn	_	_
26	rupture	_	NN	NN	_	24	pobj	_	_
27	.	_	.	.	_	5	punct	_	_

1	PPARgamma	_	NN	NN	_	3	nsubj	_	_
2	is	_	VBZ	VBZ	_	3	cop	_	_
3	likely	_	JJ	JJ	_	0	root	_	_
4	to	_	TO	TO	_	8	aux	_	_
5	be	_	VB	VB	_	8	cop	_	_
6	an	_	DT	DT	_	8	det	_	_
7	important	_	JJ	JJ	_	8	amod	_	_
8	regulator	_	NN	NN	_	3	xcomp	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	monocyte/macrophage	_	NN	NN	_	11	nn	_	_
11	function	_	NN	NN	_	9	pobj	_	_
12	with	_	IN	IN	_	11	prep	_	_
13	relevance	_	NN	NN	_	12	pobj	_	_
14	for	_	IN	IN	_	13	prep	_	_
15	human	_	JJ	JJ	_	17	amod	_	_
16	atherosclerotic	_	JJ	JJ	_	17	amod	_	_
17	disease	_	NN	NN	_	14	pobj	_	_
18	.	_	.	.	_	3	punct	_	_

1	Peripheral	_	JJ	JJ	_	4	amod	_	_
2	blood	_	NN	NN	_	4	nn	_	_
3	T	_	NN	NN	_	4	nn	_	_
4	cells	_	NNS	NNS	_	16	nsubj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	monocytes	_	NNS	NNS	_	4	conj	_	_
7	and	_	CC	CC	_	4	cc	_	_
8	B	_	NN	NN	_	10	nn	_	_
9	cell	_	NN	NN	_	10	nn	_	_
10	lines	_	NNS	NNS	_	4	conj	_	_
11	derived	_	VBN	VBN	_	4	vmod	_	_
12	from	_	IN	IN	_	11	prep	_	_
13	patients	_	NNS	NNS	_	12	pobj	_	_
14	with	_	IN	IN	_	13	prep	_	_
15	lupus	_	NN	NN	_	14	pobj	_	_
16	express	_	VBP	VBP	_	0	root	_	_
17	estrogen	_	NN	NN	_	19	nn	_	_
18	receptor	_	NN	NN	_	19	nn	_	_
19	transcripts	_	NNS	NNS	_	16	dobj	_	_
20	similar	_	JJ	JJ	_	19	amod	_	_
21	to	_	TO	TO	_	20	prep	_	_
22	those	_	DT	DT	_	21	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	normal	_	JJ	JJ	_	25	amod	_	_
25	cells	_	NNS	NNS	_	23	pobj	_	_
26	.	_	.	.	_	16	punct	_	_

1	OBJECTIVE	_	NN	NN	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	To	_	TO	TO	_	4	aux	_	_
4	identify	_	VB	VB	_	1	vmod	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	characterize	_	VB	VB	_	4	conj	_	_
7	estrogen	_	NN	NN	_	12	nn	_	_
8	receptor	_	NN	NN	_	12	nn	_	_
9	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
10	ER	_	NN	NN	_	12	nn	_	_
11	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
12	transcripts	_	NNS	NNS	_	4	dobj	_	_
13	expressed	_	VBN	VBN	_	12	vmod	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	immune	_	JJ	JJ	_	16	amod	_	_
16	cells	_	NNS	NNS	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	patients	_	NNS	NNS	_	17	pobj	_	_
19	with	_	IN	IN	_	18	prep	_	_
20	systemic	_	JJ	JJ	_	22	amod	_	_
21	lupus	_	NN	NN	_	22	nn	_	_
22	erythematosus	_	NN	NN	_	19	pobj	_	_
23	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
24	SLE	_	NN	NN	_	22	appos	_	_
25	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
26	and	_	CC	CC	_	18	cc	_	_
27	healthy	_	JJ	JJ	_	28	amod	_	_
28	donors	_	NNS	NNS	_	18	conj	_	_
29	.	_	.	.	_	1	punct	_	_

1	METHODS	_	NNS	NNS	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	Peripheral	_	JJ	JJ	_	5	amod	_	_
4	blood	_	NN	NN	_	5	nn	_	_
5	monocytes	_	NNS	NNS	_	10	nsubjpass	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	T	_	NN	NN	_	8	nn	_	_
8	cells	_	NNS	NNS	_	5	conj	_	_
9	were	_	VBD	VBD	_	10	auxpass	_	_
10	prepared	_	VBN	VBN	_	1	dep	_	_
11	from	_	IN	IN	_	10	prep	_	_
12	patients	_	NNS	NNS	_	11	pobj	_	_
13	with	_	IN	IN	_	12	prep	_	_
14	SLE	_	NN	NN	_	13	pobj	_	_
15	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
16	n	_	NN	NN	_	17	nsubj	_	_
17	=	_	JJ	JJ	_	12	dep	_	_
18	6	_	CD	CD	_	17	dobj	_	_
19	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
20	and	_	CC	CC	_	12	cc	_	_
21	healthy	_	JJ	JJ	_	22	amod	_	_
22	donors	_	NNS	NNS	_	12	conj	_	_
23	-LRB-	_	-LRB-	-LRB-	_	25	punct	_	_
24	n	_	NN	NN	_	25	nsubj	_	_
25	=	_	JJ	JJ	_	22	dep	_	_
26	8	_	CD	CD	_	25	dobj	_	_
27	-RRB-	_	-RRB-	-RRB-	_	25	punct	_	_
28	.	_	.	.	_	1	punct	_	_

1	T	_	NN	NN	_	2	nn	_	_
2	cells	_	NNS	NNS	_	4	nsubjpass	_	_
3	were	_	VBD	VBD	_	4	auxpass	_	_
4	separated	_	VBN	VBN	_	0	root	_	_
5	into	_	IN	IN	_	4	prep	_	_
6	CD4	_	NN	NN	_	5	pobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	CD8	_	NN	NN	_	6	conj	_	_
9	.	_	.	.	_	4	punct	_	_

1	Some	_	DT	DT	_	2	det	_	_
2	monocytes	_	NNS	NNS	_	7	nsubjpass	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	T	_	NN	NN	_	5	nn	_	_
5	cells	_	NNS	NNS	_	2	conj	_	_
6	were	_	VBD	VBD	_	7	auxpass	_	_
7	stimulated	_	VBN	VBN	_	0	root	_	_
8	with	_	IN	IN	_	7	prep	_	_
9	estradiol	_	NN	NN	_	8	pobj	_	_
10	,	_	,	,	_	9	punct	_	_
11	PMA	_	NN	NN	_	9	conj	_	_
12	,	_	,	,	_	9	punct	_	_
13	and	_	CC	CC	_	9	cc	_	_
14	ionomycin	_	NN	NN	_	9	conj	_	_
15	.	_	.	.	_	7	punct	_	_

1	Epstein-Barr	_	JJ	JJ	_	2	amod	_	_
2	virus-transformed	_	JJ	JJ	_	5	amod	_	_
3	B	_	NN	NN	_	5	nn	_	_
4	cell	_	NN	NN	_	5	nn	_	_
5	lines	_	NNS	NNS	_	30	nsubjpass	_	_
6	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
7	n	_	NN	NN	_	8	nsubj	_	_
8	=	_	JJ	JJ	_	5	dep	_	_
9	7	_	CD	CD	_	8	dobj	_	_
10	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
11	and	_	CC	CC	_	5	cc	_	_
12	B	_	NN	NN	_	14	nn	_	_
13	cell	_	NN	NN	_	14	nn	_	_
14	hybridomas	_	NNS	NNS	_	5	conj	_	_
15	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
16	n	_	NN	NN	_	17	nsubj	_	_
17	=	_	JJ	JJ	_	14	dep	_	_
18	2	_	LS	LS	_	17	dobj	_	_
19	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
20	established	_	VBN	VBN	_	5	vmod	_	_
21	from	_	IN	IN	_	20	prep	_	_
22	patients	_	NNS	NNS	_	21	pobj	_	_
23	with	_	IN	IN	_	22	prep	_	_
24	SLE	_	NN	NN	_	23	pobj	_	_
25	and	_	CC	CC	_	22	cc	_	_
26	a	_	DT	DT	_	28	det	_	_
27	healthy	_	JJ	JJ	_	28	amod	_	_
28	individual	_	JJ	JJ	_	22	conj	_	_
29	were	_	VBD	VBD	_	30	auxpass	_	_
30	used	_	VBN	VBN	_	0	root	_	_
31	as	_	IN	IN	_	30	prep	_	_
32	a	_	DT	DT	_	34	det	_	_
33	B	_	NN	NN	_	34	nn	_	_
34	cell	_	NN	NN	_	31	pobj	_	_
35	source	_	RB	RB	_	34	advmod	_	_
36	.	_	.	.	_	30	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	cells	_	NNS	NNS	_	4	nsubjpass	_	_
3	were	_	VBD	VBD	_	4	auxpass	_	_
4	examined	_	VBN	VBN	_	0	root	_	_
5	for	_	IN	IN	_	4	prep	_	_
6	ER	_	NN	NN	_	7	nn	_	_
7	mRNA	_	NN	NN	_	5	pobj	_	_
8	by	_	IN	IN	_	4	prep	_	_
9	reverse	_	JJ	JJ	_	11	amod	_	_
10	transcription	_	NN	NN	_	11	npadvmod	_	_
11	nested	_	JJ	JJ	_	14	amod	_	_
12	polymerase	_	NN	NN	_	14	nn	_	_
13	chain	_	NN	NN	_	14	nn	_	_
14	reaction	_	NN	NN	_	8	pobj	_	_
15	.	_	.	.	_	4	punct	_	_

1	Amplified	_	JJ	JJ	_	2	amod	_	_
2	cDNA	_	NN	NN	_	4	nsubjpass	_	_
3	were	_	VBD	VBD	_	4	auxpass	_	_
4	sequenced	_	VBN	VBN	_	0	root	_	_
5	by	_	IN	IN	_	4	prep	_	_
6	standard	_	JJ	JJ	_	7	amod	_	_
7	methods	_	NNS	NNS	_	5	pobj	_	_
8	.	_	.	.	_	4	punct	_	_

1	RESULTS	_	NNS	NNS	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	In	_	IN	IN	_	11	prep	_	_
4	all	_	DT	DT	_	5	det	_	_
5	cells	_	NNS	NNS	_	3	pobj	_	_
6	tested	_	VBN	VBN	_	5	vmod	_	_
7	,	_	,	,	_	11	punct	_	_
8	ER	_	NN	NN	_	9	nn	_	_
9	mRNA	_	NN	NN	_	11	nsubjpass	_	_
10	was	_	VBD	VBD	_	11	auxpass	_	_
11	expressed	_	VBN	VBN	_	1	dep	_	_
12	without	_	IN	IN	_	11	prep	_	_
13	prior	_	JJ	JJ	_	16	amod	_	_
14	in	_	FW	FW	_	16	amod	_	_
15	vitro	_	FW	FW	_	14	dep	_	_
16	stimulation	_	NN	NN	_	12	pobj	_	_
17	.	_	.	.	_	1	punct	_	_

1	Partial	_	JJ	JJ	_	2	amod	_	_
2	sequences	_	NNS	NNS	_	8	nsubj	_	_
3	from	_	IN	IN	_	2	prep	_	_
4	exons	_	NNS	NNS	_	3	pobj	_	_
5	1-8	_	CD	CD	_	4	num	_	_
6	were	_	VBD	VBD	_	8	cop	_	_
7	nearly	_	RB	RB	_	8	advmod	_	_
8	identical	_	JJ	JJ	_	0	root	_	_
9	to	_	TO	TO	_	8	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	published	_	VBN	VBN	_	12	amod	_	_
12	sequence	_	NN	NN	_	9	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	17	det	_	_
15	human	_	JJ	JJ	_	17	amod	_	_
16	ER	_	NN	NN	_	17	nn	_	_
17	mRNA	_	NN	NN	_	13	pobj	_	_
18	.	_	.	.	_	8	punct	_	_

1	There	_	EX	EX	_	2	expl	_	_
2	were	_	VBD	VBD	_	0	root	_	_
3	no	_	DT	DT	_	5	neg	_	_
4	notable	_	JJ	JJ	_	5	amod	_	_
5	differences	_	NNS	NNS	_	2	nsubj	_	_
6	in	_	IN	IN	_	2	prep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	ER	_	NN	NN	_	9	nn	_	_
9	transcripts	_	NNS	NNS	_	6	pobj	_	_
10	between	_	IN	IN	_	2	prep	_	_
11	patients	_	NNS	NNS	_	10	pobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	healthy	_	JJ	JJ	_	14	amod	_	_
14	controls	_	NNS	NNS	_	11	conj	_	_
15	.	_	.	.	_	2	punct	_	_

1	Variant	_	JJ	JJ	_	3	amod	_	_
2	receptor	_	NN	NN	_	3	nn	_	_
3	transcripts	_	NNS	NNS	_	19	nsubjpass	_	_
4	lacking	_	VBG	VBG	_	3	vmod	_	_
5	exon	_	NN	NN	_	4	dobj	_	_
6	5	_	CD	CD	_	5	num	_	_
7	or	_	CC	CC	_	5	cc	_	_
8	exon	_	NN	NN	_	5	conj	_	_
9	7	_	CD	CD	_	8	num	_	_
10	,	_	,	,	_	5	punct	_	_
11	which	_	WDT	WDT	_	12	nsubj	_	_
12	encodes	_	VBZ	VBZ	_	5	rcmod	_	_
13	the	_	DT	DT	_	16	det	_	_
14	hormone	_	NN	NN	_	16	nn	_	_
15	binding	_	NN	NN	_	16	nn	_	_
16	domain	_	NN	NN	_	12	dobj	_	_
17	,	_	,	,	_	5	punct	_	_
18	were	_	VBD	VBD	_	19	auxpass	_	_
19	identified	_	VBN	VBN	_	0	root	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	22	det	_	_
22	majority	_	NN	NN	_	20	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	25	det	_	_
25	cells	_	NNS	NNS	_	23	pobj	_	_
26	.	_	.	.	_	19	punct	_	_

1	Precise	_	JJ	JJ	_	2	amod	_	_
2	deletion	_	NN	NN	_	6	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	5	det	_	_
5	exons	_	NNS	NNS	_	3	pobj	_	_
6	suggests	_	VBZ	VBZ	_	0	root	_	_
7	that	_	IN	IN	_	12	mark	_	_
8	they	_	PRP	PRP	_	12	nsubj	_	_
9	are	_	VBP	VBP	_	12	cop	_	_
10	alternatively	_	RB	RB	_	11	advmod	_	_
11	spliced	_	VBN	VBN	_	12	amod	_	_
12	transcripts	_	NNS	NNS	_	6	ccomp	_	_
13	.	_	.	.	_	6	punct	_	_

1	Whether	_	IN	IN	_	6	mark	_	_
2	the	_	DT	DT	_	4	det	_	_
3	detected	_	JJ	JJ	_	4	amod	_	_
4	transcripts	_	NNS	NNS	_	6	nsubjpass	_	_
5	are	_	VBP	VBP	_	6	auxpass	_	_
6	translated	_	VBN	VBN	_	11	csubj	_	_
7	into	_	IN	IN	_	6	prep	_	_
8	functional	_	JJ	JJ	_	10	amod	_	_
9	receptor	_	NN	NN	_	10	nn	_	_
10	proteins	_	NNS	NNS	_	7	pobj	_	_
11	remains	_	VBZ	VBZ	_	0	root	_	_
12	to	_	TO	TO	_	14	aux	_	_
13	be	_	VB	VB	_	14	auxpass	_	_
14	determined	_	VBN	VBN	_	11	xcomp	_	_
15	.	_	.	.	_	11	punct	_	_

1	In	_	FW	FW	_	3	amod	_	_
2	vitro	_	FW	FW	_	1	dep	_	_
3	stimulation	_	NN	NN	_	6	nsubj	_	_
4	did	_	VBD	VBD	_	6	aux	_	_
5	not	_	RB	RB	_	6	neg	_	_
6	affect	_	VB	VB	_	0	root	_	_
7	ER	_	NN	NN	_	9	nn	_	_
8	mRNA	_	NN	NN	_	9	nn	_	_
9	expression	_	NN	NN	_	6	dobj	_	_
10	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	presence	_	NN	NN	_	7	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	variants	_	NNS	NNS	_	3	pobj	_	_
5	did	_	VBD	VBD	_	7	aux	_	_
6	not	_	RB	RB	_	7	neg	_	_
7	correlate	_	VB	VB	_	0	root	_	_
8	with	_	IN	IN	_	7	prep	_	_
9	disease	_	NN	NN	_	10	nn	_	_
10	activity	_	NN	NN	_	8	pobj	_	_
11	or	_	CC	CC	_	10	cc	_	_
12	medication	_	NN	NN	_	10	conj	_	_
13	.	_	.	.	_	7	punct	_	_

1	CONCLUSION	_	NN	NN	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	Monocytes	_	NNS	NNS	_	13	nsubj	_	_
4	,	_	,	,	_	3	punct	_	_
5	T	_	NN	NN	_	6	nn	_	_
6	cells	_	NNS	NNS	_	3	conj	_	_
7	,	_	,	,	_	3	punct	_	_
8	and	_	CC	CC	_	3	cc	_	_
9	B	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	3	conj	_	_
11	in	_	IN	IN	_	3	prep	_	_
12	patients	_	NNS	NNS	_	11	pobj	_	_
13	express	_	VBP	VBP	_	1	dep	_	_
14	transcripts	_	NNS	NNS	_	13	dobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	20	det	_	_
17	normal	_	JJ	JJ	_	20	amod	_	_
18	wild	_	JJ	JJ	_	20	amod	_	_
19	type	_	NN	NN	_	20	nn	_	_
20	ER	_	NN	NN	_	15	pobj	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	the	_	DT	DT	_	26	det	_	_
23	hormone	_	NN	NN	_	26	nn	_	_
24	binding	_	NN	NN	_	26	nn	_	_
25	domain	_	NN	NN	_	26	nn	_	_
26	variants	_	NNS	NNS	_	20	conj	_	_
27	in	_	FW	FW	_	28	nn	_	_
28	vivo	_	FW	FW	_	13	advmod	_	_
29	.	_	.	.	_	1	punct	_	_

1	Suppression	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	human	_	JJ	JJ	_	7	amod	_	_
4	anti-porcine	_	JJ	JJ	_	7	amod	_	_
5	T-cell	_	NN	NN	_	7	nn	_	_
6	immune	_	JJ	JJ	_	7	amod	_	_
7	responses	_	NNS	NNS	_	2	pobj	_	_
8	by	_	IN	IN	_	1	prep	_	_
9	major	_	JJ	JJ	_	15	amod	_	_
10	histocompatibility	_	NN	NN	_	15	nn	_	_
11	complex	_	NN	NN	_	15	nn	_	_
12	class	_	NN	NN	_	15	nn	_	_
13	II	_	CD	CD	_	15	num	_	_
14	transactivator	_	NN	NN	_	15	nn	_	_
15	constructs	_	NNS	NNS	_	8	pobj	_	_
16	lacking	_	VBG	VBG	_	15	vmod	_	_
17	the	_	DT	DT	_	20	det	_	_
18	amino	_	NN	NN	_	20	nn	_	_
19	terminal	_	JJ	JJ	_	20	amod	_	_
20	domain	_	NN	NN	_	16	dobj	_	_
21	.	_	.	.	_	1	punct	_	_

1	BACKGROUND	_	NN	NN	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	The	_	DT	DT	_	6	det	_	_
4	class	_	NN	NN	_	6	nn	_	_
5	II	_	CD	CD	_	6	num	_	_
6	transactivator	_	NN	NN	_	16	nsubj	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	CIITA	_	NN	NN	_	6	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	is	_	VBZ	VBZ	_	16	cop	_	_
11	a	_	DT	DT	_	16	det	_	_
12	bi-	_	JJ	JJ	_	16	amod	_	_
13	or	_	CC	CC	_	12	cc	_	_
14	multifunctional	_	JJ	JJ	_	12	conj	_	_
15	domain	_	NN	NN	_	16	nn	_	_
16	protein	_	NN	NN	_	1	dep	_	_
17	that	_	WDT	WDT	_	18	nsubj	_	_
18	acts	_	VBZ	VBZ	_	16	rcmod	_	_
19	as	_	IN	IN	_	18	prep	_	_
20	a	_	DT	DT	_	22	det	_	_
21	transcriptional	_	JJ	JJ	_	22	amod	_	_
22	activator	_	NN	NN	_	19	pobj	_	_
23	and	_	CC	CC	_	18	cc	_	_
24	plays	_	VBZ	VBZ	_	18	conj	_	_
25	a	_	DT	DT	_	27	det	_	_
26	critical	_	JJ	JJ	_	27	amod	_	_
27	role	_	NN	NN	_	24	dobj	_	_
28	in	_	IN	IN	_	24	prep	_	_
29	the	_	DT	DT	_	30	det	_	_
30	expression	_	NN	NN	_	28	pobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	MHC	_	NN	NN	_	35	nn	_	_
33	class	_	NN	NN	_	35	nn	_	_
34	II	_	CD	CD	_	35	num	_	_
35	genes	_	NNS	NNS	_	31	pobj	_	_
36	.	_	.	.	_	1	punct	_	_

1	We	_	PRP	PRP	_	4	nsubj	_	_
2	have	_	VBP	VBP	_	4	aux	_	_
3	previously	_	RB	RB	_	4	advmod	_	_
4	demonstrated	_	VBN	VBN	_	0	root	_	_
5	that	_	IN	IN	_	27	mark	_	_
6	a	_	DT	DT	_	8	det	_	_
7	mutated	_	VBN	VBN	_	8	amod	_	_
8	form	_	NN	NN	_	27	nsubj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	13	det	_	_
11	human	_	JJ	JJ	_	13	amod	_	_
12	CIITA	_	NN	NN	_	13	nn	_	_
13	gene	_	NN	NN	_	9	pobj	_	_
14	,	_	,	,	_	13	punct	_	_
15	coding	_	VBG	VBG	_	13	vmod	_	_
16	for	_	IN	IN	_	15	prep	_	_
17	a	_	DT	DT	_	18	det	_	_
18	protein	_	NN	NN	_	16	pobj	_	_
19	lacking	_	VBG	VBG	_	18	vmod	_	_
20	the	_	DT	DT	_	25	det	_	_
21	amino	_	NN	NN	_	25	nn	_	_
22	terminal	_	JJ	JJ	_	25	amod	_	_
23	151	_	CD	CD	_	25	num	_	_
24	amino	_	NN	NN	_	25	nn	_	_
25	acids	_	NNS	NNS	_	19	dobj	_	_
26	,	_	,	,	_	13	punct	_	_
27	acts	_	VBZ	VBZ	_	4	ccomp	_	_
28	as	_	IN	IN	_	27	prep	_	_
29	a	_	DT	DT	_	32	det	_	_
30	potent	_	JJ	JJ	_	32	amod	_	_
31	dominant-negative	_	JJ	JJ	_	32	amod	_	_
32	suppressor	_	NN	NN	_	28	pobj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	HLA	_	NN	NN	_	37	nn	_	_
35	class	_	NN	NN	_	37	nn	_	_
36	II	_	CD	CD	_	37	num	_	_
37	expression	_	NN	NN	_	33	pobj	_	_
38	.	_	.	.	_	4	punct	_	_

1	Porcine	_	NN	NN	_	5	nn	_	_
2	MHC	_	NN	NN	_	5	nn	_	_
3	class	_	NN	NN	_	5	nn	_	_
4	II	_	CD	CD	_	5	num	_	_
5	antigens	_	NNS	NNS	_	8	nsubj	_	_
6	are	_	VBP	VBP	_	8	cop	_	_
7	potent	_	JJ	JJ	_	8	amod	_	_
8	stimulators	_	NNS	NNS	_	0	root	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	direct	_	JJ	JJ	_	12	amod	_	_
11	T-cell	_	NN	NN	_	12	nn	_	_
12	recognition	_	NN	NN	_	9	pobj	_	_
13	by	_	IN	IN	_	12	prep	_	_
14	human	_	JJ	JJ	_	17	amod	_	_
15	CD4+	_	JJ	JJ	_	17	amod	_	_
16	T	_	NN	NN	_	17	nn	_	_
17	cells	_	NNS	NNS	_	13	pobj	_	_
18	and	_	CC	CC	_	8	cc	_	_
19	are	_	VBP	VBP	_	23	cop	_	_
20	,	_	,	,	_	23	punct	_	_
21	therefore	_	RB	RB	_	23	advmod	_	_
22	,	_	,	,	_	23	punct	_	_
23	likely	_	JJ	JJ	_	8	conj	_	_
24	to	_	TO	TO	_	25	aux	_	_
25	play	_	VB	VB	_	23	xcomp	_	_
26	an	_	DT	DT	_	28	det	_	_
27	important	_	JJ	JJ	_	28	amod	_	_
28	role	_	NN	NN	_	25	dobj	_	_
29	in	_	IN	IN	_	25	prep	_	_
30	the	_	DT	DT	_	32	det	_	_
31	rejection	_	NN	NN	_	32	nn	_	_
32	responses	_	NNS	NNS	_	29	pobj	_	_
33	to	_	TO	TO	_	32	prep	_	_
34	transgenic	_	JJ	JJ	_	36	amod	_	_
35	pig	_	NN	NN	_	36	nn	_	_
36	donors	_	NNS	NNS	_	33	pobj	_	_
37	in	_	IN	IN	_	32	prep	_	_
38	clinical	_	JJ	JJ	_	39	amod	_	_
39	xenotransplantation	_	NN	NN	_	37	pobj	_	_
40	.	_	.	.	_	8	punct	_	_

1	We	_	PRP	PRP	_	6	nsubjpass	_	_
2	were	_	VBD	VBD	_	6	auxpass	_	_
3	,	_	,	,	_	6	punct	_	_
4	therefore	_	RB	RB	_	6	advmod	_	_
5	,	_	,	,	_	6	punct	_	_
6	interested	_	VBD	VBD	_	0	root	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	examining	_	VBG	VBG	_	7	pcomp	_	_
9	mutated	_	VBN	VBN	_	11	amod	_	_
10	CIITA	_	NN	NN	_	11	nn	_	_
11	constructs	_	NNS	NNS	_	8	dobj	_	_
12	for	_	IN	IN	_	8	prep	_	_
13	their	_	PRP$	PRP$	_	14	poss	_	_
14	effect	_	NN	NN	_	12	pobj	_	_
15	on	_	IN	IN	_	14	prep	_	_
16	porcine	_	NN	NN	_	20	nn	_	_
17	MHC	_	NN	NN	_	20	nn	_	_
18	class	_	NN	NN	_	20	nn	_	_
19	II	_	CD	CD	_	20	num	_	_
20	expression	_	NN	NN	_	15	pobj	_	_
21	.	_	.	.	_	6	punct	_	_

1	METHODS	_	NNS	NNS	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	Stable	_	JJ	JJ	_	4	amod	_	_
4	transfectants	_	NNS	NNS	_	18	nsubjpass	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	12	det	_	_
7	porcine	_	NN	NN	_	12	nn	_	_
8	vascular	_	JJ	JJ	_	12	amod	_	_
9	endothelial	_	JJ	JJ	_	12	amod	_	_
10	cell	_	NN	NN	_	12	nn	_	_
11	line	_	NN	NN	_	12	nn	_	_
12	PIEC	_	NN	NN	_	5	pobj	_	_
13	with	_	IN	IN	_	4	prep	_	_
14	mutated	_	VBN	VBN	_	16	amod	_	_
15	CIITA	_	NN	NN	_	16	nn	_	_
16	constructs	_	NNS	NNS	_	13	pobj	_	_
17	were	_	VBD	VBD	_	18	auxpass	_	_
18	tested	_	VBN	VBN	_	1	dep	_	_
19	for	_	IN	IN	_	18	prep	_	_
20	SLA-DR	_	NN	NN	_	23	nn	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	SLA-DQ	_	NN	NN	_	20	conj	_	_
23	induction	_	NN	NN	_	19	pobj	_	_
24	by	_	IN	IN	_	23	prep	_	_
25	recombinant	_	JJ	JJ	_	27	amod	_	_
26	porcine	_	NN	NN	_	27	nn	_	_
27	interferon-gamma	_	NN	NN	_	24	pobj	_	_
28	.	_	.	.	_	1	punct	_	_

1	Transient	_	JJ	JJ	_	2	amod	_	_
2	transfectants	_	NNS	NNS	_	15	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	8	det	_	_
5	porcine	_	NN	NN	_	8	nn	_	_
6	B-cell	_	NN	NN	_	8	nn	_	_
7	line	_	NN	NN	_	8	nn	_	_
8	L23	_	NN	NN	_	3	pobj	_	_
9	with	_	IN	IN	_	2	prep	_	_
10	the	_	DT	DT	_	13	det	_	_
11	mutated	_	VBN	VBN	_	13	amod	_	_
12	CIITA	_	NN	NN	_	13	nn	_	_
13	constructs	_	NNS	NNS	_	9	pobj	_	_
14	were	_	VBD	VBD	_	15	auxpass	_	_
15	tested	_	VBN	VBN	_	0	root	_	_
16	for	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	18	det	_	_
18	suppression	_	NN	NN	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	constitutive	_	JJ	JJ	_	21	amod	_	_
21	SLA-DR	_	NN	NN	_	19	pobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	SLA-DQ	_	NN	NN	_	24	nn	_	_
24	expression	_	NN	NN	_	21	conj	_	_
25	.	_	.	.	_	15	punct	_	_

1	T-cell	_	NN	NN	_	3	nn	_	_
2	proliferation	_	NN	NN	_	3	nn	_	_
3	studies	_	NNS	NNS	_	5	nsubjpass	_	_
4	were	_	VBD	VBD	_	5	auxpass	_	_
5	performed	_	VBN	VBN	_	0	root	_	_
6	using	_	VBG	VBG	_	5	xcomp	_	_
7	highly	_	RB	RB	_	8	advmod	_	_
8	purified	_	VBN	VBN	_	12	amod	_	_
9	human	_	JJ	JJ	_	12	amod	_	_
10	CD4+	_	JJ	JJ	_	12	amod	_	_
11	T	_	NN	NN	_	12	nn	_	_
12	cells	_	NNS	NNS	_	6	dobj	_	_
13	.	_	.	.	_	5	punct	_	_

1	RESULTS	_	NNS	NNS	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	In	_	FW	FW	_	8	prep	_	_
4	preliminary	_	JJ	JJ	_	5	amod	_	_
5	studies	_	NNS	NNS	_	3	pobj	_	_
6	,	_	,	,	_	8	punct	_	_
7	we	_	PRP	PRP	_	8	nsubj	_	_
8	demonstrated	_	VBD	VBD	_	1	dep	_	_
9	that	_	IN	IN	_	20	mark	_	_
10	transfection	_	NN	NN	_	20	nsubj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	PIEC	_	NN	NN	_	14	nn	_	_
14	line	_	NN	NN	_	11	pobj	_	_
15	with	_	IN	IN	_	10	prep	_	_
16	full-length	_	JJ	JJ	_	19	amod	_	_
17	human	_	JJ	JJ	_	19	amod	_	_
18	CIITA	_	NN	NN	_	19	nn	_	_
19	constructs	_	NNS	NNS	_	15	pobj	_	_
20	resulted	_	VBD	VBD	_	8	ccomp	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	strong	_	JJ	JJ	_	23	amod	_	_
23	expression	_	NN	NN	_	21	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	SLA-DR	_	NN	NN	_	28	nn	_	_
26	and	_	CC	CC	_	25	cc	_	_
27	SLA-DQ	_	NN	NN	_	25	conj	_	_
28	antigens	_	NNS	NNS	_	24	pobj	_	_
29	,	_	,	,	_	20	punct	_	_
30	thus	_	RB	RB	_	31	advmod	_	_
31	establishing	_	VBG	VBG	_	20	xcomp	_	_
32	the	_	DT	DT	_	34	det	_	_
33	cross-species	_	JJ	JJ	_	34	amod	_	_
34	effectiveness	_	NN	NN	_	31	dobj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	human	_	JJ	JJ	_	37	amod	_	_
37	CIITA	_	NN	NN	_	35	pobj	_	_
38	in	_	IN	IN	_	34	prep	_	_
39	the	_	DT	DT	_	40	det	_	_
40	pig	_	NN	NN	_	38	pobj	_	_
41	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	5	det	_	_
2	mutated	_	VBN	VBN	_	5	amod	_	_
3	human	_	JJ	JJ	_	5	amod	_	_
4	CIITA	_	NN	NN	_	5	nn	_	_
5	constructs	_	NNS	NNS	_	10	nsubjpass	_	_
6	were	_	VBD	VBD	_	10	auxpass	_	_
7	,	_	,	,	_	10	punct	_	_
8	therefore	_	RB	RB	_	10	advmod	_	_
9	,	_	,	,	_	10	punct	_	_
10	tested	_	VBN	VBN	_	0	root	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	pig	_	NN	NN	_	11	pobj	_	_
14	.	_	.	.	_	10	punct	_	_

1	PIEC	_	NN	NN	_	2	nn	_	_
2	clones	_	NNS	NNS	_	10	nsubj	_	_
3	stably	_	RB	RB	_	4	advmod	_	_
4	transfected	_	VBN	VBN	_	2	vmod	_	_
5	with	_	IN	IN	_	4	prep	_	_
6	one	_	CD	CD	_	5	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	these	_	DT	DT	_	9	det	_	_
9	constructs	_	NNS	NNS	_	7	pobj	_	_
10	showed	_	VBD	VBD	_	0	root	_	_
11	up	_	RB	RB	_	13	quantmod	_	_
12	to	_	TO	TO	_	13	dep	_	_
13	99	_	CD	CD	_	14	dep	_	_
14	%	_	NN	NN	_	15	dep	_	_
15	suppression	_	NN	NN	_	10	dobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	SLA-DR	_	NN	NN	_	21	nn	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	SLA-DQ	_	NN	NN	_	17	conj	_	_
20	antigen	_	NN	NN	_	21	nn	_	_
21	induction	_	NN	NN	_	16	pobj	_	_
22	and	_	CC	CC	_	10	cc	_	_
23	marked	_	JJ	JJ	_	10	conj	_	_
24	suppression	_	NN	NN	_	23	dobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	SLA-DRA	_	NN	NN	_	28	nn	_	_
27	mRNA	_	NN	NN	_	28	nn	_	_
28	induction	_	NN	NN	_	25	pobj	_	_
29	.	_	.	.	_	10	punct	_	_

1	Moreover	_	RB	RB	_	11	advmod	_	_
2	,	_	,	,	_	11	punct	_	_
3	transient	_	JJ	JJ	_	4	amod	_	_
4	transfection	_	NN	NN	_	11	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	10	det	_	_
7	porcine	_	NN	NN	_	10	nn	_	_
8	B-cell	_	NN	NN	_	10	nn	_	_
9	line	_	NN	NN	_	10	nn	_	_
10	L23	_	NN	NN	_	5	pobj	_	_
11	showed	_	VBD	VBD	_	0	root	_	_
12	up	_	RB	RB	_	14	quantmod	_	_
13	to	_	TO	TO	_	14	dep	_	_
14	90	_	CD	CD	_	15	dep	_	_
15	%	_	NN	NN	_	16	dep	_	_
16	suppression	_	NN	NN	_	11	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	constitutive	_	JJ	JJ	_	19	amod	_	_
19	SLA-DR	_	NN	NN	_	17	pobj	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	SLA-DQ	_	NN	NN	_	23	nn	_	_
22	antigen	_	NN	NN	_	23	nn	_	_
23	expression	_	NN	NN	_	19	conj	_	_
24	in	_	IN	IN	_	16	prep	_	_
25	5-8	_	CD	CD	_	26	num	_	_
26	days	_	NNS	NNS	_	24	pobj	_	_
27	.	_	.	.	_	11	punct	_	_

1	In	_	IN	IN	_	14	prep	_	_
2	functional	_	JJ	JJ	_	3	amod	_	_
3	studies	_	NNS	NNS	_	1	pobj	_	_
4	,	_	,	,	_	14	punct	_	_
5	interferon-gamma-stimulated	_	JJ	JJ	_	7	amod	_	_
6	PIEC	_	NN	NN	_	7	nn	_	_
7	clones	_	NNS	NNS	_	14	nsubj	_	_
8	transfected	_	VBN	VBN	_	7	vmod	_	_
9	with	_	IN	IN	_	8	prep	_	_
10	this	_	DT	DT	_	13	det	_	_
11	mutated	_	VBN	VBN	_	13	amod	_	_
12	CIITA	_	NN	NN	_	13	nn	_	_
13	construct	_	NN	NN	_	9	pobj	_	_
14	failed	_	VBD	VBD	_	0	root	_	_
15	to	_	TO	TO	_	16	aux	_	_
16	stimulate	_	VB	VB	_	14	xcomp	_	_
17	purified	_	VBN	VBN	_	21	amod	_	_
18	human	_	JJ	JJ	_	21	amod	_	_
19	CD4+	_	JJ	JJ	_	21	amod	_	_
20	T	_	NN	NN	_	21	nn	_	_
21	lymphocytes	_	NNS	NNS	_	16	dobj	_	_
22	.	_	.	.	_	14	punct	_	_

1	CONCLUSION	_	NN	NN	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	Mutated	_	JJ	JJ	_	6	amod	_	_
4	human	_	JJ	JJ	_	6	amod	_	_
5	CIITA	_	NN	NN	_	6	nn	_	_
6	constructs	_	NNS	NNS	_	9	nsubj	_	_
7	are	_	VBP	VBP	_	9	cop	_	_
8	potent	_	JJ	JJ	_	9	amod	_	_
9	suppressors	_	NNS	NNS	_	1	dep	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	porcine	_	NN	NN	_	15	nn	_	_
12	MHC	_	NN	NN	_	15	nn	_	_
13	class	_	NN	NN	_	15	nn	_	_
14	II	_	CD	CD	_	15	num	_	_
15	expression	_	NN	NN	_	10	pobj	_	_
16	.	_	.	.	_	1	punct	_	_

1	Redox	_	NN	NN	_	2	nn	_	_
2	signals	_	NNS	NNS	_	0	root	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	NF-kappaB	_	NN	NN	_	5	nn	_	_
5	activation	_	NN	NN	_	2	conj	_	_
6	in	_	IN	IN	_	2	prep	_	_
7	T	_	NN	NN	_	8	nn	_	_
8	cells	_	NNS	NNS	_	6	pobj	_	_
9	.	_	.	.	_	2	punct	_	_

1	Accumulating	_	JJ	JJ	_	2	amod	_	_
2	data	_	NNS	NNS	_	10	nsubj	_	_
3	from	_	IN	IN	_	2	prep	_	_
4	a	_	DT	DT	_	5	det	_	_
5	number	_	NN	NN	_	3	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	laboratories	_	NNS	NNS	_	6	pobj	_	_
8	have	_	VBP	VBP	_	10	aux	_	_
9	recently	_	RB	RB	_	10	advmod	_	_
10	indicated	_	VBN	VBN	_	0	root	_	_
11	that	_	IN	IN	_	27	mark	_	_
12	the	_	DT	DT	_	13	det	_	_
13	response	_	NN	NN	_	27	nsubj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	transcription	_	NN	NN	_	17	nn	_	_
16	factor	_	NN	NN	_	17	nn	_	_
17	NF-kappaB	_	NN	NN	_	14	pobj	_	_
18	to	_	TO	TO	_	13	prep	_	_
19	alterations	_	NNS	NNS	_	18	pobj	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	23	det	_	_
22	redox	_	NN	NN	_	23	nn	_	_
23	homeostasis	_	NN	NN	_	20	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	cells	_	NNS	NNS	_	24	pobj	_	_
26	may	_	MD	MD	_	27	aux	_	_
27	play	_	VB	VB	_	10	ccomp	_	_
28	an	_	DT	DT	_	30	det	_	_
29	important	_	JJ	JJ	_	30	amod	_	_
30	role	_	NN	NN	_	27	dobj	_	_
31	in	_	IN	IN	_	27	prep	_	_
32	modulating	_	VBG	VBG	_	31	pcomp	_	_
33	immune	_	JJ	JJ	_	34	amod	_	_
34	function	_	NN	NN	_	32	dobj	_	_
35	.	_	.	.	_	10	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	activation	_	NN	NN	_	7	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	NF-kappaB	_	NN	NN	_	3	pobj	_	_
5	has	_	VBZ	VBZ	_	7	aux	_	_
6	been	_	VBN	VBN	_	7	auxpass	_	_
7	recognized	_	VBN	VBN	_	0	root	_	_
8	to	_	TO	TO	_	9	aux	_	_
9	regulate	_	VB	VB	_	7	xcomp	_	_
10	a	_	DT	DT	_	11	det	_	_
11	number	_	NN	NN	_	9	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	genes	_	NNS	NNS	_	12	pobj	_	_
14	necessary	_	JJ	JJ	_	11	amod	_	_
15	for	_	IN	IN	_	14	prep	_	_
16	normal	_	JJ	JJ	_	19	amod	_	_
17	T	_	NN	NN	_	19	nn	_	_
18	cell	_	NN	NN	_	19	nn	_	_
19	responses	_	NNS	NNS	_	15	pobj	_	_
20	including	_	VBG	VBG	_	19	prep	_	_
21	IL-2	_	NN	NN	_	20	pobj	_	_
22	,	_	,	,	_	21	punct	_	_
23	IL-6	_	NN	NN	_	21	conj	_	_
24	,	_	,	,	_	21	punct	_	_
25	IL-8	_	NN	NN	_	21	conj	_	_
26	,	_	,	,	_	21	punct	_	_
27	and	_	CC	CC	_	21	cc	_	_
28	several	_	JJ	JJ	_	32	amod	_	_
29	T	_	NN	NN	_	32	nn	_	_
30	cell	_	NN	NN	_	32	nn	_	_
31	surface	_	NN	NN	_	32	nn	_	_
32	receptors	_	NNS	NNS	_	21	conj	_	_
33	.	_	.	.	_	7	punct	_	_

1	Diminished	_	JJ	JJ	_	3	amod	_	_
2	NF-kappaB	_	NN	NN	_	3	nn	_	_
3	activity	_	NN	NN	_	6	nsubjpass	_	_
4	has	_	VBZ	VBZ	_	6	aux	_	_
5	been	_	VBN	VBN	_	6	auxpass	_	_
6	shown	_	VBN	VBN	_	0	root	_	_
7	to	_	TO	TO	_	8	aux	_	_
8	occur	_	VB	VB	_	6	xcomp	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	T	_	NN	NN	_	11	nn	_	_
11	cells	_	NNS	NNS	_	9	pobj	_	_
12	with	_	IN	IN	_	11	prep	_	_
13	aging	_	NN	NN	_	12	pobj	_	_
14	,	_	,	,	_	8	punct	_	_
15	suggesting	_	VBG	VBG	_	8	xcomp	_	_
16	that	_	IN	IN	_	22	mark	_	_
17	impaired	_	JJ	JJ	_	18	amod	_	_
18	activation	_	NN	NN	_	22	nsubj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	NF-kappaB	_	NN	NN	_	19	pobj	_	_
21	might	_	MD	MD	_	22	aux	_	_
22	occur	_	VB	VB	_	15	ccomp	_	_
23	during	_	IN	IN	_	22	prep	_	_
24	cellular	_	JJ	JJ	_	25	amod	_	_
25	senescence	_	NN	NN	_	23	pobj	_	_
26	.	_	.	.	_	6	punct	_	_

1	In	_	IN	IN	_	10	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	10	punct	_	_
4	aberrancies	_	NNS	NNS	_	10	nsubjpass	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	NF-kappaB	_	NN	NN	_	7	nn	_	_
7	activity	_	NN	NN	_	5	pobj	_	_
8	have	_	VBP	VBP	_	10	aux	_	_
9	been	_	VBN	VBN	_	10	auxpass	_	_
10	implicated	_	VBN	VBN	_	0	root	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	immunopathogenesis	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	diseases	_	NNS	NNS	_	14	pobj	_	_
16	involving	_	VBG	VBG	_	15	vmod	_	_
17	immune	_	JJ	JJ	_	20	amod	_	_
18	or	_	CC	CC	_	17	cc	_	_
19	inflammatory	_	JJ	JJ	_	17	conj	_	_
20	processes	_	NNS	NNS	_	16	dobj	_	_
21	such	_	JJ	JJ	_	22	mwe	_	_
22	as	_	IN	IN	_	20	prep	_	_
23	atherosclerosis	_	NN	NN	_	22	pobj	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	HIV-1	_	NN	NN	_	26	nn	_	_
26	infection	_	NN	NN	_	23	conj	_	_
27	.	_	.	.	_	10	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	role	_	NN	NN	_	25	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	H2O2	_	NN	NN	_	3	pobj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	other	_	JJ	JJ	_	9	amod	_	_
7	reactive	_	JJ	JJ	_	9	amod	_	_
8	oxygen	_	NN	NN	_	9	nn	_	_
9	species	_	NNS	NNS	_	4	conj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	ROS	_	NN	NN	_	9	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	as	_	IN	IN	_	2	prep	_	_
14	an	_	DT	DT	_	17	det	_	_
15	integratory	_	JJ	JJ	_	17	amod	_	_
16	secondary	_	JJ	JJ	_	17	amod	_	_
17	messenger	_	NN	NN	_	13	pobj	_	_
18	for	_	IN	IN	_	17	prep	_	_
19	divergent	_	JJ	JJ	_	22	amod	_	_
20	T	_	NN	NN	_	22	nn	_	_
21	cell	_	NN	NN	_	22	nn	_	_
22	signals	_	NNS	NNS	_	18	pobj	_	_
23	has	_	VBZ	VBZ	_	25	aux	_	_
24	been	_	VBN	VBN	_	25	auxpass	_	_
25	complicated	_	VBN	VBN	_	0	root	_	_
26	by	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	28	det	_	_
28	fact	_	NN	NN	_	26	pobj	_	_
29	that	_	IN	IN	_	39	mark	_	_
30	various	_	JJ	JJ	_	33	amod	_	_
31	T	_	NN	NN	_	33	nn	_	_
32	cell	_	NN	NN	_	33	nn	_	_
33	lines	_	NNS	NNS	_	39	nsubj	_	_
34	and	_	CC	CC	_	33	cc	_	_
35	peripheral	_	JJ	JJ	_	38	amod	_	_
36	blood	_	NN	NN	_	38	nn	_	_
37	T	_	NN	NN	_	38	nn	_	_
38	cells	_	NNS	NNS	_	33	conj	_	_
39	differ	_	VBP	VBP	_	28	ccomp	_	_
40	markedly	_	RB	RB	_	39	advmod	_	_
41	in	_	IN	IN	_	39	prep	_	_
42	the	_	DT	DT	_	43	det	_	_
43	levels	_	NNS	NNS	_	41	pobj	_	_
44	of	_	IN	IN	_	43	prep	_	_
45	NF-kappaB	_	NN	NN	_	46	nn	_	_
46	activation	_	NN	NN	_	44	pobj	_	_
47	induced	_	VBN	VBN	_	46	vmod	_	_
48	by	_	IN	IN	_	47	prep	_	_
49	oxidant	_	JJ	JJ	_	50	amod	_	_
50	stress	_	NN	NN	_	48	pobj	_	_
51	.	_	.	.	_	25	punct	_	_

1	Additionally	_	RB	RB	_	10	advmod	_	_
2	,	_	,	,	_	10	punct	_	_
3	proposed	_	JJ	JJ	_	4	amod	_	_
4	pathways	_	NNS	NNS	_	10	nsubjpass	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	NF-kappaB	_	NN	NN	_	7	nn	_	_
7	activation	_	NN	NN	_	5	pobj	_	_
8	have	_	VBP	VBP	_	10	aux	_	_
9	been	_	VBN	VBN	_	10	auxpass	_	_
10	based	_	VBN	VBN	_	0	root	_	_
11	on	_	IN	IN	_	10	prep	_	_
12	indirect	_	JJ	JJ	_	13	amod	_	_
13	evidence	_	NN	NN	_	11	pobj	_	_
14	provided	_	VBN	VBN	_	13	vmod	_	_
15	by	_	IN	IN	_	14	prep	_	_
16	experiments	_	NNS	NNS	_	15	pobj	_	_
17	which	_	WDT	WDT	_	18	nsubj	_	_
18	used	_	VBD	VBD	_	16	rcmod	_	_
19	antioxidants	_	NNS	NNS	_	18	dobj	_	_
20	to	_	TO	TO	_	21	aux	_	_
21	inhibit	_	VB	VB	_	18	vmod	_	_
22	active	_	JJ	JJ	_	24	amod	_	_
23	NF-kappaB	_	NN	NN	_	24	nn	_	_
24	formation	_	NN	NN	_	21	dobj	_	_
25	.	_	.	.	_	10	punct	_	_

1	Further	_	RB	RB	_	8	advmod	_	_
2	,	_	,	,	_	8	punct	_	_
3	complete	_	JJ	JJ	_	4	amod	_	_
4	activation	_	NN	NN	_	8	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	T	_	NN	NN	_	7	nn	_	_
7	cells	_	NNS	NNS	_	5	pobj	_	_
8	requires	_	VBZ	VBZ	_	0	root	_	_
9	at	_	IN	IN	_	11	quantmod	_	_
10	least	_	JJS	JJS	_	9	mwe	_	_
11	two	_	CD	CD	_	12	num	_	_
12	signals	_	NNS	NNS	_	8	dobj	_	_
13	,	_	,	,	_	12	punct	_	_
14	one	_	CD	CD	_	12	appos	_	_
15	that	_	IN	IN	_	16	nsubj	_	_
16	stimulates	_	VBZ	VBZ	_	14	rcmod	_	_
17	an	_	DT	DT	_	18	det	_	_
18	increase	_	NN	NN	_	16	dobj	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	intracellular	_	JJ	JJ	_	21	amod	_	_
21	calcium	_	NN	NN	_	19	pobj	_	_
22	and	_	CC	CC	_	14	cc	_	_
23	one	_	CD	CD	_	14	conj	_	_
24	that	_	WDT	WDT	_	25	nsubj	_	_
25	stimulates	_	VBZ	VBZ	_	23	rcmod	_	_
26	enzymatic	_	JJ	JJ	_	27	amod	_	_
27	processes	_	NNS	NNS	_	25	dobj	_	_
28	including	_	VBG	VBG	_	27	prep	_	_
29	kinases	_	NNS	NNS	_	28	pobj	_	_
30	.	_	.	.	_	8	punct	_	_

1	Similarly	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	substantial	_	JJ	JJ	_	4	amod	_	_
4	evidence	_	NN	NN	_	5	nsubj	_	_
5	indicates	_	VBZ	VBZ	_	0	root	_	_
6	that	_	IN	IN	_	11	mark	_	_
7	full	_	JJ	JJ	_	8	amod	_	_
8	activation	_	NN	NN	_	11	nsubj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	NF-kappaB	_	NN	NN	_	9	pobj	_	_
11	requires	_	VBZ	VBZ	_	5	ccomp	_	_
12	dual	_	JJ	JJ	_	13	amod	_	_
13	signals	_	NNS	NNS	_	11	dobj	_	_
14	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	ability	_	NN	NN	_	21	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	H2O2	_	NN	NN	_	3	pobj	_	_
5	or	_	CC	CC	_	4	cc	_	_
6	other	_	JJ	JJ	_	7	amod	_	_
7	ROS	_	NN	NN	_	4	conj	_	_
8	to	_	TO	TO	_	9	aux	_	_
9	induce	_	VB	VB	_	2	vmod	_	_
10	T	_	NN	NN	_	12	nn	_	_
11	cell	_	NN	NN	_	12	nn	_	_
12	signals	_	NNS	NNS	_	9	dobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	functional	_	JJ	JJ	_	15	amod	_	_
15	responses	_	NNS	NNS	_	12	conj	_	_
16	by	_	IN	IN	_	9	prep	_	_
17	these	_	DT	DT	_	19	det	_	_
18	two	_	CD	CD	_	19	num	_	_
19	mechanisms	_	NNS	NNS	_	16	pobj	_	_
20	is	_	VBZ	VBZ	_	21	auxpass	_	_
21	reviewed	_	VBN	VBN	_	0	root	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	the	_	DT	DT	_	25	det	_	_
24	specific	_	JJ	JJ	_	25	amod	_	_
25	response	_	NN	NN	_	35	nsubjpass	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	NF-kappaB	_	NN	NN	_	26	pobj	_	_
28	to	_	TO	TO	_	25	prep	_	_
29	redox	_	NN	NN	_	30	nn	_	_
30	changes	_	NNS	NNS	_	28	pobj	_	_
31	in	_	IN	IN	_	30	prep	_	_
32	T	_	NN	NN	_	33	nn	_	_
33	cells	_	NNS	NNS	_	31	pobj	_	_
34	is	_	VBZ	VBZ	_	35	auxpass	_	_
35	examined	_	VBN	VBN	_	21	conj	_	_
36	.	_	.	.	_	21	punct	_	_

1	Data	_	NNS	NNS	_	4	nsubjpass	_	_
2	are	_	VBP	VBP	_	4	auxpass	_	_
3	also	_	RB	RB	_	4	advmod	_	_
4	presented	_	VBN	VBN	_	0	root	_	_
5	to	_	TO	TO	_	6	aux	_	_
6	suggest	_	VB	VB	_	4	xcomp	_	_
7	that	_	IN	IN	_	16	mark	_	_
8	the	_	DT	DT	_	10	det	_	_
9	redox	_	NN	NN	_	10	nn	_	_
10	regulation	_	NN	NN	_	16	nsubj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	NF-kappaB	_	NN	NN	_	13	nn	_	_
13	activation	_	NN	NN	_	11	pobj	_	_
14	may	_	MD	MD	_	16	aux	_	_
15	be	_	VB	VB	_	16	cop	_	_
16	relevant	_	JJ	JJ	_	6	ccomp	_	_
17	to	_	TO	TO	_	16	prep	_	_
18	immune-related	_	JJ	JJ	_	19	amod	_	_
19	diseases	_	NNS	NNS	_	17	pobj	_	_
20	and	_	CC	CC	_	17	cc	_	_
21	to	_	TO	TO	_	17	conj	_	_
22	aging	_	NN	NN	_	21	pobj	_	_
23	.	_	.	.	_	4	punct	_	_

1	Ciprofloxacin	_	NN	NN	_	2	nsubj	_	_
2	induces	_	VBZ	VBZ	_	0	root	_	_
3	an	_	DT	DT	_	6	det	_	_
4	immunomodulatory	_	JJ	JJ	_	6	amod	_	_
5	stress	_	NN	NN	_	6	nn	_	_
6	response	_	NN	NN	_	2	dobj	_	_
7	in	_	IN	IN	_	2	prep	_	_
8	human	_	JJ	JJ	_	10	amod	_	_
9	T	_	NN	NN	_	10	nn	_	_
10	lymphocytes	_	NNS	NNS	_	7	pobj	_	_
11	.	_	.	.	_	2	punct	_	_

1	Exposure	_	NN	NN	_	8	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	cells	_	NNS	NNS	_	2	pobj	_	_
4	to	_	TO	TO	_	1	prep	_	_
5	adverse	_	JJ	JJ	_	7	amod	_	_
6	environmental	_	JJ	JJ	_	7	amod	_	_
7	conditions	_	NNS	NNS	_	4	pobj	_	_
8	invokes	_	VBZ	VBZ	_	0	root	_	_
9	a	_	DT	DT	_	12	det	_	_
10	genetically	_	RB	RB	_	11	advmod	_	_
11	programmed	_	VBN	VBN	_	12	amod	_	_
12	series	_	NNS	NNS	_	8	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	events	_	NNS	NNS	_	13	pobj	_	_
15	resulting	_	VBG	VBG	_	12	vmod	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	18	det	_	_
18	induction	_	NN	NN	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	specific	_	JJ	JJ	_	21	amod	_	_
21	genes	_	NNS	NNS	_	19	pobj	_	_
22	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	fluoroquinolone	_	NN	NN	_	4	nn	_	_
3	antibiotic	_	JJ	JJ	_	4	amod	_	_
4	ciprofloxacin	_	NN	NN	_	8	nsubjpass	_	_
5	has	_	VBZ	VBZ	_	8	aux	_	_
6	recently	_	RB	RB	_	8	advmod	_	_
7	been	_	VBN	VBN	_	8	auxpass	_	_
8	reported	_	VBN	VBN	_	0	root	_	_
9	to	_	TO	TO	_	10	aux	_	_
10	upregulate	_	VB	VB	_	8	xcomp	_	_
11	interleukin-2	_	NN	NN	_	16	nn	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	IL-2	_	NN	NN	_	11	appos	_	_
14	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
15	gene	_	NN	NN	_	16	nn	_	_
16	induction	_	NN	NN	_	10	dobj	_	_
17	.	_	.	.	_	8	punct	_	_

1	In	_	IN	IN	_	29	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	present	_	JJ	JJ	_	4	amod	_	_
4	investigation	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	29	punct	_	_
6	the	_	DT	DT	_	7	det	_	_
7	effect	_	NN	NN	_	29	nsubjpass	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	ciprofloxacin	_	NN	NN	_	8	pobj	_	_
10	at	_	IN	IN	_	7	prep	_	_
11	supratherapeutic	_	JJ	JJ	_	12	amod	_	_
12	concentrations	_	NNS	NNS	_	10	pobj	_	_
13	on	_	IN	IN	_	7	prep	_	_
14	immediate-early	_	JJ	JJ	_	21	amod	_	_
15	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
16	&lt;	_	JJR	JJR	_	17	quantmod	_	_
17	2	_	CD	CD	_	18	dep	_	_
18	h	_	NN	NN	_	21	dep	_	_
19	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
20	gene	_	NN	NN	_	21	nn	_	_
21	expression	_	NN	NN	_	13	pobj	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	primary	_	JJ	JJ	_	27	amod	_	_
24	human	_	JJ	JJ	_	27	amod	_	_
25	peripheral	_	JJ	JJ	_	27	amod	_	_
26	blood	_	NN	NN	_	27	nn	_	_
27	lymphocytes	_	NNS	NNS	_	22	pobj	_	_
28	was	_	VBD	VBD	_	29	auxpass	_	_
29	studied	_	VBN	VBN	_	0	root	_	_
30	with	_	IN	IN	_	29	prep	_	_
31	Northern	_	NN	NN	_	32	nn	_	_
32	blots	_	NNS	NNS	_	30	pobj	_	_
33	.	_	.	.	_	29	punct	_	_

1	In	_	IN	IN	_	24	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	24	punct	_	_
4	transcriptional	_	JJ	JJ	_	5	amod	_	_
5	activity	_	NN	NN	_	24	nsubjpass	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	IL-2	_	NN	NN	_	10	nn	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	metallothionein	_	NN	NN	_	7	conj	_	_
10	enhancer	_	NN	NN	_	6	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	promoter	_	NN	NN	_	13	nn	_	_
13	regions	_	NNS	NNS	_	10	conj	_	_
14	and	_	CC	CC	_	10	cc	_	_
15	transcription	_	NN	NN	_	16	nn	_	_
16	factors	_	NNS	NNS	_	10	conj	_	_
17	AP-1	_	NN	NN	_	16	dep	_	_
18	,	_	,	,	_	17	punct	_	_
19	NF-kappaB	_	NN	NN	_	17	conj	_	_
20	,	_	,	,	_	17	punct	_	_
21	and	_	CC	CC	_	17	cc	_	_
22	NF-AT	_	NN	NN	_	17	conj	_	_
23	were	_	VBD	VBD	_	24	auxpass	_	_
24	analyzed	_	VBN	VBN	_	0	root	_	_
25	by	_	IN	IN	_	24	prep	_	_
26	chloramphenicol	_	NN	NN	_	27	nn	_	_
27	acetyltransferase	_	NN	NN	_	25	pobj	_	_
28	-LRB-	_	-LRB-	-LRB-	_	29	punct	_	_
29	CAT	_	NN	NN	_	27	appos	_	_
30	-RRB-	_	-RRB-	-RRB-	_	29	punct	_	_
31	and	_	CC	CC	_	27	cc	_	_
32	electrophoretic	_	JJ	JJ	_	35	amod	_	_
33	mobility	_	NN	NN	_	35	nn	_	_
34	shift	_	NN	NN	_	35	nn	_	_
35	assays	_	NNS	NNS	_	27	conj	_	_
36	,	_	,	,	_	24	punct	_	_
37	respectively	_	RB	RB	_	24	advmod	_	_
38	.	_	.	.	_	24	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	concentration	_	NN	NN	_	16	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	c-fos	_	NN	NN	_	10	nn	_	_
5	,	_	,	,	_	10	punct	_	_
6	c-jun	_	NN	NN	_	10	dep	_	_
7	,	_	,	,	_	10	punct	_	_
8	c-myc	_	NN	NN	_	10	dep	_	_
9	,	_	,	,	_	10	punct	_	_
10	junB	_	NN	NN	_	3	pobj	_	_
11	,	_	,	,	_	10	punct	_	_
12	and	_	CC	CC	_	10	cc	_	_
13	fra-1	_	NN	NN	_	14	nn	_	_
14	mRNAs	_	NNS	NNS	_	10	conj	_	_
15	was	_	VBD	VBD	_	16	auxpass	_	_
16	increased	_	VBN	VBN	_	0	root	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	activated	_	VBN	VBN	_	21	amod	_	_
19	peripheral	_	JJ	JJ	_	21	amod	_	_
20	blood	_	NN	NN	_	21	nn	_	_
21	lymphocytes	_	NNS	NNS	_	17	pobj	_	_
22	incubated	_	VBN	VBN	_	21	vmod	_	_
23	with	_	IN	IN	_	22	prep	_	_
24	ciprofloxacin	_	NN	NN	_	23	pobj	_	_
25	compared	_	VBN	VBN	_	16	prep	_	_
26	to	_	TO	TO	_	25	pcomp	_	_
27	that	_	DT	DT	_	26	pobj	_	_
28	in	_	IN	IN	_	27	prep	_	_
29	untreated	_	JJ	JJ	_	30	amod	_	_
30	controls	_	NNS	NNS	_	28	pobj	_	_
31	.	_	.	.	_	16	punct	_	_

1	Ciprofloxacin	_	NN	NN	_	2	nsubj	_	_
2	increased	_	VBD	VBD	_	0	root	_	_
3	CAT	_	NN	NN	_	4	nn	_	_
4	activity	_	NN	NN	_	2	dobj	_	_
5	in	_	IN	IN	_	2	prep	_	_
6	stimulated	_	VBN	VBN	_	7	amod	_	_
7	lymphocytes	_	NNS	NNS	_	5	pobj	_	_
8	transfected	_	VBN	VBN	_	7	vmod	_	_
9	with	_	IN	IN	_	8	prep	_	_
10	plasmids	_	NNS	NNS	_	9	pobj	_	_
11	containing	_	VBG	VBG	_	10	vmod	_	_
12	either	_	CC	CC	_	14	preconj	_	_
13	the	_	DT	DT	_	14	det	_	_
14	IL-2	_	NN	NN	_	11	dobj	_	_
15	or	_	CC	CC	_	14	cc	_	_
16	metallothionein	_	NN	NN	_	17	nn	_	_
17	enhancer	_	NN	NN	_	14	conj	_	_
18	.	_	.	.	_	2	punct	_	_

1	Furthermore	_	RB	RB	_	12	advmod	_	_
2	,	_	,	,	_	12	punct	_	_
3	among	_	IN	IN	_	12	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	transcription	_	NN	NN	_	6	nn	_	_
6	factors	_	NNS	NNS	_	3	pobj	_	_
7	tested	_	VBN	VBN	_	6	vmod	_	_
8	,	_	,	,	_	12	punct	_	_
9	AP-1	_	NN	NN	_	10	nn	_	_
10	activity	_	NN	NN	_	12	nsubjpass	_	_
11	was	_	VBD	VBD	_	12	auxpass	_	_
12	increased	_	VBN	VBN	_	0	root	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	stimulated	_	VBN	VBN	_	18	amod	_	_
15	purified	_	VBN	VBN	_	18	amod	_	_
16	T	_	NN	NN	_	18	nn	_	_
17	helper	_	NN	NN	_	18	nn	_	_
18	lymphocytes	_	NNS	NNS	_	13	pobj	_	_
19	incubated	_	VBN	VBN	_	18	vmod	_	_
20	with	_	IN	IN	_	19	prep	_	_
21	ciprofloxacin	_	NN	NN	_	20	pobj	_	_
22	compared	_	VBN	VBN	_	12	prep	_	_
23	to	_	TO	TO	_	22	pcomp	_	_
24	drug-free	_	JJ	JJ	_	25	amod	_	_
25	controls	_	NNS	NNS	_	23	pobj	_	_
26	.	_	.	.	_	12	punct	_	_

1	Taken	_	VBN	VBN	_	5	vmod	_	_
2	together	_	RB	RB	_	1	advmod	_	_
3	,	_	,	,	_	5	punct	_	_
4	ciprofloxacin	_	NN	NN	_	5	nsubj	_	_
5	increased	_	VBD	VBD	_	0	root	_	_
6	the	_	DT	DT	_	7	det	_	_
7	levels	_	NNS	NNS	_	5	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	immediate-early	_	JJ	JJ	_	10	amod	_	_
10	transcripts	_	NNS	NNS	_	8	pobj	_	_
11	,	_	,	,	_	5	punct	_	_
12	enhanced	_	VBD	VBD	_	5	conj	_	_
13	IL-2	_	NN	NN	_	17	nn	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	metallothionein	_	NN	NN	_	13	conj	_	_
16	promoter	_	NN	NN	_	17	nn	_	_
17	induction	_	NN	NN	_	12	dobj	_	_
18	,	_	,	,	_	5	punct	_	_
19	and	_	CC	CC	_	5	cc	_	_
20	upregulated	_	VBD	VBD	_	5	conj	_	_
21	AP-1	_	NN	NN	_	22	nn	_	_
22	concentrations	_	NNS	NNS	_	20	dobj	_	_
23	in	_	IN	IN	_	5	prep	_	_
24	primary	_	JJ	JJ	_	25	amod	_	_
25	lymphocytes	_	NNS	NNS	_	23	pobj	_	_
26	,	_	,	,	_	5	punct	_	_
27	reflecting	_	VBG	VBG	_	5	xcomp	_	_
28	a	_	DT	DT	_	29	det	_	_
29	program	_	NN	NN	_	27	dobj	_	_
30	commonly	_	RB	RB	_	31	advmod	_	_
31	observed	_	VBN	VBN	_	29	vmod	_	_
32	in	_	IN	IN	_	31	prep	_	_
33	mammalian	_	JJ	JJ	_	35	amod	_	_
34	stress	_	NN	NN	_	35	nn	_	_
35	responses	_	NNS	NNS	_	32	pobj	_	_
36	.	_	.	.	_	5	punct	_	_

1	Recognition	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	herpes	_	NN	NN	_	9	nn	_	_
4	simplex	_	NN	NN	_	9	nn	_	_
5	virus	_	NN	NN	_	9	nn	_	_
6	type	_	NN	NN	_	9	nn	_	_
7	2	_	CD	CD	_	9	num	_	_
8	tegument	_	NN	NN	_	9	nn	_	_
9	proteins	_	NNS	NNS	_	2	pobj	_	_
10	by	_	IN	IN	_	1	prep	_	_
11	CD4	_	NN	NN	_	13	nn	_	_
12	T	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	10	pobj	_	_
14	infiltrating	_	VBG	VBG	_	13	vmod	_	_
15	human	_	JJ	JJ	_	18	amod	_	_
16	genital	_	JJ	JJ	_	18	amod	_	_
17	herpes	_	NN	NN	_	18	nn	_	_
18	lesions	_	NNS	NNS	_	14	dobj	_	_
19	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	5	det	_	_
2	local	_	JJ	JJ	_	5	amod	_	_
3	cellular	_	JJ	JJ	_	5	amod	_	_
4	immune	_	JJ	JJ	_	5	amod	_	_
5	response	_	NN	NN	_	14	nsubj	_	_
6	to	_	TO	TO	_	5	prep	_	_
7	herpes	_	NN	NN	_	9	nn	_	_
8	simplex	_	NN	NN	_	9	nn	_	_
9	virus	_	NN	NN	_	6	pobj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	HSV	_	NN	NN	_	9	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	is	_	VBZ	VBZ	_	14	cop	_	_
14	important	_	JJ	JJ	_	0	root	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	17	det	_	_
17	control	_	NN	NN	_	15	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	recurrent	_	JJ	JJ	_	21	amod	_	_
20	HSV	_	NN	NN	_	21	nn	_	_
21	infection	_	NN	NN	_	18	pobj	_	_
22	.	_	.	.	_	14	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	antiviral	_	JJ	JJ	_	3	amod	_	_
3	functions	_	NNS	NNS	_	10	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	infiltrating	_	VBG	VBG	_	8	amod	_	_
6	CD4-bearing	_	JJ	JJ	_	8	amod	_	_
7	T	_	NN	NN	_	8	nn	_	_
8	cells	_	NNS	NNS	_	4	pobj	_	_
9	may	_	MD	MD	_	10	aux	_	_
10	include	_	VBP	VBP	_	0	root	_	_
11	cytotoxicity	_	NN	NN	_	10	dobj	_	_
12	,	_	,	,	_	11	punct	_	_
13	inhibition	_	NN	NN	_	11	conj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	viral	_	JJ	JJ	_	16	amod	_	_
16	growth	_	NN	NN	_	14	pobj	_	_
17	,	_	,	,	_	11	punct	_	_
18	lymphokine	_	NN	NN	_	19	nn	_	_
19	secretion	_	NN	NN	_	11	conj	_	_
20	,	_	,	,	_	11	punct	_	_
21	and	_	CC	CC	_	11	cc	_	_
22	support	_	NN	NN	_	11	conj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	humoral	_	JJ	JJ	_	27	amod	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	CD8	_	NN	NN	_	24	conj	_	_
27	responses	_	NNS	NNS	_	23	pobj	_	_
28	.	_	.	.	_	10	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	antigens	_	NNS	NNS	_	16	nsubj	_	_
3	recognized	_	VBN	VBN	_	2	vmod	_	_
4	by	_	IN	IN	_	3	prep	_	_
5	many	_	JJ	JJ	_	9	amod	_	_
6	HSV-specific	_	JJ	JJ	_	9	amod	_	_
7	CD4	_	NN	NN	_	9	nn	_	_
8	T	_	NN	NN	_	9	nn	_	_
9	cells	_	NNS	NNS	_	10	nsubj	_	_
10	localizing	_	VBG	VBG	_	4	pcomp	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	genital	_	JJ	JJ	_	14	amod	_	_
13	HSV-2	_	NN	NN	_	14	nn	_	_
14	lesions	_	NNS	NNS	_	11	pobj	_	_
15	are	_	VBP	VBP	_	16	cop	_	_
16	unknown	_	JJ	JJ	_	0	root	_	_
17	.	_	.	.	_	16	punct	_	_

1	T	_	NN	NN	_	2	nn	_	_
2	cells	_	NNS	NNS	_	17	nsubjpass	_	_
3	recognizing	_	VBG	VBG	_	2	vmod	_	_
4	antigens	_	NNS	NNS	_	3	dobj	_	_
5	encoded	_	VBN	VBN	_	4	vmod	_	_
6	within	_	IN	IN	_	5	prep	_	_
7	map	_	NN	NN	_	8	nn	_	_
8	units	_	NNS	NNS	_	6	pobj	_	_
9	0.67	_	CD	CD	_	8	dep	_	_
10	to	_	TO	TO	_	9	dep	_	_
11	0.73	_	CD	CD	_	9	dep	_	_
12	of	_	IN	IN	_	8	prep	_	_
13	HSV	_	NN	NN	_	14	nn	_	_
14	DNA	_	NN	NN	_	12	pobj	_	_
15	are	_	VBP	VBP	_	17	auxpass	_	_
16	frequently	_	RB	RB	_	17	advmod	_	_
17	recovered	_	VBN	VBN	_	0	root	_	_
18	from	_	IN	IN	_	17	prep	_	_
19	herpetic	_	JJ	JJ	_	20	amod	_	_
20	lesions	_	NNS	NNS	_	18	pobj	_	_
21	.	_	.	.	_	17	punct	_	_

1	Expression	_	NN	NN	_	2	nn	_	_
2	cloning	_	NN	NN	_	9	nsubj	_	_
3	with	_	IN	IN	_	2	prep	_	_
4	this	_	DT	DT	_	5	det	_	_
5	region	_	NN	NN	_	3	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	DNA	_	NN	NN	_	6	pobj	_	_
8	now	_	RB	RB	_	9	advmod	_	_
9	shows	_	VBZ	VBZ	_	0	root	_	_
10	that	_	IN	IN	_	30	mark	_	_
11	tegument	_	NN	NN	_	13	nn	_	_
12	protein	_	NN	NN	_	13	nn	_	_
13	VP22	_	NN	NN	_	30	nsubj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	the	_	DT	DT	_	17	det	_	_
16	viral	_	JJ	JJ	_	17	amod	_	_
17	dUTPase	_	NN	NN	_	13	conj	_	_
18	,	_	,	,	_	13	punct	_	_
19	encoded	_	VBN	VBN	_	13	vmod	_	_
20	by	_	IN	IN	_	19	prep	_	_
21	genes	_	NNS	NNS	_	20	pobj	_	_
22	UL49	_	NN	NN	_	21	dep	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	UL50	_	NN	NN	_	22	conj	_	_
25	,	_	,	,	_	19	punct	_	_
26	respectively	_	RB	RB	_	19	advmod	_	_
27	,	_	,	,	_	13	punct	_	_
28	are	_	VBP	VBP	_	30	cop	_	_
29	T-cell	_	NN	NN	_	30	nn	_	_
30	antigens	_	NNS	NNS	_	9	ccomp	_	_
31	.	_	.	.	_	9	punct	_	_

1	Separate	_	JJ	JJ	_	2	amod	_	_
2	epitopes	_	NNS	NNS	_	6	nsubjpass	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	VP22	_	NN	NN	_	3	pobj	_	_
5	were	_	VBD	VBD	_	6	auxpass	_	_
6	defined	_	VBN	VBN	_	0	root	_	_
7	for	_	IN	IN	_	6	prep	_	_
8	T-cell	_	NN	NN	_	9	nn	_	_
9	clones	_	NNS	NNS	_	7	pobj	_	_
10	from	_	IN	IN	_	9	prep	_	_
11	each	_	DT	DT	_	10	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	three	_	CD	CD	_	14	num	_	_
14	patients	_	NNS	NNS	_	12	pobj	_	_
15	.	_	.	.	_	6	punct	_	_

1	Reactivity	_	NN	NN	_	10	nsubjpass	_	_
2	with	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	tegument	_	JJ	JJ	_	5	amod	_	_
5	protein	_	NN	NN	_	2	pobj	_	_
6	encoded	_	VBN	VBN	_	5	vmod	_	_
7	by	_	IN	IN	_	6	prep	_	_
8	UL21	_	NN	NN	_	7	pobj	_	_
9	was	_	VBD	VBD	_	10	auxpass	_	_
10	identified	_	VBN	VBN	_	0	root	_	_
11	for	_	IN	IN	_	10	prep	_	_
12	an	_	DT	DT	_	14	det	_	_
13	additional	_	JJ	JJ	_	14	amod	_	_
14	patient	_	NN	NN	_	11	pobj	_	_
15	.	_	.	.	_	10	punct	_	_

1	Three	_	CD	CD	_	3	num	_	_
2	new	_	JJ	JJ	_	3	amod	_	_
3	epitopes	_	NNS	NNS	_	5	nsubjpass	_	_
4	were	_	VBD	VBD	_	5	auxpass	_	_
5	identified	_	VBN	VBN	_	0	root	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	VP16	_	NN	NN	_	6	pobj	_	_
8	,	_	,	,	_	7	punct	_	_
9	a	_	DT	DT	_	11	det	_	_
10	tegument	_	JJ	JJ	_	11	amod	_	_
11	protein	_	NN	NN	_	7	appos	_	_
12	associated	_	VBN	VBN	_	11	vmod	_	_
13	with	_	IN	IN	_	12	prep	_	_
14	VP22	_	NN	NN	_	13	pobj	_	_
15	.	_	.	.	_	5	punct	_	_

1	Some	_	DT	DT	_	5	det	_	_
2	tegument-specific	_	JJ	JJ	_	5	amod	_	_
3	CD4	_	NN	NN	_	5	nn	_	_
4	T-cell	_	NN	NN	_	5	nn	_	_
5	clones	_	NNS	NNS	_	6	nsubj	_	_
6	exhibited	_	VBD	VBD	_	0	root	_	_
7	cytotoxic	_	JJ	JJ	_	8	amod	_	_
8	activity	_	NN	NN	_	6	dobj	_	_
9	against	_	IN	IN	_	6	prep	_	_
10	HSV-infected	_	JJ	JJ	_	11	amod	_	_
11	cells	_	NNS	NNS	_	9	pobj	_	_
12	.	_	.	.	_	6	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	10	mark	_	_
5	herpes	_	NN	NN	_	8	nn	_	_
6	simplex	_	NN	NN	_	8	nn	_	_
7	tegument	_	NN	NN	_	8	nn	_	_
8	proteins	_	NNS	NNS	_	10	nsubjpass	_	_
9	are	_	VBP	VBP	_	10	auxpass	_	_
10	processed	_	VBN	VBN	_	3	ccomp	_	_
11	for	_	IN	IN	_	10	prep	_	_
12	antigen	_	NN	NN	_	13	nn	_	_
13	presentation	_	NN	NN	_	11	pobj	_	_
14	in	_	FW	FW	_	15	nn	_	_
15	vivo	_	FW	FW	_	10	advmod	_	_
16	and	_	CC	CC	_	10	cc	_	_
17	are	_	VBP	VBP	_	20	cop	_	_
18	possible	_	JJ	JJ	_	20	amod	_	_
19	candidate	_	NN	NN	_	20	nn	_	_
20	compounds	_	NNS	NNS	_	10	conj	_	_
21	for	_	IN	IN	_	20	prep	_	_
22	herpes	_	NN	NN	_	24	nn	_	_
23	simplex	_	NN	NN	_	24	nn	_	_
24	vaccines	_	NNS	NNS	_	21	pobj	_	_
25	.	_	.	.	_	3	punct	_	_

1	Human	_	JJ	JJ	_	4	amod	_	_
2	15-lipoxygenase	_	NN	NN	_	4	nn	_	_
3	gene	_	NN	NN	_	4	nn	_	_
4	promoter	_	NN	NN	_	0	root	_	_
5	:	_	:	:	_	4	punct	_	_
6	analysis	_	NN	NN	_	4	dep	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	identification	_	NN	NN	_	6	conj	_	_
9	of	_	IN	IN	_	6	prep	_	_
10	DNA	_	NN	NN	_	12	nn	_	_
11	binding	_	NN	NN	_	12	nn	_	_
12	sites	_	NNS	NNS	_	9	pobj	_	_
13	for	_	IN	IN	_	12	prep	_	_
14	IL-13-induced	_	JJ	JJ	_	16	amod	_	_
15	regulatory	_	JJ	JJ	_	16	amod	_	_
16	factors	_	NNS	NNS	_	13	pobj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	monocytes	_	NNS	NNS	_	17	pobj	_	_
19	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	4	mark	_	_
2	order	_	NN	NN	_	4	dep	_	_
3	to	_	TO	TO	_	4	dep	_	_
4	study	_	VB	VB	_	14	advcl	_	_
5	the	_	DT	DT	_	7	det	_	_
6	transcriptional	_	JJ	JJ	_	7	amod	_	_
7	control	_	NN	NN	_	4	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	15-LO	_	NN	NN	_	10	nn	_	_
10	expression	_	NN	NN	_	8	pobj	_	_
11	,	_	,	,	_	14	punct	_	_
12	we	_	PRP	PRP	_	14	nsubj	_	_
13	have	_	VBP	VBP	_	14	aux	_	_
14	cloned	_	VBN	VBN	_	0	root	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	sequenced	_	VBD	VBD	_	14	conj	_	_
17	the	_	DT	DT	_	21	det	_	_
18	human	_	JJ	JJ	_	21	amod	_	_
19	15-LO	_	NN	NN	_	21	nn	_	_
20	promoter	_	NN	NN	_	21	nn	_	_
21	region	_	NN	NN	_	14	dobj	_	_
22	.	_	.	.	_	14	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	15-LO	_	NN	NN	_	3	nn	_	_
3	promoter	_	NN	NN	_	5	nsubjpass	_	_
4	is	_	VBZ	VBZ	_	5	auxpass	_	_
5	associated	_	VBN	VBN	_	0	root	_	_
6	with	_	IN	IN	_	5	prep	_	_
7	a	_	DT	DT	_	9	det	_	_
8	CpG	_	NN	NN	_	9	nn	_	_
9	island	_	NN	NN	_	6	pobj	_	_
10	at	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	5'-end	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	gene	_	NN	NN	_	13	pobj	_	_
16	,	_	,	,	_	5	punct	_	_
17	and	_	CC	CC	_	5	cc	_	_
18	sequence	_	NN	NN	_	19	nn	_	_
19	analysis	_	NN	NN	_	20	nsubj	_	_
20	reveals	_	VBZ	VBZ	_	5	conj	_	_
21	putative	_	JJ	JJ	_	22	amod	_	_
22	Sp1	_	NN	NN	_	20	dobj	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	Ap2	_	NN	NN	_	26	nn	_	_
25	binding	_	NN	NN	_	26	nn	_	_
26	site/s	_	NNS	NNS	_	22	conj	_	_
27	and	_	CC	CC	_	22	cc	_	_
28	absence	_	NN	NN	_	22	conj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	TATA	_	NN	NN	_	33	nn	_	_
31	or	_	CC	CC	_	30	cc	_	_
32	CAAT	_	NN	NN	_	30	conj	_	_
33	motifs	_	NNS	NNS	_	29	pobj	_	_
34	.	_	.	.	_	5	punct	_	_

1	Transcription	_	NN	NN	_	3	nsubjpass	_	_
2	is	_	VBZ	VBZ	_	3	auxpass	_	_
3	initiated	_	VBN	VBN	_	0	root	_	_
4	at	_	IN	IN	_	3	prep	_	_
5	one	_	CD	CD	_	7	num	_	_
6	major	_	JJ	JJ	_	7	amod	_	_
7	site	_	NN	NN	_	4	pobj	_	_
8	.	_	.	.	_	3	punct	_	_

1	Using	_	VBG	VBG	_	7	vmod	_	_
2	deletion	_	NN	NN	_	3	nn	_	_
3	constructs	_	NNS	NNS	_	1	dobj	_	_
4	,	_	,	,	_	7	punct	_	_
5	we	_	PRP	PRP	_	7	nsubj	_	_
6	have	_	VBP	VBP	_	7	aux	_	_
7	defined	_	VBN	VBN	_	0	root	_	_
8	an	_	DT	DT	_	11	det	_	_
9	active	_	JJ	JJ	_	11	amod	_	_
10	promoter	_	NN	NN	_	11	nn	_	_
11	region	_	NN	NN	_	7	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	1056	_	CD	CD	_	12	pobj	_	_
14	bp	_	NN	NN	_	13	dep	_	_
15	.	_	.	.	_	7	punct	_	_

1	Gel-shift	_	NN	NN	_	2	nn	_	_
2	assays	_	NNS	NNS	_	3	nsubj	_	_
3	revealed	_	VBD	VBD	_	0	root	_	_
4	that	_	IN	IN	_	22	mark	_	_
5	transcriptional	_	JJ	JJ	_	8	amod	_	_
6	factor	_	NN	NN	_	8	nn	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	s	_	NNS	NNS	_	22	nsubj	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	induced	_	VBN	VBN	_	8	vmod	_	_
11	only	_	RB	RB	_	12	advmod	_	_
12	in	_	IN	IN	_	10	prep	_	_
13	response	_	NN	NN	_	12	dep	_	_
14	to	_	TO	TO	_	12	dep	_	_
15	IL-13	_	NN	NN	_	16	nn	_	_
16	treatment	_	NN	NN	_	12	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	human	_	JJ	JJ	_	21	amod	_	_
19	peripheral	_	JJ	JJ	_	21	amod	_	_
20	blood	_	NN	NN	_	21	nn	_	_
21	monocytes	_	NNS	NNS	_	17	pobj	_	_
22	bind	_	VBP	VBP	_	3	ccomp	_	_
23	to	_	TO	TO	_	22	prep	_	_
24	the	_	DT	DT	_	27	det	_	_
25	15-LO	_	NN	NN	_	27	nn	_	_
26	promoter	_	NN	NN	_	27	nn	_	_
27	DNA	_	NN	NN	_	23	pobj	_	_
28	.	_	.	.	_	3	punct	_	_

1	Two	_	CD	CD	_	2	num	_	_
2	regions	_	NNS	NNS	_	23	nsubj	_	_
3	,	_	,	,	_	2	punct	_	_
4	DP1	_	NN	NN	_	2	appos	_	_
5	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
6	-140	_	CD	CD	_	9	num	_	_
7	to	_	TO	TO	_	9	dep	_	_
8	-92	_	CD	CD	_	9	num	_	_
9	bp	_	NN	NN	_	4	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	and	_	CC	CC	_	4	cc	_	_
12	DP2	_	NN	NN	_	4	conj	_	_
13	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
14	-353	_	CD	CD	_	17	num	_	_
15	to	_	TO	TO	_	17	dep	_	_
16	-304	_	CD	CD	_	17	num	_	_
17	bp	_	NN	NN	_	12	appos	_	_
18	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
19	of	_	IN	IN	_	4	prep	_	_
20	the	_	DT	DT	_	21	det	_	_
21	promoter	_	NN	NN	_	19	pobj	_	_
22	were	_	VBD	VBD	_	23	cop	_	_
23	essential	_	JJ	JJ	_	0	root	_	_
24	for	_	IN	IN	_	23	prep	_	_
25	transcription	_	NN	NN	_	24	pobj	_	_
26	in	_	IN	IN	_	25	prep	_	_
27	HeLa	_	NN	NN	_	28	nn	_	_
28	cells	_	NNS	NNS	_	26	pobj	_	_
29	and	_	CC	CC	_	28	cc	_	_
30	human	_	JJ	JJ	_	32	amod	_	_
31	peripheral	_	JJ	JJ	_	32	amod	_	_
32	monocytes	_	NNS	NNS	_	28	conj	_	_
33	.	_	.	.	_	23	punct	_	_

1	Hela	_	NN	NN	_	3	nn	_	_
2	nuclear	_	JJ	JJ	_	3	amod	_	_
3	extracts	_	NNS	NNS	_	4	nsubj	_	_
4	contained	_	VBD	VBD	_	0	root	_	_
5	a	_	DT	DT	_	10	det	_	_
6	specific	_	JJ	JJ	_	10	amod	_	_
7	nuclear	_	JJ	JJ	_	10	amod	_	_
8	factor	_	NN	NN	_	10	nn	_	_
9	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
10	s	_	NNS	NNS	_	4	dobj	_	_
11	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
12	binding	_	VBG	VBG	_	10	vmod	_	_
13	to	_	TO	TO	_	12	prep	_	_
14	15-LO	_	NN	NN	_	16	nn	_	_
15	promoter	_	NN	NN	_	16	nn	_	_
16	DNA	_	NN	NN	_	13	pobj	_	_
17	which	_	WDT	WDT	_	19	nsubj	_	_
18	are	_	VBP	VBP	_	19	cop	_	_
19	distinct	_	JJ	JJ	_	16	rcmod	_	_
20	from	_	IN	IN	_	19	prep	_	_
21	those	_	DT	DT	_	20	pobj	_	_
22	derived	_	VBN	VBN	_	21	vmod	_	_
23	from	_	IN	IN	_	22	prep	_	_
24	IL-13-treated	_	JJ	JJ	_	29	amod	_	_
25	human	_	JJ	JJ	_	29	amod	_	_
26	peripheral	_	JJ	JJ	_	29	amod	_	_
27	monocyte	_	NN	NN	_	29	nn	_	_
28	nuclear	_	JJ	JJ	_	29	amod	_	_
29	extracts	_	NNS	NNS	_	23	pobj	_	_
30	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	12	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	12	punct	_	_
4	fluorescent	_	JJ	JJ	_	7	amod	_	_
5	in	_	FW	FW	_	7	amod	_	_
6	situ	_	FW	FW	_	5	dep	_	_
7	hybridization	_	NN	NN	_	12	nsubj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	FISH	_	NN	NN	_	7	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	results	_	VBZ	VBZ	_	7	dep	_	_
12	refined	_	VBD	VBD	_	0	root	_	_
13	the	_	DT	DT	_	15	det	_	_
14	previous	_	JJ	JJ	_	15	amod	_	_
15	localization	_	NN	NN	_	12	dobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	15-LO	_	NN	NN	_	16	pobj	_	_
18	to	_	TO	TO	_	12	prep	_	_
19	human	_	JJ	JJ	_	21	amod	_	_
20	chromosome	_	NN	NN	_	21	nn	_	_
21	17p13.3	_	NN	NN	_	18	pobj	_	_
22	.	_	.	.	_	12	punct	_	_

1	Lack	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	T-cell-mediated	_	JJ	JJ	_	4	amod	_	_
4	recognition	_	NN	NN	_	2	pobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	fusion	_	NN	NN	_	8	nn	_	_
8	region	_	NN	NN	_	5	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	13	det	_	_
11	pml/RAR-alpha	_	NN	NN	_	13	nn	_	_
12	hybrid	_	NN	NN	_	13	nn	_	_
13	protein	_	NN	NN	_	9	pobj	_	_
14	by	_	IN	IN	_	4	prep	_	_
15	lymphocytes	_	NNS	NNS	_	14	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	acute	_	JJ	JJ	_	20	amod	_	_
18	promyelocytic	_	JJ	JJ	_	20	amod	_	_
19	leukemia	_	NN	NN	_	20	nn	_	_
20	patients	_	NNS	NNS	_	16	pobj	_	_
21	.	_	.	.	_	1	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	previous	_	JJ	JJ	_	3	amod	_	_
3	studies	_	NNS	NNS	_	1	pobj	_	_
4	,	_	,	,	_	7	punct	_	_
5	it	_	PRP	PRP	_	7	nsubjpass	_	_
6	was	_	VBD	VBD	_	7	auxpass	_	_
7	shown	_	VBN	VBN	_	0	root	_	_
8	that	_	IN	IN	_	30	mark	_	_
9	the	_	DT	DT	_	11	det	_	_
10	fusion	_	NN	NN	_	11	nn	_	_
11	region	_	NN	NN	_	30	nsubjpass	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	pml/RAR-alpha	_	NN	NN	_	15	nn	_	_
15	protein	_	NN	NN	_	12	pobj	_	_
16	,	_	,	,	_	11	punct	_	_
17	expressed	_	VBN	VBN	_	11	vmod	_	_
18	by	_	IN	IN	_	17	prep	_	_
19	acute	_	JJ	JJ	_	21	amod	_	_
20	promyelocytic	_	JJ	JJ	_	21	amod	_	_
21	leukemia	_	NN	NN	_	25	nn	_	_
22	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
23	APL	_	NN	NN	_	21	appos	_	_
24	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
25	cells	_	NNS	NNS	_	18	pobj	_	_
26	,	_	,	,	_	11	punct	_	_
27	can	_	MD	MD	_	30	aux	_	_
28	be	_	VB	VB	_	30	auxpass	_	_
29	specifically	_	RB	RB	_	30	advmod	_	_
30	recognized	_	VBN	VBN	_	7	ccomp	_	_
31	in	_	FW	FW	_	32	nn	_	_
32	vitro	_	FW	FW	_	30	advmod	_	_
33	by	_	IN	IN	_	30	prep	_	_
34	donor	_	NN	NN	_	41	nn	_	_
35	-LRB-	_	-LRB-	-LRB-	_	37	punct	_	_
36	D.	_	NNP	NNP	_	37	nn	_	_
37	E.	_	NNP	NNP	_	34	appos	_	_
38	-RRB-	_	-RRB-	-RRB-	_	37	punct	_	_
39	CD4	_	NN	NN	_	41	nn	_	_
40	T	_	NN	NN	_	41	nn	_	_
41	cells	_	NNS	NNS	_	33	pobj	_	_
42	in	_	IN	IN	_	30	prep	_	_
43	a	_	DT	DT	_	48	det	_	_
44	HLA	_	NN	NN	_	47	npadvmod	_	_
45	class	_	NN	NN	_	47	npadvmod	_	_
46	II	_	CD	CD	_	47	number	_	_
47	DR11-restricted	_	JJ	JJ	_	48	amod	_	_
48	fashion	_	NN	NN	_	42	pobj	_	_
49	.	_	.	.	_	7	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	present	_	VBP	VBP	_	0	root	_	_
3	here	_	RB	RB	_	2	advmod	_	_
4	the	_	DT	DT	_	5	det	_	_
5	results	_	NNS	NNS	_	2	dobj	_	_
6	on	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	recognition	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	several	_	JJ	JJ	_	12	amod	_	_
11	pml/RAR-alpha	_	NN	NN	_	12	nn	_	_
12	peptides	_	NNS	NNS	_	9	pobj	_	_
13	by	_	IN	IN	_	8	prep	_	_
14	APL	_	NN	NN	_	15	nn	_	_
15	patients	_	NNS	NNS	_	13	pobj	_	_
16	expressing	_	VBG	VBG	_	15	vmod	_	_
17	HLA	_	NN	NN	_	18	nn	_	_
18	DR11	_	NN	NN	_	16	dobj	_	_
19	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	in	_	FW	FW	_	4	amod	_	_
3	vitro	_	FW	FW	_	2	dep	_	_
4	immunization	_	NN	NN	_	33	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	peripheral	_	JJ	JJ	_	8	amod	_	_
7	blood	_	NN	NN	_	8	nn	_	_
8	lymphocytes	_	NNS	NNS	_	5	pobj	_	_
9	from	_	IN	IN	_	8	prep	_	_
10	four	_	CD	CD	_	11	num	_	_
11	patients	_	NNS	NNS	_	9	pobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	remission	_	NN	NN	_	12	pobj	_	_
14	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
15	S.R.	_	NNP	NNP	_	11	dep	_	_
16	,	_	,	,	_	15	punct	_	_
17	F.R.	_	NNP	NNP	_	15	appos	_	_
18	,	_	,	,	_	15	punct	_	_
19	M.M.	_	NNP	NNP	_	15	appos	_	_
20	,	_	,	,	_	15	punct	_	_
21	P.	_	NNP	NNP	_	22	nn	_	_
22	G.	_	NNP	NNP	_	15	appos	_	_
23	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
24	with	_	IN	IN	_	4	prep	_	_
25	BCR1/25	_	NN	NN	_	24	pobj	_	_
26	,	_	,	,	_	25	punct	_	_
27	a	_	DT	DT	_	29	det	_	_
28	25-mer	_	NN	NN	_	29	nn	_	_
29	pml/RAR-alpha	_	NN	NN	_	25	appos	_	_
30	,	_	,	,	_	25	punct	_	_
31	did	_	VBD	VBD	_	33	aux	_	_
32	not	_	RB	RB	_	33	neg	_	_
33	elicit	_	VB	VB	_	0	root	_	_
34	either	_	CC	CC	_	36	preconj	_	_
35	a	_	DT	DT	_	36	det	_	_
36	polyclonal	_	JJ	JJ	_	33	dobj	_	_
37	or	_	CC	CC	_	36	cc	_	_
38	a	_	DT	DT	_	39	det	_	_
39	clonal	_	JJ	JJ	_	36	conj	_	_
40	immune	_	JJ	JJ	_	41	amod	_	_
41	response	_	NN	NN	_	36	dep	_	_
42	specific	_	JJ	JJ	_	36	amod	_	_
43	to	_	TO	TO	_	42	prep	_	_
44	the	_	DT	DT	_	45	det	_	_
45	peptide	_	NN	NN	_	43	pobj	_	_
46	.	_	.	.	_	33	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	then	_	RB	RB	_	3	advmod	_	_
3	generated	_	VBD	VBD	_	0	root	_	_
4	new	_	JJ	JJ	_	9	amod	_	_
5	donor	_	NN	NN	_	9	nn	_	_
6	anti-pml/RAR-alpha	_	JJ	JJ	_	9	amod	_	_
7	CD4-LRB-+-RRB-	_	JJ	JJ	_	9	amod	_	_
8	T-cell	_	NN	NN	_	9	nn	_	_
9	clones	_	NNS	NNS	_	3	dobj	_	_
10	.	_	.	.	_	3	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	clones	_	NNS	NNS	_	4	nsubjpass	_	_
3	were	_	VBD	VBD	_	4	auxpass	_	_
4	tested	_	VBN	VBN	_	0	root	_	_
5	for	_	IN	IN	_	4	prep	_	_
6	their	_	PRP$	PRP$	_	7	poss	_	_
7	recognition	_	NN	NN	_	5	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	BCR1/25	_	NN	NN	_	8	pobj	_	_
10	.	_	.	.	_	4	punct	_	_

1	One	_	CD	CD	_	2	num	_	_
2	clone	_	NN	NN	_	13	nsubjpass	_	_
3	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
4	C3/5	_	NN	NN	_	2	dep	_	_
5	,	_	,	,	_	4	punct	_	_
6	CD3-LRB-+-RRB-	_	JJ	JJ	_	4	amod	_	_
7	,	_	,	,	_	6	punct	_	_
8	CD4-LRB-+-RRB-	_	JJ	JJ	_	6	dep	_	_
9	,	_	,	,	_	6	punct	_	_
10	CD8-LRB---RRB-	_	JJ	JJ	_	6	dep	_	_
11	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
12	was	_	VBD	VBD	_	13	auxpass	_	_
13	selected	_	VBN	VBN	_	0	root	_	_
14	for	_	IN	IN	_	13	prep	_	_
15	further	_	JJ	JJ	_	16	amod	_	_
16	analysis	_	NN	NN	_	14	pobj	_	_
17	.	_	.	.	_	13	punct	_	_

1	Clone	_	NN	NN	_	2	nn	_	_
2	C3/5	_	NN	NN	_	3	nsubj	_	_
3	showed	_	VBD	VBD	_	0	root	_	_
4	specific	_	JJ	JJ	_	5	amod	_	_
5	proliferation	_	NN	NN	_	3	dobj	_	_
6	,	_	,	,	_	5	punct	_	_
7	cytotoxicity	_	NN	NN	_	5	conj	_	_
8	,	_	,	,	_	5	punct	_	_
9	and	_	CC	CC	_	5	cc	_	_
10	cytokine	_	NN	NN	_	21	nn	_	_
11	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
12	tumor	_	NN	NN	_	15	nn	_	_
13	necrosis	_	NN	NN	_	15	nn	_	_
14	factor	_	NN	NN	_	15	nn	_	_
15	alpha	_	NN	NN	_	19	nn	_	_
16	,	_	,	,	_	15	punct	_	_
17	granulocyte-macrophage	_	JJ	JJ	_	18	amod	_	_
18	colony-stimulating	_	JJ	JJ	_	15	amod	_	_
19	factor	_	NN	NN	_	10	appos	_	_
20	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	production	_	NN	NN	_	5	conj	_	_
22	when	_	WRB	WRB	_	23	advmod	_	_
23	challenged	_	VBN	VBN	_	3	advcl	_	_
24	with	_	IN	IN	_	23	prep	_	_
25	autologous	_	JJ	JJ	_	28	amod	_	_
26	lymphoblastic	_	JJ	JJ	_	28	amod	_	_
27	cell	_	NN	NN	_	28	nn	_	_
28	lines	_	NNS	NNS	_	24	pobj	_	_
29	pulsed	_	VBN	VBN	_	28	vmod	_	_
30	with	_	IN	IN	_	29	prep	_	_
31	peptide	_	NN	NN	_	32	nn	_	_
32	BCR1/25	_	NN	NN	_	30	pobj	_	_
33	.	_	.	.	_	3	punct	_	_

1	C3/5	_	NN	NN	_	2	nn	_	_
2	cells	_	NNS	NNS	_	3	nsubj	_	_
3	developed	_	VBD	VBD	_	0	root	_	_
4	specific	_	JJ	JJ	_	5	amod	_	_
5	proliferation	_	NN	NN	_	3	dobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	cytotoxicity	_	NN	NN	_	5	conj	_	_
8	when	_	WRB	WRB	_	9	advmod	_	_
9	challenged	_	VBN	VBN	_	3	advcl	_	_
10	with	_	IN	IN	_	9	prep	_	_
11	peptide-pulsed	_	JJ	JJ	_	14	amod	_	_
12	lymphoblastic	_	JJ	JJ	_	14	amod	_	_
13	cell	_	NN	NN	_	14	nn	_	_
14	lines	_	NNS	NNS	_	10	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	peripheral	_	JJ	JJ	_	18	amod	_	_
17	blood	_	NN	NN	_	18	nn	_	_
18	lymphocytes	_	NNS	NNS	_	14	conj	_	_
19	from	_	IN	IN	_	14	prep	_	_
20	the	_	DT	DT	_	24	det	_	_
21	four	_	CD	CD	_	24	num	_	_
22	DR11-LRB-+-RRB-	_	JJ	JJ	_	24	amod	_	_
23	APL	_	NN	NN	_	24	nn	_	_
24	patients	_	NNS	NNS	_	19	pobj	_	_
25	.	_	.	.	_	3	punct	_	_

1	APL	_	NN	NN	_	2	nn	_	_
2	blasts	_	NNS	NNS	_	14	nsubjpass	_	_
3	,	_	,	,	_	2	punct	_	_
4	available	_	JJ	JJ	_	2	amod	_	_
5	only	_	RB	RB	_	6	advmod	_	_
6	from	_	IN	IN	_	4	prep	_	_
7	patients	_	NNS	NNS	_	6	pobj	_	_
8	F.R.	_	NNP	NNP	_	7	dep	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	P.G.	_	NNP	NNP	_	8	conj	_	_
11	,	_	,	,	_	2	punct	_	_
12	were	_	VBD	VBD	_	14	auxpass	_	_
13	not	_	RB	RB	_	14	neg	_	_
14	lysed	_	VBN	VBN	_	0	root	_	_
15	by	_	IN	IN	_	14	prep	_	_
16	C3/5	_	NN	NN	_	15	pobj	_	_
17	and	_	CC	CC	_	14	cc	_	_
18	were	_	VBD	VBD	_	19	cop	_	_
19	unable	_	JJ	JJ	_	14	conj	_	_
20	to	_	TO	TO	_	21	aux	_	_
21	present	_	VB	VB	_	19	xcomp	_	_
22	peptide	_	NN	NN	_	23	nn	_	_
23	BCR1/25	_	NN	NN	_	21	dobj	_	_
24	.	_	.	.	_	14	punct	_	_

1	Incubation	_	NN	NN	_	7	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	APL	_	NN	NN	_	4	nn	_	_
4	cells	_	NNS	NNS	_	2	pobj	_	_
5	with	_	IN	IN	_	1	prep	_	_
6	IFN-gamma	_	NN	NN	_	5	pobj	_	_
7	failed	_	VBD	VBD	_	0	root	_	_
8	to	_	TO	TO	_	9	aux	_	_
9	induce	_	VB	VB	_	7	xcomp	_	_
10	HLA	_	NN	NN	_	13	nn	_	_
11	class	_	NN	NN	_	13	nn	_	_
12	II	_	CD	CD	_	13	num	_	_
13	molecules	_	NNS	NNS	_	9	dobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	recognition	_	NN	NN	_	13	conj	_	_
16	by	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	C3/5	_	NN	NN	_	19	nn	_	_
19	clone	_	NN	NN	_	16	pobj	_	_
20	.	_	.	.	_	7	punct	_	_

1	Since	_	IN	IN	_	6	mark	_	_
2	APL	_	NN	NN	_	3	nn	_	_
3	cells	_	NNS	NNS	_	6	nsubj	_	_
4	do	_	VBP	VBP	_	6	aux	_	_
5	not	_	RB	RB	_	6	neg	_	_
6	express	_	VB	VB	_	13	advcl	_	_
7	HLA	_	NN	NN	_	10	nn	_	_
8	class	_	NN	NN	_	10	nn	_	_
9	II	_	CD	CD	_	10	num	_	_
10	molecules	_	NNS	NNS	_	6	dobj	_	_
11	,	_	,	,	_	13	punct	_	_
12	we	_	PRP	PRP	_	13	nsubj	_	_
13	tested	_	VBD	VBD	_	0	root	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	two	_	CD	CD	_	16	num	_	_
16	donors	_	NNS	NNS	_	14	pobj	_	_
17	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	D.E.	_	NNP	NNP	_	16	dep	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	C.H.R.	_	NNP	NNP	_	18	conj	_	_
21	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
22	and	_	CC	CC	_	14	cc	_	_
23	in	_	IN	IN	_	14	conj	_	_
24	patients	_	NNS	NNS	_	23	pobj	_	_
25	S.R.	_	NN	NN	_	24	dep	_	_
26	and	_	CC	CC	_	25	cc	_	_
27	P.G.	_	NN	NN	_	25	conj	_	_
28	whether	_	CC	CC	_	38	cc	_	_
29	the	_	DT	DT	_	30	det	_	_
30	use	_	NN	NN	_	38	nsubj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	9-mer	_	NN	NN	_	33	nn	_	_
33	peptides	_	NNS	NNS	_	31	pobj	_	_
34	-LRB-	_	-LRB-	-LRB-	_	35	punct	_	_
35	BCR1/9	_	NN	NN	_	33	appos	_	_
36	-RRB-	_	-RRB-	-RRB-	_	35	punct	_	_
37	would	_	MD	MD	_	38	aux	_	_
38	generate	_	VB	VB	_	13	ccomp	_	_
39	a	_	DT	DT	_	43	det	_	_
40	CD8/HLA	_	NN	NN	_	42	npadvmod	_	_
41	class	_	NN	NN	_	42	npadvmod	_	_
42	I-restricted	_	JJ	JJ	_	43	amod	_	_
43	response	_	NN	NN	_	38	dobj	_	_
44	.	_	.	.	_	13	punct	_	_

1	No	_	DT	DT	_	3	neg	_	_
2	peptide-specific	_	JJ	JJ	_	3	amod	_	_
3	T-cell	_	NN	NN	_	9	nsubjpass	_	_
4	line	_	NN	NN	_	3	dep	_	_
5	or	_	CC	CC	_	4	cc	_	_
6	clone	_	NN	NN	_	4	conj	_	_
7	could	_	MD	MD	_	9	aux	_	_
8	be	_	VB	VB	_	9	auxpass	_	_
9	generated	_	VBN	VBN	_	0	root	_	_
10	from	_	IN	IN	_	9	prep	_	_
11	both	_	CC	CC	_	12	preconj	_	_
12	donors	_	NNS	NNS	_	10	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	patients	_	NNS	NNS	_	12	conj	_	_
15	.	_	.	.	_	9	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	findings	_	NNS	NNS	_	4	nsubjpass	_	_
3	are	_	VBP	VBP	_	4	auxpass	_	_
4	discussed	_	VBN	VBN	_	0	root	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	relation	_	NN	NN	_	5	dep	_	_
7	to	_	TO	TO	_	5	dep	_	_
8	possible	_	JJ	JJ	_	10	amod	_	_
9	therapeutic	_	JJ	JJ	_	10	amod	_	_
10	approaches	_	NNS	NNS	_	5	pobj	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	immunotherapy	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	APL	_	NN	NN	_	14	pobj	_	_
16	.	_	.	.	_	4	punct	_	_

